Citrus Sinensis ID: 024828

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260--
Protein Sequence
MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Secondary Structure (PSIPRED)
cEEEccccHHHHHHHHHHHHHHHcccccccEEEcEEEEEccEEEEEEEccccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEcccccHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccccccccHHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHHHcccccccHHHHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEcHHHHHHHHHHHHHHHHcccccEEEEEEEEccccccEEEEEcccccEHHHHccHcccccHHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccEEcccccccEccccccHHHccHHHHHcccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHcccHHHcccHHHHHccccHccccHHHHHHcccccccccccccccccccc
Coil and Loop (DISEMBL)
MVIQMNVEESARRQIAQELKinqssqcpyvVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYlhhekhiihrdlkpsnllinhrgevkitdfGVSAIMAstsgqantfvgtynymsperisggkygyksDIWSLGLVLLEcatgqfpysppeqqdgWTSFYELMEAivdqpppsapsdqfspeFCSFISACvqkepqqrlsaqelmthpflkmygdlnvdlseyftdagsplatlsnlsgf
Flexible Loop (DISEMBL)
mviqmnveESARRQIAQELkinqssqcPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIhrdlkpsnllINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAgsplatlsnlsgf
Low Complexity Region (SEG)
MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Disordered region (IsUnstruct)
***********************SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV**************EFCSFISACVQ*********QELMTHPFLKMYGDLNVDLSEYFTDA*************
Disordered Region (DISOPRED)
MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP*****QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL******
Disordered Region (DISEMBL)
MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Disordered Region (DISPRO)
MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLAT*******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	262	2.2.26 [Sep-21-2011]
Q9S7U9	363	Mitogen-activated protein	yes	no	0.992	0.716	0.742	1e-117
Q94A06	354	Mitogen-activated protein	no	no	0.980	0.725	0.708	1e-109
Q5QN75	355	Mitogen-activated protein	no	no	0.912	0.673	0.695	1e-104
Q9FJV0	356	Mitogen-activated protein	no	no	0.919	0.676	0.677	3e-99
Q63932	401	Dual specificity mitogen-	yes	no	0.927	0.605	0.385	2e-55
Q02750	393	Dual specificity mitogen-	yes	no	0.927	0.618	0.396	2e-55
P29678	393	Dual specificity mitogen-	yes	no	0.927	0.618	0.396	3e-55
P31938	393	Dual specificity mitogen-	no	no	0.927	0.618	0.396	3e-55
Q01986	393	Dual specificity mitogen-	yes	no	0.927	0.618	0.396	3e-55
P36506	400	Dual specificity mitogen-	no	no	0.927	0.607	0.383	5e-55

>sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2

 Score =  420 bits (1080), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 193/260 (74%), Positives = 222/260 (85%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQ+N++E+ R+ IAQELKINQSSQCP +V  YQSFY NGAIS+ILEYMDGGSLADFLK 
Sbjct: 100 VIQLNIDEAIRKAIAQELKINQSSQCPNLVTSYQSFYDNGAISLILEYMDGGSLADFLKS 159

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VK IP+ YL+AI  QVL+GL+YLHH++HIIHRDLKPSNLLINHRGEVKITDFGVS +M +
Sbjct: 160 VKAIPDSYLSAIFRQVLQGLIYLHHDRHIIHRDLKPSNLLINHRGEVKITDFGVSTVMTN 219

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           T+G ANTFVGTYNYMSPERI G KYG KSDIWSLGLV+LECATG+FPY+PP Q++ WTS 
Sbjct: 220 TAGLANTFVGTYNYMSPERIVGNKYGNKSDIWSLGLVVLECATGKFPYAPPNQEETWTSV 279

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +ELMEAIVDQPPP+ PS  FSPE  SFIS C+QK+P  R SA+ELM HPFL  Y    ++
Sbjct: 280 FELMEAIVDQPPPALPSGNFSPELSSFISTCLQKDPNSRSSAKELMEHPFLNKYDYSGIN 339

Query: 242 LSEYFTDAGSPLATLSNLSG 261
           L+ YFTDAGSPLATL NLSG
Sbjct: 340 LASYFTDAGSPLATLGNLSG 359

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2

 Score =  393 bits (1009), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 182/257 (70%), Positives = 215/257 (83%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQ+N EES  R I+QEL+IN SSQCPY+V CYQSFY NG +SIILE+MDGGSLAD LKK
Sbjct: 98  VIQLNTEESTCRAISQELRINLSSQCPYLVSCYQSFYHNGLVSIILEFMDGGSLADLLKK 157

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           V  +PE  L+AIC++VL+GL Y+HHE+ IIHRDLKPSNLLINHRGEVKITDFGVS I+ S
Sbjct: 158 VGKVPENMLSAICKRVLRGLCYIHHERRIIHRDLKPSNLLINHRGEVKITDFGVSKILTS 217

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           TS  AN+FVGTY YMSPERISG  Y  KSDIWSLGLVLLECATG+FPY+PPE + GW+S 
Sbjct: 218 TSSLANSFVGTYPYMSPERISGSLYSNKSDIWSLGLVLLECATGKFPYTPPEHKKGWSSV 277

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           YEL++AIV+ PPP APS+ FSPEFCSFIS CVQK+P+ R SA+EL+ H F+KM+ D + +
Sbjct: 278 YELVDAIVENPPPCAPSNLFSPEFCSFISQCVQKDPRDRKSAKELLEHKFVKMFEDSDTN 337

Query: 242 LSEYFTDAGSPLATLSN 258
           LS YFTDAGS +  L+N
Sbjct: 338 LSAYFTDAGSLIPPLAN 354

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1

 Score =  377 bits (969), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 167/240 (69%), Positives = 210/240 (87%), Gaps = 1/240 (0%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           IQMN++E+ R+QI QELKINQ++Q  ++V+C+QSFY NG I ++LEYMD GSLAD +K+V
Sbjct: 102 IQMNIQEAVRKQIVQELKINQATQNAHIVLCHQSFYHNGVIYLVLEYMDRGSLADIIKQV 161

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           KTI E YLA +C+QVL+GLLYLHHE+H+IHRD+KPSNLL+N +GEVKITDFGVSA++AS+
Sbjct: 162 KTILEPYLAVLCKQVLEGLLYLHHERHVIHRDIKPSNLLVNRKGEVKITDFGVSAVLASS 221

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
            GQ +TFVGTYNYM+PERISG  Y YKSDIWSLGLV+LECA G+FPY P E + GW SFY
Sbjct: 222 MGQRDTFVGTYNYMAPERISGSSYDYKSDIWSLGLVILECAIGRFPYIPSEGE-GWLSFY 280

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 242
           EL+EAIVDQPPPSAP+DQFSPEFC+FIS+C+QK+P +R+SA EL+ HPF+K + D ++DL
Sbjct: 281 ELLEAIVDQPPPSAPADQFSPEFCAFISSCIQKDPAERMSASELLNHPFIKKFEDKDLDL 340

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1

 Score =  361 bits (927), Expect = 3e-99,   Method: Compositional matrix adjust.
 Identities = 164/242 (67%), Positives = 203/242 (83%), Gaps = 1/242 (0%)

Query: 2   VIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           VIQMN++E  R+QI QELKINQ SSQCP+VVVCY SFY NGA S++LEYMD GSLAD ++
Sbjct: 100 VIQMNIQEEIRKQIVQELKINQASSQCPHVVVCYHSFYHNGAFSLVLEYMDRGSLADVIR 159

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           +VKTI E YLA +C+QVL GL+YLH+E+H+IHRD+KPSNLL+NH+GEVKI+DFGVSA +A
Sbjct: 160 QVKTILEPYLAVVCKQVLLGLVYLHNERHVIHRDIKPSNLLVNHKGEVKISDFGVSASLA 219

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
           S+ GQ +TFVGTYNYMSPERISG  Y Y SDIWSLG+ +LECA G+FPY   E Q    S
Sbjct: 220 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGMSVLECAIGRFPYLESEDQQNPPS 279

Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 240
           FYEL+ AIV+ PPP+APSDQFSPEFCSF+SAC+QK+P  R S+ +L++HPF+K + D ++
Sbjct: 280 FYELLAAIVENPPPTAPSDQFSPEFCSFVSACIQKDPPARASSLDLLSHPFIKKFEDKDI 339

Query: 241 DL 242
           DL
Sbjct: 340 DL 341

Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q63932|MP2K2_MOUSE Dual specificity mitogen-activated protein kinase kinase 2 OS=Mus musculus GN=Map2k2 PE=1 SV=2

 Score =  215 bits (548), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 110/285 (38%), Positives = 161/285 (56%), Gaps = 42/285 (14%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LK+
Sbjct: 102 LIHLEIKPAVRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE 161

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
            K IPE+ L  +   VL+GL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 162 AKRIPEDILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 221

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++   SF
Sbjct: 222 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEASF 279

Query: 182 ----------------------------------------YELMEAIVDQPPPSAPSDQF 201
                                                   +EL++ IV++PPP  PS  F
Sbjct: 280 GRPVVDGADGEPHSVSPRPRPPGRPISVGHGMDSRPAMAIFELLDYIVNEPPPKLPSGVF 339

Query: 202 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
           S +F  F++ C+ K P +R   + LM H F+K      VD + + 
Sbjct: 340 SSDFQEFVNKCLIKNPAERADLKLLMNHAFIKRSEGEEVDFAGWL 384

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q02750|MP2K1_HUMAN Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens GN=MAP2K1 PE=1 SV=2

 Score =  215 bits (548), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 98  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 158 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 217

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 218 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 275

Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 276 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 335

Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 336 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P29678|MP2K1_RABIT Dual specificity mitogen-activated protein kinase kinase 1 OS=Oryctolagus cuniculus GN=MAP2K1 PE=1 SV=2

 Score =  215 bits (547), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 98  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 158 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 217

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 218 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 275

Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 276 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQ 335

Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 336 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P31938|MP2K1_MOUSE Dual specificity mitogen-activated protein kinase kinase 1 OS=Mus musculus GN=Map2k1 PE=1 SV=2

 Score =  215 bits (547), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 98  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 158 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 217

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 218 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLF 275

Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 276 GCHVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 335

Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 336 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q01986|MP2K1_RAT Dual specificity mitogen-activated protein kinase kinase 1 OS=Rattus norvegicus GN=Map2k1 PE=1 SV=2

 Score =  215 bits (547), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 98  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 158 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 217

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 218 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLF 275

Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 276 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 335

Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 336 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P36506|MP2K2_RAT Dual specificity mitogen-activated protein kinase kinase 2 OS=Rattus norvegicus GN=Map2k2 PE=2 SV=1

 Score =  214 bits (545), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 109/284 (38%), Positives = 161/284 (56%), Gaps = 41/284 (14%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LK+
Sbjct: 102 LIHLEIKPAVRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE 161

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
            K IPE+ L  +   VL+GL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 162 AKRIPEDILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 221

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++   SF
Sbjct: 222 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEASF 279

Query: 182 ---------------------------------------YELMEAIVDQPPPSAPSDQFS 202
                                                  +EL++ IV++PPP  PS  FS
Sbjct: 280 GRPVVDGADGEPHSVSPRPRPPGRPISGHGMDSRPAMAIFELLDYIVNEPPPKLPSGVFS 339

Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            +F  F++ C+ K P +R   + L  H F+K     +VD + + 
Sbjct: 340 SDFQEFVNKCLIKNPAERADLKLLTNHAFIKRSEGEDVDFAGWL 383

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	262
224142910	364	predicted protein [Populus trichocarpa]	0.973	0.700	0.854	1e-129
225444840	354	PREDICTED: mitogen-activated protein kin	0.973	0.720	0.847	1e-127
267881840	354	mitogen-activated protein kinase kinase	0.973	0.720	0.815	1e-123
51471926	357	MAPKK [Solanum lycopersicum]	0.984	0.722	0.794	1e-123
350536161	357	MAP kinase kinase [Solanum lycopersicum]	0.984	0.722	0.794	1e-122
224087969	355	predicted protein [Populus trichocarpa]	0.969	0.715	0.839	1e-122
356547903	356	PREDICTED: mitogen-activated protein kin	0.973	0.716	0.805	1e-122
7682432	357	MAP kinase kinase [Nicotiana tabacum]	0.980	0.719	0.805	1e-122
42601214	354	mitogen-activated protein kinase kinase	0.973	0.720	0.815	1e-122
15528441	356	MAP kinase kinase [Medicago sativa subsp	0.973	0.716	0.789	1e-121

>gi|224142910|ref|XP_002324775.1| predicted protein [Populus trichocarpa] gi|222866209|gb|EEF03340.1| predicted protein [Populus trichocarpa]

 Score =  466 bits (1198), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 218/255 (85%), Positives = 235/255 (92%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQMN+EE AR+ IAQELKINQSSQCPYVV+ YQSFY NGAISIILEYMDGGSLADFLK 
Sbjct: 102 VIQMNIEEPARKAIAQELKINQSSQCPYVVMSYQSFYDNGAISIILEYMDGGSLADFLKS 161

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VKTIPE YLAAIC+QVLKGLLYLHHEKHIIHRDLKPSNLL+NHRGEVKITDFGVSAIM S
Sbjct: 162 VKTIPEPYLAAICKQVLKGLLYLHHEKHIIHRDLKPSNLLVNHRGEVKITDFGVSAIMQS 221

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           TSGQAN+FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP+SPPE  +GWT+ 
Sbjct: 222 TSGQANSFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPFSPPELDEGWTNV 281

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           YELMEAIVD PPPSA SD FSPEFCSFISACVQK+P+ R +A ELM HPF+ +Y DL+VD
Sbjct: 282 YELMEAIVDHPPPSASSDHFSPEFCSFISACVQKDPKDRQAAHELMAHPFMNLYEDLHVD 341

Query: 242 LSEYFTDAGSPLATL 256
           L+ YFT+AGSPLATL
Sbjct: 342 LATYFTNAGSPLATL 356

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225444840|ref|XP_002280877.1| PREDICTED: mitogen-activated protein kinase kinase 2 [Vitis vinifera] gi|37625027|gb|AAQ96337.1| putative mitogen-activated protein kinase kinase [Vitis aestivalis] gi|297738625|emb|CBI27870.3| unnamed protein product [Vitis vinifera]

 Score =  461 bits (1187), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 216/255 (84%), Positives = 232/255 (90%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQMN++E+A + IAQELKINQSSQCPYVVVCY+SFY NGA SIILEYMDGGSL DFLKK
Sbjct: 100 VIQMNIQEAALKHIAQELKINQSSQCPYVVVCYKSFYDNGAFSIILEYMDGGSLLDFLKK 159

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VK+IPE YLAAIC QVLKGL YLHHE+HIIHRDLKPSNLLINHRGEVKITDFGVSAI+ S
Sbjct: 160 VKSIPEPYLAAICNQVLKGLSYLHHERHIIHRDLKPSNLLINHRGEVKITDFGVSAILTS 219

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           TSGQANTFVGTYNYMSPERISGGKYG KSDIWSLGLVLLECATGQFPYSPPEQ +GWTSF
Sbjct: 220 TSGQANTFVGTYNYMSPERISGGKYGSKSDIWSLGLVLLECATGQFPYSPPEQGEGWTSF 279

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           YELMEAIVDQPPP A ++QFS EFCSFISAC+QK+P  R SA ELM HPF+ MY DLNVD
Sbjct: 280 YELMEAIVDQPPPCASTNQFSAEFCSFISACIQKDPNDRKSAHELMAHPFISMYRDLNVD 339

Query: 242 LSEYFTDAGSPLATL 256
           L+ YFT+AGSPLAT 
Sbjct: 340 LATYFTNAGSPLATF 354

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|267881840|gb|ACY82515.1| mitogen-activated protein kinase kinase [Malus x domestica]

 Score =  447 bits (1150), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 208/255 (81%), Positives = 230/255 (90%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQMN+EES R+QIAQELKI+QSSQCP +VVCYQSFY NGAISIILEYMDGGSLAD LKK
Sbjct: 100 VIQMNIEESIRKQIAQELKIDQSSQCPNIVVCYQSFYENGAISIILEYMDGGSLADLLKK 159

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VKTIPE YLAAIC+QVL+GL YLHHEKHIIHRD KPSNLLINHRGE+KITDFGVSAI AS
Sbjct: 160 VKTIPEFYLAAICKQVLQGLCYLHHEKHIIHRDFKPSNLLINHRGEIKITDFGVSAIKAS 219

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           TS QANTFVGTYNYMSPERI G  Y YKSDIWSLGLVLLECATGQFPY+PP+Q + W +F
Sbjct: 220 TSEQANTFVGTYNYMSPERIVGSNYSYKSDIWSLGLVLLECATGQFPYTPPDQSEAWDNF 279

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +ELM AIV+QPP  APSDQFSPEFCSFISACVQK+P+ RLSAQ+L+ HPF+ MY D+++D
Sbjct: 280 FELMSAIVEQPPSCAPSDQFSPEFCSFISACVQKDPKDRLSAQDLLRHPFISMYDDVHID 339

Query: 242 LSEYFTDAGSPLATL 256
           LS YFT+AGSPLAT 
Sbjct: 340 LSPYFTEAGSPLATF 354

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|51471926|gb|AAU04433.1| MAPKK [Solanum lycopersicum]

 Score =  445 bits (1144), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 205/258 (79%), Positives = 228/258 (88%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQMN++ES R+ IAQEL+INQSSQCPYVV+CYQSF+ NGAIS+ILEYMDGGSLADFLKK
Sbjct: 100 VIQMNIDESMRKHIAQELRINQSSQCPYVVICYQSFFDNGAISLILEYMDGGSLADFLKK 159

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VKTIPE +LA IC+QVLKGL YLHHEKHIIHRDLKPSNLLINHRG+VKITDFGVSA++AS
Sbjct: 160 VKTIPERFLAVICKQVLKGLWYLHHEKHIIHRDLKPSNLLINHRGDVKITDFGVSAVLAS 219

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           TSG ANTFVGTYNYMSPERISGG Y YKSDIWSLGLVLLECATG FPY+PPE  +GW + 
Sbjct: 220 TSGLANTFVGTYNYMSPERISGGAYDYKSDIWSLGLVLLECATGHFPYNPPEGDEGWVNV 279

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           YELME IVDQP P AP DQFSP+FCSFISACVQK  + RLSA +LM+HPF+ MY D ++D
Sbjct: 280 YELMETIVDQPEPCAPPDQFSPQFCSFISACVQKHQKDRLSANDLMSHPFITMYDDQDID 339

Query: 242 LSEYFTDAGSPLATLSNL 259
           L  YFT AG PLATL+ L
Sbjct: 340 LGSYFTSAGPPLATLTEL 357

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350536161|ref|NP_001234744.1| MAP kinase kinase [Solanum lycopersicum] gi|9843771|emb|CAA04261.2| MAP kinase kinase [Solanum lycopersicum]

 Score =  445 bits (1144), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 205/258 (79%), Positives = 227/258 (87%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQMN++ES R+ IAQEL+INQSSQCPYVV+CYQSF+ NGAIS+ILEYMDGGSLADFLKK
Sbjct: 100 VIQMNIDESMRKHIAQELRINQSSQCPYVVICYQSFFDNGAISLILEYMDGGSLADFLKK 159

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VKTIPE +LA IC+QVLKGL YLHHEKHIIHRDLKPSNLLINHRG+VKITDFGVSA++AS
Sbjct: 160 VKTIPERFLAVICKQVLKGLWYLHHEKHIIHRDLKPSNLLINHRGDVKITDFGVSAVLAS 219

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           TSG ANTFVGTYNYMSPERISGG Y YKSDIWSLGLVLLECATG FPY PPE  +GW + 
Sbjct: 220 TSGLANTFVGTYNYMSPERISGGAYDYKSDIWSLGLVLLECATGHFPYKPPEGDEGWVNV 279

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           YELME IVDQP P AP DQFSP+FCSFISACVQK  + RLSA +LM+HPF+ MY D ++D
Sbjct: 280 YELMETIVDQPEPCAPPDQFSPQFCSFISACVQKHQKDRLSANDLMSHPFITMYDDQDID 339

Query: 242 LSEYFTDAGSPLATLSNL 259
           L  YFT AG PLATL+ L
Sbjct: 340 LGSYFTSAGPPLATLTEL 357

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087969|ref|XP_002308276.1| predicted protein [Populus trichocarpa] gi|222854252|gb|EEE91799.1| predicted protein [Populus trichocarpa]

 Score =  444 bits (1143), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 214/255 (83%), Positives = 228/255 (89%), Gaps = 1/255 (0%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQMN+EESAR+ I QELKINQSSQCPYVV+CYQSFY NGAISIILEYMDGGSLADFLK 
Sbjct: 102 VIQMNIEESARKAITQELKINQSSQCPYVVMCYQSFYDNGAISIILEYMDGGSLADFLKS 161

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VK I E YLAAI +QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM S
Sbjct: 162 VKKISEPYLAAIFKQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMQS 221

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           TSGQANTFVGTYNYMSPERISGG+Y YKSDIWSLGLVLLECATG+F  +PP   +GWT+ 
Sbjct: 222 TSGQANTFVGTYNYMSPERISGGRYDYKSDIWSLGLVLLECATGEFSITPPVPNEGWTNV 281

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           YELM AIVDQPPPSAP DQFSPEFCSFISACVQK+P+ R SA ELM HPF+ MY D +VD
Sbjct: 282 YELMVAIVDQPPPSAPPDQFSPEFCSFISACVQKDPKDRQSAHELMEHPFMNMYEDQHVD 341

Query: 242 LSEYFTDAGSPLATL 256
           LS YFT+AGS LATL
Sbjct: 342 LSSYFTNAGS-LATL 355

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356547903|ref|XP_003542344.1| PREDICTED: mitogen-activated protein kinase kinase 2-like [Glycine max]

 Score =  444 bits (1141), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 207/257 (80%), Positives = 231/257 (89%), Gaps = 2/257 (0%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQMN+EES R+QIAQELKINQ +QCPYVVVCYQSFY NG ISIILEYMDGGSLAD LKK
Sbjct: 100 VIQMNIEESMRKQIAQELKINQQAQCPYVVVCYQSFYENGVISIILEYMDGGSLADLLKK 159

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VKTIPE+YLAAIC+QVLKGL+YLHHEKHIIHRDLKPSNLLINH GEVKITDFGVSAIM S
Sbjct: 160 VKTIPEDYLAAICKQVLKGLVYLHHEKHIIHRDLKPSNLLINHIGEVKITDFGVSAIMES 219

Query: 122 TSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
           TSGQANTF+GTYNYMSPERI+G +  Y YKSDIWSLGL+LLECA G+FPY+PP+Q + W 
Sbjct: 220 TSGQANTFIGTYNYMSPERINGSQRGYNYKSDIWSLGLILLECALGRFPYAPPDQSETWE 279

Query: 180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
           S +EL+E IVD+PPP  PS+QFS EFCSFISAC+QK+P+ RLSAQELM HPF+ MY DL 
Sbjct: 280 SIFELIETIVDKPPPIPPSEQFSTEFCSFISACLQKDPKDRLSAQELMAHPFVNMYDDLE 339

Query: 240 VDLSEYFTDAGSPLATL 256
           VDLS YF++AGSPLATL
Sbjct: 340 VDLSAYFSNAGSPLATL 356

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7682432|gb|AAF67262.1|AF165186_1 MAP kinase kinase [Nicotiana tabacum]

 Score =  444 bits (1141), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 207/257 (80%), Positives = 227/257 (88%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           IQMN+EES R+ IAQEL+INQSSQ PYVV+ YQSF+ NGAISIILEYMDGGSLADFLKKV
Sbjct: 101 IQMNIEESMRKHIAQELRINQSSQVPYVVISYQSFFDNGAISIILEYMDGGSLADFLKKV 160

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           KTIPE YLAAIC+QVLKGL YLHHEKHIIHRDLKPSNLLINH G+VKITDFGVSA++AST
Sbjct: 161 KTIPERYLAAICKQVLKGLWYLHHEKHIIHRDLKPSNLLINHIGDVKITDFGVSAVLAST 220

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
           SG ANTFVGTYNYMSPERI GG YGY+SDIWSLGLVLLECATG FPYSPP+  +GW + Y
Sbjct: 221 SGLANTFVGTYNYMSPERILGGAYGYRSDIWSLGLVLLECATGVFPYSPPQADEGWVNVY 280

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 242
           ELME IVDQP PSAP DQFSP+FCSFISACVQK+ + RLSA ELM HPF+ MY DL++DL
Sbjct: 281 ELMETIVDQPAPSAPPDQFSPQFCSFISACVQKDQKDRLSANELMRHPFITMYDDLDIDL 340

Query: 243 SEYFTDAGSPLATLSNL 259
             YFT AG PLATL+ L
Sbjct: 341 GSYFTSAGPPLATLTEL 357

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42601214|gb|AAS21304.1| mitogen-activated protein kinase kinase 2 [Petroselinum crispum]

 Score =  443 bits (1139), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 208/255 (81%), Positives = 232/255 (90%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VIQMN++ESAR+QIAQELKINQSSQC  VVVCYQSFY NGAISIILEYMDGGSLADFLK 
Sbjct: 100 VIQMNIQESARKQIAQELKINQSSQCLNVVVCYQSFYDNGAISIILEYMDGGSLADFLKI 159

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VK IPE YLAAI +QVLKGL YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI+A+
Sbjct: 160 VKNIPEPYLAAIFKQVLKGLWYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAILAT 219

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           TSGQANTFVGTYNYMSPERISGG++GY SDIWSLGLVLLECATG FPYSPPEQ +GW++ 
Sbjct: 220 TSGQANTFVGTYNYMSPERISGGQHGYSSDIWSLGLVLLECATGYFPYSPPEQDEGWSNV 279

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +ELM+ IV+Q PP AP D+FSPEFCSF+SACVQK+P++R SA EL+ HPF+ MY  LN+D
Sbjct: 280 FELMDTIVNQAPPCAPPDEFSPEFCSFVSACVQKDPRKRPSANELLRHPFINMYEHLNID 339

Query: 242 LSEYFTDAGSPLATL 256
           L+ YFT+AGSPLATL
Sbjct: 340 LAGYFTEAGSPLATL 354

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15528441|emb|CAC69138.1| MAP kinase kinase [Medicago sativa subsp. x varia]

 Score =  440 bits (1131), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 203/257 (78%), Positives = 232/257 (90%), Gaps = 2/257 (0%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +IQMN+EES R++IA+ELKINQ++QCPYVVVCYQSFY NG ISIILEYMDGGS+AD LKK
Sbjct: 100 IIQMNIEESVRKRIAKELKINQAAQCPYVVVCYQSFYDNGVISIILEYMDGGSMADLLKK 159

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           VKTIPE YL+AIC+QVLKGL+YLHHE+HIIHRDLKPSNLLINH GEVKITDFGVSAIM S
Sbjct: 160 VKTIPEPYLSAICKQVLKGLIYLHHERHIIHRDLKPSNLLINHTGEVKITDFGVSAIMES 219

Query: 122 TSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
           TSGQANTF+GTYNYMSPERI+G +  Y YKSDIWSLGL+LLECA G+FPY+PP+Q + W 
Sbjct: 220 TSGQANTFIGTYNYMSPERINGSQRGYNYKSDIWSLGLILLECAMGRFPYTPPDQSERWE 279

Query: 180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
           S +EL+E IVD+PPPSAPS+QFS EFCSFISAC+QK+P  RLSAQELM  PF+ MY DL+
Sbjct: 280 SIFELIETIVDKPPPSAPSEQFSSEFCSFISACLQKDPGSRLSAQELMELPFISMYDDLH 339

Query: 240 VDLSEYFTDAGSPLATL 256
           VDLS YF+DAGSPLATL
Sbjct: 340 VDLSAYFSDAGSPLATL 356

Source: Medicago sativa subsp. x varia

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	262
TAIR|locus:2120855	354	MEK1 "MAP kinase/ ERK kinase 1	0.980	0.725	0.708	2.2e-98
TAIR|locus:2164981	356	MKK6 "MAP kinase kinase 6" [Ar	0.919	0.676	0.677	5.7e-91
DICTYBASE|DDB_G0269152	660	mekA "MAP kinase kinase (MAP2K	0.664	0.263	0.539	6.9e-61
TAIR|locus:2170578	520	MKK3 "AT5G40440" [Arabidopsis	0.958	0.482	0.463	8.4e-58
UNIPROTKB|F1PJI7	380	MAP2K1 "Uncharacterized protei	0.725	0.5	0.474	1.6e-55
UNIPROTKB|J9P5W6	393	MAP2K1 "Uncharacterized protei	0.725	0.483	0.474	1.6e-55
UNIPROTKB|Q0VD16	393	MAP2K1 "MAP2K1 protein" [Bos t	0.725	0.483	0.469	5.4e-55
UNIPROTKB|Q02750	393	MAP2K1 "Dual specificity mitog	0.725	0.483	0.469	5.4e-55
RGD|70495	393	Map2k1 "mitogen activated prot	0.725	0.483	0.469	6.9e-55
MGI|MGI:1346866	393	Map2k1 "mitogen-activated prot	0.725	0.483	0.469	8.8e-55

TAIR|locus:2120855 MEK1 "MAP kinase/ ERK kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 977 (349.0 bits), Expect = 2.2e-98, P = 2.2e-98
 Identities = 182/257 (70%), Positives = 215/257 (83%)

Query:     2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             VIQ+N EES  R I+QEL+IN SSQCPY+V CYQSFY NG +SIILE+MDGGSLAD LKK
Sbjct:    98 VIQLNTEESTCRAISQELRINLSSQCPYLVSCYQSFYHNGLVSIILEFMDGGSLADLLKK 157

Query:    62 VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
             V  +PE  L+AIC++VL+GL Y+HHE+ IIHRDLKPSNLLINHRGEVKITDFGVS I+ S
Sbjct:   158 VGKVPENMLSAICKRVLRGLCYIHHERRIIHRDLKPSNLLINHRGEVKITDFGVSKILTS 217

Query:   122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
             TS  AN+FVGTY YMSPERISG  Y  KSDIWSLGLVLLECATG+FPY+PPE + GW+S 
Sbjct:   218 TSSLANSFVGTYPYMSPERISGSLYSNKSDIWSLGLVLLECATGKFPYTPPEHKKGWSSV 277

Query:   182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
             YEL++AIV+ PPP APS+ FSPEFCSFIS CVQK+P+ R SA+EL+ H F+KM+ D + +
Sbjct:   278 YELVDAIVENPPPCAPSNLFSPEFCSFISQCVQKDPRDRKSAKELLEHKFVKMFEDSDTN 337

Query:   242 LSEYFTDAGSPLATLSN 258
             LS YFTDAGS +  L+N
Sbjct:   338 LSAYFTDAGSLIPPLAN 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0042542 "response to hydrogen peroxide" evidence=IEP;IDA

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA;IDA

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009814 "defense response, incompatible interaction" evidence=IGI;RCA

GO:0000023 "maltose metabolic process" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0019252 "starch biosynthetic process" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0009611 "response to wounding" evidence=IEP

TAIR|locus:2164981 MKK6 "MAP kinase kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 907 (324.3 bits), Expect = 5.7e-91, P = 5.7e-91
 Identities = 164/242 (67%), Positives = 203/242 (83%)

Query:     2 VIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
             VIQMN++E  R+QI QELKINQ SSQCP+VVVCY SFY NGA S++LEYMD GSLAD ++
Sbjct:   100 VIQMNIQEEIRKQIVQELKINQASSQCPHVVVCYHSFYHNGAFSLVLEYMDRGSLADVIR 159

Query:    61 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             +VKTI E YLA +C+QVL GL+YLH+E+H+IHRD+KPSNLL+NH+GEVKI+DFGVSA +A
Sbjct:   160 QVKTILEPYLAVVCKQVLLGLVYLHNERHVIHRDIKPSNLLVNHKGEVKISDFGVSASLA 219

Query:   121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
             S+ GQ +TFVGTYNYMSPERISG  Y Y SDIWSLG+ +LECA G+FPY   E Q    S
Sbjct:   220 SSMGQRDTFVGTYNYMSPERISGSTYDYSSDIWSLGMSVLECAIGRFPYLESEDQQNPPS 279

Query:   181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 240
             FYEL+ AIV+ PPP+APSDQFSPEFCSF+SAC+QK+P  R S+ +L++HPF+K + D ++
Sbjct:   280 FYELLAAIVENPPPTAPSDQFSPEFCSFVSACIQKDPPARASSLDLLSHPFIKKFEDKDI 339

Query:   241 DL 242
             DL
Sbjct:   340 DL 341

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

DICTYBASE|DDB_G0269152 mekA "MAP kinase kinase (MAP2K)" [Dictyostelium discoideum (taxid:44689)]

 Score = 498 (180.4 bits), Expect = 6.9e-61, Sum P(2) = 6.9e-61
 Identities = 95/176 (53%), Positives = 126/176 (71%)

Query:     2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             VI ++++E+ R+QI  ELK    +  PY+V  Y +FY+ G+I I LE+M+ GSL+D +KK
Sbjct:   322 VITLDIQENIRKQIILELKTLHKTSYPYIVSFYDAFYTEGSIFIALEFMELGSLSDIMKK 381

Query:    62 VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
               TIPE  L  I  QVL+GL+YLH + H+IHRD+KPSN+L+N++GE KI DFGVS  +  
Sbjct:   382 TSTIPEPVLGKIAFQVLQGLVYLHRKLHLIHRDIKPSNILVNNKGEAKIADFGVSGQLQH 441

Query:   122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP--PEQQ 175
             T  +A T+VGT  YMSPERISG  Y + S+IWSLGL +LECA G+FPY    P QQ
Sbjct:   442 TLSKAVTWVGTVTYMSPERISGRSYSFDSEIWSLGLTILECAIGKFPYGSNLPHQQ 497

GO:0030587 "sorocarp development" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0016020 "membrane" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0031152 "aggregation involved in sorocarp development" evidence=TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2170578 MKK3 "AT5G40440" [Arabidopsis thaliana (taxid:3702)]

 Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
 Identities = 121/261 (46%), Positives = 167/261 (63%)

Query:     4 QMNV-EESARRQIAQELKINQSSQCPYVVVCYQ-SFYS--NGAISIILEYMDGGSLADFL 59
             ++N+ E   R+Q+  E++    + C   +V +  +FYS  +G ISI LEYM+GGSLAD L
Sbjct:   113 KINIFEREKRQQLLTEIRTLCEAPCHEGLVDFHGAFYSPDSGQISIALEYMNGGSLADIL 172

Query:    60 KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
             K  K IPE  L+++  ++L+GL YLH  +H++HRD+KP+NLLIN +GE KITDFG+SA +
Sbjct:   173 KVTKKIPEPVLSSLFHKLLQGLSYLHGVRHLVHRDIKPANLLINLKGEPKITDFGISAGL 232

Query:   120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
              ++     TFVGT  YMSPERI    Y Y +DIWSLGL L EC TG+FPY   E      
Sbjct:   233 ENSMAMCATFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYIANEGP---- 288

Query:   180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
                 LM  I+D P P+ P  +FSPEFCSFI AC+QK+P  R +A +L++HPF+  +    
Sbjct:   289 --VNLMLQILDDPSPTPPKQEFSPEFCSFIDACLQKDPDARPTADQLLSHPFITKHEKER 346

Query:   240 VDLSEYFTDAGSPLATLSNLS 260
             VDL+ +      P   L +L+
Sbjct:   347 VDLATFVQSIFDPTQRLKDLA 367

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IEP

GO:0009866 "induced systemic resistance, ethylene mediated signaling pathway" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IMP

GO:0004707 "MAP kinase activity" evidence=IDA

UNIPROTKB|F1PJI7 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 454 (164.9 bits), Expect = 1.6e-55, Sum P(2) = 1.6e-55
 Identities = 92/194 (47%), Positives = 129/194 (66%)

Query:     2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct:    98 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query:    62 VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE+K+ DFGVS  + 
Sbjct:   158 AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 216

Query:   121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
              +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++    
Sbjct:   217 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 274

Query:   181 FYELMEAIVDQPPP 194
             F   +E  V + PP
Sbjct:   275 FGCQVEGDVAETPP 288

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|J9P5W6 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 454 (164.9 bits), Expect = 1.6e-55, Sum P(2) = 1.6e-55
 Identities = 92/194 (47%), Positives = 129/194 (66%)

Query:     2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct:    98 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query:    62 VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE+K+ DFGVS  + 
Sbjct:   158 AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 216

Query:   121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
              +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++    
Sbjct:   217 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 274

Query:   181 FYELMEAIVDQPPP 194
             F   +E  V + PP
Sbjct:   275 FGCQVEGDVAETPP 288

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q0VD16 MAP2K1 "MAP2K1 protein" [Bos taurus (taxid:9913)]

 Score = 450 (163.5 bits), Expect = 5.4e-55, Sum P(2) = 5.4e-55
 Identities = 91/194 (46%), Positives = 128/194 (65%)

Query:     2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct:    98 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query:    62 VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE+K+ DFGVS  + 
Sbjct:   158 AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 216

Query:   121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
              +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++    
Sbjct:   217 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 274

Query:   181 FYELMEAIVDQPPP 194
             F   +E    + PP
Sbjct:   275 FGCQVEGDAAETPP 288

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q02750 MAP2K1 "Dual specificity mitogen-activated protein kinase kinase 1" [Homo sapiens (taxid:9606)]

 Score = 450 (163.5 bits), Expect = 5.4e-55, Sum P(2) = 5.4e-55
 Identities = 91/194 (46%), Positives = 128/194 (65%)

Query:     2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct:    98 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query:    62 VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE+K+ DFGVS  + 
Sbjct:   158 AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 216

Query:   121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
              +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++    
Sbjct:   217 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 274

Query:   181 FYELMEAIVDQPPP 194
             F   +E    + PP
Sbjct:   275 FGCQVEGDAAETPP 288

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0008283 "cell proliferation" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IEA

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IEA

GO:0032402 "melanosome transport" evidence=IEA

GO:0032839 "dendrite cytoplasm" evidence=IEA

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IEA

GO:0033267 "axon part" evidence=IEA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IEA

GO:0043204 "perikaryon" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IEA

GO:0047496 "vesicle transport along microtubule" evidence=IEA

GO:0048313 "Golgi inheritance" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048678 "response to axon injury" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0051291 "protein heterooligomerization" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0005816 "spindle pole body" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=TAS

GO:0005634 "nucleus" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=TAS

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005925 "focal adhesion" evidence=TAS

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

GO:0006928 "cellular component movement" evidence=TAS

GO:0006935 "chemotaxis" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0000165 "MAPK cascade" evidence=TAS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007264 "small GTPase mediated signal transduction" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=IMP

GO:0008285 "negative regulation of cell proliferation" evidence=IDA

GO:0090398 "cellular senescence" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

RGD|70495 Map2k1 "mitogen activated protein kinase kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 449 (163.1 bits), Expect = 6.9e-55, Sum P(2) = 6.9e-55
 Identities = 91/194 (46%), Positives = 128/194 (65%)

Query:     2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct:    98 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query:    62 VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE+K+ DFGVS  + 
Sbjct:   158 AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 216

Query:   121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
              +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++    
Sbjct:   217 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELL 274

Query:   181 FYELMEAIVDQPPP 194
             F   +E    + PP
Sbjct:   275 FGCQVEGDAAETPP 288

GO:0000165 "MAPK cascade" evidence=IMP

GO:0000187 "activation of MAPK activity" evidence=ISO;IDA;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP;IDA;TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA;ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA;TAS

GO:0005816 "spindle pole body" evidence=IEA

GO:0005829 "cytosol" evidence=IDA;TAS

GO:0005886 "plasma membrane" evidence=ISO;IDA

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA;TAS

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=IEA;ISO

GO:0007067 "mitosis" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=TAS

GO:0008283 "cell proliferation" evidence=IDA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA;ISO

GO:0017016 "Ras GTPase binding" evidence=IPI

GO:0019901 "protein kinase binding" evidence=IPI

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IEA;ISO

GO:0030335 "positive regulation of cell migration" evidence=IMP

GO:0030425 "dendrite" evidence=IDA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IDA;IPI

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IMP

GO:0032402 "melanosome transport" evidence=IDA

GO:0032839 "dendrite cytoplasm" evidence=IDA

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IMP

GO:0033267 "axon part" evidence=IDA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IMP

GO:0043204 "perikaryon" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA;ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IEA;ISO

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IMP

GO:0047496 "vesicle transport along microtubule" evidence=IDA

GO:0048313 "Golgi inheritance" evidence=IMP

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0048678 "response to axon injury" evidence=IMP

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0048870 "cell motility" evidence=IEA;ISO

GO:0051291 "protein heterooligomerization" evidence=IPI

GO:0051384 "response to glucocorticoid stimulus" evidence=IDA

GO:0060674 "placenta blood vessel development" evidence=IEA;ISO

GO:0060711 "labyrinthine layer development" evidence=IEA;ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=IEA;ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005874 "microtubule" evidence=IDA

MGI|MGI:1346866 Map2k1 "mitogen-activated protein kinase kinase 1" [Mus musculus (taxid:10090)]

 Score = 448 (162.8 bits), Expect = 8.8e-55, Sum P(2) = 8.8e-55
 Identities = 91/194 (46%), Positives = 128/194 (65%)

Query:     2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct:    98 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 157

Query:    62 VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE+K+ DFGVS  + 
Sbjct:   158 AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 216

Query:   121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
              +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++    
Sbjct:   217 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELL 274

Query:   181 FYELMEAIVDQPPP 194
             F   +E    + PP
Sbjct:   275 FGCHVEGDAAETPP 288

GO:0000165 "MAPK cascade" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000187 "activation of MAPK activity" evidence=ISO;IMP;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IMP

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=ISO;TAS

GO:0005829 "cytosol" evidence=ISO;TAS

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005874 "microtubule" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IMP

GO:0006979 "response to oxidative stress" evidence=ISO

GO:0007050 "cell cycle arrest" evidence=ISO

GO:0007067 "mitosis" evidence=ISO

GO:0008283 "cell proliferation" evidence=ISO

GO:0008285 "negative regulation of cell proliferation" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IMP

GO:0030335 "positive regulation of cell migration" evidence=ISO

GO:0030425 "dendrite" evidence=ISO

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=ISO

GO:0032320 "positive regulation of Ras GTPase activity" evidence=ISO

GO:0032402 "melanosome transport" evidence=ISO

GO:0032839 "dendrite cytoplasm" evidence=ISO

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=ISO

GO:0033267 "axon part" evidence=ISO

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=ISO

GO:0043204 "perikaryon" evidence=ISO

GO:0043539 "protein serine/threonine kinase activator activity" evidence=ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IDA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=ISO

GO:0047496 "vesicle transport along microtubule" evidence=ISO

GO:0048313 "Golgi inheritance" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0048678 "response to axon injury" evidence=ISO

GO:0048812 "neuron projection morphogenesis" evidence=ISO

GO:0048870 "cell motility" evidence=IMP

GO:0051291 "protein heterooligomerization" evidence=ISO

GO:0051384 "response to glucocorticoid stimulus" evidence=ISO

GO:0060674 "placenta blood vessel development" evidence=IMP

GO:0060711 "labyrinthine layer development" evidence=IMP

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9S7U9	M2K2_ARATH	2, ., 7, ., 1, 2, ., 2	0.7423	0.9923	0.7162	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.2	0.946
3rd Layer	2.7.12	0.963
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	262
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-138
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-119
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-89
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-81
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-81
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-78
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-76
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-74
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-72
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-72
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-72
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-71
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-69
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-69
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-69
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-68
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-67
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-63
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-63
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-59
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-58
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-58
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-57
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-55
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-53
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-53
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-53
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-52
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-51
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-51
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-50
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-48
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-48
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-44
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-43
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-43
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-43
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-43
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-43
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-43
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-42
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-42
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-42
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-42
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-42
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-41
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-41
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-41
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-40
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-40
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-40
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-40
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-40
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-40
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-38
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-38
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-37
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-37
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-36
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-36
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-36
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-35
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-35
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-35
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-34
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-34
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-34
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-34
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-33
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-33
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-33
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-32
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-32
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-32
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-32
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-32
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-32
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-32
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-31
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-31
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-31
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-31
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-31
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-31
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-30
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-29
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-29
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-29
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-29
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-29
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-29
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-29
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-29
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-28
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-28
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-28
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-28
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-28
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-28
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-27
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-27
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-27
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-27
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-27
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-27
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-27
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-27
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-26
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-26
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-26
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-26
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-26
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-26
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-25
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-25
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-25
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-24
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-24
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-24
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-24
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-24
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-23
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-23
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-23
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-22
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-22
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-22
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-22
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-21
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-21
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-21
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-21
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-21
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-21
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-21
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-21
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-21
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-20
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-20
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-20
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-20
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-20
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-19
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-19
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-19
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-19
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-19
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-18
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-18
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-18
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-17
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-17
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-17
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-17
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-17
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-16
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-16
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-16
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-15
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-13
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-10
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-09
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	6e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	9e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	3e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-05
cd05145	190	cd05145, RIO1_like, RIO kinase family; RIO1, RIO3	4e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd05119	187	cd05119, RIO, RIO kinase family, catalytic domain	1e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	1e-04
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	3e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	4e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-04
COG1718	268	COG1718, RIO1, Serine/threonine protein kinase inv	0.002

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  388 bits (998), Expect = e-138
 Identities = 143/234 (61%), Positives = 176/234 (75%), Gaps = 4/234 (1%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            I ++ +E  R+Q+ +ELK  +S + PYVV CY +FY  G ISI+LEYMDGGSLAD LKK
Sbjct: 33  KIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK 92

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           V  IPE  LA I  Q+LKGL YLH ++HIIHRD+KPSNLLIN +GEVKI DFG+S ++ +
Sbjct: 93  VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           T  Q NTFVGT  YMSPERI G  Y Y +DIWSLGL LLECA G+FP+ PP Q     SF
Sbjct: 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSF 208

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           +ELM+AI D PPPS P+++FSPEF  FISAC+QK+P++R SA EL+ HPF+K  
Sbjct: 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  342 bits (879), Expect = e-119
 Identities = 120/235 (51%), Positives = 161/235 (68%), Gaps = 5/235 (2%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            I++ + E+ ++QI +EL I      PY+V  Y +FY+NG ISI +EYMDGGSL   LK+
Sbjct: 33  TIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKE 92

Query: 62  V-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           V   IPE  L  I   VLKGL YLH +  IIHRD+KPSN+L+N RG++K+ DFGVS  + 
Sbjct: 93  VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL- 151

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
             +  A TFVGT +YM+PERI G  Y  KSDIWSLGL L+E ATG+FPY P    D    
Sbjct: 152 -VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE--NDPPDG 208

Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            +EL++ IV++PPP  PS +FSP+F  F++ C+ K+P++R S +EL+ HPF+K Y
Sbjct: 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  266 bits (682), Expect = 3e-89
 Identities = 114/272 (41%), Positives = 159/272 (58%), Gaps = 31/272 (11%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           I + ++ + R QI +ELK+      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK 
Sbjct: 34  IHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 93

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             IPE  L  I   VL+GL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +
Sbjct: 94  GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF- 181
              AN+FVGT +YMSPER+ G  Y  +SDIWSLGL L+E A G++P  PP+ ++    F 
Sbjct: 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG 211

Query: 182 ----------------------------YELMEAIVDQPPPSAPSDQFSPEFCSFISACV 213
                                       +EL++ IV++PPP  PS  FS EF  F+  C+
Sbjct: 212 RPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCL 271

Query: 214 QKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 245
           +K P++R   +EL  HPF+K      VD + +
Sbjct: 272 KKNPKERADLKELTKHPFIKRAELEEVDFAGW 303

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  244 bits (626), Expect = 2e-81
 Identities = 86/232 (37%), Positives = 127/232 (54%), Gaps = 9/232 (3%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VI+    +  R +I +E+KI +  + P +V  Y  F     + +++EY +GG L D LKK
Sbjct: 31  VIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK 90

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              + E+       Q+L  L YL H K I+HRDLKP N+L++  G VK+ DFG++  +  
Sbjct: 91  RGRLSEDEARFYLRQILSALEYL-HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDP 149

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
              +  TFVGT  YM+PE + G  YG   DIWSLG++L E  TG+ P+   +Q       
Sbjct: 150 G-EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL----- 203

Query: 182 YELMEAIV-DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            EL + I   +PP   P    SPE    I   + K+P++RL+A+E + HPF 
Sbjct: 204 -ELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  245 bits (626), Expect = 3e-81
 Identities = 104/249 (41%), Positives = 153/249 (61%), Gaps = 7/249 (2%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           V+ +  + S R+QI +EL+I    + PY+V  Y +F +   I + +E+MD GSL    KK
Sbjct: 37  VVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK 96

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IP E L  I   V++GL YL++   I+HRD+KPSN+L+N RG++K+ DFGVS  + +
Sbjct: 97  GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ----QDG 177
           +   A+TFVGT  YMSPERI GGKY  KSD+WSLG+ ++E A G+FP++        QD 
Sbjct: 157 SI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD 214

Query: 178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM-THPFLKMYG 236
                +L++ IV +PPP  PS  F  +   F+ AC+ K+P +R + Q+L    PF++   
Sbjct: 215 PMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274

Query: 237 DLNVDLSEY 245
             NVDL  +
Sbjct: 275 ASNVDLQAW 283

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  235 bits (602), Expect = 7e-78
 Identities = 88/231 (38%), Positives = 138/231 (59%), Gaps = 12/231 (5%)

Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-K 61
            + +E   +++ I  E++I +  + P +V  Y S+     + I++E+  GGSL D LK  
Sbjct: 32  VIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST 91

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
            +T+ E  +A +C+++LKGL YLH    IIHRD+K +N+L+   GEVK+ DFG+SA ++ 
Sbjct: 92  NQTLTESQIAYVCKELLKGLEYLH-SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD 150

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           T    NT VGT  +M+PE I+G  Y YK+DIWSLG+  +E A G+ PYS           
Sbjct: 151 T-KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-------P 202

Query: 182 YELMEAIVDQPPPSAPSD-QFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            + +  I    PP   +  ++S EF  F+  C+QK P++R +A++L+ HPF
Sbjct: 203 MKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  230 bits (590), Expect = 6e-76
 Identities = 76/225 (33%), Positives = 119/225 (52%), Gaps = 4/225 (1%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
               +   +E++I +    P +V    +F     + +++EY +GG L D+L +   + E+
Sbjct: 39  SKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSED 98

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT 128
               I  Q+L+GL YLH    IIHRDLKP N+L++  G VKI DFG++  +  +S    T
Sbjct: 99  EAKKIALQILRGLEYLH-SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157

Query: 129 FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           FVGT  YM+PE + GG  YG K D+WSLG++L E  TG+ P+S     D       ++  
Sbjct: 158 FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGP 217

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +            S E    I  C+ K+P +R +A+E++ HP+ 
Sbjct: 218 PL--EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  229 bits (585), Expect = 4e-74
 Identities = 114/236 (48%), Positives = 147/236 (62%), Gaps = 15/236 (6%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VI  N E++ RRQI +E++I +    P VV C+  F  NG I ++LE+MDGGSL    + 
Sbjct: 106 VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EG 161

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                E++LA +  Q+L G+ YLH  +HI+HRD+KPSNLLIN    VKI DFGVS I+A 
Sbjct: 162 THIADEQFLADVARQILSGIAYLH-RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220

Query: 122 TSGQANTFVGTYNYMSPERISG----GKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
           T    N+ VGT  YMSPERI+     G Y GY  DIWSLG+ +LE   G+FP+    Q D
Sbjct: 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280

Query: 177 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            W S   LM AI    PP AP+   S EF  FIS C+Q+EP +R SA +L+ HPF+
Sbjct: 281 -WAS---LMCAICMSQPPEAPATA-SREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  221 bits (565), Expect = 3e-72
 Identities = 91/224 (40%), Positives = 134/224 (59%), Gaps = 16/224 (7%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAA 72
           +I +E+ I +    PY+V  Y S++ N  + I++EY   GS++D +K   KT+ EE +AA
Sbjct: 44  EIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA 103

Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT 132
           I  Q LKGL YLH     IHRD+K  N+L+N  G+ K+ DFGVS  +  T  + NT +GT
Sbjct: 104 ILYQTLKGLEYLH-SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162

Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEAIVD 190
             +M+PE I    Y  K+DIWSLG+  +E A G+ PYS   P +          +  I +
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---------IFMIPN 213

Query: 191 QPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           +PPP  S P  ++SPEF  F+  C+ K+P++R SA +L+ HPF+
Sbjct: 214 KPPPTLSDPE-KWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  221 bits (565), Expect = 5e-72
 Identities = 92/222 (41%), Positives = 126/222 (56%), Gaps = 15/222 (6%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           I QE++     + PY+   Y SF     + II+EY  GGS  D LK  K + E Y+A I 
Sbjct: 46  IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFIL 104

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 134
            +VL GL YLH E  I HRD+K +N+L++  G+VK+ DFGVS  + ST  + NTFVGT  
Sbjct: 105 REVLLGLEYLHEEGKI-HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF 163

Query: 135 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQ 191
           +M+PE I    Y  K+DIWSLG+  +E A G+ P S              M     I   
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD----------LHPMRVLFLIPKN 213

Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            PPS   ++FS  F  F+S C+ K+P++R SA+EL+ H F+K
Sbjct: 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  221 bits (564), Expect = 6e-72
 Identities = 107/241 (44%), Positives = 154/241 (63%), Gaps = 7/241 (2%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VI +++    ++QI  EL+I      PY++  Y +F+    ISI  E+MDGGSL D  +K
Sbjct: 33  VIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRK 91

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE  L  I   V+KGL YL   K I+HRD+KPSN+L+N RG+VK+ DFGVS  + +
Sbjct: 92  ---IPEHVLGRIAVAVVKGLTYLWSLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           +   A T+VGT  YM+PERISG +YG  SD+WSLG+  +E A G+FPY   ++  G    
Sbjct: 148 SI--AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
            +L++ IVD+ PP  P  QFS +F  FI+ C++K+P++R + + LM HPF+  Y D N +
Sbjct: 206 LQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAE 265

Query: 242 L 242
           +
Sbjct: 266 V 266

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  218 bits (558), Expect = 4e-71
 Identities = 81/239 (33%), Positives = 125/239 (52%), Gaps = 16/239 (6%)

Query: 2   VIQMNVEESAR---RQIAQELKINQSSQCPYVVVCYQSFYSNGA--ISIILEYMDGGSLA 56
           V  + +   +      + +E++I  S Q P +V  Y S        ++I LEY+ GGSL+
Sbjct: 30  VKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLS 89

Query: 57  DFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
             LKK   +PE  +     Q+L+GL YLH    I+HRD+K +N+L++  G VK+ DFG +
Sbjct: 90  SLLKKFGKLPEPVIRKYTRQILEGLAYLH-SNGIVHRDIKGANILVDSDGVVKLADFGCA 148

Query: 117 AIMAS--TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 174
             +    T     +  GT  +M+PE I G +YG  +DIWSLG  ++E ATG+ P+S    
Sbjct: 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208

Query: 175 QDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                     +  I     PP  P    S E   F+  C++++P++R +A EL+ HPFL
Sbjct: 209 P------MAALYKIGSSGEPPEIPEH-LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  215 bits (550), Expect = 2e-69
 Identities = 86/235 (36%), Positives = 138/235 (58%), Gaps = 14/235 (5%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKV 62
           +M + +  +  I  E+ I +  + P +V  Y S+     + +++EYMDGGSL D + +  
Sbjct: 51  KMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF 110

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             + E  +A +C +VL+GL YLH  +++IHRD+K  N+L++  G VK+ DFG +A +   
Sbjct: 111 VRMNEPQIAYVCREVLQGLEYLH-SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTS 180
             + N+ VGT  +M+PE I    YG K DIWSLG++ +E A G+ PY   PP +      
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ 223

Query: 181 FYELMEAIVDQ-PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
               +  I  +  PP    +++SPEF  F++ C+ K+P++R SA+EL+ HPFLK 
Sbjct: 224 ---ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  214 bits (547), Expect = 3e-69
 Identities = 103/244 (42%), Positives = 149/244 (61%), Gaps = 16/244 (6%)

Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVKT----IP 66
           +QI +EL+IN+S + PY+V  Y +F      +I I +EY +GGSL    KKVK     I 
Sbjct: 44  KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG 103

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           E+ L  I E VLKGL YLH  + IIHRD+KPSN+L+  +G+VK+ DFGVS  + ++   A
Sbjct: 104 EKVLGKIAESVLKGLSYLH-SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LA 160

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
            TF GT  YM+PERI G  Y   SD+WSLGL LLE A  +FP+ PPE +       EL+ 
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF-PPEGEPPLGPI-ELLS 218

Query: 187 AIVDQPPPSAPSD-----QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
            IV+ P P    +     ++S EF  FI  C++K+P +R +  +++ HP++K      V+
Sbjct: 219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVN 278

Query: 242 LSEY 245
           ++++
Sbjct: 279 MAKF 282

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  214 bits (546), Expect = 5e-69
 Identities = 101/256 (39%), Positives = 155/256 (60%), Gaps = 16/256 (6%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGS---LADFL 59
           I++ ++ES   QI  EL I   +  PY+V  Y +F+  GA+ + +EYMD GS   L    
Sbjct: 34  IRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGG 93

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
              + IPE+ L  I   V+KGL +L  E +IIHRD+KP+N+L+N  G+VK+ DFGVS  +
Sbjct: 94  VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153

Query: 120 ASTSGQANTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPE 173
            ++  + N  +G  +YM+PERI  G       Y  +SD+WSLGL +LE A G++PY PPE
Sbjct: 154 VASLAKTN--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-PPE 210

Query: 174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
               + + +  + AIVD  PP+ PS  +S +   F++ C+ K P +R +  +L+ HP+L 
Sbjct: 211 T---YANIFAQLSAIVDGDPPTLPSG-YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266

Query: 234 MYGDLNVDLSEYFTDA 249
            Y + +VD++E+ T A
Sbjct: 267 KYKNADVDMAEWVTGA 282

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  213 bits (543), Expect = 4e-68
 Identities = 109/282 (38%), Positives = 159/282 (56%), Gaps = 39/282 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 37  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 96

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 97  AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++    F
Sbjct: 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214

Query: 182 -------------------------------------YELMEAIVDQPPPSAPSDQFSPE 204
                                                +EL++ IV++PPP  PS  F  E
Sbjct: 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAE 274

Query: 205 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
           F  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 275 FQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVDFAGWL 316

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  212 bits (540), Expect = 1e-67
 Identities = 107/271 (39%), Positives = 157/271 (57%), Gaps = 41/271 (15%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LK+
Sbjct: 37  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE 96

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
            K IPEE L  +   VL+GL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 97  AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++    F
Sbjct: 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214

Query: 182 ---------------------------------------YELMEAIVDQPPPSAPSDQFS 202
                                                  +EL++ IV++PPP  P+  F+
Sbjct: 215 GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFT 274

Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           P+F  F++ C+ K P +R   + LM H F+K
Sbjct: 275 PDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  199 bits (508), Expect = 3e-63
 Identities = 96/253 (37%), Positives = 151/253 (59%), Gaps = 19/253 (7%)

Query: 3   IQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           I+  V    ++++  +L I+ +S  CPY V  Y + +  G + I +E MD  SL  F KK
Sbjct: 34  IRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKK 92

Query: 62  V----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           V     TIPE+ L  I   ++K L YLH +  +IHRD+KPSN+LIN  G+VK+ DFG+S 
Sbjct: 93  VYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152

Query: 118 IMASTSGQANTF-VGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPP 172
            +      A T   G   YM+PERI+       Y  KSD+WSLG+ ++E ATG+FPY   
Sbjct: 153 YL--VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY--- 207

Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
              D W + ++ ++ +V++P P  P+++FSPEF  F++ C++K  ++R +  EL+ HPF 
Sbjct: 208 ---DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Query: 233 KMYGDLNVDLSEY 245
           +++   N D++ +
Sbjct: 265 ELHLSKNTDVASF 277

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  197 bits (504), Expect = 7e-63
 Identities = 87/231 (37%), Positives = 128/231 (55%), Gaps = 13/231 (5%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK---- 61
           N+ E  R     E+KI +    P ++  Y+SF   G + I++EY DGG L+  +KK    
Sbjct: 37  NMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKE 96

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
            K  PEE +     Q+   L YLH  + I+HRD+KP N+ +   G VK+ DFG+S +++S
Sbjct: 97  GKPFPEEQILDWFVQLCLALKYLH-SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           T   A T VGT  Y+SPE      Y YKSDIWSLG VL E  T + P+      +G  + 
Sbjct: 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF------EG-ENL 208

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            EL   I+    P  PS Q+S E  + +S+ +QK+P++R S  +++  PF+
Sbjct: 209 LELALKILKGQYPPIPS-QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  189 bits (482), Expect = 3e-59
 Identities = 97/261 (37%), Positives = 148/261 (56%), Gaps = 28/261 (10%)

Query: 5   MNVEESARRQIAQELK--------INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 56
           M V++  R    +E K        + +S  CPY+V CY  F ++  + I +E M   +  
Sbjct: 43  MAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCL 100

Query: 57  DFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDF 113
           D L K     IPE+ L  +   ++K L YL  EKH +IHRD+KPSN+L++  G VK+ DF
Sbjct: 101 DKLLKRIQGPIPEDILGKMTVAIVKALHYLK-EKHGVIHRDVKPSNILLDASGNVKLCDF 159

Query: 114 GVSAIMASTSGQANT-FVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLLECATGQFP 168
           G+S  +     +A T   G   YM+PERI       KY  ++D+WSLG+ L+E ATGQFP
Sbjct: 160 GISGRL--VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Query: 169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELM 227
           Y          + +E++  I+ + PPS P ++ FSP+FCSF+  C+ K+ ++R   +EL+
Sbjct: 218 Y------KNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271

Query: 228 THPFLKMYGDLNVDLSEYFTD 248
            HPF++ Y    VD++ +F D
Sbjct: 272 QHPFIRRYETAEVDVAGWFQD 292

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  185 bits (472), Expect = 1e-58
 Identities = 76/232 (32%), Positives = 115/232 (49%), Gaps = 44/232 (18%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I+     S   ++ +E++I +    P +V  Y  F     + +++EY +GGSL D LK+
Sbjct: 25  IIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE 84

Query: 62  V-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIM 119
               + E+ +  I  Q+L+GL YL H   IIHRDLKP N+L++   G+VK+ DFG+S ++
Sbjct: 85  NEGKLSEDEILRILLQILEGLEYL-HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143

Query: 120 ASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
            S      T VGT  YM+PE + G G Y  KSDIWSLG++L E                 
Sbjct: 144 TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------- 187

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
                                   PE    I   +QK+P++R SA+E++ H 
Sbjct: 188 ------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  186 bits (473), Expect = 5e-58
 Identities = 96/259 (37%), Positives = 143/259 (55%), Gaps = 20/259 (7%)

Query: 3   IQMNVEESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           I+  V+E  ++++  +L  + +SS CPY+V  Y + +  G   I +E MD  SL  F K 
Sbjct: 37  IRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKY 95

Query: 62  V-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           V       IPEE L  I    +K L YL  E  IIHRD+KPSN+L++  G +K+ DFG+S
Sbjct: 96  VYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Query: 117 AIMASTSGQANTFVGTYNYMSPERI-SGGKYGY--KSDIWSLGLVLLECATGQFPYSPPE 173
             +  +  +     G   YM+PERI    + GY  +SD+WSLG+ L E ATG+FPY    
Sbjct: 156 GQLVDSIAKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY---- 210

Query: 174 QQDGWTSFYELMEAIVDQPPPSAPSD---QFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
               W S ++ +  +V   PP   +    +FSP F +FI+ C+ K+  +R   +EL+ HP
Sbjct: 211 --PKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268

Query: 231 FLKMYGDLNVDLSEYFTDA 249
           F+K Y + NVD++ Y    
Sbjct: 269 FIKDYEERNVDVAAYVQRI 287

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  183 bits (468), Expect = 1e-57
 Identities = 82/236 (34%), Positives = 123/236 (52%), Gaps = 19/236 (8%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +    ++E A + I QE+ + ++ + P +V    S  ++ ++ IILEY + GSL   +KK
Sbjct: 33  ISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK 92

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
               PE  +A    QVL+GL YLH +  +IHRD+K +N+L    G VK+ DFGV+  +  
Sbjct: 93  FGPFPESLVAVYVYQVLQGLAYLHEQG-VIHRDIKAANILTTKDGVVKLADFGVATKLND 151

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
            S    + VGT  +M+PE I        SDIWSLG  ++E  TG  PY            
Sbjct: 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY------------ 199

Query: 182 YEL-----MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           Y+L     +  IV    P  P    SPE   F+  C QK+P  R +A++L+ HP++
Sbjct: 200 YDLNPMAALFRIVQDDHPPLPEG-ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  177 bits (452), Expect = 3e-55
 Identities = 80/230 (34%), Positives = 119/230 (51%), Gaps = 24/230 (10%)

Query: 12  RRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           R+++     E  I      P++V  + +F +   + ++LEY  GG L   L K     EE
Sbjct: 34  RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE 93

Query: 69  ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
               Y A I       L YLH    II+RDLKP N+L++  G +K+TDFG++  ++S   
Sbjct: 94  RARFYAAEIVL----ALEYLH-SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148

Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           + NTF GT  Y++PE + G  YG   D WSLG++L E  TG+ P+   +++       E+
Sbjct: 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-------EI 201

Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPF 231
            E I+   P   P    SPE    IS  +QK+P +RL    A+E+  HPF
Sbjct: 202 YEKILKD-PLRFPEF-LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  174 bits (442), Expect = 2e-53
 Identities = 85/232 (36%), Positives = 133/232 (57%), Gaps = 17/232 (7%)

Query: 13  RQIA--QELKINQSSQCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKKVKTIPEEY 69
           R++A   +L+ +Q       +  Y   Y  G  + II+EY +GGS+   L K   I E+Y
Sbjct: 48  REVALLSQLRQSQPPN----ITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKY 102

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
           ++ I  +VL  L Y+H    +IHRD+K +N+L+ + G VK+ DFGV+A++   S + +TF
Sbjct: 103 ISVIIREVLVALKYIHKVG-VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF 161

Query: 130 VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           VGT  +M+PE I+ GK Y  K+DIWSLG+ + E ATG  PYS  +        +  M  I
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRAMMLI 214

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 240
               PP    + +S     F++AC+ +EP++RLSA+EL+   ++K +    V
Sbjct: 215 PKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 2e-53
 Identities = 80/243 (32%), Positives = 128/243 (52%), Gaps = 26/243 (10%)

Query: 2   VIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           +  + +E       I QE+ + +  + P +V  + S+     + I++EY  GGSL D  +
Sbjct: 33  IKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ 92

Query: 61  KVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
             +  + E  +A +C + LKGL YLH E   IHRD+K +N+L+   G+VK+ DFGVSA +
Sbjct: 93  VTRGPLSELQIAYVCRETLKGLAYLH-ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151

Query: 120 ASTSGQANTFVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            +T  +  +F+GT  +M+PE       G Y  K DIW+LG+  +E A  Q P        
Sbjct: 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM------- 204

Query: 177 GWTSFYEL--MEAI------VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                ++L  M A+         PP     +++SP F  FI  C+ K+P++R +A +L+ 
Sbjct: 205 -----FDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259

Query: 229 HPF 231
           HPF
Sbjct: 260 HPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  173 bits (440), Expect = 3e-53
 Identities = 84/231 (36%), Positives = 123/231 (53%), Gaps = 24/231 (10%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK---KVKTIPEEYLA 71
           + +E++       P VV  Y SF     + +++ Y+ GGSL D +K       + E  +A
Sbjct: 46  LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA 105

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA----STSGQAN 127
            + ++VLKGL YLH    I HRD+K  N+L+   G VKI DFGVSA +A     T     
Sbjct: 106 TVLKEVLKGLEYLHSNGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 128 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYEL 184
           TFVGT  +M+PE +     Y +K+DIWS G+  +E ATG  PYS  PP          ++
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP---------MKV 215

Query: 185 MEAIVDQPPPSAPSD----QFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
           +   +   PPS  +     ++S  F   IS C+QK+P +R +A+EL+ H F
Sbjct: 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  172 bits (437), Expect = 1e-52
 Identities = 87/250 (34%), Positives = 132/250 (52%), Gaps = 35/250 (14%)

Query: 5   MNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGA------ISIILEYMDGGSLAD 57
           M++ E    +I +E  I +  S  P +   Y +F           + +++E   GGS+ D
Sbjct: 39  MDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD 98

Query: 58  FLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
            +K +    K + EE++A I  + L+GL YLH E  +IHRD+K  N+L+    EVK+ DF
Sbjct: 99  LVKGLRKKGKRLKEEWIAYILRETLRGLAYLH-ENKVIHRDIKGQNILLTKNAEVKLVDF 157

Query: 114 GVSAIMASTSGQANTFVGTYNYMSPERISGGK-----YGYKSDIWSLGLVLLECATGQFP 168
           GVSA + ST G+ NTF+GT  +M+PE I+  +     Y  +SD+WSLG+  +E A G+ P
Sbjct: 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Query: 169 YS--PPEQQDGWTSFYELMEA---IVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLS 222
                P            M A   I   PPP+    + +S +F  FIS C+ K  +QR  
Sbjct: 218 LCDMHP------------MRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF 265

Query: 223 AQELMTHPFL 232
            +EL+ HPF+
Sbjct: 266 MEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  169 bits (430), Expect = 1e-51
 Identities = 82/240 (34%), Positives = 134/240 (55%), Gaps = 15/240 (6%)

Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +  Q P +V  Y S+     + +++E+++GG+L D + 
Sbjct: 49  VKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT 108

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +A +C  VLK L +LH +  +IHRD+K  ++L+   G VK++DFG  A ++
Sbjct: 109 HTR-MNEEQIATVCLAVLKALSFLHAQG-VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +  + VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP Q    
Sbjct: 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--- 223

Query: 179 TSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                 M+ I D  PP      + SP   SF+   + ++P QR +A EL+ HPFL   G 
Sbjct: 224 ------MKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  168 bits (428), Expect = 2e-51
 Identities = 79/228 (34%), Positives = 131/228 (57%), Gaps = 15/228 (6%)

Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA 72
           ++IA E+K+ +  + P +V  Y        + I +EY  GG+L + L+  + + E  +  
Sbjct: 44  KEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV 103

Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----GQANT 128
              Q+L+GL YLH    I+HRD+KP+N+ ++H G +K+ DFG +  + + +     +  +
Sbjct: 104 YTLQLLEGLAYLH-SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162

Query: 129 FVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
             GT  YM+PE I+GGK   +G  +DIWSLG V+LE ATG+ P+S  E  + +    ++M
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS--ELDNEF----QIM 216

Query: 186 EAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             +     P  P S Q SPE   F+  C++ +P++R +A EL+ HPF+
Sbjct: 217 FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  164 bits (418), Expect = 8e-50
 Identities = 76/228 (33%), Positives = 127/228 (55%), Gaps = 17/228 (7%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQ 76
           E+ I    + P +V  Y++++    + I++E+ DGG+L   + ++ + + E  +  +C Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           +L+ L +LH    +IHRDLK  N+L+   G+VK+ DFGVSA   ST  + +TF+GT  +M
Sbjct: 112 MLEALNFLH-SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWM 170

Query: 137 SPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +PE +         Y YK+DIWSLG+ L+E A  + P+          +   ++  I+  
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE-------LNPMRVLLKILKS 223

Query: 192 PPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
            PP    PS ++S  F  F+ +C+ K+P  R +A EL+ HPF+    D
Sbjct: 224 EPPTLDQPS-KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  161 bits (409), Expect = 1e-48
 Identities = 88/236 (37%), Positives = 131/236 (55%), Gaps = 14/236 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I +   E     I QE+ +      PY+   Y S+     + II+EY+ GGS  D LK 
Sbjct: 36  IIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP 95

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              + E Y+A I  ++LKGL YLH E+ I HRD+K +N+L++ +G+VK+ DFGV+  +  
Sbjct: 96  -GPLEETYIATILREILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTD 153

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           T  + NTFVGT  +M+PE I    Y +K+DIWSLG+  +E A G+ P S           
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD---------- 203

Query: 182 YELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
              M  +   P  S P+   Q+S  F  F+ AC+ K+P+ R +A+EL+ H F+  Y
Sbjct: 204 LHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  159 bits (405), Expect = 3e-48
 Identities = 81/225 (36%), Positives = 126/225 (56%), Gaps = 10/225 (4%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           + A +Q+ QE+ +    Q P +V    +      + I LE + GGSLA  LKK  + PE 
Sbjct: 43  QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP 102

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT 128
            +     Q+L GL YL H+++ +HRD+K +N+L++  G VK+ DFG++  +      A +
Sbjct: 103 VIRLYTRQILLGLEYL-HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKS 160

Query: 129 FVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           F G+  +M+PE I   G YG  +DIWSLG  +LE ATG+ P+S   Q +G  + +++  +
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS---QLEGVAAVFKIGRS 217

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               P P    D  S E   FI  C+Q++P  R +A EL+ HPF+
Sbjct: 218 KELPPIP----DHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  149 bits (378), Expect = 4e-44
 Identities = 86/231 (37%), Positives = 127/231 (54%), Gaps = 10/231 (4%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I +   E     I QE+ +      PYV   Y S+     + II+EY+ GGS  D L+ 
Sbjct: 36  IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR- 94

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                E  +A + +++LKGL YLH EK I HRD+K +N+L++ +G+VK+ DFGV+  +  
Sbjct: 95  AGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTD 153

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P S           
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------ 207

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             ++  I    PP+   + FS  F  FI AC+ K+P  R +A+EL+ H F+
Sbjct: 208 -RVLFLIPKNNPPTLTGE-FSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  148 bits (374), Expect = 2e-43
 Identities = 86/231 (37%), Positives = 128/231 (55%), Gaps = 10/231 (4%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GGS  D L+ 
Sbjct: 36  IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP 95

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DFGV+  +  
Sbjct: 96  -GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTD 153

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S           
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------ 207

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 208 -KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  150 bits (379), Expect = 3e-43
 Identities = 83/281 (29%), Positives = 130/281 (46%), Gaps = 25/281 (8%)

Query: 1   MVIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           +  ++  +     +  +E++I  S +  P +V  Y  F   G++ +++EY+DGGSL D L
Sbjct: 30  LAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL 89

Query: 60  KK---VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGV 115
           KK      + E     I  Q+L  L YLH  K IIHRD+KP N+L++  G  VK+ DFG+
Sbjct: 90  KKIGRKGPLSESEALFILAQILSALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGL 148

Query: 116 SAIMASTSG------QANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQ 166
           + ++             +T VGT  YM+PE + G         SDIWSLG+ L E  TG 
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Query: 167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-------QFSPEFCSFISACVQKEPQQ 219
            P+         ++  + ++ I++ P PS  S          S      +   + K+P+ 
Sbjct: 209 PPFEGE---KNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKN 265

Query: 220 RLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 260
           RLS+   ++H  L        DLS+      S    LS   
Sbjct: 266 RLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPP 306

Length = 384

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  147 bits (373), Expect = 3e-43
 Identities = 73/232 (31%), Positives = 125/232 (53%), Gaps = 14/232 (6%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           Q  V E+ R++I    ++N     P+++    +   +   ++ +E+M GGS++  L K  
Sbjct: 43  QEEVVEALRKEIRLMARLNH----PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG 98

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-VKITDFGVSAIMAST 122
              E  +    EQ+L+GL YLH E  IIHRD+K +NLLI+  G+ ++I DFG +A +A+ 
Sbjct: 99  AFKEAVIINYTEQLLRGLSYLH-ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157

Query: 123 SGQANTF----VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
              A  F    +GT  +M+PE + G +YG   D+WS+G V++E AT + P++  +  +  
Sbjct: 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
              +++  A      PS P    SP        C++ +P+ R  ++EL+ HP
Sbjct: 218 ALIFKIASAT---TAPSIPE-HLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  146 bits (372), Expect = 7e-43
 Identities = 68/258 (26%), Positives = 113/258 (43%), Gaps = 45/258 (17%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I+    +  + +     ++N     P ++  Y +F     +  +LEY   G L  +++K
Sbjct: 39  LIKEKKVKYVKIEKEVLTRLNGH---PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK 95

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
             ++ E+       ++L  L YLH  K IIHRDLKP N+L++    +KITDFG + ++  
Sbjct: 96  YGSLDEKCTRFYAAEILLALEYLH-SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154

Query: 122 TS--------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
            S                     +  +FVGT  Y+SPE ++    G  SD+W+LG ++ +
Sbjct: 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQ 214

Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAIV----DQPPPSAPSDQFSPEFCSFISACVQKEP 217
             TG+ P+    +       Y   + I+      PP       F P+    I   +  +P
Sbjct: 215 MLTGKPPFRGSNE-------YLTFQKILKLEYSFPP------NFPPDAKDLIEKLLVLDP 261

Query: 218 QQRL----SAQELMTHPF 231
           Q RL       EL  HPF
Sbjct: 262 QDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  147 bits (372), Expect = 7e-43
 Identities = 81/233 (34%), Positives = 135/233 (57%), Gaps = 11/233 (4%)

Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V  M++ +  RR++   E+ I +  Q   VV  Y+S+     + +++E++ GG+L D + 
Sbjct: 51  VKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS 110

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           + + + EE +A +CE VL+ L YLH +  +IHRD+K  ++L+   G VK++DFG  A ++
Sbjct: 111 QTR-LNEEQIATVCESVLQALCYLHSQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               +  + VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY          S
Sbjct: 169 KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-------DS 221

Query: 181 FYELMEAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             + M+ + D PPP    + + SP    F+   + +EPQ+R +AQEL+ HPFL
Sbjct: 222 PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  146 bits (370), Expect = 9e-43
 Identities = 76/237 (32%), Positives = 122/237 (51%), Gaps = 18/237 (7%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVK 63
           N+ E  ++Q+  E+ I +  + P +V  Y      SN  + I++EY +GG LA  ++K K
Sbjct: 37  NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96

Query: 64  T----IPEEYLAAICEQVLKGLLYLHHEKH----IIHRDLKPSNLLINHRGEVKITDFGV 115
                I EE++  I  Q+L  L   H+       ++HRDLKP+N+ ++    VK+ DFG+
Sbjct: 97  KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156

Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
           + I+   S  A T+VGT  YMSPE+++   Y  KSDIWSLG ++ E        SPP   
Sbjct: 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL----SPPFTA 212

Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               +  +L   I +      P  ++S E    I + +  +P +R S +EL+  P +
Sbjct: 213 ---RNQLQLASKIKEGKFRRIPY-RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  145 bits (368), Expect = 1e-42
 Identities = 75/234 (32%), Positives = 113/234 (48%), Gaps = 23/234 (9%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+  E  I   +Q PYVV  Y SF     + +++EY+ GG LA  L+ V ++ E+     
Sbjct: 39  QVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIY 98

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI--------MASTSGQ 125
             +++  L YLH    IIHRDLKP N+LI+  G +K+TDFG+S +        +     +
Sbjct: 99  IAEIVLALEYLHSNG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157

Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
               VGT +Y++PE I G  +    D WSLG +L E   G  P+     +       E+ 
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIF 210

Query: 186 EAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKM 234
           + I+      P       S E    IS  +  +P++RL   S +E+  HPF K 
Sbjct: 211 QNILNGKIEWPEDVEV--SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  145 bits (367), Expect = 2e-42
 Identities = 83/245 (33%), Positives = 129/245 (52%), Gaps = 28/245 (11%)

Query: 5   MNVEESARRQIAQELK-INQSSQCPYVVVCYQSFYS------NGAISIILEYMDGGSLAD 57
           M+V E    +I  E+  + + S    +   Y +F        +  + +++E+   GS+ D
Sbjct: 49  MDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD 108

Query: 58  FLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
            +K  K   + E+++A IC ++L+GL +LH    +IHRD+K  N+L+    EVK+ DFGV
Sbjct: 109 LVKNTKGNALKEDWIAYICREILRGLAHLH-AHKVIHRDIKGQNVLLTENAEVKLVDFGV 167

Query: 116 SAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYS 170
           SA +  T G+ NTF+GT  +M+PE I+        Y Y+SDIWSLG+  +E A G    +
Sbjct: 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG----A 223

Query: 171 PPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           PP            M A   I   PPP   S ++S +F  FI  C+ K    R S ++L+
Sbjct: 224 PP------LCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277

Query: 228 THPFL 232
            HPF+
Sbjct: 278 KHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  144 bits (365), Expect = 4e-42
 Identities = 75/221 (33%), Positives = 114/221 (51%), Gaps = 10/221 (4%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--- 63
           ++  AR+   +E+ + +    P V+    SF  N  ++I+LE  D G L+  +K  K   
Sbjct: 41  MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK 100

Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             IPE  +     Q+   L ++H  K I+HRD+KP+N+ I   G VK+ D G+    +S 
Sbjct: 101 RLIPERTIWKYFVQLCSALEHMH-SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
           +  A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+      D   + Y
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDK-MNLY 214

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 223
            L + I     P  P+D +S E    +S C+  +P++R   
Sbjct: 215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  144 bits (364), Expect = 4e-42
 Identities = 75/228 (32%), Positives = 116/228 (50%), Gaps = 15/228 (6%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIP 66
           E  RR    E+ I    Q P ++  Y  F  +  + I +EY +GG+L D +  +K +   
Sbjct: 40  EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE 99

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           EE +     Q++  + Y+H +  I+HRD+K  N+ +   G +K+ DFG+S I+ S    A
Sbjct: 100 EEMVLWYLFQIVSAVSYIH-KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE--CATGQFPYSPPEQQDGWTSFYEL 184
            T VGT  YMSPE   G KY +KSDIW+LG VL E       F  + P           L
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---------LNL 209

Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           +  IV Q   +     +S E  S + + +Q++P++R +A E++  P L
Sbjct: 210 VVKIV-QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  143 bits (362), Expect = 9e-42
 Identities = 80/226 (35%), Positives = 119/226 (52%), Gaps = 21/226 (9%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            +  E+++ ++ Q   +V  Y     +  +SI +EYM GGS+ D LK    + E      
Sbjct: 50  ALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY 109

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTF 129
             Q+L+G+ YLH    I+HRD+K +N+L +  G VK+ DFG S     I +S +G   + 
Sbjct: 110 TRQILEGVEYLH-SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM-KSV 167

Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA-- 187
            GT  +MSPE ISG  YG K+D+WS+G  ++E  T +    PP     W  F E M A  
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK----PP-----WAEF-EAMAAIF 217

Query: 188 -IVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            I  QP  P  PS   SP+  +F+     +  ++R SA+EL+ H F
Sbjct: 218 KIATQPTNPQLPSH-VSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  142 bits (360), Expect = 2e-41
 Identities = 83/242 (34%), Positives = 130/242 (53%), Gaps = 22/242 (9%)

Query: 5   MNVEESARRQIAQELK-INQSSQCPYVVVCYQSFYS------NGAISIILEYMDGGSLAD 57
           M+V      +I QE+  + + S    +   Y +F        +  + +++E+   GS+ D
Sbjct: 39  MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 98

Query: 58  FLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
            +K  K  T+ EE++A IC ++L+GL +LH  K +IHRD+K  N+L+    EVK+ DFGV
Sbjct: 99  LIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGV 157

Query: 116 SAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYS 170
           SA +  T G+ NTF+GT  +M+PE I+        Y +KSD+WSLG+  +E A G  P  
Sbjct: 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217

Query: 171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
                         +  I   P P   S ++S +F SFI +C+ K   QR + ++LM HP
Sbjct: 218 DMHPMRA-------LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270

Query: 231 FL 232
           F+
Sbjct: 271 FI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  141 bits (359), Expect = 3e-41
 Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 12/230 (5%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           VE   +  I  E +I +    P++V  Y++F     I +++EY  GG L   L+      
Sbjct: 32  VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD 91

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           E         V+    YLH+ + II+RDLKP NLL++  G VK+ DFG +  + S   + 
Sbjct: 92  EYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKT 149

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
            TF GT  Y++PE I    Y +  D WSLG++L E  TG+ P+   ++        E+  
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIYN 204

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPF 231
            I+         +         I   +++ P++RL       +++  H +
Sbjct: 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  141 bits (356), Expect = 6e-41
 Identities = 77/236 (32%), Positives = 125/236 (52%), Gaps = 18/236 (7%)

Query: 4   QMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           Q+++ +  RR+  +   E ++       Y++  Y+SF   G ++I++EY + G L   LK
Sbjct: 32  QIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK 91

Query: 61  KV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
               + +PE+ +     Q+L GL +LH +K I+HRD+K  NL ++    VKI D GV+ +
Sbjct: 92  MQRGRPLPEDQVWRFFIQILLGLAHLHSKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150

Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
           ++  +  ANT VGT  Y+SPE      Y  KSD+W+LG+VL EC TG+ P+    Q    
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--- 207

Query: 179 TSFYELMEAIVDQ--PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                L+  I+    PP S     +S +    I  C+ K+ +QR    +L+ +P L
Sbjct: 208 ----ALILKIIRGVFPPVSQM---YSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  139 bits (352), Expect = 3e-40
 Identities = 73/235 (31%), Positives = 112/235 (47%), Gaps = 12/235 (5%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           M  Q  VE+ + R +  E +I Q    P++V  + SF     + ++++ + GG L   L 
Sbjct: 33  MNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS 92

Query: 61  KVKTIPEEYLAA-ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
           +     EE +   ICE VL  L YLH  K IIHRD+KP N+L++ +G V ITDF + A  
Sbjct: 93  QKVKFSEEQVKFWICEIVL-ALEYLH-SKGIIHRDIKPDNILLDEQGHVHITDFNI-ATK 149

Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
            +      +  GT  YM+PE +    Y    D WSLG+   EC  G+ PY          
Sbjct: 150 VTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY--RGHSRTIR 207

Query: 180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS--AQELMTHPFL 232
                 +   D   P+     +S E    I+  ++++PQ+RL    ++L  HP+ 
Sbjct: 208 DQIRAKQETADVLYPAT----WSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  140 bits (354), Expect = 3e-40
 Identities = 82/239 (34%), Positives = 134/239 (56%), Gaps = 15/239 (6%)

Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++GG+L D + 
Sbjct: 50  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 109

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +AA+C  VLK L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++
Sbjct: 110 HTR-MNEEQIAAVCLAVLKALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +  + VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP      
Sbjct: 168 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------ 221

Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 222 ---LKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  140 bits (353), Expect = 4e-40
 Identities = 82/238 (34%), Positives = 130/238 (54%), Gaps = 14/238 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLK 60
           VI+   EE     +  E++I  +   PY+V    +FY +G + I++E+  GG++ A  L+
Sbjct: 44  VIETKSEEELEDYMV-EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE 102

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + E  +  IC Q+L+ L YLH  K IIHRDLK  N+L+   G++K+ DFGVSA   
Sbjct: 103 LDRGLTEPQIQVICRQMLEALQYLHSMK-IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161

Query: 121 STSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
            T  + ++F+GT  +M+PE +         Y YK+DIWSLG+ L+E A       PP  +
Sbjct: 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ----IEPPHHE 217

Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                   L++    +PP  +   ++S EF  F+   + K P+ R SA +L+ HPF+ 
Sbjct: 218 --LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  139 bits (352), Expect = 5e-40
 Identities = 82/239 (34%), Positives = 134/239 (56%), Gaps = 15/239 (6%)

Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +      VV  Y S+     + +++E+++GG+L D + 
Sbjct: 52  VKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT 111

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +A +C  VL+ L YLH++  +IHRD+K  ++L+   G +K++DFG  A ++
Sbjct: 112 HTR-MNEEQIATVCLSVLRALSYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +  + VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP Q    
Sbjct: 170 KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--- 226

Query: 179 TSFYELMEAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
                 M  I D  PP    S + S     F+   + +EP QR +AQEL+ HPFLK+ G
Sbjct: 227 ------MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  140 bits (354), Expect = 5e-40
 Identities = 72/193 (37%), Positives = 112/193 (58%), Gaps = 19/193 (9%)

Query: 45  IILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLH-HEKHIIHRDLKPSNLLI 102
           +++EY  G S +D L+   K + E  +AAIC   L+GL YLH HE+  IHRD+K  N+L+
Sbjct: 92  LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER--IHRDIKAGNILL 148

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVL 159
              G VK+ DFG +++++     AN+FVGT  +M+PE I     G+Y  K D+WSLG+  
Sbjct: 149 TEPGTVKLADFGSASLVSP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204

Query: 160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
           +E A  + P       +  ++ Y     I     P+  S+ +S  F +F+ +C+QK PQ 
Sbjct: 205 IELAERKPPLF---NMNAMSALYH----IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQD 257

Query: 220 RLSAQELMTHPFL 232
           R S++EL+ H F+
Sbjct: 258 RPSSEELLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  139 bits (352), Expect = 5e-40
 Identities = 74/232 (31%), Positives = 133/232 (57%), Gaps = 9/232 (3%)

Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + + 
Sbjct: 51  QMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 110

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A +   
Sbjct: 111 -CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
             + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   + Y
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL---NENPLRALY 225

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ HPFLK+
Sbjct: 226 LIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  135 bits (342), Expect = 1e-38
 Identities = 78/206 (37%), Positives = 108/206 (52%), Gaps = 9/206 (4%)

Query: 31  VVCYQSF-YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 89
           +V Y  F  +   +SI LEY+ GGS+   L+      E+ +    EQVL+GL YLH  K 
Sbjct: 70  IVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH-SKG 128

Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGGKYG 147
           I+HRDLK  NLL++  G  KI+DFG+S        + Q  +  G+  +M+PE I     G
Sbjct: 129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188

Query: 148 Y--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 205
           Y  K DIWSLG V+LE   G+ P+S  E      + ++L       P P   S   SP  
Sbjct: 189 YSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKRSAPPIPPDVSMNLSPVA 245

Query: 206 CSFISACVQKEPQQRLSAQELMTHPF 231
             F++AC    P  R +A+EL+ HPF
Sbjct: 246 LDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  134 bits (339), Expect = 4e-38
 Identities = 75/232 (32%), Positives = 133/232 (57%), Gaps = 9/232 (3%)

Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           Q+N+++  +++ I  E+ + +  + P +V    SF     + +++EY+ GGSL D + + 
Sbjct: 51  QINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET 110

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A +   
Sbjct: 111 -CMDEAQIAAVCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
             + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   + Y
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL---NENPLRALY 225

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            +     +  P     ++ SP F  F++ C++ + ++R SA+EL+ HPFLK+
Sbjct: 226 LIA---TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  133 bits (336), Expect = 9e-38
 Identities = 68/241 (28%), Positives = 111/241 (46%), Gaps = 38/241 (15%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
            ++ +  E    +  +E +I +    P VV    VC +       + I++EYM+GG L  
Sbjct: 35  TLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEE----EPLYIVMEYMEGGDLLS 90

Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           +L+K +  +    L +   Q+ +G+ YL   K+ IHRDL   N L+     VKI+DFG+S
Sbjct: 91  YLRKNRPKLSLSDLLSFALQIARGMEYLE-SKNFIHRDLAARNCLVGENLVVKISDFGLS 149

Query: 117 ------AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
                        G+         +M+PE +  GK+  KSD+WS G++L E  T G+ PY
Sbjct: 150 RDLYDDDYYRKRGGKL-----PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY 204

Query: 170 SPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 225
                     S  E++E + +      PP+ P     PE    +  C  ++P+ R +  E
Sbjct: 205 -------PGMSNEEVLEYLKNGYRLPQPPNCP-----PELYDLMLQCWAEDPEDRPTFSE 252

Query: 226 L 226
           L
Sbjct: 253 L 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  133 bits (336), Expect = 1e-37
 Identities = 74/232 (31%), Positives = 133/232 (57%), Gaps = 9/232 (3%)

Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + + 
Sbjct: 51  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 110

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             + E  +AA+C + L+ L +LH  + +IHRD+K  N+L+   G VK+TDFG  A +   
Sbjct: 111 -CMDEGQIAAVCRECLQALDFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
             + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   + Y
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL---NENPLRALY 225

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            +     +  P     ++ S  F  F++ C++ +  +R SA+EL+ HPFLK+
Sbjct: 226 LIA---TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  133 bits (335), Expect = 2e-37
 Identities = 77/238 (32%), Positives = 125/238 (52%), Gaps = 15/238 (6%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQ 76
           E+ I  S   P +V    +FY    + I++E+  GG++ A  L+  + + E  +  +C+Q
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
            L+ L YLH  K IIHRDLK  N+L    G++K+ DFGVSA    T  + ++F+GT  +M
Sbjct: 112 TLEALNYLHENK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170

Query: 137 SPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +PE +         Y YK+D+WSLG+ L+E A       PP  +        L++    +
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQ----IEPPHHE--LNPMRVLLKIAKSE 224

Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 249
           PP  A   ++S EF  F+  C++K    R +  +L+ HPF+ +  + N  + E   +A
Sbjct: 225 PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV--NSNKPIRELIAEA 280

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  131 bits (331), Expect = 3e-37
 Identities = 74/231 (32%), Positives = 119/231 (51%), Gaps = 15/231 (6%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT- 64
           ++ +  R     E++I  S   P ++   ++F     + I++EY   G L+  + K K  
Sbjct: 37  SMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKK 96

Query: 65  ---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ +  I  Q+L+GL  LH +K I+HRDLK +N+L+     VKI D G+S ++  
Sbjct: 97  RKLIPEQEIWRIFIQLLRGLQALHEQK-ILHRDLKSANILLVANDLVKIGDLGISKVL-- 153

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
               A T +GT +YM+PE   G  Y YKSDIWSLG +L E AT   P+     QD     
Sbjct: 154 KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LR 210

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           Y++        PP      +S +  +FI + +Q +P+ R +  +++  P +
Sbjct: 211 YKVQRGKYPPIPPI-----YSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  130 bits (330), Expect = 7e-37
 Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 39/242 (16%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
            ++ +  E    +  +E +I +    P +V    VC +       + I++EYM GG L D
Sbjct: 35  TLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE----EPLMIVMEYMPGGDLLD 90

Query: 58  FLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
           +L+K   K +    L +   Q+ +G+ YL   K+ IHRDL   N L+     VKI+DFG+
Sbjct: 91  YLRKNRPKELSLSDLLSFALQIARGMEYLE-SKNFIHRDLAARNCLVGENLVVKISDFGL 149

Query: 116 S------AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 168
           S             G+         +M+PE +  GK+  KSD+WS G++L E  T G+ P
Sbjct: 150 SRDLYDDDYYKVKGGKL-----PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204

Query: 169 YSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 224
           Y          S  E++E +        PP+ P     PE    +  C  ++P+ R +  
Sbjct: 205 YPG-------MSNAEVLEYLKKGYRLPKPPNCP-----PELYKLMLQCWAEDPEDRPTFS 252

Query: 225 EL 226
           EL
Sbjct: 253 EL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  129 bits (328), Expect = 1e-36
 Identities = 68/248 (27%), Positives = 108/248 (43%), Gaps = 55/248 (22%)

Query: 8   EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
            E  R+   +E ++ +    P VV    VC +       + ++LEYM+GG L D+L+K +
Sbjct: 36  SEEERKDFLKEARVMKKLGHPNVVRLLGVCTE----EEPLYLVLEYMEGGDLLDYLRKSR 91

Query: 64  ---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 114
                    T+  + L +   Q+ KG+ YL   K  +HRDL   N L+     VKI+DFG
Sbjct: 92  PVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-SKKFVHRDLAARNCLVGEDLVVKISDFG 150

Query: 115 VSAIMASTSGQANTFVGTYNY-----------MSPERISGGKYGYKSDIWSLGLVLLECA 163
           +S          + +   Y             M+PE +  G +  KSD+WS G++L E  
Sbjct: 151 LS---------RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201

Query: 164 T-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQ 218
           T G  PY       G ++  E++E +        P   P      E    + +C Q +P+
Sbjct: 202 TLGATPYP------GLSNE-EVLEYLRKGYRLPKPEYCP-----DELYELMLSCWQLDPE 249

Query: 219 QRLSAQEL 226
            R +  EL
Sbjct: 250 DRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  129 bits (326), Expect = 2e-36
 Identities = 79/236 (33%), Positives = 130/236 (55%), Gaps = 22/236 (9%)

Query: 4   QMNVEESAR--RQIAQ-ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           Q+ VE+  +  R  AQ E ++ +    P ++  Y++F  + A+ I++EY  GG+LA++++
Sbjct: 32  QIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ 91

Query: 61  KVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSA 117
           K     + E+ +     Q+L  L ++H  K I+HRDLK  N+L++ H+  VKI DFG+S 
Sbjct: 92  KRCNSLLDEDTILHFFVQILLALHHVH-TKLILHRDLKTQNILLDKHKMVVKIGDFGISK 150

Query: 118 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
           I++S S +A T VGT  Y+SPE   G  Y  KSDIW+LG VL E A+ +  +        
Sbjct: 151 ILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------ 203

Query: 178 WTSFYELMEAIVDQPPPS--AP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
                  + A+V +      AP SD++SP+    I + +  +P +R    ++M  P
Sbjct: 204 -----ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  128 bits (322), Expect = 9e-36
 Identities = 72/218 (33%), Positives = 116/218 (53%), Gaps = 10/218 (4%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD----FLKKV 62
           ++  AR    +E+ + +    P V+  Y SF  +  ++I+LE  D G L+     F K+ 
Sbjct: 41  MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 100

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           + IPE+ +     Q+   L ++H  + ++HRD+KP+N+ I   G VK+ D G+    +S 
Sbjct: 101 RLIPEKTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
           +  A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+   +      + Y
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLY 214

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            L + I     P  PSD +S E    ++ C+  +P++R
Sbjct: 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  126 bits (317), Expect = 4e-35
 Identities = 76/226 (33%), Positives = 111/226 (49%), Gaps = 36/226 (15%)

Query: 22  NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 81
            Q    PYV   Y SF S   + +++EY++GG  A  +K +  +PE++      +V+ G+
Sbjct: 52  IQGES-PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGV 110

Query: 82  LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPER 140
             LH ++ IIHRD+KP NLLI+  G +K+TDFG+S       G  N  FVGT +Y++PE 
Sbjct: 111 EDLH-QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPET 164

Query: 141 ISGGKYGYKSDIWSLGLVLLECATGQFPYSP--PEQ--------QDGWTSFYELMEAIVD 190
           I G      SD WSLG V+ E   G  P+    P+         +  W    +  E    
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK--EFC-- 220

Query: 191 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA---QELMTHPFLK 233
                      SPE    I+  +  +P +RL A   QE+ +HPF K
Sbjct: 221 -----------SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  126 bits (318), Expect = 5e-35
 Identities = 73/232 (31%), Positives = 131/232 (56%), Gaps = 9/232 (3%)

Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + + 
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A +   
Sbjct: 112 -CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
             + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   + Y
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALY 226

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            +     +  P     ++ S  F  F++ C+  + ++R SA+EL+ H FLK+
Sbjct: 227 LIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  125 bits (315), Expect = 9e-35
 Identities = 68/218 (31%), Positives = 114/218 (52%), Gaps = 10/218 (4%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD----FLKKV 62
           ++  AR+   +E+ + +    P V+    SF  +  ++I+LE  D G L+     F K+ 
Sbjct: 41  MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK 100

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           + IPE  +     Q+   + ++H  + ++HRD+KP+N+ I   G VK+ D G+    +S 
Sbjct: 101 RLIPERTVWKYFVQLCSAVEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
           +  A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+   +      + +
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLF 214

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            L + I     P  P++ +S +    +S C+  +P QR
Sbjct: 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  124 bits (314), Expect = 3e-34
 Identities = 74/242 (30%), Positives = 114/242 (47%), Gaps = 32/242 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++++   E     +  E +I QS + P++V  Y SF  +  + +++EY+ GG L   L+K
Sbjct: 39  IVKLKQVE----HVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK 94

Query: 62  VKTIPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
               PE     Y A    QV+  L YLH    I++RDLKP NLL++  G +KITDFG + 
Sbjct: 95  SGRFPEPVARFYAA----QVVLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAK 149

Query: 118 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
            +    G+  T  GT  Y++PE I    YG   D W+LG+++ E   G  P+        
Sbjct: 150 RV---KGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ- 205

Query: 178 WTSFYEL-MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPF 231
               YE  +E  V  P        FSP+    I   +Q +  +RL        ++  HP+
Sbjct: 206 ---IYEKILEGKVRFPSF------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256

Query: 232 LK 233
             
Sbjct: 257 FA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  124 bits (313), Expect = 3e-34
 Identities = 71/229 (31%), Positives = 122/229 (53%), Gaps = 17/229 (7%)

Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
             RQ+ + ++     +CP++V  + +F ++  + +IL+Y++GG L   L + +   E  +
Sbjct: 53  TERQVLEAVR-----RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV 107

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTF 129
                +++  L +LH    II+RD+K  N+L++  G V +TDFG+S    +    +A +F
Sbjct: 108 RVYIAEIVLALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF 166

Query: 130 VGTYNYMSPERISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
            GT  YM+PE I GG  G+    D WSLG++  E  TG  P++   +Q+   S  E+   
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRR 223

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 233
           I+   PP   +   S E   FI   ++K+P++RL    A E+  HPF +
Sbjct: 224 ILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  123 bits (311), Expect = 4e-34
 Identities = 80/211 (37%), Positives = 111/211 (52%), Gaps = 29/211 (13%)

Query: 36  SFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYLAAICEQVLKGLLYLHHEKHII 91
           S   NG   I +E + GGSL+  L+  K  P    E+ +    +Q+L+GL YLH +  I+
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLKYLH-DNQIV 130

Query: 92  HRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY-- 148
           HRD+K  N+L+N + G VKI+DFG S  +A  +    TF GT  YM+PE I  G  GY  
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 149 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-------QPPPSAPSDQF 201
            +DIWSLG  ++E ATG+    PP        F EL E           +  P  P +  
Sbjct: 191 PADIWSLGCTIVEMATGK----PP--------FIELGEPQAAMFKVGMFKIHPEIP-ESL 237

Query: 202 SPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           S E  +FI  C + +P +R SA +L+  PFL
Sbjct: 238 SAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  122 bits (309), Expect = 7e-34
 Identities = 70/235 (29%), Positives = 108/235 (45%), Gaps = 25/235 (10%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
            ++    E  R +  +E  I +    P +V    VC Q       + I+ EYM GG L D
Sbjct: 35  TLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG----EPLYIVTEYMPGGDLLD 90

Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           FL+K    +  + L  +  Q+ KG+ YL   K+ +HRDL   N L+     VKI+DFG+S
Sbjct: 91  FLRKHGEKLTLKDLLQMALQIAKGMEYL-ESKNFVHRDLAARNCLVTENLVVKISDFGLS 149

Query: 117 -AIMASTSGQANTFVGTY---NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 171
             I      +     G      +M+PE +  GK+  KSD+WS G++L E  T G+ PY  
Sbjct: 150 RDIYEDDYYRKRG--GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP- 206

Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                G ++  E++E + D      P +    E    +  C   +P+ R +  EL
Sbjct: 207 -----GMSN-EEVLELLEDGYRLPRP-ENCPDELYELMLQCWAYDPEDRPTFSEL 254

Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 9e-34
 Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 37/245 (15%)

Query: 18  ELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFL--KKVK-TIPEEYLAA 72
           E+K+ Q  + P +V   +   S   G+I ++ EYMD   L   L   +VK T  +  +  
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ--IKC 104

Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VG 131
             +Q+L+GL YLH    I+HRD+K SN+LIN+ G +K+ DFG++      +    T  V 
Sbjct: 105 YMKQLLEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 132 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPY-----------------SPPE 173
           T  Y  PE + G  +YG + D+WS+G +L E   G+  +                 SP +
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223

Query: 174 QQDGWTSFYELMEAIVDQPPPSAPS---DQF----SPEFCSFISACVQKEPQQRLSAQEL 226
           +   W    +L      +P         + F     P     +   +  +P++R+SA + 
Sbjct: 224 EN--WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281

Query: 227 MTHPF 231
           + H +
Sbjct: 282 LQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 2e-33
 Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 15/227 (6%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
            R +  E  I  +++  ++V    +F  +  + + +EY+ GG     L  +  + E+   
Sbjct: 45  VRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR 104

Query: 69  -YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
            Y+A + E V   L    HE   IHRDLKP N LI+  G +K+TDFG+S  + +    AN
Sbjct: 105 FYMAEMFEAV-DAL----HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN 156

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           + VG+ +YM+PE + G  Y +  D WSLG +L E   G  P+S     + W +     E 
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE- 215

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-SAQELMTHPFLK 233
            + +P    P    S E    I+  +  +P +R  S +++  HPF K
Sbjct: 216 TLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFK 261

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  120 bits (302), Expect = 6e-33
 Identities = 72/235 (30%), Positives = 125/235 (53%), Gaps = 15/235 (6%)

Query: 4   QMNVEESARRQ---IAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFL 59
           ++N+  ++RR+     QE ++    + P +V   +S+   +G + I++ + +GG L   L
Sbjct: 32  KLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL 91

Query: 60  K--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           K  K K +PE  +     Q+   L YLH EKHI+HRDLK  N+ +     +K+ D G++ 
Sbjct: 92  KEQKGKLLPENQVVEWFVQIAMALQYLH-EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR 150

Query: 118 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
           ++ +    A+T +GT  YMSPE  S   Y YKSD+W+LG  + E AT +  ++  +    
Sbjct: 151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-- 208

Query: 178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                 L+  I++   P  P D +SPE    I+  + K P++R S + ++  P++
Sbjct: 209 -----SLVYRIIEGKLPPMPKD-YSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  120 bits (302), Expect = 9e-33
 Identities = 70/226 (30%), Positives = 117/226 (51%), Gaps = 19/226 (8%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           +A+E+ + +  Q   +V    S      ++I LEY+ GGS+A  L       E  +    
Sbjct: 53  LAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFV 112

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANT 128
            Q+LKGL YLH+   IIHRD+K +N+L++++G +KI+DFG+S      ++   T+G   +
Sbjct: 113 RQILKGLNYLHNRG-IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
             G+  +M+PE +    Y  K+DIWSLG +++E  TG+ P+    Q          ++AI
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----------LQAI 221

Query: 189 --VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             + +          S E   F+    + +  +R +A EL+ HPFL
Sbjct: 222 FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  120 bits (301), Expect = 1e-32
 Identities = 72/220 (32%), Positives = 116/220 (52%), Gaps = 8/220 (3%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           I QE+ + +  +   +V  + S+ S   + I +EY  GGSL D       + E  +A +C
Sbjct: 53  IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 134
            + L+GL YLH  K  +HRD+K +N+L+   G+VK+ DFGV+A + +T  +  +F+GT  
Sbjct: 113 RETLQGLAYLH-SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171

Query: 135 YMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +M+PE  +    G Y    DIW++G+  +E A  Q    PP           LM     Q
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ----PPMFDLHPMRALFLMSKSNFQ 227

Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
           PP      ++S  F +F+   + K P++R +A+ L+TH F
Sbjct: 228 PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  120 bits (301), Expect = 1e-32
 Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 25/214 (11%)

Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 88
           Y+  C      +  ISI +E++ GGS++  L +   +PE       +Q+L G+ YLH   
Sbjct: 67  YLGTCLD----DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH-NN 121

Query: 89  HIIHRDLKPSNLLINHRGEVKITDFGVSAIMA------STSGQANTFVGTYNYMSPERIS 142
            ++HRD+K +N+++   G +K+ DFG +  +A      + S    +  GT  +M+PE I+
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAIVDQ--PPPSAPS 198
              YG KSDIWS+G  + E ATG+    PP       S   L  M  I       P  P 
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGK----PP-----LASMDRLAAMFYIGAHRGLMPRLP- 231

Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           D FS     F+++C+ ++  +R SA +L+ H FL
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  119 bits (299), Expect = 2e-32
 Identities = 77/225 (34%), Positives = 116/225 (51%), Gaps = 18/225 (8%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEY 69
           Q  QE ++      P +V  + SF    A  II EY +G  L   L+++K    T+ E  
Sbjct: 48  QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ 107

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
           +     Q+L G+ Y+H ++ I+HRDLK  N+ +     +KI DFGVS ++  +   A TF
Sbjct: 108 VCEWFIQLLLGVHYMH-QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTF 165

Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLE--CATGQFPYSPPEQQDGWTSFYELMEA 187
            GT  YMSPE +    Y  KSDIWSLG +L E  C    F            +F  ++  
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---------NFLSVVLR 216

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           IV+ P PS P + +S +  S + + + K+P  R SA E++ +PF+
Sbjct: 217 IVEGPTPSLP-ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 3e-32
 Identities = 73/248 (29%), Positives = 112/248 (45%), Gaps = 55/248 (22%)

Query: 25  SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKG 80
           +  P++V  Y SF     + +++EYM GG L + L +    PEE    Y+A +       
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV------ 111

Query: 81  LLYLH--HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ------------- 125
            L L   H+   IHRD+KP N+LI+  G +K+ DFG+   M     +             
Sbjct: 112 -LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 126 ----------------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
                           AN+ VGT +Y++PE + G  YG + D WSLG++L E   G  P+
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Query: 170 SPPEQQDGW---TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-SAQE 225
                Q+ +    ++ E +       PP  P    SPE    I   +  +P+ RL S +E
Sbjct: 231 YSDTLQETYNKIINWKESLRF-----PPDPP---VSPEAIDLICRLLC-DPEDRLGSFEE 281

Query: 226 LMTHPFLK 233
           + +HPF K
Sbjct: 282 IKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  118 bits (297), Expect = 3e-32
 Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 8/220 (3%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           + QE+ + +  +   +V  + S+     + I +E+  GGSL D       + E  +A + 
Sbjct: 53  VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVS 112

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 134
            + L+GL YLH  K  +HRD+K +N+L+   G VK+ DFGVSA + +T  +  +F+GT  
Sbjct: 113 RETLQGLYYLHS-KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY 171

Query: 135 YMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +M+PE  +    G Y    DIW++G+  +E A  Q    PP           LM     Q
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ----PPMFDLHPMRALFLMTKSNFQ 227

Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
           PP      ++S  F  F+   + K P++R +A++L+ HPF
Sbjct: 228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  118 bits (297), Expect = 5e-32
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 14/223 (6%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICE 75
           E KI +     ++V    +F +   + +++  M+GG L   +  V     PE        
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           Q++ GL +LH ++ I++RDLKP N+L++  G V+I+D G+ A+      +     GT  Y
Sbjct: 103 QIICGLEHLH-QRRIVYRDLKPENVLLDDHGNVRISDLGL-AVELKGGKKIKGRAGTPGY 160

Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 195
           M+PE + G  Y +  D ++LG  L E   G+ P+    Q+       EL    ++     
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF---RQRKEKVEKEELKRRTLEM--AV 215

Query: 196 APSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
              D+FSPE      A +QK+P++RL     SA E+  HP  K
Sbjct: 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  118 bits (298), Expect = 8e-32
 Identities = 67/271 (24%), Positives = 108/271 (39%), Gaps = 43/271 (15%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLA 71
            + QE+  ++  Q P ++    SF  +  + ++   M  GS  D LK      +PE  +A
Sbjct: 45  LLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA 104

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
            I + VL  L Y+H  K  IHR +K S++L++  G+V ++    S  M    G+    V 
Sbjct: 105 FILKDVLNALDYIHS-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK-HGKRQRVVH 162

Query: 132 TY--------NYMSPE----RISGGKYGYKSDIWSLGLVLLECATGQFPYS--------- 170
            +         ++SPE     + G  Y  KSDI+S+G+   E A G  P+          
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220

Query: 171 ----------------PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 214
                           P  +     S                 +  FS  F  F+  C+Q
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280

Query: 215 KEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 245
           ++P+ R SA +L+ H F K     N  L + 
Sbjct: 281 RDPESRPSASQLLNHSFFKQCKRRNTSLLDL 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 1e-31
 Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 51/267 (19%)

Query: 2   VIQMNVEE-----SARRQIA--QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGS 54
            I+++ EE     +A R+I+  +ELK       P +V      ++   + ++ EY D   
Sbjct: 31  KIRLDNEEEGIPSTALREISLLKELK------HPNIVKLLDVIHTERKLYLVFEYCDM-D 83

Query: 55  LADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
           L  +L K    +    + +I  Q+L+GL Y H    I+HRDLKP N+LIN  G +K+ DF
Sbjct: 84  LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH-SHRILHRDLKPQNILINRDGVLKLADF 142

Query: 114 GVS-----AIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ- 166
           G++      +   T       V T  Y +PE + G K Y    DIWS+G +  E  TG+ 
Sbjct: 143 GLARAFGIPLRTYTHE-----VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197

Query: 167 -FPY---------------SPPEQQDGWTSFYELME--AIVDQPPPSAPSDQFS---PEF 205
            FP                +P E+   W    +L +      + PP           PE 
Sbjct: 198 LFPGDSEIDQLFKIFQILGTPTEES--WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG 255

Query: 206 CSFISACVQKEPQQRLSAQELMTHPFL 232
              +S  +Q  P +R+SA+E + HP+ 
Sbjct: 256 IDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  117 bits (295), Expect = 2e-31
 Identities = 71/254 (27%), Positives = 115/254 (45%), Gaps = 32/254 (12%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KT 64
            +E     Q  +E+K  Q+ Q PYVV     F       +++EYM    L++ L+   + 
Sbjct: 37  RLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERP 95

Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           +PE  + +    +LKG+ Y+H    I+HRDLKP+NLLI+  G +KI DFG++ + +    
Sbjct: 96  LPEAQVKSYMRMLLKGVAYMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154

Query: 125 QANTF-VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPY----------- 169
           +  +  V T  Y +PE + G  KY    D+W++G +  E   G   FP            
Sbjct: 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214

Query: 170 ----SPPEQQDGWTSFYEL--MEAIVDQPPPSAPSDQFSPEFCS-----FISACVQKEPQ 218
               +P E+   W     L     I        P ++  P+  S      +   +  +P 
Sbjct: 215 RTLGTPNEET--WPGLTSLPDYNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPS 271

Query: 219 QRLSAQELMTHPFL 232
           +RLSA E + HP+ 
Sbjct: 272 KRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  117 bits (295), Expect = 2e-31
 Identities = 73/232 (31%), Positives = 120/232 (51%), Gaps = 21/232 (9%)

Query: 11  ARRQIAQELKIN---QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A  L  N   Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 35  AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 94

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +       +++  L YLH EK++++RDLK  NL+++  G +KITDFG+            
Sbjct: 95  DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
           TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILM 210

Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +      SPE  S +S  ++K+P+QRL      A+E+M H F 
Sbjct: 211 EEI--RFPRT-----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  116 bits (291), Expect = 3e-31
 Identities = 71/198 (35%), Positives = 103/198 (52%), Gaps = 18/198 (9%)

Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           ++I +EYM GGS+ D LK    + E        Q+L+G+ YLH    I+HRD+K +N+L 
Sbjct: 81  LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH-SNMIVHRDIKGANILR 139

Query: 103 NHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  YG K+D+WSLG  
Sbjct: 140 DSAGNVKLGDFGASKRLQTICMSGTG-IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCT 198

Query: 159 LLECATGQFPYSPPEQQDGWTSFYELMEAI--VDQPPPSAPSDQFSPEFCSFISACVQKE 216
           ++E  T + P++           YE M AI  +   P +        E       C+  E
Sbjct: 199 VVEMLTEKPPWAE----------YEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVE 248

Query: 217 PQQRLSAQELMTHPFLKM 234
            + R SA+EL+ HPF ++
Sbjct: 249 ARHRPSAEELLRHPFAQL 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 3e-31
 Identities = 66/243 (27%), Positives = 108/243 (44%), Gaps = 35/243 (14%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 73
           E+K+ +    P ++     F   G + ++ E+MD     D  K +K     +PE  + + 
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSY 103

Query: 74  CEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT 132
             Q+L+GL + H   H I+HRDLKP NLLIN  G +K+ DFG++    S       +V T
Sbjct: 104 LYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT 161

Query: 133 YNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP--------------YSPPEQQ 175
             Y +PE + G K Y    DIWS+G +  E  + +  FP                 P+ +
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE 221

Query: 176 DGWTSFYELMEAIV---DQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTH 229
             W  F  L         +         F   SP+    +S  +  +P +R++A++ + H
Sbjct: 222 V-WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280

Query: 230 PFL 232
           P+ 
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  115 bits (290), Expect = 7e-31
 Identities = 81/236 (34%), Positives = 122/236 (51%), Gaps = 24/236 (10%)

Query: 14  QIAQELKINQS-SQCPYVVVCYQSFY-----SNGAISIILEYMDGGSLADFLKKV----K 63
           +I  E  I QS    P VV  Y  FY       G + ++LE  +GGS+ + +K +    +
Sbjct: 64  EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            + E  ++ I    L GL +LH+ + IIHRD+K +N+L+   G VK+ DFGVSA + ST 
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182

Query: 124 GQANTFVGTYNYMSPERISGGK-----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
            + NT VGT  +M+PE I+  +     Y  + D+WSLG+  +E   G  P    +     
Sbjct: 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF--DMHPVK 240

Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           T F      I   PPP+    +++   F  FIS C+ K+ + R S   L+ HPF+K
Sbjct: 241 TLF-----KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  113 bits (283), Expect = 7e-30
 Identities = 75/223 (33%), Positives = 114/223 (51%), Gaps = 23/223 (10%)

Query: 25  SQCPYVVVCYQSFYSNGAIS-----IILEYMDGGSLAD----FLKKVKTIPEEYLAAICE 75
           S  P VV  Y  +Y     +     ++LE  +GGS+ D    FLK+ + + E  +A I  
Sbjct: 72  SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           + L GL +LH  K  IHRD+K +N+L+   G VK+ DFGVSA + ST  + NT VGT  +
Sbjct: 132 EALMGLQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 136 MSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           M+PE I+        Y  + D+WSLG+  +E   G  P +              +  I  
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFKIPR 243

Query: 191 QPPPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            PPP+    + +S EF  FI  C+ K+ ++R +  +L+ H F+
Sbjct: 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  112 bits (282), Expect = 1e-29
 Identities = 79/249 (31%), Positives = 118/249 (47%), Gaps = 40/249 (16%)

Query: 12  RRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           R QI Q   E  I   ++ P+VV  + SF +   + +++EY++GG  A  LK +  +P +
Sbjct: 42  RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD 101

Query: 69  ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI--MAST 122
               Y A   E VL  L YLH+   I+HRDLKP NLLI   G +K+TDFG+S I  M+ T
Sbjct: 102 MARMYFA---ETVL-ALEYLHNYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156

Query: 123 SG--------QANTFV-----GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           +             F+     GT  Y++PE I    YG   D W++G++L E   G  P+
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216

Query: 170 --SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQ 224
               PE+  G     ++     D+  P         +    IS  +++ P +RL    A 
Sbjct: 217 FGDTPEELFGQVISDDIEWPEGDEALP--------ADAQDLISRLLRQNPLERLGTGGAF 268

Query: 225 ELMTHPFLK 233
           E+  H F  
Sbjct: 269 EVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  112 bits (283), Expect = 1e-29
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 15/216 (6%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
            + + P++   +  F +   +  ++EY++GG L   +++     E        +++ GL 
Sbjct: 51  LAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQ 110

Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           +LH E+ II+RDLK  N+L++  G +KI DFG+           +TF GT +Y++PE +S
Sbjct: 111 FLH-ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 202
              YG   D W+LG++L E   GQ P+   + +D      EL ++I++           S
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDED------ELFQSILEDEVRYPRW--LS 220

Query: 203 PEFCSFISACVQKEPQQRLSA-----QELMTHPFLK 233
            E  S + + + K P++RL       Q++  HPF +
Sbjct: 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  112 bits (281), Expect = 2e-29
 Identities = 75/225 (33%), Positives = 120/225 (53%), Gaps = 17/225 (7%)

Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLA 71
           + I +E+K  Q  + P  +     +       +++EY  G S +D L+   K + E  +A
Sbjct: 66  QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIA 124

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
           AI    L+GL YLH   ++IHRD+K  N+L+   G+VK+ DFG     AS S  AN+FVG
Sbjct: 125 AITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPGQVKLADFG----SASKSSPANSFVG 179

Query: 132 TYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           T  +M+PE I     G+Y  K D+WSLG+  +E A  +    P    +  ++ Y     I
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK---PPLFNMNAMSALYH----I 232

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                P+  S++++  F  F+  C+QK PQ+R ++ EL+ H F++
Sbjct: 233 AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  112 bits (281), Expect = 3e-29
 Identities = 64/213 (30%), Positives = 112/213 (52%), Gaps = 15/213 (7%)

Query: 24  SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 83
           + + P++   + +F +   +  ++EY++GG L   ++      E        +++ GL +
Sbjct: 52  AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQF 111

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 143
           LH +K II+RDLK  N+L++  G +KI DFG+     +  G+A+TF GT +Y++PE + G
Sbjct: 112 LH-KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 144 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQF 201
            KY    D WS G++L E   GQ P+   E +D      EL ++I++  P  P       
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDED------ELFDSILNDRPHFPR----WI 219

Query: 202 SPEFCSFISACVQKEPQQRL-SAQELMTHPFLK 233
           S E    +S   +++P +RL    ++  HPF +
Sbjct: 220 SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  110 bits (276), Expect = 5e-29
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 15/218 (6%)

Query: 9   ESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---- 63
           + +   I  E+  I +  + P +V  Y++F  N  + I+++ ++G  L +    +K    
Sbjct: 49  DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ 108

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
              EE +  I  Q++  L YLH EK I+HRDL P+N+++    +V ITDFG+ A      
Sbjct: 109 RFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPE 167

Query: 124 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFY 182
            +  + VGT  Y  PE +    YG K+D+W+ G +L +  T Q P YS        T+  
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS--------TNML 219

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            L   IV+      P   +S +    I++C+  + + R
Sbjct: 220 SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  110 bits (277), Expect = 6e-29
 Identities = 73/224 (32%), Positives = 119/224 (53%), Gaps = 17/224 (7%)

Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLA 71
           + I +E++  Q  + P  +     +       +++EY  G S +D L+   K + E  +A
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIA 118

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
           A+    L+GL YLH   ++IHRD+K  N+L++  G VK+ DFG ++IMA     AN FVG
Sbjct: 119 AVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVG 173

Query: 132 TYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           T  +M+PE I     G+Y  K D+WSLG+  +E A  +    P    +  ++ Y     I
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK---PPLFNMNAMSALYH----I 226

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  111 bits (279), Expect = 7e-29
 Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 42/262 (16%)

Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKV--- 62
           A+R I +E+K+ +  +   ++                + I+ E M+     D L KV   
Sbjct: 43  AKR-ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME----TD-LHKVIKS 96

Query: 63  -KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM-- 119
            + + ++++     Q+L+GL YLH   ++IHRDLKPSN+L+N   ++KI DFG++  +  
Sbjct: 97  PQPLTDDHIQYFLYQILRGLKYLH-SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 120 -ASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y--- 169
                G    +V T  Y +PE + S  +Y    DIWS+G +  E  T +  FP   Y   
Sbjct: 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215

Query: 170 ---------SPPEQQDGWTSFYELMEAIVDQPP-PSAP-SDQF---SPEFCSFISACVQK 215
                    +P E+   + +  +    +   P  P  P S  F   SPE    +   +  
Sbjct: 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVF 275

Query: 216 EPQQRLSAQELMTHPFLKMYGD 237
           +P++R++A E + HP+L    D
Sbjct: 276 DPKKRITADEALAHPYLAQLHD 297

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  110 bits (277), Expect = 8e-29
 Identities = 77/224 (34%), Positives = 123/224 (54%), Gaps = 17/224 (7%)

Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLA 71
           + I +E+K  Q  + P  +     +       +++EY  G S +D L+   K + E  +A
Sbjct: 70  QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIA 128

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
           AI    L+GL YLH   ++IHRD+K  N+L+   G+VK+ DFG SA +AS    AN+FVG
Sbjct: 129 AITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPGQVKLADFG-SASIASP---ANSFVG 183

Query: 132 TYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           T  +M+PE I     G+Y  K D+WSLG+  +E A  +    P    +  ++ Y     I
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK---PPLFNMNAMSALYH----I 236

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                P+  S+++S  F +F+ +C+QK PQ R +++EL+ H F+
Sbjct: 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 1e-28
 Identities = 64/251 (25%), Positives = 118/251 (47%), Gaps = 30/251 (11%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E  ++   +E+K+ +  +   +V   ++F   G + ++ EY++   L         +P +
Sbjct: 41  EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPD 100

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT 128
            + +   Q+L+ + Y H   +IIHRD+KP N+L++  G +K+ DFG +  + +      T
Sbjct: 101 AVRSYIWQLLQAIAYCH-SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159

Query: 129 -FVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQ--FP--------YS------ 170
            +V T  Y +PE + G   YG   D+W++G ++ E   G+  FP        Y       
Sbjct: 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG 219

Query: 171 --PPEQQDGWTSFYELMEAIVDQPPPSAP-------SDQFSPEFCSFISACVQKEPQQRL 221
             PP  Q+ ++S           P PS P         + S     F+ AC++ +P++RL
Sbjct: 220 PLPPSHQELFSSNPRFAGVAF--PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Query: 222 SAQELMTHPFL 232
           +  EL+ HP+ 
Sbjct: 278 TCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  110 bits (275), Expect = 2e-28
 Identities = 70/231 (30%), Positives = 119/231 (51%), Gaps = 20/231 (8%)

Query: 11  ARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A    E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   E
Sbjct: 35  AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 94

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           E       +++  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      
Sbjct: 95  ERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE-LME 186
           TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+     QD    F   LME
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY---NQDHERLFELILME 210

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
            I  + P +      SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 211 EI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 2e-28
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 59/260 (22%)

Query: 13  RQIAQELKINQSSQCPYVV----VCYQSFYSNG-AISIILEYMDGGSLADFLKKV--KTI 65
           R+IA  LK  +S + P +V    VC+         ++++ E++D   LA +L K     +
Sbjct: 47  REIAL-LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGL 104

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI----MAS 121
           P E +  +  Q+L+G+ +LH  + I+HRDLKP N+L+   G+VKI DFG++ I    MA 
Sbjct: 105 PPETIKDLMRQLLRGVDFLHSHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL 163

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE--------CATG-------- 165
           TS      V T  Y +PE +    Y    D+WS+G +  E          T         
Sbjct: 164 TS-----VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218

Query: 166 -QFPYSPPEQQ------DGWTSFYELMEAIVDQPPPSAPSD--QFSPEFCS----FISAC 212
                 P E++         +SF           P   P     F PE C      +   
Sbjct: 219 FDVIGLPSEEEWPRNVSLPRSSF-----------PSYTPRSFKSFVPEICEEGLDLLKKM 267

Query: 213 VQKEPQQRLSAQELMTHPFL 232
           +   P +R+SA E + HP+ 
Sbjct: 268 LTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  109 bits (274), Expect = 3e-28
 Identities = 59/217 (27%), Positives = 115/217 (52%), Gaps = 9/217 (4%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
           Q+S  P++V  +  F +   + +++EY++GG L   +++ + +PEE+      ++   L 
Sbjct: 51  QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN 110

Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           +LH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + 
Sbjct: 111 FLH-ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 202
           G +YG+  D W+LG+++ E   G+ P+          +   L + I+++P         S
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LS 227

Query: 203 PEFCSFISACVQKEPQQRLSAQ------ELMTHPFLK 233
            +    +   + K+P++RL  Q      ++ +H F +
Sbjct: 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 3e-28
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 17/223 (7%)

Query: 25  SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 84
            + P++V    SF ++  + ++ +YM GG L   L+K     E+       +++  L +L
Sbjct: 53  DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 144
           H +  I++RDLKP N+L++  G + + DFG+S    + +   NTF GT  Y++PE +   
Sbjct: 113 H-KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 145 K-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 203
           K Y    D WSLG+++ E   G  P+   + Q         M   +       P +  S 
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKVRFPKNVLSD 223

Query: 204 EFCSFISACVQKEPQQRLSA----QELMTHPFLKMYGDLNVDL 242
           E   F+   + + PQ RL A     EL  HPF     D++ DL
Sbjct: 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA---DIDWDL 263

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  107 bits (269), Expect = 4e-28
 Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 11/203 (5%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLH 85
           P +V   +SF ++G + I++EY DGG L   +K  + K  PE+ +     Q+  G+ ++H
Sbjct: 58  PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 86  HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 145
            EK ++HRD+K  N+ +   G+VK+ DFG + ++ S    A T+VGT  Y+ PE      
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 146 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 205
           Y  KSDIWSLG +L E  T + P+    Q + W +    +     +P PS     +S E 
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYKPLPS----HYSYEL 228

Query: 206 CSFISACVQKEPQQRLSAQELMT 228
            S I    ++ P+ R SA  +++
Sbjct: 229 RSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  108 bits (271), Expect = 8e-28
 Identities = 66/231 (28%), Positives = 118/231 (51%), Gaps = 24/231 (10%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
           Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L 
Sbjct: 51  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           YLH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + 
Sbjct: 111 YLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSA 196
           G  YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P    
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 225

Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYGDLNVD 241
                S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 226 --RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 269

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  106 bits (266), Expect = 1e-27
 Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 15/226 (6%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--P 66
           E +R+++A    +      P +V   +SF  NG + I+++Y +GG L   +   + +  P
Sbjct: 44  EESRKEVAVLSNMKH----PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP 99

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           E+ +     Q+   L ++H  K I+HRD+K  N+ +   G +K+ DFG++ ++ ST   A
Sbjct: 100 EDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
            T +GT  Y+SPE      Y  KSDIW+LG VL E  T +  +     ++       L+ 
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-------LVL 211

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            I+    P   S  +S +  + +S   ++ P+ R S   ++   F+
Sbjct: 212 KIIRGSYPPVSS-HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 1e-27
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 14/223 (6%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICE 75
           E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +      EE       
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           ++  GL  LH E+ I++RDLKP N+L++  G ++I+D G+ A+           VGT  Y
Sbjct: 110 EITCGLEDLHRER-IVYRDLKPENILLDDYGHIRISDLGL-AVEIPEGETIRGRVGTVGY 167

Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 195
           M+PE +   +Y +  D W LG ++ E   G+ P+   +++       E +E  V +    
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR----EEVERRVKEDQEE 223

Query: 196 APSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
             S++FS    S     + K+P  RL      A+E+  HPF +
Sbjct: 224 Y-SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  107 bits (269), Expect = 1e-27
 Identities = 66/225 (29%), Positives = 115/225 (51%), Gaps = 23/225 (10%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAI 73
           E  I ++ + P++V    +F + G + +ILEY+ GG L   L++     E+    YL+ I
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
                  L +LH  + II+RDLKP N+L++ +G VK+TDFG+           +TF GT 
Sbjct: 110 ----SLALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            YM+PE +    +G   D WSLG ++ +  TG  P++   ++    +  ++++  ++ PP
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKGKLNLPP 221

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
                   +PE    +   +++ P  RL      A E+ +HPF +
Sbjct: 222 ------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 2e-27
 Identities = 72/235 (30%), Positives = 111/235 (47%), Gaps = 39/235 (16%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLH 85
           P +V   + F  N  +  + EYM+G +L   +K  K K   E  + +I  Q+L+GL ++H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 86  HEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYNYMSPER 140
             KH   HRDLKP NLL++    VKI DFG++  + S    T      +V T  Y +PE 
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-----DYVSTRWYRAPEI 169

Query: 141 I-SGGKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYE 183
           +     Y    DIW+LG ++ E  T +  FP S               P +QD W   Y+
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD-WPEGYK 228

Query: 184 LMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           L   +  + P  AP+         SPE    I   ++ +P++R +A + + HP+ 
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  105 bits (264), Expect = 2e-27
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 12/208 (5%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLH 85
           P +V  + SF  NG + I++EY DGG L   + + + +   E+ + +   Q+  GL ++H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 86  HEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 144
             K I+HRD+K  N+ ++  G V K+ DFG++  +  +   A T VGT  Y+SPE     
Sbjct: 119 DRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177

Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 204
            Y  K+DIWSLG VL E  T + P+          + ++L+  I  Q   +  S  FS +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEG-------NNLHQLVLKIC-QGYFAPISPNFSRD 229

Query: 205 FCSFISACVQKEPQQRLSAQELMTHPFL 232
             S IS   +  P+ R S   ++  PFL
Sbjct: 230 LRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  106 bits (265), Expect = 3e-27
 Identities = 66/229 (28%), Positives = 121/229 (52%), Gaps = 19/229 (8%)

Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA 72
           RQ+ + ++     Q P++V  + +F ++  + +IL+Y++GG L   L + +   E+ +  
Sbjct: 55  RQVLEHIR-----QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI 109

Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTSGQANTFVG 131
              +++  L +LH +  II+RD+K  N+L++  G V +TDFG+S         +A +F G
Sbjct: 110 YSGEIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168

Query: 132 TYNYMSPERISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 189
           T  YM+P+ + GG  G+    D WS+G+++ E  TG  P++   +++   S  E+   I+
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRIL 225

Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
              PP  P +  S      I   + K+P++RL      A E+  HPF +
Sbjct: 226 KSEPP-YPQE-MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  105 bits (263), Expect = 4e-27
 Identities = 72/198 (36%), Positives = 101/198 (51%), Gaps = 22/198 (11%)

Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           +SI +E+M GGS+ D LK    + E        Q+L+G+ YLH    I+HRD+K +N+L 
Sbjct: 81  LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH-SNMIVHRDIKGANILR 139

Query: 103 NHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  YG K+DIWS+G  
Sbjct: 140 DSVGNVKLGDFGASKRLQTICLSGTGM-KSVTGTPYWMSPEVISGEGYGRKADIWSVGCT 198

Query: 159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQK-- 215
           ++E  T +    PP     W  F E M AI      P+ P     P         +++  
Sbjct: 199 VVEMLTEK----PP-----WAEF-EAMAAIFKIATQPTNP--VLPPHVSDHCRDFLKRIF 246

Query: 216 -EPQQRLSAQELMTHPFL 232
            E + R SA EL+ H F+
Sbjct: 247 VEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  106 bits (265), Expect = 6e-27
 Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 18/229 (7%)

Query: 11  ARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A  L   ++ Q+++ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 35  AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 94

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +       +++  L YLH    +++RDLK  NL+++  G +KITDFG+     S      
Sbjct: 95  DRARFYGAEIVSALGYLH-SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+     QD    F  ++  
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY---NQDHEKLFELILME 210

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPF 231
            +  P         SPE  S ++  ++K+P+QRL      A+E+M H F
Sbjct: 211 EIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 8e-27
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 13/209 (6%)

Query: 27  CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 86
           CP++V    SF S   + ++L +++GG L   L++              ++L  L  LH 
Sbjct: 52  CPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH- 110

Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 146
           + ++I+RDLKP N+L++++G + + DFG+  +      + NTF GT  Y++PE + G  Y
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170

Query: 147 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 206
               D W+LG++L E  TG  P+      +        M   + Q P   P D F  +  
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNE--------MYRKILQEPLRFP-DGFDRDAK 221

Query: 207 SFISACVQKEPQQRL---SAQELMTHPFL 232
             +   + ++P +RL    AQE+  HPF 
Sbjct: 222 DLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  104 bits (262), Expect = 1e-26
 Identities = 71/214 (33%), Positives = 113/214 (52%), Gaps = 25/214 (11%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLY 83
           P++V  + +F + G + +IL+++ GG L   L K     EE    YLA   E  L  L +
Sbjct: 58  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELAL-ALDH 113

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 143
           LH    II+RDLKP N+L++  G +K+TDFG+S        +A +F GT  YM+PE ++ 
Sbjct: 114 LH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 144 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF-S 202
             +   +D WS G+++ E  TG  P+   ++++  T    +++A +  P       QF S
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT---MILKAKLGMP-------QFLS 222

Query: 203 PEFCSFISACVQKEPQQRLSA-----QELMTHPF 231
           PE  S + A  ++ P  RL A     +E+  HPF
Sbjct: 223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  104 bits (260), Expect = 3e-26
 Identities = 63/226 (27%), Positives = 117/226 (51%), Gaps = 25/226 (11%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
            +S  P++V  +  F +   +  ++E++ GG L   +++ + +PEE+      ++   L 
Sbjct: 51  TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           +LH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + 
Sbjct: 111 FLH-ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQP---P 193
           G  YG+  D W+LG+++ E   G+ P+        P+Q    T  Y L + I+++    P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN---TEDY-LFQVILEKQIRIP 225

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLK 233
            S      S +  S +   + K+P++RL         ++ +HPF +
Sbjct: 226 RS-----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  103 bits (259), Expect = 4e-26
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 24/213 (11%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++V  + SF +   +  +L+Y++GG L   L++ ++ PE        ++   L YLH  
Sbjct: 56  PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH-S 114

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
            +II+RDLKP N+L++ +G V +TDFG+       S   +TF GT  Y++PE +    Y 
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPPPSAPSDQFS 202
              D W LG VL E   G     PP        FY     E+ + I+++P    P+   S
Sbjct: 175 RTVDWWCLGAVLYEMLYGL----PP--------FYSRDTAEMYDNILNKPLRLKPN--IS 220

Query: 203 PEFCSFISACVQKEPQQRLSAQ----ELMTHPF 231
                 +   +QK+  +RL A+    E+  H F
Sbjct: 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 5e-26
 Identities = 70/196 (35%), Positives = 101/196 (51%), Gaps = 20/196 (10%)

Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           +SI +EYM GGS+ D LK    + E        Q+L+G+ YLH    I+HRD+K +N+L 
Sbjct: 81  LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-SNMIVHRDIKGANILR 139

Query: 103 NHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  YG K+D+WS+   
Sbjct: 140 DSAGNVKLGDFGASKRIQTICMSGTG-IKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198

Query: 159 LLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFISACVQK 215
           ++E  T + P++           YE M A   I  QP      D  S     F+     +
Sbjct: 199 VVEMLTEKPPWAE----------YEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVE 248

Query: 216 EPQQRLSAQELMTHPF 231
           E ++R +A+ L+ HPF
Sbjct: 249 E-KRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  103 bits (257), Expect = 7e-26
 Identities = 67/232 (28%), Positives = 118/232 (50%), Gaps = 22/232 (9%)

Query: 11  ARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A  L   ++ ++++ P++     SF +   +  ++EY++GG L   L + +   E
Sbjct: 35  AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE 94

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +       +++  L YLH  K I++RDLK  NL+++  G +KITDFG+     + +    
Sbjct: 95  DRTRFYGAEIVSALDYLHSGK-IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
           TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILM 209

Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +  +D       S +S  + K+P +RL      A+E+M H F 
Sbjct: 210 EDI--KFPRTLSADA-----KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  102 bits (254), Expect = 8e-26
 Identities = 65/240 (27%), Positives = 119/240 (49%), Gaps = 20/240 (8%)

Query: 19  LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 78
           L +  +  CP++V    +F++   +  IL+ M+GG L   L +     E+ +     +++
Sbjct: 48  LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL ++H+ + +++RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+P
Sbjct: 108 LGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAP 164

Query: 139 ERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 197
           E +  G  Y   +D +SLG +L +   G  P+   + +D        +   V+ P     
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP----- 219

Query: 198 SDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLNVDLSEYFTDAGSP 252
            D FSPE  S +   +Q++  +RL      AQE+  H F K      +D  + +     P
Sbjct: 220 -DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK-----GIDWQQVYLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 8e-26
 Identities = 69/260 (26%), Positives = 113/260 (43%), Gaps = 51/260 (19%)

Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEE-- 68
           +++  E +I  +   P++   Y SF +   + ++++Y  GG L   L++   K + EE  
Sbjct: 46  KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVA 105

Query: 69  --YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS---------- 116
             Y A    +VL  L YLH    I++RDLKP N+L++  G + ++DF +S          
Sbjct: 106 RFYAA----EVLLALEYLHLLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160

Query: 117 -------------------AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
                                    S ++N+FVGT  Y++PE ISG  +G   D W+LG+
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGI 220

Query: 158 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
           +L E   G  P+    +        E    I+ +      S   S      I   + K+P
Sbjct: 221 LLYEMLYGTTPFKGSNRD-------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDP 273

Query: 218 QQRL----SAQELMTHPFLK 233
            +RL     A E+  HPF +
Sbjct: 274 SKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  101 bits (254), Expect = 2e-25
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 37/244 (15%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIP--EEYLAA 72
           E+K+ Q  + P ++     F     I+++ E+M+     D L+KV   K+I      + +
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET----D-LEKVIKDKSIVLTPADIKS 106

Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT 132
                L+GL YLH    I+HRDLKP+NLLI   G +K+ DFG++    S + +    V T
Sbjct: 107 YMLMTLRGLEYLH-SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT 165

Query: 133 YNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSP-----------------PEQ 174
             Y +PE + G + YG   D+WS+G +  E    + P+ P                 P  
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPT- 223

Query: 175 QDGWTSFYELME--AIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTH 229
           ++ W     L +       PP       F   S +    +   +   P +R++A++ + H
Sbjct: 224 EENWPGVTSLPDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282

Query: 230 PFLK 233
           P+  
Sbjct: 283 PYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (251), Expect = 3e-25
 Identities = 69/250 (27%), Positives = 114/250 (45%), Gaps = 38/250 (15%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
            +  + EE  R    +E++I ++     +V    VC +    +  + +I+EY+  GSL D
Sbjct: 40  SLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS--LRLIMEYLPSGSLRD 97

Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           +L++ +  I  + L     Q+ KG+ YL   +  IHRDL   N+L+     VKI+DFG++
Sbjct: 98  YLQRHRDQINLKRLLLFSSQICKGMDYLG-SQRYIHRDLAARNILVESEDLVKISDFGLA 156

Query: 117 AIMASTS--------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 167
            ++            G++  F     + +PE +   K+   SD+WS G+ L E  T G  
Sbjct: 157 KVLPEDKDYYYVKEPGESPIF-----WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211

Query: 168 PYSPPEQ----------QDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKE 216
             SPP +          Q   T   EL++     P PPS P + +       +  C + E
Sbjct: 212 SQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY-----DLMKLCWEAE 266

Query: 217 PQQRLSAQEL 226
           PQ R S  +L
Sbjct: 267 PQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  100 bits (250), Expect = 5e-25
 Identities = 68/244 (27%), Positives = 116/244 (47%), Gaps = 27/244 (11%)

Query: 13  RQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           ++IA +E+++ +  + P +V   + F     + ++ EY D   L +  K  + +PE  + 
Sbjct: 44  KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK 103

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
            I  Q L+ + + H     IHRD+KP N+LI  +G++K+ DFG + I+         +V 
Sbjct: 104 KIIWQTLQAVNFCHKHN-CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA 162

Query: 132 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSP------------------- 171
           T  Y +PE + G  +YG   D+W++G V  E  TGQ P  P                   
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ-PLWPGKSDVDQLYLIRKTLGDLI 221

Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAP-SDQF---SPEFCSFISACVQKEPQQRLSAQELM 227
           P  Q  +++        + +P    P   +F   S    SF+  C+Q +P +RLS +EL+
Sbjct: 222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281

Query: 228 THPF 231
            HP+
Sbjct: 282 EHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 99.6 bits (248), Expect = 6e-25
 Identities = 64/221 (28%), Positives = 115/221 (52%), Gaps = 15/221 (6%)

Query: 19  LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 78
           L +  +  CP++V    +F++   +S IL+ M+GG L   L +     E  +     +++
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL ++H+ + +++RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+P
Sbjct: 108 LGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAP 164

Query: 139 ERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 197
           E +  G  Y   +D +SLG +L +   G  P+   + +D        +   V+ P     
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----- 219

Query: 198 SDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
            D FSPE  S +   +Q++  +RL      AQE+  HPF +
Sbjct: 220 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  100 bits (249), Expect = 1e-24
 Identities = 65/227 (28%), Positives = 117/227 (51%), Gaps = 17/227 (7%)

Query: 26  QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 85
           Q P++V  + +F +   + +IL+Y+ GG +   L +     E+ +     +++  L +LH
Sbjct: 63  QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH 122

Query: 86  HEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTSGQANTFVGTYNYMSPERISG- 143
            +  I++RD+K  N+L++  G V +TDFG+S   ++    +  +F GT  YM+PE I G 
Sbjct: 123 -KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Query: 144 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 203
           G +G   D WSLG+++ E  TG  P++   +++   +  E+   I+   PP        P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSEVSRRILKCDPPFPS--FIGP 236

Query: 204 EFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLN-VDLSE 244
           E    +   ++K+P++RL      A E+  HPF K    L+   L+ 
Sbjct: 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK---GLDWEALAL 280

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 97.8 bits (243), Expect = 4e-24
 Identities = 65/223 (29%), Positives = 109/223 (48%), Gaps = 14/223 (6%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICE 75
           E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +      E        
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           ++  GL  LH E+ I++RDLKP N+L++  G ++I+D G+ A+           VGT  Y
Sbjct: 110 EICCGLEDLHQER-IVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGY 167

Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 195
           M+PE +   +Y +  D W+LG +L E   GQ P+    QQ       E +E +V +    
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVQEE 223

Query: 196 APSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
             S++FSP+  S     + K+P++RL      A+E+  HP  K
Sbjct: 224 Y-SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 98.2 bits (245), Expect = 5e-24
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHH 86
           P++V  +  F +   +  ++EY  GG L   +   V + P     A C  V+ GL YLH 
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC--VVLGLQYLH- 118

Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 146
           E  I++RDLK  NLL++  G VKI DFG+         + +TF GT  +++PE ++   Y
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178

Query: 147 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 206
               D W LG+++ E   G+ P+ P + ++      E+ ++IV+      P    S E  
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPF-PGDDEE------EVFDSIVNDEVRY-PR-FLSREAI 229

Query: 207 SFISACVQKEPQQRL-----SAQELMTHPFLK 233
           S +   +++ P++RL      A+++   PF +
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 97.5 bits (243), Expect = 8e-24
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 15/211 (7%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH-S 119

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+   YG
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D W+ G++L E   GQ P+   E +D      EL ++I++       S   S E  S
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFD-GEDED------ELFQSIMEHNVSYPKS--LSKEAVS 230

Query: 208 FISACVQKEPQQRLSA-----QELMTHPFLK 233
                + K P +RL       +++  H F +
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 97.6 bits (243), Expect = 8e-24
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 20/223 (8%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           +AQE  I      P++V    SF     +  +LE++ GG L   L+K    P +      
Sbjct: 65  VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 134
            +++    YLH  K II+RDLKP NLL++++G VK+TDFG +        +  T  GT  
Sbjct: 125 AELVLAFEYLH-SKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCGTPE 180

Query: 135 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE-LMEAIVDQPP 193
           Y++PE I    +G   D W++G++L E   G     PP   D     YE ++   +  P 
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY----PPFFDDTPFRIYEKILAGRLKFP- 235

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRLSA-----QELMTHPF 231
                + F       +   +Q +  +RL        ++  HP+
Sbjct: 236 -----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 96.5 bits (240), Expect = 1e-23
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 15/225 (6%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 73
           E +I       ++V    +F +   + +++  M+GG L   +  V       PE      
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             Q++ GL +LH ++ II+RDLKP N+L+++ G V+I+D G++  +     +   + GT 
Sbjct: 103 TAQIISGLEHLH-QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + I++   
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRILND-- 216

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
                D+FSP   SF  A + K+P++RL     +   L THP  +
Sbjct: 217 SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 95.9 bits (239), Expect = 2e-23
 Identities = 60/185 (32%), Positives = 88/185 (47%), Gaps = 32/185 (17%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGT 132
           Q+L+GL Y H  + ++HRDLKP NLLI+ RGE+K+ DFG++    + S  + T+   V T
Sbjct: 111 QLLRGLAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVVT 166

Query: 133 YNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQQ------------- 175
             Y  P+ + G  +Y    D+W +G +  E ATG+  FP  +  E Q             
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE 226

Query: 176 DGW---TSFYELMEAIVDQPPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           + W   +S  E         PP      AP     P         +Q EP++R+SA E M
Sbjct: 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286

Query: 228 THPFL 232
            HP+ 
Sbjct: 287 KHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 2e-23
 Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 14/176 (7%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           V++      A ++I  E  +  S   P+VV    +C  S      + +I + M  G L D
Sbjct: 43  VLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSS-----QVQLITQLMPLGCLLD 97

Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           +++  K  I  +YL   C Q+ KG+ YL  EK ++HRDL   N+L+     VKITDFG++
Sbjct: 98  YVRNHKDNIGSQYLLNWCVQIAKGMSYLE-EKRLVHRDLAARNVLVKTPQHVKITDFGLA 156

Query: 117 AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
            ++     + +   G     +M+ E I    Y +KSD+WS G+ + E  T G  PY
Sbjct: 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 95.4 bits (237), Expect = 4e-23
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 23/213 (10%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   Y +F +   +  ++EY++GG L   ++               +++ GL +LH  
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH-S 114

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K I++RDLK  N+L++  G +KI DFG+         +  TF GT +Y++PE + G KY 
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI-VDQPPPSAPSDQFSPEFC 206
              D WS G++L E   GQ P+   +++       EL ++I +D P          P + 
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDNP--------CYPRWL 219

Query: 207 S-----FISACVQKEPQQRLSAQ-ELMTHPFLK 233
           +      +     +EP++RL  + ++  HPF +
Sbjct: 220 TREAKDILVKLFVREPERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 94.5 bits (235), Expect = 5e-23
 Identities = 73/261 (27%), Positives = 116/261 (44%), Gaps = 40/261 (15%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            I ++ EE       +E+ + +  +   +V  +   ++   + ++ EYMD     D  K 
Sbjct: 32  EIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK----DLKKY 87

Query: 62  VKT------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
           + T      +    + +   Q+LKG+ + H E  ++HRDLKP NLLIN RGE+K+ DFG 
Sbjct: 88  MDTHGVRGALDPNTVKSFTYQLLKGIAFCH-ENRVLHRDLKPQNLLINKRGELKLADFG- 145

Query: 116 SAIMASTSG-QANTF---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP 168
              +A   G   NTF   V T  Y +P+ + G + Y    DIWS+G ++ E  TG+  FP
Sbjct: 146 ---LARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202

Query: 169 YSPPEQQ-------------DGWTSFYELMEAIVDQPP-PSAPSDQFSPEF----CSFIS 210
            +  E Q               W    +L E     P  P     Q  P         + 
Sbjct: 203 GTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLH 262

Query: 211 ACVQKEPQQRLSAQELMTHPF 231
             +Q  P+ R+SA + + HP+
Sbjct: 263 RLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 93.5 bits (232), Expect = 1e-22
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 14/223 (6%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICE 75
           E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +      EE       
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           ++L GL  LH E + ++RDLKP N+L++  G ++I+D G+ A+           VGT  Y
Sbjct: 110 EILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGL-AVKIPEGESIRGRVGTVGY 167

Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 195
           M+PE ++  +Y    D W LG ++ E   GQ P+   +++       E ++  V      
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRV-LETEE 222

Query: 196 APSDQFSPEFCSFISACVQKEPQQRLSAQ-----ELMTHPFLK 233
             S +FS E  S     + K+P+QRL  Q     E+  HPF +
Sbjct: 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 93.5 bits (233), Expect = 2e-22
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 32/200 (16%)

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           EE++     Q+L+GL Y+H    +IHRDLKPSNLL+N   E++I DFG++  ++S+  + 
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164

Query: 127 NTF----VGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------- 169
             F    V T  Y +PE  +S  +Y    D+WS+G +  E    +  FP   Y       
Sbjct: 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLI 224

Query: 170 -----SPPEQ---QDGWTSFYELMEAIVDQPPPSAPSDQF----SPEFCSFISACVQKEP 217
                SP E+   + G     + ++ +  + P   P  +     SPE    +S  +Q +P
Sbjct: 225 LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQP--VPWSKIFPKASPEALDLLSQMLQFDP 282

Query: 218 QQRLSAQELMTHPFLKMYGD 237
           ++R++ ++ + HPFL  Y D
Sbjct: 283 EERITVEQALQHPFLAQYHD 302

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 93.1 bits (231), Expect = 3e-22
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 13/208 (6%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI-CEQVLKGLLYLHH 86
           P++   Y +F +   +  ++E+++GG L  F  + K   + Y A     +++ GL +LH 
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLH- 113

Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 146
            K II+RDLK  N++++  G +KI DFG+         +A+TF GT +Y++PE + G KY
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Query: 147 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 206
            +  D WS G++L E   GQ P+   ++        EL E+I     P  P    + E  
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESI-RVDTPHYPR-WITKESK 224

Query: 207 SFISACVQKEPQQRLSAQ-ELMTHPFLK 233
             +    +++P +RL     +  HPF K
Sbjct: 225 DILEKLFERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 3e-22
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 26/221 (11%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICE 75
           +E K+      P +V  Y        I I+ EYM  G L ++L++ K     E+L  +C 
Sbjct: 48  EEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS 107

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGT 132
            V + + YL      IHRDL   N L+     VK++DFG++  +     TS Q   F   
Sbjct: 108 DVCEAMEYLE-SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--P 164

Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI--- 188
             +  PE     ++  KSD+WS G+++ E  + G+ PY      + +++  E++E++   
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY------ERFSN-SEVVESVSAG 217

Query: 189 --VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
             + +P           E  + + +C  ++P+ R + ++L+
Sbjct: 218 YRLYRP------KLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 93.1 bits (231), Expect = 3e-22
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 14/210 (6%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++V  + SF +   +  +L++++GG L   L++ ++ PE        ++   L YLH  
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
             I++RDLKP N+L++ +G V +TDFG+     + S    TF GT  Y++PE I    Y 
Sbjct: 116 N-IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D W LG VL E   G  P+   +         E+ + I+ +P    P    S    S
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKPLVLRPG--ASLTAWS 225

Query: 208 FISACVQKEPQQRLSAQ----ELMTHPFLK 233
            +   ++K+ Q+RL A+    E+  HPF +
Sbjct: 226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 94.6 bits (235), Expect = 4e-22
 Identities = 71/231 (30%), Positives = 116/231 (50%), Gaps = 37/231 (16%)

Query: 27  CPY--VVVCYQSF-YSNGA-------ISIILEYMDGGSLADFLKK----VKTIPEEYLAA 72
           C +  +V C++ F   +         I+++L+Y + G L   +K      +T  E     
Sbjct: 88  CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147

Query: 73  ICEQVLKGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANT 128
           +  QVL   L +HH   KH+IHRD+K +N+L+   G VK+ DFG S + A+T       T
Sbjct: 148 LFIQVL---LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           F GT  Y++PE      Y  K+D++SLG++L E  T + P+      DG  +  E+M   
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF------DG-ENMEEVMHKT 257

Query: 189 V----DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           +    D  PPS      SPE    ++A +  +P++R S+ +L+  P  K++
Sbjct: 258 LAGRYDPLPPS-----ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303

Length = 496

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 4e-22
 Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 48/241 (19%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS------IILEYMDGGSLADFLKK---- 61
           R +   E  + +   C +VV         G +S      +++E M  G L  +L+     
Sbjct: 53  RIEFLNEASVMKEFNCHHVVRLL------GVVSTGQPTLVVMELMAKGDLKSYLRSRRPE 106

Query: 62  ------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
                 +     +    +  ++  G+ YL   K  +HRDL   N ++     VKI DFG+
Sbjct: 107 AENNPGLGPPTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVAEDLTVKIGDFGM 165

Query: 116 SAIMAST-----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           +  +  T      G+    V    +M+PE +  G +  KSD+WS G+VL E AT  + PY
Sbjct: 166 TRDIYETDYYRKGGKGLLPV---RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222

Query: 170 SPPEQQDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFC-SFISACVQKEPQQRLSAQE 225
                     S  E+++ ++D      P        P+     +  C Q  P+ R +  E
Sbjct: 223 QG-------LSNEEVLKFVIDGGHLDLPENC-----PDKLLELMRMCWQYNPKMRPTFLE 270

Query: 226 L 226
           +
Sbjct: 271 I 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 91.1 bits (227), Expect = 7e-22
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 6/143 (4%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P  +  Y S  +     +I++Y+  G L D LKK   + E  +  I  Q+++ L  LH +
Sbjct: 69  PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH-K 127

Query: 88  KHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 146
            +IIH D+K  N+L +  +  + + D+G+  I+ + S     + GT +Y SPE+I G  Y
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNY 183

Query: 147 GYKSDIWSLGLVLLECATGQFPY 169
               D W++G++  E  TG+ P+
Sbjct: 184 DVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 92.2 bits (229), Expect = 8e-22
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 49/196 (25%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           Q+L+GL Y+H    ++HRDLKPSN+LIN   ++KI DFG++ I      Q   +V T  Y
Sbjct: 116 QILRGLKYVH-SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYY 171

Query: 136 MSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQP 192
            +PE  ++  KY  + DIWS G +  E   G+  FP      Q     F  + + +    
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-----FSIITDLL---- 222

Query: 193 PPSAPSDQFSPEFCS-----FISACVQKE--------------------------PQQRL 221
               P D      CS     F+ +  ++E                          PQ+R+
Sbjct: 223 --GTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280

Query: 222 SAQELMTHPFLKMYGD 237
           SA E + HP+L  Y D
Sbjct: 281 SAAEALAHPYLAPYHD 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 91.3 bits (227), Expect = 1e-21
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 36/216 (16%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           ++ E++D   L D  K    + E  +     Q+L+G+ + H   +IIHRD+KP N+L++ 
Sbjct: 77  LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQ 135

Query: 105 RGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC 162
            G VK+ DFG +  +A+  G+  T +V T  Y +PE + G  KYG   DIW++G ++ E 
Sbjct: 136 SGVVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194

Query: 163 ATGQ--FPYSPPEQQDGWTSFYELM----------EAIVDQPPPSA----PSDQ------ 200
            TG+  FP      Q      Y ++          + I  + P  A    P  +      
Sbjct: 195 LTGEPLFPGDSDIDQ-----LYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLE 249

Query: 201 -----FSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
                 S         C++ +P  R S+ +L+ H F
Sbjct: 250 KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 91.6 bits (227), Expect = 1e-21
 Identities = 68/258 (26%), Positives = 120/258 (46%), Gaps = 25/258 (9%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           I++  EE A     +E+ + +  +   +V  +   ++  +++++ EY+D   L  +L   
Sbjct: 39  IRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC 97

Query: 63  -KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
             +I    +     Q+L+GL Y H  K ++HRDLKP NLLIN RGE+K+ DFG++   + 
Sbjct: 98  GNSINMHNVKLFLFQLLRGLNYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSI 156

Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQ--- 175
            +   +  V T  Y  P+ + G   Y  + D+W +G +  E +TG+  FP S  E+Q   
Sbjct: 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF 216

Query: 176 ----------DGWTSFYELMEAIVDQPPPSAP------SDQFSPEFCSFISACVQKEPQQ 219
                     + W       E      P          + +   +    +S  +Q E ++
Sbjct: 217 IFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRK 276

Query: 220 RLSAQELMTHPFLKMYGD 237
           R+SA+E M HP+    G+
Sbjct: 277 RISAEEAMKHPYFHCLGE 294

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 91.6 bits (227), Expect = 1e-21
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 10/194 (5%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   +  F +   +  ++EY++GG L   +++V    E        ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH-R 119

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           + II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+   YG
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D W+ G++L E   GQ P+   ++ +    F  +ME  V  P         S E  S
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIMEHNVSYP------KSLSKEAVS 230

Query: 208 FISACVQKEPQQRL 221
                + K P +RL
Sbjct: 231 ICKGLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 91.1 bits (226), Expect = 2e-21
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 21/215 (9%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   +  F +   +  ++EY++GG L   +++ +   E        +V   L++LH  
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
             +I+RDLK  N+L++  G  K+ DFG+            TF GT +Y++PE +   +YG
Sbjct: 116 G-VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG 174

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSPEF 205
              D W+LG+++ E   GQ P+    + D       L E+I+  D   P       S E 
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDVLYPV----WLSKEA 223

Query: 206 CSFISACVQKEPQQRLSA-------QELMTHPFLK 233
            S + A + K P +RL           +  HPF K
Sbjct: 224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 90.2 bits (224), Expect = 2e-21
 Identities = 69/258 (26%), Positives = 109/258 (42%), Gaps = 49/258 (18%)

Query: 7   VEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           V  SA R+I   +ELK         +V  Y   +S+  ++++ EY D     D  K   +
Sbjct: 42  VPSSALREICLLKELKHKN------IVRLYDVLHSDKKLTLVFEYCD----QDLKKYFDS 91

Query: 65  IPEEYLAAICE----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
              +    I +    Q+LKGL + H   +++HRDLKP NLLIN  GE+K+ DFG++    
Sbjct: 92  CNGDIDPEIVKSFMFQLLKGLAFCH-SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Query: 121 STSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPY---------- 169
                 +  V T  Y  P+ + G K Y    D+WS G +  E A    P           
Sbjct: 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210

Query: 170 --------SPPEQQDGWTSFYELMEAIVDQPPPSAPS--------DQFSPEFCSFISACV 213
                   +P E+   W    +L +    +P P  P+         + +      +   +
Sbjct: 211 KRIFRLLGTPTEES--WPGVSKLPD---YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLL 265

Query: 214 QKEPQQRLSAQELMTHPF 231
              P QR+SA+E + HP+
Sbjct: 266 VCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 90.0 bits (223), Expect = 3e-21
 Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 28/257 (10%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VI M  EE       +E  + +  +   +V+ +   ++   ++ + EYM    LA ++ +
Sbjct: 37  VISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQ 95

Query: 62  VKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                  Y +     Q+L+GL Y+H  +HI+HRDLKP NLLI++ GE+K+ DFG++   +
Sbjct: 96  HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154

Query: 121 STSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--YSPPEQ- 174
             S   ++ V T  Y  P+ + G   Y    DIW  G + +E   GQ  FP      EQ 
Sbjct: 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214

Query: 175 -----------QDGWTSFYELMEAIVD-QPPPSAPS-----DQFS--PEFCSFISACVQK 215
                      +D W    +L     +   P           + S  P+     S  +  
Sbjct: 215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMM 274

Query: 216 EPQQRLSAQELMTHPFL 232
            P+ R+SAQ+ + HP+ 
Sbjct: 275 FPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 90.1 bits (223), Expect = 3e-21
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 25/257 (9%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           I++  EE A     +E+ + +  +   +V  +   +++ +++++ EY+D   L  ++   
Sbjct: 39  IRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC 97

Query: 63  KTIPEEYLAAI-CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
             I   +   I   Q+L+GL Y H  K ++HRDLKP NLLIN RGE+K+ DFG++   + 
Sbjct: 98  GNIMSMHNVKIFLYQILRGLAYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSV 156

Query: 122 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQ---- 174
            +   +  V T  Y  P+ + G  +Y  + D+W +G +  E A+G+  FP S  E     
Sbjct: 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216

Query: 175 ---------QDGWTSFYELMEAIVDQPPPSAP------SDQFSPEFCSFISACVQKEPQQ 219
                    ++ W       E      P   P      + +   E    ++  +Q E ++
Sbjct: 217 IFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKK 276

Query: 220 RLSAQELMTHPFLKMYG 236
           R+SA+E M H + +  G
Sbjct: 277 RISAEEAMKHAYFRSLG 293

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 90.4 bits (224), Expect = 3e-21
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 15/215 (6%)

Query: 24  SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 83
           S + P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL +
Sbjct: 57  SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFF 116

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 143
           LH  K II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+ 
Sbjct: 117 LH-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175

Query: 144 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 203
             YG   D W+ G++L E   GQ P+   E +D    F  +ME  V  P         S 
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHNVAYP------KSMSK 226

Query: 204 EFCSFISACVQKEPQQRLSA-----QELMTHPFLK 233
           E  +     + K P +RL       +++  H F +
Sbjct: 227 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 90.5 bits (224), Expect = 5e-21
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 12/223 (5%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +
Sbjct: 92  EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAE 150

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNY 135
           V+  L  +H    +IHRD+KP N+L++  G +K+ DFG    M  T   + +T VGT +Y
Sbjct: 151 VVLALDAIH-SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209

Query: 136 MSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +SPE +      G YG + D WS+G+ L E   G  P+        ++   +   ++ + 
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL-NF 268

Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQ-QRLSAQELMTHPFLK 233
           P     S       C+F++    +E +  R   +E+  HPF K
Sbjct: 269 PEDVEISKHAKNLICAFLT---DREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 88.9 bits (220), Expect = 7e-21
 Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 22/227 (9%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEE----YLA 71
           E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +      E+    Y A
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
            +C     GL  L  E+ I++RDLKP N+L++ RG ++I+D G+ A+           VG
Sbjct: 110 ELC----CGLEDLQRER-IVYRDLKPENILLDDRGHIRISDLGL-AVQIPEGETVRGRVG 163

Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T  YM+PE I+  KY +  D W LG ++ E   GQ P+   +++         ++   DQ
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQ 221

Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
                 S++FS +  S     + K P++RL      A  +  HP  K
Sbjct: 222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 89.2 bits (221), Expect = 8e-21
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 16/212 (7%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   Y  F +   +  ++E+++GG L   ++K +   E        ++   L++LH +
Sbjct: 56  PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH-D 114

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K II+RDLK  N+L++H G  K+ DFG+           +TF GT +Y++PE +    YG
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D W++G++L E   G  P+   E +D      +L EAI++           S +   
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFE-AENED------DLFEAILND--EVVYPTWLSQDAVD 225

Query: 208 FISACVQKEPQQRLSA------QELMTHPFLK 233
            + A + K P  RL +      + ++ HPF K
Sbjct: 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 1e-20
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 33/229 (14%)

Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IP 66
           +R+  QE +I +    P +V    VC Q       I I++E + GGSL  FL+K K  + 
Sbjct: 36  KRKFLQEAEILKQYDHPNIVKLIGVCVQKQ----PIYIVMELVPGGSLLTFLRKKKNRLT 91

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-----AIMAS 121
            + L  +      G+ YL   K+ IHRDL   N L+     +KI+DFG+S      I   
Sbjct: 92  VKKLLQMSLDAAAGMEYLE-SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 180
           + G     +    + +PE ++ G+Y  +SD+WS G++L E  + G  PY       G ++
Sbjct: 151 SDGLKQIPI---KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP------GMSN 201

Query: 181 --FYELMEAIVDQPPPSAPSDQFSPEFCSFI-SACVQKEPQQRLSAQEL 226
               E +E+    P P     Q  PE    +   C   +P+ R S  E+
Sbjct: 202 QQTRERIESGYRMPAP-----QLCPEEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 88.1 bits (218), Expect = 2e-20
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 16/210 (7%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++V  + SF +   +  +L+Y++GG L   L++ +   E        +V   + YLH  
Sbjct: 56  PFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH-S 114

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
            +II+RDLKP N+L++ +G V +TDFG+           +TF GT  Y++PE +    Y 
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 148 YKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 206
              D W LG VL E   G  P YS    Q        + + I+ +P         +   C
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--------MYDNILHKPLQLPGGK--TVAAC 224

Query: 207 SFISACVQKEPQQRLSA----QELMTHPFL 232
             +   + K+ ++RL A     E+  H F 
Sbjct: 225 DLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 87.1 bits (216), Expect = 3e-20
 Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 40/243 (16%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK------- 60
              AR+   +E ++  + Q   +V  Y          ++ EYM+ G L  FL+       
Sbjct: 48  SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAA 107

Query: 61  -------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
                   +  +    L  I  Q+  G++YL   +H +HRDL   N L+ +   VKI DF
Sbjct: 108 FLKSPDSPMGELTLSQLLQIAVQIASGMVYLA-SQHFVHRDLATRNCLVGYDLVVKIGDF 166

Query: 114 GVSAIMAST-----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 167
           G+S  + +T      G     +    +M PE I   K+  +SD+WS G+VL E  T G+ 
Sbjct: 167 GMSRDVYTTDYYRVGGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Query: 168 PYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 223
           P+          S  E++E I    + Q P + P      E    +  C +++PQQR++ 
Sbjct: 224 PWYG-------LSNEEVIECITQGRLLQRPRTCP-----SEVYDIMLGCWKRDPQQRINI 271

Query: 224 QEL 226
           +++
Sbjct: 272 KDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 87.9 bits (218), Expect = 3e-20
 Identities = 65/236 (27%), Positives = 107/236 (45%), Gaps = 35/236 (14%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----- 68
              +E  I   S  P++     +F     + +++EY  GG L   L + +   +E     
Sbjct: 47  FFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF 106

Query: 69  YLAAICEQVLKGLLYLH--HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           YLA +       +L +H  H+   +HRD+KP N+LI+  G +K+ DFG +A + + +   
Sbjct: 107 YLAEL-------VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMV 158

Query: 127 NTF--VGTYNYMSPERI------SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
           N+   VGT +Y++PE +        G YG + D WSLG++  E   G+ P+        +
Sbjct: 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY 218

Query: 179 TSFYELMEAIVDQPPPSAPSD-QFSPEFCSFISA--CVQKEPQQRLSAQELMTHPF 231
            +       +        P D + S +F   I +  C QKE   RL  + L  HPF
Sbjct: 219 NNIMNFQRFL------KFPEDPKVSSDFLDLIQSLLCGQKE---RLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 88.0 bits (218), Expect = 4e-20
 Identities = 67/263 (25%), Positives = 104/263 (39%), Gaps = 65/263 (24%)

Query: 25  SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE---YLAAICEQVLKGL 81
           S  P+VV  Y SF     + +I+E++ GG L   L K  T  E+   +  A C   ++ +
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 82  LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA------------------------ 117
               H+   IHRD+KP N+LI+  G +K++DFG+S                         
Sbjct: 118 ----HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 118 ------------IMASTSGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWS 154
                       +  S+  Q  T+           VGT +Y++PE      YG + D WS
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233

Query: 155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFISACV 213
           LG ++ EC  G  P+      + +       E +        P D   S E    I   +
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRETL------YFPDDIHLSVEAEDLIRRLI 287

Query: 214 QKEPQQRL---SAQELMTHPFLK 233
               + RL    A E+ +HPF +
Sbjct: 288 T-NAENRLGRGGAHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 85.8 bits (213), Expect = 6e-20
 Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 27/189 (14%)

Query: 43  ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           I I+ EYM  GSL DFLK    K +    L  +  Q+ +G+ YL   ++ IHRDL   N+
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNI 134

Query: 101 LINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
           L+      KI DFG++ ++     T+ +   F     + +PE  + G++  KSD+WS G+
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIKSDVWSFGI 192

Query: 158 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ----P-PPSAPSDQFSPEFCSFISA 211
           +L E  T G+ PY       G T+  E++E  V++    P PP+ P      E    +  
Sbjct: 193 LLTEIVTYGRVPYP------GMTN-REVLEQ-VERGYRMPRPPNCP-----EELYDLMLQ 239

Query: 212 CVQKEPQQR 220
           C  K+P++R
Sbjct: 240 CWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 87.6 bits (217), Expect = 6e-20
 Identities = 71/284 (25%), Positives = 103/284 (36%), Gaps = 82/284 (28%)

Query: 12  RRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           R Q A    E  I   +   +VV  Y SF     +  +++Y+ GG +   L ++    E+
Sbjct: 42  RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED 101

Query: 69  Y-------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG------- 114
                   L    E V        H+   IHRD+KP N+LI+  G +K+TDFG       
Sbjct: 102 LARFYIAELTCAIESV--------HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153

Query: 115 -----------------------VSAIMAS-------------TSGQANTFVGTYNYMSP 138
                                   S I                    A++ VGT NY++P
Sbjct: 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213

Query: 139 ERISGGKYGYKSDIWSLGLVLLECATGQFPY---SPPEQQD---GWTSFYELMEAIVDQP 192
           E +    Y    D WS+G++L E   GQ P+   +P E Q     W +   +        
Sbjct: 214 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHI-------- 265

Query: 193 PPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 233
           P  A   + S E    I        + RL    A E+  HPF K
Sbjct: 266 PSQA---KLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 86.6 bits (215), Expect = 8e-20
 Identities = 61/186 (32%), Positives = 89/186 (47%), Gaps = 29/186 (15%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           Q+L+GL Y+H    IIHRDLKPSN+ +N   E+KI DFG++     T  +   +V T  Y
Sbjct: 126 QILRGLKYIH-SAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWY 181

Query: 136 MSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-------DGWTSFYELM 185
            +PE + +   Y    DIWS+G ++ E  TG+  FP S    Q        G T   EL+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG-TPDEELL 240

Query: 186 EAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSAQELMTHPF 231
           + I         Q  P  P   F       +P     +   +  +P +R++A E + HP+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Query: 232 LKMYGD 237
           L  Y D
Sbjct: 301 LAEYHD 306

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 86.0 bits (213), Expect = 9e-20
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 34/220 (15%)

Query: 41  GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           GA  ++ EYMD   +      +    E+++ +  +Q+L+GL Y H +K+ +HRD+K SN+
Sbjct: 89  GAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH-KKNFLHRDIKCSNI 147

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGG-KYGYKSDIWSLGLV 158
           L+N++G++K+ DFG++ +  S   +  T  V T  Y  PE + G  +YG   D+WS G +
Sbjct: 148 LLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 207

Query: 159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--------------PSDQFS-- 202
           L E     F   P  Q +   +  EL+  +   P P+               P  Q+   
Sbjct: 208 LGEL----FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRR 263

Query: 203 --PEFCSFISA--------CVQKEPQQRLSAQELMTHPFL 232
              EF SFI           +  +P +R +A+E +  P+L
Sbjct: 264 LREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 86.5 bits (215), Expect = 9e-20
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 47/195 (24%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG----VSAIMASTSGQANT-FV 130
           Q+LK L Y+H   ++IHRDLKPSN+L+N    VK+ DFG    +S +  +      T +V
Sbjct: 115 QLLKALKYIH-SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 131 GTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPE 173
            T  Y +PE + G  +Y    D+WS+G +L E   G+  FP +              PP 
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233

Query: 174 QQD--------GWTSFYELMEAIVDQPP-------PSAPSDQFSPEFCSFISACVQKEPQ 218
            +D          T    +++++  +P        P A  D         +   +   P 
Sbjct: 234 AEDIESIKSPFAAT----MLDSLPSRPRKPLDELLPKASDDAL-----DLLKKLLVFNPN 284

Query: 219 QRLSAQELMTHPFLK 233
           +RL+A+E + HP++ 
Sbjct: 285 KRLTAEEALEHPYVA 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.0 bits (210), Expect = 1e-19
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 8/158 (5%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICE 75
           +E ++      P +V  Y        I ++ E+M+ G L+D+L+  +    +E L  +C 
Sbjct: 48  EEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL 107

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGT 132
            V +G+ YL    ++IHRDL   N L+     VK++DFG++  +     TS     F   
Sbjct: 108 DVCEGMAYLE-SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--P 164

Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
             + SPE  S  KY  KSD+WS G+++ E  + G+ PY
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 86.2 bits (213), Expect = 1e-19
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 16/218 (7%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++V  + SF +   +  +L+Y++GG L   L++ +   E        ++   L YLH  
Sbjct: 56  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH-S 114

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
            +I++RDLKP N+L++ +G + +TDFG+       +G  +TF GT  Y++PE +    Y 
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D W LG VL E   G  P+             E+ + I+++P    P+   S     
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKPLQLKPNITNSAR--H 225

Query: 208 FISACVQKEPQQRLSAQ----ELMTHPFLKM--YGDLN 239
            +   +QK+  +RL A+    E+  H F     + DL 
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 86.2 bits (213), Expect = 2e-19
 Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 12/223 (5%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +
Sbjct: 92  EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAE 150

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNY 135
           V+  L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y
Sbjct: 151 VVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209

Query: 136 MSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +SPE +      G YG + D WS+G+ L E   G  P+        ++       ++   
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-F 268

Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQ-QRLSAQELMTHPFLK 233
           P  +  S +     C+F++    +E +  R   +E+  H F K
Sbjct: 269 PDDNDISKEAKNLICAFLT---DREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.5 bits (209), Expect = 2e-19
 Identities = 50/147 (34%), Positives = 80/147 (54%), Gaps = 15/147 (10%)

Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK  +   +    L  +  Q+ +G+ ++  
Sbjct: 67  YAVVTQEPIY------IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE- 119

Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
            K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 177

Query: 144 GKYGYKSDIWSLGLVLLECAT-GQFPY 169
           G +  KSD+WS G++L E  T G+ PY
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 85.0 bits (211), Expect = 2e-19
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 29/215 (13%)

Query: 43  ISIILEYM--DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           I +++EY+  D  SL + +K+     E  +  +  Q+L G+ +LH +  I+HRDLK SNL
Sbjct: 81  IYMVMEYVEHDLKSLMETMKQPFLQSE--VKCLMLQLLSGVAHLH-DNWILHRDLKTSNL 137

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVL 159
           L+N+RG +KI DFG++    S        V T  Y +PE + G K Y    D+WS+G + 
Sbjct: 138 LLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIF 197

Query: 160 LECATGQ--FP-YSPPEQ------------QDGWTSFYELMEA---IVDQPPPSAPSDQF 201
            E  T +  FP  S  +Q            +  W  F EL  A      + P +    +F
Sbjct: 198 AELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKF 257

Query: 202 SPEFCS-----FISACVQKEPQQRLSAQELMTHPF 231
                S      ++  +  +P +R+SA++ + HP+
Sbjct: 258 PALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 84.0 bits (208), Expect = 2e-19
 Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 12/179 (6%)

Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E M+ GSL  FL+    + +P   L  +  QV +G+ YL  E++ IHRDL   N+L+
Sbjct: 79  IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE-EQNSIHRDLAARNILV 137

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                 K+ DFG++ ++      ++     Y + +PE  S G +  KSD+WS G++L E 
Sbjct: 138 GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEM 197

Query: 163 AT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            T GQ PY      +    + ++        P   P      E    +  C   EP+ R
Sbjct: 198 FTYGQVPYPGMNNHE---VYDQITAGYRMPCPAKCP-----QEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 30/232 (12%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           +E  I   +   ++V  + +F  +  + +++EYM GG L + +     IPE++      +
Sbjct: 92  EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAE 150

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYN 134
           V+  L  +H     IHRD+KP N+L++  G +K+ DFG    M +  G    +T VGT +
Sbjct: 151 VVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPD 208

Query: 135 YMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           Y+SPE +      G YG + D WS+G+ L E   G      P   D     Y     I+D
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD----TPFYADSLVGTY---SKIMD 261

Query: 191 Q------PPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 233
                  P     S Q     C+F++       + RL      E+ +HPF K
Sbjct: 262 HKNSLTFPDDIEISKQAKDLICAFLTD-----REVRLGRNGVDEIKSHPFFK 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.0 bits (208), Expect = 4e-19
 Identities = 70/248 (28%), Positives = 110/248 (44%), Gaps = 47/248 (18%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
               R   +E++I +S Q   +V    VCY +   N  + +++EY+  GSL D+L+K + 
Sbjct: 46  AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRE 103

Query: 65  -IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI----- 118
            +    L     Q+ KG+ YL   K  +HRDL   N+L+     VKI DFG++ +     
Sbjct: 104 RLDHRKLLLYASQICKGMEYLG-SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162

Query: 119 ---MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY-----S 170
                   G++  F     + +PE ++  K+   SD+WS G+VL E     F Y     S
Sbjct: 163 EYYKVREPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYEL----FTYSDKSCS 213

Query: 171 PPE--------QQDGWTSFYELMEAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQ 218
           PP          + G    Y L+E + +      PP  P+     E  + +  C   +P 
Sbjct: 214 PPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPA-----EIYAIMKECWNNDPS 268

Query: 219 QRLSAQEL 226
           QR S  EL
Sbjct: 269 QRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.8 bits (207), Expect = 4e-19
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 34/203 (16%)

Query: 40  NGAISIILEYMDGGSLADFLKKVK---------TIPEEYLAAICEQVLKGLLYLHHEKHI 90
           N    II+E M+GG L  +L+  +         T+ E  L  IC  V KG +YL  + H 
Sbjct: 71  NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE--LLDICLDVAKGCVYLE-QMHF 127

Query: 91  IHRDLKPSNLLINHRGE-----VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPER 140
           IHRDL   N L++ +G      VKI DFG++  +  +      G+    V    +M+PE 
Sbjct: 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---RWMAPES 184

Query: 141 ISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 199
           +  GK+  +SD+WS G+++ E  T GQ PY     Q+       +      Q P + P  
Sbjct: 185 LLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVTAGGRLQKPENCPDK 241

Query: 200 QFSPEFCSFISACVQKEPQQRLS 222
            +       ++ C  ++P +R +
Sbjct: 242 IY-----QLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 83.9 bits (207), Expect = 5e-19
 Identities = 65/253 (25%), Positives = 119/253 (47%), Gaps = 25/253 (9%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           I++  EE A     +E+ + ++ +   +V  +   ++   ++++ EY+D   L  +L   
Sbjct: 38  IRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC 96

Query: 63  KTIPEEYLAAICE-QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
             +   +   I   Q+L+GL Y H  K I+HRDLKP NLLIN +GE+K+ DFG++   + 
Sbjct: 97  GNLMSMHNVKIFMFQLLRGLSYCHKRK-ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155

Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYSPPEQ---- 174
            +   +  V T  Y  P+ + G  +Y    D+W +G +L E ATG+  FP S  ++    
Sbjct: 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215

Query: 175 ---------QDGW---TSFYELMEAIVDQPPPSA---PSDQFSPEFCSFISACVQKEPQQ 219
                    ++ W   TS  E    +  Q         + +   +    +S+ +  E + 
Sbjct: 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKS 275

Query: 220 RLSAQELMTHPFL 232
           R+SA+  + H + 
Sbjct: 276 RISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.5 bits (206), Expect = 6e-19
 Identities = 72/245 (29%), Positives = 109/245 (44%), Gaps = 39/245 (15%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK---- 61
              ESAR+   +E ++    Q  ++V  Y        + ++ EYM  G L  FL+     
Sbjct: 45  EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 104

Query: 62  VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 110
            K +               + AI  Q+  G++YL    H +HRDL   N L+     VKI
Sbjct: 105 AKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLVGQGLVVKI 163

Query: 111 TDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT- 164
            DFG+S  + ST      G+    +    +M PE I   K+  +SDIWS G+VL E  T 
Sbjct: 164 GDFGMSRDIYSTDYYRVGGRTMLPI---RWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220

Query: 165 GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 221
           G+ P+   S  E  +  T   EL      + P + P     PE  + +  C Q+EPQQR+
Sbjct: 221 GKQPWYQLSNTEAIECITQGREL------ERPRTCP-----PEVYAIMQGCWQREPQQRM 269

Query: 222 SAQEL 226
             +++
Sbjct: 270 VIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 84.3 bits (208), Expect = 6e-19
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 27/225 (12%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            +  E KI      P+ V  Y SF     + ++LE++ GG    FL++ K  P +     
Sbjct: 77  HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY 136

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             Q++    YL    +I++RDLKP NLL++  G +K+TDFG + ++ +   +  T  GT 
Sbjct: 137 AAQIVLIFEYLQ-SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTP 192

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            Y++PE +    +G  +D W+LG+ + E   G  P+   E       + +++E I+  P 
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKILEGIIYFP- 248

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 238
                 +F    C  +              ++L++H   K YG+L
Sbjct: 249 ------KFLDNNCKHL-------------MKKLLSHDLTKRYGNL 274

Length = 340

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 6e-19
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 27/189 (14%)

Query: 43  ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           I I+ E M  GSL ++L+    + +    L  +  QV  G+ YL   ++ IHRDL   N+
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNV 134

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGL 157
           L+      K+ DFG++ ++     +A    G      + +PE     ++  KSD+WS G+
Sbjct: 135 LVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFSIKSDVWSFGI 192

Query: 158 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISA 211
           +L E  T G+ PY       G T+  E+++  VDQ      PP  P      E    +  
Sbjct: 193 LLTEIVTYGRMPYP------GMTN-AEVLQQ-VDQGYRMPCPPGCP-----KELYDIMLD 239

Query: 212 CVQKEPQQR 220
           C +++P  R
Sbjct: 240 CWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.4 bits (203), Expect = 9e-19
 Identities = 71/232 (30%), Positives = 103/232 (44%), Gaps = 41/232 (17%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLK------KVKTIP 66
           QE +I +    P +V    VC Q       I I++E + GG    FL+      KVK   
Sbjct: 42  QEARILKQYSHPNIVRLIGVCTQ----KQPIYIVMELVQGGDFLTFLRTEGPRLKVKE-- 95

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-----AIMAS 121
              L  + E    G+ YL   KH IHRDL   N L+  +  +KI+DFG+S      + AS
Sbjct: 96  ---LIQMVENAAAGMEYLE-SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTS 180
           T G     V    + +PE ++ G+Y  +SD+WS G++L E  + G  PY+    Q     
Sbjct: 152 TGGMKQIPV---KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--- 205

Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS----AQELMT 228
             E +E  V  P P    +         +  C + +P QR S     QEL +
Sbjct: 206 -REAIEQGVRLPCP----ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 83.1 bits (205), Expect = 1e-18
 Identities = 52/168 (30%), Positives = 90/168 (53%), Gaps = 3/168 (1%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E  +    +ELK+ ++ +   +V   ++F   G + ++ EY++   L    +    +P E
Sbjct: 41  EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE 100

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT 128
            + +   Q++K + + H +  I+HRD+KP NLLI+H   +K+ DFG +  ++  S    T
Sbjct: 101 KVRSYIYQLIKAIHWCH-KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159

Query: 129 -FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
            +V T  Y SPE + G  YG   D+WS+G +L E + GQ P  P E +
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ-PLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 83.1 bits (205), Expect = 2e-18
 Identities = 49/164 (29%), Positives = 88/164 (53%), Gaps = 16/164 (9%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEE----YLA 71
           +E  +  +  C ++   + +F     + ++++Y  GG L   L K +  +PE+    Y+A
Sbjct: 50  EERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA 109

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFV 130
              E VL   ++  H+ H +HRD+KP N+L++  G +++ DFG    +    + Q++  V
Sbjct: 110 ---EMVLA--IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164

Query: 131 GTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 169
           GT +Y+SPE +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 82.2 bits (203), Expect = 2e-18
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 40/250 (16%)

Query: 17  QELKINQS-SQCPYVV--VCYQSFYSNGA---ISIILEYMDGGSLADFL-----KKVKTI 65
           +E+ + Q  S+  Y+V  +  +          + ++ EY+D   L  F+        + +
Sbjct: 49  REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPL 107

Query: 66  PEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTS 123
           P + + +   Q+LKG+ + H  KH ++HRDLKP NLL++ +  + KI D G+    +   
Sbjct: 108 PAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165

Query: 124 GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP------------ 168
                 + T  Y +PE + G   Y    DIWS+G +  E +  Q  FP            
Sbjct: 166 KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225

Query: 169 ---YSPPEQQDGWTSFYELME-AIVDQPPP---SAPSDQFSPEFCSFISACVQKEPQQRL 221
               +P EQ   W    +L +     Q  P   S      SPE    +   ++ +P +R+
Sbjct: 226 KLLGTPTEQV--WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI 283

Query: 222 SAQELMTHPF 231
           SA+  +THP+
Sbjct: 284 SAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 82.4 bits (204), Expect = 2e-18
 Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 34/190 (17%)

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI------MASTSGQANT 128
            Q+L+G+ YLH E HI+HRD+K +N+LI+++G +KI DFG++             G   T
Sbjct: 122 LQLLEGINYLH-ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Query: 129 -----FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPYS---------- 170
                 V T  Y  PE + G + Y    DIW +G V  E  T +                
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240

Query: 171 ----PPEQQD--GWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRL 221
                P ++   GW S             P    ++F    PE    +S  +  +P +RL
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300

Query: 222 SAQELMTHPF 231
           +A + + HP+
Sbjct: 301 TASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 40  NGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 98
            G ++++ E MD  +L + +K  K  +PE+ + +   Q+LK L ++H    I HRD+KP 
Sbjct: 72  TGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPE 129

Query: 99  NLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGL 157
           N+LI     +K+ DFG S     +      ++ T  Y +PE + + G YG K DIW++G 
Sbjct: 130 NILI-KDDILKLADFG-SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGC 187

Query: 158 VLLECATGQFPYSPPEQQ-DGWTSFYELM-----EAIVDQPPPSAPSDQF---------- 201
           V  E  +  FP  P   + D     ++++     E +         +  F          
Sbjct: 188 VFFEILS-LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRK 246

Query: 202 -----SPEFCSFISACVQKEPQQRLSAQELMTHPF 231
                S E    +   +  +P +R++A++ + HP+
Sbjct: 247 LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 82.5 bits (204), Expect = 2e-18
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 43/227 (18%)

Query: 42  AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           ++ I+ EYM+   LA+ L++   + EE+      Q+L+GL Y+H   +++HRDLKP+N+ 
Sbjct: 90  SVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANVF 146

Query: 102 INHRGEV-KITDFGVSAIMA---STSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLG 156
           IN    V KI DFG++ I+    S  G  +  + T  Y SP  + S   Y    D+W+ G
Sbjct: 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 206

Query: 157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP----------------------- 193
            +  E  TG+  ++   +        E M+ I++  P                       
Sbjct: 207 CIFAEMLTGKPLFAGAHE-------LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG 259

Query: 194 -PSAPSDQFSPEFCS----FISACVQKEPQQRLSAQELMTHPFLKMY 235
            P  P     P        F+   +   P  RL+A+E + HP++  Y
Sbjct: 260 EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 29/226 (12%)

Query: 30  VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH---- 85
           +V  +  F S+  + +I+EY  GG   D  K++K   +E+L     +V  GLL+      
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGG---DLNKQIKQRLKEHLPFQEYEV--GLLFYQIVLA 181

Query: 86  ----HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPE 139
               H + ++HRDLK +N+ +   G +K+ DFG S   + +     A++F GT  Y++PE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 140 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSA 196
                +Y  K+D+WSLG++L E  T   P+  P Q+       E+M+ ++     P P  
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-------EIMQQVLYGKYDPFPCP 294

Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 242
            S        + +   + K P  R + Q+L+   FLK   +L  D+
Sbjct: 295 VSSGMK----ALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDI 336

Length = 478

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 82.1 bits (203), Expect = 3e-18
 Identities = 67/258 (25%), Positives = 111/258 (43%), Gaps = 46/258 (17%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KT-IPEEYLAA 72
           +ELKI    +   ++     +     I+++++ M        LKKV   K  + E  +  
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-----LKKVVDRKIRLTESQVKC 123

Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQA 126
           I  Q+L GL  LH + + +HRDL P+N+ IN +G  KI DFG++          + S   
Sbjct: 124 ILLQILNGLNVLH-KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 127 NTF--------VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQ-D 176
                      V T  Y +PE + G  KY +  D+WS+G +  E  TG+ P  P E + D
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEID 241

Query: 177 GWTSFYELMEAIVDQPPPSAPS----DQFSP----------EFCS-----FISACVQKEP 217
                +EL+    +   P A       +F+P             S      + + ++  P
Sbjct: 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301

Query: 218 QQRLSAQELMTHPFLKMY 235
            +R+SA+E + H + K  
Sbjct: 302 LERISAKEALKHEYFKSD 319

Length = 335

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 81.2 bits (200), Expect = 5e-18
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)

Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L KV    +P E +  +  Q L+GL +LH    I+HRDLKP N+
Sbjct: 82  VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENI 139

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
           L+   G+VK+ DFG++ I  S        V T  Y +PE +    Y    D+WS+G +  
Sbjct: 140 LVTSGGQVKLADFGLARIY-SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198

Query: 161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAPSDQFSPEFCSFISACVQK-- 215
           E    +  +    + D     ++L+    +   P   + P   FSP     + + V +  
Sbjct: 199 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIE 258

Query: 216 -------------EPQQRLSAQELMTHPFL 232
                         P +R+SA   + HPF 
Sbjct: 259 ESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 81.3 bits (201), Expect = 5e-18
 Identities = 42/122 (34%), Positives = 65/122 (53%), Gaps = 6/122 (4%)

Query: 43  ISIILEY--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           I +++EY   D  SL D +    +  +  +  +  Q+L+GL YLH    IIHRDLK SNL
Sbjct: 83  IFLVMEYCEQDLASLLDNMPTPFSESQ--VKCLMLQLLRGLQYLHEN-FIIHRDLKVSNL 139

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVL 159
           L+  +G +KI DFG++      +      V T  Y +PE + G      + D+W++G +L
Sbjct: 140 LLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCIL 199

Query: 160 LE 161
            E
Sbjct: 200 AE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 6e-18
 Identities = 56/171 (32%), Positives = 88/171 (51%), Gaps = 16/171 (9%)

Query: 8   EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
             + +++  +E  +      P +V    VC         + +++E    G L  +LKK +
Sbjct: 36  IAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLVMELAPLGPLLKYLKKRR 90

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMA-S 121
            IP   L  +  QV  G+ YL   KH +HRDL   N+L+ +R + KI+DFG+S A+ A S
Sbjct: 91  EIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149

Query: 122 TSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
              +A T  G +   + +PE I+ GK+  KSD+WS G+ L E  + G  PY
Sbjct: 150 DYYRATT-AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 82.6 bits (204), Expect = 9e-18
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 11/131 (8%)

Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           + EY+ G +L + L     +P      +  QVL  L   H  + I+HRDLKP N++++  
Sbjct: 57  VFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAH-NQGIVHRDLKPQNIMVSQT 115

Query: 106 G---EVKITDFGVSAIM-------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 155
           G     K+ DFG+  ++        +T  +    +GT  Y +PE++ G      SD+++ 
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 156 GLVLLECATGQ 166
           GL+ LEC TGQ
Sbjct: 176 GLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.9 bits (197), Expect = 1e-17
 Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 26/221 (11%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICE 75
           +E K+      P +V  Y        + I+ E+M+ G L ++L++ +  + ++ L ++C+
Sbjct: 48  EEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ 107

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGT 132
            V +G+ YL      IHRDL   N L++  G VK++DFG++  +     TS     F   
Sbjct: 108 DVCEGMEYLE-RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--P 164

Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ 191
             +  PE  +  KY  KSD+WS G+++ E  T G+ P+          S YE++E I   
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-------KSNYEVVEMI--- 214

Query: 192 PPPSAPSDQFSPEFCS-----FISACVQKEPQQRLSAQELM 227
              S     + P+  S      + +C  ++P+ R +  EL+
Sbjct: 215 ---SRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 59/182 (32%), Positives = 88/182 (48%), Gaps = 26/182 (14%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYN 134
           Q+L+GL YLH    I+HRD+KP NLL+N    +KI DFG++ +      +  T  V T  
Sbjct: 111 QILRGLKYLH-SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 135 YMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPY---SPPEQQD------GWTSFYEL 184
           Y +PE + G + Y    DIWS+G +  E    +  +   SP +Q D      G  S   +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229

Query: 185 MEA-------IVDQP--PPSAP-----SDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
             A       I+  P  PPS P     S Q + E    +   +  +P +R+SA + + HP
Sbjct: 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289

Query: 231 FL 232
           +L
Sbjct: 290 YL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.6 bits (196), Expect = 1e-17
 Identities = 54/178 (30%), Positives = 91/178 (51%), Gaps = 17/178 (9%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           V++   E+S R ++ +E +I      PY+V    VC        A+ +++E   GG L  
Sbjct: 29  VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVMEMASGGPLNK 83

Query: 58  FLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           FL  K   I    +  +  QV  G+ YL   K+ +HRDL   N+L+ ++   KI+DFG+S
Sbjct: 84  FLSGKKDEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLVNQHYAKISDFGLS 142

Query: 117 AIMASTSG--QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
             + +     +A +  G +   + +PE I+  K+  +SD+WS G+ + E  + GQ PY
Sbjct: 143 KALGADDSYYKARSA-GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 2e-17
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 28/201 (13%)

Query: 36  SFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 93
               N  + I+ EYM  GSL D+L+      I           V +G+ YL  EK+ +HR
Sbjct: 69  VLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE-EKNFVHR 126

Query: 94  DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSD 151
           DL   N+L++     K++DFG++    ++ GQ     G     + +PE +   K+  KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQD---SGKLPVKWTAPEALREKKFSTKSD 181

Query: 152 IWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFC 206
           +WS G++L E  + G+ PY P           +++  +      + P   P     PE  
Sbjct: 182 VWSFGILLWEIYSFGRVPY-PRIPLK------DVVPHVEKGYRMEAPEGCP-----PEVY 229

Query: 207 SFISACVQKEPQQRLSAQELM 227
             +  C + +P +R + ++L 
Sbjct: 230 KVMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 2e-17
 Identities = 45/170 (26%), Positives = 83/170 (48%), Gaps = 8/170 (4%)

Query: 4   QMNVEESAR-RQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
            M + E  R +Q      E ++ +    P+++  + + +    + +++EY+ GG L  +L
Sbjct: 33  VMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL 92

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
           +               +++  L YLH  K I++RDLKP N+L++  G +K+TDFG +   
Sbjct: 93  RNSGRFSNSTGLFYASEIVCALEYLH-SKEIVYRDLKPENILLDKEGHIKLTDFGFA--- 148

Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
                +  T  GT  Y++PE I    +    D W+LG+++ E   G  P+
Sbjct: 149 KKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 77.4 bits (191), Expect = 2e-17
 Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 28/189 (14%)

Query: 53  GSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
            SLAD L+     + EE + A+C Q L  L  LH +        K  N+L+   G +K+ 
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA-------KSGNILLTWDGLLKL- 52

Query: 112 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 171
             G  A          +    Y +M+PE I G  Y  K+DI+SLG+ L E    + PY+ 
Sbjct: 53  -DGSVAFK----TPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106

Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-------FCSFISACVQKEPQQRLSAQ 224
             +         ++E +++  P   P D+ + E       F  F+  C  + PQ+R +A 
Sbjct: 107 ERE------LSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN 160

Query: 225 ELMTHPFLK 233
             + H    
Sbjct: 161 HYLAHCRAL 169

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.9 bits (194), Expect = 2e-17
 Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 30/230 (13%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           QI ++L+ ++  Q  Y VV  +  Y      I+ EYM  GSL DFLK    +   +P   
Sbjct: 53  QIMKKLRHDKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKDGEGRALKLPN-- 103

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  QV  G+ Y+    +I HRDL+ +N+L+      KI DFG++ ++     T+ Q 
Sbjct: 104 LVDMAAQVAAGMAYIERMNYI-HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     +       E++
Sbjct: 163 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------EVL 213

Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           E +        P D         +  C +K+P++R + + L +  FL+ Y
Sbjct: 214 EQVERGYRMPCPQDC-PISLHELMLQCWKKDPEERPTFEYLQS--FLEDY 260

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 80/291 (27%), Positives = 117/291 (40%), Gaps = 71/291 (24%)

Query: 12  RRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           R Q+A    E  I   +   +VV  Y SF     +  +++Y+ GG +   L ++   PE+
Sbjct: 42  RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED 101

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST------ 122
            LA      L   +   H+   IHRD+KP N+LI+  G +K+TDFG+      T      
Sbjct: 102 -LARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160

Query: 123 -SGQ----------------------------------------ANTFVGTYNYMSPERI 141
            SG                                         A++ VGT NY++PE +
Sbjct: 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220

Query: 142 SGGKYGYKSDIWSLGLVLLECATGQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y    D WS+G++L E   GQ P+   +P E Q         M+ I  Q     P 
Sbjct: 221 LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ---------MKVINWQTSLHIPP 271

Query: 199 D-QFSPEFCSFI-SACVQKEPQQRL---SAQELMTHPFLKMYGDLNVDLSE 244
             + SPE    I   C  + P+ RL    A E+  HPF K   D + DL +
Sbjct: 272 QAKLSPEASDLIIKLC--RGPEDRLGKNGADEIKAHPFFKTI-DFSSDLRQ 319

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 70/255 (27%), Positives = 108/255 (42%), Gaps = 56/255 (21%)

Query: 24  SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLK 79
            +  P+VV  Y SF     + +I+EY+ GG +   L K  T  EE    Y+A   E +L 
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA---ETILA 113

Query: 80  GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV------------------------ 115
             +   H+   IHRD+KP NLL++ +G +K++DFG+                        
Sbjct: 114 --IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 116 ---SAIMASTSGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
               +   S+  +A T+           VGT +Y++PE      Y  + D WSLG+++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 221
              G  P+     Q+ +       E +  Q P   P    SPE    I      E ++RL
Sbjct: 232 MLVGYPPFCSDNPQETYRKIINWKETL--QFPDEVP---LSPEAKDLIKRLCC-EAERRL 285

Query: 222 ---SAQELMTHPFLK 233
                 E+ +HPF K
Sbjct: 286 GNNGVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 79.7 bits (196), Expect = 3e-17
 Identities = 48/152 (31%), Positives = 83/152 (54%), Gaps = 16/152 (10%)

Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEE----YLAAICEQVLKGLLY 83
           ++   + +F     + ++++Y  GG L   L K +  +PE+    YLA   E V+   + 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA---EMVIA--ID 116

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPERIS 142
             H+ H +HRD+KP N+L++  G +++ DFG    +M   + Q++  VGT +Y+SPE + 
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 143 G-----GKYGYKSDIWSLGLVLLECATGQFPY 169
                 GKYG + D WSLG+ + E   G+ P+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 78.7 bits (194), Expect = 3e-17
 Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 15/187 (8%)

Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 79  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 137

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 138 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 197

Query: 162 CAT-GQFPYSPPEQQDGWTSFYELME-AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +        YEL+E     + P   P     P+    + AC Q  P  
Sbjct: 198 IATYGMSPYPGIDLSQ----VYELLEKGYRMERPEGCP-----PKVYELMRACWQWNPSD 248

Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 249 RPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 79.3 bits (196), Expect = 3e-17
 Identities = 41/127 (32%), Positives = 70/127 (55%), Gaps = 5/127 (3%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           I+ E MD   L   ++  +T+ +++      Q+L+GL Y+H   +++HRDLKPSNLL+N 
Sbjct: 86  IVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLNA 143

Query: 105 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECA 163
             ++KI DFG++   +        +V T  Y +PE + +  +Y    D+WS+G +  E  
Sbjct: 144 NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203

Query: 164 TGQ--FP 168
             +  FP
Sbjct: 204 GRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 79.3 bits (195), Expect = 4e-17
 Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 14/167 (8%)

Query: 11  ARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TI 65
           A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  I
Sbjct: 52  ANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNI 106

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
             +YL   C Q+ KG+ YL  E+ ++HRDL   N+L+     VKITDFG++ ++ +   +
Sbjct: 107 GSQYLLNWCVQIAKGMNYLE-ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165

Query: 126 ANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
            +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.5 bits (193), Expect = 4e-17
 Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 25/245 (10%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           V++ N    A ++I  E  +      PYV     +C  S      + ++ + M  G L D
Sbjct: 43  VLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-----TVQLVTQLMPYGCLLD 97

Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           ++++ K  I  + L   C Q+ KG+ YL  E  ++HRDL   N+L+     VKITDFG++
Sbjct: 98  YVRENKDRIGSQDLLNWCVQIAKGMSYLE-EVRLVHRDLAARNVLVKSPNHVKITDFGLA 156

Query: 117 AIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 173
            ++    T   A+       +M+ E I   ++ ++SD+WS G+ + E  T G  PY    
Sbjct: 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216

Query: 174 QQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            ++      +L+E     P PP    D +       +  C   + + R   +EL+   F 
Sbjct: 217 ARE----IPDLLEKGERLPQPPICTIDVY-----MIMVKCWMIDSECRPRFRELV-DEFS 266

Query: 233 KMYGD 237
           +M  D
Sbjct: 267 RMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 4e-17
 Identities = 48/145 (33%), Positives = 79/145 (54%), Gaps = 16/145 (11%)

Query: 36  SFYSNGAISIILEYMDGGSLADFLKK-VKTIPEE----YLAAICEQVLKGLLYLHHEKHI 90
           +F     + ++++Y  GG L   L K    +PE+    YLA   E VL   +   H+   
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA---EMVLA--IDSVHQLGY 123

Query: 91  IHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPERISG-----G 144
           +HRD+KP N+L++  G +++ DFG    ++A  + Q+N  VGT +Y+SPE +       G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 145 KYGYKSDIWSLGLVLLECATGQFPY 169
           +YG + D WSLG+ + E   G+ P+
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 23/194 (11%)

Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II EYM+ GSL  FL++   K    + +  +   +  G+ YL  E + +HRDL   N+L+
Sbjct: 82  IITEYMENGSLDKFLRENDGKFTVGQLVGMLR-GIASGMKYLS-EMNYVHRDLAARNILV 139

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG--TYNYMSPERISGGKYGYKSDIWSLGLVLL 160
           N     K++DFG+S  +  +     T  G     + +PE I+  K+   SD+WS G+V+ 
Sbjct: 140 NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 199

Query: 161 E-CATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQK 215
           E  + G+ PY     QD       +++A+ D     PP   PS  +       +  C QK
Sbjct: 200 EVMSYGERPYWDMSNQD-------VIKAVEDGYRLPPPMDCPSALY-----QLMLDCWQK 247

Query: 216 EPQQRLSAQELMTH 229
           +  +R +  ++++ 
Sbjct: 248 DRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 4e-17
 Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 55/243 (22%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA-----ICEQVLKGLL 82
           P +V      +S   + ++ E++D     D  K + + P   L          Q+L+G+ 
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYN----- 134
           Y H  + ++HRDLKP NLLI+  G +K+ DFG+          A  F   V TY      
Sbjct: 114 YCHSHR-VLHRDLKPQNLLIDREGALKLADFGL----------ARAFGVPVRTYTHEVVT 162

Query: 135 --YMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---------------YSPPEQ 174
             Y +PE + G + Y    DIWS+G +  E    +  FP                +P E 
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE- 221

Query: 175 QDGW---TSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            D W   TS  +                      +    +S  +  +P +R+SA+  + H
Sbjct: 222 -DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280

Query: 230 PFL 232
           P+ 
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 77.8 bits (191), Expect = 6e-17
 Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 30/230 (13%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 53  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 103

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 104 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 163 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 216

Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           E     P P    +      C     C +KEP++R + + L    FL+ Y
Sbjct: 217 ERGYRMPCPPECPESLHDLMCQ----CWRKEPEERPTFEYL--QAFLEDY 260

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.3 bits (190), Expect = 7e-17
 Identities = 54/189 (28%), Positives = 97/189 (51%), Gaps = 23/189 (12%)

Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           I++E M  G+L +FL+      +    L      V +G+ YL  +K ++HRDL   N+L+
Sbjct: 75  IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK-LVHRDLAARNILV 133

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
           +  G  K++DFG++     + G  N+ +    + +PE +   K+  KSD+WS G++L E 
Sbjct: 134 SEDGVAKVSDFGLAR--VGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYGVLLWEV 190

Query: 163 -ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEP 217
            + G+ PY  P+      S  E+ E +      +PP   P+D +       +++C + EP
Sbjct: 191 FSYGRAPY--PK-----MSLKEVKECVEKGYRMEPPEGCPADVY-----VLMTSCWETEP 238

Query: 218 QQRLSAQEL 226
           ++R S  +L
Sbjct: 239 KKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 78.5 bits (193), Expect = 7e-17
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 39/206 (18%)

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           K + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N   E+KI DFG++    
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA---R 168

Query: 121 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 177
            T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  TG+  FP +    Q  
Sbjct: 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-- 226

Query: 178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ------------KEPQ------- 218
                +L+  +V  P         S    ++I +  Q              P        
Sbjct: 227 ----LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282

Query: 219 -------QRLSAQELMTHPFLKMYGD 237
                  +R++A + + H +   Y D
Sbjct: 283 MLVLDSDKRITAAQALAHAYFAQYHD 308

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 78.4 bits (193), Expect = 8e-17
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 40/229 (17%)

Query: 34  YQSFYSNGAISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHII 91
           +Q FY      +++ YM        L+K+   P  E+ +  +  Q+L GL Y+H    II
Sbjct: 92  FQDFY------LVMPYMQTD-----LQKIMGHPLSEDKVQYLVYQMLCGLKYIH-SAGII 139

Query: 92  HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKS 150
           HRDLKP NL +N   E+KI DFG++        +   +V T  Y +PE I +   Y    
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWMHYNQTV 196

Query: 151 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--------ELMEAIVD-------QPPPS 195
           DIWS+G ++ E  TG+  +   +  D  T           E ++ + D       +  P 
Sbjct: 197 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256

Query: 196 APSDQFS-------PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
            P   FS       P+    +   ++ +  +RL+A E + HP+   + D
Sbjct: 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 78.2 bits (193), Expect = 9e-17
 Identities = 46/126 (36%), Positives = 63/126 (50%), Gaps = 11/126 (8%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           Q+L G+ +LH    IIHRDLKPSN+++     +KI DFG+ A  A TS     +V T  Y
Sbjct: 126 QMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYY 183

Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 195
            +PE I G  Y    DIWS+G ++ E   G   +   +  D W    E +          
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL---------G 234

Query: 196 APSDQF 201
            PSD+F
Sbjct: 235 TPSDEF 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 3/161 (1%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++   R   A E  I ++   P ++    +F  N    +IL       L  +L   + I 
Sbjct: 122 IKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIA 180

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-TSGQ 125
              + AI   VL+ + YLH E  IIHRD+K  N+ INH G+V + DFG +       + +
Sbjct: 181 ICDILAIERSVLRAIQYLH-ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239

Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ 166
              + GT    +PE ++   YG   DIWS G+VL E AT  
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-16
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 46/217 (21%)

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGV 115
            K  +IP   + ++  Q+L G+ YLH    ++HRDLKP+N+L+      RG VKI D G+
Sbjct: 100 AKRVSIPPSMVKSLLWQILNGVHYLH-SNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Query: 116 SAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLE---------C 162
           + +  +        +  V T  Y +PE + G ++  K+ DIW++G +  E          
Sbjct: 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218

Query: 163 ATGQFPYSPPEQQDGWTSFYELM--------EAIVDQPPPSAPSDQFSPEF--CSFISAC 212
              +   S P Q+D     +E++          I   P        F  +    + ++  
Sbjct: 219 REAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKW 278

Query: 213 VQK------------------EPQQRLSAQELMTHPF 231
           ++K                  +P +R++A+E + HP+
Sbjct: 279 MEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)

Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + +++E MD    A+  + +   +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 101 VYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 155

Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A T+     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 156 VKSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Query: 162 CATGQFPYSPPEQQDGWTSFYE------------LMEAIVD--QPPPSAPSDQFSPEFCS 207
              G   +   +  D W    E            L   + +  +  P  P   F   F  
Sbjct: 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPD 274

Query: 208 FI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 237
           +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 275 WIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 76.4 bits (188), Expect = 1e-16
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 24/210 (11%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P +V  ++   S  ++ ++L++ +GG L   + K   IPEE +     +++  L  LH E
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGV-SAIMASTSGQANTFVGTYNYMSPERISGGKY 146
             I+ RDL P+N+L++ RG +++T F   S +  S  G+A   +    Y +PE     + 
Sbjct: 105 G-IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISEE 159

Query: 147 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 206
               D WSLG +L E  TG              +  E   + ++        +  S E  
Sbjct: 160 TEACDWWSLGAILFELLTG-------------KTLVECHPSGINTHTTLNIPEWVSEEAR 206

Query: 207 SFISACVQKEPQQRLSA-----QELMTHPF 231
           S +   +Q  P +RL A     +++ +HPF
Sbjct: 207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 67/266 (25%), Positives = 112/266 (42%), Gaps = 47/266 (17%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           +E+     I  E  I   +   +VV  + SF     + +I+E++ GG +   L K  T+ 
Sbjct: 40  LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99

Query: 67  EEYLA-AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA----- 120
           EE     I E VL   +   H+   IHRD+KP NLL++ +G VK++DFG+   +      
Sbjct: 100 EEATQFYIAETVLA--IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157

Query: 121 -------------------STSGQANTF-----------VGTYNYMSPERISGGKYGYKS 150
                              ++  +A T+           VGT +Y++PE      Y    
Sbjct: 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC 217

Query: 151 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 210
           D WSLG+++ E   G  P+     Q+ +       E +V   PP  P  + + +    + 
Sbjct: 218 DWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVF--PPEVPISEKAKDL--ILR 273

Query: 211 ACVQKEPQQRL---SAQELMTHPFLK 233
            C   E   R+     +E+ +HPF +
Sbjct: 274 FCTDSE--NRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 35/206 (16%)

Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + + E+ +  +  Q+LKGL Y+H    IIHRDLKP NL +N   E+KI DFG++  
Sbjct: 109 LMKHEKLSEDRIQFLVYQMLKGLKYIH-AAGIIHRDLKPGNLAVNEDCELKILDFGLA-- 165

Query: 119 MASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
              T  +   +V T  Y +PE I +   Y    DIWS+G ++ E  TG+  +   +  D 
Sbjct: 166 -RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224

Query: 178 WTSFYELMEAIVDQPP-------------------PSAPSDQF-------SPEFCSFISA 211
                E+M+ +   P                    P      F       +P   + +  
Sbjct: 225 LM---EIMK-VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEK 280

Query: 212 CVQKEPQQRLSAQELMTHPFLKMYGD 237
            +  + + R++A E + HP+ + + D
Sbjct: 281 MLVLDAESRITAAEALAHPYFEEFHD 306

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 76.6 bits (188), Expect = 2e-16
 Identities = 46/133 (34%), Positives = 76/133 (57%), Gaps = 9/133 (6%)

Query: 43  ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  +++ IHRDL+ +N+
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANI 133

Query: 101 LINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
           L++     KI DFG++ ++     T+ +   F     + +PE I+ G +  KSD+WS G+
Sbjct: 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 191

Query: 158 VLLECAT-GQFPY 169
           +L+E  T G+ PY
Sbjct: 192 LLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 35/215 (16%)

Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+
Sbjct: 84  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNI 141

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
           L+   G++K+ DFG++ I  S      + V T  Y +PE +    Y    D+WS+G +  
Sbjct: 142 LVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200

Query: 161 ECATGQFPYSP--------------------PEQQDGWTSFYELMEAIVDQPPPSAPSDQ 200
           E     F   P                    P ++D W     L          + P ++
Sbjct: 201 E----MFRRKPLFRGSSDVDQLGKILDVIGLPGEED-WPRDVALPRQAF-HSKSAQPIEK 254

Query: 201 FSPEF----CSFISACVQKEPQQRLSAQELMTHPF 231
           F  +        +  C+   P +R+SA   ++HP+
Sbjct: 255 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.2 bits (187), Expect = 2e-16
 Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 13/161 (8%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAA 72
           +E  + ++ Q   +V  Y        I II EYM  GSL DFLK  +     +P+  L  
Sbjct: 50  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK--LID 107

Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 129
              Q+ +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F
Sbjct: 108 FSAQIAEGMAYIE-RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 166

Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
                + +PE I+ G +  KSD+WS G++L E  T G+ PY
Sbjct: 167 --PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 76.5 bits (188), Expect = 3e-16
 Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 53/266 (19%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICE 75
           EL +++    P +V    +F ++  + ++  +M  GS  D +    +  + E  +A I +
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYN 134
            VLK L Y+HH  ++ HR +K S++LI+  G+V ++  G+ + ++  + GQ    V  + 
Sbjct: 109 GVLKALDYIHHMGYV-HRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFP 165

Query: 135 --------YMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYS-------------- 170
                   ++SPE +     GY  KSDI+S+G+   E A G  P+               
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225

Query: 171 -----------PPEQQDGWTSFYELMEAIVDQPPPSAPSD------------QFSPEFCS 207
                      P E+     S       + +    S P               FSP F  
Sbjct: 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285

Query: 208 FISACVQKEPQQRLSAQELMTHPFLK 233
           F+  C+Q+ P  R SA  L+ H F K
Sbjct: 286 FVEQCLQRNPDARPSASTLLNHSFFK 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 76.2 bits (187), Expect = 3e-16
 Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 36/240 (15%)

Query: 10  SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-------- 61
           +AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  FL+         
Sbjct: 49  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 108

Query: 62  VKTIPEE--------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
           V   P +         +  I  Q+  G++YL   +H +HRDL   N L+     VKI DF
Sbjct: 109 VDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDF 167

Query: 114 GVSAIMASTSGQANTFVGTYN-----YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 167
           G+S  + ST       VG +      +M PE I   K+  +SD+WS G++L E  T G+ 
Sbjct: 168 GMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Query: 168 PYSPPEQQDGWTSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           P+     Q   T   E + +  V + P   P + +       +  C Q+EPQQRL+ +E+
Sbjct: 225 PWF----QLSNTEVIECITQGRVLERPRVCPKEVY-----DIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.9 bits (186), Expect = 4e-16
 Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 39/246 (15%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK---- 61
           +  ++AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  FL+     
Sbjct: 45  DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPD 104

Query: 62  ---------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
                       + +  +  I +Q+  G++YL   +H +HRDL   N L+     VKI D
Sbjct: 105 AVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENLLVKIGD 163

Query: 113 FGVSAIMASTSGQANTFVGTYN-----YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 166
           FG+S  + ST       VG +      +M PE I   K+  +SD+WSLG+VL E  T G+
Sbjct: 164 FGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Query: 167 FPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
            P+          S  E++E I    V Q P + P + +       +  C Q+EP  RL+
Sbjct: 221 QPWYQ-------LSNNEVIECITQGRVLQRPRTCPKEVY-----DLMLGCWQREPHMRLN 268

Query: 223 AQELMT 228
            +E+ +
Sbjct: 269 IKEIHS 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.9 bits (187), Expect = 5e-16
 Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 18/159 (11%)

Query: 18  ELKINQSSQCPYVV----VCYQ--SFYSN--GAISIILEYMDGGSLADFL--KKVKTIPE 67
           E+KI Q  +   VV    +C    + Y+   G+  ++ E+ +   LA  L  K VK    
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           E +  + + +L GL Y+H  K I+HRD+K +N+LI   G +K+ DFG++ A   S + + 
Sbjct: 120 E-IKKVMKMLLNGLYYIHRNK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 127 NTF---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 161
           N +   V T  Y  PE + G + YG   D+W  G ++ E
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.0 bits (184), Expect = 6e-16
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 10/216 (4%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI--CE 75
           E +I +    P++V    +F S   + +++  M+GG L   +  V     E    I    
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYN 134
           Q+  G+L+LH    I++RD+KP N+L++ +G  +++D G++  +    G+  T   GT  
Sbjct: 103 QITCGILHLH-SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNG 159

Query: 135 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 194
           YM+PE +    Y Y  D +++G  + E   G+ P+   +++    +  EL    + +   
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK---VAKEELKRRTL-EDEV 215

Query: 195 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
                 F+ E        + K+P+ RL ++E    P
Sbjct: 216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 74.9 bits (184), Expect = 6e-16
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 8/158 (5%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICE 75
           +E K+        +V  Y        I I+ EYM  G L ++L++     +   L  +C+
Sbjct: 48  EEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK 107

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--- 132
            V +G+ YL   K  IHRDL   N L++ +G VK++DFG+S  +     +  + VG+   
Sbjct: 108 DVCEGMAYLE-SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFP 164

Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
             +  PE +   K+  KSD+W+ G+++ E  + G+ PY
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 75.5 bits (186), Expect = 8e-16
 Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 30/190 (15%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV----SAIMASTSGQANTFVG 131
           Q+L GL Y+H   +++HRDLKP NLL+N   E+KI DFG+    S      +G    +V 
Sbjct: 113 QILCGLKYIH-SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 132 TYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQFPY------------------SPP 172
           T  Y +PE  +S   Y    D+WS+G +L E    + P                   +P 
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPD 230

Query: 173 E---QQDGWTSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELM 227
           E    + G       + ++ + P     S     +P     +   +  +P +R+S +E +
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290

Query: 228 THPFLKMYGD 237
            HP+L ++ D
Sbjct: 291 EHPYLAIWHD 300

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 39/99 (39%), Positives = 59/99 (59%), Gaps = 7/99 (7%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST---SGQANTFVGT 132
           Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ I       +G    +V T
Sbjct: 114 QILRGLKYIH-SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 133 YNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FP 168
             Y +PE  ++   Y    DIWS+G +L E  + +  FP
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.9 bits (181), Expect = 1e-15
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 25/206 (12%)

Query: 39  SNGAISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 94
           S   I I+ E+M  GSL DFLK    K   +P+  L  +  Q+  G+ Y+    +I HRD
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ--LVDMAAQIADGMAYIERMNYI-HRD 127

Query: 95  LKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSD 151
           L+ +N+L+      KI DFG++ ++     T+ Q   F     + +PE    G++  KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSD 185

Query: 152 IWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFI 209
           +WS G++L E  T G+ PY     +       E++E +  +     P  Q  PE     +
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNR-------EVLEQV--ERGYRMPCPQGCPESLHELM 236

Query: 210 SACVQKEPQQRLSAQELMTHPFLKMY 235
             C +K+P +R + + + +  FL+ Y
Sbjct: 237 KLCWKKDPDERPTFEYIQS--FLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 47/250 (18%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKKV---KTIPE 67
           +++  +E KI      P +V  Y S  S+G  +   + Y++G +L   LK V   +++ +
Sbjct: 46  KKRFLREAKIAADLIHPGIVPVY-SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK 104

Query: 68  EY--------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG----- 114
           E           +I  ++   + Y+H  K ++HRDLKP N+L+   GEV I D+G     
Sbjct: 105 ELAEKTSVGAFLSIFHKICATIEYVH-SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163

Query: 115 -------------VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                           I  S+       VGT +YM+PER+ G      +DI++LG++L +
Sbjct: 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQ 223

Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK----EP 217
             T  FPY    ++ G    Y   + I+  P   AP  +  P    F+S    K    +P
Sbjct: 224 MLTLSFPY---RRKKGRKISYR--DVILS-PIEVAPYREIPP----FLSQIAMKALAVDP 273

Query: 218 QQRL-SAQEL 226
            +R  S QEL
Sbjct: 274 AERYSSVQEL 283

Length = 932

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 73.6 bits (181), Expect = 2e-15
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 12/163 (7%)

Query: 7   VEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNGAISIILEY--MDGGSLADFLKKV 62
           V  +A R+I+  +EL      Q P +V           + +I E+  MD     D L K 
Sbjct: 42  VPSTAIREISLLKEL------QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKG 95

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           + +  E + +   Q+L+G+L+ H  + ++HRDLKP NLLI+++G +K+ DFG++      
Sbjct: 96  QYMDAELVKSYLYQILQGILFCH-SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154

Query: 123 SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECAT 164
                  V T  Y +PE + G  +Y    DIWS+G +  E AT
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.1 bits (182), Expect = 2e-15
 Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 17/193 (8%)

Query: 41  GAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 98
           G I +I EY   G L +FL  K+   +  E L +   QV KG+ +L   K+ IHRDL   
Sbjct: 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAAR 170

Query: 99  NLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSL 155
           N+L+ H   VKI DFG++  + + S    + N  +    +M+PE I    Y ++SD+WS 
Sbjct: 171 NVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSY 229

Query: 156 GLVLLECAT-GQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSFISACV 213
           G++L E  + G  PY P    D  + FY+L+ E      P  AP++ +       +  C 
Sbjct: 230 GILLWEIFSLGSNPY-PGMPVD--SKFYKLIKEGYRMAQPEHAPAEIY-----DIMKTCW 281

Query: 214 QKEPQQRLSAQEL 226
             +P +R + +++
Sbjct: 282 DADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.5 bits (181), Expect = 3e-15
 Identities = 65/265 (24%), Positives = 113/265 (42%), Gaps = 55/265 (20%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           V++ +  ++AR    +E+KI      P +     VC         + +I+EYM+ G L  
Sbjct: 53  VLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD----PPLCMIMEYMENGDLNQ 108

Query: 58  FLKK-----------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 106
           FL+K            K++    L  +  Q+  G+ YL    + +HRDL   N L+    
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLATRNCLVGKNY 167

Query: 107 EVKITDFGVSAIMASTSGQANTFVGTY-----------NYMSPERISGGKYGYKSDIWSL 155
            +KI DFG+S          N +   Y            +M+ E +  GK+  KSD+W+ 
Sbjct: 168 TIKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 156 GLVLLECAT--GQFPYSP-PEQQ--DGWTSFYEL--MEAIVDQPPPSAPSDQFSPEFCSF 208
           G+ L E  T   + PY    +QQ  +    F+     +  + +PP   P D +       
Sbjct: 219 GVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNC-PKDIY-----EL 272

Query: 209 ISACVQKEPQQRLSAQELMTHPFLK 233
           +  C +++ + R + +E+  H FL+
Sbjct: 273 MLECWRRDEEDRPTFREI--HLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.3 bits (180), Expect = 3e-15
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 31/206 (15%)

Query: 48  EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 107
           ++MD   L+        IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G 
Sbjct: 87  KFMDASPLSG-------IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGA 138

Query: 108 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKS--DIWSLGLVLLECATG 165
           +K+ DFG++             V T  Y +PE + G KY Y +  DIWSLG +  E  T 
Sbjct: 139 IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVTR 197

Query: 166 Q--FPY-SPPEQ------------QDGWTSFYELMEAIVDQP--PPSAPSD---QFSPEF 205
           +  FP  S  +Q            +  W     L +     P       S        + 
Sbjct: 198 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDG 257

Query: 206 CSFISACVQKEPQQRLSAQELMTHPF 231
              +S  +  +P +R+SA+  + HPF
Sbjct: 258 RDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.4 bits (180), Expect = 3e-15
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 32/212 (15%)

Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +I+EY+  GSL D+L K K +    L    +Q+ +G+ YLH  +H IHRDL   N+L+
Sbjct: 83  LQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLH-SQHYIHRDLAARNVLL 140

Query: 103 NHRGEVKITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 154
           ++   VKI DFG++  +            G +  F     + + E +   K+ Y SD+WS
Sbjct: 141 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAVECLKENKFSYASDVWS 195

Query: 155 LGLVLLECATGQFPY-SPPEQ----------QDGWTSFYELMEAIVDQPPPSAPSDQFSP 203
            G+ L E  T      SPP++          Q       EL+E  +  P P         
Sbjct: 196 FGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP----KNCPQ 251

Query: 204 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           E    +  C + E + R + + L+  P LK  
Sbjct: 252 EVYILMKNCWETEAKFRPTFRSLI--PILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 74.8 bits (183), Expect = 4e-15
 Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 40/261 (15%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV-- 62
           ++E  + Q+  E+ + +  +   +V     F   +N  + I++E+ D G L+  ++K   
Sbjct: 51  LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110

Query: 63  --KTIPEEYLAAICEQVLKGLLYLHHEK------HIIHRDLKPSNLL----INHRGEV-- 108
               I E  +  I  Q+L  L Y H+ K       ++HRDLKP N+     I H G++  
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170

Query: 109 -----------KITDFGVSAIMASTSGQANTFVGTYNYMSPERI--SGGKYGYKSDIWSL 155
                      KI DFG+S  +   S  A++ VGT  Y SPE +      Y  KSD+W+L
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229

Query: 156 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 215
           G ++ E  +G+ P+          +F +L+  +  +  P  P    S E    I   +  
Sbjct: 230 GCIIYELCSGKTPFHKA------NNFSQLISEL--KRGPDLPIKGKSKELNILIKNLLNL 281

Query: 216 EPQQRLSAQELMTHPFLKMYG 236
             ++R SA + + +  +K  G
Sbjct: 282 SAKERPSALQCLGYQIIKNVG 302

Length = 1021

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.8 bits (179), Expect = 5e-15
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICE 75
           VC Q     G + +++EY   G+L DFL+  +   E                  L +   
Sbjct: 84  VCTQ----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG--TY 133
           QV +G+ +L  +K  IHRDL   N+L+     +KI DFG++  +        T  G    
Sbjct: 140 QVARGMEFLASKK-CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV 198

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVD 190
            +M+PE +    Y ++SD+WS G++L E  T G  PY   P E+      F  L E    
Sbjct: 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-----FKLLKEGYRM 253

Query: 191 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           + P +   + +       +  C  + P QR + ++L
Sbjct: 254 EKPQNCTQELY-----HLMRDCWHEVPSQRPTFKQL 284

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 72.7 bits (178), Expect = 5e-15
 Identities = 62/271 (22%), Positives = 119/271 (43%), Gaps = 55/271 (20%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  FL++
Sbjct: 37  MLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRE 96

Query: 62  VKTIPEEYLAAICE------------------------QVLKGLLYLHHEKHIIHRDLKP 97
            + +   YL +                           Q+ +G+ YL  E  ++HRDL  
Sbjct: 97  SRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-EMKLVHRDLAA 155

Query: 98  SNLLINHRGEVKITDFGVS-------AIMASTSGQANTFVGTYNYMSPERISGGKYGYKS 150
            N+L+    ++KI+DFG+S       + +  + G+         +M+ E +    Y  +S
Sbjct: 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV-----KWMAIESLFDHIYTTQS 210

Query: 151 DIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEA--IVDQPPPSAPSDQFSPEF 205
           D+WS G++L E  T G  PY    PE+       + L++    +++P      +  S E 
Sbjct: 211 DVWSFGVLLWEIVTLGGNPYPGIAPER------LFNLLKTGYRMERP------ENCSEEM 258

Query: 206 CSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
            + +  C ++EP +R +  ++ +    KM  
Sbjct: 259 YNLMLTCWKQEPDKRPTFADI-SKELEKMMV 288

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.2 bits (177), Expect = 5e-15
 Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 10/175 (5%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TI 65
           E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K     T+
Sbjct: 46  EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV 105

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+S ++      
Sbjct: 106 IQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162

Query: 126 ANTFVG---TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD 176
           A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY     QD
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 72.8 bits (178), Expect = 5e-15
 Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 26/256 (10%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           VI++  EE       +E  + +  +   +V+ +   ++   ++++ EY+         K 
Sbjct: 37  VIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH 96

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +  E +     Q+L+GL Y+H +++I+HRDLKP NLLI+  GE+K+ DFG++   + 
Sbjct: 97  PGGLHPENVKLFLFQLLRGLSYIH-QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155

Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATG--QFPYSPPEQQDGW 178
            S   +  V T  Y  P+ + G  +Y    D+W +G + +E   G   FP     Q    
Sbjct: 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA----------------------CVQKE 216
             F  L     D  P       F PE  +  S                        +Q  
Sbjct: 216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF 275

Query: 217 PQQRLSAQELMTHPFL 232
           P+ RLSAQ  ++H + 
Sbjct: 276 PKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 73.2 bits (179), Expect = 7e-15
 Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 51/246 (20%)

Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA-AICEQVLKGLLYLHHE 87
           +VV  + SF     + +I+E++ GG +   L K  T+ EE     I E VL   +   H+
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA--IDSIHQ 119

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA------------------------STS 123
              IHRD+KP NLL++ +G VK++DFG+   +                         ++ 
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 124 GQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 172
            +A T+           VGT +Y++PE      Y    D WSLG+++ E   G  P+   
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 173 EQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSA---QELM 227
             Q+ +       E ++  P  P S  +      FC         E + R+ A   +E+ 
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC--------EWEHRIGAPGVEEIK 291

Query: 228 THPFLK 233
           T+PF +
Sbjct: 292 TNPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.9 bits (176), Expect = 7e-15
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 15/161 (9%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           II EYM+ G+L  +L+        Y L  +   +  G+ YL  + + +HRDL   N+L+N
Sbjct: 83  IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS-DMNYVHRDLAARNILVN 141

Query: 104 HRGEVKITDFGVSAIMASTSGQANTFVG---TYNYMSPERISGGKYGYKSDIWSLGLVLL 160
              E K++DFG+S ++        T  G      + +PE I+  K+   SD+WS G+V+ 
Sbjct: 142 SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201

Query: 161 ECAT-GQFPYSPPEQQDGW-TSFYELMEAIVDQPPPSAPSD 199
           E  + G+ PY        W  S +E+M+AI D     AP D
Sbjct: 202 EVMSFGERPY--------WDMSNHEVMKAINDGFRLPAPMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 71.6 bits (175), Expect = 1e-14
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)

Query: 40  NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-ANNFVHRDLAA 130

Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 187

Query: 158 VLLECAT-GQFPY 169
           +L E  + G+ PY
Sbjct: 188 LLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.3 bits (174), Expect = 2e-14
 Identities = 44/131 (33%), Positives = 72/131 (54%), Gaps = 5/131 (3%)

Query: 43  ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I ++ + M  G L D++ + K  I  + L   C Q+ KG++YL  E+ ++HRDL   N+L
Sbjct: 83  IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVL 141

Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVL 159
           +     VKITDFG++ ++     + N   G     +M+ E I   K+ ++SD+WS G+ +
Sbjct: 142 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201

Query: 160 LECAT-GQFPY 169
            E  T G  PY
Sbjct: 202 WELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  PE         L      V KG  YL  E H IHRD+  
Sbjct: 86  ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAA 144

Query: 98  SNLLINHRGE---VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYK 149
            N L+  +G     KI DFG++  +   S     G+A   +    +M PE    G +  K
Sbjct: 145 RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI---KWMPPEAFLDGIFTSK 201

Query: 150 SDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPE 204
           +D+WS G++L E  + G  PY     Q       E+ME +       PP   P   +   
Sbjct: 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEFVTGGGRLDPPKGCPGPVY--- 251

Query: 205 FCSFISACVQKEPQQR 220
               ++ C Q  P+ R
Sbjct: 252 --RIMTDCWQHTPEDR 265

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 13/134 (9%)

Query: 45  IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           ++ E    GSL D L+K          L     Q+  G+ YL   K  IHRDL   N+L+
Sbjct: 72  MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE-SKRFIHRDLAARNILL 130

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYN------YMSPERISGGKYGYKSDIWSLG 156
               +VKI DFG   +M +     + +V   +      + +PE +    + + SD+W  G
Sbjct: 131 ASDDKVKIGDFG---LMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFG 187

Query: 157 LVLLECAT-GQFPY 169
           + L E  T G+ P+
Sbjct: 188 VTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.4 bits (172), Expect = 3e-14
 Identities = 49/171 (28%), Positives = 90/171 (52%), Gaps = 16/171 (9%)

Query: 8   EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           + + + ++ +E  + Q    PY+V    +C        +  +++E  + G L  FL+K K
Sbjct: 36  DPALKDELLREANVMQQLDNPYIVRMIGICEAE-----SWMLVMELAELGPLNKFLQKNK 90

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            + E+ +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S  + +  
Sbjct: 91  HVTEKNITELVHQVSMGMKYLE-ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149

Query: 124 G--QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
              +A T  G +   + +PE ++  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 150 NYYKAKTH-GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.2 bits (172), Expect = 3e-14
 Identities = 45/151 (29%), Positives = 65/151 (43%), Gaps = 28/151 (18%)

Query: 45  IILEYMDGGSLADFLK---------------KVKTIPEEYLA-------AICEQVLKGLL 82
           ++ EYM  G L +FL+                 +      L         I +QV  G+ 
Sbjct: 85  LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144

Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPE 139
           YL  E+  +HRDL   N L+     VKI DFG+S  + S        N  +    +M PE
Sbjct: 145 YLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI-PIRWMPPE 202

Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
            I   +Y  +SD+W+ G+VL E  + G  PY
Sbjct: 203 SIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 70.5 bits (172), Expect = 5e-14
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)

Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158

Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 162 CATGQFPYSPPEQQDGWTSFYE 183
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 70.7 bits (173), Expect = 6e-14
 Identities = 43/119 (36%), Positives = 64/119 (53%), Gaps = 13/119 (10%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           MV Q+  E  A       L +++S   P++V  Y S  S   + +++EY+ GG +   L 
Sbjct: 47  MVHQVQAERDA-------LALSKS---PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH 96

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                 EE       +V   L YLH  +H IIHRDLKP N+LI++ G +K+TDFG+S +
Sbjct: 97  IYGYFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 69.7 bits (170), Expect = 8e-14
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 37/205 (18%)

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I DFG++    
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLA---R 166

Query: 121 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 177
               +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP +     D 
Sbjct: 167 QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN-----DY 221

Query: 178 WTSFYELMEAIVDQPP------------------PSAPSDQFSPEF-------CSFISAC 212
                 +ME +    P                  P  P       F          +   
Sbjct: 222 IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281

Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +  +  +R+SA E + HP+   Y D
Sbjct: 282 LVLDSDKRISASEALAHPYFSQYHD 306

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 42/192 (21%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFVGT 132
           Q+L+ L Y+H   ++ HRDLKP N+L N   ++KI DFG++ +  + +  A     +V T
Sbjct: 111 QLLRALKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169

Query: 133 YNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEA 187
             Y +PE + G    KY    DIWS+G +  E  TG+  FP      Q       +L+  
Sbjct: 170 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ------LDLITD 222

Query: 188 IVDQPPPSA-------------------PSDQFSPEF-------CSFISACVQKEPQQRL 221
           ++  P P                         FS +F          +   +  +P+ R 
Sbjct: 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282

Query: 222 SAQELMTHPFLK 233
           +A+E +  P+ K
Sbjct: 283 TAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 42/240 (17%)

Query: 30  VVVCYQSFYSNGAISIILEYMD------GGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 83
           +V      +S   + ++ EY+D        S  DF K  + I + YL     Q+L+G+ Y
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI-KTYLY----QILRGIAY 117

Query: 84  LHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSG-QANTF---VGTYNYMSP 138
            H  + ++HRDLKP NLLI+ R   +K+ DFG    +A   G    TF   V T  Y +P
Sbjct: 118 CHSHR-VLHRDLKPQNLLIDRRTNALKLADFG----LARAFGIPVRTFTHEVVTLWYRAP 172

Query: 139 ERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---------------YSPPEQQ-DGWT 179
           E + G + Y    DIWS+G +  E    +  FP                +P E+   G T
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232

Query: 180 SFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
           S  +   A    PP    +      P     +S  ++ +P +R++A+  + H + K  GD
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.4 bits (167), Expect = 2e-13
 Identities = 40/142 (28%), Positives = 75/142 (52%), Gaps = 8/142 (5%)

Query: 42  AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++ ++ +    GSL D +++ + ++  + L   C Q+ KG+ YL  E  ++HR+L   N+
Sbjct: 82  SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE-EHRMVHRNLAARNI 140

Query: 101 LINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           L+     V+I DFGV+ ++     +   +       +M+ E I  G+Y ++SD+WS G+ 
Sbjct: 141 LLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVT 200

Query: 159 LLECAT-GQFPYS---PPEQQD 176
           + E  + G  PY+   P E  D
Sbjct: 201 VWEMMSYGAEPYAGMRPHEVPD 222

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 68.5 bits (167), Expect = 2e-13
 Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 54/279 (19%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--K 63
           N  E   + +  E+ ++   + P ++  +  F +   + +I  +M  GS    LK    +
Sbjct: 37  NCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPE 96

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST- 122
            + E  +  I    L+GL YLH   +I HR++K S++LI+  G V ++  G+S + +   
Sbjct: 97  GMSEALIGNILFGALRGLNYLHQNGYI-HRNIKASHILISGDGLVSLS--GLSHLYSLVR 153

Query: 123 SGQANTFVGTYN--------YMSPERISGGKYGY--KSDIWSLGLVLLECATGQFP---- 168
           +GQ    V  +         ++SPE +    YGY  KSDI+S+G+   E ATG+ P    
Sbjct: 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213

Query: 169 --------------YSP-------------PEQQDGWTS------FYELMEAIVDQPPPS 195
                         YSP                Q G  S          M   +      
Sbjct: 214 LRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR 273

Query: 196 APSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            PS + FSP F + +  C+Q++P++R SA  L++H F K
Sbjct: 274 TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.8 bits (166), Expect = 2e-13
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 46/206 (22%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICE--------QVLKGLLYLHHEKHIIHRDLK 96
           ++  YM+ G+L  FL++ +        A+          Q+  G+ YLH ++ +IH+D+ 
Sbjct: 86  VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KRGVIHKDIA 144

Query: 97  PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN-----------YMSPERISGGK 145
             N +I+   +VKITD  +S          + F   Y+           +M+ E +   +
Sbjct: 145 ARNCVIDEELQVKITDNALSR---------DLFPMDYHCLGDNENRPVKWMALESLVNKE 195

Query: 146 YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQ 200
           Y   SD+WS G++L E  T GQ PY    + D     +E+   + D      P + P   
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPY---VEIDP----FEMAAYLKDGYRLAQPINCPD-- 246

Query: 201 FSPEFCSFISACVQKEPQQRLSAQEL 226
              E  + ++ C   +P++R S  +L
Sbjct: 247 ---ELFAVMACCWALDPEERPSFSQL 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 3e-13
 Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 2/134 (1%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P V+    +  S     ++L +          K+ + +P +    I +Q+L+GL YLH +
Sbjct: 117 PSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           + IIHRD+K  N+ IN   +V I D G +A     +       GT    +PE ++  KY 
Sbjct: 177 R-IIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYN 234

Query: 148 YKSDIWSLGLVLLE 161
            K+DIWS G+VL E
Sbjct: 235 SKADIWSAGIVLFE 248

Length = 357

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 67.8 bits (165), Expect = 4e-13
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 40/229 (17%)

Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 97  VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 151

Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 152 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 162 CATGQFPYSPPEQQDGW--------TSFYELMEAI-------VDQPPPSA---------- 196
               +  +   +  D W        T   E M+ +       V+  P  A          
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270

Query: 197 ---PSDQ-----FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
              P+D       + +    +S  +  +P +R+S  E + HP++ ++ D
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 66.8 bits (163), Expect = 4e-13
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 23/203 (11%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPE 67
           E  RR    E  I      P ++        +  + II E+M+ G+L  FL+        
Sbjct: 46  EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV 105

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
             L  +   +  G+ YL  E + +HRDL   N+L+N     K++DFG+S  +   +    
Sbjct: 106 IQLVGMLRGIAAGMKYLS-EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP- 163

Query: 128 TFVGTYN------YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 180
           T+  +        + +PE I+  K+   SD+WS G+V+ E  + G+ PY     QD    
Sbjct: 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---- 219

Query: 181 FYELMEAIVDQ-----PPPSAPS 198
              ++ AI +Q     PP   P+
Sbjct: 220 ---VINAI-EQDYRLPPPMDCPT 238

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 49/251 (19%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLK-----------KVKTIPEEYLA-----AICE 75
           VC Q     G + +I+EY   G+L +FL+            +  +PEE L+     +   
Sbjct: 86  VCTQ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN- 134
           QV +G+ YL   +  IHRDL   N+L+     +KI DFG    +A      + +  T N 
Sbjct: 142 QVARGMEYLE-SRRCIHRDLAARNVLVTEDNVMKIADFG----LARGVHDIDYYKKTSNG 196

Query: 135 -----YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELME 186
                +M+PE +    Y ++SD+WS G+++ E  T G  PY   P E+      F  L E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-----FKLLRE 251

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
                 P +        E    +  C    P QR + ++L     ++    +   +SE +
Sbjct: 252 GHRMDKPSNCTH-----ELYMLMRECWHAVPTQRPTFKQL-----VEALDKVLAAVSEEY 301

Query: 247 TDAGSPLATLS 257
            D   P    S
Sbjct: 302 LDLSMPFEQYS 312

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 66.2 bits (161), Expect = 6e-13
 Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 26/179 (14%)

Query: 9   ESARRQIAQELKINQSSQC--------PYVV----VCYQSFYSNGAISIILEYMDGGSLA 56
           ++ +  + QELKI   S+         P +V    VC Q       I I++E + GG   
Sbjct: 25  KTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ----RQPIYIVMELVPGGDFL 80

Query: 57  DFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
            FL+K K  +  + L         G+ YL   K+ IHRDL   N L+     +KI+DFG+
Sbjct: 81  SFLRKKKDELKTKQLVKFALDAAAGMAYLE-SKNCIHRDLAARNCLVGENNVLKISDFGM 139

Query: 116 SAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
           S      + S+SG     +    + +PE ++ G+Y  +SD+WS G++L E  + G  PY
Sbjct: 140 SRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 24/208 (11%)

Query: 32  VCYQSFYSNGAIS--IILEYMDGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLY 83
           VC Q+  S G  S  +IL +M  G L  FL   +       +P + L      +  G+ Y
Sbjct: 68  VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEY 127

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERI 141
           L   K  IHRDL   N ++N    V + DFG+S  + +     Q         +++ E +
Sbjct: 128 LS-SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186

Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA--IVDQPPPSAPS 198
           +   Y  KSD+WS G+ + E AT GQ PY   E  +     Y+ +     + QPP     
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQGNRLKQPPDCLDG 242

Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQEL 226
                   S +S+C    P+ R S + L
Sbjct: 243 ------LYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 1e-12
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 3/111 (2%)

Query: 55  LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 114
           L  ++ +   +P E    I  ++L+ L YLH  + IIHRD+K  N+ ++      + DFG
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLH-GRGIIHRDVKTENIFLDEPENAVLGDFG 230

Query: 115 VSA--IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 163
            +        + Q   + GT    SPE ++   Y  K+DIWS GLVL E +
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 53/190 (27%), Positives = 79/190 (41%), Gaps = 22/190 (11%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL------- 59
            E   R +   E  +    Q P +V           +S+I  Y     L +FL       
Sbjct: 47  AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHS 106

Query: 60  --------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 109
                   K VK+   P +++  I  Q+  G+ +L    H++H+DL   N+L+  +  VK
Sbjct: 107 DVGSTDDDKTVKSTLEPADFVH-IVTQIAAGMEFLS-SHHVVHKDLATRNVLVFDKLNVK 164

Query: 110 ITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQ 166
           I+D G+      A         +    +MSPE I  GK+   SDIWS G+VL E  + G 
Sbjct: 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224

Query: 167 FPYSPPEQQD 176
            PY     QD
Sbjct: 225 QPYCGYSNQD 234

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 65/257 (25%)

Query: 35  QSFYSN--GAISIIL-EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 91
           Q ++ N  G + I++ +Y  G  L D++ K       +LA I  Q    L Y H E H++
Sbjct: 197 QRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLM 254

Query: 92  HRDLKPSNLLI----------NHRG------EVKITDFGVSAIMASTSGQANTFVGTYNY 135
           H DLKP N+L+           +R        V+I D G               V T +Y
Sbjct: 255 HTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC---CDERHSRTAIVSTRHY 311

Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-- 193
            SPE + G  + Y +D+WS+G ++ E  TG+  Y   +  D     + LME  + + P  
Sbjct: 312 RSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY---DTHDNLEHLH-LMEKTLGRLPSE 367

Query: 194 ---------------------PSAPSDQFS--------------PEFCSFISACVQKEPQ 218
                                P       +                 C  I   +  + Q
Sbjct: 368 WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427

Query: 219 QRLSAQELMTHPFLKMY 235
           +RL+A+++ THP++  Y
Sbjct: 428 KRLNARQMTTHPYVLKY 444

Length = 467

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.9 bits (158), Expect = 3e-12
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 22/183 (12%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK---- 61
           +  ++AR    +E+KI    + P ++       ++  + +I EYM+ G L  FL +    
Sbjct: 57  DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQ 116

Query: 62  -------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 114
                  V TI    L  +  Q+  G+ YL    + +HRDL   N L+     +KI DFG
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLATRNCLVGKNYTIKIADFG 175

Query: 115 VSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQF 167
           +S  + S       G+A   V    +MS E I  GK+   SD+W+ G+ L E  T   + 
Sbjct: 176 MSRNLYSGDYYRIQGRA---VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232

Query: 168 PYS 170
           PYS
Sbjct: 233 PYS 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.3 bits (156), Expect = 4e-12
 Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 26/239 (10%)

Query: 7   VEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           V E+A    R +   E  + +   C +VV             +I+E M  G L  +L+ +
Sbjct: 44  VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 103

Query: 63  KTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +   E          + +  +  ++  G+ YL+  K  +HRDL   N ++     VKI D
Sbjct: 104 RPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGD 162

Query: 113 FGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           FG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  + PY
Sbjct: 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222

Query: 170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +        +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 223 QGMSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 64.7 bits (157), Expect = 4e-12
 Identities = 43/129 (33%), Positives = 68/129 (52%), Gaps = 10/129 (7%)

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGV 115
           KK   +P   + ++  Q+L G+ YLH    ++HRDLKP+N+L+      RG VKI D G 
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158

Query: 116 SAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSP 171
           + +  S        +  V T+ Y +PE + G ++  K+ DIW++G +  E  T + P   
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFH 217

Query: 172 PEQQDGWTS 180
             Q+D  TS
Sbjct: 218 CRQEDIKTS 226

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 5e-12
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)

Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +P+E      L +   QV +G+ Y
Sbjct: 93  DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEY 152

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 153 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211

Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 212 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 63.6 bits (155), Expect = 6e-12
 Identities = 44/138 (31%), Positives = 63/138 (45%), Gaps = 23/138 (16%)

Query: 44  SIILEYMDGGSLADFLKKVKTIPEEYLAA------------------ICEQVLKGLLYLH 85
            ++ EY+  G L +FL  V+  P   + A                  I  Q+  G+ YL 
Sbjct: 84  CMLFEYLAHGDLHEFL--VRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141

Query: 86  HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISG 143
              H +HRDL   N L+     VKI+DFG+S  + S       +  +    +M PE I  
Sbjct: 142 -SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY 200

Query: 144 GKYGYKSDIWSLGLVLLE 161
           GK+  +SDIWS G+VL E
Sbjct: 201 GKFTTESDIWSFGVVLWE 218

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 39/234 (16%)

Query: 40  NGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLA-----AICEQVLKGLLY 83
           +G + +++EY   G+L ++L+  +            +PEE L      +   QV +G+ Y
Sbjct: 90  DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEY 149

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 150 LASQK-CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208

Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y ++SD+WS G++L E  T G  PY   P E+      F  L E      P +   
Sbjct: 209 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTH 263

Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQEL-------MTHPFLKMYGDLNVDLSEY 245
           + +       +  C    P QR + ++L       +T      Y DL+V   +Y
Sbjct: 264 ELY-----MIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQY 312

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.9 bits (155), Expect = 8e-12
 Identities = 43/129 (33%), Positives = 68/129 (52%), Gaps = 10/129 (7%)

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGV 115
           KK   +P   + ++  Q+L G+ YLH    ++HRDLKP+N+L+      RG VKI D G 
Sbjct: 100 KKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158

Query: 116 SAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSP 171
           + +  S        +  V T+ Y +PE + G ++  K+ DIW++G +  E  T + P   
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFH 217

Query: 172 PEQQDGWTS 180
             Q+D  TS
Sbjct: 218 CRQEDIKTS 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 74/271 (27%), Positives = 110/271 (40%), Gaps = 47/271 (17%)

Query: 9   ESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---- 63
           E+  R  A EL++  +    P ++    +  + G + I +EY   G+L DFL+K +    
Sbjct: 43  ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLET 102

Query: 64  ------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
                       T+  + L      V  G+ YL  EK  IHRDL   N+L+      KI 
Sbjct: 103 DPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS-EKQFIHRDLAARNVLVGENLASKIA 161

Query: 112 DFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 166
           DFG+S      +  T G+         +M+ E ++   Y  KSD+WS G++L E  + G 
Sbjct: 162 DFGLSRGEEVYVKKTMGRLPV-----RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG 216

Query: 167 FPYSPPEQQDGWT--SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR---- 220
            PY       G T    YE +        P    D    E    +  C +  P +R    
Sbjct: 217 TPYC------GMTCAELYEKLPQGYRMEKPRNCDD----EVYELMRQCWRDRPYERPPFA 266

Query: 221 -LSAQELMTHPFLKMYGDLNVDLSEYFTDAG 250
            +S Q        K Y  +N+ L E FT AG
Sbjct: 267 QISVQLSRMLEARKAY--VNMALFENFTYAG 295

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.0 bits (153), Expect = 1e-11
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 22/202 (10%)

Query: 42  AISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
            I +I+E++  GSL ++L + K  I  +       Q+ KG+ YL   +++ HRDL   N+
Sbjct: 82  GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV-HRDLAARNV 140

Query: 101 LINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
           L+    +VKI DFG++  + +        +       + +PE +   K+   SD+WS G+
Sbjct: 141 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV 200

Query: 158 VLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEF 205
            L E    C +   P +       P   Q   T    ++E     P PP+ P      E 
Sbjct: 201 TLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPE-----EV 255

Query: 206 CSFISACVQKEPQQRLSAQELM 227
              +  C + +P +R + Q L+
Sbjct: 256 YQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 19/160 (11%)

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---- 123
           E L +   QV KG+ +L   K+ IHRDL   N+L+ H    KI DFG++  + + S    
Sbjct: 214 EDLLSFSYQVAKGMSFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272

Query: 124 -GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 181
            G A   V    +M+PE I    Y ++SD+WS G++L E  + G  PY P    D  + F
Sbjct: 273 KGNARLPV---KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMPVD--SKF 326

Query: 182 YELM-EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
           Y+++ E      P  AP      E    + +C   +P +R
Sbjct: 327 YKMIKEGYRMLSPECAP-----SEMYDIMKSCWDADPLKR 361

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 59/179 (32%), Positives = 82/179 (45%), Gaps = 19/179 (10%)

Query: 57  DFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           D  KKV T+  E L     QV KG+ +L   K  IHRDL   N+L++    VKI DFG++
Sbjct: 170 DLYKKVLTL--EDLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLA 226

Query: 117 AIMAST-----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYS 170
             +         G A        +M+PE I    Y  +SD+WS G++L E  + G  PY 
Sbjct: 227 RDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY- 282

Query: 171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           P  + D      E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 283 PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 24/194 (12%)

Query: 45  IILEYMDGGSLADFLKKVK------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 98
           +IL +M  G L  FL   +      T+P + L      +  G+ YL   K+ IHRDL   
Sbjct: 84  VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS-SKNFIHRDLAAR 142

Query: 99  NLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 154
           N ++N    V + DFG+S  + S      G A+       +++ E ++   Y   SD+W+
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKWLALESLADNVYTTHSDVWA 200

Query: 155 LGLVLLECAT-GQFPYSPPEQQDGWTSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISAC 212
            G+ + E  T GQ PY+  E  +     Y  L++    + PP    D +       +  C
Sbjct: 201 FGVTMWEIMTRGQTPYAGVENSE----IYNYLIKGNRLKQPPDCLEDVY-----ELMCQC 251

Query: 213 VQKEPQQRLSAQEL 226
              EP+ R S Q L
Sbjct: 252 WSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.1 bits (151), Expect = 2e-11
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 22/174 (12%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQS--FYSNGAISIILEYMDGGSLADFL----KKVKTI 65
           RR++    K++  +    + +C ++   Y      +ILEY D G L  FL     K + +
Sbjct: 56  RRELDMFRKLSHKNVVRLLGLCREAEPHY------MILEYTDLGDLKQFLRATKSKDEKL 109

Query: 66  PEEYLA-----AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               L+     A+C Q+  G+ +L      +HRDL   N L++ + EVK++   +S  + 
Sbjct: 110 KPPPLSTKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168

Query: 121 STS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 171
           ++      N  +    +++PE +    +  KSD+WS G+++ E  T G+ P+  
Sbjct: 169 NSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 28/187 (14%)

Query: 45  IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           I+ EYM  G+L  FL+K +  +    L  +   +  G+ YL  E   +H+ L    +L+N
Sbjct: 83  IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVN 141

Query: 104 HRGEVKITDFG------VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
                KI+ F         AI  + SG++        + +PE I    +   SD+WS G+
Sbjct: 142 SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-----WAAPEAIQYHHFSSASDVWSFGI 196

Query: 158 VLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACV 213
           V+ E  + G+ PY     QD       +++A+ D    P P              +  C 
Sbjct: 197 VMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRLPAPR----NCPNLLHQLMLDCW 245

Query: 214 QKEPQQR 220
           QKE  +R
Sbjct: 246 QKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.0 bits (150), Expect = 3e-11
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 20/149 (13%)

Query: 40  NGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLA-----AICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +            +PEE L+     +   QV +G+ Y
Sbjct: 96  DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 156 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214

Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G++L E  T G  PY
Sbjct: 215 FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 31/191 (16%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           ++ +V ++AR    +E+KI    + P ++    VC         + +I EYM+ G L  F
Sbjct: 52  LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD----DPLCMITEYMENGDLNQF 107

Query: 59  LKK------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 106
           L +            + ++    L  +  Q+  G+ YL    + +HRDL   N L+ +  
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-SLNFVHRDLATRNCLVGNHY 166

Query: 107 EVKITDFGVSAIMAST-----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
            +KI DFG+S  + S       G+A   V    +M+ E I  GK+   SD+W+ G+ L E
Sbjct: 167 TIKIADFGMSRNLYSGDYYRIQGRA---VLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 162 CAT--GQFPYS 170
             T   + PYS
Sbjct: 224 MFTLCKEQPYS 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.2 bits (148), Expect = 5e-11
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 28/183 (15%)

Query: 9   ESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---- 63
           +   R  A EL++  +    P ++    +    G + + +EY   G+L DFL+K +    
Sbjct: 36  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 95

Query: 64  ------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
                       T+  + L      V +G+ YL  +K  IHRDL   N+L+      KI 
Sbjct: 96  DPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIA 154

Query: 112 DFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 166
           DFG+S      +  T G+         +M+ E ++   Y   SD+WS G++L E  + G 
Sbjct: 155 DFGLSRGQEVYVKKTMGRLPV-----RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209

Query: 167 FPY 169
            PY
Sbjct: 210 TPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.2 bits (148), Expect = 6e-11
 Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 14/149 (9%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGT 132
           Q+  G+ YL      +H+DL   N+LI  +  VKI+D G+S  + S      Q  + +  
Sbjct: 132 QIAAGMEYLS-SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL-P 189

Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ 191
             +M PE I  GK+   SDIWS G+VL E  + G  PY     Q       E++E +  +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------EVIEMVRKR 242

Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQR 220
                  D   P   S ++ C Q+ P +R
Sbjct: 243 QLLPCSED-CPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.8 bits (147), Expect = 7e-11
 Identities = 55/238 (23%), Positives = 100/238 (42%), Gaps = 26/238 (10%)

Query: 7   VEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ +
Sbjct: 44  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 103

Query: 63  KTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   VKI D
Sbjct: 104 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGD 162

Query: 113 FGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           FG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  + PY
Sbjct: 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 222

Query: 170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
                +       ++++ ++D      P D         +  C Q  P+ R +  E++
Sbjct: 223 QGLSNE-------QVLKFVMDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 8e-11
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 17/160 (10%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFV 130
           QV +G+ +L   K  IHRDL   N+L++    VKI DFG++  +         G A    
Sbjct: 181 QVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237

Query: 131 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV 189
               +M+PE I    Y  +SD+WS G++L E  + G  PY P  Q D      E    + 
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQID-----EEFCRRLK 290

Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           +     AP +  +PE  S +  C    P+ R +  EL+  
Sbjct: 291 EGTRMRAP-EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 21/153 (13%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS----GQANTFV 130
           QV +G+ +L   K+ IHRD+   N+L+      KI DFG++  IM  ++    G A   V
Sbjct: 220 QVAQGMDFLA-SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 131 GTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEA-- 187
               +M+PE I    Y  +SD+WS G++L E  + G+ PY P    +  + FY++++   
Sbjct: 279 ---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-PGILVN--SKFYKMVKRGY 332

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            + +P      D   PE  S +  C   EP +R
Sbjct: 333 QMSRP------DFAPPEIYSIMKMCWNLEPTER 359

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 1e-10
 Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFV 130
           QV +G+ +L   K  IHRDL   N+L++    VKI DFG++  +         G A    
Sbjct: 182 QVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238

Query: 131 GTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIV 189
               +M+PE I    Y  +SD+WS G++L E  + G  PY P  Q +      E  + + 
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQIN-----EEFCQRLK 291

Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 238
           D     AP +  +PE    + AC Q +P++R +   L     +++ GDL
Sbjct: 292 DGTRMRAP-ENATPEIYRIMLACWQGDPKERPTFSAL-----VEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
           + A+  Q+L  + Y+H E  IIHRD+K  N+L+N   ++ + DFG +A  A  S      
Sbjct: 262 VTAVARQLLSAIDYIHGEG-IIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFH 319

Query: 130 ---VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 163
               GT +  +PE ++G  Y    DIWS GLV+ E A
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 46/238 (19%)

Query: 41  GAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYL 84
           G + + +EY   G+L DFL+K +                T+  + L      V +G+ YL
Sbjct: 81  GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140

Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPER 140
             +K  IHRDL   N+L+      KI DFG+S      +  T G+         +M+ E 
Sbjct: 141 S-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWMAIES 194

Query: 141 ISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT--SFYELMEAIVDQPPPSAP 197
           ++   Y   SD+WS G++L E  + G  PY       G T    YE +        P   
Sbjct: 195 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAELYEKLPQGYRLEKPLNC 248

Query: 198 SDQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFL----KMYGDLNVDLSEYFTDAG 250
            D    E    +  C +++P +R S AQ L++   +    K Y  +N  L E FT AG
Sbjct: 249 DD----EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY--VNTTLYEKFTYAG 300

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 22/210 (10%)

Query: 32  VCYQSFYSNGAIS--IILEYMDGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLY 83
           VC+++          +IL +M  G L  FL   +       +P + L      +  G+ Y
Sbjct: 69  VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY 128

Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L + ++ IHRDL   N ++     V + DFG+S  + S        +      +++ E +
Sbjct: 129 LSN-RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 187

Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE-LMEAIVDQPPPSAPSD 199
           +   Y  KSD+W+ G+ + E AT GQ PY   E  +     Y+ L      + P      
Sbjct: 188 ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYLRHGNRLKQPEDCLD- 242

Query: 200 QFSPEFCSFISACVQKEPQQRLSAQELMTH 229
               E    + +C + +P+ R +  +L   
Sbjct: 243 ----ELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 2/97 (2%)

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG-VSAIMASTSGQANTFV 130
           AI +Q+L  + Y+H +K +IHRD+K  N+ +N  G++ + DFG               +V
Sbjct: 271 AIMKQLLCAVEYIH-DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329

Query: 131 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 167
           GT    SPE ++G  Y   +DIWS GL+LL+  +  F
Sbjct: 330 GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 13/161 (8%)

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS--GQA 126
           L +   QV +G+ +L   K+ +HRDL   N+L+     VKI DFG++  IM  ++   + 
Sbjct: 239 LLSFTYQVARGMEFLA-SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM 185
           +TF+    +M+PE I    Y   SD+WS G++L E  + G  PY P    D  ++FY  +
Sbjct: 298 STFLPV-KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY-PGMIVD--STFYNKI 353

Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           ++      P    D  + E    +  C   EP++R S   L
Sbjct: 354 KSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.9 bits (140), Expect = 6e-10
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 7/138 (5%)

Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL   K  +HRDL  
Sbjct: 68  SEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-SKKFVHRDLAA 126

Query: 98  SNLLINHRGEVKITDFGVSAIMAST---SGQANTFVG-TYNYMSPERISGGKYGYKSDIW 153
            N +++    VK+ DFG++  +      S   +T       +M+ E +   K+  KSD+W
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186

Query: 154 SLGLVLLECAT-GQFPYS 170
           S G++L E  T G  PY 
Sbjct: 187 SFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.5 bits (141), Expect = 6e-10
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 24/192 (12%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-VKITDFGVSAIMASTSGQANTFVGTYN 134
           Q+ + L Y+H  K I HRDLKP NLLI+     +K+ DFG SA       ++ +++ +  
Sbjct: 178 QLCRALAYIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYICSRF 235

Query: 135 YMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP- 192
           Y +PE + G   Y    D+WSLG ++ E   G   +S     D      +++    +   
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295

Query: 193 ------------PPSAPSD------QFSP-EFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                       P   P D      + +P +  +FIS  ++ EP +RL+  E +  PF  
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355

Query: 234 MYGDLNVDLSEY 245
              D  + L +Y
Sbjct: 356 DLRDPCIKLPKY 367

Length = 440

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 71/279 (25%), Positives = 103/279 (36%), Gaps = 70/279 (25%)

Query: 12  RRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           R Q+A    E  I   +   +VV  Y SF     +  +++Y+ GG +   L +++  PE 
Sbjct: 42  RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE- 100

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT 128
            LA      L   +   H+   IHRD+KP N+LI+  G +K+TDFG+      T      
Sbjct: 101 VLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160

Query: 129 FVGTY---NYMSPERISGGKYGYKSDIWS------LG--LVLLE-------------CAT 164
             G++   + M P           SD+W        G  L  LE                
Sbjct: 161 QKGSHIRQDSMEP-----------SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209

Query: 165 GQFPYSPPEQQ---------DGWTSFYELMEAIVDQPPPSAPSD---------------- 199
           G   Y  PE           D W+    L E +V QPP  AP+                 
Sbjct: 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHI 269

Query: 200 ----QFSPEFCSFIS--ACVQKEPQQRLSAQELMTHPFL 232
               + SPE    I+   C  +E   R  A ++  HPF 
Sbjct: 270 PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 53/267 (19%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK- 60
           +++ +  ++AR    +E+KI    + P ++           + +I EYM+ G L  FL  
Sbjct: 53  ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSS 112

Query: 61  ------------------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
                              +  I    L  +  Q+  G+ YL    + +HRDL   N L+
Sbjct: 113 HHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS-SLNFVHRDLATRNCLV 171

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTY-----------NYMSPERISGGKYGYKSD 151
                +KI DFG+S          N + G Y            +M+ E I  GK+   SD
Sbjct: 172 GENLTIKIADFGMS---------RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASD 222

Query: 152 IWSLGLVLLE----CATGQFPYSPPEQ--QDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 205
           +W+ G+ L E    C    +     EQ  ++    F +    +    PP  P   +    
Sbjct: 223 VWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY---- 278

Query: 206 CSFISACVQKEPQQRLSAQELMTHPFL 232
              +  C  ++ ++R S  ++  H FL
Sbjct: 279 -ELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 31/191 (16%)

Query: 45  IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           ++ E+++ G L   L+K K  +P  +   + +Q+   L YL  +K+++H ++   N+L+ 
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE-DKNLVHGNVCAKNILLA 151

Query: 104 HRGE-------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSL 155
             G        +K++D GVS    S   +    V    +++PE +  G      +D WS 
Sbjct: 152 RLGLAEGTSPFIKLSDPGVSFTALSREER----VERIPWIAPECVPGGNSLSTAADKWSF 207

Query: 156 GLVLLE-CATGQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 211
           G  LLE C  G+ P    +P E++     FYE    +   P PS        E  + IS 
Sbjct: 208 GTTLLEICFDGEVPLKERTPSEKE----RFYEKKHRL---PEPSCK------ELATLISQ 254

Query: 212 CVQKEPQQRLS 222
           C+  EP QR S
Sbjct: 255 CLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 45/131 (34%), Positives = 67/131 (51%), Gaps = 13/131 (9%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS--GQANTFVGT 132
           QV  G+ +L   K+ +HRDL   N+LI     VKI DFG++  IM  ++   + +TF+  
Sbjct: 247 QVANGMEFLA-SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-P 304

Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIV 189
             +M+PE I    Y   SD+WS G++L E  T G  PY   P  +Q     FY  ++   
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-----FYNAIKRGY 359

Query: 190 DQPPPSAPSDQ 200
               P+  SD+
Sbjct: 360 RMAKPAHASDE 370

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 54.1 bits (131), Expect = 6e-09
 Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 11/90 (12%)

Query: 27  CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 86
            P V   Y     N    I++EY++G  L D +        E    I   V  G L   H
Sbjct: 63  VPAV---YFVDPENF--IIVMEYIEGEPLKDLINSNGMEELELSREIGRLV--GKL---H 112

Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
              IIH DL  SN++++  G++ + DFG++
Sbjct: 113 SAGIIHGDLTTSNMILSG-GKIYLIDFGLA 141

Length = 211

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 3/121 (2%)

Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + I++E    G L  +L+  K  +    L     Q+   L YL   K  +HRD+   N+L
Sbjct: 81  VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE-SKRFVHRDIAARNVL 139

Query: 102 INHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
           ++    VK+ DFG+S  +   +  +A+       +M+PE I+  ++   SD+W  G+ + 
Sbjct: 140 VSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199

Query: 161 E 161
           E
Sbjct: 200 E 200

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 16/164 (9%)

Query: 53  GSLADFLKKVKTIPEE---------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           G L +F+   K IP+           +  +  QVL GL  LH    I+HRD+KP NLL+ 
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVT 343

Query: 104 HRGEVKITDFGVSAIMASTSGQANTFVGTYN--YMSPERISGGKYGYKSDIWSLGLVLLE 161
             G+VKI DFG +  M  T    N   G  +  Y  PE +   +   ++   ++  +L  
Sbjct: 344 VDGQVKIIDFGAAVDMC-TGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSP 402

Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 205
            A   + Y  P+  D +T+   LM+  V +  P A    F+ E 
Sbjct: 403 FA---WLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL 443

Length = 507

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 7/130 (5%)

Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           +S+ILEY   G L + L K K +  +    +     KGL  L+   +  +++L   + L+
Sbjct: 97  LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 103 NHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVL 159
               ++KI   G+  I++S      N  V    Y S + ++    +Y  K DI+SLG+VL
Sbjct: 157 TENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 160 LECATGQFPY 169
            E  TG+ P+
Sbjct: 213 WEIFTGKIPF 222

Length = 283

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 48.8 bits (116), Expect = 9e-07
 Identities = 29/123 (23%), Positives = 59/123 (47%), Gaps = 8/123 (6%)

Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
           +  +  K++K   ++ +  I + +L  L Y+H E  I H D+KP N++++      I D+
Sbjct: 112 NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGNNRGYIIDY 170

Query: 114 GVSAI-------MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ 166
           G+++        +  +  Q +   GT  Y   +  +G     + D+ SLG  +L+ A  +
Sbjct: 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK 230

Query: 167 FPY 169
            P+
Sbjct: 231 LPW 233

Length = 294

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)

Query: 45  IILEYMDGGSLADFLKKVKTI------PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 98
           ++LE+   G L ++L+  + +       +      CE V  GLL+LH +   IH DL   
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE-VASGLLWLH-QADFIHSDLALR 129

Query: 99  NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPE-------RISGGKYGYK 149
           N  +     VKI D+G+             +       +++PE        +       K
Sbjct: 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189

Query: 150 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP---SDQFSP-- 203
           S+IWSLG+ + E  T    PY  P+  D       + E  +  P P      SD++    
Sbjct: 190 SNIWSLGVTMWELFTAADQPY--PDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVM 247

Query: 204 EFCSFISACVQKEPQQRLSAQE---LMTH 229
           +FC         +P+ R +A+E   L+T+
Sbjct: 248 QFCWL-------DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 43.4 bits (103), Expect = 3e-05
 Identities = 23/73 (31%), Positives = 37/73 (50%), Gaps = 9/73 (12%)

Query: 44  SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           +I++EY++G  L D    ++   +E L  I   V  G L   H+  I+H DL  SN+++ 
Sbjct: 73  TIVMEYIEGKPLKD---VIEEGNDELLREIGRLV--GKL---HKAGIVHGDLTTSNIIVR 124

Query: 104 HRGEVKITDFGVS 116
                 I DFG+ 
Sbjct: 125 DDKLYLI-DFGLG 136

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.8 bits (101), Expect = 3e-05
 Identities = 27/121 (22%), Positives = 53/121 (43%), Gaps = 17/121 (14%)

Query: 1   MVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL 55
            V+++N          +E+ I      +    P V+   +S   +G   +++E+++G +L
Sbjct: 24  YVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES---DGWSYLLMEWIEGETL 80

Query: 56  ADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDF 113
            +       + EE    I EQ+ + L  LH      + H DL P N+L++    + I D+
Sbjct: 81  DE-------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDW 133

Query: 114 G 114
            
Sbjct: 134 E 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

 Score = 42.9 bits (102), Expect = 4e-05
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 10/89 (11%)

Query: 27  CPYVVVCYQSFYSNGAISIILEYM-DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 85
            P  ++       N    +++E++ D GS A  LK V  + EE    + EQV++ +  L+
Sbjct: 83  VPEPIL----LKKN---VLVMEFIGDDGSPAPRLKDVP-LEEEEAEELYEQVVEQMRRLY 134

Query: 86  HEKHIIHRDLKPSNLLINHRGEVKITDFG 114
            E  ++H DL   N+L  H G+  I D  
Sbjct: 135 QEAGLVHGDLSEYNILY-HDGKPYIIDVS 162

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 32/192 (16%)

Query: 45  IILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           ++ EY+  G L  FL + K  +   +   + +Q+   L YL  +K ++H ++   N+L+ 
Sbjct: 77  MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-DKKLVHGNVCGKNILVA 135

Query: 104 HRGE-------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--KYGYKSDIWS 154
             G        +K++D G+      T       V    +++PE I  G       +D WS
Sbjct: 136 RYGLNEGYVPFIKLSDPGIP----ITVLSREERVERIPWIAPECIRNGQASLTIAADKWS 191

Query: 155 LGLVLLE-CATGQFP---YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 210
            G  LLE C+ G+ P    S  E++     FY+      DQ     P      E  + I+
Sbjct: 192 FGTTLLEICSNGEEPLSTLSSSEKER----FYQ------DQHRLPMPD---CAELANLIN 238

Query: 211 ACVQKEPQQRLS 222
            C   +P +R S
Sbjct: 239 QCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain

 Score = 41.3 bits (98), Expect = 1e-04
 Identities = 19/71 (26%), Positives = 37/71 (52%), Gaps = 4/71 (5%)

Query: 45  IILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           +++E++ G  +    LK V+    E    + +Q+L+ +  L+ E  ++H DL   N+L+ 
Sbjct: 92  LVMEFIGGDGIPAPRLKDVR--LLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV- 148

Query: 104 HRGEVKITDFG 114
             G+V I D  
Sbjct: 149 DDGKVYIIDVP 159

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 23/104 (22%), Positives = 41/104 (39%), Gaps = 15/104 (14%)

Query: 38  YSNGAISIILEYMDGGSLADF--LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 95
           Y+   + + +E++DG  ++D   LK      +E    +    L+ LL         H D 
Sbjct: 237 YTTRRV-LTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL----RDGFFHADP 291

Query: 96  KPSNLLINHRGEVKITDFGVSAIMASTSGQ-----ANTFVGTYN 134
            P N+L+   G + + DFG   I+     +     A   +   N
Sbjct: 292 HPGNILVRSDGRIVLLDFG---IVGRLDPKFRRYLAELLLAFLN 332

Length = 517

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 41.0 bits (97), Expect = 2e-04
 Identities = 24/71 (33%), Positives = 40/71 (56%), Gaps = 11/71 (15%)

Query: 45  IILEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           +++EY+DG      L +V+ +  PEE L  I E+++K   Y H    IIH DL   N+L+
Sbjct: 108 VVMEYIDG----VELYRVRVLEDPEEVLDEILEEIVK--AYKHG---IIHGDLSEFNILV 158

Query: 103 NHRGEVKITDF 113
           +   ++ I D+
Sbjct: 159 DDDEKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 10/71 (14%)

Query: 44  SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           +I++EY+ G  L D L+       E +  + E V K    LH    I+H DL  SN ++ 
Sbjct: 412 TIVMEYIGGKDLKDVLEGN----PELVRKVGEIVAK----LHKAG-IVHGDLTTSNFIV- 461

Query: 104 HRGEVKITDFG 114
               + + DFG
Sbjct: 462 RDDRLYLIDFG 472

Length = 535

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 14/90 (15%)

Query: 27  CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 86
            P V              I++EY++G  L D L+       + L  +   V  G L   H
Sbjct: 63  VPIVY-----DVDPDNGLIVMEYIEGELLKDALE---EARPDLLREVGRLV--GKL---H 109

Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           +  I+H DL  SN++++  G +   DFG+ 
Sbjct: 110 KAGIVHGDLTTSNIILS-GGRIYFIDFGLG 138

Length = 204

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.8 bits (93), Expect = 6e-04
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 26/189 (13%)

Query: 45  IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           ++ EY+  GSL  +LKK K  I   +   + +Q+   L +L  +K + H ++   N+L+ 
Sbjct: 76  MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE-DKGLTHGNVCAKNVLLI 134

Query: 104 HRGE--------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWS 154
              +        +K++D G+S  +          +    ++ PE I   +     +D WS
Sbjct: 135 REEDRKTGNPPFIKLSDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWS 190

Query: 155 LGLVLLE-CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 213
            G  L E  + G  P S  + Q     FYE      D+    AP      E  + I+ C+
Sbjct: 191 FGTTLWEIFSGGDKPLSALDSQKK-LQFYE------DRHQLPAPK---WTELANLINQCM 240

Query: 214 QKEPQQRLS 222
             EP  R S
Sbjct: 241 DYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 22/71 (30%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 45  IILEYM-DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           +++E++ D G  A  LK V  +  E    + E V++ +  L+ E  ++H DL   N+L+ 
Sbjct: 143 LVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV- 200

Query: 104 HRGEVKITDFG 114
           H GE  I D  
Sbjct: 201 HDGEPYIIDVS 211

Length = 268

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	262
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PRK09188	365	serine/threonine protein kinase; Provisional	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.76
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
PRK10345	210	hypothetical protein; Provisional	99.7
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.7
KOG1243	690	consensus Protein kinase [General function predict	99.68
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.64
PRK14879	211	serine/threonine protein kinase; Provisional	99.61
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.61
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
smart00090	237	RIO RIO-like kinase.	99.57
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.47
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.43
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.4
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.38
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.2
COG4248	637	Uncharacterized protein with protein kinase and he	99.17
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.13
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.88
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.86
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.81
PRK09902	216	hypothetical protein; Provisional	98.77
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.7
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.25
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.18
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.14
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.99
PF01636	239	APH: Phosphotransferase enzyme family This family	97.84
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.84
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.79
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.77
PLN02876	822	acyl-CoA dehydrogenase	97.58
KOG2270	520	consensus Serine/threonine protein kinase involved	97.36
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.36
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.15
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.12
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.07
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.96
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.5
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.47
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.16
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.75
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.58
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.54
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.5
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.37
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.26
PRK05231	319	homoserine kinase; Provisional	95.26
PTZ00384	383	choline kinase; Provisional	95.21
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.13
PRK10271	188	thiK thiamine kinase; Provisional	95.11
PRK10593	297	hypothetical protein; Provisional	94.72
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	94.4
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.99
COG2334	331	Putative homoserine kinase type II (protein kinase	93.87
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.74
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	93.48
PLN02236	344	choline kinase	93.26
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.12
PRK11768	325	serine/threonine protein kinase; Provisional	92.36
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.02
PRK06148	1013	hypothetical protein; Provisional	91.77
COG4499	434	Predicted membrane protein [Function unknown]	91.74
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	91.15

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-56  Score=351.08  Aligned_cols=249  Identities=57%  Similarity=0.979  Sum_probs=231.2

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC-eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      .+.++..++++.+|+++++.++||+||++++.|.+++ ..+++||||+||||.+++++.+.+++...-.++.+++.||.|
T Consensus       114 ~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~Y  193 (364)
T KOG0581|consen  114 LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSY  193 (364)
T ss_pred             ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999999999999999999999999988 499999999999999999999999999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ||.+.+|+||||||.|||++..|.|||||||.+......  ...+++||..|||||.+.+..|+.++||||||++++|+.
T Consensus       194 Lh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a  271 (364)
T KOG0581|consen  194 LHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELA  271 (364)
T ss_pred             HhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHh
Confidence            996699999999999999999999999999999876544  556789999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccchh
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  243 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~  243 (262)
                      +|+.||...  .+.+....+.+..+..+.+|..+...+++++++|+..||+.||.+|||++|+++|||+++.......+.
T Consensus       272 ~GrfP~~~~--~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~  349 (364)
T KOG0581|consen  272 IGRFPYPPP--NPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMA  349 (364)
T ss_pred             hCCCCCCCc--CCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHH
Confidence            999999876  334467788999999988888887779999999999999999999999999999999999999999999


Q ss_pred             hHhhhhCCCCcccC
Q 024828          244 EYFTDAGSPLATLS  257 (262)
Q Consensus       244 ~~~~~~~~~~~~~~  257 (262)
                      ..+.+..++.+..+
T Consensus       350 ~~~~~~~~~~~~~~  363 (364)
T KOG0581|consen  350 SFVRKALSPPRSLP  363 (364)
T ss_pred             HHHHHhcccCCCCC
Confidence            99999999887654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-51  Score=338.72  Aligned_cols=220  Identities=31%  Similarity=0.515  Sum_probs=201.3

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      |+...+...++++.+|++|.++++|||||+++++|+|..+.|+|.|.|..++|..++++++++++.++..++.||+.||.
T Consensus        53 k~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~Glk  132 (592)
T KOG0575|consen   53 KKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLK  132 (592)
T ss_pred             hHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHH
Confidence            33445788999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |||+ .+|+|||||..|++++.+.+||++|||+|...........+.+||+.|.|||++.....+..+||||+||+||-|
T Consensus       133 YLH~-~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtL  211 (592)
T KOG0575|consen  133 YLHS-LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTL  211 (592)
T ss_pred             HHHh-cCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhh
Confidence            9999 999999999999999999999999999999998887888899999999999999988899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      +.|++||+..+       ..+....+.......  +..++.+.++||.+||++||.+|||++++|.|+||
T Consensus       212 L~G~PPFetk~-------vkety~~Ik~~~Y~~--P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  212 LVGRPPFETKT-------VKETYNKIKLNEYSM--PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             hhCCCCcccch-------HHHHHHHHHhcCccc--ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            99999998743       344445554444322  34789999999999999999999999999999999

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-51  Score=325.11  Aligned_cols=217  Identities=33%  Similarity=0.526  Sum_probs=192.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      ...+.+|+++|++++|||||+++++|...+..|+||||+.||+|.+.+-.++.+.+...+.+++|++.|+.|||+ .||+
T Consensus       220 ~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~  298 (475)
T KOG0615|consen  220 TRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS-QGII  298 (475)
T ss_pred             hhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH-cCcc
Confidence            345689999999999999999999999999999999999999999999999999999999999999999999999 9999


Q ss_pred             eCCCCCCCEEEccC---CcEEEEecccccccccCCCCcccccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhC
Q 024828           92 HRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        92 H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~~l~~g  165 (262)
                      ||||||+|||++.+   ..+|+.|||+|...+ ......+.+||+.|.|||++.+..   +..+.|+||+||++|-+++|
T Consensus       299 HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG  377 (475)
T KOG0615|consen  299 HRDIKPENILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG  377 (475)
T ss_pred             cccCCcceEEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence            99999999999876   469999999998876 455677889999999999998765   34588999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .+||.+...+.      ...+.+..+.....+  ...++.+..+||.+||..||++|||++++|+||||+..+
T Consensus       378 ~pPFS~~~~~~------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  378 YPPFSEEYTDP------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             CCCcccccCCc------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            99998765543      345566666655443  357899999999999999999999999999999999665

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-48  Score=306.13  Aligned_cols=224  Identities=32%  Similarity=0.547  Sum_probs=202.6

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ++....+...+|.++|.+++||.||+++..|++.+.+|+|+||+.||.|...+++.+.+++..+..++..|+.||.|||+
T Consensus        64 v~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~  143 (357)
T KOG0598|consen   64 VEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS  143 (357)
T ss_pred             hhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh
Confidence            34557788999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       .||+||||||+|||++.+|+++|+|||++...........+.+||+.|+|||++.+..++.++|.||||+++|+|++|.
T Consensus       144 -~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~  222 (357)
T KOG0598|consen  144 -KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGK  222 (357)
T ss_pred             -CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCC
Confidence             9999999999999999999999999999987666666777889999999999999999999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC----CHHHHhcCccccccCCcc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----t~~~~l~h~~~~~~~~~~  239 (262)
                      +||...+.       ..+.+++..+..+..+ ..++.+.+++++++|+.||++|.    .+.++-+||||+.+.+..
T Consensus       223 pPF~~~~~-------~~~~~~I~~~k~~~~p-~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  223 PPFYAEDV-------KKMYDKILKGKLPLPP-GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             CCCcCccH-------HHHHHHHhcCcCCCCC-ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence            99998544       3566677666643333 46899999999999999999996    789999999998776443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=312.55  Aligned_cols=234  Identities=29%  Similarity=0.523  Sum_probs=200.8

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+...+.+.+|-++|.+| +||+|++++..|+|+..+|+|+||+++|+|.+++++.+.+++...+.++.+|+.||+|||+
T Consensus       113 ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~  192 (604)
T KOG0592|consen  113 KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS  192 (604)
T ss_pred             hhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh
Confidence            455566788999999999 8999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-------------cccccccccccCcccccCCCCCcchhHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-------------ANTFVGTYNYMSPERISGGKYGYKSDIW  153 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~  153 (262)
                       +||+||||||+|||++.+++++|.|||-+..+......             ...++||..|.+||.+.....++.+|+|
T Consensus       193 -~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiW  271 (604)
T KOG0592|consen  193 -NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLW  271 (604)
T ss_pred             -cCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchH
Confidence             99999999999999999999999999998766432111             1347999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          154 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       154 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      +|||++|+|+.|.+||.+.++.       ...+++..-.  ...+..+++.+.+|++++|..||.+|+|+++|.+||||.
T Consensus       272 AlGCilyQmlaG~PPFra~Ney-------liFqkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~  342 (604)
T KOG0592|consen  272 ALGCILYQMLAGQPPFRAANEY-------LIFQKIQALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE  342 (604)
T ss_pred             HHHHHHHHHhcCCCCCccccHH-------HHHHHHHHhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence            9999999999999999987653       2233332222  223357889999999999999999999999999999999


Q ss_pred             ccCCcccchhhHhhhhCCCCccc
Q 024828          234 MYGDLNVDLSEYFTDAGSPLATL  256 (262)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~  256 (262)
                      ......     .+...+.+++-.
T Consensus       343 ~Vdw~n-----lw~~~PP~l~py  360 (604)
T KOG0592|consen  343 GVDWEN-----LWQQTPPKLQPY  360 (604)
T ss_pred             cCChhh-----hhhcCCCcccCC
Confidence            877655     566666555543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-46  Score=315.60  Aligned_cols=228  Identities=30%  Similarity=0.549  Sum_probs=207.3

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      |+.+..+.....+.+|+-||+-++||||+.++++|+...++|+|.||++||.|.+++-+.|++++.+...++.||+.|+.
T Consensus        47 k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~  126 (786)
T KOG0588|consen   47 KRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVS  126 (786)
T ss_pred             cccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHH
Confidence            34456677888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE  161 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~  161 (262)
                      |+|. .+|+|+|+||+|+|++..+++|++|||+|.... +++-..+.+|.+.|.+||++.|.+| +.++||||-|+++|.
T Consensus       127 yCH~-~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfA  204 (786)
T KOG0588|consen  127 YCHA-FNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFA  204 (786)
T ss_pred             HHhh-hcceeccCCchhhhhhcccCEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHH
Confidence            9999 999999999999999999999999999997643 4566778899999999999999886 789999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~  241 (262)
                      |++|+.||++       .++..+..++..+..-..  ..+++++++||.+||..||.+|.|.+||++|||+..+.....+
T Consensus       205 LLtG~LPFdD-------dNir~LLlKV~~G~f~MP--s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  205 LLTGKLPFDD-------DNIRVLLLKVQRGVFEMP--SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHhCCCCCCC-------ccHHHHHHHHHcCcccCC--CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            9999999996       455667777777765433  6899999999999999999999999999999999999887775

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-46  Score=307.77  Aligned_cols=216  Identities=30%  Similarity=0.567  Sum_probs=190.9

Q ss_pred             HHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|+.++++++ ||||+++++++.....+++||||+.||+|.+++.+.+++++..+..+++|++.|++|+|+ .
T Consensus        61 ~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~-~  139 (370)
T KOG0583|consen   61 KLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS-R  139 (370)
T ss_pred             ccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-C
Confidence            34566779999999998 999999999999999999999999999999999999999999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccC-CcEEEEecccccccccCCCCcccccccccccCcccccCCC-C-CcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-Y-GYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~-~~~~Di~slG~~l~~l~~g  165 (262)
                      |++||||||+|++++.+ ++++|+|||++...........+..|++.|+|||++.+.. | +.++||||+|+++|.|++|
T Consensus       140 gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G  219 (370)
T KOG0583|consen  140 GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCG  219 (370)
T ss_pred             CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhC
Confidence            99999999999999999 9999999999987643445667789999999999999877 7 4899999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCC-CHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      +.||...+.       ..+...+..+.....  ..+ ++++.+|+.+||..||.+|+|+.+++.||||+..
T Consensus       220 ~~PF~d~~~-------~~l~~ki~~~~~~~p--~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  220 RLPFDDSNV-------PNLYRKIRKGEFKIP--SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCCCCCccH-------HHHHHHHhcCCccCC--CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            999998332       344444544443332  344 9999999999999999999999999999999984

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=284.88  Aligned_cols=223  Identities=27%  Similarity=0.496  Sum_probs=200.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +.-.+.+...+|.++|+.+.||.++++++.|.+.+++|+||||++||.|.+++++.+++++..++.++.+++.||+|||+
T Consensus        83 VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~  162 (355)
T KOG0616|consen   83 VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS  162 (355)
T ss_pred             HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh
Confidence            35566778889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       ++|++||+||+|||++.+|.+++.|||+|.+..   ....+.+||+.|+|||++.+..++.++|.|+||+++|||+.|.
T Consensus       163 -~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~  238 (355)
T KOG0616|consen  163 -LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY  238 (355)
T ss_pred             -cCeeeccCChHHeeeccCCcEEEEeccceEEec---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence             999999999999999999999999999998754   3467789999999999999999999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCcccc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~~~~  241 (262)
                      +||...+.       ....+++..+....+  ..+++++++|++++|+.|-.+|.     ..++|..||||+...+..+.
T Consensus       239 pPF~~~~~-------~~iY~KI~~~~v~fP--~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~  309 (355)
T KOG0616|consen  239 PPFYDDNP-------IQIYEKILEGKVKFP--SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL  309 (355)
T ss_pred             CCCcCCCh-------HHHHHHHHhCcccCC--cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence            99998654       345566666655443  47899999999999999999994     67899999999988776663


Q ss_pred             h
Q 024828          242 L  242 (262)
Q Consensus       242 ~  242 (262)
                      .
T Consensus       310 ~  310 (355)
T KOG0616|consen  310 Q  310 (355)
T ss_pred             h
Confidence            3

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=305.67  Aligned_cols=226  Identities=25%  Similarity=0.406  Sum_probs=187.5

Q ss_pred             HHHHHHHHhcCC-CCeeEeeceEEEECC-eEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           15 IAQELKINQSSQ-CPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        15 ~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      =.||++.|++++ ||||+++.+++.+.+ .+|+||||++. +|+++++.+ +.+++..+..|+.||+.||+++|+ .|++
T Consensus        55 nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk-~GfF  132 (538)
T KOG0661|consen   55 NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK-HGFF  132 (538)
T ss_pred             HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-cCcc
Confidence            358999999998 999999999999887 99999999976 999999876 469999999999999999999999 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      |||+||+|||+..+..+||+|||+|+...+.. ..+.++.|.+|+|||++... -|+.+.|+|++||+++|+++-++.|.
T Consensus       133 HRDlKPENiLi~~~~~iKiaDFGLARev~Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  133 HRDLKPENILISGNDVIKIADFGLAREVRSKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP  211 (538)
T ss_pred             cccCChhheEecccceeEecccccccccccCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence            99999999999888899999999998775443 45567889999999998765 48999999999999999999999998


Q ss_pred             CCCccCchhhH---------------HHHHHHHhcCCCCCCC------CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          171 PPEQQDGWTSF---------------YELMEAIVDQPPPSAP------SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       171 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      +.++.++..++               ......+.-..+...+      ....++++.++|.+|+.+||.+|||++++|+|
T Consensus       212 G~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  212 GASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            87665433222               2222222222211111      13467899999999999999999999999999


Q ss_pred             ccccccCCcccchh
Q 024828          230 PFLKMYGDLNVDLS  243 (262)
Q Consensus       230 ~~~~~~~~~~~~~~  243 (262)
                      |||+.......+-.
T Consensus       292 pffq~~~~~~~~a~  305 (538)
T KOG0661|consen  292 PFFQVGRASGSSAR  305 (538)
T ss_pred             cccccccccccccc
Confidence            99998876644333

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-47  Score=288.09  Aligned_cols=210  Identities=32%  Similarity=0.614  Sum_probs=191.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeece-EEEECCe-EEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQ-SFYSNGA-ISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~   80 (262)
                      .+..++++...|+.+|++++|||||++++ .|.++.. +++|||+|.+|+|+..++..    +.+++..+++++.|++.|
T Consensus        57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A  136 (375)
T KOG0591|consen   57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA  136 (375)
T ss_pred             ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence            47888999999999999999999999998 5655555 89999999999999988643    459999999999999999


Q ss_pred             HHHHhh--cCC-eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHH
Q 024828           81 LLYLHH--EKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL  157 (262)
Q Consensus        81 l~~lh~--~~~-i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~  157 (262)
                      |..+|+  .+| ++||||||.||+++.+|.+||+|||+++............+||+.|++||.+.+..|++++||||+||
T Consensus       137 L~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGC  216 (375)
T KOG0591|consen  137 LYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGC  216 (375)
T ss_pred             HHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHH
Confidence            999997  333 88999999999999999999999999998877777777889999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          158 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       158 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      ++|||+.-++||.+       .+..++.+++.++..++.+...+|.++..++..|+..||+.||+.
T Consensus       217 llyEMcaL~~PF~g-------~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  217 LLYEMCALQSPFYG-------DNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHHhcCCCccc-------ccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            99999999999998       467788899999988878878999999999999999999999984

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=291.88  Aligned_cols=224  Identities=29%  Similarity=0.549  Sum_probs=195.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...++.+..|+.+|+.++|||||.++++..+.+..|+|||||+||+|.+|+++.+.+++..++.++.||+.||++||+ 
T Consensus        49 ~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~-  127 (429)
T KOG0595|consen   49 NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE-  127 (429)
T ss_pred             CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            5667888999999999999999999999999999999999999999999999999999999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccC------CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHR------GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      ++|+||||||+|||++..      -.+|++|||+|+... ++....+..|++.|||||++...+|+.|+|+||+|+++|+
T Consensus       128 ~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq  206 (429)
T KOG0595|consen  128 NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQ  206 (429)
T ss_pred             CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHH
Confidence            999999999999999865      358999999998765 4445567799999999999998999999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      +++|+.||......       ++.....++. ..+..+...+....+|+...+..+|..|.+..+.+.|+++...+..+.
T Consensus       207 ~l~g~~Pf~a~t~~-------eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~~  279 (429)
T KOG0595|consen  207 CLTGKPPFDAETPK-------ELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDRA  279 (429)
T ss_pred             HHhCCCCccccCHH-------HHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCccccc
Confidence            99999999875543       3333433333 233334566777889999999999999999999999999988774433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=294.49  Aligned_cols=232  Identities=33%  Similarity=0.566  Sum_probs=193.9

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .+.+.+|+..++.++||||++++..|..+..+|+||+|+.+||+.++++..  ..+++..+..+++++++||.|||. .|
T Consensus        68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~-~G  146 (516)
T KOG0582|consen   68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ-NG  146 (516)
T ss_pred             HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh-cC
Confidence            578999999999999999999999999999999999999999999999875  459999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc----ccccccccccCcccccCC--CCCcchhHHHHHHHHHHHH
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~  163 (262)
                      .+|||||+.|||++.+|.|+|+|||.+-.+...+.+.    .+++|+++|+|||++...  .|+.|+||||||++..||.
T Consensus       147 ~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA  226 (516)
T KOG0582|consen  147 HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELA  226 (516)
T ss_pred             ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHh
Confidence            9999999999999999999999999886665443222    556899999999995433  4999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCC-------CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPP-------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      +|..||.....-      ..++.++....+       .......+++.++.++..||..||.+|||++++|+|+||+...
T Consensus       227 ~G~aPf~k~pPm------kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  227 HGHAPFSKYPPM------KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             cCCCCcccCChH------HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            999999875432      233334333332       1222345678899999999999999999999999999999888


Q ss_pred             CcccchhhHhhhhC
Q 024828          237 DLNVDLSEYFTDAG  250 (262)
Q Consensus       237 ~~~~~~~~~~~~~~  250 (262)
                      ....-..+.+....
T Consensus       301 ~~~~~~~~~l~~l~  314 (516)
T KOG0582|consen  301 SKEYLVKKLLQSLP  314 (516)
T ss_pred             chhhcchhhhccCC
Confidence            66655555544433

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-46  Score=306.51  Aligned_cols=225  Identities=35%  Similarity=0.662  Sum_probs=195.0

Q ss_pred             cccchhHH-HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            3 IQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         3 ~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      |+++...+ .++-+.+|+.+|+..+|+|||.+++.|.-++.+++||||++||+|.+.+... .+++.++..++.+++.||
T Consensus       304 K~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL  382 (550)
T KOG0578|consen  304 KRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGL  382 (550)
T ss_pred             EEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHH
Confidence            33444333 4456779999999999999999999999889999999999999999999874 489999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      +|||. .||+|+|||.+||+++.+|.+||+|||++..+........+-+||+.|+|||+.....|+++.||||||+++.|
T Consensus       383 ~fLH~-~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIE  461 (550)
T KOG0578|consen  383 KFLHA-RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIE  461 (550)
T ss_pred             HHHHh-cceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHH
Confidence            99998 99999999999999999999999999999887766656667799999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      |+-|.+||-..+.      ...+......+.+.-..+..+++++++|+.+||+.|+.+|+++.++|+||||+..
T Consensus       462 MveGEPPYlnE~P------lrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  462 MVEGEPPYLNENP------LRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HhcCCCCccCCCh------HHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            9999999986332      2223333344455555567899999999999999999999999999999999543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.1e-45  Score=278.26  Aligned_cols=228  Identities=27%  Similarity=0.461  Sum_probs=194.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +.....+.+|++.|+.++|+||+.++++|.+.+.+.+|+||++. +|+..++.. ..++...++.++.++++|++|||+ 
T Consensus        42 dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~-  119 (318)
T KOG0659|consen   42 DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS-  119 (318)
T ss_pred             cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh-
Confidence            33467889999999999999999999999999999999999977 999999765 469999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~  166 (262)
                      +.|+|||+||+|+|++++|.+|++|||+++.++.+.......+-|.+|+|||.+.|.. |+...|+||+||++.||+.+.
T Consensus       120 ~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~  199 (318)
T KOG0659|consen  120 KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV  199 (318)
T ss_pred             hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC
Confidence            9999999999999999999999999999999988877777778899999999999875 999999999999999999988


Q ss_pred             CCCCCCCcc---------------CchhhHHHHHHHHhcCCCCCCCC----CCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          167 FPYSPPEQQ---------------DGWTSFYELMEAIVDQPPPSAPS----DQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       167 ~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      +.|.+..+-               ++|.++.++.....-...|..+.    ...+.+..+|+.+||..||.+|+|+.|+|
T Consensus       200 P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL  279 (318)
T KOG0659|consen  200 PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL  279 (318)
T ss_pred             CCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence            888765443               34444444444443333333222    23467789999999999999999999999


Q ss_pred             cCccccccCCc
Q 024828          228 THPFLKMYGDL  238 (262)
Q Consensus       228 ~h~~~~~~~~~  238 (262)
                      +|+||+..+..
T Consensus       280 ~~~yf~~~P~p  290 (318)
T KOG0659|consen  280 KHPYFKSLPLP  290 (318)
T ss_pred             cchhhhcCCCC
Confidence            99999976543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-45  Score=292.68  Aligned_cols=219  Identities=36%  Similarity=0.606  Sum_probs=183.6

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECC--eEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .+.+.+|+++|++++|||||++++......  .+++.|||+.+|+|.+++.+.+ .+++..+..+..|+++||+|||+ +
T Consensus        58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs-~  136 (313)
T KOG0198|consen   58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS-K  136 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            567899999999999999999999754433  6999999999999999999877 79999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEcc-CCcEEEEeccccccccc---CCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~  163 (262)
                      |++|+||||.|||++. ++.++|+|||.+.....   .........|++.|+|||++..+ ...+++|||||||++.||+
T Consensus       137 g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~  216 (313)
T KOG0198|consen  137 GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML  216 (313)
T ss_pred             CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEecc
Confidence            9999999999999999 69999999999887653   12234456899999999999953 3446999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ||+.||....     ...............| ..+..++.+.++|+.+|+..+|++|||++++|.|||.+....
T Consensus       217 Tg~~PW~~~~-----~~~~~~~~ig~~~~~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  217 TGKPPWSEFF-----EEAEALLLIGREDSLP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CCCCcchhhc-----chHHHHHHHhccCCCC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999998641     1111222222233333 445679999999999999999999999999999999987665

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.9e-46  Score=286.18  Aligned_cols=228  Identities=25%  Similarity=0.484  Sum_probs=190.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ++..++-+++|+++|++++|+|+|.++++|.-.+.+++|+|||+. ++.+-+++. .+++...+.+++.|++.|+.|+|+
T Consensus        41 d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk  119 (396)
T KOG0593|consen   41 DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK  119 (396)
T ss_pred             cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh
Confidence            355677888999999999999999999999999999999999988 777777665 568999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g  165 (262)
                       .+++||||||+||+++.+|.++|||||+|+....++...+.++-|.+|+|||.+.| .+|+...||||+||++.||++|
T Consensus       120 -~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G  198 (396)
T KOG0593|consen  120 -NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTG  198 (396)
T ss_pred             -cCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcC
Confidence             99999999999999999999999999999988877777888899999999999998 4699999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHH-------H------hcCCCCCCC---------CCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          166 QFPYSPPEQQDGWTSFYELMEA-------I------VDQPPPSAP---------SDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~-------~------~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      .+.|.+..+-++.-.+......       +      ..+...+.+         ...++.-+.+|+++||..||.+|++.
T Consensus       199 ~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc  278 (396)
T KOG0593|consen  199 EPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC  278 (396)
T ss_pred             CcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH
Confidence            9999987765433222211110       0      111111111         12345668899999999999999999


Q ss_pred             HHHhcCccccccCC
Q 024828          224 QELMTHPFLKMYGD  237 (262)
Q Consensus       224 ~~~l~h~~~~~~~~  237 (262)
                      +|++.||||..+.+
T Consensus       279 ~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  279 EQLLHHPYFDGFIE  292 (396)
T ss_pred             HHHhcChHHHHHHH
Confidence            99999999966543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.1e-45  Score=302.79  Aligned_cols=221  Identities=33%  Similarity=0.584  Sum_probs=202.4

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      |....+...+.+.+|++|++.++||||+.++++|+...++++|+||+.| +|..++...+.++++.+..++.+++.||.|
T Consensus        37 K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~y  115 (808)
T KOG0597|consen   37 KSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYY  115 (808)
T ss_pred             hcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHH
Confidence            3445666777899999999999999999999999999999999999988 999999999999999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ||+ .+|.|+|+||.||++..+|.+|+||||+++.+.....-.....|++-|+|||...+..|+..+|+|||||++||++
T Consensus       116 Lhs-~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~  194 (808)
T KOG0597|consen  116 LHS-NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELY  194 (808)
T ss_pred             HHh-cCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHh
Confidence            999 9999999999999999999999999999998877666666678999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      .|++||..       ..+....+.+......+.  ...+..+.+|++.+|..||.+|.|+.+++.|||.++.
T Consensus       195 ~G~PPF~a-------~si~~Lv~~I~~d~v~~p--~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  195 VGQPPFYA-------RSITQLVKSILKDPVKPP--STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             cCCCCchH-------HHHHHHHHHHhcCCCCCc--ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence            99999987       667777888777665544  3789999999999999999999999999999998653

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-43  Score=293.89  Aligned_cols=238  Identities=45%  Similarity=0.843  Sum_probs=197.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.
T Consensus        43 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~  122 (331)
T cd06649          43 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK  122 (331)
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            45567789999999999999999999999999999999999999999999999888899999999999999999999983


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .+++|+||+|+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+|||||++|+|++|+.
T Consensus       123 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~  200 (331)
T cd06649         123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRY  200 (331)
T ss_pred             CCEEcCCCChhhEEEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            46999999999999999999999999998755322  2234468899999999998889999999999999999999999


Q ss_pred             CCCCCCccCc---------------------------------------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 024828          168 PYSPPEQQDG---------------------------------------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  208 (262)
Q Consensus       168 p~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  208 (262)
                      ||...+..+.                                       ..........+.....+..+...+++++.+|
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  280 (331)
T cd06649         201 PIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF  280 (331)
T ss_pred             CCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHH
Confidence            9965432110                                       0112233333444444444445688999999


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCccccccCCcccchhhHhh
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  247 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~~~~  247 (262)
                      |.+||..||++|||++++++||||+..............
T Consensus       281 i~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~  319 (331)
T cd06649         281 VNKCLIKNPAERADLKMLMNHTFIKRSEVEEVDFAGWLC  319 (331)
T ss_pred             HHHHccCCcccCCCHHHHhcChHHhhcccccccHHHHHH
Confidence            999999999999999999999999988766665554443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-44  Score=293.08  Aligned_cols=209  Identities=32%  Similarity=0.583  Sum_probs=182.6

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECC-eEEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+++|.+|+.+|++++|||||++++++.... .+++||||+++|+|.+++.+  .+.++...+..++.||+.||.|||+ 
T Consensus        82 ~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~-  160 (362)
T KOG0192|consen   82 SRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS-  160 (362)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-
Confidence            3789999999999999999999999999887 79999999999999999988  5789999999999999999999998 


Q ss_pred             CC-eeeCCCCCCCEEEccCC-cEEEEecccccccccCCCCcccccccccccCccccc--CCCCCcchhHHHHHHHHHHHH
Q 024828           88 KH-IIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS--GGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        88 ~~-i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~  163 (262)
                      .+ |+|+||||+|||++.++ ++||+|||+++.............||..|+|||++.  +..++.++||||||+++|||+
T Consensus       161 ~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~  240 (362)
T KOG0192|consen  161 EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL  240 (362)
T ss_pred             CCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH
Confidence            99 99999999999999997 999999999987654433333467999999999999  558999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHh-cCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ||+.||.....       ......+. .+.++..+ ..+++.+..|+.+||..||.+||++.+++.
T Consensus       241 t~~~Pf~~~~~-------~~~~~~v~~~~~Rp~~p-~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  241 TGEIPFEDLAP-------VQVASAVVVGGLRPPIP-KECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HCCCCCCCCCH-------HHHHHHHHhcCCCCCCC-ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999998654       23334443 44444444 458999999999999999999999999875

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.7e-44  Score=295.64  Aligned_cols=226  Identities=29%  Similarity=0.508  Sum_probs=198.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....+.+..|-++|...++|+||+++..|++..++||||||++||++..+|.+.+.+++..+..++.+++.|++.+|+ 
T Consensus       181 ~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~-  259 (550)
T KOG0605|consen  181 KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ-  259 (550)
T ss_pred             hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH-
Confidence            5566778889999999999999999999999999999999999999999999999999999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccccccc---------------------C--CC-----C--------------
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---------------------T--SG-----Q--------------  125 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~---------------------~--~~-----~--------------  125 (262)
                      .|++|+||||+|+|++..|+++|.|||++.....                     +  ..     .              
T Consensus       260 ~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~  339 (550)
T KOG0605|consen  260 LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKR  339 (550)
T ss_pred             cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHh
Confidence            9999999999999999999999999999843311                     0  00     0              


Q ss_pred             -----cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCC
Q 024828          126 -----ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  200 (262)
Q Consensus       126 -----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (262)
                           ....+||+.|+|||++.+..|+..+|.|||||++|||+.|.+||.+.+..+.|.++..+...+.....     ..
T Consensus       340 nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-----~~  414 (550)
T KOG0605|consen  340 NRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-----VD  414 (550)
T ss_pred             hhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-----Cc
Confidence                 01248999999999999999999999999999999999999999999998888877777666543332     45


Q ss_pred             CCHHHHHHHHHhhcCCcCCCC---CHHHHhcCccccccCCccc
Q 024828          201 FSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       201 ~~~~l~~li~~~l~~~p~~Rp---t~~~~l~h~~~~~~~~~~~  240 (262)
                      ++++.++||.+++. ||++|.   .++||..||||+...+..+
T Consensus       415 ~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l  456 (550)
T KOG0605|consen  415 LSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHL  456 (550)
T ss_pred             ccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchh
Confidence            67999999999999 999999   5999999999988875443

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.5e-44  Score=294.95  Aligned_cols=218  Identities=29%  Similarity=0.544  Sum_probs=187.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|++++++++||||+++++.+..++..|+||||+.|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        36 ~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~  114 (323)
T cd05571          36 KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS-C  114 (323)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            344567789999999999999999999999999999999999999999999988899999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus       115 ~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P  194 (323)
T cd05571         115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  194 (323)
T ss_pred             CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCC
Confidence            99999999999999999999999999987543333334455789999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      |...+..       .....+.....  ..+..+++++.+|+.+||..||++||     +++++++||||+...
T Consensus       195 f~~~~~~-------~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         195 FYNQDHE-------KLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             CCCCCHH-------HHHHHHHcCCC--CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            9764332       22222322222  22346889999999999999999999     899999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=292.31  Aligned_cols=218  Identities=28%  Similarity=0.521  Sum_probs=187.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+.++.+++||||+++++.+.+++..++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+ .
T Consensus        34 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~  112 (312)
T cd05585          34 RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHK-F  112 (312)
T ss_pred             hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            445567889999999999999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus       113 ~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p  192 (312)
T cd05585         113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP  192 (312)
T ss_pred             CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCC
Confidence            99999999999999999999999999987543333333445689999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC---CHHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~~l~h~~~~~~~  236 (262)
                      |......       ...........  ..+..+++++.+|+.+||+.||.+||   ++.+++.||||+...
T Consensus       193 f~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         193 FYDENVN-------EMYRKILQEPL--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             cCCCCHH-------HHHHHHHcCCC--CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence            9764332       23333333322  22356889999999999999999997   589999999998763

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=266.50  Aligned_cols=217  Identities=28%  Similarity=0.463  Sum_probs=187.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+++.+|++|-+.++||||+++.+.+.+.+..|+|+|+++|++|..-+-.+.-+++..+..+++||++||.|+|. +
T Consensus        51 ~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~-n  129 (355)
T KOG0033|consen   51 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS-N  129 (355)
T ss_pred             cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-c
Confidence            346788999999999999999999999999999999999999999998766665778999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccC---CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      ||+|+|++|+|+++-+.   ..+||+|||++...+ .+....-..|++.|++||++...+++..+|||+-|+++|-|+.|
T Consensus       130 ~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G  208 (355)
T KOG0033|consen  130 GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG  208 (355)
T ss_pred             CceeccCChhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhC
Confidence            99999999999999543   359999999998876 44444557899999999999999999999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      .+||.+.+..       .+.+.+..+...  ...-..++++.++|+++||..||.+|.|+.|+|+|||+..
T Consensus       209 ~~PF~~~~~~-------rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  209 YPPFWDEDQH-------RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             CCCCCCccHH-------HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            9999885443       333444444322  2223578999999999999999999999999999999954

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-44  Score=293.04  Aligned_cols=210  Identities=27%  Similarity=0.452  Sum_probs=185.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .-..+++.+|+++|++++|++||++++++..++.+||||||++.|||.++++.  ++.+.....+.++.||++||+||++
T Consensus       242 ~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes  321 (468)
T KOG0197|consen  242 SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES  321 (468)
T ss_pred             ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh
Confidence            44457788999999999999999999999998899999999999999999987  4569999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                       ++++||||...|||++++..+|++|||+|+...... .......-+..|.|||.+..+.++.++||||||++|+|++| 
T Consensus       322 -~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~  400 (468)
T KOG0197|consen  322 -KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTY  400 (468)
T ss_pred             -CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhcc
Confidence             999999999999999999999999999999543322 12222344678999999999999999999999999999999 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      |+.|+....       ..+.++.+.++.+.+.+ ..+|+++.++|..||..+|++|||++.+.
T Consensus       401 G~~py~~ms-------n~ev~~~le~GyRlp~P-~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  401 GRVPYPGMS-------NEEVLELLERGYRLPRP-EGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CCCCCCCCC-------HHHHHHHHhccCcCCCC-CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            899998854       44778888889988887 56999999999999999999999999664

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-42  Score=288.00  Aligned_cols=237  Identities=45%  Similarity=0.839  Sum_probs=194.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+....++.+|++++++++||||+++++++.+++..++||||+.+++|.+++.+.+.++...+..++.+++.||.|||+.
T Consensus        43 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~  122 (333)
T cd06650          43 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  122 (333)
T ss_pred             CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            45567789999999999999999999999999999999999999999999999888899999999999999999999973


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .+++|+||+|+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+|||||++|++++|+.
T Consensus       123 ~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~  200 (333)
T cd06650         123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY  200 (333)
T ss_pred             CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            57999999999999999999999999998654322  2233467889999999998889999999999999999999999


Q ss_pred             CCCCCCccCc-------------------------------------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 024828          168 PYSPPEQQDG-------------------------------------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  210 (262)
Q Consensus       168 p~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  210 (262)
                      ||......+.                                     ..........+.....+......++.++.+|+.
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  280 (333)
T cd06650         201 PIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVN  280 (333)
T ss_pred             CCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHH
Confidence            9975332110                                     001112223333333444444457889999999


Q ss_pred             HhhcCCcCCCCCHHHHhcCccccccCCcccchhhHh
Q 024828          211 ACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  246 (262)
Q Consensus       211 ~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~~~  246 (262)
                      +||+.||++|||++|++.||||+.............
T Consensus       281 ~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~  316 (333)
T cd06650         281 KCLIKNPAERADLKQLMVHAFIKRSEAEEVDFAGWL  316 (333)
T ss_pred             HhccCCcccCcCHHHHhhCHHHhcCccccccHHHHH
Confidence            999999999999999999999998876555544443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-43  Score=287.22  Aligned_cols=216  Identities=23%  Similarity=0.412  Sum_probs=186.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.++++++||||+++++.+.++...++||||+.+++|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~  121 (291)
T cd05612          43 KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS-KE  121 (291)
T ss_pred             HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34567889999999999999999999999999999999999999999999988899999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++.....   ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||
T Consensus       122 i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  198 (291)
T cd05612         122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF  198 (291)
T ss_pred             eeecCCCHHHeEECCCCCEEEEecCcchhccC---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999875432   223346889999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCCc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDL  238 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~~  238 (262)
                      ......       .....+..+...  .+..+++.+.+|+++||+.||.+||+     ++++++||||+.....
T Consensus       199 ~~~~~~-------~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         199 FDDNPF-------GIYEKILAGKLE--FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             CCCCHH-------HHHHHHHhCCcC--CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence            875432       223333333221  22456889999999999999999995     9999999999876654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-44  Score=290.97  Aligned_cols=224  Identities=25%  Similarity=0.442  Sum_probs=188.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ++....-+.+|+.||++++||||+++.+...+.  +.+|+|+||++. +|.-++... -.+++.+++.+++||+.||+|+
T Consensus       156 ~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c  234 (560)
T KOG0600|consen  156 KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC  234 (560)
T ss_pred             CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH
Confidence            456677888999999999999999999998775  689999999988 999999874 4799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCC-CCcchhHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l  162 (262)
                      |+ +|++|||||..|||++.+|.++|+|||+|..+..... ..+..+.|.+|+|||.+.|.. |+.+.|+||.||++.||
T Consensus       235 H~-~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El  313 (560)
T KOG0600|consen  235 HS-RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAEL  313 (560)
T ss_pred             hh-cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHH
Confidence            99 9999999999999999999999999999986654433 355668899999999999875 99999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHH-----HhcCCCC-------CCC--------CCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEA-----IVDQPPP-------SAP--------SDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~-------~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                      +.|++.|.+..+.++...++.++..     +.....+       ..+        ...+++...+|+..||..||.+|.|
T Consensus       314 ~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t  393 (560)
T KOG0600|consen  314 FLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT  393 (560)
T ss_pred             HcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc
Confidence            9999999998876655555444321     1101111       000        1356788899999999999999999


Q ss_pred             HHHHhcCcccc
Q 024828          223 AQELMTHPFLK  233 (262)
Q Consensus       223 ~~~~l~h~~~~  233 (262)
                      +.++|.++||.
T Consensus       394 A~~aL~seyF~  404 (560)
T KOG0600|consen  394 ASSALQSEYFT  404 (560)
T ss_pred             HHHHhcCcccc
Confidence            99999999993

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-43  Score=275.43  Aligned_cols=222  Identities=26%  Similarity=0.433  Sum_probs=190.2

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      -...+|+.+|.+++|||||.+.++...  -+..|+|||||+. +|.+++.+.+ ++...+++.++.|++.|++|||. ..
T Consensus       120 ItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~-~w  197 (419)
T KOG0663|consen  120 ITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD-NW  197 (419)
T ss_pred             chhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh-ce
Confidence            356799999999999999999998865  3569999999987 9999999886 89999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |+|||||++|+|++..|.++++|||+|+.++.+.+..+..+-|.+|+|||.+.+.. |+.+.|+||+||++.||+++++.
T Consensus       198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl  277 (419)
T KOG0663|consen  198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL  277 (419)
T ss_pred             eEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence            99999999999999999999999999999999988888889999999999999875 99999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCC--------------CCC---------CCCCCHHHHHHHHHhhcCCcCCCCCHHH
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPP--------------SAP---------SDQFSPEFCSFISACVQKEPQQRLSAQE  225 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~  225 (262)
                      |.+..+.++...+...+..-.....+              ..+         ...++....+|+..+|..||.+|.|++|
T Consensus       278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence            99877766555544443221111100              000         0114578899999999999999999999


Q ss_pred             HhcCccccccC
Q 024828          226 LMTHPFLKMYG  236 (262)
Q Consensus       226 ~l~h~~~~~~~  236 (262)
                      .|+|+||...+
T Consensus       358 ~L~h~~F~e~P  368 (419)
T KOG0663|consen  358 GLKHEYFRETP  368 (419)
T ss_pred             hhcccccccCC
Confidence            99999998854

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.6e-43  Score=288.24  Aligned_cols=216  Identities=29%  Similarity=0.513  Sum_probs=186.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|+.++++++||||+++++.+.+++..|+||||+.|++|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        42 ~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~  120 (323)
T cd05584          42 KDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ-QG  120 (323)
T ss_pred             hhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34456789999999999999999999999999999999999999999999988889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++..............|+..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus       121 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf  200 (323)
T cd05584         121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF  200 (323)
T ss_pred             eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC
Confidence            99999999999999999999999999865433333344457899999999999888899999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCcccccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMY  235 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~  235 (262)
                      ...+..       .....+..+...  .+..+++++.+++.+||+.+|++||     ++++++.||||+..
T Consensus       201 ~~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         201 TAENRK-------KTIDKILKGKLN--LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             CCCCHH-------HHHHHHHcCCCC--CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            865432       233333333321  2346789999999999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-42  Score=287.62  Aligned_cols=218  Identities=29%  Similarity=0.548  Sum_probs=186.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+++++.++||||+++++.+.+++..|+||||+++++|..++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        36 ~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~  114 (323)
T cd05595          36 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-R  114 (323)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            345567788999999999999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|+.|
T Consensus       115 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~P  194 (323)
T cd05595         115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  194 (323)
T ss_pred             CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCC
Confidence            99999999999999999999999999876533333333345688999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      |...+..       .....+.....  ..+..+++++.+++.+||+.||.+|+     ++.++++||||....
T Consensus       195 f~~~~~~-------~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         195 FYNQDHE-------RLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CCCCCHH-------HHHHHHhcCCC--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            9765432       22222222221  12346889999999999999999998     999999999998755

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=277.53  Aligned_cols=230  Identities=26%  Similarity=0.466  Sum_probs=188.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      +....++..+|+++|+.++|+||+.+.+++..     -...|+|+|+++ .+|...++.+..++...+..+++|++.||.
T Consensus        61 ~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLK  139 (359)
T KOG0660|consen   61 NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLK  139 (359)
T ss_pred             chHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcc
Confidence            66778899999999999999999999998865     345899999994 499999999888999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC--CCCcccccccccccCcccccCC-CCCcchhHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVL  159 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l  159 (262)
                      |+|+ .|++|+|+||.|++++.+..+|+||||+|+.....  ....+..+-|.+|+|||++... .|+.+.||||+||++
T Consensus       140 yiHS-AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~  218 (359)
T KOG0660|consen  140 YIHS-ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCIL  218 (359)
T ss_pred             hhhc-ccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHH
Confidence            9999 99999999999999999999999999999876432  2233456789999999998654 599999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHH--------------------HHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYE--------------------LMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p  217 (262)
                      .||++|++.|.+.+..++..-+.+                    .++.+......  .....+.++...+|+++||..||
T Consensus       219 AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP  298 (359)
T KOG0660|consen  219 AEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDP  298 (359)
T ss_pred             HHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCc
Confidence            999999999988665432222111                    11111111110  01123678899999999999999


Q ss_pred             CCCCCHHHHhcCccccccCCcc
Q 024828          218 QQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      .+|+|++|+|.|||+..+.+..
T Consensus       299 ~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  299 KKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             cccCCHHHHhcChhhhhhcCCc
Confidence            9999999999999999887543

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=290.88  Aligned_cols=220  Identities=35%  Similarity=0.552  Sum_probs=198.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCe-EEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+..++.+.+|+.+++++.||||+.+.+.|..++. .+|||+||+||+|.+.+.+.+  .++++.+..|+.|++.|+.||
T Consensus        43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl  122 (426)
T KOG0589|consen   43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL  122 (426)
T ss_pred             CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            56777799999999999999999999999998887 999999999999999997664  589999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      |+ ++++|||||+.||+++.++.++|+|||+|+..+.......+.+||+.|++||.+.+.+|+.++|+|||||++|||++
T Consensus       123 H~-~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~  201 (426)
T KOG0589|consen  123 HE-NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT  201 (426)
T ss_pred             Hh-hhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh
Confidence            97 99999999999999999999999999999998877656677899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      -+++|...+       ....+.++......+. +..++.+++.+|+.||..+|..||++.++|.+|.++...
T Consensus       202 lk~aF~a~~-------m~~Li~ki~~~~~~Pl-p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  202 LKPAFKASN-------MSELILKINRGLYSPL-PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             cccccCccc-------hHHHHHHHhhccCCCC-CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            999998844       4466666666664444 368999999999999999999999999999999887444

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-42  Score=277.03  Aligned_cols=223  Identities=29%  Similarity=0.494  Sum_probs=191.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +.....+++.|-+||+.++||.++.+|..|+.+...|++||||+||+|..+++++  +.+++..+..++..++.||+|||
T Consensus       117 ~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH  196 (459)
T KOG0610|consen  117 SRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH  196 (459)
T ss_pred             hhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH
Confidence            3555668889999999999999999999999999999999999999999999877  45999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEeccccccccc---------------------------------C-C--------
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---------------------------------T-S--------  123 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~---------------------------------~-~--------  123 (262)
                      . .||++|||||+|||+-++|++.|.||+++.+...                                 . .        
T Consensus       197 m-lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~  275 (459)
T KOG0610|consen  197 M-LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDES  275 (459)
T ss_pred             h-hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccc
Confidence            8 9999999999999999999999999998743310                                 0 0        


Q ss_pred             --------------CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHh
Q 024828          124 --------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  189 (262)
Q Consensus       124 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  189 (262)
                                    ...+.++||-.|+|||++.|...+.++|.|+||+.+|||+.|..||.+.+..+.       ..++.
T Consensus       276 ~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------l~NIv  348 (459)
T KOG0610|consen  276 ASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------LRNIV  348 (459)
T ss_pred             ccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------HHHHh
Confidence                          011235788899999999999999999999999999999999999999877643       33443


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC----HHHHhcCccccccCCc
Q 024828          190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS----AQELMTHPFLKMYGDL  238 (262)
Q Consensus       190 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~~l~h~~~~~~~~~  238 (262)
                      ............+..+++||+++|..||++|..    +.||.+||||+...+.
T Consensus       349 ~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  349 GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence            333333333367899999999999999999997    9999999999988765

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8e-43  Score=289.09  Aligned_cols=214  Identities=28%  Similarity=0.487  Sum_probs=185.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.++++++||||+++++.+.+++..|+||||+.|++|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        60 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~  138 (329)
T PTZ00263         60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KD  138 (329)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34567889999999999999999999999999999999999999999999988899999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++......   .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       139 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  215 (329)
T PTZ00263        139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF  215 (329)
T ss_pred             eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCC
Confidence            999999999999999999999999998765322   23356889999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~  236 (262)
                      .+....       .....+..+...  .+..++..+.+|+.+||+.||.+||+     +++++.||||+...
T Consensus       216 ~~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        216 FDDTPF-------RIYEKILAGRLK--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             CCCCHH-------HHHHHHhcCCcC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            764322       233334333322  22457899999999999999999996     79999999998743

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-43  Score=269.43  Aligned_cols=218  Identities=27%  Similarity=0.489  Sum_probs=190.1

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...++.-.+|+.||+++ .||+|+++.++|+.+...++|+|.++.|.|.+++.+.-.+++.....++.|++++++|||. 
T Consensus        63 ~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa-  141 (411)
T KOG0599|consen   63 YEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA-  141 (411)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH-
Confidence            34556667899999999 7999999999999999999999999999999999998889999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC------CCCCcchhHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~~l~~  161 (262)
                      ++|+|+||||+|||++++.++++.|||+++... ++......+||++|+|||.+..      ..|+...|+|+.|++||-
T Consensus       142 ~~IVHRDLKpENILlddn~~i~isDFGFa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyT  220 (411)
T KOG0599|consen  142 RNIVHRDLKPENILLDDNMNIKISDFGFACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYT  220 (411)
T ss_pred             hhhhhcccChhheeeccccceEEeccceeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHH
Confidence            999999999999999999999999999999875 4455667799999999998743      357889999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      |+.|.+||..       ....-++..+..+.....+  -.+++...++||.+||+.||.+|.|++|+|.||||..+
T Consensus       221 LLaGcpPFwH-------RkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  221 LLAGCPPFWH-------RKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             HHcCCCchhH-------HHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            9999999976       3333455555555543333  24788999999999999999999999999999999443

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-42  Score=288.07  Aligned_cols=218  Identities=28%  Similarity=0.527  Sum_probs=186.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+++++.++||||+++.+.+.+++..|+||||+++++|..++...+.+++..+..++.|++.||+|||+ .
T Consensus        36 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~  114 (328)
T cd05593          36 KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS-G  114 (328)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            445667889999999999999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||||+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|+.|
T Consensus       115 ~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~P  194 (328)
T cd05593         115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  194 (328)
T ss_pred             CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCC
Confidence            99999999999999999999999999986543333333345689999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      |...+..       .....+.....  ..+..+++++.+|+.+||..||.+|+     +++++++||||....
T Consensus       195 f~~~~~~-------~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         195 FYNQDHE-------KLFELILMEDI--KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             CCCCCHH-------HHHHHhccCCc--cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9764332       22222222222  22346889999999999999999997     899999999997653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.2e-43  Score=289.37  Aligned_cols=226  Identities=25%  Similarity=0.504  Sum_probs=186.3

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+.+|..++..+ +||||+++++.+.+....|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ 
T Consensus        36 ~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-  114 (329)
T cd05588          36 DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE-  114 (329)
T ss_pred             hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            34456688999999988 7999999999999999999999999999999999888899999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|+.
T Consensus       115 ~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  194 (329)
T cd05588         115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS  194 (329)
T ss_pred             CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCC
Confidence            99999999999999999999999999988653333333445578999999999998889999999999999999999999


Q ss_pred             CCCCCCccC--chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC------HHHHhcCccccccCC
Q 024828          168 PYSPPEQQD--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS------AQELMTHPFLKMYGD  237 (262)
Q Consensus       168 p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt------~~~~l~h~~~~~~~~  237 (262)
                      ||......+  .........+.+..... . .+..++.++.+++.+||+.||.+|+|      ++++++||||+....
T Consensus       195 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         195 PFDIVGMSDNPDQNTEDYLFQVILEKQI-R-IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             CcccccccccccccchHHHHHHHHcCCC-C-CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            997432221  10111112222332222 2 23467899999999999999999997      799999999987543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-42  Score=287.39  Aligned_cols=219  Identities=27%  Similarity=0.506  Sum_probs=186.9

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+.+..|.+++..+ +||||+++++.+.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ 
T Consensus        36 ~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~-  114 (320)
T cd05590          36 DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD-  114 (320)
T ss_pred             ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            34556777888888876 7999999999999999999999999999999999988899999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|+.
T Consensus       115 ~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  194 (320)
T cd05590         115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHA  194 (320)
T ss_pred             CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCC
Confidence            99999999999999999999999999998654333333445578999999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH------HHHhcCccccccCC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYGD  237 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~------~~~l~h~~~~~~~~  237 (262)
                      ||...+..       .....+......  .+..++.++.+++++||+.||.+||++      ++++.||||+....
T Consensus       195 Pf~~~~~~-------~~~~~i~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         195 PFEAENED-------DLFEAILNDEVV--YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             CCCCCCHH-------HHHHHHhcCCCC--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            99875432       233333333322  234688999999999999999999998      99999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-42  Score=288.61  Aligned_cols=217  Identities=25%  Similarity=0.437  Sum_probs=187.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|+.+++.++||||+++++++.+++..|+||||+.|++|.+++.+.+.+++..+..++.|++.||.|||+ .
T Consensus        72 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~-~  150 (340)
T PTZ00426         72 QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-L  150 (340)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            344567889999999999999999999999999999999999999999999988899999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++.....   ......|++.|+|||.+.+..++.++|+||+||++|+|++|..|
T Consensus       151 ~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~P  227 (340)
T PTZ00426        151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP  227 (340)
T ss_pred             CeEccCCCHHHEEECCCCCEEEecCCCCeecCC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCC
Confidence            999999999999999999999999999876432   22345788999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDL  238 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~  238 (262)
                      |...+..       .....+..+...  .+..+++.+.+++++||+.+|.+|+     +++++++||||+.....
T Consensus       228 f~~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        228 FYANEPL-------LIYQKILEGIIY--FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             CCCCCHH-------HHHHHHhcCCCC--CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9865432       223334333322  2346789999999999999999995     89999999999876543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-43  Score=290.51  Aligned_cols=223  Identities=28%  Similarity=0.502  Sum_probs=185.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|++++..++||||+++++.+.++...|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||+ .|
T Consensus        43 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~  121 (333)
T cd05600          43 NEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE-LG  121 (333)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            45567889999999999999999999999999999999999999999999988889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++.....   ......|+..|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus       122 ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  198 (333)
T cd05600         122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF  198 (333)
T ss_pred             ccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCC
Confidence            99999999999999999999999999875433   233456899999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ......+.+......... ........+...+++++.+++.+||..+|.+||+++++++||||+....
T Consensus       199 ~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         199 SGSTPNETWENLKYWKET-LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             CCCCHHHHHHHHHhcccc-ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            875443222111111000 0111111111256899999999999999999999999999999997643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.7e-43  Score=284.94  Aligned_cols=220  Identities=25%  Similarity=0.460  Sum_probs=175.9

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|++++++++||||+++++++.+++..++||||+++ +|.+++...+ .++...+..++.|++.||+|||+ .|
T Consensus        46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~  123 (288)
T cd07871          46 APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK-RK  123 (288)
T ss_pred             cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            345678999999999999999999999999999999999976 9999987654 47899999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++.++|+||+||++|+|++|+.|
T Consensus       124 ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p  203 (288)
T cd07871         124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM  203 (288)
T ss_pred             cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998765433333344567889999999876 4589999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHH--------------HHHhcCCCC-------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          169 YSPPEQQDGWTSFYELM--------------EAIVDQPPP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      |......+.........              ........+       .......++++.+|+.+||++||.+|||++|++
T Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l  283 (288)
T cd07871         204 FPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL  283 (288)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            97654322111111000              000000000       001124678899999999999999999999999


Q ss_pred             cCccc
Q 024828          228 THPFL  232 (262)
Q Consensus       228 ~h~~~  232 (262)
                      +||||
T Consensus       284 ~hp~f  288 (288)
T cd07871         284 RHSYF  288 (288)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-42  Score=286.78  Aligned_cols=218  Identities=31%  Similarity=0.548  Sum_probs=185.5

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|++++..++||||+++.+.+.+++..|+||||+++++|..++.+.+.+++..+..++.|++.||.|||++.|
T Consensus        37 ~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~  116 (325)
T cd05594          37 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN  116 (325)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence            44567788999999999999999999999999999999999999999999888889999999999999999999996479


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||||+||+++.++.++|+|||++..............|+..|+|||++.+..++.++|+|||||++|+|++|+.||
T Consensus       117 ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf  196 (325)
T cd05594         117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  196 (325)
T ss_pred             EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCC
Confidence            99999999999999999999999998865433333333456899999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      ...+..       .....+.....  ..+..+++++.+|+.+||+.||.+|+     ++.++++||||+...
T Consensus       197 ~~~~~~-------~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         197 YNQDHE-------KLFELILMEEI--RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             CCCCHH-------HHHHHHhcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            765432       22222222221  12346889999999999999999997     999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.1e-43  Score=284.59  Aligned_cols=223  Identities=25%  Similarity=0.437  Sum_probs=178.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      +...+.+.+|+.+++.++||||+++++.+..++..++||||++++.+..+......++...+..++.|++.||.|||+ .
T Consensus        41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~  119 (287)
T cd07848          41 EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK-N  119 (287)
T ss_pred             ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            445677889999999999999999999999999999999999987666665555679999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.
T Consensus       120 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~  199 (287)
T cd07848         120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP  199 (287)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence            999999999999999999999999999876543221 2223467889999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHH--------HHHhc------CCCCCC---------CCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          168 PYSPPEQQDGWTSFYELM--------EAIVD------QPPPSA---------PSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~--------~~~~~------~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      ||......+.........        .....      ...+..         ....++.++.+|+++||+.||++|||++
T Consensus       200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~  279 (287)
T cd07848         200 LFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE  279 (287)
T ss_pred             CCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHH
Confidence            998754332111111110        00000      000000         0123678899999999999999999999


Q ss_pred             HHhcCccc
Q 024828          225 ELMTHPFL  232 (262)
Q Consensus       225 ~~l~h~~~  232 (262)
                      ++++||||
T Consensus       280 ~~l~hp~f  287 (287)
T cd07848         280 QCLNHPAF  287 (287)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-43  Score=287.92  Aligned_cols=217  Identities=30%  Similarity=0.513  Sum_probs=186.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|++++++++||||+++++.+.+++..|+||||+++++|.+++.+...+++..+..++.|++.||+|||+ .|
T Consensus        40 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~  118 (318)
T cd05582          40 RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LG  118 (318)
T ss_pred             hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34556788999999999999999999999999999999999999999999888889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|+.||
T Consensus       119 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~  198 (318)
T cd05582         119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF  198 (318)
T ss_pred             EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence            99999999999999999999999999876544433344557889999999999888899999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~  236 (262)
                      ...+..       .....+......  .+..+++++.+|+++||+.||.+||+     +++++.||||+...
T Consensus       199 ~~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         199 QGKDRK-------ETMTMILKAKLG--MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             CCCCHH-------HHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            765432       222333332221  23467899999999999999999999     78899999998754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.9e-42  Score=285.65  Aligned_cols=225  Identities=26%  Similarity=0.520  Sum_probs=185.1

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+.+|+.++.++ +||||+++++++.+++..++||||+++++|..++.+.+.+++..+..++.|++.||+|||+ 
T Consensus        36 ~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-  114 (329)
T cd05618          36 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-  114 (329)
T ss_pred             hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            34556788899988877 8999999999999999999999999999999999888899999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|+.
T Consensus       115 ~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  194 (329)
T cd05618         115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS  194 (329)
T ss_pred             CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCC
Confidence            99999999999999999999999999998654333333445578999999999998889999999999999999999999


Q ss_pred             CCCCCCccCc--hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC------HHHHhcCccccccC
Q 024828          168 PYSPPEQQDG--WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS------AQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt------~~~~l~h~~~~~~~  236 (262)
                      ||........  ........+.+.... .. .+..++..+.+++++||+.||.+|||      +++++.||||+...
T Consensus       195 Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~-~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         195 PFDIVGSSDNPDQNTEDYLFQVILEKQ-IR-IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             CCccCCCcCCcccccHHHHHHHHhcCC-CC-CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            9964222111  111111222222222 22 23467899999999999999999998      58999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.8e-42  Score=277.86  Aligned_cols=222  Identities=26%  Similarity=0.451  Sum_probs=184.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+|++++++++|++|+++.+.+.+++..++|+||+++++|.+++...  ..+++..+..++.|++.||+|||+ .
T Consensus        43 ~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~  121 (285)
T cd05631          43 GEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR-E  121 (285)
T ss_pred             hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            3456789999999999999999999999999999999999999999888643  368999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++...... .......|+..|+|||.+.+..++.++||||+||++|+|++|+.|
T Consensus       122 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p  200 (285)
T cd05631         122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP  200 (285)
T ss_pred             CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence            9999999999999999999999999998764322 222345688999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCCcc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDLN  239 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~~~  239 (262)
                      |..........   .....+....  ...+..+++++.+|+++||+.||.+||+     ++++++||||+......
T Consensus       201 f~~~~~~~~~~---~~~~~~~~~~--~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05631         201 FRKRKERVKRE---EVDRRVKEDQ--EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR  271 (285)
T ss_pred             CCCCCcchhHH---HHHHHhhccc--ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence            98765432211   1122222111  2223468899999999999999999997     89999999998866443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.4e-42  Score=280.72  Aligned_cols=222  Identities=23%  Similarity=0.399  Sum_probs=176.0

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ...+.+|+++++.++||||+++++++.++...++||||+.+ +|.+++.+. +.++...+..++.|++.||+|||+ .|+
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i  124 (303)
T cd07869          47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-RYI  124 (303)
T ss_pred             chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            45678999999999999999999999999999999999965 888887654 568999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      +|+||||+||+++.++.++|+|||++..............++..|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       125 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  204 (303)
T cd07869         125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF  204 (303)
T ss_pred             ecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987544333333345678899999998764 4788999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCC-------------CCC-------------CCCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQP-------------PPS-------------APSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~-------------~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      .+.....  ..............             .+.             .....+++++.+|+.+||+.||.+|||+
T Consensus       205 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~  282 (303)
T cd07869         205 PGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA  282 (303)
T ss_pred             CCCccHH--HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH
Confidence            8643211  11111111000000             000             0011245778999999999999999999


Q ss_pred             HHHhcCccccccCC
Q 024828          224 QELMTHPFLKMYGD  237 (262)
Q Consensus       224 ~~~l~h~~~~~~~~  237 (262)
                      +|+++||||+....
T Consensus       283 ~~~l~h~~f~~~~~  296 (303)
T cd07869         283 QAALSHEYFSDLPP  296 (303)
T ss_pred             HHHhcCcccccCCh
Confidence            99999999987653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.8e-41  Score=277.52  Aligned_cols=237  Identities=47%  Similarity=0.849  Sum_probs=192.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ......++.+|++++++++||||+++++.+.+++..++++||++|++|.+++++.+.++...+..++.|++.||.|||+.
T Consensus        39 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~  118 (308)
T cd06615          39 KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK  118 (308)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh
Confidence            45566789999999999999999999999999999999999999999999999888899999999999999999999973


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .+++|+||+|+||+++.++.++++|||.+......  ......++..|+|||.+.+..++.++|+||||++++++++|+.
T Consensus       119 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~  196 (308)
T cd06615         119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRY  196 (308)
T ss_pred             CCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCC
Confidence            58999999999999999999999999987654322  1233467889999999988888999999999999999999999


Q ss_pred             CCCCCCccCc-----------------------------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcC
Q 024828          168 PYSPPEQQDG-----------------------------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       168 p~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      ||...+....                             .....+..........+..+...++.++.+++.+||..+|+
T Consensus       197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  276 (308)
T cd06615         197 PIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPK  276 (308)
T ss_pred             CCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChh
Confidence            9864332110                             01111222223333333333345788999999999999999


Q ss_pred             CCCCHHHHhcCccccccCCcccchhhHh
Q 024828          219 QRLSAQELMTHPFLKMYGDLNVDLSEYF  246 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~~~~~~~~~  246 (262)
                      +|||++++++||||+........++..+
T Consensus       277 ~Rpt~~~ll~~~~~~~~~~~~~~~~~~~  304 (308)
T cd06615         277 ERADLKELTKHPFIKRAELEEVDFAGWV  304 (308)
T ss_pred             hCcCHHHHhcChhhhhcccccchhhhhh
Confidence            9999999999999998766655544443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.2e-42  Score=282.51  Aligned_cols=225  Identities=25%  Similarity=0.511  Sum_probs=187.5

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+.+.+|+.++.++ +||+|+++++.+.+....|+||||++|++|..++.+.+.+++..+..++.|++.||+|||+ 
T Consensus        36 ~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~-  114 (327)
T cd05617          36 DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE-  114 (327)
T ss_pred             hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            34556788999999888 6999999999999999999999999999999999888889999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus       115 ~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~  194 (327)
T cd05617         115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS  194 (327)
T ss_pred             CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCC
Confidence            99999999999999999999999999988754333333445678999999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC------HHHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS------AQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt------~~~~l~h~~~~~~~  236 (262)
                      ||..................+.... .. .+..++..+.+++.+||+.||.+|++      +++++.||||+...
T Consensus       195 pf~~~~~~~~~~~~~~~~~~~~~~~-~~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         195 PFDIITDNPDMNTEDYLFQVILEKP-IR-IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             CCCccCCCcccccHHHHHHHHHhCC-CC-CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            9975433322222222223332222 22 23467899999999999999999997      57999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.1e-42  Score=282.18  Aligned_cols=219  Identities=27%  Similarity=0.495  Sum_probs=186.5

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ......+.+|..++..+ +||||+++++++.+.+..|+||||++|++|..++.+.+.+++..+..++.|++.||+|||+ 
T Consensus        36 ~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-  114 (318)
T cd05570          36 DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE-  114 (318)
T ss_pred             hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            34556778899999888 7999999999999999999999999999999999988889999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+|||||++|+|++|+.
T Consensus       115 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~  194 (318)
T cd05570         115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS  194 (318)
T ss_pred             CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCC
Confidence            99999999999999999999999999988653333333344568899999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH-----HHHhcCccccccCC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-----QELMTHPFLKMYGD  237 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~~l~h~~~~~~~~  237 (262)
                      ||...+..       .....+.....  ..+..+++++.+|+++||..||.+|||+     .+++.||||+....
T Consensus       195 pf~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         195 PFEGDDED-------ELFQSILEDEV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CCCCCCHH-------HHHHHHHcCCC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99765432       22233333222  2234688999999999999999999999     99999999988653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=288.96  Aligned_cols=219  Identities=32%  Similarity=0.564  Sum_probs=186.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|++++..++||||+++++.+.+++..|+||||+.|++|.+++.+.+.++...+..++.|++.||+|||+ .|
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~g  121 (350)
T cd05573          43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK-LG  121 (350)
T ss_pred             cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            45567889999999999999999999999999999999999999999999988889999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCC-----------------------------CCcccccccccccCccc
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----------------------------GQANTFVGTYNYMSPER  140 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----------------------------~~~~~~~~~~~y~~PE~  140 (262)
                      ++|+||+|+||+++.++.++|+|||++.......                             .......|+..|+|||.
T Consensus       122 iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  201 (350)
T cd05573         122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV  201 (350)
T ss_pred             eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHH
Confidence            9999999999999999999999999987654332                             12234568999999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhc--CCCCCCCCCCCCHHHHHHHHHhhcCCcC
Q 024828          141 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPSAPSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       141 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      +.+..++.++|||||||++|+|++|+.||.......       ....+..  ..........+++++.+||.+||. +|.
T Consensus       202 ~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~  273 (350)
T cd05573         202 LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE-------TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPE  273 (350)
T ss_pred             HcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH-------HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Chh
Confidence            999899999999999999999999999998765322       2222222  111112223479999999999998 999


Q ss_pred             CCCC-HHHHhcCccccccCC
Q 024828          219 QRLS-AQELMTHPFLKMYGD  237 (262)
Q Consensus       219 ~Rpt-~~~~l~h~~~~~~~~  237 (262)
                      +||+ ++++++||||+....
T Consensus       274 ~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         274 DRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             hcCCCHHHHhcCCCcCCCCH
Confidence            9999 999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.8e-42  Score=283.12  Aligned_cols=218  Identities=27%  Similarity=0.478  Sum_probs=186.4

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+.+..|.+++..+ +||+|+++++.+.+++..|+||||+++++|..++.+.+.+++..+..++.|++.||.|||+ 
T Consensus        36 ~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-  114 (321)
T cd05591          36 DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-  114 (321)
T ss_pred             hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            34556677899988866 8999999999999999999999999999999999888889999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|+.
T Consensus       115 ~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~  194 (321)
T cd05591         115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP  194 (321)
T ss_pred             CCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCC
Confidence            99999999999999999999999999998754333333444568999999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-------CHHHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-------SAQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-------t~~~~l~h~~~~~~~  236 (262)
                      ||...+..       .....+......  .+..+++++.+++.+||+.||++||       +++++++||||+...
T Consensus       195 Pf~~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         195 PFEADNED-------DLFESILHDDVL--YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             CCCCCCHH-------HHHHHHHcCCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            99875432       233334333322  2245789999999999999999999       999999999997754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.5e-42  Score=283.46  Aligned_cols=216  Identities=29%  Similarity=0.495  Sum_probs=181.7

Q ss_pred             HHHHHHHHH-HHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      .+.+.+|.. +++.++||||+++++.+.+.+..++||||+.|++|..++.+.+.+++..+..++.|++.||.|||+ .|+
T Consensus        39 ~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi  117 (323)
T cd05575          39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS-LNI  117 (323)
T ss_pred             HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            344555555 567889999999999999999999999999999999999988889999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+||+|+||+++.++.++|+|||++..............|+..|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       118 vH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  197 (323)
T cd05575         118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (323)
T ss_pred             EeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence            99999999999999999999999988654333333344568999999999998889999999999999999999999998


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH----HHHhcCccccccCC
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA----QELMTHPFLKMYGD  237 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----~~~l~h~~~~~~~~  237 (262)
                      ..+..       +....+......  ....+++++.+++.+||+.||.+||++    .++++||||.....
T Consensus       198 ~~~~~-------~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         198 SRDTA-------EMYDNILNKPLR--LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             CCCHH-------HHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            75432       233333333222  224578999999999999999999987    69999999987553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-41  Score=275.98  Aligned_cols=222  Identities=27%  Similarity=0.489  Sum_probs=184.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ..+.+..|+++++.++|++|+++.+.+..+...++||||++|++|.+++..    ...+++..+..++.|++.||+|||+
T Consensus        36 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~  115 (280)
T cd05608          36 GYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ  115 (280)
T ss_pred             HHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999999999999999999999988743    3468999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|+
T Consensus       116 -~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  194 (280)
T cd05608         116 -RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR  194 (280)
T ss_pred             -CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999999876544333334456888999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDL  238 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~  238 (262)
                      .||........   ............  ...+..+++++.+++.+||+.||++||     |++++++||||+.....
T Consensus       195 ~pf~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         195 GPFRARGEKVE---NKELKQRILNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             CCCCCCCcchh---HHHHHHhhcccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence            99976543221   112222222221  122346889999999999999999999     88999999999875533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.4e-42  Score=282.18  Aligned_cols=217  Identities=27%  Similarity=0.503  Sum_probs=183.0

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+..|..++... +||+|+++++.+.+++..|+||||+.|++|..++.+.+.++...+..++.|++.||+|||+ .
T Consensus        37 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~-~  115 (316)
T cd05620          37 DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS-K  115 (316)
T ss_pred             chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3455667788888754 8999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       116 ~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~P  195 (316)
T cd05620         116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence            99999999999999999999999999886533333334455789999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH-HHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-QELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~~l~h~~~~~~~  236 (262)
                      |...+..       ...+.+.....  ..+..++.++.+++.+||..||++||++ ++++.||||+...
T Consensus       196 f~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         196 FHGDDED-------ELFESIRVDTP--HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             CCCCCHH-------HHHHHHHhCCC--CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            9765432       22233322221  2234678999999999999999999998 5889999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.6e-42  Score=283.71  Aligned_cols=221  Identities=29%  Similarity=0.515  Sum_probs=184.2

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|+++++.+ +||+|+++++.+.+++..++||||+.+++|.+++.+++.+++..+..++.|++.||.|||+ .
T Consensus        46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~  124 (332)
T cd05614          46 KTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK-L  124 (332)
T ss_pred             hHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3456788999999999 5999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~  166 (262)
                      |++|+||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+.. ++.++|||||||++|+|++|.
T Consensus       125 ~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  204 (332)
T cd05614         125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA  204 (332)
T ss_pred             CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence            99999999999999999999999999987543322 2223456899999999998654 788999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      .||..........   .....+.....  ..+..+++.+.+++.+||+.||++||     +++++++||||+...
T Consensus       205 ~pf~~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         205 SPFTLEGERNTQS---EVSRRILKCDP--PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CCCCCCCCCCCHH---HHHHHHhcCCC--CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            9997544332222   22222222222  22346889999999999999999999     889999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-41  Score=287.26  Aligned_cols=225  Identities=26%  Similarity=0.392  Sum_probs=178.2

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      +..+.+|++++++++||||+++++++..+...++|+|++. ++|..++...+.++...++.++.|++.||+|||+ .|++
T Consensus       127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~-~~Iv  204 (391)
T PHA03212        127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE-NRII  204 (391)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcc
Confidence            4567899999999999999999999999999999999995 5999999888889999999999999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      |+||||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       205 HrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        205 HRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             cCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            99999999999999999999999986532221 22234578999999999998889999999999999999999998765


Q ss_pred             CCCccCc-h---hhHHHHHH----------------------HHhcCCC--CC-C----CCCCCCHHHHHHHHHhhcCCc
Q 024828          171 PPEQQDG-W---TSFYELME----------------------AIVDQPP--PS-A----PSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       171 ~~~~~~~-~---~~~~~~~~----------------------~~~~~~~--~~-~----~~~~~~~~l~~li~~~l~~~p  217 (262)
                      .....+. .   ........                      .......  +. .    .....+.++.+||.+||+.||
T Consensus       285 ~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP  364 (391)
T PHA03212        285 EKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDA  364 (391)
T ss_pred             CcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCCh
Confidence            4321110 0   00000000                      0000000  00 0    011346789999999999999


Q ss_pred             CCCCCHHHHhcCccccccCCc
Q 024828          218 QQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      ++|||++|+|+||||+.....
T Consensus       365 ~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        365 HHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hhCCCHHHHhcChhhccCCCC
Confidence            999999999999999886543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=279.76  Aligned_cols=218  Identities=33%  Similarity=0.540  Sum_probs=184.2

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      +++.+|+.+|++|.|||||+++++..+  .+.+|||+|||..|.+...- ..++ +++.++++++.+++.||+|||. .|
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~-Qg  230 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHY-QG  230 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHh-cC
Confidence            578899999999999999999999876  56799999999887765432 2244 8999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCC-----CcccccccccccCcccccCCC----CCcchhHHHHHHHHH
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-----QANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLL  160 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~----~~~~~Di~slG~~l~  160 (262)
                      |+||||||.|+|++.+|++||+|||.+........     .....+||+.|+|||...++.    .+.+.||||+|+++|
T Consensus       231 iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLY  310 (576)
T KOG0585|consen  231 IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLY  310 (576)
T ss_pred             eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHH
Confidence            99999999999999999999999999876632211     112358999999999987633    467899999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      .|+.|+.||.+       ....+...++.+..........+..++++||++||+.||++|.++.++..|||...-++..
T Consensus       311 CllfG~~PF~~-------~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  311 CLLFGQLPFFD-------DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             HhhhccCCccc-------chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            99999999987       4555677777776665555556789999999999999999999999999999997775544

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-41  Score=268.97  Aligned_cols=214  Identities=32%  Similarity=0.540  Sum_probs=181.9

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|++++++++||||+++++++.++...++++|++++++|.+++.+.+.++...+..++.|++.||.+||+ .|+
T Consensus        47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i  125 (263)
T cd06625          47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS-NMI  125 (263)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            3457889999999999999999999999999999999999999999999988889999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCc---ccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      +|+||+|+||+++.++.++|+|||.+..........   ....++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus       126 ~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  205 (263)
T cd06625         126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP  205 (263)
T ss_pred             ecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCC
Confidence            999999999999999999999999986543221111   23456778999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ||...+..       ...............+..++.++.+++.+||..+|++|||+.++++||||
T Consensus       206 p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         206 PWAEFEAM-------AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CccccchH-------HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99764322       11222222222333345688999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.1e-41  Score=271.43  Aligned_cols=232  Identities=44%  Similarity=0.817  Sum_probs=191.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....+++.+|++++.+++||||+++++.+......++|+||+++++|..+    ..+++..+..++.|++.||.|||+ 
T Consensus        39 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-  113 (279)
T cd06619          39 TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWS-  113 (279)
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHH-
Confidence            345567899999999999999999999999999999999999999999765    357888999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus       114 ~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~  191 (279)
T cd06619         114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF  191 (279)
T ss_pred             CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999998765332  2233568889999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccchhhHh
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  246 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~~~  246 (262)
                      ||........................+..+...+++++.+++.+||+.+|.+||++++++.||||+........+...+
T Consensus       192 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~~~~~  270 (279)
T cd06619         192 PYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMW  270 (279)
T ss_pred             CchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccHHHHHHH
Confidence            9976443322222223333333333344344567889999999999999999999999999999998877776665544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.5e-41  Score=283.76  Aligned_cols=222  Identities=26%  Similarity=0.398  Sum_probs=181.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+.++.+++||+|+++++.+.++...|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        42 ~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~  120 (363)
T cd05628          42 KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ-L  120 (363)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            344567889999999999999999999999999999999999999999999988899999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-----------------------------------Ccccccccc
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-----------------------------------QANTFVGTY  133 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----------------------------------~~~~~~~~~  133 (262)
                      |++|+||||+||+++.++.++|+|||++........                                   ......|+.
T Consensus       121 givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~  200 (363)
T cd05628         121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP  200 (363)
T ss_pred             CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence            999999999999999999999999999865321100                                   012346899


Q ss_pred             cccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHH
Q 024828          134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISA  211 (262)
Q Consensus       134 ~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~  211 (262)
                      .|+|||++.+..++.++|+|||||++|+|++|+.||.+....       +....+....  ........+++++.+++.+
T Consensus       201 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~  273 (363)
T cd05628         201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ-------ETYKKVMNWKETLIFPPEVPISEKAKDLILR  273 (363)
T ss_pred             cccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHH
Confidence            999999999888999999999999999999999999865432       2222222211  1111123478899999999


Q ss_pred             hhcCCcC---CCCCHHHHhcCccccccCCcc
Q 024828          212 CVQKEPQ---QRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       212 ~l~~~p~---~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      |+. +|.   .||+++++++||||+......
T Consensus       274 l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         274 FCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             HcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence            875 444   468999999999998775443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-41  Score=279.37  Aligned_cols=218  Identities=28%  Similarity=0.530  Sum_probs=183.3

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+..|..++... +||||+++++.+..++..++||||++|++|..++...+.+++..+..++.|++.||+|||+ .
T Consensus        37 ~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~  115 (316)
T cd05592          37 DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK-K  115 (316)
T ss_pred             hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3445566777777654 8999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|+.|
T Consensus       116 ~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~P  195 (316)
T cd05592         116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCC
Confidence            99999999999999999999999999987543333334455789999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH-HHHhcCccccccCC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-QELMTHPFLKMYGD  237 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-~~~l~h~~~~~~~~  237 (262)
                      |...+..       +....+.... + ..+..+++++.+++.+||+.+|.+||+. .+++.||||+....
T Consensus       196 f~~~~~~-------~~~~~i~~~~-~-~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         196 FHGEDED-------ELFDSILNDR-P-HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             CCCCCHH-------HHHHHHHcCC-C-CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence            9875432       2223333222 2 2235688999999999999999999986 48899999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=291.52  Aligned_cols=222  Identities=27%  Similarity=0.514  Sum_probs=197.5

Q ss_pred             hhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ...++.+..+.|.+|+... +||.++.++..|+..+++|+||||+.||++..+ +..+.+++..+..+++.++.||.|||
T Consensus       407 l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH  485 (694)
T KOG0694|consen  407 LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLH  485 (694)
T ss_pred             eccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHH
Confidence            3677888899999999888 599999999999999999999999999995444 34478999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      + +||++||||.+|||+|.+|.++|+|||+++.....+..+.++.||+.|+|||++.+..|+.++|.|+||++||+|+.|
T Consensus       486 ~-~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~G  564 (694)
T KOG0694|consen  486 E-NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVG  564 (694)
T ss_pred             h-cCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcC
Confidence            8 999999999999999999999999999998877677788899999999999999999999999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCCcc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDLN  239 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~~~  239 (262)
                      .+||.+.+++       +....+.......  +..++.+..++++++|..+|++|..     +++|..||||+.+.+..
T Consensus       565 q~PF~gddEe-------e~FdsI~~d~~~y--P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  565 ESPFPGDDEE-------EVFDSIVNDEVRY--PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             CCCCCCCCHH-------HHHHHHhcCCCCC--CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence            9999987765       4455555554433  4578999999999999999999994     68999999999887443

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8e-43  Score=275.42  Aligned_cols=236  Identities=30%  Similarity=0.503  Sum_probs=188.6

Q ss_pred             HHHHHHHhcCCCCeeEeeceEEEEC--C---eEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828           16 AQELKINQSSQCPYVVVCYQSFYSN--G---AISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        16 ~~e~~~l~~l~h~~i~~~~~~~~~~--~---~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+|+++|+.++|||||++..+|...  .   ...+||||++. +|..+++.    +..++...++-+..||++||+|||+
T Consensus        65 nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~  143 (364)
T KOG0658|consen   65 NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS  143 (364)
T ss_pred             cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence            4899999999999999999998753  2   45799999976 99999984    4678999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccC-CcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~  164 (262)
                       .||+||||||+|+|+|.+ |.+||||||.|....... ....+..+..|+|||.+.|.. |+.+.||||.||++.||+.
T Consensus       144 -~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~  221 (364)
T KOG0658|consen  144 -HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK  221 (364)
T ss_pred             -cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc
Confidence             999999999999999976 899999999998775443 445667899999999999875 9999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHH--------HHh------------cCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          165 GQFPYSPPEQQDGWTSFYELME--------AIV------------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~--------~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      |++.|.+.+..++...+..++.        .+.            ............+++..+|+.++|..+|.+|.++.
T Consensus       222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~  301 (364)
T KOG0658|consen  222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL  301 (364)
T ss_pred             CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence            9999998666544333332220        000            00000112356789999999999999999999999


Q ss_pred             HHhcCccccccCCcccchhhHhhhhCCCCcccCCC
Q 024828          225 ELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL  259 (262)
Q Consensus       225 ~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (262)
                      |++.||||...++.....+     .|.+++.+-+|
T Consensus       302 ~~l~h~fFdelr~~~~~l~-----~g~~lp~lf~f  331 (364)
T KOG0658|consen  302 EALAHPFFDELRDPNTKLP-----NGRPLPPLFNF  331 (364)
T ss_pred             HHhcchhhHHhhCcCccCc-----CCCcCCCccCc
Confidence            9999999999988754433     33355444443

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=285.20  Aligned_cols=222  Identities=38%  Similarity=0.626  Sum_probs=198.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828            6 NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         6 ~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ...++...++++|+.+|.+++++||.++++.|..+..++++||||.||++.+.++.+..+.+..+..++.+++.|+.|||
T Consensus        49 e~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH  128 (467)
T KOG0201|consen   49 EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH  128 (467)
T ss_pred             hhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhh
Confidence            34666778899999999999999999999999999999999999999999999999777799999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      . .+.+|+|||+.||++..+|.++|+|||.+-..........+++||+.|||||++.+..|+.++||||||++.+||.+|
T Consensus       129 ~-~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~G  207 (467)
T KOG0201|consen  129 S-EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKG  207 (467)
T ss_pred             h-cceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcC
Confidence            9 999999999999999999999999999998887776677889999999999999988899999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .+|+.......       ++-.+.+.. |+.....+++.+++|+..||+.||+.||++.++|+|+|++...
T Consensus       208 ePP~s~~hPmr-------vlflIpk~~-PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  208 EPPHSKLHPMR-------VLFLIPKSA-PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             CCCCcccCcce-------EEEeccCCC-CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            99998766532       112223333 3344458999999999999999999999999999999998833

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-41  Score=279.17  Aligned_cols=216  Identities=27%  Similarity=0.518  Sum_probs=181.4

Q ss_pred             HHHHHHHHHHHHH---hcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828           10 SARRQIAQELKIN---QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        10 ~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ...+.+.+|.+++   +.++||||+++++++.++...|+||||++|++|..++.. +.+++..+..++.|++.||.|||+
T Consensus        41 ~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~  119 (324)
T cd05589          41 DEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE  119 (324)
T ss_pred             hHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3445667776655   566899999999999999999999999999999988865 579999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       .|++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus       120 -~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~  198 (324)
T cd05589         120 -NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE  198 (324)
T ss_pred             -CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence             9999999999999999999999999998865433333344557899999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      .||...+..       .....+......  .+..+++++.+++.+||+.||.+||     +++++++||||+...
T Consensus       199 ~pf~~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         199 SPFPGDDEE-------EVFDSIVNDEVR--YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             CCCCCCCHH-------HHHHHHHhCCCC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            999865432       223333333222  2346889999999999999999999     799999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.2e-41  Score=277.92  Aligned_cols=218  Identities=27%  Similarity=0.498  Sum_probs=183.4

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+....|..++... +||||+++++.+.+.+..++||||++|++|.+++.+...++...+..++.|++.||+|||+ .
T Consensus        37 ~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~-~  115 (316)
T cd05619          37 DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS-K  115 (316)
T ss_pred             chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            3445667788888764 9999999999999999999999999999999999988889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+||+||++|+|++|..|
T Consensus       116 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~p  195 (316)
T cd05619         116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCC
Confidence            99999999999999999999999999986543333333445688999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH-HHhcCccccccCC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ-ELMTHPFLKMYGD  237 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~~l~h~~~~~~~~  237 (262)
                      |...+..       +..+.+.....  ..+..++.++.+++.+||+.||++||++. +++.||||+....
T Consensus       196 f~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         196 FHGHDEE-------ELFQSIRMDNP--CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             CCCCCHH-------HHHHHHHhCCC--CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence            9865432       22233322222  12345789999999999999999999996 8999999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-41  Score=289.96  Aligned_cols=220  Identities=27%  Similarity=0.443  Sum_probs=186.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +......+.+|+.+++.++||||+++++.+..++..|+||||++|++|.+++..    ..++++..+..++.|++.||.|
T Consensus       105 ~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  184 (478)
T PTZ00267        105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDE  184 (478)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            344456778899999999999999999999999999999999999999988754    3468999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      ||+ .|++|+||||+||+++.++.++|+|||++........  ......|++.|+|||++.+..++.++|||||||++|+
T Consensus       185 lH~-~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  263 (478)
T PTZ00267        185 VHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE  263 (478)
T ss_pred             HHh-CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHH
Confidence            998 9999999999999999999999999999876543221  2234568999999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      |++|+.||.....       .........+.... .+..+++++.++|.+||..+|++||++++++.|||++...
T Consensus       264 l~tg~~Pf~~~~~-------~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~  330 (478)
T PTZ00267        264 LLTLHRPFKGPSQ-------REIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVA  330 (478)
T ss_pred             HHhCCCCCCCCCH-------HHHHHHHHhCCCCC-CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHHH
Confidence            9999999976432       23344444443332 2346789999999999999999999999999999997643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-41  Score=269.08  Aligned_cols=227  Identities=25%  Similarity=0.471  Sum_probs=187.5

Q ss_pred             HHHHHHHHHHHHhcCCCCe-eEeeceEEEECC------eEEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQCPY-VVVCYQSFYSNG------AISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLK   79 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~   79 (262)
                      ......+|+.+|+.++|+| |+.+++++....      .+++|+||.+- +|..++....    .++...++.++.||+.
T Consensus        53 ~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~  131 (323)
T KOG0594|consen   53 VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLR  131 (323)
T ss_pred             CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHH
Confidence            6677899999999999999 999999998866      79999999966 9999998765    5788899999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLV  158 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~  158 (262)
                      ||+|||+ .||+||||||+||+++++|.+||+|||+|.....+......-+.|.+|+|||++.+. .|+...|+||+||+
T Consensus       132 gl~~~H~-~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI  210 (323)
T KOG0594|consen  132 GLAFLHS-HGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI  210 (323)
T ss_pred             HHHHHHh-CCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence            9999999 999999999999999999999999999999777666666677889999999999987 58999999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCC-------------CCCCC-C-------CCCCHHHHHHHHHhhcCCc
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-------------PPSAP-S-------DQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~-~-------~~~~~~l~~li~~~l~~~p  217 (262)
                      ++||++++..|.+..+.++...+.+.+..-....             .+... +       ...+++..+++.+||+.+|
T Consensus       211 faEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p  290 (323)
T KOG0594|consen  211 FAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDP  290 (323)
T ss_pred             HHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCc
Confidence            9999999999988666433333222221110000             00000 0       1223478999999999999


Q ss_pred             CCCCCHHHHhcCccccccCCcc
Q 024828          218 QQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      .+|.|++.+|.||||+..+...
T Consensus       291 ~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  291 AKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             ccCcCHHHHhcChhhcccccch
Confidence            9999999999999999887544

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.4e-42  Score=280.78  Aligned_cols=231  Identities=25%  Similarity=0.478  Sum_probs=182.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|++++++++||||+++++++..++..++||||+.+ +|.+++...+ .++...+..++.|++.||+|||+ .|
T Consensus        47 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~  124 (309)
T cd07872          47 APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-RK  124 (309)
T ss_pred             cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            344677899999999999999999999999999999999976 8988887654 48899999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       125 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~p  204 (309)
T cd07872         125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL  204 (309)
T ss_pred             eecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654433333344678899999998754 578999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHH--------------HHHhcCCCCC-------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          169 YSPPEQQDGWTSFYELM--------------EAIVDQPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      |...+..+.........              ........+.       .....++.++.+|+.+||+.||.+|||++|++
T Consensus       205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l  284 (309)
T cd07872         205 FPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM  284 (309)
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence            98755432211111110              0000000000       01134688899999999999999999999999


Q ss_pred             cCccccccCCcccchh
Q 024828          228 THPFLKMYGDLNVDLS  243 (262)
Q Consensus       228 ~h~~~~~~~~~~~~~~  243 (262)
                      +||||+.......+.+
T Consensus       285 ~h~~~~~~~~~~~~~~  300 (309)
T cd07872         285 KHAYFRSLGTRIHSLP  300 (309)
T ss_pred             cChhhhhcccccccCC
Confidence            9999998765544443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.2e-41  Score=280.40  Aligned_cols=219  Identities=48%  Similarity=0.820  Sum_probs=178.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+.....+.+|+++++.++|+||+++++++.+++..++||||+++++|.+.    ...++..+..++.|++.||+|||+ 
T Consensus       112 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~-  186 (353)
T PLN00034        112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHR-  186 (353)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH-
Confidence            455677899999999999999999999999999999999999999998653    345677888999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-----CCCCcchhHHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l  162 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+..     ...+.++|||||||++|+|
T Consensus       187 ~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el  266 (353)
T PLN00034        187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF  266 (353)
T ss_pred             CCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence            99999999999999999999999999998765443333344578999999998743     2245689999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ++|+.||......+ +   ............+. ....++.++.+||.+||+.||++|||++|+++||||....
T Consensus       267 ~~g~~pf~~~~~~~-~---~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        267 YLGRFPFGVGRQGD-W---ASLMCAICMSQPPE-APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HhCCCCCCCCCCcc-H---HHHHHHHhccCCCC-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            99999998433221 1   22222222222222 2346789999999999999999999999999999998864

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.5e-41  Score=277.19  Aligned_cols=219  Identities=26%  Similarity=0.480  Sum_probs=185.0

Q ss_pred             HHHHHHHHHHHHHHhcCCC-CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+.+..|.+++..++| ++|+++++.+.+.+..|+||||++|++|.+++...+.+++..+..++.|++.||+|||+ 
T Consensus        41 ~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-  119 (324)
T cd05587          41 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS-  119 (324)
T ss_pred             hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            4456678899999999976 56889999999999999999999999999999988889999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+||+||++|+|++|+.
T Consensus       120 ~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~  199 (324)
T cd05587         120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP  199 (324)
T ss_pred             CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence            99999999999999999999999999988654333333344568999999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH-----HHHhcCccccccCC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-----QELMTHPFLKMYGD  237 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~~l~h~~~~~~~~  237 (262)
                      ||......       +....+.....  ..+..+++++.+++.+||..||.+|++.     +++++||||+....
T Consensus       200 pf~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         200 PFDGEDED-------ELFQSIMEHNV--SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             CCCCCCHH-------HHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            99865432       22333333322  2234688999999999999999999976     89999999987654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-41  Score=281.47  Aligned_cols=227  Identities=24%  Similarity=0.394  Sum_probs=178.6

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ....++.+|+++++.++||||+++++++...     ...|+||||+. ++|.+++.+.+.+++..+..++.|++.||.||
T Consensus        41 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L  119 (338)
T cd07859          41 SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYI  119 (338)
T ss_pred             hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHH
Confidence            3455788999999999999999999988543     35899999995 59999999888899999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccC--CCCCcchhHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVL  159 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l  159 (262)
                      |+ .|++|+||||+||+++.++.++|+|||++........   ......++..|+|||.+.+  ..++.++|||||||++
T Consensus       120 H~-~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl  198 (338)
T cd07859         120 HT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF  198 (338)
T ss_pred             HH-CCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence            99 9999999999999999999999999999875432211   1233568899999999875  5688999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhH--------------------HHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCc
Q 024828          160 LECATGQFPYSPPEQQDGWTSF--------------------YELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p  217 (262)
                      |+|++|+.||...+.......+                    ......+.......  ......++++.+++.+||+.||
T Consensus       199 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  278 (338)
T cd07859         199 AEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDP  278 (338)
T ss_pred             HHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCc
Confidence            9999999999765432111000                    00111111111110  0112467889999999999999


Q ss_pred             CCCCCHHHHhcCccccccCCc
Q 024828          218 QQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      ++|||++++++||||+.....
T Consensus       279 ~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         279 KDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             ccCCCHHHHhcCchhhhcCcc
Confidence            999999999999999877664

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-41  Score=283.26  Aligned_cols=219  Identities=29%  Similarity=0.483  Sum_probs=183.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|+.++..++||||+++++.+.++...|+||||+.|++|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~  121 (364)
T cd05599          43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK-LG  121 (364)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            44566789999999999999999999999999999999999999999999988889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCC--------------------------------------Ccccccc
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--------------------------------------QANTFVG  131 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--------------------------------------~~~~~~~  131 (262)
                      ++|+||||+||+++.++.++|+|||++........                                      ......|
T Consensus       122 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  201 (364)
T cd05599         122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG  201 (364)
T ss_pred             eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence            99999999999999999999999998865422110                                      0112358


Q ss_pred             cccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHH
Q 024828          132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFI  209 (262)
Q Consensus       132 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li  209 (262)
                      ++.|+|||++.+..++.++|+|||||++|+|++|..||......       .....+....  ........+++++.+||
T Consensus       202 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li  274 (364)
T cd05599         202 TPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ-------ETYRKIINWKETLQFPDEVPLSPEAKDLI  274 (364)
T ss_pred             CccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH-------HHHHHHHcCCCccCCCCCCCCCHHHHHHH
Confidence            99999999999888999999999999999999999999865432       1222222211  11112235789999999


Q ss_pred             HHhhcCCcCCCCC---HHHHhcCccccccCC
Q 024828          210 SACVQKEPQQRLS---AQELMTHPFLKMYGD  237 (262)
Q Consensus       210 ~~~l~~~p~~Rpt---~~~~l~h~~~~~~~~  237 (262)
                      ++|+. +|.+|++   +++++.||||+....
T Consensus       275 ~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         275 KRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             HHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99997 9999998   999999999987653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-41  Score=284.66  Aligned_cols=226  Identities=20%  Similarity=0.332  Sum_probs=183.2

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeC
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR   93 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~   93 (262)
                      ...+|++++++++||||+++++.+......|++||++. ++|.+++...+.++...+..++.|++.||.|||+ .|++|+
T Consensus       132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHr  209 (392)
T PHA03207        132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHR  209 (392)
T ss_pred             cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence            45689999999999999999999999999999999996 4999999877889999999999999999999998 999999


Q ss_pred             CCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           94 DLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        94 dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      ||||+||+++.++.++|+|||++........  ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+
T Consensus       210 Dlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  289 (392)
T PHA03207        210 DVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG  289 (392)
T ss_pred             CCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999999876543222  22235689999999999988899999999999999999999999976


Q ss_pred             CCccCchhhHHHHHHHHh----------------------cCCCCCCC------CCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          172 PEQQDGWTSFYELMEAIV----------------------DQPPPSAP------SDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      ................+.                      ....+...      ...++.++.++|++||..||++|||+
T Consensus       290 ~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa  369 (392)
T PHA03207        290 KQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA  369 (392)
T ss_pred             CCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH
Confidence            554322222222221111                      00111000      12456788999999999999999999


Q ss_pred             HHHhcCccccccCCcccc
Q 024828          224 QELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       224 ~~~l~h~~~~~~~~~~~~  241 (262)
                      .++|.||||++.+.....
T Consensus       370 ~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        370 QDILSLPLFTKEPINLLN  387 (392)
T ss_pred             HHHhhCchhhccchhhhc
Confidence            999999999887765554

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=276.64  Aligned_cols=219  Identities=31%  Similarity=0.574  Sum_probs=193.1

Q ss_pred             HHHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+..+.+|+.+|+++. ||||+.+.+.|++...+++|||++.||.|.+.+.+. .+++..+..++.|++.++.|||+ 
T Consensus        76 ~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~-  153 (382)
T KOG0032|consen   76 KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS-  153 (382)
T ss_pred             cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh-
Confidence            346789999999999998 999999999999999999999999999999999886 49999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccC----CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHR----GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      .|++|+|+||+|+++...    +.++++|||++..... .......+|++.|+|||.+.+..++..+|+||+|+++|.|+
T Consensus       154 ~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL  232 (382)
T KOG0032|consen  154 LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILL  232 (382)
T ss_pred             CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHh
Confidence            999999999999999643    4799999999998776 55667789999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +|.+||.+.....       ....+..+..  .......++..+.+++++|+..||.+|+|+.++|+|||++....
T Consensus       233 ~G~~PF~~~~~~~-------~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  233 SGVPPFWGETEFE-------IFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             hCCCCCcCCChhH-------HHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence            9999999866543       2224444432  33344578999999999999999999999999999999987643

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.5e-41  Score=279.81  Aligned_cols=217  Identities=29%  Similarity=0.503  Sum_probs=182.5

Q ss_pred             HHHHHHHHHHH-HHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....+.+|.. +++.++||||+++++.+..++..++||||+.|++|..++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        37 ~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~  115 (325)
T cd05604          37 KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS-I  115 (325)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            34455566655 467789999999999999999999999999999999999988899999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       116 givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~p  195 (325)
T cd05604         116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP  195 (325)
T ss_pred             CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCC
Confidence            99999999999999999999999999986543333334455789999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH----HHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA----QELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----~~~l~h~~~~~~~  236 (262)
                      |...+..       +....+.......  ....+.++.+++.+||..+|.+||++    .+++.||||+...
T Consensus       196 f~~~~~~-------~~~~~~~~~~~~~--~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         196 FYCRDVA-------EMYDNILHKPLVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             CCCCCHH-------HHHHHHHcCCccC--CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            9865432       2333333333222  23578999999999999999999976    5999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.8e-40  Score=268.81  Aligned_cols=218  Identities=23%  Similarity=0.435  Sum_probs=180.4

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .+.+..|++++++++||||+++.+.+.++...++||||++|++|.+++...+  +++...+..++.|++.||+|||+ .|
T Consensus        37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~  115 (277)
T cd05607          37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS-MD  115 (277)
T ss_pred             hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            4456679999999999999999999999999999999999999998886543  58899999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|+||+||++|+|++|+.||
T Consensus       116 ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~  194 (277)
T cd05607         116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF  194 (277)
T ss_pred             EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999999987654322 222346788999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH----HHHhcCcccccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA----QELMTHPFLKMY  235 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----~~~l~h~~~~~~  235 (262)
                      ........   .............. .....+++++.+|+.+||+.||++||++    ++++.||||+.+
T Consensus       195 ~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         195 KDHKEKVA---KEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CCCcchhh---HHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence            76443211   12222333322222 2234689999999999999999999999    678899999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-40  Score=266.17  Aligned_cols=222  Identities=28%  Similarity=0.483  Sum_probs=188.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|.+++.+...++...+..++.|++.||++||+ .
T Consensus        34 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~-~  112 (262)
T cd05572          34 TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN-R  112 (262)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-C
Confidence            345678999999999999999999999999999999999999999999999988889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+|++|+++|++++|..|
T Consensus       113 ~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p  191 (262)
T cd05572         113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP  191 (262)
T ss_pred             CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence            99999999999999999999999999987654332 22334678899999999888889999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGD  237 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~  237 (262)
                      |.....+     ..........+......+...++++.+++.+||+.+|.+||+     ++|+++||||+....
T Consensus       192 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         192 FGEDDED-----PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             cCCCCCC-----HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            9876531     123333333322222333445899999999999999999999     999999999997654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-41  Score=267.91  Aligned_cols=215  Identities=27%  Similarity=0.524  Sum_probs=192.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +++..-.+.+|++|++.++||||+.++++|+..+..++||||..+|.|++|+.+++.+++.+...++.||..|+.|+|+ 
T Consensus        93 deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk-  171 (668)
T KOG0611|consen   93 DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK-  171 (668)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh-
Confidence            4556667889999999999999999999999999999999999999999999999999999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~  166 (262)
                      .+++|+|||.+|||++.+++++++|||++..+.. .+...+++|++-|.+||+..|.+| ++..|.||||+++|-|+.|.
T Consensus       172 nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGt  250 (668)
T KOG0611|consen  172 NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGT  250 (668)
T ss_pred             ccceecccchhheeecCCCCeeeeccchhhhhcc-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcc
Confidence            9999999999999999999999999999987653 456678899999999999999886 78999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      +||++.+.       ..++..+..+...+.   .-|.+..-||++||-.+|++|.|++++-.|=|.+-
T Consensus       251 MPFDG~Dh-------k~lvrQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  251 MPFDGRDH-------KRLVRQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             cccCCchH-------HHHHHHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            99998654       345556655554332   34677889999999999999999999999988754

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-40  Score=268.28  Aligned_cols=224  Identities=52%  Similarity=0.956  Sum_probs=190.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+++.+|++++++++||||+++++.+..+...++++||+.+++|.+++... ..++...+..++.|++.||++||+.
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  119 (265)
T cd06605          40 EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK  119 (265)
T ss_pred             hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC
Confidence            466778999999999999999999999999999999999999989999999876 7899999999999999999999965


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||.+.........  ...++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus       120 ~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~  197 (265)
T cd06605         120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRF  197 (265)
T ss_pred             CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            89999999999999999999999999988655332221  2567889999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ||.......  ....+..+.......+..+...+++++.++|.+||..+|.+|||+.+++.||||+.+.
T Consensus       198 p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         198 PYPPENDPP--DGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             CCCcccccc--ccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            997653221  2233444555555544444444889999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=284.36  Aligned_cols=219  Identities=28%  Similarity=0.489  Sum_probs=179.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|++++++++||||+++++.+.++...|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        42 ~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~  120 (377)
T cd05629          42 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK-L  120 (377)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            344567889999999999999999999999999999999999999999999988889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--------------------------------------------
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--------------------------------------------  124 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--------------------------------------------  124 (262)
                      |++|+||||+||+++.++.++|+|||++........                                            
T Consensus       121 givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (377)
T cd05629         121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKN  200 (377)
T ss_pred             CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc
Confidence            999999999999999999999999998853211000                                            


Q ss_pred             ---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcC--CCCCCCCC
Q 024828          125 ---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSD  199 (262)
Q Consensus       125 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  199 (262)
                         ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||......+       ....+...  ........
T Consensus       201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~~  273 (377)
T cd05629         201 RRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE-------TYRKIINWRETLYFPDDI  273 (377)
T ss_pred             ccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH-------HHHHHHccCCccCCCCCC
Confidence               0012358899999999998889999999999999999999999997654322       11222211  11111223


Q ss_pred             CCCHHHHHHHHHhhcCCcCCC---CCHHHHhcCccccccC
Q 024828          200 QFSPEFCSFISACVQKEPQQR---LSAQELMTHPFLKMYG  236 (262)
Q Consensus       200 ~~~~~l~~li~~~l~~~p~~R---pt~~~~l~h~~~~~~~  236 (262)
                      .++.++.+|+.+||. +|.+|   +|+.+++.||||+...
T Consensus       274 ~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         274 HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            578999999999998 67765   5999999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-40  Score=281.34  Aligned_cols=220  Identities=27%  Similarity=0.490  Sum_probs=180.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|++++++++||||+++++.+.+++..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        42 ~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~-~  120 (381)
T cd05626          42 RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK-M  120 (381)
T ss_pred             hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            345567899999999999999999999999999999999999999999999988889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC---------------------------------------------
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---------------------------------------------  123 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------------------------------  123 (262)
                      |++|+||||+||+++.++.++|+|||++.......                                             
T Consensus       121 givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (381)
T cd05626         121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQH  200 (381)
T ss_pred             CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccc
Confidence            99999999999999999999999999874321000                                             


Q ss_pred             --CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhc--CCCCCCCCC
Q 024828          124 --GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPSAPSD  199 (262)
Q Consensus       124 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  199 (262)
                        .......|+..|+|||.+.+..++.++|||||||++|+|++|..||......+       ....+..  .........
T Consensus       201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~  273 (381)
T cd05626         201 QRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE-------TQLKVINWENTLHIPPQV  273 (381)
T ss_pred             cccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH-------HHHHHHccccccCCCCCC
Confidence              00123468999999999998889999999999999999999999998754321       1111111  111122223


Q ss_pred             CCCHHHHHHHHHhhc--CCcCCCCCHHHHhcCccccccC
Q 024828          200 QFSPEFCSFISACVQ--KEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       200 ~~~~~l~~li~~~l~--~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .+++++.+|+.+|+.  .++..|+++++++.||||+...
T Consensus       274 ~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         274 KLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             CCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            578999999999765  4555599999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-41  Score=282.44  Aligned_cols=221  Identities=24%  Similarity=0.460  Sum_probs=183.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+.+|+.+++.++|++|+++++.+.++...++||||+++++|.+++.+. +.+++..+..++.|++.||.|||+ 
T Consensus        42 ~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~-  120 (330)
T cd05601          42 QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ-  120 (330)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            345667889999999999999999999999999999999999999999999876 679999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCccccc------CCCCCcchhHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERIS------GGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~------~~~~~~~~Di~slG~~l~  160 (262)
                      .|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.      +..++.++|||||||++|
T Consensus       121 ~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~  200 (330)
T cd05601         121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY  200 (330)
T ss_pred             CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence            9999999999999999999999999999876543222 122346888999999986      345788999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|++|+.||.......       ....+.....  .......+++++.+|+.+||+ +|.+|||+++++.||||+.....
T Consensus       201 el~~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         201 EMIYGRSPFHEGTSAK-------TYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             eeccCCCCCCCCCHHH-------HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence            9999999997654322       2222222211  111223578999999999998 99999999999999999875533

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.7e-41  Score=282.70  Aligned_cols=219  Identities=28%  Similarity=0.518  Sum_probs=180.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|++++++++||||+++++.+.++...|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        42 ~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~-~  120 (382)
T cd05625          42 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK-M  120 (382)
T ss_pred             HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            345567889999999999999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccC----------------------------------------------
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST----------------------------------------------  122 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----------------------------------------------  122 (262)
                      |++|+||||+||+++.++.++|+|||++......                                              
T Consensus       121 ~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (382)
T cd05625         121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQH  200 (382)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence            9999999999999999999999999986422100                                              


Q ss_pred             -CCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhc--CCCCCCCCC
Q 024828          123 -SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPSAPSD  199 (262)
Q Consensus       123 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  199 (262)
                       ........|++.|+|||++.+..++.++|+||+||++|+|++|+.||...+..+       ....+..  .........
T Consensus       201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~~  273 (382)
T cd05625         201 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE-------TQMKVINWQTSLHIPPQA  273 (382)
T ss_pred             ccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH-------HHHHHHccCCCcCCCCcc
Confidence             000122468899999999998889999999999999999999999998654321       1112211  111122234


Q ss_pred             CCCHHHHHHHHHhhcCCcCCCCC---HHHHhcCccccccC
Q 024828          200 QFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYG  236 (262)
Q Consensus       200 ~~~~~l~~li~~~l~~~p~~Rpt---~~~~l~h~~~~~~~  236 (262)
                      .+++++.+++.+|+ .+|.+|++   ++++++||||+...
T Consensus       274 ~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         274 KLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            67899999999986 59999997   99999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-40  Score=280.38  Aligned_cols=218  Identities=28%  Similarity=0.475  Sum_probs=180.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.+++.++||||+++++.+.++...++||||++|++|.+++.+ ..+++..+..++.|++.||+|||+ .|
T Consensus        85 ~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~-~~  162 (370)
T cd05596          85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHS-MG  162 (370)
T ss_pred             hhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3445678999999999999999999999999999999999999999999876 468999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCC----CCCcchhHHHHHHHHHHHHh
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGG----KYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~----~~~~~~Di~slG~~l~~l~~  164 (262)
                      ++|+||+|+||+++.++.++|+|||++........ ......|++.|+|||.+.+.    .++.++|+|||||++|+|++
T Consensus       163 ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt  242 (370)
T cd05596         163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (370)
T ss_pred             eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh
Confidence            99999999999999999999999999876543221 22345789999999998653    37889999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCC-CC-CCCCCCCHHHHHHHHHhhcCCcCC--CCCHHHHhcCccccccC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPP-PS-APSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  236 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~h~~~~~~~  236 (262)
                      |+.||......       .....+..... .. .....++.++.+|+++||+.+|.+  |+|+++++.||||+...
T Consensus       243 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         243 GDTPFYADSLV-------GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             CCCCcCCCCHH-------HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            99999875432       22233333221 11 112357899999999999999988  99999999999998643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=280.89  Aligned_cols=216  Identities=29%  Similarity=0.493  Sum_probs=180.8

Q ss_pred             HHHHHHHHHHHhcC---CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           12 RRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        12 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......|..++...   +||+|+++++.+.+....|+||||+.+++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        37 ~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~-~  115 (330)
T cd05586          37 VAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK-Y  115 (330)
T ss_pred             HHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            34455677777655   7999999999999999999999999999999999988899999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus       116 ~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~  195 (330)
T cd05586         116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS  195 (330)
T ss_pred             CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCC
Confidence            99999999999999999999999999987543333334456789999999998765 47899999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC----CHHHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----t~~~~l~h~~~~~~~  236 (262)
                      ||...+..       .....+..+.. ..+...+++++.+++++||+.||.+||    +++++++||||+...
T Consensus       196 Pf~~~~~~-------~~~~~i~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         196 PFYAEDTQ-------QMYRNIAFGKV-RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCCCCHH-------HHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            99764432       23333333322 222345789999999999999999998    799999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.6e-40  Score=263.77  Aligned_cols=216  Identities=34%  Similarity=0.633  Sum_probs=186.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ......++.+|+++++.++||||+++++.+.+++..++|+||++|++|.+++...  ..++...+..++.+++.||.|||
T Consensus        39 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH  118 (256)
T cd08529          39 NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH  118 (256)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567788999999999999999999999999999999999999999999999774  56899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      + .|++|+||+|+||+++.++.++++|||++..............++..|+|||...+..++.++|+||||+++++|++|
T Consensus       119 ~-~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  197 (256)
T cd08529         119 S-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG  197 (256)
T ss_pred             H-CCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence            8 999999999999999999999999999887665444333445678899999999988889999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      +.||......       ........+..+... ..++.++.+++.+||+.+|++||++.++++|||+
T Consensus       198 ~~p~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         198 KHPFDANNQG-------ALILKIIRGVFPPVS-QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCCCCCCCHH-------HHHHHHHcCCCCCCc-cccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            9999765422       233334444433333 3688999999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-40  Score=265.23  Aligned_cols=213  Identities=41%  Similarity=0.726  Sum_probs=180.9

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      .+++.+|++++++++||||+++++.+.++...|+++|++.+++|.+++... ..+++..+..++.|++.||.+||+ .|+
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i  120 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-NKK  120 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            778999999999999999999999999999999999999999999999753 568999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|+.||.
T Consensus       121 ~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~  200 (256)
T cd06612         121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS  200 (256)
T ss_pred             ccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999998776544433344557889999999988889999999999999999999999997


Q ss_pred             CCCccCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          171 PPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ......       ......... ........++.++.+++.+||+.+|++|||+++++.||||
T Consensus       201 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         201 DIHPMR-------AIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             Ccchhh-------hhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            644321       111111111 1111223577899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-40  Score=269.86  Aligned_cols=207  Identities=23%  Similarity=0.325  Sum_probs=174.3

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+.+.+|++++++++||||+++++++.+    ....++||||+++++|.+++.+.+.++......++.+++.||.+||+.
T Consensus        62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~  141 (283)
T PHA02988         62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY  141 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence            4678899999999999999999999877    356899999999999999999888899999999999999999999974


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      .+++|+||+|+||+++.++.++++|||++......   .....++..|+|||.+.+  ..++.++||||||+++|+|++|
T Consensus       142 ~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g  218 (283)
T PHA02988        142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG  218 (283)
T ss_pred             CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC
Confidence            58999999999999999999999999998754322   223467889999999976  5789999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +.||......       +....+.........+...++++.+++.+||+.||++|||++++++
T Consensus       219 ~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        219 KIPFENLTTK-------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCCCCCCHH-------HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            9999865432       2233332222222233467899999999999999999999999985

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.5e-40  Score=265.49  Aligned_cols=224  Identities=31%  Similarity=0.599  Sum_probs=184.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+.+.+|+++++.++||||+++++.+..+...++|+||+++++|..++.+ .+++++..+..++.|++.||.+||+
T Consensus        42 ~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  121 (282)
T cd06643          42 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE  121 (282)
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            345567788999999999999999999999999999999999999999988765 4679999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc-----CCCCCcchhHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~  161 (262)
                       .|++|+||+|+||+++.++.++++|||++..............++..|+|||.+.     +..++.++|+||+|+++|+
T Consensus       122 -~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~e  200 (282)
T cd06643         122 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE  200 (282)
T ss_pred             -CCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHH
Confidence             9999999999999999999999999999876543333334456788999999874     3447789999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      |++|..||......       ........... ....+..++.++.+++.+||+.+|.+|||++++++||||+......
T Consensus       201 l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  272 (282)
T cd06643         201 MAQIEPPHHELNPM-------RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP  272 (282)
T ss_pred             HccCCCCccccCHH-------HHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCCC
Confidence            99999999764321       11122222221 1222346789999999999999999999999999999998765433

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.5e-41  Score=282.23  Aligned_cols=217  Identities=27%  Similarity=0.463  Sum_probs=180.2

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+.+|++++++++||||+++++.+.+++.+|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|+
T Consensus        44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i  122 (376)
T cd05598          44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK-MGF  122 (376)
T ss_pred             hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            4567889999999999999999999999999999999999999999999988889999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccC-------------------------------------------CCCcc
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMAST-------------------------------------------SGQAN  127 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-------------------------------------------~~~~~  127 (262)
                      +|+||||+||+++.++.++|+|||++......                                           .....
T Consensus       123 vHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (376)
T cd05598         123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAH  202 (376)
T ss_pred             EeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccccc
Confidence            99999999999999999999999987422100                                           00011


Q ss_pred             cccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhc--CCCCCCCCCCCCHHH
Q 024828          128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPSAPSDQFSPEF  205 (262)
Q Consensus       128 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  205 (262)
                      ...|+..|+|||++.+..++.++|||||||++|+|++|+.||......+       ....+..  ..........+++++
T Consensus       203 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~~s~~~  275 (376)
T cd05598         203 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE-------TQLKVINWETTLHIPSQAKLSREA  275 (376)
T ss_pred             ccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHH-------HHHHHhccCccccCCCCCCCCHHH
Confidence            2468899999999998889999999999999999999999998755322       1111111  111112224678999


Q ss_pred             HHHHHHhhcCCcCCCC---CHHHHhcCccccccC
Q 024828          206 CSFISACVQKEPQQRL---SAQELMTHPFLKMYG  236 (262)
Q Consensus       206 ~~li~~~l~~~p~~Rp---t~~~~l~h~~~~~~~  236 (262)
                      .+++.+|+ .+|.+|+   |++++++||||+...
T Consensus       276 ~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         276 SDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             HHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            99999976 5999999   999999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=276.10  Aligned_cols=223  Identities=28%  Similarity=0.493  Sum_probs=195.1

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~   82 (262)
                      |.+.++-....+.+|++.++.++|||||++|++......+|+|.|.-++|+|.+|+-++ ..+.+....+++.||+.|+.
T Consensus        53 KTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~  132 (864)
T KOG4717|consen   53 KTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAIS  132 (864)
T ss_pred             ccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHH
Confidence            44567778889999999999999999999999999999999999999999999999776 57999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEc-cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLL  160 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~  160 (262)
                      |+|+ ..++|+||||+||.+. .-|-|+|.|||++..+. +++...+.+|...|.|||++.|..| .++.||||||+++|
T Consensus       133 YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILy  210 (864)
T KOG4717|consen  133 YCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILY  210 (864)
T ss_pred             HHhh-hhhhcccCCcceeEEeeecCceEeeeccccccCC-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHH
Confidence            9999 9999999999998875 45899999999998764 5567778899999999999999987 57899999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .|++|++||...+..+..       ..+.+-.  ...+...+.++++||..||..||.+|.+.++|..++|++....
T Consensus       211 MLVCGq~PFqeANDSETL-------TmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  211 MLVCGQPPFQEANDSETL-------TMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHhCCCccccccchhhh-------hhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            999999999887665432       2222222  2234578999999999999999999999999999999998763

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-40  Score=274.61  Aligned_cols=218  Identities=27%  Similarity=0.493  Sum_probs=184.5

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+.+..|..++..+ +|++|+++++.+.+.+..++||||+++++|.+++...+.+++..+..++.|++.||+|||+ 
T Consensus        41 ~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-  119 (323)
T cd05616          41 DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS-  119 (323)
T ss_pred             hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            33445677788888777 5899999999999999999999999999999999888889999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|+.
T Consensus       120 ~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~  199 (323)
T cd05616         120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA  199 (323)
T ss_pred             CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence            99999999999999999999999999998754333333445578999999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~  236 (262)
                      ||...+..       .....+.....  ..+..+++++.+++.+||+.+|.+|++     ..++++||||+...
T Consensus       200 Pf~~~~~~-------~~~~~i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         200 PFEGEDED-------ELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             CCCCCCHH-------HHHHHHHhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            99865432       22333333322  223468899999999999999999997     48999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.5e-41  Score=280.62  Aligned_cols=220  Identities=26%  Similarity=0.446  Sum_probs=182.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+.++.+++||+|+++++.+.+++..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        42 ~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~-~  120 (360)
T cd05627          42 KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ-L  120 (360)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            345567889999999999999999999999999999999999999999999988899999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC-----------------------------------CCcccccccc
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----------------------------------GQANTFVGTY  133 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----------------------------------~~~~~~~~~~  133 (262)
                      |++|+||||+||+++.++.++|+|||++.......                                   .......|++
T Consensus       121 givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  200 (360)
T cd05627         121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP  200 (360)
T ss_pred             CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence            99999999999999999999999999876432110                                   0012346899


Q ss_pred             cccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHH
Q 024828          134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISA  211 (262)
Q Consensus       134 ~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~  211 (262)
                      .|+|||++.+..++.++|+|||||++|+|++|+.||......+       ....+....  ........+++++.+|+.+
T Consensus       201 ~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~  273 (360)
T cd05627         201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE-------TYRKVMNWKETLVFPPEVPISEKAKDLILR  273 (360)
T ss_pred             cccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHH-------HHHHHHcCCCceecCCCCCCCHHHHHHHHH
Confidence            9999999998889999999999999999999999998754432       222222211  1111123478999999999


Q ss_pred             hhcCCcCCCC---CHHHHhcCccccccCC
Q 024828          212 CVQKEPQQRL---SAQELMTHPFLKMYGD  237 (262)
Q Consensus       212 ~l~~~p~~Rp---t~~~~l~h~~~~~~~~  237 (262)
                      |+ .+|.+|+   +++++++||||+....
T Consensus       274 l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         274 FC-TDSENRIGSNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             hc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence            87 4999998   5899999999998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-40  Score=265.96  Aligned_cols=221  Identities=41%  Similarity=0.678  Sum_probs=188.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+++++.++|+||+++.+.+.++...++|+||+++++|.+++... +++...+..++.|++.|+.+||+ .
T Consensus        40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~-~  117 (274)
T cd06609          40 EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE-E  117 (274)
T ss_pred             chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            344567889999999999999999999999999999999999999999999875 88999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|+.|
T Consensus       118 ~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p  197 (274)
T cd06609         118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP  197 (274)
T ss_pred             CcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999987765543344445678889999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      |...+..       .....+.....+......++.++.+++.+||..+|++|||++++++||||+.....
T Consensus       198 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         198 LSDLHPM-------RVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             cccCchH-------HHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            9765422       22223333333333323388999999999999999999999999999999987765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-40  Score=276.13  Aligned_cols=214  Identities=28%  Similarity=0.501  Sum_probs=179.7

Q ss_pred             HHHHHHHH-HHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           13 RQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        13 ~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      ..+..|.. +++.++||||+++++.+.+++..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|++
T Consensus        40 ~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~gii  118 (325)
T cd05602          40 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIV  118 (325)
T ss_pred             HHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeE
Confidence            34444444 568889999999999999999999999999999999999988889999999999999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      |+||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       119 HrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (325)
T cd05602         119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (325)
T ss_pred             ecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence            99999999999999999999999987543333334455789999999999988899999999999999999999999986


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH----HHhcCccccccC
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ----ELMTHPFLKMYG  236 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~----~~l~h~~~~~~~  236 (262)
                      .+..       +....+.....  .....+++++.+++.+||+.+|.+||++.    ++++|+||....
T Consensus       199 ~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         199 RNTA-------EMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             CCHH-------HHHHHHHhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence            5432       22223322222  22246889999999999999999999765    899999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.9e-40  Score=264.27  Aligned_cols=213  Identities=33%  Similarity=0.583  Sum_probs=181.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|+.++++++||||+++++.+.+....++++||+++++|.+++.+.+.++...+..++.|++.||++||+ .|+
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i  127 (267)
T cd06628          49 MLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN-RGI  127 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh-cCc
Confidence            4467889999999999999999999999999999999999999999999988889999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCC------CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTS------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      +|+||+|+||++++++.++++|||.+.......      .......++..|+|||.+.+..++.++|+||+|+++++|++
T Consensus       128 vH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~  207 (267)
T cd06628         128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT  207 (267)
T ss_pred             ccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh
Confidence            999999999999999999999999887654211      11122356788999999998888999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      |+.||......       ...........+. .+..++.++.+++++||+.+|.+||+++++++||||
T Consensus       208 g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         208 GKHPFPDCTQL-------QAIFKIGENASPE-IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCCCCCCccHH-------HHHHHHhccCCCc-CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999865332       1122222222222 234678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1e-40  Score=288.11  Aligned_cols=213  Identities=30%  Similarity=0.497  Sum_probs=188.4

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--------------CCCHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--------------TIPEEYL   70 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~   70 (262)
                      -..+.+.+.+|.+|++++..++|||||+++++|..++.+|+|+||+..|+|.+++..++              +++..+.
T Consensus       526 d~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~  605 (774)
T KOG1026|consen  526 DKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQF  605 (774)
T ss_pred             ccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHH
Confidence            34566789999999999999999999999999999999999999999999999997542              2788999


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCc
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGY  148 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  148 (262)
                      +.|+.||+.||+||.+ ..++|+||..+|+||+++-.||++|||+++.+....  +.......+++|||||.+..+.++.
T Consensus       606 L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTt  684 (774)
T KOG1026|consen  606 LHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTT  684 (774)
T ss_pred             HHHHHHHHHHHHHHHh-CcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccc
Confidence            9999999999999998 999999999999999999999999999998654322  2222345688999999999999999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      ++||||+|+++||+++ |+.||.+...       .++++.+..+...+.+ +.+|.++++||..||+.+|.+||+++||
T Consensus       685 eSDVWs~GVvLWEIFsyG~QPy~glSn-------~EVIe~i~~g~lL~~P-e~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  685 ESDVWSFGVVLWEIFSYGKQPYYGLSN-------QEVIECIRAGQLLSCP-ENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             hhhhhhhhhhhhhhhccccCcccccch-------HHHHHHHHcCCcccCC-CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            9999999999999999 8999988554       3677888888875555 7899999999999999999999999998

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.1e-41  Score=273.64  Aligned_cols=229  Identities=25%  Similarity=0.477  Sum_probs=181.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|+.+++.++||||+++++++..++..++||||+.+ +|.+++.+. ..++...+..++.|++.||++||+ .|
T Consensus        47 ~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~  124 (301)
T cd07873          47 APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-RK  124 (301)
T ss_pred             chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            345678999999999999999999999999999999999975 999888764 568999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       125 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~  204 (301)
T cd07873         125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL  204 (301)
T ss_pred             eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654333333334568899999998764 478899999999999999999999


Q ss_pred             CCCCCccCchhhHHHHH--------HHHh------cCCCCC-------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          169 YSPPEQQDGWTSFYELM--------EAIV------DQPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~--------~~~~------~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      |...+..+.........        ..+.      ....+.       .....+++++.+||.+||+.||.+|||+++++
T Consensus       205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil  284 (301)
T cd07873         205 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM  284 (301)
T ss_pred             CCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            98655432111111100        0000      000000       01135688899999999999999999999999


Q ss_pred             cCccccccCCcccc
Q 024828          228 THPFLKMYGDLNVD  241 (262)
Q Consensus       228 ~h~~~~~~~~~~~~  241 (262)
                      +||||+..++.-..
T Consensus       285 ~h~~f~~~~~~~~~  298 (301)
T cd07873         285 KHPYFHCLGERIHK  298 (301)
T ss_pred             cCcccccccchhhc
Confidence            99999988765443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-40  Score=266.16  Aligned_cols=230  Identities=42%  Similarity=0.769  Sum_probs=189.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ++....++.+|++++++++||||+++++.+..++..++|+||+++++|..++...   ..+++..+..++.|++.||.||
T Consensus        39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L  118 (286)
T cd06622          39 DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL  118 (286)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH
Confidence            4555678999999999999999999999999999999999999999999998764   3789999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC------CCcchhHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK------YGYKSDIWSLGLV  158 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------~~~~~Di~slG~~  158 (262)
                      |+..|++|+||+|+||+++.++.++++|||.+......  ......++..|+|||.+.+..      ++.++|+||+||+
T Consensus       119 H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i  196 (286)
T cd06622         119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLS  196 (286)
T ss_pred             HhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHH
Confidence            96469999999999999999999999999988654322  222345677899999986533      4789999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|+|++|+.||......    ........+.....+..+ ..+++++.+++.+||..+|.+||++++++.||||...+..
T Consensus       197 l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         197 ILEMALGRYPYPPETYA----NIFAQLSAIVDGDPPTLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHhCCCCCCCcchh----hHHHHHHHHhhcCCCCCC-cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            99999999999764322    222333334444433333 4589999999999999999999999999999999988877


Q ss_pred             ccchhh
Q 024828          239 NVDLSE  244 (262)
Q Consensus       239 ~~~~~~  244 (262)
                      ..+...
T Consensus       272 ~~~~~~  277 (286)
T cd06622         272 DVDMAE  277 (286)
T ss_pred             ccchHH
Confidence            554443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-39  Score=262.64  Aligned_cols=217  Identities=29%  Similarity=0.548  Sum_probs=181.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|++++++++|+||+++.+++.+++..++++||++|++|.+++.+.++++...+..++.|++.||++||+ .
T Consensus        43 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~  121 (265)
T cd06631          43 EKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN-N  121 (265)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            344567899999999999999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC------CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |++|+||+|+||+++.++.++++|||.+.......      .......++..|+|||.+.+..++.++|+||||++++++
T Consensus       122 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l  201 (265)
T cd06631         122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM  201 (265)
T ss_pred             CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHH
Confidence            99999999999999999999999999887543211      111234578889999999988889999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ++|..||...+...      ...............+..++.++.+++++||..+|.+|||+.++++||||
T Consensus       202 ~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         202 ATGKPPLASMDRLA------AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HhCCCccccCChHH------HHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99999997643321      11111111112222345688999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=268.51  Aligned_cols=222  Identities=25%  Similarity=0.454  Sum_probs=184.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+|+++++.++||||+++++.+..++..++||||+.+++|.+++...  ..++...+..++.|++.||.|||+ .|
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~  122 (285)
T cd05605          44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR-ER  122 (285)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            456778999999999999999999999999999999999999999888654  458999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||++++++.++++|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|..||
T Consensus       123 ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf  201 (285)
T cd05605         123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF  201 (285)
T ss_pred             cEecCCCHHHEEECCCCCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999998764322 1223346788999999998888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~~~  240 (262)
                      .+.........   ....+...  ....+..++..+.+|+.+||..||.+||     +++++++||||+.......
T Consensus       202 ~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~  272 (285)
T cd05605         202 RQRKEKVKREE---VERRVKED--QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL  272 (285)
T ss_pred             CCCchhhHHHH---HHHHhhhc--ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH
Confidence            87554322211   22222221  1222346889999999999999999999     9999999999988655444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-40  Score=286.05  Aligned_cols=243  Identities=24%  Similarity=0.391  Sum_probs=181.5

Q ss_pred             HHHHHHHHHHHHHhcCC------CCeeEeeceEEEEC-CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQ------CPYVVVCYQSFYSN-GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...+.+..|+++++.++      |.+++++++++..+ .++|+||+++ |++|.+++.+.+.++...+..++.|++.||+
T Consensus       167 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~  245 (467)
T PTZ00284        167 KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALD  245 (467)
T ss_pred             hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH
Confidence            33445566777766664      45688999988764 5789999998 6699999988889999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCC----------------cEEEEecccccccccCCCCcccccccccccCcccccCCCC
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRG----------------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY  146 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~----------------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  146 (262)
                      |||++.||+|+||||+||+++.++                .++|+|||.+....   .......|+..|+|||++.+..+
T Consensus       246 yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~  322 (467)
T PTZ00284        246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGW  322 (467)
T ss_pred             HHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCC
Confidence            999735999999999999998665                49999999875422   22334578999999999999899


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHH----------------HHHhcC---CCCCC-----------
Q 024828          147 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----------------EAIVDQ---PPPSA-----------  196 (262)
Q Consensus       147 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~---~~~~~-----------  196 (262)
                      +.++|||||||++|+|++|+.||...+..+....+....                ..+...   ..+..           
T Consensus       323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
T PTZ00284        323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA  402 (467)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcc
Confidence            999999999999999999999998655422111111100                000000   00000           


Q ss_pred             ---CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccchhhHhhhhC--CCCccc
Q 024828          197 ---PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAG--SPLATL  256 (262)
Q Consensus       197 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~~~~~~~--~~~~~~  256 (262)
                         .....++.+.+||.+||+.||.+|||++|+|+||||+.+...-...+.+++++.  .|+++|
T Consensus       403 ~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  467 (467)
T PTZ00284        403 RPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRPTPIM  467 (467)
T ss_pred             cchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCccccCCCCCCccccCCCCCCC
Confidence               000124567899999999999999999999999999998777767777775543  444443

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.6e-40  Score=267.91  Aligned_cols=221  Identities=32%  Similarity=0.612  Sum_probs=184.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+.+|+.+++.++|+||+++++.+..+...|+||||+++++|.+++.+ ..++...+..++.|++.||+|||+ .|+
T Consensus        60 ~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~-~gi  137 (296)
T cd06654          60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQV  137 (296)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            346788999999999999999999999999999999999999999999865 468999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.
T Consensus       138 ~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~  217 (296)
T cd06654         138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (296)
T ss_pred             ccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999988754433222334467889999999988888999999999999999999999997


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      .......      ..............+..++..+.+++.+||..+|++|||++++++||||.......
T Consensus       218 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  280 (296)
T cd06654         218 NENPLRA------LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS  280 (296)
T ss_pred             CCCHHHh------HHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCcc
Confidence            6543211      11111122222222346788999999999999999999999999999998876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-39  Score=260.28  Aligned_cols=215  Identities=31%  Similarity=0.590  Sum_probs=181.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ....+.+.+|++++++++|+|++++.+.+.. +...++++||+++++|.+++...  ..++...+..++.+++.|+++||
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH  119 (257)
T cd08223          40 RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH  119 (257)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4556678999999999999999999998764 44689999999999999999763  45899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      + .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|++++++++|
T Consensus       120 ~-~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g  198 (257)
T cd08223         120 E-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL  198 (257)
T ss_pred             h-CCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence            8 999999999999999999999999999987664443334445678899999999988899999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      +.||...+.       ......+..+..+. ....+++++.+++.+||+.+|++|||+.++++||||
T Consensus       199 ~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         199 KHAFNAKDM-------NSLVYRIIEGKLPP-MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CCCCCCCCH-------HHHHHHHHhcCCCC-CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            999975432       12223333333333 235688999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.1e-40  Score=272.84  Aligned_cols=216  Identities=27%  Similarity=0.481  Sum_probs=180.3

Q ss_pred             HHHHHHHHHH-HHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|.. +++.++||||+++++.+.+.+..|+||||++|++|...+.+.+.+++..+..++.|++.||.|||+ .|
T Consensus        38 ~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~  116 (321)
T cd05603          38 EQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS-LN  116 (321)
T ss_pred             HHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3445555654 578899999999999999999999999999999999999888889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       117 ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  196 (321)
T cd05603         117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF  196 (321)
T ss_pred             eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCC
Confidence            99999999999999999999999998865433333334456889999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH----HHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA----QELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----~~~l~h~~~~~~~  236 (262)
                      ...+..       .....+.....  ..+...+.++.+++.+||+.+|.+||++    .++++|+||+...
T Consensus       197 ~~~~~~-------~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         197 YSRDVS-------QMYDNILHKPL--QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             CCCCHH-------HHHHHHhcCCC--CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            775422       23333333322  2224578899999999999999999865    5999999997543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.6e-40  Score=269.46  Aligned_cols=218  Identities=23%  Similarity=0.443  Sum_probs=170.3

Q ss_pred             HHHHHHHHHHHhcC---CCCeeEeeceEEEE-----CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSS---QCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus        12 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l   81 (262)
                      ...+.+|+.+++.+   +||||+++++++..     ....++|||++.+ +|.+++...  ..++...+..++.|++.||
T Consensus        45 ~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL  123 (290)
T cd07862          45 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL  123 (290)
T ss_pred             hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Confidence            34556677766655   79999999998852     4568999999965 999999764  3589999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      +|||+ .|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+
T Consensus       124 ~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e  201 (290)
T cd07862         124 DFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE  201 (290)
T ss_pred             HHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHH
Confidence            99998 99999999999999999999999999998755432 23334567899999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHH-----HH----------hcCCCC---CCCCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELME-----AI----------VDQPPP---SAPSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~-----~~----------~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      |++|++||......+....+.....     .+          ......   ......+++.+.+|+.+||+.||++|||+
T Consensus       202 l~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  281 (290)
T cd07862         202 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  281 (290)
T ss_pred             HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH
Confidence            9999999987654332222111100     00          000000   00112467889999999999999999999


Q ss_pred             HHHhcCccc
Q 024828          224 QELMTHPFL  232 (262)
Q Consensus       224 ~~~l~h~~~  232 (262)
                      .++++||||
T Consensus       282 ~~~l~hp~f  290 (290)
T cd07862         282 YSALSHPYF  290 (290)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-39  Score=266.38  Aligned_cols=221  Identities=33%  Similarity=0.635  Sum_probs=184.9

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|+.+++.++||||+++++.+..+...++|+||+++++|..++.+ ..++...+..++.+++.|+++||+ .|+
T Consensus        59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~~i  136 (296)
T cd06655          59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHA-NQV  136 (296)
T ss_pred             hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            456788999999999999999999999999999999999999999999876 468999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+||+|+||+++.++.++++|||++..............++..|+|||.+.+..++.++|+||||+++|++++|..||.
T Consensus       137 ~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~  216 (296)
T cd06655         137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (296)
T ss_pred             ccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987765433322333467789999999998889999999999999999999999997


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      ..+...      ...............+..+++.+.+++++||..+|.+|||+.+++.||||+......
T Consensus       217 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~  279 (296)
T cd06655         217 NENPLR------ALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLS  279 (296)
T ss_pred             CCCHHH------HHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccc
Confidence            754321      111111112222223456889999999999999999999999999999999877533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-40  Score=266.70  Aligned_cols=218  Identities=41%  Similarity=0.725  Sum_probs=179.6

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .......+|+.++++++||||+++++++.+....+++||++.+++|.+++.+.+.++...+..++.|++.||++||+ .|
T Consensus        40 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~  118 (260)
T PF00069_consen   40 EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS-KG  118 (260)
T ss_dssp             HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             cccchhhhhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cc
Confidence            33444566999999999999999999999999999999999999999999988899999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-GGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+||+|+||+++.++.++|+|||.+..............++..|.|||... +...+.++|+||+|+++++|++|..|
T Consensus       119 i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p  198 (260)
T PF00069_consen  119 IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP  198 (260)
T ss_dssp             EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999875433333444567788999999998 77899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      |......+    .................  ....+..+.+++.+||+.||++|||++++++||||
T Consensus       199 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  199 FEESNSDD----QLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             STTSSHHH----HHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             cccccchh----hhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            98762221    11122111111111100  01223889999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-40  Score=280.46  Aligned_cols=233  Identities=26%  Similarity=0.444  Sum_probs=186.5

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCC------CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQ------CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAIC   74 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~   74 (262)
                      |.++....-..+...|+++|..++      .-|+|+++++|...+++|||+|.+. .+|.++++.++  +++...+..++
T Consensus       217 KIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~  295 (586)
T KOG0667|consen  217 KIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFA  295 (586)
T ss_pred             EeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHH
Confidence            334456777789999999999995      4699999999999999999999995 49999998774  69999999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCC--cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhH
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI  152 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di  152 (262)
                      .||+.||.+||+ .||+|+||||+|||+.+.+  .+|++|||.|+....   ...+++.+..|+|||++.|.+|+.+.||
T Consensus       296 ~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q---~vytYiQSRfYRAPEVILGlpY~~~IDm  371 (586)
T KOG0667|consen  296 QQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ---RVYTYIQSRFYRAPEVILGLPYDTAIDM  371 (586)
T ss_pred             HHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccccccCC---cceeeeeccccccchhhccCCCCCccce
Confidence            999999999998 9999999999999997654  699999999987543   3336788999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHH----------------------------------------------
Q 024828          153 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELME----------------------------------------------  186 (262)
Q Consensus       153 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------------------------------  186 (262)
                      |||||+++||++|.+.|.+.++.++...+.+...                                              
T Consensus       372 WSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~  451 (586)
T KOG0667|consen  372 WSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYR  451 (586)
T ss_pred             eehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhh
Confidence            9999999999999999987665543333222220                                              


Q ss_pred             H-HhcCCCC-CCC------CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          187 A-IVDQPPP-SAP------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       187 ~-~~~~~~~-~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      . ......| ...      ...-...+.+|+++||.+||.+|+|+.++|+||||........
T Consensus       452 ~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~~~~  513 (586)
T KOG0667|consen  452 KARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSLERR  513 (586)
T ss_pred             hhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccccccc
Confidence            0 0000011 000      0122345899999999999999999999999999986554433

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.9e-40  Score=276.11  Aligned_cols=217  Identities=29%  Similarity=0.507  Sum_probs=178.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|+.+++.++||||+++++.+.++...|+||||++|++|.+++.. ..+++..+..++.|++.||+|||+ .|
T Consensus        85 ~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~-~~  162 (370)
T cd05621          85 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHS-MG  162 (370)
T ss_pred             hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3445678999999999999999999999999999999999999999999976 468999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCC----CCcchhHHHHHHHHHHHHh
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~----~~~~~Di~slG~~l~~l~~  164 (262)
                      ++|+||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..    ++.++|+||+||++|+|++
T Consensus       163 IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~  242 (370)
T cd05621         163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV  242 (370)
T ss_pred             eEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence            99999999999999999999999999876543221 223457899999999987532    7889999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCC-CCC-CCCCCCCHHHHHHHHHhhcCCcCC--CCCHHHHhcCcccccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQP-PPS-APSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMY  235 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~h~~~~~~  235 (262)
                      |+.||......       .....+.... ... .....++..+.+++.+||..++.+  |+|++++++||||+..
T Consensus       243 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         243 GDTPFYADSLV-------GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CCCCCCCCCHH-------HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999865432       2222232221 111 122357899999999999855543  8899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.2e-40  Score=265.66  Aligned_cols=221  Identities=27%  Similarity=0.479  Sum_probs=182.7

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+|+.++++++|++|+++++.+.+++..++||||+.|++|.+++...  ..+++..+..++.|++.||.|||+ .
T Consensus        43 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~  121 (285)
T cd05630          43 GESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ-E  121 (285)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            3456778999999999999999999999999999999999999999988654  358999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++++|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       122 ~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P  200 (285)
T cd05630         122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP  200 (285)
T ss_pred             CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999886543222 22234688899999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCCc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDL  238 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~~  238 (262)
                      |....................     ......+++++.+|+.+||+.||++|||     ++++++||||+.....
T Consensus       201 f~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         201 FQQRKKKIKREEVERLVKEVQ-----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             CCCCCccchHHHHHhhhhhhh-----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence            987543322222212111111     1223567899999999999999999999     9999999999875444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=264.00  Aligned_cols=222  Identities=34%  Similarity=0.663  Sum_probs=185.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+.+.+|++++++++||||+++++.+..+...++||||+++++|.+++.+. +.+++..+..++.|++.||.|||+
T Consensus        42 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~  121 (280)
T cd06611          42 SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS  121 (280)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3445567889999999999999999999999999999999999999999999764 569999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc-----CCCCCcchhHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~  161 (262)
                       .|++|+||+|+||+++.++.++++|||.+..............++..|++||.+.     +..++.++|+||+|+++|+
T Consensus       122 -~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~  200 (280)
T cd06611         122 -HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE  200 (280)
T ss_pred             -CCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHH
Confidence             9999999999999999999999999998766544433334456788999999874     2346789999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |++|+.||...+..       .....+.....+. ..+..++.++.+++.+||+.+|.+|||++++++||||....+
T Consensus       201 l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         201 LAQMEPPHHELNPM-------RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             HHhCCCCcccCCHH-------HHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence            99999999765332       2223333333221 223467899999999999999999999999999999988743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-39  Score=264.34  Aligned_cols=220  Identities=35%  Similarity=0.647  Sum_probs=185.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|+.+++.++||||+++++.+..++..++++||+.|++|.+++.. ++++...+..++.|++.||++||+ .
T Consensus        57 ~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~  134 (285)
T cd06648          57 QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA-Q  134 (285)
T ss_pred             hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            34456788999999999999999999999999999999999999999999987 678999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++++|||.+..............++..|+|||...+..++.++|+||+|+++++|++|..|
T Consensus       135 ~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p  214 (285)
T cd06648         135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP  214 (285)
T ss_pred             CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999876544333233334678899999999888889999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCC-CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSA-PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |...+..       ...........+.. ....++..+.+++.+||+.+|++|||+.++++||||+.++.
T Consensus       215 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         215 YFNEPPL-------QAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             CcCCCHH-------HHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            9764321       22223333322121 12347889999999999999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.6e-39  Score=263.06  Aligned_cols=225  Identities=33%  Similarity=0.607  Sum_probs=185.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+.+.+|+.+++.++||||+++++.+..++..++||||+++++|..++.+ ...++...+..++.|++.+|.+||+
T Consensus        49 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~  128 (292)
T cd06644          49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS  128 (292)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            445667888999999999999999999999999999999999999999988754 4568999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-----CCCCcchhHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~  161 (262)
                       .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+     ..++.++|+||||+++|+
T Consensus       129 -~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~e  207 (292)
T cd06644         129 -MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE  207 (292)
T ss_pred             -CCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHH
Confidence             99999999999999999999999999987654433333334567789999999853     346789999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      |++|..||...+..       ...........+ ......++.++.+++.+||..+|++||+++++++||||+.....+.
T Consensus       208 l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  280 (292)
T cd06644         208 MAQIEPPHHELNPM-------RVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRP  280 (292)
T ss_pred             HhcCCCCCccccHH-------HHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchh
Confidence            99999999764321       122222222222 2223467889999999999999999999999999999988877664

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.2e-40  Score=270.14  Aligned_cols=217  Identities=26%  Similarity=0.491  Sum_probs=183.2

Q ss_pred             HHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+..|.+++..+. |++|+++.+.+.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~  120 (323)
T cd05615          42 DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR-R  120 (323)
T ss_pred             hHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            44556778899988885 577888999999999999999999999999999988889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       121 ~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p  200 (323)
T cd05615         121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP  200 (323)
T ss_pred             CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCC
Confidence            99999999999999999999999999987543333333445689999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~  236 (262)
                      |......       .....+.....  ..+..+++++.+++.+||+.+|.+|++     .+++++||||+...
T Consensus       201 f~~~~~~-------~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         201 FDGEDED-------ELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             CCCCCHH-------HHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            9875432       22333333222  123467899999999999999999997     57999999998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.6e-40  Score=267.80  Aligned_cols=224  Identities=34%  Similarity=0.630  Sum_probs=186.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.+++.. +.++...+..++.|++.||+|||+ 
T Consensus        59 ~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~-  136 (292)
T cd06658          59 KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN-  136 (292)
T ss_pred             hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            345566789999999999999999999999999999999999999999998865 568999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus       137 ~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~  216 (292)
T cd06658         137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP  216 (292)
T ss_pred             CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999988655433333334567889999999988889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      ||.......       ....+....... .....++..+.+++.+||..+|.+|||++++++||||+..+....
T Consensus       217 p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         217 PYFNEPPLQ-------AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             CCCCCCHHH-------HHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence            997643321       111221111111 112357889999999999999999999999999999998877664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.9e-40  Score=275.95  Aligned_cols=226  Identities=25%  Similarity=0.404  Sum_probs=180.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC-----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ....+++.+|+++++.++|+||+++++++....     ..|+|+||+.+ +|.+++...+.++...+..++.|++.||.|
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~  118 (372)
T cd07853          40 LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKY  118 (372)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999998766     78999999965 899999887889999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCC-CCCcchhHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~  161 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||+||++++
T Consensus       119 LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e  197 (372)
T cd07853         119 LHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE  197 (372)
T ss_pred             HHh-CCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence            998 999999999999999999999999999987543222 122234578899999998875 47899999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHH----------------HHHHHhcCCC-CC------CCCCCCCHHHHHHHHHhhcCCcC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYE----------------LMEAIVDQPP-PS------APSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~-~~------~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      |++|+.||...+..+....+..                ....+..... +.      ......++++.+|+.+||+.||+
T Consensus       198 l~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~  277 (372)
T cd07853         198 LLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD  277 (372)
T ss_pred             HHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh
Confidence            9999999987554322211111                0011111111 10      11234578899999999999999


Q ss_pred             CCCCHHHHhcCccccccC
Q 024828          219 QRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~  236 (262)
                      +|||+++++.||||+...
T Consensus       278 ~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         278 KRISAADALAHPYLDEGR  295 (372)
T ss_pred             hCcCHHHHhcCHhhCCCc
Confidence            999999999999998854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-39  Score=261.74  Aligned_cols=223  Identities=63%  Similarity=1.088  Sum_probs=192.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|++++.+++|+|++++++.+..+...++++||+++++|.+++.....++...+..++.|++.|+.+||+..|
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~  120 (264)
T cd06623          41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH  120 (264)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence            56788999999999999999999999999999999999999999999999988889999999999999999999995489


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+|+||+++|++++|+.||
T Consensus       121 ~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~  200 (264)
T cd06623         121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF  200 (264)
T ss_pred             CccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999877654443333456788999999998888899999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ......    ........+.....+......++..+.+++.+||..+|++|||+.++++|||++...
T Consensus       201 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         201 LPPGQP----SFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             cccccc----CHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            876531    222344444444444444333889999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7e-40  Score=267.90  Aligned_cols=226  Identities=32%  Similarity=0.603  Sum_probs=187.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.+++.+ ..++...+..++.|++.||.+||+ .|
T Consensus        58 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~-~~  135 (297)
T cd06656          58 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS-NQ  135 (297)
T ss_pred             chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3446788999999999999999999999999999999999999999999876 567899999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++++|||.+..............++..|++||.+.+..++.++|+||+|+++|++++|..||
T Consensus       136 i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf  215 (297)
T cd06656         136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY  215 (297)
T ss_pred             cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998876543333333456788999999999888899999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccchh
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  243 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~  243 (262)
                      ...+....      .......+......+..++..+.+++.+||..+|++|||++++++||||+......-..+
T Consensus       216 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~  283 (297)
T cd06656         216 LNENPLRA------LYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTP  283 (297)
T ss_pred             CCCCcchh------eeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccccCH
Confidence            76543221      011111122222234567888999999999999999999999999999998776554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.5e-40  Score=271.46  Aligned_cols=219  Identities=22%  Similarity=0.436  Sum_probs=167.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV---------KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~l~~~   80 (262)
                      ...+.+|++++++++||||+++++.+..  +...++++||+.+ +|.+++...         ..++...+..++.|++.|
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07868          42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence            4567899999999999999999998864  4568999999965 999888532         248999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEE----ccCCcEEEEecccccccccCCC---CcccccccccccCcccccCC-CCCcchhH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDI  152 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~Di  152 (262)
                      |.|||+ .|++|+||||+||++    +.++.++|+|||++........   ......++..|+|||.+.+. .++.++|+
T Consensus       121 l~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  199 (317)
T cd07868         121 IHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI  199 (317)
T ss_pred             HHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhH
Confidence            999998 999999999999999    3557899999999876543321   22345678899999998874 48899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCccCc------hhhHHHHHH------------------------HHhcCCCC--------
Q 024828          153 WSLGLVLLECATGQFPYSPPEQQDG------WTSFYELME------------------------AIVDQPPP--------  194 (262)
Q Consensus       153 ~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~------------------------~~~~~~~~--------  194 (262)
                      ||+||++++|++|++||........      .........                        ........        
T Consensus       200 wslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (317)
T cd07868         200 WAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM  279 (317)
T ss_pred             HHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchH
Confidence            9999999999999999975443210      000000000                        00000000        


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          195 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       195 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      .......+.++.+|+.+||++||.+|||++|+|+||||
T Consensus       280 ~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         280 EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=284.80  Aligned_cols=230  Identities=24%  Similarity=0.446  Sum_probs=175.9

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEEC--------CeEEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSN--------GAISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      ...+|+.+++.++||||+++++++...        ..+++||||+++ +|.+++.    ....++...+..++.|++.||
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL  183 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRAL  183 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence            345799999999999999999877432        247799999976 8877765    345799999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCC-cEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVL  159 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l  159 (262)
                      +|||+ .|++|+||||+||+++.++ .++|+|||++....... ......+++.|+|||++.+. .++.++|+||+||++
T Consensus       184 ~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil  261 (440)
T PTZ00036        184 AYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII  261 (440)
T ss_pred             HHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence            99999 9999999999999998665 69999999997654322 22345678899999998764 589999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHH--------HHH----hcCCCCC--------CCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELM--------EAI----VDQPPPS--------APSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~----~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      |+|++|.+||.+....+.........        ...    .....+.        ..+...++++.+||.+||..||.+
T Consensus       262 ~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~  341 (440)
T PTZ00036        262 AEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLK  341 (440)
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhH
Confidence            99999999998765432221111110        000    0000000        012346789999999999999999


Q ss_pred             CCCHHHHhcCccccccCCcccchhhHh
Q 024828          220 RLSAQELMTHPFLKMYGDLNVDLSEYF  246 (262)
Q Consensus       220 Rpt~~~~l~h~~~~~~~~~~~~~~~~~  246 (262)
                      |||+.|++.||||+...+.....+.+.
T Consensus       342 R~ta~e~l~hp~f~~~~~~~~~~~~~~  368 (440)
T PTZ00036        342 RLNPIEALADPFFDDLRDPCIKLPKYI  368 (440)
T ss_pred             CcCHHHHhCChhHHhhhcccccCCCCC
Confidence            999999999999998877655544443

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-39  Score=263.30  Aligned_cols=217  Identities=36%  Similarity=0.674  Sum_probs=177.3

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVL   78 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~   78 (262)
                      .......+.+|+.+++++ +|+||+++.+.+...      ...+++|||+.+++|.+++...  ..+++..+..++.|++
T Consensus        42 ~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~  121 (272)
T cd06637          42 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL  121 (272)
T ss_pred             CCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHH
Confidence            334456788999999998 799999999998753      4689999999999999999864  3589999999999999


Q ss_pred             HHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-----CCCCcchhHH
Q 024828           79 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIW  153 (262)
Q Consensus        79 ~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~  153 (262)
                      .||+|||+ .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+     ..++.++|+|
T Consensus       122 ~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~  200 (272)
T cd06637         122 RGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW  200 (272)
T ss_pred             HHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHH
Confidence            99999998 99999999999999999999999999998765433333344567889999999863     3578899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          154 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       154 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      |+|+++|+|++|..||.......       .................++.++.+|+.+||..+|.+|||++++++||||
T Consensus       201 slGv~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         201 SLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHHHHhCCCCccccCHHH-------HHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            99999999999999997543221       1111222223333345678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=267.62  Aligned_cols=225  Identities=29%  Similarity=0.506  Sum_probs=186.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+.+.+|+++++.++|+||+++++.+.++...|+||||+.|++|.+++.+.  ..+++..+..++.|++.||+|||+ 
T Consensus        43 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-  121 (316)
T cd05574          43 NKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL-  121 (316)
T ss_pred             HHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH-
Confidence            45667899999999999999999999999999999999999999999999764  468999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-----------------------------CcccccccccccCc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-----------------------------QANTFVGTYNYMSP  138 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----------------------------~~~~~~~~~~y~~P  138 (262)
                      .|++|+||+|+||+++.++.++|+|||++........                             ......|+..|+||
T Consensus       122 ~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP  201 (316)
T cd05574         122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP  201 (316)
T ss_pred             CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH
Confidence            9999999999999999999999999998764422110                             11123577889999


Q ss_pred             ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcC
Q 024828          139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       139 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      |.+.+..++.++|+||||+++|+|++|..||...+...       .................++.++.+++.+||..+|+
T Consensus       202 E~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  274 (316)
T cd05574         202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE-------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPS  274 (316)
T ss_pred             HHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHh
Confidence            99998889999999999999999999999997655432       12222222222222234789999999999999999


Q ss_pred             CCCC----HHHHhcCccccccCCcccch
Q 024828          219 QRLS----AQELMTHPFLKMYGDLNVDL  242 (262)
Q Consensus       219 ~Rpt----~~~~l~h~~~~~~~~~~~~~  242 (262)
                      +|||    +++++.||||+..+...++.
T Consensus       275 ~R~s~~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         275 KRLGSKRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HCCCchhhHHHHHcCchhhcCChhhccc
Confidence            9999    99999999999876555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.1e-39  Score=268.50  Aligned_cols=227  Identities=26%  Similarity=0.439  Sum_probs=174.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.+++...  +.++...+..++.|++.||+|||+
T Consensus        40 ~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  119 (327)
T cd08227          40 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH  119 (327)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            345567889999999999999999999999999999999999999999999753  458999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-------CcccccccccccCcccccC--CCCCcchhHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISG--GKYGYKSDIWSLGL  157 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~  157 (262)
                       .|++|+||+|+||+++.++.+++.||+..........       ......++..|+|||.+.+  ..++.++|+||+||
T Consensus       120 -~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~  198 (327)
T cd08227         120 -MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI  198 (327)
T ss_pred             -CCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence             9999999999999999999999999975433221111       1112345677999999876  35889999999999


Q ss_pred             HHHHHHhCCCCCCCCCccCchhhHHHH-H-----------HHHh-------------cC-----C-------CCCCCCCC
Q 024828          158 VLLECATGQFPYSPPEQQDGWTSFYEL-M-----------EAIV-------------DQ-----P-------PPSAPSDQ  200 (262)
Q Consensus       158 ~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-----------~~~~-------------~~-----~-------~~~~~~~~  200 (262)
                      ++++|++|..||............... .           ....             .+     .       ........
T Consensus       199 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (327)
T cd08227         199 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRT  278 (327)
T ss_pred             HHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccc
Confidence            999999999999754322110000000 0           0000             00     0       00001123


Q ss_pred             CCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          201 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       201 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      +++++.+|+.+||+.||++|||++++++||||+...
T Consensus       279 ~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         279 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            567899999999999999999999999999998743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.4e-40  Score=267.42  Aligned_cols=220  Identities=23%  Similarity=0.468  Sum_probs=175.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ..+.+.+|+.++++++||||+++++.+.++...++||||+.+ +|.+++...   ..++...+..++.|++.||+|||+ 
T Consensus        42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-  119 (285)
T cd07861          42 VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS-  119 (285)
T ss_pred             chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh-
Confidence            346788999999999999999999999999999999999975 899888653   458999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+. .++.++|+||||+++++|++|+
T Consensus       120 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  199 (285)
T cd07861         120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK  199 (285)
T ss_pred             CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999987654443333334567889999988764 4688999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHH--------------HHHHhc------CCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          167 FPYSPPEQQDGWTSFYEL--------------MEAIVD------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~--------------~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      .||......+........              ......      ..........+++++.++|.+||+.||.+|||++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l  279 (285)
T cd07861         200 PLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA  279 (285)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            999765432111000000              000000      000011123578899999999999999999999999


Q ss_pred             hcCccc
Q 024828          227 MTHPFL  232 (262)
Q Consensus       227 l~h~~~  232 (262)
                      ++||||
T Consensus       280 l~~~~~  285 (285)
T cd07861         280 LNHPYF  285 (285)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.2e-40  Score=274.63  Aligned_cols=225  Identities=25%  Similarity=0.462  Sum_probs=176.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +......+.+|+.+++.++||||+++++++....      ..|+||||+.+ +|.+.+..  .++...+..++.|++.||
T Consensus        60 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L  136 (359)
T cd07876          60 NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGI  136 (359)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHH
Confidence            3456677889999999999999999999986543      57999999976 77777643  588899999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      .|||+ .|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+..++.++|+|||||++|+
T Consensus       137 ~~LH~-~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e  214 (359)
T cd07876         137 KHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  214 (359)
T ss_pred             HHHHh-CCcccCCCCHHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHH
Confidence            99998 99999999999999999999999999998654322 22234567889999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHH---------------HHHHHhcCCCC------------------CCCCCCCCHHHHHH
Q 024828          162 CATGQFPYSPPEQQDGWTSFYE---------------LMEAIVDQPPP------------------SAPSDQFSPEFCSF  208 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~---------------~~~~~~~~~~~------------------~~~~~~~~~~l~~l  208 (262)
                      |++|+.||...+..+.+.....               ...........                  .......++++++|
T Consensus       215 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  294 (359)
T cd07876         215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL  294 (359)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHH
Confidence            9999999987654332221111               01111111000                  00112346789999


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +.+||..||++|||++|++.||||+.+..
T Consensus       295 i~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         295 LSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence            99999999999999999999999986554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-39  Score=261.15  Aligned_cols=219  Identities=29%  Similarity=0.592  Sum_probs=183.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|++++++++|+||+++++.+.+++..++|+||+.|++|.+++.+.+++++..+..++.|++.||.+||+ .|
T Consensus        45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~-~~  123 (268)
T cd06630          45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE-NQ  123 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            35678999999999999999999999999999999999999999999999988889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCC-cEEEEecccccccccCCCC----cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           90 IIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      ++|+||+|.||+++.++ .++|+|||.+.........    .....++..|+|||.+.+..++.++|+|++|++++++++
T Consensus       124 i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~  203 (268)
T cd06630         124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT  203 (268)
T ss_pred             eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh
Confidence            99999999999998776 5999999998765433211    122356788999999988888999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      |..||........    ................+..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       204 g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         204 AKPPWNAEKHSNH----LALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCCCCCCCCcch----HHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999975443221    1222222222233333456889999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-39  Score=263.34  Aligned_cols=218  Identities=31%  Similarity=0.528  Sum_probs=186.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|++++++++||||+++++.+.++...++||||+++++|.+++.+.+.++...+..++.|++.||++||+ .|
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~  121 (290)
T cd05580          43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS-LD  121 (290)
T ss_pred             hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            45677889999999999999999999999999999999999999999999988899999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|.||+++.++.++|+|||++......   .....++..|+|||.+.+...+.++|+||||+++++|++|+.||
T Consensus       122 i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  198 (290)
T cd05580         122 IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF  198 (290)
T ss_pred             EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999998765433   23346788999999998888899999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~~~  240 (262)
                      ...+..       ........+.. . .+..++..+.+++.+||..+|.+|+     ++++++.||||+.......
T Consensus       199 ~~~~~~-------~~~~~~~~~~~-~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  265 (290)
T cd05580         199 FDDNPI-------QIYEKILEGKV-R-FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL  265 (290)
T ss_pred             CCCCHH-------HHHHHHhcCCc-c-CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence            765421       22222222222 1 2245689999999999999999999     9999999999988774433

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-39  Score=263.00  Aligned_cols=227  Identities=43%  Similarity=0.768  Sum_probs=189.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+...+++.+|+++++.++||||+++++.+.+....++|+||+++++|.+++.+.+.++...+..++.+++.+|.|||+.
T Consensus        43 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~  122 (284)
T cd06620          43 KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV  122 (284)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            34567889999999999999999999999999999999999999999999998888899999999999999999999964


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++++|||++......  ......++..|+|||.+.+..++.++|+||+||+++++++|+.
T Consensus       123 ~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~  200 (284)
T cd06620         123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF  200 (284)
T ss_pred             cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCC
Confidence            68999999999999999999999999987654222  1223467889999999988889999999999999999999999


Q ss_pred             CCCCCCcc----CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          168 PYSPPEQQ----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ||......    .......+..........+......++.++.+|+.+||+.||.+|||++++++|+||..-.
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         201 PFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             CCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            99865432    1112233344444444333333344788999999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.6e-39  Score=260.54  Aligned_cols=214  Identities=30%  Similarity=0.544  Sum_probs=177.6

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+.+|+.+++.++||||+++++.+..++..++++||+++++|.+++...+.+++..+..++.|++.|+.|||+ .|+
T Consensus        49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i  127 (267)
T cd06645          49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS-KGK  127 (267)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            3456789999999999999999999999999999999999999999999988899999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      +|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.   ...++.++|+|||||++|+|++|..
T Consensus       128 ~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~  207 (267)
T cd06645         128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP  207 (267)
T ss_pred             ecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999876544333334456888999999874   3457889999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      ||.......      ...........+..  ....++..+.+++.+||..+|++|||+++++.|||
T Consensus       208 p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         208 PMFDLHPMR------ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             Ccccccchh------hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            986543221      11111111111111  11246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.4e-39  Score=259.13  Aligned_cols=215  Identities=28%  Similarity=0.536  Sum_probs=183.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+++.+|++++++++||||+++.+.+...+..++|+||+.+++|.+++....  .++...+..++.|++.|+.+||+
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (256)
T cd08218          40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD  119 (256)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4456789999999999999999999999999999999999999999999997643  57899999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       .|++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+...+.++|+||+|++++++++|.
T Consensus       120 -~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~  198 (256)
T cd08218         120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK  198 (256)
T ss_pred             -CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCC
Confidence             9999999999999999999999999999876544333333345778899999999888899999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      .||...+..       +.......+..+.. ...++.++.+++.+||+.+|.+||+++++++||||
T Consensus       199 ~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         199 HAFEAGNMK-------NLVLKIIRGSYPPV-SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CCccCCCHH-------HHHHHHhcCCCCCC-cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            999764322       23334444443333 35678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.2e-39  Score=257.22  Aligned_cols=216  Identities=33%  Similarity=0.568  Sum_probs=185.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ++...+++.+|++++++++|+||+++++++.+++..+++|||+++++|.+++.+.  ..++...+..++.|++.+|++||
T Consensus        39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  118 (256)
T cd08221          39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH  118 (256)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4566778899999999999999999999999999999999999999999999775  45899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      + .|++|+||+|+||+++.++.++++|||.+..............++..|.|||...+..++.++|+||+|+++++|++|
T Consensus       119 ~-~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g  197 (256)
T cd08221         119 K-AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL  197 (256)
T ss_pred             h-CCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC
Confidence            8 999999999999999999999999999987654443333445678899999999888889999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ..||.....       .+....+..+..... ...++.++.+++.+||..+|.+|||++++++|||+
T Consensus       198 ~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         198 KRTFDATNP-------LNLVVKIVQGNYTPV-VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CCCCCCCCH-------HHHHHHHHcCCCCCC-ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            999976432       233333344443333 35678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.3e-39  Score=259.88  Aligned_cols=216  Identities=33%  Similarity=0.558  Sum_probs=177.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....+.+|+.++++++||||+++++.+.+  +...++++||+++++|.+++.+.+.++......++.|++.||++||+ 
T Consensus        46 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~-  124 (266)
T cd06651          46 KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS-  124 (266)
T ss_pred             HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            445678899999999999999999998876  36789999999999999999888889999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCC---CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++|+|||++.......   .......++..|+|||.+.+..++.++|+||+|++++++++
T Consensus       125 ~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~  204 (266)
T cd06651         125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT  204 (266)
T ss_pred             CCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH
Confidence            999999999999999999999999999886543211   11122457788999999998889999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      |+.||......      ... ............+..+++.+.+++ +||..+|++||+++++++||||+.
T Consensus       205 g~~pf~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~~  266 (266)
T cd06651         205 EKPPWAEYEAM------AAI-FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQL  266 (266)
T ss_pred             CCCCccccchH------HHH-HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccccC
Confidence            99999764321      111 222222222222345778899998 688899999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.5e-40  Score=265.14  Aligned_cols=220  Identities=38%  Similarity=0.685  Sum_probs=185.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|++++++++||||+++++.+..+...++|+||+++++|.+++.. +.++...+..++.|++.|+.|||+ .
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~-~  120 (277)
T cd06642          43 EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS-E  120 (277)
T ss_pred             hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc-C
Confidence            45567899999999999999999999999999999999999999999999865 568999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+..++.++|+||||++++++++|+.|
T Consensus       121 ~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p  200 (277)
T cd06642         121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999987654333233334577889999999988889999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +.......       .......... .......+.++.+++.+||..+|.+|||+.++++||||+.+...
T Consensus       201 ~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06642         201 NSDLHPMR-------VLFLIPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK  262 (277)
T ss_pred             Ccccchhh-------HHhhhhcCCC-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence            87543321       1112222222 22334678899999999999999999999999999999887643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-39  Score=263.78  Aligned_cols=219  Identities=35%  Similarity=0.679  Sum_probs=179.1

Q ss_pred             chhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEE------CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHH
Q 024828            6 NVEESARRQIAQELKINQSS-QCPYVVVCYQSFYS------NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQ   76 (262)
Q Consensus         6 ~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~   76 (262)
                      ........++..|+.+++++ +|+||+++++.+..      +...+++|||+.+++|.+++...  ..+++..+..++.|
T Consensus        50 ~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~q  129 (282)
T cd06636          50 DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE  129 (282)
T ss_pred             ecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHH
Confidence            34455667888999999999 79999999998853      45789999999999999999764  34888889999999


Q ss_pred             HHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc-----CCCCCcchh
Q 024828           77 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSD  151 (262)
Q Consensus        77 l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~D  151 (262)
                      ++.||.|||+ .|++|+|++|+||+++.++.++|+|||++..............++..|+|||.+.     +..++.++|
T Consensus       130 i~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~D  208 (282)
T cd06636         130 ILRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSD  208 (282)
T ss_pred             HHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccc
Confidence            9999999998 9999999999999999999999999999876543333334456788999999875     345788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      +||||+++|+|++|..||.......       ..........+......++.++.++|.+||+.||.+|||+.++++|||
T Consensus       209 vwslG~~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         209 IWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             hhHHHHHHHHHHhCCCCccccCHHh-------hhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            9999999999999999997643221       111222333333344568899999999999999999999999999999


Q ss_pred             c
Q 024828          232 L  232 (262)
Q Consensus       232 ~  232 (262)
                      |
T Consensus       282 ~  282 (282)
T cd06636         282 I  282 (282)
T ss_pred             C
Confidence            7

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=262.00  Aligned_cols=230  Identities=35%  Similarity=0.642  Sum_probs=189.7

Q ss_pred             hHHHHHHHHHHHHHHhcCC---CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ......++.+|+.++++++   |||++++++.+.++...+++|||++|++|.++++. +.++...+..++.|++.||.+|
T Consensus        39 ~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~l  117 (277)
T cd06917          39 PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYI  117 (277)
T ss_pred             CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHH
Confidence            4455677889999999986   99999999999999999999999999999999876 4789999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~  163 (262)
                      |+ .|++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.++ .++.++|+||||+++|+|+
T Consensus       118 h~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll  196 (277)
T cd06917         118 HK-VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA  196 (277)
T ss_pred             Hh-CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence            98 999999999999999999999999999987765444334445678899999988754 4688999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccchh
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  243 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~  243 (262)
                      +|..||......       ...........+......++.++.+++.+||+.||.+||++.+++.||||+.......+..
T Consensus       197 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~~~~~  269 (277)
T cd06917         197 TGNPPYSDVDAF-------RAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSIL  269 (277)
T ss_pred             hCCCCCCCCChh-------hhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccCchhhH
Confidence            999999764332       1112222222333333347899999999999999999999999999999988776655544


Q ss_pred             hHh
Q 024828          244 EYF  246 (262)
Q Consensus       244 ~~~  246 (262)
                      ...
T Consensus       270 ~~~  272 (277)
T cd06917         270 KEL  272 (277)
T ss_pred             HHH
Confidence            433

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-40  Score=276.44  Aligned_cols=223  Identities=31%  Similarity=0.594  Sum_probs=198.5

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCe--EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA--ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      +..++...+++..|+.+|+.|+||||++++++|.+..+  ..+|+|.+.+|+|..|+++.+..+...++.|+.||++||.
T Consensus        78 ~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~  157 (632)
T KOG0584|consen   78 VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLV  157 (632)
T ss_pred             hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhh
Confidence            34567777999999999999999999999999988554  8899999999999999999999999999999999999999


Q ss_pred             HHhh-cCCeeeCCCCCCCEEEccC-CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           83 YLHH-EKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        83 ~lh~-~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |||+ +--|+|||||.+||+++.+ |.|||+|+|+|......  .....+||+.|||||.+- ..|+...||||||++++
T Consensus       158 yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmL  234 (632)
T KOG0584|consen  158 YLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCML  234 (632)
T ss_pred             hhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHH
Confidence            9998 2339999999999999754 89999999999875433  233368999999999998 78999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ||.|+..||..+...      ..+.+++..+..|.....--.+++++||.+||.. ...|||+.|+|.||||..-+.
T Consensus       235 EMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  235 EMVTSEYPYSECTNP------AQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             HHHhccCChhhhCCH------HHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence            999999999887654      3667888889988888877889999999999999 999999999999999988654

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=259.82  Aligned_cols=214  Identities=35%  Similarity=0.627  Sum_probs=179.5

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|++++++++||||+++++.+.++...+++|||+.+++|.+++... ..+++..+..++.|++.||++||+ .
T Consensus        42 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~  120 (262)
T cd06613          42 DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE-T  120 (262)
T ss_pred             hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            35678999999999999999999999999999999999999999999999876 789999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC---CCCcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+.   .++.++|+||+|+++++|++|
T Consensus       121 ~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg  200 (262)
T cd06613         121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL  200 (262)
T ss_pred             CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhC
Confidence            99999999999999999999999999987655433333345678889999998776   788999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcC-CCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQ-PPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      ..||.......       ........ ..+  ......++.++.+++.+||..+|.+|||+++++.|+|
T Consensus       201 ~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         201 QPPMFDLHPMR-------ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             CCCCCCCCHHH-------HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99997644321       11111111 111  1112345788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.8e-39  Score=261.02  Aligned_cols=221  Identities=37%  Similarity=0.636  Sum_probs=186.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+.++++++||||+++++.+.++...++||||++|++|.+++.. ++++...+..++.|++.||+++|+ .
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~-~  120 (277)
T cd06640          43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS-E  120 (277)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            45567889999999999999999999999999999999999999999999875 578999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       121 ~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p  200 (277)
T cd06640         121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999999999999999999987654433333334577889999999888889999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      |.......       ........ .++.....++.++.+++.+||+.+|.+||++++++.||||...+...
T Consensus       201 ~~~~~~~~-------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06640         201 NSDMHPMR-------VLFLIPKN-NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKT  263 (277)
T ss_pred             CCCcChHh-------HhhhhhcC-CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhh
Confidence            97644321       11112222 22233346788999999999999999999999999999998777653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-39  Score=262.80  Aligned_cols=219  Identities=37%  Similarity=0.694  Sum_probs=184.7

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|+++++.++|+|++++++.+..+...++++||++|++|.+++...+ .++...+..++.|++.||++||+ .|
T Consensus        58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~g  136 (286)
T cd06614          58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QN  136 (286)
T ss_pred             hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            56788899999999999999999999999999999999999999999999876 89999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       137 i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~  216 (286)
T cd06614         137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY  216 (286)
T ss_pred             eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998765543333333445678899999998888899999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ......       ...........+. .....++.++.+++.+||+.+|.+|||+.+++.|+||+....
T Consensus       217 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         217 LREPPL-------RALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             CCCCHH-------HHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            754332       1111222222222 222347899999999999999999999999999999998443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-39  Score=268.01  Aligned_cols=212  Identities=28%  Similarity=0.463  Sum_probs=172.0

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhc------------------------
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKV------------------------   62 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~------------------------   62 (262)
                      ....+.+.+|++++.++ +||||+++++.+.. +...+++|||+++++|.+++...                        
T Consensus        51 ~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (338)
T cd05102          51 ASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ  130 (338)
T ss_pred             hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhh
Confidence            44567899999999999 89999999998875 44689999999999999999753                        


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEcc
Q 024828           63 --------------------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  104 (262)
Q Consensus        63 --------------------------------------~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~  104 (262)
                                                            .+++...+..++.|++.||+|||+ .|++|+||||+||+++.
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~  209 (338)
T cd05102         131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE  209 (338)
T ss_pred             hccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC
Confidence                                                  236778889999999999999998 99999999999999999


Q ss_pred             CCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhH
Q 024828          105 RGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF  181 (262)
Q Consensus       105 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~  181 (262)
                      ++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+     
T Consensus       210 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----  284 (338)
T cd05102         210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----  284 (338)
T ss_pred             CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----
Confidence            99999999999875432211  1112334578999999998889999999999999999997 999998754321     


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       .....+..+.... .+...++++.+++.+||+.||.+|||+.++++
T Consensus       285 -~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         285 -EFCQRLKDGTRMR-APENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -HHHHHHhcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             1223333333322 33567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-39  Score=272.17  Aligned_cols=218  Identities=28%  Similarity=0.479  Sum_probs=178.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.+++.++||||+++++.+.++...++||||++|++|.+++.. ..+++..+..++.|++.||+|||+ .|
T Consensus        85 ~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~-~~  162 (371)
T cd05622          85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MG  162 (371)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            4455678999999999999999999999999999999999999999999876 458999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCC----CCcchhHHHHHHHHHHHHh
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~----~~~~~Di~slG~~l~~l~~  164 (262)
                      ++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+..    ++.++|+|||||++|+|++
T Consensus       163 ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~  242 (371)
T cd05622         163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (371)
T ss_pred             EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence            99999999999999999999999999876543221 223457899999999987532    7889999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcCC--CCCHHHHhcCccccccC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  236 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~h~~~~~~~  236 (262)
                      |+.||...+..       .....+....  ........+++++.+++.+||..++.+  |++++++++||||+...
T Consensus       243 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         243 GDTPFYADSLV-------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             CCCCCCCCCHH-------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            99999875432       2223333222  111222468999999999999844433  78999999999997743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.7e-39  Score=259.72  Aligned_cols=218  Identities=34%  Similarity=0.570  Sum_probs=184.8

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|++++++++||||+++++.+..+...|+++||+.+++|.+++.+.+.++...+..++.|++.||++||+ .|
T Consensus        35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~  113 (265)
T cd05579          35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS-NG  113 (265)
T ss_pred             hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cC
Confidence            56678899999999999999999999999999999999999999999999988889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCC--------CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      ++|+||+|+||+++.++.++++|||++........        ......++..|++||...+...+.++|+||||+++++
T Consensus       114 i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~  193 (265)
T cd05579         114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYE  193 (265)
T ss_pred             eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHH
Confidence            99999999999999999999999998875433211        2223456788999999988888999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH---HHHhcCcccccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA---QELMTHPFLKMY  235 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~---~~~l~h~~~~~~  235 (262)
                      +++|..||......       .....+..+..........+..+.+++.+||+.+|.+|||+   .++++||||+..
T Consensus       194 l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         194 FLVGIPPFHGETPE-------EIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHhCCCCCCCCCHH-------HHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            99999999765432       22333333333222222358999999999999999999999   999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-39  Score=265.11  Aligned_cols=221  Identities=28%  Similarity=0.532  Sum_probs=177.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|++++++++|||++++++.+..+...++||||+++++|..++.....+++..+..++.|++.||++||+ .|+
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i  121 (286)
T cd07847          43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNC  121 (286)
T ss_pred             ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            4456789999999999999999999999999999999999998888887777789999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      +|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+. .++.++|+||+|+++++|++|..||
T Consensus       122 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~  201 (286)
T cd07847         122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW  201 (286)
T ss_pred             eecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987765443333344577889999998763 4788999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHH-------HHh------cCC-CCCC--------CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          170 SPPEQQDGWTSFYELME-------AIV------DQP-PPSA--------PSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~-------~~~------~~~-~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      .+....+..........       ...      ... .+..        ....++..+.+|+.+||+.+|++|||+.+++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil  281 (286)
T cd07847         202 PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL  281 (286)
T ss_pred             CCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence            86554321111110000       000      000 0000        0124678899999999999999999999999


Q ss_pred             cCccc
Q 024828          228 THPFL  232 (262)
Q Consensus       228 ~h~~~  232 (262)
                      .||||
T Consensus       282 ~~~~f  286 (286)
T cd07847         282 EHPYF  286 (286)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-40  Score=248.11  Aligned_cols=217  Identities=32%  Similarity=0.527  Sum_probs=189.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~--~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .....+++.+|++|-+.++||||++++++|-|....|+++||..+|+|...++  ..+.+++.....++.|++.|+.|+|
T Consensus        62 ~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h  141 (281)
T KOG0580|consen   62 KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH  141 (281)
T ss_pred             HhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc
Confidence            34556788899999999999999999999999999999999999999999999  5567999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      . ++++||||+|+|+|++..|.++++|||-+....  .....+.+||.-|.|||...+...+...|+|++|++.||++.|
T Consensus       142 ~-k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg  218 (281)
T KOG0580|consen  142 L-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVG  218 (281)
T ss_pred             c-CCcccCCCCHHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhc
Confidence            8 999999999999999999999999999887654  3344567899999999999999999999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .+||+.....+       ..+.+.......  +..++.+..++|.+|+..+|.+|.+..|++.|||..+..
T Consensus       219 ~ppFes~~~~e-------tYkrI~k~~~~~--p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~  280 (281)
T KOG0580|consen  219 LPPFESQSHSE-------TYKRIRKVDLKF--PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVANG  280 (281)
T ss_pred             CCchhhhhhHH-------HHHHHHHccccC--CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence            99999866433       223332222222  257899999999999999999999999999999998754

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-39  Score=281.92  Aligned_cols=235  Identities=21%  Similarity=0.274  Sum_probs=178.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~l~~~l   81 (262)
                      .......++.+|++++++++||||+++++++.+.+..|++++++.+ +|.+++...     .......+..++.|++.||
T Consensus       202 ~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL  280 (501)
T PHA03210        202 AGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAV  280 (501)
T ss_pred             cchHHHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHH
Confidence            3445667789999999999999999999999999999999999955 888877543     2234567788999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      .|||+ .|++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|
T Consensus       281 ~yLH~-~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  359 (501)
T PHA03210        281 EYIHD-KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL  359 (501)
T ss_pred             HHHHh-CCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHH
Confidence            99998 9999999999999999999999999999976543322 222356899999999999888999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHh------------------cCCCC--------CCCCCCCCHHHHHHHHHhhc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIV------------------DQPPP--------SAPSDQFSPEFCSFISACVQ  214 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~~~--------~~~~~~~~~~l~~li~~~l~  214 (262)
                      +|++|..++.............+.+..+.                  .....        ......++.++.+++.+||+
T Consensus       360 ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~  439 (501)
T PHA03210        360 DMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLT  439 (501)
T ss_pred             HHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhc
Confidence            99998754332221111111111111110                  00000        00012356778889999999


Q ss_pred             CCcCCCCCHHHHhcCccccccCCcccchh
Q 024828          215 KEPQQRLSAQELMTHPFLKMYGDLNVDLS  243 (262)
Q Consensus       215 ~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~  243 (262)
                      .||++|||+.|+|.||||+........+.
T Consensus       440 ~DP~~Rpsa~elL~hp~f~~~~~~~~~~~  468 (501)
T PHA03210        440 FDWHLRPGAAELLALPLFSAEEEEEILFI  468 (501)
T ss_pred             cCcccCcCHHHHhhChhhhcCCchHHHHH
Confidence            99999999999999999988765555433

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.6e-39  Score=273.05  Aligned_cols=226  Identities=25%  Similarity=0.451  Sum_probs=177.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +......+.+|+.+++.++||||+++++++...      ...|+||||+.+ +|.+++..  .++...+..++.|++.||
T Consensus        63 ~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL  139 (364)
T cd07875          63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGI  139 (364)
T ss_pred             CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHH
Confidence            345567788999999999999999999987543      357999999966 88888764  578899999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      +|||+ .|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|+|||||++|+
T Consensus       140 ~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e  217 (364)
T cd07875         140 KHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  217 (364)
T ss_pred             HHHhh-CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHH
Confidence            99998 999999999999999999999999999987654322 2234568899999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHH---------------HHHHhcCCCC------------------CCCCCCCCHHHHHH
Q 024828          162 CATGQFPYSPPEQQDGWTSFYEL---------------MEAIVDQPPP------------------SAPSDQFSPEFCSF  208 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~---------------~~~~~~~~~~------------------~~~~~~~~~~l~~l  208 (262)
                      |++|+.||...+..+.+......               ..........                  .......+.++++|
T Consensus       218 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  297 (364)
T cd07875         218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL  297 (364)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHH
Confidence            99999999876543322222110               0000000000                  00011235678999


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +.+||+.||.+|||++++|+||||+.+.+.
T Consensus       298 l~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  327 (364)
T cd07875         298 LSKMLVIDASKRISVDEALQHPYINVWYDP  327 (364)
T ss_pred             HHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence            999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=255.39  Aligned_cols=219  Identities=26%  Similarity=0.418  Sum_probs=182.3

Q ss_pred             HHHHHHHHHHhcC-CCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHh
Q 024828           13 RQIAQELKINQSS-QCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        13 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .++.+|+++--.. .|||||.++++|+.    ...+.+|||+++||.|.+.++.++.  +++.++-.|+.||..|+.|||
T Consensus        99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH  178 (400)
T KOG0604|consen   99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH  178 (400)
T ss_pred             HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH
Confidence            4556888876666 69999999998864    3457899999999999999998865  999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccC---CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .+|.||||||+|+|...+   ..+||+|||++..... .....+...|+.|.|||++-...|+..+|+||+|+++|-|
T Consensus       179 ~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIl  256 (400)
T KOG0604|consen  179 S-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL  256 (400)
T ss_pred             h-cchhhccCChhheeeecCCCCcceEecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHh
Confidence            9 999999999999999754   4699999999987554 3345566789999999999988999999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ++|.+||...........+..   .+..+.  .|.....+.|++.+++|+.+|..+|.+|.|+.+++.|||+....
T Consensus       257 LCGyPPFYS~hg~aispgMk~---rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  257 LCGYPPFYSNHGLAISPGMKR---RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             hcCCCcccccCCccCChhHHh---HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            999999998776443333322   222222  23333357889999999999999999999999999999997655

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.4e-39  Score=257.76  Aligned_cols=217  Identities=34%  Similarity=0.586  Sum_probs=177.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTI--PEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~--~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ....+.+.+|+.++++++|+||+++++.+..++..++++||+++++|.+++... ..+  +...+..++.|++.||+|||
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH  125 (268)
T cd06624          46 SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH  125 (268)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH
Confidence            445668899999999999999999999999999999999999999999999764 455  88889999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCCcccccccccccCcccccCCC--CCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l  162 (262)
                      + .|++|+||+|+||+++. ++.++|+|||.+..............++..|+|||.+.+..  ++.++|+||+|++++++
T Consensus       126 ~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l  204 (268)
T cd06624         126 D-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM  204 (268)
T ss_pred             H-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHH
Confidence            8 99999999999999976 67899999998876543333333345788999999986543  78899999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ++|..||........     ...........+ ..+..+++++.+++.+||+.+|.+|||+++++.||||
T Consensus       205 ~~g~~p~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         205 ATGKPPFIELGEPQA-----AMFKVGMFKIHP-EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HhCCCCCccccChhh-----hHhhhhhhccCC-CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999975432210     111111111122 2234678899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-40  Score=254.94  Aligned_cols=232  Identities=25%  Similarity=0.407  Sum_probs=191.1

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .-..+.++.+|++++.++ .|+||+.++++|+++..+|+|||.+.||+|...+++++-+++.++..+.++|+.||.+||.
T Consensus       115 ~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~  194 (463)
T KOG0607|consen  115 PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT  194 (463)
T ss_pred             CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh
Confidence            456788999999999999 5999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCC---cEEEEecccccccccCC-------CCcccccccccccCccccc---CC--CCCcchh
Q 024828           87 EKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTS-------GQANTFVGTYNYMSPERIS---GG--KYGYKSD  151 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~---~~--~~~~~~D  151 (262)
                       +||.|+|+||+|||..+.+   .+|||||++..-+....       ....+++|+..|||||+..   +.  -|+.++|
T Consensus       195 -kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCD  273 (463)
T KOG0607|consen  195 -KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCD  273 (463)
T ss_pred             -cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccccccccccc
Confidence             9999999999999997655   48999999876543221       1223467888999999752   22  3789999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcc-------CchhhHH-HHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcCCCC
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQ-------DGWTSFY-ELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRL  221 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  221 (262)
                      .||||+++|-|++|.+||-+....       +....-+ .+.+.+..+.  .|+.....++.+.++++..+|..||.+|.
T Consensus       274 lwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rl  353 (463)
T KOG0607|consen  274 LWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL  353 (463)
T ss_pred             HHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh
Confidence            999999999999999999764332       2222222 2334444443  23333357899999999999999999999


Q ss_pred             CHHHHhcCccccccCCccc
Q 024828          222 SAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       222 t~~~~l~h~~~~~~~~~~~  240 (262)
                      ++.+++.|||++.+...+.
T Consensus       354 sa~~vlnhPw~~~~~~eka  372 (463)
T KOG0607|consen  354 SAAQVLNHPWVQRCAPEKA  372 (463)
T ss_pred             hhhhccCCccccccchhcc
Confidence            9999999999999986643

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=261.30  Aligned_cols=217  Identities=37%  Similarity=0.676  Sum_probs=176.4

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQ   76 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~   76 (262)
                      .....+++.+|+.+++++ +|+||+++++.+.+..      ..++||||+++++|.+++...    ..++...+..++.|
T Consensus        42 ~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~q  121 (275)
T cd06608          42 IEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE  121 (275)
T ss_pred             CchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHH
Confidence            344567899999999999 7999999999997643      489999999999999998653    47899999999999


Q ss_pred             HHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-----CCCCcchh
Q 024828           77 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-----GKYGYKSD  151 (262)
Q Consensus        77 l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~D  151 (262)
                      ++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+..     ..++.++|
T Consensus       122 l~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D  200 (275)
T cd06608         122 TLRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSD  200 (275)
T ss_pred             HHHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCcccccc
Confidence            9999999998 99999999999999999999999999988765443333344567889999998754     23678899


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC-CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCc
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHP  230 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~  230 (262)
                      +||||++++++++|..||......       .....+.....+... ...++.++.+++.+||..||++|||++++++||
T Consensus       201 v~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~  273 (275)
T cd06608         201 VWSLGITAIELADGKPPLCDMHPM-------RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP  273 (275)
T ss_pred             HHHhHHHHHHHHhCCCCccccchH-------HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence            999999999999999999754322       111222222222222 234778999999999999999999999999999


Q ss_pred             cc
Q 024828          231 FL  232 (262)
Q Consensus       231 ~~  232 (262)
                      |+
T Consensus       274 ~~  275 (275)
T cd06608         274 FI  275 (275)
T ss_pred             CC
Confidence            96

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-39  Score=263.95  Aligned_cols=220  Identities=27%  Similarity=0.471  Sum_probs=173.2

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|+.++++++||||+++++++.+....++++||+.+ +|.+++.+ .+.+++..+..++.|++.||.|||+ .|
T Consensus        42 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~  119 (284)
T cd07839          42 VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-HN  119 (284)
T ss_pred             CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            345678899999999999999999999999999999999975 88888765 4679999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||||+++++|++|..|
T Consensus       120 i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p  199 (284)
T cd07839         120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  199 (284)
T ss_pred             EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999999876544333333446678999999987654 68999999999999999999888


Q ss_pred             CCCCCccC-chhhHHHH-----------HHHHhcCC-CC--------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          169 YSPPEQQD-GWTSFYEL-----------MEAIVDQP-PP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       169 ~~~~~~~~-~~~~~~~~-----------~~~~~~~~-~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      +....... ........           ........ .+        ......+++++.+++.+||+.||.+|||+++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il  279 (284)
T cd07839         200 LFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL  279 (284)
T ss_pred             CcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence            64433211 11100000           00000000 00        001124678899999999999999999999999


Q ss_pred             cCccc
Q 024828          228 THPFL  232 (262)
Q Consensus       228 ~h~~~  232 (262)
                      .||||
T Consensus       280 ~h~~f  284 (284)
T cd07839         280 QHPYF  284 (284)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.6e-39  Score=256.33  Aligned_cols=215  Identities=37%  Similarity=0.594  Sum_probs=182.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .+..+.+.+|+.+++.++|+||+++++.+.++...++++||+++++|.+++.+.+.++...+..++.|++.|+++||+ .
T Consensus        43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~  121 (258)
T cd06632          43 QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD-R  121 (258)
T ss_pred             hHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            345678999999999999999999999999999999999999999999999988889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.... ++.++|+||+|++++++++|+.
T Consensus       122 ~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~  200 (258)
T cd06632         122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP  200 (258)
T ss_pred             CcccCCCCHHHEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999887654332 223446788899999987766 8999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ||......       ...............+..+++++.+++.+||+.+|.+|||+++++.|||+
T Consensus       201 pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         201 PWSQLEGV-------AAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             CcccCcHH-------HHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            99765421       11122222122223335678999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.9e-39  Score=279.36  Aligned_cols=222  Identities=29%  Similarity=0.461  Sum_probs=185.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC--------eEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--------AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICE   75 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~   75 (262)
                      ++.....+.+|+.++..++|++++++.+.+....        ..++||||+++++|.+++...    ..+++..+..++.
T Consensus        71 ~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~  150 (496)
T PTZ00283         71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI  150 (496)
T ss_pred             CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHH
Confidence            4566778899999999999999999988775422        378999999999999998653    4689999999999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC--CCCcccccccccccCcccccCCCCCcchhHH
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISGGKYGYKSDIW  153 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~  153 (262)
                      |++.||.|||+ .|++|+||||+||+++.++.++|+|||++......  ........|++.|+|||.+.+..++.++|||
T Consensus       151 qll~aL~~lH~-~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVw  229 (496)
T PTZ00283        151 QVLLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMF  229 (496)
T ss_pred             HHHHHHHHHHh-CCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHH
Confidence            99999999998 99999999999999999999999999998754322  1223345689999999999988899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          154 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       154 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      |||+++|+|++|+.||.....       .+.......+.... .+..+++++.+++.+||+.+|.+||++.+++.|||++
T Consensus       230 SlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~  301 (496)
T PTZ00283        230 SLGVLLYELLTLKRPFDGENM-------EEVMHKTLAGRYDP-LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK  301 (496)
T ss_pred             HHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHH
Confidence            999999999999999976432       23344444443333 2356889999999999999999999999999999998


Q ss_pred             ccCCc
Q 024828          234 MYGDL  238 (262)
Q Consensus       234 ~~~~~  238 (262)
                      .....
T Consensus       302 ~~~~~  306 (496)
T PTZ00283        302 LFISG  306 (496)
T ss_pred             Hhhhh
Confidence            76543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-39  Score=272.23  Aligned_cols=225  Identities=25%  Similarity=0.455  Sum_probs=176.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +.....++.+|+.+++.++||||+++++++...      ...|+||||+++ +|.+.+..  .++...+..++.|++.||
T Consensus        56 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL  132 (355)
T cd07874          56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGI  132 (355)
T ss_pred             ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHH
Confidence            445567888999999999999999999988643      357999999976 78777754  588899999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      .|||+ .|++|+||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+|||||++|+
T Consensus       133 ~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e  210 (355)
T cd07874         133 KHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  210 (355)
T ss_pred             HHHHh-CCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHH
Confidence            99998 999999999999999999999999999987654322 2234568899999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHH---------------HHHHhcCCCC------------------CCCCCCCCHHHHHH
Q 024828          162 CATGQFPYSPPEQQDGWTSFYEL---------------MEAIVDQPPP------------------SAPSDQFSPEFCSF  208 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~---------------~~~~~~~~~~------------------~~~~~~~~~~l~~l  208 (262)
                      |++|+.||.+.+..+.+......               ..........                  .......+.++.+|
T Consensus       211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  290 (355)
T cd07874         211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL  290 (355)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHH
Confidence            99999999875533222211110               0111000000                  00112245678999


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +.+||..||.+|||++|+++||||+.+.+
T Consensus       291 i~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         291 LSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             HHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence            99999999999999999999999986643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-39  Score=266.50  Aligned_cols=219  Identities=23%  Similarity=0.445  Sum_probs=177.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|..++..++|++|+++++.+.+++..|+||||+.|++|.+++.+ ...+++..+..++.|++.||+|||+ .
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~  121 (331)
T cd05597          43 AETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ-L  121 (331)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            3455688999999999999999999999999999999999999999999976 4579999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccC-----CCCCcchhHHHHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l  162 (262)
                      |++|+||+|+||+++.++.++|+|||++........ ......|++.|+|||++.+     ..++.++|+||+||++|+|
T Consensus       122 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el  201 (331)
T cd05597         122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM  201 (331)
T ss_pred             CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence            999999999999999999999999999865543222 2223468999999999863     3468899999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCC---CCCCCCCCCCHHHHHHHHHhhcCCcCC--CCCHHHHhcCccccccC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  236 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~h~~~~~~~  236 (262)
                      ++|+.||......+       ....+....   ........++.++++++++||..++++  |+++++++.||||....
T Consensus       202 ~~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         202 LYGETPFYAESLVE-------TYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             hhCCCCCCCCCHHH-------HHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            99999997644321       222222211   111222357899999999999764444  78999999999998764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.7e-39  Score=261.13  Aligned_cols=223  Identities=29%  Similarity=0.478  Sum_probs=183.8

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....+.+|++++++++||||+++++.+...+..|+||||+++++|.+++.+.+  .+++..+..++.|++.||.+||+ 
T Consensus        35 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-  113 (277)
T cd05577          35 KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-  113 (277)
T ss_pred             hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            345566789999999999999999999999999999999999999999997765  69999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+|+++++|++|+.
T Consensus       114 ~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~  192 (277)
T cd05577         114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS  192 (277)
T ss_pred             CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCC
Confidence            9999999999999999999999999998865433 222223456778999999988888999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCcc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~~  239 (262)
                      ||..........   ...... ... ....+..+++.+.++|.+||+.+|.+||     ++.+++.||||+......
T Consensus       193 p~~~~~~~~~~~---~~~~~~-~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         193 PFRQRKEKVEKE---ELKRRT-LEM-AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             CCCCCcccccHH---HHHhcc-ccc-cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence            997755422211   111111 111 2222346789999999999999999999     899999999998766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.9e-39  Score=267.31  Aligned_cols=230  Identities=28%  Similarity=0.462  Sum_probs=183.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +....+.+.+|++++++++|+||+++++.+.++...+++|||+++++|.+++.+.  ..+++..+..++.|++.||+|||
T Consensus        39 ~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH  118 (314)
T cd08216          39 SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH  118 (314)
T ss_pred             chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4566778999999999999999999999999999999999999999999999864  45899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-------CcccccccccccCcccccCC--CCCcchhHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGG--KYGYKSDIWSLG  156 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG  156 (262)
                      + .|++|+||+|+||+++.++.++++||+.+........       ......++..|+|||.+.+.  .++.++|+||+|
T Consensus       119 ~-~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G  197 (314)
T cd08216         119 S-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG  197 (314)
T ss_pred             H-CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHH
Confidence            8 9999999999999999999999999998765432211       11223466789999998763  478899999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCC-------------------------------CCCCCCCCCCHHH
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-------------------------------PPSAPSDQFSPEF  205 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l  205 (262)
                      +++++|++|..||........      ..+......                               ........++.++
T Consensus       198 ~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (314)
T cd08216         198 ITACELANGHVPFKDMPATQM------LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHF  271 (314)
T ss_pred             HHHHHHHhCCCCCCCCCHHHH------HHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHH
Confidence            999999999999986543211      111110000                               0000111234678


Q ss_pred             HHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccchhh
Q 024828          206 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  244 (262)
Q Consensus       206 ~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~  244 (262)
                      .+|+.+||+.||.+|||++++++||||+.+.+...+..+
T Consensus       272 ~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~~~~  310 (314)
T cd08216         272 HQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLD  310 (314)
T ss_pred             HHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchhHHH
Confidence            899999999999999999999999999988866665443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.8e-39  Score=260.96  Aligned_cols=216  Identities=37%  Similarity=0.595  Sum_probs=174.9

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLK   79 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~   79 (262)
                      .....+.+|+.+++++ +|||++++++++...     +..++|+||+++++|.++++.    ...+++..+..++.|++.
T Consensus        60 ~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~  139 (291)
T cd06639          60 DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL  139 (291)
T ss_pred             cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHH
Confidence            3456778899999999 899999999998653     468999999999999998863    356899999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-----CCCcchhHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-----KYGYKSDIWS  154 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~Di~s  154 (262)
                      ||++||+ .|++|+||+|+||+++.++.++++|||.+..............++..|+|||.+...     .++.++|+||
T Consensus       140 al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s  218 (291)
T cd06639         140 GLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS  218 (291)
T ss_pred             HHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHH
Confidence            9999998 999999999999999999999999999987654433333345678889999987543     2578999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      +|+++|+|++|+.||.......       ....+.....+ .......+.++.+++.+||+.+|++||++.+++.||||+
T Consensus       219 lGvi~~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         219 LGITAIELGDGDPPLFDMHPVK-------TLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHHHhhCCCCCCCCcHHH-------HHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            9999999999999997654321       11122222221 112335678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.6e-39  Score=259.09  Aligned_cols=213  Identities=31%  Similarity=0.556  Sum_probs=176.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+.+|+.++++++||||+++++.+..+...++||||+++++|.+++...++++...+..++.|++.||.|||+ .|+
T Consensus        49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i  127 (267)
T cd06646          49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS-KGK  127 (267)
T ss_pred             hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            4456889999999999999999999999999999999999999999999888889999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      +|+|++|+||+++.++.++++|||++..............++..|+|||.+.   ...++.++|+||+|+++++|++|..
T Consensus       128 ~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~  207 (267)
T cd06646         128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP  207 (267)
T ss_pred             cccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999876643333333456788999999874   3347789999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcC-CCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQ-PPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      ||......+.       ...+... ..+.  .....++.++.+++++||+.+|++|||++++++|+|
T Consensus       208 p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         208 PMFDLHPMRA-------LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             Cccccchhhh-------heeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9865432210       0011111 1111  112356889999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-39  Score=264.71  Aligned_cols=216  Identities=25%  Similarity=0.451  Sum_probs=168.1

Q ss_pred             HHHHHHHHHhcC---CCCeeEeeceEEEE-----CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Q 024828           14 QIAQELKINQSS---QCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus        14 ~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~   83 (262)
                      .+.+|+.+++.+   +||||+++++++.+     ....++++|++.+ +|.+++.+..  .++...+..++.|++.||.|
T Consensus        45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  123 (288)
T cd07863          45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF  123 (288)
T ss_pred             HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence            455666666555   79999999998864     3458999999976 9999987643  48999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+||++|+|+
T Consensus       124 lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~  201 (288)
T cd07863         124 LHA-NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF  201 (288)
T ss_pred             HHh-CCeecCCCCHHHEEECCCCCEEECccCccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHH
Confidence            998 999999999999999999999999999987654222 223346788999999998888999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHH-----HHh------cCCCC-------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHH
Q 024828          164 TGQFPYSPPEQQDGWTSFYELME-----AIV------DQPPP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQE  225 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~-----~~~------~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  225 (262)
                      +|++||......+..........     .+.      .....       ......++.++.+++.+||+.||++|||+++
T Consensus       202 ~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~  281 (288)
T cd07863         202 RRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR  281 (288)
T ss_pred             hCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence            99999976544322222111110     000      00000       0011246788999999999999999999999


Q ss_pred             HhcCccc
Q 024828          226 LMTHPFL  232 (262)
Q Consensus       226 ~l~h~~~  232 (262)
                      ++.||||
T Consensus       282 ~l~hp~f  288 (288)
T cd07863         282 ALQHPFF  288 (288)
T ss_pred             HhcCCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-38  Score=256.23  Aligned_cols=216  Identities=33%  Similarity=0.586  Sum_probs=183.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l   81 (262)
                      .+...+++.+|+++++.++||||+++++.+..  +...++++||+++++|.+++...    .++++..+..++.|++.||
T Consensus        39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l  118 (265)
T cd08217          39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL  118 (265)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence            45667789999999999999999999997754  45689999999999999999763    5789999999999999999


Q ss_pred             HHHh-----hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHH
Q 024828           82 LYLH-----HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG  156 (262)
Q Consensus        82 ~~lh-----~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG  156 (262)
                      ++||     + .+++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+..++.++|+||||
T Consensus       119 ~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG  197 (265)
T cd08217         119 YECHNRSDPG-NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLG  197 (265)
T ss_pred             HHHhcCcccc-CcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHH
Confidence            9999     7 899999999999999999999999999988765444323445678899999999988889999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      +++++|++|+.||...+.       ......+..+..+. .+..++.++.+++.+||+.+|.+|||++++++|||+
T Consensus       198 ~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         198 CLIYELCALSPPFTARNQ-------LQLASKIKEGKFRR-IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHCCCcccCcCH-------HHHHHHHhcCCCCC-CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999987542       12333444443333 335788999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.7e-39  Score=257.25  Aligned_cols=214  Identities=38%  Similarity=0.673  Sum_probs=179.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ..+.+.+|+++++.++|+||+++++.+..+...++++|++++++|.+++.+.   ..+++..+..++.|++.||++||+ 
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-  120 (267)
T cd06610          42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-  120 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            6678999999999999999999999999999999999999999999999764   358999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC----cccccccccccCcccccCC-CCCcchhHHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l  162 (262)
                      .|++|+||+|+||++++++.++|+|||++.........    .....++..|++||.+... .++.++|+||||+++++|
T Consensus       121 ~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l  200 (267)
T cd06610         121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL  200 (267)
T ss_pred             CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHH
Confidence            99999999999999999999999999988765443322    1334578889999998876 688999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC----CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP----SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ++|+.||.......       ..........+...    ...+++++.+++.+||..||.+|||++++++||||
T Consensus       201 ~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         201 ATGAAPYSKYPPMK-------VLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HhCCCCccccChhh-------hHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999997654322       11111122111111    13578899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.2e-39  Score=266.29  Aligned_cols=219  Identities=21%  Similarity=0.431  Sum_probs=166.2

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV---------KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~l~~~   80 (262)
                      ...+.+|++++++++||||+++++++..  +...++++||+.+ +|.+++...         ..+++..+..++.|++.|
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07867          42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence            3467899999999999999999998854  5678999999965 888887532         247889999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEE----ccCCcEEEEecccccccccCCC---CcccccccccccCcccccCC-CCCcchhH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDI  152 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~Di  152 (262)
                      |.|||+ .|++|+||||+||++    +.++.++|+|||++........   ......++..|+|||.+.+. .++.++|+
T Consensus       121 L~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  199 (317)
T cd07867         121 IHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI  199 (317)
T ss_pred             HHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHH
Confidence            999998 999999999999999    4567899999999876543321   22334678899999998764 47899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCccCch------hhHHHHHH------------------------HHhcCCC--------C
Q 024828          153 WSLGLVLLECATGQFPYSPPEQQDGW------TSFYELME------------------------AIVDQPP--------P  194 (262)
Q Consensus       153 ~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~~------------------------~~~~~~~--------~  194 (262)
                      ||+||++|+|++|++||.........      ........                        .......        .
T Consensus       200 wSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (317)
T cd07867         200 WAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYM  279 (317)
T ss_pred             HhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhh
Confidence            99999999999999999754432100      00000000                        0000000        0


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          195 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       195 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      .......+..+.+|+.+||+.||.+|||++|+++||||
T Consensus       280 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         280 EKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00111235668899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-39  Score=275.80  Aligned_cols=221  Identities=21%  Similarity=0.334  Sum_probs=172.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ...+.+|++++++++|+||+++++++..++..++|+|++. ++|.+++... +.++...+..++.|++.||.|||+ .|+
T Consensus       204 ~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gI  281 (461)
T PHA03211        204 YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG-EGI  281 (461)
T ss_pred             ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCE
Confidence            3456789999999999999999999999999999999995 5999888764 469999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      +|+||||+||+++.++.++|+|||++........  ......|+..|+|||++.+..++.++|||||||++|+|++|..+
T Consensus       282 vHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~  361 (461)
T PHA03211        282 IHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS  361 (461)
T ss_pred             EECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999875432211  11234689999999999988899999999999999999987755


Q ss_pred             CCCCCcc-C---chhhHHHHHHHHhc-----------------------CCCCCCC------CCCCCHHHHHHHHHhhcC
Q 024828          169 YSPPEQQ-D---GWTSFYELMEAIVD-----------------------QPPPSAP------SDQFSPEFCSFISACVQK  215 (262)
Q Consensus       169 ~~~~~~~-~---~~~~~~~~~~~~~~-----------------------~~~~~~~------~~~~~~~l~~li~~~l~~  215 (262)
                      +...... .   ........+.....                       ...+...      ...++.++.+||.+||+.
T Consensus       362 lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  441 (461)
T PHA03211        362 LFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF  441 (461)
T ss_pred             cccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHccc
Confidence            4332211 1   00111111111100                       0000000      013456899999999999


Q ss_pred             CcCCCCCHHHHhcCccccc
Q 024828          216 EPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       216 ~p~~Rpt~~~~l~h~~~~~  234 (262)
                      ||.+|||+.|+|+||||+.
T Consensus       442 DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        442 DGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             ChhhCcCHHHHhhCcccCC
Confidence            9999999999999999974

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-38  Score=260.74  Aligned_cols=223  Identities=29%  Similarity=0.492  Sum_probs=183.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+++++.++||||+++++.+..++..++||||++|++|.++++..+.+++..+..++.|++.||.|||+ .|
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~  121 (305)
T cd05609          43 NQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN-YG  121 (305)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34567889999999999999999999999999999999999999999999888889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCC---------------CCcccccccccccCcccccCCCCCcchhHHH
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---------------GQANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      ++|+||+|.||+++.++.++++|||.+.......               .......++..|+|||.+.+..++.++|+||
T Consensus       122 i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  201 (305)
T cd05609         122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWA  201 (305)
T ss_pred             ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHH
Confidence            9999999999999999999999999875311000               0011234677899999998888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhcCCcCCCCC---HHHHhcCc
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHP  230 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~~l~h~  230 (262)
                      ||+++|++++|..||.+....       +.......... .......++.++.+++.+||+.+|.+||+   +.++++||
T Consensus       202 lG~vl~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         202 MGIILYEFLVGCVPFFGDTPE-------ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            999999999999999764322       22233322221 12222367899999999999999999997   79999999


Q ss_pred             cccccCCccc
Q 024828          231 FLKMYGDLNV  240 (262)
Q Consensus       231 ~~~~~~~~~~  240 (262)
                      ||...+....
T Consensus       275 ~~~~~~~~~~  284 (305)
T cd05609         275 FFLGLDWNGL  284 (305)
T ss_pred             cccCCCHHHH
Confidence            9988776553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.2e-39  Score=261.89  Aligned_cols=219  Identities=35%  Similarity=0.657  Sum_probs=183.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.+++.++||||+++++.+..++..++++||+++++|.+++.. ..++...+..++.|++.||++||+ .|
T Consensus        60 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~  137 (297)
T cd06659          60 QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS-QG  137 (297)
T ss_pred             chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            3456788999999999999999999999999999999999999999998765 568999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus       138 ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~  217 (297)
T cd06659         138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY  217 (297)
T ss_pred             eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998865443333333456788999999998888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ......       +....+.... ........++..+.+++.+||+.+|.+||+++++++||||.+++-
T Consensus       218 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         218 FSDSPV-------QAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             CCCCHH-------HHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            754322       1112221111 112223457889999999999999999999999999999988764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-39  Score=265.00  Aligned_cols=222  Identities=25%  Similarity=0.456  Sum_probs=178.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+++++.++||||+++++++.+++..++|+||+++++|..+......++...+..++.|++.||+|||+ .|
T Consensus        42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~  120 (286)
T cd07846          42 MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS-HN  120 (286)
T ss_pred             hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34567889999999999999999999999999999999999998998888776779999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+|++|+||+++.++.++++|||++..............++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       121 i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~  200 (286)
T cd07846         121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL  200 (286)
T ss_pred             ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999987654443333345678899999998764 478899999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHH-------H------hcCC-CCC--------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          169 YSPPEQQDGWTSFYELMEA-------I------VDQP-PPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~-------~------~~~~-~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      |......+.+.........       .      .... .+.        .....++..+.+++.+||+.+|++||+++++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  280 (286)
T cd07846         201 FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL  280 (286)
T ss_pred             CCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence            9754432211111110000       0      0000 000        0123567889999999999999999999999


Q ss_pred             hcCccc
Q 024828          227 MTHPFL  232 (262)
Q Consensus       227 l~h~~~  232 (262)
                      ++||||
T Consensus       281 l~~~~~  286 (286)
T cd07846         281 LHHEFF  286 (286)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-38  Score=258.45  Aligned_cols=213  Identities=27%  Similarity=0.436  Sum_probs=178.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLA   71 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~   71 (262)
                      ......++.+|++++++++||||+++++++.+....+++|||+++++|.+++...                ..++...+.
T Consensus        48 ~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  127 (283)
T cd05048          48 EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL  127 (283)
T ss_pred             CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHH
Confidence            4456678999999999999999999999999989999999999999999999765                447888999


Q ss_pred             HHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcc
Q 024828           72 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        72 ~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      .++.|++.||+|||+ .|++|+||+|+||++++++.++|+|||++.......  .......++..|+|||.+.+..++.+
T Consensus       128 ~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05048         128 HIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE  206 (283)
T ss_pred             HHHHHHHHHHHHHHh-CCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh
Confidence            999999999999998 999999999999999999999999999987543221  11223345678999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+|||||++|+|++ |..||.+....       +....+..+..+. .+..++.++.+|+.+||+.||.+||++.++++
T Consensus       207 sDv~slG~il~el~~~g~~p~~~~~~~-------~~~~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~  278 (283)
T cd05048         207 SDIWSFGVVLWEIFSYGLQPYYGFSNQ-------EVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHT  278 (283)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999998 99999765432       3333444444333 33578999999999999999999999999986


Q ss_pred             C
Q 024828          229 H  229 (262)
Q Consensus       229 h  229 (262)
                      +
T Consensus       279 ~  279 (283)
T cd05048         279 R  279 (283)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-39  Score=269.21  Aligned_cols=219  Identities=25%  Similarity=0.375  Sum_probs=169.1

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      ....|+.++++++||||+++++++.++...++|+|++.+ +|.+++.+. +.++...+..++.|++.||.|||+ .|++|
T Consensus       103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH  180 (357)
T PHA03209        103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIH  180 (357)
T ss_pred             ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence            345799999999999999999999999999999999965 888888654 578999999999999999999998 99999


Q ss_pred             CCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCC
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF-PYSP  171 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~-p~~~  171 (262)
                      +||||+||+++.++.++|+|||.+...... .......|+..|+|||.+.+..++.++|+|||||++|+|+++.. +|..
T Consensus       181 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        181 RDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             CCCCHHHEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            999999999999999999999988643222 12233468899999999998889999999999999999998544 4443


Q ss_pred             CCccC--ch----hhHHHHHHHHhcCC--CC--------------------------CCCCCCCCHHHHHHHHHhhcCCc
Q 024828          172 PEQQD--GW----TSFYELMEAIVDQP--PP--------------------------SAPSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       172 ~~~~~--~~----~~~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~l~~li~~~l~~~p  217 (262)
                      .....  ..    ......+.......  .+                          ......++.++.+||.+||+.||
T Consensus       260 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP  339 (357)
T PHA03209        260 PPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDA  339 (357)
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCc
Confidence            22110  00    00111111110000  00                          00012456677889999999999


Q ss_pred             CCCCCHHHHhcCcccccc
Q 024828          218 QQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~  235 (262)
                      .+|||++|+|+||||+..
T Consensus       340 ~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        340 AMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             ccCcCHHHHhcCchhccC
Confidence            999999999999999863

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.7e-39  Score=266.01  Aligned_cols=219  Identities=23%  Similarity=0.458  Sum_probs=178.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....+.+|+.++..++|++|+++++.+.+....++||||+.+++|.+++.+. +.+++..+..++.|++.||.|||+ .
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~-~  121 (332)
T cd05623          43 AETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ-L  121 (332)
T ss_pred             hHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            34455788999999999999999999999999999999999999999999874 678999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccC-----CCCCcchhHHHHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l  162 (262)
                      |++|+||||+||+++.++.++|+|||++........ ......|++.|+|||++.+     ..++.++|+|||||++|+|
T Consensus       122 ~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el  201 (332)
T cd05623         122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM  201 (332)
T ss_pred             CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence            999999999999999999999999998865432222 2223468999999999862     4578899999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCC---CCCCCCCCCHHHHHHHHHhhcCCcCC--CCCHHHHhcCccccccC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPP---PSAPSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  236 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~h~~~~~~~  236 (262)
                      ++|+.||...+..       +....+.....   .+.....+++++.+|+++|+..++.+  |++++++++||||+...
T Consensus       202 l~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         202 LYGETPFYAESLV-------ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             hcCCCCCCCCCHH-------HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            9999999764432       22223322211   12222457899999999999765544  68999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-38  Score=256.08  Aligned_cols=215  Identities=31%  Similarity=0.572  Sum_probs=181.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +......+.+|+++++.++||||+++++.+.+.+..++++||+++++|.+++..    ...++...+..++.|++.||+|
T Consensus        42 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  121 (267)
T cd08228          42 DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH  121 (267)
T ss_pred             CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            456667889999999999999999999999999999999999999999988853    2458999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ||+ .|++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+..++.++|+||+|+++++|+
T Consensus       122 LH~-~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~  200 (267)
T cd08228         122 MHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             Hhh-CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence            998 9999999999999999999999999998876544333333446788999999998888899999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|..||......     .......+.....+..+...++..+.+++.+||+.+|++||+++++++
T Consensus       201 ~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         201 ALQSPFYGDKMN-----LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             cCCCCCcccccc-----HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            999998654321     223444444444555555568899999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-38  Score=256.52  Aligned_cols=217  Identities=35%  Similarity=0.562  Sum_probs=177.0

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      .+.+.+|+.++++++|||++++++++......++|+||+++++|.+++.+.+.++...+..++.|++.||.+||+ .|++
T Consensus        52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~  130 (272)
T cd06629          52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS-KGIL  130 (272)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCee
Confidence            356788999999999999999999999999999999999999999999988889999999999999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |+||+|+||+++.++.++++|||.+........  ......++..|+|||.+.+..  ++.++|+||||++++++++|..
T Consensus       131 H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  210 (272)
T cd06629         131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR  210 (272)
T ss_pred             ecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence            999999999999999999999998865432211  122345778899999987654  7889999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ||...+...   ..............+......++.++.+++.+||..+|.+|||++++++||||
T Consensus       211 p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         211 PWSDEEAIA---AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CCcCcchHH---HHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            996533211   11111111111111222223568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.1e-39  Score=262.42  Aligned_cols=226  Identities=25%  Similarity=0.412  Sum_probs=180.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|++++++++|+||+++++++.++...++||||+ +++|.+++.... .++...+..++.|++.||.+||+ .|
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~  122 (298)
T cd07841          45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS-NW  122 (298)
T ss_pred             hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            4556778999999999999999999999999999999999 789999998766 79999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+. .++.++|+|||||++++|++|.++
T Consensus       123 i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~  202 (298)
T cd07841         123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPF  202 (298)
T ss_pred             eeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcc
Confidence            9999999999999999999999999987765543333344567789999988653 578999999999999999999888


Q ss_pred             CCCCCccCchhhHHHHH---------------HHHhcCCCC----CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          169 YSPPEQQDGWTSFYELM---------------EAIVDQPPP----SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |......+.........               ........+    .......+.++.+++.+||+++|.+|||+++++.|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         203 LPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            87644322111111100               000000000    00113456889999999999999999999999999


Q ss_pred             ccccccCCc
Q 024828          230 PFLKMYGDL  238 (262)
Q Consensus       230 ~~~~~~~~~  238 (262)
                      |||+..+..
T Consensus       283 ~~~~~~~~~  291 (298)
T cd07841         283 PYFSNDPAP  291 (298)
T ss_pred             ccccCCCCC
Confidence            999987754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=272.25  Aligned_cols=223  Identities=31%  Similarity=0.612  Sum_probs=191.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +++..+++.-|++||..|+||+||++++.|..++.++++.|||.||-+..++-.- ..+++.++..+++|++.||.|||+
T Consensus        69 seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs  148 (1187)
T KOG0579|consen   69 SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS  148 (1187)
T ss_pred             chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh
Confidence            6677889999999999999999999999999999999999999999998877654 579999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc-----CCCCCcchhHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~  161 (262)
                       .+|+|+|||..|||+.-+|.++|+|||.+............++|+++|+|||+..     ..+|++++||||||+++.+
T Consensus       149 -~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIE  227 (1187)
T KOG0579|consen  149 -QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIE  227 (1187)
T ss_pred             -cchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHH
Confidence             9999999999999999999999999999877665555666789999999999864     4568999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      |..+.+|--..+.       ..++-++.+..+| -..+...+..+.+++++||..||..||++.++|+||||+..++-
T Consensus       228 MAqiEPPHhelnp-------MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  228 MAQIEPPHHELNP-------MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HhccCCCccccch-------HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            9999888654322       2333344444333 33456788999999999999999999999999999999976643

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.6e-38  Score=253.04  Aligned_cols=216  Identities=36%  Similarity=0.639  Sum_probs=185.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+.+.+|+.++++++||||+++++.+.+.  ...++++|++++++|.+++.+...++...+..++.|++.||++||+ 
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-  119 (260)
T cd06606          41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS-  119 (260)
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            5678899999999999999999999999988  8899999999999999999988899999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      .|++|+||+|+||+++.++.++|+|||.+........  ......++..|.|||...+...+.++|+||||++++++++|
T Consensus       120 ~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g  199 (260)
T cd06606         120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG  199 (260)
T ss_pred             CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999877654432  13345678899999999888899999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ..||...+.      .................+...+..+.+++.+|+..+|.+||++.+++.||||
T Consensus       200 ~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         200 KPPWSELGN------PMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CCCCCCCCc------hHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999987651      1122223332233333445678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-38  Score=259.25  Aligned_cols=223  Identities=27%  Similarity=0.455  Sum_probs=184.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+|+++++.++|++|+++.+.+.+++..++++||+.+++|.+++...  .+++...+..++.|++.||.|||+ .
T Consensus        43 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~  121 (285)
T cd05632          43 GESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR-E  121 (285)
T ss_pred             HHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            3456788999999999999999999999999999999999999999888654  369999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++++|||++...... .......++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus       122 ~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P  200 (285)
T cd05632         122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP  200 (285)
T ss_pred             CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999988654322 122334688999999999888899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCCccc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~~~~  240 (262)
                      |........   ............  ......++.++.+|+.+||+.||.+|||     +++++.|+||+.....+.
T Consensus       201 ~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~  272 (285)
T cd05632         201 FRGRKEKVK---REEVDRRVLETE--EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL  272 (285)
T ss_pred             CCCCCHHHH---HHHHHHhhhccc--cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence            986543211   111222222221  1223467889999999999999999999     899999999998865543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-38  Score=255.82  Aligned_cols=227  Identities=44%  Similarity=0.780  Sum_probs=182.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      .....++.+|++++++++||||+++++++.+  .+..++||||+++++|.+++..    ...++...+..++.|++.||+
T Consensus        40 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~  119 (287)
T cd06621          40 PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS  119 (287)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            3566789999999999999999999998865  3468999999999999988753    245889999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |||+ .|++|+||+|+||+++.++.++++|||++........  ....++..|++||.+.+..++.++|+||||+++|+|
T Consensus       120 ~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l  196 (287)
T cd06621         120 YLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV  196 (287)
T ss_pred             HHHH-CCcccCCCCHHHEEEecCCeEEEeecccccccccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence            9998 9999999999999999999999999999765432221  233567789999999888899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCC---CC--CCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA---PS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ++|..||.......  ....+..........+..   ..  ...++++.+++.+||..+|.+|||+.|++.||||+....
T Consensus       197 ~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         197 AQNRFPFPPEGEPP--LGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             HhCCCCCCcccCCC--CChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            99999998764311  111222333322221111   11  235678999999999999999999999999999977766


Q ss_pred             ccc
Q 024828          238 LNV  240 (262)
Q Consensus       238 ~~~  240 (262)
                      .+.
T Consensus       275 ~~~  277 (287)
T cd06621         275 KKV  277 (287)
T ss_pred             chh
Confidence            554

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.9e-38  Score=253.44  Aligned_cols=215  Identities=32%  Similarity=0.495  Sum_probs=177.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+.+.+|++++++++||||+++++.+.+.  ..++++|||+++++|.+++.+.+.++...+..++.|++.||++||+ 
T Consensus        46 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~-  124 (265)
T cd06652          46 KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS-  124 (265)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            4456888999999999999999999988763  5688999999999999999888888999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCC---CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++|+|||.+.......   .......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus       125 ~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~  204 (265)
T cd06652         125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT  204 (265)
T ss_pred             CCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh
Confidence            999999999999999999999999999887543211   11223457788999999988888999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      |+.||......      ... ............+..++..+.+++.+|+. +|++||+++++++|||++
T Consensus       205 g~~p~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         205 EKPPWAEFEAM------AAI-FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CCCCCCccchH------HHH-HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            99999754221      112 22222222222334677889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.8e-38  Score=257.73  Aligned_cols=222  Identities=35%  Similarity=0.624  Sum_probs=184.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+.+++.++|+||+++++.+..++..+++|||+++++|.+++.. +.++...+..++.|++.||++||+ .
T Consensus        58 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~  135 (292)
T cd06657          58 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA-Q  135 (292)
T ss_pred             hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            34566789999999999999999999999999999999999999999998755 568999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|.||+++.++.++++|||++..............++..|+|||.+.+..++.++|+||+|+++++|++|..|
T Consensus       136 givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p  215 (292)
T cd06657         136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP  215 (292)
T ss_pred             CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999876554332223334577889999999887889999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      |......       +....+....... .....++..+.+++.+||+.+|.+||++.+++.||||.......
T Consensus       216 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         216 YFNEPPL-------KAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             CCCCCHH-------HHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence            9764332       1112221111111 12245788999999999999999999999999999999888544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-39  Score=269.68  Aligned_cols=221  Identities=26%  Similarity=0.474  Sum_probs=174.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ...+.+.+|++++++++||||+++++++...      ...|++++++ +++|.++++. +.++...+..++.|++.||.|
T Consensus        56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~  133 (343)
T cd07878          56 IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKY  133 (343)
T ss_pred             HHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4456778999999999999999999987543      3478999998 6699988764 579999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l  162 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||++.....   ......++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus       134 LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  209 (343)
T cd07878         134 IHS-AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  209 (343)
T ss_pred             HHH-CCeecccCChhhEEECCCCCEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence            998 9999999999999999999999999999876432   2234568899999999877 4588999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHH----------------HHHhcCCCCCCC-------CCCCCHHHHHHHHHhhcCCcCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELM----------------EAIVDQPPPSAP-------SDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      ++|..||...+..+......+..                ...... .+..+       ....++.+.+|+.+||..||.+
T Consensus       210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~  288 (343)
T cd07878         210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDK  288 (343)
T ss_pred             HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhh
Confidence            99999997654322111111000                000000 00000       1235677899999999999999


Q ss_pred             CCCHHHHhcCccccccCC
Q 024828          220 RLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       220 Rpt~~~~l~h~~~~~~~~  237 (262)
                      |||+.+++.||||.....
T Consensus       289 R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         289 RISASEALAHPYFSQYHD  306 (343)
T ss_pred             CCCHHHHhcCcchhccCC
Confidence            999999999999987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-38  Score=258.46  Aligned_cols=214  Identities=35%  Similarity=0.586  Sum_probs=173.2

Q ss_pred             HHHHHHHHHHHHhcC-CCCeeEeeceEEE-----ECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSS-QCPYVVVCYQSFY-----SNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~   80 (262)
                      ...++.+|+.+++.+ +||||+++++.+.     .+...++||||++|++|.+++..    ...+++..+..++.|++.|
T Consensus        57 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~  136 (286)
T cd06638          57 IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG  136 (286)
T ss_pred             hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHH
Confidence            346788999999999 7999999999874     34678999999999999998753    2468899999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-----CCCCcchhHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSL  155 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~sl  155 (262)
                      |.|||+ .+++|+||+|+||+++.++.++++|||++..............++..|+|||.+..     ..++.++|+||+
T Consensus       137 l~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  215 (286)
T cd06638         137 LQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL  215 (286)
T ss_pred             HHHHHh-CCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhH
Confidence            999998 99999999999999999999999999998765443333344568889999998753     347889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          156 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       156 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      |+++|+|++|+.||.......       ..........+ ...+..++.++.+++.+||+.+|++|||+.++++|+||
T Consensus       216 Gvi~~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         216 GITAIELGDGDPPLADLHPMR-------ALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHHHHHhcCCCCCCCCchhH-------HHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            999999999999997654321       11111112111 11223467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.8e-38  Score=254.09  Aligned_cols=219  Identities=37%  Similarity=0.650  Sum_probs=184.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|++++++++||||+++++.+..+...++|+||+++++|.+++.+ +.++...+..++.+++.++.+||+ .
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~-~  120 (277)
T cd06641          43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS-E  120 (277)
T ss_pred             hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc-C
Confidence            34556888999999999999999999999999999999999999999999875 568999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+...+.++|+||+|++++++++|..|
T Consensus       121 ~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  200 (277)
T cd06641         121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999999886554333223334577889999999887889999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |......       .....+..... ......++.++.+++.+||..+|.+||++.++++||||.....
T Consensus       201 ~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         201 HSELHPM-------KVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             CCccchH-------HHHHHHhcCCC-CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            9754321       12222222222 2233567899999999999999999999999999999988644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.4e-39  Score=256.34  Aligned_cols=215  Identities=28%  Similarity=0.503  Sum_probs=183.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|++++++++||||+++++.+.++...++|+||+.|++|.+++.+..+++...+..++.|++.||.+||+ .|
T Consensus        42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~  120 (258)
T cd05578          42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS-KG  120 (258)
T ss_pred             hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            45678999999999999999999999999999999999999999999999887789999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++++|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..||
T Consensus       121 i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  199 (258)
T cd05578         121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY  199 (258)
T ss_pred             eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCC
Confidence            9999999999999999999999999887654332 223345778899999998888899999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH--HHHhcCccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA--QELMTHPFL  232 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~--~~~l~h~~~  232 (262)
                      .......    ..........  .....+...+.++.+++.+||+.+|.+||+.  +|++.||||
T Consensus       200 ~~~~~~~----~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         200 RGHSRTI----RDQIRAKQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CCCCccH----HHHHHHHhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            8765421    1122222221  2222334678999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-38  Score=259.13  Aligned_cols=217  Identities=25%  Similarity=0.466  Sum_probs=174.6

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+|++++++++||||+++++++.+++..++||||+. ++|.+++...  ..++...+..++.|++.||+|||+ .
T Consensus        42 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~  119 (284)
T cd07860          42 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-H  119 (284)
T ss_pred             cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            44678899999999999999999999999999999999996 4899988653  468999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+.. ++.++|+||||+++|+|++|+.
T Consensus       120 ~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~  199 (284)
T cd07860         120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA  199 (284)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            999999999999999999999999998876544333333345678899999887654 5889999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCC---------------------C--CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQP---------------------P--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      ||...+..+.   ............                     .  .......++++++++|.+||+.||.+|||++
T Consensus       200 p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  276 (284)
T cd07860         200 LFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK  276 (284)
T ss_pred             CCCCCCHHHH---HHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence            9976543221   111111110000                     0  0000124678899999999999999999999


Q ss_pred             HHhcCccc
Q 024828          225 ELMTHPFL  232 (262)
Q Consensus       225 ~~l~h~~~  232 (262)
                      +++.||||
T Consensus       277 ~~l~~~~f  284 (284)
T cd07860         277 AALAHPFF  284 (284)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-38  Score=254.07  Aligned_cols=214  Identities=31%  Similarity=0.529  Sum_probs=180.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+.+.+|+++++.++|+||+++++.+.++...++|+||+++++|.+++.+..  .+++..+..++.|++.||.|||+ 
T Consensus        41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-  119 (257)
T cd08225          41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD-  119 (257)
T ss_pred             hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            455678899999999999999999999999999999999999999999997654  47899999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCc-EEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGE-VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||+|+||+++.++. ++++|||.+..............++..|+|||...+..++.++|+||+|++++++++|.
T Consensus       120 ~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~  199 (257)
T cd08225         120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK  199 (257)
T ss_pred             CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999988764 69999998876654433333446788899999998888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      .||......       .............. ...++.++.+++.+||..+|.+|||++++++||||
T Consensus       200 ~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         200 HPFEGNNLH-------QLVLKICQGYFAPI-SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCCCCccHH-------HHHHHHhcccCCCC-CCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            999754321       22233333333222 34678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-38  Score=259.78  Aligned_cols=219  Identities=32%  Similarity=0.632  Sum_probs=182.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.+++.++||||+++++.+..+...++|+||+++++|.+++.+ ..++...+..++.|++.||.+||+ .|
T Consensus        58 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~g  135 (293)
T cd06647          58 PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQ  135 (293)
T ss_pred             hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            3456788999999999999999999999999999999999999999999876 457899999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++..............++..|++||.+.+..++.++|+||+|+++|++++|..||
T Consensus       136 i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf  215 (293)
T cd06647         136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY  215 (293)
T ss_pred             EeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998765544333333446778899999998888899999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHh-cCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          170 SPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ...+....       ..... ...........++..+.+++.+||..+|++||++++++.||||+....
T Consensus       216 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         216 LNENPLRA-------LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             CCCChhhh-------eeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence            76543221       11111 111222223456788999999999999999999999999999987763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.6e-39  Score=258.07  Aligned_cols=212  Identities=32%  Similarity=0.581  Sum_probs=173.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ..+..+++.+|++.+++++||||+++++++...+..++|+||+++++|.+++...  ..++...+..++.|++.||.|||
T Consensus        41 ~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh  120 (259)
T PF07714_consen   41 SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH  120 (259)
T ss_dssp             SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4566899999999999999999999999999888899999999999999999886  67999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      + .+++|++|+++||+++.++.++|+|||++.......  ...........|+|||.+.+..++.++||||||+++||++
T Consensus       121 ~-~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~  199 (259)
T PF07714_consen  121 S-NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEIL  199 (259)
T ss_dssp             H-TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHH
T ss_pred             c-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            8 999999999999999999999999999987652211  1122334677899999998888999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      + |+.||.....       .+....+..+..+.. +..++..+.+++.+||..+|++|||+.++++
T Consensus       200 ~~~~~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  200 TLGKFPFSDYDN-------EEIIEKLKQGQRLPI-PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             TTSSGTTTTSCH-------HHHHHHHHTTEETTS-BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             cccccccccccc-------cccccccccccccee-ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9 7888876532       234455555554443 3568999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.6e-38  Score=252.14  Aligned_cols=215  Identities=39%  Similarity=0.662  Sum_probs=185.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ....+.+.+|+++++.++|||++++.+.+.++...++++|++++++|.+++.+.    ..++...+..++.+++.||.+|
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l  119 (258)
T cd08215          40 EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL  119 (258)
T ss_pred             hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH
Confidence            467778999999999999999999999999999999999999999999999764    6799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      |+ .|++|+||+|+||+++.++.++++|||.+..............++..|+|||...+..++.++|+||+|+++++|++
T Consensus       120 h~-~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~  198 (258)
T cd08215         120 HS-RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT  198 (258)
T ss_pred             Hh-CCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc
Confidence            98 99999999999999999999999999998765544323334567888999999988888999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      |..||...+.       ............... +..++.++.+++.+||..+|.+|||+.+++.||||
T Consensus       199 g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         199 LKHPFEGENL-------LELALKILKGQYPPI-PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCCCCCCcH-------HHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            9999976542       233344444433333 34788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.8e-38  Score=259.30  Aligned_cols=218  Identities=23%  Similarity=0.348  Sum_probs=171.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-------------------CCCHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-------------------TIPEE   68 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~~~~~   68 (262)
                      ....+.++.+|++++.+++||||+++++++.+.+..++||||+.+++|.+++....                   .++..
T Consensus        59 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (304)
T cd05096          59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS  138 (304)
T ss_pred             CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHH
Confidence            45567789999999999999999999999999999999999999999999986532                   35778


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCC
Q 024828           69 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKY  146 (262)
Q Consensus        69 ~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~  146 (262)
                      .+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..+
T Consensus       139 ~~~~i~~~i~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  217 (304)
T cd05096         139 SLLHVALQIASGMKYLSS-LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF  217 (304)
T ss_pred             HHHHHHHHHHHHHHHHHH-CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence            889999999999999998 9999999999999999999999999999875432211  1122344678999999988889


Q ss_pred             CcchhHHHHHHHHHHHHh--CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          147 GYKSDIWSLGLVLLECAT--GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       147 ~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      +.++|+||||+++|+|++  +..||......+................. ...+..++..+.+++.+||+.+|++|||++
T Consensus       218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY-LFRPPPCPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             CchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc-ccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence            999999999999999986  56778765433222111111111111111 112235788999999999999999999999


Q ss_pred             HHh
Q 024828          225 ELM  227 (262)
Q Consensus       225 ~~l  227 (262)
                      ++.
T Consensus       297 ~i~  299 (304)
T cd05096         297 DIH  299 (304)
T ss_pred             HHH
Confidence            994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.7e-38  Score=253.62  Aligned_cols=207  Identities=28%  Similarity=0.536  Sum_probs=171.1

Q ss_pred             HHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCE
Q 024828           21 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  100 (262)
Q Consensus        21 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~ni  100 (262)
                      ++...+||+|+.+++.+..++..++||||+++++|.+++..++.+++..+..++.|++.||+|||+ .|++|+||+|+||
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Ni  128 (279)
T cd05633          50 LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANI  128 (279)
T ss_pred             HHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHE
Confidence            334457999999999999999999999999999999999888889999999999999999999998 9999999999999


Q ss_pred             EEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchh
Q 024828          101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT  179 (262)
Q Consensus       101 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  179 (262)
                      +++.++.++++|||++.......  .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||........ .
T Consensus       129 l~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~  205 (279)
T cd05633         129 LLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-H  205 (279)
T ss_pred             EECCCCCEEEccCCcceeccccC--ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-H
Confidence            99999999999999986543222  223468899999999864 4578999999999999999999999976543221 1


Q ss_pred             hHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                          ......... ....+..++.++.+++.+||..||.+||     |++++++||||+...
T Consensus       206 ----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         206 ----EIDRMTLTV-NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             ----HHHHHhhcC-CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence                111111111 1222356889999999999999999999     699999999998855

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.7e-38  Score=252.16  Aligned_cols=217  Identities=36%  Similarity=0.662  Sum_probs=181.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      +...+.+.+|+.+++.++|+||+++++.+......++|+||+++++|.+++.+.+.++...+..++.+++.||.+||+ .
T Consensus        40 ~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~  118 (264)
T cd06626          40 PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS-H  118 (264)
T ss_pred             hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH-C
Confidence            357788999999999999999999999999999999999999999999999987778999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc----cccccccccCcccccCCC---CCcchhHHHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN----TFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLE  161 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~~  161 (262)
                      |++|+||+|+||+++.++.++++|||.+...........    ...++..|+|||.+.+..   .+.++|+||+|+++++
T Consensus       119 ~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~  198 (264)
T cd06626         119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLE  198 (264)
T ss_pred             CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHH
Confidence            999999999999999999999999999876644332211    245678899999998766   7899999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC-CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      +++|+.||...+...      ...........+..+ ....+..+.+++.+||+.+|.+|||+++++.|||+
T Consensus       199 l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         199 MATGKRPWSELDNEF------QIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHhCCCCccCCcchH------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999997653211      111122222222222 22458899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.5e-39  Score=259.65  Aligned_cols=223  Identities=28%  Similarity=0.505  Sum_probs=177.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +.....+.+|+.++++++||||+++++++.++...++|+||+ +++|.+++... ..+++..+..++.|++.||++||+ 
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-  117 (286)
T cd07832          40 GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA-  117 (286)
T ss_pred             chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            344678899999999999999999999999999999999999 88999998653 568999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g  165 (262)
                      .|++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+.. ++.++|+||+|+++++|++|
T Consensus       118 ~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg  197 (286)
T cd07832         118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG  197 (286)
T ss_pred             CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence            9999999999999999999999999999876644321 223346788999999987654 68999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHH--------------HhcCCCCC-------CCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          166 QFPYSPPEQQDGWTSFYELMEA--------------IVDQPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      .++|........+.........              ......+.       ......+.++.+++.+||+.+|++|||++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  277 (286)
T cd07832         198 SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA  277 (286)
T ss_pred             CcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHH
Confidence            8888665432221111110000              00000000       01124568899999999999999999999


Q ss_pred             HHhcCcccc
Q 024828          225 ELMTHPFLK  233 (262)
Q Consensus       225 ~~l~h~~~~  233 (262)
                      ++++||||.
T Consensus       278 ~~l~h~~~~  286 (286)
T cd07832         278 EALRHPYFT  286 (286)
T ss_pred             HHhhCcCcC
Confidence            999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=259.40  Aligned_cols=223  Identities=24%  Similarity=0.492  Sum_probs=178.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|++++++++|+||+++++.+.+++..++++||++++.+..+..+...++...+..++.|++.||++||+ .
T Consensus        41 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~  119 (288)
T cd07833          41 EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-H  119 (288)
T ss_pred             ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            445678999999999999999999999999999999999999987777666666779999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      |++|+|++|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||+|++++++++|+
T Consensus       120 ~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  199 (288)
T cd07833         120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE  199 (288)
T ss_pred             CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999876654432 22334667889999999887 7899999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHH--------HHh-----cC-CCCC---------CCCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          167 FPYSPPEQQDGWTSFYELME--------AIV-----DQ-PPPS---------APSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~--------~~~-----~~-~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      .||......+..........        ...     .. ..+.         ..+..++.++.+|+++||..+|++|||+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  279 (288)
T cd07833         200 PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC  279 (288)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH
Confidence            99976543221111100000        000     00 0000         0112347889999999999999999999


Q ss_pred             HHHhcCccc
Q 024828          224 QELMTHPFL  232 (262)
Q Consensus       224 ~~~l~h~~~  232 (262)
                      +++++||||
T Consensus       280 ~~il~~~~f  288 (288)
T cd07833         280 DELLQHPYF  288 (288)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.9e-38  Score=251.46  Aligned_cols=215  Identities=33%  Similarity=0.558  Sum_probs=180.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +....+.+.+|++++++++||||+++++.+..++..++|+||+++++|.+++...  ..+++..+..++.+++.+|++||
T Consensus        39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh  118 (256)
T cd08220          39 TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH  118 (256)
T ss_pred             ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3456778999999999999999999999999999999999999999999999764  34899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCC-cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           86 HEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      + .|++|+||+|+||+++.++ .++++|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++
T Consensus       119 ~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~  196 (256)
T cd08220         119 T-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS  196 (256)
T ss_pred             h-CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh
Confidence            8 9999999999999998654 57999999987654332 2223467889999999998888999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      |..||...+..       ............. ....++.++.+++.+||..+|.+|||+++++.||||
T Consensus       197 ~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         197 LKRAFEAANLP-------ALVLKIMSGTFAP-ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CCCCcccCchH-------HHHHHHHhcCCCC-CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            99999765432       2222333332222 234578999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.3e-38  Score=249.78  Aligned_cols=213  Identities=41%  Similarity=0.765  Sum_probs=180.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|++++++++|++++++.+.+.++...++++||+++++|.+++... +.++...+..++.|++.||.+||+ .
T Consensus        39 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~  117 (253)
T cd05122          39 EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-N  117 (253)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-C
Confidence            36778999999999999999999999999999999999999999999999876 579999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+...+.++|+||||++++++++|+.|
T Consensus       118 ~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p  196 (253)
T cd05122         118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP  196 (253)
T ss_pred             CEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999998876654332 3345678899999999888889999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCC-CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSA-PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      |...+..       ...........+.. ....++..+.+++.+||+.||++|||+.++++|||
T Consensus       197 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         197 YSELPPM-------KALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CCCCchH-------HHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            9765321       11111222222222 22234889999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-38  Score=249.27  Aligned_cols=214  Identities=36%  Similarity=0.611  Sum_probs=184.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|++++++++|+|++++.+++.++...++++|++++++|.+++...+.+++..+..++.|++.||.+||+ .|
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~  119 (254)
T cd06627          41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE-QG  119 (254)
T ss_pred             HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh-CC
Confidence            56678999999999999999999999999999999999999999999999988889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++++|||.+..............++..|+|||...+...+.++|+|++|++++++++|..||
T Consensus       120 i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~  199 (254)
T cd06627         120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY  199 (254)
T ss_pred             cccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999887655443334456788899999998777889999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ......       ...........+ ..+..++..+.+++.+||..+|++|||+++++.||||
T Consensus       200 ~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         200 YDLNPM-------AALFRIVQDDHP-PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CCccHH-------HHHHHHhccCCC-CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            764421       111122222222 2335678999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.4e-38  Score=252.40  Aligned_cols=211  Identities=22%  Similarity=0.312  Sum_probs=175.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ......+.+|+.++.+++||||+++++++..++..++||||+++++|.+++... +.++...+..++.|++.||+|||+ 
T Consensus        47 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~-  125 (266)
T cd05064          47 DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE-  125 (266)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            455678899999999999999999999999999999999999999999999774 568999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      .|++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||+||++|++++ |
T Consensus       126 ~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g  205 (266)
T cd05064         126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYG  205 (266)
T ss_pred             CCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCC
Confidence            9999999999999999999999999997654322211 1112234568999999998889999999999999999775 9


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ..||......       ...+.+..+...+ .+..++..+.+++.+||+.+|.+|||++++++
T Consensus       206 ~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         206 ERPYWDMSGQ-------DVIKAVEDGFRLP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCcCcCCHH-------HHHHHHHCCCCCC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999765432       3334444443333 34568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.7e-38  Score=252.70  Aligned_cols=215  Identities=33%  Similarity=0.601  Sum_probs=180.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +.....++.+|+++++.++||||+++++.+.+++..++++||+++++|.+++..    ...+++..+..++.|++.||.|
T Consensus        42 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  121 (267)
T cd08229          42 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH  121 (267)
T ss_pred             hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence            445567889999999999999999999999999999999999999999999864    3458999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ||+ .|++|+||+|+||+++.++.++++|||++..............++..|+|||.+.+..++.++|+||+|+++++|+
T Consensus       122 LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~  200 (267)
T cd08229         122 MHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             HHH-CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence            998 9999999999999999999999999998876543333333456788999999998888899999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|..||.....     ........+.....+..+...+++++.+++.+||..+|++|||++++++
T Consensus       201 ~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         201 ALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             hCCCCcccccc-----hHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            99999975432     1223334444444444445568899999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6e-38  Score=252.14  Aligned_cols=213  Identities=26%  Similarity=0.418  Sum_probs=176.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+....+++.+|++++++++|+||+++++.+..+...+++|||+++++|.+++....  .++...+..++.|++.||++|
T Consensus        41 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l  120 (263)
T cd05052          41 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL  120 (263)
T ss_pred             CCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            344456788999999999999999999999999999999999999999999997643  588999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc-ccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      |+ .|++|+||+|+||++++++.++++|||.+.......... .....+..|+|||.+.+..++.++|+||||+++|+|+
T Consensus       121 H~-~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  199 (263)
T cd05052         121 EK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA  199 (263)
T ss_pred             Hh-CCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            98 999999999999999999999999999987654322111 1122356799999998888999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      + |..||...+..       +....+.....+. .+..+++++.+++.+||+.+|++|||+.++++
T Consensus       200 t~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         200 TYGMSPYPGIDLS-------QVYELLEKGYRME-RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             cCCCCCCCCCCHH-------HHHHHHHCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            8 89998764432       2233333333332 33568899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=269.18  Aligned_cols=213  Identities=28%  Similarity=0.496  Sum_probs=183.8

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ......+++.+|++++++++|||||+++++..+...+++|||+|+||+|.+++++.+. ++..+...++.+.+.||+|||
T Consensus       200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh  279 (474)
T KOG0194|consen  200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH  279 (474)
T ss_pred             ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence            4578899999999999999999999999999999999999999999999999999874 999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                      + .+++||||..+|+|++.++.++++|||++..............-+..|+|||.+....++.++||||+|+++||+++ 
T Consensus       280 ~-k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~  358 (474)
T KOG0194|consen  280 S-KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFEN  358 (474)
T ss_pred             H-CCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeecc
Confidence            9 99999999999999999899999999998754322222212235679999999999999999999999999999999 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhc-CCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |..||.+...       .+....+.. +.+... +...|+++..++.+||..+|+.|||+.++.+
T Consensus       359 g~~Py~g~~~-------~~v~~kI~~~~~r~~~-~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  359 GAEPYPGMKN-------YEVKAKIVKNGYRMPI-PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CCCCCCCCCH-------HHHHHHHHhcCccCCC-CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            7889988543       355666634 444443 3578899999999999999999999998854

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-38  Score=263.09  Aligned_cols=219  Identities=24%  Similarity=0.468  Sum_probs=178.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....+.+|..++..++|++|+++++.+.+++..|+||||+.|++|.+++.+ .+.+++..+..++.|++.||+|||+ .
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~-~  121 (331)
T cd05624          43 AETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-L  121 (331)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3445678899999999999999999999999999999999999999999987 4678999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccC-----CCCCcchhHHHHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l  162 (262)
                      |++|+||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+     ..++.++|+||+|+++|+|
T Consensus       122 ~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el  201 (331)
T cd05624         122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM  201 (331)
T ss_pred             CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence            999999999999999999999999999876543222 1223468999999999875     4578899999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCC-C--CCCCCCCCCHHHHHHHHHhhcCCcCC--CCCHHHHhcCccccccC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQP-P--PSAPSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  236 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~h~~~~~~~  236 (262)
                      ++|+.||...+..       +....+.... .  .+.....+++++.+++.+|+..++.+  |++++++++||||+...
T Consensus       202 l~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         202 LYGETPFYAESLV-------ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             hhCCCCccCCCHH-------HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            9999999764432       2222222211 1  11122357899999999999876554  56999999999998643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.9e-38  Score=252.35  Aligned_cols=199  Identities=28%  Similarity=0.514  Sum_probs=167.8

Q ss_pred             CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccC
Q 024828           26 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  105 (262)
Q Consensus        26 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~  105 (262)
                      +||||+++++.+..++..++||||+++++|.+++.+.+.+++..+..++.|++.||.+||+ .|++|+||+|+||+++.+
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~  145 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRA  145 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCC
Confidence            7999999999999999999999999999999999988899999999999999999999998 999999999999999988


Q ss_pred             C-cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHH
Q 024828          106 G-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL  184 (262)
Q Consensus       106 ~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  184 (262)
                      + .++++|||.+......    ....++..|+|||.+.+..++.++|+||+|+++++|++|..||........  .....
T Consensus       146 ~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~  219 (267)
T PHA03390        146 KDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESL  219 (267)
T ss_pred             CCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHH
Confidence            8 9999999988765322    223578899999999988899999999999999999999999985433221  11111


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-HHHHhcCccccc
Q 024828          185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFLKM  234 (262)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~~~l~h~~~~~  234 (262)
                      ....   .........+++.+.++|.+||+.+|.+||+ ++++++||||+.
T Consensus       220 ~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        220 LKRQ---QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHhh---cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            1111   1122223468999999999999999999996 699999999974

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-37  Score=254.02  Aligned_cols=212  Identities=29%  Similarity=0.485  Sum_probs=177.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-------------CCCHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-------------TIPEEYLAAIC   74 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~i~   74 (262)
                      +....+.+.+|+.++++++||||+++++++..++..++++||+++++|.+++...+             .+++..+..++
T Consensus        47 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~  126 (288)
T cd05093          47 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA  126 (288)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHH
Confidence            34566789999999999999999999999999999999999999999999997543             38999999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhH
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDI  152 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di  152 (262)
                      .|++.||++||+ .|++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.++|+
T Consensus       127 ~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi  205 (288)
T cd05093         127 QQIAAGMVYLAS-QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV  205 (288)
T ss_pred             HHHHHHHHHHHh-CCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhH
Confidence            999999999998 9999999999999999999999999999875432211  1112334668999999998889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          153 WSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       153 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ||||+++++|++ |..||......       .....+..+..... ...++.++.+++.+||+.+|.+|||+++++.
T Consensus       206 wslG~il~~l~t~g~~p~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         206 WSLGVVLWEIFTYGKQPWYQLSNN-------EVIECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCcCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999999999998 89998764432       23344444443332 3468899999999999999999999999943

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.2e-38  Score=251.06  Aligned_cols=211  Identities=26%  Similarity=0.475  Sum_probs=175.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+++.+|++++++++||||+++++++......++||||+++++|.+++... +.++...+..++.|++.||+|||+ 
T Consensus        40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-  118 (256)
T cd05114          40 AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER-  118 (256)
T ss_pred             CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            344567899999999999999999999999999999999999999999999754 468999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      .|++|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||+|+++|++++ |
T Consensus       119 ~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g  198 (256)
T cd05114         119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG  198 (256)
T ss_pred             CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCC
Confidence            99999999999999999999999999988754322111 112234567999999988889999999999999999999 8


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +.||.....       .+....+..+..+.. +...+.++.+++.+||+.+|.+|||++++++
T Consensus       199 ~~p~~~~~~-------~~~~~~i~~~~~~~~-~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         199 KMPFEKKSN-------YEVVEMISRGFRLYR-PKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCCCCCCCH-------HHHHHHHHCCCCCCC-CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            999976543       233344444443332 2456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.2e-38  Score=250.49  Aligned_cols=213  Identities=31%  Similarity=0.512  Sum_probs=180.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .....+.+.+|+.+++.++|+||+++.+.+.+++..++++||+++++|.+++...  ..++...+..++.|++.||.+||
T Consensus        38 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH  117 (255)
T cd08219          38 SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH  117 (255)
T ss_pred             chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            4456678889999999999999999999999999999999999999999988653  45899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      + .|++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|
T Consensus       118 ~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g  196 (255)
T cd08219         118 E-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL  196 (255)
T ss_pred             h-CCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc
Confidence            8 999999999999999999999999999987665444333445678899999999888899999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ..||...+.       ......+..+.... .+..++..+.+++.+||+.||.+|||+++++..
T Consensus       197 ~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         197 KHPFQANSW-------KNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCCCCCCCH-------HHHHHHHhcCCCCC-CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            999976432       12233333333332 234678899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.2e-38  Score=254.55  Aligned_cols=230  Identities=39%  Similarity=0.761  Sum_probs=183.6

Q ss_pred             HHHHHHHHHHH-HhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHh
Q 024828           11 ARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        11 ~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ...++..|+.+ ++..+||||+++++.+..++..+++|||++| +|.+++...    ..+++..+..++.|++.||+|||
T Consensus        42 ~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  120 (283)
T cd06617          42 EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH  120 (283)
T ss_pred             HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            34556666665 5666999999999999999999999999975 898887642    46899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC----CCCCcchhHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~  161 (262)
                      +..+++|+||+|+||+++.++.++++|||.+....... ......++..|+|||.+.+    ..++.++|+||+|+++|+
T Consensus       121 ~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~  199 (283)
T cd06617         121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE  199 (283)
T ss_pred             hcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence            82399999999999999999999999999987653321 1222457788999998865    346889999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~  241 (262)
                      |++|+.||......      .+..........+..+...++.++.+++.+||..+|.+|||+++++.||||+.....+..
T Consensus       200 l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~  273 (283)
T cd06617         200 LATGRFPYDSWKTP------FQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTD  273 (283)
T ss_pred             HHhCCCCCCccccC------HHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccHH
Confidence            99999999653321      112223333444444445688999999999999999999999999999999999887777


Q ss_pred             hhhHhhh
Q 024828          242 LSEYFTD  248 (262)
Q Consensus       242 ~~~~~~~  248 (262)
                      .++.+.+
T Consensus       274 ~~~~~~~  280 (283)
T cd06617         274 VASFVSL  280 (283)
T ss_pred             HHHHHHh
Confidence            6665554

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-38  Score=257.97  Aligned_cols=224  Identities=23%  Similarity=0.416  Sum_probs=177.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+.+.+|++++++++||||+++++++.++...++||||+++ +|.+++.....  ++...+..++.|++.||++||+ 
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-  120 (294)
T PLN00009         43 GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS-  120 (294)
T ss_pred             cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh-
Confidence            3446788999999999999999999999999999999999965 88888866543  5788888999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g  165 (262)
                      .|++|+||+|+||+++. ++.++++|||++..............++..|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus       121 ~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg  200 (294)
T PLN00009        121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ  200 (294)
T ss_pred             CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            99999999999999985 4579999999987654433333334567889999988664 478999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcC-----------------CC--CC----CCCCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQ-----------------PP--PS----APSDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~~--~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                      +.||......+....   ........                 ..  ..    .....+++++.+++.+||+.+|++||+
T Consensus       201 ~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps  277 (294)
T PLN00009        201 KPLFPGDSEIDELFK---IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT  277 (294)
T ss_pred             CCCCCCCCHHHHHHH---HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC
Confidence            999986543321111   11100000                 00  00    011346788999999999999999999


Q ss_pred             HHHHhcCccccccCCc
Q 024828          223 AQELMTHPFLKMYGDL  238 (262)
Q Consensus       223 ~~~~l~h~~~~~~~~~  238 (262)
                      ++++++||||+..+++
T Consensus       278 ~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        278 ARAALEHEYFKDLGDA  293 (294)
T ss_pred             HHHHhcCchHhHHhcC
Confidence            9999999999988764

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.8e-38  Score=257.19  Aligned_cols=220  Identities=26%  Similarity=0.450  Sum_probs=174.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+|+.++.+++||||+++.+++...  ...|+|+||+.+ +|.+++.... .++...+..++.|++.||+|||+ 
T Consensus        47 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-  124 (293)
T cd07843          47 FPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD-  124 (293)
T ss_pred             chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            344677899999999999999999998877  889999999976 9999987654 58999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+.. .+.++|+||+|+++++|++|.
T Consensus       125 ~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  204 (293)
T cd07843         125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK  204 (293)
T ss_pred             CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999999887655433333445678899999987654 688999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHH--------------HHHhcCC---------CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          167 FPYSPPEQQDGWTSFYELM--------------EAIVDQP---------PPSAPSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~--------------~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      .||......+.........              .......         ....+...+++.+.+++++||+.+|++|||+
T Consensus       205 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~  284 (293)
T cd07843         205 PLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA  284 (293)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence            9998654432111111000              0000000         0000111157889999999999999999999


Q ss_pred             HHHhcCccc
Q 024828          224 QELMTHPFL  232 (262)
Q Consensus       224 ~~~l~h~~~  232 (262)
                      +|++.||||
T Consensus       285 ~ell~~~~f  293 (293)
T cd07843         285 EDALKHPYF  293 (293)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.4e-38  Score=254.19  Aligned_cols=225  Identities=39%  Similarity=0.730  Sum_probs=180.0

Q ss_pred             HHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-----KVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-----~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      .....+.+|+.++.++. |+||+++++.+..+...+++||++.+ ++.++..     ....+++..+..++.+++.||+|
T Consensus        44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  122 (288)
T cd06616          44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY  122 (288)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            55678899999999995 99999999999988899999999864 7665442     23579999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC---CCCcchhHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG---KYGYKSDIWSLGLVLL  160 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~  160 (262)
                      ||+..|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+.   .++.++|+||+|++++
T Consensus       123 lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~  201 (288)
T cd06616         123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY  201 (288)
T ss_pred             HhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHH
Confidence            9974599999999999999999999999999987554322 22233578889999998876   5889999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC---CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP---SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ++++|+.||....      ...+.......+..+...   ...++.++.+|+.+||+.+|.+|||+++++.||||+....
T Consensus       202 el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         202 EVATGKFPYPKWN------SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             HHHhCCCCchhcc------hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence            9999999997543      112222232222222222   1347899999999999999999999999999999988765


Q ss_pred             cccch
Q 024828          238 LNVDL  242 (262)
Q Consensus       238 ~~~~~  242 (262)
                      .....
T Consensus       276 ~~~~~  280 (288)
T cd06616         276 RNVDV  280 (288)
T ss_pred             cchhH
Confidence            55444

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=249.69  Aligned_cols=211  Identities=35%  Similarity=0.603  Sum_probs=174.6

Q ss_pred             HHHHHHHHH-hcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           14 QIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        14 ~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      .+..|..++ ...+|+|++++++.+..++..++|+||+++++|.++++..+.++...+..++.|++.||.|||+ .|++|
T Consensus        42 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H  120 (260)
T cd05611          42 NVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIH  120 (260)
T ss_pred             HHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence            444555444 4558999999999999999999999999999999999988889999999999999999999998 99999


Q ss_pred             CCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  172 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  172 (262)
                      +||+|.||+++.++.++|+|||++.....    .....++..|++||.+.+..++.++|+||+|++++++++|..||...
T Consensus       121 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         121 RDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             CCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999998765432    22345778899999998877899999999999999999999999765


Q ss_pred             CccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcCCCC---CHHHHhcCccccccC
Q 024828          173 EQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYG  236 (262)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~~l~h~~~~~~~  236 (262)
                      +...       .........  .+......+++++.+++.+||+.+|.+||   +++|++.||||+...
T Consensus       197 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         197 TPDA-------VFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             CHHH-------HHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            4321       122222111  12222336789999999999999999999   558999999997754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.2e-38  Score=264.31  Aligned_cols=213  Identities=27%  Similarity=0.403  Sum_probs=172.7

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc------------------------
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV------------------------   62 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------------------   62 (262)
                      .......+.+|+++++.+ +|+||+++++.+.+++..++||||+++++|.+++.+.                        
T Consensus        81 ~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (374)
T cd05106          81 HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNI  160 (374)
T ss_pred             CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccccccccccccccccccc
Confidence            345567889999999999 8999999999999999999999999999999998642                        


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCC
Q 024828           63 ----------------------------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK   96 (262)
Q Consensus        63 ----------------------------------------------~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~   96 (262)
                                                                    .+++...+..++.|++.||+|||+ .|++|+||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLk  239 (374)
T cd05106         161 TLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVA  239 (374)
T ss_pred             chhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCc
Confidence                                                          136788899999999999999998 999999999


Q ss_pred             CCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 024828           97 PSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE  173 (262)
Q Consensus        97 p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~  173 (262)
                      |+||+++.++.++|+|||++.........  .....++..|+|||++.+..++.++||||||+++|+|++ |+.||....
T Consensus       240 p~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         240 ARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             hheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999999998754322211  111234567999999988889999999999999999997 999997654


Q ss_pred             ccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ...      ........+.. ...+...++++.+++.+||+.||.+|||++++++
T Consensus       320 ~~~------~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         320 VNS------KFYKMVKRGYQ-MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ccH------HHHHHHHcccC-ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            322      11122222222 2223457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-37  Score=248.94  Aligned_cols=211  Identities=24%  Similarity=0.408  Sum_probs=175.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +....+.+.+|+.+++.++||||+++++.+. +...++||||+++++|.+++.+.+.+++..+..++.|++.||++||+ 
T Consensus        36 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-  113 (257)
T cd05116          36 DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE-  113 (257)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            3456778999999999999999999999875 45678999999999999999888889999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|.||+++.++.++++|||.+.........   .....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       114 ~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t  193 (257)
T cd05116         114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence            99999999999999999999999999998765433221   112233568999999988888999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......       .....+..+..++. +..+++++.++|.+||+.||++||++++|..
T Consensus       194 ~g~~p~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         194 YGQKPYKGMKGN-------EVTQMIESGERMEC-PQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCCCCCCCCHH-------HHHHHHHCCCCCCC-CCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence             99999764332       23333444443333 3568899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=249.84  Aligned_cols=210  Identities=29%  Similarity=0.483  Sum_probs=179.9

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---------KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~l~~~l   81 (262)
                      ..+++.+|+++++.++|+||+++++++.++...+++|||+++++|.+++...         ..+++..+..++.|++.||
T Consensus        39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al  118 (262)
T cd00192          39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM  118 (262)
T ss_pred             HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence            4788999999999999999999999999999999999999999999999886         6799999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      ++||+ .|++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+||+|+++
T Consensus       119 ~~lH~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  197 (262)
T cd00192         119 EYLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLL  197 (262)
T ss_pred             HHHHc-CCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHH
Confidence            99998 999999999999999999999999999987665432  222334567789999999888899999999999999


Q ss_pred             HHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          160 LECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       160 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++|++ |..||......       .....+..+..... +..+++++.+++.+||+.+|.+|||+++++++
T Consensus       198 ~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         198 WEIFTLGATPYPGLSNE-------EVLEYLRKGYRLPK-PEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCCC-CccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            99999 69999876332       23334443333332 34678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.1e-38  Score=265.19  Aligned_cols=224  Identities=25%  Similarity=0.460  Sum_probs=176.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +.....++.+|+.++++++||||+++++++...      ...|+||||+.+ +|.+.+...  ++...+..++.|++.||
T Consensus        55 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL  131 (353)
T cd07850          55 NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGI  131 (353)
T ss_pred             ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHH
Confidence            345566788999999999999999999988643      357999999965 999888753  89999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      ++||+ .|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++
T Consensus       132 ~~LH~-~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~  209 (353)
T cd07850         132 KHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  209 (353)
T ss_pred             HHHHh-CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHH
Confidence            99998 999999999999999999999999999987654322 2233457888999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHH---------------HHHHhcCCC----------------C---CCCCCCCCHHHHH
Q 024828          162 CATGQFPYSPPEQQDGWTSFYEL---------------MEAIVDQPP----------------P---SAPSDQFSPEFCS  207 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~---------------~~~~~~~~~----------------~---~~~~~~~~~~l~~  207 (262)
                      |++|+.||...+....+......               .........                +   .......++++.+
T Consensus       210 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (353)
T cd07850         210 MIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARD  289 (353)
T ss_pred             HHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHH
Confidence            99999999765543222221110               000000000                0   0001234667899


Q ss_pred             HHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          208 FISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       208 li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ++.+||+.||.+|||++++|.||||+.+-
T Consensus       290 li~~~L~~dP~~R~t~~eiL~~~~~~~~~  318 (353)
T cd07850         290 LLSKMLVIDPEKRISVDDALQHPYINVWY  318 (353)
T ss_pred             HHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence            99999999999999999999999997544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.7e-38  Score=264.26  Aligned_cols=213  Identities=26%  Similarity=0.416  Sum_probs=173.1

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC------------------------
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK------------------------   63 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------   63 (262)
                      ....+.+.+|++++..+ +||||+++++.+.+++..++||||++||+|.+++....                        
T Consensus        79 ~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (375)
T cd05104          79 LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQR  158 (375)
T ss_pred             cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhh
Confidence            34566788999999999 89999999999999999999999999999999986432                        


Q ss_pred             ---------------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           64 ---------------------------------------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        64 ---------------------------------------------------~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                                                                         .++...+..++.|++.||.|||+ .|++|
T Consensus       159 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH  237 (375)
T cd05104         159 EMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIH  237 (375)
T ss_pred             cccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence                                                               36778889999999999999998 99999


Q ss_pred             CCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY  169 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~  169 (262)
                      +||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       238 ~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~  317 (375)
T cd05104         238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY  317 (375)
T ss_pred             cCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999998765432211  111234567999999998889999999999999999998 88898


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      .......      ...+.+..+..+. .+...+.++.+|+.+||+.||++|||+.++++.
T Consensus       318 ~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         318 PGMPVDS------KFYKMIKEGYRML-SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCCchH------HHHHHHHhCccCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            7644321      1222233332222 234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=242.97  Aligned_cols=234  Identities=36%  Similarity=0.756  Sum_probs=198.5

Q ss_pred             hhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+.+..+++...+++.... +.|+||+.+++|..+...++.||.+. .+...++++- +++++..+-++...++.||.||
T Consensus       129 ~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YL  207 (391)
T KOG0983|consen  129 GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYL  207 (391)
T ss_pred             CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHH
Confidence            4677788899999988777 49999999999999988999999984 4777777654 6789988899999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC---CCCcchhHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~~  161 (262)
                      ....|++|+|+||+|||++..|++||||||.+-+..... ......|-+.|+|||.+.-.   .|+.++||||||++++|
T Consensus       208 KeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlve  286 (391)
T KOG0983|consen  208 KEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVE  286 (391)
T ss_pred             HHhcceeecccCccceEEccCCCEEeecccccceeeccc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhh
Confidence            887889999999999999999999999999998776543 33344677889999998643   58899999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCC-CCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      |.||+.||.+.+.+      ++.+.++.+..+|..+.. .+++++.+|+..||+.|+.+||.+.++|+|||+..+.....
T Consensus       287 LaTg~yPy~~c~td------Fe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~  360 (391)
T KOG0983|consen  287 LATGQYPYKGCKTD------FEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEV  360 (391)
T ss_pred             hhcccCCCCCCCcc------HHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhc
Confidence            99999999987544      466667776665544443 48999999999999999999999999999999999998888


Q ss_pred             chhhHhhh
Q 024828          241 DLSEYFTD  248 (262)
Q Consensus       241 ~~~~~~~~  248 (262)
                      .+.+.+..
T Consensus       361 dVa~WF~d  368 (391)
T KOG0983|consen  361 DVASWFKD  368 (391)
T ss_pred             cHHHHHHH
Confidence            87776654

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-37  Score=251.99  Aligned_cols=211  Identities=28%  Similarity=0.464  Sum_probs=176.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--------------CCCHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--------------TIPEEYLAAIC   74 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~i~   74 (262)
                      .+..+.+.+|+++++.++|+||+++++++..+...+++|||+++++|.+++...+              .++...+..++
T Consensus        49 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  128 (280)
T cd05049          49 NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA  128 (280)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHH
Confidence            4456889999999999999999999999999999999999999999999997643              37888999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhH
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDI  152 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di  152 (262)
                      .|++.|+.+||+ .|++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..++.++|+
T Consensus       129 ~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  207 (280)
T cd05049         129 VQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV  207 (280)
T ss_pred             HHHHHHHHHHhh-CCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence            999999999998 999999999999999999999999999886542221  11122344678999999998889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          153 WSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       153 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ||||+++++|++ |..||......       +....+..+.... .+..++..+.+++.+||+.||.+|||++|+++
T Consensus       208 ~slG~il~e~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         208 WSFGVVLWEIFTYGKQPWYGLSNE-------EVIECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            999999999998 99998765432       2333333443333 33568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-37  Score=253.09  Aligned_cols=211  Identities=29%  Similarity=0.459  Sum_probs=175.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAA   72 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~   72 (262)
                      ....+.+.+|+.++++++|+||+++++++..+...++||||+++++|.+++...+                .++...+..
T Consensus        48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  127 (291)
T cd05094          48 LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH  127 (291)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHH
Confidence            3445678999999999999999999999999999999999999999999997643                378899999


Q ss_pred             HHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcch
Q 024828           73 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        73 i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ++.|++.|+++||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++
T Consensus       128 i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  206 (291)
T cd05094         128 IASQIASGMVYLAS-QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  206 (291)
T ss_pred             HHHHHHHHHHHHHh-CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence            99999999999998 9999999999999999999999999999865433221  11223456789999999988899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+||||+++|+|++ |..||......       +..+.+..+.... .....+..+.+++.+||+.+|++|||++++++
T Consensus       207 Di~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         207 DVWSFGVILWEIFTYGKQPWFQLSNT-------EVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            99999999999998 99998764432       2333344443333 23467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-37  Score=249.40  Aligned_cols=215  Identities=34%  Similarity=0.604  Sum_probs=181.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +....+.+.+|++++++++|++++++++.+.+++..+++|||+++++|.+++.+.    ..++...+..++.+++.||.+
T Consensus        42 ~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~  121 (267)
T cd08224          42 DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH  121 (267)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHH
Confidence            3455778999999999999999999999999999999999999999999998642    458999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ||+ .|++|+||+|+||+++.++.++++|||.+..............++..|.|||.+.+..++.++|+||+|+++++++
T Consensus       122 lh~-~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~  200 (267)
T cd08224         122 MHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             HHh-CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence            998 9999999999999999999999999998876543333333446788899999998888999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+.||.....     ...........+..++.+...++.++.+++.+||..+|.+|||+.++++
T Consensus       201 ~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         201 ALQSPFYGDKM-----NLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HCCCCcccCCc-----cHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            99999965432     2223444444444444444478889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2e-37  Score=254.58  Aligned_cols=217  Identities=33%  Similarity=0.572  Sum_probs=180.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+++.+|+++++.++||||+++.+++.+++..++|+||+.| ++.+++.. .+.++...+..++.|++.||.|||+ 
T Consensus        56 ~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~-  133 (307)
T cd06607          56 NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHS-  133 (307)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            44556789999999999999999999999999999999999975 88777754 4578999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++|+|||++......    ....++..|+|||.+.   ...++.++|+||+|+++|+|++
T Consensus       134 ~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t  209 (307)
T cd06607         134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (307)
T ss_pred             CCceecCCCcccEEECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc
Confidence            99999999999999999999999999987654322    2345678899999874   3457889999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      |..||...+..       ...........+......++.++.+++.+||+.+|++||++.+++.||||......
T Consensus       210 g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  276 (307)
T cd06607         210 RKPPLFNMNAM-------SALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP  276 (307)
T ss_pred             CCCCCCCccHH-------HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence            99999764322       22222333333343344578899999999999999999999999999999876643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2e-38  Score=263.59  Aligned_cols=220  Identities=25%  Similarity=0.404  Sum_probs=177.5

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeC
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR   93 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~   93 (262)
                      .+.+|++++++++|+||+++++++..++..+++||++.+ +|.+++.....++......++.|++.||.+||+ .|++|+
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~  143 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHK-WYFMHR  143 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecc
Confidence            578999999999999999999999999999999999975 999999888889999999999999999999998 999999


Q ss_pred             CCCCCCEEEccCCcEEEEecccccccccC--------------CCCcccccccccccCcccccCCC-CCcchhHHHHHHH
Q 024828           94 DLKPSNLLINHRGEVKITDFGVSAIMAST--------------SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLV  158 (262)
Q Consensus        94 dl~p~nil~~~~~~~~l~df~~~~~~~~~--------------~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~  158 (262)
                      ||+|+||+++.++.++++|||.+......              ........++..|+|||.+.+.. ++.++|+||||++
T Consensus       144 dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~  223 (335)
T PTZ00024        144 DLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI  223 (335)
T ss_pred             cccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHH
Confidence            99999999999999999999988765411              11112234577899999987654 6899999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC----------------------CCCCCCCCHHHHHHHHHhhcCC
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP----------------------SAPSDQFSPEFCSFISACVQKE  216 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~l~~li~~~l~~~  216 (262)
                      +++|++|..||...+..+........   .......                      .......+.++.+++.+||+.+
T Consensus       224 l~el~tg~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  300 (335)
T PTZ00024        224 FAELLTGKPLFPGENEIDQLGRIFEL---LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN  300 (335)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHH---hCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCC
Confidence            99999999999876543222111111   1100000                      0001245788999999999999


Q ss_pred             cCCCCCHHHHhcCccccccCCc
Q 024828          217 PQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       217 p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      |.+|||+++++.||||+.....
T Consensus       301 P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        301 PLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             chhccCHHHHhcCcccCCCCCC
Confidence            9999999999999999876543

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.5e-38  Score=281.91  Aligned_cols=220  Identities=29%  Similarity=0.478  Sum_probs=179.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l   81 (262)
                      .+.....+.+|+.++++++||||+++++.|.+  ...+|+||||+.+++|.+++...    +.+++..++.|+.||+.||
T Consensus        52 ~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~AL  131 (1021)
T PTZ00266         52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL  131 (1021)
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence            45667789999999999999999999998865  45689999999999999999753    5699999999999999999


Q ss_pred             HHHhhcCC-------eeeCCCCCCCEEEccC-----------------CcEEEEecccccccccCCCCcccccccccccC
Q 024828           82 LYLHHEKH-------IIHRDLKPSNLLINHR-----------------GEVKITDFGVSAIMASTSGQANTFVGTYNYMS  137 (262)
Q Consensus        82 ~~lh~~~~-------i~H~dl~p~nil~~~~-----------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~  137 (262)
                      .|||+ .+       |+|+||+|+|||++.+                 +.++|+|||++....... ......+++.|+|
T Consensus       132 aYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmA  209 (1021)
T PTZ00266        132 AYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWS  209 (1021)
T ss_pred             HHHHh-cccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-cccccCCCccccC
Confidence            99997 44       9999999999999642                 348999999987653322 2234568999999


Q ss_pred             cccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcC
Q 024828          138 PERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK  215 (262)
Q Consensus       138 PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  215 (262)
                      ||++.+  ..++.++|||||||++|+|++|..||......      ......+...  +..+....+.++.+||.+||..
T Consensus       210 PEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~------~qli~~lk~~--p~lpi~~~S~eL~dLI~~~L~~  281 (1021)
T PTZ00266        210 PELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF------SQLISELKRG--PDLPIKGKSKELNILIKNLLNL  281 (1021)
T ss_pred             HHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH------HHHHHHHhcC--CCCCcCCCCHHHHHHHHHHhcC
Confidence            999865  34789999999999999999999999754322      2233333332  2233346789999999999999


Q ss_pred             CcCCCCCHHHHhcCccccccCC
Q 024828          216 EPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       216 ~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +|.+||++.++|.|||++....
T Consensus       282 dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        282 SAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             ChhHCcCHHHHhccHHHhhcCC
Confidence            9999999999999999986654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=248.41  Aligned_cols=212  Identities=35%  Similarity=0.610  Sum_probs=182.9

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+.+|++++++++||||+++++.+.++...+++||++.+++|.+++.....++...+..++.|++.|+.++|+ .|+
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~-~~~  114 (250)
T cd05123          36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS-LGI  114 (250)
T ss_pred             HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            5568899999999999999999999999999999999999999999999988889999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+||+|+||+++.++.++++|||.+..............++..|++||...+...+.++|+|+||++++++++|..||.
T Consensus       115 ~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~  194 (250)
T cd05123         115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY  194 (250)
T ss_pred             eecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999999998766543333344567889999999988888999999999999999999999997


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH---HHHhcCccc
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA---QELMTHPFL  232 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~---~~~l~h~~~  232 (262)
                      ..+..       ..........  ...+...+..+.+++++||..||++|||+   ++++.||||
T Consensus       195 ~~~~~-------~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         195 AEDRK-------EIYEKILKDP--LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCCHH-------HHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            65431       2223333222  22234568999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-37  Score=249.60  Aligned_cols=211  Identities=25%  Similarity=0.445  Sum_probs=174.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....+.+|+.++++++||||+++++++.+....+++|||+.+++|.+++... ..+++..+..++.|++.||+|||+ .
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~  119 (256)
T cd05113          41 MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-K  119 (256)
T ss_pred             ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            33467899999999999999999999999888899999999999999999764 468999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ  166 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~  166 (262)
                      |++|+||+|.||+++.++.++++|||.+......... .....++..|+|||...+..++.++|+||||+++|+|++ |.
T Consensus       120 ~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~  199 (256)
T cd05113         120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK  199 (256)
T ss_pred             CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999987654332211 111234567999999988889999999999999999998 99


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      .||......       .....+..+..... ....++.+.+++.+||+.+|.+|||+.+++.+
T Consensus       200 ~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         200 MPYERFNNS-------ETVEKVSQGLRLYR-PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCcCcCCHH-------HHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            998764432       23333444433332 34568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=258.79  Aligned_cols=226  Identities=28%  Similarity=0.474  Sum_probs=193.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ........+.+|-+||++++.+.||.+-..|+..+.+|+|+..++||+|.-.|.+.+  .++++.+..++.+|+.||++|
T Consensus       224 Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl  303 (591)
T KOG0986|consen  224 KKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL  303 (591)
T ss_pred             HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH
Confidence            345556678899999999999999999999999999999999999999998887776  799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      |+ .+|+.||+||+|||+|+.|+++|+|+|+|..+... +.....+||.+|||||++.+..|+...|.|+|||++|+|+.
T Consensus       304 H~-~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~  381 (591)
T KOG0986|consen  304 HR-RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA  381 (591)
T ss_pred             Hh-cceeeccCChhheeeccCCCeEeeccceEEecCCC-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc
Confidence            98 99999999999999999999999999999887543 33344589999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCcc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~~  239 (262)
                      |+.||....+..-+.++.   +.....  +...+..++++.+++.+.+|..||++|.     +++++.+||||+.....+
T Consensus       382 G~sPFr~~KeKvk~eEvd---rr~~~~--~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  382 GHSPFRQRKEKVKREEVD---RRTLED--PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             ccCchhhhhhhhhHHHHH---HHHhcc--hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence            999998765543332222   222222  2333478999999999999999999998     678999999999866443

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=257.33  Aligned_cols=220  Identities=22%  Similarity=0.419  Sum_probs=175.5

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+|+++++.++|||++++++++.+++..++++||++ ++|.+++....  .+++..+..++.|++.||++||+ .
T Consensus        41 ~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~  118 (283)
T cd07835          41 VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS-H  118 (283)
T ss_pred             chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            34578899999999999999999999999999999999995 59999998766  68999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|+.
T Consensus       119 ~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  198 (283)
T cd07835         119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP  198 (283)
T ss_pred             CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987654333333334567889999988764 46889999999999999999999


Q ss_pred             CCCCCCccCchhhHHH------------------HHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          168 PYSPPEQQDGWTSFYE------------------LMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~------------------~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ||...+..........                  .........  ........++.++.+++.+||+.+|.+|||+++++
T Consensus       199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il  278 (283)
T cd07835         199 LFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL  278 (283)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            9976543211111000                  000000000  00111245778899999999999999999999999


Q ss_pred             cCccc
Q 024828          228 THPFL  232 (262)
Q Consensus       228 ~h~~~  232 (262)
                      .||||
T Consensus       279 ~~~~~  283 (283)
T cd07835         279 QHPYF  283 (283)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-37  Score=253.42  Aligned_cols=220  Identities=33%  Similarity=0.552  Sum_probs=182.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ......+.+|+++++.++|||++++++++.++...++||||+.+ ++.+++.. ..+++...+..++.|++.|+.|||+ 
T Consensus        62 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~-  139 (313)
T cd06633          62 NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-  139 (313)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            34456788999999999999999999999999999999999965 88877765 4568999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++|+|||.+....    ......++..|+|||.+.   +..++.++|+||||+++++|++
T Consensus       140 ~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~  215 (313)
T cd06633         140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  215 (313)
T ss_pred             CCeecCCCChhhEEECCCCCEEEeecCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999875422    223456788999999974   3457889999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~  241 (262)
                      |..||...+..       ...........+......++..+.+|+.+||+.+|.+||+++++++||||+..+..+.-
T Consensus       216 g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~  285 (313)
T cd06633         216 RKPPLFNMNAM-------SALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVL  285 (313)
T ss_pred             CCCCCCCCChH-------HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHHH
Confidence            99998765332       22223333334444445678889999999999999999999999999999987765553

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-38  Score=254.71  Aligned_cols=216  Identities=26%  Similarity=0.478  Sum_probs=170.2

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ...+.+|++++++++|+||+++++++.++...++||||+.+ +|.+++... ..++...+..++.|++.||.|||+ .|+
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i  124 (291)
T cd07844          47 PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ-RRV  124 (291)
T ss_pred             chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            34567899999999999999999999999999999999976 999988764 468999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      +|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||
T Consensus       125 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~  204 (291)
T cd07844         125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF  204 (291)
T ss_pred             ecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999886543322222233457789999998764 4789999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCC---------------------CC----CCCCCCCC--HHHHHHHHHhhcCCcCCCCC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQP---------------------PP----SAPSDQFS--PEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~---------------------~~----~~~~~~~~--~~l~~li~~~l~~~p~~Rpt  222 (262)
                      .......   .............                     ..    .......+  .++.+++.+||+.+|.+|||
T Consensus       205 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps  281 (291)
T cd07844         205 PGSTDVE---DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS  281 (291)
T ss_pred             CCCccHH---HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC
Confidence            7654211   0001000000000                     00    00001233  77899999999999999999


Q ss_pred             HHHHhcCccc
Q 024828          223 AQELMTHPFL  232 (262)
Q Consensus       223 ~~~~l~h~~~  232 (262)
                      +++++.||||
T Consensus       282 ~~e~l~~~~f  291 (291)
T cd07844         282 AAEAMKHPYF  291 (291)
T ss_pred             HHHHhcCCCC
Confidence            9999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=254.67  Aligned_cols=231  Identities=35%  Similarity=0.611  Sum_probs=195.9

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~   80 (262)
                      ++|..--+...+++..|+.|+++|+.|+||++|+.|.-+..+++|||||..||+.++++-+ +++++.++..+++..++|
T Consensus        62 AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKG  141 (502)
T KOG0574|consen   62 AIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKG  141 (502)
T ss_pred             EEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhH
Confidence            3444555667789999999999999999999999998888899999999999999999754 689999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |+|||. ..-+|+|||..|||++.+|..+|+|||.+-.....--..++..|++.|+|||++..-.|..++||||||++..
T Consensus       142 L~YLH~-~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaI  220 (502)
T KOG0574|consen  142 LQYLHD-LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAI  220 (502)
T ss_pred             HHHHHH-HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhh
Confidence            999998 8899999999999999999999999999876655444556778999999999999888999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhc-CCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      ||..|++||.+...-..       +-.+.. ..+....+...+.++.+++++||-.+|++|.|+-++++|||.+....+.
T Consensus       221 EMAEG~PPYsDIHPMRA-------IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  221 EMAEGRPPYSDIHPMRA-------IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             hhhcCCCCcccccccce-------eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence            99999999976543210       011111 1122223345678899999999999999999999999999999888766


Q ss_pred             c
Q 024828          240 V  240 (262)
Q Consensus       240 ~  240 (262)
                      +
T Consensus       294 I  294 (502)
T KOG0574|consen  294 I  294 (502)
T ss_pred             H
Confidence            5

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4e-38  Score=255.79  Aligned_cols=220  Identities=26%  Similarity=0.485  Sum_probs=175.2

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+|+.++++++|+||+++++.+.+.+..++||||+.+ +|.+++...   ..+++..+..++.|++.||.+||+ 
T Consensus        41 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-  118 (284)
T cd07836          41 TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-  118 (284)
T ss_pred             chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH-
Confidence            456777899999999999999999999999999999999976 999988754   358999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||+|+||++++++.++++|||.+..............++..|++||.+.+. .++.++|+|++|++++++++|+
T Consensus       119 ~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  198 (284)
T cd07836         119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR  198 (284)
T ss_pred             CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999887554433333334567889999988664 4688999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHH--------HHHhcCC-----CCCC-------CCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          167 FPYSPPEQQDGWTSFYELM--------EAIVDQP-----PPSA-------PSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~--------~~~~~~~-----~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      .||...+..+......+..        +.+....     .+..       .....+..+.+++.+||+.||.+||+++++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  278 (284)
T cd07836         199 PLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA  278 (284)
T ss_pred             CCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence            9998765443222211110        0000000     0000       012357789999999999999999999999


Q ss_pred             hcCccc
Q 024828          227 MTHPFL  232 (262)
Q Consensus       227 l~h~~~  232 (262)
                      ++||||
T Consensus       279 l~~~~f  284 (284)
T cd07836         279 LQHPWF  284 (284)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=265.73  Aligned_cols=209  Identities=28%  Similarity=0.460  Sum_probs=181.6

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      ++.-.-+++-|++|+|+||+.+.++|.....+|||||||..|-|..+++.+...+......|..+|+.|+.|||. ..|+
T Consensus       156 ~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~-hKII  234 (904)
T KOG4721|consen  156 RELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL-HKII  234 (904)
T ss_pred             hhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH-hhHh
Confidence            334456889999999999999999999999999999999999999999999999999999999999999999999 8999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      |+|||.-||||+.+..|||+|||-+...... .....+.||..|||||++...+.+.++||||||+++|||+||..||.+
T Consensus       235 HRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd  313 (904)
T KOG4721|consen  235 HRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD  313 (904)
T ss_pred             hhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence            9999999999999999999999987654433 455678899999999999999999999999999999999999999987


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      .+....       +-.+..+..--..+..+|+.++-||++||+..|.+||++.+++.|
T Consensus       314 VdssAI-------IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  314 VDSSAI-------IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             cchhee-------EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            665321       111222222233345788999999999999999999999999998

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-37  Score=246.19  Aligned_cols=212  Identities=26%  Similarity=0.418  Sum_probs=174.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ..+....+.+|++++++++||||+++++++......++||||+++++|.+++.+.+ .+++..+..++.|++.||.|||+
T Consensus        33 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~  112 (252)
T cd05084          33 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES  112 (252)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45667789999999999999999999999999999999999999999999997654 58999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc--ccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .|++|+||+|.||+++.++.++|+|||.+..........  .....+..|+|||.+.+..++.++|+||||+++|++++
T Consensus       113 -~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~  191 (252)
T cd05084         113 -KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS  191 (252)
T ss_pred             -CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence             999999999999999999999999999986543211111  11122456999999988889999999999999999997


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......       .....+....... .+..++..+.+++.+||+.+|++|||++++++
T Consensus       192 ~~~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         192 LGAVPYANLSNQ-------QTREAIEQGVRLP-CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCCCCccccCHH-------HHHHHHHcCCCCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             88888654321       2223333333332 23567899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.6e-37  Score=248.43  Aligned_cols=214  Identities=34%  Similarity=0.566  Sum_probs=183.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      .+....++.+|+++++.++|+||+++.+.+.++...++|+||+++++|.+++.+    ...++...+..++.|++.||++
T Consensus        39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~  118 (256)
T cd08530          39 SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA  118 (256)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            345567888999999999999999999999999999999999999999999876    3568999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ||+ .|++|+||+|.||+++.++.++++|||.+......  ......++..|+|||.+.+..++.++|+||+|+++++++
T Consensus       119 lh~-~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~  195 (256)
T cd08530         119 LHE-QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA  195 (256)
T ss_pred             Hhh-CCcccCCCCcceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH
Confidence            998 99999999999999999999999999988765443  222345788999999999888899999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      +|+.||...+..       +..........+..+ ..++.++.+++.+||+.+|++|||+.++++||++
T Consensus       196 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         196 TFAPPFEARSMQ-------DLRYKVQRGKYPPIP-PIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             hCCCCCCCCCHH-------HHHHHHhcCCCCCCc-hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999765432       233334444444333 4688999999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-37  Score=247.53  Aligned_cols=209  Identities=27%  Similarity=0.466  Sum_probs=173.5

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+++.+|+++++.++||||+++++++. +...+++|||+.+++|.+++.+.+.+++..+..++.|++.||++||. .|
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~  115 (257)
T cd05060          38 AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES-KH  115 (257)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cC
Confidence            35678899999999999999999999876 44689999999999999999988889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCccc---ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT---FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~---~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      ++|+||+|+||+++.++.++|+|||.+............   ..++..|+|||...+..++.++|+||||+++|++++ |
T Consensus       116 i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g  195 (257)
T cd05060         116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYG  195 (257)
T ss_pred             eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCC
Confidence            999999999999999999999999998766433322111   122357999999988889999999999999999998 9


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ..||...+..       +....+...... ..+..+++.+.+++.+||+.+|++|||+.++++
T Consensus       196 ~~p~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         196 AKPYGEMKGA-------EVIAMLESGERL-PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             CCCcccCCHH-------HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9999765432       222233333322 233568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.5e-38  Score=253.49  Aligned_cols=214  Identities=30%  Similarity=0.557  Sum_probs=182.1

Q ss_pred             HHHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+.+.+|+++++++. ||||+++++.+.+++..++|||++.+++|.+++.+.+.++...+..++.|++.||.+||+ 
T Consensus        42 ~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~-  120 (280)
T cd05581          42 EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS-  120 (280)
T ss_pred             hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            445578889999999998 999999999999999999999999999999999998889999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--------------------CcccccccccccCcccccCCCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--------------------QANTFVGTYNYMSPERISGGKYG  147 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--------------------~~~~~~~~~~y~~PE~~~~~~~~  147 (262)
                      .|++|+||+|+||+++.++.++++|||++........                    ......++..|+|||...+..++
T Consensus       121 ~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~  200 (280)
T cd05581         121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG  200 (280)
T ss_pred             CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC
Confidence            9999999999999999999999999998876543321                    12233567889999999888889


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH----
Q 024828          148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA----  223 (262)
Q Consensus       148 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----  223 (262)
                      .++|+|+||++++++++|+.||......       ..........  ...+..+++.+.+++.+||+.+|.+|||+    
T Consensus       201 ~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  271 (280)
T cd05581         201 KSSDLWALGCIIYQMLTGKPPFRGSNEY-------LTFQKILKLE--YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGY  271 (280)
T ss_pred             hhhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhcC--CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCH
Confidence            9999999999999999999999876522       1222222211  12234678999999999999999999999    


Q ss_pred             HHHhcCccc
Q 024828          224 QELMTHPFL  232 (262)
Q Consensus       224 ~~~l~h~~~  232 (262)
                      +++++||||
T Consensus       272 ~~ll~~~~~  280 (280)
T cd05581         272 DELKAHPFF  280 (280)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.5e-37  Score=249.64  Aligned_cols=210  Identities=30%  Similarity=0.571  Sum_probs=173.9

Q ss_pred             HHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCC
Q 024828           19 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS   98 (262)
Q Consensus        19 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~   98 (262)
                      +++++...||+|+++.+.+.+++..++|+||+.|++|..++.+.+.+++..+..++.|++.|++|||+ .+++|+||+|+
T Consensus        48 ~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~  126 (278)
T cd05606          48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPA  126 (278)
T ss_pred             HHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHH
Confidence            34555568999999999999999999999999999999999888889999999999999999999998 99999999999


Q ss_pred             CEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCccCc
Q 024828           99 NLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG  177 (262)
Q Consensus        99 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  177 (262)
                      ||+++.++.++|+|||++......  ......++..|+|||.+.++ .++.++|+||+|+++++|++|+.||........
T Consensus       127 nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~  204 (278)
T cd05606         127 NILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK  204 (278)
T ss_pred             HEEECCCCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch
Confidence            999999999999999998654322  22334688899999998754 588999999999999999999999976533211


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCC
Q 024828          178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGD  237 (262)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~  237 (262)
                          .. ............ +..++.++.+++.+||..+|.+||     +++++++||||+....
T Consensus       205 ----~~-~~~~~~~~~~~~-~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         205 ----HE-IDRMTLTMAVEL-PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             ----HH-HHHHhhccCCCC-CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence                11 111112222222 245689999999999999999999     9999999999988653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.8e-38  Score=258.45  Aligned_cols=224  Identities=25%  Similarity=0.381  Sum_probs=175.0

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..+.+|+.++++++|+||+++++++.+.  +..++||||+.+ +|.+++... ..++...+..++.|++.||++||+ .|
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~  128 (309)
T cd07845          51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE-NF  128 (309)
T ss_pred             chhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            3566899999999999999999998764  568999999975 899888764 678999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       129 i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~  208 (309)
T cd07845         129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL  208 (309)
T ss_pred             eecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987765443333333457789999998764 478999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHH--------H---h---cCCCCCCC-------CCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          169 YSPPEQQDGWTSFYELMEA--------I---V---DQPPPSAP-------SDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~--------~---~---~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      |...+..+...........        +   .   ........       ....++++.++|.+||+.||++|||+++++
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il  288 (309)
T cd07845         209 LPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL  288 (309)
T ss_pred             CCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            9865543221111111000        0   0   00000000       123578899999999999999999999999


Q ss_pred             cCccccccCCc
Q 024828          228 THPFLKMYGDL  238 (262)
Q Consensus       228 ~h~~~~~~~~~  238 (262)
                      .||||+..+-.
T Consensus       289 ~h~~f~~~~~~  299 (309)
T cd07845         289 ESSYFKEKPLP  299 (309)
T ss_pred             cChhhccCCCC
Confidence            99999865543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=253.79  Aligned_cols=217  Identities=25%  Similarity=0.413  Sum_probs=170.0

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ...+.+|+++++.++|+||+++.+++.++...|+|+||+. ++|.+++... ..++...+..++.|++.||+|||+ .|+
T Consensus        47 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i  124 (291)
T cd07870          47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHI  124 (291)
T ss_pred             cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Confidence            3467789999999999999999999999999999999996 5887776543 567888899999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      +|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+. .++.++|+||||+++++|++|..||
T Consensus       125 ~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f  204 (291)
T cd07870         125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF  204 (291)
T ss_pred             ccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999887654433333344568899999998764 4788999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHH---------------------hcCCCCC-----CCCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          170 SPPEQQDGWTSFYELMEAI---------------------VDQPPPS-----APSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      .......  ....+....+                     .....+.     ......+.++.+++.+|+..||.+|||+
T Consensus       205 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~  282 (291)
T cd07870         205 PGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA  282 (291)
T ss_pred             CCchhHH--HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence            7654321  1110100000                     0000000     0001235788999999999999999999


Q ss_pred             HHHhcCccc
Q 024828          224 QELMTHPFL  232 (262)
Q Consensus       224 ~~~l~h~~~  232 (262)
                      ++++.||||
T Consensus       283 ~~~l~h~~~  291 (291)
T cd07870         283 QDALLHPYF  291 (291)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-37  Score=248.28  Aligned_cols=212  Identities=24%  Similarity=0.400  Sum_probs=175.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +....+++.+|++++++++||||+++++++..++..+++||++.+++|.+++....  .++...+..++.|++.|+.+||
T Consensus        41 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH  120 (261)
T cd05068          41 GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE  120 (261)
T ss_pred             CcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            33446678899999999999999999999999999999999999999999997654  6899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc-cccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      + .|++|+||+|+||+++.++.++|+|||++........... ....+..|+|||...+..++.++|+||||+++++|++
T Consensus       121 ~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t  199 (261)
T cd05068         121 A-QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             h-CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHh
Confidence            8 9999999999999999999999999999876543221111 1122457999999988889999999999999999999


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |+.||......       .....+...... ..+...+..+.+++.+||+.+|.+||+++++++
T Consensus       200 ~g~~p~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         200 YGRMPYPGMTNA-------EVLQQVDQGYRM-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             cCCCCCCCCCHH-------HHHHHHHcCCCC-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence             99999764322       222333333222 223467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=248.32  Aligned_cols=210  Identities=24%  Similarity=0.467  Sum_probs=173.7

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...++.+|++++++++||||+++++++...+..++|+||++|++|.+++... +.+++..+..++.|++.||++||+ .|
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~  120 (256)
T cd05059          42 SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES-NG  120 (256)
T ss_pred             CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3456889999999999999999999999999999999999999999999764 468999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc-cccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF  167 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~  167 (262)
                      ++|+||+|+||+++.++.++++|||.+........... ...++..|+|||.+.+..++.++|+||||+++|++++ |+.
T Consensus       121 i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~  200 (256)
T cd05059         121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM  200 (256)
T ss_pred             cccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCC
Confidence            99999999999999999999999998865432211111 1123457999999998889999999999999999998 899


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||......       +....+........+ ..++.++.+++.+||..+|++|||++++++.
T Consensus       201 p~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         201 PYERFSNS-------EVVESVSAGYRLYRP-KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CCCCCCHH-------HHHHHHHcCCcCCCC-CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            99764432       223333333333332 4689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.3e-38  Score=260.24  Aligned_cols=224  Identities=26%  Similarity=0.457  Sum_probs=176.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+++|.+++.+..  .+++..+..++.|++.||+|||
T Consensus        39 ~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH  118 (328)
T cd08226          39 TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH  118 (328)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            34456788999999999999999999999999999999999999999999998653  4899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-------cccccccccccCcccccCC--CCCcchhHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-------ANTFVGTYNYMSPERISGG--KYGYKSDIWSLG  156 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG  156 (262)
                      + .|++|+||||+||+++.++.++++||+.+.........       .....++..|++||.+.+.  .++.++|+||+|
T Consensus       119 ~-~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG  197 (328)
T cd08226         119 Q-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG  197 (328)
T ss_pred             h-CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHH
Confidence            8 99999999999999999999999999754332211111       1111235569999998764  478999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhc--------------------------------------------CC
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--------------------------------------------QP  192 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~  192 (262)
                      |++++|++|+.||........      .......                                            ..
T Consensus       198 ~~l~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (328)
T cd08226         198 ITACELATGRVPFQDMLRTQM------LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSER  271 (328)
T ss_pred             HHHHHHHhCCCCCCCcChHHH------HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccc
Confidence            999999999999976543211      0010000                                            00


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          193 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       193 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      ........+++++.+|+++||+.||++|||++++++||||+.....
T Consensus       272 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         272 LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             ccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            0001122456789999999999999999999999999999877664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.5e-37  Score=248.22  Aligned_cols=212  Identities=26%  Similarity=0.440  Sum_probs=175.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +....+.+.+|+.+++.++|+||+++++.+.+++..++++||+.+++|.+++.+.  ..++...+..++.|++.||+|||
T Consensus        41 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH  120 (261)
T cd05072          41 GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE  120 (261)
T ss_pred             CchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4445678999999999999999999999999999999999999999999999754  46889999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      + .|++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus       121 ~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t  199 (261)
T cd05072         121 R-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT  199 (261)
T ss_pred             H-CCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHc
Confidence            8 9999999999999999999999999999876543221 1122334667999999988889999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......       .....+......+ ....++.++.+++.+||+.+|++|||++++++
T Consensus       200 ~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         200 YGKIPYPGMSNS-------DVMSALQRGYRMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             cCCCCCCCCCHH-------HHHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             99999764332       2223333333322 23468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-39  Score=249.28  Aligned_cols=222  Identities=28%  Similarity=0.528  Sum_probs=195.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ...+....-.-|-++|+.++||.+..+...|+.++.+|+||||.+||.|.-.+++.+.+++.....+...|+.||.|||+
T Consensus       207 iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs  286 (516)
T KOG0690|consen  207 IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS  286 (516)
T ss_pred             eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh
Confidence            34555566678889999999999999999999999999999999999999999998999999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       ++|+.+|+|.+|.+++.+|++++.|||++......+....+++|++.|+|||++....|+.+.|.|.+|++||||++|+
T Consensus       287 -~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGR  365 (516)
T KOG0690|consen  287 -RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGR  365 (516)
T ss_pred             -CCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhcc
Confidence             9999999999999999999999999999987777777788899999999999999999999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDL  238 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~  238 (262)
                      .||.+.+.+.    ..+++-.   ...  ..+..++++.+.|+..+|..||.+|.     .+.++.+|+||....+.
T Consensus       366 LPFyn~dh~k----LFeLIl~---ed~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  366 LPFYNKDHEK----LFELILM---EDL--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             CcccccchhH----HHHHHHh---hhc--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence            9999877643    2222211   111  12357899999999999999999998     78999999999877643

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.7e-37  Score=249.50  Aligned_cols=212  Identities=26%  Similarity=0.444  Sum_probs=174.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-----------------CCCCHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-----------------KTIPEEYLA   71 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------~~~~~~~~~   71 (262)
                      .....++.+|+.++++++||||+++++++..+...|++|||+++++|.+++...                 ..++...+.
T Consensus        48 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  127 (283)
T cd05090          48 PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL  127 (283)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHH
Confidence            445578899999999999999999999999999999999999999999998532                 236788899


Q ss_pred             HHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcc
Q 024828           72 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        72 ~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      .++.|++.||+|||+ .|++|+||+|+||+++.++.++++|||++.......  .......++..|+|||.+.+..++.+
T Consensus       128 ~i~~~i~~al~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05090         128 HIAIQIAAGMEYLSS-HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD  206 (283)
T ss_pred             HHHHHHHHHHHHHHh-cCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCch
Confidence            999999999999998 999999999999999999999999999987653221  11222334567999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+||||+++++|++ |..||.+...       ....+......... .+..+++.+.+++.+||+.+|.+||+++++++
T Consensus       207 ~Dv~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  278 (283)
T cd05090         207 SDIWSFGVVLWEIFSFGLQPYYGFSN-------QEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT  278 (283)
T ss_pred             hhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999999998 9999876432       12333333333332 33568899999999999999999999999976


Q ss_pred             C
Q 024828          229 H  229 (262)
Q Consensus       229 h  229 (262)
                      +
T Consensus       279 ~  279 (283)
T cd05090         279 R  279 (283)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-37  Score=255.29  Aligned_cols=223  Identities=28%  Similarity=0.487  Sum_probs=178.7

Q ss_pred             hhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+.+...-+.+|+..|.++ .|.+|+.++++-..++.+|+|||+-+. +|..++++... .+.-.++.+.+||+.|+.++
T Consensus       398 ~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I  476 (677)
T KOG0596|consen  398 ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI  476 (677)
T ss_pred             cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHH
Confidence            4677778899999999999 599999999999999999999999865 99999988754 44458899999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCC-----------CCCcchh
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGG-----------KYGYKSD  151 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-----------~~~~~~D  151 (262)
                      |. .||+|.||||.|+++ -.|.+||+|||.|..+.....  .....+||..|++||++...           ..++++|
T Consensus       477 H~-~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SD  554 (677)
T KOG0596|consen  477 HQ-HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSD  554 (677)
T ss_pred             HH-hceeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccc
Confidence            98 999999999999999 689999999999987654332  23456899999999998542           2578999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCc
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP  230 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~  230 (262)
                      ||||||++|+|+.|+.||...      .+....+..+....- .+.+...-..++.++++.||.+||++|||+.++|+||
T Consensus       555 vWSLGCILYqMvYgktPf~~~------~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp  628 (677)
T KOG0596|consen  555 VWSLGCILYQMVYGKTPFGQI------INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP  628 (677)
T ss_pred             hhhhhhHHHHHHhcCCchHHH------HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence            999999999999999999643      222233333332211 1111112234499999999999999999999999999


Q ss_pred             cccccCCc
Q 024828          231 FLKMYGDL  238 (262)
Q Consensus       231 ~~~~~~~~  238 (262)
                      |++-++=.
T Consensus       629 Fl~~~~i~  636 (677)
T KOG0596|consen  629 FLQIQPIP  636 (677)
T ss_pred             cccccccc
Confidence            99885533

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.6e-37  Score=248.85  Aligned_cols=213  Identities=26%  Similarity=0.434  Sum_probs=174.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKG   80 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~l~~~   80 (262)
                      .......+.+|+.+++.++|+||+++++++.+....++||||+.|++|.+++.+.+       .+++..+..++.|++.|
T Consensus        49 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~  128 (277)
T cd05036          49 SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG  128 (277)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHH
Confidence            34556778999999999999999999999998889999999999999999997653       48899999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCC---cEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      |+|||+ .|++|+||+|+||+++.++   .++|+|||++........  .......+..|+|||.+.+..++.++|||||
T Consensus       129 l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  207 (277)
T cd05036         129 CKYLEE-NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF  207 (277)
T ss_pred             HHHHHH-CCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHH
Confidence            999998 9999999999999998655   589999999876532111  1112233567999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          156 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       156 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||++|+|++ |..||......       +....+....... .+..++..+.+++.+||+.+|.+|||++++++|
T Consensus       208 G~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         208 GVLLWEIFSLGYMPYPGRTNQ-------EVMEFVTGGGRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999997 99999764432       2233333333322 235678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-38  Score=259.73  Aligned_cols=228  Identities=26%  Similarity=0.450  Sum_probs=183.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC-----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ....+.+.+|+.++++++||||+++.+++.+..     ..|++|||+.+ +|.+++.+...+++..+..++.+++.||++
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~  118 (330)
T cd07834          40 LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKY  118 (330)
T ss_pred             chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            455678999999999999999999999988765     78999999975 999999887889999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC---CCcccccccccccCcccccCC-CCCcchhHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVL  159 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l  159 (262)
                      ||+ .|++|+||+|.||+++.++.++|+|||.+.......   .......++..|+|||.+.+. .++.++|+||+|+++
T Consensus       119 LH~-~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il  197 (330)
T cd07834         119 LHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIF  197 (330)
T ss_pred             HHh-CCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHH
Confidence            998 999999999999999999999999999988765443   123334578889999999887 789999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHH--------------------HHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYEL--------------------MEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p  217 (262)
                      ++|++|++||...+..+........                    ..........  .......+.++.+++.+||+.+|
T Consensus       198 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  277 (330)
T cd07834         198 AELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP  277 (330)
T ss_pred             HHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh
Confidence            9999999999776543211111110                    0000000000  00012367889999999999999


Q ss_pred             CCCCCHHHHhcCccccccCCc
Q 024828          218 QQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .+|||+++++.||||+.....
T Consensus       278 ~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         278 KKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhCCCHHHHHhCccHHhhccc
Confidence            999999999999999877654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.9e-37  Score=249.24  Aligned_cols=211  Identities=24%  Similarity=0.416  Sum_probs=172.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------TIPEEYLAAICEQVLK   79 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~l~~   79 (262)
                      ....++.+|+.+++.++||||+++++++.++...++||||+++++|.+++.+.+          .++...+..++.|++.
T Consensus        51 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  130 (277)
T cd05062          51 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD  130 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHH
Confidence            455678899999999999999999999999999999999999999999997532          2567888999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGL  157 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~  157 (262)
                      ||+|||+ .|++|+||+|+||+++.++.++++|||++........  ......++..|+|||.+.+..++.++|+||||+
T Consensus       131 ~l~~lH~-~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  209 (277)
T cd05062         131 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV  209 (277)
T ss_pred             HHHHHHH-CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHH
Confidence            9999998 9999999999999999999999999998865432211  111223467899999999888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          158 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       158 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++|+|++ |..||......       +..........+. .+...++.+.+++.+||+.+|++|||+.+++++
T Consensus       210 ~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         210 VLWEIATLAEQPYQGMSNE-------QVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999998 78898764332       2223333333222 235678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.7e-37  Score=245.27  Aligned_cols=210  Identities=26%  Similarity=0.430  Sum_probs=172.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+.+|+.++++++||||+++++.+.. ...++||||+++++|.+++.. ...+++..+..++.|++.||++||+ 
T Consensus        36 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-  113 (257)
T cd05115          36 KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG-  113 (257)
T ss_pred             hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            4456679999999999999999999998764 568999999999999999975 4578999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc---ccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++|+|||.+..........   ....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus       114 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  193 (257)
T cd05115         114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS  193 (257)
T ss_pred             cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhc
Confidence            999999999999999999999999999987543322111   11122467999999988888999999999999999996


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......       +....+..+..+.. +...++++.+++.+||..+|++||++.++.+
T Consensus       194 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         194 YGQKPYKKMKGP-------EVMSFIEQGKRLDC-PAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCCCCcCcCCHH-------HHHHHHHCCCCCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             99999765432       23334444443333 3467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-37  Score=245.48  Aligned_cols=212  Identities=24%  Similarity=0.426  Sum_probs=177.3

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...+....+++.+|+.+++.++|+||+++++.+.++...++||||+++++|.+++.+..  .++...+..++.|++.||.
T Consensus        37 ~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  116 (256)
T cd05039          37 LKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME  116 (256)
T ss_pred             eccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence            33333457789999999999999999999999998899999999999999999998765  6899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |||+ .|++|+||+|+||+++.++.++|+|||.+........   ....+..|.|||.+.+..++.++|+||||++++++
T Consensus       117 ~lh~-~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l  192 (256)
T cd05039         117 YLEE-KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI  192 (256)
T ss_pred             HHHh-CCccchhcccceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHH
Confidence            9998 9999999999999999999999999999876532221   23345679999999888889999999999999999


Q ss_pred             Hh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          163 AT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       163 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ++ |..||......       .....+........ +..+++++.+++.+||..+|.+|||+++++.
T Consensus       193 ~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         193 YSFGRVPYPRIPLK-------DVVPHVEKGYRMEA-PEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HhcCCCCCCCCCHH-------HHHHHHhcCCCCCC-ccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            97 99998764322       23333333333322 3567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-37  Score=247.19  Aligned_cols=213  Identities=24%  Similarity=0.413  Sum_probs=177.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+.++.+|+.++++++||||+++++.+..++..+++|||+++++|.+++... +.++...+..++.|++.||++||+
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~  124 (266)
T cd05033          45 SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE  124 (266)
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4556778899999999999999999999999999999999999999999999764 468999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .|++|+||+|+||+++.++.++++|||++.........  .....++..|+|||.+.+..++.++|+||||++++++++
T Consensus       125 -~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~  203 (266)
T cd05033         125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS  203 (266)
T ss_pred             -CCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHc
Confidence             99999999999999999999999999998876421111  111234567999999998889999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                       |..||......       +....+......+. +..+++.+.+++.+||+.+|++||++++++++
T Consensus       204 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         204 YGERPYWDMSNQ-------DVIKAVEDGYRLPP-PMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             cCCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             99998654322       23334433333322 34678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.8e-37  Score=249.22  Aligned_cols=217  Identities=23%  Similarity=0.424  Sum_probs=177.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------TIPEEYLAAICEQVLK   79 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~l~~   79 (262)
                      ....++.+|+.+++.++||||+++++.+.++...++||||+++++|.+++.+.+          .++...+..++.|++.
T Consensus        51 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  130 (288)
T cd05061          51 RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD  130 (288)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHH
Confidence            345568899999999999999999999999999999999999999999997532          2456788899999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGL  157 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~  157 (262)
                      ||.|||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||
T Consensus       131 ~l~~lH~-~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~  209 (288)
T cd05061         131 GMAYLNA-KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV  209 (288)
T ss_pred             HHHHHHh-CCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHH
Confidence            9999998 9999999999999999999999999998865432211  111223456799999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc------Cc
Q 024828          158 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT------HP  230 (262)
Q Consensus       158 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~------h~  230 (262)
                      ++++|++ |..||......       +....+..+..... +...++.+.+++.+||+.+|.+|||+.++++      ||
T Consensus       210 ~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         210 VLWEITSLAEQPYQGLSNE-------QVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             HHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence            9999998 78898764322       23333333333322 2456889999999999999999999999987      89


Q ss_pred             ccccc
Q 024828          231 FLKMY  235 (262)
Q Consensus       231 ~~~~~  235 (262)
                      ||+..
T Consensus       282 ~~~~~  286 (288)
T cd05061         282 SFPEV  286 (288)
T ss_pred             CCCCC
Confidence            98765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=254.97  Aligned_cols=221  Identities=26%  Similarity=0.491  Sum_probs=177.5

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....+.+|++++++++|++|+++++.+.++...++++||+.+ +|.+++... ..++...+..++.|++.||.+||+ .
T Consensus        40 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~  117 (283)
T cd05118          40 GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-H  117 (283)
T ss_pred             hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            4567888999999999999999999999999999999999976 888888764 578999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+. .++.++|+||+|++++++++|+.
T Consensus       118 ~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~  197 (283)
T cd05118         118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP  197 (283)
T ss_pred             CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999887665443233334577889999998876 68999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHH---------------HHH----hcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          168 PYSPPEQQDGWTSFYELM---------------EAI----VDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~---------------~~~----~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      ||...+..+......+..               ...    ......  ......++.++.+++.+||++||.+||++.++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l  277 (283)
T cd05118         198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA  277 (283)
T ss_pred             CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence            997655432211111100               000    000000  00112467889999999999999999999999


Q ss_pred             hcCccc
Q 024828          227 MTHPFL  232 (262)
Q Consensus       227 l~h~~~  232 (262)
                      +.||||
T Consensus       278 l~~~~~  283 (283)
T cd05118         278 LAHPYF  283 (283)
T ss_pred             hhCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.7e-37  Score=248.97  Aligned_cols=213  Identities=34%  Similarity=0.557  Sum_probs=178.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ....++.+|+.+++.++||||+++++.+.+....++|+||+++++|.+++.+    ...+++..+..++.|++.||.+||
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH  123 (260)
T cd08222          44 NETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH  123 (260)
T ss_pred             chHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH
Confidence            3445677899999999999999999999999999999999999999998864    356899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      + .|++|+||+|+||+++ ++.++++|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|
T Consensus       124 ~-~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~  201 (260)
T cd08222         124 Q-RRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL  201 (260)
T ss_pred             H-cCccccCCChhheEee-cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            8 9999999999999996 4679999999887654433333345577889999999877788999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ..||.....       .........+..+. .+..++.++.+++.+||+.+|.+||+++++++||||
T Consensus       202 ~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         202 AHAFEGQNF-------LSVVLRIVEGPTPS-LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             CCCCCCccH-------HHHHHHHHcCCCCC-CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            999965322       23333333333333 335788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.2e-37  Score=251.48  Aligned_cols=212  Identities=28%  Similarity=0.449  Sum_probs=174.4

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ....+.+.+|+++++++ +||||+++++.+..++..+++|||+.+++|.+++....  .++...+..++.|++.||.|||
T Consensus        79 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH  158 (302)
T cd05055          79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA  158 (302)
T ss_pred             hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45567889999999999 79999999999999999999999999999999997643  3899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      + .|++|+||+|+||+++.++.++++|||.+........  ......++..|+|||.+.+..++.++|+||+|+++|+++
T Consensus       159 ~-~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~  237 (302)
T cd05055         159 S-KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF  237 (302)
T ss_pred             H-CCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHH
Confidence            8 9999999999999999999999999999875533221  111223466799999999888999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      + |..||......+      ........+.. .......++++.+++.+||+.+|++|||+++++.
T Consensus       238 t~g~~p~~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         238 SLGSNPYPGMPVDS------KFYKLIKEGYR-MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             hCCCCCcCCCCchH------HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8 999987654321      11122222222 2233457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5e-37  Score=249.02  Aligned_cols=212  Identities=31%  Similarity=0.482  Sum_probs=176.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC---------------CCCHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---------------TIPEEYLAA   72 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~   72 (262)
                      .......+.+|+++++.++|+||+++++++.++...+++|||+.+++|.+++...+               .++...+..
T Consensus        47 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~  126 (280)
T cd05092          47 SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA  126 (280)
T ss_pred             CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHH
Confidence            45566789999999999999999999999999999999999999999999997653               378899999


Q ss_pred             HHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcch
Q 024828           73 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        73 i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ++.|++.|++|||+ .|++|+||+|+||++++++.++|+|||++........  ......++..|+|||...+..++.++
T Consensus       127 ~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  205 (280)
T cd05092         127 IASQIASGMVYLAS-LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES  205 (280)
T ss_pred             HHHHHHHHHHHHHH-CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchh
Confidence            99999999999998 9999999999999999999999999998865432111  11122345789999999988899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+|||||++|+|++ |.+||......       ........+..... +..+++.+.+++.+||+.||++||+++++++
T Consensus       206 Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         206 DIWSFGVVLWEIFTYGKQPWYQLSNT-------EAIECITQGRELER-PRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             hHHHHHHHHHHHHcCCCCCCccCCHH-------HHHHHHHcCccCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999998 89999764332       22333434433332 3568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.9e-37  Score=252.09  Aligned_cols=217  Identities=24%  Similarity=0.446  Sum_probs=171.5

Q ss_pred             HHHHHHHHHHHhcCC-CCeeEeeceEEEECCe-----EEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSSQ-CPYVVVCYQSFYSNGA-----ISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~l~~~   80 (262)
                      ...+.+|+.+++.+. ||||+++++++.....     .|++|||+++ +|.+++...     ..+++..+..++.|++.|
T Consensus        44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  122 (295)
T cd07837          44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG  122 (295)
T ss_pred             chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence            457889999999995 6999999999887655     8999999986 898888643     357999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLV  158 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~  158 (262)
                      |.|||+ .|++|+||+|+||+++. ++.++++|||.+..............+++.|+|||.+.+. .++.++|+||||++
T Consensus       123 L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~  201 (295)
T cd07837         123 VAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI  201 (295)
T ss_pred             HHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHH
Confidence            999998 99999999999999998 7899999999987654433333334567889999988654 47899999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCC----------------------CCCCCCCCCHHHHHHHHHhhcCC
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP----------------------PSAPSDQFSPEFCSFISACVQKE  216 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~li~~~l~~~  216 (262)
                      +|+|++|..||......+..   ......+.....                      .......++.++.++|.+||..|
T Consensus       202 l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  278 (295)
T cd07837         202 FAEMSRKQPLFPGDSELQQL---LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYD  278 (295)
T ss_pred             HHHHHcCCCCCCCCCHHHHH---HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCC
Confidence            99999999999765433211   111111100000                      00011347888999999999999


Q ss_pred             cCCCCCHHHHhcCcccc
Q 024828          217 PQQRLSAQELMTHPFLK  233 (262)
Q Consensus       217 p~~Rpt~~~~l~h~~~~  233 (262)
                      |.+|||+++++.||||+
T Consensus       279 P~~R~~~~eil~~~~~~  295 (295)
T cd07837         279 PAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhcCCHHHHhcCCCcC
Confidence            99999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.6e-37  Score=246.62  Aligned_cols=209  Identities=26%  Similarity=0.455  Sum_probs=175.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...++.+|+++++.++|+||+++++++.+....++||||+++++|.+++.+.  ..++...+..++.|++.||.+||+ .
T Consensus        45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~  123 (261)
T cd05148          45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-Q  123 (261)
T ss_pred             hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            4667899999999999999999999999999999999999999999999764  458999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~  167 (262)
                      |++|+||+|+||+++.++.++++|||.+..............++..|+|||...+..++.++|+||||+++++|++ |+.
T Consensus       124 ~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~  203 (261)
T cd05148         124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV  203 (261)
T ss_pred             CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999998765433322223345667999999988889999999999999999998 899


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ||......       +....+........ +..+++++.+++.+||+.+|.+|||++++++
T Consensus       204 p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         204 PYPGMNNH-------EVYDQITAGYRMPC-PAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CCCcCCHH-------HHHHHHHhCCcCCC-CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99764422       22333333333322 3578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=245.27  Aligned_cols=215  Identities=31%  Similarity=0.511  Sum_probs=179.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+.+.+|++++++++|+||+++++.+.+.  ..+++++||+++++|.+++.+.+.++...+..++.|++.||.+||+
T Consensus        45 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~  124 (264)
T cd06653          45 SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS  124 (264)
T ss_pred             hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45567889999999999999999999998764  4688999999999999999888889999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC---CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++++|||.+.......   .......++..|+|||.+.+..++.++|+||||+++++++
T Consensus       125 -~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  203 (264)
T cd06653         125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML  203 (264)
T ss_pred             -CCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence             999999999999999999999999999987653211   1112345788899999999888899999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      +|+.||......       ...............+..+++++.+++.+||. +|.+||++.+++.|||.
T Consensus       204 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         204 TEKPPWAEYEAM-------AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             hCCCCCCccCHH-------HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999764322       22223333333333456788999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.6e-38  Score=259.34  Aligned_cols=229  Identities=25%  Similarity=0.450  Sum_probs=178.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ...+.+.+|+.++++++||||+++.+++..    ....++|+||+.+ +|.+++...+.++...+..++.|++.||+|||
T Consensus        46 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  124 (334)
T cd07855          46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH  124 (334)
T ss_pred             cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345677889999999999999999998753    4568999999964 99999988888999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC----cccccccccccCcccccC-CCCCcchhHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~  160 (262)
                      + .|++|+||+|+||+++.++.++|+|||++.........    .....++..|+|||.+.+ ..++.++|+||+|+++|
T Consensus       125 ~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~  203 (334)
T cd07855         125 S-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFA  203 (334)
T ss_pred             H-CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHH
Confidence            8 99999999999999999999999999998765432211    123467889999999865 35789999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHH----------------HHHHhcCCC--CCC----CCCCCCHHHHHHHHHhhcCCcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYEL----------------MEAIVDQPP--PSA----PSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~--~~~----~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      +|++|+.||...+...........                .........  ...    .....++++.+++++||+.+|.
T Consensus       204 el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  283 (334)
T cd07855         204 EMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPE  283 (334)
T ss_pred             HHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChh
Confidence            999999999765432111100000                000000000  000    0134688999999999999999


Q ss_pred             CCCCHHHHhcCccccccCCccc
Q 024828          219 QRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      +|||+++++.||||+.......
T Consensus       284 ~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         284 ERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hCcCHHHHHhChhhhhccCCcc
Confidence            9999999999999987765543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=238.79  Aligned_cols=216  Identities=25%  Similarity=0.371  Sum_probs=171.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC-----eEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVL   78 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~   78 (262)
                      +.+..+.+++|++..++++||||+++++....+.     ..|++++|...|||.+.++..    ..+++.+++.|+.+++
T Consensus        58 ~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic  137 (302)
T KOG2345|consen   58 SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGIC  137 (302)
T ss_pred             chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHH
Confidence            4588899999999999999999999998764433     389999999999999999765    2589999999999999


Q ss_pred             HHHHHHhhcCC--eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc---------cccccccccCcccccC---C
Q 024828           79 KGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN---------TFVGTYNYMSPERISG---G  144 (262)
Q Consensus        79 ~~l~~lh~~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---------~~~~~~~y~~PE~~~~---~  144 (262)
                      +||++||. ..  ++|+||||.||++++.+.+.+.|||.++..........         .-..+..|+|||.+.-   .
T Consensus       138 ~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~  216 (302)
T KOG2345|consen  138 RGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC  216 (302)
T ss_pred             HHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc
Confidence            99999998 88  99999999999999999999999998875532221111         1246889999999864   4


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       145 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      ..+.++|||||||++|.|+.|..||+..-+...     .+.-.+..+...-+....++..+.+++++||+.||.+||++.
T Consensus       217 ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-----SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~  291 (302)
T KOG2345|consen  217 TITERTDIWSLGCTLYAMMFGESPFERIYQQGG-----SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIP  291 (302)
T ss_pred             ccccccchhhhhHHHHHHHHcCCcchHHhhcCC-----eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHH
Confidence            478999999999999999999999974222110     000111222222222345899999999999999999999999


Q ss_pred             HHhcC
Q 024828          225 ELMTH  229 (262)
Q Consensus       225 ~~l~h  229 (262)
                      +++.+
T Consensus       292 ~ll~~  296 (302)
T KOG2345|consen  292 ELLSK  296 (302)
T ss_pred             HHHHH
Confidence            99864

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.7e-37  Score=245.45  Aligned_cols=213  Identities=23%  Similarity=0.398  Sum_probs=173.8

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEE-ECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKG   80 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~   80 (262)
                      |........+.+.+|+.++++++|++++++++.+. .+...++++||+++++|.+++.+.+  .++...+..++.|++.|
T Consensus        35 k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~  114 (256)
T cd05082          35 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA  114 (256)
T ss_pred             EEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            33334445668899999999999999999999764 4567899999999999999997654  37899999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |++||+ .|++|+||+|+||+++.++.++++|||++.......   .....+..|+|||.+.+..++.++|+|||||++|
T Consensus       115 l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~  190 (256)
T cd05082         115 MEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW  190 (256)
T ss_pred             HHHHHh-CCEeccccchheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHH
Confidence            999998 999999999999999999999999999887543322   2223456799999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|++ |+.||.....       ......+..+..+ .....+++.+.+++.+||+.+|.+|||++++++
T Consensus       191 ~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         191 EIYSFGRVPYPRIPL-------KDVVPRVEKGYKM-DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHhCCCCCCCCCCH-------HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9997 9999875432       2223333333322 233568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-37  Score=257.75  Aligned_cols=228  Identities=22%  Similarity=0.397  Sum_probs=178.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ......+.+|+.+++.++|+||+++++++...     ...|+++||+. ++|.+++.+.+.+++..+..++.|++.||.+
T Consensus        45 ~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~  123 (337)
T cd07858          45 RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY  123 (337)
T ss_pred             cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            33455677899999999999999999988654     34899999995 5999999888889999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l  162 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++.++|+||||+++++|
T Consensus       124 LH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  202 (337)
T cd07858         124 IHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL  202 (337)
T ss_pred             HHh-CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHH
Confidence            998 99999999999999999999999999998765443333334467889999998765 4588999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHH--------------------HHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFY--------------------ELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQR  220 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R  220 (262)
                      ++|+.||...+.........                    ...+.......+  ......+++++.+++++||+.+|++|
T Consensus       203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  282 (337)
T cd07858         203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR  282 (337)
T ss_pred             HcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhc
Confidence            99999997643211110000                    000000000000  00123578889999999999999999


Q ss_pred             CCHHHHhcCccccccCCc
Q 024828          221 LSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       221 pt~~~~l~h~~~~~~~~~  238 (262)
                      ||++++++||||+.....
T Consensus       283 ps~~ell~h~~~~~~~~~  300 (337)
T cd07858         283 ITVEEALAHPYLASLHDP  300 (337)
T ss_pred             cCHHHHHcCcchhhhcCc
Confidence            999999999999876544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8.1e-37  Score=249.70  Aligned_cols=231  Identities=38%  Similarity=0.793  Sum_probs=183.9

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ......+.+|+.++.+. +||||+++++++.++...+++|||+.+ +|.+++.. .+.++...+..++.|++.||+|||+
T Consensus        54 ~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~  132 (296)
T cd06618          54 KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE  132 (296)
T ss_pred             hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34556677788767666 599999999999999999999999955 88888765 3578999999999999999999997


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC----CCcchhHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~Di~slG~~l~~l  162 (262)
                      ..|++|+||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+..    ++.++|+||||+++|+|
T Consensus       133 ~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el  211 (296)
T cd06618         133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL  211 (296)
T ss_pred             hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHH
Confidence            359999999999999999999999999998765432222 2234677899999987553    78899999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCC-CCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~  241 (262)
                      ++|+.||......      .+..........+..+. ..++.++.+|+.+||+.||.+|||+++++.||||+........
T Consensus       212 ~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~  285 (296)
T cd06618         212 ATGQFPYKNCKTE------FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVD  285 (296)
T ss_pred             HhCCCCCCcchhH------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHHH
Confidence            9999999753221      12233333333332222 2478999999999999999999999999999999998887776


Q ss_pred             hhhHhh
Q 024828          242 LSEYFT  247 (262)
Q Consensus       242 ~~~~~~  247 (262)
                      .+.-+.
T Consensus       286 ~~~~~~  291 (296)
T cd06618         286 VAGWFQ  291 (296)
T ss_pred             HHHHHH
Confidence            665544

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.1e-37  Score=251.05  Aligned_cols=223  Identities=33%  Similarity=0.531  Sum_probs=184.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+++.+|+++++.++|+|++++.+++..+...++|+||+.| ++.+++.. ..+++...+..++.|++.|+.+||+ 
T Consensus        56 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-  133 (308)
T cd06634          56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-  133 (308)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            34556788999999999999999999999999999999999975 88877754 4568999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++++|||++.....    .....++..|+|||.+.   ....+.++|+||||+++++|++
T Consensus       134 ~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  209 (308)
T cd06634         134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (308)
T ss_pred             CCcccCCCCHHhEEECCCCcEEECCcccceeecC----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence            9999999999999999999999999998765432    22345778999999874   3457889999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccchhh
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  244 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~  244 (262)
                      |..||...+..       ...........+......++..+.++|.+||..+|++||+++++++|||+..........+.
T Consensus       210 g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~~~~  282 (308)
T cd06634         210 RKPPLFNMNAM-------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL  282 (308)
T ss_pred             CCCCCccccHH-------HHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChhHHHHH
Confidence            99998764321       22233333444444445788999999999999999999999999999999998766554433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-36  Score=243.98  Aligned_cols=210  Identities=22%  Similarity=0.376  Sum_probs=174.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+++.+|++++++++||||+++++.+.+ ...++++||+++++|.+++.+..  .++...+..++.|++.||.+||+ 
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-  115 (257)
T cd05040          38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES-  115 (257)
T ss_pred             HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh-
Confidence            567789999999999999999999999988 88999999999999999997764  68999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++++|||++.........   .....++..|+|||.+.+..++.++|+||||+++++|++
T Consensus       116 ~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t  195 (257)
T cd05040         116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT  195 (257)
T ss_pred             CCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHh
Confidence            99999999999999999999999999998766432211   112345678999999988889999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......       +..+.+.........+...+..+.+++.+||+.+|++|||+.+++.
T Consensus       196 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         196 YGEEPWAGLSGS-------QILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CCCCCCCCCCHH-------HHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence             99999754332       2222222222222233467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-38  Score=270.71  Aligned_cols=213  Identities=28%  Similarity=0.415  Sum_probs=175.8

Q ss_pred             cchhHHHHHHHHHHHHHHhcCC-CCeeEeeceEEE-E---C---CeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFY-S---N---GAISIILEYMDGGSLADFLKKV--KTIPEEYLAAIC   74 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~---~---~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~   74 (262)
                      +..++.+.+.+.+|++++++|+ |+|||.+++... .   +   -.+.|.||||.|++|-++++++  ..|++.++++|+
T Consensus        71 ~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf  150 (738)
T KOG1989|consen   71 YVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIF  150 (738)
T ss_pred             ecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHH
Confidence            4458899999999999999995 999999999321 1   1   2367889999999999999855  469999999999


Q ss_pred             HHHHHHHHHHhhcCC--eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc---------cccccccccCcccc--
Q 024828           75 EQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN---------TFVGTYNYMSPERI--  141 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---------~~~~~~~y~~PE~~--  141 (262)
                      .++++|+++||. ..  |+|||||-+|||++.+|..||||||.++..........         ...-|+.|++||.+  
T Consensus       151 ~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl  229 (738)
T KOG1989|consen  151 YDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL  229 (738)
T ss_pred             HHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh
Confidence            999999999998 88  99999999999999999999999998875543332111         12468899999975  


Q ss_pred             -cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCC
Q 024828          142 -SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  220 (262)
Q Consensus       142 -~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  220 (262)
                       .+...+.|+|||+|||+||-|+....||+.....           .+.++.....+...++..+.+||+.||++||.+|
T Consensus       230 ysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~R  298 (738)
T KOG1989|consen  230 YSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDER  298 (738)
T ss_pred             hcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccC
Confidence             4567899999999999999999999999976432           2333333333445799999999999999999999


Q ss_pred             CCHHHHhcC
Q 024828          221 LSAQELMTH  229 (262)
Q Consensus       221 pt~~~~l~h  229 (262)
                      |++-|++.+
T Consensus       299 PnI~Qv~~~  307 (738)
T KOG1989|consen  299 PNIYQVLEE  307 (738)
T ss_pred             CCHHHHHHH
Confidence            999999865

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=277.02  Aligned_cols=213  Identities=27%  Similarity=0.488  Sum_probs=186.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-------KTIPEEYLAAICEQVLK   79 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~l~~   79 (262)
                      .+++...+|.+|..+++.++|||||++++++.+....++++||+.||+|..++++.       ..++....+.++.|++.
T Consensus       734 ~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~  813 (1025)
T KOG1095|consen  734 SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAK  813 (1025)
T ss_pred             CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhh
Confidence            46889999999999999999999999999999999999999999999999999876       34899999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC--CCCcccccccccccCcccccCCCCCcchhHHHHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL  157 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~  157 (262)
                      |+.||++ ++++|+||..+|+|++....+|++|||+|+.+...  .........+..|+|||.+....++.++||||||+
T Consensus       814 G~~YLe~-~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGV  892 (1025)
T KOG1095|consen  814 GMNYLES-KHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGV  892 (1025)
T ss_pred             hhHHHHh-CCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHH
Confidence            9999998 99999999999999999999999999999843221  11112235567899999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          158 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       158 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ++||+++ |..||.+.+..       +++.....+.+.+.+ ..+|..+.++|..||+.+|++||++..|++
T Consensus       893 llWEifslG~~PY~~~~n~-------~v~~~~~~ggRL~~P-~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  893 LLWEIFSLGATPYPSRSNF-------EVLLDVLEGGRLDPP-SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HHHHHHhCCCCCCCCcchH-------HHHHHHHhCCccCCC-CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            9999999 89999986543       455555555555444 578999999999999999999999999988

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5e-37  Score=250.85  Aligned_cols=218  Identities=23%  Similarity=0.361  Sum_probs=173.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLAAICEQV   77 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~l   77 (262)
                      ....+.+.+|++++++++||||+++++++..++..++++|++.+++|.+++.+..           .++...+..++.|+
T Consensus        60 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  139 (296)
T cd05051          60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI  139 (296)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHH
Confidence            4567789999999999999999999999999999999999999999999998765           68999999999999


Q ss_pred             HHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHH
Q 024828           78 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        78 ~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      +.||+|||+ .|++|+||+|+||+++.++.++++|||.+........  ......++..|+|||.+.+..++.++|||||
T Consensus       140 ~~al~~LH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  218 (296)
T cd05051         140 ASGMRYLES-LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF  218 (296)
T ss_pred             HHHHHHHHH-cCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence            999999998 9999999999999999999999999999865432211  1122345678999999988889999999999


Q ss_pred             HHHHHHHHh--CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          156 GLVLLECAT--GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       156 G~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+++|++++  +..||......+.+........... ..........++.++.+++.+||+.+|.+|||+.+++.
T Consensus       219 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         219 GVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG-RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc-ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            999999998  6778866543322111111100000 11111122356789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.9e-37  Score=249.30  Aligned_cols=212  Identities=27%  Similarity=0.414  Sum_probs=173.8

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~   70 (262)
                      .....+.+.+|+.++.++ +||||+++++.+...+..++++||+++++|.+++.+..                .++...+
T Consensus        42 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  121 (297)
T cd05089          42 SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL  121 (297)
T ss_pred             CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHH
Confidence            345567889999999999 79999999999999999999999999999999997542                4788899


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcch
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ..++.|++.||++||+ .|++|+||+|+||+++.++.++|+|||++....... .......+..|+|||...+..++.++
T Consensus       122 ~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~  199 (297)
T cd05089         122 LQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKS  199 (297)
T ss_pred             HHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchh
Confidence            9999999999999998 999999999999999999999999999875422111 11112234569999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||||||+++|+|++ |..||......       +.......+..+. .+..++.++.+|+.+||+.+|.+|||++++++.
T Consensus       200 DvwSlG~il~el~t~g~~pf~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         200 DVWSFGVLLWEIVSLGGTPYCGMTCA-------ELYEKLPQGYRME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999997 99999765432       2333444433332 234688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.2e-37  Score=252.19  Aligned_cols=212  Identities=26%  Similarity=0.411  Sum_probs=173.9

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~   70 (262)
                      +....+.+.+|++++.++ +|+||+++++++.+++..++|+||+++++|.+++.+.+                .++...+
T Consensus        47 ~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  126 (303)
T cd05088          47 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL  126 (303)
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHH
Confidence            455667889999999999 89999999999999999999999999999999997542                4788999


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcch
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++
T Consensus       127 ~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~  204 (303)
T cd05088         127 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNS  204 (303)
T ss_pred             HHHHHHHHHHHHHHHh-CCccccccchheEEecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccc
Confidence            9999999999999998 999999999999999999999999999875322111 11122335679999999888889999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |+||||++++++++ |..||......       +............ .....++++.+|+.+||+.+|.+||++++++.+
T Consensus       205 Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         205 DVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cchhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999998 99999754432       2233333332222 224578899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-37  Score=252.94  Aligned_cols=221  Identities=23%  Similarity=0.426  Sum_probs=171.6

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...+.+.+|+.++++++||||+++++.+.+.  ...++||||+.+ +|.+++...     ..+++..+..++.|++.||.
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  122 (316)
T cd07842          44 GISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH  122 (316)
T ss_pred             CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHH
Confidence            3346678899999999999999999999987  789999999965 888777532     26899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEcc----CCcEEEEecccccccccCCC---CcccccccccccCcccccCC-CCCcchhHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINH----RGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWS  154 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~----~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s  154 (262)
                      |||+ .|++|+||+|+||+++.    ++.++++|||++........   ......++..|+|||.+.+. .++.++|+||
T Consensus       123 ~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  201 (316)
T cd07842         123 YLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWA  201 (316)
T ss_pred             HHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHH
Confidence            9998 99999999999999998    88999999999876543322   12233567889999988764 4789999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCc------hhhHHHHHHHHhc--------------------CCCCCCCC----------
Q 024828          155 LGLVLLECATGQFPYSPPEQQDG------WTSFYELMEAIVD--------------------QPPPSAPS----------  198 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~--------------------~~~~~~~~----------  198 (262)
                      ||+++++|++|+.||........      ..........+..                    ........          
T Consensus       202 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (316)
T cd07842         202 IGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK  281 (316)
T ss_pred             HHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHh
Confidence            99999999999999986554320      0011111111000                    00000000          


Q ss_pred             -CCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          199 -DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       199 -~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                       ...+.++.+++.+||++||++|||+++++.||||
T Consensus       282 ~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             ccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence             1466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=260.22  Aligned_cols=227  Identities=25%  Similarity=0.423  Sum_probs=205.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828            6 NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         6 ~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .++....+.+..|-+||..++.|.||++|..|.++.+.|+.||-|-||.|+..++.++.+.......++..+++|++|||
T Consensus       458 IVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH  537 (732)
T KOG0614|consen  458 IVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH  537 (732)
T ss_pred             ccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH
Confidence            35677788899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      + +||+.+||||+|.+++.+|.+||.|||++..++.. ..+.+++||+.|.|||++.+...+.++|.|+||+++|||++|
T Consensus       538 ~-k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G  615 (732)
T KOG0614|consen  538 R-KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG  615 (732)
T ss_pred             h-cCceeccCChhheeeccCCceEEeehhhHHHhccC-CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence            9 99999999999999999999999999999988754 467789999999999999999999999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCCccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~~~~  240 (262)
                      .+||.+.+.-..+       ..++++...-..+..+++...+||+++...+|.+|..     +.+|-+|.||..+.+.+.
T Consensus       616 ~pPFs~~dpmktY-------n~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  616 SPPFSGVDPMKTY-------NLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             CCCCCCCchHHHH-------HHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence            9999997765333       3344444444555788999999999999999999995     899999999999998776


Q ss_pred             c
Q 024828          241 D  241 (262)
Q Consensus       241 ~  241 (262)
                      .
T Consensus       689 r  689 (732)
T KOG0614|consen  689 R  689 (732)
T ss_pred             h
Confidence            4

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.9e-37  Score=249.71  Aligned_cols=212  Identities=25%  Similarity=0.431  Sum_probs=175.1

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHH
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLA   71 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~   71 (262)
                      +....++.+|+++++++ +|+||+++++++..++..+++|||+.+++|.++++..                +.++...+.
T Consensus        56 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  135 (293)
T cd05053          56 EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV  135 (293)
T ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHH
Confidence            44556788999999999 8999999999999999999999999999999999643                358899999


Q ss_pred             HHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcc
Q 024828           72 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        72 ~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      .++.|++.||.|||+ .|++|+||+|.||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.+
T Consensus       136 ~i~~qi~~al~~LH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  214 (293)
T cd05053         136 SFAYQVARGMEFLAS-KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ  214 (293)
T ss_pred             HHHHHHHHHHHHHHH-CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc
Confidence            999999999999998 9999999999999999999999999999876543221  1112234567999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+|||||++|++++ |..||......       +....+..+..+.. +...+.++.+|+.+||..+|++|||++++++
T Consensus       215 ~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~eil~  286 (293)
T cd05053         215 SDVWSFGVLLWEIFTLGGSPYPGIPVE-------ELFKLLKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRPTFKQLVE  286 (293)
T ss_pred             cceeehhhHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999999997 88998764332       23333434433332 3467889999999999999999999999987


Q ss_pred             C
Q 024828          229 H  229 (262)
Q Consensus       229 h  229 (262)
                      +
T Consensus       287 ~  287 (293)
T cd05053         287 D  287 (293)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-36  Score=246.88  Aligned_cols=211  Identities=25%  Similarity=0.446  Sum_probs=173.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc------------------------CC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV------------------------KT   64 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~   64 (262)
                      .....++.+|+++++.++||||+++++.+..++..++++||+.+++|.+++...                        ..
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  123 (290)
T cd05045          44 SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA  123 (290)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccc
Confidence            344578899999999999999999999999999999999999999999998643                        24


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCccccc
Q 024828           65 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS  142 (262)
Q Consensus        65 ~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~  142 (262)
                      ++...+..++.|++.||++||+ .|++|+||+|+||++++++.++|+|||++........  ......++..|+|||.+.
T Consensus       124 l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  202 (290)
T cd05045         124 LTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF  202 (290)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHH-CCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence            7888999999999999999998 9999999999999999999999999999875432221  112223456899999998


Q ss_pred             CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC
Q 024828          143 GGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL  221 (262)
Q Consensus       143 ~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  221 (262)
                      +..++.++|+||||+++++|++ |..||......       ...+......... .+..++.++.+++.+||+.+|++||
T Consensus       203 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp  274 (290)
T cd05045         203 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-------RLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRP  274 (290)
T ss_pred             cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCC
Confidence            8889999999999999999998 99999764432       2222333332222 2356889999999999999999999


Q ss_pred             CHHHHhc
Q 024828          222 SAQELMT  228 (262)
Q Consensus       222 t~~~~l~  228 (262)
                      +++++++
T Consensus       275 ~~~~i~~  281 (290)
T cd05045         275 TFADISK  281 (290)
T ss_pred             CHHHHHH
Confidence            9999964

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.1e-37  Score=244.31  Aligned_cols=200  Identities=25%  Similarity=0.360  Sum_probs=166.1

Q ss_pred             HHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCC
Q 024828           16 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL   95 (262)
Q Consensus        16 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl   95 (262)
                      .+|...+....||||+++++.+.++...+++|||++|++|.+++.+...++...+..++.|++.||+|||+ .|++|+||
T Consensus        33 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl  111 (237)
T cd05576          33 SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR-EGIVCRDL  111 (237)
T ss_pred             hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCC
Confidence            34555555667999999999999999999999999999999999888889999999999999999999998 99999999


Q ss_pred             CCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 024828           96 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ  175 (262)
Q Consensus        96 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  175 (262)
                      +|+||+++.++.++++|||.+.......   ....++..|+|||...+..++.++|+||+|++++++++|..|+......
T Consensus       112 kp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~  188 (237)
T cd05576         112 NPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG  188 (237)
T ss_pred             CHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh
Confidence            9999999999999999999775543221   2234466799999998888899999999999999999999887542211


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH-----HHHhcCccc
Q 024828          176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-----QELMTHPFL  232 (262)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~~l~h~~~  232 (262)
                      .            ...... ..+..+++.+.+++.+||+.||.+||++     ++++.||||
T Consensus       189 ~------------~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         189 I------------NTHTTL-NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             c------------cccccc-CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            0            000011 1224578999999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.3e-36  Score=249.80  Aligned_cols=212  Identities=24%  Similarity=0.416  Sum_probs=174.4

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHH
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLA   71 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~   71 (262)
                      +....++.+|+++++.+ +||||+++++.+..++..++|+||+.+++|.+++..++                .++...+.
T Consensus        64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~  143 (307)
T cd05098          64 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV  143 (307)
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHH
Confidence            45567888999999999 79999999999999999999999999999999997642                37888999


Q ss_pred             HHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcc
Q 024828           72 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        72 ~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      .++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.+
T Consensus       144 ~~~~qi~~aL~~lH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  222 (307)
T cd05098         144 SCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ  222 (307)
T ss_pred             HHHHHHHHHHHHHHH-CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH
Confidence            999999999999998 9999999999999999999999999999865432211  1111223467999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+||||+++|+|++ |..||.....       .+....+....... .+...+.++.+++.+||..+|++|||++++++
T Consensus       223 ~DvwslG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         223 SDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            999999999999998 8888865432       23333333333333 23567899999999999999999999999976


Q ss_pred             C
Q 024828          229 H  229 (262)
Q Consensus       229 h  229 (262)
                      +
T Consensus       295 ~  295 (307)
T cd05098         295 D  295 (307)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.3e-36  Score=247.73  Aligned_cols=219  Identities=34%  Similarity=0.564  Sum_probs=181.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+..+.+.+|++++++++|||++++++++.++...++||||+.| +|.+.+.. ..+++...+..++.+++.||.+||+ 
T Consensus        66 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-  143 (317)
T cd06635          66 NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-  143 (317)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            44556889999999999999999999999999999999999976 88777754 4678999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++++|||++.....    .....++..|+|||.+.   +..++.++|+||+|+++++|++
T Consensus       144 ~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~  219 (317)
T cd06635         144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  219 (317)
T ss_pred             CCcccCCCCcccEEECCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh
Confidence            9999999999999999999999999998764322    22345778899999974   3458899999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      |..||......       .....+.....+......+++.+.+++.+||+.+|.+||++.++++|+|+........
T Consensus       220 g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         220 RKPPLFNMNAM-------SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             CCCCCCCccHH-------HHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            99998764321       2223333344444444568889999999999999999999999999999976655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-36  Score=243.56  Aligned_cols=210  Identities=25%  Similarity=0.427  Sum_probs=171.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+.+.+|++++++++|||++++++++.. ...+++|||+.+++|.+++.+..  .++...+..++.|++.||+|||+
T Consensus        42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  120 (260)
T cd05069          42 TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER  120 (260)
T ss_pred             CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3445678899999999999999999988754 56889999999999999997643  47899999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                       .|++|+||+|+||++++++.++|+|||.+........ ......++..|+|||...+...+.++|+||||+++|+|++ 
T Consensus       121 -~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~  199 (260)
T cd05069         121 -MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK  199 (260)
T ss_pred             -CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhC
Confidence             9999999999999999999999999999875533221 1112234567999999988889999999999999999999 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |..||.+....       +....+....... .+...+..+.+++.+||..+|++||+++++++
T Consensus       200 g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         200 GRVPYPGMVNR-------EVLEQVERGYRMP-CPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CCCCCCCCCHH-------HHHHHHHcCCCCC-CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            89999764432       2223333333222 23467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-36  Score=245.46  Aligned_cols=217  Identities=24%  Similarity=0.361  Sum_probs=171.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ......+.+|+++++.++||||+++++++..  ....+++|||+++++|.+++.. ..++...+..++.|++.||.+||+
T Consensus        47 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~  125 (283)
T cd05080          47 QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHS  125 (283)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3456788899999999999999999998765  3468999999999999999976 469999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++|+||||+++++|+
T Consensus       126 -~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~  204 (283)
T cd05080         126 -QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL  204 (283)
T ss_pred             -CCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence             99999999999999999999999999998765432211   11223456799999998888999999999999999999


Q ss_pred             hCCCCCCCCCccCc--------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 TGQFPYSPPEQQDG--------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|..|+........        .................. .+..++.++.+++.+||+.+|++|||+++++.
T Consensus       205 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         205 THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            99999865432100        000111111122222222 23567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-36  Score=244.61  Aligned_cols=215  Identities=27%  Similarity=0.460  Sum_probs=175.9

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...+....+++.+|+.++++++|+||+++++.+..+...+++||++++++|.+++.+..  .++...+..++.+++.|+.
T Consensus        38 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~  117 (261)
T cd05034          38 LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA  117 (261)
T ss_pred             ecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHH
Confidence            33344556789999999999999999999999998889999999999999999997653  6899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      +||+ .|++|+||+|+||+++.++.++++|||.+........ .......+..|+|||.+.+...+.++|+||+|+++++
T Consensus       118 ~lh~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~  196 (261)
T cd05034         118 YLES-RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTE  196 (261)
T ss_pred             HHHh-CCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHH
Confidence            9998 9999999999999999999999999998876542111 1111223567999999998889999999999999999


Q ss_pred             HHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +++ |+.||......       .....+..+.....+ ...+.++.+++.+||+.+|.+||+++++++
T Consensus       197 l~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         197 IVTYGRVPYPGMTNR-------EVLEQVERGYRMPRP-PNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHhCCCCCCCCCCHH-------HHHHHHHcCCCCCCC-CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            998 99999654322       233344433332222 356889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=252.24  Aligned_cols=222  Identities=27%  Similarity=0.493  Sum_probs=177.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+.+.+|+.++++++|+|++++++++.+.+..++|+|++.+ +|.+++.+. ..++...+..++.+++.||++||+ 
T Consensus        39 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~-  116 (282)
T cd07829          39 EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS-  116 (282)
T ss_pred             ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            33456778899999999999999999999999999999999975 999999886 579999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||++++++++|+
T Consensus       117 ~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~  196 (282)
T cd07829         117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK  196 (282)
T ss_pred             CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999887654443333334556789999998776 6889999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHH-----------HH--hcCCCCC-------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          167 FPYSPPEQQDGWTSFYELME-----------AI--VDQPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~-----------~~--~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      .||......+..........           .+  .....+.       ......+.++.+++.+||..+|++||+++++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  276 (282)
T cd07829         197 PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA  276 (282)
T ss_pred             CCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence            99977543322111111100           00  0000000       1112347889999999999999999999999


Q ss_pred             hcCccc
Q 024828          227 MTHPFL  232 (262)
Q Consensus       227 l~h~~~  232 (262)
                      +.||||
T Consensus       277 l~~p~~  282 (282)
T cd07829         277 LKHPYF  282 (282)
T ss_pred             hhCcCC
Confidence            999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-36  Score=247.63  Aligned_cols=223  Identities=28%  Similarity=0.509  Sum_probs=183.7

Q ss_pred             HHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..+.+.+|+++++++ +|++|+++++.+..+...++|+||+++++|.+++...++++...+..++.|++.||.+||+ .|
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~  125 (290)
T cd05613          47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-LG  125 (290)
T ss_pred             HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            446778999999999 6999999999999999999999999999999999988889999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      ++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+.  ..+.++|+||+|+++|++++|.
T Consensus       126 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~  205 (290)
T cd05613         126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA  205 (290)
T ss_pred             eeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCC
Confidence            9999999999999999999999999887643321 122234578899999998753  3678999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCcc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~~  239 (262)
                      .||.......   ..............+  .+..+++.+.+++.+||..+|.+||     ++++++.||||+......
T Consensus       206 ~p~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         206 SPFTVDGEKN---SQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             CCCCcCCccc---cHHHHHHHhhccCCC--CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence            9997543322   122333333333222  2345789999999999999999997     899999999999887433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-36  Score=248.76  Aligned_cols=212  Identities=23%  Similarity=0.408  Sum_probs=173.1

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~   70 (262)
                      ......++.+|+++++++ +||||+++++++.+++..++++||+++++|.+++...                ..++...+
T Consensus        57 ~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~  136 (314)
T cd05099          57 TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL  136 (314)
T ss_pred             ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHH
Confidence            345566788999999999 6999999999999999999999999999999999764                24788899


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCc
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGY  148 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~  148 (262)
                      ..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.
T Consensus       137 ~~~~~qi~~aL~~lH~-~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (314)
T cd05099         137 VSCAYQVARGMEYLES-RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH  215 (314)
T ss_pred             HHHHHHHHHHHHHHHH-CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence            9999999999999998 99999999999999999999999999998755322111  11122345799999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ++|+||||+++|++++ |..||......       .....+....... ....++.++.+++.+||+.+|++|||+.+++
T Consensus       216 ~~DiwslG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll  287 (314)
T cd05099         216 QSDVWSFGILMWEIFTLGGSPYPGIPVE-------ELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLV  287 (314)
T ss_pred             cchhhHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            9999999999999999 88898664332       2223333333222 2346788999999999999999999999998


Q ss_pred             c
Q 024828          228 T  228 (262)
Q Consensus       228 ~  228 (262)
                      .
T Consensus       288 ~  288 (314)
T cd05099         288 E  288 (314)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=254.81  Aligned_cols=216  Identities=28%  Similarity=0.476  Sum_probs=169.8

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECC-eEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .++|.+|+.++.+++|||+|+++++|.+.+ ..+||+||+..|+|.+++....  ++++..+.+|+.+++.||+|||...
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~  194 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC  194 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence            566999999999999999999999999988 5999999999999999997765  8999999999999999999999855


Q ss_pred             C--eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccc-cccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           89 H--IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~-~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      .  ++|+|||+.|||+|.+...|++|||++............. .|+.+|++||+...+..+.++||||||++++|+++|
T Consensus       195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitg  274 (361)
T KOG1187|consen  195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITG  274 (361)
T ss_pred             CCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhC
Confidence            3  9999999999999999999999999995433212222222 789999999999988999999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHH-HhcCC-----CCCCCCCCCC-----HHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEA-IVDQP-----PPSAPSDQFS-----PEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +.+......... ....++... +..+.     .+......++     ..+..+..+|++.+|.+||+..++++
T Consensus       275 r~~~d~~~~~~~-~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  275 RKAVDQSRPRGE-LSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CcccCCCCCccc-ccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            988875431111 112222211 11111     1111102333     22567888999999999999999744

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-36  Score=256.47  Aligned_cols=213  Identities=28%  Similarity=0.396  Sum_probs=173.6

Q ss_pred             hHHHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc------------------------
Q 024828            8 EESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV------------------------   62 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------------------   62 (262)
                      .....+.+.+|+++++++. ||||+++++++.+....|+||||+++++|.+++.++                        
T Consensus        80 ~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (400)
T cd05105          80 RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPA  159 (400)
T ss_pred             ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcc
Confidence            3555678999999999995 999999999999999999999999999999988642                        


Q ss_pred             ------------------------------------------------------------------------CCCCHHHH
Q 024828           63 ------------------------------------------------------------------------KTIPEEYL   70 (262)
Q Consensus        63 ------------------------------------------------------------------------~~~~~~~~   70 (262)
                                                                                              ..++...+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~  239 (400)
T cd05105         160 DESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDL  239 (400)
T ss_pred             cccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHH
Confidence                                                                                    13677888


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCc
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGY  148 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  148 (262)
                      ..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.
T Consensus       240 ~~~~~qi~~aL~~LH~-~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  318 (400)
T cd05105         240 LSFTYQVARGMEFLAS-KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT  318 (400)
T ss_pred             HHHHHHHHHHHHHHHh-CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc
Confidence            8999999999999998 9999999999999999999999999999875432221  112234567899999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ++||||||+++|+|++ |..||.......      .....+..+..+. ....++.++.+++.+||+.+|++|||+.++.
T Consensus       319 ~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  391 (400)
T cd05105         319 LSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLS  391 (400)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence            9999999999999997 889987643321      1222333333322 2356789999999999999999999999886


Q ss_pred             c
Q 024828          228 T  228 (262)
Q Consensus       228 ~  228 (262)
                      +
T Consensus       392 ~  392 (400)
T cd05105         392 D  392 (400)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-36  Score=248.41  Aligned_cols=219  Identities=26%  Similarity=0.392  Sum_probs=173.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-----------CCCHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLAAICEQ   76 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~   76 (262)
                      ......++.+|+++++.++|+||+++++++.+++..+++|||+++++|.+++.+..           .++...+..++.|
T Consensus        59 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  138 (296)
T cd05095          59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ  138 (296)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHH
Confidence            45567789999999999999999999999999999999999999999999997643           2567789999999


Q ss_pred             HHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHH
Q 024828           77 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        77 l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      ++.||++||+ .|++|+||+|+||+++.++.++|+|||++........  .......+..|++||...++.++.++|+||
T Consensus       139 i~~al~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS  217 (296)
T cd05095         139 IASGMKYLSS-LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA  217 (296)
T ss_pred             HHHHHHHHHH-CCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence            9999999998 9999999999999999999999999999875432211  111223456799999988888999999999


Q ss_pred             HHHHHHHHHh--CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          155 LGLVLLECAT--GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       155 lG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |||++|+|++  |..||......+.................. ..+..+++.+.+|+.+||+.||.+||++.++++
T Consensus       218 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         218 FGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYL-PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999998  778887654433222111111111111111 122457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=244.19  Aligned_cols=211  Identities=26%  Similarity=0.414  Sum_probs=172.4

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~   70 (262)
                      .....+.+.+|++++.++ +||||+++++.+...+..+++|||+++++|.+++.+.+                .++...+
T Consensus        35 ~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~  114 (270)
T cd05047          35 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL  114 (270)
T ss_pred             CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHH
Confidence            345667889999999999 89999999999999999999999999999999997543                3788999


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcch
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ..++.|++.||+|||+ .|++|+||+|+||+++.++.++++|||++....... .......+..|+|||.+.+..++.++
T Consensus       115 ~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~  192 (270)
T cd05047         115 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNS  192 (270)
T ss_pred             HHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchh
Confidence            9999999999999998 999999999999999999999999999875322111 11112234579999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+||||+++++|++ |..||......       .....+..+..... ....+.++.+++.+||..+|.+|||+++++.
T Consensus       193 Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         193 DVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             hHHHHHHHHHHHHcCCCCCccccCHH-------HHHHHHhCCCCCCC-CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            99999999999997 99999764322       22333333333222 2457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.7e-37  Score=253.11  Aligned_cols=215  Identities=24%  Similarity=0.402  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECC--------eEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNG--------AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...+.+|++++++++||||+++++++....        ..++|+||+.+ +|.+++.+.. .+++..+..++.|++.||.
T Consensus        55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~  133 (310)
T cd07865          55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLY  133 (310)
T ss_pred             hhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999886543        46999999965 8988887653 6899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC----cccccccccccCcccccCCC-CCcchhHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPERISGGK-YGYKSDIWSLGL  157 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~  157 (262)
                      |||+ .|++|+||+|+||+++.++.++|+|||.+.........    .....++..|+|||.+.+.. ++.++|+||+|+
T Consensus       134 ~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  212 (310)
T cd07865         134 YIHR-NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC  212 (310)
T ss_pred             HHHH-CCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHH
Confidence            9998 99999999999999999999999999998765432211    12235677899999887654 688999999999


Q ss_pred             HHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC------------------C---------CCCCCCCHHHHHHHH
Q 024828          158 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP------------------S---------APSDQFSPEFCSFIS  210 (262)
Q Consensus       158 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~---------~~~~~~~~~l~~li~  210 (262)
                      ++++|++|+.||...+.....    ..+..+.....+                  .         ......++.+.+||.
T Consensus       213 ~l~el~t~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~  288 (310)
T cd07865         213 IMAEMWTRSPIMQGNTEQHQL----TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLID  288 (310)
T ss_pred             HHHHHHhCCCCCCCCCHHHHH----HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHH
Confidence            999999999999765432211    111111110000                  0         001123567889999


Q ss_pred             HhhcCCcCCCCCHHHHhcCccc
Q 024828          211 ACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       211 ~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      +||..||.+|||++++++||||
T Consensus       289 ~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         289 KLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHhcCChhhccCHHHHhcCCCC
Confidence            9999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=261.36  Aligned_cols=219  Identities=33%  Similarity=0.553  Sum_probs=194.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .+.+...++..|++.|++++|||.+.+.++|.-+...++|||||-| |-.+++.-. +++.+..+..|+.+.+.||+|||
T Consensus        65 Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH  143 (948)
T KOG0577|consen   65 QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH  143 (948)
T ss_pred             ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH
Confidence            3566778999999999999999999999999988889999999966 999999755 67999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC---CCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l  162 (262)
                      + .+.+|+|||..|||+++.|.|+|+|||.+....    ..+.++||+.|+|||++..   +.|+-++||||||+++.+|
T Consensus       144 S-~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIEL  218 (948)
T KOG0577|consen  144 S-HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  218 (948)
T ss_pred             H-hhHHhhhccccceEecCCCeeeeccccchhhcC----chhcccCCccccchhHheeccccccCCccceeeccchhhhh
Confidence            9 999999999999999999999999999876543    4457899999999998754   6799999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .-.++|+-+.+       ...-+..+..+..|.......+..+++|+..||+.-|.+|||.+++|+|+|...-+-.
T Consensus       219 AERkPPlFnMN-------AMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  219 AERKPPLFNMN-------AMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             hhcCCCccCch-------HHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            99999987643       3355677778888888888999999999999999999999999999999999765543

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-36  Score=251.54  Aligned_cols=213  Identities=27%  Similarity=0.441  Sum_probs=172.3

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhc------------------------
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKV------------------------   62 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~------------------------   62 (262)
                      ....+.+.+|+.++.++ +|+||+++++.+.. +...++++||+++++|.+++...                        
T Consensus        51 ~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (337)
T cd05054          51 ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK  130 (337)
T ss_pred             HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccc
Confidence            44556788999999999 89999999998765 45688999999999999998642                        


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccC
Q 024828           63 -------------------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  105 (262)
Q Consensus        63 -------------------------------------~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~  105 (262)
                                                           .+++...+..++.|++.||+|||+ .|++|+||+|+||+++.+
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~  209 (337)
T cd05054         131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSEN  209 (337)
T ss_pred             cccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCC
Confidence                                                 257889999999999999999998 999999999999999999


Q ss_pred             CcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHH
Q 024828          106 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  182 (262)
Q Consensus       106 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~  182 (262)
                      +.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++++|++ |..||......+      
T Consensus       210 ~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------  283 (337)
T cd05054         210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------  283 (337)
T ss_pred             CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------
Confidence            9999999999876532221  1122345668999999998889999999999999999998 999997643322      


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      .....+..+... ..+...++++.+++.+||+.+|++||+++++++|
T Consensus       284 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         284 EFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             HHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            122222222222 2234678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-36  Score=242.38  Aligned_cols=209  Identities=29%  Similarity=0.487  Sum_probs=176.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ..+.+.+|+.+++.++|+||+++++.+.+.+..+++||++++++|.+++.....  +++..+..++.|++.||++||+ .
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~  122 (258)
T smart00219       44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-K  122 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc-C
Confidence            677899999999999999999999999999999999999999999999987554  9999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc-cccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ  166 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~  166 (262)
                      |++|+||+|+||+++.++.++++|||.+........... ...++..|+|||...+..++.++|+|++|+++++|++ |.
T Consensus       123 ~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~  202 (258)
T smart00219      123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE  202 (258)
T ss_pred             CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999999876543311111 1235678999999987789999999999999999998 78


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      .||.....       ....+.......... ...++.++.+++.+||+.+|++|||+.++++
T Consensus       203 ~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      203 SPYPGMSN-------EEVLEYLKKGYRLPK-PENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CCCCCCCH-------HHHHHHHhcCCCCCC-CCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            88876332       233334444443333 3458999999999999999999999999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-37  Score=249.58  Aligned_cols=222  Identities=28%  Similarity=0.486  Sum_probs=175.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +.....+.+|++++++++|+|++++++.+.+.  +..++|+||+++ +|.+++.+. ..++...+..++.|++.||++||
T Consensus        39 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH  117 (287)
T cd07840          39 EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH  117 (287)
T ss_pred             ccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34456788999999999999999999999987  889999999976 999998765 57999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~  163 (262)
                      + .|++|+||+|+||++++++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||||+++++|+
T Consensus       118 ~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~  196 (287)
T cd07840         118 S-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF  196 (287)
T ss_pred             H-CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence            8 9999999999999999999999999999876654331 12223457789999987654 4789999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcC-------------CCC---------CCCCCCCCHHHHHHHHHhhcCCcCCCC
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQ-------------PPP---------SAPSDQFSPEFCSFISACVQKEPQQRL  221 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rp  221 (262)
                      +|+.||......................             ...         ......+++.+.+++.+||+.+|.+||
T Consensus       197 t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  276 (287)
T cd07840         197 LGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI  276 (287)
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc
Confidence            9999997655432221111110000000             000         000111378899999999999999999


Q ss_pred             CHHHHhcCccc
Q 024828          222 SAQELMTHPFL  232 (262)
Q Consensus       222 t~~~~l~h~~~  232 (262)
                      ++++++.||||
T Consensus       277 ~~~~~l~~~~~  287 (287)
T cd07840         277 SADQALQHEYF  287 (287)
T ss_pred             CHHHHhhCcCC
Confidence            99999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=266.81  Aligned_cols=221  Identities=33%  Similarity=0.590  Sum_probs=188.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTI--PEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~--~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ....+-+.+|+.+-++++|.|||++++.+..++.+-+.||-.+||||.++++.. +++  .+..+-.+.+||++||.|||
T Consensus       613 sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH  692 (1226)
T KOG4279|consen  613 SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH  692 (1226)
T ss_pred             chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh
Confidence            344456789999999999999999999999999999999999999999999755 777  78889999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCCcccccccccccCcccccCCC--CCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l  162 (262)
                      . ..|+|+|||-+||+++. .|.+|++|||-+++...-+.-+.++.||..|+|||++..+.  |+.++|||||||++.||
T Consensus       693 e-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEM  771 (1226)
T KOG4279|consen  693 E-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEM  771 (1226)
T ss_pred             h-cceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEee
Confidence            8 99999999999999964 58899999999999887777888899999999999997654  89999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .||++||-.......  .++  .-.+.+. -|+ .+..++.+.+.+|.+|+.++|..||+++++|.+||++...
T Consensus       772 ATGrPPF~ElgspqA--AMF--kVGmyKv-HP~-iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  772 ATGRPPFVELGSPQA--AMF--KVGMYKV-HPP-IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             ccCCCCeeecCChhH--hhh--hhcceec-CCC-CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence            999999987655431  111  1111111 122 2356888999999999999999999999999999998773

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-36  Score=245.69  Aligned_cols=211  Identities=23%  Similarity=0.402  Sum_probs=175.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---------TIPEEYLAAICEQVLKGL   81 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~i~~~l~~~l   81 (262)
                      ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.+++....         .++...+..++.|++.||
T Consensus        51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l  130 (275)
T cd05046          51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM  130 (275)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence            56789999999999999999999999999899999999999999999998765         689999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      .|||+ .|++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+...+.++|+||||++++
T Consensus       131 ~~LH~-~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  209 (275)
T cd05046         131 DHLSN-ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMW  209 (275)
T ss_pred             HHhhh-cCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHH
Confidence            99998 999999999999999999999999999875432211 1122234567799999998888899999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++++ |..||......       ........+.........++..+.+++.+||+.+|.+|||+.+++..
T Consensus       210 ~l~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         210 EVFTQGELPFYGLSDE-------EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HHHhCCCCCccccchH-------HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            9998 78898654322       23333333333333345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-36  Score=246.37  Aligned_cols=216  Identities=24%  Similarity=0.425  Sum_probs=169.0

Q ss_pred             HHHHHHHHHHhcCC-CCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           13 RQIAQELKINQSSQ-CPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        13 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+|+.++.++. |+|++++++++.++  +..++|+||+.+ +|.+.+... +.+++..+..++.|++.||++||+ .
T Consensus        42 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~  119 (282)
T cd07831          42 VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-N  119 (282)
T ss_pred             hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            34457888898884 99999999999987  889999999975 888888764 568999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++. +.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||+||++++|++|..
T Consensus       120 ~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~  197 (282)
T cd07831         120 GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP  197 (282)
T ss_pred             CceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence            9999999999999998 9999999999876543322 223456789999997654 457889999999999999999999


Q ss_pred             CCCCCCccCchhhHHHH--------HHHHhcCCCC--C----------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          168 PYSPPEQQDGWTSFYEL--------MEAIVDQPPP--S----------APSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~--------~~~~~~~~~~--~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ||...+..+........        ..........  .          .....++.++.+++.+||+.+|++|||+++++
T Consensus       198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l  277 (282)
T cd07831         198 LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL  277 (282)
T ss_pred             CCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence            99775543211111110        0010000000  0          00124678999999999999999999999999


Q ss_pred             cCccc
Q 024828          228 THPFL  232 (262)
Q Consensus       228 ~h~~~  232 (262)
                      +||||
T Consensus       278 ~~~~~  282 (282)
T cd07831         278 RHPYF  282 (282)
T ss_pred             hCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.8e-36  Score=242.94  Aligned_cols=211  Identities=26%  Similarity=0.424  Sum_probs=175.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++.+. +.++...+..++.|++.||.+||+ 
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-  124 (267)
T cd05066          46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD-  124 (267)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            455678999999999999999999999999999999999999999999999765 468999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc---cccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++++|||.+...........   ...++..|++||.+.+..++.++|+||||++++++++
T Consensus       125 ~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~  204 (267)
T cd05066         125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS  204 (267)
T ss_pred             CCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhc
Confidence            9999999999999999999999999998876543222111   1123457999999998889999999999999999886


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......       .....+......+. ....++.+.+++.+||+.+|.+||++.++++
T Consensus       205 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         205 YGERPYWEMSNQ-------DVIKAIEEGYRLPA-PMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCCCcccCCHH-------HHHHHHhCCCcCCC-CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence             99999765432       22233333333222 2467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=244.37  Aligned_cols=211  Identities=24%  Similarity=0.430  Sum_probs=174.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------TIPEEYLAAICEQVL   78 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~l~   78 (262)
                      ......+.+|+.++..++||||+++++++..+...++||||+++++|.+++....          .++...+..++.|++
T Consensus        50 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  129 (277)
T cd05032          50 MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA  129 (277)
T ss_pred             HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHH
Confidence            3456678899999999999999999999999999999999999999999996532          367788999999999


Q ss_pred             HHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHHH
Q 024828           79 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLG  156 (262)
Q Consensus        79 ~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG  156 (262)
                      .||.|||+ .|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+||||
T Consensus       130 ~~l~~lH~-~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  208 (277)
T cd05032         130 DGMAYLAA-KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFG  208 (277)
T ss_pred             HHHHHHHh-CCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHH
Confidence            99999998 999999999999999999999999999887543322  112233456789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          157 LVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       157 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +++|++++ |..||......       +..+....+..+.. +...+.++.+++.+||+.+|++|||+.+++.
T Consensus       209 ~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         209 VVLWEMATLAEQPYQGLSNE-------EVLKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHHHhhccCCCCCccCCHH-------HHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999998 89999764332       22333333333333 3457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-36  Score=244.99  Aligned_cols=212  Identities=25%  Similarity=0.411  Sum_probs=175.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAA   72 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~   72 (262)
                      ....+.+.+|+.++..++||||+++++.+.+....++++||+.+++|.+++...                ..++...+..
T Consensus        49 ~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  128 (283)
T cd05091          49 GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH  128 (283)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence            345677899999999999999999999999999999999999999999998532                2478888999


Q ss_pred             HHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcch
Q 024828           73 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        73 i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ++.|++.||.|+|+ .|++|+||+|.||++++++.++|+|||++........  ......++..|+|||.+.+..++.++
T Consensus       129 ~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (283)
T cd05091         129 IVTQIAAGMEFLSS-HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS  207 (283)
T ss_pred             HHHHHHHHHHHHHH-cCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch
Confidence            99999999999998 9999999999999999999999999998765432221  11223456789999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |+||||+++++|++ |..||.....       .+....+........ ...++..+.+++.+||+.+|.+||++++++..
T Consensus       208 Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         208 DIWSYGVVLWEVFSYGLQPYCGYSN-------QDVIEMIRNRQVLPC-PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCcCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            99999999999998 8888876432       233444444443332 35689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=273.60  Aligned_cols=238  Identities=25%  Similarity=0.449  Sum_probs=196.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....-|..|-++|...+.+.|+.++..|+|+.++|+||||++||+|-.++++.+++++..+..++..|+.||.-+|+ .
T Consensus       116 r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~-m  194 (1317)
T KOG0612|consen  116 RAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS-M  194 (1317)
T ss_pred             chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh-c
Confidence            344566888999999999999999999999999999999999999999999999999999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccC-CCCcccccccccccCcccccC-----CCCCcchhHHHHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-SGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l  162 (262)
                      |++||||||+|||++..|+++|+|||.+-.+... .-.....+|||.|.+||++..     +.|++.+|.||+|+++|||
T Consensus       195 gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM  274 (1317)
T KOG0612|consen  195 GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM  274 (1317)
T ss_pred             cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence            9999999999999999999999999988777633 345566799999999999853     4589999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC---HHHHhcCccccccCCcc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYGDLN  239 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~~l~h~~~~~~~~~~  239 (262)
                      +.|..||......+.+..+..-...   -..|  ....+|.+.++||++.+.. |+.|..   ++++..||||.+..+.+
T Consensus       275 lyG~TPFYadslveTY~KIm~hk~~---l~FP--~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  275 LYGETPFYADSLVETYGKIMNHKES---LSFP--DETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             HcCCCcchHHHHHHHHHHHhchhhh---cCCC--cccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCChhh
Confidence            9999999875544333222222111   1122  2245899999999999875 778887   99999999999877643


Q ss_pred             --cchhhHhhhhCCCC
Q 024828          240 --VDLSEYFTDAGSPL  253 (262)
Q Consensus       240 --~~~~~~~~~~~~~~  253 (262)
                        -+.+.++.+..||+
T Consensus       349 iR~~~pP~vPevssd~  364 (1317)
T KOG0612|consen  349 IRESVPPVVPEVSSDD  364 (1317)
T ss_pred             hhhcCCCCCCcCCCCC
Confidence              34555555555543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.7e-36  Score=238.78  Aligned_cols=211  Identities=25%  Similarity=0.406  Sum_probs=173.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ......+.+|++++++++||||+++++.+...+..++||||+++++|.+++... ..+++..+..++.+++.+|.++|+ 
T Consensus        33 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-  111 (250)
T cd05085          33 QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES-  111 (250)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            445567899999999999999999999999999999999999999999998754 457899999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      .|++|+||+|+||+++.++.++++|||++......... .....++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       112 ~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g  191 (250)
T cd05085         112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLG  191 (250)
T ss_pred             CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999988654322111 111233567999999988889999999999999999998 9


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ..||......       ........+..... +..++..+.+++.+||+.+|++||++.++++
T Consensus       192 ~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         192 VCPYPGMTNQ-------QAREQVEKGYRMSC-PQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999765332       22233333333322 3467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.3e-36  Score=246.09  Aligned_cols=222  Identities=30%  Similarity=0.535  Sum_probs=181.8

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|++++.++ +||+|+++.+.+..+...++||||+.+++|.+++.+...++...+..++.|++.+|.+||+ .
T Consensus        46 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~  124 (288)
T cd05583          46 KTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ-L  124 (288)
T ss_pred             hHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3456788999999999 6999999999999999999999999999999999887889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||+|.||+++.++.++++|||++........ ......++..|++||...+..  .+.++|+||+|+++++|++|
T Consensus       125 ~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg  204 (288)
T cd05583         125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG  204 (288)
T ss_pred             CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence            999999999999999999999999998765433221 122235788999999987654  78899999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC---HHHHhcCccccccCC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYGD  237 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~~l~h~~~~~~~~  237 (262)
                      ..||........   ..+..+.......  ..+..++.++.+++.+||+.+|++|||   +.++++||||+....
T Consensus       205 ~~p~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         205 ASPFTVDGEQNS---QSEISRRILKSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             CCCcccCcccch---HHHHHHHHHccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            999975433221   1222223322222  223457899999999999999999998   567899999988764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-36  Score=242.64  Aligned_cols=209  Identities=26%  Similarity=0.444  Sum_probs=170.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+++.+|+.++++++|++++++++.+.. ...+++|||+.+++|.+++...  ..++...+..++.+++.||+|||+
T Consensus        42 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  120 (260)
T cd05070          42 TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER  120 (260)
T ss_pred             CCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3345678999999999999999999998754 5588999999999999999764  358999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                       .|++|+||+|+||+++.++.++++|||.+........ ......++..|+|||...+..++.++|+||||++++++++ 
T Consensus       121 -~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~  199 (260)
T cd05070         121 -MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK  199 (260)
T ss_pred             -CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence             9999999999999999999999999999876533221 1112234567999999988889999999999999999999 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      |..||...+.       .+....+......+. +...+.++.+++.+||..+|.+|||++++.
T Consensus       200 g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         200 GRVPYPGMNN-------REVLEQVERGYRMPC-PQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             CCCCCCCCCH-------HHHHHHHHcCCCCCC-CCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            8999976432       123333433333322 356789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=259.25  Aligned_cols=205  Identities=26%  Similarity=0.438  Sum_probs=173.6

Q ss_pred             HHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           13 RQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        13 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      .+..+|+.++... +||||+++.+.+.++.+.|+|||.++|+-+.+-+...+.+. ..+..|+.+|+.|+.|||. .|++
T Consensus       360 ~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvv  437 (612)
T KOG0603|consen  360 DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE-QGVV  437 (612)
T ss_pred             cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh-cCee
Confidence            4456777666666 79999999999999999999999999988888777655555 7788899999999999999 9999


Q ss_pred             eCCCCCCCEEE-ccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           92 HRDLKPSNLLI-NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        92 H~dl~p~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      ||||||+|||+ +..++++|+|||.++.....   ..+..-+..|.|||......+++++|+||||+++|+|++|+.||.
T Consensus       438 hRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~  514 (612)
T KOG0603|consen  438 HRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA  514 (612)
T ss_pred             ecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence            99999999999 58899999999998765433   334456788999999998889999999999999999999999998


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      .....      .+....+..+..    ...+|.+.++|+.+||+.||.+||+++++..||||
T Consensus       515 ~~P~~------~ei~~~i~~~~~----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  515 AHPAG------IEIHTRIQMPKF----SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cCCch------HHHHHhhcCCcc----ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            76543      233333322222    26789999999999999999999999999999999

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-36  Score=246.66  Aligned_cols=212  Identities=23%  Similarity=0.402  Sum_probs=175.2

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHHH
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLA   71 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~   71 (262)
                      ....+++.+|+.+++.+ +||||+++++.+......+++|||+.+++|.+++.+..                .++...+.
T Consensus        61 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (304)
T cd05101          61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV  140 (304)
T ss_pred             hHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHH
Confidence            45567899999999999 89999999999999999999999999999999997642                36778889


Q ss_pred             HHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcc
Q 024828           72 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        72 ~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      .++.|++.||.|||+ .|++|+||+|+||+++.++.++++|||.+.........  .....++..|+|||++.+..++.+
T Consensus       141 ~~~~qi~~al~~LH~-~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  219 (304)
T cd05101         141 SCTYQVARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ  219 (304)
T ss_pred             HHHHHHHHHHHHHHH-CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch
Confidence            999999999999998 99999999999999999999999999998765432211  112234567999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+||||+++|++++ |..||.....       ......+........ ...++.++.+++.+||..+|.+|||+.++++
T Consensus       220 ~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         220 SDVWSFGVLMWEIFTLGGSPYPGIPV-------EELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             hhHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            999999999999998 7888865432       233334443433322 3567899999999999999999999999987


Q ss_pred             C
Q 024828          229 H  229 (262)
Q Consensus       229 h  229 (262)
                      .
T Consensus       292 ~  292 (304)
T cd05101         292 D  292 (304)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-36  Score=242.46  Aligned_cols=210  Identities=27%  Similarity=0.483  Sum_probs=171.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .....++.+|+.++++++|+||+++++++. .+..++++|++.+++|.+++...  ..++...+..++.|++.||++||+
T Consensus        42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~  120 (260)
T cd05067          42 SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER  120 (260)
T ss_pred             CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            344567889999999999999999999874 45689999999999999998653  358899999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                       .|++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.+..++.++|+||||++++++++ 
T Consensus       121 -~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~  199 (260)
T cd05067         121 -KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTY  199 (260)
T ss_pred             -CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhC
Confidence             999999999999999999999999999886554221 11122234668999999988889999999999999999998 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+.||.+....       +....+......+ .....+.++.+++.+||+.+|++|||++++++
T Consensus       200 g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         200 GRIPYPGMTNP-------EVIQNLERGYRMP-RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCCCCCCCChH-------HHHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99999765432       2233333333333 23467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=259.96  Aligned_cols=221  Identities=28%  Similarity=0.479  Sum_probs=193.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+...+..+.+|++++..++|||||+++.+......+|+||||+.++.+.+++.+.+...+.....++.|+..|++|||+
T Consensus        94 ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~  173 (596)
T KOG0586|consen   94 LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS  173 (596)
T ss_pred             cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh
Confidence            35666677999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g  165 (262)
                       .+|+|+|||++|++++.+..++|+|||++..+. ......++.|++.|.|||++.+..+ ++.+|+|++|+++|.|+.|
T Consensus       174 -k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~G  251 (596)
T KOG0586|consen  174 -KNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEG  251 (596)
T ss_pred             -cceeccccchhhcccccccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeec
Confidence             999999999999999999999999999998876 4556677899999999999998774 7899999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      ..||++..-.       +.......+..  ..+..++-++.++|+++|.++|.+|++.+++..|.|.....+.
T Consensus       252 sLPFDG~~lk-------~Lr~rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  252 SLPFDGQNLK-------ELRPRVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ccccCCcccc-------cccchheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999975433       22222222222  1123567889999999999999999999999999999877766

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.9e-36  Score=241.14  Aligned_cols=212  Identities=24%  Similarity=0.387  Sum_probs=175.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .....+++.+|++++++++||||+++.+++.+.+..++||||+++++|.+++... +.++...+..++.|++.|+++||+
T Consensus        46 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~  125 (268)
T cd05063          46 TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD  125 (268)
T ss_pred             CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3455678999999999999999999999999999999999999999999999764 568999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc---cccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++++|||++...........   ....+..|+|||.+.+..++.++|+||||+++|+++
T Consensus       126 -~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell  204 (268)
T cd05063         126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM  204 (268)
T ss_pred             -CCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence             9999999999999999999999999998875543221111   112244699999998888899999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      + |+.||......       .....+......+ .....+.++.+++.+||+.+|++||++.++++
T Consensus       205 ~~g~~p~~~~~~~-------~~~~~i~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         205 SFGERPYWDMSNH-------EVMKAINDGFRLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             hCCCCCCCcCCHH-------HHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            7 99999764332       2333333333222 23467899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-36  Score=253.43  Aligned_cols=226  Identities=25%  Similarity=0.445  Sum_probs=176.4

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ......+.+|+.+++++ +||||+++++++...  ...++||||+.+ +|.+++.+. .++...+..++.|++.||++||
T Consensus        47 ~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH  124 (337)
T cd07852          47 ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIH  124 (337)
T ss_pred             chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            44556778899999999 999999999988653  468999999975 999998875 7889999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-----CcccccccccccCcccccC-CCCCcchhHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVL  159 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l  159 (262)
                      + .|++|+||+|+||+++.++.++|+|||.+........     ......++..|+|||.+.+ ...+.++|+||+|+++
T Consensus       125 ~-~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l  203 (337)
T cd07852         125 S-GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL  203 (337)
T ss_pred             H-CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHH
Confidence            8 9999999999999999999999999998876543321     2223457888999998765 3478899999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHH----------------HHHHhc----C--CCCCCCCCCCCHHHHHHHHHhhcCCc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYEL----------------MEAIVD----Q--PPPSAPSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~----~--~~~~~~~~~~~~~l~~li~~~l~~~p  217 (262)
                      |+|++|+.||......+........                ...+..    .  .........++.++.+++.+||+.+|
T Consensus       204 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P  283 (337)
T cd07852         204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP  283 (337)
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCc
Confidence            9999999999764432211110000                000000    0  00111123468899999999999999


Q ss_pred             CCCCCHHHHhcCccccccCC
Q 024828          218 QQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .+|||+.++++|||++.+..
T Consensus       284 ~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         284 NKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             ccccCHHHHhhChhhhhhcc
Confidence            99999999999999988754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=286.06  Aligned_cols=223  Identities=34%  Similarity=0.608  Sum_probs=196.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|.++|..++|||+|+++++-.+.+..+|.||||+||+|++.+..++..++.....+..|++.|++|||+ .
T Consensus      1275 ~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~-~ 1353 (1509)
T KOG4645|consen 1275 HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE-H 1353 (1509)
T ss_pred             cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh-c
Confidence            445567889999999999999999999999999999999999999999999998888999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC----CCcccccccccccCcccccCCC---CCcchhHHHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----GQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLE  161 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~~  161 (262)
                      ||+|+||||.||+++.+|.+|++|||.|..+....    ...+..+||+.|+|||.+.+..   ...++|||||||++.|
T Consensus      1354 gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlE 1433 (1509)
T KOG4645|consen 1354 GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLE 1433 (1509)
T ss_pred             CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEE
Confidence            99999999999999999999999999998765442    2233458999999999998743   5779999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      |+||+.||...+.+      ..++.++.-+..|..+. .++++.++|+.+||..||++|-++.|++.|-|-+.+.+.-
T Consensus      1434 M~tGkrPW~~~dne------~aIMy~V~~gh~Pq~P~-~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1434 MATGKRPWAELDNE------WAIMYHVAAGHKPQIPE-RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred             eecCCCchhhccch------hHHHhHHhccCCCCCch-hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence            99999999876543      35677777777777764 4999999999999999999999999999999988776543

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-36  Score=246.09  Aligned_cols=219  Identities=24%  Similarity=0.365  Sum_probs=171.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC------------CCCHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK------------TIPEEYLAAICE   75 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~i~~   75 (262)
                      ....+..+.+|++++++++|+|++++++++......++||||+.+++|.+++....            .++...+..++.
T Consensus        57 ~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~  136 (295)
T cd05097          57 TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAV  136 (295)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHH
Confidence            35566789999999999999999999999999999999999999999999996532            367888999999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHH
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIW  153 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~  153 (262)
                      |++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|
T Consensus       137 ~i~~al~~lH~-~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  215 (295)
T cd05097         137 QIASGMKYLAS-LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVW  215 (295)
T ss_pred             HHHHHHHHHHh-cCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHH
Confidence            99999999998 9999999999999999999999999998865432211  11122346689999999888899999999


Q ss_pred             HHHHHHHHHHh--CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          154 SLGLVLLECAT--GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       154 slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |||+++++|++  +..||......+............... ........+++.+.+|+.+||..+|++|||++++++
T Consensus       216 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         216 AFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ-IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccc-ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999988  567777644322111111111111111 111223457899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-36  Score=238.09  Aligned_cols=210  Identities=27%  Similarity=0.419  Sum_probs=172.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....+.+|++++++++|+||+++++++.+....++|+||+.|++|.+++.+. ..++...+..++.+++.++++||+ .
T Consensus        34 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~-~  112 (251)
T cd05041          34 DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES-K  112 (251)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            46678999999999999999999999999999999999999999999999664 468999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc--ccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      |++|+||+|+||+++.++.++++|||.+..........  .....+..|+|||.+.+..++.++|+||||+++++|++ |
T Consensus       113 ~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~  192 (251)
T cd05041         113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLG  192 (251)
T ss_pred             CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999887543211111  11123456999999988889999999999999999998 8


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ..||......       .....+..... ...+...+.++.+++.+||+.+|.+|||++++++
T Consensus       193 ~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         193 DTPYPGMSNQ-------QTRERIESGYR-MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             CCCCccCCHH-------HHHHHHhcCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            8888765432       12222222222 2223567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.3e-36  Score=244.48  Aligned_cols=212  Identities=26%  Similarity=0.408  Sum_probs=173.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------------CC
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------------TI   65 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~   65 (262)
                      .....+++.+|+.++++++||||+++++++.++...++++||+++++|.+++....                      .+
T Consensus        48 ~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l  127 (288)
T cd05050          48 SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL  127 (288)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccccccccccccccccccc
Confidence            34556789999999999999999999999999999999999999999999997532                      36


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccC
Q 024828           66 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISG  143 (262)
Q Consensus        66 ~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~  143 (262)
                      +...++.++.|++.||++||+ .|++|+||+|.||+++.++.++++|||.+.......  ........+..|+|||.+.+
T Consensus       128 ~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (288)
T cd05050         128 SCTEQLCIAKQVAAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY  206 (288)
T ss_pred             CHHHHHHHHHHHHHHHHHHHh-CCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence            788889999999999999998 999999999999999999999999999886543221  11112234567999999988


Q ss_pred             CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          144 GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       144 ~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                      ..++.++|+||||+++|+|++ |..||.+....       +....+..+..... +...+.++.+++.+||+.+|.+|||
T Consensus       207 ~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt  278 (288)
T cd05050         207 NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-------EVIYYVRDGNVLSC-PDNCPLELYNLMRLCWSKLPSDRPS  278 (288)
T ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCCCCCC-CCCCCHHHHHHHHHHcccCcccCCC
Confidence            889999999999999999997 88888654332       23334444433332 3467899999999999999999999


Q ss_pred             HHHHhc
Q 024828          223 AQELMT  228 (262)
Q Consensus       223 ~~~~l~  228 (262)
                      ++|+++
T Consensus       279 ~~el~~  284 (288)
T cd05050         279 FASINR  284 (288)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=247.18  Aligned_cols=223  Identities=27%  Similarity=0.452  Sum_probs=177.7

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCC------CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQC------PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQ   76 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~   76 (262)
                      +..-...++...-|+++|+++.+      --++.+.++|...++.|+|+|.+ |.|+.+++.+++  +++...+..+++|
T Consensus       122 ik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~Q  200 (415)
T KOG0671|consen  122 IKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQ  200 (415)
T ss_pred             HHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHH
Confidence            34456677888899999999932      24677888899999999999999 779999998864  7999999999999


Q ss_pred             HHHHHHHHhhcCCeeeCCCCCCCEEEcc--------------------CCcEEEEecccccccccCCCCccccccccccc
Q 024828           77 VLKGLLYLHHEKHIIHRDLKPSNLLINH--------------------RGEVKITDFGVSAIMASTSGQANTFVGTYNYM  136 (262)
Q Consensus        77 l~~~l~~lh~~~~i~H~dl~p~nil~~~--------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~  136 (262)
                      ++.++++||+ .+++|.||||+||++.+                    +..++++|||.|+...   ......+.|..|+
T Consensus       201 L~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYR  276 (415)
T KOG0671|consen  201 LLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYR  276 (415)
T ss_pred             HHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec---cCcceeeeccccC
Confidence            9999999999 99999999999999942                    3358999999887543   2335668899999


Q ss_pred             CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-----------------CCCC-
Q 024828          137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-----------------SAPS-  198 (262)
Q Consensus       137 ~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~-  198 (262)
                      |||++.+-.++.++||||+||++.|+++|...|..-+..+    ...+++.+....+.                 ..+. 
T Consensus       277 APEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E----HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~  352 (415)
T KOG0671|consen  277 APEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE----HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEV  352 (415)
T ss_pred             CchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH----HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccc
Confidence            9999999999999999999999999999999997655322    22333333221111                 1000 


Q ss_pred             -----------------------CCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          199 -----------------------DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       199 -----------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                                             .....++.+|+++||..||.+|+|+.|+|.||||+...
T Consensus       353 ~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  353 SSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             cccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence                                   01123488999999999999999999999999998654

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.5e-36  Score=239.99  Aligned_cols=207  Identities=24%  Similarity=0.447  Sum_probs=171.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +.....+.+|+.++++++|||++++++.+..+ ..+++|||+.+++|.+++....  .++...+..++.|++.||.+||+
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~  118 (254)
T cd05083          40 DVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES  118 (254)
T ss_pred             cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34556889999999999999999999998765 4799999999999999997653  47899999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                       .|++|+||+|+||+++.++.++|+|||.+.......   .....+..|+|||.+.+..++.++|+||||+++++|++ |
T Consensus       119 -~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g  194 (254)
T cd05083         119 -KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYG  194 (254)
T ss_pred             -CCeeccccCcceEEEcCCCcEEECCCccceeccccC---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCC
Confidence             999999999999999999999999999886543221   12233567999999988889999999999999999997 9


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +.||......       +.......+..+. ....++..+.+++.+||+.+|++||++++++.
T Consensus       195 ~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         195 RAPYPKMSLK-------EVKECVEKGYRME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCCCccCCHH-------HHHHHHhCCCCCC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999765432       2333333443333 33568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.6e-36  Score=241.73  Aligned_cols=209  Identities=26%  Similarity=0.445  Sum_probs=170.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+++.+|++++++++||||+++++.+.. ...++||||+++++|.+++.+.  ..++...+..++.|++.||+++|+ 
T Consensus        43 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-  120 (262)
T cd05071          43 MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-  120 (262)
T ss_pred             cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            345678999999999999999999988754 5579999999999999999764  357899999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc-ccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      .|++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||...+..++.++|+||||+++|++++ |
T Consensus       121 ~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g  200 (262)
T cd05071         121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG  200 (262)
T ss_pred             CCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence            999999999999999999999999999987554322111 12235567999999988889999999999999999999 8


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ..||......       ............. ....++..+.+++.+|++.+|.+|||+++++.
T Consensus       201 ~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         201 RVPYPGMVNR-------EVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CCCCCCCChH-------HHHHHHhcCCCCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            8888765432       2223333332222 23467899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=252.56  Aligned_cols=226  Identities=24%  Similarity=0.455  Sum_probs=174.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ....++.+|+.++++++|+||+++++++...     ...++++||+.+ +|.+.+.. +.+++..+..++.|++.||++|
T Consensus        45 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~L  122 (336)
T cd07849          45 TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYI  122 (336)
T ss_pred             hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            4556788999999999999999999987654     358999999965 89888754 5799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccC-CCCCcchhHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~  160 (262)
                      |+ .|++|+||+|+||+++.++.++++|||++.........   .....++..|+|||.+.+ ..++.++|+||+|++++
T Consensus       123 H~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~  201 (336)
T cd07849         123 HS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILA  201 (336)
T ss_pred             Hh-CCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHH
Confidence            98 99999999999999999999999999998765432211   122457888999998754 45889999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHH--------HHH--------HhcCCC--CCC----CCCCCCHHHHHHHHHhhcCCcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYEL--------MEA--------IVDQPP--PSA----PSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~--------~~~--------~~~~~~--~~~----~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      +|++|+.||...+....+......        ...        ......  ...    .....++++.+++.+||+.+|+
T Consensus       202 el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  281 (336)
T cd07849         202 EMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH  281 (336)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChh
Confidence            999999999764432111111000        000        000000  000    0124578899999999999999


Q ss_pred             CCCCHHHHhcCccccccCCc
Q 024828          219 QRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|||+.+++.||||+.....
T Consensus       282 ~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         282 KRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hCcCHHHHhcCccccccCCC
Confidence            99999999999999977653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.7e-36  Score=241.79  Aligned_cols=210  Identities=27%  Similarity=0.501  Sum_probs=172.6

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-------KTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ....++.+|+++++.++||||+++++++.+.+..+++|||+++++|.+++.+.       ..++...+..++.|++.||.
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  120 (269)
T cd05044          41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV  120 (269)
T ss_pred             hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence            45678899999999999999999999999999999999999999999999643       23788999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCC-----cEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRG-----EVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~-----~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      |||+ .+++|+||+|+||+++.++     .++++|||++........  ......++..|+|||.+.+..++.++|+|||
T Consensus       121 ~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  199 (269)
T cd05044         121 YLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF  199 (269)
T ss_pred             HHHh-CCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHH
Confidence            9998 9999999999999999877     899999998865432211  1112244678999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          156 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       156 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+++|+|++ |..||......       +....+..+.... ....++..+.+++.+||..+|.+||+++++++
T Consensus       200 G~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         200 GVLMWEILTLGQQPYPALNNQ-------EVLQHVTAGGRLQ-KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHHHHHHHcCCCCCcccCHH-------HHHHHHhcCCccC-CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            999999998 99999754321       2223333333222 23567899999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.7e-36  Score=240.01  Aligned_cols=211  Identities=24%  Similarity=0.377  Sum_probs=169.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEE-ECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+.+.+|+.+++.++||||+++++.+. .++..++++||+.+++|.+++.+. ...+...+..++.|++.||+|||+
T Consensus        37 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  116 (262)
T cd05058          37 LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS  116 (262)
T ss_pred             HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            445678889999999999999999999765 456689999999999999999764 346788889999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC----CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                       .|++|+||+|+||+++.++.++|+|||.+.......    .......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus       117 -~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  195 (262)
T cd05058         117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL  195 (262)
T ss_pred             -CCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHH
Confidence             999999999999999999999999999886543211    111122346679999999888899999999999999999


Q ss_pred             HhC-CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          163 ATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       163 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ++| .+||...+.       .+....+..+..+.. +...++.+.+++.+||..+|++||++.+++.
T Consensus       196 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         196 MTRGAPPYPDVDS-------FDITVYLLQGRRLLQ-PEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HcCCCCCCCCCCH-------HHHHHHHhcCCCCCC-CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            994 666654322       233334444433332 3457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1e-35  Score=241.18  Aligned_cols=209  Identities=22%  Similarity=0.380  Sum_probs=170.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....++..|+.++.+++||||+++++++.. ...++++|++.+++|.+++... +.+++..+..++.|++.||+|||+ .
T Consensus        51 ~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~  128 (279)
T cd05111          51 QTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE-H  128 (279)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            345678888889999999999999998754 4578999999999999999764 568999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      |++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       129 ~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g  208 (279)
T cd05111         129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG  208 (279)
T ss_pred             CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence            999999999999999999999999999876532221  1122345678999999988889999999999999999998 9


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ..||.+....       ...+.+..+..+. .....+.++.+++.+||..+|.+|||+.++++
T Consensus       209 ~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         209 AEPYAGMRPH-------EVPDLLEKGERLA-QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCCCCCHH-------HHHHHHHCCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999765332       1222233333332 23456788999999999999999999999866

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=246.87  Aligned_cols=219  Identities=25%  Similarity=0.453  Sum_probs=170.8

Q ss_pred             HHHHHHHHHHHHhcC---CCCeeEeeceEEEECCe-----EEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSS---QCPYVVVCYQSFYSNGA-----ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKG   80 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~   80 (262)
                      ....+.+|+.+++++   +|+|++++++.+.+...     .+++||++.+ +|.+++.+..  .+++..+..++.|++.|
T Consensus        41 ~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~a  119 (287)
T cd07838          41 IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG  119 (287)
T ss_pred             hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence            345666787777655   69999999999988776     9999999976 8999887653  48999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |.+||+ .|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++
T Consensus       120 l~~LH~-~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~  197 (287)
T cd07838         120 VDFLHS-HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA  197 (287)
T ss_pred             HHHHHH-CCeeeccCChhhEEEccCCCEEEeccCcceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence            999998 999999999999999999999999999887654332 222334678899999999888999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHH---------------hcCCCCC---CCCCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAI---------------VDQPPPS---APSDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                      +|++|++||......+....+.......               .......   ......++.+.+++.+||+.||.+||+
T Consensus       198 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  277 (287)
T cd07838         198 ELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS  277 (287)
T ss_pred             HHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC
Confidence            9999999998755433222211110000               0000000   001134577899999999999999999


Q ss_pred             HHHHhcCccc
Q 024828          223 AQELMTHPFL  232 (262)
Q Consensus       223 ~~~~l~h~~~  232 (262)
                      +++++.||||
T Consensus       278 ~~~il~~~~~  287 (287)
T cd07838         278 AFEALQHPYF  287 (287)
T ss_pred             HHHHhcCcCC
Confidence            9999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.1e-36  Score=240.42  Aligned_cols=209  Identities=26%  Similarity=0.462  Sum_probs=173.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..++.+|++++++++||+++++++.+......++++||+++++|.+++... +.++...+..++.+++.++++||+ .|+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i  121 (256)
T cd05112          43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES-SNV  121 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            457889999999999999999999999999999999999999999999764 468999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCC-cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP  168 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p  168 (262)
                      +|+||+|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||+|+++|++++ |..|
T Consensus       122 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  201 (256)
T cd05112         122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP  201 (256)
T ss_pred             cccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999988654322111 111234568999999988889999999999999999998 8999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |.....       ......+..+..... +...+..+.+|+.+||+.+|++|||++++++.
T Consensus       202 ~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         202 YENRSN-------SEVVETINAGFRLYK-PRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CCcCCH-------HHHHHHHhCCCCCCC-CCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            976432       223334433333222 24568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-36  Score=239.85  Aligned_cols=201  Identities=22%  Similarity=0.354  Sum_probs=166.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ...+.+|+.++++++||||+++++.+.. ...++|+||+++++|.+++...+ .++...+..++.|++.||.|||+ .|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i  122 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED-KKL  122 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCe
Confidence            6788999999999999999999999888 77899999999999999998766 78999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCC-------cEEEEecccccccccCCCCcccccccccccCcccccCC--CCCcchhHHHHHHHHHH
Q 024828           91 IHRDLKPSNLLINHRG-------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~  161 (262)
                      +|+||+|+||+++.++       .++++|||++.....    .....++..|+|||.+.+.  .++.++|+||||+++++
T Consensus       123 ~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~  198 (259)
T cd05037         123 VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLE  198 (259)
T ss_pred             ecccCccceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence            9999999999998877       799999999876543    2223456789999998876  68999999999999999


Q ss_pred             HHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +++ |..||......+       ............   ......+.+++.+||..+|.+|||+.++++
T Consensus       199 l~~~~~~p~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         199 ICSNGEEPLSTLSSSE-------KERFYQDQHRLP---MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHhCCCCCcccCCchh-------HHHHHhcCCCCC---CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            999 577886654221       111111111111   122378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.3e-36  Score=248.44  Aligned_cols=213  Identities=23%  Similarity=0.409  Sum_probs=175.3

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~   70 (262)
                      .....+++.+|+++++++ +||||+++++.+.+++..++++||+++++|.+++.+..                .++...+
T Consensus        57 ~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  136 (334)
T cd05100          57 TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL  136 (334)
T ss_pred             CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHH
Confidence            345567899999999999 79999999999999999999999999999999997532                3678888


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCc
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGY  148 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~  148 (262)
                      ..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.
T Consensus       137 ~~~~~qi~~al~~LH~-~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (334)
T cd05100         137 VSCAYQVARGMEYLAS-QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  215 (334)
T ss_pred             HHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence            9999999999999998 99999999999999999999999999998754332111  11122345799999999888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ++|+||||+++|+|++ |..||......       +....+......+. ...++.++.+++.+||+.+|++|||+.+++
T Consensus       216 ~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~ell  287 (334)
T cd05100         216 QSDVWSFGVLLWEIFTLGGSPYPGIPVE-------ELFKLLKEGHRMDK-PANCTHELYMIMRECWHAVPSQRPTFKQLV  287 (334)
T ss_pred             hhhhHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence            9999999999999998 88888764322       23333433333333 346788999999999999999999999999


Q ss_pred             cC
Q 024828          228 TH  229 (262)
Q Consensus       228 ~h  229 (262)
                      .+
T Consensus       288 ~~  289 (334)
T cd05100         288 ED  289 (334)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.4e-36  Score=247.55  Aligned_cols=212  Identities=25%  Similarity=0.407  Sum_probs=173.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .....+++.+|+.+++.++||||+++++.+..+ ..+++++|+.+++|.+++.+. ..++...+..++.|++.||+|||+
T Consensus        49 ~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~  127 (316)
T cd05108          49 SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE  127 (316)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            455677899999999999999999999998765 477999999999999999875 458899999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc--ccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .|++|+||+|+||+++.++.++|+|||++..........  .....+..|++||.+.+..++.++|+||||+++|++++
T Consensus       128 -~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t  206 (316)
T cd05108         128 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  206 (316)
T ss_pred             -cCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence             999999999999999999999999999997654332211  11223567999999998889999999999999999997


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                       |..||.+....       +.......+..... +..++.++.+++.+||..+|.+|||+.+++.+
T Consensus       207 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         207 FGSKPYDGIPAS-------EISSILEKGERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCCCCCCCHH-------HHHHHHhCCCCCCC-CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             99999764321       12222223322222 34678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.8e-36  Score=239.75  Aligned_cols=206  Identities=18%  Similarity=0.346  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+....+.+|+.+++.++||||+++++++......+++|||+++++|..++.+. ..++...+..++.|++.||+|||+ 
T Consensus        45 ~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-  123 (262)
T cd05077          45 RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED-  123 (262)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-
Confidence            344557888999999999999999999999988999999999999999998754 568999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCc-------EEEEecccccccccCCCCcccccccccccCccccc-CCCCCcchhHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGE-------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-GGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l  159 (262)
                      .|++|+||+|+||+++.++.       ++++|||.+......    ....++..|+|||.+. +..++.++||||||+++
T Consensus       124 ~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l  199 (262)
T cd05077         124 KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTL  199 (262)
T ss_pred             CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHH
Confidence            99999999999999986654       899999987654322    2345678899999887 45688999999999999


Q ss_pred             HHHH-hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          160 LECA-TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       160 ~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |+|+ +|..||......+       . .........  .....+.++.+|+.+||+.||++||++.+++++
T Consensus       200 ~el~~~~~~p~~~~~~~~-------~-~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         200 WEICYNGEIPLKDKTLAE-------K-ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHhCCCCCCCCcchhH-------H-HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            9997 5888886543211       1 111112111  112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.4e-36  Score=241.40  Aligned_cols=213  Identities=25%  Similarity=0.384  Sum_probs=171.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKV------KTIPEEYLAAICE   75 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~   75 (262)
                      +....+.+.+|+++++.++||||+++++.+...      ...++++||+.+++|.+++...      ..++...+..++.
T Consensus        40 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  119 (272)
T cd05075          40 TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT  119 (272)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHH
Confidence            456677889999999999999999999876432      2478999999999999987421      3478999999999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHH
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIW  153 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~  153 (262)
                      |++.||+|||+ .|++|+||+|+||+++.++.++++|||++........  ......++..|++||...+..++.++|+|
T Consensus       120 ~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~  198 (272)
T cd05075         120 DIASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVW  198 (272)
T ss_pred             HHHHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHH
Confidence            99999999998 9999999999999999999999999999876543221  11222356679999999988899999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          154 SLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       154 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |||+++|++++ |+.||......       .....+..+..... ...++..+.+++.+||+.+|.+|||+++++++
T Consensus       199 slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         199 SFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGNRLKQ-PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999998 88999764322       22333333333222 34678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9.9e-37  Score=236.23  Aligned_cols=224  Identities=23%  Similarity=0.446  Sum_probs=176.6

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+.+|+.+++.++||||+.+..+|.. +...++++||.+. +|..+++-+     +.++...++.++.||+.|+.|||+ 
T Consensus        73 SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-  150 (438)
T KOG0666|consen   73 SACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-  150 (438)
T ss_pred             HHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-
Confidence            45689999999999999999999977 7889999999987 999999643     458999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccC----CcEEEEecccccccccCCCCc---ccccccccccCcccccCCC-CCcchhHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHR----GEVKITDFGVSAIMASTSGQA---NTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVL  159 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l  159 (262)
                      +=+.||||||.||++..+    |+|+++|+|+++.+..+-+..   ...+-|++|+|||.+.|.. |+.+.|+|++||++
T Consensus       151 NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIf  230 (438)
T KOG0666|consen  151 NWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIF  230 (438)
T ss_pred             hheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHH
Confidence            779999999999999887    899999999999887665443   2346789999999999875 99999999999999


Q ss_pred             HHHHhCCCCCCCCCcc------------------------CchhhHH------HHHHHHhcCCCCCC-------CCCCCC
Q 024828          160 LECATGQFPYSPPEQQ------------------------DGWTSFY------ELMEAIVDQPPPSA-------PSDQFS  202 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~------------------------~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~  202 (262)
                      .||++-.+.|.+.+..                        +.|....      ..+..+........       ....-+
T Consensus       231 aElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~  310 (438)
T KOG0666|consen  231 AELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKD  310 (438)
T ss_pred             HHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCC
Confidence            9999988888653321                        1111111      11111111111000       011234


Q ss_pred             HHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       203 ~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      +...+|+.+||+.||.+|.|++++++|+||.+-+-..
T Consensus       311 ~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp  347 (438)
T KOG0666|consen  311 PSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPP  347 (438)
T ss_pred             chHHHHHHHHhccCchhhccHHHHhcccccccCCCCC
Confidence            5588999999999999999999999999998875443

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.3e-36  Score=240.19  Aligned_cols=215  Identities=22%  Similarity=0.318  Sum_probs=165.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----TIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ......+.+|+.++++++||||+++++.+.+....++||||+++++|.+++....     ..+...+..++.|++.|++|
T Consensus        36 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~  115 (269)
T cd05087          36 VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH  115 (269)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHH
Confidence            3445678899999999999999999999999889999999999999999997532     35677788999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCC-------CCCcchhHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGG-------KYGYKSDIWS  154 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-------~~~~~~Di~s  154 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+.       .++.++|+||
T Consensus       116 lH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  194 (269)
T cd05087         116 LHK-NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS  194 (269)
T ss_pred             HHH-CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence            998 9999999999999999999999999998865432211  11223456789999988642       3578999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          155 LGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       155 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+++++|++ |+.||......+..   .............+......++.+.+++.+|+ .+|++|||+++++.
T Consensus       195 lG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         195 LGVTIWELFELGSQPYRHLSDEQVL---TYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             HHHHHHHHHhCCCCCCCCCChHHHH---HHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            9999999996 99999765432211   01111111111112222346788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.2e-36  Score=241.15  Aligned_cols=212  Identities=23%  Similarity=0.389  Sum_probs=165.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----TIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ......+.+|+.+++.++||||+++++.+.+....++||||+++++|.+++....     ..+......++.|++.||+|
T Consensus        36 ~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  115 (269)
T cd05042          36 PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW  115 (269)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHH
Confidence            4456678899999999999999999999999999999999999999999997643     24677788999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccC-------CCCCcchhHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISG-------GKYGYKSDIWS  154 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~s  154 (262)
                      ||+ .|++|+||+|.||+++.++.++++|||++.......  .......++..|+|||.+..       ..++.++|+||
T Consensus       116 lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  194 (269)
T cd05042         116 LHQ-ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS  194 (269)
T ss_pred             HHh-cCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence            998 999999999999999999999999999876432211  11122334667999998642       34688999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCC---CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          155 LGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       155 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |||++|+|++ |..||......+      ..........   ........+++.+.+++..|+ .||.+|||++++++
T Consensus       195 lG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         195 LGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            9999999998 788887653321      1111111111   112223467888999999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-36  Score=249.31  Aligned_cols=216  Identities=27%  Similarity=0.449  Sum_probs=170.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECC----------eEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNG----------AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLK   79 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~   79 (262)
                      ....+.+|++++++++||||+++++++.+..          ..++++||+++ ++...+.+. ..++...+..++.|++.
T Consensus        49 ~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~  127 (302)
T cd07864          49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLE  127 (302)
T ss_pred             chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence            3456778999999999999999999887644          79999999977 787777654 46899999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCC-CCCcchhHHHHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGL  157 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~  157 (262)
                      ||+|||+ .|++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+. ..+.++|+||+|+
T Consensus       128 aL~~LH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~  206 (302)
T cd07864         128 GLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC  206 (302)
T ss_pred             HHHHHHh-CCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHH
Confidence            9999998 9999999999999999999999999998876543321 11122456789999988654 4788999999999


Q ss_pred             HHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCC-------------------------CCCCCCCHHHHHHHHHh
Q 024828          158 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-------------------------APSDQFSPEFCSFISAC  212 (262)
Q Consensus       158 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~  212 (262)
                      ++++|++|+.||...+..+..    ..+........+.                         .....++..+.+++.+|
T Consensus       207 ~~~el~~g~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  282 (302)
T cd07864         207 ILGELFTKKPIFQANQELAQL----ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHM  282 (302)
T ss_pred             HHHHHHhCCCCCCCCChHHHH----HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHH
Confidence            999999999999765432211    1111111111000                         01124688999999999


Q ss_pred             hcCCcCCCCCHHHHhcCccc
Q 024828          213 VQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       213 l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      |+.+|.+|||+++++.||||
T Consensus       283 l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         283 LTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccCChhhCCCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.7e-36  Score=239.17  Aligned_cols=214  Identities=25%  Similarity=0.432  Sum_probs=174.0

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...++...+.+.+|++++++++|+||+++++.+.+ ...+++|||+++++|.+++.+.  ..++...+..++.|++.||.
T Consensus        38 ~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~  116 (260)
T cd05073          38 MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA  116 (260)
T ss_pred             cCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHH
Confidence            33345566789999999999999999999999887 7789999999999999999764  35788899999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      +||+ .|++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++++
T Consensus       117 ~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  195 (260)
T cd05073         117 FIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME  195 (260)
T ss_pred             HHHh-CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHH
Confidence            9998 9999999999999999999999999998865432211 1112234567999999988888999999999999999


Q ss_pred             HHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +++ |..||...+..       .....+..+...+ .....+.++.+++.+||+.+|++||+++++++
T Consensus       196 l~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         196 IVTYGRIPYPGMSNP-------EVIRALERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHhcCCCCCCCCCHH-------HHHHHHhCCCCCC-CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            998 99999764432       2223333333322 33568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.9e-36  Score=241.83  Aligned_cols=219  Identities=27%  Similarity=0.444  Sum_probs=170.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      +....+.+.+|++++++++||||+++.+++..  ....++|+||+++++|.+++.+. ..++...+..++.|++.||+||
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L  124 (284)
T cd05081          45 TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL  124 (284)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH
Confidence            34556788999999999999999999997653  34689999999999999999764 4689999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      |+ .|++|+||+|+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++|+||||+++++
T Consensus       125 H~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e  203 (284)
T cd05081         125 GS-KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE  203 (284)
T ss_pred             HH-CCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHH
Confidence            98 99999999999999999999999999998765432211   111123446999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCccC---------chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CATGQFPYSPPEQQD---------GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |++|..++.......         ...........+..... ......++.++.+|+.+||..+|++|||+++++.
T Consensus       204 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         204 LFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999876654332110         00011112222222222 2233567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-35  Score=240.99  Aligned_cols=211  Identities=24%  Similarity=0.407  Sum_probs=172.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .....+.+.+|+.++..++||||+++++++... ..+++++++++++|.+++... +.++...+..++.|++.||+|||+
T Consensus        49 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~  127 (279)
T cd05109          49 SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE  127 (279)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            455667889999999999999999999988754 478999999999999999764 568999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .|++|+||+|+||++++++.++|+|||++.........  .....++..|+|||...+..++.++|+|||||++|++++
T Consensus       128 -~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t  206 (279)
T cd05109         128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT  206 (279)
T ss_pred             -CCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence             99999999999999999999999999998765432221  111234567999999988889999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......       .....+..+..++ ....++.++.+++.+||..||++||++.+++.
T Consensus       207 ~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         207 FGAKPYDGIPAR-------EIPDLLEKGERLP-QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCCCCCCCCHH-------HHHHHHHCCCcCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             89998754321       2222233333332 23468899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-37  Score=254.63  Aligned_cols=225  Identities=26%  Similarity=0.472  Sum_probs=176.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCe------EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ....+.+.+|+.++++++|||++++.+.+.....      .++|+|++ +++|.+++.. ..+++..+..++.|++.||.
T Consensus        55 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~  132 (343)
T cd07851          55 AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLK  132 (343)
T ss_pred             hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            4455678899999999999999999998866544      89999999 5699999876 57999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~  161 (262)
                      +||+ .|++|+||+|+||+++.++.++|+|||.+......   .....++..|+|||...+. .++.++|+||||+++++
T Consensus       133 ~LH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~e  208 (343)
T cd07851         133 YIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE  208 (343)
T ss_pred             HHHH-CCeecCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHH
Confidence            9998 99999999999999999999999999998765332   2334567889999988653 57889999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHH--------------------HHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELM--------------------EAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      +++|+.||.............+..                    .........  ......+++++.+++.+||+.+|.+
T Consensus       209 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~  288 (343)
T cd07851         209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK  288 (343)
T ss_pred             HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhh
Confidence            999999997654322111111100                    000000000  0001245889999999999999999


Q ss_pred             CCCHHHHhcCccccccCCcc
Q 024828          220 RLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       220 Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      |||+.+++.||||+.+....
T Consensus       289 Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         289 RITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             CCCHHHHhcCCCccccCCCc
Confidence            99999999999998876553

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=240.07  Aligned_cols=212  Identities=23%  Similarity=0.379  Sum_probs=173.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCe------EEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGGSLADFLKKV------KTIPEEYLAAICEQ   76 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~   76 (262)
                      ......+.+|+++++.++||||+++++.+.....      .++++||+++++|..++...      ..++...+..++.|
T Consensus        42 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~  121 (273)
T cd05035          42 YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD  121 (273)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHH
Confidence            4456688999999999999999999998765443      79999999999999998543      35899999999999


Q ss_pred             HHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHH
Q 024828           77 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        77 l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      ++.||+|||+ .|++|+||+|+||++++++.++|+|||.+.........  ......+..|++||.+.+..++.++|+||
T Consensus       122 i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~S  200 (273)
T cd05035         122 IALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA  200 (273)
T ss_pred             HHHHHHHHHh-CCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHH
Confidence            9999999998 99999999999999999999999999998765432211  11123456799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          155 LGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       155 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |||++|+|++ |..||......       +.......+..... +..+++++.+++.+||+.||++|||+.+++++
T Consensus       201 lG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         201 FGVTMWEIATRGQTPYPGVENH-------EIYDYLRHGNRLKQ-PEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC-CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999 88998764432       23344444443333 35788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-35  Score=238.56  Aligned_cols=214  Identities=28%  Similarity=0.527  Sum_probs=176.8

Q ss_pred             hHHHHHHHHHHHHHHhc-CCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      .+....++.+|+.++.+ ++||||+++++.+.+++..+++|||+.|++|.+++..    ...++...++.++.|++.+|.
T Consensus        48 ~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~  127 (269)
T cd08528          48 RDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR  127 (269)
T ss_pred             chHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHH
Confidence            34455677889998865 7999999999999999999999999999999988743    346899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      +||+..|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||...+..++.++|+||||+++|++
T Consensus       128 ~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l  206 (269)
T cd08528         128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM  206 (269)
T ss_pred             HhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHH
Confidence            99964789999999999999999999999999987654432 33345678889999999988899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++|+.||...+.       .............+.....+++++.+++.+||+.||++||++.++..+
T Consensus       207 ~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         207 CTLQPPFYSTNM-------LSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HhCCCcccccCH-------HHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            999999975432       223333333433333444678999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.7e-36  Score=241.94  Aligned_cols=219  Identities=23%  Similarity=0.371  Sum_probs=172.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .....++.+|+.++++++||||+++.+++.+.  ...++||||++|++|.+++.+.. .++...+..++.|++.||++||
T Consensus        47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH  126 (284)
T cd05079          47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG  126 (284)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44566899999999999999999999998775  56899999999999999997653 5899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .|++|+||+|+||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++|+||||++++++
T Consensus       127 ~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el  205 (284)
T cd05079         127 S-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL  205 (284)
T ss_pred             H-CCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhh
Confidence            8 9999999999999999999999999999876543221   11223456679999999888899999999999999999


Q ss_pred             HhCCCCCCCCCcc--------CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          163 ATGQFPYSPPEQQ--------DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       163 ~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++++.|.......        ...............+...+ ....++.++.+|+.+||+.+|.+|||+++++++
T Consensus       206 lt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         206 LTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             hcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            9977654321110        00001112222233333322 234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-35  Score=238.89  Aligned_cols=212  Identities=24%  Similarity=0.425  Sum_probs=173.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ++....++.+|+.++++++||||+++.+.+.++...++||||+++++|.+++... +.++...+..++.|++.||++||+
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~  124 (269)
T cd05065          45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE  124 (269)
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4566788999999999999999999999999999999999999999999999764 568999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc--c-cc--cccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--N-TF--VGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~-~~--~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                       .|++|+||+|+||+++.++.++++|||.+..........  . ..  ..+..|+|||.+.+..++.++|+||+|+++++
T Consensus       125 -~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e  203 (269)
T cd05065         125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE  203 (269)
T ss_pred             -CCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHH
Confidence             999999999999999999999999999876543221110  0 11  11346999999998889999999999999999


Q ss_pred             HHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +++ |..||......       +....+......+. ...++..+.+++.+||..+|.+||++++++.
T Consensus       204 ~l~~g~~p~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         204 VMSYGERPYWDMSNQ-------DVINAIEQDYRLPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HhcCCCCCCCCCCHH-------HHHHHHHcCCcCCC-cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            886 99999765432       22233322222222 2467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.9e-36  Score=250.24  Aligned_cols=226  Identities=24%  Similarity=0.430  Sum_probs=175.5

Q ss_pred             HHHHHHHHHHHHhcC-CCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828           11 ARRQIAQELKINQSS-QCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ..+.+.+|+.+++++ +||||+++++.+..    ....+++++++. ++|.+++.....++...+..++.|++.||++||
T Consensus        44 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH  122 (332)
T cd07857          44 LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH  122 (332)
T ss_pred             hHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            456788999999999 59999999987543    245789999995 599999988888999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC----CcccccccccccCcccccC-CCCCcchhHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~  160 (262)
                      + .|++|+||+|+||+++.++.++|+|||.+........    ......++..|+|||...+ ..++.++|+||+|++++
T Consensus       123 ~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~  201 (332)
T cd07857         123 S-ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA  201 (332)
T ss_pred             h-CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHH
Confidence            8 9999999999999999999999999999876543221    1223467889999998765 45889999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHH--------------------HHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYEL--------------------MEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      ++++|.+||...+...........                    ........  .........+.++.+++.+||+.||.
T Consensus       202 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  281 (332)
T cd07857         202 ELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT  281 (332)
T ss_pred             HHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc
Confidence            999999999765432111110000                    00000000  00111234578899999999999999


Q ss_pred             CCCCHHHHhcCccccccCCc
Q 024828          219 QRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|||+++++.||||+.+...
T Consensus       282 ~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         282 KRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             cCCCHHHHhcChhhhhhcCc
Confidence            99999999999999988753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.9e-36  Score=267.72  Aligned_cols=214  Identities=26%  Similarity=0.439  Sum_probs=171.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-----------KTIPEEYLAAICEQV   77 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------~~~~~~~~~~i~~~l   77 (262)
                      +...+++.+|++++++++||||+++++++.+++..+++|||++|++|.+++.+.           ...+...+..++.|+
T Consensus        43 e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QI  122 (932)
T PRK13184         43 PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI  122 (932)
T ss_pred             HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHH
Confidence            455678999999999999999999999999999999999999999999998642           235567788999999


Q ss_pred             HHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC------------------CCcccccccccccCcc
Q 024828           78 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS------------------GQANTFVGTYNYMSPE  139 (262)
Q Consensus        78 ~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------------------~~~~~~~~~~~y~~PE  139 (262)
                      +.||+|||+ .|++|+||||+||+++.++.++++|||++.......                  .......|++.|+|||
T Consensus       123 a~AL~yLHs-~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE  201 (932)
T PRK13184        123 CATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE  201 (932)
T ss_pred             HHHHHHHHH-CCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHH
Confidence            999999998 999999999999999999999999999987652110                  0111246899999999


Q ss_pred             cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          140 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       140 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      .+.+..++.++|+||+||++++|++|+.||........      .............+...+++.+.+++.+||..||++
T Consensus       202 ~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki------~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~k  275 (932)
T PRK13184        202 RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI------SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAE  275 (932)
T ss_pred             HhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh------hhhhhccChhhccccccCCHHHHHHHHHHccCChhh
Confidence            99988899999999999999999999999976432211      011111111111223468899999999999999999


Q ss_pred             CCCHHHHhcC
Q 024828          220 RLSAQELMTH  229 (262)
Q Consensus       220 Rpt~~~~l~h  229 (262)
                      ||+..+.+.+
T Consensus       276 R~ss~eeLl~  285 (932)
T PRK13184        276 RYSSVQELKQ  285 (932)
T ss_pred             CcCHHHHHHH
Confidence            9876655543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-35  Score=238.14  Aligned_cols=204  Identities=21%  Similarity=0.359  Sum_probs=164.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|+.+++.++||||+++++++.++...++||||+++++|..++.+ .+.++...+..++.|++.||+|||+ .|
T Consensus        59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~  137 (274)
T cd05076          59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED-KN  137 (274)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CC
Confidence            345788899999999999999999999999999999999999999999865 4568999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCC-------cEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHH
Q 024828           90 IIHRDLKPSNLLINHRG-------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~  161 (262)
                      ++|+||+|+||+++..+       .++++|||.+......    ....++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus       138 iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~e  213 (274)
T cd05076         138 LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE  213 (274)
T ss_pred             ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHH
Confidence            99999999999997543       3799999987543211    22346778999998875 458999999999999999


Q ss_pred             HH-hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          162 CA-TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       162 l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++ +|..||......+.    ...   ......   .+...++++.+++.+||+.+|.+|||+++++++
T Consensus       214 l~~~g~~p~~~~~~~~~----~~~---~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         214 ICFDGEVPLKERTPSEK----ERF---YEKKHR---LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhCCCCCccccChHHH----HHH---HHhccC---CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            84 68999976543211    111   111111   112356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.1e-35  Score=238.25  Aligned_cols=211  Identities=25%  Similarity=0.385  Sum_probs=173.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .+..+.+.+|+.+++.++||||+++++++.++ ..++||||+++++|.+++.+.. .++...+..++.+++.||++||+ 
T Consensus        48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-  125 (270)
T cd05056          48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES-  125 (270)
T ss_pred             HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            55677899999999999999999999988764 5789999999999999997654 58999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      .|++|+||+|+||+++.++.++++|||++......... .....++..|+|||.+.+..++.++|+||||++++++++ |
T Consensus       126 ~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g  205 (270)
T cd05056         126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLG  205 (270)
T ss_pred             CCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcC
Confidence            99999999999999999999999999988654332211 112233457999999988889999999999999999986 9


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ..||......       +....+..+..... +..++.++.+++.+|+..+|.+|||+.+++..
T Consensus       206 ~~pf~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         206 VKPFQGVKNN-------DVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CCCCCCCCHH-------HHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999765432       22233333333332 35678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-35  Score=237.55  Aligned_cols=215  Identities=17%  Similarity=0.313  Sum_probs=165.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ....+.+.+|+.+++.++||||+++++.+.+....++||||+++++|.+++.+.    ...+...+..++.|++.||+||
T Consensus        36 ~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l  115 (268)
T cd05086          36 SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM  115 (268)
T ss_pred             hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH
Confidence            456678999999999999999999999999999999999999999999999764    2356777889999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccC-------CCCCcchhHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISG-------GKYGYKSDIWSL  155 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~sl  155 (262)
                      |+ .+++|+||+|+||+++.++.++++|||.+.......  .......++..|+|||.+..       ..++.++|+|||
T Consensus       116 H~-~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl  194 (268)
T cd05086         116 HK-HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL  194 (268)
T ss_pred             HH-CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHH
Confidence            98 999999999999999999999999999875422111  11123456788999998743       235789999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          156 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       156 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+++|+|++ |..||......+.   ..............+.....+++.+.+++..|| .+|.+||+++++++
T Consensus       195 G~~l~el~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         195 GVTLWELFENAAQPYSHLSDREV---LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHH---HHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            999999997 5778865433211   111111111111112222357888999999999 67999999999965

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-35  Score=249.71  Aligned_cols=213  Identities=28%  Similarity=0.403  Sum_probs=172.4

Q ss_pred             HHHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC------------------------
Q 024828            9 ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK------------------------   63 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------   63 (262)
                      ....+.+.+|++++.++. ||||+++++.+...+..++|+||+.+++|.+++.+.+                        
T Consensus        81 ~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (401)
T cd05107          81 SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTP  160 (401)
T ss_pred             hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccc
Confidence            444567899999999997 9999999999999999999999999999999996532                        


Q ss_pred             --------------------------------------------------------------------------CCCHHH
Q 024828           64 --------------------------------------------------------------------------TIPEEY   69 (262)
Q Consensus        64 --------------------------------------------------------------------------~~~~~~   69 (262)
                                                                                                .++...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  240 (401)
T cd05107         161 LSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMD  240 (401)
T ss_pred             ccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHH
Confidence                                                                                      256667


Q ss_pred             HHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCC
Q 024828           70 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYG  147 (262)
Q Consensus        70 ~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~  147 (262)
                      +..++.|++.||+|||+ .|++|+||+|.||+++.++.++|+|||++........  ......++..|+|||.+.+..++
T Consensus       241 ~~~~~~qi~~aL~~LH~-~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  319 (401)
T cd05107         241 LVGFSYQVANGMEFLAS-KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT  319 (401)
T ss_pred             HHHHHHHHHHHHHHHhc-CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC
Confidence            88899999999999998 9999999999999999999999999999875432211  11223456789999999888899


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          148 YKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       148 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      .++|+||+|+++++|++ |..||......+      .....+..+..+. .+..++.++.+++.+||..+|.+||+++++
T Consensus       320 ~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~el  392 (401)
T cd05107         320 TLSDVWSFGILLWEIFTLGGTPYPELPMNE------QFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQL  392 (401)
T ss_pred             cHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            99999999999999998 888987643321      1122223332222 234678999999999999999999999999


Q ss_pred             hcC
Q 024828          227 MTH  229 (262)
Q Consensus       227 l~h  229 (262)
                      ++.
T Consensus       393 l~~  395 (401)
T cd05107         393 VHL  395 (401)
T ss_pred             HHH
Confidence            864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-35  Score=237.86  Aligned_cols=210  Identities=27%  Similarity=0.419  Sum_probs=173.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....++.+|+.++.+++||||+++++++.. ...++|+||+.+++|.+++.+. ..+++..+..++.|++.||+|||+ 
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-  127 (279)
T cd05057          50 PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE-  127 (279)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            4556788999999999999999999999887 7899999999999999999774 468999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc--cccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN--TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                      .|++|+||+|+||+++.++.++|+|||.+...........  ...++..|++||.+.+..++.++|+||+|++++++++ 
T Consensus       128 ~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~  207 (279)
T cd05057         128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF  207 (279)
T ss_pred             CCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcC
Confidence            9999999999999999999999999999876543222111  1123457999999988889999999999999999998 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+.||......       +....+..+..... +...+..+.+++.+||..+|++|||+.++++
T Consensus       208 g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         208 GAKPYEGIPAV-------EIPDLLEKGERLPQ-PPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCCCCCCHH-------HHHHHHhCCCCCCC-CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999765332       23333333333222 3457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-35  Score=235.41  Aligned_cols=213  Identities=39%  Similarity=0.695  Sum_probs=181.4

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      .+.+.+|++.+++++|++|+++.+.+......++++|++.+++|.+++.....++...+..++.+++.++.+||+ .|++
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~  109 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHS-NGII  109 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH-cCee
Confidence            689999999999999999999999999999999999999999999999887778999999999999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      |+||+|.||+++.++.++++|||.+....... ......++..|++||...+...+.++|+|++|++++++++|..||..
T Consensus       110 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      110 HRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             cCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999987765432 22344577889999999888889999999999999999999999976


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCCCCCC-CCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ....      ....+.............. ++.++.+++.+||..+|++||++.++++||||
T Consensus       189 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      189 DDQL------LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CCcH------HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            4222      1223333333332222222 88999999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.2e-36  Score=246.73  Aligned_cols=224  Identities=27%  Similarity=0.499  Sum_probs=175.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+.+|++++++++||||+++.+++.. +...++++||+ +++|.++++. .+++...+..++.|++.||.+||+ 
T Consensus        50 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~-  126 (328)
T cd07856          50 PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHS-  126 (328)
T ss_pred             cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            3456778899999999999999999999865 56789999999 5599988865 568888999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||+|.||+++.++.++++|||.+.....   ......++..|+|||.+.+ ..++.++|+||+|++++++++|+
T Consensus       127 ~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~  203 (328)
T cd07856         127 AGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK  203 (328)
T ss_pred             CCcccCCCCHHHEeECCCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999998865322   2223456788999998766 45899999999999999999999


Q ss_pred             CCCCCCCccCchhhHHH--------------------HHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          167 FPYSPPEQQDGWTSFYE--------------------LMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      .||........+....+                    ...........+  .....++.++.++|.+||+.+|++|||++
T Consensus       204 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~  283 (328)
T cd07856         204 PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA  283 (328)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            99976543211111110                    000000000000  01134678999999999999999999999


Q ss_pred             HHhcCccccccCCc
Q 024828          225 ELMTHPFLKMYGDL  238 (262)
Q Consensus       225 ~~l~h~~~~~~~~~  238 (262)
                      +++.||||+.....
T Consensus       284 ell~~~~~~~~~~~  297 (328)
T cd07856         284 EALAHPYLAPYHDP  297 (328)
T ss_pred             HHhcCCccccccCC
Confidence            99999999777654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-36  Score=250.21  Aligned_cols=224  Identities=24%  Similarity=0.432  Sum_probs=173.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ....+.+.+|+.++++++||||+++.+++...      ...+++++++ |++|.++++. +.++...+..++.|++.||.
T Consensus        57 ~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~  134 (345)
T cd07877          57 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLK  134 (345)
T ss_pred             hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            33456788999999999999999999988643      3478888888 6799988865 46899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~  161 (262)
                      |||+ .|++|+||+|+||+++.++.++++|||++.....   ......++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus       135 ~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e  210 (345)
T cd07877         135 YIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE  210 (345)
T ss_pred             HHHH-CCeeecCCChHHEEEcCCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHH
Confidence            9998 9999999999999999999999999999875432   2233457788999999876 457889999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHH--------------------HHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYE--------------------LMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~--------------------~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      |++|+.||...+..........                    ..........  ........++++.++|.+||+.||.+
T Consensus       211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  290 (345)
T cd07877         211 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK  290 (345)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhh
Confidence            9999999976443221111100                    0000000000  00001235788999999999999999


Q ss_pred             CCCHHHHhcCccccccCCc
Q 024828          220 RLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       220 Rpt~~~~l~h~~~~~~~~~  238 (262)
                      |||+.+++.||||+.+...
T Consensus       291 R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         291 RITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             cCCHHHHhcChhhhhcCCC
Confidence            9999999999999976643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-35  Score=237.58  Aligned_cols=205  Identities=21%  Similarity=0.336  Sum_probs=165.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|+.+++.++||||+++++.+..+...++||||+++++|.+++..++ .++...+..++.|++.||+|||+ .
T Consensus        41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~  119 (258)
T cd05078          41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED-K  119 (258)
T ss_pred             HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            344678899999999999999999999999899999999999999999997654 58999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCc--------EEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRGE--------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVL  159 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l  159 (262)
                      |++|+||+|+||+++.++.        ++++|||.+.....    .....++..|+|||.+.+. .++.++|+||||+++
T Consensus       120 ~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l  195 (258)
T cd05078         120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTL  195 (258)
T ss_pred             CeecCCCccceEEEecccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence            9999999999999987664        69999998765432    2234567889999999874 478999999999999


Q ss_pred             HHHHhC-CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          160 LECATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       160 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |++++| ..|+...+...       ...... .. . ..+...+.++.+++.+||+.+|++|||++++++.
T Consensus       196 ~~l~~g~~~~~~~~~~~~-------~~~~~~-~~-~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         196 WEIFSGGDKPLSALDSQK-------KLQFYE-DR-H-QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHcCCCCChhhccHHH-------HHHHHH-cc-c-cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            999998 46665433211       111111 11 1 1123456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.4e-36  Score=249.15  Aligned_cols=225  Identities=27%  Similarity=0.460  Sum_probs=170.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--------------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSN--------------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE   75 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~   75 (262)
                      ...+.+.+|++++++++||||+++++.+...              ...++|+||+++ +|.+++.. +.++...+..++.
T Consensus        44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~  121 (342)
T cd07854          44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMY  121 (342)
T ss_pred             chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHH
Confidence            4456788999999999999999999876543              357999999975 99988865 5689999999999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCC---cccccccccccCcccccC-CCCCcch
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISG-GKYGYKS  150 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~-~~~~~~~  150 (262)
                      |++.||.|||+ .|++|+||+|+||+++. ++.++++|||.+.........   .....++..|+|||.+.+ ..++.++
T Consensus       122 qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  200 (342)
T cd07854         122 QLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI  200 (342)
T ss_pred             HHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchh
Confidence            99999999998 99999999999999975 457899999998754322111   122356778999998765 4578899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCccCchhhHHH---------------HH-HHHh-cCCCCCC----CCCCCCHHHHHHH
Q 024828          151 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LM-EAIV-DQPPPSA----PSDQFSPEFCSFI  209 (262)
Q Consensus       151 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------~~-~~~~-~~~~~~~----~~~~~~~~l~~li  209 (262)
                      |+|||||++|+|++|+.||......+.......               .. .... .......    ....++.++.+|+
T Consensus       201 DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  280 (342)
T cd07854         201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFL  280 (342)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHH
Confidence            999999999999999999976543211111000               00 0000 0000000    1135778899999


Q ss_pred             HHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          210 SACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       210 ~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .+||+.||.+|||+++++.||||+.+..
T Consensus       281 ~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         281 EQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             HHHhCCCchhccCHHHHhCCCccccccC
Confidence            9999999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=252.40  Aligned_cols=212  Identities=24%  Similarity=0.425  Sum_probs=183.6

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      -..+.++.|..|..+++.++||||+++++++.+. ..++|||.++-|.|..|++.++ .++......++.||+.||+|||
T Consensus       430 ~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe  508 (974)
T KOG4257|consen  430 CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE  508 (974)
T ss_pred             CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH
Confidence            3566799999999999999999999999999875 4899999999999999998775 5999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc-cccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      + ..++||||...|||+++...|||+|||+++.......... ....++.|++||-+.-..++.++|||.||+++||++.
T Consensus       509 S-krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~  587 (974)
T KOG4257|consen  509 S-KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILS  587 (974)
T ss_pred             h-hchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHH
Confidence            9 9999999999999999999999999999988765432222 2345678999999998899999999999999999877


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||.+....+       ++..+.++.+++.+ ..+|+.++.|+.+||..+|.+||++.++..
T Consensus       588 lGvkPfqgvkNsD-------VI~~iEnGeRlP~P-~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  588 LGVKPFQGVKNSD-------VIGHIENGERLPCP-PNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             hcCCccccccccc-------eEEEecCCCCCCCC-CCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence             999998866553       34555667766666 578999999999999999999999877643

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.8e-36  Score=248.30  Aligned_cols=222  Identities=28%  Similarity=0.475  Sum_probs=172.5

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      +.....+.+|+.++++++||||+++.+++...      ..+++|+||+.. +|..+..  ..++...+..++.|++.||+
T Consensus        55 ~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~  131 (342)
T cd07879          55 EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLK  131 (342)
T ss_pred             ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHH
Confidence            34456788999999999999999999998754      346999999965 8877653  46899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~  161 (262)
                      +||+ .|++|+||+|+||+++.++.++|+|||++.....   ......++..|+|||.+.+ ..++.++|+||||+++++
T Consensus       132 ~LH~-~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~e  207 (342)
T cd07879         132 YIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAE  207 (342)
T ss_pred             HHHH-CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHH
Confidence            9998 9999999999999999999999999999865422   1223456788999999876 357889999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHH--------H--------HHHhcCCCCCCC-------CCCCCHHHHHHHHHhhcCCcC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYEL--------M--------EAIVDQPPPSAP-------SDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~--------~--------~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~  218 (262)
                      |++|+.||...+...........        .        ...... .+..+       ....++++.+|+.+||+.||.
T Consensus       208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  286 (342)
T cd07879         208 MLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS-LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVD  286 (342)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhh-cCCcccchHHHHhcCCCHHHHHHHHHHcCCChh
Confidence            99999999865432211111110        0        000000 00000       124577899999999999999


Q ss_pred             CCCCHHHHhcCccccccCCc
Q 024828          219 QRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +||++++++.||||+.+...
T Consensus       287 ~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         287 KRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             hCcCHHHHhcCcchhhcccc
Confidence            99999999999999988754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=247.32  Aligned_cols=225  Identities=26%  Similarity=0.431  Sum_probs=175.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +......+.+|++++++++||||+++.+.+..+.      .+++|+|++ |++|.+++.. ..+++..+..++.|++.||
T Consensus        54 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al  131 (343)
T cd07880          54 SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGL  131 (343)
T ss_pred             chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence            3445667889999999999999999999987643      468999999 6699988865 6789999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~  160 (262)
                      ++||+ .|++|+||+|+||+++.++.++++|||++......   .....++..|++||.+.+ ..++.++|+||+|++++
T Consensus       132 ~~LH~-~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~  207 (343)
T cd07880         132 KYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA  207 (343)
T ss_pred             HHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence            99998 99999999999999999999999999998754322   223356788999999876 35789999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHH--------------------HHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYE--------------------LMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~--------------------~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      ++++|..||...+..........                    ....+.....  ........++++.+++.+|++.||.
T Consensus       208 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  287 (343)
T cd07880         208 EMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE  287 (343)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChh
Confidence            99999999976543211110000                    0000000000  0011135678899999999999999


Q ss_pred             CCCCHHHHhcCccccccCCc
Q 024828          219 QRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|||+.+++.||||+.+...
T Consensus       288 ~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         288 SRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             hCCCHHHHhcCccHhhhcCc
Confidence            99999999999999987643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.8e-35  Score=237.95  Aligned_cols=212  Identities=23%  Similarity=0.358  Sum_probs=173.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKV--------KTIPEEYLAAICEQVL   78 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~l~   78 (262)
                      +....+.+.+|+.+++.++||||+++++++.. +...+++++|+.+++|.+++...        ..++...+..++.|++
T Consensus        48 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~  127 (280)
T cd05043          48 SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA  127 (280)
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHH
Confidence            45667888999999999999999999998765 56789999999999999999754        3488999999999999


Q ss_pred             HHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHH
Q 024828           79 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLG  156 (262)
Q Consensus        79 ~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG  156 (262)
                      .||+|||+ .|++|+||+|+||+++.++.++++|||++.........  .....++..|+|||.+.+..++.++||||||
T Consensus       128 ~~l~~LH~-~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG  206 (280)
T cd05043         128 CGMSYLHK-RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFG  206 (280)
T ss_pred             HHHHHHHH-CCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhH
Confidence            99999998 99999999999999999999999999998654322111  1112345679999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          157 LVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       157 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +++|++++ |+.||...+..       +....+........ ...+++++.+++.+||..+|++|||+.++++
T Consensus       207 ~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         207 VLLWELMTLGQTPYVEIDPF-------EMAAYLKDGYRLAQ-PINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHHHHHhcCCCCCcCcCCHH-------HHHHHHHcCCCCCC-CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999998 99999764321       23333333333232 3457899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-35  Score=240.31  Aligned_cols=216  Identities=25%  Similarity=0.409  Sum_probs=173.2

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ..+.+.+|+++++.++||||+++++++..  +...+++|||+++++|.+++.+.. .++...+..++.|++.||++||+ 
T Consensus        49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~-  127 (284)
T cd05038          49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-  127 (284)
T ss_pred             HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh-
Confidence            57789999999999999999999999877  557999999999999999997754 58999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++++|||.+.........   .....++..|++||...+..++.++|+||||+++++|++
T Consensus       128 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~t  207 (284)
T cd05038         128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT  207 (284)
T ss_pred             CCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeec
Confidence            99999999999999999999999999998766422211   112234556999999988889999999999999999999


Q ss_pred             CCCCCCCCCccCch--------hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 GQFPYSPPEQQDGW--------TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |..|+.........        .........+....... ....++.++.+++.+||+.+|.+|||+.+++.
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         208 YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCCcccccchhccccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            99888653322100        01112222222222222 23467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=242.88  Aligned_cols=218  Identities=28%  Similarity=0.430  Sum_probs=171.2

Q ss_pred             HHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           12 RRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....+|+..+.+++ |+|++++++.+.+++..++||||+ +++|.+++....  .++...+..++.|++.+|.+||+ .
T Consensus        41 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~  118 (283)
T cd07830          41 ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-H  118 (283)
T ss_pred             HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            334567999999998 999999999999999999999999 669999887765  78999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||++++++++|+.
T Consensus       119 ~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~  197 (283)
T cd07830         119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP  197 (283)
T ss_pred             CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCC
Confidence            999999999999999999999999999876543222 223456788999998754 447899999999999999999999


Q ss_pred             CCCCCCccCchhhHHH---------------HHHHHhcCCC------CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          168 PYSPPEQQDGWTSFYE---------------LMEAIVDQPP------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~---------------~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      ||......+.......               ..........      ........+.++.+++.+||+.+|.+|||++|+
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  277 (283)
T cd07830         198 LFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA  277 (283)
T ss_pred             ccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence            9976543221111100               0000000000      000011236789999999999999999999999


Q ss_pred             hcCccc
Q 024828          227 MTHPFL  232 (262)
Q Consensus       227 l~h~~~  232 (262)
                      +.||||
T Consensus       278 ~~~~~~  283 (283)
T cd07830         278 LQHPYF  283 (283)
T ss_pred             hhCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.3e-36  Score=247.60  Aligned_cols=219  Identities=27%  Similarity=0.463  Sum_probs=166.6

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEEC--------CeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSN--------GAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...+.+|++++++++||||+++++.+.+.        ...++|+||+.+ +|...+.. ...++...+..++.|++.||+
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~  129 (311)
T cd07866          51 PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGIN  129 (311)
T ss_pred             chhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHH
Confidence            34667899999999999999999987543        346999999965 78777765 357999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-----------cccccccccccCcccccCC-CCCcch
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-----------ANTFVGTYNYMSPERISGG-KYGYKS  150 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----------~~~~~~~~~y~~PE~~~~~-~~~~~~  150 (262)
                      |||+ .|++|+||+|+||+++.++.++++|||++.........           .....++..|+|||.+.+. .++.++
T Consensus       130 ~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  208 (311)
T cd07866         130 YLHE-NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV  208 (311)
T ss_pred             HHHh-CCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchh
Confidence            9998 99999999999999999999999999988654322211           1123457789999988654 478999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHH-----------HHhcCC-------CCC---CCCCCCCHHHHHHH
Q 024828          151 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME-----------AIVDQP-------PPS---APSDQFSPEFCSFI  209 (262)
Q Consensus       151 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~-------~~~---~~~~~~~~~l~~li  209 (262)
                      |+||+|+++++|++|++||.+...............           .+....       .+.   ......++.+.+++
T Consensus       209 Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  288 (311)
T cd07866         209 DIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLL  288 (311)
T ss_pred             HhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHH
Confidence            999999999999999999976544321111111000           000000       000   00123457789999


Q ss_pred             HHhhcCCcCCCCCHHHHhcCccc
Q 024828          210 SACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       210 ~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      .+||+.+|.+|||+.+++.||||
T Consensus       289 ~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         289 SKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHcccCcccCcCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=217.71  Aligned_cols=227  Identities=24%  Similarity=0.454  Sum_probs=188.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ++.....+.+|+-+|+.++|.|||+++++.-.+..+-+|+|||.. +|..+.... +.++.+.+..++.|++.+|.++|+
T Consensus        41 degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs  119 (292)
T KOG0662|consen   41 DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS  119 (292)
T ss_pred             CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh
Confidence            344556788999999999999999999999999999999999965 999998765 679999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHh-
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~-  164 (262)
                       .++.|+|+||+|.+++.+|.++++|||+++.++.+.+-...-+-+.+|+||.++.|.. |+...|+||.||++.|+.. 
T Consensus       120 -hnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelana  198 (292)
T KOG0662|consen  120 -HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_pred             -hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhc
Confidence             9999999999999999999999999999998887766555567799999999999876 8999999999999999977 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC--------------------CCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--------------------SDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      |++.|.+.+..++...+...........-|...                    -..++..-++|++++|.-+|.+|.+++
T Consensus       199 grplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae  278 (292)
T KOG0662|consen  199 GRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE  278 (292)
T ss_pred             CCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence            888898887776555554444322222111100                    012234467999999999999999999


Q ss_pred             HHhcCccccccC
Q 024828          225 ELMTHPFLKMYG  236 (262)
Q Consensus       225 ~~l~h~~~~~~~  236 (262)
                      +.++||||....
T Consensus       279 aalqhpyf~d~s  290 (292)
T KOG0662|consen  279 AALQHPYFSDFS  290 (292)
T ss_pred             HHhcCccccccC
Confidence            999999997653

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.6e-35  Score=242.12  Aligned_cols=213  Identities=29%  Similarity=0.462  Sum_probs=169.6

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhcC-----------------------
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVK-----------------------   63 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-----------------------   63 (262)
                      ......+.+|+.++.++ +||||+++++.+.. +...+++|||+++++|.+++....                       
T Consensus        51 ~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (343)
T cd05103          51 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDI  130 (343)
T ss_pred             hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccch
Confidence            44566788999999999 68999999998765 456899999999999999986431                       


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCC
Q 024828           64 --------------------------------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN   99 (262)
Q Consensus        64 --------------------------------------------~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~n   99 (262)
                                                                  .++...+..++.|++.||+|||+ .|++|+||+|+|
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~N  209 (343)
T cd05103         131 SEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARN  209 (343)
T ss_pred             hhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCe
Confidence                                                        35777888999999999999998 999999999999


Q ss_pred             EEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccC
Q 024828          100 LLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  176 (262)
Q Consensus       100 il~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~  176 (262)
                      |+++.++.++++|||++........  ......++..|+|||.+.+..++.++|+||||++++++++ |..||.......
T Consensus       210 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  289 (343)
T cd05103         210 ILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  289 (343)
T ss_pred             EEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH
Confidence            9999999999999999876432211  1112234567999999988889999999999999999997 899987643321


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          177 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                            ........+..... +...++++.+++.+||+.+|.+|||+.++++|
T Consensus       290 ------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         290 ------EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ------HHHHHHhccCCCCC-CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  12222333333222 23567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=252.03  Aligned_cols=213  Identities=23%  Similarity=0.412  Sum_probs=178.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      -.++..+.|.+|+..|++.+|-||+-+.+++..... .+|+-||+|.+|+.++.-. ..+.+...+.|++|++.|+.|||
T Consensus       427 pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH  505 (678)
T KOG0193|consen  427 PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH  505 (678)
T ss_pred             CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh
Confidence            366788999999999999999999999999987765 9999999999999999754 46999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC--CCCcccccccccccCcccccC---CCCCcchhHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~  160 (262)
                      . ++|+|+|||..||++.+++.|+|+|||++......  ........+...|+|||++..   .++++.+||||||+++|
T Consensus       506 A-K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~Y  584 (678)
T KOG0193|consen  506 A-KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWY  584 (678)
T ss_pred             h-hhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHH
Confidence            9 99999999999999999999999999998754332  233445567889999999754   35899999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcC---CCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ||++|..||.....+       .++-.+..+   ..........++++++|+..||..++++||.+.+||.
T Consensus       585 ELltg~lPysi~~~d-------qIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  585 ELLTGELPYSIQNRD-------QIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHhCcCCcCCCChh-------heEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            999999999854332       122233334   2222333467789999999999999999999999987

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=250.91  Aligned_cols=217  Identities=25%  Similarity=0.396  Sum_probs=178.7

Q ss_pred             chhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHH
Q 024828            6 NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         6 ~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~   83 (262)
                      ......+++|.+|+++|.+|+||||+.++++|..++.+|+|+||++.|+|.+++.++..  ...+....++.||+.||+|
T Consensus       573 ~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaY  652 (807)
T KOG1094|consen  573 DATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAY  652 (807)
T ss_pred             ccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHH
Confidence            35667789999999999999999999999999999999999999999999999998732  3556667799999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      |.+ .+++|||+.+.|+|++.+.++|++|||+++......  +-....+.+++|+|||.+.-++++.++|+|++|+++||
T Consensus       653 Les-~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE  731 (807)
T KOG1094|consen  653 LES-LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE  731 (807)
T ss_pred             HHh-hchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence            999 999999999999999999999999999998543322  22233567889999999999999999999999999999


Q ss_pred             HHh--CCCCCCCCCccCchhhHHHHHHHHhcCCCCC---CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          162 CAT--GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS---APSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       162 l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      +++  ...||.....++..+    -...+.......   ..+.-++..+.++|.+||..+-.+||+++++.
T Consensus       732 ~~~~C~e~Py~~lt~e~vve----n~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  732 VFMLCREQPYSQLTDEQVVE----NAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             HHHHHhhCchhhhhHHHHHH----hhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            865  678888766543322    222232222211   12346789999999999999999999999983

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.6e-34  Score=236.93  Aligned_cols=211  Identities=26%  Similarity=0.411  Sum_probs=170.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....++.+|+.+++.++||||+++++.+... ..+++++|+++++|.+++.... .++...+..++.|++.||+|||+ 
T Consensus        50 ~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-  127 (303)
T cd05110          50 PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE-  127 (303)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh-
Confidence            34445788999999999999999999988654 4679999999999999997754 58999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                      .|++|+||+|+||+++.++.++|+|||.+.........  .....++..|++||.+.+..++.++|+||||+++|++++ 
T Consensus       128 ~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~  207 (303)
T cd05110         128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTF  207 (303)
T ss_pred             cCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhC
Confidence            99999999999999999999999999998765432221  112234568999999988889999999999999999997 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |..||.+...    .   .....+..+.... .....+..+.+++.+||..+|++||+++++++.
T Consensus       208 g~~p~~~~~~----~---~~~~~~~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         208 GGKPYDGIPT----R---EIPDLLEKGERLP-QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCCCCCCH----H---HHHHHHHCCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8899876432    1   1222222232222 234578899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=246.14  Aligned_cols=215  Identities=25%  Similarity=0.427  Sum_probs=181.7

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKG   80 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~   80 (262)
                      |.++.+.-..++|..|+.+++.++|||+|+++++|..+..+|||+||+..|+|.+|++++.  .++....++++.||..|
T Consensus       298 KtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSa  377 (1157)
T KOG4278|consen  298 KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSA  377 (1157)
T ss_pred             hhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHH
Confidence            3344455667899999999999999999999999999999999999999999999998874  37788889999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc-ccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      ++||.. ++++|+||...|.|+..+..|+++|||+++.+....... .-..-++.|.|||-+....++.++|||+||+++
T Consensus       378 MeYLEk-knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLL  456 (1157)
T KOG4278|consen  378 MEYLEK-KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLL  456 (1157)
T ss_pred             HHHHHH-hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHH
Confidence            999999 999999999999999999999999999998775432111 112336789999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          160 LECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       160 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      ||+.| |..||.+.+.    .   .+..-+.++.+...+ ..+++.+++||+.||+++|..||++.|+
T Consensus       457 WEIATYGMsPYPGidl----S---qVY~LLEkgyRM~~P-eGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  457 WEIATYGMSPYPGIDL----S---QVYGLLEKGYRMDGP-EGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHhcCCCCCCCccH----H---HHHHHHhccccccCC-CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            99988 8899988654    2   222333444444444 6789999999999999999999999998

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=231.85  Aligned_cols=220  Identities=27%  Similarity=0.452  Sum_probs=180.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ....+++.+|+..+..++|+||++++.+|...      ...|+|||++.. +|...+.  -.++-..+..++.|++.|+.
T Consensus        56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik  132 (369)
T KOG0665|consen   56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIK  132 (369)
T ss_pred             CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHH
Confidence            44567889999999999999999999998654      358999999966 9988887  35778889999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      +||+ .||+||||||+||++..++.++++|||++...... -....++.+..|.|||++.+-.+...+||||+||++.||
T Consensus       133 ~lhs-~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEl  210 (369)
T KOG0665|consen  133 HLHS-AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL  210 (369)
T ss_pred             HHHh-cceeecccCcccceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHH
Confidence            9999 99999999999999999999999999999875543 344556788899999999988899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHH---------------HhcCC----------------CCCC--CCCCCCHHHHHHH
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEA---------------IVDQP----------------PPSA--PSDQFSPEFCSFI  209 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~----------------~~~~--~~~~~~~~l~~li  209 (262)
                      ++|+..|.+.+.-++|....+....               .....                .+..  .+..-+..+++++
T Consensus       211 i~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll  290 (369)
T KOG0665|consen  211 ILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLL  290 (369)
T ss_pred             hhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHH
Confidence            9999999987776666554433211               11100                0000  0112234588999


Q ss_pred             HHhhcCCcCCCCCHHHHhcCcccc
Q 024828          210 SACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       210 ~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      .+||..+|++|.+++++|+|||++
T Consensus       291 ~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  291 SKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhccChhhcccHHHHhcCCeee
Confidence            999999999999999999999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-35  Score=224.18  Aligned_cols=227  Identities=23%  Similarity=0.377  Sum_probs=177.8

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEE--------CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYS--------NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~   80 (262)
                      .-.....+|+++|..++|+|++.++++|..        ...+|+||++|+. +|.-++.+. -+++...+..++++++.|
T Consensus        58 GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~G  136 (376)
T KOG0669|consen   58 GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNG  136 (376)
T ss_pred             CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHH
Confidence            344567899999999999999999988753        2358999999987 999999876 579999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC----CCcccccccccccCcccccCC-CCCcchhHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----GQANTFVGTYNYMSPERISGG-KYGYKSDIWSL  155 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~sl  155 (262)
                      |.|+|. ..|+|+|+|+.|++++.+|.++|+|||+++.+....    ......+-|.+|++||.+.|. .++++.|+|+.
T Consensus       137 L~~iHr-~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgA  215 (376)
T KOG0669|consen  137 LYYIHR-NKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGA  215 (376)
T ss_pred             HHHHHH-hhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhH
Confidence            999998 999999999999999999999999999996654322    223344668999999999886 49999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccC---------------chhhHHHH--HHHHhcCCCCCC---------CCCCCCHHHHHHH
Q 024828          156 GLVLLECATGQFPYSPPEQQD---------------GWTSFYEL--MEAIVDQPPPSA---------PSDQFSPEFCSFI  209 (262)
Q Consensus       156 G~~l~~l~~g~~p~~~~~~~~---------------~~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~l~~li  209 (262)
                      ||++.+|+++.+.+.+..+..               .|.+..++  .+.+.....+..         .+-.-+++..+|+
T Consensus       216 gCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLl  295 (376)
T KOG0669|consen  216 GCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLL  295 (376)
T ss_pred             HHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHH
Confidence            999999999988887654432               22222111  111110100000         0112245788999


Q ss_pred             HHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          210 SACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       210 ~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .+++..||.+|+++++++.|.||..-+..
T Consensus       296 e~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  296 EKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             HHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            99999999999999999999999776655

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-34  Score=241.59  Aligned_cols=223  Identities=25%  Similarity=0.424  Sum_probs=184.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .......+..|-+||...++..||+++..|+|.+++|+||||++||++-++|-+.+-+++..+..++..+..|+++.|. 
T Consensus       669 ~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk-  747 (1034)
T KOG0608|consen  669 MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK-  747 (1034)
T ss_pred             hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh-
Confidence            3455566788999999999999999999999999999999999999999999999999999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccc--------cCCCC----------------------------------
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--------STSGQ----------------------------------  125 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~--------~~~~~----------------------------------  125 (262)
                      .|++|+||||+|||||.+|++||.|||+++-+-        ..+.+                                  
T Consensus       748 mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~  827 (1034)
T KOG0608|consen  748 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRIL  827 (1034)
T ss_pred             ccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhh
Confidence            999999999999999999999999999985331        00000                                  


Q ss_pred             cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 024828          126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  205 (262)
Q Consensus       126 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  205 (262)
                      ....+|++.|+|||++....++..+|.|+.|+++|+|+.|+.||-.....+....+..+..     ..-......++++.
T Consensus       828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-----~l~~~~~~~ls~e~  902 (1034)
T KOG0608|consen  828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN-----FLHIPYQGNLSKEA  902 (1034)
T ss_pred             hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-----ccccccccccCHHH
Confidence            1134799999999999999999999999999999999999999987766554333322221     11222335789999


Q ss_pred             HHHHHHhhcCCcCCCC---CHHHHhcCccccccCC
Q 024828          206 CSFISACVQKEPQQRL---SAQELMTHPFLKMYGD  237 (262)
Q Consensus       206 ~~li~~~l~~~p~~Rp---t~~~~l~h~~~~~~~~  237 (262)
                      .++|.++. .++++|.   .++++..||||+.+.-
T Consensus       903 ~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  903 LDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             HHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence            99998865 4578888   5677999999987653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=252.84  Aligned_cols=217  Identities=25%  Similarity=0.422  Sum_probs=191.1

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~   82 (262)
                      |....+.++.+|..|+.|+-+++||||+++.++..-....++|+||+++|+|..+++++ +.++..++..+++.|+.||.
T Consensus       666 K~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMk  745 (996)
T KOG0196|consen  666 KAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMK  745 (996)
T ss_pred             ccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhH
Confidence            44457899999999999999999999999999999999999999999999999999876 56999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccc---cccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~---~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      ||.+ .|++||||..+|||++.+-..|++|||+++.........++.   ..+++|.|||.+...+++.++||||+|++|
T Consensus       746 YLsd-m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVm  824 (996)
T KOG0196|consen  746 YLSD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM  824 (996)
T ss_pred             HHhh-cCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEE
Confidence            9998 999999999999999999999999999998664433222221   235689999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          160 LECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       160 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||.++ |..||.+...       +++++.+..+.+.+.+ -.+|..+.+||..||+.|-++||++.||+..
T Consensus       825 WEVmSyGERPYWdmSN-------QdVIkaIe~gyRLPpP-mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  825 WEVMSYGERPYWDMSN-------QDVIKAIEQGYRLPPP-MDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             EEecccCCCcccccch-------HHHHHHHHhccCCCCC-CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            99877 8888877544       4678888888887766 4789999999999999999999999998763

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-36  Score=245.45  Aligned_cols=220  Identities=29%  Similarity=0.507  Sum_probs=184.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ......++.+|+.||+.+.||+||.+...|+..+..++|||.+.|.=|.-++. +.+++++...+.++.||+.||.|||-
T Consensus       603 p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~  682 (888)
T KOG4236|consen  603 PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF  682 (888)
T ss_pred             CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh
Confidence            44455788899999999999999999999999999999999997744555554 44789999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCC---cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .||+|.||||+|||+.+..   ++||||||+++.++... .....+||+.|+|||++....|....|+||+|+++|.-+
T Consensus       683 -knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL  760 (888)
T KOG4236|consen  683 -KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL  760 (888)
T ss_pred             -cceeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEe
Confidence             9999999999999997654   69999999998876443 344568999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      +|..||...++-      .+.+++-..- .|+.+...++++..+||..+|+..-.+|.|++..+.|||++.+.
T Consensus       761 SGTFPFNEdEdI------ndQIQNAaFM-yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  761 SGTFPFNEDEDI------NDQIQNAAFM-YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             cccccCCCccch------hHHhhccccc-cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            999999865432      1222222222 23344468899999999999999999999999999999998754

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-33  Score=227.50  Aligned_cols=212  Identities=25%  Similarity=0.373  Sum_probs=168.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLKKV------KTIPEEYLAAICE   75 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~   75 (262)
                      +....+++.+|++++++++||||+++++++....      ..+++++|+.+++|.+++...      ..++...+..++.
T Consensus        41 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~  120 (273)
T cd05074          41 SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI  120 (273)
T ss_pred             ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence            3456678899999999999999999999886532      247889999999999887432      2478899999999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHH
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIW  153 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~  153 (262)
                      |++.||+|||+ .|++|+||+|+||+++.++.++++|||.+........  ......++..|++||.+.+..++.++|+|
T Consensus       121 ~i~~~l~~lH~-~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~  199 (273)
T cd05074         121 DIASGMEYLSS-KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVW  199 (273)
T ss_pred             HHHHHHHHHHh-CCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhH
Confidence            99999999998 9999999999999999999999999998876532211  11122345679999999888889999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          154 SLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       154 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |||+++|++++ |+.||...+..       +....+........ ....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       200 slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         200 AFGVTMWEIMTRGQTPYAGVENS-------EIYNYLIKGNRLKQ-PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             HHHHHHHHHhhCCCCCCCCCCHH-------HHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999998 88888754332       22233333332222 2357789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-34  Score=231.68  Aligned_cols=232  Identities=28%  Similarity=0.452  Sum_probs=177.5

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCC--------CCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhc--CCCCHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQ--------CPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKV--KTIPEE   68 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~   68 (262)
                      |.+...+.-.+.+..|+++|++++        ..+||++++.|..    +.++|+|+|++ |.+|..+|.+.  +.++..
T Consensus       109 KVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~  187 (590)
T KOG1290|consen  109 KVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLS  187 (590)
T ss_pred             EEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHH
Confidence            334456666778899999999882        4689999999976    56899999999 77999999765  579999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEc---------------------------------------------
Q 024828           69 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---------------------------------------------  103 (262)
Q Consensus        69 ~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~---------------------------------------------  103 (262)
                      .+++|++|++.||.|||.++||+|.||||+|||+.                                             
T Consensus       188 ~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~  267 (590)
T KOG1290|consen  188 CVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSK  267 (590)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccch
Confidence            99999999999999999999999999999999995                                             


Q ss_pred             ---------------------------------------------------------------------cC---------
Q 024828          104 ---------------------------------------------------------------------HR---------  105 (262)
Q Consensus       104 ---------------------------------------------------------------------~~---------  105 (262)
                                                                                           ..         
T Consensus       268 ~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~  347 (590)
T KOG1290|consen  268 SKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNT  347 (590)
T ss_pred             hhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccc
Confidence                                                                                 00         


Q ss_pred             -------------------------------------------CcEEEEecccccccccCCCCcccccccccccCccccc
Q 024828          106 -------------------------------------------GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS  142 (262)
Q Consensus       106 -------------------------------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  142 (262)
                                                                 -++||+|||.|++..   ++.+..+.|..|++||++.
T Consensus       348 sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~---khFT~DIQTRQYRapEVll  424 (590)
T KOG1290|consen  348 SLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH---KHFTEDIQTRQYRAPEVLL  424 (590)
T ss_pred             cccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh---hhhchhhhhhhccCcceee
Confidence                                                       025677777776643   2334456788999999999


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccC------chhhHHHHHHHH----hcCCC------------------C
Q 024828          143 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD------GWTSFYELMEAI----VDQPP------------------P  194 (262)
Q Consensus       143 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~----~~~~~------------------~  194 (262)
                      |..|+..+||||++|+++||.||...|+.-....      ....+.+++..+    ..+..                  .
T Consensus       425 GsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK  504 (590)
T KOG1290|consen  425 GSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLK  504 (590)
T ss_pred             cCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccC
Confidence            9999999999999999999999999997533321      111222222111    00000                  0


Q ss_pred             C-----------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          195 S-----------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       195 ~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .           ..+..-..++.+|+.-||+.+|++|||+.++|+|||++..+..
T Consensus       505 ~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  505 PWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             CCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            0           0011223458899999999999999999999999999988876

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=233.17  Aligned_cols=218  Identities=27%  Similarity=0.498  Sum_probs=191.4

Q ss_pred             HHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           13 RQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        13 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      +--+.|-++|... +-|.++.+...|+.-+.+|+||||++||+|--.++.-+.+.+..+..++..|+-||-+||+ +||+
T Consensus       394 ectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIi  472 (683)
T KOG0696|consen  394 ECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGII  472 (683)
T ss_pred             cceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc-CCee
Confidence            3345666777665 5788889999999999999999999999999999999999999999999999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      .+|||.+||+++.+|++++.|||++.........+.++.||+.|+|||++...+|+.++|.||+|+++|||+.|++||++
T Consensus       473 YRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  473 YRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             eeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999999999998777777778889999999999999999999999999999999999999999999


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH-----HHHhcCccccccCCccc
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-----QELMTHPFLKMYGDLNV  240 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~~l~h~~~~~~~~~~~  240 (262)
                      .++++       +.+.+......  .+..+|.+..++.+..|..+|.+|...     .++-.||||+...+.++
T Consensus       553 eDE~e-------lF~aI~ehnvs--yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  553 EDEDE-------LFQAIMEHNVS--YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             CCHHH-------HHHHHHHccCc--CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence            77653       44444433332  246789999999999999999999843     68999999999887765

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-33  Score=251.59  Aligned_cols=108  Identities=35%  Similarity=0.581  Sum_probs=101.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+.++..++||||+++++.+......|+||||+.|++|.+++...+.++...++.++.||+.||.|||. .
T Consensus        45 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~-~  123 (669)
T cd05610          45 KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR-H  123 (669)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            445678899999999999999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      |++|+||||+||+++.++.++|+|||++.
T Consensus       124 gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.1e-33  Score=227.58  Aligned_cols=207  Identities=17%  Similarity=0.246  Sum_probs=161.4

Q ss_pred             HHHHHHhcCCCCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           17 QELKINQSSQCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        17 ~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      .+...+..++|++++++++.+....    ..+++++++. .++.+.++.....+...+..++.|++.||+|||+ .|++|
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH  149 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE-HGISH  149 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence            4445567779999999998765533    3578888874 4888888776667888999999999999999998 99999


Q ss_pred             CCCCCCCEEEccCCcEEEEecccccccccCC-------CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIMASTS-------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      +||||+||+++.++.++|+|||++.......       .......|+..|+|||++.+..++.++|||||||++++|++|
T Consensus       150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999999999999999999999987653221       111234689999999999988899999999999999999999


Q ss_pred             CCCCCCCCccCchhh--HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          166 QFPYSPPEQQDGWTS--FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ..||...........  .......+..+..   .....++++.++++.|+..+|++||+++++++
T Consensus       230 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        230 KLPWKGFGHNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             CCCCCccccchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            999987643321111  1112223322221   22356899999999999999999999999875

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=246.76  Aligned_cols=226  Identities=37%  Similarity=0.661  Sum_probs=190.8

Q ss_pred             cccchhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEE-----CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAIC   74 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~   74 (262)
                      |..+-+++.-+++..|.+||+.. .|||++.++++|.-     ++.++||||||.|||.-+++++.  ..+.++.+..|+
T Consensus        50 kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~  129 (953)
T KOG0587|consen   50 KIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYIL  129 (953)
T ss_pred             EeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHH
Confidence            44455677778899999999988 69999999999863     56799999999999999999876  468899999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-----CCCcc
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-----KYGYK  149 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~  149 (262)
                      ..++.|+.+||. ..++|+|++-.|||++.++.|+|+|||.+...........+.+|++.|+|||++...     .++.+
T Consensus       130 re~lrgl~HLH~-nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R  208 (953)
T KOG0587|consen  130 REILRGLAHLHN-NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR  208 (953)
T ss_pred             HHHHHHHHHHhh-cceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccc
Confidence            999999999998 889999999999999999999999999999888888888899999999999998653     47789


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+||||++..||--|.+|+.++....      .++. +....+| ...+...+.++.++|..||..|.++||+..++|+
T Consensus       209 ~D~WsLGITaIEladG~PPl~DmHPmr------aLF~-IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  209 SDLWSLGITAIEMAEGAPPLCDMHPMR------ALFL-IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cchhhccceeehhcCCCCCccCcchhh------hhcc-CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            999999999999999999998765421      1111 1111111 1113456788999999999999999999999999


Q ss_pred             CccccccC
Q 024828          229 HPFLKMYG  236 (262)
Q Consensus       229 h~~~~~~~  236 (262)
                      |||.+...
T Consensus       282 hpFi~e~~  289 (953)
T KOG0587|consen  282 HPFITEQP  289 (953)
T ss_pred             CCcccccc
Confidence            99998443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=7.9e-34  Score=211.60  Aligned_cols=226  Identities=23%  Similarity=0.406  Sum_probs=175.4

Q ss_pred             hHHHHHHHHHHHHHHhcCC-CCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQ-CPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ..-..+++.+|++||+.+. ||||++++++..+  .....+|+|++++.+...+...   ++.-.+..++.+++.||.|+
T Consensus        72 KPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyC  148 (338)
T KOG0668|consen   72 KPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYC  148 (338)
T ss_pred             chHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHH
Confidence            3556789999999999995 9999999999876  4568899999988777666544   78888999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCC-cEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l  162 (262)
                      |+ .||+|+|+||+|++++... .++|+|||+|.... ++...+..+.+..|..||.+..- .++...|+|||||++..|
T Consensus       149 HS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~m  226 (338)
T KOG0668|consen  149 HS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM  226 (338)
T ss_pred             Hh-cCcccccCCcceeeechhhceeeeeecchHhhcC-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHH
Confidence            99 9999999999999998765 59999999998654 34455556667788999998764 489999999999999999


Q ss_pred             HhCCCCCCCCCcc-CchhhHHHH---------HHHH-------------------hcCCCCCCCCCCCCHHHHHHHHHhh
Q 024828          163 ATGQFPYSPPEQQ-DGWTSFYEL---------MEAI-------------------VDQPPPSAPSDQFSPEFCSFISACV  213 (262)
Q Consensus       163 ~~g~~p~~~~~~~-~~~~~~~~~---------~~~~-------------------~~~~~~~~~~~~~~~~l~~li~~~l  213 (262)
                      +..+-||-..... ++...+...         +.+-                   ...........-.+++..+|+.++|
T Consensus       227 iFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklL  306 (338)
T KOG0668|consen  227 IFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLL  306 (338)
T ss_pred             HhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHH
Confidence            9998887544332 221111111         1110                   0011111222234689999999999


Q ss_pred             cCCcCCCCCHHHHhcCccccccCCc
Q 024828          214 QKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       214 ~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      ..|-++|+|++|++.||||....+.
T Consensus       307 rYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  307 RYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             hhccccccchHHHhcCchHHHHHHH
Confidence            9999999999999999999765543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=246.90  Aligned_cols=214  Identities=29%  Similarity=0.392  Sum_probs=170.8

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CC---CCHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KT---IPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~---~~~~~~~~i~~~l~~~l~~   83 (262)
                      .+...-+.+|+..|+.. +||||+++++.-.+....|+..|.|.. +|.++++.. ..   ......+.++.|+++||++
T Consensus       543 ~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaH  621 (903)
T KOG1027|consen  543 EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAH  621 (903)
T ss_pred             hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHH
Confidence            44556788999999888 699999999999999999999999976 999999874 11   1224457889999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEcc---CC--cEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINH---RG--EVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~---~~--~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      ||+ .+|+||||||+||||+.   ++  +++|+|||++.+......   ......|+.+|+|||++.....+.++||||+
T Consensus       622 LHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFsl  700 (903)
T KOG1027|consen  622 LHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSL  700 (903)
T ss_pred             HHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhc
Confidence            999 99999999999999976   33  689999999987754332   2344578999999999998888889999999


Q ss_pred             HHHHHHHHhC-CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCC-CCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          156 GLVLLECATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       156 G~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      ||++|+.++| .+||++....+         .++..+...-.... .-..+..+||.+|++++|..||++.++|.||+|=
T Consensus       701 GCvfyYvltgG~HpFGd~~~R~---------~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  701 GCVFYYVLTGGSHPFGDSLERQ---------ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             CceEEEEecCCccCCCchHHhh---------hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence            9999998885 99998754322         22222222211111 1112789999999999999999999999999993

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=221.52  Aligned_cols=228  Identities=25%  Similarity=0.488  Sum_probs=191.0

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +++...=++.|..+..+. +||.+|-+...|+.+..+++|.||.+||+|--.++++..++++.+..+...|+.||.|||+
T Consensus       290 ddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~  369 (593)
T KOG0695|consen  290 DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE  369 (593)
T ss_pred             CcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh
Confidence            444555566777777777 7999999999999999999999999999999999999999999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       +||+.+|+|.+|++++.+|+++|.|+|++.....++..+.++.|++.|.|||++.+..|+...|.|+||++|+||+.|+
T Consensus       370 -rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagr  448 (593)
T KOG0695|consen  370 -RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR  448 (593)
T ss_pred             -cCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCC
Confidence             9999999999999999999999999999987777777888899999999999999999999999999999999999999


Q ss_pred             CCCCCCC--ccCchhhHHHHHHHHhc-CCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC------CHHHHhcCccccccCC
Q 024828          167 FPYSPPE--QQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLKMYGD  237 (262)
Q Consensus       167 ~p~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------t~~~~l~h~~~~~~~~  237 (262)
                      .||....  ..+...+. .+.+-++. ....+   ..++-....+++..|+.||.+|.      .+.++..|+||+...+
T Consensus       449 spfdivgm~n~d~nted-ylfqvilekqirip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  449 SPFDIVGMDNPDMNTED-YLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             CCcceecCCCcccchhH-HHHHHHhhhccccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence            9997432  22222221 12222222 22222   34566677899999999999997      5789999999997775


Q ss_pred             ccc
Q 024828          238 LNV  240 (262)
Q Consensus       238 ~~~  240 (262)
                      .-.
T Consensus       525 d~l  527 (593)
T KOG0695|consen  525 DLL  527 (593)
T ss_pred             HHH
Confidence            443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-33  Score=244.00  Aligned_cols=215  Identities=27%  Similarity=0.469  Sum_probs=182.6

Q ss_pred             chhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHH
Q 024828            6 NVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEE   68 (262)
Q Consensus         6 ~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~   68 (262)
                      ...+...+.+..|+++++.+ +|+||+.+.+.+...+..++|+||+..|+|.+++++.+                .++..
T Consensus       339 ~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~  418 (609)
T KOG0200|consen  339 NASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTK  418 (609)
T ss_pred             ccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHH
Confidence            34557889999999999999 69999999999999899999999999999999998765                38899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc-cccc--ccccccCcccccCCC
Q 024828           69 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFV--GTYNYMSPERISGGK  145 (262)
Q Consensus        69 ~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~--~~~~y~~PE~~~~~~  145 (262)
                      ....++.||+.|++||++ .+++||||..+||++..+..++++|||+++......... ....  -+..|+|||.+....
T Consensus       419 dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~  497 (609)
T KOG0200|consen  419 DLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV  497 (609)
T ss_pred             HHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence            999999999999999998 999999999999999999999999999998543322111 1111  356799999999988


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          146 YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       146 ~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      ++.++||||+|+++||+++ |..||.+...      ..+..+.+..+.....+ ..++.+++++|+.||+.+|++||++.
T Consensus       498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~~------~~~l~~~l~~G~r~~~P-~~c~~eiY~iM~~CW~~~p~~RP~F~  570 (609)
T KOG0200|consen  498 FTSKSDVWSFGILLWEIFTLGGTPYPGIPP------TEELLEFLKEGNRMEQP-EHCSDEIYDLMKSCWNADPEDRPTFS  570 (609)
T ss_pred             ccccchhhHHHHHHHHHhhCCCCCCCCCCc------HHHHHHHHhcCCCCCCC-CCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            9999999999999999999 8899977321      22445567777776666 45699999999999999999999999


Q ss_pred             HHhc
Q 024828          225 ELMT  228 (262)
Q Consensus       225 ~~l~  228 (262)
                      ++..
T Consensus       571 ~~~~  574 (609)
T KOG0200|consen  571 ECVE  574 (609)
T ss_pred             HHHH
Confidence            8854

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.1e-34  Score=238.31  Aligned_cols=226  Identities=21%  Similarity=0.382  Sum_probs=175.9

Q ss_pred             cchhHHHHHHHHHHHHHHhcCC------CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQ------CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIPEEYLAAICE   75 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~   75 (262)
                      +-.++-..+.=..|+++|++|+      --++++++..|.+..++|||||.+. -+|.+++++.+   ++....+..+++
T Consensus       465 IRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaq  543 (752)
T KOG0670|consen  465 IRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQ  543 (752)
T ss_pred             eecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHH
Confidence            3456777778889999999994      4589999999999999999999994 49999998875   488999999999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEccCC-cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHH
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      |++.||..|.. +|++|.||||.|||++... .++|||||.|...+...  .+.+.-+..|.|||++.|-.|+...|+||
T Consensus       544 QLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WS  620 (752)
T KOG0670|consen  544 QLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWS  620 (752)
T ss_pred             HHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCcccee
Confidence            99999999998 9999999999999998664 58999999987654332  22334567899999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHHHH------------------------------------------------
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYELME------------------------------------------------  186 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------------  186 (262)
                      +||++||++||+..|.+....+...-..++..                                                
T Consensus       621 vgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkd  700 (752)
T KOG0670|consen  621 VGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKD  700 (752)
T ss_pred             eceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchh
Confidence            99999999999999987554332111111100                                                


Q ss_pred             ---HHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          187 ---AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                         .+......+......-.++.+|+.+||..||++|.|++++|.||||+.
T Consensus       701 l~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  701 LGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence               000000000000011134889999999999999999999999999975

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=237.55  Aligned_cols=215  Identities=22%  Similarity=0.345  Sum_probs=183.2

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .-.+|.+|+.++.+++|+|++++|++..+ ....+|||.+++|||.+.+.+.  ..+-......++.||+.||.||.+ +
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes-k  231 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES-K  231 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh-h
Confidence            66799999999999999999999999998 6688999999999999999873  458899999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc---cccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                      +++|+||...|+++.....||++|||+.+..+.......   .......|+|||.+....++.++|+|++|+++|||++ 
T Consensus       232 rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFty  311 (1039)
T KOG0199|consen  232 RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTY  311 (1039)
T ss_pred             hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhcc
Confidence            999999999999999989999999999987654432221   1123557999999999999999999999999999999 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      |..||.+...       ..+++++..+.+.+.+ +.++.+++++++.||..+|.+|||+.+|...-+..+.
T Consensus       312 GEePW~G~~g-------~qIL~~iD~~erLpRP-k~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  312 GEEPWVGCRG-------IQILKNIDAGERLPRP-KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             CCCCCCCCCH-------HHHHHhccccccCCCC-CCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            8999988654       3455555555555554 5789999999999999999999999999766555443

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-34  Score=216.35  Aligned_cols=227  Identities=36%  Similarity=0.629  Sum_probs=185.6

Q ss_pred             hhHHHHHHHHHHHHHHhc-CCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-----KVKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-----~~~~~~~~~~~~i~~~l~~~   80 (262)
                      ..+...+++..|.+...+ -+.||||++++....++-.++.||.++- ||..+.+     ....++++-+-.|....+.|
T Consensus       101 n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~A  179 (361)
T KOG1006|consen  101 NIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDA  179 (361)
T ss_pred             cchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhH
Confidence            355677788888876544 4799999999998888889999999954 8866553     23568999888999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC--CCCcchhHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLV  158 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~  158 (262)
                      |.||..+..++|||+||+|||++..|.+||||||.+-...... ..+...|-..|+|||.+...  .++.++|+||||++
T Consensus       180 L~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGIT  258 (361)
T KOG1006|consen  180 LDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGIT  258 (361)
T ss_pred             HHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH-HhhhccCCccccChhccCCccCCcchhhhhhhhcce
Confidence            9999988999999999999999999999999999886543322 22334566789999998653  48999999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCC----CCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS----DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      ++|+.||+.|+..      |....+.+..+..+.+|....    -.++..+..++.-||..|-..||++++++++||++.
T Consensus       259 L~EvAtG~fPyr~------w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  259 LYEVATGNFPYRK------WDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             EeeeecCCCCcch------HHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence            9999999999976      455667777777776654432    247899999999999999999999999999999998


Q ss_pred             cCCcccc
Q 024828          235 YGDLNVD  241 (262)
Q Consensus       235 ~~~~~~~  241 (262)
                      +......
T Consensus       333 y~~~~~~  339 (361)
T KOG1006|consen  333 YAVEGPD  339 (361)
T ss_pred             hhhcCCc
Confidence            8765553

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-31  Score=216.43  Aligned_cols=222  Identities=32%  Similarity=0.562  Sum_probs=180.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEE-ECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH-   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~-   86 (262)
                      +.-.+.+.+|.+|-+.++||.||++|++|. +.+.+|-|.|||+|.+|.-|++.++..++.++..|+.||+.||.||.. 
T Consensus       508 eNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi  587 (775)
T KOG1151|consen  508 ENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI  587 (775)
T ss_pred             hhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc
Confidence            344567889999999999999999999996 456799999999999999999999999999999999999999999986 


Q ss_pred             cCCeeeCCCCCCCEEEccC---CcEEEEecccccccccCCCC-------cccccccccccCcccccCC----CCCcchhH
Q 024828           87 EKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQ-------ANTFVGTYNYMSPERISGG----KYGYKSDI  152 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~----~~~~~~Di  152 (262)
                      ...|+|.||||.|||+-+.   |.+++.|||++..+......       +....|+.+|+|||++.-+    ..+.++||
T Consensus       588 kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV  667 (775)
T KOG1151|consen  588 KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV  667 (775)
T ss_pred             CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceee
Confidence            2349999999999999543   56999999999877543322       2345789999999987543    36889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          153 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       153 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      ||+|+++|.++.|+.||.........-..    ..+.+..... ++-...+++..+||++||.+.-+.|..+.++-.|||
T Consensus       668 WSvGVIFyQClYGrKPFGhnqsQQdILqe----NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy  743 (775)
T KOG1151|consen  668 WSVGVIFYQCLYGRKPFGHNQSQQDILQE----NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY  743 (775)
T ss_pred             EeeehhhhhhhccCCCCCCchhHHHHHhh----hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence            99999999999999999876544321111    1222222221 222467899999999999999999999999999999


Q ss_pred             ccc
Q 024828          232 LKM  234 (262)
Q Consensus       232 ~~~  234 (262)
                      |.-
T Consensus       744 llP  746 (775)
T KOG1151|consen  744 LLP  746 (775)
T ss_pred             ccc
Confidence            964

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.5e-31  Score=232.96  Aligned_cols=201  Identities=22%  Similarity=0.325  Sum_probs=139.0

Q ss_pred             EECCeEEEEEeecCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCC
Q 024828           38 YSNGAISIILEYMDGGSLADFLKKVKT--------------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP   97 (262)
Q Consensus        38 ~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p   97 (262)
                      ..+...++|+||+.+++|.+++.....                    .....+..++.|++.||+|||+ .||+|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP  283 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKP  283 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCH
Confidence            345679999999999999999875421                    1233466799999999999998 9999999999


Q ss_pred             CCEEEcc-CCcEEEEecccccccccCC-CCcccccccccccCcccccCCC----------------------CCcchhHH
Q 024828           98 SNLLINH-RGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGK----------------------YGYKSDIW  153 (262)
Q Consensus        98 ~nil~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~----------------------~~~~~Di~  153 (262)
                      +||+++. ++.++|+|||++....... .......+++.|+|||.+....                      ++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999985 5789999999997543221 2223457789999999764321                      23456999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCccCchhh--------HHHHHHHHhcCCCCC-----CCCCCCCHHHHHHHHHhhcCCcCCC
Q 024828          154 SLGLVLLECATGQFPYSPPEQQDGWTS--------FYELMEAIVDQPPPS-----APSDQFSPEFCSFISACVQKEPQQR  220 (262)
Q Consensus       154 slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~R  220 (262)
                      |+||++|+|+++..++....  ..+..        ...+.........+.     ...........+||.+||+.||++|
T Consensus       364 SlGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999998765543210  00000        000101110000000     0001123446689999999999999


Q ss_pred             CCHHHHhcCccccccCCcccc
Q 024828          221 LSAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       221 pt~~~~l~h~~~~~~~~~~~~  241 (262)
                      ||++++|+||||+.......+
T Consensus       442 ~ta~e~L~Hpff~~~~~~~~~  462 (566)
T PLN03225        442 ISAKAALAHPYFDREGLLGLS  462 (566)
T ss_pred             CCHHHHhCCcCcCCCCccccc
Confidence            999999999999987765443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=3.8e-32  Score=248.41  Aligned_cols=202  Identities=21%  Similarity=0.221  Sum_probs=148.6

Q ss_pred             HhcCCC-CeeEeeceEE-------EECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           22 NQSSQC-PYVVVCYQSF-------YSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        22 l~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      .+.++| .||++++++|       .+...++.++|++ +++|.+++... ..++...+..++.||+.||+|||+ .||+|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH  103 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV  103 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence            344566 6888888887       2334678889988 55999999763 469999999999999999999998 99999


Q ss_pred             CCCCCCCEEEccCCc-------------------EEEEecccccccccCC----------------CCcccccccccccC
Q 024828           93 RDLKPSNLLINHRGE-------------------VKITDFGVSAIMASTS----------------GQANTFVGTYNYMS  137 (262)
Q Consensus        93 ~dl~p~nil~~~~~~-------------------~~l~df~~~~~~~~~~----------------~~~~~~~~~~~y~~  137 (262)
                      +||||+|||++..+.                   ++++|||++.......                .......+++.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999965444                   5555555554321000                00011357888999


Q ss_pred             cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCc
Q 024828          138 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       138 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  217 (262)
                      ||.+.+..++.++|||||||++|||++|..|+....         .....+.....++... ...+...+++.+||+++|
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P  253 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEP  253 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCCh
Confidence            999998899999999999999999999888765321         1111111111222111 124557799999999999


Q ss_pred             CCCCCHHHHhcCcccccc
Q 024828          218 QQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~  235 (262)
                      .+||++.|+++||||...
T Consensus       254 ~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        254 SCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hhCcChHHHhhchhhhhh
Confidence            999999999999999764

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=226.81  Aligned_cols=166  Identities=31%  Similarity=0.548  Sum_probs=144.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLK   79 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~   79 (262)
                      ...++...+|+++|++++|+|||++.++-++..      ...++||||.||||...+++-   .++++.+.+.++.++..
T Consensus        52 ~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~  131 (732)
T KOG4250|consen   52 LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVS  131 (732)
T ss_pred             cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHH
Confidence            455677889999999999999999999876543      578999999999999999643   57999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccC--Cc--EEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHR--GE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWS  154 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~--~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s  154 (262)
                      ||.|||. +||+||||||.||++-..  |+  -||+|||.|+...... .....+||..|++||.+.. +.++..+|.||
T Consensus       132 al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS  209 (732)
T KOG4250|consen  132 ALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWS  209 (732)
T ss_pred             HHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhh
Confidence            9999997 999999999999999532  33  6999999998765443 6667899999999999985 77999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccC
Q 024828          155 LGLVLLECATGQFPYSPPEQQD  176 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~  176 (262)
                      +||++|++.||..||.......
T Consensus       210 ~GvtlY~caTG~lPF~p~~~pk  231 (732)
T KOG4250|consen  210 FGVTLYECATGELPFIPFGGPK  231 (732)
T ss_pred             hhhHHHHHhccCCCCCcCCCcc
Confidence            9999999999999998766553

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=1.5e-30  Score=243.30  Aligned_cols=203  Identities=21%  Similarity=0.322  Sum_probs=155.4

Q ss_pred             HHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeee
Q 024828           16 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH---HEKHIIH   92 (262)
Q Consensus        16 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh---~~~~i~H   92 (262)
                      .+|++++++++||||+++++++.++...++||||+++++|.++++.   +++..+..++.|++.||+|||   + .+++|
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH  806 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCS-PAVVV  806 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCC-CCeec
Confidence            3568899999999999999999999999999999999999999964   888999999999999999999   5 69999


Q ss_pred             CCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  172 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  172 (262)
                      +|+||+||+++.++..++. ++......    ......++..|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        807 GNLSPEKIIIDGKDEPHLR-LSLPGLLC----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             CCCCHHhEEECCCCceEEE-eccccccc----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence            9999999999888877665 44432211    112235778999999999888999999999999999999999998543


Q ss_pred             CccCchhhHHHHHHHHhc---------CCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          173 EQQDGWTSFYELMEAIVD---------QPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~---------~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ....  ....++......         ......  .......++.+++.+||+.+|++|||++|+++.
T Consensus       882 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        882 FGVH--GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cCCC--CcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            2211  112222211111         000000  001112357789999999999999999999764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=5.2e-30  Score=219.89  Aligned_cols=217  Identities=21%  Similarity=0.258  Sum_probs=153.1

Q ss_pred             HHHHHHHhcCCCCee-----EeeceEEEE--------CCeEEEEEeecCCCCHHHHHHhcC-------------------
Q 024828           16 AQELKINQSSQCPYV-----VVCYQSFYS--------NGAISIILEYMDGGSLADFLKKVK-------------------   63 (262)
Q Consensus        16 ~~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~-------------------   63 (262)
                      ..|+.++.+++|.++     ++++++|..        .+..++|+||+.+++|.+++....                   
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            346667777765543     566666543        346899999999999999886421                   


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccC
Q 024828           64 -----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS  137 (262)
Q Consensus        64 -----~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~  137 (262)
                           .++...+..++.|++.+|.|+|+ .+++|+||||+||+++.++.++++|||++........ ......+++.|+|
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence                 13556788899999999999998 9999999999999999999999999999865432211 1112234789999


Q ss_pred             cccccCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCCccC----chhhHHHHHHHHhc
Q 024828          138 PERISGGKY----------------------GYKSDIWSLGLVLLECATGQF-PYSPPEQQD----GWTSFYELMEAIVD  190 (262)
Q Consensus       138 PE~~~~~~~----------------------~~~~Di~slG~~l~~l~~g~~-p~~~~~~~~----~~~~~~~~~~~~~~  190 (262)
                      ||.+.....                      ..+.|+||+||++++|+++.. ||.......    .+............
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            998754321                      124699999999999999875 665321110    11111111112222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhcCCc---CCCCCHHHHhcCcccc
Q 024828          191 QPPPSAPSDQFSPEFCSFISACVQKEP---QQRLSAQELMTHPFLK  233 (262)
Q Consensus       191 ~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rpt~~~~l~h~~~~  233 (262)
                      ...........++..++|+.+||..+|   .+|+|++|+|+||||.
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            222222335678899999999999766   6899999999999995

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.9e-29  Score=193.40  Aligned_cols=179  Identities=41%  Similarity=0.712  Sum_probs=160.5

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|++.++.++|++|+++++.+......++++|++.|++|.+++... ..++...+..++.+++.++.+||+ .|
T Consensus        34 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~  112 (215)
T cd00180          34 LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS-NG  112 (215)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            3578999999999999999999999999989999999999989999999876 578999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCC
Q 024828           90 IIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        90 i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      ++|+||+|.||+++. ++.++++||+.+..............+...|.+||..... ..+.+.|+|++|++++++     
T Consensus       113 ~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----  187 (215)
T cd00180         113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----  187 (215)
T ss_pred             eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----
Confidence            999999999999998 8999999999887654433223334567889999999877 788999999999999999     


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP  230 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~  230 (262)
                                                         ..+.+++.+|++.+|.+||+++++++++
T Consensus       188 -----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                               5688999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-30  Score=188.74  Aligned_cols=190  Identities=38%  Similarity=0.707  Sum_probs=152.9

Q ss_pred             cchhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHH----HhcCCCCHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLK   79 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l----~~~~~~~~~~~~~i~~~l~~   79 (262)
                      ...+.+..++..+|+++..+. .+|.+|.+++.+..++..++.||.++- ||..+-    ++++..++..+-+|+..++.
T Consensus        81 ~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~  159 (282)
T KOG0984|consen   81 ATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVH  159 (282)
T ss_pred             hhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHH
Confidence            345678888999999988777 799999999998888889999999965 887665    45567999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC----CCCCcchhHHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG----GKYGYKSDIWSL  155 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~Di~sl  155 (262)
                      ||.|||+...++|||+||+|||++..|++|+||||.+-.....- ......|-..|+|||.+..    ..|+.++|||||
T Consensus       160 al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSL  238 (282)
T KOG0984|consen  160 ALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSL  238 (282)
T ss_pred             HHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhh
Confidence            99999999999999999999999999999999999986654332 2222345668999998754    358999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 024828          156 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  202 (262)
Q Consensus       156 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (262)
                      |+++.||.+++.||....      .-++.++.+.....|..+...+|
T Consensus       239 GItmiElA~lr~PY~~w~------tpF~qLkqvVeep~P~Lp~~~FS  279 (282)
T KOG0984|consen  239 GITMIEMAILRFPYESWG------TPFQQLKQVVEEPSPQLPADTFS  279 (282)
T ss_pred             hhhhhhhhhccccccccC------CHHHHHHHHhcCCCCCCcccccC
Confidence            999999999999998644      33455555555555544444444

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=6.1e-30  Score=193.44  Aligned_cols=166  Identities=29%  Similarity=0.458  Sum_probs=127.7

Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccc
Q 024828           53 GSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  131 (262)
Q Consensus        53 ~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  131 (262)
                      |+|.+++.+. +++++..+..++.|++.||.|||+ .+      ||+||+++.++.+++  ||.+.......     ..+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCccceee--ccceEeecccc-----CCC
Confidence            5899999874 569999999999999999999998 76      999999999999998  99876543321     257


Q ss_pred             cccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCC-CCCCCCCH--HHHHH
Q 024828          132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSP--EFCSF  208 (262)
Q Consensus       132 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~l~~l  208 (262)
                      +..|+|||++.+..++.++||||+||++|+|++|+.||.......  ................. .....++.  ++.++
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            899999999999899999999999999999999999997543321  11111111111111000 01122333  69999


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      +.+||..+|.+||++.+++.|+|+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=7.6e-30  Score=227.36  Aligned_cols=182  Identities=31%  Similarity=0.532  Sum_probs=145.5

Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccc
Q 024828           42 AISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  120 (262)
Q Consensus        42 ~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~  120 (262)
                      .+||-||||+..++.+++..+... .....+.++.+|++||+|+|+ .|++||||||.||+++..+.|+|+|||+++...
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~-~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD-QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh-CceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            478999999986777777765544 478889999999999999998 999999999999999999999999999997621


Q ss_pred             ------------------cCCCCcccccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCccCchh
Q 024828          121 ------------------STSGQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT  179 (262)
Q Consensus       121 ------------------~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  179 (262)
                                        ......+..+||.-|.|||++.+..   |+.|+|+||||++++||+.   ||...      .
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts------M  819 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS------M  819 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch------H
Confidence                              1111334568999999999987654   8999999999999999984   56432      2


Q ss_pred             hHHHHHHHHhcCCCCCC---CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          180 SFYELMEAIVDQPPPSA---PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       180 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      +-...+.++.++..|..   .... -+.-.++|++|++.||++|||+.|+|.+.||-.
T Consensus       820 ERa~iL~~LR~g~iP~~~~f~~~~-~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  820 ERASILTNLRKGSIPEPADFFDPE-HPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             HHHHHHHhcccCCCCCCccccccc-chHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            33355666666666555   2222 344679999999999999999999999999983

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=202.82  Aligned_cols=227  Identities=22%  Similarity=0.389  Sum_probs=177.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      +-...+++-+|+++|...+|.|++...++.+..     ..+|+++|.+.. +|..++-.-..++...++-.++||+.||.
T Consensus        92 ~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLK  170 (449)
T KOG0664|consen   92 NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLK  170 (449)
T ss_pred             HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhH
Confidence            345667889999999999999999998877543     247889999966 99988888778999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC-CCCcccccccccccCcccccCCC-CCcchhHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL  160 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~  160 (262)
                      |||+ .||.|+||||.|.+++++..+|+||||+++..... ..+.+.-+-+..|++||++.|.. |+.+.||||+||++.
T Consensus       171 YLHs-A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFa  249 (449)
T KOG0664|consen  171 YLHT-ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFA  249 (449)
T ss_pred             HHhh-cchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHH
Confidence            9999 99999999999999999999999999999764322 23333445678999999999875 999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHH----------------HHHHhcCCCCCCCC---------CCCCHHHHHHHHHhhcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYEL----------------MEAIVDQPPPSAPS---------DQFSPEFCSFISACVQK  215 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~  215 (262)
                      |++..+..|.....-++..-+.++                ...++++.......         ..-..+...++..|+..
T Consensus       250 ELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~  329 (449)
T KOG0664|consen  250 ELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHF  329 (449)
T ss_pred             HHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCC
Confidence            999988888765443322111111                11223332222111         12234577899999999


Q ss_pred             CcCCCCCHHHHhcCccccccC
Q 024828          216 EPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       216 ~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ||.+|.+.++.+.|++..+.+
T Consensus       330 d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  330 DPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             CCcccccHhhhcccccccccc
Confidence            999999999999999997655

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=5.6e-30  Score=205.85  Aligned_cols=231  Identities=25%  Similarity=0.449  Sum_probs=177.2

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      -.+...++.+|+++|..+ .+.||+++.+.+..++..++|+||++...-.++...   ++...+..+++.++.||.++|.
T Consensus        74 ~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~  150 (418)
T KOG1167|consen   74 RTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHK  150 (418)
T ss_pred             cccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhc
Confidence            344556799999999999 699999999999999999999999999888888765   7799999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccC-CcEEEEeccccccccc----------------C--CC-----------------------
Q 024828           87 EKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMAS----------------T--SG-----------------------  124 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~----------------~--~~-----------------------  124 (262)
                       .||+|+||||.|++++.. +.-.|+|||++.....                +  +.                       
T Consensus       151 -~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~  229 (418)
T KOG1167|consen  151 -NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDG  229 (418)
T ss_pred             -cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCC
Confidence             999999999999999854 6789999999862100                0  00                       


Q ss_pred             ---CcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCccC------------------------
Q 024828          125 ---QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQD------------------------  176 (262)
Q Consensus       125 ---~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------------------------  176 (262)
                         ......||++|+|||++...+ .+.+.||||.|++++.+++++.||-....+-                        
T Consensus       230 r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~  309 (418)
T KOG1167|consen  230 RPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGR  309 (418)
T ss_pred             ccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCc
Confidence               001236899999999998764 7889999999999999999999984322110                        


Q ss_pred             --chh-----hHHHHH--------HHHhcC----CCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          177 --GWT-----SFYELM--------EAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       177 --~~~-----~~~~~~--------~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                        .|.     ...+..        ..+...    .......+.++..+.+|+.+|+..||.+|.|++++|+||||.....
T Consensus       310 ~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  310 ILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             eeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence              010     111111        111110    1112223456678999999999999999999999999999997765


Q ss_pred             cccch
Q 024828          238 LNVDL  242 (262)
Q Consensus       238 ~~~~~  242 (262)
                      ....+
T Consensus       390 ~~~~~  394 (418)
T KOG1167|consen  390 TERGL  394 (418)
T ss_pred             hhhhh
Confidence            54433

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=217.44  Aligned_cols=212  Identities=25%  Similarity=0.389  Sum_probs=179.5

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ...+...++.+|+-++.+++|||++++++++.... ..||++|+++|+|.++++.+ +++.....+.|..||++||.|||
T Consensus       737 t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe  815 (1177)
T KOG1025|consen  737 TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE  815 (1177)
T ss_pred             CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            35566788999999999999999999999998766 88999999999999999866 56889999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccc--cccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF--VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~--~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      . ..++||||..+|||+..-..+++.|||++.............  .-.+.|+|-|.+....++.++||||+|+++||++
T Consensus       816 ~-qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElm  894 (1177)
T KOG1025|consen  816 E-QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELM  894 (1177)
T ss_pred             h-cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHH
Confidence            8 999999999999999999999999999998765544433332  2345688889988889999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      | |..|+.+...       .++.+-+..+.+...+ ...+-+++-++.+||..|+..||+++++..
T Consensus       895 TFGa~Py~gi~~-------~eI~dlle~geRLsqP-piCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  895 TFGAKPYDGIPA-------EEIPDLLEKGERLSQP-PICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             hcCCCccCCCCH-------HHhhHHHhccccCCCC-CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            8 8889887543       2444555555554443 578899999999999999999999988753

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-28  Score=194.02  Aligned_cols=215  Identities=21%  Similarity=0.326  Sum_probs=178.3

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhcC--------CCCHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVK--------TIPEEYLAAICE   75 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~i~~   75 (262)
                      ...++-+...+..|.-++..+.|||+..+.++..+ ....+.++++..-|+|..++..++        .++..+...++.
T Consensus       324 ~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~mas  403 (563)
T KOG1024|consen  324 QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMAS  403 (563)
T ss_pred             hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHH
Confidence            34567777888899999999999999999998754 567888999998899999998432        367778888999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHH
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIW  153 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~  153 (262)
                      |++.|+++||+ .|++|.||..+|.++++.-+++|+|=.+++..-....+  ...--.+..|++||.+....++.++|+|
T Consensus       404 Qla~am~hlh~-~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvW  482 (563)
T KOG1024|consen  404 QLAMAMEHLHN-HGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVW  482 (563)
T ss_pred             HHHHHHHHHHh-cCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhH
Confidence            99999999998 99999999999999999999999998887643211100  0001235579999999999999999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          154 SLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       154 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |||+++|||+| |+.|+..-+..       ++...++++.+...+ .++|+++..+|.-||...|++||+++|++.
T Consensus       483 sfGVllWELmtlg~~PyaeIDPf-------Em~~ylkdGyRlaQP-~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  483 SFGVLLWELMTLGKLPYAEIDPF-------EMEHYLKDGYRLAQP-FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HHHHHHHHHHhcCCCCccccCHH-------HHHHHHhccceecCC-CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            99999999998 89999876653       566667777776655 689999999999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-29  Score=212.20  Aligned_cols=225  Identities=32%  Similarity=0.548  Sum_probs=183.9

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+-+++|+-+++.++||||+.+++.+.-.+.+++.||||.|++|++.-.-.+++++.++..+++..+.+++|||+ .|-
T Consensus        55 d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs-~gk  133 (829)
T KOG0576|consen   55 DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHS-QGK  133 (829)
T ss_pred             cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhc-CCc
Confidence            3456778999999999999999999999989999999999999999999999999999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      +|||||-.||++++.|.+++.|||.+-.++........+.|++.|+|||+-.   .+.|...+|+|++|++..|+-.-++
T Consensus       134 ~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqp  213 (829)
T KOG0576|consen  134 IHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQP  213 (829)
T ss_pred             ccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCC
Confidence            9999999999999999999999999877765555556779999999999753   3568899999999999999977666


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      |.......    +...++.+..-..+.-......++.+-+|++.+|..+|++|||++.+|.|||....-+.+.
T Consensus       214 plfdlhpm----r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl  282 (829)
T KOG0576|consen  214 PLFDLHPM----RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRL  282 (829)
T ss_pred             cccccchH----HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHH
Confidence            65443321    1112222221122222222356788999999999999999999999999999976644333

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-27  Score=193.85  Aligned_cols=215  Identities=27%  Similarity=0.416  Sum_probs=164.5

Q ss_pred             hHHHHHHHHHHHHHHhcC--CCCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSS--QCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      ..+.++.+.+|-+|++..  +|+||+++++.-..+.    .++||++|.+.|||.+|++. ...+......++..++.||
T Consensus       242 p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGL  320 (534)
T KOG3653|consen  242 PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGL  320 (534)
T ss_pred             CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHH
Confidence            577888999999998877  7999999998876555    79999999999999999987 5579999999999999999


Q ss_pred             HHHhh--------cCCeeeCCCCCCCEEEccCCcEEEEecccccccccC--CCCcccccccccccCcccccCCC-CC---
Q 024828           82 LYLHH--------EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISGGK-YG---  147 (262)
Q Consensus        82 ~~lh~--------~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~-~~---  147 (262)
                      +|||+        -..|+|||||.+|||+..+++..|+|||+|.+....  .......+||.+|||||++.|.. +.   
T Consensus       321 a~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~  400 (534)
T KOG3653|consen  321 AHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRD  400 (534)
T ss_pred             HHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHH
Confidence            99998        234899999999999999999999999999876422  22223358999999999998753 22   


Q ss_pred             --cchhHHHHHHHHHHHHhCCCCCCC-------------CCccCchhhHHHHHHHHhcCCCCCCCC----CCCCHHHHHH
Q 024828          148 --YKSDIWSLGLVLLECATGQFPYSP-------------PEQQDGWTSFYELMEAIVDQPPPSAPS----DQFSPEFCSF  208 (262)
Q Consensus       148 --~~~Di~slG~~l~~l~~g~~p~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l  208 (262)
                        .+.||||+|.++||+++....+..             ........++++..-  .+..+|..+.    ......+++.
T Consensus       401 Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV--~kK~RP~~p~~W~~h~~~~~l~et  478 (534)
T KOG3653|consen  401 AFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVV--RKKQRPKIPDAWRKHAGMAVLCET  478 (534)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHH--hhccCCCChhhhhcCccHHHHHHH
Confidence              368999999999999985443321             111122333333321  1222222221    1334668999


Q ss_pred             HHHhhcCCcCCCCCHHH
Q 024828          209 ISACVQKEPQQRLSAQE  225 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~  225 (262)
                      +..||+.||+.|.|+.=
T Consensus       479 ~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  479 IEECWDHDAEARLTAGC  495 (534)
T ss_pred             HHHHcCCchhhhhhhHH
Confidence            99999999999999853

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.5e-28  Score=213.73  Aligned_cols=225  Identities=23%  Similarity=0.384  Sum_probs=180.0

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeC
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR   93 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~   93 (262)
                      .+..|+-+-..++|||++.....+.+.....-.||||++ +|..++...+.++..++..+++|++.|+.|+|+ .|+.|+
T Consensus       367 ~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~-~Giahr  444 (601)
T KOG0590|consen  367 NITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS-MGLAHR  444 (601)
T ss_pred             hhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh-cCceec
Confidence            366777778888999999888887776666666999999 999999998889999999999999999999999 999999


Q ss_pred             CCCCCCEEEccCCcEEEEecccccccccCCCC----cccccccccccCcccccCCCCCc-chhHHHHHHHHHHHHhCCCC
Q 024828           94 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPERISGGKYGY-KSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        94 dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p  168 (262)
                      |+|++|+++..+|.++++|||.+.....+...    ....+|+..|.|||.+.+..|.+ ..||||.|+++..|++|+.|
T Consensus       445 dlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~  524 (601)
T KOG0590|consen  445 DLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP  524 (601)
T ss_pred             cCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence            99999999999999999999998766444332    23457888999999999988754 68999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      |......+..-..............+......++...+.+|.+||+++|.+|.|+++|++.+||+....+-+
T Consensus       525 Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v  596 (601)
T KOG0590|consen  525 WKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV  596 (601)
T ss_pred             cccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence            987665543110000011111111222223456788899999999999999999999999999998875543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-26  Score=187.15  Aligned_cols=215  Identities=27%  Similarity=0.418  Sum_probs=161.3

Q ss_pred             HHHHHHHHHHHHHHhcC--CCCeeEeeceEEEEC----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSS--QCPYVVVCYQSFYSN----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ....+...+|.+|++..  +|.||+.+++.-.-+    ..++||++|.+.|||.||+.+ ..++.+...+++..++.||+
T Consensus       244 srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLa  322 (513)
T KOG2052|consen  244 SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLA  322 (513)
T ss_pred             ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHH
Confidence            33445667888888766  999999999865432    358999999999999999998 77899999999999999999


Q ss_pred             HHhh-------cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC----CCcccccccccccCcccccCCC------
Q 024828           83 YLHH-------EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----GQANTFVGTYNYMSPERISGGK------  145 (262)
Q Consensus        83 ~lh~-------~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~------  145 (262)
                      +||.       -..|+|||||..||++.+++...++|+|+|.......    ...+..+||.+|+|||++...-      
T Consensus       323 HLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fe  402 (513)
T KOG2052|consen  323 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFE  402 (513)
T ss_pred             HHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhh
Confidence            9997       2348999999999999999999999999997764432    3445679999999999986532      


Q ss_pred             CCcchhHHHHHHHHHHHHh----------CCCCCCCCCccC-chhhHHHHHHHHhcCCCCCCCCCC----CCHHHHHHHH
Q 024828          146 YGYKSDIWSLGLVLLECAT----------GQFPYSPPEQQD-GWTSFYELMEAIVDQPPPSAPSDQ----FSPEFCSFIS  210 (262)
Q Consensus       146 ~~~~~Di~slG~~l~~l~~----------g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~  210 (262)
                      .-..+||||||.++||+..          -++||.+.-..+ +++.+...+  ..+..+|..+..-    .-..+..+|+
T Consensus       403 syk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV--Cv~~~RP~ipnrW~s~~~l~~m~klMk  480 (513)
T KOG2052|consen  403 SYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV--CVQKLRPNIPNRWKSDPALRVMAKLMK  480 (513)
T ss_pred             hhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce--eecccCCCCCcccccCHHHHHHHHHHH
Confidence            1246999999999999976          246777654433 222222221  1222233333221    1234678899


Q ss_pred             HhhcCCcCCCCCHHHH
Q 024828          211 ACVQKEPQQRLSAQEL  226 (262)
Q Consensus       211 ~~l~~~p~~Rpt~~~~  226 (262)
                      .||..+|.-|.|+--+
T Consensus       481 eCW~~Np~aRltALri  496 (513)
T KOG2052|consen  481 ECWYANPAARLTALRI  496 (513)
T ss_pred             HhhcCCchhhhHHHHH
Confidence            9999999999987554

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-27  Score=181.33  Aligned_cols=223  Identities=21%  Similarity=0.380  Sum_probs=168.6

Q ss_pred             cccchhHHHHHHHHHHHHHHhcC-CCCeeEeeceE-EEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS-FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~   80 (262)
                      |-+-......++|.+|..---.| .|.||+.-++. |+..+.+++++||++.|+|.+-+.. .++.+...+.++.|+++|
T Consensus        55 Kavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SA  133 (378)
T KOG1345|consen   55 KAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSA  133 (378)
T ss_pred             eccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHH
Confidence            33445667778999999866666 58999988874 7888899999999999999988776 557888999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccC--CcEEEEecccccccccCCCCcccccccccccCcccccC---C--CCCcchhHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---G--KYGYKSDIW  153 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~--~~~~~~Di~  153 (262)
                      ++|+|+ ++++|||||.+|||+...  .+++|||||.+...+...+...   ....|.+||....   +  ...+.+|+|
T Consensus       134 i~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~---~~~~y~~pe~~~~~~ne~~~~~ps~D~W  209 (378)
T KOG1345|consen  134 IEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLE---YVNNYHAPELCDTVVNEKLVVNPSTDIW  209 (378)
T ss_pred             HHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccCceehhhh---hhcccCCcHHHhhccccceEecccccch
Confidence            999999 999999999999999543  3799999999887665443332   2446888886432   2  257889999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCCC---CCHHHHhc
Q 024828          154 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQR---LSAQELMT  228 (262)
Q Consensus       154 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R---pt~~~~l~  228 (262)
                      +||++++.+++|+.||......+  ..+.++.+ +..+..  .+.....+++.+..+.++-|.+++++|   -+++....
T Consensus       210 qfGIi~f~cltG~~PWQka~~~d--~~Y~~~~~-w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  210 QFGIIFFYCLTGKFPWQKASIMD--KPYWEWEQ-WLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             heeeeeeeeecCCCcchhhhccC--chHHHHHH-HhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            99999999999999998433222  22223222 222222  222335678889999999999999999   46666666


Q ss_pred             Ccccc
Q 024828          229 HPFLK  233 (262)
Q Consensus       229 h~~~~  233 (262)
                      ..|..
T Consensus       287 ~~w~E  291 (378)
T KOG1345|consen  287 CLWKE  291 (378)
T ss_pred             HHHHH
Confidence            67763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.2e-25  Score=176.08  Aligned_cols=160  Identities=36%  Similarity=0.630  Sum_probs=142.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..+.+.+|++.++.++|+|++++++.+......++++|++++++|.+++..... ++...+..++.+++.++.+||+ .|
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~  118 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS-LG  118 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            577899999999999999999999999988999999999999999999988766 8999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      ++|+|++|.||+++.++.++++|||.+....... .......+...|++||.. ....++.++|+|+||++++++++|+.
T Consensus       119 i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~  198 (225)
T smart00221      119 IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE  198 (225)
T ss_pred             eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence            9999999999999999999999999887664432 122334567789999998 55667889999999999999999999


Q ss_pred             CCCC
Q 024828          168 PYSP  171 (262)
Q Consensus       168 p~~~  171 (262)
                      ||..
T Consensus       199 pf~~  202 (225)
T smart00221      199 PFSG  202 (225)
T ss_pred             Cccc
Confidence            9965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-27  Score=196.01  Aligned_cols=154  Identities=31%  Similarity=0.522  Sum_probs=139.3

Q ss_pred             HHHHHHHHhcCC---CCeeEeeceEEEECCeEEEEEeec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           15 IAQELKINQSSQ---CPYVVVCYQSFYSNGAISIILEYM-DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        15 ~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      +--|+.||..++   |+||+|++++|++++++|++||.. +|.+|.+++.....+++.+...|+.|++.|+++||+ .||
T Consensus       613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~i  691 (772)
T KOG1152|consen  613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGI  691 (772)
T ss_pred             cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc-cCc
Confidence            446999999996   999999999999999999999974 478999999999999999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      +|||||-+||.++.+|.++|+|||.+....+.  ....++||..|.|||++.|..| +..-|||++|+++|-++....||
T Consensus       692 vhrdikdenvivd~~g~~klidfgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  692 VHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             eecccccccEEEecCCeEEEeeccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99999999999999999999999988765433  4456789999999999999875 67789999999999999888888


Q ss_pred             CC
Q 024828          170 SP  171 (262)
Q Consensus       170 ~~  171 (262)
                      .+
T Consensus       770 yn  771 (772)
T KOG1152|consen  770 YN  771 (772)
T ss_pred             cC
Confidence            64

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-25  Score=198.49  Aligned_cols=219  Identities=20%  Similarity=0.219  Sum_probs=160.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ...+-.+|++ ....++||++.+.-.-..+...|+|-+|... +|.|.+..+.-+...+.+.|+.|++.|+..+|. .|+
T Consensus        65 ~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~-~gV  141 (1431)
T KOG1240|consen   65 PFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK-LGV  141 (1431)
T ss_pred             HHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH-cCc
Confidence            3444445555 5666999999999988888889999999977 999999998889999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcc-------cccccccccCcccccC----------CC-CCcchhH
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-------TFVGTYNYMSPERISG----------GK-YGYKSDI  152 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-------~~~~~~~y~~PE~~~~----------~~-~~~~~Di  152 (262)
                      +|||||.+|||++..+.+.|.||...+....+.....       +.....+|.|||.+..          +. .+++.||
T Consensus       142 cHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDI  221 (1431)
T KOG1240|consen  142 CHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDI  221 (1431)
T ss_pred             cccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhh
Confidence            9999999999999999999999986543322211111       1233457999998754          12 5789999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC-CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCc
Q 024828          153 WSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHP  230 (262)
Q Consensus       153 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~  230 (262)
                      ||+||+++|+++ |+++|.-.       +.......-  ...++.. ..--+..++.++..|++.||.+|.++++.|+.-
T Consensus       222 FS~GCViaELf~Eg~PlF~LS-------QL~aYr~~~--~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  222 FSAGCVIAELFLEGRPLFTLS-------QLLAYRSGN--ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             hhhhHHHHHHHhcCCCcccHH-------HHHhHhccC--ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            999999999988 78998631       111111110  0000000 001134689999999999999999999999874


Q ss_pred             cccccCCcccc
Q 024828          231 FLKMYGDLNVD  241 (262)
Q Consensus       231 ~~~~~~~~~~~  241 (262)
                      -=..+++.+.+
T Consensus       293 rG~~FP~yFy~  303 (1431)
T KOG1240|consen  293 RGLVFPEYFYS  303 (1431)
T ss_pred             hccccHHHHHH
Confidence            33333433333

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-22  Score=167.25  Aligned_cols=210  Identities=22%  Similarity=0.276  Sum_probs=164.6

Q ss_pred             HHHHHHHHHhcCC----CCeeEeeceEE-EECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828           14 QIAQELKINQSSQ----CPYVVVCYQSF-YSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        14 ~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+..|..++..+.    .++++.+++.+ ..+...++||+.+ |.+|.++....  +.++..++..++.|++.+|+++|+
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~  140 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS  140 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence            6778888888886    36999999998 5778899999999 88999998655  479999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccC-----CcEEEEeccccc--ccccCC-------CC-cccccccccccCcccccCCCCCcchh
Q 024828           87 EKHIIHRDLKPSNLLINHR-----GEVKITDFGVSA--IMASTS-------GQ-ANTFVGTYNYMSPERISGGKYGYKSD  151 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~-----~~~~l~df~~~~--~~~~~~-------~~-~~~~~~~~~y~~PE~~~~~~~~~~~D  151 (262)
                       .|++||||||.|+++...     ..+.+.|||+++  ......       .. .....||..|.++.+..+...+++.|
T Consensus       141 -~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DD  219 (322)
T KOG1164|consen  141 -KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDD  219 (322)
T ss_pred             -cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchh
Confidence             999999999999999865     359999999998  322111       11 22356999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      +||+++++.++..|..||....................   . .......+.++.++...+-..+...+|.+..+...
T Consensus       220 les~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  220 LESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL---T-DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc---c-ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            99999999999999999977654432222222211111   1 11223456778888888888999999998877554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=4.9e-21  Score=157.87  Aligned_cols=223  Identities=35%  Similarity=0.580  Sum_probs=177.8

Q ss_pred             HHHHHHHHHHHHhcCCCC-eeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhh
Q 024828           11 ARRQIAQELKINQSSQCP-YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+.+|+.++..+.|+ +++++.+.+......+++++++.++++.+++....   .++......++.|++.++.++|+
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~  119 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS  119 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            577899999999999988 79999999988777899999999999998887765   79999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCC-cEEEEecccccccccCCC------CcccccccccccCcccccC---CCCCcchhHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG------QANTFVGTYNYMSPERISG---GKYGYKSDIWSLG  156 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG  156 (262)
                       .|++|+|++|+||+++..+ .++++|||.+........      ......++..|.+||...+   ...+...|+|++|
T Consensus       120 -~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g  198 (384)
T COG0515         120 -KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLG  198 (384)
T ss_pred             -CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHH
Confidence             9999999999999999888 799999999875443332      2355688999999999987   5788999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC---CCCCCCC----CHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++++++++|..||........   .......+.....+   .......    ...+.+++.+++..+|..|.+..+...+
T Consensus       199 ~~~~~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         199 ITLYELLTGLPPFEGEKNSSA---TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHHhCCCCCCCCCcccc---HHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            999999999999766543201   11222222222221   1111111    2578999999999999999999999988


Q ss_pred             ccccccCC
Q 024828          230 PFLKMYGD  237 (262)
Q Consensus       230 ~~~~~~~~  237 (262)
                      ++......
T Consensus       276 ~~~~~~~~  283 (384)
T COG0515         276 DLLAHLKL  283 (384)
T ss_pred             hHhhCccc
Confidence            76655443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-22  Score=153.25  Aligned_cols=221  Identities=19%  Similarity=0.319  Sum_probs=178.2

Q ss_pred             CccccchhHHHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHH
Q 024828            1 MVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVL   78 (262)
Q Consensus         1 v~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~   78 (262)
                      |++|+..+.....++.-|.++.+.++ ..+|+.+..++.+..+-++|||.. |.||.++.+-+ +.++..+++-++-|++
T Consensus        43 VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml  121 (341)
T KOG1163|consen   43 VAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQML  121 (341)
T ss_pred             EEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHH
Confidence            56788877777788999999999995 589999999999999999999999 88999999755 5799999999999999


Q ss_pred             HHHHHHhhcCCeeeCCCCCCCEEEccC---CcEEEEecccccccccCCC-------CcccccccccccCcccccCCCCCc
Q 024828           79 KGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGY  148 (262)
Q Consensus        79 ~~l~~lh~~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~  148 (262)
                      .-++|+|. ++++|+||||+|+|..-+   .++.++|||+|....+...       ......||.+|.+-.+..+...+.
T Consensus       122 ~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSR  200 (341)
T KOG1163|consen  122 SRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSR  200 (341)
T ss_pred             HHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhh
Confidence            99999998 999999999999999644   3699999999987754432       223457899999998888888899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          149 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      +.|+-|+|+++.++-.|..||.+...... .+..+.+....-....+..-..+|.++.-.+.-|-...-++-|.+.
T Consensus       201 RDDmeSvgYvLmYfnrG~LPWQglka~tk-~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  201 RDDMESVGYVLMYFNRGSLPWQGLKAATK-KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             hhhhhhhcceeeeeecCCCcccccchhhH-HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            99999999999999999999988654422 2223333333334444444567888888888888777777777653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-23  Score=176.60  Aligned_cols=205  Identities=28%  Similarity=0.421  Sum_probs=176.6

Q ss_pred             HHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           14 QIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        14 ~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      .-..|-.++..++ ||.++++...++.....+++.++..|+.|...+.+...+.......+...++-+++++|+ .|++|
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiy  120 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAY  120 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHH
Confidence            4456777888886 999999999999999999999999999999999888889999999999999999999999 99999


Q ss_pred             CCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  172 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  172 (262)
                      +|+|++||+++.+|++++.|||.++........    .|+.-|+|||+..  ....++|.|++|+++++|++|..||.. 
T Consensus       121 rd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-  193 (612)
T KOG0603|consen  121 RDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-  193 (612)
T ss_pred             hcccccceeecccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-
Confidence            999999999999999999999998765543322    7899999999999  456789999999999999999999986 


Q ss_pred             CccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCCc
Q 024828          173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDL  238 (262)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~~  238 (262)
                                +....+.+.....  +...+..+.+++..++..+|.+|.-     +.++++|+||+...+.
T Consensus       194 ----------~~~~~Il~~~~~~--p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  194 ----------DTMKRILKAELEM--PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ----------HHHHHHhhhccCC--chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                      3344444433322  3567889999999999999999984     5799999999887755

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.5e-22  Score=157.02  Aligned_cols=221  Identities=21%  Similarity=0.341  Sum_probs=175.4

Q ss_pred             CccccchhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHH
Q 024828            1 MVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVL   78 (262)
Q Consensus         1 v~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~   78 (262)
                      |+||..--.+...++..|.+..+.| ..++|+..+.+.+++.+-.||+|.+ |.||.++..-++ .++...+..++.|++
T Consensus        56 VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi  134 (449)
T KOG1165|consen   56 VAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMI  134 (449)
T ss_pred             EEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHH
Confidence            5677777777778889999999988 5799999999999999999999999 889999998664 699999999999999


Q ss_pred             HHHHHHhhcCCeeeCCCCCCCEEEccCC-----cEEEEecccccccccCCCC-------cccccccccccCcccccCCCC
Q 024828           79 KGLLYLHHEKHIIHRDLKPSNLLINHRG-----EVKITDFGVSAIMASTSGQ-------ANTFVGTYNYMSPERISGGKY  146 (262)
Q Consensus        79 ~~l~~lh~~~~i~H~dl~p~nil~~~~~-----~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~  146 (262)
                      .-++++|+ +.++.+||||+|+||...+     .+.++|||++...-.+...       .....||.+||+-....|...
T Consensus       135 ~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ  213 (449)
T KOG1165|consen  135 TRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ  213 (449)
T ss_pred             HHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchh
Confidence            99999998 9999999999999997543     4899999999877554432       223478999999999999999


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          147 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       147 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      +++.|+-|||-++++++.|..||.+..-+.. +...+.+..-......+.....+|.++..-+.-.-..+-.+-|.++
T Consensus       214 SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  214 SRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             hhhhhHHHhhhhhhhhccCCCccccccCcch-HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence            9999999999999999999999988665433 2222222222333333333456777777777666666666667654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=7e-22  Score=151.66  Aligned_cols=204  Identities=18%  Similarity=0.283  Sum_probs=162.6

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ...-++|..|.-.|+-+.||||+.+++.+....++.++..|++.+||+..+.....  .+..+...++.+++.+++|||+
T Consensus       228 ~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhs  307 (448)
T KOG0195|consen  228 ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS  307 (448)
T ss_pred             hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh
Confidence            33445788888899999999999999999999999999999999999999988754  5677888999999999999999


Q ss_pred             cCC--eeeCCCCCCCEEEccCCc--EEEEecccccccccCCCCcccccccccccCcccccCCC---CCcchhHHHHHHHH
Q 024828           87 EKH--IIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVL  159 (262)
Q Consensus        87 ~~~--i~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l  159 (262)
                       ..  +.-..++...++++++-+  +..+|-.++...  .     -....+.|++||.++..+   .-.++|+|||++++
T Consensus       308 -lep~ipr~~lns~hvmidedltarismad~kfsfqe--~-----gr~y~pawmspealqrkped~n~raadmwsfaill  379 (448)
T KOG0195|consen  308 -LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--V-----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILL  379 (448)
T ss_pred             -cchhhhhhhcccceEEecchhhhheecccceeeeec--c-----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHH
Confidence             43  445578999999988765  445554443221  1     123467899999998754   35689999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ||+.|...||.+...      +...++--+.+.....+ ..++.....|+.-|++.||.+||.++.++
T Consensus       380 wel~trevpfadlsp------mecgmkialeglrv~ip-pgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  380 WELNTREVPFADLSP------MECGMKIALEGLRVHIP-PGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHhhccccccccCCc------hhhhhhhhhccccccCC-CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            999999999987543      33445555666666655 46888999999999999999999998764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=7.1e-21  Score=160.37  Aligned_cols=207  Identities=21%  Similarity=0.328  Sum_probs=158.7

Q ss_pred             HhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCE
Q 024828           22 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  100 (262)
Q Consensus        22 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~ni  100 (262)
                      |+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+... -.++......+.++++.||+|+|.....+|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999999999999874 35777788889999999999999844459999999999


Q ss_pred             EEccCCcEEEEeccccccccc--CCCCcccccccccccCcccccCCC-------CCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828          101 LINHRGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGGK-------YGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus       101 l~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      +++..-.+++.|||+......  ............-|.|||.+.+..       .+.+.|+||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999998765431  111112223455699999987631       46679999999999999999999987


Q ss_pred             CCccCchhhHHHHHHH-HhcCCCCCCCCC-CCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          172 PEQQDGWTSFYELMEA-IVDQPPPSAPSD-QFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ........+....+++ -.....|..... ..++++..++++||..+|.+||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            5554433222222222 111122332222 45668999999999999999999998843

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-20  Score=151.56  Aligned_cols=189  Identities=19%  Similarity=0.301  Sum_probs=139.8

Q ss_pred             CCCeeEeeceEEEE---------------------------CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 024828           26 QCPYVVVCYQSFYS---------------------------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL   78 (262)
Q Consensus        26 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~   78 (262)
                      +|||||++.+.|.+                           +..+|+||...+. +|..++-.+. .+--...-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999999987643                           2358999999977 9999997744 35556677899999


Q ss_pred             HHHHHHhhcCCeeeCCCCCCCEEEcc--CC--cEEEEecccccccccC------CCCcccccccccccCcccccCCC---
Q 024828           79 KGLLYLHHEKHIIHRDLKPSNLLINH--RG--EVKITDFGVSAIMAST------SGQANTFVGTYNYMSPERISGGK---  145 (262)
Q Consensus        79 ~~l~~lh~~~~i~H~dl~p~nil~~~--~~--~~~l~df~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~---  145 (262)
                      +|+.|||+ .|+.|+|+|.+||++.-  ++  .+.++|||++-.-...      ....-..-|+...+|||+.+..+   
T Consensus       352 Eav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  352 EAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            99999999 99999999999999953  33  4789999976322110      11112234677889999986532   


Q ss_pred             ---CCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          146 ---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       146 ---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                         .-.++|.|+.|.+.||+++...||....+.-     .+. ........ +..+..+++.+++|+..+|+.||++|++
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-----L~~-r~Yqe~qL-Palp~~vpp~~rqlV~~lL~r~pskRvs  503 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-----LDT-RTYQESQL-PALPSRVPPVARQLVFDLLKRDPSKRVS  503 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchhe-----ech-hhhhhhhC-CCCcccCChHHHHHHHHHhcCCccccCC
Confidence               2358999999999999999999998743221     011 11222233 3344678999999999999999999997


Q ss_pred             HH
Q 024828          223 AQ  224 (262)
Q Consensus       223 ~~  224 (262)
                      ++
T Consensus       504 p~  505 (598)
T KOG4158|consen  504 PN  505 (598)
T ss_pred             cc
Confidence            64

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=5.9e-21  Score=151.61  Aligned_cols=160  Identities=20%  Similarity=0.327  Sum_probs=110.2

Q ss_pred             EEEEEeecCCCCHHHHHHh---cC----CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEeccc
Q 024828           43 ISIILEYMDGGSLADFLKK---VK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  115 (262)
Q Consensus        43 ~~lv~e~~~~~sL~~~l~~---~~----~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~  115 (262)
                      .+++|+-+.+ +|.+++.-   ..    .+.......+..|++..+++||. .|++|+||+|+|++++.+|.+.|+||+.
T Consensus       114 ~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi~~~nfll~~~G~v~Lg~F~~  191 (288)
T PF14531_consen  114 RFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDIKPENFLLDQDGGVFLGDFSS  191 (288)
T ss_dssp             EEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEE-TTS-EEE--GGG
T ss_pred             hhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecccceeeEEEcCCCCEEEcChHH
Confidence            5788999866 99888742   11    24455667778999999999999 9999999999999999999999999987


Q ss_pred             ccccccCCCCcccccccccccCcccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHH
Q 024828          116 SAIMASTSGQANTFVGTYNYMSPERISG--------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA  187 (262)
Q Consensus       116 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  187 (262)
                      ..+.+.....   ...+..|.|||....        ..++.+.|.|+||+++|.+++++.||........-..       
T Consensus       192 ~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------  261 (288)
T PF14531_consen  192 LVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------  261 (288)
T ss_dssp             EEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------
T ss_pred             HeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------
Confidence            7665443221   234567999997643        2478899999999999999999999987654432111       


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCC
Q 024828          188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  220 (262)
Q Consensus       188 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  220 (262)
                           ....- .++|+.++.||..+|++||.+|
T Consensus       262 -----~f~~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 -----DFSRC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -----GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             -----cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence                 01111 2688999999999999999988

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.7e-20  Score=154.67  Aligned_cols=176  Identities=30%  Similarity=0.480  Sum_probs=138.7

Q ss_pred             eEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           42 AISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        42 ~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      ++|+.|++|...+|.+|+..+.   ..+......++.|++.|++|    +|.+|+|++|.||+...+++++++|||+...
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccchhhhhhhhhheee
Confidence            5889999999999999997543   46788899999999999998    7899999999999999999999999999876


Q ss_pred             cccCC------CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCccCchhhHHHHHHHHhcC
Q 024828          119 MASTS------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYELMEAIVDQ  191 (262)
Q Consensus       119 ~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~  191 (262)
                      .....      .......|+..|++||++.+..++.++|||+||.+++|++.- .-.++          -......+.++
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r~g  475 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIRDG  475 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhhcC
Confidence            54333      233456899999999999999999999999999999999872 11111          11223344455


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       192 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ..++.....+|. -..|+.+|+.+.|.+||++.+.-.|+|.
T Consensus       476 ~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 IIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            555433334443 4689999999999999988777777765

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.6e-18  Score=131.28  Aligned_cols=150  Identities=14%  Similarity=0.082  Sum_probs=110.8

Q ss_pred             HHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ...+.+|+++|+++. ++++++++++    ...+++|+|+.|.+|......       ....++.|++.+|.++|+ .|+
T Consensus        45 ~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~-~GI  112 (218)
T PRK12274         45 WWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHR-CGV  112 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHH-CcC
Confidence            346889999999994 5889999885    346999999999998754322       123577899999999998 999


Q ss_pred             eeCCC-CCCCEEEccCCcEEEEecccccccccCCCC----c---------ccccccccccCcccccC-CCCC-cchhHHH
Q 024828           91 IHRDL-KPSNLLINHRGEVKITDFGVSAIMASTSGQ----A---------NTFVGTYNYMSPERISG-GKYG-YKSDIWS  154 (262)
Q Consensus        91 ~H~dl-~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~---------~~~~~~~~y~~PE~~~~-~~~~-~~~Di~s  154 (262)
                      +|+|| +|+||+++.++.++|+|||++.........    .         ......+.++.|+...- ...+ .+.+.++
T Consensus       113 vHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~  192 (218)
T PRK12274        113 AHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFA  192 (218)
T ss_pred             ccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHH
Confidence            99999 799999999999999999999754432211    0         01123445555554321 1223 5678889


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 024828          155 LGLVLLECATGQFPYSPPE  173 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~  173 (262)
                      .|+-+|.++|+..+..+..
T Consensus       193 ~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        193 TGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             hcchHHHHHhccCCccccC
Confidence            9999999999988765543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.7e-18  Score=143.22  Aligned_cols=123  Identities=21%  Similarity=0.289  Sum_probs=96.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEe-eceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVV-CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...++.+.+|+++|++++|+|++. +++    .+..|+||||++|++|... ..   ..   ...++.+++.+|.+||+ 
T Consensus        62 ~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~-  129 (365)
T PRK09188         62 PLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHR-  129 (365)
T ss_pred             HHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHH-
Confidence            345778999999999999999985 433    2458999999999999732 11   11   24678999999999998 


Q ss_pred             CCeeeCCC-CCCCEEEccCCcEEEEecccccccccCCCC--------cccccccccccCcccccC
Q 024828           88 KHIIHRDL-KPSNLLINHRGEVKITDFGVSAIMASTSGQ--------ANTFVGTYNYMSPERISG  143 (262)
Q Consensus        88 ~~i~H~dl-~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~y~~PE~~~~  143 (262)
                      .|++|+|| ||+||+++.++.++|+|||++.........        .....++..|.+||.+..
T Consensus       130 ~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        130 AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999999 999999998899999999999865433211        123456677899998864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.76  E-value=5.1e-19  Score=136.59  Aligned_cols=127  Identities=18%  Similarity=0.289  Sum_probs=98.8

Q ss_pred             HHHHHHHHhcCCCCeeEeeceEEEEC--------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828           15 IAQELKINQSSQCPYVVVCYQSFYSN--------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        15 ~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +.+|++.+.++.|++|..+.+++.+.        +..+++|||++|.+|.++..    ++.    ....+++.++..+|.
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~  153 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ  153 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH
Confidence            68999999999999999999886643        35889999999999988732    333    345699999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+|++|.||+++++| ++++|||.+....... ..           ........+..++|+|+||+++..+.
T Consensus       154 -~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~-a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        154 -HGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK-AK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -cCCccCCCChHHEEEeCCC-EEEEECCCcccccchh-hH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence             9999999999999999888 9999999765432111 00           01223334667899999999987765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.74  E-value=1.6e-17  Score=126.51  Aligned_cols=102  Identities=18%  Similarity=0.187  Sum_probs=82.9

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCCeee
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL-HHEKHIIH   92 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l-h~~~~i~H   92 (262)
                      ...+|++.+.++.++++........ .. .++||||++|+++.....+.++++...+..++.|++.+|.++ |+ .|++|
T Consensus        65 ~~~~E~~~l~~l~~~~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiH  141 (190)
T cd05147          65 WAEKEMRNLKRLVTAGIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD-CRLVH  141 (190)
T ss_pred             HHHHHHHHHHHHHHCCCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence            4456999999998877754433322 22 389999999877766554557899999999999999999999 67 99999


Q ss_pred             CCCCCCCEEEccCCcEEEEeccccccc
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                      +||||+||+++ ++.++|+|||++...
T Consensus       142 rDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         142 ADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCCHHHEEEE-CCcEEEEEccccccC
Confidence            99999999997 588999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=6.7e-18  Score=150.28  Aligned_cols=170  Identities=30%  Similarity=0.493  Sum_probs=133.5

Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---------
Q 024828           54 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---------  124 (262)
Q Consensus        54 sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---------  124 (262)
                      +=...++.-++++...        +.+++|+|+ .||+|+|++|+|.++..-|++++.|||++........         
T Consensus       137 Dc~tllk~~g~lPvdm--------vla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~  207 (1205)
T KOG0606|consen  137 DCATLLKNIGPLPVDM--------VLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE  207 (1205)
T ss_pred             hhhhhcccCCCCcchh--------hHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence            4455556656666544        789999998 9999999999999999999999999998864321110         


Q ss_pred             ------CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCC
Q 024828          125 ------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  198 (262)
Q Consensus       125 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (262)
                            .....+|++.|+|||++....|+..+|.|++|+++|+++-|..||.+...++.+.......-      ..+...
T Consensus       208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i------~wpE~d  281 (1205)
T KOG0606|consen  208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI------EWPEED  281 (1205)
T ss_pred             HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc------cccccC
Confidence                  01123789999999999998999999999999999999999999998766544333332222      222224


Q ss_pred             CCCCHHHHHHHHHhhcCCcCCCC---CHHHHhcCccccccCCc
Q 024828          199 DQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYGDL  238 (262)
Q Consensus       199 ~~~~~~l~~li~~~l~~~p~~Rp---t~~~~l~h~~~~~~~~~  238 (262)
                      ..++++.++++.++|..+|..|.   .+-++.+|+||+.....
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            57889999999999999999998   56688999999988766

>PRK10345 hypothetical protein; Provisional

Probab=99.70  E-value=1.3e-16  Score=122.67  Aligned_cols=102  Identities=23%  Similarity=0.283  Sum_probs=82.6

Q ss_pred             HHHHHHHHHHHHhcC-----CCCeeEeeceEEEECC---eEE-EEEee--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSS-----QCPYVVVCYQSFYSNG---AIS-IILEY--MDGGSLADFLKKVKTIPEEYLAAICEQVLK   79 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~   79 (262)
                      ..+++.+|+++++.+     +||||++++++++++.   ..+ +|+||  +.+++|.+++++ +.+++.  ..++.+++.
T Consensus        39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~  115 (210)
T PRK10345         39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLK  115 (210)
T ss_pred             hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHH
Confidence            456799999999999     6799999999998863   333 78999  557899999976 346655  356777777


Q ss_pred             HH-HHHhhcCCeeeCCCCCCCEEEccC----CcEEEEecccc
Q 024828           80 GL-LYLHHEKHIIHRDLKPSNLLINHR----GEVKITDFGVS  116 (262)
Q Consensus        80 ~l-~~lh~~~~i~H~dl~p~nil~~~~----~~~~l~df~~~  116 (262)
                      ++ +|||+ .+|+|+||||+||+++..    +.++|+|++.+
T Consensus       116 ~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        116 KLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            77 99998 999999999999999743    37999995433

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.70  E-value=1.9e-16  Score=120.90  Aligned_cols=103  Identities=19%  Similarity=0.197  Sum_probs=83.7

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeC
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR   93 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~   93 (262)
                      .+.+|.+.+.++.++++.....+....  .++||||++|+++........+++......++.|++.++.++|++.|++|+
T Consensus        65 ~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHr  142 (190)
T cd05145          65 WAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHG  142 (190)
T ss_pred             HHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            446899999999998875544443332  489999999876544433446788889999999999999999976899999


Q ss_pred             CCCCCCEEEccCCcEEEEeccccccc
Q 024828           94 DLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        94 dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                      ||||+||+++ ++.++++|||++...
T Consensus       143 DlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         143 DLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             CCChhhEEEE-CCCEEEEEcccceec
Confidence            9999999998 889999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.68  E-value=1.3e-15  Score=130.41  Aligned_cols=149  Identities=18%  Similarity=0.330  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+.++.|+.++||||+++++.++..+..|+|+|.+.  .|..++++.+   ...+...+.||+.||.+||..++
T Consensus        51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~  125 (690)
T KOG1243|consen   51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCN  125 (690)
T ss_pred             hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCC
Confidence            445678899999999999999999999999999999999984  7888888744   77788899999999999987699


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      ++|++|.-..|+++..|.++|++|.++..................|..|+.+....  -..|.|.|||++++++.|
T Consensus       126 lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  126 LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            99999999999999999999999988765433332222223334566666554333  346999999999999998

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=3.2e-18  Score=150.42  Aligned_cols=220  Identities=28%  Similarity=0.444  Sum_probs=178.0

Q ss_pred             HHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHh-
Q 024828           10 SARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVK-TIPEEYLAAICEQVLKGLLYLH-   85 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l-~~~~-~~~~~~~~~i~~~l~~~l~~lh-   85 (262)
                      .....+..|..+-..+. |+|++.+++...+....++++++..|+++.+.+ .... ..+......++.|+..++.|+| 
T Consensus        62 ~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~  141 (601)
T KOG0590|consen   62 DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP  141 (601)
T ss_pred             chhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc
Confidence            34445556777777776 999999999999999999999999999999998 5544 6777888899999999999999 


Q ss_pred             hcCCeeeCCCCCCCEEEccCC-cEEEEeccccccccc-CC--CCcccccc-cccccCcccccCC-CCCcchhHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMAS-TS--GQANTFVG-TYNYMSPERISGG-KYGYKSDIWSLGLVL  159 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~-~~--~~~~~~~~-~~~y~~PE~~~~~-~~~~~~Di~slG~~l  159 (262)
                      . .++.|+|++|+|.+++..+ .++..|||++..... .+  .......| +..|.+||...+. ...+..|+||.|+++
T Consensus       142 ~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l  220 (601)
T KOG0590|consen  142 E-NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVL  220 (601)
T ss_pred             c-cccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccc
Confidence            7 9999999999999999999 999999999987654 22  12233467 8899999999984 467889999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      ..+++|..|+........  ....+...-  ......+...++....+++.+++..+|.+|.+.+++..++|+..
T Consensus       221 ~~~~~g~~p~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  221 SAMLTGELPWDFPSRKDG--RYSSWKSNK--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccccCCCCccccccccc--cceeecccc--cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            999999999987655441  111111111  22233444677888999999999999999999999999999988

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.64  E-value=6.6e-16  Score=121.92  Aligned_cols=209  Identities=24%  Similarity=0.328  Sum_probs=146.9

Q ss_pred             HHhcCCCCeeEeeceEEEECC-----eEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCC--
Q 024828           21 INQSSQCPYVVVCYQSFYSNG-----AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKH--   89 (262)
Q Consensus        21 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lh~~~~--   89 (262)
                      -|-++.|.|+++++.+|.+..     ...+++||+..+++..++++.    ..+......+|+.||+.||.|||+ ..  
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            344557999999999987643     478999999999999999765    358889999999999999999999 54  


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEeccccccc--ccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIM--ASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~--~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      ++|+++..+.|++..+|-++++--.-....  .....  ......+-++|.+||.-.....+-++|||++|.+..+|.-+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            899999999999998887777643211110  00000  11112346788999877766677899999999999999776


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~  241 (262)
                      ..--......   ....+-..+...+..        ..--+.++.+|++..|+.||++.+++.||.+-+.+..+.-
T Consensus       279 Eiq~tnseS~---~~~ee~ia~~i~~le--------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkll  343 (458)
T KOG1266|consen  279 EIQSTNSESK---VEVEENIANVIIGLE--------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKLL  343 (458)
T ss_pred             eeccCCCcce---eehhhhhhhheeecc--------CccccCcCcccccCCCCCCcchhhhhcCceeeecchHHHH
Confidence            5332221111   001111111111111        1113468999999999999999999999999877765543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.61  E-value=4.7e-15  Score=115.25  Aligned_cols=101  Identities=25%  Similarity=0.398  Sum_probs=89.6

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      ..++.+|+.++..+.|++++....++.+....+++|||++|++|.+++.....    ....++.+++.+|.++|+ .|++
T Consensus        43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~-~~i~  117 (211)
T PRK14879         43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS-AGII  117 (211)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh-CCcc
Confidence            45788999999999999988877777777888999999999999999876432    788999999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccc
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      |+|++|.||+++ ++.++++|||.+..
T Consensus       118 H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        118 HGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             cCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999998 78899999998754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=5.8e-15  Score=133.37  Aligned_cols=138  Identities=24%  Similarity=0.302  Sum_probs=116.6

Q ss_pred             CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEcc---
Q 024828           28 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---  104 (262)
Q Consensus        28 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~---  104 (262)
                      +.|.++...+.-.+.-++|++|.+.|+|.++++..+..++..+..+..|++..++.||. .+|+||||||+|+++..   
T Consensus       754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~  832 (974)
T KOG1166|consen  754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREIC  832 (974)
T ss_pred             cchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccC
Confidence            45555555555566678999999999999999988889999999999999999999998 99999999999999952   


Q ss_pred             ----CCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828          105 ----RGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus       105 ----~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                          .--++|+|||.+.-+.....  .....+++-.+-.+|...|.++++..|.|+++.+++.|+.|+
T Consensus       833 ~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  833 ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence                22489999999876543322  233456778899999999999999999999999999999985

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.59  E-value=9.2e-15  Score=112.55  Aligned_cols=98  Identities=20%  Similarity=0.342  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      ..++.+|+++++.+.|+++....-++.+....+++|||++|++|.+++.....       .++.+++.+|.++|+ .|++
T Consensus        41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~-~gi~  112 (199)
T TIGR03724        41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHK-AGIV  112 (199)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH-CCee
Confidence            46788999999999888766555555666677899999999999998765321       889999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccc
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      |+|++|.||+++ ++.++++|||.+..
T Consensus       113 H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724       113 HGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             cCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999998 88999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=1.5e-14  Score=114.13  Aligned_cols=103  Identities=18%  Similarity=0.297  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCee--EeeceEEEEC-C---eEEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYV--VVCYQSFYSN-G---AISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~-~---~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ..+.++.+|++++.++.|++|  ++.++..... .   ..++|||+++| .+|.+++.. .+++..    .+.+++.++.
T Consensus        82 ~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~  156 (239)
T PRK01723         82 LERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIA  156 (239)
T ss_pred             hhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHH
Confidence            455678999999999988775  6666654332 2   23599999997 799998865 455554    3568999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      +||+ .|++|+||+|.||+++.++.++++|||.+..
T Consensus       157 ~lH~-~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        157 RFHD-AGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHH-CCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            9998 9999999999999999888999999997654

>smart00090 RIO RIO-like kinase

Probab=99.57  E-value=1.2e-14  Score=114.36  Aligned_cols=101  Identities=22%  Similarity=0.214  Sum_probs=81.8

Q ss_pred             HHHHHHHHHHHhcCCCC--eeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           12 RRQIAQELKINQSSQCP--YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      +..+.+|+..+.++.+.  .++++++.   . ..++||||+.|.+|.........+.......++.|++.++.+||+ .|
T Consensus        94 ~~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g  168 (237)
T smart00090       94 RLWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK-EG  168 (237)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh-cC
Confidence            34567899999999653  34444432   2 358999999998887766454566777788999999999999998 99


Q ss_pred             -eeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           90 -IIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        90 -i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                       ++|+|++|+||+++ ++.++++|||.+..
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence             99999999999998 88999999998764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.56  E-value=2.1e-14  Score=126.43  Aligned_cols=98  Identities=21%  Similarity=0.306  Sum_probs=87.4

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+++.+|+++++.++|++++....++.+....++||||++|++|.+++.        ....++.+++.+|.+||+ .|+
T Consensus       379 ~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~-~gi  449 (535)
T PRK09605        379 RTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK-AGI  449 (535)
T ss_pred             HHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh-CCC
Confidence            34678899999999999999988777777777899999999999999886        357789999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      +|+|++|+||++ .++.++++|||++..
T Consensus       450 iHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        450 VHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999999 678899999998754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=4.7e-14  Score=119.63  Aligned_cols=214  Identities=24%  Similarity=0.304  Sum_probs=166.4

Q ss_pred             HHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHhh
Q 024828           13 RQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLK----GLLYLHH   86 (262)
Q Consensus        13 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~----~l~~lh~   86 (262)
                      ..-.+|+.....+ .|++.++....+...+..++-+|.|. .+|..+...... ++...++..+.+...    |+..+|+
T Consensus       162 ~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs  240 (524)
T KOG0601|consen  162 KRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS  240 (524)
T ss_pred             ccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC
Confidence            3444666666666 59999999999999999999999994 699999887655 888889999998888    9999999


Q ss_pred             cCCeeeCCCCCCCEEEccC-CcEEEEecccccccccCCCCcc-----cccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQAN-----TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~-----~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                       .+++|.|++|.||+...+ ...++.||++...++...-...     ...+...|++||...+ .++...|++++|.++.
T Consensus       241 -~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l  318 (524)
T KOG0601|consen  241 -NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVIL  318 (524)
T ss_pred             -CcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhH
Confidence             999999999999999988 7789999999887765542222     2267889999999884 6788999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +-.++..+.-.... ..|.       .+.....+.......+.++...+..|++.+|..|++.+.++.+++.....-
T Consensus       319 ~~~l~~~~~~~g~~-~~W~-------~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~  387 (524)
T KOG0601|consen  319 EAILGSHLPSVGKN-SSWS-------QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLF  387 (524)
T ss_pred             hhHhhcccccCCCC-CCcc-------ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhh
Confidence            98886554433211 1111       111222333333456777888999999999999999999999999975543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.47  E-value=5.1e-14  Score=125.97  Aligned_cols=211  Identities=30%  Similarity=0.489  Sum_probs=168.5

Q ss_pred             CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccC
Q 024828           26 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  105 (262)
Q Consensus        26 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~  105 (262)
                      .+|-++.....+......++++++..|++|...+++-+..+.+........+..++++||. ..+.|+|++|.|.+...+
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~  940 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYD  940 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhccc
Confidence            4566666666666777899999999999999999988878888888888889999999998 779999999999999999


Q ss_pred             CcEEEEecccccccccC-------------------------------CCCcccccccccccCcccccCCCCCcchhHHH
Q 024828          106 GEVKITDFGVSAIMAST-------------------------------SGQANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus       106 ~~~~l~df~~~~~~~~~-------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      ++..+.||+.....+.-                               ........++..|.+||...+......+|.|+
T Consensus       941 gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~ 1020 (1205)
T KOG0606|consen  941 GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWS 1020 (1205)
T ss_pred             CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhh
Confidence            99999999733222100                               01122347889999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHH---HHhcCc
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQ---ELMTHP  230 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~---~~l~h~  230 (262)
                      +|+++++.++|.+||......       ...+++..+..+ .......+.+..+++.+.+..+|.+|..+.   ++-.|+
T Consensus      1021 ~g~~l~e~l~g~pp~na~tpq-------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1021 SGVCLFEVLTGIPPFNAETPQ-------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred             hhhhhhhhhcCCCCCCCcchh-------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence            999999999999999886554       333444444433 333456788899999999999999999888   889999


Q ss_pred             cccccCCcccchhh
Q 024828          231 FLKMYGDLNVDLSE  244 (262)
Q Consensus       231 ~~~~~~~~~~~~~~  244 (262)
                      ||+......++...
T Consensus      1094 ~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1094 FFQDVDWENLALQK 1107 (1205)
T ss_pred             ccCCCCcccccccc
Confidence            99988876665443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.43  E-value=5.3e-13  Score=102.64  Aligned_cols=96  Identities=19%  Similarity=0.215  Sum_probs=77.5

Q ss_pred             HHHHHHHHHHhcCCCCe--eEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           13 RQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+|+.++..+.+++  +++.++    ....+++|||++|++|......      .....++.+++.++.++|+ .|+
T Consensus        78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~-~gi  146 (198)
T cd05144          78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK-HGI  146 (198)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH-CCC
Confidence            45778999999987774  334333    2346899999999998775431      3456788999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEeccccccc
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                      +|+||+|.||+++.++.++++|||.+...
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            99999999999999999999999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.40  E-value=5.8e-13  Score=97.52  Aligned_cols=99  Identities=26%  Similarity=0.309  Sum_probs=85.0

Q ss_pred             HHHHHHHHHHHhcCCC--CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--
Q 024828           12 RRQIAQELKINQSSQC--PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE--   87 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~--   87 (262)
                      ...+.+|+.+++.+++  .++++++......+..++++||+.|.++..+       +......++.+++.+++.+|..  
T Consensus        35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~  107 (155)
T cd05120          35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL  107 (155)
T ss_pred             hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence            5678899999999976  5888998888877889999999998777654       5567788899999999999972  


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .+++|+|++|.||+++..+.++++||+.+.
T Consensus       108 ~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120         108 LVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             eEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            269999999999999988999999999764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=2.2e-13  Score=117.47  Aligned_cols=169  Identities=17%  Similarity=0.280  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc---c------cccccccccCccc
Q 024828           70 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---N------TFVGTYNYMSPER  140 (262)
Q Consensus        70 ~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~------~~~~~~~y~~PE~  140 (262)
                      ...=+.+.+.|+.++|...+++|++|.|++|.++.++.+++++|+++.....+....   +      .......|.+||.
T Consensus       101 ~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~  180 (700)
T KOG2137|consen  101 GFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY  180 (700)
T ss_pred             hhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence            334445566899999999999999999999999999999999999875543322110   0      1134557999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          141 ISGGKYGYKSDIWSLGLVLLECA-TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       141 ~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      +.+...+.++|++|+|+++|.++ .|+..+.........    . ......+.........+|+++++=+.+++..++..
T Consensus       181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~  255 (700)
T KOG2137|consen  181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----S-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAV  255 (700)
T ss_pred             hccccccccccceeeeeEEEEEecCCcchhhccCCcchh----h-hhhcccccccccccccCcHHHHHHHHHHhcCCccc
Confidence            99888899999999999999999 566666654433211    1 11111222222233678999999999999999999


Q ss_pred             CCCHHHHhcCccccccCCcccchh
Q 024828          220 RLSAQELMTHPFLKMYGDLNVDLS  243 (262)
Q Consensus       220 Rpt~~~~l~h~~~~~~~~~~~~~~  243 (262)
                      ||++..++..|||+.-+-.-+.+.
T Consensus       256 rp~~~~l~~~~ff~D~~~~aLrfL  279 (700)
T KOG2137|consen  256 RPTLDLLLSIPFFSDPGLKALRFL  279 (700)
T ss_pred             CcchhhhhcccccCCchhhhhhhc
Confidence            999999999999987765444443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.34  E-value=1.1e-11  Score=94.00  Aligned_cols=102  Identities=18%  Similarity=0.146  Sum_probs=76.6

Q ss_pred             HHHHHHHHHHHhcCC--CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcC
Q 024828           12 RRQIAQELKINQSSQ--CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL-HHEK   88 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l-h~~~   88 (262)
                      +.-..+|++.|+++.  .-++++++++    ...++||||+.+..+....-+...++......+..+++.+|..+ |. .
T Consensus        70 ~~wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~-~  144 (197)
T cd05146          70 RMWAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE-C  144 (197)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh-C
Confidence            334558999999994  3456666654    45789999997654432222223456667778889999999988 87 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEeccccccc
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                      |++|||+++.||++. ++.+.++|||.+...
T Consensus       145 glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         145 NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999999999995 578999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=1.1e-11  Score=91.23  Aligned_cols=100  Identities=25%  Similarity=0.339  Sum_probs=82.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      -.+.+-.+|++++.+++--+|.-..=+..+.....++|||++|..|.+.+...       ...++..+-.-+.-||. .|
T Consensus        41 lrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~-~g  112 (204)
T COG3642          41 LRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK-AG  112 (204)
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHh-cC
Confidence            34567789999999997667766666666777788999999999999998874       25667777788889998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      |+|||+.++||+++. +.+.++|||++..
T Consensus       113 ivHGDLTtsNiIl~~-~~i~~IDfGLg~~  140 (204)
T COG3642         113 IVHGDLTTSNIILSG-GRIYFIDFGLGEF  140 (204)
T ss_pred             eecCCCccceEEEeC-CcEEEEECCcccc
Confidence            999999999999954 4499999999753

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=9.4e-11  Score=86.07  Aligned_cols=109  Identities=26%  Similarity=0.399  Sum_probs=88.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCC-CCHHHHHHhcC-C-CCHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG-GSLADFLKKVK-T-IPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~-~-~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .-.+++..+|+++|.++.--+|.-..-++.|...-+++|||++| .++.+++.... . ...+.....+.++-+.+.-||
T Consensus        51 kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH  130 (229)
T KOG3087|consen   51 KLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH  130 (229)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh
Confidence            34677889999999999777777777777777778899999977 57888887653 2 233333788999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCC---cEEEEecccccc
Q 024828           86 HEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAI  118 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~  118 (262)
                      . .+++||||..+||++.+++   .+.++|||++..
T Consensus       131 ~-ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  131 D-NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             h-CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9 9999999999999997665   358999999764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.20  E-value=6.8e-11  Score=90.02  Aligned_cols=93  Identities=22%  Similarity=0.274  Sum_probs=69.2

Q ss_pred             HHHHHHHhcCCCCe--eEeeceEEEECCeEEEEEeecCCCC-----HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           16 AQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGGS-----LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        16 ~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~s-----L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ..|.+.+.++.+.+  ++++++.    ...+++|||++|++     |.+...     . .....++.+++.++.++|.+.
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-----~-~~~~~~~~~~~~~l~~lh~~~  134 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-----L-EDPEELYDQILELMRKLYREA  134 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhh-----c-ccHHHHHHHHHHHHHHHhhcc
Confidence            45666666664332  3444432    23689999999843     333221     1 667889999999999999768


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEeccccccc
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                      |++|+|++|+||+++ ++.++++|||.+...
T Consensus       135 ~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         135 GLVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            999999999999998 889999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.17  E-value=2.8e-10  Score=93.60  Aligned_cols=200  Identities=15%  Similarity=0.237  Sum_probs=134.0

Q ss_pred             EEEEEeecCCC-CHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEeccc
Q 024828           43 ISIILEYMDGG-SLADFLK------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  115 (262)
Q Consensus        43 ~~lv~e~~~~~-sL~~~l~------~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~  115 (262)
                      .-++|+.+.|. .+..+.+      .............+..++.+.+.||. .|..-||++++|+++++++.+.|.|-+.
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCceEEEEcccc
Confidence            67888887663 2333332      11336788889999999999999998 9999999999999999999999998653


Q ss_pred             ccccccCCCCcccccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCccCc----hh-----h
Q 024828          116 SAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDG----WT-----S  180 (262)
Q Consensus       116 ~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~----~~-----~  180 (262)
                      . .+...+......+|...|+|||.-.     +..-+...|.|.||+++++++.| ++||.+......    .+     .
T Consensus       164 f-qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         164 F-QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             e-eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            2 2233444445568899999999754     34457789999999999998875 999975221110    00     0


Q ss_pred             HHHHHHHHhcCC---CCCCCCCCCCHHHHHHHHHhhcC--CcCCCCCHHHHhcCccccccCCcccchhhHhhhh
Q 024828          181 FYELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQK--EPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  249 (262)
Q Consensus       181 ~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~--~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~~~~~~  249 (262)
                      .+.....-..+.   +-..+..-+++++..|..+|+..  ++.-|||++.     |....++..-++.++..+.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a-----W~aAl~al~~~L~~C~v~a  311 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA-----WVAALDALRQQLKKCTVSA  311 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH-----HHHHHHHHHHhhhhhhhcc
Confidence            001111111111   11223346789999999999874  3678999864     4455555555555554444

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.13  E-value=6.3e-11  Score=88.71  Aligned_cols=94  Identities=20%  Similarity=0.191  Sum_probs=69.8

Q ss_pred             HHHHHHHHHHHhcCCCCee-EeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-
Q 024828           12 RRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-   89 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-   89 (262)
                      ...+.+|+.+++.+.+.++ ++++...  ....++||||++|.++...     .   ......+.+++.+|+.||+ .+ 
T Consensus        36 ~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~-~~~  104 (170)
T cd05151          36 LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE-----D---FSDPENLEKIAKLLKKLHS-SPL  104 (170)
T ss_pred             ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc-----c---ccCHHHHHHHHHHHHHHhC-CCC
Confidence            3456788999988854443 4454443  3345799999999887643     1   1123456789999999998 77 


Q ss_pred             ----eeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           90 ----IIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        90 ----i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                          ++|+|++|.||+++ ++.++++||+.+.
T Consensus       105 ~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151         105 PDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence                49999999999998 6789999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.12  E-value=2.6e-10  Score=97.67  Aligned_cols=102  Identities=21%  Similarity=0.299  Sum_probs=71.8

Q ss_pred             HHHHHHHHhcC-----CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHhhc
Q 024828           15 IAQELKINQSS-----QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLK-GLLYLHHE   87 (262)
Q Consensus        15 ~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~-~l~~lh~~   87 (262)
                      +.+|.+.+.++     +++++.-..-+....+..++||||++|.+|.++.... ...+   ...++.+++. .+..+|. 
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~-  275 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR-  275 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh-
Confidence            44555555554     2444433322233345579999999999998876532 1222   3456666665 4788898 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  120 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~  120 (262)
                      .|++|+|++|.||+++.++.++++|||++....
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=7.2e-10  Score=88.57  Aligned_cols=103  Identities=16%  Similarity=0.072  Sum_probs=79.7

Q ss_pred             HHHHHHHHHhcCCCCeeE--eeceEEEE-----CCeEEEEEeecCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Q 024828           14 QIAQELKINQSSQCPYVV--VCYQSFYS-----NGAISIILEYMDGG-SLADFLKK--VKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~~~~~lv~e~~~~~-sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      .+.+|.+.+.++...+|.  .++.+...     ...-++|||++++. +|.+++..  ..+.+......++.+++..+..
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            477899988888433333  33444433     22478999999885 79999864  2456677788999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEcc-------CCcEEEEeccccc
Q 024828           84 LHHEKHIIHRDLKPSNLLINH-------RGEVKITDFGVSA  117 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~-------~~~~~l~df~~~~  117 (262)
                      ||. .|++|+|++++||+++.       +..+.++||+.+.
T Consensus       154 LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        154 MHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            998 99999999999999975       3579999999764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=8.7e-10  Score=85.19  Aligned_cols=106  Identities=19%  Similarity=0.181  Sum_probs=83.5

Q ss_pred             HHHHHHHHHHHHhcCCCCe--eEeeceEEEEC----CeEEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQCPY--VVVCYQSFYSN----GAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      .+.++.+|.+.+..+..-+  +++++.+....    ...++|+|++++ .+|.+++......+......++.+++..++.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            3456778888877774322  33444444431    235899999987 4899999876667788889999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCC---cEEEEeccccc
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSA  117 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~  117 (262)
                      ||. .|++|+|+++.|||++.++   .+.++||+-+.
T Consensus       134 lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  134 LHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            998 9999999999999998887   79999998654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=9.6e-11  Score=99.79  Aligned_cols=203  Identities=24%  Similarity=0.217  Sum_probs=147.5

Q ss_pred             HHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           14 QIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        14 ~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      .-..|+.+...+ .|.+++.+...|...++.|+--|||+++++...+.-...+.+..++.+..|++.++.++|+ ..++|
T Consensus       311 ~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~  389 (524)
T KOG0601|consen  311 FSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS-KLFVH  389 (524)
T ss_pred             cchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc-hhhhc
Confidence            344666666666 5889999888888888888999999999988777544568888899999999999999998 99999


Q ss_pred             CCCCCCCEEEccC-CcEEEEecccccccccCCCCccccccccccc--CcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           93 RDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYM--SPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        93 ~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~--~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      .|++|.||++..+ +.-.++||+.........   ......-++.  ++.......+..+.|+++||..+.+..++...-
T Consensus       390 ~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  390 LDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ccccccceeeccchhhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence            9999999999876 667889998876532211   1112223333  344444445788999999999999999875443


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ......          ..+..+..+.  ......++..+.+.+..+++..||.+.++..|.=|
T Consensus       467 ~~~~~~----------~~i~~~~~p~--~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  467 ESGVQS----------LTIRSGDTPN--LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             cccccc----------eeeecccccC--CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            322211          1111121111  12334778899999999999999999999877544

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=1.4e-09  Score=82.16  Aligned_cols=104  Identities=24%  Similarity=0.315  Sum_probs=69.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCC--eeEeeceEEEECCeEEEEEeecC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCP--YVVVCYQSFYSNGAISIILEYMD--GGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ....+....+|.+.|.++...  ++++++++.    ..++||||++  |..+..+...  .++......++.+++..+..
T Consensus        48 ~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~  121 (188)
T PF01163_consen   48 RYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIK  121 (188)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHH
Confidence            445567888999999999765  466666442    2469999998  6555544332  11234566777788875555


Q ss_pred             -HhhcCCeeeCCCCCCCEEEccCCcEEEEeccccccc
Q 024828           84 -LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        84 -lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                       +|. .|++|||+++.||+++.+ .+.++|||.+...
T Consensus       122 ~~~~-~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  122 MLHK-AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             HHHC-TTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             HHHh-cCceecCCChhhEEeecc-eEEEEecCcceec
Confidence             577 999999999999999766 8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.88  E-value=1.6e-09  Score=94.20  Aligned_cols=73  Identities=18%  Similarity=0.347  Sum_probs=52.9

Q ss_pred             CCeEEEEEeecCCCCHHHHH--HhcC----CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCC----cEE
Q 024828           40 NGAISIILEYMDGGSLADFL--KKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVK  109 (262)
Q Consensus        40 ~~~~~lv~e~~~~~sL~~~l--~~~~----~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~----~~~  109 (262)
                      .+..++||||+.|+++.++-  ...+    .+....+..++.|       +.. .|++|+|+||.||+++.++    ++.
T Consensus       233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~-~GffHaDpHPGNIlv~~~g~~~~~i~  304 (537)
T PRK04750        233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFR-DGFFHADMHPGNIFVSYDPPENPRYI  304 (537)
T ss_pred             CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHh-CCeeeCCCChHHeEEecCCCCCCeEE
Confidence            45578999999999998753  3322    1222233333333       345 8999999999999999888    899


Q ss_pred             EEecccccccc
Q 024828          110 ITDFGVSAIMA  120 (262)
Q Consensus       110 l~df~~~~~~~  120 (262)
                      ++|||++....
T Consensus       305 llDFGivg~l~  315 (537)
T PRK04750        305 ALDFGIVGSLN  315 (537)
T ss_pred             EEecceEEECC
Confidence            99999986653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.86  E-value=8.4e-08  Score=81.15  Aligned_cols=181  Identities=18%  Similarity=0.264  Sum_probs=127.9

Q ss_pred             HHHHHHHHhcCCCCeeEeeceEEEE----CCeEEEEEeecCC-CCHHHHHH---------------hcCCCCHHHHHHHH
Q 024828           15 IAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDG-GSLADFLK---------------KVKTIPEEYLAAIC   74 (262)
Q Consensus        15 ~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~sL~~~l~---------------~~~~~~~~~~~~i~   74 (262)
                      ...-+++++++.|+|||++.++|..    +..+++|++|.++ ++|.++-=               .+...++..++.++
T Consensus       320 ~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~  399 (655)
T KOG3741|consen  320 DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYI  399 (655)
T ss_pred             chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHH
Confidence            3455788999999999999999873    4569999999774 46665541               11347889999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHH
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      .|+..||.++|+ .|+.-.-|.|.+|++..+.++++..-|.........            .  +-+.   --.+.|.=.
T Consensus       400 ~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------------~--~~le---~~Qq~D~~~  461 (655)
T KOG3741|consen  400 SQLTAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------------T--EPLE---SQQQNDLRD  461 (655)
T ss_pred             HHHHHHHHHHHh-cCceeecccHhHeEeeCcceEEEecccceeeecCCC------------C--cchh---HHhhhhHHH
Confidence            999999999999 999999999999999877788887766544332111            0  1111   123678999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHH-HHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYEL-MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||.+++.|.+|..--...+.      ..+. .+.+         ...++.++++++.-....++++ -++.+++.+
T Consensus       462 lG~ll~aLAt~~~ns~~~d~------~~~s~~~~I---------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  462 LGLLLLALATGTENSNRTDS------TQSSHLTRI---------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHhhcccccccccc------hHHHHHHHh---------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            99999999998532111110      0111 1111         2467888999999888888876 677777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=9.8e-09  Score=80.28  Aligned_cols=100  Identities=19%  Similarity=0.258  Sum_probs=78.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCC--eeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCP--YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .-.+..+.+|.++|.++...  .|++.++.    +..++|||+++|..|...-     ++......++..|+.-+..+-.
T Consensus       150 ~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~  220 (304)
T COG0478         150 YVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYR  220 (304)
T ss_pred             hhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHH
Confidence            44677889999999999654  77777764    3468999999997776542     2345566667777777666666


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                       .|++|||+++.||+++.+|.+.++||..+..
T Consensus       221 -~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         221 -RGIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             -cCccccCCchheEEEecCCCEEEEeCccccc
Confidence             9999999999999999999999999976543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.81  E-value=8.1e-09  Score=80.64  Aligned_cols=106  Identities=20%  Similarity=0.271  Sum_probs=77.6

Q ss_pred             HHHHHHHHHHHHhcCCC--CeeEeeceEEEEC---CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828           11 ARRQIAQELKINQSSQC--PYVVVCYQSFYSN---GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ...++.+|.++++.+.+  ..+++++.+....   +..++||||++|.++.+.+.. ..++......++.+++.+|..||
T Consensus        38 ~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH  116 (223)
T cd05154          38 SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALH  116 (223)
T ss_pred             ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHh
Confidence            35678899999999965  3456666666553   367899999999888765432 34566666666677777776666


Q ss_pred             h-------------------------------------------------------cCCeeeCCCCCCCEEEcc--CCcE
Q 024828           86 H-------------------------------------------------------EKHIIHRDLKPSNLLINH--RGEV  108 (262)
Q Consensus        86 ~-------------------------------------------------------~~~i~H~dl~p~nil~~~--~~~~  108 (262)
                      +                                                       ...++|+|+++.||+++.  ++.+
T Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~  196 (223)
T cd05154         117 SVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVV  196 (223)
T ss_pred             CCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEE
Confidence            3                                                       134699999999999988  5668


Q ss_pred             EEEeccccc
Q 024828          109 KITDFGVSA  117 (262)
Q Consensus       109 ~l~df~~~~  117 (262)
                      .++||+.+.
T Consensus       197 ~iID~e~~~  205 (223)
T cd05154         197 AVLDWELAT  205 (223)
T ss_pred             EEEeccccc
Confidence            999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK09902 hypothetical protein; Provisional

Probab=98.77  E-value=5.6e-08  Score=74.10  Aligned_cols=105  Identities=17%  Similarity=0.142  Sum_probs=81.7

Q ss_pred             HHHHHHHHHHHHhcCCCCe--eEeeceEEEE---C--CeEEEEEeecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQCPY--VVVCYQSFYS---N--GAISIILEYMDG-GSLADFLKKV--KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~---~--~~~~lv~e~~~~-~sL~~~l~~~--~~~~~~~~~~i~~~l~~~   80 (262)
                      .+..+.+|...++++..-+  ++++. ++..   +  -..+||+|-+.| .+|.+++.+.  .+.+......++.+++.+
T Consensus        62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~  140 (216)
T PRK09902         62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA  140 (216)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence            5678899999999884322  44554 2221   1  136799997752 6899998763  356888889999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCc--EEEEeccccc
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSA  117 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~--~~l~df~~~~  117 (262)
                      ++.||+ .|+.|+|+.+.||+++.+|.  +.++||.-+.
T Consensus       141 ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        141 FKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             HHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            999999 99999999999999986777  9999997554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.70  E-value=1.7e-07  Score=86.11  Aligned_cols=212  Identities=23%  Similarity=0.304  Sum_probs=145.6

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEECCe----EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYSNGA----ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .....|+..+..+.|+|++.++.+-.....    ..+..++|...++...++.-+..+.+..+.+..++.++++++|+ .
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~-~  305 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS-L  305 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH-h
Confidence            344566777788899999999887654322    23556789999999999998999999999999999999999998 6


Q ss_pred             CeeeCCCCCC---CEEEccCCcEEEE--ecccccccccCCCCcccccccccccCcccccCCC--CCcchhHHHHHHHHHH
Q 024828           89 HIIHRDLKPS---NLLINHRGEVKIT--DFGVSAIMASTSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLE  161 (262)
Q Consensus        89 ~i~H~dl~p~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~  161 (262)
                      ...|.-+...   +.-.+..+.+...  ||+.+......... .....+..+.++|......  .+...|+|++|.+...
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            5544444443   2233344445555  77766554433222 2223455567777766554  3455799999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~  241 (262)
                      +..|..+-....          ....+.        .........+.+.+|+.-++++|+++.+++.|+|.+.......+
T Consensus       385 ~~~~~~i~~~~~----------~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~~  446 (1351)
T KOG1035|consen  385 LSQGEDISEKSA----------VPVSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNESS  446 (1351)
T ss_pred             hhhcCccccccc----------chhhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccccccc
Confidence            988754432211          111111        11122267889999999999999999999999999887776664


Q ss_pred             hhh
Q 024828          242 LSE  244 (262)
Q Consensus       242 ~~~  244 (262)
                      ...
T Consensus       447 ~~~  449 (1351)
T KOG1035|consen  447 EFA  449 (1351)
T ss_pred             ccc
Confidence            433

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.56  E-value=2.2e-07  Score=71.13  Aligned_cols=66  Identities=26%  Similarity=0.527  Sum_probs=51.9

Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccc
Q 024828           41 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  116 (262)
Q Consensus        41 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~  116 (262)
                      ...+++|||++|..|.+...    +++    .+...+..++..+|+ .|++|||.+|.|+++++ +.++++|++..
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~-~~i~iID~~~k  181 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSN-NGIRIIDTQGK  181 (229)
T ss_pred             eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEEC-CcEEEEECccc
Confidence            34678999999988876532    222    345667788999999 99999999999999975 55999999753

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=2.8e-06  Score=66.58  Aligned_cols=106  Identities=13%  Similarity=0.208  Sum_probs=63.6

Q ss_pred             HHHHHHHHHHHHhcCCCCe--eEeeceEEEECCeEEEEEeecCCCC-HH--------------HHHH-------hc--CC
Q 024828           11 ARRQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGGS-LA--------------DFLK-------KV--KT   64 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~s-L~--------------~~l~-------~~--~~   64 (262)
                      ....+.+|.++++.+...+  +++.+.+..+++...+|||+++|.+ +.              ..+-       ..  ..
T Consensus        35 ~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~  114 (226)
T TIGR02172        35 DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT  114 (226)
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence            3456789999998885433  4677788777778889999999963 11              1110       00  01


Q ss_pred             CCHHHHHHHHH-----------HHHH-HHHHHh---hcCCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           65 IPEEYLAAICE-----------QVLK-GLLYLH---HEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        65 ~~~~~~~~i~~-----------~l~~-~l~~lh---~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .+......-..           .+.. ...+|.   ....++|+|++|.||+++.++ +.++||+.+.
T Consensus       115 ~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       115 STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            11111111000           0111 111121   134578999999999998877 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.25  E-value=4.7e-06  Score=66.20  Aligned_cols=47  Identities=11%  Similarity=-0.032  Sum_probs=35.5

Q ss_pred             HHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHH
Q 024828           12 RRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADF   58 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~   58 (262)
                      ..++.+|+++++.+. +--+++++.....++..++||++++|.++...
T Consensus        35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            345678888888773 45566788877776778999999999887644

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.23  E-value=3.2e-06  Score=65.68  Aligned_cols=99  Identities=19%  Similarity=0.199  Sum_probs=68.4

Q ss_pred             HHHHHHHhcCC--CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeC
Q 024828           16 AQELKINQSSQ--CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR   93 (262)
Q Consensus        16 ~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~   93 (262)
                      .+|..-|+++.  +-.+++.+.+..    -.|||||+......--.-+.-++.......+..+++..+.-|-...|++|+
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHg  191 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHG  191 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccc
Confidence            46666677773  445556665544    679999995431111111111233335777888888888888766899999


Q ss_pred             CCCCCCEEEccCCcEEEEeccccccc
Q 024828           94 DLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        94 dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                      ||+..|||+. ++.+.++|++.+...
T Consensus       192 DLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         192 DLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             cchhhheEEE-CCeEEEEECcccccc
Confidence            9999999997 889999999987654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.18  E-value=1.1e-05  Score=61.29  Aligned_cols=100  Identities=26%  Similarity=0.217  Sum_probs=77.5

Q ss_pred             HHHHHHHhcCCC-CeeEeeceEEEECCeEEEEEeecCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhh--cCC
Q 024828           16 AQELKINQSSQC-PYVVVCYQSFYSNGAISIILEYMDGGSLADF---LKKVKTIPEEYLAAICEQVLKGLLYLHH--EKH   89 (262)
Q Consensus        16 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~~~~~~~~~i~~~l~~~l~~lh~--~~~   89 (262)
                      .+|.-+++.+++ +++++++++|-    ..+++|+...+++...   +......++..+.+++.++++.+++++.  ...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            367888888865 69999999884    4578999976555321   1122345899999999999999999986  123


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEeccccccc
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                      +.-.|++++|+-+++++++++.|.+.....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            788899999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.14  E-value=6.2e-07  Score=77.89  Aligned_cols=205  Identities=21%  Similarity=0.196  Sum_probs=134.5

Q ss_pred             HHHHHHHHHhcCCCCe-eEeeceEEEECCeEEEEEeecCCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           14 QIAQELKINQSSQCPY-VVVCYQSFYSNGAISIILEYMDGG-SLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ...-++++|.+++||| .+...+.++.+...++.++++.++ +....... ...+..-+...+...-.++++++|+ ..-
T Consensus       279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~  357 (829)
T KOG0576|consen  279 SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYK  357 (829)
T ss_pred             hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccc-ccc
Confidence            3456888999999999 677777777788899999999775 22211110 0113333344455556778999997 444


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+|    ||+. .++..+.++|+......... ......+++.+++||....+.+..+.|.|++|.-..++--|-+|-.
T Consensus       358 ~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  358 VHRD----NILG-SEEEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCcc----cccc-cccccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            6776    7766 45778999998765543322 3456678999999999998889999999999987777766655543


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCC-----CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAP-----SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .+...-           ..-+..+..+     ...-+..-.++...|+..-|..|+....++.|-+|..|+
T Consensus       432 ~P~~~~-----------~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  432 SPPAVL-----------PMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             CCcccc-----------CCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            211000           0000000000     000001111477789999999999999999999999887

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.08  E-value=1.8e-05  Score=68.97  Aligned_cols=91  Identities=24%  Similarity=0.377  Sum_probs=63.1

Q ss_pred             CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEc
Q 024828           26 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN  103 (262)
Q Consensus        26 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~  103 (262)
                      +.+++.-..=+++-.+.-+++|||++|..+.+..  +. ...+...+...+.++.  +..+-. .|++|.|.+|.||+++
T Consensus       224 ~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~-dgffHaDpHpGNi~v~  299 (517)
T COG0661         224 DDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLR-DGFFHADPHPGNILVR  299 (517)
T ss_pred             CCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHh-cCccccCCCccceEEe
Confidence            3555554444445456788999999999998884  33 4455333333222221  233333 7899999999999999


Q ss_pred             cCCcEEEEecccccccc
Q 024828          104 HRGEVKITDFGVSAIMA  120 (262)
Q Consensus       104 ~~~~~~l~df~~~~~~~  120 (262)
                      .+|++.+.|||+.....
T Consensus       300 ~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         300 SDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cCCcEEEEcCcceecCC
Confidence            99999999999876553

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.99  E-value=1.9e-05  Score=62.34  Aligned_cols=30  Identities=33%  Similarity=0.522  Sum_probs=24.8

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .+++|+|+++.||+++.++..-++||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            458999999999999765555799999754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.84  E-value=0.00013  Score=57.22  Aligned_cols=55  Identities=18%  Similarity=0.183  Sum_probs=37.3

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCC--eeEeeceEE---EECCeEEEEEeecCCCCHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCP--YVVVCYQSF---YSNGAISIILEYMDGGSLAD   57 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~~~~sL~~   57 (262)
                      .|..........+.+|..+++.+...  .+++++...   ......+++|++++|..+..
T Consensus        25 lK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   25 LKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             EEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             EEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            44444446778888999998888422  356666543   33456899999999988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.84  E-value=7.4e-06  Score=77.92  Aligned_cols=214  Identities=12%  Similarity=-0.013  Sum_probs=142.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHh
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ++-...|.+-++...|+++.....-..+  ....+..++++.+|.+.+.+-++    .++...-+....++.+.+..-+|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            3344455555566688888866654432  34578999999999999999765    22344334444444355555555


Q ss_pred             hcCC----eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           86 HEKH----IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        86 ~~~~----i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      +..|    -+|.++++-|.++..+..++++++|+.+.............+++.|+.|++...-.++.++|+|..|+.+|.
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence            5233    478899999999999999999999998733322222333466778888998887788888999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      ...|..+|..        ..+...+........-..+...|.+.......+|-+.-..||.-...+..+.|-
T Consensus      1433 rs~~n~~fi~--------flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1433 RSDGNAYFIF--------FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HhcccHHHHH--------HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            9887766531        111222222222222222234456666677777777788899999888888773

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.79  E-value=0.00013  Score=63.60  Aligned_cols=85  Identities=21%  Similarity=0.390  Sum_probs=56.0

Q ss_pred             eEeeceEEEECCeEEEEEeecCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEcc---
Q 024828           30 VVVCYQSFYSNGAISIILEYMDGGSLADF--LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---  104 (262)
Q Consensus        30 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~---  104 (262)
                      |++++-.+  ....+|+|||++|..+.+.  +.+ .+.+...+..-+.+...-  .+=. .|++|+|-+|.||++..   
T Consensus       266 VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~--qIf~-~GffHaDPHPGNilv~~~~~  339 (538)
T KOG1235|consen  266 VPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLE--QIFK-TGFFHADPHPGNILVRPNPE  339 (538)
T ss_pred             CCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHH--HHHh-cCCccCCCCCCcEEEecCCC
Confidence            55554433  3568899999999877644  344 334544444333333222  2222 78999999999999984   


Q ss_pred             -CCcEEEEecccccccc
Q 024828          105 -RGEVKITDFGVSAIMA  120 (262)
Q Consensus       105 -~~~~~l~df~~~~~~~  120 (262)
                       ++.+.+.|||+.....
T Consensus       340 ~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  340 GDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CCccEEEEccccccccc
Confidence             5579999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.77  E-value=0.00042  Score=52.97  Aligned_cols=96  Identities=25%  Similarity=0.397  Sum_probs=68.8

Q ss_pred             HHHHHHHHHHHHhcCC------CCeeEeeceEEEECCeEEEEEeecC------CCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQ------CPYVVVCYQSFYSNGAISIILEYMD------GGSLADFLKKVKTIPEEYLAAICEQVL   78 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~------~~sL~~~l~~~~~~~~~~~~~i~~~l~   78 (262)
                      ..++..+|++-..++.      +.+|.+++++.+.+....+|+|.+.      ..+|.+++.+ +.++. .....+.   
T Consensus        54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---  128 (199)
T PF10707_consen   54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---  128 (199)
T ss_pred             hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---
Confidence            3455566666555554      8999999999999988999999765      3578888855 44555 3344444   


Q ss_pred             HHHHHHhhcCCeeeCCCCCCCEEEccCC----cEEEEe
Q 024828           79 KGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITD  112 (262)
Q Consensus        79 ~~l~~lh~~~~i~H~dl~p~nil~~~~~----~~~l~d  112 (262)
                      +-..+|-. .+|+..|++|+||++...+    .+.++|
T Consensus       129 ~f~~~l~~-~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  129 EFKRYLLD-HHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             HHHHHHHH-cCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            44556665 8899999999999996443    467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.58  E-value=0.00042  Score=64.66  Aligned_cols=43  Identities=19%  Similarity=0.282  Sum_probs=33.0

Q ss_pred             HHHHHHHHHHHhcCC-CCee--EeeceEEEEC---CeEEEEEeecCCCC
Q 024828           12 RRQIAQELKINQSSQ-CPYV--VVCYQSFYSN---GAISIILEYMDGGS   54 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~s   54 (262)
                      ...+.+|.++++.+. |+++  ++++.++.+.   +..|+||||++|..
T Consensus        82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            457889999999995 6665  6777776653   46789999999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.36  E-value=0.00048  Score=56.96  Aligned_cols=100  Identities=17%  Similarity=0.200  Sum_probs=73.2

Q ss_pred             HHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCC
Q 024828           16 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL   95 (262)
Q Consensus        16 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl   95 (262)
                      ..|++-|.+++..+|+-.--+..  ...+|||+|+.+..-....-+.-.++...+..+-++++.-+..|-+.++++|.||
T Consensus       214 EKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADL  291 (520)
T KOG2270|consen  214 EKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADL  291 (520)
T ss_pred             HHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccch
Confidence            35666677776666654433333  3467999999543333333333457777888888899998888877799999999


Q ss_pred             CCCCEEEccCCcEEEEecccccc
Q 024828           96 KPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        96 ~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      +--|+|+ .+|.+.++|.+.+..
T Consensus       292 SEfN~Ly-hdG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  292 SEFNLLY-HDGKLYIIDVSQSVE  313 (520)
T ss_pred             hhhhheE-ECCEEEEEEcccccc
Confidence            9999999 789999999987653

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.36  E-value=0.00067  Score=58.42  Aligned_cols=166  Identities=21%  Similarity=0.230  Sum_probs=100.7

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      .++..-..+++.+.|++...++++-.. .....+|+|++ +.||.+++..+. +......              . .|+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~-~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------A-HGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------c-cccc
Confidence            456677788899999999988887654 23478899999 559999988754 3222211              1 2222


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      |.     |++.       ..| .+...      . ..                ...+++|||++|.++.+++-|...+..
T Consensus        90 ~~-----~~~~-------~td-~~~t~------~-~~----------------~~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   90 HL-----NIIY-------ITD-HFLTK------Y-PS----------------PIGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             ee-----hhhh-------ccc-ccccc------C-CC----------------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            22     1221       222 11100      0 00                112499999999999999988766654


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCC-------CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSA-------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      ....    +..+.+.+.........       .-...+.-+.++..+|+...|..||...++.+++-|.+.
T Consensus       134 ~~~s----~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  134 LTES----EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHH----HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            3321    11122222111110000       001345567889999999999999999999999988766

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.15  E-value=0.0035  Score=51.95  Aligned_cols=104  Identities=21%  Similarity=0.250  Sum_probs=72.5

Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEeccccccc
Q 024828           40 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  119 (262)
Q Consensus        40 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~  119 (262)
                      +.+.|++|++. |++|...    +.-..++...++.+.+..++-+...-.+-|+++...||+++ +|++.|+||-+++.-
T Consensus       298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            44678888887 5566532    23456788899999888888887766788999999999998 999999999988743


Q ss_pred             ccCCCCcccccccccccCcccccCCCCCcchhHHHH
Q 024828          120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus       120 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      ...+...     ....--|-.+.|.. +..-+||-+
T Consensus       372 ~~q~~is-----y~rldhp~lF~G~d-d~QFeIYrl  401 (488)
T COG5072         372 YSQGIIS-----YNRLDHPDLFNGVD-DYQFEIYRL  401 (488)
T ss_pred             cCCceee-----ccccCchhhhcCcc-ceeeeHHHH
Confidence            3222211     11233455555433 566677763

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.12  E-value=0.00055  Score=55.72  Aligned_cols=96  Identities=16%  Similarity=0.227  Sum_probs=69.2

Q ss_pred             HHHHHHHHHHHhcCCC--CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           12 RRQIAQELKINQSSQC--PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      +-.+.+|...++.+..  --|++.++.    ...|+|||++.|..|...-+-      ...-.+...++..+-.|.. .|
T Consensus       154 Rlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~-~G  222 (465)
T KOG2268|consen  154 RLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLAN-HG  222 (465)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHH-cC
Confidence            4456778888888843  344555543    347899999999887754322      1233455556666667776 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      ++|+|++--||++.+++.+.++||.....
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhhc
Confidence            99999999999999999999999975543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.07  E-value=0.0015  Score=48.46  Aligned_cols=103  Identities=26%  Similarity=0.286  Sum_probs=71.3

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCCCeeE-eeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQCPYVV-VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~   80 (262)
                      +.|+-..++-+..+..|+++|..+.--++. +++.+..    .++.|||+.|.+|.++....   +    .+-+..+++.
T Consensus        49 a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~  117 (201)
T COG2112          49 ALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEK  117 (201)
T ss_pred             EEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHH
Confidence            456666788899999999999999766554 3333333    23459999998888765431   2    2333445555


Q ss_pred             HHHHhhcCCeeeCCCC-CC-CEEEccCCcEEEEeccccc
Q 024828           81 LLYLHHEKHIIHRDLK-PS-NLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~-p~-nil~~~~~~~~l~df~~~~  117 (262)
                      .--|.. .||-|+.++ |. ||++ .++.+.++||..|+
T Consensus       118 a~~LD~-~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At  154 (201)
T COG2112         118 AYKLDR-LGIEHGELSRPWKNVLV-NDRDVYIIDFDSAT  154 (201)
T ss_pred             HHHHHH-hccchhhhcCCceeEEe-cCCcEEEEEccchh
Confidence            555665 999999987 44 5555 55599999999776

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.96  E-value=0.0031  Score=51.58  Aligned_cols=30  Identities=27%  Similarity=0.402  Sum_probs=26.1

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .+++|+|++|.||+++.++.+.++||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            579999999999999887667899998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.50  E-value=0.0089  Score=48.40  Aligned_cols=30  Identities=23%  Similarity=0.541  Sum_probs=24.7

Q ss_pred             CCeeeCCCCCCCEEEccCCc-EEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGE-VKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~-~~l~df~~~~  117 (262)
                      ..++|+|+++.||++++++. .-++||+.+.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            34899999999999987565 4699999764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.47  E-value=0.019  Score=47.20  Aligned_cols=30  Identities=23%  Similarity=0.578  Sum_probs=26.9

Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      .++|||+++.|++++.++.+-++||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            379999999999999988899999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.16  E-value=0.011  Score=46.58  Aligned_cols=30  Identities=27%  Similarity=0.470  Sum_probs=26.1

Q ss_pred             CCeeeCCCCCCCEEEcc-CCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINH-RGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~-~~~~~l~df~~~~  117 (262)
                      .+++|+|+++.||+++. ++.+.++||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            46999999999999987 4789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.75  E-value=0.028  Score=46.13  Aligned_cols=30  Identities=23%  Similarity=0.420  Sum_probs=26.2

Q ss_pred             CCeeeCCCCCCCEEEccC----CcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHR----GEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~----~~~~l~df~~~~  117 (262)
                      .+++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            568999999999999874    789999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.58  E-value=0.029  Score=45.24  Aligned_cols=50  Identities=22%  Similarity=0.379  Sum_probs=38.3

Q ss_pred             HHHHHHHHHHHHHHHHHhhc-CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           68 EYLAAICEQVLKGLLYLHHE-KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        68 ~~~~~i~~~l~~~l~~lh~~-~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      ......+..+-.++.-.+.+ .-++|+|+.|+|++.++.+.+.|+||..|.
T Consensus       132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            33444555566666667653 358999999999999988999999998764

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.54  E-value=0.12  Score=42.62  Aligned_cols=84  Identities=25%  Similarity=0.305  Sum_probs=64.9

Q ss_pred             CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccC
Q 024828           26 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  105 (262)
Q Consensus        26 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~  105 (262)
                      ..|.+|++.       ..+|||.|+...-+.--.-+.-.++..++...-.|+..++..|..++-++|.|++-.|+|+.. 
T Consensus       348 pcP~vV~lk-------khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~-  419 (531)
T KOG2269|consen  348 PCPQVVKLK-------KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTP-  419 (531)
T ss_pred             CCCceeeee-------cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecC-
Confidence            577777664       367899998654444333333458889999999999999999877799999999999999964 


Q ss_pred             CcEEEEeccccc
Q 024828          106 GEVKITDFGVSA  117 (262)
Q Consensus       106 ~~~~l~df~~~~  117 (262)
                      |.+-++|...+.
T Consensus       420 gKvw~IDVsQsv  431 (531)
T KOG2269|consen  420 GKVWVIDVSQSV  431 (531)
T ss_pred             CceEEEechhcc
Confidence            589999987654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.50  E-value=0.051  Score=42.18  Aligned_cols=84  Identities=19%  Similarity=0.246  Sum_probs=55.9

Q ss_pred             HHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeeC
Q 024828           15 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH-EKHIIHR   93 (262)
Q Consensus        15 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~-~~~i~H~   93 (262)
                      +.++.+++.++  .+|+++..-  .+-.+.++.|.|-..            .....-.+... +.+|.-.|+ +.+..||
T Consensus       105 y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~------------~i~~~N~i~ag-i~~L~~fH~~~~~~lHG  167 (308)
T PF07387_consen  105 YFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKI------------KINFSNFITAG-IKDLMDFHSENQHCLHG  167 (308)
T ss_pred             hhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCc------------ccchhHHHHHh-HHHHHHhhccCCCeecC
Confidence            45666666655  366776632  233477899998431            11111222222 456777884 5679999


Q ss_pred             CCCCCCEEEccCCcEEEEeccc
Q 024828           94 DLKPSNLLINHRGEVKITDFGV  115 (262)
Q Consensus        94 dl~p~nil~~~~~~~~l~df~~  115 (262)
                      |..|+||+-+..|.+||.|-+.
T Consensus       168 D~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  168 DCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             CCChhheeecCCCCEEecChhh
Confidence            9999999999999999999764

The function of this family is unknown.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.37  E-value=0.052  Score=44.63  Aligned_cols=29  Identities=28%  Similarity=0.501  Sum_probs=25.2

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .+++|||+++.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            67999999999999976 678999998643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.26  E-value=0.021  Score=44.17  Aligned_cols=30  Identities=47%  Similarity=0.763  Sum_probs=21.2

Q ss_pred             CCeeeCCCCCCCEEE-ccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLI-NHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~-~~~~~~~l~df~~~~  117 (262)
                      ..++|+|+.+.||++ +.++.++++||..+.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            458999999999999 788999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK05231 homoserine kinase; Provisional

Probab=95.26  E-value=0.048  Score=45.11  Aligned_cols=31  Identities=26%  Similarity=0.321  Sum_probs=25.8

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      .|++|+|++|.||+++.+...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            5899999999999997555558999997643

>PTZ00384 choline kinase; Provisional

Probab=95.21  E-value=0.094  Score=44.57  Aligned_cols=29  Identities=24%  Similarity=0.264  Sum_probs=24.2

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      ..++|.|+.+.||+.+ ++.+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence            4689999999999974 5569999998763

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.13  E-value=0.038  Score=45.49  Aligned_cols=31  Identities=29%  Similarity=0.490  Sum_probs=27.0

Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      ..+++|+|+++.||+++.++...++||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3789999999999999887767899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.11  E-value=0.021  Score=43.10  Aligned_cols=28  Identities=21%  Similarity=0.478  Sum_probs=24.4

Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      -.+|+|+.|.|+++++++ ++++||+.+.
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            469999999999997766 9999999864

>PRK10593 hypothetical protein; Provisional

Probab=94.72  E-value=0.056  Score=44.29  Aligned_cols=71  Identities=20%  Similarity=0.168  Sum_probs=50.7

Q ss_pred             HHHHHHHHHHHHhcCCC---CeeEeeceEEEE---CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQC---PYVVVCYQSFYS---NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ....+.+|...|+.+..   ..++++++.+.+   .+..++|||+++|.++.+.     ..+......+..+++.+|+.|
T Consensus        50 ~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~L  124 (297)
T PRK10593         50 TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAW  124 (297)
T ss_pred             cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHH
Confidence            34688999999988842   467888887754   3668999999999877641     123334556667777888888


Q ss_pred             hh
Q 024828           85 HH   86 (262)
Q Consensus        85 h~   86 (262)
                      |+
T Consensus       125 H~  126 (297)
T PRK10593        125 HR  126 (297)
T ss_pred             hC
Confidence            86

>TIGR02721 ycfN_thiK thiamine kinase

Probab=94.40  E-value=0.034  Score=44.41  Aligned_cols=28  Identities=25%  Similarity=0.539  Sum_probs=24.6

Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .++|+|+.|.||+++.++ +.++||..+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            589999999999998776 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.99  E-value=0.11  Score=42.84  Aligned_cols=30  Identities=17%  Similarity=0.274  Sum_probs=27.1

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .+++|+|+.++|++++.++.+.++||..++
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            479999999999999988899999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.87  E-value=0.14  Score=42.51  Aligned_cols=28  Identities=36%  Similarity=0.640  Sum_probs=25.0

Q ss_pred             eeeCCCCCCCEEEccCCc-EEEEeccccc
Q 024828           90 IIHRDLKPSNLLINHRGE-VKITDFGVSA  117 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~-~~l~df~~~~  117 (262)
                      ++|+|+.|.||+++.+.. .-++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999988875 8899999764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.74  E-value=0.31  Score=38.18  Aligned_cols=45  Identities=18%  Similarity=0.065  Sum_probs=34.8

Q ss_pred             HHHHHHHHHHHHhcC---CCCeeEeeceEEEECCeEEEEEeecCCCCH
Q 024828           11 ARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISIILEYMDGGSL   55 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL   55 (262)
                      ....+..|+.-|+.+   +.-.|++++....+.++.|+|+||++-+.+
T Consensus        51 ~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          51 QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            345666777766655   567788999999999999999999986554

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=93.48  E-value=0.25  Score=37.77  Aligned_cols=30  Identities=27%  Similarity=0.454  Sum_probs=24.8

Q ss_pred             CCeeeCCCCCCCEEEccCC-----cEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRG-----EVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~-----~~~l~df~~~~  117 (262)
                      ..++|||+.+.|+++..++     .+.++||..+.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            5689999999999997543     58999998653

subfamily of choline kinases

>PLN02236 choline kinase

Probab=93.26  E-value=0.17  Score=42.41  Aligned_cols=30  Identities=23%  Similarity=0.464  Sum_probs=25.6

Q ss_pred             CCeeeCCCCCCCEEEcc-CCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINH-RGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~-~~~~~l~df~~~~  117 (262)
                      ..++|+|+++.||++++ ++.+.++||.++.
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            46899999999999976 4679999998764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.12  E-value=0.35  Score=41.22  Aligned_cols=64  Identities=27%  Similarity=0.446  Sum_probs=46.6

Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccC
Q 024828           41 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  105 (262)
Q Consensus        41 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~  105 (262)
                      ....++=+|..|.++..+++. ...+++....++.-...|+-.+---.+++|.|++|.||++..+
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ccceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            346677788889999999876 3456666666666666665544333789999999999999543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=92.36  E-value=0.27  Score=40.83  Aligned_cols=28  Identities=21%  Similarity=0.304  Sum_probs=23.7

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .+++|+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            5789999999999995 4 57899999754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.02  E-value=0.28  Score=40.83  Aligned_cols=28  Identities=32%  Similarity=0.609  Sum_probs=24.6

Q ss_pred             eeeCCCCCCCEEEcc-CCcEEEEeccccc
Q 024828           90 IIHRDLKPSNLLINH-RGEVKITDFGVSA  117 (262)
Q Consensus        90 i~H~dl~p~nil~~~-~~~~~l~df~~~~  117 (262)
                      ++|+|+.+.||++++ ++.++++||..+.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999975 4689999998764

>PRK06148 hypothetical protein; Provisional

Probab=91.77  E-value=0.32  Score=46.85  Aligned_cols=31  Identities=26%  Similarity=0.549  Sum_probs=26.2

Q ss_pred             CCeeeCCCCCCCEEEccCC--cEE-EEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRG--EVK-ITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~--~~~-l~df~~~~~  118 (262)
                      .+++|+|+++.||+++.++  ++. ++|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            6799999999999998775  554 999998754

>COG4499 Predicted membrane protein [Function unknown]

Probab=91.74  E-value=2.5  Score=35.37  Aligned_cols=125  Identities=15%  Similarity=0.140  Sum_probs=75.3

Q ss_pred             HHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCC
Q 024828           17 QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK   96 (262)
Q Consensus        17 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~   96 (262)
                      .+..++.+ ..|+++.-+.  ++++.+.|-++-..  +...+-.- +.......+.++.+.+..|..+.  +.-.|-=++
T Consensus        40 ~~~~lld~-~~~f~~~eit--~~~Ds~vIsy~i~~--~~~~F~~~-k~~~k~~Klr~a~~~I~~l~e~~--~tr~~~~la  111 (434)
T COG4499          40 LLAELLDK-SPPFIVAEIT--EDNDSFVISYPIPE--AAKSFASA-KRKEKTRKLRLALQNIATLSELN--NTRYTFFLA  111 (434)
T ss_pred             HHHHHhcc-CCCccceeec--ccCceeEEEecCcc--ccchHHHH-HHHHHHHHHHHHHHHHHHHHHhh--ccceeEEec
Confidence            34555555 3445544332  33444555555432  22222211 23456667777888888887764  456788899


Q ss_pred             CCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           97 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        97 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      |+||+++.++.+.+.-+|+-...            +|.=+.||.+.          -.+-+++..++.|+.+|..
T Consensus       112 PeNilf~~~l~p~~vH~Glk~~l------------pPye~tee~f~----------~~ykA~~~~~fn~k~~Fe~  164 (434)
T COG4499         112 PENILFDGGLTPFFVHRGLKNSL------------PPYEMTEERFL----------KEYKALAIYAFNGKFSFES  164 (434)
T ss_pred             chheEEcCCCceEEEecchhccC------------CCCCCCHHHHH----------HHHHHHHHHHHcCCccHHH
Confidence            99999999999999999874322            11112233222          2566788888889888853

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=91.15  E-value=1.3  Score=34.02  Aligned_cols=85  Identities=22%  Similarity=0.272  Sum_probs=58.5

Q ss_pred             HHHHHHHHHHhcCC---CCee--EeeceEEEEC------------------CeEEEEEeecCCCCHHHHHHhcCCCCHHH
Q 024828           13 RQIAQELKINQSSQ---CPYV--VVCYQSFYSN------------------GAISIILEYMDGGSLADFLKKVKTIPEEY   69 (262)
Q Consensus        13 ~~~~~e~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~   69 (262)
                      .-|..|.+...+++   +-++  ++++++..-.                  ....||.||.+...         .++.  
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~--  167 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI--  167 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch--
Confidence            35778888777773   4455  8888876321                  12568888876633         2232  


Q ss_pred             HHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccc
Q 024828           70 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  116 (262)
Q Consensus        70 ~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~  116 (262)
                        .-+.+|.+-+..+|+ .||+-+|+++.|..   +  -+|+|||.+
T Consensus       168 --~~~~~~~~dl~~~~k-~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  168 --RDIPQMLRDLKILHK-LGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             --hHHHHHHHHHHHHHH-CCeeeccCcccccc---C--CEEEecccC
Confidence              334566777788999 99999999999987   2  478999753

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	262
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-60
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-59
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-58
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-56
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-56
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-56
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-56
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-56
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-56
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-55
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-43
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-43
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-40
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-39
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-39
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-37
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-36
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-36
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-36
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-35
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-35
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-35
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-35
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-35
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-34
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-34
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-34
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-33
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-33
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-33
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-33
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-31
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-31
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-31
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-31
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-31
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-30
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-30
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-30
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-30
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-30
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-30
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-29
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-29
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-29
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-27
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-27
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-27
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-27
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-27
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-27
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-27
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-25
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-25
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-25
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-25
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-25
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-25
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-25
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-25
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-25
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-24
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-24
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-24
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-24
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-24
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-24
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-24
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-24
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-24
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-24
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-24
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-23
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-23
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-23
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-23
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-23
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-23
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-23
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-23
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-23
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-23
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-23
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-23
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-23
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-23
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-23
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-23
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-23
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-23
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-23
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-23
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-23
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-22
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-22
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-22
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-22
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-22
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-22
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-22
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-22
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-22
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-22
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-22
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-22
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-22
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-22
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-22
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-22
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-22
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-22
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-22
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-22
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-22
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-22
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-22
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-22
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-22
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-22
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-22
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-22
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-22
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-22
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-22
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-22
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-22
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-22
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-22
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-21
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-21
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-21
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-21
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-21
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-21
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-21
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-21
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-21
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-21
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-21
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-21
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-21
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-21
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-21
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-21
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-21
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-21
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-21
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-21
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-20
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-20
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-20
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-20
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-20
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-20
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-20
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-20
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-20
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-20
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-20
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-20
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-19
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-19
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-19
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-19
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-19
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-19
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-19
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-19
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-18
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-18
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-18
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-18
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-18
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-18
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-18
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-18
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-18
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-18
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-18
3soa_A	444	Full-Length Human Camkii Length = 444		1e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-18
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-18
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-18
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-18
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-18
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-18
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-18
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-18
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-18
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-18
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-18
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-18
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-18
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-18
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-18
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-18
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-18
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-18
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-18
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-17
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-17
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-17
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-17
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-16
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-16
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-16
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-16
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		9e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-15
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-15
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-15
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-15
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-15
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-15
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-15
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-15
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-15
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-15
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-15
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-15
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-15
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-15
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-15
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-15
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-14
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-14
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-14
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-14
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-14
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-14
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-14
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-14
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-14
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-14
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-14
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-14
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-14
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-14
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-14
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-14
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-14
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-14
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-13
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-13
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-13
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		4e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-13
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		9e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-13
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		9e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-12
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-12
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-09

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  227 bits (578), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 109/248 (43%), Positives = 160/248 (64%), Gaps = 5/248 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 38  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT-- 179
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPP 215
Query: 180 -SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 238
            + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H F+K     
Sbjct: 216 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 275
Query: 239 NVDLSEYF 246
            VD + + 
Sbjct: 276 EVDFAGWL 283

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  223 bits (568), Expect = 9e-59,   Method: Compositional matrix adjust.
 Identities = 108/245 (44%), Positives = 156/245 (63%), Gaps = 5/245 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 57  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 116
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 117 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 176
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P        G  + 
Sbjct: 177 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG---SGSGSMAI 231
Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD
Sbjct: 232 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 291
Query: 242 LSEYF 246
            + + 
Sbjct: 292 FAGWL 296

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  221 bits (563), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 108/245 (44%), Positives = 154/245 (62%), Gaps = 9/245 (3%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 41  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 100
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 101 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 160
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
               AN FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  P        + 
Sbjct: 161 E--MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP-------MAI 211
Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD
Sbjct: 212 FELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 271
Query: 242 LSEYF 246
            + + 
Sbjct: 272 FAGWL 276

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  215 bits (548), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 65  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 303 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 342

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 38  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 38  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 38  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 38  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  214 bits (546), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 161/280 (57%), Gaps = 37/280 (13%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 100 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 159
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 160 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 219
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 220 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 277
Query: 177 -------------------------GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFC 206
                                    G  S      +EL++ IV++PPP  PS  FS EF 
Sbjct: 278 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQ 337
Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 338 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 377

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  211 bits (538), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 108/284 (38%), Positives = 161/284 (56%), Gaps = 41/284 (14%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LK+
Sbjct: 48  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE 107
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
            K IPEE L  +   VL+GL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 108 AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 167
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ------ 175
           +   AN+FVGT +YM+PER+ G  Y  +SDIWS+GL L+E A G++P  PP+ +      
Sbjct: 168 S--MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225
Query: 176 -----DG----------------------------WTSFYELMEAIVDQPPPSAPSDQFS 202
                DG                              + +EL++ IV++PPP  P+  F+
Sbjct: 226 GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFT 285
Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
           P+F  F++ C+ K P +R   + L  H F+K      VD + + 
Sbjct: 286 PDFQEFVNKCLIKNPAERADLKMLTNHTFIKRSEVEEVDFAGWL 329

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  171 bits (432), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 90/252 (35%), Positives = 146/252 (57%), Gaps = 17/252 (6%)
Query: 3   IQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I +E MD  SL  F K+
Sbjct: 84  IRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQ 142
Query: 62  V----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN  G+VK+ DFG+S 
Sbjct: 143 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 202
Query: 118 IMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 173
            +  +  +     G   YM+PERI    +   Y  KSDIWSLG+ ++E A  +FPY    
Sbjct: 203 YLVDSVAK-TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY---- 257
Query: 174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++R +  ELM HPF  
Sbjct: 258 --DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 315
Query: 234 MYGDLNVDLSEY 245
           ++     D++ +
Sbjct: 316 LHESKGTDVASF 327

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  171 bits (432), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 90/252 (35%), Positives = 146/252 (57%), Gaps = 17/252 (6%)
Query: 3   IQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I +E MD  SL  F K+
Sbjct: 40  IRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQ 98
Query: 62  V----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN  G+VK+ DFG+S 
Sbjct: 99  VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158
Query: 118 IMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 173
            +     + +   G   YM+PERI    +   Y  KSDIWSLG+ ++E A  +FPY    
Sbjct: 159 YLVDDVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY---- 213
Query: 174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++R +  ELM HPF  
Sbjct: 214 --DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271
Query: 234 MYGDLNVDLSEY 245
           ++     D++ +
Sbjct: 272 LHESKGTDVASF 283

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 144/253 (56%), Gaps = 20/253 (7%)
Query: 6   NVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           N EE+ R  I  +L +  +S  CPY+V C+ +F +N  + I +E M  G+ A+ LKK   
Sbjct: 63  NKEENKR--ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQ 118
Query: 65  --IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             IPE  L  +   ++K L YL  +  +IHRD+KPSN+L++ RG++K+ DFG+S  +   
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178
Query: 123 SGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
             +  +  G   YM+PERI     +   Y  ++D+WSLG+ L+E ATGQFPY        
Sbjct: 179 KAKDRS-AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK------N 231
Query: 178 WTSFYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
             + +E++  ++ + PP  P    FS +F SF+  C+ K+ ++R    +L+ H F+K Y 
Sbjct: 232 CKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291
Query: 237 DLNVDLSEYFTDA 249
            L VD++ +F D 
Sbjct: 292 TLEVDVASWFKDV 304

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 87/252 (34%), Positives = 140/252 (55%), Gaps = 17/252 (6%)
Query: 3   IQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I  E  D  SL  F K+
Sbjct: 67  IRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDT-SLDKFYKQ 125
Query: 62  V----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN  G+VK  DFG+S 
Sbjct: 126 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISG 185
Query: 118 IMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 173
            +     + +   G   Y +PERI    +   Y  KSDIWSLG+  +E A  +FPY    
Sbjct: 186 YLVDDVAK-DIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPY---- 240
Query: 174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++R +  EL  HPF  
Sbjct: 241 --DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFFT 298
Query: 234 MYGDLNVDLSEY 245
           ++     D++ +
Sbjct: 299 LHESKGTDVASF 310

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 91/256 (35%), Positives = 141/256 (55%), Gaps = 21/256 (8%)
Query: 3   IQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           I+  V+E  ++Q+  +L +  +SS CPY+V  Y + +  G   I +E M   S   F K 
Sbjct: 55  IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKY 113
Query: 62  V-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           V       IPEE L  I    +K L +L     IIHRD+KPSN+L++  G +K+ DFG+S
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173
Query: 117 AIMASTSGQANTFVGTYNYMSPERI--SGGKYGY--KSDIWSLGLVLLECATGQFPYSPP 172
             +  +  +     G   YM+PERI  S  + GY  +SD+WSLG+ L E ATG+FPY   
Sbjct: 174 GQLVDSIAKTRD-AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP-- 230
Query: 173 EQQDGWTSFYELMEAIVDQPPP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
                W S ++ +  +V   PP   ++   +FSP F +F++ C+ K+  +R   +EL+ H
Sbjct: 231 ----KWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286
Query: 230 PFLKMYGDLNVDLSEY 245
           PF+ MY +  V+++ Y
Sbjct: 287 PFILMYEERAVEVACY 302

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  151 bits (381), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 86/230 (37%), Positives = 129/230 (56%), Gaps = 14/230 (6%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           QE+ +      PY+   + S+  +  + II+EY+ GGS  D LK    + E Y+A I  +
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILRE 124
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           +LKGL YLH E+ I HRD+K +N+L++ +G+VK+ DFGV+  +  T  + N FVGT  +M
Sbjct: 125 ILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWM 183
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 196
           +PE I    Y +K+DIWSLG+  +E A G+    PP       S    M  +   P  S 
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGE----PP------NSDLHPMRVLFLIPKNSP 233
Query: 197 PS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE 244
           P+   Q S  F  F+ AC+ K+P+ R +A+EL+ H F+  Y      L+E
Sbjct: 234 PTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTE 283

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 82/230 (35%), Positives = 128/230 (55%), Gaps = 16/230 (6%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPE 67
           ES  ++I +E+ I Q    P+VV  Y S++ N  + I++EY   GS++D ++ + KT+ E
Sbjct: 65  ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE 124
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           + +A I +  LKGL YLH  + I HRD+K  N+L+N  G  K+ DFGV+  +     + N
Sbjct: 125 DEIATILQSTLKGLEYLHFMRKI-HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRN 183
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
             +GT  +M+PE I    Y   +DIWSLG+  +E A G+ PY+              M A
Sbjct: 184 XVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD----------IHPMRA 233
Query: 188 IV---DQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           I      PPP+    + +S  F  F+  C+ K P+QR +A +L+ HPF++
Sbjct: 234 IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  147 bits (372), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 83/216 (38%), Positives = 123/216 (56%), Gaps = 10/216 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           QE+ +      PYV   Y S+  +  + II+EY+ GGS  D L+    + E  +A I  +
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILRE 132
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           +LKGL YLH EK I HRD+K +N+L++  GEVK+ DFGV+  +  T  + NTFVGT  +M
Sbjct: 133 ILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 196
           +PE I    Y  K+DIWSLG+  +E A G+ P+S            +++  I    PP+ 
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNNPPTL 244
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 245 EGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  147 bits (372), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 83/216 (38%), Positives = 123/216 (56%), Gaps = 10/216 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           QE+ +      PYV   Y S+  +  + II+EY+ GGS  D L+    + E  +A I  +
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILRE 112
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           +LKGL YLH EK I HRD+K +N+L++  GEVK+ DFGV+  +  T  + NTFVGT  +M
Sbjct: 113 ILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 171
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 196
           +PE I    Y  K+DIWSLG+  +E A G+ P+S            +++  I    PP+ 
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNNPPTL 224
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 225 EGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/216 (37%), Positives = 122/216 (56%), Gaps = 10/216 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           QE+ +      PYV   Y S+  +  + II+EY+ GGS  D L+    + E  +A I  +
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILRE 127
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           +LKGL YLH EK I HRD+K +N+L++  GEVK+ DFGV+  +  T  + N FVGT  +M
Sbjct: 128 ILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 186
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 196
           +PE I    Y  K+DIWSLG+  +E A G+ P+S            +++  I    PP+ 
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNNPPTL 239
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 240 EGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/216 (37%), Positives = 122/216 (56%), Gaps = 10/216 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           QE+ +      PYV   Y S+  +  + II+EY+ GGS  D L+    + E  +A I  +
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILRE 112
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           +LKGL YLH EK I HRD+K +N+L++  GEVK+ DFGV+  +  T  + N FVGT  +M
Sbjct: 113 ILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 171
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 196
           +PE I    Y  K+DIWSLG+  +E A G+ P+S            +++  I    PP+ 
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-------KVLFLIPKNNPPTL 224
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 225 EGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 82/216 (37%), Positives = 121/216 (56%), Gaps = 10/216 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           QE+ +       YV   Y S+     + II+EY+ GGS  D L+      E  +A + ++
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKE 128
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           +LKGL YLH EK I HRD+K +N+L++ +G+VK+ DFGV+  +  T  + NTFVGT  +M
Sbjct: 129 ILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 187
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 196
           +PE I    Y  K+DIWSLG+  +E A G+ P S             ++  I    PP+ 
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------RVLFLIPKNNPPTL 240
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             D F+  F  FI AC+ K+P  R +A+EL+ H F+
Sbjct: 241 VGD-FTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 82/237 (34%), Positives = 135/237 (56%), Gaps = 11/237 (4%)
Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V  M++ +  RR++   E+ I +  Q   VV  Y+S+     + +++E++ GG+L D + 
Sbjct: 75  VKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS 134
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           +V+ + EE +A +CE VL+ L YLH +  +IHRD+K  ++L+   G VK++DFG  A ++
Sbjct: 135 QVR-LNEEQIATVCEAVLQALAYLHAQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               +    VGT  +M+PE IS   Y  + DIWSLG++++E   G+ PY          S
Sbjct: 193 KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-------DS 245
Query: 181 FYELMEAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
             + M+ + D PPP    S + SP    F+   + ++PQ+R +AQEL+ HPFL   G
Sbjct: 246 PVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  144 bits (363), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/246 (34%), Positives = 134/246 (54%), Gaps = 28/246 (11%)
Query: 5   MNVEESARRQIAQELK-INQSSQCPYVVVCYQSFYS------NGAISIILEYMDGGSLAD 57
           M+V      +I QE+  + + S    +   Y +F        +  + +++E+   GS+ D
Sbjct: 57  MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 58  FLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
            +K  K  T+ EE++A IC ++L+GL +LH  K +IHRD+K  N+L+    EVK+ DFGV
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 116 SAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYS 170
           SA +  T G+ NTF+GT  +M+PE I+        Y +KSD+WSLG+  +E A G    +
Sbjct: 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG----A 231
Query: 171 PPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           PP            M A   I   P P   S ++S +F SFI +C+ K   QR + ++LM
Sbjct: 232 PP------LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285
Query: 228 THPFLK 233
            HPF++
Sbjct: 286 KHPFIR 291

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 133/239 (55%), Gaps = 15/239 (6%)
Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++GG+L D + 
Sbjct: 54  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 113
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++
Sbjct: 114 HTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 171
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP      
Sbjct: 172 KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------ 225
Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 226 ---LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 281

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 133/239 (55%), Gaps = 15/239 (6%)
Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++GG+L D + 
Sbjct: 50  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 109
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++
Sbjct: 110 HTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP      
Sbjct: 168 KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------ 221
Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 222 ---LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 132/239 (55%), Gaps = 15/239 (6%)
Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +      VV  Y S+     + +++E+++GG+L D + 
Sbjct: 75  VKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVT 134
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +A +C  VL+ L YLH++  +IHRD+K  ++L+   G +K++DFG  A ++
Sbjct: 135 HTR-MNEEQIATVCLSVLRALSYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 192
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP Q    
Sbjct: 193 KEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--- 249
Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
                 M  I D  PP      + S     F+   + +EP QR +AQEL+ HPFLK+ G
Sbjct: 250 ------MRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLKLAG 302

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 133/239 (55%), Gaps = 15/239 (6%)
Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++GG+L D + 
Sbjct: 59  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 118
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++
Sbjct: 119 HTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 176
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP      
Sbjct: 177 KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------ 230
Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 231 ---LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 286

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 133/239 (55%), Gaps = 15/239 (6%)
Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++GG+L D + 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 120
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++
Sbjct: 121 HTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 178
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP      
Sbjct: 179 KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------ 232
Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 233 ---LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 288

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 133/239 (55%), Gaps = 15/239 (6%)
Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++GG+L D + 
Sbjct: 104 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 163
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++
Sbjct: 164 HTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP      
Sbjct: 222 KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------ 275
Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 276 ---LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/239 (33%), Positives = 133/239 (55%), Gaps = 15/239 (6%)
Query: 2   VIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++GG+L D + 
Sbjct: 181 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 240
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++
Sbjct: 241 HTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGW 178
               +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   PP      
Sbjct: 299 KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------ 352
Query: 179 TSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 353 ---LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 128/237 (54%), Gaps = 14/237 (5%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLK 60
           VI+   EE     I  E++I  +   PY+V    ++Y +G + I++E+  GG++ A  L+
Sbjct: 43  VIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE 101
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + E  +  +C Q+L+ L +LH  K IIHRDLK  N+L+   G++++ DFGVSA   
Sbjct: 102 LDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 160
Query: 121 STSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
            T  + ++F+GT  +M+PE +         Y YK+DIWSLG+ L+E A       PP  +
Sbjct: 161 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ----IEPPHHE 216
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                   L++     PP      ++S EF  F+   + K P+ R SA +L+ HPF+
Sbjct: 217 --LNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 128/237 (54%), Gaps = 14/237 (5%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLK 60
           VI+   EE     I  E++I  +   PY+V    ++Y +G + I++E+  GG++ A  L+
Sbjct: 51  VIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE 109
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + + E  +  +C Q+L+ L +LH  K IIHRDLK  N+L+   G++++ DFGVSA   
Sbjct: 110 LDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168
Query: 121 STSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
            T  + ++F+GT  +M+PE +         Y YK+DIWSLG+ L+E A       PP  +
Sbjct: 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ----IEPPHHE 224
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                   L++     PP      ++S EF  F+   + K P+ R SA +L+ HPF+
Sbjct: 225 --LNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  131 bits (330), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 132/234 (56%), Gaps = 9/234 (3%)
Query: 2   VIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           + QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + 
Sbjct: 50  IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A + 
Sbjct: 110 ET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   +
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRA 224
Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            Y +     +  P     ++ S  F  F++ C+  + ++R SA+EL+ H FLK+
Sbjct: 225 LYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  130 bits (326), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 132/232 (56%), Gaps = 9/232 (3%)
Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + + 
Sbjct: 53  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 112
Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             + E  +AA+C + L+ L +LH    +IHR++K  N+L+   G VK+TDFG  A +   
Sbjct: 113 -CMDEGQIAAVCRECLQALEFLHS-NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE 170
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
             + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   + Y
Sbjct: 171 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALY 227
Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FLK+
Sbjct: 228 LIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKI 276

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  130 bits (326), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 132/234 (56%), Gaps = 9/234 (3%)
Query: 2   VIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           + QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + 
Sbjct: 50  IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A + 
Sbjct: 110 ET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   +
Sbjct: 168 PEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRA 224
Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            Y +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FLK+
Sbjct: 225 LYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 132/234 (56%), Gaps = 9/234 (3%)
Query: 2   VIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           + QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + 
Sbjct: 51  IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 110
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A + 
Sbjct: 111 ET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 168
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   +
Sbjct: 169 PEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRA 225
Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            Y +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FLK+
Sbjct: 226 LYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKI 276

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 131/234 (55%), Gaps = 9/234 (3%)
Query: 2   VIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           + QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + 
Sbjct: 50  IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A + 
Sbjct: 110 ET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY     ++   +
Sbjct: 168 PEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRA 224
Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            Y +     +  P     ++ S  F  F++ C+  + ++R SA+EL+ H FLK+
Sbjct: 225 LYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  128 bits (321), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 125/243 (51%), Gaps = 15/243 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQ 76
           E+ I  S   P +V    +FY    + I++E+  GG++ A  L+  + + E  +  +C+Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
            L  L YLH  K IIHRDLK  N+L    G++K+ DFGVSA    T  + ++F+GT  +M
Sbjct: 144 TLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 202
Query: 137 SPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +PE +         Y YK+D+WSLG+ L+E A       PP  +        L++    +
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAE----IEPPHHE--LNPMRVLLKIAKSE 256
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGS 251
           PP  A   ++S  F  F+  C++K    R +  +L+ HPF+ +  D N  + E   +A +
Sbjct: 257 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV--DSNKPIRELIAEAKA 314
Query: 252 PLA 254
            + 
Sbjct: 315 EVT 317

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 10/218 (4%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-- 64
           ++  AR    +E+ + +    P V+  Y SF  +  ++I+LE  D G L+  +K  K   
Sbjct: 71  MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 65  --IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             IPE  +     Q+   L ++H  + ++HRD+KP+N+ I   G VK+ D G+    +S 
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
           +  A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+   +      + Y
Sbjct: 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLY 244
Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            L + I     P  PSD +S E    ++ C+  +P++R
Sbjct: 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  127 bits (320), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 123/239 (51%), Gaps = 34/239 (14%)
Query: 20  KINQSSQC--PYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--------KVKTIPEEY 69
           +I   SQC  P +V  Y SF     + ++++ + GGS+ D +K        K   + E  
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-----STSG 124
           +A I  +VL+GL YLH    I HRD+K  N+L+   G V+I DFGVSA +A     + + 
Sbjct: 123 IATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSF 181
              TFVGT  +M+PE +   + Y +K+DIWS G+  +E ATG  PY   PP +       
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------ 235
Query: 182 YELMEAIVDQPPPSAPSDQ-------FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             LM  + + PP      Q       +   F   IS C+QK+P++R +A EL+ H F +
Sbjct: 236 --LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  127 bits (320), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 123/239 (51%), Gaps = 34/239 (14%)
Query: 20  KINQSSQC--PYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--------KVKTIPEEY 69
           +I   SQC  P +V  Y SF     + ++++ + GGS+ D +K        K   + E  
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-----STSG 124
           +A I  +VL+GL YLH    I HRD+K  N+L+   G V+I DFGVSA +A     + + 
Sbjct: 118 IATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 176
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSF 181
              TFVGT  +M+PE +   + Y +K+DIWS G+  +E ATG  PY   PP +       
Sbjct: 177 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------ 230
Query: 182 YELMEAIVDQPPPSAPSDQ-------FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             LM  + + PP      Q       +   F   IS C+QK+P++R +A EL+ H F +
Sbjct: 231 --LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 287

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 123/240 (51%), Gaps = 15/240 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQ 76
           E+ I  S   P +V    +FY    + I++E+  GG++ A  L+  + + E  +  +C+Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
            L  L YLH  K IIHRDLK  N+L    G++K+ DFGVSA       + ++F+GT  +M
Sbjct: 144 TLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWM 202
Query: 137 SPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +PE +         Y YK+D+WSLG+ L+E A       PP  +        L++    +
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAE----IEPPHHE--LNPMRVLLKIAKSE 256
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGS 251
           PP  A   ++S  F  F+  C++K    R +  +L+ HPF+ +  D N  + E   +A +
Sbjct: 257 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV--DSNKPIRELIAEAKA 314

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 122/240 (50%), Gaps = 15/240 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQ 76
           E+ I  S   P +V    +FY    + I++E+  GG++ A  L+  + + E  +  +C+Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
            L  L YLH  K IIHRDLK  N+L    G++K+ DFGVSA       + + F+GT  +M
Sbjct: 144 TLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWM 202
Query: 137 SPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +PE +         Y YK+D+WSLG+ L+E A       PP  +        L++    +
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAE----IEPPHHE--LNPMRVLLKIAKSE 256
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGS 251
           PP  A   ++S  F  F+  C++K    R +  +L+ HPF+ +  D N  + E   +A +
Sbjct: 257 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV--DSNKPIRELIAEAKA 314

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 119/232 (51%), Gaps = 21/232 (9%)
Query: 11  ARRQIAQELKIN---QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A  L  N   Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 188 AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 247
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +       +++  L YLH EK++++RDLK  NL+++  G +KITDFG+            
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
           TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILM 363
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +       PE  S +S  ++K+P+QRL      A+E+M H F 
Sbjct: 364 EEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 119/232 (51%), Gaps = 21/232 (9%)
Query: 11  ARRQIAQELKIN---QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A  L  N   Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 191 AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 250
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +       +++  L YLH EK++++RDLK  NL+++  G +KITDFG+            
Sbjct: 251 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 310
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
           TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 311 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILM 366
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +       PE  S +S  ++K+P+QRL      A+E+M H F 
Sbjct: 367 EEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 124/234 (52%), Gaps = 29/234 (12%)
Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYL 70
           + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+  K  P    E+ +
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTI 124
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTF 129
               +Q+L+GL YL H+  I+HRD+K  N+LIN + G +KI+DFG S  +A  +    TF
Sbjct: 125 GFYTKQILEGLKYL-HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183
Query: 130 VGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
            GT  YM+PE I  G  GY   +DIWSLG  ++E ATG+    PP        FYEL E 
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP--------FYELGEP 231
Query: 188 IVD-------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                     +  P  P +  S E  +FI  C + +P +R  A +L+   FLK+
Sbjct: 232 QAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 84/233 (36%), Positives = 123/233 (52%), Gaps = 29/233 (12%)
Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYL 70
           + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+  K  P    E+ +
Sbjct: 52  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTI 110
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTF 129
               +Q+L+GL YL H+  I+HRD+K  N+LIN + G +KI+DFG S  +A  +    TF
Sbjct: 111 GFYTKQILEGLKYL-HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 169
Query: 130 VGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
            GT  YM+PE I  G  GY   +DIWSLG  ++E ATG+    PP        FYEL E 
Sbjct: 170 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP--------FYELGEP 217
Query: 188 IVD-------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                     +  P  P +  S E  +FI  C + +P +R  A +L+   FLK
Sbjct: 218 QAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 21/232 (9%)
Query: 11  ARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A  L   ++ Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 50  AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 109
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +       +++  L YLH EK++++RDLK  NL+++  G +KITDFG+            
Sbjct: 110 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 169
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
            F GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 170 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILM 225
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +       PE  S +S  ++K+P+QRL      A+E+M H F 
Sbjct: 226 EEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 118/230 (51%), Gaps = 17/230 (7%)
Query: 11  ARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A  L   ++ Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 49  AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 108
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +       +++  L YLH EK++++RDLK  NL+++  G +KITDFG+            
Sbjct: 109 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 168
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
            F GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +  +     LME 
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEE 226
Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           I  + P +       PE  S +S  ++K+P+QRL      A+E+M H F 
Sbjct: 227 I--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 118/230 (51%), Gaps = 17/230 (7%)
Query: 11  ARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A  L   ++ Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 48  AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 107
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +       +++  L YLH EK++++RDLK  NL+++  G +KITDFG+            
Sbjct: 108 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 167
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
            F GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +  +     LME 
Sbjct: 168 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEE 225
Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           I  + P +       PE  S +S  ++K+P+QRL      A+E+M H F 
Sbjct: 226 I--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 120/232 (51%), Gaps = 22/232 (9%)
Query: 11  ARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A    E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   E
Sbjct: 45  AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 104
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           E       +++  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      
Sbjct: 105 ERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
           TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILM 219
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +      SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 220 EEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 118/231 (51%), Gaps = 24/231 (10%)
Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
           Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L 
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           YLH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + 
Sbjct: 168 YLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSA 196
           G  YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P    
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 283
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLKMYGDLNVD 241
                S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 284 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 326

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 120/232 (51%), Gaps = 22/232 (9%)
Query: 11  ARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A    E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   E
Sbjct: 45  AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 104
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           E       +++  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      
Sbjct: 105 ERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
           TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILM 219
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +      SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 220 EEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   EE       ++
Sbjct: 58  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 117
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      TF GT  Y++
Sbjct: 118 VSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 176
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPS 195
           PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LME I  + P +
Sbjct: 177 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEI--RFPRT 230
Query: 196 APSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
                 SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 231 -----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 119/232 (51%), Gaps = 22/232 (9%)
Query: 11  ARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A    E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   E
Sbjct: 50  AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 109
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           E       +++  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      
Sbjct: 110 ERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 168
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
            F GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILM 224
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +      SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 225 EEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 119/232 (51%), Gaps = 22/232 (9%)
Query: 11  ARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A    E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   E
Sbjct: 45  AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 104
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           E       +++  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      
Sbjct: 105 ERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
            F GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILM 219
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +      SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 220 EEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 119/232 (51%), Gaps = 22/232 (9%)
Query: 11  ARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A    E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   E
Sbjct: 45  AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 104
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           E       +++  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      
Sbjct: 105 ERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
            F GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILM 219
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +      SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 220 EEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 119/232 (51%), Gaps = 22/232 (9%)
Query: 11  ARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           A+ ++A    E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   E
Sbjct: 45  AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE 104
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           E       +++  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      
Sbjct: 105 ERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LM 185
            F GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +      +E  LM
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILM 219
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 232
           E I  + P +      SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 220 EEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  110 bits (274), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +E    Q+ +E++I    + P ++  Y  F+    I ++LE+   G L   L+K     E
Sbjct: 55  KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE 114
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +  A   E++   L Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S  + + S +  
Sbjct: 115 QRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRR 171
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
              GT +Y+ PE I G  +  K D+W  G++  E   G  P+  P       S  E    
Sbjct: 172 XMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-------SHTETHRR 224
Query: 188 IVDQPPPSAPSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 233
           IV+        D   P F S      IS  ++  P QRL  + +M HP++K
Sbjct: 225 IVN-------VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 117/231 (50%), Gaps = 24/231 (10%)
Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
           Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L 
Sbjct: 61  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           YLH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + 
Sbjct: 121 YLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSA 196
           G  YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P    
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 236
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLKMYGDLNVD 241
                S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 237 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 279

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +E    Q+ +E++I    + P ++  Y  F+    I ++LE+   G L   L+K     E
Sbjct: 54  KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE 113
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +  A   E++   L Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S  + + S +  
Sbjct: 114 QRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRR 170
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
              GT +Y+ PE I G  +  K D+W  G++  E   G  P+  P       S  E    
Sbjct: 171 XMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-------SHTETHRR 223
Query: 188 IVDQPPPSAPSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 233
           IV+        D   P F S      IS  ++  P QRL  + +M HP++K
Sbjct: 224 IVN-------VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 117/231 (50%), Gaps = 24/231 (10%)
Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
           Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L 
Sbjct: 65  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           YLH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + 
Sbjct: 125 YLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSA 196
           G  YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P    
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 240
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLKMYGDLNVD 241
                S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 241 ---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 283

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 120/233 (51%), Gaps = 19/233 (8%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           + V +  R ++ ++  I      P+VV  + +F + G + +IL+++ GG L   L K   
Sbjct: 69  LKVRDRVRTKMERD--ILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 126
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
             EE +     ++  GL +LH    II+RDLKP N+L++  G +K+TDFG+S        
Sbjct: 127 FTEEDVKFYLAELALGLDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEK 185
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +A +F GT  YM+PE ++   + + +D WS G+++ E  TG  P+   ++++  T    +
Sbjct: 186 KAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTL---I 242
Query: 185 MEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRL-----SAQELMTHPF 231
           ++A +  P       QF S E  S + A  ++ P  RL      A+E+  H F
Sbjct: 243 LKAKLGMP-------QFLSTEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVF 288

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 117/231 (50%), Gaps = 24/231 (10%)
Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
           Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L 
Sbjct: 76  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 135
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           YLH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + 
Sbjct: 136 YLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSA 196
           G  YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P    
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 251
Query: 197 PSDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYGDLNVD 241
                S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 252 ---SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR-----NVD 294

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 119/224 (53%), Gaps = 17/224 (7%)
Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLA 71
           + I +E++  Q  + P  +     +       +++EY   GS +D L+   K + E  +A
Sbjct: 99  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 157
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
           A+    L+GL YLH   ++IHRD+K  N+L++  G VK+ DFG ++IMA     AN FVG
Sbjct: 158 AVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVG 212
Query: 132 TYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           T  +M+PE I     G+Y  K D+WSLG+  +E A  + P       +  ++ Y     I
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----I 265
Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+
Sbjct: 266 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 120/234 (51%), Gaps = 19/234 (8%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ GG L   L K   
Sbjct: 65  LKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
             EE +     ++   L +LH    II+RDLKP N+L++  G +K+TDFG+S        
Sbjct: 123 FTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   ++++  T    +
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM---I 238
Query: 185 MEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QELMTHPFL 232
           ++A +  P       QF SPE  S +    ++ P  RL A     +E+  H F 
Sbjct: 239 LKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 120/234 (51%), Gaps = 19/234 (8%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ GG L   L K   
Sbjct: 65  LKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
             EE +     ++   L +LH    II+RDLKP N+L++  G +K+TDFG+S        
Sbjct: 123 FTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   ++++  T    +
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM---I 238
Query: 185 MEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QELMTHPFL 232
           ++A +  P       QF SPE  S +    ++ P  RL A     +E+  H F 
Sbjct: 239 LKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 120/234 (51%), Gaps = 19/234 (8%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ GG L   L K   
Sbjct: 66  LKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 123
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
             EE +     ++   L +LH    II+RDLKP N+L++  G +K+TDFG+S        
Sbjct: 124 FTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 182
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   ++++  T    +
Sbjct: 183 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM---I 239
Query: 185 MEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QELMTHPFL 232
           ++A +  P       QF SPE  S +    ++ P  RL A     +E+  H F 
Sbjct: 240 LKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY 117
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +T  GT 
Sbjct: 118 ITELANALSYCH-SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTL 174
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G     PP +   +   Y  +  +     
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGM----PPFEAHTYQETYRRISRV----- 225
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 233
                 +F+ P+F +      IS  ++    QRL+  E++ HP++K
Sbjct: 226 ------EFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 119/224 (53%), Gaps = 17/224 (7%)
Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLA 71
           + I +E++  Q  + P  +     +       +++EY   GS +D L+   K + E  +A
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA 118
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
           A+    L+GL YLH   ++IHRD+K  N+L++  G VK+ DFG ++IMA     AN FVG
Sbjct: 119 AVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVG 173
Query: 132 TYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           T  +M+PE I     G+Y  K D+WSLG+  +E A  + P       +  ++ Y     I
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----I 226
Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 118
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 119 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 175
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 226
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 ------EFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 116/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 114
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +T  GT 
Sbjct: 115 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTL 171
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 222
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY 117
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 118 ITELANALSYCH-SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTL 174
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G     PP +   +   Y  +  +     
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGM----PPFEAHTYQETYRRISRV----- 225
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 233
                 +F+ P+F +      IS  ++    QRL+  E++ HP++K
Sbjct: 226 ------EFTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 117
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 118 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 174
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 225
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 226 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 139
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 140 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 196
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 247
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 248 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 53  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 112
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 113 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 169
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 220
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 221 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 114 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 170
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 221
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 222 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 117 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 173
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 224
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G +   L+K+    E+  A  
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY 118
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 119 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 175
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 226
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 51  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 110
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 111 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 167
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 218
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 219 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/246 (30%), Positives = 120/246 (48%), Gaps = 17/246 (6%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           M  Q  VE +  R + +EL+I Q  + P++V  + SF     + ++++ + GG L   L+
Sbjct: 48  MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ 107
Query: 61  KVKTIPEEYLAA-ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
           +     EE +   ICE V+  L YL +++ IIHRD+KP N+L++  G V ITDF ++A++
Sbjct: 108 QNVHFKEETVKLFICELVM-ALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAML 165
Query: 120 ASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
              + Q  T  GT  YM+PE  S   G  Y +  D WSLG+   E   G+ PY       
Sbjct: 166 PRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224
Query: 177 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-QELMTHPFLKMY 235
                +     +V  P        +S E  S +   ++  P QR S   ++   P++   
Sbjct: 225 SKEIVHTFETTVVTYPSA------WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM--- 275
Query: 236 GDLNVD 241
            D+N D
Sbjct: 276 NDINWD 281

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 117 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 173
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 224
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 118
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 119 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 175
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 226
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 71  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 130
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT 
Sbjct: 131 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTL 187
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 238
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 239 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+ +  + +ILEY   G++   L+K+    E+  A  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H +K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT 
Sbjct: 114 ITELANALSYCHSKK-VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTL 170
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+ P+     QD +     +         
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV--------- 221
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 222 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 114
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S    + S +  T  GT 
Sbjct: 115 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSC--HAPSSRRTTLSGTL 171
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 222
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +   GT 
Sbjct: 117 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTL 173
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 224
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI +FG S  + + S +  T  GT 
Sbjct: 117 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTL 173
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 224
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 139
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +   GT 
Sbjct: 140 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTL 196
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 247
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 248 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 114/221 (51%), Gaps = 15/221 (6%)
Query: 19  LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 78
           L +  +  CP++V    +F++   +S IL+ M+GG L   L +     E  +     +++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL ++H+ + +++RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+P
Sbjct: 303 LGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAP 359
Query: 139 ERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 197
           E +  G  Y   +D +SLG +L +   G  P+   + +D        +   V+ P     
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----- 414
Query: 198 SDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
            D FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 415 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 114/221 (51%), Gaps = 15/221 (6%)
Query: 19  LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 78
           L +  +  CP++V    +F++   +S IL+ M+GG L   L +     E  +     +++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL ++H+ + +++RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+P
Sbjct: 303 LGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAP 359
Query: 139 ERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 197
           E +  G  Y   +D +SLG +L +   G  P+   + +D        +   V+ P     
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----- 414
Query: 198 SDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
            D FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 415 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 11/221 (4%)
Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLA 71
           +++  E+KI+   + P ++  Y  F  +  + ++LE    G +  +LK +VK   E    
Sbjct: 56  QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR 115
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q++ G+LYLH    I+HRDL  SNLL+     +KI DFG++  +     +  T  G
Sbjct: 116 HFMHQIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG 174
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T NY+SPE  +   +G +SD+WSLG +      G+ P+     ++           + D 
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-----VLADY 229
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             PS      S E    I   +++ P  RLS   ++ HPF+
Sbjct: 230 EMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 114/221 (51%), Gaps = 15/221 (6%)
Query: 19  LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 78
           L +  +  CP++V    +F++   +S IL+ M+GG L   L +     E  +     +++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL ++H+ + +++RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+P
Sbjct: 303 LGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAP 359
Query: 139 ERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 197
           E +  G  Y   +D +SLG +L +   G  P+   + +D        +   V+ P     
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----- 414
Query: 198 SDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
            D FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 415 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 114/221 (51%), Gaps = 15/221 (6%)
Query: 19  LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 78
           L +  +  CP++V    +F++   +S IL+ M+GG L   L +     E  +     +++
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL ++H+ + +++RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+P
Sbjct: 302 LGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAP 358
Query: 139 ERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 197
           E +  G  Y   +D +SLG +L +   G  P+   + +D        +   V+ P     
Sbjct: 359 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----- 413
Query: 198 SDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
            D FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 414 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 453

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 115/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 115
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI +FG S  + + S +  T  GT 
Sbjct: 116 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTL 172
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 223
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 224 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 116/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT 
Sbjct: 114 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTL 170
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 221
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 222 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 114 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTL 170
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 221
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 222 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 113/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G +   L+K+    E+  A  
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY 118
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 119 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTL 175
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 226
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 114 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTL 170
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 221
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 222 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 114
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 115 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTL 171
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 222
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 116/225 (51%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT 
Sbjct: 117 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTL 173
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 224
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 118
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 119 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTL 175
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 226
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 114 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTL 170
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 221
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 222 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 114 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTL 170
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 221
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 222 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 116
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 117 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTL 173
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 224
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 114 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTL 170
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 221
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 222 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A  
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 115
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT 
Sbjct: 116 ITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTL 172
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
           +Y+ PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +     
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV----- 223
Query: 194 PSAPSDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 232
                 +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 224 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 119/234 (50%), Gaps = 18/234 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAISIILEYMDGGSLADFL----KKV 62
           E+ ++ +  E+ + +  + P +V  Y      +N  + I++EY +GG LA  +    K+ 
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           + + EE++  +  Q+   L   H        ++HRDLKP+N+ ++ +  VK+ DFG++ I
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
           +   +  A TFVGT  YMSPE+++   Y  KSDIWSLG +L E      P++   Q+   
Sbjct: 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--- 222
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               EL   I +      P  ++S E    I+  +  +   R S +E++ +P +
Sbjct: 223 ----ELAGKIREGKFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 114/226 (50%), Gaps = 12/226 (5%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +E    Q+ +E++I      P ++  Y  FY    I +ILEY   G L   L+K  T  E
Sbjct: 63  KEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDE 122
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +  A I E++   L+Y H +K +IHRD+KP NLL+  +GE+KI DFG S  + + S +  
Sbjct: 123 QRTATIMEELADALMYCHGKK-VIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRK 179
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           T  GT +Y+ PE I G  +  K D+W +G++  E   G    +PP +       Y  +  
Sbjct: 180 TMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG----NPPFESASHNETYRRIVK 235
Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           +  + P S P+          IS  ++  P +RL   ++  HP+++
Sbjct: 236 VDLKFPASVPTGA-----QDLISKLLRHNPSERLPLAQVSAHPWVR 276

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 120/235 (51%), Gaps = 21/235 (8%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           ++ +E+   +  + P+++  Y    +   I +++EY  GG L D++ + K + E+     
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGT 132
            +Q++  + Y H  K I+HRDLKP NLL++    VKI DFG+S IM  T G    T  G+
Sbjct: 114 FQQIICAIEYCHRHK-IVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGS 170
Query: 133 YNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
            NY +PE I+G  Y G + D+WS G+VL     G+ P+      +   + ++ + + V  
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD----DEFIPNLFKKVNSCVYV 226
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
            P     D  SP   S I   +  +P QR++ QE+   P+       NV+L +Y 
Sbjct: 227 MP-----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW------FNVNLPDYL 270

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 56  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 115
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 116 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 175 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 228
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 229 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 56  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 115
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 116 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 175 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 228
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 229 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 118/230 (51%), Gaps = 16/230 (6%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           ++V    RR+I Q LK+ +    P+++  YQ   +   I +++EY+ GG L D++ K   
Sbjct: 57  LDVVGKIRREI-QNLKLFRH---PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR 112
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           + E+    + +Q+L G+ Y H    ++HRDLKP N+L++     KI DFG+S +M+    
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
Query: 125 QANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
              +  G+ NY +PE ISG  Y G + DIWS G++L     G  P+   +     T F +
Sbjct: 172 LRXS-CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKK 227
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           + + I   P         +P   S +   +Q +P +R + +++  H + K
Sbjct: 228 ICDGIFYTP------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 14/223 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICE 75
           E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +     PE        
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           ++  GL  LH E+ I++RDLKP N+L++  G ++I+D G+ A+           VGT  Y
Sbjct: 294 EICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGY 351
Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 195
           M+PE +   +Y +  D W+LG +L E   GQ P+    QQ       E +E +V + P  
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVPEE 407
Query: 196 APSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
             S++FSP+  S  S  + K+P +RL     SA+E+  HP  K
Sbjct: 408 Y-SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 21/229 (9%)
Query: 10  SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 69
            A R I +E+K       P++V    +F + G + +ILEY+ GG L   L++     E+ 
Sbjct: 69  KAERNILEEVK------HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT 122
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
                 ++   L +LH +K II+RDLKP N+++NH+G VK+TDFG+           +TF
Sbjct: 123 ACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181
Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 189
            GT  YM+PE +    +    D WSLG ++ +  TG  P++   ++    +  ++++  +
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILKCKL 238
Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 233
           + PP        + E    +   +++    RL      A E+  HPF +
Sbjct: 239 NLPP------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 14/223 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICE 75
           E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +     PE        
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           ++  GL  LH E+ I++RDLKP N+L++  G ++I+D G+ A+           VGT  Y
Sbjct: 294 EICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGY 351
Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 195
           M+PE +   +Y +  D W+LG +L E   GQ P+    QQ       E +E +V + P  
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVPEE 407
Query: 196 APSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
             S++FSP+  S  S  + K+P +RL     SA+E+  HP  K
Sbjct: 408 Y-SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 71  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD 130
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 131 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN+FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 190 RANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 246
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 247 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 72  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 131
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 132 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 190
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN+FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 191 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 247
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 248 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 118/234 (50%), Gaps = 18/234 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAISIILEYMDGGSLADFL----KKV 62
           E+ ++ +  E+ + +  + P +V  Y      +N  + I++EY +GG LA  +    K+ 
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           + + EE++  +  Q+   L   H        ++HRDLKP+N+ ++ +  VK+ DFG++ I
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
           +   +  A  FVGT  YMSPE+++   Y  KSDIWSLG +L E      P++   Q+   
Sbjct: 166 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--- 222
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               EL   I +      P  ++S E    I+  +  +   R S +E++ +P +
Sbjct: 223 ----ELAGKIREGKFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 119/229 (51%), Gaps = 19/229 (8%)
Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA 72
           RQ+ + ++     Q P++V  + +F +   + +IL+Y++GG L   L + +   E  +  
Sbjct: 109 RQVLEHIR-----QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 163
Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTSGQANTFVG 131
              +++  L +LH +  II+RD+K  N+L++  G V +TDFG+S   +A  + +A  F G
Sbjct: 164 YVGEIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 132 TYNYMSPERISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 189
           T  YM+P+ + GG  G+    D WSLG+++ E  TG  P++   +++   S  E+   I+
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRIL 279
Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
              PP     + S      I   + K+P++RL      A E+  H F +
Sbjct: 280 KSEPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 68  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 127
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 128 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 186
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN+FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 187 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 243
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 244 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 69  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 128
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 129 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 188 RANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 244
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 245 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 69  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 128
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 129 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 188 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 244
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 245 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 123/242 (50%), Gaps = 27/242 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R +I +E+ I +  + P ++  +  F +   + +ILE + GG L DFL + +++ E+  
Sbjct: 51  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 110
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H K I H DLKP N+++  +      +K+ DFG++  + + +   
Sbjct: 111 TQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+  T+      
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI----- 223
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLKMYGDL 238
                   SA +  F  E+ S        FI   + K+P++R++  + + H ++K     
Sbjct: 224 --------SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
Query: 239 NV 240
           NV
Sbjct: 276 NV 277

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 69  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 128
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 129 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 188 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 244
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 245 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 71  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 130
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 131 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 190 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 246
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 247 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 69  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 128
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 129 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 188 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 244
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 245 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 46  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 105
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 106 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 164
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 165 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 221
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 222 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 72  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 131
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 132 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 190
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 191 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 247
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 248 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 71  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 130
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 131 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 190 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 246
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 247 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 71  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 130
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 131 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 190 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 246
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 247 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 53  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 112
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 113 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 171
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 172 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 228
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 229 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 277

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 68  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 127
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 128 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 186
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 187 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 243
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 244 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 122/265 (46%), Gaps = 39/265 (14%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF------LKKV 62
           +S       EL+I    +  Y + C     +   + II EYM+  S+  F      L K 
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 63  KT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
            T  IP + +  I + VL    Y+H+EK+I HRD+KPSN+L++  G VK++DFG S  M 
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 121 STSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
               + +   GTY +M PE  S      G K DIWSLG+ L        P+S        
Sbjct: 204 DKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK------ 255
Query: 179 TSFYELMEAI----VDQP------------PPSAPSDQF-SPEFCSFISACVQKEPQQRL 221
            S  EL   I    ++ P              S  S+ F S E   F+   ++K P +R+
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 222 SAQELMTHPFLKMYGDLNV-DLSEY 245
           ++++ + H +L    D N+ DL E+
Sbjct: 316 TSEDALKHEWL---ADTNIEDLREF 337

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 47  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 106
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 107 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 166 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 222
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 223 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 49  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 108
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 109 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 167
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 168 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 224
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 225 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 48  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 107
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 108 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 166
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 167 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 223
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 224 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 117/234 (50%), Gaps = 18/234 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAISIILEYMDGGSLADFL----KKV 62
           E+ ++ +  E+ + +  + P +V  Y      +N  + I++EY +GG LA  +    K+ 
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           + + EE++  +  Q+   L   H        ++HRDLKP+N+ ++ +  VK+ DFG++ I
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
           +      A  FVGT  YMSPE+++   Y  KSDIWSLG +L E      P++   Q+   
Sbjct: 166 LNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--- 222
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               EL   I +      P  ++S E    I+  +  +   R S +E++ +P +
Sbjct: 223 ----ELAGKIREGKFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 122/242 (50%), Gaps = 27/242 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R +I +E+ I +  + P ++  +  F +   + +ILE + GG L DFL + +++ E+  
Sbjct: 72  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 131
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H K I H DLKP N+++  +      +K+ DFG++  + + +   
Sbjct: 132 TQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 190
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+  T+      
Sbjct: 191 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI----- 244
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLKMYGDL 238
                   SA +  F  E+ S        FI   + K+P++R+   + + H ++K     
Sbjct: 245 --------SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRR 296
Query: 239 NV 240
           NV
Sbjct: 297 NV 298

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 113/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y  F  +  +   L Y   G L  +++K+ +  
Sbjct: 76  IKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 135
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 136 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 194
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 195 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 251
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 252 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 300

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 10  SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 69
            A R I +E+K       P++V    +F + G + +ILEY+ GG L   L++     E+ 
Sbjct: 69  KAERNILEEVK------HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT 122
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
                 ++   L +LH +K II+RDLKP N+++NH+G VK+TDFG+           + F
Sbjct: 123 ACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXF 181
Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 189
            GT  YM+PE +    +    D WSLG ++ +  TG  P++   ++    +  ++++  +
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILKCKL 238
Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 233
           + PP        + E    +   +++    RL      A E+  HPF +
Sbjct: 239 NLPP------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 113/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 71  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 130
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 131 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +      F ++
Sbjct: 190 RANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAKI 246
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 247 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 118/233 (50%), Gaps = 27/233 (11%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +I +E+ I +    P ++  +  + +   + +ILE + GG L DFL + +++ EE   
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQAN 127
           +  +Q+L G+ YLH +K I H DLKP N+++  +      +K+ DFG++  +       N
Sbjct: 119 SFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
            F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +       
Sbjct: 178 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------ 230
Query: 188 IVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFL 232
                  +A S  F  EF S        FI   + KE ++RL+ QE + HP++
Sbjct: 231 -------TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 111/228 (48%), Gaps = 10/228 (4%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE     SL +  K+ K 
Sbjct: 79  MLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKA 138
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI DFG++  +     
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 197
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +  T  GT NY++PE +    + ++ DIWSLG +L     G+ P+         TS  + 
Sbjct: 198 RKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE--------TSCLKE 249
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               + +   S P    +P   + I   +  +P  R S  EL+T  F 
Sbjct: 250 TYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 120/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R  I +E+ I +  Q P V+  ++ + +   + +I E + GG L DFL + +++ EE  
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEA 116
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +   +   
Sbjct: 117 TEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 176 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----- 229
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA + +F  E+ S        FI   + K+P++R++ Q+ + HP++K
Sbjct: 230 --------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 113/235 (48%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 71  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 130
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 131 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +      F ++
Sbjct: 190 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAKI 246
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P      ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 247 IKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 114/242 (47%), Gaps = 23/242 (9%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P ++  Y+ F       +++E   GG L D +   +   E   A I +QVL G  YL H+
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL-HK 122
Query: 88  KHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 144
            +I+HRDLKP NLL+  +     +KI DFG+SA      G+    +GT  Y++PE +   
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLR-K 180
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD--QFS 202
           KY  K D+WS G++L     G  P+     Q       E+++ +        P D  Q S
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQ-------EILKRVEKGKFSFDPPDWTQVS 233
Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLAT--LSNLS 260
            E    +   +  EP +R+SA+E + HP++  +       S+  TD G    T  L N+ 
Sbjct: 234 DEAKQLVKLMLTYEPSKRISAEEALNHPWIVKF------CSQKHTDVGKHALTGALGNMK 287
Query: 261 GF 262
            F
Sbjct: 288 KF 289

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKT 64
           +S R++  +E +  +  Q P +V  Y S+ S       I ++ E    G+L  +LK+ K 
Sbjct: 66  KSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKV 125
Query: 65  IPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAST 122
              + L + C Q+LKGL +LH     IIHRDLK  N+ I    G VKI D G++ +  ++
Sbjct: 126 XKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
             +A   +GT  + +PE     KY    D+++ G   LE AT ++PYS  E Q+    + 
Sbjct: 186 FAKA--VIGTPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYS--ECQNAAQIYR 240
Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            +   +     P++      PE    I  C+++   +R S ++L+ H F +
Sbjct: 241 RVTSGV----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 112/235 (47%), Gaps = 18/235 (7%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 74  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 133
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
           E        +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG + +++  S Q 
Sbjct: 134 ETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 192
Query: 126 -ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
            AN FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +   +  F ++
Sbjct: 193 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI 249
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
           ++   D P        F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 250 IKLEYDFPA------AFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 298

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 66
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 67  E---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
           +   E +A  C+      L   H+  IIHRD+KP+N+LI+    VK+ DFG++  +A + 
Sbjct: 116 KRAIEVIADACQA-----LNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSG 170
Query: 124 G---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G + 
Sbjct: 171 NSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSP 224
Query: 181 FYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
                + + + P PPSA  +  S +  + +   + K P+ R      M    ++++    
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
Query: 240 VDLSEYFTDA 249
            +  +  TDA
Sbjct: 285 PEAPKVLTDA 294

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 120/235 (51%), Gaps = 27/235 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R +I +E+ I +  + P ++  +  F +   + +ILE + GG L DFL + +++ E+  
Sbjct: 58  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 117
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
               +Q+L G+ YL H K I H DLKP N+++  +      +K+ DFG++  + + +   
Sbjct: 118 TQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 176
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+  T+      
Sbjct: 177 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI----- 230
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFLK 233
                   SA +  F  E+ S        FI   + K+P++R+   + + H ++K
Sbjct: 231 --------SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 18/211 (8%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P+++  + +F     I +I++Y++GG L   L+K +  P         +V   L YLH  
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-S 124
Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K II+RDLKP N+L++  G +KITDFG +  +   +       GT +Y++PE +S   Y 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YXLCGTPDYIAPEVVSTKPYN 181
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D WS G+++ E   G   Y+P    +   ++ +++ A +  PP       F+ +   
Sbjct: 182 KSIDWWSFGILIYEMLAG---YTPFYDSNTMKTYEKILNAELRFPP------FFNEDVKD 232
Query: 208 FISACVQKEPQQRL-----SAQELMTHPFLK 233
            +S  + ++  QRL       +++  HP+ K
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 115/228 (50%), Gaps = 18/228 (7%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL----KKVKTIPEEY 69
           QI  E+++ +S   P ++  ++ F     + I++E  +GG L + +     + K + E Y
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSGQA 126
           +A + +Q++  L Y H  +H++H+DLKP N+L         +KI DFG++ +  S     
Sbjct: 126 VAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N   GT  YM+PE +      +K DIWS G+V+    TG  P++        TS  E+ +
Sbjct: 185 NA-AGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFT-------GTSLEEVQQ 235
Query: 187 -AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            A   +P  +      +P+    +   + K+P++R SA +++ H + K
Sbjct: 236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 10/228 (4%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE     SL +  K+ K 
Sbjct: 63  MLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKA 122
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI DFG++  +     
Sbjct: 123 VTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 181
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +     GT NY++PE +    + ++ DIWSLG +L     G+ P+         TS  + 
Sbjct: 182 RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE--------TSCLKE 233
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               + +   S P    +P   + I   +  +P  R S  EL+T  F 
Sbjct: 234 TYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 27/234 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R +I +E+ I +      V+  +  + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
            +  +Q+L G+ YLH +K I H DLKP N+++  +      +K+ DFG++  +       
Sbjct: 118 TSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 177 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----- 230
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFL 232
                   +A S  F  EF S        FI   + KE ++RL+ QE + HP++
Sbjct: 231 --------TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 118/234 (50%), Gaps = 27/234 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R +I +E+ I +      V+  +  + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
            +  +Q+L G+ YLH +K I H DLKP N+++  +      +K+ DFG++  +       
Sbjct: 118 TSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 177 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----- 230
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFL 232
                   +A S  F  EF S        FI   + KE ++RL+ QE + HP++
Sbjct: 231 --------TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 66
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 67  E---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
           +   E +A  C+      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A + 
Sbjct: 116 KRAIEVIADACQA-----LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 124 G---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G + 
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSP 224
Query: 181 FYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
                + + + P PPSA  +  S +  + +   + K P+ R      M    ++++    
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
Query: 240 VDLSEYFTDA 249
            +  +  TDA
Sbjct: 285 PEAPKVLTDA 294

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 117/250 (46%), Gaps = 27/250 (10%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 66
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 67  E---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
           +   E +A  C+      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A + 
Sbjct: 116 KRAIEVIADACQA-----LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 124 G---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G + 
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSP 224
Query: 181 FYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
                + + + P PPSA  +  S +  + +   + K P+ R      M    ++++    
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284
Query: 240 VDLSEYFTDA 249
            +  +  TDA
Sbjct: 285 PEAPKVLTDA 294

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 114/227 (50%), Gaps = 15/227 (6%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-- 65
            E +RR++A    +  + + P +V   +SF  NG++ I+++Y +GG L   +   K +  
Sbjct: 67  REESRREVA----VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            E+ +     Q+   L ++H  K I+HRD+K  N+ +   G V++ DFG++ ++ ST   
Sbjct: 123 QEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181
Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
           A   +GT  Y+SPE      Y  KSDIW+LG VL E  T +  +     ++       ++
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVL 235
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           + I    PP   S  +S +  S +S   ++ P+ R S   ++   F+
Sbjct: 236 KIISGSFPPV--SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 10/228 (4%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE     SL +  K+ K 
Sbjct: 79  MLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKA 138
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI DFG++  +     
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 197
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +     GT NY++PE +    + ++ DIWSLG +L     G+ P+         TS  + 
Sbjct: 198 RKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE--------TSCLKE 249
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               + +   S P    +P   + I   +  +P  R S  EL+T  F 
Sbjct: 250 TYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 45  IILEYMDGGSLADFLKKVKTI-PE---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           I++EY+DG +L D +     + P+   E +A  C+      L   H+  IIHRD+KP+N+
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA-----LNFSHQNGIIHRDVKPANI 147
Query: 101 LINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
           +I+    VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 158 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKE 216
           VL E  TG+ P++      G +      + + + P PPSA  +  S +  + +   + K 
Sbjct: 208 VLYEVLTGEPPFT------GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 261
Query: 217 PQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 249
           P+ R      M    ++++     +  +  TDA
Sbjct: 262 PENRYQTAAEMRADLVRVHNGEPPEAPKVLTDA 294

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 10/228 (4%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE     SL +  K+ K 
Sbjct: 79  MLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKA 138
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI DFG++  +     
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 197
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +     GT NY++PE +    + ++ DIWSLG +L     G+ P+         TS  + 
Sbjct: 198 RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE--------TSCLKE 249
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               + +   S P    +P   + I   +  +P  R S  EL+T  F 
Sbjct: 250 TYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 19/246 (7%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 66
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-- 124
           +  +  I +      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A +    
Sbjct: 116 KRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 125 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
            Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++         ++  
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT--GDSPDSVAYQH 231
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 243
           + E   D  PPSA  +  S +  + +   + K P+ R      M    ++++     +  
Sbjct: 232 VRE---DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288
Query: 244 EYFTDA 249
           +  TDA
Sbjct: 289 KVLTDA 294

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 118/236 (50%), Gaps = 11/236 (4%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++ + +V  S+  ++ +E+ + +    P ++  Y  F       +++E   GG L D + 
Sbjct: 69  IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSA 117
                 E   A I +QVL G+ YL H+ +I+HRDLKP NLL+  + +   +KI DFG+SA
Sbjct: 129 HRMKFNEVDAAVIIKQVLSGVTYL-HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 118 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
           +  +   +    +GT  Y++PE +   KY  K D+WS+G++L     G  P+     Q+ 
Sbjct: 188 VFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245
Query: 178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                E  +   D P     S+         I   +Q + Q+R+SAQ+ + HP++K
Sbjct: 246 LRKV-EKGKYTFDSPEWKNVSEGAK----DLIKQMLQFDSQRRISAQQALEHPWIK 296

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--K 60
           ++++ EE       +E+ + +  +   +V  Y   ++   ++++ E+MD   L  ++  +
Sbjct: 38  VKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSR 96
Query: 61  KVKTIPEEYLAAICE----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
            V   P      + +    Q+L+GL + H  K I+HRDLKP NLLIN RG++K+ DFG++
Sbjct: 97  TVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-ILHRDLKPQNLLINKRGQLKLGDFGLA 155
Query: 117 AIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPYSPPE 173
                     ++ V T  Y +P+ + G + Y    DIWS G +L E  TG+  FP +  E
Sbjct: 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE 215
Query: 174 QQ-------------DGWTSFYEL--MEAIVDQPPPSAPSDQFSPE--------FCSFIS 210
           +Q               W S  +L      + Q PP        P            F+ 
Sbjct: 216 EQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLH 275
Query: 211 ACVQKEPQQRLSAQELMTHPFLKMY 235
             +Q  P  RLSA++ + HP+   Y
Sbjct: 276 GLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 10/221 (4%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E    
Sbjct: 61  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 120
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q++ G  YLH  + +IHRDLK  NL +N   EVKI DFG++  +     +  T  G
Sbjct: 121 YYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 179
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T NY++PE +S   + ++ D+WS+G ++     G+ P+         TS  +     + +
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKK 231
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
              S P    +P   S I   +Q +P  R +  EL+   F 
Sbjct: 232 NEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEFF 271

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 10/221 (4%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E    
Sbjct: 61  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 120
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q++ G  YLH  + +IHRDLK  NL +N   EVKI DFG++  +     +  T  G
Sbjct: 121 YYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 179
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T NY++PE +S   + ++ D+WS+G ++     G+ P+         TS  +     + +
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKK 231
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
              S P    +P   S I   +Q +P  R +  EL+   F 
Sbjct: 232 NEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEFF 271

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 118/234 (50%), Gaps = 27/234 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R +I +E+ I +      V+  +  + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
            +  +Q+L G+ YLH +K I H DLKP N+++  +      +K+ DFG++  +       
Sbjct: 118 TSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 177 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----- 230
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFL 232
                   ++ S  F  EF S        FI   + KE ++RL+ QE + HP++
Sbjct: 231 --------TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 10/221 (4%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E    
Sbjct: 65  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 124
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q++ G  YLH  + +IHRDLK  NL +N   EVKI DFG++  +     +  T  G
Sbjct: 125 YYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 183
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T NY++PE +S   + ++ D+WS+G ++     G+ P+         TS  +     + +
Sbjct: 184 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKK 235
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
              S P    +P   S I   +Q +P  R +  EL+   F 
Sbjct: 236 NEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEFF 275

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 117/243 (48%), Gaps = 22/243 (9%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            +  E++I +    P  ++  ++F+      I+LE M+GG L D +   K + E      
Sbjct: 200 NVETEIEILKKLNHP-CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFV 130
             Q+L  + YLH E  IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  
Sbjct: 259 FYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC 316
Query: 131 GTYNYMSPE-RISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           GT  Y++PE  +S G  GY    D WSLG++L  C +G  P+S    Q        L + 
Sbjct: 317 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQ 370
Query: 188 IVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 245
           I        P    + S +    +   +  +P+ R + +E + HP+L+     + D+   
Sbjct: 371 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRK 425
Query: 246 FTD 248
           F D
Sbjct: 426 FQD 428

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 118/234 (50%), Gaps = 27/234 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R +I +E+ I +      V+  +  + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
            +  +Q+L G+ YLH +K I H DLKP N+++  +      +K+ DFG++  +       
Sbjct: 118 TSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 177 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----- 230
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFL 232
                   ++ S  F  EF S        FI   + KE ++RL+ QE + HP++
Sbjct: 231 --------TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P ++  Y+ F       +++E   GG L D +   +   E   A I +QVL G  YL H+
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL-HK 139
Query: 88  KHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 144
            +I+HRDLKP NLL+  +     +KI DFG+SA      G+    +GT  Y++PE +   
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLR-K 197
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD--QFS 202
           KY  K D+WS G++L     G  P+     Q       E+++ +        P D  Q S
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQ-------EILKRVEKGKFSFDPPDWTQVS 250
Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            E    +   +  EP +R+SA+E + HP++
Sbjct: 251 DEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 118/234 (50%), Gaps = 27/234 (11%)
Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           +R +I +E+ I +      V+  +  + +   + +ILE + GG L DFL + +++ EE  
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQA 126
            +  +Q+L G+ YLH +K I H DLKP N+++  +      +K+ DFG++  +       
Sbjct: 118 TSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           N F GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q+   +      
Sbjct: 177 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----- 230
Query: 187 AIVDQPPPSAPSDQFSPEFCS--------FISACVQKEPQQRLSAQELMTHPFL 232
                   ++ S  F  EF S        FI   + KE ++RL+ QE + HP++
Sbjct: 231 --------TSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 90
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 91  IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 146
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 147 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 202
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 248
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 117/243 (48%), Gaps = 22/243 (9%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            +  E++I +    P  ++  ++F+      I+LE M+GG L D +   K + E      
Sbjct: 186 NVETEIEILKKLNHP-CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFV 130
             Q+L  + YLH E  IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  
Sbjct: 245 FYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC 302
Query: 131 GTYNYMSPE-RISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           GT  Y++PE  +S G  GY    D WSLG++L  C +G  P+S    Q        L + 
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQ 356
Query: 188 IVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 245
           I        P    + S +    +   +  +P+ R + +E + HP+L+     + D+   
Sbjct: 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRK 411
Query: 246 FTD 248
           F D
Sbjct: 412 FQD 414

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 90
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 91  IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 146
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 147 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 202
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 248
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 90
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 83  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 141
Query: 91  IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 146
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 142 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 200
Query: 147 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 202
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 201 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 254
Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 248
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 255 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 295

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 90
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 91  IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 146
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 147 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 202
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 248
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 90
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 76  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 134
Query: 91  IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 146
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 135 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 193
Query: 147 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 202
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 194 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 247
Query: 203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 248
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 248 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 288

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 73
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 73
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 73
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 73
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 21/233 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 66
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 77  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 132
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-- 124
           +  +  I +      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A +    
Sbjct: 133 KRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 190
Query: 125 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
            Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G +    
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSV 244
Query: 184 LMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
             + + + P PPSA  +  S +  + +   + K P+ R      M    ++++
Sbjct: 245 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 297

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 10/221 (4%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E    
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 118
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q++ G  YLH  + +IHRDLK  NL +N   EVKI DFG++  +     +     G
Sbjct: 119 YYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T NY++PE +S   + ++ D+WS+G ++     G+ P+         TS  +     + +
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKK 229
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
              S P    +P   S I   +Q +P  R +  EL+   F 
Sbjct: 230 NEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEFF 269

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           I++  EE A     +E+ + +  +   +V  +   ++  +++++ EY+D   L  +L   
Sbjct: 35  IRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC 93
Query: 63  KTIPEEY-LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
             I   + +     Q+L+GL Y H +K ++HRDLKP NLLIN RGE+K+ DFG++   + 
Sbjct: 94  GNIINMHNVKLFLFQLLRGLAYCHRQK-VLHRDLKPQNLLINERGELKLADFGLARAKSI 152
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGW 178
            +   +  V T  Y  P+ + G   Y  + D+W +G +  E ATG+  FP S  E+Q  +
Sbjct: 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212
Query: 179 TSFYELMEAIVDQPPPSAPSDQ-----------------FSPEFCS----FISACVQKEP 217
              + ++    ++  P   S++                  +P   S     ++  +Q E 
Sbjct: 213 --IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEG 270
Query: 218 QQRLSAQELMTHPFLKMYGD 237
           + R+SA++ M HPF    G+
Sbjct: 271 RNRISAEDAMKHPFFLSLGE 290

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 10/221 (4%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E    
Sbjct: 85  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 144
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q++ G  YLH  + +IHRDLK  NL +N   EVKI DFG++  +     +     G
Sbjct: 145 YYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T NY++PE +S   + ++ D+WS+G ++     G+ P+         TS  +     + +
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKK 255
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
              S P    +P   S I   +Q +P  R +  EL+   F 
Sbjct: 256 NEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEFF 295

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 10/221 (4%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E    
Sbjct: 83  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 142
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q++ G  YLH  + +IHRDLK  NL +N   EVKI DFG++  +     +     G
Sbjct: 143 YYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 201
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T NY++PE +S   + ++ D+WS+G ++     G+ P+         TS  +     + +
Sbjct: 202 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKK 253
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
              S P    +P   S I   +Q +P  R +  EL+   F 
Sbjct: 254 NEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEFF 293

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 18/229 (7%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            + +E  I    + P++V   +++ S+G + ++ E+MDG  L   + K       Y  A+
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 74  C----EQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQA 126
                 Q+L+ L Y H + +IIHRD+KP N+L+  +     VK+ DFGV+  +  +   A
Sbjct: 132 ASHYMRQILEALRYCH-DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVA 190
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
              VGT ++M+PE +    YG   D+W  G++L    +G  P+   +++        L E
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--------LFE 242
Query: 187 AIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            I+       P      S      +   +  +P +R++  E + HP+LK
Sbjct: 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   + +F +   +  ++EY++GG L   ++               +++ GL +LH  
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH-S 136
Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K I++RDLK  N+L++  G +KI DFG+         + N F GT +Y++PE + G KY 
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYN 196
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
           +  D WS G++L E   GQ P+   ++++ + S        +    P  P      E   
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS--------IRMDNPFYPR-WLEKEAKD 247
Query: 208 FISACVQKEPQQRLSAQ-ELMTHPFLK 233
            +     +EP++RL  + ++  HP  +
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPLFR 274

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 10/222 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +
Sbjct: 124 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAE 182
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNY 135
           V+  L  +H    +IHRD+KP N+L++  G +K+ DFG    M  T     +T VGT +Y
Sbjct: 183 VVLALDAIH-SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY 241
Query: 136 MSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           +SPE +      G YG + D WS+G+ L E   G  P+        ++   +   ++   
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLC-F 300
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           P  +  S       C+F++   ++    R   +E+  HPF K
Sbjct: 301 PEDAEISKHAKNLICAFLTD--REVRLGRNGVEEIKQHPFFK 340

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   + +F +   +  ++EY++GG L   ++               +++ GL +LH  
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH-S 137
Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K I++RDLK  N+L++  G +KI DFG+         + N F GT +Y++PE + G KY 
Sbjct: 138 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYN 197
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
           +  D WS G++L E   GQ P+   ++++ + S        +    P  P      E   
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS--------IRMDNPFYPR-WLEKEAKD 248
Query: 208 FISACVQKEPQQRLSAQ-ELMTHPFLK 233
            +     +EP++RL  + ++  HP  +
Sbjct: 249 LLVKLFVREPEKRLGVRGDIRQHPLFR 275

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 117/236 (49%), Gaps = 22/236 (9%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           V E+ RR+      + Q +  P+++    S+ S+  + ++ + M  G L D+L +   + 
Sbjct: 142 VREATRRETH---ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS 198
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           E+   +I   +L+ + +LH   +I+HRDLKP N+L++   +++++DFG S  +     + 
Sbjct: 199 EKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKL 256
Query: 127 NTFVGTYNYMSPERI------SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
               GT  Y++PE +      +   YG + D+W+ G++L     G  P+        W  
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF--------WHR 308
Query: 181 FYELMEAIV--DQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
              LM  ++   Q   S+P  D  S      IS  +Q +P+ RL+A++ + HPF +
Sbjct: 309 RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 21/235 (8%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           +I +E+   +  + P+++  Y    S   I +++EY  G  L D++ +   + E+     
Sbjct: 50  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRF 108
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGT 132
            +Q++  + Y H  K I+HRDLKP NLL++    VKI DFG+S IM  T G    T  G+
Sbjct: 109 FQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGS 165
Query: 133 YNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
            NY +PE ISG  Y G + D+WS G++L      + P+   + +     F  +   +   
Sbjct: 166 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLFKNISNGVYTL 222
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
           P         SP     I   +   P  R+S  E+M   + K      VDL EY 
Sbjct: 223 P------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK------VDLPEYL 265

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 21/237 (8%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           +I +E+   +  + P+++  Y    S   I +++EY  G  L D++ +   + E+     
Sbjct: 60  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRF 118
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGT 132
            +Q++  + Y H  K I+HRDLKP NLL++    VKI DFG+S IM  T G    T  G+
Sbjct: 119 FQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGS 175
Query: 133 YNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
            NY +PE ISG  Y G + D+WS G++L      + P+   + +     F  +   +   
Sbjct: 176 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLFKNISNGVYTL 232
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 248
           P         SP     I   +   P  R+S  E+M   + K      VDL EY  +
Sbjct: 233 PK------FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK------VDLPEYLLE 277

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 21/235 (8%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           +I +E+   +  + P+++  Y    S   I +++EY  G  L D++ +   + E+     
Sbjct: 54  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRF 112
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGT 132
            +Q++  + Y H  K I+HRDLKP NLL++    VKI DFG+S IM  T G    T  G+
Sbjct: 113 FQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGS 169
Query: 133 YNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
            NY +PE ISG  Y G + D+WS G++L      + P+   + +     F  +   +   
Sbjct: 170 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLFKNISNGVYTL 226
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
           P         SP     I   +   P  R+S  E+M   + K      VDL EY 
Sbjct: 227 P------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK------VDLPEYL 269

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 13/226 (5%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYL 70
           +  +E+ I +  + P +V+   +      +SI+ EY+  GSL   L K    + + E   
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 71  AAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
            ++   V KG+ YLH+    I+HR+LK  NLL++ +  VK+ DFG+S + AST   + + 
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 189
            GT  +M+PE +       KSD++S G++L E AT Q P+       G  +  +++ A+ 
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-------GNLNPAQVVAAVG 252
Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLK 233
            +          +P+  + I  C   EP +R S   +M    P +K
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 21/235 (8%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           +I +E+   +  + P+++  Y    S   I +++EY  G  L D++ +   + E+     
Sbjct: 59  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRF 117
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGT 132
            +Q++  + Y H  K I+HRDLKP NLL++    VKI DFG+S IM  T G    T  G+
Sbjct: 118 FQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGS 174
Query: 133 YNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
            NY +PE ISG  Y G + D+WS G++L      + P+   + +     F  +   +   
Sbjct: 175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF---DDESIPVLFKNISNGVYTL 231
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 246
           P         SP     I   +   P  R+S  E+M   + K      VDL EY 
Sbjct: 232 PK------FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK------VDLPEYL 274

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 32/254 (12%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP-- 66
           ES R+    EL+       P +V  Y +  +   + +++EY +GGSL + L   + +P  
Sbjct: 43  ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYY 100
Query: 67  -EEYLAAICEQVLKGLLYLH--HEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAST 122
              +  + C Q  +G+ YLH    K +IHRDLKP NLL+   G V KI DFG +  + + 
Sbjct: 101 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT- 159
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
                   G+  +M+PE   G  Y  K D++S G++L E  T + P+     + G  +F 
Sbjct: 160 --HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD----EIGGPAF- 212
Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE---LMTHPFLKMYGDLN 239
            +M A+ +   P    +   P   S ++ C  K+P QR S +E   +MTH          
Sbjct: 213 RIMWAVHNGTRPPLIKNLPKP-IESLMTRCWSKDPSQRPSMEEIVKIMTH---------- 261
Query: 240 VDLSEYFTDAGSPL 253
             L  YF  A  PL
Sbjct: 262 --LMRYFPGADEPL 273

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 32/254 (12%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP-- 66
           ES R+    EL+       P +V  Y +  +   + +++EY +GGSL + L   + +P  
Sbjct: 42  ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYY 99
Query: 67  -EEYLAAICEQVLKGLLYLH--HEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAST 122
              +  + C Q  +G+ YLH    K +IHRDLKP NLL+   G V KI DFG +  + + 
Sbjct: 100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT- 158
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
                   G+  +M+PE   G  Y  K D++S G++L E  T + P+     + G  +F 
Sbjct: 159 --HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD----EIGGPAF- 211
Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE---LMTHPFLKMYGDLN 239
            +M A+ +   P    +   P   S ++ C  K+P QR S +E   +MTH          
Sbjct: 212 RIMWAVHNGTRPPLIKNLPKP-IESLMTRCWSKDPSQRPSMEEIVKIMTH---------- 260
Query: 240 VDLSEYFTDAGSPL 253
             L  YF  A  PL
Sbjct: 261 --LMRYFPGADEPL 272

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+  T  GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 136
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+  T  GT  Y++
Sbjct: 137 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEYLA 192
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 90/162 (55%), Gaps = 3/162 (1%)
Query: 10  SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 69
           ++ +++ +E++I +    P +V  ++   +   + +I+EY  GG + D+L     + E+ 
Sbjct: 53  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 112
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
             +   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    +  G+ +TF
Sbjct: 113 ARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDTF 170
Query: 130 VGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
            G+  Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 171 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 13/226 (5%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYL 70
           +  +E+ I +  + P +V+   +      +SI+ EY+  GSL   L K    + + E   
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 71  AAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
            ++   V KG+ YLH+    I+HRDLK  NLL++ +  VK+ DFG+S + AS    +   
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA 199
Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 189
            GT  +M+PE +       KSD++S G++L E AT Q P+       G  +  +++ A+ 
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-------GNLNPAQVVAAVG 252
Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLK 233
            +          +P+  + I  C   EP +R S   +M    P +K
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 4/153 (2%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
            E +I Q+   P++V    SF  N  + +++EYM GG +   L+++    E +      Q
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           ++    YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y+
Sbjct: 150 IVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYL 205
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           +PE I    Y    D W+LG+++ E A G  P+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 4/153 (2%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
            E +I Q+   P++V    SF  N  + +++EYM GG +   L+++    E +      Q
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           ++    YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y+
Sbjct: 150 IVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYL 205
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           +PE I    Y    D W+LG+++ E A G  P+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   +  F +   +  ++E+++GG L   ++K +   E        +++  L++LH +
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH-D 142
Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K II+RDLK  N+L++H G  K+ DFG+            TF GT +Y++PE +    YG
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEF 205
              D W++G++L E   G  P+    + D       L EAI++     P+   +  +   
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVVYPTWLHEDATGIL 255
Query: 206 CSFISACVQKEPQQRLSA------QELMTHPFLK 233
            SF++    K P  RL +        ++ HPF K
Sbjct: 256 KSFMT----KNPTMRLGSLTQGGEHAILRHPFFK 285

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 115/230 (50%), Gaps = 16/230 (6%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           ++V    +R+I Q LK+ +    P+++  YQ   +     +++EY+ GG L D++ K   
Sbjct: 52  LDVVGKIKREI-QNLKLFRH---PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR 107
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           + E     + +Q+L  + Y H    ++HRDLKP N+L++     KI DFG+S +M S   
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGE 165
Query: 125 QANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
              T  G+ NY +PE ISG  Y G + DIWS G++L     G  P+   + +   T F +
Sbjct: 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKK 222
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           +   +   P      +  +    + +   +Q +P +R + +++  H + K
Sbjct: 223 IRGGVFYIP------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 11/228 (4%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  + P +V  + S    G   +I + + GG L + +   +   E
Sbjct: 61  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE 120
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG 124
              +   +Q+L+ +L+ H +  ++HRDLKP NLL+  +     VK+ DFG++  +     
Sbjct: 121 ADASHCIQQILEAVLHCH-QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 179
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
               F GT  Y+SPE +    YG   D+W+ G++L     G   Y P   +D    + ++
Sbjct: 180 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG---YPPFWDEDQHRLYQQI 236
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE    I+  +   P +R++A E + HP++
Sbjct: 237 KAGAYDFPSPEW--DTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 171
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G   T  GT  Y++
Sbjct: 172 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGATWTLCGTPEYLA 227
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + ++LEY  GG +   L+++    E +      Q+
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 90/162 (55%), Gaps = 3/162 (1%)
Query: 10  SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 69
           ++ +++ +E++I +    P +V  ++   +   + +++EY  GG + D+L     + E+ 
Sbjct: 56  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
             A   Q++  + Y H +K+I+HRDLK  NLL++    +KI DFG S    +   + +TF
Sbjct: 116 ARAKFRQIVSAVQYCH-QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF-TVGNKLDTF 173
Query: 130 VGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
            G+  Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 174 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 116/230 (50%), Gaps = 16/230 (6%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           ++V    +R+I Q LK+ +    P+++  YQ   +     +++EY+ GG L D++ K   
Sbjct: 52  LDVVGKIKREI-QNLKLFRH---PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR 107
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           + E     + +Q+L  + Y H    ++HRDLKP N+L++     KI DFG+S +M+    
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 125 QANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
             ++  G+ NY +PE ISG  Y G + DIWS G++L     G  P+   + +   T F +
Sbjct: 167 LRDS-CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKK 222
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           +   +   P      +  +    + +   +Q +P +R + +++  H + K
Sbjct: 223 IRGGVFYIP------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLAGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 11/224 (4%)
Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           I +E+++ +    P ++  ++    + +  I+ E   GG L D + K K   E   A I 
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVG 131
           +QV  G+ Y+ H+ +I+HRDLKP N+L+  +    ++KI DFG+S      +   +  +G
Sbjct: 128 KQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IG 185
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T  Y++PE +  G Y  K D+WS G++L    +G  P+    + D      E  +   D 
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-ETGKYAFDL 243
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           P     SD         I   +   P  R++A + + HP+++ Y
Sbjct: 244 PQWRTISDDAK----DLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 11/224 (4%)
Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           I +E+++ +    P ++  ++    + +  I+ E   GG L D + K K   E   A I 
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVG 131
           +QV  G+ Y+ H+ +I+HRDLKP N+L+  +    ++KI DFG+S      +   +  +G
Sbjct: 128 KQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IG 185
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T  Y++PE +  G Y  K D+WS G++L    +G  P+    + D      E  +   D 
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-ETGKYAFDL 243
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           P     SD         I   +   P  R++A + + HP+++ Y
Sbjct: 244 PQWRTISDDAK----DLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 4/153 (2%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
            E +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           ++    YLH    +I+RDLKP NL+I+ +G +K+TDFG++       G+     GT  Y+
Sbjct: 150 IVLTFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGLA---KRVKGRTWXLCGTPEYL 205
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           +PE I    Y    D W+LG+++ E A G  P+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 11/224 (4%)
Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           I +E+++ +    P ++  ++    + +  I+ E   GG L D + K K   E   A I 
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVG 131
           +QV  G+ Y+ H+ +I+HRDLKP N+L+  +    ++KI DFG+S      +   +  +G
Sbjct: 128 KQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-IG 185
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
           T  Y++PE +  G Y  K D+WS G++L    +G  P+    + D      E  +   D 
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-ETGKYAFDL 243
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           P     SD         I   +   P  R++A + + HP+++ Y
Sbjct: 244 PQWRTISDDAK----DLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 93/171 (54%), Gaps = 3/171 (1%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++ +  +  S+ +++ +E++I +    P +V  ++   +   + +++EY  GG + D+L 
Sbjct: 46  IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV 105
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               + E+   A   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    
Sbjct: 106 AHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF- 163
Query: 121 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
           +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 93/171 (54%), Gaps = 3/171 (1%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++ +  +  S+ +++ +E++I +    P +V  ++   +   + +++EY  GG + D+L 
Sbjct: 46  IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV 105
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               + E+   A   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    
Sbjct: 106 AHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF- 163
Query: 121 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
           +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            + QE K+    + P ++           + +++E+  GG L   L   K IP + L   
Sbjct: 52  NVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNW 110
Query: 74  CEQVLKGLLYLHHEK--HIIHRDLKPSNLLINHRGE--------VKITDFGVSAIMASTS 123
             Q+ +G+ YLH E    IIHRDLK SN+LI  + E        +KITDFG++     T+
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170
Query: 124 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
             +    G Y +M+PE I    +   SD+WS G++L E  TG+ P+      DG    Y 
Sbjct: 171 KMSAA--GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF---RGIDGLAVAYG 225
Query: 184 LMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQRLSAQELM 227
           +    +  P PS       PE F   +  C   +P  R S   ++
Sbjct: 226 VAMNKLALPIPST-----CPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 93/171 (54%), Gaps = 3/171 (1%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++ +  +  S+ +++ +E++I +    P +V  ++   +   + +++EY  GG + D+L 
Sbjct: 46  IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV 105
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               + E+   A   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    
Sbjct: 106 AHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF- 163
Query: 121 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
           +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 4/156 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 173
           PE I    Y    D W+LG+++ E A G  P+   E
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADE 242

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLXGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 4/153 (2%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
            E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 142
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           ++    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y+
Sbjct: 143 IVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYL 198
Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           +PE I    Y    D W+LG+++ E A G  P+
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 143
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 144 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 199
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 145
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 146 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 201
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 137
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 138 VLTFEYLH-SLDLIYRDLKPENLLIDEQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 193
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 171
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 172 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 227
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 171
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 172 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 227
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 115/237 (48%), Gaps = 9/237 (3%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I   +E + +++I   LK+ +    P +V  ++ F+      +++E ++GG L + +KK
Sbjct: 43  IISKRMEANTQKEITA-LKLCEGH--PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK 99
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAI 118
            K   E   + I  +++  + ++H +  ++HRDLKP NLL    N   E+KI DFG + +
Sbjct: 100 KKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158
Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
               +    T   T +Y +PE ++   Y    D+WSLG++L    +GQ P+   ++    
Sbjct: 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218
Query: 179 TSFYELMEAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           TS  E+M+ I   D           S E    I   +  +P +RL    L  + +L+
Sbjct: 219 TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 93/171 (54%), Gaps = 3/171 (1%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++ +  +  S+ +++ +E++I +    P +V  ++   +   + +++EY  GG + D+L 
Sbjct: 39  IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV 98
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               + E+   A   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    
Sbjct: 99  AHGWMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF- 156
Query: 121 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
           +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 157 TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 80/152 (52%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 11/228 (4%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  + P +V  + S    G   +I + + GG L + +   +   E
Sbjct: 50  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE 109
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG 124
              +   +Q+L+ +L+ H +  ++HR+LKP NLL+  +     VK+ DFG++  +     
Sbjct: 110 ADASHCIQQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
               F GT  Y+SPE +    YG   D+W+ G++L     G   Y P   +D    + ++
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG---YPPFWDEDQHRLYQQI 225
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE    I+  +   P +R++A E + HP++
Sbjct: 226 KAGAYDFPSPEW--DTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 88/162 (54%), Gaps = 3/162 (1%)
Query: 10  SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 69
           ++ +++ +E++I +    P +V  ++   +   + +I+EY  GG + D+L     + E+ 
Sbjct: 56  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
             +   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    +  G+ + F
Sbjct: 116 ARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAF 173
Query: 130 VGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
            G   Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   +  F +   +  ++EY++GG L   +++V    E        ++  GL +LH +
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH-K 138
Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           + II+RDLK  N++++  G +KI DFG+             F GT +Y++PE I+   YG
Sbjct: 139 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYG 198
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D W+ G++L E   GQ P+   + +D    F  +ME  V  P         S E  S
Sbjct: 199 KSVDWWAYGVLLYEMLAGQPPF---DGEDEDELFQSIMEHNVSYP------KSLSKEAVS 249
Query: 208 FISACVQKEPQQRLSA-----QELMTHPFLK 233
                + K P +RL       +++  H F +
Sbjct: 250 ICKGLMTKHPAKRLGCGPEGERDVREHAFFR 280

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLIIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 11/231 (4%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +++ +  + +E+++ +    P ++  Y+ F   G   ++ E   GG L D +   K   E
Sbjct: 72  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 131
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              A I  QVL G+ Y+H  K I+HRDLKP NLL+  + +   ++I DFG+S    ++  
Sbjct: 132 VDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 190
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P++   + D      E 
Sbjct: 191 MKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-EK 247
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            +   + P     S+         I   +   P  R+SA++ + H +++ Y
Sbjct: 248 GKYTFELPQWKKVSESAK----DLIRKMLTYVPSMRISARDALDHEWIQTY 294

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +++TDFG++       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLMIDQQGYIQVTDFGLA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 11/231 (4%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +++ +  + +E+++ +    P ++  Y+ F   G   ++ E   GG L D +   K   E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              A I  QVL G+ Y+H  K I+HRDLKP NLL+  + +   ++I DFG+S    ++  
Sbjct: 126 VDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P++   + D      E 
Sbjct: 185 MKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-EK 241
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            +   + P     S+         I   +   P  R+SA++ + H +++ Y
Sbjct: 242 GKYTFELPQWKKVSESAK----DLIRKMLTYVPSMRISARDALDHEWIQTY 288

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 15/232 (6%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+ +R+I      ++S + P +V   +   +   ++II+EY  GG L + +       
Sbjct: 59  IDENVQREIIN----HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS 114
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSG 124
           E+      +Q+L G+ Y  H   I HRDLK  N L++      +KI DFG S   +    
Sbjct: 115 EDEARFFFQQLLSGVSYC-HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHS 172
Query: 125 QANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
           Q  + VGT  Y++PE +   +Y G  +D+WS G+ L     G +P+  PE+   +    +
Sbjct: 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
Query: 184 LMEAIVDQPPPSAPSD-QFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLK 233
            + ++      S P D + SPE C  IS     +P  R+S  E+ TH  FLK
Sbjct: 233 RILSV----KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL +L   
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-S 139
Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K II+RDLK  N++++  G +KI DFG+             F GT +Y++PE I+   YG
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 199
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D W+ G++L E   GQ P+   E +D    F  +ME  V  P         S E  +
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHNVAYP------KSMSKEAVA 250
Query: 208 FISACVQKEPQQRLSA-----QELMTHPFLK 233
                + K P +RL       +++  H F +
Sbjct: 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 112/228 (49%), Gaps = 12/228 (5%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  Q P +V  + S        ++ + + GG L + +   +   E
Sbjct: 45  SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE 104
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              +   +Q+L+ + Y H    I+HR+LKP NLL+  + +   VK+ DFG+ AI  + S 
Sbjct: 105 ADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSE 162
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             + F GT  Y+SPE +    Y    DIW+ G++L     G   Y P   +D    + ++
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG---YPPFWDEDQHRLYAQI 219
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE  S I + +   P++R++A + +  P++
Sbjct: 220 KAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 11/228 (4%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  + P +V  + S    G   ++ + + GG L + +   +   E
Sbjct: 70  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE 129
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG 124
              +    Q+L+ + ++H +  I+HRDLKP NLL+  +     VK+ DFG++  +     
Sbjct: 130 ADASHCIHQILESVNHIH-QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ 188
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
               F GT  Y+SPE +    YG   DIW+ G++L     G   Y P   +D    + ++
Sbjct: 189 AWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG---YPPFWDEDQHKLYQQI 245
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE  + I+  +   P +R++A + + HP++
Sbjct: 246 KAGAYDFPSPEW--DTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 101/189 (53%), Gaps = 25/189 (13%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAI--CEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           I +E+ D G+L  +++K +    + + A+   EQ+ KG+ Y+H +K +IHRDLKPSN+ +
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LIHRDLKPSNIFL 169
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE- 161
               +VKI DFG+   + +  G+     GT  YMSPE+IS   YG + D+++LGL+L E 
Sbjct: 170 VDTKQVKIGDFGLVTSLKN-DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 162 ---CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
              C T  F  S          F +L + I+        SD F  +  + +   + K+P+
Sbjct: 229 LHVCDTA-FETSK--------FFTDLRDGII--------SDIFDKKEKTLLQKLLSKKPE 271
Query: 219 QRLSAQELM 227
            R +  E++
Sbjct: 272 DRPNTSEIL 280

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 122/233 (52%), Gaps = 13/233 (5%)
Query: 9   ESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTI 65
           +  R +I  E+ + + +  CP V+  ++ + +   I +ILEY  GG +      +  + +
Sbjct: 69  QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMAST 122
            E  +  + +Q+L+G+ YLH + +I+H DLKP N+L++     G++KI DFG+S  +   
Sbjct: 129 SENDVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH- 186
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
           + +    +GT  Y++PE ++       +D+W++G++     T   P+   + Q+   ++ 
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYL 243
Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            + +  VD    +  S   S     FI + + K P++R +A+  ++H +L+ +
Sbjct: 244 NISQVNVDYSEETFSS--VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ + A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL +L   
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-S 460
Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
           K II+RDLK  N++++  G +KI DFG+             F GT +Y++PE I+   YG
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 520
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
              D W+ G++L E   GQ P+   E +D    F  +ME  V  P         S E  +
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHNVAYP------KSMSKEAVA 571
Query: 208 FISACVQKEPQQRLSA-----QELMTHPFLK 233
                + K P +RL       +++  H F +
Sbjct: 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 112/228 (49%), Gaps = 12/228 (5%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  Q P +V  + S        ++ + + GG L + +   +   E
Sbjct: 45  SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE 104
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              +   +Q+L+ + Y H    I+HR+LKP NLL+  + +   VK+ DFG+ AI  + S 
Sbjct: 105 ADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSE 162
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             + F GT  Y+SPE +    Y    DIW+ G++L     G   Y P   +D    + ++
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG---YPPFWDEDQHRLYAQI 219
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE  S I + +   P++R++A + +  P++
Sbjct: 220 KAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 112/234 (47%), Gaps = 20/234 (8%)
Query: 12  RRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           R    +E+ I  + S  P ++    ++ +N    ++ + M  G L D+L +  T+ E+  
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV 130
             I   +L+ +  LH + +I+HRDLKP N+L++    +K+TDFG S  +     +  +  
Sbjct: 127 RKIMRALLEVICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRSVC 184
Query: 131 GTYNYMSPERISGGK------YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           GT +Y++PE I          YG + D+WS G+++     G  P+        W     L
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------WHRKQML 236
Query: 185 MEAIV---DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           M  ++   +    S   D +S      +S  +  +PQ+R +A+E + HPF + Y
Sbjct: 237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 117/234 (50%), Gaps = 17/234 (7%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +++ +  + +E+++ +    P ++  Y+ F   G   ++ E   GG L D +   K   E
Sbjct: 89  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 148
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              A I  QVL G+ Y+H  K I+HRDLKP NLL+  + +   ++I DFG+S    ++  
Sbjct: 149 VDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 207
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P++   +       Y++
Sbjct: 208 MKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDI 258
Query: 185 MEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           ++  V++   +    Q+   S      I   +   P  R+SA++ + H +++ Y
Sbjct: 259 LKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 311

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLMIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 112/228 (49%), Gaps = 12/228 (5%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  Q P +V  + S        ++ + + GG L + +   +   E
Sbjct: 44  SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE 103
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              +   +Q+L+ + Y H    I+HR+LKP NLL+  + +   VK+ DFG+ AI  + S 
Sbjct: 104 ADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSE 161
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             + F GT  Y+SPE +    Y    DIW+ G++L     G   Y P   +D    + ++
Sbjct: 162 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG---YPPFWDEDQHRLYAQI 218
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE  S I + +   P++R++A + +  P++
Sbjct: 219 KAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 117/234 (50%), Gaps = 17/234 (7%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +++ +  + +E+++ +    P ++  Y+ F   G   ++ E   GG L D +   K   E
Sbjct: 90  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 149
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              A I  QVL G+ Y+H  K I+HRDLKP NLL+  + +   ++I DFG+S    ++  
Sbjct: 150 VDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 208
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P++   +       Y++
Sbjct: 209 MKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDI 259
Query: 185 MEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           ++  V++   +    Q+   S      I   +   P  R+SA++ + H +++ Y
Sbjct: 260 LKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 312

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 112/246 (45%), Gaps = 27/246 (10%)
Query: 13  RQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           ++IA +E+++ +  + P +V   + F     + ++ EY D   L +  +  + +PE  + 
Sbjct: 46  KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK 105
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
           +I  Q L+ + + H + + IHRD+KP N+LI     +K+ DFG + ++   S   +  V 
Sbjct: 106 SITWQTLQAVNFCH-KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 132 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSP------------------- 171
           T  Y SPE + G  +YG   D+W++G V  E  +G  P  P                   
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF----CSFISACVQKEPQQRLSAQELM 227
           P  Q  +++        +  P    P +   P         +  C+  +P +RL+ ++L+
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 228 THPFLK 233
            HP+ +
Sbjct: 284 HHPYFE 289

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q+
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++
Sbjct: 152 VLTFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLA 207
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 92/171 (53%), Gaps = 3/171 (1%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++ +  +  S+ +++ +E++I +    P +V  ++   +   + +++EY  GG + D+L 
Sbjct: 46  IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV 105
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               + E+   A   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    
Sbjct: 106 AHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF- 163
Query: 121 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
           +   + + F G+  Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 164 TFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 112/228 (49%), Gaps = 12/228 (5%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  Q P +V  + S        ++ + + GG L + +   +   E
Sbjct: 68  SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE 127
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              +   +Q+L+ + Y H    I+HR+LKP NLL+  + +   VK+ DFG+ AI  + S 
Sbjct: 128 ADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSE 185
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             + F GT  Y+SPE +    Y    DIW+ G++L     G   Y P   +D    + ++
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG---YPPFWDEDQHRLYAQI 242
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE  S I + +   P++R++A + +  P++
Sbjct: 243 KAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 14/224 (6%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           Q+ QE+ I +    P VV   +     +   + ++ E ++ G + + +  +K + E+   
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQAR 140
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
              + ++KG+ YLH++K IIHRD+KPSNLL+   G +KI DFGVS     +    +  VG
Sbjct: 141 FYFQDLIKGIEYLHYQK-IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 132 TYNYMSPERISGGKY---GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           T  +M+PE +S  +    G   D+W++G+ L     GQ P+         +         
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF 259
Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            DQP         + +    I+  + K P+ R+   E+  HP++
Sbjct: 260 PDQP-------DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 91/171 (53%), Gaps = 3/171 (1%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++ +  +  S+ +++ +E++I +    P +V  ++   +   + +++EY  GG + D+L 
Sbjct: 46  IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV 105
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               + E+   A   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    
Sbjct: 106 AHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDADMNIKIADFGFSNEF- 163
Query: 121 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
           +   + + F G   Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 164 TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 11/228 (4%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  +   +V  + S    G   ++ + + GG L + +   +   E
Sbjct: 43  SARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE 102
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG 124
              +   +Q+L+ +L+ H +  ++HRDLKP NLL+  +     VK+ DFG++  +     
Sbjct: 103 ADASHCIQQILEAVLHCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ 161
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
               F GT  Y+SPE +    YG   DIW+ G++L     G   Y P   +D    + ++
Sbjct: 162 AWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG---YPPFWDEDQHKLYQQI 218
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE  + I+  +   P +R++A E + HP++
Sbjct: 219 KAGAYDFPSPE--WDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 112/237 (47%), Gaps = 20/237 (8%)
Query: 9   ESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +  R    +E+ I  + S  P ++    ++ +N    ++ + M  G L D+L +  T+ E
Sbjct: 51  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 110
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +    I   +L+ +  LH + +I+HRDLKP N+L++    +K+TDFG S  +     +  
Sbjct: 111 KETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLR 168
Query: 128 TFVGTYNYMSPERISGGK------YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
              GT +Y++PE I          YG + D+WS G+++     G  P+        W   
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------WHRK 220
Query: 182 YELMEAIV---DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
             LM  ++   +    S   D +S      +S  +  +PQ+R +A+E + HPF + Y
Sbjct: 221 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           P  I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 7/158 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAE 181
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNY 135
           V+  L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y
Sbjct: 182 VVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 136 MSPERISG----GKYGYKSDIWSLGLVLLECATGQFPY 169
           +SPE +      G YG + D WS+G+ L E   G  P+
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 111/234 (47%), Gaps = 20/234 (8%)
Query: 12  RRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 70
           R    +E+ I  + S  P ++    ++ +N    ++ + M  G L D+L +  T+ E+  
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV 130
             I   +L+ +  LH + +I+HRDLKP N+L++    +K+TDFG S  +     +     
Sbjct: 127 RKIMRALLEVICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVC 184
Query: 131 GTYNYMSPERISGGK------YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           GT +Y++PE I          YG + D+WS G+++     G  P+        W     L
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------WHRKQML 236
Query: 185 MEAIV---DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           M  ++   +    S   D +S      +S  +  +PQ+R +A+E + HPF + Y
Sbjct: 237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 7/158 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAE 176
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNY 135
           V+  L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y
Sbjct: 177 VVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 136 MSPERISG----GKYGYKSDIWSLGLVLLECATGQFPY 169
           +SPE +      G YG + D WS+G+ L E   G  P+
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 70  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 128
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 204
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 245
Query: 205 FCSFISACVQKEPQQRLS 222
               ++ C++K+  +R S
Sbjct: 246 MKRLMAECLKKKRDERPS 263

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 7/158 (4%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ 76
           +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAE 181
Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNY 135
           V+  L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y
Sbjct: 182 VVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 136 MSPERISG----GKYGYKSDIWSLGLVLLECATGQFPY 169
           +SPE +      G YG + D WS+G+ L E   G  P+
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            + +E  I    + P++V   +++ S+G + ++ E+MDG  L   + K       Y  A+
Sbjct: 74  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 133
Query: 74  C----EQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQA 126
                 Q+L+ L Y H + +IIHRD+KP  +L+  +     VK+  FGV+  +  +   A
Sbjct: 134 ASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 192
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
              VGT ++M+PE +    YG   D+W  G++L    +G  P+   +++        L E
Sbjct: 193 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--------LFE 244
Query: 187 AIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            I+       P      S      +   +  +P +R++  E + HP+LK
Sbjct: 245 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 18/229 (7%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            + +E  I    + P++V   +++ S+G + ++ E+MDG  L   + K       Y  A+
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 74  C----EQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQA 126
                 Q+L+ L Y H + +IIHRD+KP  +L+  +     VK+  FGV+  +  +   A
Sbjct: 132 ASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
              VGT ++M+PE +    YG   D+W  G++L    +G  P+   +++        L E
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--------LFE 242
Query: 187 AIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            I+       P      S      +   +  +P +R++  E + HP+LK
Sbjct: 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 16/238 (6%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E     +  E+ +    + P +V     + S G + +I++ + GG L D + +     E 
Sbjct: 57  EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER 116
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INHRGEVKITDFGVSAIMASTSGQ 125
             + +  QVL  + YL H+  I+HRDLKP NLL   ++   ++ I+DFG+S  M      
Sbjct: 117 DASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSV 174
Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLECATGQFPYSPPEQQDGWTSFYE 183
            +T  GT  Y++PE ++   Y    D WS+G++  +L C      Y P   ++    F +
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-----YPPFYDENDAKLFEQ 229
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +++A  +   P    D  S     FI   ++K+P++R + ++ + HP++   GD  +D
Sbjct: 230 ILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA--GDTALD 283

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 16/238 (6%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E     +  E+ +    + P +V     + S G + +I++ + GG L D + +     E 
Sbjct: 57  EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER 116
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INHRGEVKITDFGVSAIMASTSGQ 125
             + +  QVL  + YL H+  I+HRDLKP NLL   ++   ++ I+DFG+S  M      
Sbjct: 117 DASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSV 174
Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLECATGQFPYSPPEQQDGWTSFYE 183
            +T  GT  Y++PE ++   Y    D WS+G++  +L C      Y P   ++    F +
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-----YPPFYDENDAKLFEQ 229
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +++A  +   P    D  S     FI   ++K+P++R + ++ + HP++   GD  +D
Sbjct: 230 ILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA--GDTALD 283

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 16/238 (6%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E     +  E+ +    + P +V     + S G + +I++ + GG L D + +     E 
Sbjct: 57  EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER 116
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INHRGEVKITDFGVSAIMASTSGQ 125
             + +  QVL  + YL H+  I+HRDLKP NLL   ++   ++ I+DFG+S  M      
Sbjct: 117 DASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSV 174
Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLECATGQFPYSPPEQQDGWTSFYE 183
            +T  GT  Y++PE ++   Y    D WS+G++  +L C      Y P   ++    F +
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-----YPPFYDENDAKLFEQ 229
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +++A  +   P    D  S     FI   ++K+P++R + ++ + HP++   GD  +D
Sbjct: 230 ILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA--GDTALD 283

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 11/228 (4%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  + P +V  + S    G   ++ + + GG L + +   +   E
Sbjct: 43  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE 102
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              +   +Q+L+ + + H    I+HRDLKP NLL+  + +   VK+ DFG++  +     
Sbjct: 103 ADASHCIQQILESVNHCHLNG-IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ 161
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
               F GT  Y+SPE +    YG   D+W+ G++L     G   Y P   +D    + ++
Sbjct: 162 AWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG---YPPFWDEDQHRLYQQI 218
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE    I+  +   P +R++A E + HP++
Sbjct: 219 KAGAYDFPSPEW--DTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 116/238 (48%), Gaps = 16/238 (6%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E     +  E+ +    + P +V     + S G + +I++ + GG L D + +     E 
Sbjct: 57  EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER 116
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INHRGEVKITDFGVSAIMASTSGQ 125
             + +  QVL  + YL H+  I+HRDLKP NLL   ++   ++ I+DFG+S  M      
Sbjct: 117 DASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSV 174
Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLECATGQFPYSPPEQQDGWTSFYE 183
            +T  GT  Y++PE ++   Y    D WS+G++  +L C      Y P   ++    F +
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-----YPPFYDENDAKLFEQ 229
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
           +++A  +   P    D  S     FI   ++K+P++R + ++ + HP++   GD  +D
Sbjct: 230 ILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA--GDTALD 283

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 118/246 (47%), Gaps = 14/246 (5%)
Query: 1   MVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           M   + + + ++R   +E++I  +  Q P ++     +     + ++ E M GG L D +
Sbjct: 48  MEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI 107
Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE---VKITDFGV 115
            + K   E   +A+   + K + YLH +  ++HRDLKPSN+L ++  G    ++I DFG 
Sbjct: 108 LRQKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
           +  + + +G   T   T N+++PE +    Y    DIWSLG++L    TG  P++     
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA----- 221
Query: 176 DGWTSFYELMEAIVDQPPPSAPS---DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           +G     E + A +     S      +  S      +S  +  +P QRL+A  ++ HP++
Sbjct: 222 NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281
Query: 233 KMYGDL 238
             +  L
Sbjct: 282 VHWDQL 287

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 11/228 (4%)
Query: 10  SAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           SAR  +++ +E +I +  + P +V  + S    G   ++ + + GG L + +   +   E
Sbjct: 43  SARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE 102
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              +   +Q+L+ + + H    I+HRDLKP NLL+  + +   VK+ DFG++  +     
Sbjct: 103 ADASHCIQQILESVNHCHLNG-IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ 161
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
               F GT  Y+SPE +    YG   D+W+ G++L     G   Y P   +D    + ++
Sbjct: 162 AWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG---YPPFWDEDQHRLYQQI 218
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                D P P    D  +PE    I+  +   P +R++A E + HP++
Sbjct: 219 KAGAYDFPSPEW--DTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 3/171 (1%)
Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++ +  +  S+ +++ +E++I +    P +V  ++   +   + ++ EY  GG + D+L 
Sbjct: 46  IIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLV 105
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                 E+   A   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S    
Sbjct: 106 AHGRXKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDADXNIKIADFGFSNEF- 163
Query: 121 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS 170
           +   + + F G   Y +PE   G KY G + D+WSLG++L    +G  P+ 
Sbjct: 164 TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 4/152 (2%)
Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q+
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 137
           +    YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT   ++
Sbjct: 151 VLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEALA 206
Query: 138 PERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           PE I    Y    D W+LG+++ E A G  P+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 26/255 (10%)
Query: 3   IQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           I+++ E+      A +E+ + +    P +V      +S   ++++ E+M+   L   L +
Sbjct: 53  IRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE 111
Query: 62  VKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
            KT + +  +     Q+L+G+ + H  + I+HRDLKP NLLIN  G +K+ DFG++    
Sbjct: 112 NKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFG 170
Query: 121 STSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-- 175
                    V T  Y +P+ + G  KY    DIWS+G +  E  TG+  FP    + Q  
Sbjct: 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP 230
Query: 176 -----------DGWTSFYEL------MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                        W    EL         + ++ P S+    F  E    +S  +  +P 
Sbjct: 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290
Query: 219 QRLSAQELMTHPFLK 233
           +R+SA++ M HP+ K
Sbjct: 291 KRISARDAMNHPYFK 305

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 26/255 (10%)
Query: 3   IQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           I+++ E+      A +E+ + +    P +V      +S   ++++ E+M+   L   L +
Sbjct: 53  IRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE 111
Query: 62  VKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
            KT + +  +     Q+L+G+ + H  + I+HRDLKP NLLIN  G +K+ DFG++    
Sbjct: 112 NKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFG 170
Query: 121 STSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-- 175
                    V T  Y +P+ + G  KY    DIWS+G +  E  TG+  FP    + Q  
Sbjct: 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP 230
Query: 176 -----------DGWTSFYEL------MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                        W    EL         + ++ P S+    F  E    +S  +  +P 
Sbjct: 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290
Query: 219 QRLSAQELMTHPFLK 233
           +R+SA++ M HP+ K
Sbjct: 291 KRISARDAMNHPYFK 305

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 39  IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 158 NNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 11/231 (4%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +++ +  + +E+++ +    P +   Y+ F   G   ++ E   GG L D +   K   E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG 124
              A I  QVL G+ Y H  K I+HRDLKP NLL+  + +   ++I DFG+S    ++  
Sbjct: 126 VDAARIIRQVLSGITYXHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P++   + D      E 
Sbjct: 185 XKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-EK 241
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            +   + P     S+         I   +   P  R+SA++ + H +++ Y
Sbjct: 242 GKYTFELPQWKKVSESAK----DLIRKXLTYVPSXRISARDALDHEWIQTY 288

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 14/216 (6%)
Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 82
           ++ + P++V  + SF +   +  +L+Y++GG L   L++ +   E        ++   L 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 142
           YLH   +I++RDLKP N+L++ +G + +TDFG+       +   +TF GT  Y++PE + 
Sbjct: 154 YLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 202
              Y    D W LG VL E   G  P+          +  E+ + I+++P    P+   S
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYS-------RNTAEMYDNILNKPLQLKPNITNS 265
Query: 203 PEFCSFISACVQKEPQQRLSAQ----ELMTHPFLKM 234
                 +   +QK+  +RL A+    E+ +H F  +
Sbjct: 266 AR--HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 16  AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE 75
           A+EL        P +V  Y +      ++I +E ++GGSL   +K+   +PE+       
Sbjct: 133 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG 192
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFV---- 130
           Q L+GL YL H + I+H D+K  N+L++  G    + DFG  A+     G   + +    
Sbjct: 193 QALEGLEYL-HSRRILHGDVKADNVLLSSDGSHAALCDFG-HAVCLQPDGLGKSLLTGDY 250
Query: 131 --GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LME 186
             GT  +M+PE + G     K D+WS   ++L    G  P         WT F+   L  
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP---------WTQFFRGPLCL 301
Query: 187 AIVDQPPPSA---PSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            I  +PPP     PS   +P     I   ++KEP  R+SA EL
Sbjct: 302 KIASEPPPVREIPPS--CAPLTAQAIQEGLRKEPIHRVSAAEL 342

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 28/240 (11%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           +  +E  +R   +E+K+ +  + P V+      Y +  ++ I EY+ GG+L   +K + +
Sbjct: 44  IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS 103
Query: 65  -IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
             P     +  + +  G+ YLH   +IIHRDL   N L+     V + DFG++ +M    
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162
Query: 124 GQAN--------------TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
            Q                T VG   +M+PE I+G  Y  K D++S G+VL E   G+   
Sbjct: 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE-IIGRVNA 221
Query: 170 SP---PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            P   P   D   +    ++      PP+ P     P F      C   +P++R S  +L
Sbjct: 222 DPDYLPRTMDFGLNVRGFLDRYC---PPNCP-----PSFFPITVRCCDLDPEKRPSFVKL 273

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 37  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 96
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 97  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 39  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 39  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 39  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 39  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 39  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 101/189 (53%), Gaps = 25/189 (13%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAI--CEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           I +E+ D G+L  +++K +    + + A+   EQ+ KG+ Y+H +K +I+RDLKPSN+ +
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LINRDLKPSNIFL 155
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE- 161
               +VKI DFG+   + +  G+     GT  YMSPE+IS   YG + D+++LGL+L E 
Sbjct: 156 VDTKQVKIGDFGLVTSLKN-DGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 162 ---CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
              C T  F  S          F +L + I+        SD F  +  + +   + K+P+
Sbjct: 215 LHVCDTA-FETSK--------FFTDLRDGII--------SDIFDKKEKTLLQKLLSKKPE 257
Query: 219 QRLSAQELM 227
            R +  E++
Sbjct: 258 DRPNTSEIL 266

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 39  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E    +I  E+ + +S   P ++  +  F       ++ E+ +GG L + +       E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQ 125
             A I +Q+L G+ YLH   +I+HRD+KP N+L+ ++     +KI DFG+S+   S   +
Sbjct: 147 DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYK 204
Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
               +GT  Y++PE +   KY  K D+WS G+++     G  P+     QD       ++
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------II 256
Query: 186 EAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 243
           + +         +D    S E    I   +  +  +R +A+E +   ++K Y + N++ S
Sbjct: 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN-NINKS 315
Query: 244 EYFTDAGSPLATLSNLSGF 262
           +  T  G+    LSN+  F
Sbjct: 316 DQKTLCGA----LSNMRKF 330

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 38  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 97
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 157 NNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 11/223 (4%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           +  QE++I +S   P ++  Y++F  N  I +++E   GG L + +   +   E   A I
Sbjct: 52  RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI 111
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFV 130
            + VL  + Y  H+ ++ HRDLKP N L    +    +K+ DFG++A          T V
Sbjct: 112 MKDVLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKV 169
Query: 131 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           GT  Y+SP+ +  G YG + D WS G+++     G  P+S P   +      E       
Sbjct: 170 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTF-- 226
Query: 191 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
              P       SP+  S I   + K P+QR+++ + + H + +
Sbjct: 227 ---PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 16  AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE 75
           A+EL        P +V  Y +      ++I +E ++GGSL   +K+   +PE+       
Sbjct: 114 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG 173
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTY- 133
           Q L+GL YL H + I+H D+K  N+L++  G    + DFG +  +       +   G Y 
Sbjct: 174 QALEGLEYL-HSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYI 232
Query: 134 ----NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LMEA 187
                +M+PE + G     K D+WS   ++L    G  P         WT F+   L   
Sbjct: 233 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP---------WTQFFRGPLCLK 283
Query: 188 IVDQPPPSA---PSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           I  +PPP     PS   +P     I   ++KEP  R+SA EL
Sbjct: 284 IASEPPPVREIPPS--CAPLTAQAIQEGLRKEPIHRVSAAEL 323

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 11/223 (4%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
           +  QE++I +S   P ++  Y++F  N  I +++E   GG L + +   +   E   A I
Sbjct: 69  RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI 128
Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFV 130
            + VL  + Y  H+ ++ HRDLKP N L    +    +K+ DFG++A          T V
Sbjct: 129 MKDVLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKV 186
Query: 131 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           GT  Y+SP+ +  G YG + D WS G+++     G  P+S P   +      E       
Sbjct: 187 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTF-- 243
Query: 191 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
              P       SP+  S I   + K P+QR+++ + + H + +
Sbjct: 244 ---PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 82  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 140
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 204
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 205 FCSFISACVQKEPQQRLS 222
               ++ C++K+  +R S
Sbjct: 258 MKRLMAECLKKKRDERPS 275

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 13/189 (6%)
Query: 8   EESARRQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
           EE+ +R    E +++ SSQ  +  +V        +    +++EY++G +L+++++    +
Sbjct: 52  EETLKRF---EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL 108
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-G 124
             +       Q+L G+ + H +  I+HRD+KP N+LI+    +KI DFG++  ++ TS  
Sbjct: 109 SVDTAINFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167
Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           Q N  +GT  Y SPE+  G      +DI+S+G+VL E   G+ P+      +G T+    
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF------NGETAVSIA 221
Query: 185 MEAIVDQPP 193
           ++ I D  P
Sbjct: 222 IKHIQDSVP 230

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 4/174 (2%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN       VV  Y          + LEY  GG L D ++ 
Sbjct: 39  IVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98
Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 122 TSGQA--NTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPP 172
            + +   N   GT  Y++PE +   ++  +  D+WS G+VL     G+ P+  P
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 82  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 140
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 204
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 205 FCSFISACVQKEPQQRLS 222
               ++ C++K+  +R S
Sbjct: 258 MKRLMAECLKKKRDERPS 275

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 68  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 126
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 218

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 116/242 (47%), Gaps = 14/242 (5%)
Query: 5   MNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           + + + ++R   +E++I  +  Q P ++     +     + ++ E   GG L D + + K
Sbjct: 52  VKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK 111
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE---VKITDFGVSAIM 119
              E   +A+   + K + YLH +  ++HRDLKPSN+L ++  G    ++I DFG +  +
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
            + +G   T   T N+++PE +    Y    DIWSLG++L    TG  P++     +G  
Sbjct: 171 RAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFA-----NGPD 225
Query: 180 SFYELMEAIVDQPPPSAPS---DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
              E + A +     S      +  S      +S  +  +P QRL+A  ++ HP++  + 
Sbjct: 226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWD 285
Query: 237 DL 238
            L
Sbjct: 286 QL 287

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 129
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 129
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE- 75
           +E+ I +  +   +V  Y   ++   + ++ E++D       LKK+  + E  L ++   
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-----LKKLLDVCEGGLESVTAK 103
Query: 76  ----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+KI DFG++        +    V 
Sbjct: 104 SFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV 162
Query: 132 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           T  Y +P+ + G  KY    DIWS+G +  E   G   +    + D     + ++     
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 191 QPPPSAPS-DQFSPEFCSF-------------------ISACVQKEPQQRLSAQELMTHP 230
           +  P+     ++ P F  +                   +S  ++ +P QR++A++ + H 
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 231 FLK 233
           + K
Sbjct: 283 YFK 285

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 93  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 151
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 243

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 152
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE- 75
           +E+ I +  +   +V  Y   ++   + ++ E++D       LKK+  + E  L ++   
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-----LKKLLDVCEGGLESVTAK 103
Query: 76  ----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+KI DFG++        +    V 
Sbjct: 104 SFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV 162
Query: 132 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           T  Y +P+ + G  KY    DIWS+G +  E   G   +    + D     + ++     
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNS 222
Query: 191 QPPPSAPS-DQFSPEFCSF-------------------ISACVQKEPQQRLSAQELMTHP 230
           +  P+     ++ P F  +                   +S  ++ +P QR++A++ + H 
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 231 FLK 233
           + K
Sbjct: 283 YFK 285

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           EE +  +  Q+LKGL Y+H    ++HRDLKP NL +N   E+KI DFG++        + 
Sbjct: 125 EEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEM 180
Query: 127 NTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--- 182
             +V T  Y +PE I S   Y    DIWS+G ++ E  TG+  +   +  D  T      
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 183 -----ELMEAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSA 223
                E ++ + D       Q  P  P   F       SP+    +   ++ +  +RL+A
Sbjct: 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 300
Query: 224 QELMTHPFLKMYGD 237
            + +THPF + + D
Sbjct: 301 AQALTHPFFEPFRD 314

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE- 75
           +E+ I +  +   +V  Y   ++   + ++ E++D       LKK+  + E  L ++   
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-----LKKLLDVCEGGLESVTAK 103
Query: 76  ----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+KI DFG++        +    + 
Sbjct: 104 SFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 132 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           T  Y +P+ + G  KY    DIWS+G +  E   G   +    + D     + ++     
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 191 QPPPSAPS-DQFSPEFCSF-------------------ISACVQKEPQQRLSAQELMTHP 230
           +  P+     ++ P F  +                   +S  ++ +P QR++A++ + H 
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 231 FLK 233
           + K
Sbjct: 283 YFK 285

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI-- 102
           ++++ + GG L D + +     E+  + + +QVL  + YLH E  I+HRDLKP NLL   
Sbjct: 83  LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLT 141
Query: 103 -NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--L 159
                ++ ITDFG+S +    +G  +T  GT  Y++PE ++   Y    D WS+G++  +
Sbjct: 142 PEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYI 199
Query: 160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
           L C      Y P  ++     F ++ E   +   P    D  S     FI   ++K+P +
Sbjct: 200 LLCG-----YPPFYEETESKLFEKIKEGYYEFESPFW--DDISESAKDFICHLLEKDPNE 252
Query: 220 RLSAQELMTHPFLKMYGDLNVDL 242
           R + ++ ++HP++     L+ D+
Sbjct: 253 RYTCEKALSHPWIDGNTALHRDI 275

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           EE +  +  Q+LKGL Y+H    ++HRDLKP NL +N   E+KI DFG++        + 
Sbjct: 143 EEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEM 198
Query: 127 NTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--- 182
             +V T  Y +PE I S   Y    DIWS+G ++ E  TG+  +   +  D  T      
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 183 -----ELMEAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSA 223
                E ++ + D       Q  P  P   F       SP+    +   ++ +  +RL+A
Sbjct: 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 318
Query: 224 QELMTHPFLKMYGD 237
            + +THPF + + D
Sbjct: 319 AQALTHPFFEPFRD 332

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L   +T  + + L  I  Q  +G+ YLH  K+
Sbjct: 94  ILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH-AKN 152
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRD+K +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 204
            + ++SD++S G+VL E  TG+ PYS    +D       ++      P  S         
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFMVGRGYASPDLSKLYKNCPKA 269
Query: 205 FCSFISACVQKEPQQR------LSAQELMTHPFLKM 234
               ++ CV+K  ++R      LS+ EL+ H   K+
Sbjct: 270 MKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 107/224 (47%), Gaps = 10/224 (4%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD-FLKKVKTIPEEYL 70
           + ++  E+ +        ++  Y +F S   I +++EY+DGG L D  + +   + E   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--EVKITDFGVSAIMASTSGQANT 128
               +Q+ +G+ ++ H+ +I+H DLKP N+L  +R   ++KI DFG++            
Sbjct: 190 ILFMKQICEGIRHM-HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248
Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           F GT  +++PE ++     + +D+WS+G++     +G  P+      +   +       +
Sbjct: 249 F-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL 307
Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            D+          S E   FIS  + KE   R+SA E + HP+L
Sbjct: 308 EDE-----EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 117/241 (48%), Gaps = 16/241 (6%)
Query: 1   MVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           M   + V + ++R  ++E++I  +  Q P ++     +     + ++ E M GG L D +
Sbjct: 53  MEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI 112
Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE---VKITDFGV 115
            + K   E   + +   + K + YLH +  ++HRDLKPSN+L ++  G    ++I DFG 
Sbjct: 113 LRQKFFSEREASFVLHTIGKTVEYLHSQG-VVHRDLKPSNILYVDESGNPECLRICDFGF 171
Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS--PPE 173
           +  + + +G   T   T N+++PE +    Y    DIWSLG++L     G  P++  P +
Sbjct: 172 AKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD 231
Query: 174 QQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
             +      E++  I            +  S      +S  +  +P QRL+A++++ HP+
Sbjct: 232 TPE------EILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285
Query: 232 L 232
           +
Sbjct: 286 V 286

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           ++   R   +E+K+ Q    P ++    +F     IS++ ++M+             +  
Sbjct: 52  KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP 111
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
            ++ A     L+GL YLH +  I+HRDLKP+NLL++  G +K+ DFG++    S +    
Sbjct: 112 SHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYX 170
Query: 128 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQ-DGWTSFYELM 185
             V T  Y +PE + G + YG   D+W++G +L E    + P+ P +   D  T  +E +
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETL 229
Query: 186 EAIVDQPPPSAPSDQFSPEFCSF 208
                      P+++  P+ CS 
Sbjct: 230 ---------GTPTEEQWPDMCSL 243

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 93/168 (55%), Gaps = 10/168 (5%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           E+A  +  +++ +N  S+  ++   + +F  +  + ++++Y  GG L   L K +  +PE
Sbjct: 117 ETACFREERDVLVNGDSK--WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE 174
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           E       +++  +  +H + H +HRD+KP N+L++  G +++ DFG    +M   + Q+
Sbjct: 175 EMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233
Query: 127 NTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 169
           +  VGT +Y+SPE +       G+YG + D WSLG+ + E   G+ P+
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 117/240 (48%), Gaps = 14/240 (5%)
Query: 1   MVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           M   + V + ++R  ++E++I  +  Q P ++     +     + ++ E M GG L D +
Sbjct: 53  MEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI 112
Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE---VKITDFGV 115
            + K   E   + +   + K + YLH +  ++HRDLKPSN+L ++  G    ++I DFG 
Sbjct: 113 LRQKFFSEREASFVLHTIGKTVEYLHSQG-VVHRDLKPSNILYVDESGNPECLRICDFGF 171
Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
           +  + + +G   T   T N+++PE +    Y    DIWSLG++L     G  P++     
Sbjct: 172 AKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFA----- 226
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           +G +   E +   +     +     +   S      +S  +  +P QRL+A++++ HP++
Sbjct: 227 NGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 116/269 (43%), Gaps = 33/269 (12%)
Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           +  E+ I      P ++  + +F     + +ILE++ GG L D     +   E+Y  +  
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD-----RIAAEDYKMSEA 149
Query: 75  E------QVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQA 126
           E      Q  +GL ++H E  I+H D+KP N++   +    VKI DFG+ A   +     
Sbjct: 150 EVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGL-ATKLNPDEIV 207
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
                T  + +PE +     G+ +D+W++G++     +G  P++    +D   +   +  
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA---GEDDLETLQNVKR 264
Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK------------- 233
              D           SPE   FI   +QKEP++RL+  + + HP+LK             
Sbjct: 265 C--DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322
Query: 234 MYGDLNVDLSEYFTDAGSPLATLSNLSGF 262
            Y  +   + E + D  +P   +  ++ F
Sbjct: 323 RYNKIRQKIKEKYADWPAPQPAIGRIANF 351

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 75  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 127
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 145
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 238
Query: 202 SPEFCSFISACVQKEPQQR 220
             E    +  C ++ P+ R
Sbjct: 239 --ELYQLMRLCWKERPEDR 255

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 145
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 202 SPEFCSFISACVQKEPQQR 220
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 76  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 128
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 145
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 129 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 239
Query: 202 SPEFCSFISACVQKEPQQR 220
             E    +  C ++ P+ R
Sbjct: 240 --ELYQLMRLCWKERPEDR 256

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 80  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 132
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 145
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 243
Query: 202 SPEFCSFISACVQKEPQQR 220
             E    +  C ++ P+ R
Sbjct: 244 --ELYQLMRLCWKERPEDR 260

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 69  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 121
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 179
Query: 144 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 199
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 232
Query: 200 QFSPEFCSFISACVQKEPQQR 220
               E    +  C ++ P+ R
Sbjct: 233 ----ELYQLMRLCWKERPEDR 249

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 83  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 135
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 145
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 136 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 195
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 196 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 246
Query: 202 SPEFCSFISACVQKEPQQR 220
             E    +  C ++ P+ R
Sbjct: 247 --ELYQLMRLCWKERPEDR 263

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 145
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 202 SPEFCSFISACVQKEPQQR 220
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 86  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 144
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 236

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 82  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 134
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 145
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 135 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 245
Query: 202 SPEFCSFISACVQKEPQQR 220
             E    +  C ++ P+ R
Sbjct: 246 --ELYQLMRLCWKERPEDR 262

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 80  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 132
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 190
Query: 144 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 199
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 243
Query: 200 QFSPEFCSFISACVQKEPQQR 220
               E    +  C ++ P+ R
Sbjct: 244 ----ELYQLMRLCWKERPEDR 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 79  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 131
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 132 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 189
Query: 144 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 199
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 242
Query: 200 QFSPEFCSFISACVQKEPQQR 220
               E    +  C ++ P+ R
Sbjct: 243 ----ELYQLMRLCWKERPEDR 259

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 29/223 (13%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           V++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG L  
Sbjct: 44  VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGPLHK 98
Query: 58  FL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           FL  K + IP   +A +  QV  G+ YL  EK+ +HRDL   N+L+ +R   KI+DFG+S
Sbjct: 99  FLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
Query: 117 -AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP- 171
            A+ A  S       G +   + +PE I+  K+  +SD+WS G+ + E  + GQ PY   
Sbjct: 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
Query: 172 --PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 212
             PE      +F E  + +  + PP  P     PE  + +S C
Sbjct: 218 KGPEV----MAFIEQGKRM--ECPPECP-----PELYALMSDC 249

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 145
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 202 SPEFCSFISACVQKEPQQR 220
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 12/162 (7%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA--IC 74
           +E  +  +  C ++   + +F     + ++++Y  GG L   L K +    E +A   I 
Sbjct: 123 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 182
Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGT 132
           E VL   +   H+ H +HRD+KP N+L++  G +++ DFG S +  +  G  Q++  VGT
Sbjct: 183 EMVLA--IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGT 239
Query: 133 YNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 169
            +Y+SPE +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 184
Query: 144 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 199
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 237
Query: 200 QFSPEFCSFISACVQKEPQQR 220
               E    +  C ++ P+ R
Sbjct: 238 ----ELYQLMRLCWKERPEDR 254

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 47  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 103
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 104 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 162
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 163 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 273
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 274 NQRPSFRDL 282

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 47  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 103
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 104 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 162
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 163 VLPQDKEFFKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 273
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 274 NQRPSFRDL 282

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 12/162 (7%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA--IC 74
           +E  +  +  C ++   + +F     + ++++Y  GG L   L K +    E +A   I 
Sbjct: 139 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 198
Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGT 132
           E VL   +   H+ H +HRD+KP N+L++  G +++ DFG S +  +  G  Q++  VGT
Sbjct: 199 EMVLA--IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGT 255
Query: 133 YNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 169
            +Y+SPE +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 89
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 152
Query: 90  IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 144
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 53  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 109
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 110 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 168
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 169 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 223
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 224 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 279
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 280 NQRPSFRDL 288

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 65  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 121
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 122 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 180
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 181 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 235
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 236 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 291
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 292 NQRPSFRDL 300

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 120/253 (47%), Gaps = 16/253 (6%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+ +R+I      ++S + P +V   +   +   ++I++EY  GG L + +       
Sbjct: 58  IDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 113
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSG 124
           E+      +Q++ G+ Y  H   + HRDLK  N L++      +KI DFG S      S 
Sbjct: 114 EDEARFFFQQLISGVSYA-HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHS- 171
Query: 125 QANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
           Q  + VGT  Y++PE +   +Y G  +D+WS G+ L     G +P+  PE+     +F +
Sbjct: 172 QPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRK 228
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLK-MYGDLNVD 241
            +  I++           SPE    IS     +P +R+S  E+  H  FLK +  DL  D
Sbjct: 229 TIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMND 288
Query: 242 --LSEYFTDAGSP 252
             ++  F ++  P
Sbjct: 289 NTMTTQFDESDQP 301

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 78  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 134
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 135 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 193
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 194 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 248
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 249 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 304
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 305 NQRPSFRDL 313

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 112/235 (47%), Gaps = 14/235 (5%)
Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           I  E+ + +  +   +V     + S   + ++++ + GG L D + +     E+  + + 
Sbjct: 67  IENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLI 126
Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVG 131
            QVL  + YLH    I+HRDLKP NLL    +   ++ I+DFG+S  M       +T  G
Sbjct: 127 RQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACG 184
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLV--LLECATGQFPYSPPEQQDGWTSFYELMEAIV 189
           T  Y++PE ++   Y    D WS+G++  +L C      Y P   ++    F ++++A  
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-----YPPFYDENDSKLFEQILKAEY 239
Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE 244
           +   P    D  S     FI   ++K+P +R + ++   HP++     LN ++ E
Sbjct: 240 EFDSPYW--DDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHE 292

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 52  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 108
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 109 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 167
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 168 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 222
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 223 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 278
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 279 NQRPSFRDL 287

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 51  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 107
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 108 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 166
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 167 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 221
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 222 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 277
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 278 NQRPSFRDL 286

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 50  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 106
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 107 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 165
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 166 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 220
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 221 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 276
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 277 NQRPSFRDL 285

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 65  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 121
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 122 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 180
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 181 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 235
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 236 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 291
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 292 NQRPSFRDL 300

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 133 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 190
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 191 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247
Query: 165 GQ--FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK------- 215
           G+  FP +     D      ++M  +   PP S  S   S E  ++I++  Q        
Sbjct: 248 GRTLFPGT-----DHINQLQQIMR-LTGTPPASVISRMPSHEARNYINSLPQMPKRNFAD 301
Query: 216 -------------------EPQQRLSAQELMTHPFLKMYGD 237
                              +  +R++A E + HP+   Y D
Sbjct: 302 VFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHD 342

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 47  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 103
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 104 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 162
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 163 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 273
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 274 NQRPSFRDL 282

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 46  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 102
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 103 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 161
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 162 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 216
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 217 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 272
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 273 NQRPSFRDL 281

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 54  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 110
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 111 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 169
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 170 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 224
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 225 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 280
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 281 NQRPSFRDL 289

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 84  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 136
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 137 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 194
Query: 144 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 199
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 247
Query: 200 QFSPEFCSFISACVQKEPQQR 220
               E    +  C ++ P+ R
Sbjct: 248 ----ELYQLMRLCWKERPEDR 264

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 109/231 (47%), Gaps = 10/231 (4%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVK 63
           M   ES +  + +E++     + P +V  + +F  +  + +I E+M GG L + +  +  
Sbjct: 85  MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 144
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMAS 121
            + E+       QV KGL ++H E + +H DLKP N++   +   E+K+ DFG++A +  
Sbjct: 145 KMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 203
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
                 T  GT  + +PE   G   GY +D+WS+G++     +G  P+   E  D     
Sbjct: 204 KQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRN 261
Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +  +  +D    S      S +   FI   +  +P  R++  + + HP+L
Sbjct: 262 VKSCDWNMDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 45  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 101
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 102 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 160
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 161 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 215
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 216 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 271
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 272 NQRPSFRDL 280

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 55  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 111
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 112 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 170
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 171 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 229
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 230 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 54  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 110
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 111 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 170 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 228
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 229 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 37/253 (14%)
Query: 7   VEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           V  SA R+I   +ELK         +V  +   +S+  ++++ E+ D      F      
Sbjct: 44  VPSSALREICLLKELKHKN------IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD 97
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           +  E + +   Q+LKGL + H  ++++HRDLKP NLLIN  GE+K+ DFG++        
Sbjct: 98  LDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDG------ 177
             +  V T  Y  P+ + G K Y    D+WS G +  E A    P  P    D       
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIF 216
Query: 178 ----------WTSFYELMEAIVDQPPPSAPSD--------QFSPEFCSFISACVQKEPQQ 219
                     W S  +L +    +P P  P+         + +      +   ++  P Q
Sbjct: 217 RLLGTPTEEQWPSMTKLPDY---KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 220 RLSAQELMTHPFL 232
           R+SA+E + HP+ 
Sbjct: 274 RISAEEALQHPYF 286

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 61  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 117
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 118 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 176
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 177 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 235
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 236 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 100 KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 156
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 157 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 216 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 275 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 109/231 (47%), Gaps = 10/231 (4%)
Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVK 63
           M   ES +  + +E++     + P +V  + +F  +  + +I E+M GG L + +  +  
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMAS 121
            + E+       QV KGL ++H E + +H DLKP N++   +   E+K+ DFG++A +  
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
                 T  GT  + +PE   G   GY +D+WS+G++     +G  P+   E  D     
Sbjct: 310 KQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRN 367
Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +  +  +D    S      S +   FI   +  +P  R++  + + HP+L
Sbjct: 368 VKSCDWNMDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 56  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 113 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 172 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 230
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 231 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 106 KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 162
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 163 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 221
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 222 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 280
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 281 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 56  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 113 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 172 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 230
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 231 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 54  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 110
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 111 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 170 SHNSLTEPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 228
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 229 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           +S R +IA   K+ Q S    ++  Y    ++  I +++E      L  +LKK K+I   
Sbjct: 71  DSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 127
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQA 126
              +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   
Sbjct: 128 ERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 185
Query: 127 NTFVGTYNYMSPERISGGKYGYKS-----------DIWSLGLVLLECATGQFPYSPPEQQ 175
           ++ VGT NYM PE I       ++           D+WSLG +L     G+ P+     Q
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + AI+D        D    +    +  C++++P+QR+S  EL+ HP++++
Sbjct: 246 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 62  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 118
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 119 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 177
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 178 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 236
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 237 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 60  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 116
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 117 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 175
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 176 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 234
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 235 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 109/239 (45%), Gaps = 33/239 (13%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK------KV 62
           ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L  FL+      K+
Sbjct: 61  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 120
Query: 63  KTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
               E+          L A+  QV  G++YL    H +HRDL   N L+     VKI DF
Sbjct: 121 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDF 179
Query: 114 GVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY- 169
           G+S  + ST         +    +M PE I   K+  +SD+WS G+VL E  T G+ P+ 
Sbjct: 180 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 239
Query: 170 --SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
             S  E  D  T   EL      + P + P     PE  + +  C Q+EPQQR S +++
Sbjct: 240 QLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 111/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L DF+    +  
Sbjct: 47  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTG 101
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 102 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 160
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 161 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 220
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 221 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 281 KAALAHPFFQ 290

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 70  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 126
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 127 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 185
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D+WSLG+++     G  P+        SP 
Sbjct: 186 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 244
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 245 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           +S R +IA   K+ Q S    ++  Y    ++  I +++E      L  +LKK K+I   
Sbjct: 55  DSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 111
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQA 126
              +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   
Sbjct: 112 ERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 169
Query: 127 NTFVGTYNYMSPERISGGKYGYKS-----------DIWSLGLVLLECATGQFPYSPPEQQ 175
           ++ VGT NYM PE I       ++           D+WSLG +L     G+ P+     Q
Sbjct: 170 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 229
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + AI+D        D    +    +  C++++P+QR+S  EL+ HP++++
Sbjct: 230 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 282

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 111/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L DF+    +  
Sbjct: 48  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTG 102
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 162 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 221
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 222 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 282 KAALAHPFFQ 291

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           +S R +IA   K+ Q S    ++  Y    ++  I +++E      L  +LKK K+I   
Sbjct: 51  DSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 107
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQA 126
              +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   
Sbjct: 108 ERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 165
Query: 127 NTFVGTYNYMSPERISGGKYGYKS-----------DIWSLGLVLLECATGQFPYSPPEQQ 175
           ++ VGT NYM PE I       ++           D+WSLG +L     G+ P+     Q
Sbjct: 166 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 225
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + AI+D        D    +    +  C++++P+QR+S  EL+ HP++++
Sbjct: 226 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 278

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 109/239 (45%), Gaps = 33/239 (13%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK------KV 62
           ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L  FL+      K+
Sbjct: 55  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 114
Query: 63  KTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
               E+          L A+  QV  G++YL    H +HRDL   N L+     VKI DF
Sbjct: 115 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDF 173
Query: 114 GVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY- 169
           G+S  + ST         +    +M PE I   K+  +SD+WS G+VL E  T G+ P+ 
Sbjct: 174 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 233
Query: 170 --SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
             S  E  D  T   EL      + P + P     PE  + +  C Q+EPQQR S +++
Sbjct: 234 QLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 114/235 (48%), Gaps = 14/235 (5%)
Query: 2   VIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           V++  V++   R +I   L+++     P ++   + F +   IS++LE + GG L D + 
Sbjct: 85  VLKKTVDKKIVRTEIGVLLRLSH----PNIIKLKEIFETPTEISLVLELVTGGELFDRIV 140
Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSA 117
           +     E   A   +Q+L+ + YLH E  I+HRDLKP NLL         +KI DFG+S 
Sbjct: 141 EKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199
Query: 118 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
           I+        T  GT  Y +PE + G  YG + D+WS+G++      G  P+   E+ D 
Sbjct: 200 IVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY-DERGDQ 257
Query: 178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           +  F  ++        P    D+ S      +   +  +P++RL+  + + HP++
Sbjct: 258 FM-FRRILNCEYYFISPWW--DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 13/231 (5%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+ +R+I      ++S + P +V   +   +   ++I++EY  GG L + +       
Sbjct: 57  IDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 112
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSG 124
           E+      +Q++ G+ Y  H   + HRDLK  N L++      +KI DFG S   +    
Sbjct: 113 EDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHS 170
Query: 125 QANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
           Q  + VGT  Y++PE +   +Y G  +D+WS G+ L     G +P+  PE+     +F +
Sbjct: 171 QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRK 227
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLK 233
            +  I++           SPE    IS     +P +R+S  E+  H  FLK
Sbjct: 228 TIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 278

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 86
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 120
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E  +IHRDL   N L+     +K++DFG++  +     TS     F     + SPE  S 
Sbjct: 121 EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSF 178
Query: 144 GKYGYKSDIWSLGLVLLEC-ATGQFPY 169
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 34/232 (14%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLA 71
           QI ++LK ++  Q  Y VV  +  Y      I+ EYM+ GSL DFLK  + + +    L 
Sbjct: 56  QIMKKLKHDKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKDGEGRALKLPNLV 108
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANT 128
            +  QV  G+ Y+    +I HRDL+ +N+L+ +    KI DFG++ ++     T+ Q   
Sbjct: 109 DMAAQVAAGMAYIERMNYI-HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAK 167
Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP----------------YSP 171
           F     + +PE    G++  KSD+WS G++L E  T G+ P                Y  
Sbjct: 168 F--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 225
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--FISACVQKEPQQRL 221
           P  QD   S +ELM     + P   P+ ++   F    F +   Q +P + L
Sbjct: 226 PCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL 277

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 111/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L DF+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           +S R +IA   K+ Q S    ++  Y    ++  I +++E      L  +LKK K+I   
Sbjct: 99  DSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQA 126
              +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   
Sbjct: 156 ERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 213
Query: 127 NTFVGTYNYMSPERISGGKYGYKS-----------DIWSLGLVLLECATGQFPYSPPEQQ 175
           ++ VGT NYM PE I       ++           D+WSLG +L     G+ P+     Q
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + AI+D        D    +    +  C++++P+QR+S  EL+ HP++++
Sbjct: 274 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 109/239 (45%), Gaps = 33/239 (13%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK------KV 62
           ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L  FL+      K+
Sbjct: 84  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 63  KTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
               E+          L A+  QV  G++YL    H +HRDL   N L+     VKI DF
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDF 202
Query: 114 GVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY- 169
           G+S  + ST         +    +M PE I   K+  +SD+WS G+VL E  T G+ P+ 
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262
Query: 170 --SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
             S  E  D  T   EL      + P + P     PE  + +  C Q+EPQQR S +++
Sbjct: 263 QLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           +S R +IA   K+ Q S    ++  Y    ++  I +++E      L  +LKK K+I   
Sbjct: 52  DSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 108
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQA 126
              +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   
Sbjct: 109 ERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 166
Query: 127 NTFVGTYNYMSPERISGGKYGYKS-----------DIWSLGLVLLECATGQFPYSPPEQQ 175
           ++ VGT NYM PE I       ++           D+WSLG +L     G+ P+     Q
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + AI+D        D    +    +  C++++P+QR+S  EL+ HP++++
Sbjct: 227 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 86
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 70  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 122
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E++ IHR+L+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 180
Query: 144 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 199
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 233
Query: 200 QFSPEFCSFISACVQKEPQQR 220
               E    +  C ++ P+ R
Sbjct: 234 ----ELYQLMRLCWKERPEDR 250

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           V++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG L  
Sbjct: 370 VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGPLHK 424
Query: 58  FL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           FL  K + IP   +A +  QV  G+ YL  EK+ +HR+L   N+L+ +R   KI+DFG+S
Sbjct: 425 FLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 117 -AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPP 172
            A+ A  S       G +   + +PE I+  K+  +SD+WS G+ + E  + GQ PY   
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--- 540
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 212
           ++  G      + +    + PP  P     PE  + +S C
Sbjct: 541 KKMKGPEVMAFIEQGKRMECPPECP-----PELYALMSDC 575

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 86
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 118
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 143
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 176
Query: 144 GKYGYKSDIWSLGLVLLEC-ATGQFPY 169
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPY 203

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 111/252 (44%), Gaps = 33/252 (13%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG---SLADFLKKV 62
           +R   +EL+I +  + P VV     FYSNG       ++++LEY+      +   + K  
Sbjct: 76  KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK 135
Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMAS 121
           +T+P   +     Q+L+ L Y+H    I HRD+KP NLL++   G +K+ DFG + I+ +
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    DIWS G V+ E   GQ  FP          
Sbjct: 195 GEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
Query: 169 ----YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS----PEFCSFISACVQKEPQQR 220
                  P ++   T     ME    Q  P   S  F     P+    IS  ++  P  R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 221 LSAQELMTHPFL 232
           L+A E + HPF 
Sbjct: 314 LTAIEALCHPFF 325

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 154
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 155 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+  G   F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 213 DEEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257
Query: 232 LK 233
           ++
Sbjct: 258 MQ 259

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 86
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 120
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E  +IHRDL   N L+     +K++DFG++  +     TS     F     + SPE  S 
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSF 178
Query: 144 GKYGYKSDIWSLGLVLLEC-ATGQFPY 169
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 86
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 65  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 123
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E  +IHRDL   N L+     +K++DFG++  +     TS     F     + SPE  S 
Sbjct: 124 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSF 181
Query: 144 GKYGYKSDIWSLGLVLLEC-ATGQFPY 169
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPY 208

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 86
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 82  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 140
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E  +IHRDL   N L+     +K++DFG++  +     TS     F     + SPE  S 
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSF 198
Query: 144 GKYGYKSDIWSLGLVLLEC-ATGQFPY 169
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPY 225

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 24/239 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           +S R +IA   K+ Q S    ++  Y    ++  I +++E      L  +LKK K+I   
Sbjct: 99  DSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQA 126
              +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   
Sbjct: 156 ERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 213
Query: 127 NTFVGTYNYMSPERISGGKYGYKS-----------DIWSLGLVLLECATGQFPYSPPEQQ 175
           ++ VGT NYM PE I       ++           D+WSLG +L     G+ P+     Q
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + AI+D        D    +    +  C++++P+QR+S  EL+ HP++++
Sbjct: 274 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 48  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 104
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HR+L   N+L+ +   VKI DFG++ 
Sbjct: 105 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRNLATRNILVENENRVKIGDFGLTK 163
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 164 VLPQDKEYYKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 218
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 219 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 274
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 275 NQRPSFRDL 283

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 186
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 187 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+  G   F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 245 DEEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289
Query: 232 LK 233
           ++
Sbjct: 290 MQ 291

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 187
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 188 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+  G   F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 246 DEEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290
Query: 232 LK 233
           ++
Sbjct: 291 MQ 292

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 187
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 188 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+  G   F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 246 DEEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290
Query: 232 LK 233
           ++
Sbjct: 291 MQ 292

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 187
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 188 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+  G   F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 246 DEEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290
Query: 232 LK 233
           ++
Sbjct: 291 MQ 292

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 186
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 187 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+  G   F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 245 DEEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289
Query: 232 LK 233
           ++
Sbjct: 290 MQ 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 186
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 187 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+  G   F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 245 DEEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 289
Query: 232 LK 233
           ++
Sbjct: 290 MQ 291

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 111/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++D   L  F+    +  
Sbjct: 48  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTG 102
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 162 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 221
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 222 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 282 KAALAHPFFQ 291

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 187
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 188 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 245
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+  G   F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 246 DEEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290
Query: 232 LK 233
           ++
Sbjct: 291 MQ 292

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 41  GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
            ++ I+ EYM+   LA+ L++   + EE+      Q+L+GL Y+H   +++HRDLKP+NL
Sbjct: 95  NSVYIVQEYMET-DLANVLEQGPLL-EEHARLFMYQLLRGLKYIH-SANVLHRDLKPANL 151
Query: 101 LINHRGEV-KITDFGVSAIMA---STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSL 155
            IN    V KI DFG++ IM    S  G  +  + T  Y SP   +S   Y    D+W+ 
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211
Query: 156 GLVLLECATGQFPYS---------------PPEQQDGWTSFYELMEAIV--DQPPPSAPS 198
           G +  E  TG+  ++               P   ++       ++   +  D   P  P 
Sbjct: 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL 271
Query: 199 DQFSP----EFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            Q  P    E   F+   +   P  RL+A+E ++HP++ +Y
Sbjct: 272 TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 86
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 121
Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 143
           E  +IHRDL   N L+     +K++DFG++  +     TS     F     + SPE  S 
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSF 179
Query: 144 GKYGYKSDIWSLGLVLLEC-ATGQFPY 169
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 117/251 (46%), Gaps = 12/251 (4%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E     + +E+  ++S + P +V   +   +   ++I++EY  GG L + +       E+
Sbjct: 56  EKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQA 126
                 +Q++ G+ Y  H   + HRDLK  N L++      +KI DFG S   +    Q 
Sbjct: 116 EARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP 173
Query: 127 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
            + VGT  Y++PE +   +Y G  +D+WS G+ L     G +P+  PE+     +F + +
Sbjct: 174 KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTI 230
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLK-MYGDLNVD-- 241
             I++           SPE    IS     +P +R+S  E+  H  FLK +  DL  D  
Sbjct: 231 HRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNT 290
Query: 242 LSEYFTDAGSP 252
           ++  F ++  P
Sbjct: 291 MTTQFDESDQP 301

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 30  VVVCYQSFYSNGAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 88
           V+     F    +  +ILE M+    L DF+ +   + EE   +   QVL+ + + H+  
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 89  HIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY- 146
            ++HRD+K  N+LI+ +RGE+K+ DFG  A++  T      F GT  Y  PE I   +Y 
Sbjct: 135 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYH 191
Query: 147 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 206
           G  + +WSLG++L +   G  P+   E+      F+                 + S E  
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------------QRVSSECQ 236
Query: 207 SFISACVQKEPQQRLSAQELMTHPFLK 233
             I  C+   P  R + +E+  HP+++
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM+ GSL DFLK    K   +P+  
Sbjct: 62  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKGETGKYLRLPQ-- 112
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 113 LVDMSAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG 171
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 172 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 225
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +KEP++R
Sbjct: 226 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 256

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM+ GSL DFLK    K   +P+  
Sbjct: 62  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKGETGKYLRLPQ-- 112
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 113 LVDMSAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 171
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 172 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 225
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +KEP++R
Sbjct: 226 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 256

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEYLAA 72
           QE ++ +  +   +V  Y +  S   I I+ EYM  GSL DFLK    K   +P+  L  
Sbjct: 52  QEAQVMKKLRHEKLVQLY-AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQ--LVD 108
Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 129
           +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q   F
Sbjct: 109 MAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF 167
Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 188
                + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +E  
Sbjct: 168 --PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERG 221
Query: 189 VDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
              P PP  P           +  C +KEP++R
Sbjct: 222 YRMPCPPECPES-----LHDLMCQCWRKEPEER 249

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 44/231 (19%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + +++E MD    A+  + +   +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 102 VYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 156
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  AST+     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 157 VKSDCTLKILDFGL-ARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 162 CATGQFPYSPPEQQDGW--------TSFYELMEAIVDQPP--------PSAPSDQFSPEF 205
              G   +   +  D W        T   E M A+  QP         P+ P   F   F
Sbjct: 216 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL--QPTVRNYVENRPAYPGIAFEELF 273
Query: 206 CSFI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 237
             +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 274 PDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 324

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 14/176 (7%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G+++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 117/249 (46%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+
Sbjct: 50  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDY 106
Query: 59  LK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+   + I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 107 LQAHAERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 165
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 166 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 220
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 221 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 276
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 277 NQRPSFRDL 285

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 14/176 (7%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G+++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 37/253 (14%)
Query: 7   VEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           V  SA R+I   +ELK         +V  +   +S+  ++++ E+ D      F      
Sbjct: 44  VPSSALREICLLKELKHKN------IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD 97
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           +  E + +   Q+LKGL + H  ++++HRDLKP NLLIN  GE+K+ +FG++        
Sbjct: 98  LDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDG------ 177
             +  V T  Y  P+ + G K Y    D+WS G +  E A    P  P    D       
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 178 ----------WTSFYELMEAIVDQPPPSAPSD--------QFSPEFCSFISACVQKEPQQ 219
                     W S  +L +    +P P  P+         + +      +   ++  P Q
Sbjct: 217 RLLGTPTEEQWPSMTKLPDY---KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 220 RLSAQELMTHPFL 232
           R+SA+E + HP+ 
Sbjct: 274 RISAEEALQHPYF 286

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 52  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 106
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 107 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 165
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 166 TYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 225
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 226 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 286 KAALAHPFFQ 295

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 58  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 108
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 109 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 167
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 168 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 221
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +KEP++R
Sbjct: 222 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 252

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY--MDGGSLADFLKKVKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E+  MD     D    +  
Sbjct: 46  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMD-ASALTG 100
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 101 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 159
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 160 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 219
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 220 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 280 KAALAHPFFQ 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 46  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 100
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 101 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 159
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 160 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 219
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 220 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 280 KAALAHPFFQ 289

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 44  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 98
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 278 KAALAHPFFQ 287

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 44  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 98
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 278 KAALAHPFFQ 287

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY--MDGGSLADFLKKVKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E+  MD     D    +  
Sbjct: 48  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMD-ASALTG 102
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 161
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 162 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 221
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 222 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 282 KAALAHPFFQ 291

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 44  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 98
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 278 KAALAHPFFQ 287

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 52  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 106
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 107 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 165
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 166 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 225
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 226 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 286 KAALAHPFFQ 295

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 118/249 (47%), Gaps = 38/249 (15%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADF 58
           +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+E++  GSL ++
Sbjct: 50  LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEFLPYGSLREY 106
Query: 59  LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   VKI DFG++ 
Sbjct: 107 LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRVKIGDFGLTK 165
Query: 118 IM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFP 168
           ++            G++  F     + +PE ++  K+   SD+WS G+VL E  T  +  
Sbjct: 166 VLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 220
Query: 169 YSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACVQKEP 217
            SPP +        + G    + L+E + +    P P    D    E    ++ C     
Sbjct: 221 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMIMTECWNNNV 276
Query: 218 QQRLSAQEL 226
            QR S ++L
Sbjct: 277 NQRPSFRDL 285

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAA 72
           +E  + ++ Q   +V  Y        I II EYM  GSL DFLK  +     +P+  L  
Sbjct: 57  EEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK--LID 114
Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 129
              Q+ +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F
Sbjct: 115 FSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 173
Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
                + +PE I+ G +  KSD+WS G++L E  T G+ PY
Sbjct: 174 --PIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I++EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVIEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 112/248 (45%), Gaps = 43/248 (17%)
Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
           +  ++AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  FL+     
Sbjct: 53  DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG-- 110
Query: 66  PEEYLAA---------------ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 110
           P+  L A               I +Q+  G++YL   +H +HRDL   N L+     VKI
Sbjct: 111 PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENLLVKI 169
Query: 111 TDFGVSAIMASTSGQANTFVGTY-----NYMSPERISGGKYGYKSDIWSLGLVLLECAT- 164
            DFG+S  + ST       VG +      +M PE I   K+  +SD+WSLG+VL E  T 
Sbjct: 170 GDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 226
Query: 165 GQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
           G+ P+          S  E++E I    V Q P + P + +       +  C Q+EP  R
Sbjct: 227 GKQPWYQ-------LSNNEVIECITQGRVLQRPRTCPQEVY-----ELMLGCWQREPHMR 274
Query: 221 LSAQELMT 228
            + + + T
Sbjct: 275 KNIKGIHT 282

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I++EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVIEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 49  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 103
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 104 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 162
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 163 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 222
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 223 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 283 KAALAHPFFQ 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 46  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 100
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 101 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 159
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 160 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 219
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 220 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 280 KAALAHPFFQ 289

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 314 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 364
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 365 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 424 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 477
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 478 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYLQA--FLEDY 521

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXG-VLHRDIKDENILIDLNRGELKLID 154
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 155 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 213 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 257
Query: 232 LK 233
           ++
Sbjct: 258 MQ 259

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 46  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 100
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 101 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 159
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 160 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 219
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 220 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 280 KAALAHPFFQ 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 47  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 101
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 102 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR 160
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 161 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 220
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 221 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 281 KAALAHPFFQ 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 46  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 100
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 101 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 159
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 160 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 219
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 220 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 280 KAALAHPFFQ 289

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 114/239 (47%), Gaps = 24/239 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           +S R +IA   K+ Q S    ++  Y    ++  I +++E      L  +LKK K+I   
Sbjct: 99  DSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQA 126
              +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   
Sbjct: 156 ERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 213
Query: 127 NTFVGTYNYMSPERISGGKYGYKS-----------DIWSLGLVLLECATGQFPYSPPEQQ 175
           ++ VG  NYM PE I       ++           D+WSLG +L     G+ P+     Q
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + AI+D        D    +    +  C++++P+QR+S  EL+ HP++++
Sbjct: 274 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 44  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 98
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 158 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 278 KAALAHPFFQ 287

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 44  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 98
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 158 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 278 KAALAHPFFQ 287

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 21/223 (9%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAA 72
           ++A   K+      P V+     F +     ++LE  +    L D++ +   + E     
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVG 131
              QV+  + + H  + ++HRD+K  N+LI+  RG  K+ DFG  A++         F G
Sbjct: 144 FFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDG 200
Query: 132 TYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           T  Y  PE IS  +Y    + +WSLG++L +   G  P+    ++D      E++EA + 
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF----ERD-----QEILEAELH 251
Query: 191 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            P         SP+ C+ I  C+  +P  R S +E++  P+++
Sbjct: 252 FP------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 45  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 99
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 100 IPLPLIKSYLFQLLQGLSFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 159 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 218
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 219 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 279 KAALAHPFFQ 288

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 47  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 101
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 102 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 160
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 161 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 220
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 221 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 281 KAALAHPFFQ 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 49  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 103
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 104 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 162
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 163 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 222
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 223 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 283 KAALAHPFFQ 292

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/312 (24%), Positives = 130/312 (41%), Gaps = 57/312 (18%)
Query: 2   VIQMNVEESARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 58
           V ++N+E  +   +     EL +++    P +V    +F ++  + ++  +M  GS  D 
Sbjct: 57  VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDL 116
Query: 59  L--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           +    +  + E  +A I + VLK L Y+HH  ++ HR +K S++LI+  G+V ++    +
Sbjct: 117 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHILISVDGKVYLSGLRSN 175
Query: 117 AIMASTSGQANTFVGTYN--------YMSPERISGGKYGY--KSDIWSLGLVLLECATGQ 166
             M S  GQ    V  +         ++SPE +     GY  KSDI+S+G+   E A G 
Sbjct: 176 LSMIS-HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
Query: 167 FPYS--------------------------------PPEQQDGWTSFYELMEAIVDQP-- 192
            P+                                  P +    +   + +     +P  
Sbjct: 235 VPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN 294
Query: 193 --PPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 249
              PS P  + FSP F  F+  C+Q+ P  R SA  L+ H F K    +    SE   + 
Sbjct: 295 GDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK---QIKRRASEALPEL 351
Query: 250 GSPLATLSNLSG 261
             P+  ++N  G
Sbjct: 352 LRPVTPITNFEG 363

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 48  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 102
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 162 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 221
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 222 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 282 KAALAHPFFQ 291

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 48  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 102
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 162 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 221
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 222 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 282 KAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 47  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 101
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 102 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 160
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 161 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 220
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 221 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 281 KAALAHPFFQ 290

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 17/188 (9%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 84  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 142
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 143 GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 202
Query: 162 CAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
            AT G  PY    P Q       YEL+E       P    ++        + AC Q  P 
Sbjct: 203 IATYGMSPYPGIDPSQ------VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPS 252
Query: 219 QRLSAQEL 226
            R S  E+
Sbjct: 253 DRPSFAEI 260

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 16/253 (6%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+ +R+I      ++S + P +V   +   +   ++I++EY  GG L + +       
Sbjct: 58  IDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 113
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSG 124
           E+      +Q++ G+ Y  H   + HRDLK  N L++      +KI  FG S   +    
Sbjct: 114 EDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK-SSVLHS 171
Query: 125 QANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
           Q  + VGT  Y++PE +   +Y G  +D+WS G+ L     G +P+  PE+     +F +
Sbjct: 172 QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRK 228
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLK-MYGDLNVD 241
            +  I++           SPE    IS     +P +R+S  E+  H  FLK +  DL  D
Sbjct: 229 TIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMND 288
Query: 242 --LSEYFTDAGSP 252
             ++  F ++  P
Sbjct: 289 NTMTTQFDESDQP 301

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
           V  +A R+I+   ++N     P +V      ++   + ++ E++    L  F+    +  
Sbjct: 48  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTG 102
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++        
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 161
Query: 125 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
                V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D     + 
Sbjct: 162 TYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 221
Query: 184 LM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEPQQRLSA 223
            +            ++ D  P  P      FS        +  S +S  +  +P +R+SA
Sbjct: 222 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 224 QELMTHPFLK 233
           +  + HPF +
Sbjct: 282 KAALAHPFFQ 291

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/312 (24%), Positives = 130/312 (41%), Gaps = 57/312 (18%)
Query: 2   VIQMNVEESARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 58
           V ++N+E  +   +     EL +++    P +V    +F ++  + ++  +M  GS  D 
Sbjct: 41  VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDL 100
Query: 59  L--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           +    +  + E  +A I + VLK L Y+HH  ++ HR +K S++LI+  G+V ++    +
Sbjct: 101 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHILISVDGKVYLSGLRSN 159
Query: 117 AIMASTSGQANTFVGTYN--------YMSPERISGGKYGY--KSDIWSLGLVLLECATGQ 166
             M S  GQ    V  +         ++SPE +     GY  KSDI+S+G+   E A G 
Sbjct: 160 LSMIS-HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 218
Query: 167 FPYS--------------------------------PPEQQDGWTSFYELMEAIVDQP-- 192
            P+                                  P +    +   + +     +P  
Sbjct: 219 VPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN 278
Query: 193 --PPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 249
              PS P  + FSP F  F+  C+Q+ P  R SA  L+ H F K    +    SE   + 
Sbjct: 279 GDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK---QIKRRASEALPEL 335
Query: 250 GSPLATLSNLSG 261
             P+  ++N  G
Sbjct: 336 LRPVTPITNFEG 347

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL  +   +HRDL   N+LIN     K++DFG+S +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLS-DMGFVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVGEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 112/239 (46%), Gaps = 24/239 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           +S R +IA   K+ Q S    ++  Y    ++  I +++E      L  +LKK K+I   
Sbjct: 71  DSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 127
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-- 126
              +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M         
Sbjct: 128 ERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDXXXVVK 185
Query: 127 NTFVGTYNYMSPERISGGKYGYKS-----------DIWSLGLVLLECATGQFPYSPPEQQ 175
           ++ VGT NYM PE I       ++           D+WSLG +L     G+ P+     Q
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + AI+D        D    +    +  C++++P+QR+S  EL+ HP++++
Sbjct: 246 ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 80/145 (55%), Gaps = 9/145 (6%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK 88
           +V   +  +   I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  ++
Sbjct: 72  LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QR 130
Query: 89  HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGK 145
           + IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ G 
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGS 188
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY 169
           +  KSD+WS G++L+E  T G+ PY
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 109/256 (42%), Gaps = 41/256 (16%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE--------YMDGGSLADF 58
           V  +A R+I+   ++N     P +V      ++   + ++ E        +MD  +L   
Sbjct: 44  VPSTAIREISLLKELNH----PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTG- 98
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                 IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G +K+ DFG++  
Sbjct: 99  ------IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARA 151
Query: 119 MASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
                      V T  Y +PE + G K Y    DIWSLG +  E  T +  +    + D 
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
Query: 178 WTSFYELM-----------EAIVDQPP--PSAPSDQFSP-------EFCSFISACVQKEP 217
               +  +            ++ D  P  P      FS        +  S +S  +  +P
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 218 QQRLSAQELMTHPFLK 233
            +R+SA+  + HPF +
Sbjct: 272 NKRISAKAALAHPFFQ 287

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 54  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 104
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 105 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 163
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 164 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 217
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 218 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 248

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 56  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 106
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 107 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 165
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 166 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 219
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 220 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 250

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 87  IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 145
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 146 GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 205
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 206 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 257
Query: 221 LSAQEL 226
            S  E+
Sbjct: 258 PSFAEI 263

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 42/230 (18%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   +     +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A T+     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 163 ATGQFPYSPPEQQDGW--------TSFYELMEAIVDQPP--------PSAPSDQFSPEFC 206
             G   +   +  D W        T   E M A+  QP         P  P  +F   F 
Sbjct: 219 VKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL--QPTVRNYVENRPKYPGIKFEELFP 276
Query: 207 SFI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 237
            +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 277 DWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 326

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 119/253 (47%), Gaps = 16/253 (6%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+ +R+I      ++S + P +V   +   +   ++I++EY  GG L + +       
Sbjct: 58  IDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 113
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSG 124
           E+      +Q++ G+ Y  H   + HRDLK  N L++      +KI  FG S      S 
Sbjct: 114 EDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ 172
Query: 125 QANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
             +T VGT  Y++PE +   +Y G  +D+WS G+ L     G +P+  PE+     +F +
Sbjct: 173 PKDT-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRK 228
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLK-MYGDLNVD 241
            +  I++           SPE    IS     +P +R+S  E+  H  FLK +  DL  D
Sbjct: 229 TIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMND 288
Query: 242 --LSEYFTDAGSP 252
             ++  F ++  P
Sbjct: 289 NTMTTQFDESDQP 301

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 42/243 (17%)
Query: 10  SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-------- 61
           +AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  FL+         
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 62  VKTIPEE--------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
           V   P +         +  I  Q+  G++YL   +H +HRDL   N L+     VKI DF
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 114 GVSAIMASTSGQANTFVGTY-----NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 167
           G+S  + ST       VG +      +M PE I   K+  +SD+WS G++L E  T G+ 
Sbjct: 178 GMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 168 PYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 223
           P+          S  E++E I    V + P   P + +       +  C Q+EPQQRL+ 
Sbjct: 235 PWFQ-------LSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQREPQQRLNI 282
Query: 224 QEL 226
           +E+
Sbjct: 283 KEI 285

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 154
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 155 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 213 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257
Query: 232 LK 233
           ++
Sbjct: 258 MQ 259

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 SELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 256
Query: 221 LSAQEL 226
            S  E+
Sbjct: 257 PSFAEI 262

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 157
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 158 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 215
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 216 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 260
Query: 232 LK 233
           ++
Sbjct: 261 MQ 262

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVCEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K
Sbjct: 78  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 137
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S +
Sbjct: 138 HDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRV 194
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 195 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 254
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 255 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 300

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKSQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG   +   T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 SELKILDFG---LCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 12  RRQIAQELKINQSSQCPYVVVCY------QSFYSNGAISIILEYMDGGSLADFLKKVKT- 64
           R +   E++I +    P VV         Q    N    + +EY +GG L  +L + +  
Sbjct: 56  RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC 115
Query: 65  --IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIM 119
             + E  +  +   +   L YLH E  IIHRDLKP N+++     R   KI D G +  +
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174
Query: 120 ASTSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
               G+  T FVGT  Y++PE +   KY    D WS G +  EC TG  P+ P  Q   W
Sbjct: 175 --DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 SELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEYLAA 72
           QE ++ +  +   +V  Y +  S   I I+ EYM  GSL DFLK    K   +P+  L  
Sbjct: 62  QEAQVMKKIRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ--LVD 118
Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 129
           +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q   F
Sbjct: 119 MAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 177
Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 188
                + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +E  
Sbjct: 178 --PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERG 231
Query: 189 VDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
              P PP  P           +  C +K+P++R
Sbjct: 232 YRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 15/187 (8%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 12  RRQIAQELKINQSSQCPYVVVCY------QSFYSNGAISIILEYMDGGSLADFLKKVKT- 64
           R +   E++I +    P VV         Q    N    + +EY +GG L  +L + +  
Sbjct: 57  RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC 116
Query: 65  --IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIM 119
             + E  +  +   +   L YLH E  IIHRDLKP N+++     R   KI D G +  +
Sbjct: 117 CGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 175
Query: 120 ASTSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
               G+  T FVGT  Y++PE +   KY    D WS G +  EC TG  P+ P  Q   W
Sbjct: 176 --DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 233

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 91  IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 149
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 210 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 261
Query: 221 LSAQEL 226
            S  E+
Sbjct: 262 PSFAEI 267

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 60  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGXLLDYVREHKDN 114
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 115 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 174 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLID 159
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 160 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 218 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 262
Query: 232 LK 233
           ++
Sbjct: 263 MQ 264

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 18/233 (7%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K 
Sbjct: 69  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 128
Query: 63  K---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
               T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S ++
Sbjct: 129 DAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRVL 185
Query: 120 ASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 175
                 A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     Q
Sbjct: 186 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 245
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           D       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 246 D---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 290

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLID 159
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 160 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 218 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 262
Query: 232 LK 233
           ++
Sbjct: 263 MQ 264

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLID 158
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 159 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 216
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 217 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 261
Query: 232 LK 233
           ++
Sbjct: 262 MQ 263

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 201
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 202 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 260 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304
Query: 232 LK 233
           ++
Sbjct: 305 MQ 306

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 186
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 187 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 244
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 245 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289
Query: 232 LK 233
           ++
Sbjct: 290 MQ 291

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 44/240 (18%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 90
            V Y  F S   + ++L+ M+   L   +   + +  E++     Q+L+GL Y+H    +
Sbjct: 125 TVPYGEFKS---VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-SAQV 179
Query: 91  IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF----VGTYNYMSPE-RISGGK 145
           IHRDLKPSNLL+N   E+KI DFG++  + ++  +   F    V T  Y +PE  +S  +
Sbjct: 180 IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 239
Query: 146 YGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPP--------- 194
           Y    D+WS+G +  E    +  FP         +    +L+  ++  P P         
Sbjct: 240 YTQAIDLWSVGCIFGEMLARRQLFP------GKNYVHQLQLIMMVLGTPSPAVIQAVGAE 293
Query: 195 -------SAPSDQFSP----------EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                  S P  Q  P          +  S +   ++ EP  R+SA   + HPFL  Y D
Sbjct: 294 RVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLID 159
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 160 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 217
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 218 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 262
Query: 232 LK 233
           ++
Sbjct: 263 MQ 264

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK 88
           +V   +  +   I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  ++
Sbjct: 245 LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QR 303
Query: 89  HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGK 145
           + IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ G 
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGS 361
Query: 146 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 201
           +  KSD+WS G++L+E  T G+ PY   S PE        Y +        P + P    
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------PENCPE--- 412
Query: 202 SPEFCSFISACVQKEPQQR 220
             E  + +  C +  P++R
Sbjct: 413 --ELYNIMMRCWKNRPEER 429

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 113
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 44/240 (18%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 90
            V Y  F S   + ++L+ M+   L   +   + +  E++     Q+L+GL Y+H    +
Sbjct: 126 TVPYGEFKS---VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-SAQV 180
Query: 91  IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF----VGTYNYMSPE-RISGGK 145
           IHRDLKPSNLL+N   E+KI DFG++  + ++  +   F    V T  Y +PE  +S  +
Sbjct: 181 IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 240
Query: 146 YGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPP--------- 194
           Y    D+WS+G +  E    +  FP         +    +L+  ++  P P         
Sbjct: 241 YTQAIDLWSVGCIFGEMLARRQLFP------GKNYVHQLQLIMMVLGTPSPAVIQAVGAE 294
Query: 195 -------SAPSDQFSP----------EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                  S P  Q  P          +  S +   ++ EP  R+SA   + HPFL  Y D
Sbjct: 295 RVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 18/233 (7%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K 
Sbjct: 52  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 111
Query: 63  K---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
               T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S ++
Sbjct: 112 DAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRVL 168
Query: 120 ASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 175
                 A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     Q
Sbjct: 169 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 228
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           D       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 229 D---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 273

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 201
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 202 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 260 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304
Query: 232 LK 233
           ++
Sbjct: 305 MQ 306

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 32/231 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 232 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 282
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG+  ++     T+ Q 
Sbjct: 283 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG 341
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 342 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 395
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           E     P PP  P           +  C +K+P++R + + L    FL+ Y
Sbjct: 396 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEERPTFEYL--QAFLEDY 439

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 115
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 116 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 60  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 114
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 115 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 174 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 173
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 174 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 232 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 276
Query: 232 LK 233
           ++
Sbjct: 277 MQ 278

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 120
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 121 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 174
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 175 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 233 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 277
Query: 232 LK 233
           ++
Sbjct: 278 MQ 279

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 116
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 117 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 193
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 194 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 252 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296
Query: 232 LK 233
           ++
Sbjct: 297 MQ 298

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 117
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 118 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 176
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 177 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 173
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 174 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 231
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 232 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 276
Query: 232 LK 233
           ++
Sbjct: 277 MQ 278

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 201
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 202 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 259
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 260 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 304
Query: 232 LK 233
           ++
Sbjct: 305 MQ 306

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I++EYM  G L DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVMEYMSKGCLLDFLKGEMGKYLRLPQ-- 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 174
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 175 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 233 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 277
Query: 232 LK 233
           ++
Sbjct: 278 MQ 279

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 174
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 175 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 232
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 233 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPW 277
Query: 232 LK 233
           ++
Sbjct: 278 MQ 279

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 181
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 182 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 239
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 240 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 284
Query: 232 LK 233
           ++
Sbjct: 285 MQ 286

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 112
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 206
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 171
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 207 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 264
Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 265 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 309
Query: 232 LK 233
           ++
Sbjct: 310 MQ 311

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 89/188 (47%), Gaps = 17/188 (9%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 84  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 142
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 143 GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 202
Query: 162 CAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
            AT G  PY    P Q       YEL+E       P    ++        + AC Q  P 
Sbjct: 203 IATYGMSPYPGIDPSQ------VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPS 252
Query: 219 QRLSAQEL 226
            R S  E+
Sbjct: 253 DRPSFAEI 260

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 149
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 150 GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 210 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 261
Query: 221 LSAQEL 226
            S  E+
Sbjct: 262 PSFAEI 267

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 115 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 172
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 173 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 230 GRTLFP 235

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 114 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 171
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 172 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 229 GRTLFP 234

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 103 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 160
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 161 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 218 GRTLFP 223

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG++ +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLARV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 85/163 (52%), Gaps = 9/163 (5%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 67
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 68  ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--ST 122
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 165
           +   +  VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 189 TVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 19/189 (10%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 84  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 142
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 143 GENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 202
Query: 162 CAT-GQFPYS--PPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEP 217
            AT G  PY    P Q       YEL+E     + P   P   +       + AC Q  P
Sbjct: 203 IATYGMSPYPGIDPSQ------VYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNP 251
Query: 218 QQRLSAQEL 226
             R S  E+
Sbjct: 252 SDRPSFAEI 260

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 40/248 (16%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  FL++
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119
Query: 62  VKTI------------------PEEY------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
            + +                  P+E       L +   Q+ +G+ YL  E  ++HRDL  
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAA 178
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSL 155
            N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+WS 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 156 GLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 212
           G++L E  T G  PY   PPE+       + L++       P    D  S E    +  C
Sbjct: 239 GVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLMLQC 288
Query: 213 VQKEPQQR 220
            ++EP +R
Sbjct: 289 WKQEPDKR 296

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL  +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 101 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 158
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 159 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 216 GRTLFP 221

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 115 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 172
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 173 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 230 GRTLFP 235

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 256
Query: 221 LSAQEL 226
            S  E+
Sbjct: 257 PSFAEI 262

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 101 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 158
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 159 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 216 GRTLFP 221

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P +V  Y +      ++I +E ++GGSL   +K++  +PE+       Q L+GL YL H 
Sbjct: 126 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HT 184
Query: 88  KHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFV------GTYNYMSPER 140
           + I+H D+K  N+L++  G    + DFG  A+     G   + +      GT  +M+PE 
Sbjct: 185 RRILHGDVKADNVLLSSDGSRAALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 141 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAP 197
           + G     K DIWS   ++L    G  P         WT ++     ++   + PP    
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNGCHP---------WTQYFRGPLCLKIASEPPPIREI 294
Query: 198 SDQFSPEFCSFISACVQKEPQQRLSAQEL 226
               +P     I   ++KEP  R SA EL
Sbjct: 295 PPSCAPLTAQAIQEGLRKEPVHRASAMEL 323

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 149
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 210 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 261
Query: 221 LSAQEL 226
            S  E+
Sbjct: 262 PSFAEI 267

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 127 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 184
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 185 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 242 GRTLFP 247

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 123 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 180
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 181 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 238 GRTLFP 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 102 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 159
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 160 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 217 GRTLFP 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 123 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 180
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 181 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 238 GRTLFP 243

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 256
Query: 221 LSAQEL 226
            S  E+
Sbjct: 257 PSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 149
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 210 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 260
Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 261 RPSFAEI 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 90  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 148
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 149 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 208
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 209 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 260
Query: 221 LSAQEL 226
            S  E+
Sbjct: 261 PSFAEI 266

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 40/248 (16%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  FL++
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119
Query: 62  VKTI------------------PEEY------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
            + +                  P+E       L +   Q+ +G+ YL  E  ++HRDL  
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMSLVHRDLAA 178
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSL 155
            N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+WS 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 156 GLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 212
           G++L E  T G  PY   PPE+       + L++       P    D  S E    +  C
Sbjct: 239 GVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLMLQC 288
Query: 213 VQKEPQQR 220
            ++EP +R
Sbjct: 289 WKQEPDKR 296

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 99  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 157
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 158 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 217
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 218 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 268
Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 269 RPSFAEI 275

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+  +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P +V  Y +      ++I +E ++GGSL   +K++  +PE+       Q L+GL YL H 
Sbjct: 124 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HT 182
Query: 88  KHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFV------GTYNYMSPER 140
           + I+H D+K  N+L++  G    + DFG  A+     G   + +      GT  +M+PE 
Sbjct: 183 RRILHGDVKADNVLLSSDGSRAALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 141 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAP 197
           + G     K DIWS   ++L    G  P         WT ++     ++   + PP    
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNGCHP---------WTQYFRGPLCLKIASEPPPIREI 292
Query: 198 SDQFSPEFCSFISACVQKEPQQRLSAQEL 226
               +P     I   ++KEP  R SA EL
Sbjct: 293 PPSCAPLTAQAIQEGLRKEPVHRASAMEL 321

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 127 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 184
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 185 CELKILDFGLA---RHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 242 GRTLFP 247

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 146
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 207 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 258
Query: 221 LSAQEL 226
            S  E+
Sbjct: 259 PSFAEI 264

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P +V  Y +      ++I +E ++GGSL   +K++  +PE+       Q L+GL YL H 
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HT 168
Query: 88  KHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFV------GTYNYMSPER 140
           + I+H D+K  N+L++  G    + DFG  A+     G   + +      GT  +M+PE 
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 141 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAP 197
           + G     K DIWS   ++L    G  P         WT ++     ++   + PP    
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP---------WTQYFRGPLCLKIASEPPPIREI 278
Query: 198 SDQFSPEFCSFISACVQKEPQQRLSAQEL 226
               +P     I   ++KEP  R SA EL
Sbjct: 279 PPSCAPLTAQAIQEGLRKEPVHRASAMEL 307

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 117
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG + ++ +   
Sbjct: 118 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 176
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 177 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 84/163 (51%), Gaps = 9/163 (5%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 67
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 68  ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--ST 122
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 165
           +      VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 189 TVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 146
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 207 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 257
Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 258 RPSFAEI 264

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGXLLDYVREHKDN 113
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 115
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG + ++ +   
Sbjct: 116 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 84  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 138
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 139 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 197
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 198 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 149
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 210 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 260
Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 261 RPSFAEI 267

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I++ M  G L D++++ K  
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGCLLDYVREHKDN 115
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG + ++ +   
Sbjct: 116 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 69  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 123
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 124 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 182
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 183 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 116
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 117 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 113
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 14/168 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 65  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 119
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 120 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 178
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 179 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 93  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 147
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 148 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 206
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 207 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 116
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 117 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 8/132 (6%)
Query: 43  ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I II EYM  G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L
Sbjct: 79  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCL 137
Query: 102 INHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +N +G VK++DFG+S  +     TS + + F     +  PE +   K+  KSDIW+ G++
Sbjct: 138 VNDQGVVKVSDFGLSRYVLDDEYTSSRGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVL 195
Query: 159 LLEC-ATGQFPY 169
           + E  + G+ PY
Sbjct: 196 MWEIYSLGKMPY 207

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 40/248 (16%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  FL++
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119
Query: 62  VKTI------------------PEEY------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
            + +                  P+E       L +   Q+ +G+ YL  E  ++HRDL  
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAA 178
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSL 155
            N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+WS 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 156 GLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 212
           G++L E  T G  PY   PPE+       + L++       P    D  S E    +  C
Sbjct: 239 GVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLMLQC 288
Query: 213 VQKEPQQR 220
            ++EP +R
Sbjct: 289 WKQEPDKR 296

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 14/168 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 120
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 121 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 53  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 107
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 108 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 113
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 116
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 117 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 115
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 116 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 120
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 121 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 69
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  G L DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGCLLDFLKGEMGKYLRLPQ-- 115
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 126
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 185
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 186 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 36  SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------K 88
           S +S+  + +I  Y + GSL D+L+ + T+       I   +  GL +LH E        
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 89  HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPE----- 139
            I HRDLK  N+L+   G+  I D G++ + + ++ Q     N  VGT  YM+PE     
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192
Query: 140 -RISGGKYGYKSDIWSLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-V 189
            ++       + DIW+ GLVL E A           Y PP  +      SF ++ + + V
Sbjct: 193 IQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV 252
Query: 190 DQPPPSAPSDQFS-PEFCS---FISACVQKEPQQRLSA 223
           DQ  P+ P+  FS P   S    +  C  + P  RL+A
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAA 72
           +E  + ++ Q   +V  Y        I II E+M  GSL DFLK  +     +P+  L  
Sbjct: 56  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPK--LID 113
Query: 73  ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 129
              Q+ +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F
Sbjct: 114 FSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 172
Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
                + +PE I+ G +  KS++WS G++L E  T G+ PY
Sbjct: 173 --PIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 36  SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------K 88
           S +S+  + +I  Y + GSL D+L+ + T+       I   +  GL +LH E        
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 89  HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPE----- 139
            I HRDLK  N+L+   G+  I D G++ + + ++ Q     N  VGT  YM+PE     
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192
Query: 140 -RISGGKYGYKSDIWSLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-V 189
            ++       + DIW+ GLVL E A           Y PP  +      SF ++ + + V
Sbjct: 193 IQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV 252
Query: 190 DQPPPSAPSDQFS-PEFCS---FISACVQKEPQQRLSA 223
           DQ  P+ P+  FS P   S    +  C  + P  RL+A
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 113 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        PEQ+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 232 LDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 291
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 292 LTFNPHKRIEVEQALAHPYLEQYYD 316

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
              G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 54/268 (20%)
Query: 17  QELKINQSSQCPYVVVCYQ-----SFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEY 69
           +E+KI +  +   ++  +      SF +   + II E M      D  + + T  + +++
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDH 113
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM-------AST 122
           +     Q L+ +  LH   ++IHRDLKPSNLLIN   ++K+ DFG++ I+       +  
Sbjct: 114 IQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 123 SGQAN---TFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
           +GQ +    FV T  Y +PE  ++  KY    D+WS G +L E     F   P      +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL----FLRRPIFPGRDY 228
Query: 179 TSFYELMEAIVDQPP-----------------------PSAPSDQF----SPEFCSFISA 211
                L+  I+  P                        P+AP ++     +P+    +  
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 212 CVQKEPQQRLSAQELMTHPFLKMYGDLN 239
            +  +P +R++A+E + HP+L+ Y D N
Sbjct: 289 MLVFDPAKRITAKEALEHPYLQTYHDPN 316

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 113
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 83/163 (50%), Gaps = 9/163 (5%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 67
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 68  ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 124 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 125 QA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 165
                  VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 183 XVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 224

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 76/142 (53%), Gaps = 13/142 (9%)
Query: 31  VVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK 88
           +V   +  +   I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  ++
Sbjct: 239 LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QR 297
Query: 89  HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 148
           + IHRDL+ +N+L++     KI DFG++ + A              + +PE I+ G +  
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGLARVGAKFP---------IKWTAPEAINFGSFTI 348
Query: 149 KSDIWSLGLVLLECAT-GQFPY 169
           KSD+WS G++L+E  T G+ PY
Sbjct: 349 KSDVWSFGILLMEIVTYGRIPY 370

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  FLKK 
Sbjct: 58  LKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKN 117
Query: 63  K---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
               T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S ++
Sbjct: 118 DGQFTVIQ--LVGMLRGISAGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRVL 174
Query: 120 ASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 175
                 A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY     Q
Sbjct: 175 EDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQ 234
Query: 176 D 176
           D
Sbjct: 235 D 235

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 36  SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------K 88
           S +S+  + +I  Y + GSL D+L+ + T+       I   +  GL +LH E        
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 161
Query: 89  HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPE----- 139
            I HRDLK  N+L+   G+  I D G++ + + ++ Q     N  VGT  YM+PE     
Sbjct: 162 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 221
Query: 140 -RISGGKYGYKSDIWSLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-V 189
            ++       + DIW+ GLVL E A           Y PP  +      SF ++ + + V
Sbjct: 222 IQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV 281
Query: 190 DQPPPSAPSDQFS-PEFCS---FISACVQKEPQQRLSA 223
           DQ  P+ P+  FS P   S    +  C  + P  RL+A
Sbjct: 282 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 319

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 15/222 (6%)
Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLA 71
           R++A+     +  Q P  V   Q++   G + +  E + G SL    +    ++PE  + 
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVW 160
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
                 L  L +LH +  ++H D+KP+N+ +  RG  K+ DFG+  +   T+G      G
Sbjct: 161 GYLRDTLLALAHLHSQG-LVHLDVKPANIFLGPRGRCKLGDFGL-LVELGTAGAGEVQEG 218
Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
              YM+PE +  G YG  +D++SLGL +LE A        P   +GW    +L +  +  
Sbjct: 219 DPRYMAPELLQ-GSYGTAADVFSLGLTILEVACN---MELPHGGEGWQ---QLRQGYL-- 269
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            PP   +   S E  S +   ++ +P+ R +A+ L+  P L+
Sbjct: 270 -PPEFTAG-LSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI D+G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDYGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 56  ADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
           AD  K +KT  +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DF
Sbjct: 130 ADLYKLLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDF 188
Query: 114 GVSAIM---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--F 167
           G++ +       +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  F
Sbjct: 189 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248
Query: 168 P--------------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS---- 207
           P                 P Q+D       +    ++  P  +  P ++  P   S    
Sbjct: 249 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 308
Query: 208 FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
            +   +   P +R+  ++ + HP+L+ Y D
Sbjct: 309 LLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 16/182 (8%)
Query: 45  IILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           II EYM+ G+L  FL+ K        L  +   +  G+ YL +  ++ HRDL   N+L+N
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV-HRDLAARNILVN 181
Query: 104 HRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLL 160
                K++DFG+S ++        T  G      + +PE IS  K+   SD+WS G+V+ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241
Query: 161 ECAT-GQFPYSPPEQQDGWT-SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
           E  T G+ PY        W  S +E+M+AI D      P D  S  +   +  C Q+E  
Sbjct: 242 EVMTYGERPY--------WELSNHEVMKAINDGFRLPTPMDCPSAIY-QLMMQCWQQERA 292
Query: 219 QR 220
           +R
Sbjct: 293 RR 294

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +    V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 31/240 (12%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I+ E +DGG L   ++    +
Sbjct: 100 KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQ 156
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 157 AFTEREASEIXKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
           S +         Y Y++PE +   KY    D WSLG++      G  P+        SP 
Sbjct: 216 SHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPG 274
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR +  E   HP++
Sbjct: 275 XKTRIRXGQYEF---------PNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           ++ E M GGS+   + K +   E   + + + V   L +LH+ K I HRDLKP N+L  H
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH 146
Query: 105 RGE---VKITDFGV-SAIMAS------TSGQANTFVGTYNYMSPERI-----SGGKYGYK 149
             +   VKI DFG+ S I  +      ++ +  T  G+  YM+PE +         Y  +
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 150 SDIWSLGLVLLECATGQFPYSPPEQQD-GWT------SFYELMEAIVDQPPPSAPSDQFS 202
            D+WSLG++L    +G  P+      D GW       +   ++   + +     P   ++
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWA 266
Query: 203 PEFCS---FISACVQKEPQQRLSAQELMTHPFLK 233
              C+    IS  + ++ +QRLSA +++ HP+++
Sbjct: 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 115
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG + ++ +   
Sbjct: 116 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 87  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 145
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A         + +PE ++  K+  KSD+W+ G++L E
Sbjct: 146 GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 205
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 206 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 256
Query: 220 RLSAQEL 226
           R S  E+
Sbjct: 257 RPSFAEI 263

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 113
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG + ++ +   
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 172
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 146
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A         + +PE ++  K+  KSD+W+ G++L E
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 207 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 258
Query: 221 LSAQEL 226
            S  E+
Sbjct: 259 PSFAEI 264

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 73/132 (55%), Gaps = 8/132 (6%)
Query: 43  ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I II EYM  G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L
Sbjct: 78  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCL 136
Query: 102 INHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +N +G VK++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G++
Sbjct: 137 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVL 194
Query: 159 LLEC-ATGQFPY 169
           + E  + G+ PY
Sbjct: 195 MWEIYSLGKMPY 206

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           +++ +M G  L   +K  K + E+ +  +  Q+LKGL Y+H    IIHRDLKP NL +N 
Sbjct: 107 LVMPFM-GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNE 163
Query: 105 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECA 163
             E+KI DFG++        +    V T  Y +PE I +  +Y    DIWS+G ++ E  
Sbjct: 164 DCELKILDFGLA---RQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPP-------------------PSAPSDQF--- 201
           TG+  +   +  D      E+M+ +   PP                   P      F   
Sbjct: 221 TGKTLFKGSDHLD---QLKEIMK-VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276
Query: 202 ----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
               SP   + +   +  + +QR++A E + HP+ +   D
Sbjct: 277 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE-YMDGGSLADFLKKVKTI 65
           +E+    ++  E+ I    +   ++     F + G   +++E +  G  L  F+ +   +
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            E   + I  Q++  + YL   K IIHRD+K  N++I     +K+ DFG SA        
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERGKL 185
Query: 126 ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
             TF GT  Y +PE + G  Y G + ++WSLG+ L      + P+   E         E 
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE---------ET 236
Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           +EA +       P    S E  S +S  +Q  P++R + ++L+T P++
Sbjct: 237 VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL  +   +HRDL   N+LIN     K++DFG+S +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLS-DMGAVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 18/234 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  FL+K
Sbjct: 80  TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK 139
Query: 62  VK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S +
Sbjct: 140 HDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 257 QD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 73/132 (55%), Gaps = 8/132 (6%)
Query: 43  ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I II EYM  G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L
Sbjct: 74  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCL 132
Query: 102 INHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +N +G VK++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G++
Sbjct: 133 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVL 190
Query: 159 LLEC-ATGQFPY 169
           + E  + G+ PY
Sbjct: 191 MWEIYSLGKMPY 202

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLLIN   ++KI DFG++ I
Sbjct: 135 LLKSQQLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLINTTCDLKICDFGLARI 193
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 194 ADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253
Query: 169 ----------YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF-------CSFISA 211
                        P Q+D       +      Q  PS     ++  F          +  
Sbjct: 254 LDQLNHILGILGSPSQED-LNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDR 312
Query: 212 CVQKEPQQRLSAQELMTHPFLKMYGD 237
            +   P +R++ +E + HP+L+ Y D
Sbjct: 313 MLTFNPNKRITVEEALAHPYLEQYYD 338

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 120
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG + ++ +   
Sbjct: 121 IGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 179
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNI 151
Query: 101 LINHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 156
           L+   G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G
Sbjct: 152 LVTSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------------SAPSDQFS 202
            +  E    +  +      D      +++    ++  P              + P ++F 
Sbjct: 207 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 266
Query: 203 PEF----CSFISACVQKEPQQRLSAQELMTHPFLK 233
            +        +  C+   P +R+SA   ++HP+ +
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 73/132 (55%), Gaps = 8/132 (6%)
Query: 43  ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I II EYM  G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L
Sbjct: 79  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCL 137
Query: 102 INHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +N +G VK++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G++
Sbjct: 138 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVL 195
Query: 159 LLEC-ATGQFPY 169
           + E  + G+ PY
Sbjct: 196 MWEIYSLGKMPY 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 73/132 (55%), Gaps = 8/132 (6%)
Query: 43  ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I II EYM  G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCL 152
Query: 102 INHRGEVKITDFGVSAIM---ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +N +G VK++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G++
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVL 210
Query: 159 LLEC-ATGQFPY 169
           + E  + G+ PY
Sbjct: 211 MWEIYSLGKMPY 222

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNI 151
Query: 101 LINHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 156
           L+   G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G
Sbjct: 152 LVTSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------------SAPSDQFS 202
            +  E    +  +      D      +++    ++  P              + P ++F 
Sbjct: 207 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 266
Query: 203 PEF----CSFISACVQKEPQQRLSAQELMTHPFLK 233
            +        +  C+   P +R+SA   ++HP+ +
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+
Sbjct: 94  LTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNI 151
Query: 101 LINHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 156
           L+   G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G
Sbjct: 152 LVTSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------------SAPSDQFS 202
            +  E    +  +      D      +++    ++  P              + P ++F 
Sbjct: 207 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 266
Query: 203 PEF----CSFISACVQKEPQQRLSAQELMTHPFLK 233
            +        +  C+   P +R+SA   ++HP+ +
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DFG++     T  +    V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 33/196 (16%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------------ISIILEYM 50
           I++   E AR ++ +E+K     + P +V  + ++                 + I ++  
Sbjct: 38  IRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLC 97
Query: 51  DGGSLADFLKKVKTIPEEYLAAICE----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 106
              +L D++    TI EE   ++C     Q+ + + +LH  K ++HRDLKPSN+      
Sbjct: 98  RKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDD 155
Query: 107 EVKITDFGVSAIMASTSGQANTF------------VGTYNYMSPERISGGKYGYKSDIWS 154
            VK+ DFG+   M     +                VGT  YMSPE+I G  Y +K DI+S
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215
Query: 155 LGLVLLECATGQFPYS 170
           LGL+L E     +P+S
Sbjct: 216 LGLILFELL---YPFS 228

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 10  SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 64
            A ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  
Sbjct: 56  KANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN 110
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I  +YL   C Q+ +G+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   
Sbjct: 111 IGSQYLLNWCVQIAEGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 169
Query: 125 QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
           + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY 
Sbjct: 170 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 73/132 (55%), Gaps = 8/132 (6%)
Query: 43  ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I II EYM  G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCL 152
Query: 102 INHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +N +G VK++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G++
Sbjct: 153 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVL 210
Query: 159 LLEC-ATGQFPY 169
           + E  + G+ PY
Sbjct: 211 MWEIYSLGKMPY 222

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 106 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 160
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     FV T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 161 VKSDCTLKILDFGL-ARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 219
Query: 162 CATGQFPYSPPEQQDGWTSFYE 183
              G   +   +  D W    E
Sbjct: 220 MIKGGVLFPGTDHIDQWNKVIE 241

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMDGGSLADFLKKVKT-IPEE 68
           +R   +E++I ++    ++V      Y  G  ++ +++EY+  G L DFL++ +  +   
Sbjct: 55  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS 114
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM--------A 120
            L     Q+ KG+ YL   +  +HRDL   N+L+     VKI DFG++ ++         
Sbjct: 115 RLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 173
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 164
              GQ+  F     + +PE +S   +  +SD+WS G+VL E  T
Sbjct: 174 REPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 73/132 (55%), Gaps = 8/132 (6%)
Query: 43  ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I II EYM  G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L
Sbjct: 85  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCL 143
Query: 102 INHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           +N +G VK++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G++
Sbjct: 144 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVL 201
Query: 159 LLEC-ATGQFPY 169
           + E  + G+ PY
Sbjct: 202 MWEIYSLGKMPY 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 25/240 (10%)
Query: 5   MNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV- 62
           M VEE  +   + +E+K     Q   V      FY      I+ EYM  G+L D+L++  
Sbjct: 70  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFY------IVTEYMPYGNLLDYLRECN 123
Query: 63  -KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
            + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S +M  
Sbjct: 124 REEVTAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG 182
Query: 122 TSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 179
            +  A+        + +PE ++   +  KSD+W+ G++L E AT G  PY   +     +
Sbjct: 183 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----S 238
Query: 180 SFYELME-AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH-PFLKMYGD 237
             Y+L+E     + P   P     P+    + AC +  P  R S  E  TH  F  M+ D
Sbjct: 239 QVYDLLEKGYRMEQPEGCP-----PKVYELMRACWKWSPADRPSFAE--THQAFETMFHD 291

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 18/233 (7%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  FL+K 
Sbjct: 52  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH 111
Query: 63  K---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
               T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+S ++
Sbjct: 112 DAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGLSRVL 168
Query: 120 ASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 175
                 A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY     Q
Sbjct: 169 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 228
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           D       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 229 D---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 273

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHR+L   N L+
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLV 351
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 352 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 412 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEK----VYELMRACWQWNPSDR 463
Query: 221 LSAQEL 226
            S  E+
Sbjct: 464 PSFAEI 469

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKIXDFGLARV 173
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 49/244 (20%)
Query: 36  SFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHR 93
           SF +   + II E M      D  + + T  + ++++     Q L+ +  LH   ++IHR
Sbjct: 82  SFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHR 136
Query: 94  DLKPSNLLINHRGEVKITDFGVSAIM-------ASTSGQAN---TFVGTYNYMSPE-RIS 142
           DLKPSNLLIN   ++K+ DFG++ I+       +  +GQ +    +V T  Y +PE  ++
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLT 196
Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--------- 193
             KY    D+WS G +L E     F   P      +     L+  I+  P          
Sbjct: 197 SAKYSRAMDVWSCGCILAEL----FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE 252
Query: 194 --------------PSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
                         P+AP ++     +P+    +   +  +P +R++A+E + HP+L+ Y
Sbjct: 253 SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312
Query: 236 GDLN 239
            D N
Sbjct: 313 HDPN 316

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMDGGSLADFLKKVKT-IPEE 68
           +R   +E++I ++    ++V      Y  G  ++ +++EY+  G L DFL++ +  +   
Sbjct: 56  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS 115
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM--------A 120
            L     Q+ KG+ YL   +  +HRDL   N+L+     VKI DFG++ ++         
Sbjct: 116 RLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 174
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 164
              GQ+  F     + +PE +S   +  +SD+WS G+VL E  T
Sbjct: 175 REPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMDGGSLADFLKKVKT-IPEE 68
           +R   +E++I ++    ++V      Y  G  ++ +++EY+  G L DFL++ +  +   
Sbjct: 68  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS 127
Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM--------A 120
            L     Q+ KG+ YL   +  +HRDL   N+L+     VKI DFG++ ++         
Sbjct: 128 RLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 164
              GQ+  F     + +PE +S   +  +SD+WS G+VL E  T
Sbjct: 187 REPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 105 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 159
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 160 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 162 CATGQFPYSPPEQQDGWTSFYE 183
              G   +   +  D W    E
Sbjct: 219 MIKGGVLFPGTDHIDQWNKVIE 240

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 52  GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
           G  L + +K  + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I 
Sbjct: 116 GADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 112 DFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FP 168
           DFG++        +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP
Sbjct: 174 DFGLA---RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFP 230
Query: 169 YSPPEQQDGWTSFYELMEAIVDQPP------------------PSAPSDQFS-------P 203
            S     D       +ME +    P                  P  P    S       P
Sbjct: 231 GS-----DYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANP 285
Query: 204 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                +   +  +  QR+SA E + H +   Y D
Sbjct: 286 LAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHD 319

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 162 CATGQFPYSPPEQQDGWTSFYE 183
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 72/133 (54%), Gaps = 5/133 (3%)
Query: 42  AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
            I ++ + M  G L +++ + K  I  + L   C Q+ KG++YL  E+ ++HRDL   N+
Sbjct: 90  TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNV 148
Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLV 158
           L+     VKITDFG++ ++     + N   G     +M+ E I   K+ ++SD+WS G+ 
Sbjct: 149 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVT 208
Query: 159 LLECAT-GQFPYS 170
           + E  T G  PY 
Sbjct: 209 IWELMTFGGKPYD 221

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 37  FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 96
           F  +    ++ E + GGS+   ++K K   E   + +   V   L +LH  K I HRDLK
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLH-TKGIAHRDLK 138
Query: 97  PSNLLINHRGE---VKITDFGVSAIMA-------STSGQANTFVGTYNYMSPERIS---- 142
           P N+L     +   VKI DF + + M         T+ +  T  G+  YM+PE +     
Sbjct: 139 PENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTD 198
Query: 143 -GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD-GWTSF-------YELMEAIVDQPP 193
               Y  + D+WSLG+VL    +G  P+      D GW           +L E+I +   
Sbjct: 199 QATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY 258
Query: 194 --PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             P       S E    IS  + ++ +QRLSA +++ HP+++
Sbjct: 259 EFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHR+L   N L+
Sbjct: 332 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLV 390
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 391 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 450
Query: 162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 451 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEK----VYELMRACWQWNPSDR 502
Query: 221 LSAQEL 226
            S  E+
Sbjct: 503 PSFAEI 508

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI  FG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILGFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 53  GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           G+  + + K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I D
Sbjct: 116 GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDSELRILD 174
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPY 169
           FG++        +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP 
Sbjct: 175 FGLA---RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231
Query: 170 SPPEQQDGWTSFYELMEAIVDQPP------------------PSAPSDQFS-------PE 204
           S     D       +ME +    P                  P  P    S       P 
Sbjct: 232 S-----DYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPL 286
Query: 205 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
               +   +  +  QR+SA E + H +   Y D
Sbjct: 287 AIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHD 319

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 120 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 179 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 239 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 298
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 299 LTFNPHKRIEVEQALAHPYLEQYYD 323

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLEQYYD 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 121 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 179
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 180 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 239
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 240 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 299
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 300 LTFNPHKRIEVEQALAHPYLEQYYD 324

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 112 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 170
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 171 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 230
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 231 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 290
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 291 LTFNPHKRIEVEQALAHPYLEQYYD 315

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 113 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 232 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 291
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 292 LTFNPHKRIEVEQALAHPYLEQYYD 316

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTSDLKICDFGLARV 175
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 169 ----------YSPPEQQDGWTSF-YELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L  Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLAQYYD 320

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 123 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 181
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 182 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 241
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 242 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 301
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 302 LTFNPHKRIEVEQALAHPYLEQYYD 326

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDAGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKCQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDRGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 17/163 (10%)
Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGA--ISIILEYMDGGSLADFLKKVKT-IPEEY 69
           R   +E++I ++    ++V      Y  G   + +++EY+  G L DFL++ +  +    
Sbjct: 53  RDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASR 112
Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM--------AS 121
           L     Q+ KG+ YL   +  +HRDL   N+L+     VKI DFG++ ++          
Sbjct: 113 LLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVR 171
Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 164
             GQ+  F     + +PE +S   +  +SD+WS G+VL E  T
Sbjct: 172 EPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 135 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 193
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 194 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 254 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 313
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 314 LTFNPHKRIEVEQALAHPYLEQYYD 338

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI DF ++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFYLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 12/212 (5%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +  +E +     Q P+VV  +     +G + +    ++G  LA  L++   +      
Sbjct: 78  RTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAV 137
Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV-SAIMASTSGQANTFV 130
           AI  Q+    L   H     HRD+KP N+L++      + DFG+ SA       Q    V
Sbjct: 138 AIVRQI-GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 131 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           GT  Y +PER S     Y++DI++L  VL EC TG    SPP Q D  +    +  A ++
Sbjct: 197 GTLYYXAPERFSESHATYRADIYALTCVLYECLTG----SPPYQGDQLS----VXGAHIN 248
Query: 191 Q--PPPSAPSDQFSPEFCSFISACVQKEPQQR 220
           Q  P PS         F + I+    K P+ R
Sbjct: 249 QAIPRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 72/133 (54%), Gaps = 5/133 (3%)
Query: 42  AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
            I ++ + M  G L +++ + K  I  + L   C Q+ KG++YL  E+ ++HRDL   N+
Sbjct: 113 TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNV 171
Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLV 158
           L+     VKITDFG++ ++     + N   G     +M+ E I   K+ ++SD+WS G+ 
Sbjct: 172 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVT 231
Query: 159 LLECAT-GQFPYS 170
           + E  T G  PY 
Sbjct: 232 IWELMTFGGKPYD 244

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L  Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLAQYYD 320

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 46  ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 106 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 164
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDGGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 165 GQ--FP 168
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 45  IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNL 100
           ++L  +  G L +FLKK+++   +  + +  I  Q  + + ++H +K  IIHRDLK  NL
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENL 169
Query: 101 LINHRGEVKITDFGVSAIMA-----STSGQANTFV-------GTYNYMSPERI---SGGK 145
           L++++G +K+ DFG +  ++     S S Q    V        T  Y +PE I   S   
Sbjct: 170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP 229
Query: 146 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 205
            G K DIW+LG +L      Q P+     +DG          IV+      P D     F
Sbjct: 230 IGEKQDIWALGCILYLLCFRQHPF-----EDGAKL------RIVNGKYSIPPHDTQYTVF 278
Query: 206 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 241
            S I A +Q  P++RLS  E++ H   ++    NV+
Sbjct: 279 HSLIRAMLQVNPEERLSIAEVV-HQLQEIAAARNVN 313

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 53  GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           G+  + + K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I D
Sbjct: 108 GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILD 166
Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPY 169
           FG++        +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP 
Sbjct: 167 FGLA---RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 223
Query: 170 SPPEQQDGWTSFYELMEAIVDQPP------------------PSAPSDQFS-------PE 204
           S     D       +ME +    P                  P  P    S       P 
Sbjct: 224 S-----DYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPL 278
Query: 205 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
               +   +  +  QR+SA E + H +   Y D
Sbjct: 279 AIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHD 311

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH---------HEKHIIHRDL 95
           +I  + + GSL+DFLK    +    L  I E + +GL YLH         H+  I HRD+
Sbjct: 99  LITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157
Query: 96  KPSNLLINHRGEVKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGG-----KYGY 148
           K  N+L+ +     I DFG++       ++G  +  VGT  YM+PE + G          
Sbjct: 158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 149 KSDIWSLGLVLLE----CATGQFPYS----PPEQQDGWT-SFYELMEAIVDQPPPSAPSD 199
           + D++++GLVL E    C     P      P E++ G   S  ++ E +V +       D
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277
Query: 200 QFSPE-----FCSFISACVQKEPQQRLSA 223
            +         C  I  C   + + RLSA
Sbjct: 278 YWQKHAGMAMLCETIEECWDHDAEARLSA 306

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 158
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 162 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 196
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 197 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 49/244 (20%)
Query: 36  SFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHR 93
           SF +   + II E M      D  + + T  + ++++     Q L+ +  LH   ++IHR
Sbjct: 82  SFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHR 136
Query: 94  DLKPSNLLINHRGEVKITDFGVSAIM-------ASTSGQANTF---VGTYNYMSPE-RIS 142
           DLKPSNLLIN   ++K+ DFG++ I+       +  +GQ +     V T  Y +PE  ++
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLT 196
Query: 143 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--------- 193
             KY    D+WS G +L E     F   P      +     L+  I+  P          
Sbjct: 197 SAKYSRAMDVWSCGCILAEL----FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE 252
Query: 194 --------------PSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
                         P+AP ++     +P+    +   +  +P +R++A+E + HP+L+ Y
Sbjct: 253 SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312
Query: 236 GDLN 239
            D N
Sbjct: 313 HDPN 316

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 112/256 (43%), Gaps = 34/256 (13%)
Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           V++ A R+I    ++   +    + VC +         ++ E++D   L D       + 
Sbjct: 67  VKKIAMREIKLLKQLRHENLVNLLEVCKKK----KRWYLVFEFVDHTILDDLELFPNGLD 122
Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
            + +     Q++ G+ + H   +IIHRD+KP N+L++  G VK+ DFG +  +A+     
Sbjct: 123 YQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181
Query: 127 NTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
           +  V T  Y +PE + G  KYG   D+W++G ++ E   G+ P  P +        Y +M
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PLFPGDSD--IDQLYHIM 238
Query: 186 ----------EAIVDQPPPSA-----------PSDQFSPEFCSFI----SACVQKEPQQR 220
                     + + ++ P  A           P ++  P+    +      C+  +P +R
Sbjct: 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR 298
Query: 221 LSAQELMTHPFLKMYG 236
               EL+ H F +M G
Sbjct: 299 PFCAELLHHDFFQMDG 314

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 97  VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 151
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 152 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 162 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 196
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 197 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 158
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 162 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 196
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 197 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 45  IILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           I +EY + G+L D +  + +    +EY   +  Q+L+ L Y+H +  IIHRDLKP N+ I
Sbjct: 92  IQMEYCENGTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRDLKPMNIFI 149
Query: 103 NHRGEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GKYG 147
           +    VKI DFG+              S  +  +S    + +GT  Y++ E + G G Y 
Sbjct: 150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
            K D++SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E   
Sbjct: 210 EKIDMYSLGIIFFEMI---YPFSTGMER---VNILKKLRSVSIEFPPDFDDNKMKVE-KK 262
Query: 208 FISACVQKEPQQRLSAQELMTHPFL 232
            I   +  +P +R  A+ L+   +L
Sbjct: 263 IIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           ++ E M GGS+   + K +   E   + + + V   L +LH+ K I HRDLKP N+L  H
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH 146
Query: 105 RGE---VKITDFGV-SAIMAS------TSGQANTFVGTYNYMSPERI-----SGGKYGYK 149
             +   VKI DF + S I  +      ++ +  T  G+  YM+PE +         Y  +
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 150 SDIWSLGLVLLECATGQFPYSPPEQQD-GWT------SFYELMEAIVDQPPPSAPSDQFS 202
            D+WSLG++L    +G  P+      D GW       +   ++   + +     P   ++
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWA 266
Query: 203 PEFCS---FISACVQKEPQQRLSAQELMTHPFLK 233
              C+    IS  + ++ +QRLSA +++ HP+++
Sbjct: 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 104/240 (43%), Gaps = 52/240 (21%)
Query: 10  SARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISIILEYMDGGSLADFLKKV--K 63
            ARR++    +   +SQCP++V     Y++ Y+    + I++E +DGG L   ++    +
Sbjct: 56  KARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA 120
              E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +    
Sbjct: 113 AFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---- 167
Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--------SPP 172
                             +  +G KY    D+WSLG+++     G  P+        SP 
Sbjct: 168 ------------------KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 209
Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
            +       YE          P+    + S E    I   ++ EP QR++  E M HP++
Sbjct: 210 MKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 162 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 196
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 197 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 14/193 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TI 65
           +  RR    E  I      P ++           + II EYM+ GSL  FL+K     T+
Sbjct: 50  DKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 109
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+S ++      
Sbjct: 110 IQ--LVGMLRGIGSGMKYLSDMSYV-HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 166
Query: 126 ANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF 181
           A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY     QD     
Sbjct: 167 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----V 222
Query: 182 YELMEAIVDQPPP 194
            + +E     PPP
Sbjct: 223 IKAIEEGYRLPPP 235

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 109/238 (45%), Gaps = 27/238 (11%)
Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
           N E + +++I    ++   +    V V Y        + +++EY     +    + + ++
Sbjct: 48  NGEANVKKEIQLLRRLRHKNVIQLVDVLYNE--EKQKMYMVMEY----CVCGMQEMLDSV 101
Query: 66  PEEYLAAICE------QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
           PE+    +C+      Q++ GL YLH +  I+H+D+KP NLL+   G +KI+  GV+  +
Sbjct: 102 PEKRFP-VCQAHGYFCQLIDGLEYLHSQG-IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 120 A--STSGQANTFVGTYNYMSPERISGGKY--GYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
              +      T  G+  +  PE  +G     G+K DIWS G+ L    TG +P+      
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE----- 214
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
               + Y+L E I  +   + P D   P     +   ++ EP +R S +++  H + +
Sbjct: 215 --GDNIYKLFENI-GKGSYAIPGD-CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 14/193 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TI 65
           +  RR    E  I      P ++           + II EYM+ GSL  FL+K     T+
Sbjct: 71  DKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 130
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            +  L  +   +  G+ YL  +   +HRDL   N+L+N     K++DFG+S ++      
Sbjct: 131 IQ--LVGMLRGIGSGMKYLS-DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 187
Query: 126 ANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF 181
           A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY     QD     
Sbjct: 188 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----V 243
Query: 182 YELMEAIVDQPPP 194
            + +E     PPP
Sbjct: 244 IKAIEEGYRLPPP 256

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 14/193 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TI 65
           +  RR    E  I      P ++           + II EYM+ GSL  FL+K     T+
Sbjct: 56  DKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 115
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+S ++      
Sbjct: 116 IQ--LVGMLRGIGSGMKYLSDMSYV-HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 172
Query: 126 ANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF 181
           A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY     QD     
Sbjct: 173 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----V 228
Query: 182 YELMEAIVDQPPP 194
            + +E     PPP
Sbjct: 229 IKAIEEGYRLPPP 241

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS      V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 162 CATGQFPYSPPEQQDGWTSFYE 183
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 18/232 (7%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           +++   E  RR    E  I      P VV           + I++E+M+ G+L  FL+K 
Sbjct: 79  LKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKH 138
Query: 63  K---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
               T+ +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+S ++
Sbjct: 139 DGQFTVIQ--LVGMLRGIAAGMRYLADMGYV-HRDLAARNILVNSNLVCKVSDFGLSRVI 195
Query: 120 ASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 175
                   T  G      + +PE I   K+   SD+WS G+V+ E  + G+ PY     Q
Sbjct: 196 EDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 255
Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           D       +++AI +     AP D         +  C QKE  +R   ++++
Sbjct: 256 D-------VIKAIEEGYRLPAPMD-CPAGLHQLMLDCWQKERAERPKFEQIV 299

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 120 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178
Query: 119 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 168
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 179 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238
Query: 169 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 212
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 239 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 298
Query: 213 VQKEPQQRLSAQELMTHPFLKMYGD 237
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 299 LTFNPHKRIEVEQALAHPYLEQYYD 323

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 9/163 (5%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 67
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  Y   GSL D L  +   P 
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELL-GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 68  ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 121 LSWHXRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 125 QA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 165
               +  VGT  Y +PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 180 XVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG 221

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 65/121 (53%), Gaps = 5/121 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+
Sbjct: 86  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENI 143
Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
           L+   G VK+ DFG++ I +     A   V T  Y +PE +    Y    D+WS+G +  
Sbjct: 144 LVTSGGTVKLADFGLARIYSYQMALAPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFA 202
Query: 161 E 161
           E
Sbjct: 203 E 203

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 142 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 196
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 197 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 162 CATGQFPYSPPEQQDGWTSFYE 183
               +  +   +  D W    E
Sbjct: 256 MVRHKILFPGRDYIDQWNKVIE 277

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYE 183
              +  +   +  D W    E
Sbjct: 219 VRHKILFPGRDYIDQWNKVIE 239

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 50/241 (20%)
Query: 40  NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           NG   +++  + G +L   +KK   + IP  Y+  I +Q+L GL Y+H    IIH D+KP
Sbjct: 101 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160
Query: 98  SNLLIN------HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 151
            N+L+       +  ++KI D G +         +   + T  Y SPE + G  +G  +D
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAPWGCGAD 217
Query: 152 IWSLGLVLLECATGQFPYSPPE------QQDGWTSFYELMEAIVD--------------- 190
           IWS   ++ E  TG F + P E        D      EL+  +                 
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 191 ------------QPPPSAPSDQF------SPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                        P     ++++      + E   F+S  +Q +P++R  A  L+ HP+L
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
Query: 233 K 233
           K
Sbjct: 338 K 338

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA----------- 196
              +  +   +  D W            E M+ +       V+  P  A           
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 278
Query: 197 --PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 279 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 105 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 160
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 161 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 163 ATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA----------- 196
              +  +   +  D W            E M+ +       V+  P  A           
Sbjct: 220 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 279
Query: 197 --PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 280 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 327

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA----------- 196
              +  +   +  D W            E M+ +       V+  P  A           
Sbjct: 219 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 278
Query: 197 --PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 279 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 97
           +I +Y + GSL D+LK   T+  + +  +    + GL +LH E         I HRDLK 
Sbjct: 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERI--SGGKYGYKS- 150
            N+L+   G   I D G++    S + +     NT VGT  YM PE +  S  +  ++S 
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 151 ---DIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIV--DQPPPS 195
              D++S GL+L E    C +G      Q PY      D     YE M  IV   +  PS
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD---PSYEDMREIVCIKKLRPS 287
Query: 196 AP----SDQFSPEFCSFISACVQKEPQQRLSA 223
            P    SD+   +    ++ C    P  RL+A
Sbjct: 288 FPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 197
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 198 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 163 ATGQFPYSPPEQQDGWTSFYE 183
              +  +   +  D W    E
Sbjct: 257 VRHKILFPGRDYIDQWNKVIE 277

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 50/241 (20%)
Query: 40  NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           NG   +++  + G +L   +KK   + IP  Y+  I +Q+L GL Y+H    IIH D+KP
Sbjct: 101 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160
Query: 98  SNLLIN------HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 151
            N+L+       +  ++KI D G +         +   + T  Y SPE + G  +G  +D
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAPWGCGAD 217
Query: 152 IWSLGLVLLECATGQFPYSPPE------QQDGWTSFYELMEAIVD--------------- 190
           IWS   ++ E  TG F + P E        D      EL+  +                 
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 191 ------------QPPPSAPSDQF------SPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                        P     ++++      + E   F+S  +Q +P++R  A  L+ HP+L
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
Query: 233 K 233
           K
Sbjct: 338 K 338

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 105 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 160
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 161 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 163 ATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA----------- 196
              +  +   +  D W            E M+ +       V+  P  A           
Sbjct: 220 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 279
Query: 197 --PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 280 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 327

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 212
Query: 163 ATGQFPYSPPEQQDGWTSFYE 183
              +  +   +  D W    E
Sbjct: 213 VRHKILFPGRDYIDQWNKVIE 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 212
Query: 163 ATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA----------- 196
              +  +   +  D W            E M+ +       V+  P  A           
Sbjct: 213 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 272
Query: 197 --PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 273 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 320

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 38/228 (16%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 103 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 158
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 159 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 217
Query: 163 ATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA----------- 196
              +  +   +  D W            E M+ +       V+  P  A           
Sbjct: 218 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 277
Query: 197 --PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 325

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 97  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 152
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 153 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 163 ATGQFPYSPPEQQDGWTSFYE 183
              +  +   +  D W    E
Sbjct: 212 VRHKILFPGRDYIDQWNKVIE 232

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    D+WS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 212
Query: 163 ATGQFPYSPPEQQDGWTSFYE 183
              +  +   +  D W    E
Sbjct: 213 VCHKILFPGRDYIDQWNKVIE 233

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 109 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 163
Query: 102 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    D+WS+G ++ E
Sbjct: 164 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGE 222
Query: 162 CATGQFPYSPPEQQDGWTSFYE 183
               +  +   +  D W    E
Sbjct: 223 MVCHKILFPGRDYIDQWNKVIE 244

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYL 84
           G + +I+E+   G+L+ +L+         K  PE         E+L     QV KG+ +L
Sbjct: 96  GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 155
Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPE 139
              K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+PE
Sbjct: 156 ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPE 211
Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            I    Y  +SD+WS G++L E  + G  PY P  + D      E    + +     AP 
Sbjct: 212 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP- 264
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           D  +PE    +  C   EP QR +  EL+ H
Sbjct: 265 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +     NT  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 65/121 (53%), Gaps = 5/121 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+
Sbjct: 86  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENI 143
Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
           L+   G VK+ DFG++ I  S     +  V T  Y +PE +    Y    D+WS+G +  
Sbjct: 144 LVTSGGTVKLADFGLARIY-SYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 202
Query: 161 E 161
           E
Sbjct: 203 E 203

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 2   VIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           +++     S  R +  ELKI  +       V +        G + +I+E+   G+L+ +L
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 60  KKVKT------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 107
           +  +             +  E+L     QV KG+ +L   K  IHRDL   N+L++ +  
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK-XIHRDLAARNILLSEKNV 182
Query: 108 VKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
           VKI DFG++  +         G A        +M+PE I    Y  +SD+WS G++L E 
Sbjct: 183 VKIXDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239
Query: 163 -ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 221
            + G  PY P  + D      E    + +     AP D  +PE    +  C   EP QR 
Sbjct: 240 FSLGASPY-PGVKIDE-----EFXRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRP 292
Query: 222 SAQELMTH 229
           +  EL+ H
Sbjct: 293 TFSELVEH 300

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYL 84
           G + +I+E+   G+L+ +L+         K  PE         E+L     QV KG+ +L
Sbjct: 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 164
Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPE 139
              K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+PE
Sbjct: 165 ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPE 220
Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            I    Y  +SD+WS G++L E  + G  PY       G     E    + +     AP 
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEFCRRLKEGTRMRAP- 273
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           D  +PE    +  C   EP QR +  EL+ H
Sbjct: 274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 79  KGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNY 135
           +GL YLH   +  IIHRD+K +N+L++   E  + DFG++ +M          V GT  +
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQD-----GWTSFY---ELM 185
           ++PE +S GK   K+D++  G++LLE  TGQ  F  +     D      W       + +
Sbjct: 210 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 269
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           EA+VD        D+   +       C Q  P +R    E++
Sbjct: 270 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 106/251 (42%), Gaps = 34/251 (13%)
Query: 2   VIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           +++     S  R +  ELKI  +       V +        G + +I+E+   G+L+ +L
Sbjct: 65  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
Query: 60  KKVKT------IPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           +  +        PE         E+L     QV KG+ +L   K  IHRDL   N+L++ 
Sbjct: 125 RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSE 183
Query: 105 RGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 159
           +  VKI DFG++  +         G A        +M+PE I    Y  +SD+WS G++L
Sbjct: 184 KNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 160 LEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
            E  + G  PY       G     E    + +     AP D  +PE    +  C   EP 
Sbjct: 241 WEIFSLGASPYP------GVKIDEEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPS 293
Query: 219 QRLSAQELMTH 229
           QR +  EL+ H
Sbjct: 294 QRPTFSELVEH 304

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 14/177 (7%)
Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           V++ N    A ++I  E  +      PYV     +C  S      + ++ + M  G L D
Sbjct: 53  VLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTS-----TVQLVTQLMPYGCLLD 107
Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
            +++ +  +  + L   C Q+ KG+ YL  +  ++HRDL   N+L+     VKITDFG++
Sbjct: 108 HVRENRGRLGSQDLLNWCMQIAKGMSYLE-DVRLVHRDLAARNVLVKSPNHVKITDFGLA 166
Query: 117 AIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
            ++    T   A+       +M+ E I   ++ ++SD+WS G+ + E  T G  PY 
Sbjct: 167 RLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 52/98 (53%), Gaps = 13/98 (13%)
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF------ 129
           Q+ + + +LH  K ++HRDLKPSN+       VK+ DFG+   M     +          
Sbjct: 172 QIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 130 ------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
                 VGT  YMSPE+I G  Y +K DI+SLGL+L E
Sbjct: 231 ATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYL 84
           G + +I+E+   G+L+ +L+         K  PE         E+L     QV KG+ +L
Sbjct: 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 164
Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPE 139
              K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+PE
Sbjct: 165 ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPE 220
Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            I    Y  +SD+WS G++L E  + G  PY P  + D      E    + +     AP 
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP- 273
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           D  +PE    +  C   EP QR +  EL+ H
Sbjct: 274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 64/121 (52%), Gaps = 5/121 (4%)
Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+
Sbjct: 94  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENI 151
Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
           L+   G VK+ DFG++ I  S        V T  Y +PE +    Y    D+WS+G +  
Sbjct: 152 LVTSGGTVKLADFGLARIY-SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 210
Query: 161 E 161
           E
Sbjct: 211 E 211

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 40  NGAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLY 83
            G + +I+E+   G+L+ +L+         K  PE         E+L     QV KG+ +
Sbjct: 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSP 138
           L   K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+P
Sbjct: 201 LASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAP 256
Query: 139 ERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 197
           E I    Y  +SD+WS G++L E  + G  PY P  + D      E    + +     AP
Sbjct: 257 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP 310
Query: 198 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            D  +PE    +  C   EP QR +  EL+ H
Sbjct: 311 -DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 30/226 (13%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKT 64
           E  RR+   E  I    + P ++       ++  + I+ E+M+ G+L  FL+    +   
Sbjct: 58  ERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV 117
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I    L  +   +  G+ YL  E   +HRDL   N+L+N     K++DFG+S  +   S 
Sbjct: 118 I---QLVGMLRGIASGMRYLA-EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS 173
Query: 125 ---QANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
              + ++  G     + +PE I+  K+   SD WS G+V+ E  + G+ PY     QD  
Sbjct: 174 DPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD-- 231
Query: 179 TSFYELMEAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQQR 220
                ++ AI       PPP  P+          +  C QK+   R
Sbjct: 232 -----VINAIEQDYRLPPPPDCPTS-----LHQLMLDCWQKDRNAR 267

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 28/157 (17%)
Query: 41  GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
            ++ +++EY+  GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHRDL   N+
Sbjct: 108 ASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-AQHYIHRDLAARNV 165
Query: 101 LINHRGEVKITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
           L+++   VKI DFG++  +            G +  F     + +PE +   K+ Y SD+
Sbjct: 166 LLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVF-----WYAPECLKEYKFYYASDV 220
Query: 153 WSLGLVLLE----CATGQFPYSPPEQQDGWTSFYELM 185
           WS G+ L E    C + Q   SPP      T F EL+
Sbjct: 221 WSFGVTLYELLTHCDSSQ---SPP------TKFLELI 248

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYL 84
           G + +I E+   G+L+ +L+         K  PE         E+L     QV KG+ +L
Sbjct: 96  GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 155
Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPE 139
              K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+PE
Sbjct: 156 ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPE 211
Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            I    Y  +SD+WS G++L E  + G  PY P  + D      E    + +     AP 
Sbjct: 212 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP- 264
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           D  +PE    +  C   EP QR +  EL+ H
Sbjct: 265 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 106/250 (42%), Gaps = 33/250 (13%)
Query: 2   VIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           +++     S  R +  ELKI  +       V +        G + +I+E+   G+L+ +L
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 60  KKVKT-----IPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           +  +       PE         E+L     QV KG+ +L   K  IHRDL   N+L++ +
Sbjct: 126 RSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK-XIHRDLAARNILLSEK 184
Query: 106 GEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
             VKI DFG++  +         G A        +M+PE I    Y  +SD+WS G++L 
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 161 EC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
           E  + G  PY       G     E    + +     AP D  +PE    +  C   EP Q
Sbjct: 242 EIFSLGASPYP------GVKIDEEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQ 294
Query: 220 RLSAQELMTH 229
           R +  EL+ H
Sbjct: 295 RPTFSELVEH 304

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 2   VIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           +++     S  R +  ELKI  +       V +        G + +I+E+   G+L+ +L
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 60  KKVKT------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 107
           +  +             +  E+L     QV KG+ +L   K  IHRDL   N+L++ +  
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK-XIHRDLAARNILLSEKNV 182
Query: 108 VKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
           VKI DFG++  +         G A        +M+PE I    Y  +SD+WS G++L E 
Sbjct: 183 VKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239
Query: 163 -ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 221
            + G  PY P  + D      E    + +     AP D  +PE    +  C   EP QR 
Sbjct: 240 FSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRP 292
Query: 222 SAQELMTH 229
           +  EL+ H
Sbjct: 293 TFSELVEH 300

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYL 84
           G + +I+E+   G+L+ +L+         K  PE         E+L     QV KG+ +L
Sbjct: 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 164
Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM-----ASTSGQANTFVGTYNYMSPE 139
              K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+PE
Sbjct: 165 ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL---PLKWMAPE 220
Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            I    Y  +SD+WS G++L E  + G  PY       G     E    + +     AP 
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEFCRRLKEGTRMRAP- 273
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           D  +PE    +  C   EP QR +  EL+ H
Sbjct: 274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 72/141 (51%), Gaps = 5/141 (3%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS      V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYE 183
              +  +   +  D W    E
Sbjct: 219 VCHKILFPGRDYIDQWNKVIE 239

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 45  IILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           I +EY +  +L D +  + +    +EY   +  Q+L+ L Y+H +  IIHRDLKP N+ I
Sbjct: 92  IQMEYCENRTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRDLKPMNIFI 149
Query: 103 NHRGEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GKYG 147
           +    VKI DFG+              S  +  +S    + +GT  Y++ E + G G Y 
Sbjct: 150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
            K D++SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E   
Sbjct: 210 EKIDMYSLGIIFFEMI---YPFSTGMER---VNILKKLRSVSIEFPPDFDDNKMKVE-KK 262
Query: 208 FISACVQKEPQQRLSAQELMTHPFL 232
            I   +  +P +R  A+ L+   +L
Sbjct: 263 IIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 11/139 (7%)
Query: 45  IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           +I +YM+ G+L   L        ++  E    IC    +GL YLH  + IIHRD+K  N+
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINI 170
Query: 101 LINHRGEVKITDFGVSAIMASTSGQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
           L++     KITDFG+S    +  GQ +      GT  Y+ PE    G+   KSD++S G+
Sbjct: 171 LLDENFVPKITDFGISK-KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 158 VLLE--CATGQFPYSPPEQ 174
           VL E  CA      S P +
Sbjct: 230 VLFEVLCARSAIVQSLPRE 248

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 23  QSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICE 75
           Q+S  P++V C    Y N       + II+E M+GG L   +++   +   E   A I  
Sbjct: 58  QASGGPHIV-CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 116
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGT 132
            +   + +LH   +I HRD+KP NLL   + +   +K+TDFG +    +T     T   T
Sbjct: 117 DIGTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYT 173
Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP--YSPPEQ--QDGWTSFYELMEAI 188
             Y++PE +   KY    D+WSLG+++     G FP  YS   Q    G      L +  
Sbjct: 174 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-FPPFYSNTGQAISPGMKRRIRLGQYG 232
Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
              P  S    + S +    I   ++ +P +RL+  + M HP++
Sbjct: 233 FPNPEWS----EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKT 64
           E  RR+   E  I    + P ++       ++  + I+ E+M+ G+L  FL+    +   
Sbjct: 56  ERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV 115
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I    L  +   +  G+ YL  E   +HRDL   N+L+N     K++DFG+S  +   S 
Sbjct: 116 I---QLVGMLRGIASGMRYLA-EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS 171
Query: 125 QANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG 177
              T+  +        + +PE I+  K+   SD WS G+V+ E  + G+ PY     QD 
Sbjct: 172 DP-TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD- 229
Query: 178 WTSFYELMEAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQQR 220
                 ++ AI       PPP  P+          +  C QK+   R
Sbjct: 230 ------VINAIEQDYRLPPPPDCPTS-----LHQLMLDCWQKDRNAR 265

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYL 84
           G + +I+E+   G+L+ +L+         K  PE         E+L     QV KG+ +L
Sbjct: 107 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 166
Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPE 139
              K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+PE
Sbjct: 167 ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPE 222
Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            I    Y  +SD+WS G++L E  + G  PY       G     E    + +     AP 
Sbjct: 223 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEFCRRLKEGTRMRAP- 275
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           D  +PE    +  C   EP QR +  EL+ H
Sbjct: 276 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 23  QSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICE 75
           Q+S  P++V C    Y N       + II+E M+GG L   +++   +   E   A I  
Sbjct: 77  QASGGPHIV-CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGT 132
            +   + +LH   +I HRD+KP NLL   + +   +K+TDFG +    +T     T   T
Sbjct: 136 DIGTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYT 192
Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD---GWTSFYELMEAIV 189
             Y++PE +   KY    D+WSLG+++     G  P+     Q    G      L +   
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252
Query: 190 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             P  S    + S +    I   ++ +P +RL+  + M HP++
Sbjct: 253 PNPEWS----EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/123 (34%), Positives = 66/123 (53%), Gaps = 9/123 (7%)
Query: 43  ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+
Sbjct: 86  VTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENI 143
Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTF--VGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           L+   G VK+ DFG++ I    S Q   F  V T  Y +PE +    Y    D+WS+G +
Sbjct: 144 LVTSGGTVKLADFGLARIY---SYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 200
Query: 159 LLE 161
             E
Sbjct: 201 FAE 203

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYL 84
           G + +I E+   G+L+ +L+         K  PE         E+L     QV KG+ +L
Sbjct: 96  GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 155
Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPE 139
              K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+PE
Sbjct: 156 ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPE 211
Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            I    Y  +SD+WS G++L E  + G  PY P  + D      E    + +     AP 
Sbjct: 212 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP- 264
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           D  +PE    +  C   EP QR +  EL+ H
Sbjct: 265 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 42  AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           ++ +++EY+  GSL D+L +   +    L    +Q+ +G+ YLH  +H IHR L   N+L
Sbjct: 87  SVQLVMEYVPLGSLRDYLPR-HCVGLAQLLLFAQQICEGMAYLH-AQHYIHRALAARNVL 144
Query: 102 INHRGEVKITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 153
           +++   VKI DFG++  +            G +  F     + +PE +   K+ Y SD+W
Sbjct: 145 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKECKFYYASDVW 199
Query: 154 SLGLVLLE----CATGQFPYSPPEQQDGWT-------SFYELMEAIVDQPPPSAPSDQFS 202
           S G+ L E    C + Q P++   +  G T          EL+E     P P    D+  
Sbjct: 200 SFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRP----DRCP 255
Query: 203 PEFCSFISACVQKEPQQRLSAQELM 227
            E    +  C + E   R + Q L+
Sbjct: 256 CEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYL 84
           G + +I E+   G+L+ +L+         K  PE         E+L     QV KG+ +L
Sbjct: 96  GPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 155
Query: 85  HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPE 139
              K  IHRDL   N+L++ +  VKI DFG++  +         G A        +M+PE
Sbjct: 156 ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPE 211
Query: 140 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            I    Y  +SD+WS G++L E  + G  PY P  + D      E    + +     AP 
Sbjct: 212 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP- 264
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           D  +PE    +  C   EP QR +  EL+ H
Sbjct: 265 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 42  AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           ++ +++EY+  GSL D+L +   +    L    +Q+ +G+ YLH  +H IHR L   N+L
Sbjct: 86  SVQLVMEYVPLGSLRDYLPR-HCVGLAQLLLFAQQICEGMAYLH-AQHYIHRALAARNVL 143
Query: 102 INHRGEVKITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 153
           +++   VKI DFG++  +            G +  F     + +PE +   K+ Y SD+W
Sbjct: 144 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKECKFYYASDVW 198
Query: 154 SLGLVLLE----CATGQFPYSPPEQQDGWT-------SFYELMEAIVDQPPPSAPSDQFS 202
           S G+ L E    C + Q P++   +  G T          EL+E     P P    D+  
Sbjct: 199 SFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRP----DRCP 254
Query: 203 PEFCSFISACVQKEPQQRLSAQELM 227
            E    +  C + E   R + Q L+
Sbjct: 255 CEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 12/183 (6%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL-EYMDGGSLADFLKKVK---T 64
           E  RR    E  I      P ++   +   + G +++I+ EYM+ GSL  FL+      T
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I +  L  +   V  G+ YL    ++ HRDL   N+L++     K++DFG+S ++     
Sbjct: 150 IMQ--LVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 125 QANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTS 180
            A T  G      + +PE I+   +   SD+WS G+V+ E  A G+ PY     +D  +S
Sbjct: 207 AAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266
Query: 181 FYE 183
             E
Sbjct: 267 VEE 269

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 79  KGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNY 135
           +GL YLH   +  IIHRD+K +N+L++   E  + DFG++ +M          V G   +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 136 MSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQD-----GWTSFY---ELM 185
           ++PE +S GK   K+D++  G++LLE  TGQ  F  +     D      W       + +
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           EA+VD        D+   +       C Q  P +R    E++
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 24/223 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TI 65
           E  RR    E  I      P V+        +  + II E+M+ GSL  FL++     T+
Sbjct: 75  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 134
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            +  L  +   +  G+ YL  + + +HRDL   N+L+N     K++DFG+S  +   +  
Sbjct: 135 IQ--LVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 191
Query: 126 ANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
             T+           + +PE I   K+   SD+WS G+V+ E  + G+ PY     QD  
Sbjct: 192 P-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-- 248
Query: 179 TSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQR 220
                 +E     PPP   PS          +  C QK+   R
Sbjct: 249 --VINAIEQDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHR 284

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 72/141 (51%), Gaps = 5/141 (3%)
Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + I++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS      V T  Y +PE I G  Y    D+WS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 218
Query: 163 ATGQFPYSPPEQQDGWTSFYE 183
              +  +   +  D W    E
Sbjct: 219 VCHKILFPGRDYIDQWNKVIE 239

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 12/183 (6%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL-EYMDGGSLADFLKKVK---T 64
           E  RR    E  I      P ++   +   + G +++I+ EYM+ GSL  FL+      T
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I +  L  +   V  G+ YL    ++ HRDL   N+L++     K++DFG+S ++     
Sbjct: 150 IMQ--LVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 125 QANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTS 180
            A T  G      + +PE I+   +   SD+WS G+V+ E  A G+ PY     +D  +S
Sbjct: 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266
Query: 181 FYE 183
             E
Sbjct: 267 VEE 269

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 40  NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 317
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 374
Query: 158 VLLECAT-GQFPY 169
           +L E  + G+ PY
Sbjct: 375 LLWEIYSFGRVPY 387

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 100 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 159
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 160 LASQK-CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 218
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 219 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 32/210 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH----------HEKHIIHRD 94
           +I  + D GSL D+LK    I    L  + E + +GL YLH          H+  I HRD
Sbjct: 90  LITAFHDKGSLTDYLKG-NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRD 148
Query: 95  LKPSNLLINHRGEVKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGG-----KYG 147
            K  N+L+       + DFG++         G  +  VGT  YM+PE + G         
Sbjct: 149 FKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAF 208
Query: 148 YKSDIWSLGLVLLE----CATGQFPYS----PPEQQDGWT-SFYELMEAIVDQPPPSAPS 198
            + D++++GLVL E    C     P      P E++ G   S  EL E +V +       
Sbjct: 209 LRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIK 268
Query: 199 DQF-----SPEFCSFISACVQKEPQQRLSA 223
           D +       + C  I  C   + + RLSA
Sbjct: 269 DHWLKHPGLAQLCVTIEECWDHDAEARLSA 298

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 40  NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 145
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 146 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 202
Query: 158 VLLECAT-GQFPY 169
           +L E  + G+ PY
Sbjct: 203 LLWEIYSFGRVPY 215

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 122 TSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T        G     +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 185 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 242
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 243 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 286

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 219 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 15/195 (7%)
Query: 52  GGSLADFLKKVKTIPEEYLAA-ICEQVLKGLLYLHHEKHIIHRDLKPSNLLI--NHRGEV 108
            GS+  F + +  +  E L + I  Q+   L YLH++  I HRD+KP N L   N   E+
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-ICHRDIKPENFLFSTNKSFEI 209
Query: 109 KITDFGVSA-IMASTSGQ---ANTFVGTYNYMSPERI--SGGKYGYKSDIWSLGLVLLEC 162
           K+ DFG+S       +G+     T  GT  +++PE +  +   YG K D WS G++L   
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
             G  P+  P   D  T    L + +  + P     +  SP     +S  + +   +R  
Sbjct: 270 LMGAVPF--PGVNDADTISQVLNKKLCFENP---NYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 223 AQELMTHPFLKMYGD 237
           A   + HP++  + D
Sbjct: 325 AMRALQHPWISQFSD 339

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 105 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 164
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 165 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 223
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 224 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 28/156 (17%)
Query: 42  AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           ++ +++EY+  GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHR+L   N+L
Sbjct: 92  SLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-SQHYIHRNLAARNVL 149
Query: 102 INHRGEVKITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 153
           +++   VKI DFG++  +            G +  F     + +PE +   K+ Y SD+W
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKEYKFYYASDVW 204
Query: 154 SLGLVLLE----CATGQFPYSPPEQQDGWTSFYELM 185
           S G+ L E    C + Q   SPP      T F EL+
Sbjct: 205 SFGVTLYELLTHCDSSQ---SPP------TKFLELI 231

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 111/258 (43%), Gaps = 34/258 (13%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--- 59
           ++   E   R +   E  +    Q P VV        +  +S+I  Y   G L +FL   
Sbjct: 64  LKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMR 123
Query: 60  ------------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
                       + VK+   P +++  +  Q+  G+ YL    H++H+DL   N+L+  +
Sbjct: 124 SPHSDVGSTDDDRTVKSALEPPDFVHLVA-QIAAGMEYLS-SHHVVHKDLATRNVLVYDK 181
Query: 106 GEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC- 162
             VKI+D G+      A         +    +M+PE I  GK+   SDIWS G+VL E  
Sbjct: 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC-SFISACVQKEPQQRL 221
           + G  PY     QD       ++E I ++     P D   P +  + +  C  + P +R 
Sbjct: 242 SYGLQPYCGYSNQD-------VVEMIRNRQVLPCPDD--CPAWVYALMIECWNEFPSRRP 292
Query: 222 SAQELMTHPFLKMYGDLN 239
             +++  H  L+ +G+L+
Sbjct: 293 RFKDI--HSRLRAWGNLS 308

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 102 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 161
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 162 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 220
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 221 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 40  NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAA 130
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 187
Query: 158 VLLECAT-GQFPY 169
           +L E  + G+ PY
Sbjct: 188 LLWEIYSFGRVPY 200

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 28/156 (17%)
Query: 42  AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           ++ +++EY+  GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHR+L   N+L
Sbjct: 92  SLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-AQHYIHRNLAARNVL 149
Query: 102 INHRGEVKITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 153
           +++   VKI DFG++  +            G +  F     + +PE +   K+ Y SD+W
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKEYKFYYASDVW 204
Query: 154 SLGLVLLE----CATGQFPYSPPEQQDGWTSFYELM 185
           S G+ L E    C + Q   SPP      T F EL+
Sbjct: 205 SFGVTLYELLTHCDSSQ---SPP------TKFLELI 231

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 21/165 (12%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK------KVKTIPEEYL 70
           QE +I +    P +V           I I++E + GG    FL+      +VKT     L
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKT-----L 215
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-----AIMASTSGQ 125
             +      G+ YL   K  IHRDL   N L+  +  +KI+DFG+S      + A++ G 
Sbjct: 216 LQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGL 274
Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               V    + +PE ++ G+Y  +SD+WS G++L E  + G  PY
Sbjct: 275 RQVPV---KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 67/138 (48%), Gaps = 9/138 (6%)
Query: 45  IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           +I +YM+ G+L   L        ++  E    IC    +GL YLH  + IIHRD+K  N+
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINI 170
Query: 101 LINHRGEVKITDFGVS--AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           L++     KITDFG+S        +       GT  Y+ PE    G+   KSD++S G+V
Sbjct: 171 LLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230
Query: 159 LLE--CATGQFPYSPPEQ 174
           L E  CA      S P +
Sbjct: 231 LFEVLCARSAIVQSLPRE 248

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE 87
           ++   + +F     + +++EY  GG L   L K  + IP E       +++  +  +H  
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF--VGTYNYMSPERISGGK 145
            ++ HRD+KP N+L++  G +++ DFG S +     G   +   VGT +Y+SPE +    
Sbjct: 182 GYV-HRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 146 YGY-------KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME----AIVDQPPP 194
            G        + D W+LG+   E   GQ P+      + +       E     +VD+  P
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 195 SAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFL 232
               D      C          P+ RL    A +  THPF 
Sbjct: 300 EEARDFIQRLLCP---------PETRLGRGGAGDFRTHPFF 331

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 117/289 (40%), Gaps = 71/289 (24%)
Query: 8   EESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           E+   RQ A+E++I              V+   ++F     I +  E +   +L + +KK
Sbjct: 133 EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKK 191
Query: 62  VK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGV 115
            K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +G   +K+ DFG 
Sbjct: 192 NKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
           S        +  T + +  Y +PE I G +YG   D+WSLG +L E  TG +P  P E +
Sbjct: 249 SCY---EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDE 304
Query: 176 -DGWTSFYELM----EAIVDQ--------------------------------------- 191
            D      EL+    + ++D                                        
Sbjct: 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364
Query: 192 --PPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             PP S     A      P F  F+  C++ +P  R++  + + HP+L+
Sbjct: 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 21/165 (12%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK------KVKTIPEEYL 70
           QE +I +    P +V           I I++E + GG    FL+      +VKT     L
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKT-----L 215
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-----AIMASTSGQ 125
             +      G+ YL   K  IHRDL   N L+  +  +KI+DFG+S      + A++ G 
Sbjct: 216 LQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274
Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               V    + +PE ++ G+Y  +SD+WS G++L E  + G  PY
Sbjct: 275 RQVPV---KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 18/180 (10%)
Query: 7   VEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 63  KTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   VKI D
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGD 173
Query: 113 FGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           FG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  + PY
Sbjct: 174 FGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 233

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 117/289 (40%), Gaps = 71/289 (24%)
Query: 8   EESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           E+   RQ A+E++I              V+   ++F     I +  E +   +L + +KK
Sbjct: 133 EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKK 191
Query: 62  VK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGV 115
            K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +G   +K+ DFG 
Sbjct: 192 NKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
           S        +  T + +  Y +PE I G +YG   D+WSLG +L E  TG +P  P E +
Sbjct: 249 SCY---EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDE 304
Query: 176 -DGWTSFYELM----EAIVDQ--------------------------------------- 191
            D      EL+    + ++D                                        
Sbjct: 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364
Query: 192 --PPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             PP S     A      P F  F+  C++ +P  R++  + + HP+L+
Sbjct: 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 18/180 (10%)
Query: 7   VEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 63  KTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   VKI D
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGD 173
Query: 113 FGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           FG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  + PY
Sbjct: 174 FGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 233

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     ++I DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 18/180 (10%)
Query: 7   VEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ +
Sbjct: 52  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 111
Query: 63  KTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   VKI D
Sbjct: 112 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGD 170
Query: 113 FGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           FG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  + PY
Sbjct: 171 FGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 230

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 57  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 116
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 117 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 175
Query: 122 TSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T        G     +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 176 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 233
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
              + +   ++D+P      D         +  C Q  P+ R S  E+++
Sbjct: 234 VLRFVMEGGLLDKP------DNCPDMLLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 110
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 111 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 26/202 (12%)
Query: 48  EYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
           EY +  +L D +  + +    +EY   +  Q+L+ L Y+H +  IIHR+LKP N+ I+  
Sbjct: 95  EYCENRTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRNLKPXNIFIDES 152
Query: 106 GEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKS 150
             VKI DFG+              S  +  +S    + +GT  Y++ E + G G Y  K 
Sbjct: 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKI 212
Query: 151 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 210
           D +SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E    I 
Sbjct: 213 DXYSLGIIFFEXI---YPFSTGXER---VNILKKLRSVSIEFPPDFDDNKXKVE-KKIIR 265
Query: 211 ACVQKEPQQRLSAQELMTHPFL 232
             +  +P +R  A+ L+   +L
Sbjct: 266 LLIDHDPNKRPGARTLLNSGWL 287

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 126
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 127 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 126
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 127 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 15/176 (8%)
Query: 1   MVIQMNVEESARRQIAQEL-KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           M+ + ++ E    Q AQ + K++      +  VC + +     I I+ EY+  G L ++L
Sbjct: 39  MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY----PIYIVTEYISNGCLLNYL 94
Query: 60  KKV-KTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSA 117
           +   K +    L  +C  V +G+ +L  E H  IHRDL   N L++    VK++DFG++ 
Sbjct: 95  RSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152
Query: 118 IMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
            +     Q  + VGT     + +PE     KY  KSD+W+ G+++ E  + G+ PY
Sbjct: 153 YVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 40  NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 136
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
            N+L++     K++DFG++   +ST       V    + +PE +    +  KSD+WS G+
Sbjct: 137 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREAAFSTKSDVWSFGI 193
Query: 158 VLLECAT-GQFPY 169
           +L E  + G+ PY
Sbjct: 194 LLWEIYSFGRVPY 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 124
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 125 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 102 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 160
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 161 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 220
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 221 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 268
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 269 IMTQCWQHQPEDR 281

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 110 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 168
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 276
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 277 IMTQCWQHQPEDR 289

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEE-------YLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 117 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 175
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 176 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 235
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 236 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 283
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 284 IMTQCWQHQPEDR 296

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 59  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 177
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 235
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 236 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 279

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 94  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 153
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 154 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 122 TSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T        G     +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 213 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 270
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 271 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 314

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEE-------YLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 241
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 242 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 285

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 468
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 469 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 34/256 (13%)
Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--- 59
           ++   E   R +   E  +    Q P VV        +  +S+I  Y   G L +FL   
Sbjct: 47  LKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMR 106
Query: 60  ------------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 105
                       + VK+   P +++  +  Q+  G+ YL    H++H+DL   N+L+  +
Sbjct: 107 SPHSDVGSTDDDRTVKSALEPPDFVHLVA-QIAAGMEYLS-SHHVVHKDLATRNVLVYDK 164
Query: 106 GEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC- 162
             VKI+D G+      A         +    +M+PE I  GK+   SDIWS G+VL E  
Sbjct: 165 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC-SFISACVQKEPQQRL 221
           + G  PY     QD       ++E I ++     P D   P +  + +  C  + P +R 
Sbjct: 225 SYGLQPYCGYSNQD-------VVEMIRNRQVLPCPDD--CPAWVYALMIECWNEFPSRRP 275
Query: 222 SAQELMTHPFLKMYGD 237
             +++  H  L+ +G+
Sbjct: 276 RFKDI--HSRLRAWGN 289

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 185 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 242
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 243 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 286

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 39/223 (17%)
Query: 2   VIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           +++   + S R  +  ELK+  Q      +V    +   +G I +I EY   G L ++L+
Sbjct: 82  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141
Query: 61  -----------------------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
                                   +  +  E L     QV KG+ +L   K  +HRDL  
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAA 200
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N+L+ H   VKI DFG++  + S S     G A   V    +M+PE +  G Y  KSD+
Sbjct: 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV---KWMAPESLFEGIYTIKSDV 257
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEA--IVDQP 192
           WS G++L E  + G  PY P    D   +FY+L++    +DQP
Sbjct: 258 WSYGILLWEIFSLGVNPY-PGIPVDA--NFYKLIQNGFKMDQP 297

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 63  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 122
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 123 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 239
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 240 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 283

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 116
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 117 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEE-------YLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 127 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 185
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 186 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 245
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 246 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 293
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 294 IMTQCWQHQPEDR 306

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 469
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 470 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 106
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 107 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTI-----------PEEYLAA-----ICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +             PEE L++        QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEAL 224
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G++L E  T G  PY
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 104
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 105 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLL 82
           G   +I EY   G L +FL++        KT P            E L +   QV KG+ 
Sbjct: 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMS 137
           +L   K+ IHRDL   N+L+ H    KI DFG++  + + S     G A   V    +M+
Sbjct: 160 FLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMA 215
Query: 138 PERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPS 195
           PE I    Y ++SD+WS G+ L E  + G  PY P    D  + FY+++ E      P  
Sbjct: 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEH 272
Query: 196 APSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           AP++ +       +  C   +P +R + ++++
Sbjct: 273 APAEMY-----DIMKTCWDADPLKRPTFKQIV 299

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 241
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 242 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLL 82
           G   +I EY   G L +FL++        KT P            E L +   QV KG+ 
Sbjct: 123 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 182
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMS 137
           +L   K+ IHRDL   N+L+ H    KI DFG++  + + S     G A   V    +M+
Sbjct: 183 FLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMA 238
Query: 138 PERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPS 195
           PE I    Y ++SD+WS G+ L E  + G  PY P    D  + FY+++ E      P  
Sbjct: 239 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEH 295
Query: 196 APSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           AP++ +       +  C   +P +R + ++++
Sbjct: 296 APAEMY-----DIMKTCWDADPLKRPTFKQIV 322

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEE-------YLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 137 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 195
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 196 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 255
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 256 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 303
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 304 IMTQCWQHQPEDR 316

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLL 82
           G   +I EY   G L +FL++        KT P            E L +   QV KG+ 
Sbjct: 118 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 177
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMS 137
           +L   K+ IHRDL   N+L+ H    KI DFG++  + + S     G A   V    +M+
Sbjct: 178 FLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMA 233
Query: 138 PERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPS 195
           PE I    Y ++SD+WS G+ L E  + G  PY P    D  + FY+++ E      P  
Sbjct: 234 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEH 290
Query: 196 APSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           AP++ +       +  C   +P +R + ++++
Sbjct: 291 APAEMY-----DIMKTCWDADPLKRPTFKQIV 317

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 131
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 248
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 249 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 12  RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 110
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 126
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 111 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 127 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 169
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLL 82
           G   +I EY   G L +FL++        KT P            E L +   QV KG+ 
Sbjct: 123 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 182
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMS 137
           +L   K+ IHRDL   N+L+ H    KI DFG++  + + S     G A   V    +M+
Sbjct: 183 FLA-SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPV---KWMA 238
Query: 138 PERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPS 195
           PE I    Y ++SD+WS G+ L E  + G  PY P    D  + FY+++ E      P  
Sbjct: 239 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEH 295
Query: 196 APSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           AP++ +       +  C   +P +R + ++++
Sbjct: 296 APAEMY-----DIMKTCWDADPLKRPTFKQIV 322

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+ Y   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 41  GAISIILEYMDGGSLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLL 82
           G   +I EY   G L +FL++        KT P            E L +   QV KG+ 
Sbjct: 116 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 175
Query: 83  YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMS 137
           +L   K+ IHRDL   N+L+ H    KI DFG++  + + S     G A   V    +M+
Sbjct: 176 FLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMA 231
Query: 138 PERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPS 195
           PE I    Y ++SD+WS G+ L E  + G  PY P    D  + FY+++ E      P  
Sbjct: 232 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEH 288
Query: 196 APSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           AP++ +       +  C   +P +R + ++++
Sbjct: 289 APAEMY-----DIMKTCWDADPLKRPTFKQIV 315

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 18/181 (9%)
Query: 6   NVEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ 
Sbjct: 54  TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 62  VKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
           ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   VKI 
Sbjct: 114 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIG 172
Query: 112 DFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 168
           DFG++  +  T+   +    +    +M+PE +  G +   SD+WS G+VL E  +  + P
Sbjct: 173 DFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 169 Y 169
           Y
Sbjct: 233 Y 233

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 24/223 (10%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TI 65
           E  RR    E  I      P V+        +  + II E+M+ GSL  FL++     T+
Sbjct: 49  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 108
Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            +  L  +   +  G+ YL  + + +HR L   N+L+N     K++DFG+S  +   +  
Sbjct: 109 IQ--LVGMLRGIAAGMKYLA-DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSD 165
Query: 126 ANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
             T+           + +PE I   K+   SD+WS G+V+ E  + G+ PY     QD  
Sbjct: 166 P-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-- 222
Query: 179 TSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQR 220
                 +E     PPP   PS          +  C QK+   R
Sbjct: 223 --VINAIEQDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHR 258

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I++E M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 122
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 191 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 249
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 181
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY P  + D     
Sbjct: 250 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKID----- 300
Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 301 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 122
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 193 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 181
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY P  + D     
Sbjct: 252 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKID----- 302
Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 303 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 9/115 (7%)
Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGV 115
           KK   +P   + ++  Q+L G+ YLH    ++HRDLKP+N+L+      RG VKI D G 
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 116 SAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKS-DIWSLGLVLLECATGQ 166
           + +  S        +  V T+ Y +PE + G ++  K+ DIW++G +  E  T +
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 18/181 (9%)
Query: 6   NVEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ 
Sbjct: 54  TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
Query: 62  VKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
           ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   VKI 
Sbjct: 114 LRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIG 172
Query: 112 DFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 168
           DFG++  +  T    +    +    +M+PE +  G +   SD+WS G+VL E  +  + P
Sbjct: 173 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 169 Y 169
           Y
Sbjct: 233 Y 233

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I++E M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 168
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 276
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 277 IMTQCWQHQPEDR 289

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 122
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 198 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 256
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 181
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY       G    
Sbjct: 257 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKID 307
Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 308 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 122
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 200 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 258
Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 181
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY       G    
Sbjct: 259 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKID 309
Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 310 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 83
           +G + +I+ Y   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 99  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 158
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 159 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 217
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 218 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 271
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +    E    +  C    P QR + ++L+
Sbjct: 272 N----ELYMMMRDCWHAVPSQRPTFKQLV 296

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 278
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +    E    +  C    P QR + ++L+
Sbjct: 279 N----ELYMMMRDCWHAVPSQRPTFKQLV 303

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 91  DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 151 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
               Y ++SD+WS G++L E  T G  PY
Sbjct: 210 FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 207 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 265
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 266 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 319
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +    E    +  C    P QR + ++L+
Sbjct: 320 N----ELYMMMRDCWHAVPSQRPTFKQLV 344

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 20/169 (11%)
Query: 45  IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           +I+E+   GSL   L++      +PE     +   V+ G+ +L  E  I+HR++KP N++
Sbjct: 86  LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIM 144
Query: 102 --INHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPE--------RISGGKYGYK 149
             I   G+   K+TDFG +  +     Q  +  GT  Y+ P+        +    KYG  
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 150 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            D+WS+G+     ATG  P+ P E   G     E+M  I+   P  A S
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFE---GPRRNKEVMYKIITGKPSGAIS 249

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 102 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 160
Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M      + +   G      +M+ E +   K+  KSD+W
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 220
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 221 SFGVLLWELMTRGAPPYP 238

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 71/289 (24%)
Query: 8   EESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           E+   RQ A+E++I              V+   ++F     I +  E +   +L + +KK
Sbjct: 133 EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKK 191
Query: 62  VK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGV 115
            K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +G   +K+ DFG 
Sbjct: 192 NKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
           S        +    + +  Y +PE I G +YG   D+WSLG +L E  TG +P  P E +
Sbjct: 249 SCY---EHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDE 304
Query: 176 -DGWTSFYELM----EAIVDQ--------------------------------------- 191
            D      EL+    + ++D                                        
Sbjct: 305 GDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364
Query: 192 --PPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             PP S     A      P F  F+  C++ +P  R++  + + HP+L+
Sbjct: 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 278
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +    E    +  C    P QR + ++L+
Sbjct: 279 N----ELYMMMRDCWHAVPSQRPTFKQLV 303

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 98  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 157
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 158 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 216
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 217 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 270
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +    E    +  C    P QR + ++L+
Sbjct: 271 N----ELYMMMRDCWHAVPSQRPTFKQLV 295

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLH 85
           Y  +C +       I +I+E++  GSL ++L K K    + ++   A+  Q+ KG+ YL 
Sbjct: 88  YKGICTED--GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYLG 143
Query: 86  HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN----YMSPERI 141
             +++ HRDL   N+L+    +VKI DFG++  +  T  +  T     +    + +PE +
Sbjct: 144 SRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 142 SGGKYGYKSDIWSLGLVLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVD 190
              K+   SD+WS G+ L E    C +   P +       P   Q   T     ++    
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261
Query: 191 QP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
            P PP+ P + +       +  C + +P  R S Q L+
Sbjct: 262 LPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLI 294

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 95  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 154
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 155 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 213
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 214 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 267
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +    E    +  C    P QR + ++L+
Sbjct: 268 N----ELYMMMRDCWHAVPSQRPTFKQLV 292

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLH 85
           Y  +C +       I +I+E++  GSL ++L K K    + ++   A+  Q+ KG+ YL 
Sbjct: 76  YKGICTED--GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYLG 131
Query: 86  HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN----YMSPERI 141
             +++ HRDL   N+L+    +VKI DFG++  +  T  +  T     +    + +PE +
Sbjct: 132 SRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 142 SGGKYGYKSDIWSLGLVLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVD 190
              K+   SD+WS G+ L E    C +   P +       P   Q   T     ++    
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 249
Query: 191 QP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
            P PP+ P + +       +  C + +P  R S Q L+
Sbjct: 250 LPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLI 282

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-------T 64
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++        
Sbjct: 62  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 121
Query: 65  IPEEYLAAICE---QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           +    L+ + +   ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 238
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 239 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 282

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 7   VEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ +
Sbjct: 54  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 113
Query: 63  KTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   VKI D
Sbjct: 114 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGD 172
Query: 113 FGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           FG++  +  T    +    +    +M+PE +  G +   SD+WS G+VL E  +  + PY
Sbjct: 173 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 232

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 75/136 (55%), Gaps = 11/136 (8%)
Query: 42  AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++ ++ +Y+  GSL D +++ +  +  + L     Q+ KG+ YL  E  ++HR+L   N+
Sbjct: 106 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNV 164
Query: 101 LINHRGEVKITDFGVSAIMASTSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSL 155
           L+    +V++ DFGV+ ++     Q     A T +    +M+ E I  GKY ++SD+WS 
Sbjct: 165 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIHFGKYTHQSDVWSY 221
Query: 156 GLVLLECAT-GQFPYS 170
           G+ + E  T G  PY+
Sbjct: 222 GVTVWELMTFGAEPYA 237

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 82/193 (42%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 209
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  A    +    +    +M PE    G +  K+D 
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 270 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 317
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 318 IMTQCWQHQPEDR 330

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 82/193 (42%), Gaps = 30/193 (15%)
Query: 45  IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 128 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 186
Query: 98  SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
            N L+   G     KI DFG++  +  A    +    +    +M PE    G +  K+D 
Sbjct: 187 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 246
Query: 153 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 207
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 247 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 294
Query: 208 FISACVQKEPQQR 220
            ++ C Q +P+ R
Sbjct: 295 IMTQCWQHQPEDR 307

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 86
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 87  -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 143
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 232
Query: 144 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 195
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-------T 64
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++        
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 65  IPEEYLAAICE---QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
           +    L+ + +   ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 248
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
                +ME  +   P + P   F       +  C Q  P+ R S  E+++
Sbjct: 249 -VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 75/136 (55%), Gaps = 11/136 (8%)
Query: 42  AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           ++ ++ +Y+  GSL D +++ +  +  + L     Q+ KG+ YL  E  ++HR+L   N+
Sbjct: 88  SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNV 146
Query: 101 LINHRGEVKITDFGVSAIMASTSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSL 155
           L+    +V++ DFGV+ ++     Q     A T +    +M+ E I  GKY ++SD+WS 
Sbjct: 147 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIHFGKYTHQSDVWSY 203
Query: 156 GLVLLECAT-GQFPYS 170
           G+ + E  T G  PY+
Sbjct: 204 GVTVWELMTFGAEPYA 219

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 2   VIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           +++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +FL+
Sbjct: 83  MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
Query: 61  KVKT-----------IPEEYLAA-----ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           + +             PEE L++        QV +G+ +L   K+ IHRD+   N+L+ +
Sbjct: 143 RKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTN 201
Query: 105 RGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 159
               KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++L
Sbjct: 202 GHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILL 258
Query: 160 LEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEP 217
            E  + G  PY         + FY+L++       P+     F+P+   S + AC   EP
Sbjct: 259 WEIFSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEP 310
Query: 218 QQRLSAQELMT 228
             R + Q++ +
Sbjct: 311 THRPTFQQICS 321

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 86
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 98  YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 156
Query: 87  -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 143
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 157 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 213
Query: 144 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 195
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 269

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 29  YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 86
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 87  -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 143
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 176 PELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 232
Query: 144 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 195
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 20/169 (11%)
Query: 45  IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           +I+E+   GSL   L++      +PE     +   V+ G+ +L  E  I+HR++KP N++
Sbjct: 86  LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIM 144
Query: 102 --INHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPE--------RISGGKYGYK 149
             I   G+   K+TDFG +  +     Q     GT  Y+ P+        +    KYG  
Sbjct: 145 RVIGEDGQSVYKLTDFGAARELEDDE-QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 150 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
            D+WS+G+     ATG  P+ P E   G     E+M  I+   P  A S
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFE---GPRRNKEVMYKIITGKPSGAIS 249

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 40  NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 83
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 84  LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 141
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 198
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 278
Query: 199 DQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +    E    +  C    P QR + ++L+
Sbjct: 279 N----ELYMMMRDCWHAVPSQRPTFKQLV 303

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 103 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 161
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 222 SFGVLLWELMTRGAPPYP 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 103 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 161
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 222 SFGVLLWELMTRGAPPYP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 102 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 160
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 220
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 221 SFGVLLWELMTRGAPPYP 238

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 22/230 (9%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE--- 68
           R +   E  + +   C +VV             +I+E M  G L  +L+ ++   E    
Sbjct: 59  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 69  -------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   +  +  ++  G+ YL+  K  +HRDL   N  +     VKI DFG++  +  
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 122 TS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
           T    +    +    +MSPE +  G +   SD+WS G+VL E AT  + PY     +   
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 235
Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
              + +   ++D+P      D         +  C Q  P+ R S  E+++
Sbjct: 236 VLRFVMEGGLLDKP------DNCPDMLLELMRMCWQYNPKMRPSFLEIIS 279

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 122 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 180
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 181 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 240
Query: 154 SLGLVLLECAT-GQFPY 169
           S G++L E  T G  PY
Sbjct: 241 SFGVLLWELMTRGAPPY 257

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 95  SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 153
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 154 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 213
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 214 SFGVLLWELMTRGAPPYP 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 98  SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 156
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 217 SFGVLLWELMTRGAPPYP 234

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 101 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 159
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 160 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 219
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 220 SFGVLLWELMTRGAPPYP 237

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 158
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 219 SFGVLLWELMTRGAPPYP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 121 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 179
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 180 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 239
Query: 154 SLGLVLLECAT-GQFPY 169
           S G++L E  T G  PY
Sbjct: 240 SFGVLLWELMTRGAPPY 256

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 73/132 (55%), Gaps = 12/132 (9%)
Query: 41  GAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 98  GSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 153
Query: 98  SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 152
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 154 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 213
Query: 153 WSLGLVLLECAT 164
           W  G ++ E  T
Sbjct: 214 WGAGCIMAEMWT 225

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 104 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 162
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 163 RNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 222
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 223 SFGVLLWELMTRGAPPYP 240

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 105/259 (40%), Gaps = 37/259 (14%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK-TIPE 67
           +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K T+P 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPV 121
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQA 126
            Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +       
Sbjct: 122 IYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 127 NTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------------- 168
           +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP               
Sbjct: 181 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 169 YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 223
            +P  +Q       +T F      I   P       +  PE  +  S  ++  P  RL+ 
Sbjct: 240 GTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 224 QELMTHPFLKMYGDLNVDL 242
            E   H F     D NV L
Sbjct: 298 LEACAHSFFDELRDPNVKL 316

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 101 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 159
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 160 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 219
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 220 SFGVLLWELMTRGAPPYP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 103 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 161
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 222 SFGVLLWELMTRGAPPYP 239

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 103 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 161
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 221
Query: 154 SLGLVLLECAT-GQFPY 169
           S G++L E  T G  PY
Sbjct: 222 SFGVLLWELMTRGAPPY 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 220
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 280
Query: 154 SLGLVLLECAT-GQFPY 169
           S G++L E  T G  PY
Sbjct: 281 SFGVLLWELMTRGAPPY 297

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 65/226 (28%)
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT------- 128
           Q++K + YLH    ++HRD+KPSN+L+N    VK+ DFG+S    +     N        
Sbjct: 117 QLIKVIKYLH-SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 129 --------------FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYSP 171
                         +V T  Y +PE + G  KY    D+WSLG +L E   G+  FP S 
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235
Query: 172 --------------PEQQD--------GWTSFYELMEAIVDQPPPSAPSDQFSP------ 203
                         P  +D          T    L E +  +   S   D F+       
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV--EIRQSNKRDIFTKWKNLLL 293
Query: 204 ----------EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
                     E    +   +Q  P +R+SA + + HPF+ ++ + N
Sbjct: 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 57  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV- 174
Query: 122 TSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------- 168
             G+ N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP         
Sbjct: 175 -RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 169 ------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
                  +P  +Q       +T F      I   P       +  PE  +  S  ++  P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
             RL+  E   H F     D NV L
Sbjct: 292 TARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 73/133 (54%), Gaps = 12/133 (9%)
Query: 40  NGAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 96
            G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K
Sbjct: 96  KGSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMK 151
Query: 97  PSNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSD 151
            +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D
Sbjct: 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPID 211
Query: 152 IWSLGLVLLECAT 164
           +W  G ++ E  T
Sbjct: 212 LWGAGCIMAEMWT 224

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDL 110
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 111 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKA 169
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 229
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 230 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 7   VEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ +
Sbjct: 55  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
Query: 63  KTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +   E          + +  +  ++  G+ YL+ +K  +HR+L   N ++ H   VKI D
Sbjct: 115 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRNLAARNCMVAHDFTVKIGD 173
Query: 113 FGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           FG++  +  T    +    +    +M+PE +  G +   SD+WS G+VL E  +  + PY
Sbjct: 174 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 108 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 166
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 167 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 226
Query: 154 SLGLVLLECAT-GQFPY 169
           S G++L E  T G  PY
Sbjct: 227 SFGVLLWELMTRGAPPY 243

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 6/138 (4%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           S G+  ++L YM  G L +F++     P  + L     QV KG+ +L  +K  +HRDL  
Sbjct: 104 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAA 162
Query: 98  SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 153
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 163 RNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 222
Query: 154 SLGLVLLECATGQFPYSP 171
           S G++L E  T   P  P
Sbjct: 223 SFGVLLWELMTRGAPPYP 240

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 12  RRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK------- 63
           +  +  ELKI +   Q   +V    +    G + +I EY   G L +FL++         
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 64  -------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
                  T+    L     QV +G+ +L   K+ IHRD+   N+L+ +    KI DFG++
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 117 AIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYS 170
             + + S     G A   V    +M+PE I    Y  +SD+WS G++L E  + G  PY 
Sbjct: 212 RDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268
Query: 171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQRLSAQEL 226
                   + FY+L++       P+     F+P+   S + AC   EP  R + Q++
Sbjct: 269 GILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 7   VEESA----RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           V ESA    R +   E  + +   C +VV             +++E M  G L  +L+ +
Sbjct: 56  VNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 115
Query: 63  KTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +   E          + +  +  ++  G+ YL+ +K  +HR+L   N ++ H   VKI D
Sbjct: 116 RPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRNLAARNCMVAHDFTVKIGD 174
Query: 113 FGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 169
           FG++  +  T    +    +    +M+PE +  G +   SD+WS G+VL E  +  + PY
Sbjct: 175 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 110/260 (42%), Gaps = 39/260 (15%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK-TIPE 67
           +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K T+P 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQA 126
            Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +    G+ 
Sbjct: 122 IYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEP 178
Query: 127 N-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP-------------- 168
           N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP              
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 169 -YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
             +P  +Q       +T F      I   P       +  PE  +  S  ++  P  RL+
Sbjct: 239 LGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 223 AQELMTHPFLKMYGDLNVDL 242
             E   H F     D NV L
Sbjct: 297 PLEACAHSFFDELRDPNVKL 316

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 62  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 121
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 122 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV- 179
Query: 122 TSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------- 168
             G+ N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP         
Sbjct: 180 -RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 238
Query: 169 ------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
                  +P  +Q       +T F      I   P       +  PE  +  S  ++  P
Sbjct: 239 EIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 296
Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
             RL+  E   H F     D NV L
Sbjct: 297 TARLTPLEACAHSFFDELRDPNVKL 321

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 70  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 129
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 130 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV- 187
Query: 122 TSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------- 168
             G+ N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP         
Sbjct: 188 -RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 169 ------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
                  +P  +Q       +T F      I   P       +  PE  +  S  ++  P
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 304
Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
             RL+  E   H F     D NV L
Sbjct: 305 TARLTPLEACAHSFFDELRDPNVKL 329

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 12  RRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--- 67
           +  +  ELKI +   Q   +V    +    G + +I EY   G L +FL++   + E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 68  -----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
                        L     QV +G+ +L   K+ IHRD+   N+L+ +    KI DFG++
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 117 AIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYS 170
             + + S     G A   V    +M+PE I    Y  +SD+WS G++L E  + G  PY 
Sbjct: 212 RDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268
Query: 171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQRLSAQEL 226
                   + FY+L++       P+     F+P+   S + AC   EP  R + Q++
Sbjct: 269 GILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 73/132 (55%), Gaps = 12/132 (9%)
Query: 41  GAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 98  GSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 153
Query: 98  SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 152
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 154 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 213
Query: 153 WSLGLVLLECAT 164
           W  G ++ E  T
Sbjct: 214 WGAGCIMAEMWT 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 110/260 (42%), Gaps = 39/260 (15%)
Query: 17  QELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK-TIPE 67
           +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K T+P 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQA 126
            Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +    G+ 
Sbjct: 122 IYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEP 178
Query: 127 N-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP-------------- 168
           N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP              
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 169 -YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
             +P  +Q       +T F      I   P       +  PE  +  S  ++  P  RL+
Sbjct: 239 LGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 223 AQELMTHPFLKMYGDLNVDL 242
             E   H F     D NV L
Sbjct: 297 PLEACAHSFFDELRDPNVKL 316

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 91  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 150
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 151 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV- 208
Query: 122 TSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------- 168
             G+ N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP         
Sbjct: 209 -RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 169 ------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
                  +P  +Q       +T F      I   P       +  PE  +  S  ++  P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
             RL+  E   H F     D NV L
Sbjct: 326 TARLTPLEACAHSFFDELRDPNVKL 350

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 85  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 144
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 145 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV- 202
Query: 122 TSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------- 168
             G+ N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP         
Sbjct: 203 -RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 169 ------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
                  +P  +Q       +T F      I   P       +  PE  +  S  ++  P
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 319
Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
             RL+  E   H F     D NV L
Sbjct: 320 TARLTPLEACAHSFFDELRDPNVKL 344

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 136 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 195
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 196 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV- 253
Query: 122 TSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------- 168
             G+ N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP         
Sbjct: 254 -RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 169 ------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
                  +P  +Q       +T F      I   P       +  PE  +  S  ++  P
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 370
Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
             RL+  E   H F     D NV L
Sbjct: 371 TARLTPLEACAHSFFDELRDPNVKL 395

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 30/233 (12%)
Query: 12  RRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-------- 62
           +  +  ELKI +   Q   +V    +    G + +I EY   G L +FL++         
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 63  --KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + +    L     QV +G+ +L   K+ IHRD+   N+L+ +    KI DFG++  + 
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 203
Query: 121 STS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQ 174
           + S     G A   V    +M+PE I    Y  +SD+WS G++L E  + G  PY     
Sbjct: 204 NDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 260
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQRLSAQEL 226
               + FY+L++       P+     F+P+   S + AC   EP  R + Q++
Sbjct: 261 N---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 57  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 176 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 69  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 128
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 129 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 188 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 247 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 304
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 305 ARLTPLEACAHSFFDELRDPNVKL 328

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 57  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 176 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 58  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 117
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 118 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 176
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 177 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 235
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 236 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 293
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 294 ARLTPLEACAHSFFDELRDPNVKL 317

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 61  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 120
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 121 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 179
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 180 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 239 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 296
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 297 ARLTPLEACAHSFFDELRDPNVKL 320

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 57  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 176 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHII 91
           S+  + +I  Y + GSL DFL++ +T+       +      GL +LH E         I 
Sbjct: 77  SSTQLWLITHYHEHGSLYDFLQR-QTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIA 135
Query: 92  HRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERI-----S 142
           HRD K  N+L+    +  I D G++ + +  S       N  VGT  YM+PE +     +
Sbjct: 136 HRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRT 195
Query: 143 GGKYGYK-SDIWSLGLVLLECATGQF------PYSPP--EQQDGWTSFYELMEAI-VDQP 192
                YK +DIW+ GLVL E A           Y PP  +      SF ++ + + VDQ 
Sbjct: 196 DCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKVVCVDQQ 255
Query: 193 PPSAP----SDQFSPEFCSFISACVQKEPQQRLSA 223
            P+ P    +D         +  C    P  RL+A
Sbjct: 256 TPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTA 290

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 93  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 152
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 153 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV- 210
Query: 122 TSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------- 168
             G+ N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP         
Sbjct: 211 -RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 169 ------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
                  +P  +Q       +T F      I   P       +  PE  +  S  ++  P
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 327
Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
             RL+  E   H F     D NV L
Sbjct: 328 TARLTPLEACAHSFFDELRDPNVKL 352

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 39/265 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 95  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 154
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 155 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV- 212
Query: 122 TSGQAN-TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP--------- 168
             G+ N +++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP         
Sbjct: 213 -RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 169 ------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 217
                  +P  +Q       +T F      I   P       +  PE  +  S  ++  P
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 329
Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
             RL+  E   H F     D NV L
Sbjct: 330 TARLTPLEACAHSFFDELRDPNVKL 354

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 65  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 124
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 125 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 183
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 184 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 242
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 243 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 300
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 301 ARLTPLEACAHSFFDELRDPNVKL 324

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 69  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 128
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 129 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 188 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 247 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 304
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 305 ARLTPLEACAHSFFDELRDPNVKL 328

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 76  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 135
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 136 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 194
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 195 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 253
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 254 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 311
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 312 ARLTPLEACAHSFFDELRDPNVKL 335

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 30/233 (12%)
Query: 12  RRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-------- 62
           +  +  ELKI +   Q   +V    +    G + +I EY   G L +FL++         
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 63  --KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
             + +    L     QV +G+ +L   K+ IHRD+   N+L+ +    KI DFG++  + 
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 211
Query: 121 STS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQ 174
           + S     G A   V    +M+PE I    Y  +SD+WS G++L E  + G  PY     
Sbjct: 212 NDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 268
Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQRLSAQEL 226
               + FY+L++       P+     F+P+   S + AC   EP  R + Q++
Sbjct: 269 N---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 13/156 (8%)
Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGT 132
           QV +G+ +L   K  IHRDL   N+L++    VKI DFG++  +        + +T +  
Sbjct: 207 QVARGMEFLSSRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL-P 264
Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQ 191
             +M+PE I    Y  KSD+WS G++L E  + G  PY   +  + + S   L E +  +
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCS--RLREGMRMR 322
Query: 192 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
            P  +     +PE    +  C  ++P++R    EL+
Sbjct: 323 APEYS-----TPEIYQIMLDCWHRDPKERPRFAELV 353

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 37/264 (14%)
Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG--SLADFLKKVK 63
           +R   +EL+I +      +V     FYS+G       ++++L+Y+      +A    + K
Sbjct: 91  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 150
Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
            T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 151 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 122 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 168
                +     Y Y +PE I G   Y    D+WS G VL E   GQ  FP          
Sbjct: 210 GEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
Query: 169 -----YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 218
                 +P  +Q       +T F      I   P       +  PE  +  S  ++  P 
Sbjct: 269 IIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326
Query: 219 QRLSAQELMTHPFLKMYGDLNVDL 242
            RL+  E   H F     D NV L
Sbjct: 327 ARLTPLEACAHSFFDELRDPNVKL 350

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 40  NGAISIILEYMDG---GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 96
           N  +++I+EY+       L  F++  ++IP   ++    Q+ + + ++H    I HRD+K
Sbjct: 110 NKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIK 168
Query: 97  PSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWS 154
           P NLL+N +   +K+ DFG +  +  +          + Y +PE + G  +Y    D+WS
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF-YRAPELMLGATEYTPSIDLWS 227
Query: 155 LGLVLLECATGQFPYSPPEQQDGWTSFYELM-----EAIVDQPP-------PSAPSDQFS 202
           +G V  E   G+  +S     D      ++M     E ++   P       P+  +  + 
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287
Query: 203 ---PE-----FCSFISACVQKEPQQRLSAQELMTHPFL 232
              PE         +   ++ EP  R++  E M HPF 
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDL 110
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 111 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 169
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 229
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 230 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 80  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDL 138
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 139 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 197
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 198 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 257
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 258 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDL 110
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 111 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 169
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 229
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 230 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 57  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDL 115
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 116 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 174
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 235 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 49  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDL 107
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 108 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 227 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 65/118 (55%), Gaps = 9/118 (7%)
Query: 52  GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
            G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K +N+LI   G +K+ 
Sbjct: 112 AGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLA 167
Query: 112 DFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECAT 164
           DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+W  G ++ E  T
Sbjct: 168 DFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 54  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDL 112
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 113 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 171
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 172 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 231
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 232 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 55  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDL 113
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 114 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 172
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 173 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 232
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 233 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDL 110
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 111 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKA 169
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 229
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 230 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 17/223 (7%)
Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPE 67
           +S R +  QE    +    P++V        N  + II+E    G L  FL+  K ++  
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDL 490
Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQA 126
             L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A
Sbjct: 491 ASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD--GWTSFYE 183
           +       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  D  G     E
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609
Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 610 RLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 102/227 (44%), Gaps = 20/227 (8%)
Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYL 70
           + +E+ I   ++   ++  ++SF S   + +I E++ G    D  +++ T    + E  +
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISG---LDIFERINTSAFELNEREI 104
Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQANT 128
            +   QV + L +LH   +I H D++P N++   R    +KI +FG +  +         
Sbjct: 105 VSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           F     Y +PE          +D+WSLG ++    +G  P+     Q       +++E I
Sbjct: 164 FTAP-EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENI 215
Query: 189 VDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           ++           + S E   F+   + KE + R++A E + HP+LK
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 44  SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           +++ EY++     DF +  + + +  +     ++LK L Y H  K I+HRD+KP N++I+
Sbjct: 111 ALVFEYINN---TDFKQLYQILTDFDIRFYMYELLKALDYCH-SKGIMHRDVKPHNVMID 166
Query: 104 H-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 161
           H + ++++ D+G+ A     + + N  V +  +  PE +   + Y Y  D+WSLG +L  
Sbjct: 167 HQQKKLRLIDWGL-AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 225
Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAI-------------VDQPP--------------- 193
               + P+     QD +     + + +             +D  P               
Sbjct: 226 MIFRREPFF--HGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWE 283
Query: 194 ---PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               S      SPE    +   ++ + QQRL+A+E M HP+ 
Sbjct: 284 NFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 108/250 (43%), Gaps = 45/250 (18%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-- 65
           E++A R++     + Q S   +VV  + ++  +  + I  EY +GGSLAD + +   I  
Sbjct: 54  EQNALREVYAHAVLGQHS---HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS 110
Query: 66  --PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-------EVKITDFGVS 116
              E  L  +  QV +GL Y+H    ++H D+KPSN+ I+          E    D+  +
Sbjct: 111 YFKEAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169
Query: 117 AIMASTSGQANTFVGTYNYMSPERISGGKYGY--------------KSDIWSLGLVLLEC 162
            +M          +G    +S  ++  G   +              K+DI++L L ++ C
Sbjct: 170 KVMFKIGD-----LGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-C 223
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
           A G  P   P   D W   +E+ +  + + P        S EF   +   +  +P++R S
Sbjct: 224 AAGAEPL--PRNGDQW---HEIRQGRLPRIP-----QVLSQEFTELLKVMIHPDPERRPS 273
Query: 223 AQELMTHPFL 232
           A  L+ H  L
Sbjct: 274 AMALVKHSVL 283

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 108/250 (43%), Gaps = 45/250 (18%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-- 65
           E++A R++     + Q S   +VV  + ++  +  + I  EY +GGSLAD + +   I  
Sbjct: 52  EQNALREVYAHAVLGQHS---HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS 108
Query: 66  --PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-------EVKITDFGVS 116
              E  L  +  QV +GL Y+H    ++H D+KPSN+ I+          E    D+  +
Sbjct: 109 YFKEAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 167
Query: 117 AIMASTSGQANTFVGTYNYMSPERISGGKYGY--------------KSDIWSLGLVLLEC 162
            +M          +G    +S  ++  G   +              K+DI++L L ++ C
Sbjct: 168 KVMFKIGD-----LGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-C 221
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
           A G  P   P   D W   +E+ +  + + P        S EF   +   +  +P++R S
Sbjct: 222 AAGAEPL--PRNGDQW---HEIRQGRLPRIP-----QVLSQEFTELLKVMIHPDPERRPS 271
Query: 223 AQELMTHPFL 232
           A  L+ H  L
Sbjct: 272 AMALVKHSVL 281

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 108/250 (43%), Gaps = 45/250 (18%)
Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-- 65
           E++A R++     + Q S   +VV  + ++  +  + I  EY +GGSLAD + +   I  
Sbjct: 52  EQNALREVYAHAVLGQHS---HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS 108
Query: 66  --PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-------EVKITDFGVS 116
              E  L  +  QV +GL Y+H    ++H D+KPSN+ I+          E    D+  +
Sbjct: 109 YFKEAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 167
Query: 117 AIMASTSGQANTFVGTYNYMSPERISGGKYGY--------------KSDIWSLGLVLLEC 162
            +M          +G    +S  ++  G   +              K+DI++L L ++ C
Sbjct: 168 KVMFKIGD-----LGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-C 221
Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
           A G  P   P   D W   +E+ +  + + P        S EF   +   +  +P++R S
Sbjct: 222 AAGAEPL--PRNGDQW---HEIRQGRLPRIP-----QVLSQEFTELLKVMIHPDPERRPS 271
Query: 223 AQELMTHPFL 232
           A  L+ H  L
Sbjct: 272 AMALVKHSVL 281

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 44  SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           +++ EY++     DF +  + + +  +     ++LK L Y H  K I+HRD+KP N++I+
Sbjct: 116 ALVFEYINN---TDFKQLYQILTDFDIRFYMYELLKALDYCH-SKGIMHRDVKPHNVMID 171
Query: 104 H-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 161
           H + ++++ D+G+ A     + + N  V +  +  PE +   + Y Y  D+WSLG +L  
Sbjct: 172 HQQKKLRLIDWGL-AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 230
Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAI-------------VDQPP--------------- 193
               + P+     QD +     + + +             +D  P               
Sbjct: 231 MIFRREPFF--HGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWE 288
Query: 194 ---PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
               S      SPE    +   ++ + QQRL+A+E M HP+ 
Sbjct: 289 NFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	262
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-127
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-124
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-123
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-121
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-118
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-79
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-78
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-78
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-78
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-77
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-77
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-77
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-76
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-74
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-74
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-72
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-72
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-71
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-71
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-70
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-70
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-69
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-67
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-66
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-66
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-65
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-64
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-64
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-58
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-55
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-55
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-54
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-54
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-54
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-54
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-53
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-51
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-49
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-47
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-46
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-46
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-46
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-46
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-46
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-46
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-45
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-45
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-45
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-45
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-45
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-44
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-44
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-44
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-44
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-44
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-44
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-44
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-44
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-43
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-43
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-43
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-43
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-43
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-43
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-43
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-43
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-43
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-43
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-42
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-42
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-42
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-42
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-42
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-42
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-42
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-42
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-42
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-42
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-42
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-42
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-41
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-41
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-41
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-41
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-41
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-41
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-41
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-41
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-41
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-40
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-40
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-40
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-40
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-40
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-40
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-40
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-39
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-39
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-39
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-39
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-39
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-39
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-39
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-39
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-39
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-39
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-38
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-38
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-38
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-38
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-38
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-37
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-37
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-37
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-37
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-36
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-36
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-36
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-35
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-34
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-32
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-32
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-32
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-31
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-31
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-30
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-29
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-28
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-28
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-28
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-28
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-28
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-27
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-26
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-24
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-24
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-24
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-24
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-24
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-24
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-24
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-24
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-23
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-23
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-23
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-23
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-22
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-11
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	4e-04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	7e-04

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  364 bits (937), Expect = e-127
 Identities = 109/283 (38%), Positives = 160/283 (56%), Gaps = 37/283 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 65  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242

Query: 177 ------------------------------GWTSFYELMEAIVDQPPPSAPSDQFSPEFC 206
                                            + +EL++ IV++PPP  PS  FS EF 
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302

Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 249
            F++ C+ K P +R   ++LM H F+K      VD + +    
Sbjct: 303 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCST 345

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  353 bits (909), Expect = e-124
 Identities = 89/256 (34%), Positives = 144/256 (56%), Gaps = 17/256 (6%)

Query: 2   VIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
            I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I +E MD  SL  F K
Sbjct: 39  RIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYK 97

Query: 61  KV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           +V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN  G+VK+ DFG+S
Sbjct: 98  QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

Query: 117 AIMASTSGQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPP 172
             +       +   G   YM+PERI+       Y  KSDIWSLG+ ++E A  +FPY   
Sbjct: 158 GYLVD-DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS- 215

Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++R +  ELM HPF 
Sbjct: 216 -----WGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

Query: 233 KMYGDLNVDLSEYFTD 248
            ++     D++ +   
Sbjct: 271 TLHESKGTDVASFVKL 286

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  347 bits (893), Expect = e-121
 Identities = 81/254 (31%), Positives = 140/254 (55%), Gaps = 14/254 (5%)

Query: 2   VIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
            ++ +  +   ++I  +L +  +S  CPY+V C+ +F +N  + I +E M   +     +
Sbjct: 57  QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR 116

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               IPE  L  +   ++K L YL  +  +IHRD+KPSN+L++ RG++K+ DFG+S  + 
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176

Query: 121 STSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
               + +   G   YM+PERI     +   Y  ++D+WSLG+ L+E ATGQFPY      
Sbjct: 177 DDKAK-DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN---- 231

Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
               + +E++  ++ + PP  P    FS +F SF+  C+ K+ ++R    +L+ H F+K 
Sbjct: 232 --CKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

Query: 235 YGDLNVDLSEYFTD 248
           Y  L VD++ +F D
Sbjct: 290 YETLEVDVASWFKD 303

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  341 bits (876), Expect = e-118
 Identities = 89/260 (34%), Positives = 137/260 (52%), Gaps = 21/260 (8%)

Query: 2   VIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
            I+  V+E  ++Q+  +L +  +SS CPY+V  Y + +  G   I +E M   S   F K
Sbjct: 54  RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYK 112

Query: 61  KVK-----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
            V       IPEE L  I    +K L +L     IIHRD+KPSN+L++  G +K+ DFG+
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172

Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSP 171
           S  +  +  +     G   YM+PERI        Y  +SD+WSLG+ L E ATG+FPY  
Sbjct: 173 SGQLVDSIAKTRD-AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231

Query: 172 PEQQDGWTSFYELMEAIVDQPPPSAPSD---QFSPEFCSFISACVQKEPQQRLSAQELMT 228
                 W S ++ +  +V   PP   +    +FSP F +F++ C+ K+  +R   +EL+ 
Sbjct: 232 ------WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

Query: 229 HPFLKMYGDLNVDLSEYFTD 248
           HPF+ MY +  V+++ Y   
Sbjct: 286 HPFILMYEERAVEVACYVCK 305

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  240 bits (615), Expect = 2e-79
 Identities = 76/244 (31%), Positives = 132/244 (54%), Gaps = 21/244 (8%)

Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + + 
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE- 110

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A +   
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTS 180
             + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY    P        
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------- 221

Query: 181 FYELMEA---IVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               + A   I     P     ++ S  F  F++ C++ + ++R SA+EL+ H FLK+  
Sbjct: 222 ----LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277

Query: 237 DLNV 240
            L+ 
Sbjct: 278 PLSS 281

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  239 bits (611), Expect = 1e-78
 Identities = 86/244 (35%), Positives = 134/244 (54%), Gaps = 21/244 (8%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV- 62
           Q+ VE   + +I +E+ I Q    P+VV  Y S++ N  + I++EY   GS++D ++   
Sbjct: 61  QVPVESDLQ-EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           KT+ E+ +A I +  LKGL YLH     IHRD+K  N+L+N  G  K+ DFGV+  +  T
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLH-FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTS 180
             + NT +GT  +M+PE I    Y   +DIWSLG+  +E A G+ PY+   P        
Sbjct: 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------- 230

Query: 181 FYELMEA---IVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               M A   I   PPP+    + +S  F  F+  C+ K P+QR +A +L+ HPF++   
Sbjct: 231 ----MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286

Query: 237 DLNV 240
            +++
Sbjct: 287 GVSI 290

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  239 bits (611), Expect = 1e-78
 Identities = 80/242 (33%), Positives = 133/242 (54%), Gaps = 21/242 (8%)

Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
            M++ +  RR+ +  E+ I +  Q   VV  Y+S+     + +++E++ GG+L D + + 
Sbjct: 77  MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ- 135

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
             + EE +A +CE VL+ L YLH  + +IHRD+K  ++L+   G VK++DFG  A ++  
Sbjct: 136 VRLNEEQIATVCEAVLQALAYLH-AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTS 180
             +  + VGT  +M+PE IS   Y  + DIWSLG++++E   G+ PY    P        
Sbjct: 195 VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------- 246

Query: 181 FYELMEA---IVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               ++A   + D PPP    S + SP    F+   + ++PQ+R +AQEL+ HPFL   G
Sbjct: 247 ----VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302

Query: 237 DL 238
             
Sbjct: 303 LP 304

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  238 bits (610), Expect = 3e-78
 Identities = 85/253 (33%), Positives = 131/253 (51%), Gaps = 32/253 (12%)

Query: 4   QMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAIS------IILEYMDGGSLA 56
            M+V      +I QE+ +  + S    +   Y +F             +++E+   GS+ 
Sbjct: 56  VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115

Query: 57  DFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 114
           D +K  K  T+ EE++A IC ++L+GL +LH +  +IHRD+K  N+L+    EVK+ DFG
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENAEVKLVDFG 174

Query: 115 VSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPY 169
           VSA +  T G+ NTF+GT  +M+PE I         Y +KSD+WSLG+  +E A G  P 
Sbjct: 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

Query: 170 S--PPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 224
               P            M A   I   P P   S ++S +F SFI +C+ K   QR + +
Sbjct: 235 CDMHP------------MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATE 282

Query: 225 ELMTHPFLKMYGD 237
           +LM HPF++   +
Sbjct: 283 QLMKHPFIRDQPN 295

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  235 bits (602), Expect = 2e-77
 Identities = 90/248 (36%), Positives = 132/248 (53%), Gaps = 22/248 (8%)

Query: 4   QMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +++EE+      I QE+ +      PYV   Y S+  +  + II+EY+ GGS  D L+ 
Sbjct: 54  IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP 113

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              + E  +A I  ++LKGL YLH EK  IHRD+K +N+L++  GEVK+ DFGV+  +  
Sbjct: 114 -GPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWT 179
           T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   P       
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------- 224

Query: 180 SFYELMEA---IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
                M+    I    PP+     +S     F+ AC+ KEP  R +A+EL+ H F+    
Sbjct: 225 -----MKVLFLIPKNNPPTL-EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278

Query: 237 DLNVDLSE 244
                L+E
Sbjct: 279 KKTSYLTE 286

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  234 bits (599), Expect = 5e-77
 Identities = 73/250 (29%), Positives = 126/250 (50%), Gaps = 26/250 (10%)

Query: 4   QMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
            +  +     +    E++I  +   PY+V    ++Y +G + I++E+  GG++   + ++
Sbjct: 51  VIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL 110

Query: 63  -KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
            + + E  +  +C Q+L+ L +LH  K IIHRDLK  N+L+   G++++ DFGVSA    
Sbjct: 111 DRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169

Query: 122 TSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQ 174
           T  + ++F+GT  +M+PE +         Y YK+DIWSLG+ L+E A  + P+    P  
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-- 227

Query: 175 QDGWTSFYELMEA---IVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
                     M     I    PP+     ++S EF  F+   + K P+ R SA +L+ HP
Sbjct: 228 ----------MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277

Query: 231 FLKMYGDLNV 240
           F+        
Sbjct: 278 FVSSITSNKA 287

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  234 bits (599), Expect = 7e-77
 Identities = 72/235 (30%), Positives = 114/235 (48%), Gaps = 12/235 (5%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
            M+ +   R    +E+ + +    P V+  Y SF  +  ++I+LE  D G L+  +K  K
Sbjct: 70  LMDAKA--RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127

Query: 64  ----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
                IPE  +     Q+   L ++H  + ++HRD+KP+N+ I   G VK+ D G+    
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186

Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
           +S +  A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+          
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKM 241

Query: 180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
           + Y L + I     P  PSD +S E    ++ C+  +P++R     +        
Sbjct: 242 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  233 bits (595), Expect = 8e-76
 Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 11/229 (4%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIP 66
              R +  +E+ +  + + P +V   +SF  NG++ I+++Y +GG L   +   K     
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           E+ +     Q+   L ++H ++ I+HRD+K  N+ +   G V++ DFG++ ++ ST   A
Sbjct: 124 EDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
              +GT  Y+SPE      Y  KSDIW+LG VL E  T +  +          S   L+ 
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE-------AGSMKNLVL 235

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            I+    P      +S +  S +S   ++ P+ R S   ++   F+   
Sbjct: 236 KIISGSFPPVSL-HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  229 bits (586), Expect = 2e-74
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 23/240 (9%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           ++ +E        +EL        P +V  Y +      ++I +E ++GGSL   +K++ 
Sbjct: 90  KVRLEVFRV----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMAS- 121
            +PE+       Q L+GL YL H + I+H D+K  N+L++  G    + DFG +  +   
Sbjct: 146 CLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 122 ----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
               +    +   GT  +M+PE + G     K DIWS   ++L    G      P     
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC----HP----- 255

Query: 178 WTSFYEL--MEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
           WT ++       I  +PPP        +P     I   ++KEP  R SA EL       +
Sbjct: 256 WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  226 bits (578), Expect = 6e-74
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 21/237 (8%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFY----SNGAISIILEYMDGGSLADFLKK 61
            + +S R++  +E ++ +  Q P +V  Y S+         I ++ E M  G+L  +LK+
Sbjct: 63  KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122

Query: 62  VKTIPEEYLAAICEQVLKGLLYLH-HEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIM 119
            K +  + L + C Q+LKGL +LH     IIHRDLK  N+ I    G VKI D G++ + 
Sbjct: 123 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182

Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS---PPEQQD 176
            ++   A   +GT  +M+PE      Y    D+++ G+ +LE AT ++PYS      Q  
Sbjct: 183 RAS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-- 237

Query: 177 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                  +   +     P++      PE    I  C+++   +R S ++L+ H F +
Sbjct: 238 -------IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  222 bits (568), Expect = 3e-72
 Identities = 81/266 (30%), Positives = 129/266 (48%), Gaps = 42/266 (15%)

Query: 4   QMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK- 60
           ++N+E+      ++ +E++       P +V  Y SF     + ++++ + GGS+ D +K 
Sbjct: 47  RINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH 106

Query: 61  -------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
                  K   + E  +A I  +VL+GL YLH    I HRD+K  N+L+   G V+I DF
Sbjct: 107 IVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADF 165

Query: 114 GVSAIMASTSGQA-----NTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQF 167
           GVSA +A+           TFVGT  +M+PE +   + Y +K+DIWS G+  +E ATG  
Sbjct: 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225

Query: 168 PYS--PPEQQDGWTSFYELMEA---IVDQPPPS--------APSDQFSPEFCSFISACVQ 214
           PY   PP            M+     +   PPS            ++   F   IS C+Q
Sbjct: 226 PYHKYPP------------MKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ 273

Query: 215 KEPQQRLSAQELMTHPFLKMYGDLNV 240
           K+P++R +A EL+ H F +   +   
Sbjct: 274 KDPEKRPTAAELLRHKFFQKAKNKEF 299

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  222 bits (568), Expect = 9e-72
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 29/249 (11%)

Query: 4   QMNVEESARR----QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           +M+            I +E++  Q  + P  +     +       +++EY  G +     
Sbjct: 86  KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 145

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
              K + E  +AA+    L+GL YL H  ++IHRD+K  N+L++  G VK+ DFG ++IM
Sbjct: 146 VHKKPLQEVEIAAVTHGALQGLAYL-HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204

Query: 120 ASTSGQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYS--PPEQ 174
           A     AN+FVGT  +M+PE I       Y  K D+WSLG+  +E A  + P        
Sbjct: 205 A----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-- 258

Query: 175 QDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
                     M A   I     P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F
Sbjct: 259 ----------MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308

Query: 232 LKMYGDLNV 240
           +       V
Sbjct: 309 VLRERPPTV 317

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  220 bits (563), Expect = 1e-71
 Identities = 79/231 (34%), Positives = 122/231 (52%), Gaps = 21/231 (9%)

Query: 13  RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIPEEY 69
           + + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+         E+ 
Sbjct: 64  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANT 128
           +    +Q+L+GL YLH +  I+HRD+K  N+LIN + G +KI+DFG S  +A  +    T
Sbjct: 124 IGFYTKQILEGLKYLH-DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182

Query: 129 FVGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           F GT  YM+PE I  G  GY   +DIWSLG  ++E ATG+    PP     +    E   
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP-----FYELGEPQA 233

Query: 187 AI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           A+    + +  P  P +  S E  +FI  C + +P +R  A +L+   FLK
Sbjct: 234 AMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  220 bits (562), Expect = 2e-71
 Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 16/234 (6%)

Query: 2   VIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
            +        R +   E+  ++   Q P  V   Q++   G + +  E   G SL    +
Sbjct: 90  SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE 148

Query: 61  KV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
               ++PE  +       L  L +LH  + ++H D+KP+N+ +  RG  K+ DFG+   +
Sbjct: 149 AWGASLPEAQVWGYLRDTLLALAHLH-SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207

Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
             T+G      G   YM+PE + G  YG  +D++SLGL +LE A        P   +GW 
Sbjct: 208 -GTAGAGEVQEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVACN---MELPHGGEGW- 261

Query: 180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
              +L +  +            S E  S +   ++ +P+ R +A+ L+  P L+
Sbjct: 262 --QQLRQGYLPPEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  217 bits (554), Expect = 2e-70
 Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 33/241 (13%)

Query: 11  ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----------------IILEYMDGGS 54
              +  +E+K         +V     +                       I +E+ D G+
Sbjct: 47  NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGT 106

Query: 55  LADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           L  +++K +   + +     + EQ+ KG+ Y+H  K +I+RDLKPSN+ +    +VKI D
Sbjct: 107 LEQWIEKRRGEKLDKVLALELFEQITKGVDYIH-SKKLINRDLKPSNIFLVDTKQVKIGD 165

Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 172
           FG+   + +   +     GT  YMSPE+IS   YG + D+++LGL+L E           
Sbjct: 166 FGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AF 222

Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           E         +    + D        D F  +  + +   + K+P+ R +  E++    +
Sbjct: 223 ETS-------KFFTDLRDGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

Query: 233 K 233
            
Sbjct: 272 W 272

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  216 bits (553), Expect = 2e-70
 Identities = 68/242 (28%), Positives = 117/242 (48%), Gaps = 20/242 (8%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKK 61
            M   E  ++ +  E+ + +  + P +V  Y      +N  + I++EY +GG LA  + K
Sbjct: 43  SMTEAE--KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100

Query: 62  VK----TIPEEYLAAICEQVLKGLLYLHHEK----HIIHRDLKPSNLLINHRGEVKITDF 113
                  + EE++  +  Q+   L   H        ++HRDLKP+N+ ++ +  VK+ DF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160

Query: 114 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 173
           G++ I+   +  A TFVGT  YMSPE+++   Y  KSDIWSLG +L E      P++   
Sbjct: 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--- 217

Query: 174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                 S  EL   I +      P  ++S E    I+  +  +   R S +E++ +P + 
Sbjct: 218 ----AFSQKELAGKIREGKFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

Query: 234 MY 235
            +
Sbjct: 273 EH 274

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  216 bits (551), Expect = 9e-69
 Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 52/290 (17%)

Query: 4   QMNVEESAR---RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           ++N+E  +      +  EL +++    P +V    +F ++  + ++  +M  GS  D + 
Sbjct: 59  RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118

Query: 61  --KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
              +  + E  +A I + VLK L Y+HH  ++ HR +K S++LI+  G+V ++    +  
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHILISVDGKVYLSGLRSNLS 177

Query: 119 MASTSGQANT-------FVGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPY 169
           M S   +           V    ++SPE +     GY  KSDI+S+G+   E A G  P+
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

Query: 170 S---------------PPEQQDGWTSFYE----------------------LMEAIVDQP 192
                            P   D  T   E                               
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297

Query: 193 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 242
           P       FSP F  F+  C+Q+ P  R SA  L+ H F K       + 
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA 347

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  210 bits (536), Expect = 1e-67
 Identities = 57/257 (22%), Positives = 98/257 (38%), Gaps = 41/257 (15%)

Query: 2   VIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
             +        +   +E+  +    Q  +VV  + ++  +  + I  EY +GGSLAD + 
Sbjct: 44  SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAIS 103

Query: 61  KVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--------- 107
           +         E  L  +  QV +GL Y+H    ++H D+KPSN+ I+             
Sbjct: 104 ENYRIMSYFKEAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGD 162

Query: 108 ----------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLG 156
                      KI D G    ++S         G   +++ E +     +  K+DI++L 
Sbjct: 163 EDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALA 218

Query: 157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 216
           L ++  A  +     P   D W         I     P  P    S EF   +   +  +
Sbjct: 219 LTVVCAAGAE---PLPRNGDQW-------HEIRQGRLPRIP-QVLSQEFTELLKVMIHPD 267

Query: 217 PQQRLSAQELMTHPFLK 233
           P++R SA  L+ H  L 
Sbjct: 268 PERRPSAMALVKHSVLL 284

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  208 bits (532), Expect = 2e-66
 Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 24/245 (9%)

Query: 6   NVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
             +         E+            ++  Y    ++  I +++E      L  +LKK K
Sbjct: 45  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 103

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--S 121
           +I      +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +
Sbjct: 104 SIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 161

Query: 122 TSGQANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYS 170
           TS   ++ VGT NYM PE I              K   KSD+WSLG +L     G+ P+ 
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 220

Query: 171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
                    +    + AI+D        D    +    +  C++++P+QR+S  EL+ HP
Sbjct: 221 -----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275

Query: 231 FLKMY 235
           ++++ 
Sbjct: 276 YVQIQ 280

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  206 bits (527), Expect = 6e-66
 Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 24/245 (9%)

Query: 6   NVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
             +         E+            ++  Y    ++  I +++E      L  +LKK K
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--S 121
           +I      +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 180

Query: 122 TSGQANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYS 170
           TS   ++ VGT NYM PE I              K   KSD+WSLG +L     G+ P+ 
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 239

Query: 171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
                    +    + AI+D        D    +    +  C++++P+QR+S  EL+ HP
Sbjct: 240 -----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294

Query: 231 FLKMY 235
           ++++ 
Sbjct: 295 YVQIQ 299

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  206 bits (527), Expect = 4e-65
 Identities = 61/245 (24%), Positives = 108/245 (44%), Gaps = 24/245 (9%)

Query: 6   NVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
             +         E+            ++  Y    ++  I +++E      L  +LKK K
Sbjct: 92  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 150

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--S 121
           +I      +  + +L+ +  +H +  I+H DLKP+N LI   G +K+ DFG++  M   +
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 208

Query: 122 TSGQANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYS 170
           TS   ++ VG  NYM PE I              K   KSD+WSLG +L     G+ P+ 
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF- 267

Query: 171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
                    +    + AI+D        D    +    +  C++++P+QR+S  EL+ HP
Sbjct: 268 -----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322

Query: 231 FLKMY 235
           ++++ 
Sbjct: 323 YVQIQ 327

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  202 bits (517), Expect = 1e-64
 Identities = 57/263 (21%), Positives = 99/263 (37%), Gaps = 41/263 (15%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS-------------IILEYM 50
           ++   E     I  E+ +  S    YVV  Y ++                    I +EY 
Sbjct: 38  KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC 97

Query: 51  DGGSLADFLKKVKTIPEEYLAA-ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 109
           + G+L D +       +      +  Q+L+ L Y+H  + IIHRDLKP N+ I+    VK
Sbjct: 98  ENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH-SQGIIHRDLKPMNIFIDESRNVK 156

Query: 110 ITDFGVSAIMAST--------------SGQANTFVGTYNYMSPERISG-GKYGYKSDIWS 154
           I DFG++  +  +              S    + +GT  Y++ E + G G Y  K D++S
Sbjct: 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216

Query: 155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISAC 212
           LG++  E                      +++ +       P    D         I   
Sbjct: 217 LGIIFFEMIYPFSTGM---------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLL 267

Query: 213 VQKEPQQRLSAQELMTHPFLKMY 235
           +  +P +R  A+ L+   +L + 
Sbjct: 268 IDHDPNKRPGARTLLNSGWLPVK 290

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  201 bits (512), Expect = 7e-64
 Identities = 58/259 (22%), Positives = 99/259 (38%), Gaps = 38/259 (14%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS------------IILEY 49
            I++   E AR ++ +E+K     + P +V  + ++                   I ++ 
Sbjct: 37  RIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQL 96

Query: 50  MDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 106
               +L D++    T           I  Q+ + + +LH  K ++HRDLKPSN+      
Sbjct: 97  CRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDD 155

Query: 107 EVKITDFGVSAIMASTSGQANTF------------VGTYNYMSPERISGGKYGYKSDIWS 154
            VK+ DFG+   M     +                VGT  YMSPE+I G  Y +K DI+S
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215

Query: 155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 214
           LGL+L E         P             +  + +   P   + Q  P     +   + 
Sbjct: 216 LGLILFELLY------PFS---TQMERVRTLTDVRNLKFPPLFT-QKYPCEYVMVQDMLS 265

Query: 215 KEPQQRLSAQELMTHPFLK 233
             P +R  A  ++ +   +
Sbjct: 266 PSPMERPEAINIIENAVFE 284

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  188 bits (478), Expect = 2e-58
 Identities = 52/240 (21%), Positives = 97/240 (40%), Gaps = 26/240 (10%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--- 65
            S     + +++          V   Q       + I ++     +L D++ +  ++   
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
                  I  Q+ + + +LH  K ++HRDLKPSN+       VK+ DFG+   M     +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220

Query: 126 ANTF------------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 173
                           VGT  YMSPE+I G  Y +K DI+SLGL+L E     + +S   
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQM 277

Query: 174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           ++        ++  + +   P   + Q  P+    +   +   P +R  A +++ +   +
Sbjct: 278 ER------VRIITDVRNLKFPLLFT-QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  180 bits (458), Expect = 3e-55
 Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----- 61
             +S       EL+I    +  Y + C     +   + II EYM+  S+  F +      
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141

Query: 62  ---VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                 IP + +  I + VL    Y+H+EK+I HRD+KPSN+L++  G VK++DFG S  
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201

Query: 119 MASTSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
           M     +     GTY +M PE  S      G K DIWSLG+ L        P+       
Sbjct: 202 M--VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF------S 253

Query: 177 GWTSFYELMEAIV-----------------DQPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
              S  EL   I                       +  ++  S E   F+   ++K P +
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313

Query: 220 RLSAQELMTHPFLKMYG 236
           R+++++ + H +L    
Sbjct: 314 RITSEDALKHEWLADTN 330

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  178 bits (453), Expect = 3e-55
 Identities = 66/235 (28%), Positives = 111/235 (47%), Gaps = 16/235 (6%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
            + +  VE     Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+
Sbjct: 46  QLEKAGVEH----QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           K+    E+  A    ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S    
Sbjct: 102 KLSKFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-- 158

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
           + S +     GT +Y+ PE I G  +  K D+WSLG++  E   G     PP + + +  
Sbjct: 159 APSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG----KPPFEANTYQE 214

Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            Y+ +  +    P        +      IS  ++  P QR   +E++ HP++   
Sbjct: 215 TYKRISRVEFTFPDF-----VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  176 bits (449), Expect = 2e-54
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 10/225 (4%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
              R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E 
Sbjct: 56  PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP 115

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT 128
                  Q++ G  YLH    +IHRDLK  NL +N   EVKI DFG++  +     +   
Sbjct: 116 EARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174

Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
             GT NY++PE +S   + ++ D+WS+G ++     G+ P+   E      ++  + +  
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNE 231

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
              P         +P   S I   +Q +P  R +  EL+   F  
Sbjct: 232 YSIPK------HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  177 bits (450), Expect = 2e-54
 Identities = 49/243 (20%), Positives = 96/243 (39%), Gaps = 27/243 (11%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFY----SNGAISIILEYMDGGSLADFLKKVK 63
           E+  R +  +E  +++    P ++           +     ++L +   G+L + ++++K
Sbjct: 66  EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125

Query: 64  T----IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
                + E+ +  +   + +GL  +H  K   HRDLKP+N+L+   G+  + D G     
Sbjct: 126 DKGNFLTEDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184

Query: 120 ---------ASTSGQANTFVGTYNYMSPERISGGKY---GYKSDIWSLGLVLLECATGQF 167
                    A T         T +Y +PE  S   +     ++D+WSLG VL     G+ 
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244

Query: 168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           PY      D      + +   V        S + S      +++ +  +P QR     L+
Sbjct: 245 PY------DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298

Query: 228 THP 230
           +  
Sbjct: 299 SQL 301

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  175 bits (446), Expect = 3e-54
 Identities = 70/234 (29%), Positives = 112/234 (47%), Gaps = 16/234 (6%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           + +  VE     Q+ +E++I    + P ++  Y  F+    I ++LE+   G L   L+K
Sbjct: 52  LEKEGVEH----QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK 107

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                E+  A   E++   L Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S    +
Sbjct: 108 HGRFDEQRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--A 164

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
            S +  T  GT +Y+ PE I G  +  K D+W  G++  E   G     PP      T  
Sbjct: 165 PSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG----MPPFDSPSHTET 220

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           +  +  +  + PP       S      IS  ++  P QRL  + +M HP++K  
Sbjct: 221 HRRIVNVDLKFPPF-----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  174 bits (444), Expect = 7e-54
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 11/230 (4%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTI 65
            +    +++  E+KI+   + P ++  Y  F  +  + ++LE    G +  +LK +VK  
Sbjct: 50  YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF 109

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            E        Q++ G+LYLH    I+HRDL  SNLL+     +KI DFG++  +     +
Sbjct: 110 SENEARHFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168

Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
             T  GT NY+SPE  +   +G +SD+WSLG +      G     PP   D   +    +
Sbjct: 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG----RPPFDTDTVKNTLNKV 224

Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
                + P        S E    I   +++ P  RLS   ++ HPF+   
Sbjct: 225 VLADYEMPSF-----LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  175 bits (447), Expect = 1e-53
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 10/227 (4%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++   R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + 
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 139

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 126
           E        Q++ G  YLH    +IHRDLK  NL +N   EVKI DFG++  +     + 
Sbjct: 140 EPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
               GT NY++PE +S   + ++ D+WS+G ++     G+ P+   E      ++  + +
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKK 255

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                P         +P   S I   +Q +P  R +  EL+   F  
Sbjct: 256 NEYSIPK------HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  171 bits (434), Expect = 6e-51
 Identities = 52/234 (22%), Positives = 96/234 (41%), Gaps = 22/234 (9%)

Query: 14  QIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLA 71
              +E+++  +S + P V+  + +        I +E     +L +++ +K          
Sbjct: 63  FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPI 121

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-----VKITDFGVSAIMA---STS 123
            + +Q   GL +L H  +I+HRDLKP N+LI+           I+DFG+   +A    + 
Sbjct: 122 TLLQQTTSGLAHL-HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180

Query: 124 GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 179
            + +   GT  +++PE +S        Y  DI+S G V     + G  P+    Q+    
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--- 237

Query: 180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
               ++           P           I   +  +PQ+R SA+ ++ HPF  
Sbjct: 238 --ANILLGACSLDCLH-PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  163 bits (414), Expect = 5e-49
 Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 31/225 (13%)

Query: 33  CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--- 89
             +    +  + +I  + + GSL+DFLK    +    L  I E + +GL YLH +     
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLK 145

Query: 90  ------IIHRDLKPSNLLINHRGEVKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERI 141
                 I HRD+K  N+L+ +     I DFG++       ++G  +  VGT  YM+PE +
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205

Query: 142 SGG-----KYGYKSDIWSLGLVLLECATGQFPYS--------PPEQQDGWTSFYELMEAI 188
            G          + D++++GLVL E A+              P E++ G     E M+ +
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEV 265

Query: 189 VDQ------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           V                      C  I  C   + + RLSA  + 
Sbjct: 266 VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  160 bits (408), Expect = 3e-48
 Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 21/187 (11%)

Query: 43  ISIILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPS 98
           +SI+ EY+  GSL   L K    + + E    ++   V KG+ YLH+    I+HR+LK  
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168

Query: 99  NLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 158
           NLL++ +  VK+ DFG+S + AST   + +  GT  +M+PE +       KSD++S G++
Sbjct: 169 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228

Query: 159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISACV 213
           L E AT Q P+          +  +++ A+  +      P +       P+  + I  C 
Sbjct: 229 LWELATLQQPWG-------NLNPAQVVAAVGFKCKRLEIPRNLN-----PQVAAIIEGCW 276

Query: 214 QKEPQQR 220
             EP +R
Sbjct: 277 TNEPWKR 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  159 bits (404), Expect = 1e-47
 Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 40/247 (16%)

Query: 5   MNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLK 60
           +  +E  +R   +E+K+ +  + P V+    V Y+       ++ I EY+ GG+L   +K
Sbjct: 44  IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD----KRLNFITEYIKGGTLRGIIK 99

Query: 61  KVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
            + +  P     +  + +  G+ YLH   +IIHRDL   N L+     V + DFG++ +M
Sbjct: 100 SMDSQYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158

Query: 120 ASTSGQAN--------------TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 165
                Q                T VG   +M+PE I+G  Y  K D++S G+VL E    
Sbjct: 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

Query: 166 Q--FPYSPPEQQD---GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
               P   P   D       F +         PP+ P     P F      C   +P++R
Sbjct: 219 VNADPDYLPRTMDFGLNVRGFLDR------YCPPNCP-----PSFFPITVRCCDLDPEKR 267

Query: 221 LSAQELM 227
            S  +L 
Sbjct: 268 PSFVKLE 274

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  158 bits (402), Expect = 3e-47
 Identities = 50/269 (18%), Positives = 95/269 (35%), Gaps = 45/269 (16%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAISIILEYMDGGSLADFL 59
           V              +E ++ +      +V  +      +     +I+E+   GSL   L
Sbjct: 41  VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL 100

Query: 60  KKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITD 112
           ++      +PE     +   V+ G+ +L  E  I+HR++KP N++     + +   K+TD
Sbjct: 101 EEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159

Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGG--------KYGYKSDIWSLGLVLLECAT 164
           FG +  +     Q  +  GT  Y+ P+             KYG   D+WS+G+     AT
Sbjct: 160 FGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 165 GQFPYSPPEQQDGWTSFYELMEAIV-----------------------DQPPPSAPSDQF 201
           G  P+ P E         E+M  I+                       D P   + S   
Sbjct: 219 GSLPFRPFEGPR---RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGL 275

Query: 202 SPEFCSFISACVQKEPQQRLSAQELMTHP 230
                  ++  ++ + ++     +     
Sbjct: 276 QVLLTPVLANILEADQEKCWGFDQFFAET 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  158 bits (401), Expect = 4e-47
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 25/232 (10%)

Query: 8   EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL---K 60
            ES R+    EL+       P +V     C           +++EY +GGSL + L   +
Sbjct: 41  SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC------LVMEYAEGGSLYNVLHGAE 94

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEK--HIIHRDLKPSNLLINHRGEV-KITDFGVSA 117
            +      +  + C Q  +G+ YLH  +   +IHRDLKP NLL+   G V KI DFG + 
Sbjct: 95  PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154

Query: 118 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
            + +         G+  +M+PE   G  Y  K D++S G++L E  T + P+      + 
Sbjct: 155 DIQTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEI 206

Query: 178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
               + +M A+ +   P    +       S ++ C  K+P QR S +E++  
Sbjct: 207 GGPAFRIMWAVHNGTRPPLIKN-LPKPIESLMTRCWSKDPSQRPSMEEIVKI 257

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  157 bits (398), Expect = 6e-47
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 18/197 (9%)

Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           ++I+ ++ +G SL   L   +T    + L  I  Q  +G+ YLH  K IIHRDLK +N+ 
Sbjct: 94  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKSIIHRDLKSNNIF 152

Query: 102 INHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERI---SGGKYGYKSDIWSLG 156
           ++    VKI DFG++   +    S Q     G+  +M+PE I       Y ++SD+++ G
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212

Query: 157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ----PPPSAPSDQFSPEFCSFISAC 212
           +VL E  TGQ PYS         +  +++E +             S+         ++ C
Sbjct: 213 IVLYELMTGQLPYS------NINNRDQIIEMVGRGSLSPDLSKVRSN-CPKRMKRLMAEC 265

Query: 213 VQKEPQQRLSAQELMTH 229
           ++K+  +R S   ++  
Sbjct: 266 LKKKRDERPSFPRILAE 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  156 bits (397), Expect = 1e-46
 Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 31/226 (13%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-- 89
               S +S+  + +I  Y + GSL D+L+   T+       I   +  GL +LH E    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 90  -----IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPER 140
                I HRDLK  N+L+   G+  I D G++ + + ++ Q     N  VGT  YM+PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 141 ISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ----DGWT----SFYELME 186
           +             + DIW+ GLVL E A         E              SF ++ +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248

Query: 187 AIVDQ---P--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
            +      P  P    SD         +  C  + P  RL+A  + 
Sbjct: 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  158 bits (401), Expect = 1e-46
 Identities = 34/250 (13%), Positives = 70/250 (28%), Gaps = 15/250 (6%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAISIILEYMDG------GSLADF 58
            E   RR++            P           Y+     +++            +L   
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184

Query: 59  LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                      L  +  Q+++    L   K ++H    P NL I   G + + D      
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 119 MASTSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
           + +             Y   E ++     + +  + W LGL +        P+       
Sbjct: 244 VGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 177 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLKMY 235
             +     +                     + I   +  + ++RL   E M  P FL++ 
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360

Query: 236 GDLNVDLSEY 245
            +++  LS  
Sbjct: 361 NEISSSLSTG 370

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  158 bits (402), Expect = 1e-46
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 24/237 (10%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           VE +  R + +EL+I Q  + P++V  + SF     + ++++ + GG L   L++     
Sbjct: 54  VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK 113

Query: 67  EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           EE    +   ICE V+  L YL   + IIHRD+KP N+L++  G V ITDF ++A++   
Sbjct: 114 EETVKLF---ICELVM-ALDYLQ-NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PR 167

Query: 123 SGQANTFVGTYNYMSPE---RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
             Q  T  GT  YM+PE      G  Y +  D WSLG+   E   G+ PY          
Sbjct: 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--- 224

Query: 180 SFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRL-SAQELMTHPFLK 233
              E++          PSA    +S E  S +   ++  P QR     ++   P++ 
Sbjct: 225 -SKEIVHTFETTVVTYPSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  155 bits (394), Expect = 2e-46
 Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 22/198 (11%)

Query: 43  ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK--HIIHRDLKPSNL 100
           + +++E+  GG L   L   K IP + L     Q+ +G+ YLH E    IIHRDLK SN+
Sbjct: 81  LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI 139

Query: 101 LINHRGE--------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 152
           LI  + E        +KITDFG++     T+    +  G Y +M+PE I    +   SD+
Sbjct: 140 LILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDV 197

Query: 153 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-PPPSAPSDQFSPEFCSFISA 211
           WS G++L E  TG+ P+       G      +   +         PS      F   +  
Sbjct: 198 WSYGVLLWELLTGEVPF------RGID-GLAVAYGVAMNKLALPIPST-CPEPFAKLMED 249

Query: 212 CVQKEPQQRLSAQELMTH 229
           C   +P  R S   ++  
Sbjct: 250 CWNPDPHSRPSFTNILDQ 267

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  155 bits (395), Expect = 3e-46
 Identities = 56/188 (29%), Positives = 84/188 (44%), Gaps = 15/188 (7%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           + +  ++G  LA  L++   +      AI  Q+   L   H      HRD+KP N+L++ 
Sbjct: 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH-AAGATHRDVKPENILVSA 169

Query: 105 RGEVKITDFG-VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 163
                + DFG  SA       Q    VGT  YM+PER S     Y++DI++L  VL EC 
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229

Query: 164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD---QFSPEFCSFISACVQKEPQQR 220
           TG  PY       G      +M A ++Q  P  PS         F + I+  + K P+ R
Sbjct: 230 TGSPPY------QGDQ--LSVMGAHINQAIPR-PSTVRPGIPVAFDAVIARGMAKNPEDR 280

Query: 221 -LSAQELM 227
            ++  +L 
Sbjct: 281 YVTCGDLS 288

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  156 bits (396), Expect = 4e-46
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 31/226 (13%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-- 89
              +   S   + +I +Y + GSL D+LK   T+  + +  +    + GL +LH E    
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 90  -----IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPER 140
                I HRDLK  N+L+   G   I D G++    S + +     NT VGT  YM PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

Query: 141 ISGG------KYGYKSDIWSLGLVLLECATGQFPYSP-PEQQDGWT-------SFYELME 186
           +         +    +D++S GL+L E A          E Q  +        S+ ++ E
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277

Query: 187 AIVDQ---P--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
            +  +   P  P    SD+   +    ++ C    P  RL+A  + 
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  153 bits (388), Expect = 2e-45
 Identities = 46/240 (19%), Positives = 94/240 (39%), Gaps = 33/240 (13%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL-K 60
                  ++  +E+ I  +   P +V    + +          +++E++  G L   L  
Sbjct: 61  TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLD 114

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE-----VKITDFG 114
           K   I       +   +  G+ Y+ ++   I+HRDL+  N+ +    E      K+ DFG
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174

Query: 115 VSAIMASTSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYS-- 170
           +S     +       +G + +M+PE I      Y  K+D +S  ++L    TG+ P+   
Sbjct: 175 LSQQSVHSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

Query: 171 PPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
              +        + +  I ++   P+ P D   P   + I  C   +P++R     ++  
Sbjct: 232 SYGK-------IKFINMIREEGLRPTIPED-CPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  153 bits (388), Expect = 2e-45
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
             +V        +    +++EY++G +L+++++    +  +       Q+L G+ +  H+
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH-AHD 129

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFG-VSAIMASTSGQANTFVGTYNYMSPERISGGKY 146
             I+HRD+KP N+LI+    +KI DFG   A+  ++  Q N  +GT  Y SPE+  G   
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 147 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSD--- 199
              +DI+S+G+VL E   G+ P+      +G T+      +I    +    P+  +D   
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPF------NGETAV-----SIAIKHIQDSVPNVTTDVRK 238

Query: 200 QFSPEFCSFISACVQKEPQQR-LSAQELM 227
                  + I    +K+   R  + QE+ 
Sbjct: 239 DIPQSLSNVILRATEKDKANRYKTIQEMK 267

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  153 bits (390), Expect = 2e-45
 Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 13/244 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I   +E + +++I   LK       P +V  ++ F+      +++E ++GG L + +KK
Sbjct: 43  IISKRMEANTQKEI-TALK--LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK 99

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAI 118
            K   E   + I  +++  + ++H +  ++HRDLKP NLL     +   +KI DFG + +
Sbjct: 100 KKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158

Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQD 176
               +    T   T +Y +PE ++   Y    D+WSLG++L  +    GQ P+   ++  
Sbjct: 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS--GQVPFQSHDRSL 216

Query: 177 GWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
             TS  E+M+ I               S E    I   +  +P +RL    L  + +L+ 
Sbjct: 217 TCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

Query: 235 YGDL 238
              L
Sbjct: 277 GSQL 280

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  153 bits (389), Expect = 6e-45
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 78
              Q P++V  + +F +   + +IL+Y++GG L   L + +   E     Y+     +++
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIV 169

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMS 137
             L +LH +  II+RD+K  N+L++  G V +TDFG+S   +A  + +A  F GT  YM+
Sbjct: 170 LALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228

Query: 138 PERISGGKYGY-KS-DIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPPP 194
           P+ + GG  G+ K+ D WSLG+++ E  TG  P     E+        E+   I+   PP
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSEPP 284

Query: 195 SAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
                  S      I   + K+P++RL      A E+  H F +
Sbjct: 285 YPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  155 bits (393), Expect = 7e-45
 Identities = 55/266 (20%), Positives = 103/266 (38%), Gaps = 45/266 (16%)

Query: 2   VIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
            + ++  + A      E+K+  +S   P V+  Y S  ++  + I LE     +L D ++
Sbjct: 46  RMLIDFCDIALM----EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVE 100

Query: 61  K-------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE------ 107
                   +K   E    ++  Q+  G+ +LH    IIHRDLKP N+L++          
Sbjct: 101 SKNVSDENLKLQKEYNPISLLRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQ 159

Query: 108 -------VKITDFGVSAIM----ASTSGQANTFVGTYNYMSPERISGG-------KYGYK 149
                  + I+DFG+   +    +S     N   GT  + +PE +          +    
Sbjct: 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219

Query: 150 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCS 207
            DI+S+G V     + G+ P+     ++       ++  I                E   
Sbjct: 220 IDIFSMGCVFYYILSKGKHPFGDKYSRE-----SNIIRGIFSLDEMKCLHDRSLIAEATD 274

Query: 208 FISACVQKEPQQRLSAQELMTHPFLK 233
            IS  +  +P +R +A +++ HP   
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFW 300

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  150 bits (381), Expect = 2e-44
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 14/225 (6%)

Query: 14  QIAQELKINQSSQCPYVVVCYQ--SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           Q+ QE+ I +    P VV   +     +   + ++ E ++ G + +       + E+   
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQAR 140

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
              + ++KG+ YLH+ + IIHRD+KPSNLL+   G +KI DFGVS     +    +  VG
Sbjct: 141 FYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199

Query: 132 TYNYMSPERISGGKYGY---KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
           T  +M+PE +S  +  +     D+W++G+ L     GQ P+      D       L   I
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-----MD--ERIMCLHSKI 252

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             Q          + +    I+  + K P+ R+   E+  HP++ 
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  152 bits (385), Expect = 3e-44
 Identities = 36/241 (14%), Positives = 70/241 (29%), Gaps = 37/241 (15%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD--------GGSLADFLKKVK 63
             +      + +  Q   ++           +S    Y          G  L       K
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
           ++       +  QV++ L  LHH   ++H  L+P +++++ RG V +T F          
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEH----LVRD 256

Query: 124 GQANTFVGTYNYMSPERIS-----------GGKYGYKSDIWSLGLVLLECATGQFPYSPP 172
           G       +  +  PE  +                +  D W+LGLV+        P +  
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316

Query: 173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                        E I                  + +   ++   + RL   + M  P  
Sbjct: 317 AA-------LGGSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363

Query: 233 K 233
           +
Sbjct: 364 E 364

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  154 bits (391), Expect = 4e-44
 Identities = 71/262 (27%), Positives = 121/262 (46%), Gaps = 19/262 (7%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
           +V  S+  ++ +E+ + +    P ++  Y  F       +++E   GG L D +      
Sbjct: 74  SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF 133

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMAST 122
            E   A I +QVL G+ YL H+ +I+HRDLKP NLL+  + +   +KI DFG+SA+  + 
Sbjct: 134 NEVDAAVIIKQVLSGVTYL-HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
             +    +GT  Y++PE +   KY  K D+WS+G++L     G  P+     Q       
Sbjct: 193 K-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------- 243

Query: 183 ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 240
           E++  +        S      S      I   +Q + Q+R+SAQ+ + HP++K       
Sbjct: 244 EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC---- 299

Query: 241 DLSEYFTDAGSPLATLSNLSGF 262
              E   +  S    + N+  F
Sbjct: 300 SKKESGIELPSLANAIENMRKF 321

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  150 bits (380), Expect = 5e-44
 Identities = 54/188 (28%), Positives = 95/188 (50%), Gaps = 12/188 (6%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           I++EY+DG +L D +     +  +    +     + L +  H+  IIHRD+KP+N++I+ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF-SHQNGIIHRDVKPANIMISA 151

Query: 105 RGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
              VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211

Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQR 220
             TG+ P+       G +      + + + P  PSA  +  S +  + +   + K P+ R
Sbjct: 212 VLTGEPPF------TGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

Query: 221 -LSAQELM 227
             +A E+ 
Sbjct: 266 YQTAAEMR 273

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  150 bits (380), Expect = 5e-44
 Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 27/240 (11%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY-MDGGSLADFLKKV 62
            ++   +   ++A   K+      P V+     F +     ++LE  +    L D++ + 
Sbjct: 74  PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK 133

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMAS 121
             + E        QV+  + + H  + ++HRD+K  N+LI+  RG  K+ DFG  A++  
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-- 190

Query: 122 TSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
                  F GT  Y  PE IS  +Y    + +WSLG++L +   G  P            
Sbjct: 191 HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP------------ 238

Query: 181 FY---ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
           F    E++EA +  P         SP+ C+ I  C+  +P  R S +E++  P+++   +
Sbjct: 239 FERDQEILEAELHFPA------HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  156 bits (395), Expect = 6e-44
 Identities = 59/263 (22%), Positives = 98/263 (37%), Gaps = 29/263 (11%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ------SFYSNGAISIILEYMDGGSL 55
             +  +    R +   E++I +    P VV   +          N    + +EY +GG L
Sbjct: 46  QCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL 105

Query: 56  ADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVK 109
             +L + +    + E  +  +   +   L YLH E  IIHRDLKP N+++     R   K
Sbjct: 106 RKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHK 164

Query: 110 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           I D G +  +         FVGT  Y++PE +   KY    D WS G +  EC TG  P+
Sbjct: 165 IIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

Query: 170 SPPEQQDGWTSFYE---------------LMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 214
            P  Q   W                     ++     P P+  S   + +   ++   + 
Sbjct: 224 LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLM 283

Query: 215 KEPQQRLSAQELMTHPFLKMYGD 237
              +QR +  +       +    
Sbjct: 284 WHQRQRGTDPQNPNVGCFQALDS 306

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  156 bits (396), Expect = 6e-44
 Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 28/244 (11%)

Query: 2   VIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
           +     E  A   R +   L +  +  CP++V    +F++   +S IL+ M+GG L   L
Sbjct: 227 IKMKQGETLALNERIM---LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 283

Query: 60  KKVKTIPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
            +     E     Y A    +++ GL ++H  + +++RDLKP+N+L++  G V+I+D G+
Sbjct: 284 SQHGVFSEADMRFYAA----EIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGL 338

Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQ 174
           +     +  + +  VGT+ YM+PE +  G  Y   +D +SLG +L +   G      P +
Sbjct: 339 A--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFR 392

Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTH 229
           Q      +E+    +         D FSPE  S +   +Q++  +RL      AQE+   
Sbjct: 393 QHKTKDKHEIDRMTLTMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450

Query: 230 PFLK 233
           PF +
Sbjct: 451 PFFR 454

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  150 bits (380), Expect = 7e-44
 Identities = 45/204 (22%), Positives = 85/204 (41%), Gaps = 28/204 (13%)

Query: 43  ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           ++II     G +L   ++  K  +       I ++++KG+ YLH  K I+H+DLK  N+ 
Sbjct: 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH-AKGILHKDLKSKNVF 162

Query: 102 INHRGEVKITDFGVSAIMAST-----SGQANTFVGTYNYMSPERISGGK---------YG 147
            ++ G+V ITDFG+ +I           +     G   +++PE I             + 
Sbjct: 163 YDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221

Query: 148 YKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 205
             SD+++LG +  E    ++P+   P E          ++  +     P+        E 
Sbjct: 222 KHSDVFALGTIWYELHAREWPFKTQPAEA---------IIWQMGTGMKPNLSQIGMGKEI 272

Query: 206 CSFISACVQKEPQQRLSAQELMTH 229
              +  C   E ++R +  +LM  
Sbjct: 273 SDILLFCWAFEQEERPTFTKLMDM 296

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  151 bits (382), Expect = 1e-43
 Identities = 50/268 (18%), Positives = 95/268 (35%), Gaps = 45/268 (16%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAISIILEYMDGGSLADFL 59
           V              +E ++ +      +V  +      +     +I+E+   GSL   L
Sbjct: 41  VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL 100

Query: 60  KKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITD 112
           ++      +PE     +   V+ G+ +L  E  I+HR++KP N++     + +   K+TD
Sbjct: 101 EEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159

Query: 113 FGVSAIMASTSGQANTFVGTYNYMSPERISGG--------KYGYKSDIWSLGLVLLECAT 164
           FG +  +     Q  +  GT  Y+ P+             KYG   D+WS+G+     AT
Sbjct: 160 FGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 165 GQFPYSPPEQQDGWTSFYELMEAIV-----------------------DQPPPSAPSDQF 201
           G  P+ P E         E+M  I+                       D P   + S   
Sbjct: 219 GSLPFRPFEGPR---RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGL 275

Query: 202 SPEFCSFISACVQKEPQQRLSAQELMTH 229
                  ++  ++ + ++     +    
Sbjct: 276 QVLLTPVLANILEADQEKCWGFDQFFAE 303

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  152 bits (387), Expect = 2e-43
 Identities = 62/259 (23%), Positives = 118/259 (45%), Gaps = 20/259 (7%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           ++ +  + +E+++ +    P ++  Y+ F   G   ++ E   GG L D +   K   E 
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQ 125
             A I  QVL G+ Y+ H+  I+HRDLKP NLL+  + +   ++I DFG+S    ++  +
Sbjct: 127 DAARIIRQVLSGITYM-HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-K 184

Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
               +GT  Y++PE +  G Y  K D+WS G++L    +G  P++   +        +++
Sbjct: 185 MKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DIL 236

Query: 186 EAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 243
           + +             + S      I   +   P  R+SA++ + H +++ Y    +   
Sbjct: 237 KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS-- 294

Query: 244 EYFTDAGSPLATLSNLSGF 262
               D  S    + N+  F
Sbjct: 295 ---VDVPSLDNAILNIRQF 310

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  148 bits (376), Expect = 2e-43
 Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 37/241 (15%)

Query: 12  RRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
             ++     E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  E 
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130

Query: 69  ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS--AIMAST 122
               Y A    +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG +      S 
Sbjct: 131 CTRFYTA----EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 185

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSF 181
             +AN+FVGT  Y+SPE ++       SD+W+LG ++ +   G  P  +  E        
Sbjct: 186 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------- 237

Query: 182 YELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFL 232
           Y + + I+      P       F P+    +   +  +  +RL          L  HPF 
Sbjct: 238 YLIFQKIIKLEYDFPEK-----FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

Query: 233 K 233
           +
Sbjct: 293 E 293

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  150 bits (382), Expect = 2e-43
 Identities = 71/243 (29%), Positives = 110/243 (45%), Gaps = 21/243 (8%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
             I    E      +  E++I +    P ++     F+      I+LE M+GG L D + 
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVV 231

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSA 117
             K + E        Q+L  + YL HE  IIHRDLKP N+L++ + E   +KITDFG S 
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYL-HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290

Query: 118 IMASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 174
           I+  TS    T  GT  Y++PE +       Y    D WSLG++L  C +G  P+S    
Sbjct: 291 ILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349

Query: 175 QDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
           Q        L + I     +  P      + S +    +   +  +P+ R + +E + HP
Sbjct: 350 Q------VSLKDQITSGKYNFIPE--VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401

Query: 231 FLK 233
           +L+
Sbjct: 402 WLQ 404

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  148 bits (377), Expect = 2e-43
 Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 33/230 (14%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAI 73
           E  I      P++V  + +F + G + +IL+++ GG L   L K     EE    YLA  
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-- 133

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L +LH    II+RDLKP N+L++  G +K+TDFG+S        +A +F GT 
Sbjct: 134 --ELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI 188
            YM+PE ++   +   +D WS G+++ E  TG      P        F      E M  I
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT----LP--------FQGKDRKETMTMI 238

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
           +            SPE  S +    ++ P  RL       +E+  H F  
Sbjct: 239 LKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  149 bits (377), Expect = 3e-43
 Identities = 56/252 (22%), Positives = 98/252 (38%), Gaps = 37/252 (14%)

Query: 12  RRQIAQELKINQSS--QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
            R   +E +I Q+   +   ++       +   +   + ++ +Y + GSL D+L +  T+
Sbjct: 78  ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTV 136

Query: 66  PEEYLAAICEQVLKGLLYLHHEKH-------IIHRDLKPSNLLINHRGEVKITDFGVSAI 118
             E +  +      GL +LH E         I HRDLK  N+L+   G   I D G++  
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196

Query: 119 MASTSGQA----NTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFP 168
             S +       N  VGT  YM+PE +         +   ++DI+++GLV  E A     
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

Query: 169 YS-PPEQQDGW-------TSFYELMEAIVDQ---P--PPSAPSDQFSPEFCSFISACVQK 215
                + Q  +        S  E+ + + +Q   P  P    S +        +  C   
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316

Query: 216 EPQQRLSAQELM 227
               RL+A  + 
Sbjct: 317 NGAARLTALRIK 328

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  148 bits (377), Expect = 3e-43
 Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 20/239 (8%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
                +I     + +  Q P ++     +     + ++ E M GG L D + + K   E 
Sbjct: 60  RDPTEEIE---ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER 116

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSG 124
             +A+   + K + YLH  + ++HRDLKPSN+L          ++I DFG +  + + +G
Sbjct: 117 EASAVLFTITKTVEYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175

Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYE 183
              T   T N+++PE +    Y    DIWSLG++L    TG  P  + P+         E
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EE 230

Query: 184 LMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 238
           ++  I              +  S      +S  +  +P QRL+A  ++ HP++  +  L
Sbjct: 231 ILARIGSGKFSLSGG--YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  148 bits (375), Expect = 4e-43
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 33/230 (14%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAI 73
           E  I +  + P++V    +F + G + +ILEY+ GG L   L++     E+    YLA  
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-- 128

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             ++   L +LH +K II+RDLKP N+++NH+G VK+TDFG+           +TF GT 
Sbjct: 129 --EISMALGHLH-QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI 188
            YM+PE +    +    D WSLG ++ +  TG     PP        F      + ++ I
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA----PP--------FTGENRKKTIDKI 233

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
           +       P    + E    +   +++    RL      A E+  HPF +
Sbjct: 234 LKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  146 bits (372), Expect = 5e-43
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 28/231 (12%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           + +E +I +  Q P +V  + S        ++ + + GG L + +   +   E   +   
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 111

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVG 131
           +Q+L+ + Y H    I+HR+LKP NLL+  + +   VK+ DFG++  + + S   + F G
Sbjct: 112 QQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAG 169

Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----EL 184
           T  Y+SPE +    Y    DIW+ G++L  L                G+  F+      L
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLV--------------GYPPFWDEDQHRL 215

Query: 185 MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
              I       PS   D  +PE  S I + +   P++R++A + +  P++ 
Sbjct: 216 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  147 bits (374), Expect = 6e-43
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 14/229 (6%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
            ++ +++ +E++I +    P +V  ++   +   + +I+EY  GG + D+L     + E+
Sbjct: 55  PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK 114

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-N 127
              +   Q++  + Y H +K I+HRDLK  NLL++    +KI DFG S     T G   +
Sbjct: 115 EARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLD 171

Query: 128 TFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
            F G   Y +PE   G KY G + D+WSLG++L    +G  P+   + Q+       ++ 
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF---DGQNLKELRERVLR 228

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
                P         S +  + +   +   P +R + +++M   ++   
Sbjct: 229 GKYRIPF------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  150 bits (381), Expect = 6e-43
 Identities = 68/225 (30%), Positives = 115/225 (51%), Gaps = 22/225 (9%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAI 73
           E ++ Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E+    Y A  
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-- 255

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             +++  L YLH EK++++RDLK  NL+++  G +KITDFG+            TF GT 
Sbjct: 256 --EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            Y++PE +    YG   D W LG+V+ E   G+ P+   + +       +L E I+ +  
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEI 366

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
               +    PE  S +S  ++K+P+QRL      A+E+M H F  
Sbjct: 367 RFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  145 bits (369), Expect = 1e-42
 Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 19/235 (8%)

Query: 10  SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 69
               +  QE++I +S   P ++  Y++F  N  I +++E   GG L + +   +   E  
Sbjct: 48  EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD 107

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQA 126
            A I + VL  + Y  H+ ++ HRDLKP N L         +K+ DFG++A         
Sbjct: 108 AARIMKDVLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MM 165

Query: 127 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYEL 184
            T VGT  Y+SP+ +  G YG + D WS G+++  L C  G  P+S P          E+
Sbjct: 166 RTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLC--GYPPFSAPTDS-------EV 215

Query: 185 MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
           M  I +     P       SP+  S I   + K P+QR+++ + + H + +    
Sbjct: 216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  147 bits (372), Expect = 2e-42
 Identities = 56/293 (19%), Positives = 103/293 (35%), Gaps = 68/293 (23%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
            +      +I  E+++ +    P +   Y+ +     I +++E   GG L D L      
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 66  P----------------------------------------EEYLAAICEQVLKGLLYLH 85
                                                    E+ ++ I  Q+   L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 86  HEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTS----GQANTFVGTYNYMSPE 139
             + I HRD+KP N L +      +K+ DFG+S      +        T  GT  +++PE
Sbjct: 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 140 --RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQP 192
               +   YG K D WS G++L     G    + P        F      + +  ++++ 
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMG----AVP--------FPGVNDADTISQVLNKK 292

Query: 193 P--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 243
               +   +  SP     +S  + +   +R  A   + HP++  + D    +S
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  150 bits (380), Expect = 2e-42
 Identities = 61/260 (23%), Positives = 116/260 (44%), Gaps = 22/260 (8%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
           E    +I  E+ + +S   P ++  +  F       ++ E+ +GG L + +       E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQ 125
             A I +Q+L G+ YL H+ +I+HRD+KP N+L+ ++     +KI DFG+S+  +    +
Sbjct: 147 DAANIMKQILSGICYL-HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-K 204

Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYEL 184
               +GT  Y++PE +   KY  K D+WS G+++     G  P     +Q        ++
Sbjct: 205 LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DI 255

Query: 185 MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 242
           ++ +               S E    I   +  +  +R +A+E +   ++K Y +     
Sbjct: 256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK- 314

Query: 243 SEYFTDAGSPLATLSNLSGF 262
               +D  +    LSN+  F
Sbjct: 315 ----SDQKTLCGALSNMRKF 330

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  145 bits (368), Expect = 2e-42
 Identities = 63/242 (26%), Positives = 113/242 (46%), Gaps = 28/242 (11%)

Query: 9   ESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +  R    +E+ I +  S  P ++    ++ +N    ++ + M  G L D+L +  T+ E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +    I   +L+ +  LH + +I+HRDLKP N+L++    +K+TDFG S  +     +  
Sbjct: 124 KETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLR 181

Query: 128 TFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
              GT +Y++PE I          YG + D+WS G+++     G    SPP        F
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG----SPP--------F 229

Query: 182 Y-----ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
           +      ++  I+       S   D +S      +S  +  +PQ+R +A+E + HPF + 
Sbjct: 230 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

Query: 235 YG 236
           Y 
Sbjct: 290 YV 291

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  146 bits (371), Expect = 2e-42
 Identities = 59/245 (24%), Positives = 103/245 (42%), Gaps = 30/245 (12%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
              +   + +E  I    + P++V   +++ S+G + ++ E+MDG  L   + K      
Sbjct: 66  PGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF 125

Query: 68  EYL----AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMA 120
            Y     +    Q+L+ L Y H + +IIHRD+KP  +L+  +     VK+  FGV+  + 
Sbjct: 126 VYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGW 178
            +   A   VGT ++M+PE +    YG   D+W  G++L  L           P      
Sbjct: 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG------CLP------ 232

Query: 179 TSFY----ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
             FY     L E I+              S      +   +  +P +R++  E + HP+L
Sbjct: 233 --FYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

Query: 233 KMYGD 237
           K    
Sbjct: 291 KERDR 295

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  149 bits (378), Expect = 3e-42
 Identities = 60/262 (22%), Positives = 120/262 (45%), Gaps = 19/262 (7%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
           + +      I +E+++ +    P ++  ++    + +  I+ E   GG L D + K K  
Sbjct: 59  SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMAST 122
            E   A I +QV  G+ Y+ H+ +I+HRDLKP N+L+  + +   +KI DFG+S      
Sbjct: 119 SEHDAARIIKQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 123 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
           + +    +GT  Y++PE +  G Y  K D+WS G++L    +G  P+    +        
Sbjct: 178 T-KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEY------- 228

Query: 183 ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 240
           ++++ +               S +    I   +   P  R++A + + HP+++ Y     
Sbjct: 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP 288

Query: 241 DLSEYFTDAGSPLATLSNLSGF 262
            +S+  +      + ++N+  F
Sbjct: 289 TISDLPSLE----SAMTNIRQF 306

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  150 bits (380), Expect = 4e-42
 Identities = 63/245 (25%), Positives = 116/245 (47%), Gaps = 27/245 (11%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL----AD 57
           + +    + A      E KI       ++V    +F +   + +++  M+GG +     +
Sbjct: 223 LKKRKGYQGAM----VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN 278

Query: 58  FLKKVKTIPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 113
             +      E     Y A    Q++ GL +LH +++II+RDLKP N+L++  G V+I+D 
Sbjct: 279 VDEDNPGFQEPRAIFYTA----QIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDL 333

Query: 114 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 173
           G++  + +   +   + GT  +M+PE + G +Y +  D ++LG+ L E    +    P  
Sbjct: 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFR 390

Query: 174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMT 228
            +       EL + +++Q       D+FSP    F  A +QK+P++RL     S   L T
Sbjct: 391 ARGEKVENKELKQRVLEQAVTY--PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448

Query: 229 HPFLK 233
           HP  +
Sbjct: 449 HPLFR 453

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  145 bits (369), Expect = 4e-42
 Identities = 65/225 (28%), Positives = 114/225 (50%), Gaps = 23/225 (10%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAI 73
           E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +   EE    Y A  
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-- 112

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             +++  L YLH  + +++RD+K  NL+++  G +KITDFG+     S      TF GT 
Sbjct: 113 --EIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 193
            Y++PE +    YG   D W LG+V+ E   G+ P+   + +        L E I+ +  
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEI 222

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
               +   SPE  S ++  ++K+P+QRL      A+E+M H F  
Sbjct: 223 RFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  145 bits (368), Expect = 4e-42
 Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 27/252 (10%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE-YMDGGSLADFLKKVKTI 65
           +E+    ++  E+ I    +   ++     F + G   +++E +  G  L  F+ +   +
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
            E   + I  Q++  + YL   K IIHRD+K  N++I     +K+ DFG +A +    G+
Sbjct: 128 DEPLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGK 184

Query: 126 A-NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
              TF GT  Y +PE + G  Y G + ++WSLG+ L      + P            F E
Sbjct: 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP------------FCE 232

Query: 184 L---MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 240
           L   +EA +  P         S E  S +S  +Q  P++R + ++L+T P++    +L  
Sbjct: 233 LEETVEAAIHPPYL------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLAD 286

Query: 241 DLSEYFTDAGSP 252
              E       P
Sbjct: 287 YTWEEVFRVNKP 298

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  146 bits (370), Expect = 5e-42
 Identities = 61/260 (23%), Positives = 110/260 (42%), Gaps = 36/260 (13%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           + +E +I +  Q P +V  + S        ++ + + GG L + +   +   E   +   
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVG 131
           +Q+L+ + Y H    I+HR+LKP NLL+  + +   VK+ DFG++  +  +    + F G
Sbjct: 135 QQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAG 192

Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----EL 184
           T  Y+SPE +    Y    DIW+ G++L  L                G+  F+      L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLV--------------GYPPFWDEDQHRL 238

Query: 185 MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 242
              I       PS   D  +PE  S I + +   P++R++A + +  P++     +    
Sbjct: 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV---- 294

Query: 243 SEYFTDAGSPLATLSNLSGF 262
                 A     T+  L  F
Sbjct: 295 ----ASAIHRQDTVDCLKKF 310

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  145 bits (367), Expect = 5e-42
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 23/227 (10%)

Query: 14  QIAQELKINQ--SSQCPYVVVCYQSFYSNGAISIILEYMDG-GSLADFLKKVKTIPEEYL 70
           ++  E+ + +  SS    V+     F    +  +ILE  +    L DF+ +   + EE  
Sbjct: 92  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTF 129
            +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DFG  A++         F
Sbjct: 152 RSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF 208

Query: 130 VGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 188
            GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   E  +      E++   
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHDE------EIIRGQ 259

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           V          + S E    I  C+   P  R + +E+  HP+++  
Sbjct: 260 VFFRQ------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  145 bits (367), Expect = 6e-42
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 41/279 (14%)

Query: 8   EESARRQIAQELKINQS-SQCPYVVVCYQSFY-------SNGAISIILEYMDGGSLADFL 59
           EE   R I QE+   +  S  P +V    +         +  A  ++L  +  G L +FL
Sbjct: 65  EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124

Query: 60  KKVKT---IPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGV 115
           KK+++   +  + +  I  Q  + + ++H +K  IIHRDLK  NLL++++G +K+ DFG 
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184

Query: 116 SAIMASTSGQAN------------TFVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLL 160
           +  ++     +             T   T  Y +PE I   S    G K DIW+LG +L 
Sbjct: 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244

Query: 161 ECATGQFPYSPPEQQDGWTSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
                Q P            F +     IV+      P D     F S I A +Q  P++
Sbjct: 245 LLCFRQHP------------FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEE 292

Query: 220 RLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSN 258
           RLS  E++     ++    NV+     T+         +
Sbjct: 293 RLSIAEVVHQLQ-EIAAARNVNPKSPITELLEQNGGYGS 330

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  145 bits (368), Expect = 1e-41
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 32/224 (14%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 78
           ++ + P++V  + SF +   +  +L+Y++GG L   L++ +   E     Y A    ++ 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA----EIA 149

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
             L YLH   +I++RDLKP N+L++ +G + +TDFG+       +   +TF GT  Y++P
Sbjct: 150 SALGYLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208

Query: 139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP 193
           E +    Y    D W LG VL E   G     PP        FY     E+ + I+++P 
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGL----PP--------FYSRNTAEMYDNILNKPL 256

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTHPFLK 233
              P+   +      +   +QK+  +RL       E+ +H F  
Sbjct: 257 QLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  144 bits (365), Expect = 1e-41
 Identities = 71/243 (29%), Positives = 110/243 (45%), Gaps = 21/243 (8%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
             I    E      +  E++I +    P ++     F +     I+LE M+GG L D + 
Sbjct: 48  FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVV 106

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSA 117
             K + E        Q+L  + YLH E  IIHRDLKP N+L++ + E   +KITDFG S 
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165

Query: 118 IMASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 174
           I+  TS    T  GT  Y++PE +       Y    D WSLG++L  C +G  P+S    
Sbjct: 166 ILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

Query: 175 QDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
           Q        L + I     +  P      + S +    +   +  +P+ R + +E + HP
Sbjct: 225 Q------VSLKDQITSGKYNFIPE--VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276

Query: 231 FLK 233
           +L+
Sbjct: 277 WLQ 279

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  146 bits (371), Expect = 1e-41
 Identities = 60/235 (25%), Positives = 107/235 (45%), Gaps = 27/235 (11%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           + +E +I +  + P +V  + S    G   +I + + GG L + +   +   E   +   
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 116

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVG 131
           +Q+L+ +L+ H +  ++HR+LKP NLL+  + +   VK+ DFG++  +         F G
Sbjct: 117 QQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175

Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----EL 184
           T  Y+SPE +    YG   D+W+ G++L  L    G   Y P         F+      L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLV--G---YPP---------FWDEDQHRL 221

Query: 185 MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
            + I       PS   D  +PE    I+  +   P +R++A E + HP++     
Sbjct: 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRST 276

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  144 bits (365), Expect = 2e-41
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 29/221 (13%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 78
            + + P++   + +F +   +  ++EY++GG L   ++            Y A    +++
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA----EII 128

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL +LH  K I++RDLK  N+L++  G +KI DFG+         + NTF GT +Y++P
Sbjct: 129 LGLQFLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 187

Query: 139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP 193
           E + G KY +  D WS G++L E   GQ     P        F+     EL  +I    P
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ----SP--------FHGQDEEELFHSIRMDNP 235

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-SAQELMTHPFLK 233
                     E    +     +EP++RL    ++  HP  +
Sbjct: 236 FYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  145 bits (368), Expect = 2e-41
 Identities = 36/210 (17%), Positives = 68/210 (32%), Gaps = 21/210 (10%)

Query: 52  GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
           G  L       K++       +  QV++ L  LHH   ++H  L+P +++++ RG V +T
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLT 253

Query: 112 DFGVSAIM-ASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATG 165
            F       AS               +   +           +  D W+LGL +      
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 225
             P +         +     E I                  + +   ++   + RL   +
Sbjct: 314 DLPNTDD-------AALGGSEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQ 360

Query: 226 LMTHP-FLKMYGDLNVDLSEYFTDAGSPLA 254
            M  P + ++  +L+  L  Y TD      
Sbjct: 361 AMETPEYEQLRTELSAALPLYQTDGEPTRE 390

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  142 bits (360), Expect = 3e-41
 Identities = 57/234 (24%), Positives = 109/234 (46%), Gaps = 15/234 (6%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
            +      I +E+++ +    P ++  ++    + +  I+ E   GG L D + K K   
Sbjct: 60  AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTS 123
           E   A I +QV  G+ Y+ H+ +I+HRDLKP N+L+  + +   +KI DFG+S      +
Sbjct: 120 EHDAARIIKQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178

Query: 124 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
            +    +GT  Y++PE +  G Y  K D+WS G++L    +G  P+    +        +
Sbjct: 179 -KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------D 229

Query: 184 LMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           +++ +               S +    I   +   P  R++A + + HP+++ Y
Sbjct: 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  141 bits (359), Expect = 3e-41
 Identities = 38/225 (16%), Positives = 82/225 (36%), Gaps = 24/225 (10%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL-- 59
           +      R   +E    +    P V+     C      +   ++I  +M  GSL + L  
Sbjct: 45  DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH--PTLITHWMPYGSLYNVLHE 102

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLH-HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
                + +         + +G+ +LH  E  I    L   +++I+     +I+   V   
Sbjct: 103 GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162

Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGY---KSDIWSLGLVLLECATGQFPYSPPEQQ 175
             S        +    +++PE +           +D+WS  ++L E  T + P++     
Sbjct: 163 FQSPGR-----MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA----- 212

Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
              ++    M+  ++   P+ P    SP     +  C+ ++P +R
Sbjct: 213 -DLSNMEIGMKVALEGLRPTIPPG-ISPHVSKLMKICMNEDPAKR 255

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  143 bits (364), Expect = 3e-41
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 19/223 (8%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 78
           Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE    Y A    ++ 
Sbjct: 65  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----EIS 120

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
             L YLH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY++P
Sbjct: 121 LALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179

Query: 139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW--TSFYELMEAIVDQPPPSA 196
           E + G  YG+  D W+LG+++ E   G+ P+      D     +   L + I+++     
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239

Query: 197 PSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLK 233
            S   S +  S + + + K+P++RL         ++  HPF +
Sbjct: 240 RS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  142 bits (361), Expect = 3e-41
 Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 33/247 (13%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
              +  E+ + +  +   +V     + S     ++++ + GG L D + +     E+  +
Sbjct: 50  DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS 109

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANT 128
            + +QVL  + YLH E  I+HRDLKP NLL     E   + ITDFG+S +  +  G  +T
Sbjct: 110 LVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMST 166

Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFY---- 182
             GT  Y++PE ++   Y    D WS+G++   L C  G   Y P         FY    
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC--G---YPP---------FYEETE 212

Query: 183 -ELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
            +L E I     +   P    D  S     FI   ++K+P +R + ++ ++HP++     
Sbjct: 213 SKLFEKIKEGYYEFESP--FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270

Query: 238 LNVDLSE 244
           L+ D+  
Sbjct: 271 LHRDIYP 277

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  148 bits (374), Expect = 4e-41
 Identities = 69/243 (28%), Positives = 116/243 (47%), Gaps = 26/243 (10%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           + +   E  A      E +I +     +VV    ++ +  A+ ++L  M+GG L   +  
Sbjct: 222 IKKRKGEAMAL----NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 277

Query: 62  VKTI--PEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
           +     PE     Y A    ++  GL  LH  + I++RDLKP N+L++  G ++I+D G+
Sbjct: 278 MGQAGFPEARAVFYAA----EICCGLEDLH-RERIVYRDLKPENILLDDHGHIRISDLGL 332

Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
           +  +          VGT  YM+PE +   +Y +  D W+LG +L E   GQ   SP +Q+
Sbjct: 333 AVHV-PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ---SPFQQR 388

Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHP 230
                  E+   + + P     S++FSP+  S  S  + K+P +RL     SA+E+  HP
Sbjct: 389 KKKIKREEVERLVKEVPEEY--SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446

Query: 231 FLK 233
             K
Sbjct: 447 LFK 449

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  142 bits (360), Expect = 7e-41
 Identities = 50/226 (22%), Positives = 81/226 (35%), Gaps = 45/226 (19%)

Query: 44  SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--------IIHRDL 95
            +++EY   GSL  +L    T        +   V +GL YLH E          I HRDL
Sbjct: 88  LLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146

Query: 96  KPSNLLINHRGEVKITDFGVSAIMAST--------SGQANTFVGTYNYMSPERISG---- 143
              N+L+ + G   I+DFG+S  +              A + VGT  YM+PE + G    
Sbjct: 147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL 206

Query: 144 ---GKYGYKSDIWSLGLVLLECATG-------------QFPYSPPEQQDGWTSFYELMEA 187
                   + D+++LGL+  E                 Q  +          +F ++   
Sbjct: 207 RDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHP--TFEDMQVL 264

Query: 188 IVDQ------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +  +      P     +          I  C  ++ + RL+AQ   
Sbjct: 265 VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  142 bits (360), Expect = 1e-40
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 33/225 (14%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 78
              + P++   +  F +   +  ++EY++GG L   +++V    E     Y A I     
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI--- 132

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL +L   K II+RDLK  N++++  G +KI DFG+            TF GT +Y++P
Sbjct: 133 -GLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 190

Query: 139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP 193
           E I+   YG   D W+ G++L E   GQ     P        F      EL ++I++   
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ----AP--------FEGEDEDELFQSIMEHNV 238

Query: 194 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
               S   S E  +     + K P +RL       +++  H F +
Sbjct: 239 AYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  141 bits (358), Expect = 3e-40
 Identities = 61/249 (24%), Positives = 116/249 (46%), Gaps = 32/249 (12%)

Query: 1   MVIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL 59
             +     E  R    +E  I +  +  P+++    S+ S+  + ++ + M  G L D+L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
            +   + E+   +I   +L+ + +LH   +I+HRDLKP N+L++   +++++DFG S  +
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250

Query: 120 ASTSGQANTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVL--LECATGQFPYSP 171
                +     GT  Y++PE +          YG + D+W+ G++L  L    G    SP
Sbjct: 251 EPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA--G----SP 303

Query: 172 PEQQDGWTSFY-----ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 224
           P        F+      ++  I++      S   D  S      IS  +Q +P+ RL+A+
Sbjct: 304 P--------FWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAE 355

Query: 225 ELMTHPFLK 233
           + + HPF +
Sbjct: 356 QALQHPFFE 364

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  140 bits (356), Expect = 3e-40
 Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 24/242 (9%)

Query: 12  RRQIAQELKI-NQSSQCPYVVVCYQSF----YSNGAISIILEYMDGGSLADFL--KKVKT 64
             +  QE+    Q+S  P++V     +    +    + II+E M+GG L   +  +  + 
Sbjct: 65  SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124

Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMAS 121
             E   A I   +   + +LH   +I HRD+KP NLL   + +   +K+TDFG +     
Sbjct: 125 FTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-- 181

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFP-YSPPEQQDGW 178
           T     T   T  Y++PE +   KY    D+WSLG+++  L C  G  P YS   Q    
Sbjct: 182 TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC--GFPPFYSNTGQA--- 236

Query: 179 TSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
                +   I       P+    + S +    I   ++ +P +RL+  + M HP++    
Sbjct: 237 -ISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295

Query: 237 DL 238
            +
Sbjct: 296 VV 297

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  142 bits (359), Expect = 4e-40
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 19/223 (8%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 78
           Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE    Y A    ++ 
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA----EIS 163

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
             L YLH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY++P
Sbjct: 164 LALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222

Query: 139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT--SFYELMEAIVDQPPPSA 196
           E + G  YG+  D W+LG+++ E   G+ P+      D     +   L + I+++     
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282

Query: 197 PSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLK 233
            S   S +  S + + + K+P++RL         ++  HPF +
Sbjct: 283 RS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  140 bits (355), Expect = 5e-40
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 19/227 (8%)

Query: 15  IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 74
           +  E+ +      P ++   + F +   IS++LE + GG L D + +     E   A   
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154

Query: 75  EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVG 131
           +Q+L+ + YLH E  I+HRDLKP NLL         +KI DFG+S I+        T  G
Sbjct: 155 KQILEAVAYLH-ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTVCG 212

Query: 132 TYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFP-YSPPEQQDGWTSFYELMEAI 188
           T  Y +PE + G  YG + D+WS+G++   L C  G  P Y     Q        +   I
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLC--GFEPFYDERGDQ-------FMFRRI 263

Query: 189 VDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           ++      S   D+ S      +   +  +P++RL+  + + HP++ 
Sbjct: 264 LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  138 bits (350), Expect = 6e-40
 Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 10/224 (4%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            I +E+ IN+      VV  Y          + LEY  GG L D ++    +PE      
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF 110

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVG 131
             Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   G
Sbjct: 111 FHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 132 TYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           T  Y++PE +   ++     D+WS G+VL     G+ P+      D  +   +      +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKE 223

Query: 191 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
           +     P  +      + +   + + P  R++  ++    +   
Sbjct: 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  138 bits (351), Expect = 9e-40
 Identities = 64/252 (25%), Positives = 107/252 (42%), Gaps = 31/252 (12%)

Query: 10  SARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 68
             R ++ +E+++  Q      V+   + F       ++ E M GGS+   + K +   E 
Sbjct: 52  HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL 111

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIM------ 119
             + + + V   L +LH  K I HRDLKP N+L  H  +   VKI DF + + +      
Sbjct: 112 EASVVVQDVASALDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170

Query: 120 -ASTSGQANTFVGTYNYMSPE-----RISGGKYGYKSDIWSLGLVL--LECATGQFP-YS 170
              ++ +  T  G+  YM+PE           Y  + D+WSLG++L  L    G  P   
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS--GYPPFVG 228

Query: 171 PPEQQDGWTSFY-------ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRL 221
                 GW            L E+I +     P       S      IS  + ++ +QRL
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL 288

Query: 222 SAQELMTHPFLK 233
           SA +++ HP+++
Sbjct: 289 SAAQVLQHPWVQ 300

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  139 bits (352), Expect = 1e-39
 Identities = 60/246 (24%), Positives = 114/246 (46%), Gaps = 33/246 (13%)

Query: 12  RRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEE 68
           R +I  E+ +   +  CP V+  ++ + +   I +ILEY  GG +      +  + + E 
Sbjct: 72  RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN 131

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQ 125
            +  + +Q+L+G+ YLH + +I+H DLKP N+L++       +KI DFG+S  +   + +
Sbjct: 132 DVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACE 189

Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY 182
               +GT  Y++PE ++       +D+W++G+   +LL   T     SP         F 
Sbjct: 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL---TH---TSP---------FV 234

Query: 183 -----ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
                E    I               S     FI + + K P++R +A+  ++H +L+ +
Sbjct: 235 GEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294

Query: 236 GDLNVD 241
              N+ 
Sbjct: 295 DFENLF 300

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  139 bits (353), Expect = 1e-39
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 24/221 (10%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 78
            +   P++   +  F +   +  ++E+++GG L   ++K +   E     Y A    +++
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA----EII 134

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
             L++LH +K II+RDLK  N+L++H G  K+ DFG+            TF GT +Y++P
Sbjct: 135 SALMFLH-DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAP 193

Query: 139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
           E +    YG   D W++G++L E   G  P+    +        +L EAI++        
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDEVVYPTW 246

Query: 199 DQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLK 233
                +    + + + K P  RL          ++ HPF K
Sbjct: 247 --LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  138 bits (349), Expect = 2e-39
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 40/232 (17%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAI 73
           E  +      P+++  + +F     I +I++Y++GG L   L+K +  P      Y A  
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-- 113

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             +V   L YLH  K II+RDLKP N+L++  G +KITDFG +  +        T  GT 
Sbjct: 114 --EVCLALEYLH-SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTP 167

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI 188
           +Y++PE +S   Y    D WS G+++ E   G      P        FY     +  E I
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY----TP--------FYDSNTMKTYEKI 215

Query: 189 VDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
           ++     P      F+ +    +S  + ++  QRL       +++  HP+ K
Sbjct: 216 LNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  138 bits (349), Expect = 2e-39
 Identities = 63/245 (25%), Positives = 114/245 (46%), Gaps = 35/245 (14%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE   
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQAN 127
              +Q+L G+ YL H   I H DLKP N+++  R      +KI DFG++  +     +  
Sbjct: 118 EFLKQILNGVYYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFK 175

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-- 182
              GT  +++PE ++    G ++D+WS+G+   +LL   +G    SP         F   
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL---SG---ASP---------FLGD 220

Query: 183 ---ELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
              E +  +     +           S     FI   + K+P++R++ Q+ + HP++K  
Sbjct: 221 TKQETLANVSAVNYEFEDE--YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278

Query: 236 GDLNV 240
                
Sbjct: 279 DTQQA 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  138 bits (349), Expect = 3e-39
 Identities = 63/242 (26%), Positives = 113/242 (46%), Gaps = 35/242 (14%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +I +E+ I +      V+  +  + +   + +ILE + GG L DFL + +++ EE   
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQAN 127
           +  +Q+L G+ YL H K I H DLKP N+++  +      +K+ DFG++  +     +  
Sbjct: 119 SFIKQILDGVNYL-HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFK 176

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-- 182
              GT  +++PE ++    G ++D+WS+G+   +LL   +G    SP         F   
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL---SG---ASP---------FLGD 221

Query: 183 ---ELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
              E +  I     D           S     FI   + KE ++RL+ QE + HP++   
Sbjct: 222 TKQETLANITSVSYDFDEE--FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

Query: 236 GD 237
            +
Sbjct: 280 DN 281

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  136 bits (346), Expect = 3e-39
 Identities = 61/243 (25%), Positives = 114/243 (46%), Gaps = 31/243 (12%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +I +E+ I +  + P ++  +  F +   + +ILE + GG L DFL + +++ E+   
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQAN 127
              +Q+L G+ YL H K I H DLKP N+++  +      +K+ DFG++  +     +  
Sbjct: 112 QFLKQILDGVHYL-HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFK 169

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-- 182
              GT  +++PE ++    G ++D+WS+G+   +LL   +G    SP         F   
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL---SG---ASP---------FLGE 214

Query: 183 ---ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
              E +  I               S     FI   + K+P++R++  + + H ++K    
Sbjct: 215 TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274

Query: 238 LNV 240
            NV
Sbjct: 275 RNV 277

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  139 bits (351), Expect = 3e-39
 Identities = 64/238 (26%), Positives = 114/238 (47%), Gaps = 35/238 (14%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 71
           R +I +E+ I +    P ++  +  + +   + +ILE + GG L DFL + +++ EE   
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQAN 127
           +  +Q+L G+ YL H K I H DLKP N+++  +      +K+ DFG++  +     +  
Sbjct: 119 SFIKQILDGVNYL-HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFK 176

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-- 182
              GT  +++PE ++    G ++D+WS+G+   +LL   +G    SP         F   
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL---SG---ASP---------FLGD 221

Query: 183 ---ELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
              E +  I     D         Q S     FI   + KE ++RL+ QE + HP++ 
Sbjct: 222 TKQETLANITAVSYDFDEE--FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  143 bits (362), Expect = 3e-39
 Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 34/215 (15%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           I++EY+ G SL     +   +P     A   ++L  L YLH    +++ DLKP N+++  
Sbjct: 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLH-SIGLVYNDLKPENIMLTE 217

Query: 105 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 164
              +K+ D G      S         GT  + +PE +  G     +DI+++G  L     
Sbjct: 218 EQ-LKLIDLGA----VSRINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTL 271

Query: 165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR-LSA 223
                      +G           VD  P   P  +    +   +   +  +P+QR  +A
Sbjct: 272 DLPTR------NG---------RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTA 316

Query: 224 QELMTHPFLKMYGDLNVDLSEYFT-DAGSPLATLS 257
           +E        M   L   L E    D G P   LS
Sbjct: 317 EE--------MSAQLTGVLREVVAQDTGVPRPGLS 343

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  138 bits (349), Expect = 4e-39
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 42/233 (18%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAI 73
           E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E     Y A  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-- 148

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 133
             Q++    YLH    +I+RDLKP NLLI+ +G +++TDFG +  +    G+  T  GT 
Sbjct: 149 --QIVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWTLCGTP 202

Query: 134 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI 188
             ++PE I    Y    D W+LG+++ E A G     PP        F+     ++ E I
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGY----PP--------FFADQPIQIYEKI 250

Query: 189 VDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
           V      P       FS +    +   +Q +  +R         ++  H +  
Sbjct: 251 VSGKVRFPSH-----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  136 bits (344), Expect = 5e-39
 Identities = 60/228 (26%), Positives = 110/228 (48%), Gaps = 12/228 (5%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
                 +I +E++  +  + P+++  YQ   +     +++EY+ GG L D++ K   + E
Sbjct: 51  SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE 110

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
                + +Q+L  + Y H    ++HRDLKP N+L++     KI DFG+S +M S      
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLR 168

Query: 128 TFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           T  G+ NY +PE ISG  Y G + DIWS G++L     G  P+   + +   T F ++  
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRG 225

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
            +   P         +    + +   +Q +P +R + +++  H + K 
Sbjct: 226 GVFYIPE------YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  135 bits (343), Expect = 7e-39
 Identities = 59/236 (25%), Positives = 112/236 (47%), Gaps = 24/236 (10%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL----KKVKT 64
           +    QI  E+++ +S   P ++  ++ F     + I++E  +GG L + +     + K 
Sbjct: 61  QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120

Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMAS 121
           + E Y+A + +Q++  L Y H  +H++H+DLKP N+L         +KI DFG++ +  S
Sbjct: 121 LSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWT 179
               +    GT  YM+PE        +K DIWS G+V+  L    G  P++    +    
Sbjct: 180 DE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT--GCLPFTGTSLE---- 231

Query: 180 SFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
              E+ +    + P          +P+    +   + K+P++R SA +++ H + K
Sbjct: 232 ---EVQQKATYKEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  136 bits (346), Expect = 8e-39
 Identities = 52/239 (21%), Positives = 101/239 (42%), Gaps = 30/239 (12%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYL 70
           +  + +E+ I   ++   ++  ++SF S   + +I E++ G  + +        + E  +
Sbjct: 45  QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI 104

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANT 128
            +   QV + L +LH   +I H D++P N++   R    +KI +FG +  +         
Sbjct: 105 VSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRL 162

Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY--- 182
                 Y +PE          +D+WSLG    VLL   +G    +P         F    
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL---SG---INP---------FLAET 207

Query: 183 --ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             +++E I++           + S E   F+   + KE + R++A E + HP+LK   +
Sbjct: 208 NQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  135 bits (343), Expect = 2e-38
 Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 10/224 (4%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            I +E+ IN+      VV  Y          + LEY  GG L D ++    +PE      
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF 110

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVG 131
             Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   G
Sbjct: 111 FHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 132 TYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           T  Y++PE +   ++     D+WS G+VL     G+ P+      D  +   +      +
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKE 223

Query: 191 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
           +     P  +      + +   + + P  R++  ++    +   
Sbjct: 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  137 bits (348), Expect = 2e-38
 Identities = 65/250 (26%), Positives = 104/250 (41%), Gaps = 45/250 (18%)

Query: 11  ARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIP 66
            R +++    E  +  +    ++   + +F     + +++EY  GG L   L K  + IP
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP 160

Query: 67  EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMAS 121
            E    YLA   E V+  +  +H     +HRD+KP N+L++  G +++ DFG    + A 
Sbjct: 161 AEMARFYLA---EIVM-AIDSVH-RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215

Query: 122 TSGQANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 174
            + ++   VGT +Y+SPE +         G YG + D W+LG+   E   GQ     P  
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ----TP-- 269

Query: 175 QDGWTSFY-----ELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL---SA 223
                 FY     E    IV            +    E   FI   +   P+ RL    A
Sbjct: 270 ------FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCP-PETRLGRGGA 322

Query: 224 QELMTHPFLK 233
            +  THPF  
Sbjct: 323 GDFRTHPFFF 332

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  141 bits (356), Expect = 2e-38
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 23/220 (10%)

Query: 23  QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 78
              + P++   +  F +   +  ++EY++GG L   +++V    E     Y A I     
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI--- 453

Query: 79  KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 138
            GL +L   K II+RDLK  N++++  G +KI DFG+            TF GT +Y++P
Sbjct: 454 -GLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 511

Query: 139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 198
           E I+   YG   D W+ G++L E   GQ P+   ++        EL ++I++       S
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNVAYPKS 564

Query: 199 DQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
              S E  +     + K P +RL       +++  H F +
Sbjct: 565 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  137 bits (346), Expect = 2e-38
 Identities = 59/239 (24%), Positives = 106/239 (44%), Gaps = 30/239 (12%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYL 70
           +  +  E+ I      P ++  + +F     + +ILE++ GG L D +  +   + E  +
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANT 128
                Q  +GL ++H E  I+H D+KP N++   +    VKI DFG++  + +       
Sbjct: 152 INYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKV 209

Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY--- 182
              T  + +PE +     G+ +D+W++G+   VLL   +G    SP         F    
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL---SG---LSP---------FAGED 254

Query: 183 --ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             E ++ +               SPE   FI   +QKEP++RL+  + + HP+LK    
Sbjct: 255 DLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  137 bits (346), Expect = 6e-38
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 43/248 (17%)

Query: 11  ARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-P 66
            R + A   +E  +  +    ++   + +F  +  + ++++Y  GG L   L K +   P
Sbjct: 114 KRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP 173

Query: 67  EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMAS 121
           EE    YLA   E V+  +  +H + H +HRD+KP N+L++  G +++ DFG    +M  
Sbjct: 174 EEMARFYLA---EMVI-AIDSVH-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228

Query: 122 TSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 176
            + Q++  VGT +Y+SPE +       G+YG + D WSLG+ + E   G+     P    
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE----TP---- 280

Query: 177 GWTSFY-----ELMEAIVDQPPP-SAPSD--QFSPEFCSFISACVQKEPQQRL---SAQE 225
               FY     E    I++       P+     S      I   +    + RL     ++
Sbjct: 281 ----FYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS-REHRLGQNGIED 335

Query: 226 LMTHPFLK 233
              HPF  
Sbjct: 336 FKKHPFFS 343

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  136 bits (345), Expect = 4e-37
 Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 30/243 (12%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYL 70
           +  + +E++     + P +V  + +F  +  + +I E+M GG L + +  +   + E+  
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANT 128
                QV KGL ++H E + +H DLKP N++   +    +K+ DFG++A +         
Sbjct: 258 VEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKV 315

Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY--- 182
             GT  + +PE   G   GY +D+WS+G+   +LL   +G    SP         F    
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL---SG---LSP---------FGGEN 360

Query: 183 --ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 238
             E +  +         +     S +   FI   +  +P  R++  + + HP+L      
Sbjct: 361 DDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420

Query: 239 NVD 241
             D
Sbjct: 421 GRD 423

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  133 bits (336), Expect = 6e-37
 Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 30/238 (12%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD-FLKKVKTIPEEYL 70
           + ++  E+ +        ++  Y +F S   I +++EY+DGG L D  + +   + E   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANT 128
               +Q+ +G+ ++H + +I+H DLKP N+L  +R    +KI DFG++        +   
Sbjct: 190 ILFMKQICEGIRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKV 247

Query: 129 FVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY--- 182
             GT  +++PE ++     + +D+WS+G+   +LL   +G    SP         F    
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL---SG---LSP---------FLGDN 292

Query: 183 --ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
             E +  I+              S E   FIS  + KE   R+SA E + HP+L  + 
Sbjct: 293 DAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  132 bits (334), Expect = 7e-37
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 8/224 (3%)

Query: 14  QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 73
            + +E+  ++S + P +V   +   +   ++II+EY  GG L + +       E+     
Sbjct: 62  NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF 121

Query: 74  CEQVLKGLLYLHHEKHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTSGQANTFVG 131
            +Q+L G+ Y H    I HRDLK  N L+  +    +KI DFG S        Q  + VG
Sbjct: 122 FQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVG 179

Query: 132 TYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 190
           T  Y++PE +   +Y G  +D+WS G+ L     G +P+   E  +    + + ++ I+ 
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF---EDPEEPRDYRKTIQRILS 236

Query: 191 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                    + SPE C  IS     +P  R+S  E+ TH +   
Sbjct: 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  132 bits (333), Expect = 8e-37
 Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 13/229 (5%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +     ++ +E+   +  + P+++  Y    +   I +++EY  GG L D++ + K + E
Sbjct: 49  KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE 107

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +      +Q++  + Y H    I+HRDLKP NLL++    VKI DFG+S IM +      
Sbjct: 108 DEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLK 165

Query: 128 TFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           T  G+ NY +PE I+G  Y G + D+WS G+VL     G+ P+   + +     F ++  
Sbjct: 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF---DDEFIPNLFKKVNS 222

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            +   P         SP   S I   +  +P QR++ QE+   P+  + 
Sbjct: 223 CVYVMPD------FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  132 bits (334), Expect = 1e-36
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 23/243 (9%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSF----YSNGAISIILEYMDGGSLAD--FLKKV 62
             ARR++    +    SQCP++V     +         + I++E +DGG L      +  
Sbjct: 99  PKARREVELHWRA---SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 155

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIM 119
           +   E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG +   
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214

Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDG 177
            ++     T   T  Y++PE +   KY    D+WSLG+++  L C  G   Y P     G
Sbjct: 215 -TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC--G---YPPFYSNHG 268

Query: 178 WTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
                 +   I       P+    + S E    I   ++ EP QR++  E M HP++   
Sbjct: 269 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

Query: 236 GDL 238
             +
Sbjct: 329 TKV 331

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  130 bits (329), Expect = 2e-36
 Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 25/243 (10%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQ--SFYSNGAISIILEYMDGGS--LADFL 59
           ++    +    + +E+++ +  +   V+             + +++EY   G   + D +
Sbjct: 42  KLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV 101

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
            + K  P         Q++ GL YLH  + I+H+D+KP NLL+   G +KI+  GV+  +
Sbjct: 102 PE-KRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

Query: 120 ASTS--GQANTFVGTYNYMSPERISGGK-Y-GYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
              +      T  G+  +  PE  +G   + G+K DIWS G+ L    TG +P+      
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF------ 213

Query: 176 DGWTSFYELMEAIVD---QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           +G  + Y+L E I       P         P     +   ++ EP +R S +++  H + 
Sbjct: 214 EG-DNIYKLFENIGKGSYAIPGD-----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

Query: 233 KMY 235
           +  
Sbjct: 268 RKK 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  133 bits (337), Expect = 2e-36
 Identities = 65/229 (28%), Positives = 114/229 (49%), Gaps = 12/229 (5%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
                 +I +E++  +  + P+++  YQ   +   I +++EY+ GG L D++ K   + E
Sbjct: 56  SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +    + +Q+L G+ Y H    ++HRDLKP N+L++     KI DFG+S +M S      
Sbjct: 116 KESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLR 173

Query: 128 TFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 186
           T  G+ NY +PE ISG  Y G + DIWS G++L     G  P+   +     T F ++ +
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKKICD 230

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
            I   P         +P   S +   +Q +P +R + +++  H + K  
Sbjct: 231 GIFYTPQ------YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  131 bits (331), Expect = 5e-36
 Identities = 66/245 (26%), Positives = 106/245 (43%), Gaps = 41/245 (16%)

Query: 11  ARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
            R   A   +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPE 167

Query: 68  E----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMAST 122
           +    Y A    +V+  L  +H     IHRD+KP N+L++  G +K+ DFG    +    
Sbjct: 168 KWARFYTA----EVVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222

Query: 123 SGQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
             + +T VGT +Y+SPE +      G YG + D WS+G+ L E   G      P      
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD----TP------ 272

Query: 179 TSFY-----ELMEAIVD--QPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMT 228
             FY          I++          +  S E  + I A    + + RL     +E+  
Sbjct: 273 --FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRLGRNGVEEIKR 329

Query: 229 HPFLK 233
           H F K
Sbjct: 330 HLFFK 334

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (320), Expect = 8e-35
 Identities = 33/236 (13%), Positives = 75/236 (31%), Gaps = 32/236 (13%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----TIPEEYLA 71
           Q ++  + S     +  Y +        ++ E    G+L + +   K      +P+  + 
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----------GEVKITDFGVSAIMA 120
           +   ++L  +  +H +  IIH D+KP N ++ +              + + D G S  M 
Sbjct: 176 SFAMRMLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 121 S--TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
                        T  +   E +S   + Y+ D + +   +     G +     + + G 
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM--KVKNEGGE 292

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                L   +      +            F    +       L + +L+     K+
Sbjct: 293 CKPEGLFRRLPHLDMWN-----------EFFHVMLNIPDCHHLPSLDLLRQKLKKV 337

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  125 bits (315), Expect = 5e-34
 Identities = 60/257 (23%), Positives = 102/257 (39%), Gaps = 57/257 (22%)

Query: 29  YVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLL 82
           +++     F   G       ++ E + G +L   +KK   + IP  Y+  I +Q+L GL 
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145

Query: 83  YLHHEKHIIHRDLKPSNLLINH------RGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           Y+H    IIH D+KP N+L+          ++KI D G +             + T  Y 
Sbjct: 146 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQTREYR 202

Query: 137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPP 193
           SPE + G  +G  +DIWS   ++ E  TG F +  P++   +T   +    +  ++ + P
Sbjct: 203 SPEVLLGAPWGCGADIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIAQIIELLGELP 261

Query: 194 PS-------------------------------------APSDQFSPEFCSFISACVQKE 216
                                                    S   + E   F+S  +Q +
Sbjct: 262 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 321

Query: 217 PQQRLSAQELMTHPFLK 233
           P++R  A  L+ HP+LK
Sbjct: 322 PRKRADAGGLVNHPWLK 338

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  121 bits (305), Expect = 1e-32
 Identities = 55/245 (22%), Positives = 102/245 (41%), Gaps = 30/245 (12%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQ 76
           E+K+ +  +   +V   +         ++ E++D  ++ D L+     +  + +     Q
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
           ++ G+ + H   +IIHRD+KP N+L++  G VK+ DFG +  +A+     +  V T  Y 
Sbjct: 133 IINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191

Query: 137 SPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP--------Y-------SPPEQQDGW 178
           +PE + G   YG   D+W++G ++ E   G+  FP        Y       +   +    
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH--Q 249

Query: 179 TSFYELMEAI-VDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
             F +      V  P             + S         C+  +P +R    EL+ H F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

Query: 232 LKMYG 236
            +M G
Sbjct: 310 FQMDG 314

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  120 bits (303), Expect = 1e-32
 Identities = 60/254 (23%), Positives = 97/254 (38%), Gaps = 39/254 (15%)

Query: 10  SARRQIA--QELKINQSSQCPYVV-----VCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           S  R++A  + L+   + + P VV                ++++ E++D   L  +L K 
Sbjct: 57  STVREVALLRRLE---AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA 112

Query: 63  KT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
               +P E +  +  Q L+GL +LH    I+HRDLKP N+L+   G VK+ DFG    +A
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLADFG----LA 167

Query: 121 STSGQANTF---VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ 174
                       V T  Y +PE +    Y    D+WS+G +  E    +  F   S  +Q
Sbjct: 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227

Query: 175 ------------QDGWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQ 219
                       +D W     L         P                 +   +   P +
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287

Query: 220 RLSAQELMTHPFLK 233
           R+SA   + H +L 
Sbjct: 288 RISAFRALQHSYLH 301

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  119 bits (301), Expect = 2e-32
 Identities = 57/242 (23%), Positives = 104/242 (42%), Gaps = 30/242 (12%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQ 76
           E+++ +  + P +V   + F     + ++ EY D  ++   L + +  +PE  + +I  Q
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM 136
            L+ + + H + + IHRD+KP N+LI     +K+ DFG + ++   S   +  V T  Y 
Sbjct: 111 TLQAVNFCH-KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169

Query: 137 SPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP--------Y-------SPPEQQDGW 178
           SPE + G   YG   D+W++G V  E  +G   +P        Y           +    
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH--Q 227

Query: 179 TSFYELMEAI-VDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPF 231
             F        V  P P             S      +  C+  +P +RL+ ++L+ HP+
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

Query: 232 LK 233
            +
Sbjct: 288 FE 289

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  118 bits (299), Expect = 5e-32
 Identities = 59/266 (22%), Positives = 106/266 (39%), Gaps = 44/266 (16%)

Query: 3   IQMNVEE-----SARRQIA--QELKINQSSQCPYVV-----VCYQSFYSNGAISIILEYM 50
           +++   E     S  R++A  + L+   + + P VV                ++++ E++
Sbjct: 45  VRVQTGEEGMPLSTIREVAVLRHLE---TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101

Query: 51  DGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 108
           D   L  +L KV    +P E +  +  Q+L+GL +LH    ++HRDLKP N+L+   G++
Sbjct: 102 DQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQI 159

Query: 109 KITDFGVSAIMASTSGQANTF---VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 165
           K+ DFG    +A            V T  Y +PE +    Y    D+WS+G +  E    
Sbjct: 160 KLADFG----LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

Query: 166 Q--FP-YSPPEQ------------QDGWTSFYELMEAIVDQPPPSAPSDQF---SPEFCS 207
           +  F   S  +Q            ++ W     L                          
Sbjct: 216 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 275

Query: 208 FISACVQKEPQQRLSAQELMTHPFLK 233
            +  C+   P +R+SA   ++HP+ +
Sbjct: 276 LLLKCLTFNPAKRISAYSALSHPYFQ 301

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  118 bits (297), Expect = 9e-32
 Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 33/243 (13%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQ 76
           E+ + +    P +V      +S   ++++ E+M+   L   L + KT + +  +     Q
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTF---VGT 132
           +L+G+ + H    I+HRDLKP NLLIN  G +K+ DFG    +A   G    ++   V T
Sbjct: 128 LLRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFG----LARAFGIPVRSYTHEVVT 182

Query: 133 YNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QD 176
             Y +P+ + G K Y    DIWS+G +  E  TG+  FP  +  +Q              
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242

Query: 177 GWTSFYELMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHP 230
            W    EL                      F  E    +S  +  +P +R+SA++ M HP
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302

Query: 231 FLK 233
           + K
Sbjct: 303 YFK 305

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  117 bits (296), Expect = 2e-31
 Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 55/285 (19%)

Query: 3   IQMNVEE----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 58
           I++  EE    +A R    E+ + +  +   +V  +   ++  +++++ EY+D   L  +
Sbjct: 35  IRLEHEEGAPCTAIR----EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQY 89

Query: 59  LKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
           L      I    +     Q+L+GL Y H  + ++HRDLKP NLLIN RGE+K+ DFG   
Sbjct: 90  LDDCGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERGELKLADFG--- 145

Query: 118 IMA-STSGQANTF---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-Y 169
            +A + S    T+   V T  Y  P+ + G   Y  + D+W +G +  E ATG+  FP  
Sbjct: 146 -LARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204

Query: 170 SPPEQ------------QDGWTSFYELMEAIVDQPPPSAPSD------QFSPEFCSFISA 211
           +  EQ            ++ W       E      P            +   +    ++ 
Sbjct: 205 TVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTK 264

Query: 212 CVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL 256
            +Q E + R+SA++ M HP              +F   G  +  L
Sbjct: 265 LLQFEGRNRISAEDAMKHP--------------FFLSLGERIHKL 295

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  114 bits (289), Expect = 8e-31
 Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 35/248 (14%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQ 76
           E+ I +  +   +V  Y   ++   + ++ E++D   L   L   +  +      +   Q
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTF---VGT 132
           +L G+ Y H  + ++HRDLKP NLLIN  GE+KI DFG    +A   G     +   + T
Sbjct: 109 LLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFG----LARAFGIPVRKYTHEIVT 163

Query: 133 YNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QD 176
             Y +P+ + G K Y    DIWS+G +  E   G   FP  S  +Q              
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223

Query: 177 GWTSFYELMEAIVDQP--PPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            W +  EL +   +     P                 +S  ++ +P QR++A++ + H +
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

Query: 232 LKMYGDLN 239
            K   + N
Sbjct: 284 FK---ENN 288

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  112 bits (282), Expect = 9e-30
 Identities = 60/245 (24%), Positives = 107/245 (43%), Gaps = 37/245 (15%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQ 76
           E+ + +  +   +V  +   +S+  ++++ E+ D   L  +       +  E + +   Q
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTF---VGT 132
           +LKGL + H  ++++HRDLKP NLLIN  GE+K+ +FG    +A   G     +   V T
Sbjct: 110 LLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFG----LARAFGIPVRCYSAEVVT 164

Query: 133 YNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPY------------------SPPE 173
             Y  P+ + G K Y    D+WS G +  E A    P                   +P E
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224

Query: 174 QQDGWTSFYELMEAIV--DQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMT 228
           +Q  W S  +L +       P  ++  +     +      +   ++  P QR+SA+E + 
Sbjct: 225 EQ--WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

Query: 229 HPFLK 233
           HP+  
Sbjct: 283 HPYFS 287

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  112 bits (281), Expect = 1e-29
 Identities = 61/243 (25%), Positives = 99/243 (40%), Gaps = 44/243 (18%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSF----YSNGAISIILEYMDGGSLAD--FLKKV 62
             ARR++    +    SQCP++V     +         + I++E +DGG L      +  
Sbjct: 55  PKARREVELHWRA---SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 111

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIM 119
           +   E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG     
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFG----- 165

Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDG 177
                            + E  +G KY    D+WSLG+++  L C  G   Y P     G
Sbjct: 166 ----------------FAKE-TTGEKYDKSCDMWSLGVIMYILLC--G---YPPFYSNHG 203

Query: 178 WTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
                 +   I       P+    + S E    I   ++ EP QR++  E M HP++   
Sbjct: 204 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

Query: 236 GDL 238
             +
Sbjct: 264 TKV 266

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  111 bits (281), Expect = 2e-29
 Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 50/271 (18%)

Query: 3   IQMNVEE----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 58
           ++++ EE    +A R    E+ + +  +   +V  Y   ++   ++++ E+MD   L  +
Sbjct: 38  VKLDSEEGTPSTAIR----EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKY 92

Query: 59  LKKVKT------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
           +           +    +     Q+L+GL + H    I+HRDLKP NLLIN RG++K+ D
Sbjct: 93  MDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRGQLKLGD 151

Query: 113 FGVSAIMASTSG-QANTF---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ- 166
           FG    +A   G   NTF   V T  Y +P+ + G + Y    DIWS G +L E  TG+ 
Sbjct: 152 FG----LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207

Query: 167 -FP-YSPPEQ------------QDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFIS 210
            FP  +  EQ            +  W S  +L +   +    PP        P     + 
Sbjct: 208 LFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLD 267

Query: 211 A--------CVQKEPQQRLSAQELMTHPFLK 233
                     +Q  P  RLSA++ + HP+  
Sbjct: 268 GNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  111 bits (279), Expect = 4e-29
 Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 31/248 (12%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
            ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G L D
Sbjct: 51  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLD 105

Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           ++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

Query: 117 AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 173
            ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY    
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---- 220

Query: 174 QQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
             DG  +  E+   +        PP         +    +  C   +   R   +EL+  
Sbjct: 221 --DGIPA-SEISSILEKGERLPQPPICT-----IDVYMIMRKCWMIDADSRPKFRELIIE 272

Query: 230 PFLKMYGD 237
            F KM  D
Sbjct: 273 -FSKMARD 279

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  111 bits (279), Expect = 4e-29
 Identities = 53/247 (21%), Positives = 94/247 (38%), Gaps = 37/247 (14%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 77
           E+ + +  Q   ++      + N  + +I EY +   L  ++ K   +    + +   Q+
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLIN-----HRGEVKITDFGVSAIMASTSG-QANTF-- 129
           + G+ + H  +  +HRDLKP NLL++         +KI DFG    +A   G     F  
Sbjct: 142 INGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG----LARAFGIPIRQFTH 196

Query: 130 -VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPYSPPEQQ---------- 175
            + T  Y  PE + G + Y    DIWS+  +  E       FP      Q          
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256

Query: 176 ---DGWTSFYELMEAIVDQPPPSAPS------DQFSPEFCSFISACVQKEPQQRLSAQEL 226
                W     L +     P     +           E    ++A ++ +P +R+SA+  
Sbjct: 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316

Query: 227 MTHPFLK 233
           + HP+  
Sbjct: 317 LEHPYFS 323

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  111 bits (279), Expect = 8e-29
 Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 29/230 (12%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
              + +  QE +I +    P +V    VC Q       I I++E + GG    FL+    
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQK----QPIYIVMELVQGGDFLTFLRTEGA 208

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            +  + L  +      G+ YL   K  IHRDL   N L+  +  +KI+DFG+S   A   
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267

Query: 124 GQANTFVGTYNY--MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 180
             A+  +        +PE ++ G+Y  +SD+WS G++L E  + G  PY         ++
Sbjct: 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY------PNLSN 321

Query: 181 FYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
             +  E +        P   P           +  C   EP QR S   +
Sbjct: 322 -QQTREFVEKGGRLPCPELCP-----DAVFRLMEQCWAYEPGQRPSFSTI 365

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  111 bits (280), Expect = 1e-28
 Identities = 70/260 (26%), Positives = 106/260 (40%), Gaps = 39/260 (15%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDG---GSLADFLKKVKTIPEE 68
           EL+I +      +V     FYS+G       ++++L+Y+          + +  +T+P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQAN 127
           Y+     Q+ + L Y+H    I HRD+KP NLL++     +K+ DFG SA      G+ N
Sbjct: 157 YVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFG-SA-KQLVRGEPN 213

Query: 128 T-FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPY-------------- 169
             ++ +  Y +PE I G   Y    D+WS G VL E   GQ  FP               
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273

Query: 170 -SPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQF----SPEFCSFISACVQKEPQQRLSA 223
            +P  +Q       Y   E    Q      +  F     PE  +  S  ++  P  RL+ 
Sbjct: 274 GTPTREQIREMNPNY--TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 331

Query: 224 QELMTHPFLKMYGDLNVDLS 243
            E   H F     D NV L 
Sbjct: 332 LEACAHSFFDELRDPNVKLP 351

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  110 bits (277), Expect = 1e-28
 Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 31/239 (12%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQ 76
           E+K+ Q    P ++    +F     IS++ ++M+   L   +K     +   ++ A    
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 77  VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-TF---VGT 132
            L+GL YLH +  I+HRDLKP+NLL++  G +K+ DFG    +A + G  N  +   V T
Sbjct: 121 TLQGLEYLH-QHWILHRDLKPNNLLLDENGVLKLADFG----LAKSFGSPNRAYTHQVVT 175

Query: 133 YNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QD 176
             Y +PE + G + YG   D+W++G +L E        P  S  +Q            ++
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235

Query: 177 GWTSFYELMEAIVDQPPPSAP-SDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPF 231
            W     L + +  +  P  P    F     +    I       P  R++A + +   +
Sbjct: 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  109 bits (274), Expect = 1e-28
 Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 30/225 (13%)

Query: 8   EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           + + + ++  E  + Q    PY+V    +C        +  +++E  + G L  +L++ +
Sbjct: 58  DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-----SWMLVMEMAELGPLNKYLQQNR 112

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            + ++ +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S  + +  
Sbjct: 113 HVKDKNIIELVHQVSMGMKYL-EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171

Query: 124 GQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 179
                         + +PE I+  K+  KSD+WS G+++ E  + GQ PY       G  
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY------RGMK 225

Query: 180 SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
              E+   +        P   P      E    ++ C   + + R
Sbjct: 226 G-SEVTAMLEKGERMGCPAGCP-----REMYDLMNLCWTYDVENR 264

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  109 bits (275), Expect = 1e-28
 Identities = 58/275 (21%), Positives = 105/275 (38%), Gaps = 59/275 (21%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
              R +   E  + +   C +VV    V  Q         +I+E M  G L  +L+ ++ 
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRP 124

Query: 65  IPEEY----------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 114
                          +  +  ++  G+ YL+     +HRDL   N ++     VKI DFG
Sbjct: 125 AMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFG 183

Query: 115 VSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLEC 162
           ++  +  T          Y Y            MSPE +  G +   SD+WS G+VL E 
Sbjct: 184 MTRDIYETD---------Y-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

Query: 163 AT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEP 217
           AT  + PY       G ++  +++  +++      P + P           +  C Q  P
Sbjct: 234 ATLAEQPYQ------GLSNE-QVLRFVMEGGLLDKPDNCP-----DMLFELMRMCWQYNP 281

Query: 218 QQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSP 252
           + R S  E+++    +       ++S Y+++    
Sbjct: 282 KMRPSFLEIISS-IKEEMEPGFREVSFYYSEENKL 315

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  108 bits (273), Expect = 2e-28
 Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 28/243 (11%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL 59
           +     +    + +E++I ++     +V    +C +   +   I +I+E++  GSL ++L
Sbjct: 59  KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG--IKLIMEFLPSGSLKEYL 116

Query: 60  KKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
            K K  I  +       Q+ KG+ YL   +  +HRDL   N+L+    +VKI DFG++  
Sbjct: 117 PKNKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175

Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           + +                + +PE +   K+   SD+WS G+ L E  T      SP   
Sbjct: 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

Query: 175 QDGWTSFY-------ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 223
                           L+  + +      PP+ P      E    +  C + +P  R S 
Sbjct: 236 FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCP-----DEVYQLMRKCWEFQPSNRTSF 290

Query: 224 QEL 226
           Q L
Sbjct: 291 QNL 293

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  108 bits (273), Expect = 3e-28
 Identities = 52/190 (27%), Positives = 79/190 (41%), Gaps = 25/190 (13%)

Query: 48  EYMDGGSLADFL---KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
            YM  GSL D L        +       I +    G+ +LH E H IHRD+K +N+L++ 
Sbjct: 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDE 168

Query: 105 RGEVKITDFGVSAIMASTSGQANT--FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
               KI+DFG++      +    T   VGT  YM+PE +  G+   KSDI+S G+VLLE 
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEI 227

Query: 163 ATGQFPYSPPEQQD---GWTSFY----ELMEAIVDQPPPSAPS-DQFSPE----FCSFIS 210
            TG        +               + +E  +D         +           S  S
Sbjct: 228 ITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID------KKMNDADSTSVEAMYSVAS 281

Query: 211 ACVQKEPQQR 220
            C+ ++  +R
Sbjct: 282 QCLHEKKNKR 291

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  109 bits (275), Expect = 3e-28
 Identities = 63/323 (19%), Positives = 108/323 (33%), Gaps = 102/323 (31%)

Query: 9   ESARRQIAQELKINQSSQ----CPYVVVCYQSFYSNGA----ISIILEYMDGGSLADFLK 60
           E+A  +I     +  S         VV     F  +G     I ++ E + G  L  ++ 
Sbjct: 78  ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII 136

Query: 61  K--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN--------------- 103
           K   + +P   +  I +QVL+GL YLH +  IIH D+KP N+L++               
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196

Query: 104 ----------------------------------HRGEVKITDFGVSAIMASTSGQANTF 129
                                              + +VKI D G +             
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTED 253

Query: 130 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEA 187
           + T  Y S E + G  Y   +DIWS   +  E ATG + + P   ++       +  +  
Sbjct: 254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313

Query: 188 IVDQPPP-----SAPSDQF--------------------------------SPEFCSFIS 210
           ++ + P         S +F                                +  F  F+ 
Sbjct: 314 LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL 373

Query: 211 ACVQKEPQQRLSAQELMTHPFLK 233
             ++  P++R +A E + HP+L 
Sbjct: 374 PMLELIPEKRATAAECLRHPWLN 396

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  108 bits (273), Expect = 3e-28
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 30/225 (13%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
           E  R     E  I        ++    V  +       + II EYM+ G+L  FL++   
Sbjct: 87  EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY----KPMMIITEYMENGALDKFLREKDG 142

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
                 L  +   +  G+ YL    + +HRDL   N+L+N     K++DFG+S ++    
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201

Query: 124 GQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 179
               T  G      + +PE IS  K+   SD+WS G+V+ E  T G+ PY         +
Sbjct: 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY------WELS 255

Query: 180 SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
           + +E+M+AI D      P   P           +  C Q+E  +R
Sbjct: 256 N-HEVMKAINDGFRLPTPMDCP-----SAIYQLMMQCWQQERARR 294

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (272), Expect = 4e-28
 Identities = 58/267 (21%), Positives = 99/267 (37%), Gaps = 47/267 (17%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQS--FYSNGAISIILEYMDGGSLADFLKKV 62
           E  RR    E  I      P ++    V  +           I+ EYM+ GSL  FL+  
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM------IVTEYMENGSLDTFLRTH 144

Query: 63  K-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
                   L  +   V  G+ YL  +   +HRDL   N+L++     K++DFG+S ++  
Sbjct: 145 DGQFTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203

Query: 122 TSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG 177
               A T  G      + +PE I+   +   SD+WS G+V+ E    G+ PY        
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------WN 257

Query: 178 WTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
            T+  +++ ++ +      P   P           +  C  K+  QR    ++++     
Sbjct: 258 MTN-RDVISSVEEGYRLPAPMGCP-----HALHQLMLDCWHKDRAQRPRFSQIVSV---- 307

Query: 234 MYGDLNVDLSEYFTDAGSPLATLSNLS 260
                   L          L   + +S
Sbjct: 308 --------LDALIRSP-ESLRATATVS 325

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  108 bits (272), Expect = 5e-28
 Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 30/239 (12%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLA 71
           +E++I ++    ++V    V Y     +  + +++EY+  G L DFL++ +  +    L 
Sbjct: 73  REIQILKALHSDFIVKYRGVSYGPGRQS--LRLVMEYLPSGCLRDFLQRHRARLDASRLL 130

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
               Q+ KG+ YL   +  +HRDL   N+L+     VKI DFG++ ++            
Sbjct: 131 LYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189

Query: 132 T---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY----- 182
                 + +PE +S   +  +SD+WS G+VL E  T      SP  +             
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249

Query: 183 --ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
              L+E + +      PP+ P      E    +  C    PQ R S   L   P L M 
Sbjct: 250 LSRLLELLEEGQRLPAPPACP-----AEVHELMKLCWAPSPQDRPSFSAL--GPQLDML 301

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  108 bits (271), Expect = 6e-28
 Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 30/246 (12%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
              R    QE+ I ++    +++     C  +  ++  + +++EY+  GSL D+L +  +
Sbjct: 74  PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPR-HS 130

Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
           I    L    +Q+ +G+ YLH  +H IHRDL   N+L+++   VKI DFG++  +     
Sbjct: 131 IGLAQLLLFAQQICEGMAYLH-AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189

Query: 125 QANTFVGTYN---YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT- 179
                    +   + +PE +   K+ Y SD+WS G+ L E  T      SPP +      
Sbjct: 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249

Query: 180 ------SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
                 +   L E +        P   P      E    +  C + E   R + + L   
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCP-----AEVYHLMKNCWETEASFRPTFENL--I 302

Query: 230 PFLKMY 235
           P LK  
Sbjct: 303 PILKTV 308

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (273), Expect = 7e-28
 Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 42/266 (15%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
           E  RR    E  I      P ++    V  +S      + I+ EYM+ GSL  FL+K   
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS----KPVMIVTEYMENGSLDSFLRKHDA 142

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
                 L  +   +  G+ YL  +   +HRDL   N+LIN     K++DFG+  ++    
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

Query: 124 GQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 179
             A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY         +
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------WEMS 255

Query: 180 SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           +  ++++A+ +     PP   P           +  C QK+   R   +++++       
Sbjct: 256 N-QDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSI------ 303

Query: 236 GDLNVDLSEYFTDAGSPLATLSNLSG 261
                 L +   + GS     S  + 
Sbjct: 304 ------LDKLIRNPGSLKIITSAAAR 323

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  107 bits (270), Expect = 8e-28
 Identities = 56/196 (28%), Positives = 86/196 (43%), Gaps = 29/196 (14%)

Query: 48  EYMDGGSLADFLKKVKTIPEEYL-----AAICEQVLKGLLYLHHEK--HIIHRDLKPSNL 100
            YM  GS+A  L++ +   +  L       I     +GL YLH      IIHRD+K +N+
Sbjct: 107 PYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNYMSPERISGGKYGYKSDIWSLGLVL 159
           L++   E  + DFG++ +M        T V GT  +++PE +S GK   K+D++  G++L
Sbjct: 166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225

Query: 160 LECATGQFPY---SPPEQQDG----WTSFYELME-----AIVDQPPPSAPSDQFSPEFCS 207
           LE  TGQ  +         D     W     L++     A+VD        +    E   
Sbjct: 226 LELITGQRAFDLARLANDDDVMLLDWV--KGLLKEKKLEALVD---VDLQGNYKDEEVEQ 280

Query: 208 FI---SACVQKEPQQR 220
            I     C Q  P +R
Sbjct: 281 LIQVALLCTQSSPMER 296

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  106 bits (267), Expect = 9e-28
 Identities = 24/199 (12%), Positives = 52/199 (26%), Gaps = 32/199 (16%)

Query: 28  PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 87
           P V       ++     ++ E++ GGSL +      +          + +       H  
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLAAAADAAH-R 147

Query: 88  KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 147
             +      PS + ++  G+V +                         M           
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA-------N 180

Query: 148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 207
            + DI  +G  L      ++P      + G                P+        +  +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP--IEPADIDRDIPFQISA 238

Query: 208 FISACVQKEPQQRLSAQEL 226
             +  VQ +   R ++  L
Sbjct: 239 VAARSVQGDGGIRSASTLL 257

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  106 bits (268), Expect = 9e-28
 Identities = 52/227 (22%), Positives = 85/227 (37%), Gaps = 32/227 (14%)

Query: 8   EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           +  A     +E+    S     ++    V          + ++ E    GSL D L+K +
Sbjct: 61  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKHQ 115

Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
                  L+    QV +G+ YL   K  IHRDL   NLL+  R  VKI DFG+   +   
Sbjct: 116 GHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

Query: 123 SGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
                        + + +PE +    + + SD W  G+ L E  T GQ P+       G 
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW------IGL 228

Query: 179 TSFYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISACVQKEPQQR 220
               +++  I  +      P   P      +  + +  C   +P+ R
Sbjct: 229 NG-SQILHKIDKEGERLPRPEDCP-----QDIYNVMVQCWAHKPEDR 269

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  108 bits (271), Expect = 1e-27
 Identities = 56/265 (21%), Positives = 104/265 (39%), Gaps = 43/265 (16%)

Query: 17  QELKINQSSQCPYVVVCYQSFYSNGA-------ISIILEYMDG---GSLADFLKKVKTIP 66
           Q ++       P +V     FY+ G        +++++EY+         ++ ++    P
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP 127

Query: 67  EEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSG 124
              +     Q+++ +  LH     + HRD+KP N+L+N   G +K+ DFG SA    +  
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SA-KKLSPS 185

Query: 125 QANT-FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---Y-------- 169
           + N  ++ +  Y +PE I G + Y    DIWS+G +  E   G+  F             
Sbjct: 186 EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245

Query: 170 ----SPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQF-------SPEFCSFISACVQKEP 217
                P  +        +   +  +        S+ F       + E    +SA +Q  P
Sbjct: 246 RVLGCPSREVLRKLNPSH--TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP 303

Query: 218 QQRLSAQELMTHPFLKMYGDLNVDL 242
           ++R+   E + HP+     D    L
Sbjct: 304 EERMKPYEALCHPYFDELHDPATKL 328

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  108 bits (272), Expect = 1e-27
 Identities = 81/277 (29%), Positives = 118/277 (42%), Gaps = 44/277 (15%)

Query: 18  ELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDG---GSLADFLKKVKTIPEE 68
           EL+I +  + P VV     FYSNG       ++++LEY+      +   + K  +T+P  
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQAN 127
            +     Q+L+ L Y+H    I HRD+KP NLL++   G +K+ DFG SA     +G+ N
Sbjct: 142 LIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFG-SA-KILIAGEPN 198

Query: 128 T-FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPY-------------- 169
             ++ +  Y +PE I G   Y    DIWS G V+ E   GQ  FP               
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258

Query: 170 -SPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQF----SPEFCSFISACVQKEPQQRLSA 223
            +P  +Q       Y  ME    Q  P   S  F     P+    IS  ++  P  RL+A
Sbjct: 259 GTPSREQIKTMNPNY--MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316

Query: 224 QELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 260
            E + HPF          +       G  L  L N +
Sbjct: 317 IEALCHPFFDELRTGEARMP-----NGRELPPLFNWT 348

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (269), Expect = 2e-27
 Identities = 55/240 (22%), Positives = 91/240 (37%), Gaps = 46/240 (19%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
                Q   E  I +    P V+    +C +S    G+  ++L YM  G L +F++    
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVLPYMKHGDLRNFIRNETH 187

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
               + L     QV KG+ +L   K  +HRDL   N +++ +  VK+ DFG++  M    
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246

Query: 124 GQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
                     +             M+ E +   K+  KSD+WS G++L E  T G  PY 
Sbjct: 247 --------FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

Query: 171 PPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                    +F ++   ++       P   P           +  C   + + R S  EL
Sbjct: 299 ------DVNTF-DITVYLLQGRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSEL 346

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  109 bits (273), Expect = 2e-27
 Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 33/230 (14%)

Query: 5   MNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLK 60
           +  +     +  +E  + +  + P +V    VC +         II E+M  G+L D+L+
Sbjct: 253 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE----PPFYIITEFMTYGNLLDYLR 308

Query: 61  KV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
           +   + +    L  +  Q+   + YL  +K+ IHR+L   N L+     VK+ DFG+S +
Sbjct: 309 ECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367

Query: 119 MAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           M     T+     F     + +PE ++  K+  KSD+W+ G++L E AT G  PY     
Sbjct: 368 MTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----- 420

Query: 175 QDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
             G     ++ E +      + P   P      +    + AC Q  P  R
Sbjct: 421 -PGIDL-SQVYELLEKDYRMERPEGCP-----EKVYELMRACWQWNPSDR 463

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  107 bits (270), Expect = 3e-27
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYL 70
           QE ++ +  +   +V    V  +       I I+ EYM  GSL DFLK    K +    L
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQAN 127
             +  Q+  G+ Y+    + +HRDL+ +N+L+      K+ DFG++ ++     T+ Q  
Sbjct: 283 VDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME 186
            F     + +PE    G++  KSD+WS G++L E  T G+ PY       G  +  E+++
Sbjct: 342 KF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP------GMVN-REVLD 392

Query: 187 AIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            +        PP  P           +  C +KEP++R
Sbjct: 393 QVERGYRMPCPPECP-----ESLHDLMCQCWRKEPEER 425

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (264), Expect = 4e-27
 Identities = 66/239 (27%), Positives = 104/239 (43%), Gaps = 29/239 (12%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
           E   R   +E++I +S Q   +V    VCY +      + +I+EY+  GSL D+L+K K 
Sbjct: 52  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKE 109

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            I    L     Q+ KG+ YL   K  IHRDL   N+L+ +   VKI DFG++ ++    
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

Query: 124 GQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 179
                         + +PE ++  K+   SD+WS G+VL E  T  +   SPP +     
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

Query: 180 --------SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                     + L+E + +      P   P      E    ++ C      QR S ++L
Sbjct: 229 GNDKQGQMIVFHLIELLKNNGRLPRPDGCP-----DEIYMIMTECWNNNVNQRPSFRDL 282

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  106 bits (266), Expect = 6e-27
 Identities = 60/249 (24%), Positives = 90/249 (36%), Gaps = 58/249 (23%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           E        E  I        +V    V  QS        I+LE M GG L  FL++ + 
Sbjct: 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRP 170

Query: 65  IPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFG 114
            P +        L  +   +  G  YL  E H IHRD+   N L+   G     KI DFG
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229

Query: 115 VSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLEC 162
           ++  +             Y Y            M PE    G +  K+D WS G++L E 
Sbjct: 230 MARDIYRAG---------Y-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

Query: 163 AT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEP 217
            + G  PY         ++  E++E +       PP + P           ++ C Q +P
Sbjct: 280 FSLGYMPYP------SKSN-QEVLEFVTSGGRMDPPKNCP-----GPVYRIMTQCWQHQP 327

Query: 218 QQRLSAQEL 226
           + R +   +
Sbjct: 328 EDRPNFAII 336

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  105 bits (264), Expect = 6e-27
 Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 35/197 (17%)

Query: 48  EYMDGGSLADFLKKVKTIPEEYLA-----AICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           +YM+ G+L   L     +P   ++      IC    +GL YLH  + IIHRD+K  N+L+
Sbjct: 115 KYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILL 172

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFV-----GTYNYMSPERISGGKYGYKSDIWSLGL 157
           +     KITDFG+S           T +     GT  Y+ PE    G+   KSD++S G+
Sbjct: 173 DENFVPKITDFGISKKGTELD---QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 158 VLLECATGQFP--YSPPEQQDG---WTSFY---ELMEAIVDQPPPSAPS--DQFSPE--- 204
           VL E    +     S P +      W         +E IVD      P+  D+  PE   
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLADKIRPESLR 283

Query: 205 -FCSFISACVQKEPQQR 220
            F      C+    + R
Sbjct: 284 KFGDTAVKCLALSSEDR 300

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (264), Expect = 6e-27
 Identities = 59/249 (23%), Positives = 91/249 (36%), Gaps = 58/249 (23%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           E        E  I        +V    V  Q    +    I++E M GG L  FL++ + 
Sbjct: 74  EQDELDFLMEALIISKFNHQNIVRCIGVSLQ----SLPRFILMELMAGGDLKSFLRETRP 129

Query: 65  IPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFG 114
            P +        L  +   +  G  YL  E H IHRD+   N L+   G     KI DFG
Sbjct: 130 RPSQPSSLAMLDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188

Query: 115 VSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLEC 162
           ++  +   S         Y Y            M PE    G +  K+D WS G++L E 
Sbjct: 189 MARDIYRAS---------Y-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

Query: 163 AT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEP 217
            + G  PY         ++  E++E +       PP + P           ++ C Q +P
Sbjct: 239 FSLGYMPYP------SKSN-QEVLEFVTSGGRMDPPKNCP-----GPVYRIMTQCWQHQP 286

Query: 218 QQRLSAQEL 226
           + R +   +
Sbjct: 287 EDRPNFAII 295

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  104 bits (262), Expect = 6e-27
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 31/228 (13%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK 61
             E++   ++ +E +I      PY+V    VC        A+ +++E   GG L  FL  
Sbjct: 48  GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVG 102

Query: 62  VK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
            +  IP   +A +  QV  G+ YL  EK+ +HRDL   N+L+ +R   KI+DFG+S  + 
Sbjct: 103 KREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161

Query: 121 STSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD 176
           +                + +PE I+  K+  +SD+WS G+ + E  + GQ PY       
Sbjct: 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY------K 215

Query: 177 GWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
                 E+M  I      + PP  P     PE  + +S C   + + R
Sbjct: 216 KMKG-PEVMAFIEQGKRMECPPECP-----PELYALMSDCWIYKWEDR 257

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  104 bits (262), Expect = 7e-27
 Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 30/232 (12%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
                Q   E  I +    P V+    +C +S    G+  ++L YM  G L +F++    
Sbjct: 67  IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVLPYMKHGDLRNFIRNETH 123

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMAST 122
               + L     QV KG+ YL   K  +HRDL   N +++ +  VK+ DFG++  +    
Sbjct: 124 NPTVKDLIGFGLQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182

Query: 123 SGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
               +   G      +M+ E +   K+  KSD+WS G++L E  T G  PY         
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DV 236

Query: 179 TSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +F ++   ++       P   P           +  C   + + R S  EL
Sbjct: 237 NTF-DITVYLLQGRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSEL 282

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  104 bits (261), Expect = 8e-27
 Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 30/224 (13%)

Query: 8   EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV- 62
            ++  +    E  +    +   +V    V  +     G + I+ EYM  GSL D+L+   
Sbjct: 54  NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIVTEYMAKGSLVDYLRSRG 110

Query: 63  -KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +  + L      V + + YL    + +HRDL   N+L++     K++DFG++   +S
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 180
           T       V    + +PE +   K+  KSD+WS G++L E  + G+ PY           
Sbjct: 170 TQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY------PRIPL 220

Query: 181 FYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
             +++  +        P   P     P     +  C   +   R
Sbjct: 221 -KDVVPRVEKGYKMDAPDGCP-----PAVYEVMKNCWHLDAAMR 258

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (262), Expect = 9e-27
 Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 29/239 (12%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
           E   R   +E++I +S Q   +V    VCY +   N  + +I+EY+  GSL D+L+K K 
Sbjct: 83  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKE 140

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            I    L     Q+ KG+ YL   K  IHRDL   N+L+ +   VKI DFG++ ++    
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199

Query: 124 GQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 179
                         + +PE ++  K+   SD+WS G+VL E  T  +   SPP +     
Sbjct: 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259

Query: 180 --------SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                     + L+E + +      P   P      E    ++ C      QR S ++L
Sbjct: 260 GNDKQGQMIVFHLIELLKNNGRLPRPDGCP-----DEIYMIMTECWNNNVNQRPSFRDL 313

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (263), Expect = 1e-26
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 35/271 (12%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
            ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G L D
Sbjct: 51  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLD 105

Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           ++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

Query: 117 AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 173
            ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY    
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---- 220

Query: 174 QQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
             DG  +  E+   +        PP         +    +  C   +   R   +EL+  
Sbjct: 221 --DGIPA-SEISSILEKGERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIE 272

Query: 230 PFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 260
            F KM      D   Y    G     L + +
Sbjct: 273 -FSKMA----RDPQRYLVIQGDERMHLPSPT 298

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  103 bits (259), Expect = 1e-26
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 32/223 (14%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLA 71
           +E ++      P +V    VC +       I ++ E+M+ G L+D+L+  +     E L 
Sbjct: 52  EEAEVMMKLSHPKLVQLYGVCLEQ----APICLVTEFMEHGCLSDYLRTQRGLFAAETLL 107

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
            +C  V +G+ YL  E  +IHRDL   N L+     +K++DFG++  +      ++T  G
Sbjct: 108 GMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--G 164

Query: 132 T---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA 187
           T     + SPE  S  +Y  KSD+WS G+++ E  + G+ PY      +  ++  E++E 
Sbjct: 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY------ENRSN-SEVVED 217

Query: 188 IVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           I        P  A            ++ C ++ P+ R +   L
Sbjct: 218 ISTGFRLYKPRLAS-----THVYQIMNHCWRERPEDRPAFSRL 255

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  107 bits (268), Expect = 1e-26
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYL 70
           QE ++ +  +   +V    V  +       I I+ EYM  GSL DFLK    K +    L
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 365

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQAN 127
             +  Q+  G+ Y+    + +HRDL+ +N+L+      K+ DFG++ ++     T+ Q  
Sbjct: 366 VDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME 186
            F     + +PE    G++  KSD+WS G++L E  T G+ PY       G  +  E+++
Sbjct: 425 KF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP------GMVN-REVLD 475

Query: 187 AIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            +        PP  P           +  C +KEP++R
Sbjct: 476 QVERGYRMPCPPECP-----ESLHDLMCQCWRKEPEER 508

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  107 bits (268), Expect = 1e-26
 Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 31/232 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           V++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG L  
Sbjct: 370 VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHK 424

Query: 58  FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           FL   +  IP   +A +  QV  G+ YL  EK+ +HR+L   N+L+ +R   KI+DFG+S
Sbjct: 425 FLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRHYAKISDFGLS 483

Query: 117 AIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPP 172
             + +                + +PE I+  K+  +SD+WS G+ + E  + GQ PY   
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--- 540

Query: 173 EQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
                     E+M  I      + PP  P     PE  + +S C   + + R
Sbjct: 541 ---KKMKG-PEVMAFIEQGKRMECPPECP-----PELYALMSDCWIYKWEDR 583

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  104 bits (261), Expect = 1e-26
 Identities = 49/246 (19%), Positives = 87/246 (35%), Gaps = 51/246 (20%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQS-FYSNGAISIILEYMDGGSLADFLKKVK 63
           +    +   E    +    P V+    VC +          +IL +M  G L  +L   +
Sbjct: 77  QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136

Query: 64  TIPEEY------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
                       L      +  G+ YL   ++ +HRDL   N ++     V + DFG+S 
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYLS-NRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

Query: 118 IMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT- 164
            + S           Y Y            ++ E ++   Y  KSD+W+ G+ + E AT 
Sbjct: 196 KIYSGD---------Y-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

Query: 165 GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
           G  PY       G  +  E+ + ++     + P          E    + +C + +P  R
Sbjct: 246 GMTPYP------GVQNH-EMYDYLLHGHRLKQPEDCL-----DELYEIMYSCWRTDPLDR 293

Query: 221 LSAQEL 226
            +   L
Sbjct: 294 PTFSVL 299

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  103 bits (259), Expect = 2e-26
 Identities = 59/264 (22%), Positives = 101/264 (38%), Gaps = 62/264 (23%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
              R +   E  +    Q P VV    V  +       +S+I  Y   G L +FL     
Sbjct: 53  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKD----QPLSMIFSYCSHGDLHEFLVMRSP 108

Query: 65  IPEEY----------------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 108
             +                     +  Q+  G+ YL    H++H+DL   N+L+  +  V
Sbjct: 109 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVYDKLNV 167

Query: 109 KITDFGVSAIMASTSGQANTFVGTYN----------YMSPERISGGKYGYKSDIWSLGLV 158
           KI+D G+   + +           Y           +M+PE I  GK+   SDIWS G+V
Sbjct: 168 KISDLGLFREVYAAD--------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219

Query: 159 LLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACV 213
           L E  + G  PY       G+++  +++E I +      P   P         + +  C 
Sbjct: 220 LWEVFSYGLQPYC------GYSN-QDVVEMIRNRQVLPCPDDCP-----AWVYALMIECW 267

Query: 214 QKEPQQRLSAQELMTHPFLKMYGD 237
            + P +R   +++  H  L+ +G+
Sbjct: 268 NEFPSRRPRFKDI--HSRLRAWGN 289

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  104 bits (261), Expect = 2e-26
 Identities = 53/251 (21%), Positives = 89/251 (35%), Gaps = 54/251 (21%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQS--FYSNGAISIILEYMDGGSLADFLKKV 62
            S   +  +E    +    P+V     V  +S          +IL +M  G L  FL   
Sbjct: 66  SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125

Query: 63  KTIPEEY------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 116
           +     +      L      +  G+ YL   ++ IHRDL   N ++     V + DFG+S
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLS-SRNFIHRDLAARNCMLAEDMTVCVADFGLS 184

Query: 117 AIMASTSGQANTFVGTYNY-------------MSPERISGGKYGYKSDIWSLGLVLLECA 163
             + S            +Y             ++ E ++   Y   SD+W+ G+ + E  
Sbjct: 185 RKIYSG-----------DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

Query: 164 T-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQ 218
           T GQ PY+      G  +  E+   ++     + PP         E    +  C   +P+
Sbjct: 234 TRGQTPYA------GIENA-EIYNYLIGGNRLKQPPECM-----EEVYDLMYQCWSADPK 281

Query: 219 QRLSAQELMTH 229
           QR S   L   
Sbjct: 282 QRPSFTCLRME 292

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  104 bits (262), Expect = 2e-26
 Identities = 54/259 (20%), Positives = 94/259 (36%), Gaps = 51/259 (19%)

Query: 18  ELKINQSSQCPYVV----VCY----QSFYSNGAISIILEYMDGGSLADFLKKV-----KT 64
           E+KI Q  +   VV    +C           G+I ++ ++ +     D L  +       
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HD-LAGLLSNVLVK 120

Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTS 123
                +  + + +L GL Y+H    I+HRD+K +N+LI   G +K+ DFG++ A   + +
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 124 GQANTF---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPY-------- 169
            Q N +   V T  Y  PE + G + YG   D+W  G ++ E  T               
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239

Query: 170 -------SPPEQQDGWTSFYELMEAIVDQPPPSAPSD--------QFSPEFCSFISACVQ 214
                  S   +   W +          +                   P     I   + 
Sbjct: 240 LISQLCGSITPEV--WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 297

Query: 215 KEPQQRLSAQELMTHPFLK 233
            +P QR+ + + + H F  
Sbjct: 298 LDPAQRIDSDDALNHDFFW 316

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  103 bits (258), Expect = 2e-26
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 32/223 (14%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLA 71
           +E K+  +     +V    VC +       I II EYM  G L ++L++++     + L 
Sbjct: 68  EEAKVMMNLSHEKLVQLYGVCTKQ----RPIFIITEYMANGCLLNYLREMRHRFQTQQLL 123

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
            +C+ V + + YL   K  +HRDL   N L+N +G VK++DFG+S  +      ++   G
Sbjct: 124 EMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--G 180

Query: 132 T---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA 187
           +     +  PE +   K+  KSDIW+ G+++ E  + G+ PY      + +T+  E  E 
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------ERFTN-SETAEH 233

Query: 188 IVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           I        P  A       +  + + +C  ++  +R + + L
Sbjct: 234 IAQGLRLYRPHLAS-----EKVYTIMYSCWHEKADERPTFKIL 271

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  105 bits (264), Expect = 2e-26
 Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 30/224 (13%)

Query: 8   EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV- 62
            ++  +    E  +    +   +V    V  +     G + I+ EYM  GSL D+L+   
Sbjct: 226 NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIVTEYMAKGSLVDYLRSRG 282

Query: 63  -KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +  + L      V + + YL    + +HRDL   N+L++     K++DFG++   +S
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 180
           T       V    + +PE +   K+  KSD+WS G++L E  + G+ PY           
Sbjct: 342 TQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY------PRIPL 392

Query: 181 FYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
             +++  +        P   P     P     +  C   +   R
Sbjct: 393 -KDVVPRVEKGYKMDAPDGCP-----PAVYDVMKNCWHLDAATR 430

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  103 bits (258), Expect = 2e-26
 Identities = 47/240 (19%), Positives = 89/240 (37%), Gaps = 51/240 (21%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
              + +   E  I ++   P++V    +            II+E    G L  +L++ K 
Sbjct: 54  LDNKEKFMSEAVIMKNLDHPHIVKLIGII-----EEEPTWIIMELYPYGELGHYLERNKN 108

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
           ++    L     Q+ K + YL    + +HRD+   N+L+     VK+ DFG+S  +    
Sbjct: 109 SLKVLTLVLYSLQICKAMAYLE-SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE- 166

Query: 124 GQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
                     +Y            MSPE I+  ++   SD+W   + + E  + G+ P+ 
Sbjct: 167 ----------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF- 215

Query: 171 PPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                    +  +++  +        P   P     P   + ++ C   +P  R    EL
Sbjct: 216 -----FWLEN-KDVIGVLEKGDRLPKPDLCP-----PVLYTLMTRCWDYDPSDRPRFTEL 264

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  103 bits (259), Expect = 4e-26
 Identities = 50/231 (21%), Positives = 94/231 (40%), Gaps = 38/231 (16%)

Query: 39  SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 98
            +   +++ E+++     DF +  +T+ +  +     ++LK L Y H    I+HRD+KP 
Sbjct: 104 VSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPH 159

Query: 99  NLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLG 156
           N++I+H   ++++ D+G+ A       + N  V +  +  PE +   + Y Y  D+WSLG
Sbjct: 160 NVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218

Query: 157 LVLLECATGQFPYSP-----------------PEQQDGWTSFYELMEA--IVDQPP---- 193
            +L      + P+                    +  D +   Y +       D       
Sbjct: 219 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD-YIDKYNIELDPRFNDILGRHSR 277

Query: 194 -------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                   S      SPE   F+   ++ + Q RL+A+E M HP+      
Sbjct: 278 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  103 bits (259), Expect = 4e-26
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 57/226 (25%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--------------LAAICEQV 77
            C       G + +I EY   G L +FL++   + E                L     QV
Sbjct: 118 ACTH----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 78  LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY-- 135
            +G+ +L   K+ IHRD+   N+L+ +    KI DFG++  + + S          NY  
Sbjct: 174 AQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS----------NYIV 222

Query: 136 ----------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL 184
                     M+PE I    Y  +SD+WS G++L E  + G  PY       G     + 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP------GILVNSKF 276

Query: 185 MEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            + + D      P  AP         S + AC   EP  R + Q++
Sbjct: 277 YKLVKDGYQMAQPAFAP-----KNIYSIMQACWALEPTHRPTFQQI 317

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  101 bits (255), Expect = 4e-26
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 32/225 (14%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLA 71
           QE +       P +V    VC +       I I+ EY+  G L ++L+     +    L 
Sbjct: 52  QEAQTMMKLSHPKLVKFYGVCSKE----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL 107

Query: 72  AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 131
            +C  V +G+ +L      IHRDL   N L++    VK++DFG++  +      ++   G
Sbjct: 108 EMCYDVCEGMAFLE-SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--G 164

Query: 132 T---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA 187
           T     + +PE     KY  KSD+W+ G+++ E  + G+ PY      D +T+  E++  
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY------DLYTN-SEVVLK 217

Query: 188 IVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 228
           +        P  A            + +C  + P++R + Q+L++
Sbjct: 218 VSQGHRLYRPHLAS-----DTIYQIMYSCWHELPEKRPTFQQLLS 257

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  103 bits (258), Expect = 5e-26
 Identities = 71/254 (27%), Positives = 108/254 (42%), Gaps = 63/254 (24%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK--- 61
           ESAR+   +E ++    Q  ++V    VC +       + ++ EYM  G L  FL+    
Sbjct: 84  ESARQDFQREAELLTMLQHQHIVRFFGVCTEG----RPLLMVFEYMRHGDLNRFLRSHGP 139

Query: 62  ------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 109
                          +    L A+  QV  G++YL    H +HRDL   N L+     VK
Sbjct: 140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVK 198

Query: 110 ITDFGVSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGL 157
           I DFG+S  + ST          Y Y            M PE I   K+  +SD+WS G+
Sbjct: 199 IGDFGMSRDIYSTD---------Y-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248

Query: 158 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISAC 212
           VL E  T G+ P+         ++  E ++ I      + P + P     PE  + +  C
Sbjct: 249 VLWEIFTYGKQPWY------QLSN-TEAIDCITQGRELERPRACP-----PEVYAIMRGC 296

Query: 213 VQKEPQQRLSAQEL 226
            Q+EPQQR S +++
Sbjct: 297 WQREPQQRHSIKDV 310

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  104 bits (261), Expect = 6e-26
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 34/230 (14%)

Query: 5   MNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLK 60
           M     +      E  + ++ Q   +V    V  +       I II E+M  GSL DFLK
Sbjct: 220 MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-----PIYIITEFMAKGSLLDFLK 274

Query: 61  KVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 118
             +    P   L     Q+ +G+ ++  +++ IHRDL+ +N+L++     KI DFG++ +
Sbjct: 275 SDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASLVCKIADFGLARV 333

Query: 119 MASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
           +      A    G      + +PE I+ G +  KSD+WS G++L+E  T G+ PY     
Sbjct: 334 IEDNEYTARE--GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP---- 387

Query: 175 QDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
             G ++  E++ A+        P + P      E  + +  C +  P++R
Sbjct: 388 --GMSN-PEVIRALERGYRMPRPENCP-----EELYNIMMRCWKNRPEER 429

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (254), Expect = 7e-26
 Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 51/240 (21%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
           +S R +  QE    +    P++V    V  ++      + II+E    G L  FL+  K 
Sbjct: 57  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKY 111

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
           ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M  + 
Sbjct: 112 SLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 169

Query: 124 GQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
                      Y            M+PE I+  ++   SD+W  G+ + E    G  P+ 
Sbjct: 170 ----------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF- 218

Query: 171 PPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                 G  +  +++  I +      PP+ P     P   S ++ C   +P +R    EL
Sbjct: 219 -----QGVKN-NDVIGRIENGERLPMPPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 267

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (255), Expect = 7e-26
 Identities = 67/255 (26%), Positives = 106/255 (41%), Gaps = 64/255 (25%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK--- 61
            +AR+   +E ++  + Q  ++V    VC         + ++ EYM  G L  FL+    
Sbjct: 58  LAARKDFQREAELLTNLQHEHIVKFYGVCGDG----DPLIMVFEYMKHGDLNKFLRAHGP 113

Query: 62  -------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 108
                           +    +  I  Q+  G++YL   +H +HRDL   N L+     V
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLV 172

Query: 109 KITDFGVSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLG 156
           KI DFG+S  + ST          Y Y            M PE I   K+  +SD+WS G
Sbjct: 173 KIGDFGMSRDVYSTD---------Y-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 222

Query: 157 LVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISA 211
           ++L E  T G+ P+         ++  E++E I      + P   P      E    +  
Sbjct: 223 VILWEIFTYGKQPWF------QLSN-TEVIECITQGRVLERPRVCP-----KEVYDVMLG 270

Query: 212 CVQKEPQQRLSAQEL 226
           C Q+EPQQRL+ +E+
Sbjct: 271 CWQREPQQRLNIKEI 285

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  102 bits (257), Expect = 1e-25
 Identities = 55/289 (19%), Positives = 99/289 (34%), Gaps = 70/289 (24%)

Query: 12  RRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT- 64
             Q   E+++      + +    Y+V   + F     + ++ E +   +L D L+     
Sbjct: 94  LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR 152

Query: 65  -IPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINH--RGEVKITDFGVSAIMA 120
            +         +Q+   LL+L   +  IIH DLKP N+L+ +  R  +KI DFG S+   
Sbjct: 153 GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL 211

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FP---------- 168
               +   ++ +  Y SPE + G  Y    D+WSLG +L+E  TG+  F           
Sbjct: 212 G--QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269

Query: 169 ------------------------------YSPPEQQDG-----WTSFYELMEAIVDQPP 193
                                         ++  + +DG          +L   +  +  
Sbjct: 270 IVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 329

Query: 194 PSAPSDQFSPE--------FCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                              F   I   +  +P+ R+     + H F K 
Sbjct: 330 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (252), Expect = 2e-25
 Identities = 49/240 (20%), Positives = 87/240 (36%), Gaps = 46/240 (19%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
                   +E  + +    P V+    +        G   ++L YM  G L  F++  + 
Sbjct: 63  MQQVEAFLREGLLMRGLNHPNVLALIGIMLPP---EGLPHVLLPYMCHGDLLQFIRSPQR 119

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
               + L +   QV +G+ YL  E+  +HRDL   N +++    VK+ DFG++  +    
Sbjct: 120 NPTVKDLISFGLQVARGMEYLA-EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178

Query: 124 GQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 170
                    Y+              + E +   ++  KSD+WS G++L E  T G  PY 
Sbjct: 179 --------YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230

Query: 171 PPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                     F +L   +        P   P           +  C + +P  R + + L
Sbjct: 231 ------HIDPF-DLTHFLAQGRRLPQPEYCP-----DSLYQVMQQCWEADPAVRPTFRVL 278

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  101 bits (253), Expect = 2e-25
 Identities = 48/224 (21%), Positives = 93/224 (41%), Gaps = 30/224 (13%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
             + + +   +    S    ++V    +C  S     ++ ++ +Y+  GSL D +++ + 
Sbjct: 56  RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-----SLQLVTQYLPLGSLLDHVRQHRG 110

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            +  + L     Q+ KG+ YL  E  ++HR+L   N+L+    +V++ DFGV+ ++    
Sbjct: 111 ALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

Query: 124 GQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 180
            Q           +M+ E I  GKY ++SD+WS G+ + E  T G  PY       G   
Sbjct: 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY------AGLRL 223

Query: 181 FYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
             E+ + +        P          +    +  C   +   R
Sbjct: 224 -AEVPDLLEKGERLAQPQICT-----IDVYMVMVKCWMIDENIR 261

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  100 bits (251), Expect = 2e-25
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYL 70
           +E  + +  + P +V    VC +         II E+M  G+L D+L++   + +    L
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTRE----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV 130
             +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S +M   +  A+   
Sbjct: 114 LYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-- 170

Query: 131 GT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME 186
           G      + +PE ++  K+  KSD+W+ G++L E AT G  PY       G     ++ E
Sbjct: 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDL-SQVYE 223

Query: 187 AIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            +      + P   P      +    + AC Q  P  R
Sbjct: 224 LLEKDYRMERPEGCP-----EKVYELMRACWQWNPSDR 256

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =   99 bits (250), Expect = 3e-25
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)

Query: 17  QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYL 70
            E  + +  Q   +V    V      +   I II EYM+ GSL DFLK      +    L
Sbjct: 57  AEANLMKQLQHQRLVRLYAVV-----TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL 111

Query: 71  AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV 130
             +  Q+ +G+ ++  E++ IHRDL+ +N+L++     KI DFG++ ++      A    
Sbjct: 112 LDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-- 168

Query: 131 GT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME 186
           G      + +PE I+ G +  KSD+WS G++L E  T G+ PY       G T+  E+++
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY------PGMTN-PEVIQ 221

Query: 187 AIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
            +        P + P      E    +  C ++ P+ R
Sbjct: 222 NLERGYRMVRPDNCP-----EELYQLMRLCWKERPEDR 254

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  103 bits (258), Expect = 3e-25
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 35/232 (15%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
           +S R +  QE    +    P++V    V  ++      + II+E    G L  FL+  K 
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKF 486

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-- 121
           ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M    
Sbjct: 487 SLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

Query: 122 --TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
              + +    +    +M+PE I+  ++   SD+W  G+ + E    G  P+       G 
Sbjct: 546 YYKASKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF------QGV 596

Query: 179 TSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            +  +++  I +      PP+ P     P   S ++ C   +P +R    EL
Sbjct: 597 KN-NDVIGRIENGERLPMPPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 642

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  100 bits (251), Expect = 6e-25
 Identities = 58/292 (19%), Positives = 100/292 (34%), Gaps = 81/292 (27%)

Query: 12  RRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VK 63
                 E+++         +     V   + F  +G I I+ E + G S  DF+K+    
Sbjct: 55  CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFL 113

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH------------------- 104
               +++  +  Q+ K + +LH    + H DLKP N+L                      
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLH-SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172

Query: 105 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 164
             ++K+ DFG SA         +T V T +Y +PE I    +    D+WS+G +L+E   
Sbjct: 173 NPDIKVVDFG-SATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

Query: 165 GQ--FP-YSPPEQQDGWTSFYELMEAIVDQPPPS-------------------------- 195
           G   FP +   E          +ME I+   P                            
Sbjct: 230 GFTVFPTHDSKEH-------LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282

Query: 196 -------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 234
                           D         I   ++ +P +R++ +E + HPF  +
Sbjct: 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 58/228 (25%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKK----------------VKTIPEEYLAAICE 75
            C +     G + +I+E+   G+L+ +L+                    +  E+L     
Sbjct: 99  ACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           QV KG+ +L   +  IHRDL   N+L++ +  VKI DFG++  +              +Y
Sbjct: 156 QVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----------DY 204

Query: 136 ------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 182
                       M+PE I    Y  +SD+WS G++L E  + G  PY       G     
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDE 258

Query: 183 ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           E    + +    + P         PE    +  C   EP QR +  EL
Sbjct: 259 EFCRRLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQRPTFSEL 301

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 41/231 (17%)

Query: 45  IILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           II E M      D  + + T    ++++     Q L+ +  LH   ++IHRDLKPSNLLI
Sbjct: 91  IIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLI 145

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM----------SPERI-SGGKYGYKSD 151
           N   ++K+ DFG++ I+  ++   +   G  + M          +PE + +  KY    D
Sbjct: 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD 205

Query: 152 IWSLGLVLLECATGQ--FP---Y------------SPPEQQDGWTSFYELMEAIVDQPPP 194
           +WS G +L E    +  FP   Y            +P    D            +   P 
Sbjct: 206 VWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPM 265

Query: 195 SAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
              +       + +P+    +   +  +P +R++A+E + HP+L+ Y D N
Sbjct: 266 YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 98.6 bits (246), Expect = 4e-24
 Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 60/228 (26%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICE 75
            C Q    +G + +I+EY   G+L ++L+  +    EY                L +   
Sbjct: 155 ACTQ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           Q+ +G+ YL   +  IHRDL   N+L+     +KI DFG++  + +             Y
Sbjct: 211 QLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----------YY 259

Query: 136 ------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 182
                       M+PE +    Y ++SD+WS G+++ E  T G  PY       G     
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP------GIPV-E 312

Query: 183 ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           EL + + +      P +        E    +  C    P QR + ++L
Sbjct: 313 ELFKLLKEGHRMDKPANCT-----NELYMMMRDCWHAVPSQRPTFKQL 355

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 98.2 bits (245), Expect = 4e-24
 Identities = 51/256 (19%), Positives = 84/256 (32%), Gaps = 61/256 (23%)

Query: 34  YQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHII 91
              F  +G + I  E + G +  +FLK+   +  P  ++  +  Q+   L +LH  + + 
Sbjct: 88  SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ-LT 145

Query: 92  HRDLKPSNLLINH-------------------RGEVKITDFGVSAIMASTSGQANTFVGT 132
           H DLKP N+L  +                      +++ DFG SA          T V T
Sbjct: 146 HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFDHE--HHTTIVAT 202

Query: 133 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYS---------------PPEQ- 174
            +Y  PE I    +    D+WS+G +L E   G   F                   P   
Sbjct: 203 RHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM 262

Query: 175 ----------QDGWTSFYELMEAIVDQPPPSAPSDQ-------FSPEFCSFISACVQKEP 217
                       G   + E             P             +    +   ++ +P
Sbjct: 263 IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322

Query: 218 QQRLSAQELMTHPFLK 233
            QR++  E + HPF  
Sbjct: 323 AQRITLAEALLHPFFA 338

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.2 bits (245), Expect = 4e-24
 Identities = 61/263 (23%), Positives = 90/263 (34%), Gaps = 72/263 (27%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK--- 61
              +    +E  +      P +V    VC         + ++ EYM  G L +FL+    
Sbjct: 91  ADMQADFQREAALMAEFDNPNIVKLLGVCAVG----KPMCLLFEYMAYGDLNEFLRSMSP 146

Query: 62  ---------------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
                                   +       I  QV  G+ YL  E+  +HRDL   N 
Sbjct: 147 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNC 205

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGY 148
           L+     VKI DFG+S  + S           Y Y            M PE I   +Y  
Sbjct: 206 LVGENMVVKIADFGLSRNIYSAD---------Y-YKADGNDAIPIRWMPPESIFYNRYTT 255

Query: 149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSP 203
           +SD+W+ G+VL E  + G  PY       G     E++  + D      P + P      
Sbjct: 256 ESDVWAYGVVLWEIFSYGLQPYY------GMAH-EEVIYYVRDGNILACPENCP-----L 303

Query: 204 EFCSFISACVQKEPQQRLSAQEL 226
           E  + +  C  K P  R S   +
Sbjct: 304 ELYNLMRLCWSKLPADRPSFCSI 326

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 98.1 bits (245), Expect = 5e-24
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 36/219 (16%)

Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           +++ +M      D L+K+      EE +  +  Q+LKGL Y+H    ++HRDLKP NL +
Sbjct: 106 LVMPFMQ----TD-LQKIMGLKFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAV 159

Query: 103 NHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLL 160
           N   E+KI DFG    +A  +    T +V T  Y +PE I S   Y    DIWS+G ++ 
Sbjct: 160 NEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215

Query: 161 ECATGQ--FPYS--------------PPEQQDGWTSFYELMEAIVDQPPPSAPSD----- 199
           E  TG+  F                  P  +       +  ++ +   P +   D     
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275

Query: 200 -QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
            + SP+    +   ++ +  +RL+A + +THPF + + D
Sbjct: 276 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 98.2 bits (245), Expect = 5e-24
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 45  IILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           +++ +M      D  K +K     E+ +  +  Q+LKGL Y+H    IIHRDLKP NL +
Sbjct: 107 LVMPFMG----TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAV 161

Query: 103 NHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLL 160
           N   E+KI DFG    +A  +    T +V T  Y +PE I +  +Y    DIWS+G ++ 
Sbjct: 162 NEDCELKILDFG----LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217

Query: 161 ECATGQ--FPYS--------------PPEQQDGWTSFYELMEAIVDQPPPSAPSD----- 199
           E  TG+  F  S               P  +       +  +  +   P     D     
Sbjct: 218 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 277

Query: 200 -QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
              SP   + +   +  + +QR++A E + HP+ +   D
Sbjct: 278 TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 98.6 bits (246), Expect = 5e-24
 Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 73/286 (25%)

Query: 12  RRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT- 64
            RQ A+E++I              V+   ++F     I +  E +   +L + +KK K  
Sbjct: 137 HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQ 195

Query: 65  -IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMAS 121
                 +      +L+ L  LH  + IIH DLKP N+L+    R  +K+ DFG       
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFG------- 247

Query: 122 TSGQANTFVGTY----NYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYS----- 170
           +S   +  V TY     Y +PE I G +YG   D+WSLG +L E  TG    P       
Sbjct: 248 SSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307

Query: 171 ----------PP----------------EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 204
                     P                 +    + +   L +  V      +   +    
Sbjct: 308 LACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGP 367

Query: 205 FCS-----------------FISACVQKEPQQRLSAQELMTHPFLK 233
             S                 F+  C++ +P  R++  + + HP+L+
Sbjct: 368 PESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 97.7 bits (244), Expect = 6e-24
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)

Query: 43  ISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 99
           + I+ + M+     D L K+   + +  +++     Q+L+GL Y+H   +++HRDLKPSN
Sbjct: 105 VYIVQDLME----TD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSN 158

Query: 100 LLINHRGEVKITDFGVSAIMASTSGQANT---FVGTYNYMSPERI-SGGKYGYKSDIWSL 155
           LL+N   ++KI DFG++ +             +V T  Y +PE + +   Y    DIWS+
Sbjct: 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218

Query: 156 GLVLLECATGQ--FPYS--------------PPEQQDGWTSFYELMEAIVDQPPPSAPSD 199
           G +L E  + +  FP                 P Q+D            +   P      
Sbjct: 219 GCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVP 278

Query: 200 ------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                     +    +   +   P +R+  ++ + HP+L+ Y D
Sbjct: 279 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 6e-24
 Identities = 55/217 (25%), Positives = 86/217 (39%), Gaps = 57/217 (26%)

Query: 45  IILEYMDGGSLADFLKK------------------VKTIPEEYLAAICEQVLKGLLYLHH 86
           +I EY   G L +FL++                     +  E L +   QV KG+ +L  
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA- 162

Query: 87  EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY----------- 135
            K+ IHRDL   N+L+ H    KI DFG++  + + S          NY           
Sbjct: 163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS----------NYVVKGNARLPVK 212

Query: 136 -MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD--- 190
            M+PE I    Y ++SD+WS G+ L E  + G  PY       G     +  + I +   
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP------GMPVDSKFYKMIKEGFR 266

Query: 191 -QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
              P  AP      E    +  C   +P +R + +++
Sbjct: 267 MLSPEHAP-----AEMYDIMKTCWDADPLKRPTFKQI 298

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 97.5 bits (243), Expect = 8e-24
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 44/229 (19%)

Query: 45  IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           I++E MD    A+ L +V    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 107 IVMELMD----AN-LCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 160

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 161 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219

Query: 163 ATGQ--FPYS--------------PPEQQDGWT------------------SFYELMEAI 188
             G   FP +               P  +                      SF +L    
Sbjct: 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD- 278

Query: 189 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
           V  P  S  +   + +    +S  +  +  +R+S  E + HP++ ++ D
Sbjct: 279 VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 97.4 bits (243), Expect = 9e-24
 Identities = 40/195 (20%), Positives = 73/195 (37%), Gaps = 44/195 (22%)

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
            +L GL  LH E  ++HRDL P N+L+    ++ I DF + A   +       +V    Y
Sbjct: 142 HILLGLHVLH-EAGVVHRDLHPGNILLADNNDITICDFNL-AREDTADANKTHYVTHRWY 199

Query: 136 MSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQDG 177
            +PE +     +    D+WS G V+ E    +  F    +            +P      
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI---- 255

Query: 178 WTSFYELMEAI--------VDQPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLS 222
                E +           +     + P+  +        P     I+  ++  PQ+R+S
Sbjct: 256 -----EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310

Query: 223 AQELMTHPFLKMYGD 237
            ++ + HP+ +   D
Sbjct: 311 TEQALRHPYFESLFD 325

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 97.0 bits (242), Expect = 9e-24
 Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 60/228 (26%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICE 75
            C Q    +G + +I+EY   G+L ++L+  +    EY                L +   
Sbjct: 109 ACTQ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           Q+ +G+ YL   +  IHRDL   N+L+     +KI DFG++  + +             Y
Sbjct: 165 QLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----------YY 213

Query: 136 ------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 182
                       M+PE +    Y ++SD+WS G+++ E  T G  PY       G     
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP------GIPV-E 266

Query: 183 ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           EL + + +      P +        E    +  C    P QR + ++L
Sbjct: 267 ELFKLLKEGHRMDKPANCT-----NELYMMMRDCWHAVPSQRPTFKQL 309

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 97.0 bits (242), Expect = 1e-23
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 33/218 (15%)

Query: 45  IILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           ++   M     AD    VK     ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +
Sbjct: 111 LVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAV 165

Query: 103 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLE 161
           N   E+KI DFG++     T+ +   +V T  Y +PE + +   Y    DIWS+G ++ E
Sbjct: 166 NEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222

Query: 162 CATGQ--FPYS--------------PPEQQDGWTSFYELMEAIVDQPPPSAPSD------ 199
             TG+  FP +               P  +       E     +         +      
Sbjct: 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282

Query: 200 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
             +P     +   +  +  +R++A + + H +   Y D
Sbjct: 283 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 96.8 bits (241), Expect = 2e-23
 Identities = 55/286 (19%), Positives = 105/286 (36%), Gaps = 65/286 (22%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY--------MDGG 53
            +  SA R+I     + +  + P V+    V      ++  + ++ +Y        +   
Sbjct: 60  GISMSACREI----ALLRELKHPNVISLQKVFLSH--ADRKVWLLFDYAEHDLWHIIKFH 113

Query: 54  SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVK 109
             +   KK   +P   + ++  Q+L G+ YLH    ++HRDLKP+N+L+      RG VK
Sbjct: 114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVK 172

Query: 110 ITDFGVS---AIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 165
           I D G +             +  V T+ Y +PE + G + Y    DIW++G +  E  T 
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

Query: 166 Q--FP-------YSPPEQQD------------------GWTS---FYELMEAIVDQPPPS 195
           +  F         S P   D                            LM+        +
Sbjct: 233 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTN 292

Query: 196 APSDQFSPEFCSFISA--------CVQKEPQQRLSAQELMTHPFLK 233
               ++  +      +         +  +P +R+++++ M  P+  
Sbjct: 293 CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 95.9 bits (239), Expect = 4e-23
 Identities = 64/297 (21%), Positives = 98/297 (32%), Gaps = 86/297 (28%)

Query: 12  RRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKT 64
            R    E  I     N       +V  +  F     + +I E + G SL + + +     
Sbjct: 75  TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNG 133

Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-------------------- 104
              E +   C ++LK L YL  +  + H DLKP N+L++                     
Sbjct: 134 FHIEDIKLYCIEILKALNYLR-KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192

Query: 105 -----RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 159
                   +K+ DFG  A   S      + + T  Y +PE I    +   SD+WS G VL
Sbjct: 193 IYRTKSTGIKLIDFG-CATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249

Query: 160 LECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPP----------------------- 194
            E  TG   F      +         +ME+I+   P                        
Sbjct: 250 AELYTGSLLFRTHEHMEH------LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303

Query: 195 ----------------SAPSDQFS--PEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                             P  +      FC F+ + +Q +P  R S  EL+ H FL+
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 96.0 bits (239), Expect = 4e-23
 Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 33/221 (14%)

Query: 45  IILEYMDG---GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           +I+EY+       L  F++  ++IP   ++    Q+ + + ++H    I HRD+KP NLL
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLL 173

Query: 102 IN-HRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGG-KYGYKSDIWSLGLV 158
           +N     +K+ DFG SA       + +  ++ +  Y +PE + G  +Y    D+WS+G V
Sbjct: 174 VNSKDNTLKLCDFG-SA-KKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231

Query: 159 LLECATGQ--FP---Y------------SPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQ 200
             E   G+  F                 +P ++Q       Y   E              
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY--TEVRFPTLKAKDWRKI 289

Query: 201 FS----PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                       +   ++ EP  R++  E M HPF     +
Sbjct: 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 94.6 bits (236), Expect = 6e-23
 Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 53/231 (22%)

Query: 45  IILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           I+ EYM+     D L  V     + EE+      Q+L+GL Y+H   +++HRDLKP+NL 
Sbjct: 99  IVQEYME----TD-LANVLEQGPLLEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANLF 152

Query: 102 INHRG-EVKITDFGVSAIMASTSGQANT---FVGTYNYMSPERI-SGGKYGYKSDIWSLG 156
           IN     +KI DFG++ IM             + T  Y SP  + S   Y    D+W+ G
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212

Query: 157 LVLLECATGQ--FP---Y------------SPPEQQDGWTSFYELMEAI-------VDQP 192
            +  E  TG+  F                    E         E  + +       +   
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE---------EDRQELLSVIPVYIRND 263

Query: 193 PPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                          S E   F+   +   P  RL+A+E ++HP++ +Y  
Sbjct: 264 MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 94.7 bits (236), Expect = 7e-23
 Identities = 59/235 (25%), Positives = 87/235 (37%), Gaps = 66/235 (28%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKK-----------------------VKTIPEE 68
            C      +G I +I EY   G L ++L+                        +  +  E
Sbjct: 117 ACTL----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 69  YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT 128
            L     QV KG+ +L   K  +HRDL   N+L+ H   VKI DFG++  + S S     
Sbjct: 173 DLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS----- 226

Query: 129 FVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 175
                NY            M+PE +  G Y  KSD+WS G++L E  + G  PY      
Sbjct: 227 -----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----- 276

Query: 176 DGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
            G        + I +      P  A       E    + +C   + ++R S   L
Sbjct: 277 -GIPVDANFYKLIQNGFKMDQPFYAT-----EEIYIIMQSCWAFDSRKRPSFPNL 325

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 95.7 bits (238), Expect = 8e-23
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 44/231 (19%)

Query: 43  ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           + +++E MD    A+ L +V    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+
Sbjct: 142 VYLVMELMD----AN-LCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNI 195

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
           ++     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ 
Sbjct: 196 VVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254

Query: 161 ECATGQ--FPYS--------------PPEQQDGWT------------------SFYELME 186
           E    +  FP                 P  +                      +F +L  
Sbjct: 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 314

Query: 187 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
                P  S  +   + +    +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 315 D-SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 93.8 bits (234), Expect = 9e-23
 Identities = 58/263 (22%), Positives = 100/263 (38%), Gaps = 72/263 (27%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
            S  R +  E  + +    P+V+     C Q    +G + +I+EY   GSL  FL++ + 
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQ----DGPLLLIVEYAKYGSLRGFLRESRK 122

Query: 65  IPEEY------------------------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 100
           +   Y                        L +   Q+ +G+ YL  E  ++HRDL   N+
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNI 181

Query: 101 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGY 148
           L+    ++KI+DFG+S  +              +Y            M+ E +    Y  
Sbjct: 182 LVAEGRKMKISDFGLSRDVYEED----------SYVKRSQGRIPVKWMAIESLFDHIYTT 231

Query: 149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSP 203
           +SD+WS G++L E  T G  PY       G      L   +      + P +        
Sbjct: 232 QSDVWSFGVLLWEIVTLGGNPYP------GIPP-ERLFNLLKTGHRMERPDNCS-----E 279

Query: 204 EFCSFISACVQKEPQQRLSAQEL 226
           E    +  C ++EP +R    ++
Sbjct: 280 EMYRLMLQCWKQEPDKRPVFADI 302

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 94.7 bits (236), Expect = 9e-23
 Identities = 57/230 (24%), Positives = 90/230 (39%), Gaps = 64/230 (27%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICE 75
            C Q    +G + +I+EY   G+L ++L+  +    EY                L +   
Sbjct: 143 ACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 198

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 135
           QV +G+ YL   K  IHRDL   N+L+     +KI DFG++  +               Y
Sbjct: 199 QVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----------YY 247

Query: 136 ------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTS 180
                       M+PE +    Y ++SD+WS G++L E  T G  PY   P E       
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------- 300

Query: 181 FYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
             EL + + +      P +        E    +  C    P QR + ++L
Sbjct: 301 --ELFKLLKEGHRMDKPSNCT-----NELYMMMRDCWHAVPSQRPTFKQL 343

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 92.0 bits (229), Expect = 3e-22
 Identities = 45/246 (18%), Positives = 83/246 (33%), Gaps = 56/246 (22%)

Query: 9   ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 63
            +      +   +       ++V    VC           ++ E++  GSL  +LKK K 
Sbjct: 53  RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG----DENILVQEFVKFGSLDTYLKKNKN 108

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--------VKITDFGV 115
            I   +   + +Q+   + +L  E  +IH ++   N+L+    +        +K++D G+
Sbjct: 109 CINILWKLEVAKQLAAAMHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167

Query: 116 SAIMASTSGQANTFVGTYNY------MSPERIS-GGKYGYKSDIWSLGLVLLECAT-GQF 167
           S  +                      + PE I         +D WS G  L E  + G  
Sbjct: 168 SITVLPKDI----------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

Query: 168 PYSPPEQQDGWTSFYELMEAIVD-----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
           P S         S    ++   D      P           E  + I+ C+  EP  R S
Sbjct: 218 PLS------ALDS-QRKLQFYEDRHQLPAPKA--------AELANLINNCMDYEPDHRPS 262

Query: 223 AQELMT 228
            + ++ 
Sbjct: 263 FRAIIR 268

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 92.3 bits (230), Expect = 4e-22
 Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 51/222 (22%)

Query: 32  VCYQSFYSNGAISIILEYMDGGSLADFLKK----------------VKTIPEEYLAAICE 75
            C       G + + +EY   G+L DFL+K                  T+  + L     
Sbjct: 94  ACEH----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 76  QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN- 134
            V +G+ YL  +K  IHRDL   N+L+      KI DFG+S            +V     
Sbjct: 150 DVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMG 201

Query: 135 -----YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 188
                +M+ E ++   Y   SD+WS G++L E  + G  PY       G T   EL E +
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTC-AELYEKL 254

Query: 189 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                 + P +        E    +  C +++P +R S  ++
Sbjct: 255 PQGYRLEKPLNCD-----DEVYDLMRQCWREKPYERPSFAQI 291

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 89.7 bits (223), Expect = 6e-21
 Identities = 54/260 (20%), Positives = 97/260 (37%), Gaps = 69/260 (26%)

Query: 43  ISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 99
           + ++ +YM+     D L  V     +   +   +  Q++K + YLH    ++HRD+KPSN
Sbjct: 86  VYLVFDYME----TD-LHAVIRANILEPVHKQYVVYQLIKVIKYLH-SGGLLHRDMKPSN 139

Query: 100 LLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------------------YMSP 138
           +L+N    VK+ DFG+S    +     N    + N                     Y +P
Sbjct: 140 ILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199

Query: 139 ERI-SGGKYGYKSDIWSLGLVLLECATGQ--FPYS------------------------- 170
           E +    KY    D+WSLG +L E   G+  FP S                         
Sbjct: 200 EILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQ 259

Query: 171 -----------PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 219
                        + +   ++  ++     +      P    + E    +   +Q  P +
Sbjct: 260 SPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319

Query: 220 RLSAQELMTHPFLKMYGDLN 239
           R+SA + + HPF+ ++ + N
Sbjct: 320 RISANDALKHPFVSIFHNPN 339

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 55/268 (20%), Positives = 84/268 (31%), Gaps = 75/268 (27%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           I+LE  D   L    K    + EE++  I   +L G  ++H E  IIHRDLKP+N L+N 
Sbjct: 107 IVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIH-ESGIIHRDLKPANCLLNQ 164

Query: 105 RGEVKITDFGVSAIMASTSGQANTFVGTYN----------------------YMSPERIS 142
              VK+ DFG++  + S            N                      Y +PE I 
Sbjct: 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224

Query: 143 GGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQD-----GWTSFYELMEAIVDQPPPSA 196
             + Y    DIWS G +  E       +            G + F    +    +    +
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284

Query: 197 PSDQF----------SPEFCSFI-SACVQK------------------------------ 215
             DQ           + +    I    V K                              
Sbjct: 285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344

Query: 216 ----EPQQRLSAQELMTHPFLKMYGDLN 239
                P +R++  + + HP+LK      
Sbjct: 345 MLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.4 bits (201), Expect = 8e-18
 Identities = 50/276 (18%), Positives = 82/276 (29%), Gaps = 83/276 (30%)

Query: 45  IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           ++LE  D        +    + E ++  +   +L G+ Y+H    I+HRDLKP+N L+N 
Sbjct: 134 VVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH-SAGILHRDLKPANCLVNQ 191

Query: 105 RGEVKITDFGVSAIMASTSGQANTFVGTYN---------------------------YMS 137
              VK+ DFG++  +       +    +                             Y +
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251

Query: 138 PERI-SGGKYGYKSDIWSLGLVLLECATGQ-------------FP----YSPPEQQDGWT 179
           PE I     Y    D+WS+G +  E                  FP    +     Q    
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGN 311

Query: 180 SFYELMEAIVDQ----------P--------------------PPSAPSD------QFSP 203
            F        DQ          P                    P    +D        S 
Sbjct: 312 DFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371

Query: 204 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
           +    +   +   P +R++  E + HPF K      
Sbjct: 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 27/168 (16%)

Query: 70  LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 129
           L     QV KG+ +L   +  IHRDL   N+L++ +  VKI DFG    +A    +   +
Sbjct: 195 LICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDY 249

Query: 130 VGTYN------YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 182
           V   +      +M+PE I    Y  +SD+WS G++L E  + G  PY       G     
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDE 303

Query: 183 ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
           E    + +    + P         PE    +  C   EP QR +  EL
Sbjct: 304 EFCRRLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQRPTFSEL 346

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.3 bits (175), Expect = 1e-14
 Identities = 36/179 (20%), Positives = 67/179 (37%), Gaps = 20/179 (11%)

Query: 50  MD--GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 107
           M+  G  L     +  T  +  +  +  ++L  L Y+H E   +H D+K +NLL+ ++  
Sbjct: 131 MERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNP 189

Query: 108 VKIT--DFGVSAIMASTS-------GQANTFVGTYNYMSPERIS---GGKYGYKSDIWSL 155
            ++   D+G+S                     GT  + S   +    G     +SD+  L
Sbjct: 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---LDAHKGVALSRRSDVEIL 246

Query: 156 GLVLLECATGQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 212
           G  +L    G+ P+     +     T+   L++ +       APS     E   F+   
Sbjct: 247 GYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCA 305

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.8 bits (167), Expect = 1e-13
 Identities = 35/218 (16%), Positives = 64/218 (29%), Gaps = 28/218 (12%)

Query: 33  CYQSFYSNGAISIILEYMDGG-SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 91
               F+ +  + I+LE+  GG  L     K+ ++      +I  Q+   L          
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFE 184

Query: 92  HRDLKPSNLLINHRGEVKITD-----------FGVSAIMASTSGQANTFVGTYNYMSPER 140
           HRDL   N+L+      K+              G+   +   +       G   +     
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244

Query: 141 ---ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF---YELMEAIVDQPPP 194
              +  G   Y+ DI+ L         G++    P     W  +     L +        
Sbjct: 245 DEDLFTGDGDYQFDIYRLMKKENNNRWGEY---HPYSNVLWLHYLTDKMLKQMTFKTKCN 301

Query: 195 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
           +    Q   +   F    +        SA +L+    L
Sbjct: 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 38/139 (27%), Positives = 58/139 (41%), Gaps = 26/139 (18%)

Query: 50  MD--GGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           +D  G SL D L        VKT+     A   +Q+L  +  +H EK +++RD+KP N L
Sbjct: 85  IDLLGPSLEDLLDLCGRKFSVKTV-----AMAAKQMLARVQSIH-EKSLVYRDIKPDNFL 138

Query: 102 I-----NHRGEVKITDFGVSA--IMASTSG-----QANTFVGTYNYMSPERISGGKYGYK 149
           I      +   + + DFG+        T       +     GT  YMS     G +   +
Sbjct: 139 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR 198

Query: 150 SDIWSLGLVLLECATGQFP 168
            D+ +LG V +    G  P
Sbjct: 199 DDLEALGHVFMYFLRGSLP 217

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.4 bits (157), Expect = 4e-12
 Identities = 26/132 (19%), Positives = 52/132 (39%), Gaps = 14/132 (10%)

Query: 50  MD--GGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI--N 103
           +   G SL   L       + E  +  +  ++L  L +LH E   +H ++   N+ +   
Sbjct: 137 LPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH-ENEYVHGNVTAENIFVDPE 195

Query: 104 HRGEVKITDFGVSAIMASTS-------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 156
            + +V +  +G +     +        G  +   G   ++S +   G     +SD+ SLG
Sbjct: 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255

Query: 157 LVLLECATGQFP 168
             +L+   G  P
Sbjct: 256 YCMLKWLYGFLP 267

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.9 bits (156), Expect = 4e-12
 Identities = 35/139 (25%), Positives = 59/139 (42%), Gaps = 26/139 (18%)

Query: 50  MD--GGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           ++  G SL D          +KT+       I  Q++  + Y+H  K++I+RD+KP N L
Sbjct: 84  LELLGPSLEDLFDLCDRTFSLKTV-----LMIAIQLISRMEYVH-SKNLIYRDVKPENFL 137

Query: 102 I-----NHRGEVKITDFGVSA--IMASTS-----GQANTFVGTYNYMSPERISGGKYGYK 149
           I       +  + I DF ++   I   T       +  +  GT  YMS     G +   +
Sbjct: 138 IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRR 197

Query: 150 SDIWSLGLVLLECATGQFP 168
            D+ +LG + +    G  P
Sbjct: 198 DDLEALGHMFMYFLRGSLP 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 63.2 bits (154), Expect = 8e-12
 Identities = 39/137 (28%), Positives = 58/137 (42%), Gaps = 24/137 (17%)

Query: 50  MD--GGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           M+  G SL D          +KT+       + +Q++  + Y+H  K+ IHRD+KP N L
Sbjct: 84  MELLGPSLEDLFNFCSRKFSLKTV-----LLLADQMISRIEYIH-SKNFIHRDVKPDNFL 137

Query: 102 I---NHRGEVKITDFGVSA--IMASTSG-----QANTFVGTYNYMSPERISGGKYGYKSD 151
           +        V I DFG++     A T       +     GT  Y S     G +   + D
Sbjct: 138 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDD 197

Query: 152 IWSLGLVLLECATGQFP 168
           + SLG VL+    G  P
Sbjct: 198 LESLGYVLMYFNLGSLP 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.9 bits (153), Expect = 1e-11
 Identities = 36/180 (20%), Positives = 72/180 (40%), Gaps = 21/180 (11%)

Query: 50  MD--GGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 106
           MD  G  L    +   K    + +  +  ++L  L Y+H E   +H D+K SNLL+N++ 
Sbjct: 131 MDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH-EHEYVHGDIKASNLLLNYKN 189

Query: 107 EVKIT--DFGVSAIMASTSGQA-------NTFVGTYNYMSPERISGGKYGYKSDIWSLGL 157
             ++   D+G++                     GT  + S +  +G     + D+  LG 
Sbjct: 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249

Query: 158 VLLECATGQFPY-----SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 212
            +++  TG  P+      P   +D    + E + +++D+     P+     E   ++   
Sbjct: 250 CMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK---CFPAANAPGEIAKYMETV 306

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 37/137 (27%), Positives = 59/137 (43%), Gaps = 24/137 (17%)

Query: 50  MD--GGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 101
           MD  G SL D          +KT+       + +Q++  + ++H  K  +HRD+KP N L
Sbjct: 82  MDLLGPSLEDLFNFCSRKLSLKTV-----LMLADQMINRVEFVH-SKSFLHRDIKPDNFL 135

Query: 102 I---NHRGEVKITDFGVSAI-MASTSGQ------ANTFVGTYNYMSPERISGGKYGYKSD 151
           +       +V I DFG++     +++ Q           GT  Y S     G +   + D
Sbjct: 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDD 195

Query: 152 IWSLGLVLLECATGQFP 168
           + SLG VL+    G  P
Sbjct: 196 LESLGYVLMYFLRGSLP 212

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 39.7 bits (92), Expect = 4e-04
 Identities = 14/89 (15%), Positives = 30/89 (33%), Gaps = 7/89 (7%)

Query: 26  QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 85
             P              + +     D       ++  + + E  +  I   V++ +  L+
Sbjct: 133 SVPQPYTYM-----KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLY 187

Query: 86  HEKHIIHRDLKPSNLLINHRGEVKITDFG 114
            E  ++H DL   N++     +V   D G
Sbjct: 188 QEAELVHADLSEYNIMYID--KVYFIDMG 214

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	262
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.54
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.24
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.0
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.91
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.9
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.77
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.54
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.44
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.44
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.2
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.88
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.78
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.56
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.89
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.88
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.69
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.51
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.97
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	93.64
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.41
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	93.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	93.26
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.9
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.72
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	92.35
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	91.69
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.61
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.35
3mes_A	424	Choline kinase; malaria, structural genomics, stru	85.45

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-56  Score=368.34  Aligned_cols=219  Identities=35%  Similarity=0.629  Sum_probs=192.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..++.+.+|+++|++++|||||+++++|.+++.+|+|||||+||+|.+++.+ +++++..+..++.||+.||+|||+ .|
T Consensus       113 ~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~-~~  190 (346)
T 4fih_A          113 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QG  190 (346)
T ss_dssp             SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3456788999999999999999999999999999999999999999999976 679999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      |+||||||+|||++.+|.+||+|||+|.............+||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       191 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF  270 (346)
T 4fih_A          191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY  270 (346)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999999999988766655666789999999999999989999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .+.+..       +....+.....+. .....+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       271 ~~~~~~-------~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          271 FNEPPL-------KAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             TTSCHH-------HHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             CCcCHH-------HHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            874432       3333443333322 223468999999999999999999999999999999987654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-56  Score=357.98  Aligned_cols=218  Identities=31%  Similarity=0.590  Sum_probs=189.1

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      .+...++++.+|++++++++|||||+++++|.+    +..+|+|||||+||+|.+++.+.+.+++..+..++.|++.||+
T Consensus        64 ~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~  143 (290)
T 3fpq_A           64 LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ  143 (290)
T ss_dssp             SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence            356677899999999999999999999999875    3568999999999999999999999999999999999999999


Q ss_pred             HHhhcCC--eeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           83 YLHHEKH--IIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        83 ~lh~~~~--i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      |||+ .|  |+||||||+|||++. ++.+||+|||+|....  .......+||+.|+|||++.+ .++.++|||||||++
T Consensus       144 ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvil  219 (290)
T 3fpq_A          144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM  219 (290)
T ss_dssp             HHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred             HHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHH
Confidence            9998 88  999999999999974 7899999999997532  233445689999999999875 699999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      |+|++|+.||.+...      .......+..+..+...+...++++.+||.+||..||++|||++|+|+||||++
T Consensus       220 yelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          220 LEMATSEYPYSECQN------AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999976433      224455566665555555678899999999999999999999999999999985

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-56  Score=369.40  Aligned_cols=222  Identities=27%  Similarity=0.487  Sum_probs=194.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .++..++++.+|++++++++|||||++++++.+++.+|+|||||+||+|.+++...+  .+++..+..++.||+.||+||
T Consensus        62 ~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~yl  141 (350)
T 4b9d_A           62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV  141 (350)
T ss_dssp             SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            356678899999999999999999999999999999999999999999999997553  578999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      |+ .||+||||||+|||++.+|.+||+|||+|.............+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       142 H~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt  220 (350)
T 4b9d_A          142 HD-RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT  220 (350)
T ss_dssp             HH-TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HH-CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence            99 99999999999999999999999999999876543333345679999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |+.||.+.+.       .+....+..+..+.. ...+++++.+||.+||+.||++|||++|+|+||||++..+
T Consensus       221 G~~PF~~~~~-------~~~~~~i~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~  285 (350)
T 4b9d_A          221 LKHAFEAGSM-------KNLVLKIISGSFPPV-SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE  285 (350)
T ss_dssp             SSCSCCCSSH-------HHHHHHHHHTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred             CCCCCCCcCH-------HHHHHHHHcCCCCCC-CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence            9999987543       344455555554433 3578999999999999999999999999999999976443

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.1e-56  Score=361.91  Aligned_cols=221  Identities=28%  Similarity=0.503  Sum_probs=194.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+++|++++||||++++++|++++.+|+|||||+||+|.+++++.+.+++..+..++.||+.||+|||+ +|
T Consensus        74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~-~~  152 (311)
T 4aw0_A           74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KG  152 (311)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            44578999999999999999999999999999999999999999999999999999999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |+||||||+|||++.++.++|+|||+|.......  ....+.+||+.|+|||++.+..++.++|+||+||++|+|++|+.
T Consensus       153 IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~  232 (311)
T 4aw0_A          153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP  232 (311)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999998764332  23456789999999999999899999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHH------HhcCccccccCCccc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLKMYGDLNV  240 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~------~l~h~~~~~~~~~~~  240 (262)
                      ||.+.+.       .+....+......  .+..+++++++||.+||..||++|||++|      +++||||+......+
T Consensus       233 PF~~~~~-------~~~~~~i~~~~~~--~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          233 PFRAGNE-------GLIFAKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             SSCCSSH-------HHHHHHHHHTCCC--CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             CCCCCCH-------HHHHHHHHcCCCC--CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            9987543       2344444444332  23578999999999999999999999987      589999998775544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-56  Score=362.80  Aligned_cols=216  Identities=30%  Similarity=0.490  Sum_probs=184.7

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      ..++.+|++++++++||||+++++++.+++.+|+|||||+||+|.+++.+.+.+++..+..++.|++.||+|||+ .||+
T Consensus        70 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~Ii  148 (304)
T 3ubd_A           70 RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGII  148 (304)
T ss_dssp             CC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCc
Confidence            446889999999999999999999999999999999999999999999999999999999999999999999999 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      ||||||+|||++.+|.++|+|||+|..............||+.|+|||++.+..++.++||||+||++|+|++|+.||.+
T Consensus       149 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             CSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999998765555555667899999999999999999999999999999999999999987


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCC
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGD  237 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~  237 (262)
                      .+..       +....+......  .+..+|+++.+||.+||+.||++|||     ++|+++||||+....
T Consensus       229 ~~~~-------~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          229 KDRK-------ETMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             SSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             cCHH-------HHHHHHHcCCCC--CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence            5432       344444444432  23578999999999999999999998     589999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9e-55  Score=365.58  Aligned_cols=219  Identities=35%  Similarity=0.626  Sum_probs=193.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..++.+.+|+++|++++|||||+++++|.+++.+|+|||||+||+|.++++. +.+++..+..++.||+.||+|||+ .|
T Consensus       190 ~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~-~~  267 (423)
T 4fie_A          190 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QG  267 (423)
T ss_dssp             SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3456788999999999999999999999999999999999999999999976 679999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      |+||||||+|||++.+|.+||+|||+|.............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||
T Consensus       268 IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF  347 (423)
T 4fie_A          268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY  347 (423)
T ss_dssp             EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999999999987766555666778999999999999999999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .+....       +....+.....+ ......+++++.+||.+||..||++|||++|+|+||||++...
T Consensus       348 ~~~~~~-------~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          348 FNEPPL-------KAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             TTSCHH-------HHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             CCcCHH-------HHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            864432       333344333332 2233578999999999999999999999999999999997654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.1e-55  Score=349.68  Aligned_cols=215  Identities=29%  Similarity=0.509  Sum_probs=178.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +....+++.+|++++++++||||+++++++.+++.+|+||||+ +|+|.+++.+++++++..+..++.|++.||+|||+ 
T Consensus        53 ~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-  130 (275)
T 3hyh_A           53 KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-  130 (275)
T ss_dssp             ---CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            3455678999999999999999999999999999999999999 56999999999999999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++||||||+||+++.++.++|+|||+|...... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+
T Consensus       131 ~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~  209 (275)
T 3hyh_A          131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR  209 (275)
T ss_dssp             TTCCCCCCCTTTEEECTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCC
Confidence            99999999999999999999999999999765433 23345689999999999998775 68999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      .||.+.+.       ....+.+..+...  .+..+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       210 ~PF~~~~~-------~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          210 LPFDDESI-------PVLFKNISNGVYT--LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             CSSCCSSH-------HHHHHHHHHTCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CCCCCCCH-------HHHHHHHHcCCCC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            99986432       2344444444432  23578999999999999999999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-53  Score=349.36  Aligned_cols=217  Identities=28%  Similarity=0.439  Sum_probs=185.4

Q ss_pred             HHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCC
Q 024828           16 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL   95 (262)
Q Consensus        16 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl   95 (262)
                      .+|++++++++|||||++++++.+++.+|+|||||+|++|.+++++.+.+++..+..++.|++.||+|||+ .||+||||
T Consensus        98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDl  176 (336)
T 4g3f_A           98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT-RRILHGDV  176 (336)
T ss_dssp             THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccc
Confidence            47999999999999999999999999999999999999999999999999999999999999999999998 99999999


Q ss_pred             CCCCEEEccCC-cEEEEecccccccccCCC-----CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           96 KPSNLLINHRG-EVKITDFGVSAIMASTSG-----QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        96 ~p~nil~~~~~-~~~l~df~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ||+|||++.+| .+||+|||+|........     .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       177 Kp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf  256 (336)
T 4g3f_A          177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW  256 (336)
T ss_dssp             CGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence            99999999887 699999999986543221     122357999999999999999999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH-------------hcCcccccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL-------------MTHPFLKMY  235 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~-------------l~h~~~~~~  235 (262)
                      .+....+..       ..+..... ....+..+++++.+||.+||+.||.+|||+.|+             ++|||++..
T Consensus       257 ~~~~~~~~~-------~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          257 TQYFRGPLC-------LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             TTTCCSCCH-------HHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             CCCCHHHHH-------HHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            876655432       22222222 122345789999999999999999999999997             679999988


Q ss_pred             CCccc
Q 024828          236 GDLNV  240 (262)
Q Consensus       236 ~~~~~  240 (262)
                      .+.+-
T Consensus       330 ~~Pr~  334 (336)
T 4g3f_A          330 KEPRG  334 (336)
T ss_dssp             CCCCC
T ss_pred             CCCCC
Confidence            76654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.7e-52  Score=337.42  Aligned_cols=218  Identities=29%  Similarity=0.483  Sum_probs=188.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-------------CCCCHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-------------KTIPEEYLAAIC   74 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------------~~~~~~~~~~i~   74 (262)
                      ++..++++.+|++++++++|||||++++++.+++..|+|||||++|+|.+++.+.             ..+++..+..++
T Consensus        55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~  134 (299)
T 4asz_A           55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA  134 (299)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence            5667889999999999999999999999999999999999999999999999764             358999999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhH
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDI  152 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di  152 (262)
                      .|++.||+|||+ .+++||||||+|||++.++.+||+|||+|+.......  ......||+.|+|||++.+..++.++||
T Consensus       135 ~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DV  213 (299)
T 4asz_A          135 QQIAAGMVYLAS-QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV  213 (299)
T ss_dssp             HHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHHh-CCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhH
Confidence            999999999999 9999999999999999999999999999975533221  2223468999999999999999999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          153 WSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       153 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      |||||++|||+| |+.||.+...       .+....+..+..++.+ ..+|+++.+|+.+||+.||++|||++++  ++|
T Consensus       214 wS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~~i~~~~~~~~p-~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~  283 (299)
T 4asz_A          214 WSLGVVLWEIFTYGKQPWYQLSN-------NEVIECITQGRVLQRP-RTCPQEVYELMLGCWQREPHMRKNIKGI--HTL  283 (299)
T ss_dssp             HHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHHTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHH
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCCCCCC-ccchHHHHHHHHHHcCCChhHCcCHHHH--HHH
Confidence            999999999998 8999987543       2445555556554443 5789999999999999999999999999  567


Q ss_pred             ccccC
Q 024828          232 LKMYG  236 (262)
Q Consensus       232 ~~~~~  236 (262)
                      ++...
T Consensus       284 L~~~~  288 (299)
T 4asz_A          284 LQNLA  288 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-51  Score=331.78  Aligned_cols=216  Identities=24%  Similarity=0.416  Sum_probs=176.0

Q ss_pred             chhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 024828            6 NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         6 ~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ..+.+..+++.+|++++++++|||||++++++.+ +.+++|||||+||+|.+++... +++++..+..++.|++.||+||
T Consensus        70 ~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yL  148 (307)
T 3omv_A           70 DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL  148 (307)
T ss_dssp             SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            3467778899999999999999999999998754 5689999999999999999765 5799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC--CCCcccccccccccCcccccC---CCCCcchhHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVL  159 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l  159 (262)
                      |+ .||+||||||+|||++.++.+||+|||+|......  ........||+.|+|||++.+   ..++.++|||||||++
T Consensus       149 H~-~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl  227 (307)
T 3omv_A          149 HA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL  227 (307)
T ss_dssp             HH-TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred             HH-CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence            99 99999999999999999999999999999765432  223345689999999999864   3589999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC---CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |||+||+.||.+.+...      .....+..+...   ......+++++.+|+.+||+.||++|||+.|++++
T Consensus       228 ~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          228 YELMTGELPYSHINNRD------QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHSSCTTTTCCCHH------HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHCCCCCCCCChHH------HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999998654321      222333333222   22345789999999999999999999999987543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.6e-51  Score=335.25  Aligned_cols=213  Identities=31%  Similarity=0.475  Sum_probs=179.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc---------------CCCCHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---------------KTIPEEYLAA   72 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~   72 (262)
                      ++..+++|.+|+++|++++|||||++++++.+++..|+|||||++|+|.+++.+.               +++++..+..
T Consensus        83 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  162 (329)
T 4aoj_A           83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA  162 (329)
T ss_dssp             SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHH
Confidence            5677889999999999999999999999999999999999999999999999764               3589999999


Q ss_pred             HHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcch
Q 024828           73 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        73 i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       163 i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~s  241 (329)
T 4aoj_A          163 VASQVAAGMVYLAG-LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES  241 (329)
T ss_dssp             HHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHH
T ss_pred             HHHHHHHHHHHHhc-CCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccc
Confidence            99999999999998 999999999999999999999999999997653322  222345789999999999999999999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |||||||++|||+| |+.||.....       .+....+..+..++.+ ..+++++.+|+.+||+.||++|||++|++++
T Consensus       242 DvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~~i~~g~~~~~p-~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          242 DVWSFGVVLWEIFTYGKQPWYQLSN-------TEAIDCITQGRELERP-RACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTCSSCH-------HHHHHHHHHTCCCCCC-TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCCCCCc-ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            99999999999999 8999987543       2344555555554443 5789999999999999999999999999764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.7e-51  Score=330.86  Aligned_cols=220  Identities=26%  Similarity=0.393  Sum_probs=173.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC------------eEEEEEeecCCCCHHHHHHhcCC---CCHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------------AISIILEYMDGGSLADFLKKVKT---IPEEYLA   71 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~   71 (262)
                      ..+..++++.+|++++++++|||||+++++|.+.+            .+|+|||||+|++|.++++..+.   .+...+.
T Consensus        42 ~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~  121 (299)
T 4g31_A           42 NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL  121 (299)
T ss_dssp             SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHH
Confidence            35667788999999999999999999999987643            37999999999999999987654   4556788


Q ss_pred             HHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC------------CcccccccccccCcc
Q 024828           72 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG------------QANTFVGTYNYMSPE  139 (262)
Q Consensus        72 ~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~y~~PE  139 (262)
                      .++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+|........            .....+||+.|+|||
T Consensus       122 ~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE  200 (299)
T 4g31_A          122 HIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE  200 (299)
T ss_dssp             HHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred             HHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence            999999999999999 9999999999999999999999999999976543221            122357999999999


Q ss_pred             cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          140 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       140 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      ++.+..++.++|||||||++|+|++   ||...      .........+.....++.. ...++.+.+||.+||+.||++
T Consensus       201 ~~~~~~y~~~~DiwSlGvilyell~---Pf~~~------~~~~~~~~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~  270 (299)
T 4g31_A          201 QIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------MERVRTLTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPME  270 (299)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH------HHHHHHHHHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGG
T ss_pred             HHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc------cHHHHHHHHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhH
Confidence            9999999999999999999999996   67532      1222333334333333221 234677889999999999999


Q ss_pred             CCCHHHHhcCccccccCC
Q 024828          220 RLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       220 Rpt~~~~l~h~~~~~~~~  237 (262)
                      |||+.|+++||||+....
T Consensus       271 Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          271 RPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             SCCHHHHHTSGGGCCC--
T ss_pred             CcCHHHHhcCHhhCCCCC
Confidence            999999999999987653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=339.66  Aligned_cols=228  Identities=26%  Similarity=0.429  Sum_probs=184.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE------CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      .....+++.+|+++|++++||||+++++++..      .+.+|+|||||+ ++|.+++.+.+++++..+..++.||+.||
T Consensus        93 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al  171 (398)
T 4b99_A           93 VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGL  171 (398)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Confidence            45667789999999999999999999998764      367999999996 58999999989999999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC----CCCcccccccccccCcccccCCC-CCcchhHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST----SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLG  156 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG  156 (262)
                      +|||+ .||+||||||+|||++.++.++++|||++......    .......+||+.|+|||++.+.. ++.++||||+|
T Consensus       172 ~ylH~-~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG  250 (398)
T 4b99_A          172 KYMHS-AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG  250 (398)
T ss_dssp             HHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             HHHHH-CcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhH
Confidence            99999 99999999999999999999999999999765332    22344568999999999988764 69999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHH----------------HHHhcCCCCCCC------CCCCCHHHHHHHHHhhc
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELM----------------EAIVDQPPPSAP------SDQFSPEFCSFISACVQ  214 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~------~~~~~~~l~~li~~~l~  214 (262)
                      |++|+|++|++||.+.+..+....+....                ...........+      ....++++.+||.+||.
T Consensus       251 ~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~  330 (398)
T 4b99_A          251 CIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLR  330 (398)
T ss_dssp             HHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSC
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCc
Confidence            99999999999998765433221111110                000000000000      12468899999999999


Q ss_pred             CCcCCCCCHHHHhcCccccccCC
Q 024828          215 KEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       215 ~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .||++|||++|+|+||||+....
T Consensus       331 ~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          331 FEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             SSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             CChhHCcCHHHHhcCHhhCcCCC
Confidence            99999999999999999998764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-50  Score=337.67  Aligned_cols=229  Identities=24%  Similarity=0.385  Sum_probs=178.6

Q ss_pred             cccchhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +|.........++.+|+++|+.+ +||||++++++|.+++++|+||||++|++|.++++   .+++..+..++.|++.||
T Consensus        54 iK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al  130 (361)
T 4f9c_A           54 LKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKAL  130 (361)
T ss_dssp             EEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHH
T ss_pred             EEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHH
Confidence            33333334456788999999998 69999999999999999999999999999999984   599999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccC-CcEEEEecccccccccCC----------------------------CCccccccc
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTS----------------------------GQANTFVGT  132 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~----------------------------~~~~~~~~~  132 (262)
                      +|||+ .||+||||||+|||++.+ +.++|+|||+|.......                            ......+||
T Consensus       131 ~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT  209 (361)
T 4f9c_A          131 KRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGT  209 (361)
T ss_dssp             HHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCC
T ss_pred             HHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccC
Confidence            99999 999999999999999876 799999999996543211                            112345799


Q ss_pred             ccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCccC-chhhHHH---------------------------
Q 024828          133 YNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQD-GWTSFYE---------------------------  183 (262)
Q Consensus       133 ~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~---------------------------  183 (262)
                      +.|+|||++.+.. ++.++||||+||++|+|++|+.||.....+. ....+..                           
T Consensus       210 ~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~  289 (361)
T 4f9c_A          210 PGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQ  289 (361)
T ss_dssp             GGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCC
T ss_pred             ccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcch
Confidence            9999999998764 8999999999999999999999996544321 1111100                           


Q ss_pred             ----HHHHHhc--------------CCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          184 ----LMEAIVD--------------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       184 ----~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                          ..+.+..              ..........+++++.+||++||+.||++|||++|+|+||||+..
T Consensus       290 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          290 DLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             hhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                0000000              000011124578999999999999999999999999999999865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-50  Score=330.18  Aligned_cols=213  Identities=25%  Similarity=0.440  Sum_probs=184.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLA   71 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~~~   71 (262)
                      +...+++|.+|+.++++++|||||++++++.+++..++|||||++|+|.+++...                ..+++..+.
T Consensus        69 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~  148 (308)
T 4gt4_A           69 EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV  148 (308)
T ss_dssp             CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHH
Confidence            3455678999999999999999999999999999999999999999999999653                358999999


Q ss_pred             HHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcc
Q 024828           72 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        72 ~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      .++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++......  .......|++.|+|||++.+..++.+
T Consensus       149 ~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k  227 (308)
T 4gt4_A          149 HLVAQIAAGMEYLSS-HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID  227 (308)
T ss_dssp             HHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHHHh-CCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence            999999999999999 999999999999999999999999999997654322  23344578999999999999999999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +||||||+++|||+| |..||.+...       .+....+..+..++.+ ..+|+++.+|+.+||+.||++|||++||++
T Consensus       228 sDVwSfGvvl~El~t~g~~Pf~~~~~-------~~~~~~i~~~~~~~~p-~~~~~~~~~li~~C~~~dP~~RPs~~ei~~  299 (308)
T 4gt4_A          228 SDIWSYGVVLWEVFSYGLQPYCGYSN-------QDVVEMIRNRQVLPCP-DDCPAWVYALMIECWNEFPSRRPRFKDIHS  299 (308)
T ss_dssp             HHHHHHHHHHHHHHTTTCCTTTTCCH-------HHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCCCc-ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999998 8999987543       2445556666555444 578999999999999999999999999976


Q ss_pred             C
Q 024828          229 H  229 (262)
Q Consensus       229 h  229 (262)
                      +
T Consensus       300 ~  300 (308)
T 4gt4_A          300 R  300 (308)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.5e-49  Score=343.65  Aligned_cols=217  Identities=28%  Similarity=0.505  Sum_probs=186.3

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeC
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR   93 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~   93 (262)
                      ...+++.+++.++|||||+++++|.+.+.+|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||+ .||+||
T Consensus       238 ~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHR  316 (689)
T 3v5w_A          238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYR  316 (689)
T ss_dssp             HHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT-TTEECC
T ss_pred             HHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccc
Confidence            3345577788889999999999999999999999999999999999999999999999999999999999998 999999


Q ss_pred             CCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 024828           94 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPP  172 (262)
Q Consensus        94 dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~  172 (262)
                      ||||+|||++.+|.++|+|||+|......  ...+.+||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.
T Consensus       317 DLKPeNILld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          317 DLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             CCchHHeEEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999875432  3456789999999999975 46999999999999999999999999765


Q ss_pred             CccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCCcc
Q 024828          173 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDLN  239 (262)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~~~  239 (262)
                      ...+    ..............  .+..+++++.+||.+||+.||++|++     ++|+++||||+...+..
T Consensus       395 ~~~~----~~~i~~~i~~~~~~--~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          395 KTKD----KHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             GCCC----HHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred             ChHH----HHHHHHhhcCCCCC--CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence            4332    22333333333322  23578999999999999999999998     79999999999876543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.3e-49  Score=326.05  Aligned_cols=214  Identities=29%  Similarity=0.462  Sum_probs=182.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCC-CeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHH
Q 024828            8 EESARRQIAQELKINQSSQC-PYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKV----------------KTIPEEY   69 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~   69 (262)
                      .....+++.+|+++|.+++| ||||+++++|.. ++.+++|||||++|+|.+++++.                ..+++..
T Consensus       107 ~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~  186 (353)
T 4ase_A          107 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH  186 (353)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHH
T ss_pred             ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHH
Confidence            45667889999999999965 899999999866 45789999999999999999753                2489999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCC
Q 024828           70 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYG  147 (262)
Q Consensus        70 ~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~  147 (262)
                      +..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+|+.......  ......||+.|+|||++.+..++
T Consensus       187 ~~~~~~qia~gl~yLH~-~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~  265 (353)
T 4ase_A          187 LICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  265 (353)
T ss_dssp             HHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHhHhh-CCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence            99999999999999999 9999999999999999999999999999976543322  22345688999999999999999


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          148 YKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       148 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      .++|||||||++|||+| |+.||.+....+      .....+..+..+..+ ..+++++.+++.+||+.||++|||++++
T Consensus       266 ~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------~~~~~i~~g~~~~~p-~~~~~~~~~li~~c~~~dP~~RPt~~ei  338 (353)
T 4ase_A          266 IQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSEL  338 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CcccEeehHHHHHHHHhCCCCCCCCCCHHH------HHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence            99999999999999998 899998765432      233444445544443 5689999999999999999999999999


Q ss_pred             hcC
Q 024828          227 MTH  229 (262)
Q Consensus       227 l~h  229 (262)
                      ++|
T Consensus       339 l~~  341 (353)
T 4ase_A          339 VEH  341 (353)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            987

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.8e-48  Score=340.75  Aligned_cols=221  Identities=24%  Similarity=0.449  Sum_probs=191.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .....+.+.+|+++|+.++||||++++++|.+...+|+|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||+
T Consensus       194 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~  273 (573)
T 3uto_A          194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE  273 (573)
T ss_dssp             SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            455677899999999999999999999999999999999999999999999964 4679999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccC--CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .||+||||||+||+++.+  +.++|+|||++...... ......+||+.|+|||++.+..++.++||||+||++|+|++
T Consensus       274 -~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~  351 (573)
T 3uto_A          274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS  351 (573)
T ss_dssp             -TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred             -CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH
Confidence             999999999999999854  78999999999876432 33445689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |.+||.+.+..       +....+.....  +......+++++.+||.+||..||.+|||++|+|+||||+....
T Consensus       352 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          352 GLSPFGGENDD-------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             SCCSSCCSSHH-------HHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             CCCCCCCcCHH-------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            99999875432       33444444432  22233578999999999999999999999999999999987653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-46  Score=310.23  Aligned_cols=219  Identities=25%  Similarity=0.473  Sum_probs=191.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +....+++.+|+++++.++||||+++++++.+.+..|+||||++|++|.+++...+.+++..+..++.|++.||+|||+ 
T Consensus        54 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-  132 (328)
T 3fe3_A           54 NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ-  132 (328)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            5567788999999999999999999999999999999999999999999999988999999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG-YKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||||+||+++.++.++|+|||++...... .......|++.|+|||.+.+..+. .++||||+||++|+|++|+
T Consensus       133 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  211 (328)
T 3fe3_A          133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS  211 (328)
T ss_dssp             TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSS
T ss_pred             CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCC
Confidence            99999999999999999999999999998765433 234456789999999999887764 8999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .||.+.+.       ......+..+...  .+..+++++.+|+++||..||.+|||++|+++||||+...+
T Consensus       212 ~pf~~~~~-------~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          212 LPFDGQNL-------KELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             CSSCCSSH-------HHHHHHHHHCCCC--CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             CCCCCCCH-------HHHHHHHHhCCCC--CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            99987543       2334444444332  23468999999999999999999999999999999987653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4e-46  Score=303.61  Aligned_cols=222  Identities=32%  Similarity=0.610  Sum_probs=191.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.++++++||||+++++++.+++..++||||+.|++|.+++.+ ..++...+..++.|++.||+|||+ .|
T Consensus        59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~  136 (297)
T 3fxz_A           59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQ  136 (297)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            3456788999999999999999999999999999999999999999999987 468999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus       137 i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  216 (297)
T 3fxz_A          137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY  216 (297)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999887665555555668999999999999989999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      ...+...      ...............+..+++.+.+|+.+||+.||.+|||++++++||||+......
T Consensus       217 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  280 (297)
T 3fxz_A          217 LNENPLR------ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS  280 (297)
T ss_dssp             TTSCHHH------HHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             CCCCHHH------HHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccc
Confidence            7654321      111222223323333457899999999999999999999999999999999776543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=318.14  Aligned_cols=221  Identities=26%  Similarity=0.446  Sum_probs=192.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+....+.+.+|++++++++||||+++++++.+++..++||||+.|++|.+.+...+.+++..+..++.|++.||.|||+
T Consensus        49 ~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~  128 (444)
T 3soa_A           49 LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ  128 (444)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35566788999999999999999999999999999999999999999999999998999999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEc---cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||||+||+++   .++.++|+|||++..............|++.|+|||++.+..++.++||||+|+++|+|+
T Consensus       129 -~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell  207 (444)
T 3soa_A          129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL  207 (444)
T ss_dssp             -TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             -CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHH
Confidence             9999999999999998   457899999999977655544445568999999999999888999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      +|..||.+.+..       .....+..+...  ......+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       208 ~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          208 VGYPPFWDEDQH-------RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HSSCSCCCSSHH-------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             hCCCCCCCccHH-------HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999775432       333333333322  22234789999999999999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.3e-46  Score=306.71  Aligned_cols=217  Identities=29%  Similarity=0.549  Sum_probs=190.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|+++++.++||||+++++.+.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        47 ~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~  125 (337)
T 1o6l_A           47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD  125 (337)
T ss_dssp             TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34567889999999999999999999999999999999999999999999988899999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||||+||+++.+|.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|+.||
T Consensus       126 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  205 (337)
T 1o6l_A          126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCC
Confidence            99999999999999999999999999876544444555678999999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      ...+..       .....+......  .+..+++++.+||.+||+.||++||     +++++++||||+...
T Consensus       206 ~~~~~~-------~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          206 YNQDHE-------RLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             CCSSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CCCCHH-------HHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            875432       233333333222  2356899999999999999999999     999999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=311.16  Aligned_cols=218  Identities=26%  Similarity=0.510  Sum_probs=186.2

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+.+|.++++.+ +||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ 
T Consensus        64 ~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-  142 (353)
T 3txo_A           64 DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD-  142 (353)
T ss_dssp             HTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            34556788999999988 7999999999999999999999999999999999998999999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|+.
T Consensus       143 ~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~  222 (353)
T 3txo_A          143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA  222 (353)
T ss_dssp             TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCC
Confidence            99999999999999999999999999998765444445556689999999999988889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH------HHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~------~~~l~h~~~~~~~  236 (262)
                      ||...+..       +....+.......  +..+++++.+|+++||+.||.+||++      +++++||||+...
T Consensus       223 Pf~~~~~~-------~~~~~i~~~~~~~--p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          223 PFEAENED-------DLFEAILNDEVVY--PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             SSCCSSHH-------HHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             CCCCCCHH-------HHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            99875442       3344444443322  34689999999999999999999998      8999999998765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-45  Score=307.14  Aligned_cols=217  Identities=28%  Similarity=0.482  Sum_probs=188.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|+.++++++||||+++++++.+....++||||++|++|.+++...+.+++..+..++.|++.||.|||+ .|+
T Consensus        58 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi  136 (361)
T 2yab_A           58 CREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKI  136 (361)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            3567899999999999999999999999999999999999999999999988899999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCC----cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           91 IHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      +|+||+|+||+++.++    .++|+|||++...... .......|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus       137 vHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~  215 (361)
T 2yab_A          137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  215 (361)
T ss_dssp             ECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred             ccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence            9999999999998776    7999999999765433 2334557899999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .||.+....       +....+........  ....+++++.+||.+||..||.+|||++|+++||||+...
T Consensus       216 ~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          216 SPFLGDTKQ-------ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             CSSCCSSHH-------HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             CCCCCCCHH-------HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            999875432       33344444332211  1246789999999999999999999999999999998654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.7e-46  Score=308.23  Aligned_cols=226  Identities=25%  Similarity=0.401  Sum_probs=173.3

Q ss_pred             HHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ....+.+|+.+++.+. ||||+++++++.++...|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        48 ~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~  126 (325)
T 3kn6_A           48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD-VG  126 (325)
T ss_dssp             GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            4567789999999996 999999999999999999999999999999999998899999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCC---cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           90 IIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      ++|+||+|+||+++.++   .++|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|+
T Consensus       127 ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  206 (325)
T 3kn6_A          127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ  206 (325)
T ss_dssp             EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence            99999999999998766   799999999986655444445567899999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCC--CCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .||.............+....+..+.......  ..+++++.+|+.+||+.||.+|||++++++||||+....
T Consensus       207 ~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          207 VPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             CTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            99987665444444556666666555433221  357899999999999999999999999999999987543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.8e-46  Score=314.77  Aligned_cols=226  Identities=26%  Similarity=0.525  Sum_probs=189.4

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+.+.+|..++.++ +||||+++++++.+.+..|+||||++|++|..++.+.+.+++..+..++.|++.||+|||+
T Consensus        92 ~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~  171 (396)
T 4dc2_A           92 DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE  171 (396)
T ss_dssp             ----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            344556788999999887 8999999999999999999999999999999999998999999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       .|++|+||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus       172 -~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~  250 (396)
T 4dc2_A          172 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  250 (396)
T ss_dssp             -TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             -CCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999999976544555566678999999999999999999999999999999999999


Q ss_pred             CCCCCCCccCc--hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH------HHHhcCccccccC
Q 024828          167 FPYSPPEQQDG--WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYG  236 (262)
Q Consensus       167 ~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~------~~~l~h~~~~~~~  236 (262)
                      .||......+.  ........+.+......  .+..+++++.+||++||+.||.+||++      +|+++||||+...
T Consensus       251 ~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          251 SPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             CSSTTTTC------CCHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             CCCcccccccccchhhHHHHHHHHhccccC--CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            99975432221  11122233333333322  234689999999999999999999984      8999999998765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.9e-46  Score=302.57  Aligned_cols=225  Identities=23%  Similarity=0.319  Sum_probs=169.6

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL   78 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~   78 (262)
                      |++..++.......+|+..+.+++||||+++++++.+++    .+|+||||++||+|.+++++ .+++.+.+..++.|++
T Consensus        32 K~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia  110 (303)
T 3hmm_A           32 KIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTA  110 (303)
T ss_dssp             EEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHH
T ss_pred             EEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHH
Confidence            344444444444556777788899999999999998653    58999999999999999976 5689999999999999


Q ss_pred             HHHHHHhhcC--------CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC----CcccccccccccCcccccCC--
Q 024828           79 KGLLYLHHEK--------HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISGG--  144 (262)
Q Consensus        79 ~~l~~lh~~~--------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~--  144 (262)
                      .||+|||+ .        +|+||||||+|||++.++.+||+|||++........    ......||+.|+|||++.+.  
T Consensus       111 ~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~  189 (303)
T 3hmm_A          111 SGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN  189 (303)
T ss_dssp             HHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC
T ss_pred             HHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccccc
Confidence            99999997 5        899999999999999999999999999976644332    22235799999999998764  


Q ss_pred             ----CCCcchhHHHHHHHHHHHHhCCCCCCCCCccC--------chhhHHHHHHHHhcCC-CCCCCCC----CCCHHHHH
Q 024828          145 ----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWTSFYELMEAIVDQP-PPSAPSD----QFSPEFCS  207 (262)
Q Consensus       145 ----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~l~~  207 (262)
                          .++.++|||||||++|||+||..||......+        ...........+.... .+..+..    ..++.+.+
T Consensus       190 ~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~  269 (303)
T 3hmm_A          190 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK  269 (303)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHH
T ss_pred             ccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHH
Confidence                36779999999999999999987765432211        0112233333333332 2222211    12346889


Q ss_pred             HHHHhhcCCcCCCCCHHHHhcC
Q 024828          208 FISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       208 li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |+.+||+.||++|||+.++++.
T Consensus       270 li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          270 IMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcccCHhHCcCHHHHHHH
Confidence            9999999999999999999863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-45  Score=306.61  Aligned_cols=226  Identities=26%  Similarity=0.525  Sum_probs=191.3

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+.+.+|..+++++ +||||+++++++.+....|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+
T Consensus        49 ~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~  128 (345)
T 3a8x_A           49 DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE  128 (345)
T ss_dssp             SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456677889999999988 8999999999999999999999999999999999988899999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       .|++|+||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus       129 -~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  207 (345)
T 3a8x_A          129 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR  207 (345)
T ss_dssp             -TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             -CCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999999876544444555668999999999999988999999999999999999999


Q ss_pred             CCCCCCCccCc--hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH------HHHhcCccccccC
Q 024828          167 FPYSPPEQQDG--WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYG  236 (262)
Q Consensus       167 ~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~------~~~l~h~~~~~~~  236 (262)
                      .||......+.  ..........+......  .+..+++++.+||.+||+.||.+||++      +++++||||+...
T Consensus       208 ~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          208 SPFDIVGSSDNPDQNTEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             CTTTTTTC-------CHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCcCCcccccccccccHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            99975332211  01122233333333322  235689999999999999999999985      8999999998765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.1e-46  Score=310.27  Aligned_cols=224  Identities=28%  Similarity=0.467  Sum_probs=179.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +....+.+.+|+.++++++||||+++++++.+.+..++||||+.|++|.+++.+.+.++...+..++.|++.||+|||+ 
T Consensus        56 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-  134 (361)
T 3uc3_A           56 GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-  134 (361)
T ss_dssp             STTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            3344567889999999999999999999999999999999999999999999988899999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCc--EEEEecccccccccCCCCcccccccccccCcccccCCCCCcc-hhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK-SDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~  164 (262)
                      .|++|+||||+||+++.++.  ++|+|||++...... .......|++.|+|||++.+..++.+ +|||||||++|+|++
T Consensus       135 ~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  213 (361)
T 3uc3_A          135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV  213 (361)
T ss_dssp             TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh
Confidence            99999999999999987765  999999998743322 22334578999999999988777655 899999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      |+.||........+.   .....+............+++++.+||.+||..||.+|||++++++||||....
T Consensus       214 g~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          214 GAYPFEDPEEPRDYR---KTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             SSCSCC----CCCHH---HHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             CCCCCCCCccHHHHH---HHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            999998766654433   333444444433333446899999999999999999999999999999996543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.9e-46  Score=303.74  Aligned_cols=222  Identities=27%  Similarity=0.482  Sum_probs=183.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+.+.+|++++++++||||+++++++.++...++||||+++ +|.+++... ..+++..+..++.|++.||+|||+ 
T Consensus        60 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-  137 (311)
T 3niz_A           60 EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ-  137 (311)
T ss_dssp             -CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            33457889999999999999999999999999999999999976 888888765 459999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||||+||+++.++.++|+|||++..............++..|+|||.+.+ ..++.++||||||+++|+|++|+
T Consensus       138 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  217 (311)
T 3niz_A          138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK  217 (311)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence            99999999999999999999999999999876555445555678999999999876 45899999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCC-------------------------CCCCCCHHHHHHHHHhhcCCcCCCC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSA-------------------------PSDQFSPEFCSFISACVQKEPQQRL  221 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rp  221 (262)
                      .||......+....+...   . ....+..                         ....+++++.+||.+||+.||++||
T Consensus       218 ~pf~~~~~~~~~~~i~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  293 (311)
T 3niz_A          218 PLFPGVTDDDQLPKIFSI---L-GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI  293 (311)
T ss_dssp             CSCCCSSTTTHHHHHHHH---H-CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC
T ss_pred             CCCCCCChHHHHHHHHHH---H-CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC
Confidence            999876665433222221   1 1111100                         0134678999999999999999999


Q ss_pred             CHHHHhcCccccccC
Q 024828          222 SAQELMTHPFLKMYG  236 (262)
Q Consensus       222 t~~~~l~h~~~~~~~  236 (262)
                      |++|+++||||+...
T Consensus       294 t~~ell~hp~f~~~~  308 (311)
T 3niz_A          294 SARDAMNHPYFKDLD  308 (311)
T ss_dssp             CHHHHHTSGGGTTSC
T ss_pred             CHHHHhcCcccccCC
Confidence            999999999999865

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-45  Score=305.70  Aligned_cols=216  Identities=26%  Similarity=0.506  Sum_probs=189.3

Q ss_pred             HHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..+.+.+|.+++..+ +||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~  138 (345)
T 1xjd_A           60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KG  138 (345)
T ss_dssp             CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            456778899999877 9999999999999999999999999999999999988899999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||||+||+++.+|.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       139 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  218 (345)
T 1xjd_A          139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF  218 (345)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999999876544444455678999999999999988999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH-HHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ-ELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~~l~h~~~~~~~  236 (262)
                      ...+..       .....+......  .+..+++++.+||.+||..||++||++. ++++||||+...
T Consensus       219 ~~~~~~-------~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          219 HGQDEE-------ELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             CCSSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             CCCCHH-------HHHHHHHhCCCC--CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            875432       233333333322  2346899999999999999999999998 999999998775

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.4e-45  Score=296.19  Aligned_cols=225  Identities=24%  Similarity=0.423  Sum_probs=181.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ++...+.+.+|++++++++||||+++++++.+++..++||||+++ ++.+.+.. .+.+++..+..++.|++.||+|||+
T Consensus        41 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~  119 (292)
T 3o0g_A           41 DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS  119 (292)
T ss_dssp             STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            445567888999999999999999999999999999999999987 66665544 5789999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g  165 (262)
                       .|++|+||||+||+++.++.++|+|||++..............++..|+|||.+.+.. ++.++||||+|+++++|++|
T Consensus       120 -~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~  198 (292)
T 3o0g_A          120 -RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             -TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             -CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence             9999999999999999999999999999987665555555667899999999998766 79999999999999999988


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCC-----------------------CCCCCCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPP-----------------------PSAPSDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                      ..||.......  ...............                       .......+++++.+|+.+||+.||++|||
T Consensus       199 ~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  276 (292)
T 3o0g_A          199 GRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS  276 (292)
T ss_dssp             SCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC
Confidence            77754433221  111111111111000                       00111247889999999999999999999


Q ss_pred             HHHHhcCccccccC
Q 024828          223 AQELMTHPFLKMYG  236 (262)
Q Consensus       223 ~~~~l~h~~~~~~~  236 (262)
                      ++|+++||||+.+.
T Consensus       277 ~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          277 AEEALQHPYFSDFC  290 (292)
T ss_dssp             HHHHHTSGGGTTC-
T ss_pred             HHHHhcCcccccCC
Confidence            99999999999764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-46  Score=304.49  Aligned_cols=223  Identities=22%  Similarity=0.382  Sum_probs=189.2

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +.........+.+|+.+++.++||||+++++++.+.+..++||||++|++|.+++...+ .+++..+..++.|++.||.|
T Consensus        38 ~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~  117 (321)
T 1tki_A           38 VKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF  117 (321)
T ss_dssp             ECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             EecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            33445566788999999999999999999999999999999999999999999997654 79999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEcc--CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      ||+ .|++|+||+|+||+++.  ++.++|+|||++...... .......+++.|+|||.+.+..++.++|+||||+++|+
T Consensus       118 lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  195 (321)
T 1tki_A          118 LHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYV  195 (321)
T ss_dssp             HHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHH
T ss_pred             HHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHH
Confidence            999 99999999999999987  789999999998765432 22334568999999999998888999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      |++|..||......       .....+........  ....+++++.+|+.+||..||.+|||+.|+++||||+...
T Consensus       196 ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          196 LLSGINPFLAETNQ-------QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHSSCTTCCSSHH-------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHhCCCCCcCCCHH-------HHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            99999999875432       33334433332221  1246889999999999999999999999999999998653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4e-45  Score=305.38  Aligned_cols=219  Identities=25%  Similarity=0.431  Sum_probs=187.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +....+.+.+|++++++++||||+++++++.+++..|+||||+.|++|.+++...+.+++..+..++.|++.||.|||+ 
T Consensus        68 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-  146 (362)
T 2bdw_A           68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-  146 (362)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            4566778999999999999999999999999999999999999999999999988889999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCC---cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++   .++|+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++
T Consensus       147 ~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  225 (362)
T 2bdw_A          147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV  225 (362)
T ss_dssp             TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH
Confidence            9999999999999997654   59999999987655332 3334578999999999998889999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      |..||...+..       .....+..+....  .....+++++.+||.+||..||.+|||++++++||||+..
T Consensus       226 g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          226 GYPPFWDEDQH-------RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             SSCSSCCSSHH-------HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             CCCCCCCCCHH-------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            99999875432       2333333333221  1224678999999999999999999999999999999753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.6e-45  Score=302.68  Aligned_cols=218  Identities=28%  Similarity=0.476  Sum_probs=178.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+.+.++...+..++.|++.||.|||+ .
T Consensus        62 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~  140 (327)
T 3a62_A           62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ-K  140 (327)
T ss_dssp             ---------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             hhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            345567889999999999999999999999999999999999999999999988899999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+||||+++|+|++|+.|
T Consensus       141 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  220 (327)
T 3a62_A          141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP  220 (327)
T ss_dssp             TCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCC
Confidence            99999999999999999999999999987654444444556789999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      |......       .....+......  .+..+++++.+|+.+||..||.+||     +++++++||||+...
T Consensus       221 f~~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          221 FTGENRK-------KTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             CCCSSHH-------HHHHHHHHTCCC--CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             CCCCCHH-------HHHHHHHhCCCC--CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence            9875432       223333333222  2246889999999999999999999     899999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.5e-45  Score=303.71  Aligned_cols=217  Identities=26%  Similarity=0.482  Sum_probs=189.7

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|.+++..+ +||+|+++++++.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~  140 (353)
T 2i0e_A           62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-K  140 (353)
T ss_dssp             TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3456788999999988 8999999999999999999999999999999999988899999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||||+||+++.+|.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|+.|
T Consensus       141 givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P  220 (353)
T 2i0e_A          141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP  220 (353)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCC
Confidence            99999999999999999999999999987654444455567899999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      |...+..       +....+......  .+..+++++.+||.+||..||.+||     +++++++||||+...
T Consensus       221 f~~~~~~-------~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          221 FEGEDED-------ELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             SCCSSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             CCCCCHH-------HHHHHHHhCCCC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            9875432       333444433322  2357899999999999999999999     479999999998754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=305.34  Aligned_cols=234  Identities=25%  Similarity=0.409  Sum_probs=179.3

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      ++|+.......+.+.+|++++++++||||+++++++.+....++||||++|++|.+++...+.++...+..++.|++.||
T Consensus        82 avK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L  161 (349)
T 2w4o_A           82 ALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAV  161 (349)
T ss_dssp             EEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHH
T ss_pred             EEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Confidence            33444444566788899999999999999999999999999999999999999999999888899999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEcc---CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV  158 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~  158 (262)
                      .|||+ .|++|+||+|+||+++.   ++.++|+|||++....... ......|++.|+|||.+.+..++.++|||||||+
T Consensus       162 ~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  239 (349)
T 2w4o_A          162 AYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGII  239 (349)
T ss_dssp             HHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHH
T ss_pred             HHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHH
Confidence            99998 99999999999999975   7899999999987654322 2234568999999999998889999999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      +|+|++|..||.......      .....+.......  .....++.++.+|+.+||..||++|||+.++++||||+...
T Consensus       240 l~ell~g~~pf~~~~~~~------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          240 TYILLCGFEPFYDERGDQ------FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHHHSSCTTCCTTCHH------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHhCCCCCCCCcccH------HHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999997654321      2233333333222  22256899999999999999999999999999999999877


Q ss_pred             Ccccchh
Q 024828          237 DLNVDLS  243 (262)
Q Consensus       237 ~~~~~~~  243 (262)
                      .......
T Consensus       314 ~~~~~~~  320 (349)
T 2w4o_A          314 ANFVHMD  320 (349)
T ss_dssp             CCCSCCH
T ss_pred             cchhhhc
Confidence            6554433

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-44  Score=305.73  Aligned_cols=231  Identities=26%  Similarity=0.419  Sum_probs=183.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...  +.+++..+..++.|++.||+|||
T Consensus        66 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH  145 (389)
T 3gni_B           66 SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH  145 (389)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567788999999999999999999999999999999999999999999999876  67999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-------CCcccccccccccCcccccC--CCCCcchhHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-------GQANTFVGTYNYMSPERISG--GKYGYKSDIWSLG  156 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG  156 (262)
                      + .|++|+||||+||+++.++.++|+|||.+.......       .......++..|+|||.+.+  ..++.++||||||
T Consensus       146 ~-~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  224 (389)
T 3gni_B          146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG  224 (389)
T ss_dssp             H-TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHH
T ss_pred             h-CCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHH
Confidence            9 999999999999999999999999999876543221       12223468889999999987  5689999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHH-HHHh------------------------------------cCCCCCCCCC
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELM-EAIV------------------------------------DQPPPSAPSD  199 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~------------------------------------~~~~~~~~~~  199 (262)
                      |++|+|++|+.||.+....+......... ....                                    ..........
T Consensus       225 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (389)
T 3gni_B          225 ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHR  304 (389)
T ss_dssp             HHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------------------------
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccc
Confidence            99999999999998755443211110000 0000                                    0000011234


Q ss_pred             CCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          200 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       200 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      .+++++.+||.+||+.||++|||++|+|+||||+......
T Consensus       305 ~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~  344 (389)
T 3gni_B          305 TFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA  344 (389)
T ss_dssp             -CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred             ccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence            5789999999999999999999999999999999877543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-45  Score=297.85  Aligned_cols=213  Identities=28%  Similarity=0.518  Sum_probs=187.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|..+++.++||||+++++++.+....|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|+
T Consensus        49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i  127 (318)
T 1fot_A           49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDI  127 (318)
T ss_dssp             CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTE
T ss_pred             HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            3567889999999999999999999999999999999999999999999998899999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+||+|+||+++.+|.++|+|||++.....   ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus       128 vHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  204 (318)
T 1fot_A          128 IYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  204 (318)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cccCCChheEEEcCCCCEEEeecCcceecCC---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999876432   2345578999999999998889999999999999999999999998


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      ..+..       .....+......  .+..+++++.+++.+||..||.+||     +++++++||||+...
T Consensus       205 ~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          205 DSNTM-------KTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             CSSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             CCCHH-------HHHHHHHhCCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            75432       233333333322  2346899999999999999999999     999999999998765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.8e-44  Score=295.76  Aligned_cols=221  Identities=35%  Similarity=0.643  Sum_probs=189.5

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.++++++||||+++++++..++..++||||++|++|.+++.+ ..+++..+..++.|++.||+|||+ .|
T Consensus        84 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~-~~  161 (321)
T 2c30_A           84 QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHA-QG  161 (321)
T ss_dssp             CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3456788999999999999999999999999999999999999999999875 579999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus       162 ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf  241 (321)
T 2c30_A          162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY  241 (321)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999999877655444445567899999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      ......       .....+.....+. .....+++++.+++.+||+.||++|||++++++||||+......
T Consensus       242 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          242 FSDSPV-------QAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             TTSCHH-------HHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             CCCCHH-------HHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence            765432       2223333333222 22345789999999999999999999999999999998765433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.5e-45  Score=305.56  Aligned_cols=217  Identities=27%  Similarity=0.485  Sum_probs=184.6

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ..+.+.+|+++++.++||||+++++++.+++..|+||||++|++|.+++.+.    ..+++..+..++.|++.||+|||+
T Consensus        69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~  148 (351)
T 3c0i_A           69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD  148 (351)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999999999999999999999999888643    258999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCc---EEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||||+||+++.++.   ++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|+
T Consensus       149 -~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  227 (351)
T 3c0i_A          149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL  227 (351)
T ss_dssp             -TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             -CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHH
Confidence             99999999999999986654   99999999987655444444567999999999999888999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      +|..||.....        .....+..+......  ...+++++.+||.+||..||++|||+.++++||||+...
T Consensus       228 ~g~~pf~~~~~--------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          228 SGCLPFYGTKE--------RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HSSCSSCSSHH--------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             HCCCCCCCcHH--------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            99999986421        223333333322211  146789999999999999999999999999999998643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=299.20  Aligned_cols=215  Identities=28%  Similarity=0.495  Sum_probs=181.2

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ..+++.+|++++++++||||+++++++.+  +...++||||+++++|.+++. .+++++..+..++.|++.||+|||+ .
T Consensus        79 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~  156 (298)
T 2zv2_A           79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHY-Q  156 (298)
T ss_dssp             --CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             hHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            34678999999999999999999999987  568999999999999988654 3679999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+..   .+.++|+||||+++|+|++|
T Consensus       157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            999999999999999999999999999987654433344567899999999998755   37889999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      +.||.....       ......+............+++++.+|+.+||+.||++|||++|+++||||++
T Consensus       237 ~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          237 QCPFMDERI-------MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             SCSSCCSSH-------HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             CCCCCCccH-------HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            999976432       22333333333333334578999999999999999999999999999999963

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=298.72  Aligned_cols=217  Identities=28%  Similarity=0.497  Sum_probs=186.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      .++.+.+|+.++++++||||+++++++.+....++||||++|++|.+++...+.+++..+..++.|++.||.|||+ .|+
T Consensus        57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i  135 (326)
T 2y0a_A           57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQI  135 (326)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            3678899999999999999999999999999999999999999999999988889999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCC----cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           91 IHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      +|+||+|+||+++.++    .++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       136 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  214 (326)
T 2y0a_A          136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  214 (326)
T ss_dssp             ECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred             EcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCc
Confidence            9999999999998877    79999999987654332 333457899999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .||......       +....+......  ......+++++.+|+.+||..||.+|||++++++||||+...
T Consensus       215 ~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          215 SPFLGDTKQ-------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             CSSCCSSHH-------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             CCCCCCCHH-------HHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            999765432       222222222211  111246789999999999999999999999999999998654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.4e-45  Score=305.79  Aligned_cols=237  Identities=46%  Similarity=0.840  Sum_probs=202.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +....+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+.++...+..++.|++.||+|||+.
T Consensus        71 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~  150 (360)
T 3eqc_A           71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  150 (360)
T ss_dssp             CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            56777899999999999999999999999999999999999999999999999988999999999999999999999982


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++......  ......++..|+|||++.+..++.++||||||+++|+|++|+.
T Consensus       151 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  228 (360)
T 3eqc_A          151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY  228 (360)
T ss_dssp             HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSC
T ss_pred             CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            38999999999999999999999999998655332  2234578999999999999889999999999999999999999


Q ss_pred             CCCCCCccCc-----------------------------------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 024828          168 PYSPPEQQDG-----------------------------------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  212 (262)
Q Consensus       168 p~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  212 (262)
                      ||......+.                                   .....+....+.....+..+...++.++.+||.+|
T Consensus       229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  308 (360)
T 3eqc_A          229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC  308 (360)
T ss_dssp             CSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHH
Confidence            9976443210                                   01123444555555556666667899999999999


Q ss_pred             hcCCcCCCCCHHHHhcCccccccCCcccchhhHh
Q 024828          213 VQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  246 (262)
Q Consensus       213 l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~~~  246 (262)
                      |+.||++|||++++++||||+........+....
T Consensus       309 L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~  342 (360)
T 3eqc_A          309 LIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL  342 (360)
T ss_dssp             HCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHH
T ss_pred             hhcChhhCCCHHHHhhChHhhcchHhhhhHHHHH
Confidence            9999999999999999999999888888776655

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-44  Score=300.10  Aligned_cols=214  Identities=26%  Similarity=0.460  Sum_probs=188.7

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|+++++.++||||+++++++.++...|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|+
T Consensus        84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i  162 (350)
T 1rdq_E           84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDL  162 (350)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            4567889999999999999999999999999999999999999999999998899999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+||||+||+++.++.++|+|||++.....   ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       163 vHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  239 (350)
T 1rdq_E          163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccCccceEEECCCCCEEEcccccceeccC---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence            9999999999999999999999999976543   2345578999999999998889999999999999999999999998


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCC
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGD  237 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~  237 (262)
                      ..+..       .....+..+...  .+..+++++.+||.+||+.||.+||+     ++++++||||+....
T Consensus       240 ~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          240 ADQPI-------QIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             CSSHH-------HHHHHHHHCCCC--CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             CCCHH-------HHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence            75432       333444444322  23568999999999999999999998     999999999987653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.3e-45  Score=300.88  Aligned_cols=212  Identities=30%  Similarity=0.525  Sum_probs=182.9

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      ..++.+|+++++.++||||+++++++.+.+..++||||+ +++|.+++.+.+.+++..+..++.|++.||.|||+ .|++
T Consensus        53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giv  130 (336)
T 3h4j_B           53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKIV  130 (336)
T ss_dssp             SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeE
Confidence            457899999999999999999999999999999999999 66999999988999999999999999999999999 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      |+||+|+||+++.++.++|+|||++...... .......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.
T Consensus       131 H~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~  209 (336)
T 3h4j_B          131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD  209 (336)
T ss_dssp             CCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred             ecCCchhhEEEcCCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998765433 23345578999999999998775 789999999999999999999998


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      ..........       +..  .....+..+++++.+|+.+||..||.+|||++|+++||||+..
T Consensus       210 ~~~~~~~~~~-------i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          210 DEFIPNLFKK-------VNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             CSSSTTCBCC-------CCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             CccHHHHHHH-------HHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            7544332111       111  1122335689999999999999999999999999999999753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-44  Score=296.92  Aligned_cols=224  Identities=25%  Similarity=0.477  Sum_probs=184.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV------KTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ...+.+.+|++++++++||||+++++++.+++..++||||++| +|.+++...      ..++...+..++.|++.||.|
T Consensus        45 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~  123 (317)
T 2pmi_A           45 GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF  123 (317)
T ss_dssp             CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            3446788999999999999999999999999999999999975 999999754      358999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l  162 (262)
                      ||+ .|++|+||||+||+++.++.++|+|||++..............++..|+|||++.+. .++.++|||||||++|+|
T Consensus       124 lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  202 (317)
T 2pmi_A          124 CHE-NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM  202 (317)
T ss_dssp             HHH-TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             HHH-CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHH
Confidence            999 999999999999999999999999999998765444444456789999999999864 589999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCC----------------------------CCCCCCCCCHHHHHHHHHhhc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPP----------------------------PSAPSDQFSPEFCSFISACVQ  214 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~  214 (262)
                      ++|+.||......+....+.   ........                            .......+++++.+|+.+||+
T Consensus       203 ~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  279 (317)
T 2pmi_A          203 ITGKPLFPGTNDEEQLKLIF---DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ  279 (317)
T ss_dssp             HHSSCSCCCSSHHHHHHHHH---HHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSC
T ss_pred             HhCCCCCCCCChHHHHHHHH---HHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCC
Confidence            99999998765432221111   11110000                            000112578899999999999


Q ss_pred             CCcCCCCCHHHHhcCccccccCCc
Q 024828          215 KEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       215 ~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .||++|||++|+++||||+.+...
T Consensus       280 ~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          280 LNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             SSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             CCcccCCCHHHHhCChhhhcccch
Confidence            999999999999999999987654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.2e-45  Score=295.33  Aligned_cols=221  Identities=24%  Similarity=0.423  Sum_probs=178.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|++++++++||||+++++++.+.+..++|||++.+ +|.+++... +.++...+..++.|++.||+|||+ .
T Consensus        42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~  119 (288)
T 1ob3_A           42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-R  119 (288)
T ss_dssp             CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3446788999999999999999999999999999999999976 999999865 679999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      |++|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+. .++.++|+||||+++|+|++|+.
T Consensus       120 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  199 (288)
T 1ob3_A          120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP  199 (288)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987765444444455789999999999764 48999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCC-----------------------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPP-----------------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      ||......+..   .............                       ......+++++.+|+.+||+.||++|||++
T Consensus       200 pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  276 (288)
T 1ob3_A          200 LFPGVSEADQL---MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK  276 (288)
T ss_dssp             SCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCCCCHHHHH---HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence            99876543221   1111111111000                       001235789999999999999999999999


Q ss_pred             HHhcCcccccc
Q 024828          225 ELMTHPFLKMY  235 (262)
Q Consensus       225 ~~l~h~~~~~~  235 (262)
                      |+++||||+..
T Consensus       277 e~l~hp~f~~~  287 (288)
T 1ob3_A          277 QALEHAYFKEN  287 (288)
T ss_dssp             HHHTSGGGGC-
T ss_pred             HHhcCcchhhc
Confidence            99999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.5e-45  Score=302.26  Aligned_cols=222  Identities=24%  Similarity=0.436  Sum_probs=185.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|+.+++.++||||+++++++.+++..++||||++|++|.+++...+.+++..+..++.|++.||+|||+ .
T Consensus        46 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~  124 (323)
T 3tki_A           46 VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I  124 (323)
T ss_dssp             -----CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            344577899999999999999999999999999999999999999999999888889999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||+|+||+++.++.++|+|||++.......  .......|++.|+|||++.+..+ +.++||||||+++|+|++|
T Consensus       125 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  204 (323)
T 3tki_A          125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (323)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence            99999999999999999999999999997553222  22334578999999999987765 7789999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +.||........      .................+++++.+|+.+||..||.+|||++|+++||||+....
T Consensus       205 ~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          205 ELPWDQPSDSCQ------EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             SCSCSSSCTTSH------HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             CCCCCCCchHHH------HHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            999987554321      122222333333333568999999999999999999999999999999986543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=307.89  Aligned_cols=240  Identities=24%  Similarity=0.378  Sum_probs=190.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ 
T Consensus       127 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-  205 (373)
T 2x4f_A          127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ-  205 (373)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            356678999999999999999999999999999999999999999999988654 469999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEE--ccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      .|++|+||+|+||++  +.++.++|+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       206 ~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  284 (373)
T 2x4f_A          206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG  284 (373)
T ss_dssp             TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhC
Confidence            999999999999999  456789999999998654332 23345689999999999988899999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccchh
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  243 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~  243 (262)
                      ..||......       +....+.....  +......+++++.+||.+||+.||.+|||++|+++||||+..........
T Consensus       285 ~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~~~~~  357 (373)
T 2x4f_A          285 LSPFLGDNDA-------ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSA  357 (373)
T ss_dssp             SCTTCCSSHH-------HHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHHHHHHH
T ss_pred             CCCCCCCCHH-------HHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchhhhhhh
Confidence            9999875443       22233322222  12222468999999999999999999999999999999998765544444


Q ss_pred             hHhhhhCCCCcccC
Q 024828          244 EYFTDAGSPLATLS  257 (262)
Q Consensus       244 ~~~~~~~~~~~~~~  257 (262)
                      ...++.+++.+++.
T Consensus       358 ~~~~~~~~~~~d~~  371 (373)
T 2x4f_A          358 QKKKNRGSDAQDFV  371 (373)
T ss_dssp             C-------------
T ss_pred             hhccCCccchhhhh
Confidence            44566666666553

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-45  Score=297.16  Aligned_cols=232  Identities=23%  Similarity=0.445  Sum_probs=182.8

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+.++...+..++.|++.||+|||+
T Consensus        41 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~  120 (311)
T 4agu_A           41 DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK  120 (311)
T ss_dssp             C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34566788899999999999999999999999999999999999999999999888889999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g  165 (262)
                       .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++++|++|
T Consensus       121 -~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  199 (311)
T 4agu_A          121 -HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG  199 (311)
T ss_dssp             -TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             -CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence             99999999999999999999999999999876544444455678999999999976 4579999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHH--------HH-----hcCCCCCCC---------CCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          166 QFPYSPPEQQDGWTSFYELME--------AI-----VDQPPPSAP---------SDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~--------~~-----~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      +.||......+..........        ..     ........+         ...+++++.+|+.+||+.||.+|||+
T Consensus       200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  279 (311)
T 4agu_A          200 VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC  279 (311)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH
T ss_pred             CCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH
Confidence            999987655432211111100        00     000000000         13578889999999999999999999


Q ss_pred             HHHhcCccccccCCcc
Q 024828          224 QELMTHPFLKMYGDLN  239 (262)
Q Consensus       224 ~~~l~h~~~~~~~~~~  239 (262)
                      +|+++||||+...+..
T Consensus       280 ~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          280 EQLLHHPYFENIREIE  295 (311)
T ss_dssp             HHHHTSGGGTTCC---
T ss_pred             HHHhcChHHHhccCHH
Confidence            9999999999887654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.8e-45  Score=311.75  Aligned_cols=220  Identities=30%  Similarity=0.534  Sum_probs=180.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+++++.++||||+++++++.+++..|+||||++|++|.+++.+.+.++...+..++.|++.||+|||++.
T Consensus       189 ~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~  268 (446)
T 4ejn_A          189 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK  268 (446)
T ss_dssp             ------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            34556788999999999999999999999999999999999999999999999899999999999999999999999648


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       269 giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  348 (446)
T 4ejn_A          269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  348 (446)
T ss_dssp             CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCC
Confidence            99999999999999999999999999987654444445567899999999999988999999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGD  237 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~  237 (262)
                      |...+..       .....+......  .+..+++++.+||.+||+.||.+||     |++|+++||||+....
T Consensus       349 f~~~~~~-------~~~~~i~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          349 FYNQDHE-------KLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             SCCSSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             CCCCCHH-------HHHHHHHhCCCC--CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence            9875432       223333333222  2346899999999999999999999     9999999999998653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.2e-45  Score=299.68  Aligned_cols=225  Identities=22%  Similarity=0.391  Sum_probs=174.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      .....+.+.+|++++++++||||+++++++.++...++||||+.| +|.+++...+.++...+..++.|++.||+|||+ 
T Consensus        73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-  150 (329)
T 3gbz_A           73 EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-  150 (329)
T ss_dssp             -------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            444566788999999999999999999999999999999999976 999999998899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEc-----cCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLIN-----HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE  161 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~  161 (262)
                      .|++|+||||+||+++     .++.++|+|||++..............++..|+|||++.+.. ++.++|||||||++|+
T Consensus       151 ~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  230 (329)
T 3gbz_A          151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAE  230 (329)
T ss_dssp             TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred             CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHH
Confidence            9999999999999995     445599999999987655444445567899999999998754 8999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC------------------------CCCCCHHHHHHHHHhhcCCc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP------------------------SDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~l~~li~~~l~~~p  217 (262)
                      |++|+.||......+.   ................+                        ...+++++.+||.+||+.||
T Consensus       231 ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  307 (329)
T 3gbz_A          231 MLMKTPLFPGDSEIDQ---LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDP  307 (329)
T ss_dssp             HHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSG
T ss_pred             HHHCCCCcCCCCHHHH---HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCCh
Confidence            9999999987654322   22222221111110000                        01167899999999999999


Q ss_pred             CCCCCHHHHhcCccccccCC
Q 024828          218 QQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .+|||++|+++||||+....
T Consensus       308 ~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          308 VKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             GGSCCHHHHHTSGGGSSSCS
T ss_pred             hhCCCHHHHhCCcccCCCCC
Confidence            99999999999999998653

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.6e-44  Score=290.40  Aligned_cols=217  Identities=31%  Similarity=0.596  Sum_probs=186.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +....+.+.+|++++++++||||+++++++.+    +...++||||+++++|.+++.+.+.++...+..++.|++.||.|
T Consensus        65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~  144 (290)
T 1t4h_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence            56778899999999999999999999999876    35689999999999999999998899999999999999999999


Q ss_pred             HhhcCC--eeeCCCCCCCEEEc-cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           84 LHHEKH--IIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        84 lh~~~~--i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      ||+ .|  ++|+||+|+||+++ .++.++|+|||++......  ......+++.|+|||.+.+ .++.++|+||||++++
T Consensus       145 lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~  220 (290)
T 1t4h_A          145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML  220 (290)
T ss_dssp             HHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred             HHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHH
Confidence            998 88  99999999999997 7889999999998654322  2334568999999998874 5899999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      +|++|+.||......      .........+..+.......++++.+++.+||+.||.+|||++++++||||+.
T Consensus       221 ~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          221 EMATSEYPYSECQNA------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHhCCCCCCCcCcH------HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999765432      23444555555555555677899999999999999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=300.09  Aligned_cols=220  Identities=28%  Similarity=0.499  Sum_probs=189.0

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|+++++.++||||+++++++.+....|+||||+.|++|.+++...+.+++..+..++.|++.||.|||+ .|+
T Consensus        58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~gi  136 (384)
T 4fr4_A           58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN-QRI  136 (384)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            4567889999999999999999999999999999999999999999999998899999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      +|+||||+||+++.+|.++|+|||++...... .......|++.|+|||++.+   ..++.++|+|||||++|+|++|+.
T Consensus       137 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~  215 (384)
T 4fr4_A          137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR  215 (384)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             eeccCcHHHeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence            99999999999999999999999999765432 33445679999999999874   358999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-HHHHhcCccccccCCc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFLKMYGDL  238 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~~~l~h~~~~~~~~~  238 (262)
                      ||.......    .......+......  .+..+++++.+||.+||+.||.+||+ ++++++||||+.....
T Consensus       216 Pf~~~~~~~----~~~~~~~~~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          216 PYHIRSSTS----SKEIVHTFETTVVT--YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             SSCCCTTSC----HHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             CCCCCCCcc----HHHHHHHHhhcccC--CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence            998654432    22333333333322  23468999999999999999999998 9999999999887643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.8e-44  Score=288.45  Aligned_cols=224  Identities=25%  Similarity=0.441  Sum_probs=191.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +....+++.+|++++++++||||+++++++.++...++||||+.|++|.+.+...+.++...+..++.|++.||++||+ 
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-  123 (284)
T 3kk8_A           45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-  123 (284)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            4566788999999999999999999999999999999999999999999999988899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCc---EEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.   ++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++++|++
T Consensus       124 ~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~  202 (284)
T 3kk8_A          124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV  202 (284)
T ss_dssp             TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH
Confidence            99999999999999986655   9999999987654332 2334578999999999999889999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      |+.||......       .....+..+.  .+......+++++.+|+.+||+.||.+|||++|+++||||+......-
T Consensus       203 g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          203 GYPPFWDEDQH-------RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             SSCSSCCSSHH-------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             CCCCCCCCchh-------HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence            99999775432       2222222222  222223478999999999999999999999999999999988765544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-44  Score=304.80  Aligned_cols=216  Identities=27%  Similarity=0.473  Sum_probs=183.2

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeC
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR   93 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~   93 (262)
                      .+.+|.++++.++||||+++++++.++...|+||||++|++|.+++++ ..+++..+..++.|++.||+|||+ .|++|+
T Consensus       115 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~-~givHr  192 (410)
T 3v8s_A          115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHR  192 (410)
T ss_dssp             THHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeEec
Confidence            478999999999999999999999999999999999999999999976 579999999999999999999999 999999


Q ss_pred             CCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCC
Q 024828           94 DLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        94 dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ||||+||+++.++.++|+|||++........ ......|++.|+|||++.+..    ++.++|+||||+++|+|++|+.|
T Consensus       193 DLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  272 (410)
T 3v8s_A          193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  272 (410)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence            9999999999999999999999976543321 233567999999999998654    78999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcCC--CCCHHHHhcCccccccCCc
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~h~~~~~~~~~  238 (262)
                      |...+..+       ....+....  ........+++++.+||.+||+.+|.+  ||+++|+++||||+.....
T Consensus       273 f~~~~~~~-------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          273 FYADSLVG-------TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             TCCSSHHH-------HHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             CCCCChhh-------HHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence            98755432       222222211  111122468999999999999999988  9999999999999986543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-43  Score=287.70  Aligned_cols=220  Identities=27%  Similarity=0.415  Sum_probs=192.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...++.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++...+.++...+..++.|++.||++||+ 
T Consensus        55 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-  133 (294)
T 2rku_A           55 KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-  133 (294)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            4567788999999999999999999999999999999999999999999999988899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|+.
T Consensus       134 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~  213 (294)
T 2rku_A          134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP  213 (294)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999999876544444455678999999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ||......       +....+.....  ..+..+++++.+++.+||+.||++|||++++++||||+....
T Consensus       214 p~~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          214 PFETSCLK-------ETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             TTCCSSHH-------HHHHHHHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             CCCCCCHH-------HHHHHHhhccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence            99875432       22233333322  223468899999999999999999999999999999987654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.7e-44  Score=301.01  Aligned_cols=218  Identities=27%  Similarity=0.493  Sum_probs=180.7

Q ss_pred             HHHHHHHHHHHHH-HhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ......+.+|..+ ++.++||||+++++.+.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ 
T Consensus        79 ~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-  157 (373)
T 2r5t_A           79 KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-  157 (373)
T ss_dssp             ------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            4455667778877 57789999999999999999999999999999999999998899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||||+||+++.+|.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       158 ~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~  237 (373)
T 2r5t_A          158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP  237 (373)
T ss_dssp             TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999999865544445556789999999999999889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH----HHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA----QELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----~~~l~h~~~~~~~  236 (262)
                      ||...+..       +....+......  .+..+++++.+||.+||+.||.+||++    +++++||||+...
T Consensus       238 Pf~~~~~~-------~~~~~i~~~~~~--~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          238 PFYSRNTA-------EMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             TTCCSBHH-------HHHHHHHHSCCC--CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             CCCCCCHH-------HHHHHHHhcccC--CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            99875432       333333333222  234689999999999999999999986    6999999998765

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.1e-44  Score=306.97  Aligned_cols=222  Identities=23%  Similarity=0.445  Sum_probs=185.2

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      .+.+|..++..++||||+++++++.+++..|+||||+.|++|.+++.+ .+.+++..+..++.|++.||+|||+ .|++|
T Consensus       120 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiH  198 (437)
T 4aw2_A          120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVH  198 (437)
T ss_dssp             CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEe
Confidence            388999999999999999999999999999999999999999999987 4689999999999999999999999 99999


Q ss_pred             CCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCC
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      +||||+||+++.++.++|+|||++........ ......|++.|+|||++.     +..++.++|+|||||++|+|++|+
T Consensus       199 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~  278 (437)
T 4aw2_A          199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE  278 (437)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred             cccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence            99999999999999999999999876543322 223457999999999987     456899999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCC--CCCHHHHhcCccccccCCccc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      .||...+..+....+   .........+ .....+++++.+||++||..+|++  ||+++|+++||||+...+..+
T Consensus       279 ~Pf~~~~~~~~~~~i---~~~~~~~~~p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          279 TPFYAESLVETYGKI---MNHKERFQFP-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             CTTCCSSHHHHHHHH---HTHHHHCCCC-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             CCCCCCChhHHHHhh---hhccccccCC-cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            999875543222111   1111111222 222468999999999999988888  999999999999988765443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.5e-44  Score=293.59  Aligned_cols=225  Identities=36%  Similarity=0.637  Sum_probs=191.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...+++.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ...++...+..++.|++.||.+||+ 
T Consensus        65 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-  143 (314)
T 3com_A           65 ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF-  143 (314)
T ss_dssp             TSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            34456789999999999999999999999999999999999999999999974 4679999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       144 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  223 (314)
T 3com_A          144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP  223 (314)
T ss_dssp             TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999999776554444455678999999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  241 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~  241 (262)
                      ||.......       ......... ........+++++.+|+.+||..||.+|||++++++||||+........
T Consensus       224 p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~  291 (314)
T 3com_A          224 PYADIHPMR-------AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL  291 (314)
T ss_dssp             TTTTSCHHH-------HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGG
T ss_pred             CCCCCChHH-------HHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHH
Confidence            998654321       111222222 2222234578999999999999999999999999999999988766554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.3e-44  Score=289.01  Aligned_cols=217  Identities=30%  Similarity=0.486  Sum_probs=185.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      .+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.+.+.++...+..++.|++.||+|||+ .|++
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~  131 (279)
T 3fdn_A           53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVI  131 (279)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTCE
T ss_pred             HHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEe
Confidence            567899999999999999999999999999999999999999999999988899999999999999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      |+||+|+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+||||+++++|++|..||..
T Consensus       132 H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  209 (279)
T 3fdn_A          132 HRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  209 (279)
T ss_dssp             ECCCCGGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccCChHhEEEcCCCCEEEEeccccccCCcc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999999988654322  22345688999999999988899999999999999999999999986


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      ....       .....+......  .+..+++++.+|+.+||+.||.+|||++|+++||||+.......
T Consensus       210 ~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~  269 (279)
T 3fdn_A          210 NTYQ-------ETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS  269 (279)
T ss_dssp             SSHH-------HHHHHHHHTCCC--CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCC
T ss_pred             CcHH-------HHHHHHHhCCCC--CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCcc
Confidence            5432       222222222222  23468899999999999999999999999999999988775543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=287.96  Aligned_cols=216  Identities=28%  Similarity=0.508  Sum_probs=161.7

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      .+++.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ++++...+..++.|++.||.|||+ .|+
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i  133 (278)
T 3cok_A           55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS-HGI  133 (278)
T ss_dssp             HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            467899999999999999999999999999999999999999999999876 579999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      +|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++++|++|+.||.
T Consensus       134 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  213 (278)
T 3cok_A          134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD  213 (278)
T ss_dssp             ECSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred             ecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999998876544444445578899999999998889999999999999999999999998


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .......       ........  ...+..++.++.+++.+||+.||++|||++++++||||+....
T Consensus       214 ~~~~~~~-------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          214 TDTVKNT-------LNKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             CCSCC------------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             ChhHHHH-------HHHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            7554321       11111111  1223468899999999999999999999999999999987553

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-43  Score=292.32  Aligned_cols=219  Identities=27%  Similarity=0.423  Sum_probs=191.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +...++.+.+|+.+++.++||||+++++++.+++..++||||+.+++|.+++...+.++...+..++.|++.||+|||+ 
T Consensus        81 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-  159 (335)
T 2owb_A           81 KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-  159 (335)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            4567888999999999999999999999999999999999999999999999988899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus       160 ~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  239 (335)
T 2owb_A          160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP  239 (335)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcC
Confidence            99999999999999999999999999999876544444455678999999999998889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ||......       +....+.....  ..+..+++++.+|+.+||+.||++|||++++++||||+...
T Consensus       240 pf~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          240 PFETSCLK-------ETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             TTCCSSHH-------HHHHHHHHTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             CCCCCCHH-------HHHHHHhcCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            99865432       12222222222  12346889999999999999999999999999999998654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=301.76  Aligned_cols=220  Identities=26%  Similarity=0.487  Sum_probs=176.1

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      .+.+|++++++++||||+++++++.+++..++||||+.| +|.+++...+ .++...+..++.|++.||.|||+ .|++|
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH  123 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-QKVLH  123 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEE
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccC
Confidence            566899999999999999999999999999999999976 9999987754 59999999999999999999999 99999


Q ss_pred             CCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           93 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        93 ~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      +||+|+||+++.++.++|+|||++..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+
T Consensus       124 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (324)
T 3mtl_A          124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG  203 (324)
T ss_dssp             SSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998766544444445578999999999887 4589999999999999999999999987


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCC-------------------------CCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSA-------------------------PSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      ....+..    ..+...........                         ....+++++.+|+.+||+.||.+|||++|+
T Consensus       204 ~~~~~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  279 (324)
T 3mtl_A          204 STVEEQL----HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA  279 (324)
T ss_dssp             SSHHHHH----HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCHHHHH----HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence            6543221    11111111111100                         012468899999999999999999999999


Q ss_pred             hcCccccccCCcc
Q 024828          227 MTHPFLKMYGDLN  239 (262)
Q Consensus       227 l~h~~~~~~~~~~  239 (262)
                      ++||||+...+..
T Consensus       280 l~hp~f~~~~~~~  292 (324)
T 3mtl_A          280 MKHPFFLSLGERI  292 (324)
T ss_dssp             TTSGGGGGGCSTT
T ss_pred             hcChhhhhccccc
Confidence            9999999887543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-44  Score=307.66  Aligned_cols=214  Identities=29%  Similarity=0.522  Sum_probs=187.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+.+|+++++.++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|+
T Consensus        59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi  137 (476)
T 2y94_A           59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR-HMV  137 (476)
T ss_dssp             THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT-TTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCC
Confidence            3567899999999999999999999999999999999999999999999988899999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      +|+||||+||+++.++.++|+|||++...... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||
T Consensus       138 vHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf  216 (476)
T 2y94_A          138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF  216 (476)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CcccccHHHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC
Confidence            99999999999999999999999998765432 23345678999999999998765 78999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      ......       .....+..+...  .+..+++++.+|+.+||+.||.+|||++++++||||+..
T Consensus       217 ~~~~~~-------~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          217 DDDHVP-------TLFKKICDGIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             CCSSSH-------HHHHHHHTTCCC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CCCCHH-------HHHHHHhcCCcC--CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            865432       333444444332  234688999999999999999999999999999999764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-44  Score=298.65  Aligned_cols=218  Identities=27%  Similarity=0.441  Sum_probs=184.2

Q ss_pred             HHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeee
Q 024828           14 QIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH   92 (262)
Q Consensus        14 ~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H   92 (262)
                      ...+|++++.++ +||||+++++++.++...|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|++|
T Consensus        61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH  139 (342)
T 2qr7_A           61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-QGVVH  139 (342)
T ss_dssp             CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred             ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEe
Confidence            345788888887 7999999999999999999999999999999999998899999999999999999999999 99999


Q ss_pred             CCCCCCCEEEccC-C---cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           93 RDLKPSNLLINHR-G---EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        93 ~dl~p~nil~~~~-~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      +||||+||++.++ +   .++|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus       140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  219 (342)
T 2qr7_A          140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP  219 (342)
T ss_dssp             SCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCC
Confidence            9999999998543 2   59999999998765554455566789999999999877789999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      |......    ...+....+..+.....  ....+++++.+||.+||..||++|||++++++||||..+.
T Consensus       220 f~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          220 FANGPDD----TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             SCSSTTS----CHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             CCCCCcC----CHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence            9864322    22233444444433222  2246899999999999999999999999999999997654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=302.39  Aligned_cols=222  Identities=23%  Similarity=0.401  Sum_probs=182.6

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      .+.+.+|.+++..++||||+++++++.+.+..|+||||++|++|.+++.+.+ .+++..+..++.|++.||+|||+ .|+
T Consensus       105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~gi  183 (412)
T 2vd5_A          105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR-LGY  183 (412)
T ss_dssp             GCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            3457899999999999999999999999999999999999999999998764 79999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCccccc-------CCCCCcchhHHHHHHHHHHH
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERIS-------GGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~-------~~~~~~~~Di~slG~~l~~l  162 (262)
                      +|+||||+||+++.++.++|+|||++........ ......|++.|+|||++.       +..++.++|+|||||++|+|
T Consensus       184 iHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyel  263 (412)
T 2vd5_A          184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM  263 (412)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHH
T ss_pred             eecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHH
Confidence            9999999999999999999999999976543322 223457999999999987       35689999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCC---CCHHHHhcCccccccCCcc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR---LSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---pt~~~~l~h~~~~~~~~~~  239 (262)
                      ++|+.||...+..+....+...   ...... +.....+++++.+||++||. +|.+|   |+++++++||||+...+..
T Consensus       264 ltG~~Pf~~~~~~~~~~~i~~~---~~~~~~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~  338 (412)
T 2vd5_A          264 FYGQTPFYADSTAETYGKIVHY---KEHLSL-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG  338 (412)
T ss_dssp             HHSSCTTCCSSHHHHHHHHHTH---HHHCCC-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred             HhCCCCCCCCCHHHHHHHHHhc---ccCcCC-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            9999999876543222111111   111111 21235689999999999999 99998   5999999999998765443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.4e-44  Score=287.03  Aligned_cols=224  Identities=24%  Similarity=0.429  Sum_probs=188.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.....++...+..++.|++.||.+||+ .
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~  124 (276)
T 2yex_A           46 VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I  124 (276)
T ss_dssp             TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            345678999999999999999999999999999999999999999999999887889999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..+ +.++|+||||+++++|++|
T Consensus       125 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  204 (276)
T 2yex_A          125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (276)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhC
Confidence            99999999999999999999999999987653322  22334568899999999987765 7799999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      +.||........      ....+............+++++.+|+.+||+.||.+|||++++++||||+.....+
T Consensus       205 ~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          205 ELPWDQPSDSCQ------EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             SCCCSCSCTTSH------HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             CCCCCCCchHHH------HHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence            999987554321      11222222222223346899999999999999999999999999999998765543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-43  Score=286.32  Aligned_cols=218  Identities=29%  Similarity=0.469  Sum_probs=186.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|++++++++||||+++++++.++...++||||+++++|.+++...+.+++..+..++.|++.||++||+ .|
T Consensus        48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~  126 (277)
T 3f3z_A           48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-LN  126 (277)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34567899999999999999999999999999999999999999999999988899999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEE---ccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           90 IIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        90 i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      ++|+||+|+||++   +.++.++|+|||.+...... .......+++.|+|||.+.+ .++.++|+||||+++++|++|+
T Consensus       127 i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~  204 (277)
T 3f3z_A          127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGY  204 (277)
T ss_dssp             EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCC
Confidence            9999999999999   77889999999998765433 23344578999999999875 4899999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .||......       .....+..+......  ...+++++.+++.+||+.||.+|||+.++++||||+....
T Consensus       205 ~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          205 PPFSAPTDS-------EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             CSSCCSSHH-------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             CCCCCCCHH-------HHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            999875432       233333333322211  1267899999999999999999999999999999976543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-43  Score=291.97  Aligned_cols=218  Identities=27%  Similarity=0.473  Sum_probs=187.5

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+++.+|++++++++||||+++++++.+....++||||++|++|.+++...+.++...+..++.|++.||+|||+ .|+
T Consensus        58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i  136 (321)
T 2a2a_A           58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKI  136 (321)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            3677899999999999999999999999999999999999999999999988889999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCC----cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           91 IHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      +|+||+|+||+++.++    .++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       137 vH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  215 (321)
T 2a2a_A          137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  215 (321)
T ss_dssp             ECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred             ecCCCChHHEEEecCCCCcCCEEEccCccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCC
Confidence            9999999999998887    79999999987654432 233456899999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .||......       +....+........  ....+++.+.+|+.+||..||++|||++++++||||+....
T Consensus       216 ~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          216 SPFLGDTKQ-------ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             CSSCCSSHH-------HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             CCCCCCCHH-------HHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            999765432       23333333322111  11467899999999999999999999999999999987653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=297.76  Aligned_cols=220  Identities=24%  Similarity=0.440  Sum_probs=186.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ......+.+|++++++++||||+++++++.++...++||||+.|++|.+++...+ .+++..+..++.|++.||+|||+ 
T Consensus        89 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-  167 (387)
T 1kob_A           89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-  167 (387)
T ss_dssp             HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            3456689999999999999999999999999999999999999999999997654 79999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEcc--CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      .|++|+||+|+||+++.  ++.++|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       168 ~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg  246 (387)
T 1kob_A          168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG  246 (387)
T ss_dssp             TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             CCeeecccchHHeEEecCCCCceEEEecccceecCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhC
Confidence            99999999999999974  4679999999997654322 22344689999999999988899999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ..||......       .....+....  .+......+++++.+||.+||..||.+|||++++++||||+....
T Consensus       247 ~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          247 LSPFAGEDDL-------ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             CCSSCCSSHH-------HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             CCCCCCCCHH-------HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            9999875432       2223333222  122223468999999999999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-43  Score=285.13  Aligned_cols=214  Identities=28%  Similarity=0.567  Sum_probs=175.5

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ..+.+.+|++++++++||||+++++++.+....++||||+++++|.+++...    ..++...+..++.|++.||+|||+
T Consensus        63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  142 (285)
T 3is5_A           63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS  142 (285)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4578899999999999999999999999999999999999999999998543    679999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEE---ccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+. ..++.++|+||||+++++|+
T Consensus       143 -~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll  219 (285)
T 3is5_A          143 -QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL  219 (285)
T ss_dssp             -TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             -CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHH
Confidence             999999999999999   445789999999987654332 233456899999999986 46899999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHh-cCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      +|+.||......       ....... ...........+++++.+|+.+||+.||.+|||++|+++||||++
T Consensus       220 ~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          220 TGCLPFTGTSLE-------EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HSSCSSCCSSHH-------HHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             hCCCCCCCCCHH-------HHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999875432       2222222 222222223457899999999999999999999999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-44  Score=298.42  Aligned_cols=229  Identities=23%  Similarity=0.401  Sum_probs=182.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+.++...+..++.|++.||++||+
T Consensus        63 ~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  142 (331)
T 4aaa_A           63 DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS  142 (331)
T ss_dssp             SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35566778899999999999999999999999999999999999998999988877889999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g  165 (262)
                       .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+. .++.++||||||+++|+|++|
T Consensus       143 -~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  221 (331)
T 4aaa_A          143 -HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG  221 (331)
T ss_dssp             -TTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred             -CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhC
Confidence             999999999999999999999999999997765544444556789999999999875 689999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHH-----------HH--HhcCCC-CCC--------CCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          166 QFPYSPPEQQDGWTSFYELM-----------EA--IVDQPP-PSA--------PSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~-----------~~--~~~~~~-~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      +.||......+.........           ..  ...+.. +..        ....+++++.+|+.+||+.||.+|||+
T Consensus       222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  301 (331)
T 4aaa_A          222 EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC  301 (331)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG
T ss_pred             CCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH
Confidence            99998765432211111100           00  000000 000        012578999999999999999999999


Q ss_pred             HHHhcCccccccC
Q 024828          224 QELMTHPFLKMYG  236 (262)
Q Consensus       224 ~~~l~h~~~~~~~  236 (262)
                      +|+|+||||+..+
T Consensus       302 ~ell~hp~f~~~~  314 (331)
T 4aaa_A          302 AELLHHDFFQMDG  314 (331)
T ss_dssp             GGGGGSHHHHGGG
T ss_pred             HHHhcCchhccCC
Confidence            9999999998754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.9e-43  Score=284.12  Aligned_cols=214  Identities=31%  Similarity=0.516  Sum_probs=186.4

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      .+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.+.+.++...+..++.|++.||.+||+ .|++
T Consensus        58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~  136 (284)
T 2vgo_A           58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKVI  136 (284)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Confidence            467899999999999999999999999999999999999999999999988899999999999999999999998 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      |+||+|+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.++|+||||+++++|++|..||..
T Consensus       137 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          137 HRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ecCCCHHHEEEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999999998654432  23345688999999999988899999999999999999999999987


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ....       .....+......  .+..+++++.+++.+||..||.+|||++++++||||+....
T Consensus       215 ~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          215 PSHT-------ETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             SSHH-------HHHHHHHTTCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             CCHh-------HHHHHHhccccC--CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            5432       222333333221  23468899999999999999999999999999999986554

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.5e-43  Score=292.96  Aligned_cols=218  Identities=33%  Similarity=0.551  Sum_probs=186.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+++.+|++++++++||||+++++++.+++..++||||+.| +|.+++.. .++++...+..++.|++.||.|||+
T Consensus        94 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~  172 (348)
T 1u5q_A           94 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS  172 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            456667899999999999999999999999999999999999975 88888854 4679999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++|+|||++.....    .....|++.|+|||++.   +..++.++||||||+++++|+
T Consensus       173 -~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell  247 (348)
T 1u5q_A          173 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  247 (348)
T ss_dssp             -TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred             -CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence             9999999999999999999999999999876532    23457899999999984   456899999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|+.||......       .....+.....+......+++.+.+|+.+||+.||++|||++++++||||......
T Consensus       248 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          248 ERKPPLFNMNAM-------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             HSSCTTTTSCHH-------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             hCCCCCCCCChH-------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence            999999765432       22333444444555556789999999999999999999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.4e-43  Score=305.20  Aligned_cols=220  Identities=27%  Similarity=0.486  Sum_probs=189.2

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+.+|++++++++||||+++++++.+....|+||||++|++|.+++.+.    ..+++..+..++.|++.||+|||+ 
T Consensus       229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-  307 (543)
T 3c4z_A          229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-  307 (543)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-
Confidence            467889999999999999999999999999999999999999999999764    369999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .|++|+||||+||+++.+|.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|+.
T Consensus       308 ~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~  387 (543)
T 3c4z_A          308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG  387 (543)
T ss_dssp             TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCC
Confidence            99999999999999999999999999999876544444445689999999999999889999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccCC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGD  237 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~~  237 (262)
                      ||..........   .....+......  .+..+++++.+||.+||+.||.+||+     ++++++||||+....
T Consensus       388 PF~~~~~~~~~~---~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          388 PFRARGEKVENK---ELKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             SSCCTTCCCCHH---HHHHHHHHCCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             CCCCCccchhHH---HHHHHHhhcccC--CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence            998765432222   233333333322  23578999999999999999999996     589999999998653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-43  Score=307.36  Aligned_cols=218  Identities=30%  Similarity=0.505  Sum_probs=186.3

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ......+.+|+++++.++||||+++++++.+....|+||||+.|++|.+.+.+...+++..+..++.|++.||.|||+ .
T Consensus        77 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~  155 (494)
T 3lij_A           77 TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK-H  155 (494)
T ss_dssp             -CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            334678899999999999999999999999999999999999999999999988999999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccC---CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||||+||+++..   +.++|+|||++....... ......|++.|+|||++. ..++.++||||+||++|+|++|
T Consensus       156 ~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g  233 (494)
T 3lij_A          156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG  233 (494)
T ss_dssp             TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhC
Confidence            99999999999999764   459999999987665332 334557899999999987 4689999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ..||......       +....+..+.....  ....+++++.+||.+||+.||.+|||++++|+||||+...
T Consensus       234 ~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          234 YPPFGGQTDQ-------EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             SCSSCCSSHH-------HHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             CCCCCCCCHH-------HHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence            9999875432       33344444433222  2246899999999999999999999999999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-44  Score=302.27  Aligned_cols=229  Identities=24%  Similarity=0.436  Sum_probs=181.6

Q ss_pred             hHHHHHHHHHHHHHHhcCC-CCeeEeeceEEEECC--eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNG--AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      +....+++.+|+.+++++. ||||+++++++...+  ..|+||||+.+ +|..++.. +.++...+..++.|++.||+||
T Consensus        48 ~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~L  125 (388)
T 3oz6_A           48 NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYL  125 (388)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            4667778899999999997 999999999997643  78999999975 99999976 5799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC---------------------CCCcccccccccccCcccccC
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST---------------------SGQANTFVGTYNYMSPERISG  143 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~---------------------~~~~~~~~~~~~y~~PE~~~~  143 (262)
                      |+ .|++|+||||+||+++.++.++|+|||++......                     ........+++.|+|||++.+
T Consensus       126 H~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (388)
T 3oz6_A          126 HS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG  204 (388)
T ss_dssp             HH-TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred             Hh-CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence            99 99999999999999999999999999999764321                     111233578999999999987


Q ss_pred             -CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHH--------------------HHHhcCC---C--C---
Q 024828          144 -GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------------------EAIVDQP---P--P---  194 (262)
Q Consensus       144 -~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------~~~~~~~---~--~---  194 (262)
                       ..++.++|||||||++++|++|++||.+.+..+....+....                    ..+....   .  .   
T Consensus       205 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (388)
T 3oz6_A          205 STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDI  284 (388)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCC
T ss_pred             CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHh
Confidence             568999999999999999999999998765433222211110                    0000000   0  0   


Q ss_pred             ----------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          195 ----------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       195 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                                ..+....++++.+|+.+||+.||.+|||++|+++||||+.+....
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~  339 (388)
T 3oz6_A          285 FTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN  339 (388)
T ss_dssp             HHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGG
T ss_pred             CcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCc
Confidence                      001236789999999999999999999999999999998876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-43  Score=291.03  Aligned_cols=228  Identities=27%  Similarity=0.435  Sum_probs=179.0

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+++.+|++++.++ +||||+++++++.+++..++||||++|++|.+++.+.+.++...+..++.|++.||+|||+ .
T Consensus        52 ~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~  130 (316)
T 2ac3_A           52 HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-K  130 (316)
T ss_dssp             CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            3467889999999885 7999999999999999999999999999999999988899999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCc---EEEEecccccccccCC-------CCcccccccccccCcccccC-----CCCCcchhHH
Q 024828           89 HIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTS-------GQANTFVGTYNYMSPERISG-----GKYGYKSDIW  153 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~  153 (262)
                      |++|+||+|+||+++.++.   ++|+|||++.......       .......++..|+|||.+.+     ..++.++|||
T Consensus       131 ~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  210 (316)
T 2ac3_A          131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW  210 (316)
T ss_dssp             TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHH
T ss_pred             CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccH
Confidence            9999999999999987775   9999999987543221       11223458999999999875     4578999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCccC-chh-------hHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          154 SLGLVLLECATGQFPYSPPEQQD-GWT-------SFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       154 slG~~l~~l~~g~~p~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      ||||++|+|++|+.||......+ .|.       ........+..+......  ...+++++.+|+.+||+.||.+|||+
T Consensus       211 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (316)
T 2ac3_A          211 SLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA  290 (316)
T ss_dssp             HHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH
Confidence            99999999999999998754332 111       012233333333322111  13578999999999999999999999


Q ss_pred             HHHhcCccccccCCc
Q 024828          224 QELMTHPFLKMYGDL  238 (262)
Q Consensus       224 ~~~l~h~~~~~~~~~  238 (262)
                      +|+++||||+.....
T Consensus       291 ~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          291 AQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHSTTCC-----
T ss_pred             HHHhcChhhcCCCCc
Confidence            999999999986543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.4e-43  Score=286.97  Aligned_cols=220  Identities=37%  Similarity=0.640  Sum_probs=190.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.++++++||||+++++++.++...++||||+++++|.+++.. ++++...+..++.|++.||.+||+ .|
T Consensus        62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~  139 (303)
T 3a7i_A           62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS-EK  139 (303)
T ss_dssp             TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            4567899999999999999999999999999999999999999999999876 679999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|+.||
T Consensus       140 i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  219 (303)
T 3a7i_A          140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH  219 (303)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCC
Confidence            99999999999999999999999999977655444445567899999999999888999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      ......       .....+.....+ .....++.++.+|+.+||+.||.+|||++++++||||.......
T Consensus       220 ~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  281 (303)
T 3a7i_A          220 SELHPM-------KVLFLIPKNNPP-TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT  281 (303)
T ss_dssp             TTSCHH-------HHHHHHHHSCCC-CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred             CCcCHH-------HHHHHhhcCCCC-CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCcc
Confidence            765432       222223333332 33457899999999999999999999999999999998766543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.2e-43  Score=288.95  Aligned_cols=219  Identities=29%  Similarity=0.466  Sum_probs=176.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~~l~~l   84 (262)
                      +....+++.+|++++++++||||+++++++.+....++||||+++++|.+++.+.+.   ++...+..++.|++.||+||
T Consensus        74 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L  153 (309)
T 3p86_A           74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL  153 (309)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            456677899999999999999999999999999999999999999999999987653   99999999999999999999


Q ss_pred             hhcCC--eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           85 HHEKH--IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        85 h~~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |+ .|  ++|+||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++||||||+++|+|
T Consensus       154 H~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  232 (309)
T 3p86_A          154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL  232 (309)
T ss_dssp             HT-SSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             Hc-CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHH
Confidence            98 99  9999999999999999999999999987655444344456789999999999998899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc--Cccccc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLKM  234 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~--h~~~~~  234 (262)
                      ++|+.||......       ...............+..+++++.+|+.+||+.||.+|||++++++  +++++.
T Consensus       233 ltg~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          233 ATLQQPWGNLNPA-------QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHCCCTTTTSCHH-------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HhCCCCCCCCCHH-------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999875432       2223332233333344678999999999999999999999999987  455543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2e-43  Score=315.99  Aligned_cols=217  Identities=26%  Similarity=0.479  Sum_probs=192.3

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|.+++..+ +||+|+++++++.+.+.+|+||||++|++|.+++.+.+.+++..+..++.||+.||+|||+ .
T Consensus       383 ~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~  461 (674)
T 3pfq_A          383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-K  461 (674)
T ss_dssp             TTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            3456788999999988 7999999999999999999999999999999999998999999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ||+|+||||+|||++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|+.|
T Consensus       462 gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~P  541 (674)
T 3pfq_A          462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP  541 (674)
T ss_dssp             SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCC
Confidence            99999999999999999999999999998654444555667899999999999999999999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH-----HHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-----QELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~-----~~~l~h~~~~~~~  236 (262)
                      |.+.+.       .+....+.......  +..+++++.+||++||+.||.+||++     +|+++||||+...
T Consensus       542 f~~~~~-------~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          542 FEGEDE-------DELFQSIMEHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             SCCSSH-------HHHHHHHHSSCCCC--CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             CCCCCH-------HHHHHHHHhCCCCC--CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            987543       24445555544322  35789999999999999999999997     9999999998765

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.6e-43  Score=307.48  Aligned_cols=220  Identities=28%  Similarity=0.499  Sum_probs=188.0

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++...+  .+++..+..++.||+.||+|||+ .
T Consensus       227 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~-~  305 (576)
T 2acx_A          227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR-E  305 (576)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            34568899999999999999999999999999999999999999999998764  39999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||||+||+++.+|.++|+|||++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|+.|
T Consensus       306 gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~P  384 (576)
T 2acx_A          306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP  384 (576)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEeccCCchheEEEeCCCCeEEEecccceecccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999997654322 23345799999999999988899999999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGD  237 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~  237 (262)
                      |..............   .+....  ...+..+++++.+||.+||+.||.+||     +++|+++||||+....
T Consensus       385 F~~~~~~~~~~~i~~---~i~~~~--~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          385 FQQRKKKIKREEVER---LVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             SSCSSSCCCHHHHHH---HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             CcccccchhHHHHHH---Hhhccc--ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence            987654433222222   222222  222357899999999999999999999     8999999999998653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-43  Score=307.44  Aligned_cols=219  Identities=26%  Similarity=0.488  Sum_probs=186.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+.+|++++++++||||+++++++.+....++||||+.|++|.+.+.+.+.+++..+..++.|++.||.|||+ .|+
T Consensus        64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i  142 (486)
T 3mwu_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNI  142 (486)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTC
T ss_pred             HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            4578899999999999999999999999999999999999999999999888999999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEc---cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           91 IHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        91 ~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      +|+||||+||+++   .++.++|+|||++...... .......|++.|+|||++.+ .++.++||||+||++|+|++|..
T Consensus       143 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~  220 (486)
T 3mwu_A          143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP  220 (486)
T ss_dssp             CCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             EeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999995   4557999999998765433 23344578999999999986 58999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      ||.+....       +....+..+.....  ....+++++.+||.+||+.||.+|||+.++|+||||+......
T Consensus       221 pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          221 PFYGKNEY-------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             SSCCSSHH-------HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             CCCCCCHH-------HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            99875432       33344443332221  2246789999999999999999999999999999999876554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-43  Score=292.63  Aligned_cols=217  Identities=25%  Similarity=0.393  Sum_probs=177.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC----------------------------------------------
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----------------------------------------------   41 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------------------------------------------   41 (262)
                      .+...+.+.+|++++++++||||+++++++.+..                                              
T Consensus        44 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  123 (332)
T 3qd2_B           44 RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT  123 (332)
T ss_dssp             TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------------------------------
T ss_pred             chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccc
Confidence            4556788999999999999999999999986543                                              


Q ss_pred             -----------eEEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCc
Q 024828           42 -----------AISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  107 (262)
Q Consensus        42 -----------~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~  107 (262)
                                 ..++||||++|++|.+++.+...   .+...+..++.|++.||+|||+ .|++|+||||+||+++.++.
T Consensus       124 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~  202 (332)
T 3qd2_B          124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDV  202 (332)
T ss_dssp             --------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCC
T ss_pred             cccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCCC
Confidence                       38999999999999999987643   5666789999999999999998 99999999999999999999


Q ss_pred             EEEEecccccccccCC------------CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 024828          108 VKITDFGVSAIMASTS------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ  175 (262)
Q Consensus       108 ~~l~df~~~~~~~~~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  175 (262)
                      ++|+|||++.......            .......|++.|+|||.+.+..++.++|+||||+++|+|++|..|+.     
T Consensus       203 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----  277 (332)
T 3qd2_B          203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----  277 (332)
T ss_dssp             EEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----
T ss_pred             EEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----
Confidence            9999999997765432            12233568999999999999889999999999999999999876542     


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                          ..............+.. ....++++.+|+.+||+.||.+|||++|+++||||+..
T Consensus       278 ----~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          278 ----ERVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ----HHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ----HHHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                22233333333332221 23456788999999999999999999999999999863

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-44  Score=293.60  Aligned_cols=224  Identities=35%  Similarity=0.653  Sum_probs=181.2

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEE------CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYS------NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVL   78 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~   78 (262)
                      .....+.+.+|+.+++++ +||||+++++++..      ....++||||+++++|.+++...  ..++...+..++.|++
T Consensus        60 ~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~  139 (326)
T 2x7f_A           60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL  139 (326)
T ss_dssp             CSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHH
T ss_pred             CcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence            344557888999999999 89999999999987      46799999999999999999865  5699999999999999


Q ss_pred             HHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc-----CCCCCcchhHH
Q 024828           79 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIW  153 (262)
Q Consensus        79 ~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~  153 (262)
                      .||.|||+ .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.     +..++.++|||
T Consensus       140 ~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~  218 (326)
T 2x7f_A          140 RGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW  218 (326)
T ss_dssp             HHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred             HHHHHHHH-CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHH
Confidence            99999999 9999999999999999999999999999876654433344557899999999987     45688999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          154 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       154 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      |||+++|+|++|..||......       .....+.....+......+++.+.+||.+||..||.+|||++++++||||+
T Consensus       219 slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          219 SLGITAIEMAEGAPPLCDMHPM-------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            9999999999999999765432       222233334444444567899999999999999999999999999999999


Q ss_pred             ccCCcc
Q 024828          234 MYGDLN  239 (262)
Q Consensus       234 ~~~~~~  239 (262)
                      ......
T Consensus       292 ~~~~~~  297 (326)
T 2x7f_A          292 DQPNER  297 (326)
T ss_dssp             CCTTHH
T ss_pred             hCcccc
Confidence            877554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.8e-44  Score=295.82  Aligned_cols=224  Identities=25%  Similarity=0.453  Sum_probs=181.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--------------------------
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--------------------------   62 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------------------   62 (262)
                      ....+++.+|++++++++||||+++++++.+.+..++||||++|++|.+++...                          
T Consensus        69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (345)
T 3hko_A           69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE  148 (345)
T ss_dssp             -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence            456678999999999999999999999999999999999999999999998521                          


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCC--cEEEEecccccccccCCC--
Q 024828           63 --------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--EVKITDFGVSAIMASTSG--  124 (262)
Q Consensus        63 --------------~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~--  124 (262)
                                    ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++  .++|+|||++........  
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~  227 (345)
T 3hko_A          149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE  227 (345)
T ss_dssp             HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-
T ss_pred             ccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccc
Confidence                          123677888999999999999999 9999999999999998776  899999999976543221  


Q ss_pred             --CcccccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCC--CC
Q 024828          125 --QANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PS  198 (262)
Q Consensus       125 --~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  198 (262)
                        ......+++.|+|||.+.+  ..++.++||||||+++|+|++|+.||......       .....+........  ..
T Consensus       228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~  300 (345)
T 3hko_A          228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFENPNY  300 (345)
T ss_dssp             -------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTSGGG
T ss_pred             cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCCccc
Confidence              2234568999999999875  56889999999999999999999999875543       22233333322221  12


Q ss_pred             CCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          199 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       199 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      ..+++++.+||.+||+.||.+|||+.++++||||+...+.-.
T Consensus       301 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~~  342 (345)
T 3hko_A          301 NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY  342 (345)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCSS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhhE
Confidence            347899999999999999999999999999999998876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.1e-43  Score=285.67  Aligned_cols=219  Identities=26%  Similarity=0.433  Sum_probs=185.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++...+.++...+..++.|++.||.|||+ .|
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~  126 (304)
T 2jam_A           48 FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE-NG  126 (304)
T ss_dssp             ----HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34567889999999999999999999999999999999999999999999988899999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEE---ccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           90 IIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        90 i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      ++|+||+|+||++   +.++.++|+|||.+......  ......+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       127 i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  204 (304)
T 2jam_A          127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY  204 (304)
T ss_dssp             CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence            9999999999999   67889999999998654322  223346889999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .||......       .....+..+...  ......+++++.+++.+||..||++|||++++++||||+.....
T Consensus       205 ~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (304)
T 2jam_A          205 PPFYEETES-------KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL  271 (304)
T ss_dssp             CTTTTSCHH-------HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred             CCCCCCCHH-------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence            999775432       233333333322  22235689999999999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=288.19  Aligned_cols=218  Identities=24%  Similarity=0.415  Sum_probs=174.1

Q ss_pred             HHHHHHHHHHhcC---CCCeeEeeceEEEECC-----eEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHH
Q 024828           13 RQIAQELKINQSS---QCPYVVVCYQSFYSNG-----AISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        13 ~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~l~   82 (262)
                      ..+.+|+++++++   +||||+++++++.+..     ..++|||++.+ +|.+++.....  +++..+..++.|++.||+
T Consensus        56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~  134 (308)
T 3g33_A           56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD  134 (308)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            3455677666666   5999999999998755     58999999975 99999988754  999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |||+ .|++|+||||+||+++.++.++|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|
T Consensus       135 ~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  212 (308)
T 3g33_A          135 FLHA-NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM  212 (308)
T ss_dssp             HHHH-TTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHT
T ss_pred             HHHH-CCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHH
Confidence            9999 99999999999999999999999999998765432 233445789999999999988899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCC---------------------CCCCCCHHHHHHHHHhhcCCcCCCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA---------------------PSDQFSPEFCSFISACVQKEPQQRL  221 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rp  221 (262)
                      ++|+.||......+...   ..............                     ....+++++.+||.+||+.||.+||
T Consensus       213 ~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  289 (308)
T 3g33_A          213 FRRKPLFCGNSEADQLG---KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI  289 (308)
T ss_dssp             TTSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HhCCCCCCCCCHHHHHH---HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC
Confidence            99999998765433221   22222111111000                     0135788999999999999999999


Q ss_pred             CHHHHhcCccccccC
Q 024828          222 SAQELMTHPFLKMYG  236 (262)
Q Consensus       222 t~~~~l~h~~~~~~~  236 (262)
                      |++|+|+||||+...
T Consensus       290 t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          290 SAFRALQHSYLHKDE  304 (308)
T ss_dssp             CHHHHHTSTTC----
T ss_pred             CHHHHhcCccccCCC
Confidence            999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.2e-43  Score=304.68  Aligned_cols=218  Identities=25%  Similarity=0.466  Sum_probs=188.2

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|+.++++++||||+++++++.++...|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|+
T Consensus        89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i  167 (504)
T 3q5i_A           89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK-HNI  167 (504)
T ss_dssp             THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCe
Confidence            4578899999999999999999999999999999999999999999999988999999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCC---cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           91 IHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      +|+||+|+||+++.++   .++|+|||++...... .......|++.|+|||.+. ..++.++||||+|+++|+|++|..
T Consensus       168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~  245 (504)
T 3q5i_A          168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP  245 (504)
T ss_dssp             ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCC
Confidence            9999999999998776   6999999999765433 2334557899999999987 468999999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      ||.+....       +....+..+......  ...+++++.+||.+||..||.+|||++|+|+||||+.....
T Consensus       246 pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          246 PFGGQNDQ-------DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             SSCCSSHH-------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCCCCCHH-------HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            99875432       334444444332211  14688999999999999999999999999999999887654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.5e-43  Score=292.43  Aligned_cols=217  Identities=26%  Similarity=0.506  Sum_probs=184.5

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +..++.+.+|+.+++++ +||||+++++++...+..++||||++|++|.+++.....++...+..++.|++.||.|||+ 
T Consensus       140 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-  218 (365)
T 2y7j_A          140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-  218 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            34467889999999999 8999999999999999999999999999999999988899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC------CCCCcchhHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~~l~~  161 (262)
                      .|++|+||+|+||+++.++.++++|||++...... .......|++.|+|||++.+      ..++.++||||||+++|+
T Consensus       219 ~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e  297 (365)
T 2y7j_A          219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT  297 (365)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHH
T ss_pred             CCeecCCCCHHHEEECCCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHH
Confidence            99999999999999999999999999998765433 23344678999999998853      357889999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      |++|..||......       .....+..+......  ...+++++.+|+.+||+.||++|||++++++||||++
T Consensus       298 ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          298 LLAGSPPFWHRRQI-------LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSSCSSCCSSHH-------HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHCCCCCCCCCHH-------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            99999999764332       222333333222111  1367889999999999999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.4e-43  Score=284.19  Aligned_cols=220  Identities=26%  Similarity=0.482  Sum_probs=185.0

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|++++++++||||+++++++.+....++||||+++++|.+++.+.+.++...+..++.|++.||.+||+ .|+
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i  129 (283)
T 3bhy_A           51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS-KRI  129 (283)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Confidence            3678899999999999999999999999999999999999999999999988899999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCC----cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           91 IHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      +|+||+|+||+++.++    .++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++++|++|.
T Consensus       130 ~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  208 (283)
T 3bhy_A          130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  208 (283)
T ss_dssp             ECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCChHHEEEecCCCCCCceEEEecccceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCC
Confidence            9999999999998777    79999999987654332 223446889999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      .||......       .....+.......  .....+++.+.+++.+||..||++|||+.++++||||+......
T Consensus       209 ~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          209 SPFLGETKQ-------ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             CTTCCSSHH-------HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             CCCCCcchH-------HHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            999875432       2223333222211  11246789999999999999999999999999999998876544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=288.35  Aligned_cols=209  Identities=27%  Similarity=0.465  Sum_probs=181.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG-SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..+.+.+|++++++++||||+++++++.+.+..++|||++.++ +|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~  150 (335)
T 3dls_A           72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL-KD  150 (335)
T ss_dssp             TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            3446778999999999999999999999999999999998665 999999998899999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      ++|+||||+||+++.++.++|+|||++....... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|..|
T Consensus       151 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  229 (335)
T 3dls_A          151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP  229 (335)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eEEeccCHHHEEEcCCCcEEEeecccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCc
Confidence            9999999999999999999999999987654332 3334578999999999988776 8899999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      |......             ...  ....+..+++++.+|+.+||+.||.+|||++++++||||+...
T Consensus       230 f~~~~~~-------------~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          230 FCELEET-------------VEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CSSGGGG-------------TTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             hhhHHHH-------------Hhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            9763321             111  1122346899999999999999999999999999999997644

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-43  Score=306.44  Aligned_cols=220  Identities=26%  Similarity=0.496  Sum_probs=188.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+.+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++...+.+++..+..++.|++.||.|||+ .
T Consensus        67 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~  145 (484)
T 3nyv_A           67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK-N  145 (484)
T ss_dssp             SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            345678999999999999999999999999999999999999999999999998899999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEE---ccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||||+||++   +.++.++|+|||++....... ......|++.|+|||++.+ .++.++||||+|+++|+|++|
T Consensus       146 ~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g  223 (484)
T 3nyv_A          146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSG  223 (484)
T ss_dssp             TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHC
Confidence            99999999999999   456789999999987654332 3334578999999999986 689999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .+||......       +....+..+.....  ....+++++.+||.+||+.||.+|||++++|+||||+.....
T Consensus       224 ~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          224 CPPFNGANEY-------DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             SCSSCCSSHH-------HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             CCCCCCCCHH-------HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence            9999875432       33344444433222  124688999999999999999999999999999999876643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-42  Score=282.57  Aligned_cols=222  Identities=27%  Similarity=0.473  Sum_probs=186.6

Q ss_pred             HHHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +..++.+.+|+++++++. ||||+++++++.++...++||||+++++|.+++.....++...+..++.|++.||.+||+ 
T Consensus        64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-  142 (298)
T 1phk_A           64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-  142 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            355678899999999995 999999999999999999999999999999999988899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc------CCCCCcchhHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS------GGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~------~~~~~~~~Di~slG~~l~~  161 (262)
                      .|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.      ...++.++|+||||+++++
T Consensus       143 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~  221 (298)
T 1phk_A          143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT  221 (298)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred             CCcccCCCCcceEEEcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence            99999999999999999999999999998765432 2334456889999999874      4457899999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      |++|..||......       .....+..+....  .....+++++.+++.+||+.||.+|||++++++||||+......
T Consensus       222 l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          222 LLAGSPPFWHRKQM-------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             HHHSSCSSCCSSHH-------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             HHHCCCCCcCccHH-------HHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence            99999999765432       2223333332221  12246889999999999999999999999999999999876544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.8e-43  Score=294.21  Aligned_cols=221  Identities=28%  Similarity=0.443  Sum_probs=180.0

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCC-----CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQ-----CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQ   76 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~   76 (262)
                      .+.......+.+..|+.+++.+.     ||||+++++++...+..++|||++ +++|.+++....  .++...+..++.|
T Consensus        67 ~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~q  145 (360)
T 3llt_A           67 VVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE  145 (360)
T ss_dssp             EECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHH
T ss_pred             EeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHH
Confidence            33344666778889999999886     999999999999999999999999 889999998764  5999999999999


Q ss_pred             HHHHHHHHhhcCCeeeCCCCCCCEEEcc-------------------------CCcEEEEecccccccccCCCCcccccc
Q 024828           77 VLKGLLYLHHEKHIIHRDLKPSNLLINH-------------------------RGEVKITDFGVSAIMASTSGQANTFVG  131 (262)
Q Consensus        77 l~~~l~~lh~~~~i~H~dl~p~nil~~~-------------------------~~~~~l~df~~~~~~~~~~~~~~~~~~  131 (262)
                      ++.||+|||+ .|++|+||||+||+++.                         ++.++|+|||++.....   ......+
T Consensus       146 i~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~g  221 (360)
T 3llt_A          146 ILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIIN  221 (360)
T ss_dssp             HHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCS
T ss_pred             HHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccC
Confidence            9999999999 99999999999999975                         78899999999876432   2334578


Q ss_pred             cccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-----------------
Q 024828          132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-----------------  194 (262)
Q Consensus       132 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------  194 (262)
                      ++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..    ..+.........                 
T Consensus       222 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  297 (360)
T 3llt_A          222 TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL----AMMESIIQPIPKNMLYEATKTNGSKYVNK  297 (360)
T ss_dssp             CGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHTCCCCHHHHHHHTTSGGGGGEET
T ss_pred             cccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH----HHHHHhcCCCCHHHHhhhhhccCccccCc
Confidence            99999999999989999999999999999999999999875543221    111111111000                 


Q ss_pred             --------C----------------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          195 --------S----------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       195 --------~----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                              .                ......++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus       298 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             TTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             ccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence                    0                00012247788999999999999999999999999996

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=296.12  Aligned_cols=226  Identities=27%  Similarity=0.458  Sum_probs=183.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~   80 (262)
                      .++...+++.+|++++++++||||+++++++....      .+|+||||+ +++|.++++. ..++...+..++.|++.|
T Consensus        63 ~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~  140 (367)
T 1cm8_A           63 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKG  140 (367)
T ss_dssp             SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHH
Confidence            35667788999999999999999999999997653      469999999 7799999987 679999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVL  159 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l  159 (262)
                      |+|||+ .|++|+||||+||+++.++.++|+|||++.....   ......++..|+|||++.+ ..++.++|+||+||++
T Consensus       141 L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  216 (367)
T 1cm8_A          141 LRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM  216 (367)
T ss_dssp             HHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred             HHHHHH-CCccccCcCHHHEEEcCCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence            999999 9999999999999999999999999999876543   2334578999999999887 5689999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHH--------------------HHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYEL--------------------MEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p  217 (262)
                      ++|++|+.||.+.+..+....+...                    ...+....  .........++++.+|+.+||..||
T Consensus       217 ~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP  296 (367)
T 1cm8_A          217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA  296 (367)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCCh
Confidence            9999999999876543322221111                    00100000  0011123568999999999999999


Q ss_pred             CCCCCHHHHhcCccccccCCc
Q 024828          218 QQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .+|||++++++||||+...+.
T Consensus       297 ~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          297 EQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             TTSCCHHHHHHSGGGTTTC--
T ss_pred             hHCCCHHHHhcChHHHhhcCC
Confidence            999999999999999987653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.8e-43  Score=281.11  Aligned_cols=215  Identities=27%  Similarity=0.471  Sum_probs=177.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+++.+|+++++.++||||+++++++.+.+..++||||+++++|.+++.+.+.++...+..++.|++.||.+||+ .|+
T Consensus        54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i  132 (276)
T 2h6d_A           54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMV  132 (276)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HCS
T ss_pred             HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCC
Confidence            3567899999999999999999999999999999999999999999999988899999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      +|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.+.+..+ +.++|+||||+++++|++|+.||
T Consensus       133 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             SCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCCCChhhEEECCCCCEEEeecccccccCCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987654322 2234467889999999987765 68999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ......       .....+......  .+..++.++.+++.+||+.||.+|||++++++||||+...
T Consensus       212 ~~~~~~-------~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          212 DDEHVP-------TLFKKIRGGVFY--IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             CCSSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             CCCcHH-------HHHHHhhcCccc--CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence            764332       223333333222  2346789999999999999999999999999999997643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=291.60  Aligned_cols=222  Identities=27%  Similarity=0.457  Sum_probs=181.4

Q ss_pred             hhHHHHHHHHHHHHHHhcCCC--CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQC--PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+....+.+.+|+.++++++|  |||+++++++.++...++|||+. +++|.+++.+.+.++...+..++.|++.||.||
T Consensus        46 ~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~l  124 (343)
T 3dbq_A           46 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI  124 (343)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            356667889999999999976  99999999999999999999965 679999999989999999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccC-----------CCCCcchh
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISG-----------GKYGYKSD  151 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~-----------~~~~~~~D  151 (262)
                      |+ .|++|+||||+||+++ ++.++|+|||++........  ......|++.|+|||++.+           ..++.++|
T Consensus       125 H~-~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  202 (343)
T 3dbq_A          125 HQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  202 (343)
T ss_dssp             HH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHH
T ss_pred             Hh-CCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhh
Confidence            99 9999999999999995 78899999999976543322  2234578999999999864           56889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      |||||+++|+|++|+.||.....      .................+...++++.+|+.+||+.||.+|||+.++++|||
T Consensus       203 iwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          203 VWSLGCILYYMTYGKTPFQQIIN------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HHHHHHHHHHHHhCCCcchhhhh------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence            99999999999999999975432      122333344444334444567889999999999999999999999999999


Q ss_pred             ccccCC
Q 024828          232 LKMYGD  237 (262)
Q Consensus       232 ~~~~~~  237 (262)
                      |+....
T Consensus       277 ~~~~~~  282 (343)
T 3dbq_A          277 VQIQTH  282 (343)
T ss_dssp             HHSCCC
T ss_pred             ccccCC
Confidence            986543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-43  Score=303.98  Aligned_cols=225  Identities=25%  Similarity=0.451  Sum_probs=175.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +....+++.+|+++++.++||||+++++++...      ...|+||||+++ +|.+.+..  .++...+..++.|++.||
T Consensus       101 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL  177 (464)
T 3ttj_A          101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGI  177 (464)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHH
Confidence            566778899999999999999999999999654      457999999976 77777754  589999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      +|||+ .|++|+||||+||+++.++.++|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+
T Consensus       178 ~~lH~-~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  255 (464)
T 3ttj_A          178 KHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  255 (464)
T ss_dssp             HHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             HHHHH-CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHH
Confidence            99999 99999999999999999999999999999765432 23345678999999999999899999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHH---------------HHHhcCCCCCCCC-------C-----------CCCHHHHHH
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELM---------------EAIVDQPPPSAPS-------D-----------QFSPEFCSF  208 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~-------~-----------~~~~~l~~l  208 (262)
                      |++|+.||.+.+..+.+..+....               .............       .           ..++++.+|
T Consensus       256 ll~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  335 (464)
T 3ttj_A          256 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL  335 (464)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHH
Confidence            999999998866543332222211               1111111100000       0           014678999


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |.+||..||++|||++|+|+||||+.+..
T Consensus       336 l~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          336 LSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             HHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence            99999999999999999999999987653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.2e-43  Score=295.73  Aligned_cols=221  Identities=26%  Similarity=0.425  Sum_probs=174.3

Q ss_pred             HHHHHHHHHHh-cCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 024828           13 RQIAQELKINQ-SSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        13 ~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ..+.+|+.++. ..+||||+++++++..    ...+|+||||++|++|.+++...+  .+++..+..++.|++.||.|||
T Consensus        99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH  178 (400)
T 1nxk_A           99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  178 (400)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34667888774 4589999999999876    567899999999999999998754  5999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEcc---CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .|++|+||||+||+++.   ++.++|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|
T Consensus       179 ~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  256 (400)
T 1nxk_A          179 S-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL  256 (400)
T ss_dssp             H-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHH
T ss_pred             H-CCccccCcCcceEEEecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHH
Confidence            9 99999999999999987   788999999998765432 223455789999999999988899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ++|+.||...............+.. .....+......+++++.+||.+||+.||++|||++++++||||....
T Consensus       257 l~g~~pf~~~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          257 LCGYPPFYSNHGLAISPGMKTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             HHSSCSCCCCTTCSSCCSHHHHHHH-TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             HhCCCCCCCCccccccHHHHHHHHc-CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            9999999876544322222222221 111122222346899999999999999999999999999999997654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-42  Score=297.26  Aligned_cols=231  Identities=25%  Similarity=0.376  Sum_probs=178.1

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      .+....+++.+|++++++++||||+++++++...     ...|+|||++.+ +|.++++....+++..+..++.||+.||
T Consensus        64 ~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL  142 (432)
T 3n9x_A           64 EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGE  142 (432)
T ss_dssp             TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHH
Confidence            3566778999999999999999999999999776     579999999965 9999999888899999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC----------------------CcccccccccccCcc
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----------------------QANTFVGTYNYMSPE  139 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----------------------~~~~~~~~~~y~~PE  139 (262)
                      +|||+ .|++|+||||+||+++.++.++|+|||++........                      ......++..|+|||
T Consensus       143 ~~LH~-~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  221 (432)
T 3n9x_A          143 NFIHE-SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE  221 (432)
T ss_dssp             HHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred             HHHHH-CCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence            99999 9999999999999999999999999999986543221                      224567899999999


Q ss_pred             cc-cCCCCCcchhHHHHHHHHHHHHhCCCC-----------CCCCCccC----c---------hhhHHHHH---------
Q 024828          140 RI-SGGKYGYKSDIWSLGLVLLECATGQFP-----------YSPPEQQD----G---------WTSFYELM---------  185 (262)
Q Consensus       140 ~~-~~~~~~~~~Di~slG~~l~~l~~g~~p-----------~~~~~~~~----~---------~~~~~~~~---------  185 (262)
                      ++ .+..++.++|||||||++|+|++|..|           |.+.+...    .         .......+         
T Consensus       222 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~  301 (432)
T 3n9x_A          222 LILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE  301 (432)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCH
T ss_pred             HHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCH
Confidence            86 445699999999999999999985444           33322100    0         00000000         


Q ss_pred             ------------HHHhcCCCCCC-----CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          186 ------------EAIVDQPPPSA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       186 ------------~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                                  ..+........     ....+++++.+||.+||..||.+|||++|+|+||||+......
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          302 DDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence                        11111000000     0135789999999999999999999999999999999887544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=285.30  Aligned_cols=227  Identities=33%  Similarity=0.558  Sum_probs=179.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++....   .++...+..++.|++.||.+||
T Consensus        60 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  139 (295)
T 2clq_A           60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH  139 (295)
T ss_dssp             C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH
Confidence            4456789999999999999999999999999999999999999999999998752   4678899999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCCcccccccccccCcccccCCC--CCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l  162 (262)
                      + .|++|+||+|+||+++. ++.++|+|||.+..............++..|+|||.+.+..  ++.++|+||||+++|+|
T Consensus       140 ~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l  218 (295)
T 2clq_A          140 D-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM  218 (295)
T ss_dssp             H-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHH
T ss_pred             h-CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHH
Confidence            9 99999999999999987 88999999999877654433344567899999999987643  78999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccch
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  242 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~  242 (262)
                      ++|+.||.......     ............+ ..+..+++++.+++.+||+.||++|||++++++||||+.....+...
T Consensus       219 ~~g~~pf~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~  292 (295)
T 2clq_A          219 ATGKPPFYELGEPQ-----AAMFKVGMFKVHP-EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ  292 (295)
T ss_dssp             HHTSCTTGGGSSHH-----HHHHHHHHHCCCC-CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--------
T ss_pred             HHCCCCccCCCchh-----HHHHhhccccccc-cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCCCC
Confidence            99999997543221     1111111122222 23357899999999999999999999999999999999877655443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.5e-43  Score=285.03  Aligned_cols=232  Identities=37%  Similarity=0.682  Sum_probs=180.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      .....+.+.++...++.++||||+++++++.+++..++||||++| +|.+++..    ...+++..+..++.|++.||+|
T Consensus        46 ~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~  124 (290)
T 3fme_A           46 SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH  124 (290)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            344444555666668889999999999999999999999999976 98877754    4679999999999999999999


Q ss_pred             HhhcC-CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccc----cCCCCCcchhHHHHHHH
Q 024828           84 LHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLV  158 (262)
Q Consensus        84 lh~~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~----~~~~~~~~~Di~slG~~  158 (262)
                      ||+ . |++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+    .+..++.++|+||+|++
T Consensus       125 lH~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i  202 (290)
T 3fme_A          125 LHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT  202 (290)
T ss_dssp             HHH-HSCCCCCCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred             Hhh-cCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence            998 7 99999999999999999999999999987654332 22334688999999996    45568999999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +++|++|+.||......      ............+......+++++.+++.+||+.||++|||++++++||||+...+.
T Consensus       203 l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~  276 (290)
T 3fme_A          203 MIELAILRFPYDSWGTP------FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK  276 (290)
T ss_dssp             HHHHHHTSCSSCCCSCH------HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             HHHHHHCCCCccccCch------HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc
Confidence            99999999999764322      122333334444455556789999999999999999999999999999999987777


Q ss_pred             ccchhhHhhh
Q 024828          239 NVDLSEYFTD  248 (262)
Q Consensus       239 ~~~~~~~~~~  248 (262)
                      ...+.++++.
T Consensus       277 ~~~~~~~~~~  286 (290)
T 3fme_A          277 GTDVASFVKL  286 (290)
T ss_dssp             CCCHHHHHHH
T ss_pred             ccCHHHHHHH
Confidence            7666665543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-42  Score=280.32  Aligned_cols=212  Identities=25%  Similarity=0.347  Sum_probs=177.5

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l~   82 (262)
                      +.....++.+|+.++..+ +||||+++++++.+.+..++||||++|++|.+++.+.    +.+++..+..++.|++.||.
T Consensus        50 ~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~  129 (289)
T 1x8b_A           50 GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR  129 (289)
T ss_dssp             TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHH
Confidence            355677888999999999 9999999999999999999999999999999999765    67999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccC-------------------CcEEEEecccccccccCCCCcccccccccccCcccccC
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHR-------------------GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG  143 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~-------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  143 (262)
                      |||+ .|++|+||+|+||+++.+                   ..++++|||.+.......    ...++..|+|||.+.+
T Consensus       130 ~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~  204 (289)
T 1x8b_A          130 YIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQE  204 (289)
T ss_dssp             HHHH-TTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTT
T ss_pred             HHHh-CCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcC
Confidence            9999 999999999999999844                   379999999987654322    3358899999999987


Q ss_pred             C-CCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          144 G-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       144 ~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                      . .++.++||||||+++++|++|.+++....          ....+..+..+.. +..+++++.+++.+||+.||++|||
T Consensus       205 ~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps  273 (289)
T 1x8b_A          205 NYTHLPKADIFALALTVVCAAGAEPLPRNGD----------QWHEIRQGRLPRI-PQVLSQEFTELLKVMIHPDPERRPS  273 (289)
T ss_dssp             CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----------HHHHHHTTCCCCC-SSCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCchhhHHHHHHHHHHHhcCCCCCcchh----------HHHHHHcCCCCCC-CcccCHHHHHHHHHHhCCCcccCCC
Confidence            6 46689999999999999999987765431          1233334443333 3578999999999999999999999


Q ss_pred             HHHHhcCcccccc
Q 024828          223 AQELMTHPFLKMY  235 (262)
Q Consensus       223 ~~~~l~h~~~~~~  235 (262)
                      ++++++||||+..
T Consensus       274 ~~~ll~h~~~~~~  286 (289)
T 1x8b_A          274 AMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHTCTTC---
T ss_pred             HHHHhhChHhhhh
Confidence            9999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.2e-43  Score=290.18  Aligned_cols=225  Identities=25%  Similarity=0.499  Sum_probs=185.2

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ......+.+|+.+++.+ +||||+++++++.+.+..++||||+.|++|.+++...  +.+++..+..++.|++.||+|||
T Consensus        69 ~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH  148 (327)
T 3lm5_A           69 QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH  148 (327)
T ss_dssp             EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            34467889999999999 5699999999999999999999999999999998553  67999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEcc---CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .|++|+||+|+||+++.   ++.++|+|||++....... ......+++.|+|||++.+..++.++|+||||+++|+|
T Consensus       149 ~-~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l  226 (327)
T 3lm5_A          149 Q-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML  226 (327)
T ss_dssp             H-TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             H-CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHH
Confidence            9 99999999999999987   7899999999997654332 22345789999999999988999999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      ++|+.||......+.    ...+... ....+......+++.+.+|+.+||+.||.+|||++++++||||+.......
T Consensus       227 l~g~~pf~~~~~~~~----~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          227 LTHTSPFVGEDNQET----YLNISQV-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             HHSSCSSCCSSHHHH----HHHHHHT-CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             HhCCCCCCCCCchHH----HHHHHhc-ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence            999999987544321    1111111 222233333578999999999999999999999999999999998876554

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=293.80  Aligned_cols=221  Identities=24%  Similarity=0.387  Sum_probs=183.1

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      .+.+.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++... ..++...+..++.|++.||+|||+ .|+
T Consensus        56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i  133 (346)
T 1ua2_A           56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWI  133 (346)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTC
T ss_pred             hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCE
Confidence            35788999999999999999999999999999999999977 999988765 368999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      +|+||+|+||+++.++.++|+|||++..............+++.|+|||.+.+. .++.++||||||+++|+|++|.+||
T Consensus       134 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~  213 (346)
T 1ua2_A          134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL  213 (346)
T ss_dssp             CCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999998765555455556789999999999765 4889999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCC----------------------CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSA----------------------PSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ......+.   ................                      ....+++++.+||.+||..||.+|||++|++
T Consensus       214 ~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  290 (346)
T 1ua2_A          214 PGDSDLDQ---LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL  290 (346)
T ss_dssp             CCSSHHHH---HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred             CCCCHHHH---HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence            87654322   1222222211110000                      0135678999999999999999999999999


Q ss_pred             cCccccccCC
Q 024828          228 THPFLKMYGD  237 (262)
Q Consensus       228 ~h~~~~~~~~  237 (262)
                      +||||+..+.
T Consensus       291 ~h~~f~~~~~  300 (346)
T 1ua2_A          291 KMKYFSNRPG  300 (346)
T ss_dssp             TSGGGTSSSC
T ss_pred             cChhhhcCCC
Confidence            9999987653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-43  Score=302.66  Aligned_cols=230  Identities=22%  Similarity=0.321  Sum_probs=176.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      +....+++.+|+++|++++||||+++++++...     ...|+|||++. ++|.+++.....+++..+..++.||+.||+
T Consensus        92 ~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~  170 (458)
T 3rp9_A           92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVK  170 (458)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHH
Confidence            566778899999999999999999999998543     56999999995 599999998888999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC---------------------------CCcccccccccc
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---------------------------GQANTFVGTYNY  135 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------------~~~~~~~~~~~y  135 (262)
                      |||+ .|++|+||||+|||++.++.++|+|||++.......                           ......+||+.|
T Consensus       171 ~LH~-~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  249 (458)
T 3rp9_A          171 YVHS-AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY  249 (458)
T ss_dssp             HHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTT
T ss_pred             HHHh-CCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccc
Confidence            9999 999999999999999999999999999997654221                           122334679999


Q ss_pred             cCcccc-cCCCCCcchhHHHHHHHHHHHHh-----------CCCCCCCCCccCc----------------hhhHHHHHHH
Q 024828          136 MSPERI-SGGKYGYKSDIWSLGLVLLECAT-----------GQFPYSPPEQQDG----------------WTSFYELMEA  187 (262)
Q Consensus       136 ~~PE~~-~~~~~~~~~Di~slG~~l~~l~~-----------g~~p~~~~~~~~~----------------~~~~~~~~~~  187 (262)
                      +|||++ .+..++.++|||||||++|+|++           |+++|.+......                .......+..
T Consensus       250 ~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~  329 (458)
T 3rp9_A          250 RAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN  329 (458)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHH
T ss_pred             cChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHH
Confidence            999986 45569999999999999999998           6666655431100                0001111111


Q ss_pred             Hh--------------------cCCCC------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          188 IV--------------------DQPPP------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       188 ~~--------------------~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      +.                    .....      .......++++.+||.+||..||++|||++|+|+||||+......
T Consensus       330 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          330 ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             HHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             HcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            10                    00000      001134589999999999999999999999999999999886543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-42  Score=289.13  Aligned_cols=224  Identities=24%  Similarity=0.376  Sum_probs=179.6

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEE--------CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYS--------NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l   81 (262)
                      ....+.+|++++++++||||+++++++.+        ++..++||||+.+ +|.+.+... ..++...+..++.|++.||
T Consensus        59 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l  137 (351)
T 3mi9_A           59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL  137 (351)
T ss_dssp             SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence            34577899999999999999999999987        4568999999976 888777654 5799999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC----CCCcccccccccccCcccccCC-CCCcchhHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST----SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLG  156 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG  156 (262)
                      +|||+ .|++|+||||+||+++.++.++|+|||++......    ........+++.|+|||++.+. .++.++||||||
T Consensus       138 ~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG  216 (351)
T 3mi9_A          138 YYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG  216 (351)
T ss_dssp             HHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred             HHHHH-CCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence            99999 99999999999999999999999999998765422    1222345678999999998764 579999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCC---------------------------CCCHHHHHHH
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD---------------------------QFSPEFCSFI  209 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~li  209 (262)
                      +++++|++|+.||......+.    ...+........+.....                           ..++++.+||
T Consensus       217 ~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  292 (351)
T 3mi9_A          217 CIMAEMWTRSPIMQGNTEQHQ----LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI  292 (351)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHH
Confidence            999999999999987654322    222222222222211111                           0267799999


Q ss_pred             HHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          210 SACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       210 ~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      .+||+.||.+|||++|+++||||+.......
T Consensus       293 ~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  323 (351)
T 3mi9_A          293 DKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  323 (351)
T ss_dssp             HHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred             HHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence            9999999999999999999999987665443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.1e-43  Score=285.28  Aligned_cols=223  Identities=32%  Similarity=0.606  Sum_probs=183.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+++.+|+++++.++||||+++++++.+++..++||||+++++|.+++.. .+.++...+..++.|++.||.|||+ 
T Consensus        57 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-  135 (302)
T 2j7t_A           57 EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS-  135 (302)
T ss_dssp             -CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc-
Confidence            34467889999999999999999999999999999999999999999999876 4679999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccc-----cCCCCCcchhHHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~-----~~~~~~~~~Di~slG~~l~~l  162 (262)
                      .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+     .+..++.++|+||||+++++|
T Consensus       136 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l  215 (302)
T 2j7t_A          136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM  215 (302)
T ss_dssp             TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHH
T ss_pred             CCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHH
Confidence            999999999999999999999999999875443322233345688999999998     356689999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      ++|..||......       ........... ....+..++.++.+++.+||+.||.+|||++++++||||+......
T Consensus       216 ~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          216 AQIEPPHHELNPM-------RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK  286 (302)
T ss_dssp             HHSSCTTTTSCHH-------HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred             hcCCCCCccCCHH-------HHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence            9999999875432       22222222222 2223456789999999999999999999999999999999877643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-42  Score=293.36  Aligned_cols=222  Identities=27%  Similarity=0.471  Sum_probs=182.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCC--CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQ--CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+....+.+.+|++++++++  ||||+++++++..++..|+|||+ .+++|.+++.+.+.++...+..++.|++.||.||
T Consensus        93 ~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~l  171 (390)
T 2zmd_A           93 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI  171 (390)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            35667788999999999996  59999999999999999999995 5779999999988999999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccC-----------CCCCcchh
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISG-----------GKYGYKSD  151 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~-----------~~~~~~~D  151 (262)
                      |+ .|++|+||||+||+++ ++.++|+|||++........  ......|++.|+|||++.+           ..++.++|
T Consensus       172 H~-~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  249 (390)
T 2zmd_A          172 HQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD  249 (390)
T ss_dssp             HT-TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHH
T ss_pred             HH-CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhh
Confidence            98 9999999999999994 68899999999976543221  2234578999999999865           35889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      ||||||++|+|++|+.||......      ......+.........+...++++.+|+.+||+.||.+|||+.++++|||
T Consensus       250 iwSlGvil~ell~G~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          250 VWSLGCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HHHHHHHHHHHHHCCCcchhhhHH------HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence            999999999999999999754321      12333444444333334556889999999999999999999999999999


Q ss_pred             ccccCC
Q 024828          232 LKMYGD  237 (262)
Q Consensus       232 ~~~~~~  237 (262)
                      |+....
T Consensus       324 ~~~~~~  329 (390)
T 2zmd_A          324 VQIQTH  329 (390)
T ss_dssp             HHSCC-
T ss_pred             ccccCc
Confidence            986654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=285.05  Aligned_cols=213  Identities=26%  Similarity=0.404  Sum_probs=173.6

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ......+..+|+..+.++ +||||+++++++.+++..++|||++ +++|.+++...+ .+++..+..++.|++.||+|||
T Consensus        96 ~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  174 (311)
T 3p1a_A           96 GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH  174 (311)
T ss_dssp             SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344555556666655555 9999999999999999999999999 559999887654 6999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      + .|++|+||||+||+++.++.++|+|||++....... ......|++.|+|||++.+ .++.++||||||+++++|++|
T Consensus       175 ~-~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g  251 (311)
T 3p1a_A          175 S-QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACN  251 (311)
T ss_dssp             H-TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHT
T ss_pred             H-CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhC
Confidence            9 999999999999999999999999999987654332 3334568999999999886 789999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      ..++....          ....+..+..+......+++++.+|+.+||+.||++|||++++++||||+.
T Consensus       252 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          252 MELPHGGE----------GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CCCCSSHH----------HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CCCCCCcc----------HHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            76664421          122333333333334568999999999999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.9e-43  Score=290.42  Aligned_cols=219  Identities=32%  Similarity=0.521  Sum_probs=185.6

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHH
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF------LKK--VKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      +.+.+|++++++++||||+++++++.+.+..++||||+++++|.++      +.+  ...++...+..++.|++.||.||
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999999999998      665  56799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCc-chhHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGY-KSDIWSLGLVLLEC  162 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~-~~Di~slG~~l~~l  162 (262)
                      |+..|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+. .++. ++|+||||+++++|
T Consensus       168 H~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l  245 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM  245 (348)
T ss_dssp             HHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred             hccCCEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence            96489999999999999999999999999998765433  33345688999999999887 5655 99999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC-----------------CCCCCHHHHHHHHHhhcCCcCCCCCHHH
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP-----------------SDQFSPEFCSFISACVQKEPQQRLSAQE  225 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~  225 (262)
                      ++|..||......      .+....+..+......                 ...+++++.+|+.+||+.||.+|||+++
T Consensus       246 ~~g~~pf~~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  319 (348)
T 2pml_X          246 FYNVVPFSLKISL------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED  319 (348)
T ss_dssp             HHSSCSSCCSSCS------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HhCCCCCCCCCcH------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence            9999999876542      1333444433322221                 1468899999999999999999999999


Q ss_pred             HhcCccccccCCcc
Q 024828          226 LMTHPFLKMYGDLN  239 (262)
Q Consensus       226 ~l~h~~~~~~~~~~  239 (262)
                      +++||||+......
T Consensus       320 ~l~hp~f~~~~~~~  333 (348)
T 2pml_X          320 ALKHEWLADTNIED  333 (348)
T ss_dssp             HHTSGGGTTCCHHH
T ss_pred             HhcCccccCCCHHH
Confidence            99999999876444

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.2e-43  Score=283.08  Aligned_cols=220  Identities=30%  Similarity=0.521  Sum_probs=184.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~l~~~l   81 (262)
                      ++..++.+.+|++++++++||||+++++++.+  +...++||||+++++|.+++...    ..++...+..++.|++.||
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l  124 (279)
T 2w5a_A           45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  124 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence            56678899999999999999999999998854  56899999999999999999764    3499999999999999999


Q ss_pred             HHHhhcCC-----eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHH
Q 024828           82 LYLHHEKH-----IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG  156 (262)
Q Consensus        82 ~~lh~~~~-----i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG  156 (262)
                      ++||+ .|     ++|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||
T Consensus       125 ~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  203 (279)
T 2w5a_A          125 KECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG  203 (279)
T ss_dssp             HHHHH-HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHH
T ss_pred             HHHhc-ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHH
Confidence            99999 88     9999999999999999999999999987654332222334678899999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      +++|+|++|+.||......       .....+..+..+.. +..+++++.+++.+||+.||.+|||++++++|+|+.+-.
T Consensus       204 ~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          204 CLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRI-PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             HHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             HHHHHHHHCCCCCcccCHH-------HHHHHHhhcccccC-CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            9999999999999875432       33344444443332 357899999999999999999999999999999997644

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=290.14  Aligned_cols=222  Identities=28%  Similarity=0.497  Sum_probs=185.8

Q ss_pred             HHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..+.+.+|+++++++ +||||+++++++.++...++||||+++++|.+++...+.++...+..++.|++.||.|||+ .|
T Consensus       101 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~  179 (355)
T 1vzo_A          101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LG  179 (355)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            345677899999999 6999999999999999999999999999999999988899999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccC-CCCcccccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-SGQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      ++|+||||+||+++.++.++|+|||++...... ........|++.|+|||++.+.  .++.++|||||||++|+|++|+
T Consensus       180 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~  259 (355)
T 1vzo_A          180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  259 (355)
T ss_dssp             CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence            999999999999999999999999998765322 2223345789999999999863  4789999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCCc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDL  238 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~~  238 (262)
                      .||..........   ...........+  .+..++..+.+||.+||..||++||     |++++++||||+.....
T Consensus       260 ~pf~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          260 SPFTVDGEKNSQA---EISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             CTTSCTTSCCCHH---HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             CCCccCCccchHH---HHHHHHhccCCC--CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence            9998655443322   233333333222  2356889999999999999999999     99999999999986543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.9e-42  Score=280.42  Aligned_cols=225  Identities=22%  Similarity=0.414  Sum_probs=183.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ..+...+++.+|+.++++++||||+++++++.+++..++||||++|++|.+++.+.++++...+..++.|++.||+|||+
T Consensus        50 ~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~  129 (294)
T 4eqm_A           50 EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD  129 (294)
T ss_dssp             CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35677789999999999999999999999999999999999999999999999998999999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                       .|++|+||+|+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       130 -~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g  208 (294)
T 4eqm_A          130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG  208 (294)
T ss_dssp             -TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             -CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence             999999999999999999999999999987654332 222335689999999999998899999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCC---CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPS---APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      +.||......       ...........+.   .....+++.+.+++.+||..||.+||+..+.+.++|.+...+..
T Consensus       209 ~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          209 EPPFNGETAV-------SIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             SCSSCSSCHH-------HHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             CCCCCCCChH-------HHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            9999875432       1222222222221   12356889999999999999999999777777777766555443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-42  Score=283.68  Aligned_cols=222  Identities=34%  Similarity=0.630  Sum_probs=167.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--------VKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--------~~~~~~~~~~~i~~~l~~~   80 (262)
                      ....+++.+|++++++++||||+++++++.+.+..++||||++|++|.+++..        .+.++...+..++.|++.|
T Consensus        54 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  133 (303)
T 2vwi_A           54 QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG  133 (303)
T ss_dssp             ------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHH
Confidence            44567888999999999999999999999999999999999999999999974        3568999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-----CCcccccccccccCcccccC-CCCCcchhHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISG-GKYGYKSDIWS  154 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s  154 (262)
                      |.|||+ .|++|+||+|+||+++.++.++|+|||.+.......     .......+++.|+|||.+.+ ..++.++|+||
T Consensus       134 l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  212 (303)
T 2vwi_A          134 LEYLHK-NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS  212 (303)
T ss_dssp             HHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHH
T ss_pred             HHHHHh-CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHH
Confidence            999999 999999999999999999999999999886553321     11233468899999999875 45889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC--------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      ||+++|+|++|+.||........      ..... ....+        ......+++++.+++.+||+.||.+|||+.++
T Consensus       213 lG~il~~l~~g~~pf~~~~~~~~------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  285 (303)
T 2vwi_A          213 FGITAIELATGAAPYHKYPPMKV------LMLTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL  285 (303)
T ss_dssp             HHHHHHHHHHSSCTTTTSCGGGH------HHHHH-TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHhCCCCCccCchhhH------HHHHh-ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence            99999999999999987654321      11111 11111        11224678999999999999999999999999


Q ss_pred             hcCccccccCCc
Q 024828          227 MTHPFLKMYGDL  238 (262)
Q Consensus       227 l~h~~~~~~~~~  238 (262)
                      ++||||+.....
T Consensus       286 l~h~~~~~~~~~  297 (303)
T 2vwi_A          286 LRHKFFQKAKNK  297 (303)
T ss_dssp             HTSTTC------
T ss_pred             hhChhhhcCCCC
Confidence            999999887654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.3e-42  Score=285.44  Aligned_cols=227  Identities=23%  Similarity=0.423  Sum_probs=183.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      .....+++.+|++++++++||||+++++++...     ...++|||++.+ +|.++++. +.++...+..++.|++.||+
T Consensus        65 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~  142 (364)
T 3qyz_A           65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLK  142 (364)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHH
Confidence            456668899999999999999999999998764     468999999975 99999976 56999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCC-CCCcchhHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLV  158 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~  158 (262)
                      |||+ .|++|+||+|+||+++.++.++|+|||++........   ......+++.|+|||++.+. .++.++||||||++
T Consensus       143 ~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  221 (364)
T 3qyz_A          143 YIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI  221 (364)
T ss_dssp             HHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHH
T ss_pred             HHHH-CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHH
Confidence            9999 9999999999999999999999999999976543322   12345789999999987654 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHH-----------------HHHhcCCCCCC-----CCCCCCHHHHHHHHHhhcCC
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELM-----------------EAIVDQPPPSA-----PSDQFSPEFCSFISACVQKE  216 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~  216 (262)
                      +|+|++|+.||......+....+....                 ...........     ....+++++.+||.+||+.|
T Consensus       222 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  301 (364)
T 3qyz_A          222 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN  301 (364)
T ss_dssp             HHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCC
Confidence            999999999998776554332222110                 00000000000     01357899999999999999


Q ss_pred             cCCCCCHHHHhcCccccccCC
Q 024828          217 PQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       217 p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |.+|||++|+++||||+.+..
T Consensus       302 P~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          302 PHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             TTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhCCCHHHHhcCcchhhccC
Confidence            999999999999999998744

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=294.96  Aligned_cols=225  Identities=21%  Similarity=0.404  Sum_probs=169.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV---------KTIPEEYLAAICEQVLK   79 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~l~~   79 (262)
                      ....+.+|+.++++++||||+++++++.+  +...++||||+.+ +|.+++...         ..+++..+..++.||+.
T Consensus        61 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~  139 (405)
T 3rgf_A           61 ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD  139 (405)
T ss_dssp             CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence            34568899999999999999999999965  6789999999976 998888632         24999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEE----ccCCcEEEEecccccccccCC---CCcccccccccccCcccccCC-CCCcchh
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPERISGG-KYGYKSD  151 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~-~~~~~~D  151 (262)
                      ||+|||+ .|++|+||||+||++    +.++.++|+|||++.......   .......|++.|+|||++.+. .++.++|
T Consensus       140 al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  218 (405)
T 3rgf_A          140 GIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID  218 (405)
T ss_dssp             HHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHH
T ss_pred             HHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhh
Confidence            9999999 999999999999999    667899999999997664322   222345789999999999875 4899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccC------chhhHHHHHHHHhcCCCCC------------------------------
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQD------GWTSFYELMEAIVDQPPPS------------------------------  195 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~------------------------------  195 (262)
                      ||||||++|+|++|+.||.......      ...........+.......                              
T Consensus       219 iwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (405)
T 3rgf_A          219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKY  298 (405)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHH
T ss_pred             hHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhh
Confidence            9999999999999999997654321      0111111111111100000                              


Q ss_pred             --CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          196 --APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       196 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                        ......++++.+||.+||..||.+|||++|+|+||||+..+.
T Consensus       299 ~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          299 MEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL  342 (405)
T ss_dssp             HHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred             HhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence              000123678999999999999999999999999999987654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.4e-43  Score=296.71  Aligned_cols=217  Identities=30%  Similarity=0.493  Sum_probs=173.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ....+.+|++++++++||||+++++++.. ...++||||+.+++|.+++...+.+++..+..++.|++.||+|||+ .|+
T Consensus       183 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i  260 (419)
T 3i6u_A          183 PALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGI  260 (419)
T ss_dssp             --CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTC
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCc
Confidence            34468899999999999999999999854 5589999999999999999888899999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCC---cEEEEecccccccccCCCCcccccccccccCcccccC---CCCCcchhHHHHHHHHHHHHh
Q 024828           91 IHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~~  164 (262)
                      +|+||||+||+++.++   .++|+|||++...... .......|++.|+|||++.+   ..++.++|+||||+++|+|++
T Consensus       261 vHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt  339 (419)
T 3i6u_A          261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS  339 (419)
T ss_dssp             CCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred             cccCCChHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence            9999999999997654   4999999999765432 23334578999999999864   457889999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC--CCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      |+.||........      ....+..+.....+  ...+++++.+|+.+||+.||.+|||++++++||||+...
T Consensus       340 g~~pf~~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          340 GYPPFSEHRTQVS------LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             SSCSSCCCSSSCC------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             CCCCCCCCcchHH------HHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            9999987554432      12222233222211  146789999999999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.1e-42  Score=280.25  Aligned_cols=218  Identities=26%  Similarity=0.503  Sum_probs=184.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|++++++++||||+++++++.+....++|+|++.+++|.+++.+.+.++...+..++.|++.||.+||+ .|
T Consensus        63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~  141 (287)
T 2wei_A           63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HN  141 (287)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            45678899999999999999999999999999999999999999999999888899999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCC---cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           90 IIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      ++|+||+|+||+++.++   .++|+|||++....... ......++..|+|||.+.+ .++.++|+||||+++++|++|.
T Consensus       142 i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~  219 (287)
T 2wei_A          142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT  219 (287)
T ss_dssp             CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCC
Confidence            99999999999997643   69999999987654332 2233467889999999875 4899999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .||......       .....+..+.....  ....+++++.+++.+||..||.+|||++++++||||+...+
T Consensus       220 ~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          220 PPFYGKNEY-------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             CSSCCSSHH-------HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             CCCCCCCHH-------HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            999875432       23333333332221  12468999999999999999999999999999999987654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.9e-44  Score=301.94  Aligned_cols=211  Identities=17%  Similarity=0.234  Sum_probs=170.4

Q ss_pred             hHHHHHHHHHHH---HHHhcCCCCeeEeec-------eEEEECC-----------------eEEEEEeecCCCCHHHHHH
Q 024828            8 EESARRQIAQEL---KINQSSQCPYVVVCY-------QSFYSNG-----------------AISIILEYMDGGSLADFLK   60 (262)
Q Consensus         8 ~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~sL~~~l~   60 (262)
                      .....+.+.+|+   +++++++||||++++       +++.+.+                 ..|+||||+ +++|.+++.
T Consensus       113 ~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~  191 (377)
T 3byv_A          113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGE  191 (377)
T ss_dssp             CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHH
Confidence            445678899999   555666899999998       6655543                 388999999 569999998


Q ss_pred             hcCCCCH-------HHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccc
Q 024828           61 KVKTIPE-------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  133 (262)
Q Consensus        61 ~~~~~~~-------~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  133 (262)
                      +.+.++.       ..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.....   ......| +
T Consensus       192 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~  266 (377)
T 3byv_A          192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-R  266 (377)
T ss_dssp             HHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-T
T ss_pred             hccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-c
Confidence            7655555       8888899999999999999 9999999999999999999999999999875332   2334466 8


Q ss_pred             cccCcccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 024828          134 NYMSPERISGG-----------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  202 (262)
Q Consensus       134 ~y~~PE~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (262)
                      .|+|||++.+.           .++.++||||||+++|+|++|+.||............       ..      ....++
T Consensus       267 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~-------~~------~~~~~~  333 (377)
T 3byv_A          267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-------FR------SCKNIP  333 (377)
T ss_dssp             TCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG-------GS------SCCCCC
T ss_pred             CccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh-------hh------hccCCC
Confidence            99999999877           7899999999999999999999999775543322111       11      124678


Q ss_pred             HHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          203 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       203 ~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +++.+|+.+||+.||++|||+.++++||||+...+
T Consensus       334 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence            99999999999999999999999999999987653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=278.98  Aligned_cols=217  Identities=26%  Similarity=0.449  Sum_probs=180.6

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .+....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.. .+.++...+..++.|++.||+|||
T Consensus        46 ~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH  125 (310)
T 3s95_A           46 FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH  125 (310)
T ss_dssp             CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577888999999999999999999999999999999999999999999999987 467999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--------------cccccccccccCcccccCCCCCcchh
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--------------ANTFVGTYNYMSPERISGGKYGYKSD  151 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------------~~~~~~~~~y~~PE~~~~~~~~~~~D  151 (262)
                      + .|++|+||+|+||+++.++.++|+|||++.........              .....|++.|+|||++.+..++.++|
T Consensus       126 ~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  204 (310)
T 3s95_A          126 S-MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD  204 (310)
T ss_dssp             H-TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred             h-CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHH
Confidence            9 99999999999999999999999999999765432211              11457899999999999989999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCc--hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDG--WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |||||+++|+|++|..|+........  ..........    .    .+..+++++.+++.+||+.||++|||++++++ 
T Consensus       205 i~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~-  275 (310)
T 3s95_A          205 VFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----Y----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH-  275 (310)
T ss_dssp             HHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----T----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH-
T ss_pred             HHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----c----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH-
Confidence            99999999999999999876443221  1111111111    1    12467888999999999999999999999986 


Q ss_pred             ccccc
Q 024828          230 PFLKM  234 (262)
Q Consensus       230 ~~~~~  234 (262)
                       +++.
T Consensus       276 -~L~~  279 (310)
T 3s95_A          276 -WLET  279 (310)
T ss_dssp             -HHHH
T ss_pred             -HHHH
Confidence             4443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-42  Score=289.60  Aligned_cols=225  Identities=24%  Similarity=0.423  Sum_probs=169.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +....+++.+|+++++.++||||+++++++...      ...++|+|++ +++|.+++.. +.++...+..++.|++.||
T Consensus        68 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL  145 (367)
T 2fst_X           68 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGL  145 (367)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence            456778899999999999999999999998654      5689999999 6799999876 6799999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~  160 (262)
                      +|||+ .|++|+||||+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|||||||+++
T Consensus       146 ~~LH~-~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  221 (367)
T 2fst_X          146 KYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  221 (367)
T ss_dssp             HHHHH-TTCCCCCCCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHH
T ss_pred             HHHHH-CCeeeCCCCHhhEEECCCCCEEEeecccccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHH
Confidence            99999 99999999999999999999999999998764322   334578999999999887 56899999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHH----------------HHHhcCCCC--CC----CCCCCCHHHHHHHHHhhcCCcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELM----------------EAIVDQPPP--SA----PSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~~--~~----~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      +|++|+.||.+.+..+....+....                .........  ..    .....++++.+||.+||..||.
T Consensus       222 ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~  301 (367)
T 2fst_X          222 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD  301 (367)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGG
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcc
Confidence            9999999998765433222221110                000000000  00    0124678899999999999999


Q ss_pred             CCCCHHHHhcCccccccCCc
Q 024828          219 QRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|||++++|+||||+.....
T Consensus       302 ~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          302 KRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             GSCCHHHHHTSGGGTTTCCG
T ss_pred             cCcCHHHHhcChhhhhccCC
Confidence            99999999999999987653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.3e-42  Score=286.51  Aligned_cols=213  Identities=22%  Similarity=0.413  Sum_probs=181.8

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~   70 (262)
                      .+...+++.+|+++++++ +||||+++++++.+.+..|+||||+.|++|.+++...+                .++...+
T Consensus       126 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (370)
T 2psq_A          126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL  205 (370)
T ss_dssp             BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHH
Confidence            456678899999999999 89999999999999999999999999999999998753                3789999


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCc
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGY  148 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  148 (262)
                      ..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++........  ......+++.|+|||++.+..++.
T Consensus       206 ~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  284 (370)
T 2psq_A          206 VSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  284 (370)
T ss_dssp             HHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred             HHHHHHHHHHHHHHHh-CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc
Confidence            9999999999999999 9999999999999999999999999999976543321  223345677899999999888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ++||||||+++|+|++ |..||......+       ....+..+..+.. +..+++++.+++.+||+.||.+|||+.+++
T Consensus       285 ~~DvwslG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell  356 (370)
T 2psq_A          285 QSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRPTFKQLV  356 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhcCCCCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            9999999999999999 999998755432       2333444443333 357899999999999999999999999998


Q ss_pred             cC
Q 024828          228 TH  229 (262)
Q Consensus       228 ~h  229 (262)
                      ++
T Consensus       357 ~~  358 (370)
T 2psq_A          357 ED  358 (370)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.2e-42  Score=284.32  Aligned_cols=225  Identities=24%  Similarity=0.429  Sum_probs=181.9

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCC------eeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCP------YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICE   75 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~   75 (262)
                      .........+.+.+|+++++.++|+      +++++++++.+.+..++||||+ +++|.+++...+  +++...+..++.
T Consensus        47 ~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~  125 (339)
T 1z57_A           47 IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY  125 (339)
T ss_dssp             EECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHH
T ss_pred             EEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHH
Confidence            3344556678889999999888654      5999999999999999999999 779999998765  689999999999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEcc-------------------CCcEEEEecccccccccCCCCccccccccccc
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINH-------------------RGEVKITDFGVSAIMASTSGQANTFVGTYNYM  136 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~-------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~  136 (262)
                      |++.||+|||+ .|++|+||+|+||+++.                   ++.++|+|||.+.....   ......++..|+
T Consensus       126 qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~  201 (339)
T 1z57_A          126 QICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYR  201 (339)
T ss_dssp             HHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGC
T ss_pred             HHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc---ccccccCCcccc
Confidence            99999999999 99999999999999987                   56799999999876432   233457899999


Q ss_pred             CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC----------------------
Q 024828          137 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP----------------------  194 (262)
Q Consensus       137 ~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------  194 (262)
                      |||.+.+..++.++|+||||+++|+|++|..||...+..+.    ...+.......+.                      
T Consensus       202 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  277 (339)
T 1z57_A          202 APEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH----LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH  277 (339)
T ss_dssp             CHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH----HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTT
T ss_pred             ChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHhhccchhHHhhcccccccc
Confidence            99999988899999999999999999999999987554321    1112221111000                      


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          195 -----------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       195 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                                       .......++++.+|+.+||+.||.+|||++|+++||||+...+
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             ccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence                             0011223567899999999999999999999999999997654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3e-43  Score=288.39  Aligned_cols=227  Identities=25%  Similarity=0.448  Sum_probs=182.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +.....++.+|++++++++||||+++++++....    ..|+||||++|++|.+++...+.++...+..++.|++.||+|
T Consensus        52 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~  131 (311)
T 3ork_A           52 DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF  131 (311)
T ss_dssp             SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            4566778999999999999999999999987643    359999999999999999988899999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||++........   ......|++.|+|||++.+..++.++||||||+++|
T Consensus       132 lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~  210 (311)
T 3ork_A          132 SHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY  210 (311)
T ss_dssp             HHH-TTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred             HHH-CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHH
Confidence            999 9999999999999999999999999999876543321   222346899999999999988999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      +|++|+.||......+      ...........+ ......+++++.+++.+||+.||.+||+..+++.|+|++......
T Consensus       211 ~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          211 EVLTGEPPFTGDSPVS------VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             HHHHSSCSCCCSSHHH------HHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             HHHhCCCCCCCCChHH------HHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence            9999999997754321      111222222211 112346899999999999999999999999999999998765544


Q ss_pred             cc
Q 024828          240 VD  241 (262)
Q Consensus       240 ~~  241 (262)
                      ..
T Consensus       285 ~~  286 (311)
T 3ork_A          285 PE  286 (311)
T ss_dssp             CS
T ss_pred             CC
Confidence            43

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.5e-42  Score=292.43  Aligned_cols=229  Identities=28%  Similarity=0.477  Sum_probs=181.3

Q ss_pred             cccchhHHHHHHHHHHHHHHhcC------CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSS------QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAIC   74 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~   74 (262)
                      |.+..+....+++.+|+++++.+      +|+||+++++.+......++|||++.+ +|.+++....  .++...+..++
T Consensus       128 K~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~  206 (429)
T 3kvw_A          128 KMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFA  206 (429)
T ss_dssp             EEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHH
T ss_pred             EEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHH
Confidence            44445566667888888888776      678999999999999999999999965 9999998764  49999999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCc--EEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhH
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI  152 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di  152 (262)
                      .|++.||+|||+ .|++|+||||+||+++.++.  ++|+|||++.....   ......+++.|+|||++.+..++.++||
T Consensus       207 ~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di  282 (429)
T 3kvw_A          207 HSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDM  282 (429)
T ss_dssp             HHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHH
T ss_pred             HHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecccceecCC---cccccCCCCCccChHHHhCCCCCchHHH
Confidence            999999999999 99999999999999998887  99999999865432   3334578999999999999889999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCccCchhhHHHHH--------------HHHhcCC-CC-----------------------
Q 024828          153 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------------EAIVDQP-PP-----------------------  194 (262)
Q Consensus       153 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~-~~-----------------------  194 (262)
                      |||||++|+|++|..||...+..+....+.+..              ....... .+                       
T Consensus       283 wSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (429)
T 3kvw_A          283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRG  362 (429)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTC
T ss_pred             HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchh
Confidence            999999999999999998766543222221110              0000000 00                       


Q ss_pred             -----C-------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          195 -----S-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       195 -----~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                           .       ......++++.+||.+||++||++|||++|+|+||||+...
T Consensus       363 ~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          363 KLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             CEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             hccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence                 0       00123478899999999999999999999999999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=278.14  Aligned_cols=217  Identities=25%  Similarity=0.490  Sum_probs=178.6

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEE--ECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ...+.+.+|++++++++||||+++++++.  +....++||||+.+ +|.+++...  +.++...+..++.|++.||.|||
T Consensus        48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH  126 (305)
T 2wtk_C           48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH  126 (305)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSE-EHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccC-CHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999984  45679999999987 588887653  56999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCC--CCcchhHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLE  161 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~  161 (262)
                      + .|++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.+..  .+.++|+||||+++|+
T Consensus       127 ~-~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~  205 (305)
T 2wtk_C          127 S-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYN  205 (305)
T ss_dssp             H-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHH
T ss_pred             H-CCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHH
Confidence            9 999999999999999999999999999987654221  2223456889999999998654  4789999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |++|+.||.....       ......+......  .+..+++++.+++.+||+.||.+|||++++++||||+....
T Consensus       206 l~~g~~p~~~~~~-------~~~~~~i~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          206 ITTGLYPFEGDNI-------YKLFENIGKGSYA--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHSSCSCCCSSH-------HHHHHHHHHCCCC--CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHhCCCCCCCchH-------HHHHHHHhcCCCC--CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            9999999986432       2333334333322  23468999999999999999999999999999999987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.3e-42  Score=281.51  Aligned_cols=212  Identities=24%  Similarity=0.378  Sum_probs=179.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+..++.+.+|++++++++||||+++++++.+++..++||||++|++|.+++... +.++...+..++.|++.||+|||+
T Consensus        90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  169 (325)
T 3kul_A           90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD  169 (325)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            5667789999999999999999999999999999999999999999999999765 579999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc---ccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++|+|||++..........   ....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus       170 -~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell  248 (325)
T 3kul_A          170 -LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL  248 (325)
T ss_dssp             -TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             -CCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHH
Confidence             999999999999999999999999999997654332211   1223466799999999888999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      + |..||......       .....+..+..... +..+++++.+|+.+||..||.+|||++++++
T Consensus       249 ~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          249 AYGERPYWNMTNR-------DVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TTSCCTTTTSCHH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCcccCCHH-------HHHHHHHcCCCCCC-CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9 99999775432       34444444444333 3578999999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.8e-42  Score=276.21  Aligned_cols=216  Identities=24%  Similarity=0.460  Sum_probs=181.2

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ...+....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++... +.++...+..++.|++.||++
T Consensus        42 ~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~  121 (269)
T 4hcu_A           42 IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY  121 (269)
T ss_dssp             ECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             ecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHH
Confidence            3333334567899999999999999999999999999999999999999999999764 458999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||+|+++++|
T Consensus       122 lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l  200 (269)
T 4hcu_A          122 LEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV  200 (269)
T ss_dssp             HHH-TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             HHh-CCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHH
Confidence            998 999999999999999999999999999987553221 122233456789999999988899999999999999999


Q ss_pred             Hh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          163 AT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       163 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++ |+.||......       .....+........ +...++++.+++.+||+.||.+|||+++++++
T Consensus       201 l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          201 FSEGKIPYENRSNS-------EVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HTTSCCTTTTCCHH-------HHHHHHHTTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCCCCHH-------HHHHHHhcCccCCC-CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            99 99999875432       34444444433333 35679999999999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.8e-42  Score=281.04  Aligned_cols=224  Identities=22%  Similarity=0.350  Sum_probs=171.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeE------EEEEeecCCCCHHHHHHhcC------CCCHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI------SIILEYMDGGSLADFLKKVK------TIPEEYLAAICE   75 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~   75 (262)
                      .....+++.+|++++++++||||+++++++.+....      ++||||+.+++|.+++....      .++...+..++.
T Consensus        65 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~  144 (323)
T 3qup_A           65 ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV  144 (323)
T ss_dssp             -CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHH
Confidence            345678899999999999999999999999876554      99999999999999996543      589999999999


Q ss_pred             HHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHH
Q 024828           76 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIW  153 (262)
Q Consensus        76 ~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~  153 (262)
                      |++.||+|||+ .|++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|||
T Consensus       145 qi~~al~~LH~-~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  223 (323)
T 3qup_A          145 DIACGMEYLSS-RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVW  223 (323)
T ss_dssp             HHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHHHHc-CCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchh
Confidence            99999999999 9999999999999999999999999999876543221  12233456789999999988899999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-------HHH
Q 024828          154 SLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-------AQE  225 (262)
Q Consensus       154 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-------~~~  225 (262)
                      |||+++|+|++ |..||......+       ....+..+..... ...+++++.+|+.+||+.||.+|||       +++
T Consensus       224 slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  295 (323)
T 3qup_A          224 AFGVTMWEIMTRGQTPYAGIENAE-------IYNYLIGGNRLKQ-PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN  295 (323)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCCCCC-CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCccccChHH-------HHHHHhcCCCCCC-CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            99999999999 999998765542       2233333333333 3578999999999999999999999       889


Q ss_pred             HhcCccccccCCccc
Q 024828          226 LMTHPFLKMYGDLNV  240 (262)
Q Consensus       226 ~l~h~~~~~~~~~~~  240 (262)
                      ++.|||+.......+
T Consensus       296 ~l~~~~~~~~~~~pl  310 (323)
T 3qup_A          296 ILGHLSVLSTSQDPL  310 (323)
T ss_dssp             HHHC-----------
T ss_pred             HHHHhhhcCCCCCCC
Confidence            999999987665443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.5e-42  Score=288.01  Aligned_cols=225  Identities=25%  Similarity=0.453  Sum_probs=171.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      +....+++.+|+.+++.++||||+++++++....      ..|+||||+++ +|.+.+.  ..++...+..++.|++.||
T Consensus        64 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al  140 (371)
T 2xrw_A           64 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI  140 (371)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHH
Confidence            4667788999999999999999999999997654      78999999976 8988886  4689999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      .|||+ .|++|+||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+
T Consensus       141 ~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  218 (371)
T 2xrw_A          141 KHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  218 (371)
T ss_dssp             HHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             HHHHH-CCeecccCCHHHEEEcCCCCEEEEEeeccccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence            99999 999999999999999999999999999987654322 2334578999999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHH---------------HHHHHhcCCCCCCC------------C------CCCCHHHHHH
Q 024828          162 CATGQFPYSPPEQQDGWTSFYE---------------LMEAIVDQPPPSAP------------S------DQFSPEFCSF  208 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~------------~------~~~~~~l~~l  208 (262)
                      |++|+.||.+.+..+.+..+..               ..............            +      ...++++.+|
T Consensus       219 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  298 (371)
T 2xrw_A          219 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL  298 (371)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHH
Confidence            9999999987654322211110               00000000000000            0      0014678999


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |.+||..||.+|||++|+++||||+.+..
T Consensus       299 i~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          299 LSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence            99999999999999999999999987654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-41  Score=276.42  Aligned_cols=225  Identities=26%  Similarity=0.440  Sum_probs=176.5

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-------------CCeEEEEEeecCCCCHHHHHHhcC-CCCHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-------------NGAISIILEYMDGGSLADFLKKVK-TIPEE   68 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~   68 (262)
                      |+........+.+.+|++++++++||||+++++.+.+             ....++||||+++++|.+++...+ .++..
T Consensus        37 K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  116 (303)
T 1zy4_A           37 KKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD  116 (303)
T ss_dssp             EEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHH
T ss_pred             EEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchH
Confidence            3444566777899999999999999999999998865             356899999999999999998654 57889


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC--------------CCCccccccccc
Q 024828           69 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--------------SGQANTFVGTYN  134 (262)
Q Consensus        69 ~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--------------~~~~~~~~~~~~  134 (262)
                      .+..++.|++.||++||+ .|++|+||+|+||+++.++.++|+|||.+......              ........++..
T Consensus       117 ~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (303)
T 1zy4_A          117 EYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAM  195 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CT
T ss_pred             HHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCccc
Confidence            999999999999999999 99999999999999999999999999998765322              112234468889


Q ss_pred             ccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHH
Q 024828          135 YMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISA  211 (262)
Q Consensus       135 y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~  211 (262)
                      |+|||.+.+. .++.++|+||||+++|+|++   ||...      .........+....  .+.......++.+.+++.+
T Consensus       196 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  266 (303)
T 1zy4_A          196 YVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL  266 (303)
T ss_dssp             TSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH------HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHH
T ss_pred             ccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc------hhHHHHHHhccccccccCccccccchHHHHHHHHH
Confidence            9999999865 58999999999999999997   44432      11222333333322  2233335677889999999


Q ss_pred             hhcCCcCCCCCHHHHhcCccccccCC
Q 024828          212 CVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       212 ~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ||+.||.+|||++++++||||+....
T Consensus       267 ~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (303)
T 1zy4_A          267 LIDHDPNKRPGARTLLNSGWLPVKHQ  292 (303)
T ss_dssp             HTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred             HHhcCcccCcCHHHHhCCCCcCCCCh
Confidence            99999999999999999999976543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.3e-41  Score=285.71  Aligned_cols=222  Identities=29%  Similarity=0.481  Sum_probs=174.6

Q ss_pred             HHHHHHHhcCCCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828           16 AQELKINQSSQCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        16 ~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .+|+++++.++||||+++++++...+      ..++||||+.+ ++...+.    ....++...+..++.|++.||+|||
T Consensus        80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH  158 (394)
T 4e7w_A           80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH  158 (394)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999986543      38899999987 5544443    3467999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEc-cCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~  163 (262)
                      + .|++|+||||+||+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++||||+||++|+|+
T Consensus       159 ~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  236 (394)
T 4e7w_A          159 S-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM  236 (394)
T ss_dssp             H-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             H-CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence            9 9999999999999998 78999999999997654332 33345789999999998765 4899999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHH--------HHH----hcCCCCCC--------CCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          164 TGQFPYSPPEQQDGWTSFYELM--------EAI----VDQPPPSA--------PSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~--------~~~----~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      +|+.||.+.+..+....+....        ...    .....+..        .....++++.+|+.+||..||.+|||+
T Consensus       237 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (394)
T 4e7w_A          237 QGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA  316 (394)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence            9999998765443222221110        000    00000000        113478899999999999999999999


Q ss_pred             HHHhcCccccccCCccc
Q 024828          224 QELMTHPFLKMYGDLNV  240 (262)
Q Consensus       224 ~~~l~h~~~~~~~~~~~  240 (262)
                      .|+++||||+.......
T Consensus       317 ~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          317 IEALCHPFFDELRTGEA  333 (394)
T ss_dssp             HHHHTSGGGSTTTSSCC
T ss_pred             HHHhcChhhhhhccccc
Confidence            99999999998776544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-41  Score=280.76  Aligned_cols=230  Identities=23%  Similarity=0.432  Sum_probs=180.1

Q ss_pred             HHHHHHHHHHhcC---CCCeeEeeceEEE-----ECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Q 024828           13 RQIAQELKINQSS---QCPYVVVCYQSFY-----SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        13 ~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~   82 (262)
                      ..+.+|+.+++.+   +||||+++++++.     .....++||||+.| +|.+++....  .++...+..++.|++.||.
T Consensus        56 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~  134 (326)
T 1blx_A           56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD  134 (326)
T ss_dssp             CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence            3455677766655   8999999999987     45678999999975 9999998754  4899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |||+ .|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.++||||||+++|+|
T Consensus       135 ~lH~-~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  212 (326)
T 1blx_A          135 FLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM  212 (326)
T ss_dssp             HHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             HHHH-CCceeccCCHHHeEEcCCCCEEEecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence            9999 999999999999999999999999999987654322 23345688999999999988899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCC---------------------CCCCCCCCCCHHHHHHHHHhhcCCcCCCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQP---------------------PPSAPSDQFSPEFCSFISACVQKEPQQRL  221 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  221 (262)
                      ++|+.||......+...   ..........                     ........+++++.+|+.+||+.||.+||
T Consensus       213 ~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  289 (326)
T 1blx_A          213 FRRKPLFRGSSDVDQLG---KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI  289 (326)
T ss_dssp             HHSSCSCCCSSHHHHHH---HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC
T ss_pred             HcCCCCCCCCCHHHHHH---HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCC
Confidence            99999998765432211   1111111000                     00111246789999999999999999999


Q ss_pred             CHHHHhcCccccccCCcccchhhHhhh
Q 024828          222 SAQELMTHPFLKMYGDLNVDLSEYFTD  248 (262)
Q Consensus       222 t~~~~l~h~~~~~~~~~~~~~~~~~~~  248 (262)
                      |+.++++||||+......-+.......
T Consensus       290 t~~e~l~hp~~~~~~~~~~~~~~~~~~  316 (326)
T 1blx_A          290 SAYSALSHPYFQDLERCKENLDSHLPP  316 (326)
T ss_dssp             CHHHHHTSGGGTTCCCCCCC-------
T ss_pred             CHHHHhcCccccccchhhhhhccCCCC
Confidence            999999999999988776555544433

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.5e-42  Score=275.07  Aligned_cols=214  Identities=23%  Similarity=0.386  Sum_probs=179.7

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .+....+++.+|++++++++||||+++++++.++...++||||+++++|.+++...+ .++...+..++.|++.||++||
T Consensus        42 ~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH  121 (268)
T 3sxs_A           42 EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE  121 (268)
T ss_dssp             BTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            333345678999999999999999999999999999999999999999999998764 5999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      + .|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++
T Consensus       122 ~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  200 (268)
T 3sxs_A          122 S-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS  200 (268)
T ss_dssp             H-TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHT
T ss_pred             H-CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHc
Confidence            9 9999999999999999999999999999876543321 1122345667999999998889999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                       |+.||......       ........+..... +...++++.+++.+||+.||.+|||+++++++
T Consensus       201 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          201 LGKMPYDLYTNS-------EVVLKVSQGHRLYR-PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             TTCCTTTTSCHH-------HHHHHHHTTCCCCC-CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCccccChH-------HHHHHHHcCCCCCC-CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             99999765432       23333444433333 35678999999999999999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.4e-43  Score=293.17  Aligned_cols=223  Identities=12%  Similarity=0.131  Sum_probs=162.3

Q ss_pred             hHHHHHHHHHHH---HHHhcCCCCeeEeec-------eEEEEC-----------------CeEEEEEeecCCCCHHHHHH
Q 024828            8 EESARRQIAQEL---KINQSSQCPYVVVCY-------QSFYSN-----------------GAISIILEYMDGGSLADFLK   60 (262)
Q Consensus         8 ~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~sL~~~l~   60 (262)
                      +....+.+.+|+   ++|+. +||||++++       +++...                 ...|+||||++ ++|.+++.
T Consensus       102 ~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~  179 (371)
T 3q60_A          102 SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFS  179 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHH
T ss_pred             cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHH
Confidence            456667778884   55555 799988755       444432                 34899999998 69999998


Q ss_pred             hc-CCCCHHHH------HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccc
Q 024828           61 KV-KTIPEEYL------AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  133 (262)
Q Consensus        61 ~~-~~~~~~~~------~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  133 (262)
                      .. ..++...+      ..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++......   .....+++
T Consensus       180 ~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~  255 (371)
T 3q60_A          180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPV  255 (371)
T ss_dssp             HHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCG
T ss_pred             HhccccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCc
Confidence            64 34455555      6788999999999998 99999999999999999999999999998765422   21345669


Q ss_pred             cccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCc--hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 024828          134 NYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG--WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  209 (262)
Q Consensus       134 ~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  209 (262)
                      .|+|||++.+  ..++.++||||||+++|+|++|+.||........  +....  ................+++++.+||
T Consensus       256 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li  333 (371)
T 3q60_A          256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS--LRVPGTDSLAFGSCTPLPDFVKTLI  333 (371)
T ss_dssp             GGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCC--TTSCCCCSCCCTTSSCCCHHHHHHH
T ss_pred             CCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhh--hhhccccccchhhccCCCHHHHHHH
Confidence            9999999987  5689999999999999999999999987643211  00000  0000011111122247899999999


Q ss_pred             HHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          210 SACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       210 ~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      .+||+.||++|||++++++||||+...+.
T Consensus       334 ~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  362 (371)
T 3q60_A          334 GRFLNFDRRRRLLPLEAMETPEFLQLQNE  362 (371)
T ss_dssp             HHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred             HHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence            99999999999999999999999876543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.1e-42  Score=282.39  Aligned_cols=219  Identities=30%  Similarity=0.480  Sum_probs=178.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|++++++++||||+++++++..+. .++||||+++++|.+++...+.++...+..++.|++.||.|||+ .|
T Consensus        57 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~  134 (322)
T 2ycf_A           57 DPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NG  134 (322)
T ss_dssp             ----CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34456889999999999999999999987655 89999999999999999888899999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCc---EEEEecccccccccCCCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHHHH
Q 024828           90 IIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ++|+||+|+||+++.++.   ++|+|||++....... ......++..|+|||.+.   +..++.++|+||||+++|+|+
T Consensus       135 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~  213 (322)
T 2ycf_A          135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  213 (322)
T ss_dssp             EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence            999999999999987664   9999999987653221 122346789999999974   456889999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +|..||..........      ..+..+....  .....+++++.+|+.+||..||++|||++++++||||+....
T Consensus       214 ~g~~pf~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          214 SGYPPFSEHRTQVSLK------DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             HSSCSSCSTTCSSCHH------HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             hCCCCCcccchHHHHH------HHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence            9999998765443211      1122222111  112467899999999999999999999999999999987553

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-41  Score=285.42  Aligned_cols=220  Identities=25%  Similarity=0.436  Sum_probs=174.7

Q ss_pred             HHHHHHHHhcCCCCeeEeeceEEEE--------------------------------------CCeEEEEEeecCCCCHH
Q 024828           15 IAQELKINQSSQCPYVVVCYQSFYS--------------------------------------NGAISIILEYMDGGSLA   56 (262)
Q Consensus        15 ~~~e~~~l~~l~h~~i~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~sL~   56 (262)
                      ..+|+++++.++||||+++++++..                                      +...++||||+++ +|.
T Consensus        47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~  125 (383)
T 3eb0_A           47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH  125 (383)
T ss_dssp             CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHH
T ss_pred             HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHH
Confidence            3479999999999999999999843                                      3458999999976 877


Q ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEc-cCCcEEEEecccccccccCCCCcccccc
Q 024828           57 DFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVG  131 (262)
Q Consensus        57 ~~l~----~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~  131 (262)
                      +.+.    ..+.++...+..++.|++.||+|||+ .|++|+||||+||+++ .++.++|+|||.+....... ......+
T Consensus       126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~  203 (383)
T 3eb0_A          126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYIC  203 (383)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCC
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCccc
Confidence            7665    34679999999999999999999998 9999999999999997 57899999999997654332 3344577


Q ss_pred             cccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHH--------HHHhc----CCCCCC--
Q 024828          132 TYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIVD----QPPPSA--  196 (262)
Q Consensus       132 ~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~----~~~~~~--  196 (262)
                      +..|+|||.+.+.. ++.++||||+||++|+|++|+.||.+....+....+....        .....    ...+..  
T Consensus       204 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  283 (383)
T 3eb0_A          204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA  283 (383)
T ss_dssp             CSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCC
T ss_pred             CCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCc
Confidence            89999999988754 8999999999999999999999998765543222221110        00000    000000  


Q ss_pred             ------CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          197 ------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       197 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                            .+...++++.+|+.+||..||.+|||+.|+++||||+....
T Consensus       284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence                  12357889999999999999999999999999999987754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.2e-41  Score=277.40  Aligned_cols=213  Identities=25%  Similarity=0.438  Sum_probs=181.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC-----------------------
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-----------------------   64 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------------------   64 (262)
                      +....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++...+.                       
T Consensus        66 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (314)
T 2ivs_A           66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER  145 (314)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------C
T ss_pred             CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccccc
Confidence            466778899999999999999999999999999999999999999999999987543                       


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccc
Q 024828           65 -IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI  141 (262)
Q Consensus        65 -~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~  141 (262)
                       ++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+
T Consensus       146 ~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  224 (314)
T 2ivs_A          146 ALTMGDLISFAWQISQGMQYLAE-MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL  224 (314)
T ss_dssp             EECHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHH-CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh
Confidence             8999999999999999999999 9999999999999999999999999999876543322  12233567789999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCC
Q 024828          142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  220 (262)
Q Consensus       142 ~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  220 (262)
                      .+..++.++|+||||+++|+|++ |..||.......       ....+..+.... .+..+++++.+++.+||+.||.+|
T Consensus       225 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R  296 (314)
T 2ivs_A          225 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER-------LFNLLKTGHRME-RPDNCSEEMYRLMLQCWKQEPDKR  296 (314)
T ss_dssp             HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             cCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHhhcCCcCC-CCccCCHHHHHHHHHHccCChhhC
Confidence            88889999999999999999999 999998765432       223333333333 335789999999999999999999


Q ss_pred             CCHHHHhcC
Q 024828          221 LSAQELMTH  229 (262)
Q Consensus       221 pt~~~~l~h  229 (262)
                      ||+++++++
T Consensus       297 ps~~~l~~~  305 (314)
T 2ivs_A          297 PVFADISKD  305 (314)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.7e-42  Score=290.08  Aligned_cols=227  Identities=27%  Similarity=0.438  Sum_probs=178.1

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCC--------CCeeEeeceEEE----ECCeEEEEEeecCCCCHHHHHHhc--CCCCHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQ--------CPYVVVCYQSFY----SNGAISIILEYMDGGSLADFLKKV--KTIPEE   68 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~   68 (262)
                      |.+.......+.+.+|++++++++        |+||+++++.+.    ++...|+|||++ +++|.+++...  +.++..
T Consensus        68 K~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~  146 (397)
T 1wak_A           68 KVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLP  146 (397)
T ss_dssp             EEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHH
T ss_pred             EEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHH
Confidence            444455667788999999999884        788999999987    456799999999 55777777554  469999


Q ss_pred             HHHHHHHHHHHHHHHHhhcC-CeeeCCCCCCCEEEccCC-----------------------------------------
Q 024828           69 YLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRG-----------------------------------------  106 (262)
Q Consensus        69 ~~~~i~~~l~~~l~~lh~~~-~i~H~dl~p~nil~~~~~-----------------------------------------  106 (262)
                      .+..++.||+.||+|||+ . |++|+||||+||+++.++                                         
T Consensus       147 ~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (397)
T 1wak_A          147 CVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPL  225 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTT
T ss_pred             HHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccc
Confidence            999999999999999998 7 999999999999998765                                         


Q ss_pred             --------cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCch
Q 024828          107 --------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW  178 (262)
Q Consensus       107 --------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  178 (262)
                              .++|+|||.+......   .....++..|+|||++.+..++.++|||||||++|+|++|+.||......+..
T Consensus       226 ~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  302 (397)
T 1wak_A          226 EPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYT  302 (397)
T ss_dssp             SGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC
T ss_pred             ccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC
Confidence                    7999999998765432   33457899999999999888999999999999999999999999876544322


Q ss_pred             hhHH--HHHHHHhcCCCC-------------------------------------CCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          179 TSFY--ELMEAIVDQPPP-------------------------------------SAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       179 ~~~~--~~~~~~~~~~~~-------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      ....  ..+.........                                     .......++++.+||.+||+.||++
T Consensus       303 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  382 (397)
T 1wak_A          303 RDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK  382 (397)
T ss_dssp             HHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGG
T ss_pred             chHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhh
Confidence            2111  111111111000                                     0001123456889999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 024828          220 RLSAQELMTHPFLKM  234 (262)
Q Consensus       220 Rpt~~~~l~h~~~~~  234 (262)
                      |||++|+|+||||+.
T Consensus       383 Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          383 RATAAECLRHPWLNS  397 (397)
T ss_dssp             SCCHHHHHTSGGGGC
T ss_pred             cCCHHHHhhCccccC
Confidence            999999999999973

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.6e-41  Score=282.70  Aligned_cols=229  Identities=24%  Similarity=0.422  Sum_probs=180.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ......++.+|++++++++||||+++++++...     ...++|||++.+ +|.+++.. +.++...+..++.|++.||+
T Consensus        49 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~  126 (353)
T 2b9h_A           49 KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVK  126 (353)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHH
Confidence            456677889999999999999999999987654     679999999975 99999887 67999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC----------CcccccccccccCcccccC-CCCCcchh
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----------QANTFVGTYNYMSPERISG-GKYGYKSD  151 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~y~~PE~~~~-~~~~~~~D  151 (262)
                      |||+ .|++|+||+|+||+++.++.++|+|||++........          ......|+..|+|||.+.+ ..++.++|
T Consensus       127 ~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  205 (353)
T 2b9h_A          127 VLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD  205 (353)
T ss_dssp             HHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHH
T ss_pred             HHHH-CCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhh
Confidence            9999 9999999999999999999999999999876543211          1223467899999998764 56899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHH-----------------HHHhcCCCCCC------CCCCCCHHHHHH
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM-----------------EAIVDQPPPSA------PSDQFSPEFCSF  208 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~------~~~~~~~~l~~l  208 (262)
                      +||||+++++|++|+.||.+.+..+....+....                 ...........      ....+++++.+|
T Consensus       206 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  285 (353)
T 2b9h_A          206 VWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDL  285 (353)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHH
Confidence            9999999999999999998765322111110000                 00000000000      013678999999


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      +.+||+.||.+|||++++++||||+......
T Consensus       286 i~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          286 LQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             HHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            9999999999999999999999999876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-42  Score=280.66  Aligned_cols=216  Identities=22%  Similarity=0.401  Sum_probs=175.6

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECC--eEEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ...+.+.+|++++++++||||+++++++.+..  ..++||||+++++|.+++.....   ++...+..++.|++.||+||
T Consensus        49 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L  128 (319)
T 4euu_A           49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL  128 (319)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            34567789999999999999999999998755  78999999999999999987543   99999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEE----ccCCcEEEEecccccccccCCCCcccccccccccCccccc--------CCCCCcchhH
Q 024828           85 HHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS--------GGKYGYKSDI  152 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~Di  152 (262)
                      |+ .|++|+||||+||++    +.++.++|+|||++....... ......++..|+|||++.        +..++.++||
T Consensus       129 H~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di  206 (319)
T 4euu_A          129 RE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL  206 (319)
T ss_dssp             HH-TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHH
T ss_pred             HH-CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHH
Confidence            99 999999999999999    677789999999997654433 333456899999999886        4678999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCC-----------------------CCCCCCCHHHHHHH
Q 024828          153 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-----------------------APSDQFSPEFCSFI  209 (262)
Q Consensus       153 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li  209 (262)
                      |||||++|+|++|+.||..........   +.+..+..+.+..                       .....+++.+.+++
T Consensus       207 wslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll  283 (319)
T 4euu_A          207 WSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL  283 (319)
T ss_dssp             HHHHHHHHHHHHSSCSEECTTCGGGCH---HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCccchhH---HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHH
Confidence            999999999999999997655443222   2222322222111                       11123456789999


Q ss_pred             HHhhcCCcCCCCCHHHHhcCc
Q 024828          210 SACVQKEPQQRLSAQELMTHP  230 (262)
Q Consensus       210 ~~~l~~~p~~Rpt~~~~l~h~  230 (262)
                      ++||+.||++|||++|+++||
T Consensus       284 ~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          284 ANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHhccCChhhhccHHHhhhcc
Confidence            999999999999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-41  Score=279.54  Aligned_cols=222  Identities=23%  Similarity=0.402  Sum_probs=177.3

Q ss_pred             HHHHHHHHHHHHhcCC-CCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           11 ARRQIAQELKINQSSQ-CPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ..+.+.+|++++++++ ||||+++++++.+  ....++||||+.+++|.++++.   ++...+..++.|++.||+|||+ 
T Consensus        73 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~-  148 (330)
T 3nsz_A           73 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS-  148 (330)
T ss_dssp             CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHh-
Confidence            3567899999999996 9999999999988  6779999999999999998864   8999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCC-cEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      .|++|+||+|+||+++.++ .++|+|||++....... ......++..|+|||.+.+ ..++.++|||||||++++|++|
T Consensus       149 ~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  227 (330)
T 3nsz_A          149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR  227 (330)
T ss_dssp             TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhC
Confidence            9999999999999999777 89999999997654332 3344578889999999987 5689999999999999999999


Q ss_pred             CCCCCCCCccCc-hhhHHH------HHHHHhcCC----------------------CCCCCCCCCCHHHHHHHHHhhcCC
Q 024828          166 QFPYSPPEQQDG-WTSFYE------LMEAIVDQP----------------------PPSAPSDQFSPEFCSFISACVQKE  216 (262)
Q Consensus       166 ~~p~~~~~~~~~-~~~~~~------~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~~  216 (262)
                      +.||........ ......      ....+....                      ........+++++.+||.+||+.|
T Consensus       228 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  307 (330)
T 3nsz_A          228 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD  307 (330)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSS
T ss_pred             CCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCC
Confidence            999965433210 000000      000011000                      001111237899999999999999


Q ss_pred             cCCCCCHHHHhcCccccccCC
Q 024828          217 PQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       217 p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |.+|||++|+|+||||+....
T Consensus       308 P~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          308 HQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             GGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccCCCHHHHhcCccHhhhcc
Confidence            999999999999999997653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-42  Score=285.64  Aligned_cols=217  Identities=24%  Similarity=0.391  Sum_probs=184.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKG   80 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~l~~~   80 (262)
                      ......++.+|+.++++++||||+++++++.+....++||||+.|++|.+++...+       .++...+..++.|++.|
T Consensus       114 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a  193 (367)
T 3l9p_A          114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG  193 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHH
T ss_pred             ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHH
Confidence            46667789999999999999999999999999999999999999999999998753       48999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCC---cEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      |+|||+ .|++|+||||+||+++.++   .++|+|||++.......  .......+++.|+|||++.+..++.++|||||
T Consensus       194 L~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl  272 (367)
T 3l9p_A          194 CQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF  272 (367)
T ss_dssp             HHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHh-CCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHH
Confidence            999999 9999999999999998555   49999999987543222  22334567889999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          156 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       156 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      ||++|+|++ |..||.....       .+....+..+..... +..+++++.+|+.+||+.||.+|||+++++++.++-
T Consensus       273 G~il~ellt~g~~pf~~~~~-------~~~~~~i~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          273 GVLLWEIFSLGYMPYPSKSN-------QEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            999999998 9999987543       234444554444333 357899999999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=283.96  Aligned_cols=213  Identities=24%  Similarity=0.423  Sum_probs=183.6

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~   70 (262)
                      .+...+++.+|+++++++ +||||+++++++.+++..++||||+.+++|.+++....                .+++..+
T Consensus       114 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  193 (382)
T 3tt0_A          114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL  193 (382)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHH
Confidence            466678899999999999 99999999999999999999999999999999998754                4899999


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCc
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGY  148 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  148 (262)
                      ..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.......  .......++..|+|||++.+..++.
T Consensus       194 ~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  272 (382)
T 3tt0_A          194 VSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH  272 (382)
T ss_dssp             HHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCH
T ss_pred             HHHHHHHHHHHHHHHh-CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCc
Confidence            9999999999999999 999999999999999999999999999997654332  2223345678899999999888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ++||||||+++++|++ |..||.....       .+....+..+..... +..+++++.+|+.+||+.||.+|||+++++
T Consensus       273 ~~DiwslG~il~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell  344 (382)
T 3tt0_A          273 QSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLV  344 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCC-CSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            9999999999999999 9999986543       234444444444433 357899999999999999999999999999


Q ss_pred             cC
Q 024828          228 TH  229 (262)
Q Consensus       228 ~h  229 (262)
                      ++
T Consensus       345 ~~  346 (382)
T 3tt0_A          345 ED  346 (382)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2e-41  Score=281.04  Aligned_cols=212  Identities=25%  Similarity=0.391  Sum_probs=180.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc------------------------C
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV------------------------K   63 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------------------------~   63 (262)
                      .....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...                        .
T Consensus        90 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (343)
T 1luf_A           90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP  169 (343)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCC
Confidence            4566788999999999999999999999999999999999999999999999864                        5


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccc
Q 024828           64 TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERI  141 (262)
Q Consensus        64 ~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~  141 (262)
                      .++...++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+
T Consensus       170 ~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  248 (343)
T 1luf_A          170 PLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI  248 (343)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence            68999999999999999999999 999999999999999999999999999987653322  222334678889999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCC
Q 024828          142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  220 (262)
Q Consensus       142 ~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  220 (262)
                      .+..++.++|+||||+++|+|++ |..||.....       .+....+..+..... +..+++++.+++.+||+.||.+|
T Consensus       249 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~R  320 (343)
T 1luf_A          249 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-------EEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADR  320 (343)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             ccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-------HHHHHHHhCCCcCCC-CCCCCHHHHHHHHHHcccCcccC
Confidence            88889999999999999999999 9999986543       233444444444333 35789999999999999999999


Q ss_pred             CCHHHHhc
Q 024828          221 LSAQELMT  228 (262)
Q Consensus       221 pt~~~~l~  228 (262)
                      ||+.++++
T Consensus       321 ps~~~~~~  328 (343)
T 1luf_A          321 PSFCSIHR  328 (343)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHHH
Confidence            99999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-41  Score=277.08  Aligned_cols=225  Identities=28%  Similarity=0.453  Sum_probs=179.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCC--CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQ--CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+....+.+.+|++++++++  ||||+++++++.++...++|||+. +++|.+++.+.+.++...+..++.|++.||.||
T Consensus        65 ~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L  143 (313)
T 3cek_A           65 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI  143 (313)
T ss_dssp             CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecC-CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            35667788999999999996  599999999999999999999955 679999999988999999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccC-----------CCCCcchh
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISG-----------GKYGYKSD  151 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~-----------~~~~~~~D  151 (262)
                      |+ .|++|+||+|+||+++ ++.++|+|||++........  ......++..|+|||.+.+           ..++.++|
T Consensus       144 H~-~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  221 (313)
T 3cek_A          144 HQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  221 (313)
T ss_dssp             HH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHH
T ss_pred             HH-CCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHH
Confidence            99 9999999999999995 58999999999876543322  1233468999999999875           36788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcc
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  231 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~  231 (262)
                      |||||+++|+|++|+.||......      ................+...++++.+++.+||+.||.+|||++++++|||
T Consensus       222 i~slG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  295 (313)
T 3cek_A          222 VWSLGCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  295 (313)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HHHHHHHHHHHHhCCCchhhHHHH------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence            999999999999999999764321      12233333333333334567899999999999999999999999999999


Q ss_pred             ccccCCccc
Q 024828          232 LKMYGDLNV  240 (262)
Q Consensus       232 ~~~~~~~~~  240 (262)
                      |+.......
T Consensus       296 ~~~~~~~~~  304 (313)
T 3cek_A          296 VQIQTHPVN  304 (313)
T ss_dssp             HHCC-----
T ss_pred             ccCCCCchh
Confidence            987654433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.8e-42  Score=275.69  Aligned_cols=211  Identities=25%  Similarity=0.430  Sum_probs=179.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+++.+|++++++++||||+++++++.++...++||||+.+++|.+++.. ...++...+..++.|++.||.+||+ .
T Consensus        61 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~  139 (283)
T 3gen_A           61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-K  139 (283)
T ss_dssp             BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3456789999999999999999999999999999999999999999999987 4679999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ  166 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~  166 (262)
                      |++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |+
T Consensus       140 ~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~  219 (283)
T 3gen_A          140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK  219 (283)
T ss_dssp             TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTC
T ss_pred             CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987553221 11222345678999999998889999999999999999998 99


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      .||......       .....+........ +...++.+.+++.+||+.||.+|||++++++|
T Consensus       220 ~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          220 MPYERFTNS-------ETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CTTTTSCHH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCccccChh-------HHHHHHhcccCCCC-CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999875432       33344444433333 35678999999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-41  Score=282.45  Aligned_cols=229  Identities=23%  Similarity=0.386  Sum_probs=182.0

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCe------eEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPY------VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQ   76 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~   76 (262)
                      ........+.+.+|++++++++|++      ++.+.+++...+..++|||++ +++|.+++....  .++...+..++.|
T Consensus        53 ~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~q  131 (355)
T 2eu9_A           53 IRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ  131 (355)
T ss_dssp             ECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHH
T ss_pred             EcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHH
Confidence            3345566778889999999886555      899999999999999999999 558888776653  6999999999999


Q ss_pred             HHHHHHHHhhcCCeeeCCCCCCCEEE-------------------ccCCcEEEEecccccccccCCCCcccccccccccC
Q 024828           77 VLKGLLYLHHEKHIIHRDLKPSNLLI-------------------NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS  137 (262)
Q Consensus        77 l~~~l~~lh~~~~i~H~dl~p~nil~-------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~  137 (262)
                      ++.||+|||+ .|++|+||||+||++                   +.++.++|+|||++.....   ......++..|+|
T Consensus       132 i~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~a  207 (355)
T 2eu9_A          132 LCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRP  207 (355)
T ss_dssp             HHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCC
T ss_pred             HHHHHHHHHH-CCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc---cccCCcCCCcccC
Confidence            9999999998 999999999999999                   5678899999999876432   2334578999999


Q ss_pred             cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-----------------------
Q 024828          138 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-----------------------  194 (262)
Q Consensus       138 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------  194 (262)
                      ||++.+..++.++|+||||+++|+|++|+.||......+..    ..+.......+.                       
T Consensus       208 PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  283 (355)
T 2eu9_A          208 PEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL----VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS  283 (355)
T ss_dssp             HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTS
T ss_pred             CeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHcCCCcHHHhhhccchhhhccccccccccc
Confidence            99999888999999999999999999999999876543221    111221111000                       


Q ss_pred             ----------------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcccch
Q 024828          195 ----------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  242 (262)
Q Consensus       195 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~  242 (262)
                                      .......+.++.+|+.+||+.||.+|||++|+++||||+.......++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~  347 (355)
T 2eu9_A          284 SDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSF  347 (355)
T ss_dssp             HHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHHHHC-
T ss_pred             chhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCChhhccc
Confidence                            001112245789999999999999999999999999999887655443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.1e-41  Score=275.27  Aligned_cols=232  Identities=36%  Similarity=0.719  Sum_probs=179.8

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+...+.+.++..+++.++||||+++++++.+++..++||||+ ++.+..+... .+.++...+..++.|++.||.|||+
T Consensus        64 ~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  142 (318)
T 2dyl_A           64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE  142 (318)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3444455556666788889999999999999999999999999 5577776654 4679999999999999999999998


Q ss_pred             cC-CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc-----CCCCCcchhHHHHHHHHH
Q 024828           87 EK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        87 ~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~  160 (262)
                       . |++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.     +..++.++||||||+++|
T Consensus       143 -~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~  220 (318)
T 2dyl_A          143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV  220 (318)
T ss_dssp             -HHCCCCCCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHH
T ss_pred             -hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHH
Confidence             6 99999999999999999999999999987654322 223446889999999984     456889999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCC-CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA-PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      +|++|+.||......      ............+.. ....+++++.+++.+||+.||.+|||++++++||||+......
T Consensus       221 ~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (318)
T 2dyl_A          221 ELATGQFPYKNCKTD------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE  294 (318)
T ss_dssp             HHHHSSCTTTTCCSH------HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSC
T ss_pred             HHHhCCCCCCCCCcc------HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccccc
Confidence            999999999864322      123333333333222 2246899999999999999999999999999999999988777


Q ss_pred             cchhhHhhh
Q 024828          240 VDLSEYFTD  248 (262)
Q Consensus       240 ~~~~~~~~~  248 (262)
                      ....+.+.+
T Consensus       295 ~~~~~~~~~  303 (318)
T 2dyl_A          295 VDVASWFKD  303 (318)
T ss_dssp             CCHHHHHHH
T ss_pred             chhHHHhhc
Confidence            777766655

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-40  Score=272.42  Aligned_cols=215  Identities=33%  Similarity=0.601  Sum_probs=174.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++..    ...++...+..++.|++.||.+
T Consensus        72 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~  151 (310)
T 2wqm_A           72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH  151 (310)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHH
Confidence            467788899999999999999999999999999999999999999999999964    3568999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||++..............++..|+|||.+.+..++.++|+||||+++++|+
T Consensus       152 LH~-~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~  230 (310)
T 2wqm_A          152 MHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  230 (310)
T ss_dssp             HHH-TTCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             Hhh-CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence            999 9999999999999999999999999999876654444444557889999999999888999999999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|..||.....     ........+.....+......+++++.+++.+||+.||.+|||++++++
T Consensus       231 ~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          231 ALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HSSCTTC---C-----CHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hCCCCCcccch-----hHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999976432     2234445555555555555678999999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-41  Score=283.00  Aligned_cols=224  Identities=27%  Similarity=0.461  Sum_probs=177.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeE------EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI------SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      ++...+++.+|+.+++.++||||+++++++...+..      ++||||+.+ +|.+++..  .++...+..++.|++.||
T Consensus        81 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~aL  157 (371)
T 4exu_A           81 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGM--EFSEEKIQYLVYQMLKGL  157 (371)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCE-EHHHHTTS--CCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccc-cHHHHhhc--CCCHHHHHHHHHHHHHHH
Confidence            566678899999999999999999999999876654      999999975 99888753  599999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~  160 (262)
                      +|||+ .|++|+||+|+||+++.++.++|+|||++......   .....+++.|+|||.+.+ ..++.++||||||++++
T Consensus       158 ~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (371)
T 4exu_A          158 KYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA  233 (371)
T ss_dssp             HHHHH-TTCCCSCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred             HHHHH-CCCcCCCcCHHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHH
Confidence            99999 99999999999999999999999999998765432   234567999999999987 57899999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHH--------------------HHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYEL--------------------MEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      +|++|+.||.+.+..+........                    ...........  .....+++++.+||.+||+.||.
T Consensus       234 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  313 (371)
T 4exu_A          234 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD  313 (371)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTT
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChh
Confidence            999999999876543222111110                    00000000000  00135689999999999999999


Q ss_pred             CCCCHHHHhcCccccccCCc
Q 024828          219 QRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|||++|+++||||+.....
T Consensus       314 ~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          314 KRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             TSCCHHHHHTSGGGTTTCCG
T ss_pred             hcCCHHHHhcCcccccCCCc
Confidence            99999999999999877643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.3e-41  Score=284.00  Aligned_cols=233  Identities=22%  Similarity=0.387  Sum_probs=179.4

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCe-------EEEEEeecCCCCHHHHHH----hcCCCCHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-------ISIILEYMDGGSLADFLK----KVKTIPEEYLAAI   73 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i   73 (262)
                      +..+.....+..++++.+..++||||+++++++...+.       .++||||+.+ +|...+.    ....++...+..+
T Consensus        56 ~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~  134 (360)
T 3e3p_A           56 VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF  134 (360)
T ss_dssp             EECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHH
T ss_pred             EecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHH
Confidence            33344445567788888899999999999999876333       8899999987 6655443    4567899999999


Q ss_pred             HHHHHHHHHHHh--hcCCeeeCCCCCCCEEEcc-CCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcc
Q 024828           74 CEQVLKGLLYLH--HEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYK  149 (262)
Q Consensus        74 ~~~l~~~l~~lh--~~~~i~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~  149 (262)
                      +.|++.||.|||  + .|++|+||||+||+++. ++.++|+|||++....... ......++..|+|||.+.+.. ++.+
T Consensus       135 ~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~  212 (360)
T 3e3p_A          135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTA  212 (360)
T ss_dssp             HHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTH
T ss_pred             HHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcH
Confidence            999999999999  8 99999999999999986 8899999999997654332 333456899999999987655 8999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHH--------HHHhcCCC---------------CCCCCCCCCHHHH
Q 024828          150 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIVDQPP---------------PSAPSDQFSPEFC  206 (262)
Q Consensus       150 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~---------------~~~~~~~~~~~l~  206 (262)
                      +||||||+++|+|++|+.||................        ..+.....               ........++++.
T Consensus       213 ~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (360)
T 3e3p_A          213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY  292 (360)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHH
Confidence            999999999999999999998765443222221110        00000000               0011123568899


Q ss_pred             HHHHHhhcCCcCCCCCHHHHhcCccccccCCccc
Q 024828          207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       207 ~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~~  240 (262)
                      +|+.+||+.||.+|||+.|+++||||+...+...
T Consensus       293 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          293 DLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             HHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence            9999999999999999999999999998876544

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-41  Score=283.18  Aligned_cols=227  Identities=19%  Similarity=0.358  Sum_probs=174.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-----CCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l   81 (262)
                      +....+++.+|++++++++||||+++++++..     ....|+||||+.| +|.+++... ..++...+..++.|++.||
T Consensus        69 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l  147 (362)
T 3pg1_A           69 DSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGL  147 (362)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHH
Confidence            45567899999999999999999999999854     3368999999975 888888765 4699999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~  160 (262)
                      .|||+ .|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|
T Consensus       148 ~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  225 (362)
T 3pg1_A          148 HVLHE-AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA  225 (362)
T ss_dssp             HHHHH-TTCCCCCCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHH
T ss_pred             HHHHH-CcCEecCCChHHEEEcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHH
Confidence            99999 999999999999999999999999999987543322 2334568889999999887 56899999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHH----------------HHHhcCCCCCCC-------CCCCCHHHHHHHHHhhcCCc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELM----------------EAIVDQPPPSAP-------SDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p  217 (262)
                      +|++|+.||......+.........                ...........+       ....++.+.+|+.+||+.||
T Consensus       226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  305 (362)
T 3pg1_A          226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP  305 (362)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence            9999999998765432221111100                000011111111       13567889999999999999


Q ss_pred             CCCCCHHHHhcCccccccCC
Q 024828          218 QQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .+|||++++++||||+....
T Consensus       306 ~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          306 QRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             GGSCCHHHHHTSGGGTTTCC
T ss_pred             hhCCCHHHHHcCchhhhccC
Confidence            99999999999999998754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-40  Score=282.84  Aligned_cols=223  Identities=26%  Similarity=0.409  Sum_probs=174.1

Q ss_pred             HHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Q 024828           15 IAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        15 ~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ..+|++++++++||||+++++++...      ..+++||||+.+ +|.+.+.    ....++...+..++.|++.||+||
T Consensus        94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L  172 (420)
T 1j1b_A           94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI  172 (420)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            45799999999999999999988542      247799999976 7776664    346799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccC-CcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l  162 (262)
                      |+ .|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||++.+. .++.++|||||||++|+|
T Consensus       173 H~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el  250 (420)
T 1j1b_A          173 HS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL  250 (420)
T ss_dssp             HT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HH-CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHH
Confidence            98 999999999999999865 568999999997654322 23345789999999999765 689999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHH--------HHHHhcCC----CCCC--------CCCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYEL--------MEAIVDQP----PPSA--------PSDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~----~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                      ++|+.||.+....+....+...        +.......    .+..        .....++++.+||.+||..||.+|||
T Consensus       251 l~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t  330 (420)
T 1j1b_A          251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT  330 (420)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence            9999999876543322222111        01110000    0000        12356889999999999999999999


Q ss_pred             HHHHhcCccccccCCccc
Q 024828          223 AQELMTHPFLKMYGDLNV  240 (262)
Q Consensus       223 ~~~~l~h~~~~~~~~~~~  240 (262)
                      +.|+++||||+...+...
T Consensus       331 ~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          331 PLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             HHHHHTSGGGGGGGCTTC
T ss_pred             HHHHhCCHhhcccccccc
Confidence            999999999988765443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.8e-41  Score=289.01  Aligned_cols=213  Identities=23%  Similarity=0.399  Sum_probs=178.3

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC-eEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKG   80 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~   80 (262)
                      |....+...+++.+|++++++++||||+++++++.+.. ..++||||+++++|.+++.+.+.  ++...+..++.|++.|
T Consensus       222 K~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~  301 (450)
T 1k9a_A          222 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA  301 (450)
T ss_dssp             EEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHH
T ss_pred             EEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            33333346678999999999999999999999987654 79999999999999999987654  7999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |+|||+ .|++|+||+|+||+++.++.++|+|||++......   .....++..|+|||.+.+..++.++||||||+++|
T Consensus       302 l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~  377 (450)
T 1k9a_A          302 MEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW  377 (450)
T ss_dssp             HHHHHH-TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred             HHHHHh-CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHH
Confidence            999999 99999999999999999999999999998754322   12235678899999999889999999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|++ |+.||......+       ....+..+..... +..+++++.+||.+||+.||.+|||+.++++
T Consensus       378 el~t~g~~P~~~~~~~~-------~~~~i~~~~~~~~-p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          378 EIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDA-PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHTTTCCSSTTSCTTT-------HHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC-CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9998 999998765432       2334444444433 3578999999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.5e-41  Score=274.08  Aligned_cols=219  Identities=29%  Similarity=0.445  Sum_probs=176.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      +....+++.+|++++++++||||+++++++..  ....++||||+++++|.+++...+ .++...+..++.|++.||+||
T Consensus        51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l  130 (295)
T 3ugc_A           51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL  130 (295)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH
Confidence            55667789999999999999999999999854  356899999999999999998754 499999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      |+ .|++|+||+|+||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++||||||+++|+
T Consensus       131 H~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~  209 (295)
T 3ugc_A          131 GT-KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE  209 (295)
T ss_dssp             HH-TTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             hc-CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHH
Confidence            98 9999999999999999999999999999976543321   1223346677999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCcc---------CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CATGQFPYSPPEQQ---------DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |++|..|+......         ............+........ +..+++++.+++.+||+.||++|||++++++
T Consensus       210 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          210 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCC-CcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999988653211         111112233344444444333 4578999999999999999999999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-41  Score=280.59  Aligned_cols=215  Identities=27%  Similarity=0.399  Sum_probs=178.4

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-----------------------
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----------------------   63 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------   63 (262)
                      .....+.+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++....                       
T Consensus        88 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (344)
T 1rjb_A           88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN  167 (344)
T ss_dssp             ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred             CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccc
Confidence            445667899999999999 89999999999999999999999999999999998653                       


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccc
Q 024828           64 TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERI  141 (262)
Q Consensus        64 ~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~  141 (262)
                      .++...+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++.........  .....+++.|+|||.+
T Consensus       168 ~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  246 (344)
T 1rjb_A          168 VLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  246 (344)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHH-TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence            27899999999999999999999 99999999999999999999999999999765433221  2233567789999999


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCC
Q 024828          142 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  220 (262)
Q Consensus       142 ~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  220 (262)
                      .+..++.++||||||+++|+|++ |..||.......      .....+..+..+ ..+..+++++.+|+.+||..||.+|
T Consensus       247 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~R  319 (344)
T 1rjb_A          247 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA------NFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKR  319 (344)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             ccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH------HHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhC
Confidence            88889999999999999999998 999998765432      122222333322 3335689999999999999999999


Q ss_pred             CCHHHHhcCc
Q 024828          221 LSAQELMTHP  230 (262)
Q Consensus       221 pt~~~~l~h~  230 (262)
                      ||+++++++-
T Consensus       320 ps~~~l~~~l  329 (344)
T 1rjb_A          320 PSFPNLTSFL  329 (344)
T ss_dssp             CCHHHHHHHH
T ss_pred             cCHHHHHHHH
Confidence            9999998864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.7e-41  Score=280.93  Aligned_cols=212  Identities=25%  Similarity=0.400  Sum_probs=149.3

Q ss_pred             HHhcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCC
Q 024828           21 INQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRD   94 (262)
Q Consensus        21 ~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~d   94 (262)
                      .++.++||||+++++++..    +...++||||++|++|.+++.+.+  .+++..+..++.|++.||.|||+ .|++|+|
T Consensus        75 ~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~d  153 (336)
T 3fhr_A           75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRD  153 (336)
T ss_dssp             HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred             HHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence            3566799999999999976    455899999999999999998764  69999999999999999999999 9999999


Q ss_pred             CCCCCEEEccC---CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 024828           95 LKPSNLLINHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  171 (262)
Q Consensus        95 l~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  171 (262)
                      |+|+||+++.+   +.++|+|||++......  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus       154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (336)
T 3fhr_A          154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS  231 (336)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CCHHHEEEEecCCCceEEEeccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            99999999764   45999999998765432  22345678999999999888899999999999999999999999976


Q ss_pred             CCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          172 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ................. ....+......+++++.+|+.+||+.||.+|||++++++||||+...
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          232 NTGQAISPGMKRRIRLG-QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             --------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             ccchhhhhhHHHhhhcc-ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            55433211111111111 11122222346899999999999999999999999999999998654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-41  Score=275.17  Aligned_cols=218  Identities=20%  Similarity=0.292  Sum_probs=178.9

Q ss_pred             HHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+.+.+|+++++.+ +|++++++++++.++...++||||+ +++|.+++...+ +++...+..++.|++.||+|||+
T Consensus        46 ~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~  124 (298)
T 1csn_A           46 RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE  124 (298)
T ss_dssp             CTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34455788999999999 7999999999999999999999999 889999998754 59999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCc-----EEEEecccccccccCCC-------CcccccccccccCcccccCCCCCcchhHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGE-----VKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                       .|++|+||+|+||+++.++.     ++|+|||++........       ......|+..|+|||.+.+..++.++||||
T Consensus       125 -~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s  203 (298)
T 1csn_A          125 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA  203 (298)
T ss_dssp             -TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred             -CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHH
Confidence             99999999999999987765     99999999976654322       233456899999999999888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||+++|+|++|+.||....................... .......+++++.+++.+||+.||++|||++++++.
T Consensus       204 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          204 LGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            99999999999999988654433222222222221111 111124688999999999999999999999999753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-41  Score=270.88  Aligned_cols=208  Identities=27%  Similarity=0.489  Sum_probs=170.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-   89 (262)
                      ..+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++.. ++++...+..++.|++.||+|||+ .| 
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~-~~~  126 (271)
T 3dtc_A           49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHD-EAI  126 (271)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHH-SSS
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCC
Confidence            346788999999999999999999999999999999999999999999864 679999999999999999999999 88 


Q ss_pred             --eeeCCCCCCCEEEcc--------CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           90 --IIHRDLKPSNLLINH--------RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        90 --i~H~dl~p~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                        ++|+||+|+||+++.        ++.++|+|||.+.......  .....++..|+|||.+.+..++.++|+||||+++
T Consensus       127 ~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l  204 (271)
T 3dtc_A          127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLL  204 (271)
T ss_dssp             SCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred             CceeecCCchHHEEEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHH
Confidence              899999999999985        6789999999987654332  2244688999999999988899999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++|++|+.||......       ...............+..+++++.+++.+||+.||.+|||+.+++++
T Consensus       205 ~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          205 WELLTGEVPFRGIDGL-------AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHHCCCTTTTSCHH-------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCCCCCCCCHH-------HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            9999999999875432       22333334444444456789999999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.1e-41  Score=277.01  Aligned_cols=225  Identities=25%  Similarity=0.371  Sum_probs=176.8

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV   77 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l   77 (262)
                      +|+...+........+|+.++++++||||+++++++.+..    .+++||||+++++|.++++. ..++...+..++.|+
T Consensus        52 vK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi  130 (322)
T 3soc_A           52 VKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETM  130 (322)
T ss_dssp             EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred             EEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHH
Confidence            3444455566667788999999999999999999998743    47999999999999999977 569999999999999


Q ss_pred             HHHHHHHhhcC----------CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCC-
Q 024828           78 LKGLLYLHHEK----------HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGG-  144 (262)
Q Consensus        78 ~~~l~~lh~~~----------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-  144 (262)
                      +.||+|||+ .          |++|+||||+||+++.++.++|+|||++........  ......+++.|+|||++.+. 
T Consensus       131 ~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  209 (322)
T 3soc_A          131 ARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI  209 (322)
T ss_dssp             HHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhccccc
Confidence            999999998 8          999999999999999999999999999976543322  22335789999999999863 


Q ss_pred             ----CCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchh---------hHHHHHHHHhcCCCCCCCCC-----CCCHHHH
Q 024828          145 ----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT---------SFYELMEAIVDQPPPSAPSD-----QFSPEFC  206 (262)
Q Consensus       145 ----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~  206 (262)
                          .++.++|||||||++|+|++|+.||.+........         ...............+....     ..++++.
T Consensus       210 ~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (322)
T 3soc_A          210 NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC  289 (322)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHH
T ss_pred             ccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHH
Confidence                45678899999999999999999998654432111         12222233333322222211     1234599


Q ss_pred             HHHHHhhcCCcCCCCCHHHHhc
Q 024828          207 SFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       207 ~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+.+||+.||++|||++++++
T Consensus       290 ~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          290 ETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999976

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.8e-41  Score=270.98  Aligned_cols=212  Identities=25%  Similarity=0.394  Sum_probs=169.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ++...+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++...+ .++...+..++.|++.||.|||+
T Consensus        56 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  134 (281)
T 1mp8_A           56 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES  134 (281)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4667788999999999999999999999985 456899999999999999998654 69999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                       .|++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ 
T Consensus       135 -~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~  213 (281)
T 1mp8_A          135 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH  213 (281)
T ss_dssp             -TTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred             -CCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhc
Confidence             9999999999999999999999999999876543221 1223345678999999988889999999999999999996 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |..||......+       ....+..+.... .+..+++++.+++.+||+.||.+|||+++++++
T Consensus       214 g~~pf~~~~~~~-------~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          214 GVKPFQGVKNND-------VIGRIENGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             SCCTTTTCCGGG-------HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcCCHHH-------HHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999998765432       223333333333 335789999999999999999999999999763

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-41  Score=283.28  Aligned_cols=214  Identities=29%  Similarity=0.457  Sum_probs=178.4

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECC-eEEEEEeecCCCCHHHHHHhcCC---------------------
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKKVKT---------------------   64 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~---------------------   64 (262)
                      .....+.+.+|++++.++ +||||+++++++.+.+ ..++||||++|++|.+++.....                     
T Consensus        65 ~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (359)
T 3vhe_A           65 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA  144 (359)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------
T ss_pred             CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccc
Confidence            455667899999999999 7999999999988754 48999999999999999987543                     


Q ss_pred             ---------------------------------------------CCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCC
Q 024828           65 ---------------------------------------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN   99 (262)
Q Consensus        65 ---------------------------------------------~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~n   99 (262)
                                                                   +++..+..++.|++.||+|||+ .|++|+||||+|
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~N  223 (359)
T 3vhe_A          145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARN  223 (359)
T ss_dssp             ---------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             cchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhh
Confidence                                                         8999999999999999999999 999999999999


Q ss_pred             EEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccC
Q 024828          100 LLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  176 (262)
Q Consensus       100 il~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~  176 (262)
                      |+++.++.++|+|||++........  ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus       224 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  303 (359)
T 3vhe_A          224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  303 (359)
T ss_dssp             EEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             EEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH
Confidence            9999999999999999976533222  2233467788999999998889999999999999999998 999998765432


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          177 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                            .....+..+.... .+..+++++.+++.+||+.||.+|||++++++|
T Consensus       304 ------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          304 ------EFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ------HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                  2222333333332 235689999999999999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.6e-41  Score=281.37  Aligned_cols=212  Identities=26%  Similarity=0.422  Sum_probs=170.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+..++++.+|++++++++||||+++++++.++...++||||+++++|.+++.+.+ .++...+..++.|++.||+|||+
T Consensus        86 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  165 (373)
T 2qol_A           86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD  165 (373)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            56677899999999999999999999999999999999999999999999998764 69999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCc---ccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++|+|||++..........   ....++..|+|||.+.+..++.++||||||+++|+++
T Consensus       166 -~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ell  244 (373)
T 2qol_A          166 -MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM  244 (373)
T ss_dssp             -TTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             -CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHH
Confidence             999999999999999999999999999987654332211   1123466899999999888999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      + |+.||......       .....+..+..... ...++.++.+++.+||+.||.+|||++++++
T Consensus       245 t~g~~P~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          245 SYGERPYWEMSNQ-------DVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TTC-CTTTTCCHH-------HHHHHHHTTEECCC-CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hCCCCCCCCCCHH-------HHHHHHHcCCCCCC-CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8 99999765432       33344444433332 3468899999999999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.4e-41  Score=284.12  Aligned_cols=212  Identities=25%  Similarity=0.396  Sum_probs=178.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ..+..+++.+|++++++++||||+++++++.+++..++||||+++++|.+++...+ .++...+..++.|++.||+|||+
T Consensus       152 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~  231 (377)
T 3cbl_A          152 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES  231 (377)
T ss_dssp             CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45667789999999999999999999999999899999999999999999998654 59999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       232 -~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t  310 (377)
T 3cbl_A          232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS  310 (377)
T ss_dssp             -TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             -CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHh
Confidence             9999999999999999999999999999875432211  1112234678999999988889999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......       +....+..+...+. +..+++++.+|+.+||+.||++|||++++++
T Consensus       311 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          311 LGASPYPNLSNQ-------QTREFVEKGGRLPC-PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TSCCSSTTSCHH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             99999875432       23334444443333 3568999999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.3e-41  Score=275.71  Aligned_cols=227  Identities=27%  Similarity=0.458  Sum_probs=177.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEE--------------ECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFY--------------SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI   73 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i   73 (262)
                      +....+++.+|++++++++||||+++++++.              +....++||||+.| +|.+++.+ ++++...+..+
T Consensus        48 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~  125 (320)
T 2i6l_A           48 DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLF  125 (320)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHH
Confidence            4566788999999999999999999998873              34678999999975 99999975 67999999999


Q ss_pred             HHHHHHHHHHHhhcCCeeeCCCCCCCEEEc-cCCcEEEEecccccccccCC---CCcccccccccccCcccccC-CCCCc
Q 024828           74 CEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPERISG-GKYGY  148 (262)
Q Consensus        74 ~~~l~~~l~~lh~~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~-~~~~~  148 (262)
                      +.|++.||+|||+ .|++|+||+|+||+++ .++.++|+|||.+.......   .......++..|+|||.+.+ ..++.
T Consensus       126 ~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (320)
T 2i6l_A          126 MYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK  204 (320)
T ss_dssp             HHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCH
T ss_pred             HHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCc
Confidence            9999999999999 9999999999999997 45689999999987654221   12233456888999998875 56899


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHH--------HHHHhc---------CCCCC----CCCCCCCHHHHH
Q 024828          149 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------MEAIVD---------QPPPS----APSDQFSPEFCS  207 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~---------~~~~~----~~~~~~~~~l~~  207 (262)
                      ++|+||||+++|+|++|+.||......+........        ......         ...+.    .....+++++.+
T Consensus       205 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (320)
T 2i6l_A          205 AIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVD  284 (320)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHH
T ss_pred             hhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHH
Confidence            999999999999999999999876543211111100        000000         00000    011357899999


Q ss_pred             HHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          208 FISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       208 li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |+.+||+.||.+|||++++++||||+....
T Consensus       285 li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          285 FLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            999999999999999999999999987653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-41  Score=280.93  Aligned_cols=215  Identities=20%  Similarity=0.314  Sum_probs=176.3

Q ss_pred             HHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+++.+|+++++++ +||||+++++++.++...++||||+ +++|.+++... +.++...+..++.|++.||+|||+ 
T Consensus        46 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-  123 (330)
T 2izr_A           46 SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS-  123 (330)
T ss_dssp             CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            3445688999999999 9999999999999999999999999 88999999874 679999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCc-----EEEEecccccccccCCCC-------cccccccccccCcccccCCCCCcchhHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGE-----VKITDFGVSAIMASTSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      .|++|+||||+||+++.++.     ++|+|||++.........       .....|++.|+|||.+.+..++.++|+|||
T Consensus       124 ~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  203 (330)
T 2izr_A          124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEAL  203 (330)
T ss_dssp             TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHH
Confidence            99999999999999998887     999999999865433221       235678999999999999889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          156 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       156 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+++|+|++|+.||................... ...........++ ++.+++.+||+.||.+||+++++++
T Consensus       204 G~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          204 GHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK-RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH-HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhcCCCCccccccccHHHHHHHHHhhh-ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            999999999999998865443322222221111 1111111112344 8999999999999999999998876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-40  Score=267.34  Aligned_cols=208  Identities=16%  Similarity=0.270  Sum_probs=175.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~   83 (262)
                      +....+.+.+|++++++++||||+++++++.+.  ...++||||+++++|.+++.+.+  .++...+..++.|++.||.|
T Consensus        47 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~  126 (271)
T 3kmu_A           47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF  126 (271)
T ss_dssp             CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence            456678899999999999999999999999876  77899999999999999998765  48999999999999999999


Q ss_pred             HhhcCC--eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCc---chhHHHHHHH
Q 024828           84 LHHEKH--IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY---KSDIWSLGLV  158 (262)
Q Consensus        84 lh~~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~---~~Di~slG~~  158 (262)
                      ||+ .|  ++|+||+|+||+++.++.++++|||++....     .....+++.|+|||.+.+...+.   ++||||||++
T Consensus       127 lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~i  200 (271)
T 3kmu_A          127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL  200 (271)
T ss_dssp             HTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHH
T ss_pred             Hhc-CCCceecCCCccceEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHH
Confidence            998 89  9999999999999999999999988765422     22346789999999998765444   7999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+|++|+.||......       ...............+..+++++.+++.+||+.||++|||++++++
T Consensus       201 l~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          201 LWELVTREVPFADLSNM-------EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHCSCTTTTSCHH-------HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCCCccccChH-------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999865432       2222333333333344678999999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1e-40  Score=280.82  Aligned_cols=231  Identities=26%  Similarity=0.447  Sum_probs=177.6

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCC-CC-----eeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQ-CP-----YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAIC   74 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~   74 (262)
                      |.+.......+++.+|+++++.++ |+     +|+++++.+...+..|+|||++.+ +|.+++...  +.++...+..++
T Consensus        85 K~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~  163 (382)
T 2vx3_A           85 KIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFA  163 (382)
T ss_dssp             EEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHH
T ss_pred             EEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHH
Confidence            334445566778888999988874 44     499999999999999999999965 999999876  469999999999


Q ss_pred             HHHHHHHHHHhh-cCCeeeCCCCCCCEEEc--cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchh
Q 024828           75 EQVLKGLLYLHH-EKHIIHRDLKPSNLLIN--HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD  151 (262)
Q Consensus        75 ~~l~~~l~~lh~-~~~i~H~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D  151 (262)
                      .|++.||.|||+ +.|++|+||||+||+++  .++.++|+|||++.....   ......+++.|+|||++.+..++.++|
T Consensus       164 ~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~D  240 (382)
T 2vx3_A          164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAID  240 (382)
T ss_dssp             HHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHH
T ss_pred             HHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc---ccccccCCccccChHHHcCCCCCcHHH
Confidence            999999999994 37999999999999995  467899999999976543   233457899999999999989999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHH----HHhcCC---------CCC---------------CCCC----
Q 024828          152 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME----AIVDQP---------PPS---------------APSD----  199 (262)
Q Consensus       152 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~---------------~~~~----  199 (262)
                      ||||||++|+|++|+.||...+..+....+.....    ......         .+.               ..+.    
T Consensus       241 iwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  320 (382)
T 2vx3_A          241 MWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKL  320 (382)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhH
Confidence            99999999999999999987654432222111100    000000         000               0000    


Q ss_pred             -------------------C----CCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          200 -------------------Q----FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       200 -------------------~----~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                                         .    .++++.+||.+||+.||++|||++|+|+||||+...+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          321 HNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             HHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred             HHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCCC
Confidence                               0    0137899999999999999999999999999987653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-41  Score=270.66  Aligned_cols=216  Identities=24%  Similarity=0.455  Sum_probs=180.5

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ...+....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++.+. +.++...+..++.|++.||.+
T Consensus        40 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  119 (267)
T 3t9t_A           40 IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY  119 (267)
T ss_dssp             ECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHH
Confidence            3333334568899999999999999999999999999999999999999999999875 468999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      ||+ .|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus       120 lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  198 (267)
T 3t9t_A          120 LEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV  198 (267)
T ss_dssp             HHH-TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             HHh-CCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHH
Confidence            999 999999999999999999999999999987553221 112233466789999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          163 AT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       163 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++ |+.||......       +....+..+..... +..+++++.+++.+||+.||.+|||+++++++
T Consensus       199 ~~~g~~p~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          199 FSEGKIPYENRSNS-------EVVEDISTGFRLYK-PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HTTSCCTTTTCCHH-------HHHHHHHTTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccCCCCCCCCCHH-------HHHHHHhcCCcCCC-CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99 89999875432       33444444433332 35678999999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=279.89  Aligned_cols=224  Identities=27%  Similarity=0.455  Sum_probs=177.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCe------EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      ++...+++.+|+.++++++||||+++++++.....      .++||||+.+ +|.+++..  .++...+..++.|++.||
T Consensus        63 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al  139 (353)
T 3coi_A           63 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGL  139 (353)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHH
Confidence            55667889999999999999999999999987643      5999999975 88887753  599999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~  160 (262)
                      .|||+ .|++|+||+|+||+++.++.++|+|||++......   .....++..|+|||.+.+ ..++.++|+||||++++
T Consensus       140 ~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~  215 (353)
T 3coi_A          140 KYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA  215 (353)
T ss_dssp             HHHHH-TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred             HHHHH-CCcccCCCCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHH
Confidence            99999 99999999999999999999999999998764322   234467899999999887 56899999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHH--------------------HHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYEL--------------------MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      +|++|+.||.+.+..+........                    ...+.....  .......+++++.+|+.+||+.||+
T Consensus       216 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  295 (353)
T 3coi_A          216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD  295 (353)
T ss_dssp             HHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTT
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcc
Confidence            999999999876543221111110                    000000000  1112246789999999999999999


Q ss_pred             CCCCHHHHhcCccccccCCc
Q 024828          219 QRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|||++++++||||+.....
T Consensus       296 ~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          296 KRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             TSCCHHHHHTSGGGTTTCCG
T ss_pred             cCCCHHHHhcCcchhhccCc
Confidence            99999999999999877643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5e-41  Score=275.20  Aligned_cols=214  Identities=26%  Similarity=0.420  Sum_probs=179.9

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC------------------CCCHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK------------------TIPEE   68 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~~~~   68 (262)
                      .....+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++....                  .++..
T Consensus        66 ~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (313)
T 1t46_A           66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE  145 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred             hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHH
Confidence            345678899999999999 99999999999999999999999999999999998654                  48999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCC
Q 024828           69 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKY  146 (262)
Q Consensus        69 ~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~  146 (262)
                      .+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..+
T Consensus       146 ~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  224 (313)
T 1t46_A          146 DLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY  224 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence            999999999999999999 99999999999999999999999999998765443221  223346778999999988889


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHH
Q 024828          147 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE  225 (262)
Q Consensus       147 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  225 (262)
                      +.++||||||+++++|++ |..||.......   ..   ......... ......+++++.+++.+||+.||.+|||+++
T Consensus       225 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  297 (313)
T 1t46_A          225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDS---KF---YKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---HH---HHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCCcccchh---HH---HHHhccCCC-CCCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            999999999999999998 999998765432   11   122222222 2233568999999999999999999999999


Q ss_pred             HhcC
Q 024828          226 LMTH  229 (262)
Q Consensus       226 ~l~h  229 (262)
                      ++++
T Consensus       298 ll~~  301 (313)
T 1t46_A          298 IVQL  301 (313)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.7e-41  Score=275.63  Aligned_cols=212  Identities=26%  Similarity=0.408  Sum_probs=176.8

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~   70 (262)
                      +....+++.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.+.+                .++...+
T Consensus        65 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (327)
T 1fvr_A           65 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL  144 (327)
T ss_dssp             -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred             chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHH
Confidence            455667899999999999 89999999999999999999999999999999998754                6999999


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcch
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++
T Consensus       145 ~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~  222 (327)
T 1fvr_A          145 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNS  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHHHHHh-CCccCCCCccceEEEcCCCeEEEcccCcCccccccc-cccCCCCCccccChhhhccccCCchh
Confidence            9999999999999999 999999999999999999999999999986433221 22234567789999999888889999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |+||||+++|+|++ |+.||.....       ......+..+..... +..+++++.+|+.+||..||.+|||+++++++
T Consensus       223 Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          223 DVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHGGGTCCCCC-CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCCCCCCCcH-------HHHHHHhhcCCCCCC-CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999998 9999987543       234444444433333 35789999999999999999999999999885

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.9e-41  Score=272.45  Aligned_cols=217  Identities=24%  Similarity=0.370  Sum_probs=178.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ...+.+.+|++++++++||||+++++++.+.  ...++||||+++++|.+++.+. ..++...+..++.|++.||++||+
T Consensus        65 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  144 (302)
T 4e5w_A           65 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS  144 (302)
T ss_dssp             CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc
Confidence            3457889999999999999999999999876  6689999999999999999554 579999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus       145 -~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  223 (302)
T 4e5w_A          145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL  223 (302)
T ss_dssp             -TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             -CCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHH
Confidence             9999999999999999999999999999876544321   223345777899999999888999999999999999999


Q ss_pred             hCCCCCCCCC--------ccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          164 TGQFPYSPPE--------QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       164 ~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|..|+....        ..............+..+..... +..+++++.+|+.+||+.||.+|||++++++
T Consensus       224 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          224 TYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCC-CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9998864321        11111223334444444444333 3578999999999999999999999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.9e-41  Score=276.62  Aligned_cols=227  Identities=37%  Similarity=0.689  Sum_probs=163.9

Q ss_pred             HHHHHHHHHHHH-HHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-----VKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         9 ~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      .....++.+|+. +++.++||||+++++++.+++..++||||+.+ +|.+++..     ...++...+..++.|++.||.
T Consensus        61 ~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~  139 (327)
T 3aln_A           61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALN  139 (327)
T ss_dssp             HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHH
Confidence            445556666666 77888999999999999999999999999976 99888864     467999999999999999999


Q ss_pred             HHhhcC-CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccc----cCCCCCcchhHHHHHH
Q 024828           83 YLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGL  157 (262)
Q Consensus        83 ~lh~~~-~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~----~~~~~~~~~Di~slG~  157 (262)
                      +||+ . |++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+    .+..++.++|+||||+
T Consensus       140 ~lH~-~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~  217 (327)
T 3aln_A          140 HLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGI  217 (327)
T ss_dssp             HHHH-HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHH
T ss_pred             HHhc-cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHH
Confidence            9998 7 99999999999999999999999999987654332 22234688999999998    4556899999999999


Q ss_pred             HHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCC---CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          158 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA---PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       158 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      ++|+|++|+.||.......      ........+..+..   ....+++++.+|+.+||+.||.+|||++++++||||..
T Consensus       218 il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          218 TLYELATGRFPYPKWNSVF------DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             HHHHHHHSCCCSSCC-------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHCCCCCCCcchHH------HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            9999999999997643211      11112222222221   12468899999999999999999999999999999987


Q ss_pred             cCCcccchhh
Q 024828          235 YGDLNVDLSE  244 (262)
Q Consensus       235 ~~~~~~~~~~  244 (262)
                      ..+.......
T Consensus       292 ~~~~~~~~~~  301 (327)
T 3aln_A          292 YEERAVEVAC  301 (327)
T ss_dssp             HHHSCCCHHH
T ss_pred             hHhhHHHHHH
Confidence            7655444333

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-40  Score=270.02  Aligned_cols=210  Identities=21%  Similarity=0.381  Sum_probs=177.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+++.+|++++++++||||+++++++ ..+..++||||+.+++|.+++...+.++...+..++.|++.||.+||+ .
T Consensus        59 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~  136 (291)
T 1xbb_A           59 PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-S  136 (291)
T ss_dssp             CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            34577899999999999999999999999 567789999999999999999998889999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                      |++|+||+|+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++|+||||+++|+|++ 
T Consensus       137 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  216 (291)
T 1xbb_A          137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY  216 (291)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred             CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhc
Confidence            9999999999999999999999999998765433221   112345678999999988888999999999999999999 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+.||......       .....+..+..+.. +..+++++.+++.+||+.||.+|||+.++++
T Consensus       217 g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          217 GQKPYRGMKGS-------EVTAMLEKGERMGC-PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TCCSSTTCCHH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999875432       23344444443333 3578999999999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-41  Score=284.08  Aligned_cols=230  Identities=28%  Similarity=0.477  Sum_probs=176.6

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCC-----------CCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhc--CCC
Q 024828            3 IQMNVEESARRQIAQELKINQSSQ-----------CPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKV--KTI   65 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~--~~~   65 (262)
                      |.+..+....+.+.+|++++++++           ||||+++++++...+    ..++|||++ +++|.+++...  +.+
T Consensus        50 K~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~  128 (373)
T 1q8y_A           50 KIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI  128 (373)
T ss_dssp             EEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCC
T ss_pred             EEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCC
Confidence            334445666778899999998885           899999999998654    789999999 77999999874  459


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcC-CeeeCCCCCCCEEEccC------CcEEEEecccccccccCCCCcccccccccccCc
Q 024828           66 PEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHR------GEVKITDFGVSAIMASTSGQANTFVGTYNYMSP  138 (262)
Q Consensus        66 ~~~~~~~i~~~l~~~l~~lh~~~-~i~H~dl~p~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~P  138 (262)
                      +...+..++.|++.||+|||+ . |++|+||||+||+++.+      +.++|+|||++......   .....++..|+||
T Consensus       129 ~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aP  204 (373)
T 1q8y_A          129 PLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSP  204 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCH
T ss_pred             cHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCc
Confidence            999999999999999999998 7 99999999999999533      37999999998765432   2344789999999


Q ss_pred             ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhh---HHHHHHHHhcCCC----------------------
Q 024828          139 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS---FYELMEAIVDQPP----------------------  193 (262)
Q Consensus       139 E~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~----------------------  193 (262)
                      |++.+..++.++||||||+++|+|++|+.||...........   .......+ ...+                      
T Consensus       205 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~  283 (373)
T 1q8y_A          205 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRN  283 (373)
T ss_dssp             HHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSS
T ss_pred             HHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc-CCCCHHHHhccchhhhhcCCcchhcc
Confidence            999998899999999999999999999999986543221111   11111111 0000                      


Q ss_pred             ---------------CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          194 ---------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       194 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                                     ....+...++++.+||.+||+.||.+|||++|+++||||+.....
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  343 (373)
T 1q8y_A          284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM  343 (373)
T ss_dssp             CCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred             cccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCc
Confidence                           000112345778999999999999999999999999999986543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-40  Score=269.93  Aligned_cols=216  Identities=26%  Similarity=0.453  Sum_probs=167.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+.+.+|++++++++||||++++++. .....++||||+.+++|.+++... ..++...+..++.|++.||.|||+
T Consensus        60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~  138 (289)
T 3og7_A           60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA  138 (289)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            566778899999999999999999999954 556689999999999999999644 569999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccC--CCCcccccccccccCccccc---CCCCCcchhHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~~  161 (262)
                       .|++|+||+|+||+++.++.++|+|||++......  ........++..|+|||.+.   +..++.++||||||+++++
T Consensus       139 -~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e  217 (289)
T 3og7_A          139 -KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE  217 (289)
T ss_dssp             -TTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHH
T ss_pred             -CCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHH
Confidence             99999999999999999999999999998754321  12223346899999999986   5568889999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |++|+.||......+   .....................+++++.+|+.+||+.||.+|||++++++
T Consensus       218 l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          218 LMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHSSCTTSSCCCHH---HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHCCCCccccchHH---HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999999998754432   1222222211122222233578899999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.4e-41  Score=271.93  Aligned_cols=217  Identities=24%  Similarity=0.399  Sum_probs=181.8

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~   80 (262)
                      |....+....+++.+|++++++++||||+++++++.++...++||||++|++|.+++...  ..++...+..++.|++.|
T Consensus        44 K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~  123 (288)
T 3kfa_A           44 KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA  123 (288)
T ss_dssp             EEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHH
T ss_pred             EecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHH
Confidence            334445556788999999999999999999999999999999999999999999999874  358999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      |.+||+ .|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++
T Consensus       124 l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  202 (288)
T 3kfa_A          124 MEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL  202 (288)
T ss_dssp             HHHHHH-HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             HHHHHH-CCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHH
Confidence            999999 9999999999999999999999999999876543321 12223456789999999988899999999999999


Q ss_pred             HHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          160 LECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       160 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ++|++ |..||...+...       ....+...... ..+..+++++.+|+.+||..||.+|||++++++
T Consensus       203 ~~ll~~g~~p~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          203 WEIATYGMSPYPGIDLSQ-------VYELLEKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHTTSCCSSTTCCGGG-------HHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCCCCCCCHHH-------HHHHHhccCCC-CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            99999 999998765432       22233333332 233578999999999999999999999999976

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-40  Score=268.47  Aligned_cols=213  Identities=27%  Similarity=0.442  Sum_probs=180.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+++.+|++++++++||||+++++++ ..+..++|||++.+++|.+++... ..++...+..++.|++.||.+||+
T Consensus        50 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~  128 (287)
T 1u59_A           50 EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  128 (287)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH
Confidence            466788899999999999999999999999 556799999999999999999654 569999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus       129 -~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  207 (287)
T 1u59_A          129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  207 (287)
T ss_dssp             -TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             -CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence             9999999999999999999999999999876543321   122234578899999998888999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCc
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP  230 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~  230 (262)
                      + |+.||......       +....+..+..+.. +..+++++.+++.+||+.||.+|||+.+++++.
T Consensus       208 t~g~~p~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          208 SYGQKPYKKMKGP-------EVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             TTSCCTTTTCCTH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             cCCCCCcccCCHH-------HHHHHHhcCCcCCC-CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            8 99999875442       23344444443333 357899999999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-40  Score=272.25  Aligned_cols=213  Identities=23%  Similarity=0.403  Sum_probs=180.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----------KTIPEEYLAAICEQV   77 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~l   77 (262)
                      ......++.+|++++++++||||+++++++.+++..++||||+++++|.+++...          ..++...+..++.|+
T Consensus        68 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi  147 (322)
T 1p4o_A           68 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI  147 (322)
T ss_dssp             CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHH
Confidence            4456678999999999999999999999999999999999999999999999753          356999999999999


Q ss_pred             HHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHH
Q 024828           78 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        78 ~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      +.||.+||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||
T Consensus       148 ~~~l~~lH~-~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  226 (322)
T 1p4o_A          148 ADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  226 (322)
T ss_dssp             HHHHHHHHH-TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHH-CCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence            999999999 9999999999999999999999999999876543221  1223356788999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          156 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       156 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |+++|+|++ |..||......       .....+..+..... ...+++++.+++.+||+.||.+|||+.+++++
T Consensus       227 G~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          227 GVVLWEIATLAEQPYQGLSNE-------QVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHHHHHTSCCTTTTSCHH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCccccCCHH-------HHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999 89999765432       33344444443333 35789999999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-40  Score=273.22  Aligned_cols=213  Identities=25%  Similarity=0.386  Sum_probs=175.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .+..+.++.+|++++++++||||+++++++.+.+..++||||+++++|.+++... +.++...+..++.|++.||.+||+
T Consensus        86 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  165 (333)
T 1mqb_A           86 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN  165 (333)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4566778999999999999999999999999999999999999999999999765 579999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++|+||+|+||+++.++.++|+|||++.........   .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus       166 -~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  244 (333)
T 1mqb_A          166 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM  244 (333)
T ss_dssp             -TTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             -CCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHH
Confidence             99999999999999999999999999998765433211   11223567899999999888999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      + |+.||.....       .+....+..+..... +..+++++.+++.+||+.||.+||++.+++++
T Consensus       245 t~g~~pf~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          245 TYGERPYWELSN-------HEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TTSCCTTTTCCH-------HHHHHHHHTTCCCCC-CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cCCCCCcccCCH-------HHHHHHHHCCCcCCC-cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8 9999976543       233444444443333 35689999999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9e-40  Score=267.54  Aligned_cols=213  Identities=27%  Similarity=0.409  Sum_probs=170.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ++...+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+.++...+..++.|++.||.|||+ 
T Consensus        74 ~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-  152 (309)
T 2h34_A           74 DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-  152 (309)
T ss_dssp             SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            4556788999999999999999999999999999999999999999999999988899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus       153 ~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  232 (309)
T 2h34_A          153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS  232 (309)
T ss_dssp             TTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSS
T ss_pred             CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999987654322 1223446889999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhcCCcCCCC-CHHHHhc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRL-SAQELMT  228 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~~l~  228 (262)
                      .||......       .....+..... +......+++++.+++.+||+.||++|| |++++++
T Consensus       233 ~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          233 PPYQGDQLS-------VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CSSCSCHHH-------HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCCCchHH-------HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            999864321       22222222222 2223457899999999999999999999 7887765

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.7e-41  Score=275.93  Aligned_cols=218  Identities=24%  Similarity=0.395  Sum_probs=182.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKG   80 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~l~~~   80 (262)
                      .+....++.+|+.++++++||||+++++++.+....++||||+++++|.+++....       .++...+..++.|++.|
T Consensus        73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a  152 (327)
T 2yfx_A           73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG  152 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHH
Confidence            45667789999999999999999999999999999999999999999999998763       48999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccC---CcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      |.|||+ .|++|+||+|+||+++.+   ..++|+|||++.......  .......++..|+|||.+.+..++.++|||||
T Consensus       153 l~~LH~-~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  231 (327)
T 2yfx_A          153 CQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF  231 (327)
T ss_dssp             HHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHhh-CCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHH
Confidence            999999 999999999999999844   469999999987543322  22233467889999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          156 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       156 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      |+++|+|++ |..||......       .....+..+.... ....+++.+.+++.+||+.||.+|||+++++++.|+-.
T Consensus       232 G~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          232 GVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHHHHHHTTSCCSSTTCCHH-------HHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCcCHH-------HHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            999999998 99999765432       3334444444333 33578999999999999999999999999999988643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.6e-40  Score=273.52  Aligned_cols=213  Identities=23%  Similarity=0.414  Sum_probs=180.6

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL   70 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~   70 (262)
                      .+...+++.+|+++++++ +||||+++++++.+.+..++||||+.+++|.+++....                .++...+
T Consensus        80 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (334)
T 2pvf_A           80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL  159 (334)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHH
T ss_pred             cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHH
Confidence            456678899999999999 89999999999999999999999999999999998754                3899999


Q ss_pred             HHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCc
Q 024828           71 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGY  148 (262)
Q Consensus        71 ~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~  148 (262)
                      ..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.
T Consensus       160 ~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  238 (334)
T 2pvf_A          160 VSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  238 (334)
T ss_dssp             HHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHHh-CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence            9999999999999999 9999999999999999999999999999876543321  122335677899999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          149 KSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      ++||||||+++|+|++ |..||......       +....+..+.... .+..+++++.+++.+||+.||.+|||+++++
T Consensus       239 ~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  310 (334)
T 2pvf_A          239 QSDVWSFGVLMWEIFTLGGSPYPGIPVE-------ELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLV  310 (334)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcCcCCHH-------HHHHHHhcCCCCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999999999999 99999765432       2333333343333 2357899999999999999999999999998


Q ss_pred             cC
Q 024828          228 TH  229 (262)
Q Consensus       228 ~h  229 (262)
                      ++
T Consensus       311 ~~  312 (334)
T 2pvf_A          311 ED  312 (334)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-40  Score=289.13  Aligned_cols=212  Identities=25%  Similarity=0.410  Sum_probs=179.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +....+++.+|++++++++||||+++++++.+....++||||+++++|.+++.+.  ..++...+..++.|++.||+|||
T Consensus       256 ~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH  335 (495)
T 1opk_A          256 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE  335 (495)
T ss_dssp             SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3345678999999999999999999999999999999999999999999999864  45899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      + .|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       336 ~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t  414 (495)
T 1opk_A          336 K-KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT  414 (495)
T ss_dssp             H-TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             h-CCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHh
Confidence            9 999999999999999999999999999987653221 11122345678999999998889999999999999999999


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||...+..+       ....+..+.... .+..+++++.+||.+||+.||.+|||+.++++
T Consensus       415 ~g~~p~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          415 YGMSPYPGIDLSQ-------VYELLEKDYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             TSCCSSTTCCGGG-------HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHHH-------HHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence             999998765432       223333333333 23578999999999999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=265.08  Aligned_cols=213  Identities=21%  Similarity=0.340  Sum_probs=176.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeE-EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI-SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+....+.+.+|++++++++||||+++++++.+.+.. ++|+||+.+++|.+++... ..++...+..++.|++.||+||
T Consensus        61 ~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  140 (298)
T 3pls_A           61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL  140 (298)
T ss_dssp             CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            3456678899999999999999999999999876554 9999999999999999874 5689999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccC----CCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |+ .|++|+||+|+||+++.++.++|+|||++......    ........++..|+|||.+.+..++.++|+||||+++|
T Consensus       141 H~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  219 (298)
T 3pls_A          141 AE-QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLW  219 (298)
T ss_dssp             HH-TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             Hh-CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHH
Confidence            99 99999999999999999999999999998754322    12233446788999999999888999999999999999


Q ss_pred             HHHhCCCC-CCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          161 ECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       161 ~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|++|..| |...+..       .....+....... .+..+++++.+++.+||+.||.+|||++++++
T Consensus       220 ~l~~g~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          220 ELLTRGAPPYRHIDPF-------DLTHFLAQGRRLP-QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHTSCCTTTTSCGG-------GHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhhCCCCCCccCCHH-------HHHHHhhcCCCCC-CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99995554 5443322       2223333333332 34568999999999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3e-40  Score=271.70  Aligned_cols=221  Identities=23%  Similarity=0.314  Sum_probs=178.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++....    .++...+..++.|++.||+||
T Consensus        76 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l  155 (321)
T 2qkw_B           76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL  155 (321)
T ss_dssp             SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh
Confidence            3456789999999999999999999999999999999999999999999986543    589999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |+ .|++|+||+|+||+++.++.++|+|||++.......  .......|+..|+|||.+.+..++.++||||||+++|+|
T Consensus       156 H~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  234 (321)
T 2qkw_B          156 HT-RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV  234 (321)
T ss_dssp             HH-TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHH
T ss_pred             cC-CCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHH
Confidence            99 999999999999999999999999999987643222  122334588999999999888899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCC--------CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP  230 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~  230 (262)
                      ++|+.||......+..............+...        .......+..+.+++.+||+.||++|||+++++++-
T Consensus       235 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             HHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            99999998765543322211111111111111        111122356789999999999999999999999763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-40  Score=286.70  Aligned_cols=214  Identities=25%  Similarity=0.439  Sum_probs=178.1

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~   82 (262)
                      +..+....+++.+|++++++++||||+++++++. ....++||||+.+++|.+++...  ..++...+..++.|++.||+
T Consensus       220 ~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~  298 (454)
T 1qcf_A          220 MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA  298 (454)
T ss_dssp             ECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHH
T ss_pred             ecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence            3333445778999999999999999999999986 56789999999999999999754  36899999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      |||+ .|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+
T Consensus       299 ~LH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~e  377 (454)
T 1qcf_A          299 FIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME  377 (454)
T ss_dssp             HHHH-TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             HHHh-CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHH
Confidence            9999 999999999999999999999999999997653221 11122345678999999998889999999999999999


Q ss_pred             HHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |++ |+.||.+....       +....+..+...+. +..+++++.+||.+||+.||++|||++++++
T Consensus       378 l~t~g~~P~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          378 IVTYGRIPYPGMSNP-------EVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHTTSCCSSTTCCHH-------HHHHHHHHTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            999 99999875432       33344444444333 3578999999999999999999999999975

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.1e-40  Score=272.34  Aligned_cols=220  Identities=24%  Similarity=0.426  Sum_probs=180.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEE--ECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      +....+.+.+|++++++++||||+++++++.  +....++||||+++++|.+++... ..++...+..++.|++.||+||
T Consensus        64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l  143 (327)
T 3lxl_A           64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL  143 (327)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            4566778999999999999999999999886  456799999999999999999874 5699999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      |+ .|++|+||+|+||+++.++.++|+|||.+........   ......++..|+|||.+.+..++.++||||||+++++
T Consensus       144 H~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  222 (327)
T 3lxl_A          144 GS-RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE  222 (327)
T ss_dssp             HH-TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred             Hh-CCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHH
Confidence            99 9999999999999999999999999999976543321   2223457778999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCcc--------CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          162 CATGQFPYSPPEQQ--------DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       162 l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |++|..||......        ...............+..... +..+++++.+|+.+||+.||.+|||+++++++
T Consensus       223 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          223 LFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA-PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC-CCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999998653321        111222333444444444333 46789999999999999999999999999654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-40  Score=274.56  Aligned_cols=213  Identities=28%  Similarity=0.419  Sum_probs=178.0

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--------------CCCCHHHHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--------------KTIPEEYLAA   72 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~   72 (262)
                      .....+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++...              ..++...+..
T Consensus        89 ~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (333)
T 2i1m_A           89 HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH  168 (333)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHH
Confidence            446678899999999999 8999999999999999999999999999999999753              3579999999


Q ss_pred             HHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcch
Q 024828           73 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKS  150 (262)
Q Consensus        73 i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~  150 (262)
                      ++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++
T Consensus       169 ~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  247 (333)
T 2i1m_A          169 FSSQVAQGMAFLAS-KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS  247 (333)
T ss_dssp             HHHHHHHHHHHHHH-TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHHhc-CCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHH
Confidence            99999999999999 99999999999999999999999999998765433221  2233467789999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          151 DIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       151 Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ||||||+++|+|++ |..||.......   ...   ........ ...+...++++.+++.+||+.||.+|||++++++
T Consensus       248 Di~slG~il~el~t~g~~p~~~~~~~~---~~~---~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          248 DVWSYGILLWEIFSLGLNPYPGILVNS---KFY---KLVKDGYQ-MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHHHHHHTTTSCCSSTTCCSSH---HHH---HHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccchhH---HHH---HHHhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            99999999999998 999998755432   111   12222222 2233567899999999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-40  Score=273.23  Aligned_cols=212  Identities=25%  Similarity=0.410  Sum_probs=175.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+++.+|+.++++++||||+++++++.++. .++|++++.+++|.+++... +.++...+..++.|++.||+|||+
T Consensus        57 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~  135 (327)
T 3poz_A           57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED  135 (327)
T ss_dssp             ---CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            3455678999999999999999999999998765 78999999999999999874 579999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .|++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       136 -~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  214 (327)
T 3poz_A          136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             -TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             -CCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence             99999999999999999999999999999765433222  222345778999999998889999999999999999999


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                       |+.||......+       ....+..+.... .+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       215 ~g~~p~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          215 FGSKPYDGIPASE-------ISSILEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TSCCTTTTCCGGG-------HHHHHHTTCCCC-CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cCCCCccCCCHHH-------HHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence             999998765432       223333333333 335688999999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.8e-40  Score=269.02  Aligned_cols=213  Identities=22%  Similarity=0.361  Sum_probs=171.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC-----eEEEEEeecCCCCHHHHHHh------cCCCCHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQ   76 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~------~~~~~~~~~~~i~~~   76 (262)
                      +....+.+.+|++++++++||||+++++++.+..     ..++||||+.+++|.+++..      ...++...+..++.|
T Consensus        76 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q  155 (313)
T 3brb_A           76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD  155 (313)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHH
Confidence            4566778999999999999999999999997654     35999999999999999943      356999999999999


Q ss_pred             HHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHH
Q 024828           77 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        77 l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      ++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+||
T Consensus       156 i~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  234 (313)
T 3brb_A          156 IALGMEYLSN-RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA  234 (313)
T ss_dssp             HHHHHHHHHT-TTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHH
T ss_pred             HHHHHHHHHh-CCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHH
Confidence            9999999998 999999999999999999999999999987654322  1222345677899999999888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          155 LGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       155 lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||+++|+|++ |..||......+       ....+..+..+.. +..+++++.+++.+||..||.+|||+++++++
T Consensus       235 lG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          235 FGVTMWEIATRGMTPYPGVQNHE-------MYDYLLHGHRLKQ-PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCGGG-------HHHHHHTTCCCCC-BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCccCCHHH-------HHHHHHcCCCCCC-CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999 899998765432       2233334433333 35789999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5e-40  Score=270.10  Aligned_cols=218  Identities=25%  Similarity=0.391  Sum_probs=179.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .....+.+.+|++++++++||||+++++++.+  ....++||||+++++|.+++.+. +++...+..++.|++.||++||
T Consensus        73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH  151 (318)
T 3lxp_A           73 GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH  151 (318)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            45677889999999999999999999999988  46789999999999999999774 5999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .|++|+||+|+||+++.++.++|+|||.+........   ......++..|+|||.+.+..++.++||||||+++++|
T Consensus       152 ~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  230 (318)
T 3lxp_A          152 A-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL  230 (318)
T ss_dssp             H-TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred             h-CCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence            9 9999999999999999999999999999976643321   12234567789999999988899999999999999999


Q ss_pred             HhCCCCCCCCCcc--------CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          163 ATGQFPYSPPEQQ--------DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       163 ~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ++|..||......        ............+...... ..+..+++++.+|+.+||+.||.+|||++++++
T Consensus       231 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          231 LTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999998753221        0111222233333334333 334678999999999999999999999999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.1e-41  Score=286.48  Aligned_cols=217  Identities=24%  Similarity=0.365  Sum_probs=163.4

Q ss_pred             HHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP-------EEYLAAICEQVLKGLLY   83 (262)
Q Consensus        12 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~i~~~l~~~l~~   83 (262)
                      .+.+.+|+++++++ +||||+++++.+.+++..|+||||+.| +|.+++...+...       ...+..++.|++.||+|
T Consensus        52 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  130 (434)
T 2rio_A           52 CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH  130 (434)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHH
Confidence            35678999999876 899999999999999999999999965 9999998764332       22356799999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccC-------------CcEEEEecccccccccCCC----CcccccccccccCcccccC---
Q 024828           84 LHHEKHIIHRDLKPSNLLINHR-------------GEVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISG---  143 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~-------------~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~---  143 (262)
                      ||+ .|++|+||||+||+++.+             +.++|+|||++........    ......|++.|+|||++.+   
T Consensus       131 LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  209 (434)
T 2rio_A          131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNN  209 (434)
T ss_dssp             HHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCT
T ss_pred             HHH-CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccc
Confidence            999 999999999999999754             3799999999987644321    1223578999999999875   


Q ss_pred             ----CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhcCCc
Q 024828          144 ----GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       144 ----~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p  217 (262)
                          ..++.++|||||||++|+|++ |..||......     ............. .......+++++.+|+.+||+.||
T Consensus       210 ~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  284 (434)
T 2rio_A          210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-----ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP  284 (434)
T ss_dssp             TSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-----HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred             cccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-----HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCCh
Confidence                568999999999999999998 99999754321     1111111111100 011111345789999999999999


Q ss_pred             CCCCCHHHHhcCcccccc
Q 024828          218 QQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~  235 (262)
                      .+|||+.++++||||...
T Consensus       285 ~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          285 LKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             GGSCCHHHHHTSGGGSCH
T ss_pred             hhCCCHHHHHhCCccCCc
Confidence            999999999999999643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-40  Score=267.10  Aligned_cols=214  Identities=26%  Similarity=0.458  Sum_probs=177.9

Q ss_pred             cchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHH
Q 024828            5 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         5 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...+....+.+.+|++++++++||||+++++++.+ +..++||||+.+++|.+++....  .++...+..++.|++.||+
T Consensus        45 ~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~  123 (279)
T 1qpc_A           45 LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA  123 (279)
T ss_dssp             ECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHH
T ss_pred             ecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHH
Confidence            33334456789999999999999999999998864 45899999999999999997653  6999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      +||+ .|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++
T Consensus       124 ~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  202 (279)
T 1qpc_A          124 FIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTE  202 (279)
T ss_dssp             HHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             HHHH-CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHH
Confidence            9999 9999999999999999999999999999876543221 1223345678999999988889999999999999999


Q ss_pred             HHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |++ |+.||......       +....+..+.... .+..+++++.+++.+||..||++|||++++++
T Consensus       203 l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          203 IVTHGRIPYPGMTNP-------EVIQNLERGYRMV-RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHTTTCCSSTTCCHH-------HHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhCCCCCCcccCHH-------HHHHHHhcccCCC-CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            999 99999865432       3334444443333 33578999999999999999999999999976

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.9e-40  Score=265.50  Aligned_cols=212  Identities=23%  Similarity=0.362  Sum_probs=174.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .....+++.+|++++++++||||+++++++.++ ..++||||+.+++|.+++.+.+ .++...+..++.|++.||.+||+
T Consensus        53 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~  131 (281)
T 3cc6_A           53 TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES  131 (281)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH
Confidence            456778899999999999999999999998754 4689999999999999997754 59999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                       .|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ 
T Consensus       132 -~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~  210 (281)
T 3cc6_A          132 -INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF  210 (281)
T ss_dssp             -TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhC
Confidence             9999999999999999999999999999876543221 1223356778999999988889999999999999999998 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |+.||......+       ....+....... .+..+++.+.+++.+||..||.+|||+.+++++
T Consensus       211 g~~p~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          211 GKQPFFWLENKD-------VIGVLEKGDRLP-KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCTTTTSCGGG-------HHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccCChHH-------HHHHHhcCCCCC-CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            999997655432       122222232222 235689999999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.1e-40  Score=267.81  Aligned_cols=211  Identities=24%  Similarity=0.362  Sum_probs=177.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+++.+|++++++++||||+++++++.++. .++|+|++.+++|.+++.+. +.++...+..++.|++.||.+||+ 
T Consensus        62 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-  139 (291)
T 1u46_A           62 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-  139 (291)
T ss_dssp             CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh-
Confidence            356778999999999999999999999998765 88999999999999999765 569999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||+|+||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++|+||||+++++|++
T Consensus       140 ~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  219 (291)
T 1u46_A          140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT  219 (291)
T ss_dssp             TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999999876543322   1123346678999999988888999999999999999999


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |+.||......       .....+............+++++.+++.+||..||.+|||+.++++
T Consensus       220 ~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          220 YGQEPWIGLNGS-------QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             TSCCTTTTCCHH-------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcccCCHH-------HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             99999875432       3344444444444444678999999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-40  Score=268.52  Aligned_cols=213  Identities=23%  Similarity=0.406  Sum_probs=170.1

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKG   80 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~l~~~   80 (262)
                      |....+...+++.+|++++++++||||+++++++.+ ++..++||||+++++|.+++.+.+.  ++...+..++.|++.|
T Consensus        50 K~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~  129 (278)
T 1byg_A           50 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA  129 (278)
T ss_dssp             EECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHH
Confidence            333334466789999999999999999999998654 4578999999999999999987643  8999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |++||+ .|++|+||+|+||+++.++.++|+|||++.......   ....++..|+|||.+.+..++.++|+||||++++
T Consensus       130 l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  205 (278)
T 1byg_A          130 MEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW  205 (278)
T ss_dssp             HHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHh-CCccccCCCcceEEEeCCCcEEEeeccccccccccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHH
Confidence            999999 999999999999999999999999999987544322   2335678899999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|++ |+.||......+       ....+..+... ..+..+++++.+++.+||+.||.+|||+.++++
T Consensus       206 ~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          206 EIYSFGRVPYPRIPLKD-------VVPRVEKGYKM-DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHTTSCCSCTTSCGGG-------HHHHHTTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHH-------HHHHHhcCCCC-CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            9998 999998754432       22333333333 333578999999999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.5e-39  Score=262.13  Aligned_cols=205  Identities=21%  Similarity=0.415  Sum_probs=171.5

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH--   89 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~--   89 (262)
                      +++.+|++++++++||||+++++++.+..  ++||||+++++|.+++.+. ..++...+..++.|++.||+|||+ .|  
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~  144 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPP  144 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSC
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh-CCCC
Confidence            68899999999999999999999987665  6999999999999888654 479999999999999999999998 99  


Q ss_pred             eeeCCCCCCCEEEccCCc-----EEEEecccccccccCCCCcccccccccccCccccc--CCCCCcchhHHHHHHHHHHH
Q 024828           90 IIHRDLKPSNLLINHRGE-----VKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS--GGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l  162 (262)
                      ++|+||+|+||+++.++.     ++|+|||++.....   ......++..|+|||.+.  +..++.++|+||||+++|+|
T Consensus       145 ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l  221 (287)
T 4f0f_A          145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI  221 (287)
T ss_dssp             CBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHH
T ss_pred             eecCCCCcceEEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHH
Confidence            999999999999987776     99999999875332   333457899999999984  34578999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      ++|+.||.......     ................+..+++++.+++.+||+.||.+|||++++++
T Consensus       222 ~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          222 LTGEGPFDEYSYGK-----IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHSSCTTTTCCCCH-----HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCCCCccccccH-----HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999998655432     12223333333334444678999999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=277.05  Aligned_cols=212  Identities=19%  Similarity=0.282  Sum_probs=173.1

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ..+.+|+.+++.++||||+++++++.+    ....++||||+ |++|.+++...+.+++..+..++.|++.||+|||+ .
T Consensus        93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~  170 (345)
T 2v62_A           93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-N  170 (345)
T ss_dssp             HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            356788999999999999999999988    77899999999 88999999888899999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCC--cEEEEecccccccccCCC-------CcccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLINHRG--EVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      |++|+||+|+||+++.++  .++|+|||++........       ......++..|+|||.+.+..++.++||||||+++
T Consensus       171 ~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  250 (345)
T 2v62_A          171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM  250 (345)
T ss_dssp             TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred             CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence            999999999999998877  999999999976533221       11345789999999999988899999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC----CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP----SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+|++|+.||.......  ................    ......+++++.+++.+||..||++|||++++++
T Consensus       251 ~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          251 LRWLCGKLPWEQNLKDP--VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHSSCTTGGGTTCH--HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhCCCCcccccccc--HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            99999999996532221  1122222222211111    0112368899999999999999999999999876

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-39  Score=265.29  Aligned_cols=213  Identities=25%  Similarity=0.371  Sum_probs=175.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEE-EECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSF-YSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+....+++.+|++++++++||||+++++++ ..++..++||||+.+++|.+++.+. ..++...+..++.|++.||++|
T Consensus        65 ~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l  144 (298)
T 3f66_A           65 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL  144 (298)
T ss_dssp             CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            3556678899999999999999999999985 4566789999999999999999764 5689999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC----CCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |+ .|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+..++.++|+||||++++
T Consensus       145 H~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  223 (298)
T 3f66_A          145 AS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW  223 (298)
T ss_dssp             HH-TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             Hh-CCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHH
Confidence            99 999999999999999999999999999987654322    1222335677899999999888999999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|++ |.+||......+       .......+... ..+..+++++.+++.+||+.||.+|||++++++
T Consensus       224 ~l~~~~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          224 ELMTRGAPPYPDVNTFD-------ITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHTTSCCSSTTSCTTT-------HHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCCCccCCHHH-------HHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999 566776554432       22233333332 233568999999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.8e-40  Score=273.60  Aligned_cols=223  Identities=22%  Similarity=0.321  Sum_probs=176.1

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .++.+|+++++.++||||+++++++.+.+..++||||+.+++|.+++....    .++...+..++.|++.||+|||+ .
T Consensus        72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~  150 (326)
T 3uim_A           72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-H  150 (326)
T ss_dssp             CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-S
T ss_pred             HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            368999999999999999999999999999999999999999999998653    48999999999999999999999 8


Q ss_pred             ---CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           89 ---HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        89 ---~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                         |++|+||+|+||+++.++.++|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       151 ~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  230 (326)
T 3uim_A          151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT  230 (326)
T ss_dssp             SSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH
T ss_pred             CCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh
Confidence               999999999999999999999999999976543322 2233458999999999988889999999999999999999


Q ss_pred             CCCCCCCCCccCc-hhhHHHHHHHHhcCCCCC---------CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          165 GQFPYSPPEQQDG-WTSFYELMEAIVDQPPPS---------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       165 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      |+.||........ ..................         ......++++.+++.+||+.||.+|||++++++|-.-..
T Consensus       231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             CCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             CCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            9999963111100 011111211111111110         011122367999999999999999999999999865443


Q ss_pred             cC
Q 024828          235 YG  236 (262)
Q Consensus       235 ~~  236 (262)
                      ..
T Consensus       311 ~~  312 (326)
T 3uim_A          311 LA  312 (326)
T ss_dssp             CS
T ss_pred             hh
Confidence            33

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.7e-40  Score=267.27  Aligned_cols=224  Identities=21%  Similarity=0.333  Sum_probs=177.8

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCCCeeEeeceE-EEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQS-FYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLK   79 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~   79 (262)
                      ++|+........++.+|+++++.++|++++..+.. +.++...++|||++ +++|.+++.. .+.++...+..++.|++.
T Consensus        38 avK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~  116 (296)
T 4hgt_A           38 AIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMIS  116 (296)
T ss_dssp             EEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHH
T ss_pred             EEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHH
Confidence            34444445556678999999999988776665554 46788899999999 8899999985 457999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEE---ccCCcEEEEecccccccccCCC-------CcccccccccccCcccccCCCCCcc
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      ||.|||+ .|++|+||+|+||++   +.++.++|+|||.+........       ......++..|+|||.+.+..++.+
T Consensus       117 ~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  195 (296)
T 4hgt_A          117 RIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR  195 (296)
T ss_dssp             HHHHHHH-TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH
T ss_pred             HHHHHHH-CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCch
Confidence            9999999 999999999999999   7889999999999976544322       2234578999999999999899999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +||||||+++|+|++|+.||....................... .......+++++.+++.+||+.||++|||++++++
T Consensus       196 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          196 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            9999999999999999999987665543333333333322221 11112467899999999999999999999999976

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-40  Score=268.36  Aligned_cols=207  Identities=20%  Similarity=0.359  Sum_probs=171.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .....+++.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+. ++...+..++.|++.||.|||+
T Consensus        52 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  131 (289)
T 4fvq_A           52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE  131 (289)
T ss_dssp             GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            345567899999999999999999999999999999999999999999999987654 9999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCc--------EEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGE--------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGL  157 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~  157 (262)
                       .|++|+||+|+||+++.++.        ++|+|||.+.....    .....++..|+|||.+.+ ..++.++||||||+
T Consensus       132 -~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  206 (289)
T 4fvq_A          132 -NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGT  206 (289)
T ss_dssp             -TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHH
T ss_pred             -CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHH
Confidence             99999999999999998887        99999999865422    223457888999999987 56899999999999


Q ss_pred             HHHHHHhCC-CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          158 VLLECATGQ-FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       158 ~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++|+|++|. +|+......       ..........   ..+...++++.+|+.+||+.||.+|||+++++++
T Consensus       207 il~el~~g~~~~~~~~~~~-------~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          207 TLWEICSGGDKPLSALDSQ-------RKLQFYEDRH---QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHHHTTTCCTTTTSCHH-------HHHHHHHTTC---CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCccccchH-------HHHHHhhccC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999954 555443221       1112222211   1223457889999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-40  Score=284.26  Aligned_cols=215  Identities=25%  Similarity=0.446  Sum_probs=175.4

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+++.+|++++++++||||+++++++.+ +..++||||+++++|.+++...  ..++...+..++.|++.||+|||+ 
T Consensus       221 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-  298 (452)
T 1fmk_A          221 MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-  298 (452)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            345689999999999999999999999876 6689999999999999999753  569999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-C
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g  165 (262)
                      .|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus       299 ~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g  378 (452)
T 1fmk_A          299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG  378 (452)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCC
Confidence            999999999999999999999999999997654321 11122345678999999988889999999999999999999 9


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc--Cccccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLKM  234 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~--h~~~~~  234 (262)
                      +.||.+....       +....+..+..... +..+++++.++|.+||+.||++|||++++++  ..++..
T Consensus       379 ~~P~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          379 RVPYPGMVNR-------EVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCSSTTCCHH-------HHHHHHHTTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            9999875432       34444455544433 3578999999999999999999999999986  355543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-40  Score=276.24  Aligned_cols=213  Identities=24%  Similarity=0.363  Sum_probs=169.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEE-ECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      +....+++.+|+.++++++||||+++++++. .++..++||||+++++|.+++.+. ..++...+..++.|++.||+|||
T Consensus       130 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH  209 (373)
T 3c1x_A          130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA  209 (373)
T ss_dssp             CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4566788999999999999999999999864 456789999999999999999865 45899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC----CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      + .|++|+||+|+||+++.++.++|+|||++........    ......++..|+|||.+.+..++.++||||||+++|+
T Consensus       210 ~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e  288 (373)
T 3c1x_A          210 S-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE  288 (373)
T ss_dssp             H-TTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             H-CCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHH
Confidence            9 9999999999999999999999999999875532211    1122346678999999998889999999999999999


Q ss_pred             HHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          162 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       162 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |++ |.+||......+       ....+..+.... .+..+++++.+++.+||+.||++|||+++++++
T Consensus       289 llt~~~~p~~~~~~~~-------~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          289 LMTRGAPPYPDVNTFD-------ITVYLLQGRRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHTTSCCSCTTSCSSC-------HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCcCCCCCCCCHHH-------HHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999 778887655433       222333333333 235689999999999999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.9e-40  Score=268.83  Aligned_cols=207  Identities=28%  Similarity=0.466  Sum_probs=177.8

Q ss_pred             HHHHHHHHHHhcCC--CCeeEeeceEEEECCeEEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           13 RQIAQELKINQSSQ--CPYVVVCYQSFYSNGAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        13 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      +++.+|+.++++++  |+||+++++++.+.+..++|+|++.+ ++|.+++...+.++...+..++.|++.||+|||+ .|
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~  169 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CG  169 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            45678999999995  59999999999999999999999975 7999999988999999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEc-cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCC
Q 024828           90 IIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        90 i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~  167 (262)
                      ++|+||+|+||+++ .++.++|+|||++......  ......++..|+|||++.+..+ +.++|+||||+++|+|++|+.
T Consensus       170 ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~  247 (320)
T 3a99_A          170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI  247 (320)
T ss_dssp             EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence            99999999999998 6789999999998765432  2334568999999999877665 688999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ||....             .......  .....+++++.+|+.+||+.||++|||++++++||||+....
T Consensus       248 pf~~~~-------------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          248 PFEHDE-------------EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             SCCSHH-------------HHHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CCCChh-------------hhhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            996521             1111111  123568999999999999999999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-40  Score=267.58  Aligned_cols=216  Identities=30%  Similarity=0.515  Sum_probs=172.4

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLK   79 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l~~   79 (262)
                      +|....+...+.+.+|++++++++||||+++++++.+  ..++||||++|++|.+++....   .++...+..++.|++.
T Consensus        36 vK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~  113 (307)
T 2eva_A           36 IKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ  113 (307)
T ss_dssp             EEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHH
T ss_pred             EEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHH
Confidence            3444455667889999999999999999999998873  4789999999999999998765   3789999999999999


Q ss_pred             HHHHHhhc--CCeeeCCCCCCCEEEccCCc-EEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHH
Q 024828           80 GLLYLHHE--KHIIHRDLKPSNLLINHRGE-VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG  156 (262)
Q Consensus        80 ~l~~lh~~--~~i~H~dl~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG  156 (262)
                      ||+|||+.  .|++|+||+|+||+++.++. ++|+|||++......   .....++..|+|||.+.+..++.++||||||
T Consensus       114 ~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG  190 (307)
T 2eva_A          114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWG  190 (307)
T ss_dssp             HHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHH
T ss_pred             HHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHH
Confidence            99999972  58999999999999988886 799999998754322   2234689999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          157 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       157 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      +++++|++|+.||.......     .........+..+.. ...+++.+.+++.+||+.||.+|||+++++++
T Consensus       191 ~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          191 IILWEVITRRKPFDEIGGPA-----FRIMWAVHNGTRPPL-IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHHTCCTTTTTCSSH-----HHHHHHHHTTCCCCC-BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHCCCCchhhCccH-----HHHHHHHhcCCCCCc-ccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999997644321     122233333333333 35789999999999999999999999999873

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.2e-40  Score=270.77  Aligned_cols=214  Identities=29%  Similarity=0.457  Sum_probs=178.6

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECC-eEEEEEeecCCCCHHHHHHhcCC----------------CCHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLKKVKT----------------IPEEY   69 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~   69 (262)
                      .....+.+.+|++++.++ +||||+++++++...+ ..++||||+++++|.+++.....                ++...
T Consensus        70 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (316)
T 2xir_A           70 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH  149 (316)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHH
T ss_pred             CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHH
Confidence            455667899999999999 7999999999987754 58999999999999999987654                89999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCC
Q 024828           70 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYG  147 (262)
Q Consensus        70 ~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~  147 (262)
                      +..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++
T Consensus       150 ~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (316)
T 2xir_A          150 LICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  228 (316)
T ss_dssp             HHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence            99999999999999999 9999999999999999999999999999876543322  12234567789999999888899


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          148 YKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       148 ~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      .++|+||||+++|+|++ |..||......+      .....+..+.... .+..+++++.+++.+||+.||.+|||+.++
T Consensus       229 ~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~el  301 (316)
T 2xir_A          229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSEL  301 (316)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHHHhccCccCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            99999999999999998 999998755432      2223333333322 235688999999999999999999999999


Q ss_pred             hcC
Q 024828          227 MTH  229 (262)
Q Consensus       227 l~h  229 (262)
                      ++|
T Consensus       302 l~~  304 (316)
T 2xir_A          302 VEH  304 (316)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=280.63  Aligned_cols=213  Identities=24%  Similarity=0.388  Sum_probs=165.1

Q ss_pred             HHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           14 QIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        14 ~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      .+.+|+++++++ +||||+++++++.+....|+|||++.| +|.+++.... ..+...+..++.|++.||.|||+ .|++
T Consensus        63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~iv  140 (432)
T 3p23_A           63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS-LNIV  140 (432)
T ss_dssp             ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH-TTCC
T ss_pred             HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH-CcCE
Confidence            466899999999 899999999999999999999999965 9999998754 35555678999999999999999 9999


Q ss_pred             eCCCCCCCEEEcc---CC--cEEEEecccccccccCC---CCcccccccccccCcccccC---CCCCcchhHHHHHHHHH
Q 024828           92 HRDLKPSNLLINH---RG--EVKITDFGVSAIMASTS---GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        92 H~dl~p~nil~~~---~~--~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~  160 (262)
                      |+||||+||+++.   ++  .++|+|||++.......   .......|++.|+|||++.+   ..++.++|||||||++|
T Consensus       141 HrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~  220 (432)
T 3p23_A          141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFY  220 (432)
T ss_dssp             CCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHH
T ss_pred             eCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHH
Confidence            9999999999953   22  58899999987654332   22334568999999999974   45788999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      +|++ |..||......        ............  ......+..+.+|+.+||+.||.+|||++++++||||....
T Consensus       221 ellt~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          221 YVISEGSHPFGKSLQR--------QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             HHHTTSCBTTBSTTTH--------HHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             HHHcCCCCCcchhhHH--------HHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            9999 99999653321        111121111111  11223355688999999999999999999999999997643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=268.63  Aligned_cols=211  Identities=25%  Similarity=0.413  Sum_probs=172.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+.+.+|++++++++||||+++++++.++. .++|++++.+++|.+++... +.++...+..++.|++.||.|||+
T Consensus        57 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~  135 (327)
T 3lzb_A           57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED  135 (327)
T ss_dssp             SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            3445678999999999999999999999998765 78999999999999999774 569999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .|++|+||||+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       136 -~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~  214 (327)
T 3lzb_A          136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             -TTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             -CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence             99999999999999999999999999999765433221  222345678999999998889999999999999999999


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||......+       ....+....... .+..++.++.+++.+||..||.+|||++++++
T Consensus       215 ~g~~p~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          215 FGSKPYDGIPASE-------ISSILEKGERLP-QPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TSCCTTTTCCGGG-------HHHHHHTTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHHH-------HHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             999998765432       223333333333 33568999999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6e-40  Score=291.68  Aligned_cols=210  Identities=21%  Similarity=0.381  Sum_probs=176.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....+++.+|++++++++||||+++++++.+ +..++||||+.+++|.+++...+.++...+..++.|++.||+|||+ .
T Consensus       411 ~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~  488 (635)
T 4fl3_A          411 PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-S  488 (635)
T ss_dssp             GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            3456789999999999999999999999864 4589999999999999999988889999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                      |++|+||||+||+++.++.++|+|||++........   ......++..|+|||++.+..++.++||||||+++|+|++ 
T Consensus       489 ~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~  568 (635)
T 4fl3_A          489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY  568 (635)
T ss_dssp             TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence            999999999999999999999999999876543221   1222345678999999998889999999999999999998 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+.||......       +....+..+..... +..+++++.+||.+||+.||++|||++++++
T Consensus       569 G~~Pf~~~~~~-------~~~~~i~~~~~~~~-p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          569 GQKPYRGMKGS-------EVTAMLEKGERMGC-PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TCCSSTTCCHH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999875442       34444555544433 3578999999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7e-40  Score=266.35  Aligned_cols=215  Identities=21%  Similarity=0.331  Sum_probs=173.1

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceE-EEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQS-FYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ..+++.+|+++++.++|++++..+.. +.++...++||||+ +++|.+++.. .+.++...+..++.|++.||+|||+ .
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~  124 (296)
T 3uzp_A           47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-K  124 (296)
T ss_dssp             SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-C
Confidence            34568899999999988776655554 46678899999999 8899999974 4579999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEE---ccCCcEEEEecccccccccCCC-------CcccccccccccCcccccCCCCCcchhHHHHHHH
Q 024828           89 HIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV  158 (262)
Q Consensus        89 ~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~  158 (262)
                      |++|+||+|+||++   +.++.++|+|||.+........       ......++..|+|||.+.+..++.++||||||++
T Consensus       125 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i  204 (296)
T 3uzp_A          125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV  204 (296)
T ss_dssp             TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred             CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHH
Confidence            99999999999999   4788999999999876654332       1234578999999999999889999999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|+|++|+.||....................... .......+++++.+++.+||+.||.+|||++++++
T Consensus       205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            9999999999987654433333333332222211 11112467899999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=271.52  Aligned_cols=210  Identities=25%  Similarity=0.485  Sum_probs=171.3

Q ss_pred             HHHHHHHHHHHHhcC----CCCeeEeeceEEEECCeEEEEEee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828           11 ARRQIAQELKINQSS----QCPYVVVCYQSFYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ....+.+|+.++.++    +||||+++++++.+.+..++|+|+ +.+++|.+++.+.+.++...+..++.|++.||+|||
T Consensus        77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH  156 (312)
T 2iwi_A           77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH  156 (312)
T ss_dssp             --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344566899999888    899999999999998999999999 788999999998889999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEc-cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECA  163 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~  163 (262)
                      + .|++|+||+|+||+++ .++.++|+|||++......  ......++..|+|||.+.+..+ +.++|+||||+++|+|+
T Consensus       157 ~-~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  233 (312)
T 2iwi_A          157 S-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV  233 (312)
T ss_dssp             H-HTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred             H-CCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence            9 9999999999999998 7889999999998765432  2334568899999999876665 45899999999999999


Q ss_pred             hCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          164 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       164 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +|+.||....         ..    .....  .....+++++.+++.+||+.||++|||++++++||||+...+.
T Consensus       234 ~g~~pf~~~~---------~~----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          234 CGDIPFERDQ---------EI----LEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             HSSCSCCSHH---------HH----HHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             HCCCCCCChH---------HH----hhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence            9999996521         11    11111  1235688999999999999999999999999999999987653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.8e-40  Score=269.74  Aligned_cols=208  Identities=21%  Similarity=0.355  Sum_probs=173.5

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      .+++.+|+.++++++||||+++++++. +...++|+||+.+++|.+++... +.++...+..++.|++.||+|||+ .|+
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i  136 (325)
T 3kex_A           59 FQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE-HGM  136 (325)
T ss_dssp             BCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH-TTC
T ss_pred             HHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh-CCC
Confidence            356778999999999999999999886 45689999999999999999875 578999999999999999999999 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCC
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF  167 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~  167 (262)
                      +|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       137 vH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~  216 (325)
T 3kex_A          137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE  216 (325)
T ss_dssp             CCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCC
Confidence            9999999999999999999999999987643322  2233456778999999998889999999999999999999 999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||......       +....+..+..... +..++.++.+++.+||..||.+|||+.+++++
T Consensus       217 p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          217 PYAGLRLA-------EVPDLLEKGERLAQ-PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTTSCTT-------HHHHHHHTTCBCCC-CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CccccCHH-------HHHHHHHcCCCCCC-CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99875443       22333333333332 34578889999999999999999999999886

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-39  Score=266.18  Aligned_cols=219  Identities=26%  Similarity=0.400  Sum_probs=178.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+...+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...   .+++...+..++.|++.||.||
T Consensus        70 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l  149 (307)
T 2nru_A           70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL  149 (307)
T ss_dssp             TTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999999999999999999999999999743   4699999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |+ .|++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+ .++.++|+||||+++|+|
T Consensus       150 H~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l  227 (307)
T 2nru_A          150 HE-NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEI  227 (307)
T ss_dssp             HH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHH
T ss_pred             hc-CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHH
Confidence            99 99999999999999999999999999998765432221  223468899999999875 578999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHH-------HHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELME-------AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ++|..||.................       ....... .......+..+.+++.+||+.||.+|||+++++++
T Consensus       228 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          228 ITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999987665543333322211       1111111 11122345779999999999999999999999863

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.8e-40  Score=274.11  Aligned_cols=210  Identities=17%  Similarity=0.265  Sum_probs=168.1

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEEC----CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYSN----GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .+..|+..++.++||||+++++++.+.    ...++||||+ |++|.+++... +.++...+..++.|++.||+|||+ .
T Consensus        94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~  171 (364)
T 3op5_A           94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE-H  171 (364)
T ss_dssp             HHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence            344566677888999999999998764    4589999999 88999999876 679999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEc--cCCcEEEEecccccccccCCC-------CcccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           89 HIIHRDLKPSNLLIN--HRGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        89 ~i~H~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      |++|+||||+||+++  .++.++|+|||++........       ......|++.|+|||.+.+..++.++||||||+++
T Consensus       172 ~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l  251 (364)
T 3op5_A          172 EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM  251 (364)
T ss_dssp             TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHH
Confidence            999999999999998  788999999999976543221       11234589999999999998899999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHH-----HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYE-----LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+|++|+.||..............     ....+....   .....+++++.+++.+||..+|.+||+++++++
T Consensus       252 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          252 IQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKC---FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHH---SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHh---cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            999999999986433321111110     001111111   112467899999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-39  Score=267.26  Aligned_cols=211  Identities=27%  Similarity=0.432  Sum_probs=162.7

Q ss_pred             HHHHHHHHh--cCCCCeeEeeceEEEEC----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           15 IAQELKINQ--SSQCPYVVVCYQSFYSN----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        15 ~~~e~~~l~--~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ..+|.+++.  .++||||+++++++.+.    ...++||||+++++|.++++. ..++...+..++.|++.||.|||+ .
T Consensus        76 ~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~-~  153 (337)
T 3mdy_A           76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHT-E  153 (337)
T ss_dssp             HHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHS-C
T ss_pred             hhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-h
Confidence            344444444  45999999999999887    789999999999999999976 579999999999999999999998 7


Q ss_pred             --------CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC----cccccccccccCcccccCCCCCcc------h
Q 024828           89 --------HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPERISGGKYGYK------S  150 (262)
Q Consensus        89 --------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~------~  150 (262)
                              |++|+||||+||+++.++.++|+|||++.........    .....|+..|+|||++.+......      +
T Consensus       154 ~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  233 (337)
T 3mdy_A          154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA  233 (337)
T ss_dssp             BCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHH
T ss_pred             hhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcccc
Confidence                    9999999999999999999999999998765433222    124578999999999987665554      9


Q ss_pred             hHHHHHHHHHHHHhC----------CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHhhcC
Q 024828          151 DIWSLGLVLLECATG----------QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISACVQK  215 (262)
Q Consensus       151 Di~slG~~l~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~  215 (262)
                      ||||||+++|+|++|          +.||........  ..................+     ..+++++.+|+.+||+.
T Consensus       234 DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  311 (337)
T 3mdy_A          234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP--SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH  311 (337)
T ss_dssp             HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCS
T ss_pred             chHHHHHHHHHHHhccCcccccccccccHhhhcCCCC--chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhh
Confidence            999999999999999          666655433321  1112222222222211111     24556799999999999


Q ss_pred             CcCCCCCHHHHhcC
Q 024828          216 EPQQRLSAQELMTH  229 (262)
Q Consensus       216 ~p~~Rpt~~~~l~h  229 (262)
                      ||.+|||+++++++
T Consensus       312 dP~~Rps~~ell~~  325 (337)
T 3mdy_A          312 NPASRLTALRVKKT  325 (337)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCCCHHHHHHH
Confidence            99999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-39  Score=264.39  Aligned_cols=212  Identities=26%  Similarity=0.435  Sum_probs=164.0

Q ss_pred             HHHHHHHHHHhc--CCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-
Q 024828           13 RQIAQELKINQS--SQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH-   85 (262)
Q Consensus        13 ~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh-   85 (262)
                      ..+.+|.+++..  ++||||+++++.+.+    ....++||||+++++|.++++. ..++...+..++.|++.||+||| 
T Consensus        45 ~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~  123 (301)
T 3q4u_A           45 KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHI  123 (301)
T ss_dssp             HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHS
T ss_pred             hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHH
Confidence            444555555555  799999999998654    2458999999999999999965 57999999999999999999999 


Q ss_pred             -------hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC----cccccccccccCcccccCC------CCCc
Q 024828           86 -------HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ----ANTFVGTYNYMSPERISGG------KYGY  148 (262)
Q Consensus        86 -------~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~------~~~~  148 (262)
                             + .|++|+||||+||+++.++.++|+|||++.........    .....|++.|+|||.+.+.      .++.
T Consensus       124 ~~~~~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  202 (301)
T 3q4u_A          124 EIFGTQGK-PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK  202 (301)
T ss_dssp             CBCSTTCB-CEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHH
T ss_pred             hhhhccCC-CCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCc
Confidence                   7 99999999999999999999999999998765433221    2234789999999999876      4457


Q ss_pred             chhHHHHHHHHHHHHhC----------CCCCCCCCccCchhhHHHHHHHHhcC-CCCCCCC----CCCCHHHHHHHHHhh
Q 024828          149 KSDIWSLGLVLLECATG----------QFPYSPPEQQDGWTSFYELMEAIVDQ-PPPSAPS----DQFSPEFCSFISACV  213 (262)
Q Consensus       149 ~~Di~slG~~l~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~l~~li~~~l  213 (262)
                      ++||||||+++|+|++|          ..||.........  ........... ..+..+.    ...++++.+|+.+||
T Consensus       203 ~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  280 (301)
T 3q4u_A          203 RVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS--FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW  280 (301)
T ss_dssp             HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHC
T ss_pred             hhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc--hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHh
Confidence            99999999999999999          8888665443321  11222222222 2222211    124567999999999


Q ss_pred             cCCcCCCCCHHHHhc
Q 024828          214 QKEPQQRLSAQELMT  228 (262)
Q Consensus       214 ~~~p~~Rpt~~~~l~  228 (262)
                      +.||++|||++++++
T Consensus       281 ~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          281 YQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             hcChhhCCCHHHHHH
Confidence            999999999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.8e-39  Score=261.20  Aligned_cols=207  Identities=27%  Similarity=0.417  Sum_probs=175.2

Q ss_pred             HHHHHHHHHHhcCCCCeeEeeceEEEE----------------CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHH
Q 024828           13 RQIAQELKINQSSQCPYVVVCYQSFYS----------------NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAIC   74 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~   74 (262)
                      ..+.+|++++++++||||+++++++..                ....++||||+++++|.+++.+.  ..++...+..++
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~  128 (284)
T 2a19_B           49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF  128 (284)
T ss_dssp             GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence            357799999999999999999998864                44589999999999999999764  579999999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHH
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      .|++.||.+||+ .|++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||
T Consensus       129 ~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  206 (284)
T 2a19_B          129 EQITKGVDYIHS-KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYA  206 (284)
T ss_dssp             HHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHH
T ss_pred             HHHHHHHHHHHh-CCeeeccCCHHHEEEcCCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHH
Confidence            999999999999 999999999999999999999999999987654432 233456899999999999888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccc
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  234 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~  234 (262)
                      ||+++++|++|..|+..         .......+.....    ...+++++.+++.+||+.||.+|||+.+++++.+.-.
T Consensus       207 lG~il~~l~~~~~~~~~---------~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          207 LGLILAELLHVCDTAFE---------TSKFFTDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHHHHHHSCCSSHHH---------HHHHHHHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCCcchh---------HHHHHHHhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            99999999999887642         1122333333322    2467899999999999999999999999999977643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=288.06  Aligned_cols=210  Identities=27%  Similarity=0.449  Sum_probs=175.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ....+++.+|++++++++||||+++++++.+ +..++||||+.+++|.+++... ..++...+..++.|++.||+|||+ 
T Consensus       377 ~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-  454 (613)
T 2ozo_A          377 KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-  454 (613)
T ss_dssp             STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            3467789999999999999999999999976 5699999999999999999754 459999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++|+||||+||+++.++.++|+|||++.........   .....++..|+|||++.+..++.++||||||+++|+|++
T Consensus       455 ~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt  534 (613)
T 2ozo_A          455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS  534 (613)
T ss_dssp             TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999765432211   112234578999999998889999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |+.||......       +....+..+.....+ ..+++++.+||.+||+.||++|||++++++
T Consensus       535 ~G~~Pf~~~~~~-------~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          535 YGQKPYKKMKGP-------EVMAFIEQGKRMECP-PECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TSCCTTTTCCSH-------HHHHHHHTTCCCCCC-TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCCCCHH-------HHHHHHHcCCCCCCC-CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             99999876543       334445555544433 568999999999999999999999999854

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=267.69  Aligned_cols=219  Identities=28%  Similarity=0.440  Sum_probs=176.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC--CeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      +....+++.+|++++++++||||+++++++...  ...++||||+++++|.+++.+. ..++...+..++.|++.||++|
T Consensus        82 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L  161 (326)
T 2w1i_A           82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL  161 (326)
T ss_dssp             CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            455677899999999999999999999988654  3689999999999999999876 4599999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~  161 (262)
                      |+ .|++|+||+|+||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++||||||+++++
T Consensus       162 H~-~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  240 (326)
T 2w1i_A          162 GT-KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE  240 (326)
T ss_dssp             HH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred             Hh-CCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHH
Confidence            98 9999999999999999999999999999876543322   1223356677999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCc---------cCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          162 CATGQFPYSPPEQ---------QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       162 l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |++|..|+.....         .............+....... .+..+++++.+++.+||+.||.+|||+.++++
T Consensus       241 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP-RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC-CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999988864311         000011122333333333333 34578999999999999999999999999975

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=268.03  Aligned_cols=215  Identities=22%  Similarity=0.339  Sum_probs=173.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLK   79 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~   79 (262)
                      +....+.+.+|+++++.++||||+++++++..    ....++||||+.+++|.+++..    ...++...+..++.|++.
T Consensus        66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~  145 (317)
T 2buj_A           66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR  145 (317)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence            56677889999999999999999999999873    3478999999999999999976    467999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---------cccccccccccCcccccCCC---CC
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---------ANTFVGTYNYMSPERISGGK---YG  147 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~y~~PE~~~~~~---~~  147 (262)
                      ||+|||+ .|++|+||+|+||+++.++.++|+|||.+.........         .....++..|+|||.+.+..   ++
T Consensus       146 ~L~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  224 (317)
T 2buj_A          146 GLEAIHA-KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID  224 (317)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEEC
T ss_pred             HHHHHHh-CCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCC
Confidence            9999999 99999999999999999999999999987654321111         11234688999999987654   68


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       148 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      .++||||||+++|+|++|+.||........  .   ......... .......+++++.+++.+||+.||.+|||+++++
T Consensus       225 ~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  298 (317)
T 2buj_A          225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--S---VALAVQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLL  298 (317)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTHHHHHTTS--C---HHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCChhhhhcccc--h---hhHHhhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHH
Confidence            899999999999999999999964221110  1   111122222 2222356899999999999999999999999999


Q ss_pred             cC
Q 024828          228 TH  229 (262)
Q Consensus       228 ~h  229 (262)
                      ++
T Consensus       299 ~~  300 (317)
T 2buj_A          299 SQ  300 (317)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.3e-40  Score=272.13  Aligned_cols=212  Identities=17%  Similarity=0.274  Sum_probs=173.1

Q ss_pred             HHHHHHHHHHhcCCCCeeEe---------------eceEEEE-CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHH
Q 024828           13 RQIAQELKINQSSQCPYVVV---------------CYQSFYS-NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAIC   74 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~   74 (262)
                      +.+.+|++++++++||||++               +++++.. +...++||||+ +++|.+++...  +.+++..+..++
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~  165 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA  165 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence            46789999999999999887               5667766 67899999999 88999999876  789999999999


Q ss_pred             HHHHHHHHHHhhcCCeeeCCCCCCCEEEccCC--cEEEEecccccccccCCC-------CcccccccccccCcccccCCC
Q 024828           75 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--EVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGK  145 (262)
Q Consensus        75 ~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~  145 (262)
                      .|++.||.|||+ .|++|+||+|+||+++.++  .++|+|||++........       ......+++.|+|||.+.+..
T Consensus       166 ~qi~~~L~~LH~-~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  244 (352)
T 2jii_A          166 CRLLDALEFLHE-NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG  244 (352)
T ss_dssp             HHHHHHHHHHHH-TTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHh-CCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC
Confidence            999999999999 9999999999999999888  899999999976543221       123347899999999999888


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCC----CCCCCHHHHHHHHHhhcCCcCCCC
Q 024828          146 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP----SDQFSPEFCSFISACVQKEPQQRL  221 (262)
Q Consensus       146 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp  221 (262)
                      ++.++||||||+++|+|++|+.||.......  ...................    ...+++++.+|+.+||+.||++||
T Consensus       245 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  322 (352)
T 2jii_A          245 PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT--EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP  322 (352)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcccCCcCH--HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC
Confidence            9999999999999999999999998654221  2223333333222221111    125789999999999999999999


Q ss_pred             CHHHHhc
Q 024828          222 SAQELMT  228 (262)
Q Consensus       222 t~~~~l~  228 (262)
                      |++++++
T Consensus       323 s~~~l~~  329 (352)
T 2jii_A          323 PYAMLRN  329 (352)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999976

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.3e-40  Score=290.27  Aligned_cols=228  Identities=26%  Similarity=0.439  Sum_probs=179.0

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE------CCeEEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYS------NGAISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQV   77 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~l   77 (262)
                      .+....+++.+|++++++++||||+++++++.+      ++..++||||++|++|.+++....   .++...+..++.|+
T Consensus        51 ~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QL  130 (676)
T 3qa8_A           51 LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI  130 (676)
T ss_dssp             CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHH
Confidence            356778889999999999999999999998765      677899999999999999998754   58999999999999


Q ss_pred             HHHHHHHhhcCCeeeCCCCCCCEEEccCCc---EEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHH
Q 024828           78 LKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS  154 (262)
Q Consensus        78 ~~~l~~lh~~~~i~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  154 (262)
                      +.||+|||+ .|++|+||+|+||+++.++.   ++|+|||.+....... ......++..|+|||.+.+..++.++|+||
T Consensus       131 l~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwS  208 (676)
T 3qa8_A          131 SSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWS  208 (676)
T ss_dssp             HHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHH
T ss_pred             HHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHH
Confidence            999999999 99999999999999987764   8999999998754332 334457899999999999889999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccCchhhHHHH--HHHH-----hcC--------CCCCCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          155 LGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAI-----VDQ--------PPPSAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       155 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-----~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      ||+++|+|++|..||........|......  ....     ..+        ..+......+++.+.+|+.+||.+||++
T Consensus       209 LGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~k  288 (676)
T 3qa8_A          209 FGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ  288 (676)
T ss_dssp             HHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC-
T ss_pred             HHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhh
Confidence            999999999999999764322111000000  0000     000        0011112235688999999999999999


Q ss_pred             CCCHHHHhcCccccccC
Q 024828          220 RLSAQELMTHPFLKMYG  236 (262)
Q Consensus       220 Rpt~~~~l~h~~~~~~~  236 (262)
                      |||++++++||||+...
T Consensus       289 RPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          289 RGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             --CCTTCCCCTTHHHHH
T ss_pred             CcCHHHHhcCHHHHHHH
Confidence            99999999999997654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=269.94  Aligned_cols=209  Identities=22%  Similarity=0.372  Sum_probs=174.0

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..+.+.+|+.++++++||||+++++++.+....++||||++|++|.+++...+ .++...+..++.|++.||++||+ .|
T Consensus        72 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~  150 (319)
T 2y4i_B           72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA-KG  150 (319)
T ss_dssp             CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            34567789999999999999999999999999999999999999999998764 69999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccC-----CCCcccccccccccCcccccC---------CCCCcchhHHHH
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFVGTYNYMSPERISG---------GKYGYKSDIWSL  155 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~---------~~~~~~~Di~sl  155 (262)
                      ++|+||+|+||+++ ++.++|+|||++......     ........++..|+|||.+.+         ..++.++|||||
T Consensus       151 i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl  229 (319)
T 2y4i_B          151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL  229 (319)
T ss_dssp             CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred             ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence            99999999999997 789999999987654321     122233458889999999874         347889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          156 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       156 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      |+++|+|++|+.||......       .....+..+..+......++.++.+++.+||..||.+|||++++++
T Consensus       230 G~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          230 GTIWYELHAREWPFKTQPAE-------AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHHHHHHHSSCSSSSCCHH-------HHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHH-------HHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999865432       3344555555555555578899999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.8e-40  Score=285.64  Aligned_cols=216  Identities=25%  Similarity=0.443  Sum_probs=179.4

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ....+++.+|++++++++||||+++++++.+ +..++||||+.+++|.+++...  ..++...+..++.|++.||+|||+
T Consensus       303 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~  381 (535)
T 2h8h_A          303 TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER  381 (535)
T ss_dssp             SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3345689999999999999999999999876 6689999999999999999753  569999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-  164 (262)
                       .|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       382 -~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~  460 (535)
T 2h8h_A          382 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK  460 (535)
T ss_dssp             -TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             -CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence             999999999999999999999999999987653211 11122345678999999988889999999999999999999 


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC--ccccc
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH--PFLKM  234 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h--~~~~~  234 (262)
                      |+.||......       +....+..+..... +..+++++.+||.+||+.||++|||++++++.  .++..
T Consensus       461 g~~P~~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          461 GRVPYPGMVNR-------EVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             TCCSSTTCCHH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCCCCCCCHH-------HHHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            99999875432       34444445544333 35789999999999999999999999999863  55543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.1e-39  Score=265.25  Aligned_cols=210  Identities=30%  Similarity=0.433  Sum_probs=156.3

Q ss_pred             hHHHHHHHHHHHHHHhcCC-CCeeEeeceEEE--------ECCeEEEEEeecCCCCHHHHHHh---cCCCCHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQ-CPYVVVCYQSFY--------SNGAISIILEYMDGGSLADFLKK---VKTIPEEYLAAICE   75 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~   75 (262)
                      +....+.+.+|+.++.++. ||||+++++++.        .....+++|||+.| +|.+++..   .++++...+..++.
T Consensus        65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~  143 (337)
T 3ll6_A           65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFY  143 (337)
T ss_dssp             SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHH
Confidence            4566778999999999995 999999999984        33458999999964 99998865   45799999999999


Q ss_pred             HHHHHHHHHhhcCC--eeeCCCCCCCEEEccCCcEEEEecccccccccCCCC------------cccccccccccCcccc
Q 024828           76 QVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ------------ANTFVGTYNYMSPERI  141 (262)
Q Consensus        76 ~l~~~l~~lh~~~~--i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------~~~~~~~~~y~~PE~~  141 (262)
                      |++.||.|||+ .|  ++|+||+|+||+++.++.++|+|||++.........            .....+++.|+|||.+
T Consensus       144 qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  222 (337)
T 3ll6_A          144 QTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII  222 (337)
T ss_dssp             HHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------------------------
T ss_pred             HHHHHHHHHHh-CCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence            99999999998 89  999999999999999999999999998765432211            1134588899999998


Q ss_pred             ---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcC
Q 024828          142 ---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       142 ---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  218 (262)
                         .+..++.++||||||+++|+|++|+.||.......           ..............+..+.+|+.+||+.||.
T Consensus       223 ~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  291 (337)
T 3ll6_A          223 DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPE  291 (337)
T ss_dssp             -CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------CCCCTTCCSSGGGHHHHHHHSCSSGG
T ss_pred             hccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----------hhcCcccCCcccccchHHHHHHHHHccCChh
Confidence               45668899999999999999999999997643321           1122222333456778899999999999999


Q ss_pred             CCCCHHHHhcCc
Q 024828          219 QRLSAQELMTHP  230 (262)
Q Consensus       219 ~Rpt~~~~l~h~  230 (262)
                      +|||+++++++-
T Consensus       292 ~Rps~~e~l~~l  303 (337)
T 3ll6_A          292 ERLSIAEVVHQL  303 (337)
T ss_dssp             GSCCHHHHHHHH
T ss_pred             hCcCHHHHHHHH
Confidence            999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=265.88  Aligned_cols=222  Identities=22%  Similarity=0.297  Sum_probs=161.1

Q ss_pred             HHHHHHHHHhcCCCCeeEeeceEEEE-----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           14 QIAQELKINQSSQCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        14 ~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ....|+..+..++||||+++++.+..     ...+++||||+++++|.++++.. ..+...+..++.|++.||+|||+ .
T Consensus        53 ~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~-~  130 (336)
T 3g2f_A           53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHT-E  130 (336)
T ss_dssp             HHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHC-C
T ss_pred             HHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHh-h
Confidence            33445555566899999999986543     23578999999999999999764 45889999999999999999998 8


Q ss_pred             ---------CeeeCCCCCCCEEEccCCcEEEEecccccccccCC--------CCcccccccccccCcccccC-------C
Q 024828           89 ---------HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--------GQANTFVGTYNYMSPERISG-------G  144 (262)
Q Consensus        89 ---------~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~-------~  144 (262)
                               |++|+||||+||+++.++.++|+|||++.......        .......|+..|+|||++.+       .
T Consensus       131 ~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  210 (336)
T 3g2f_A          131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE  210 (336)
T ss_dssp             BCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHH
T ss_pred             hccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccc
Confidence                     99999999999999999999999999997654221        12223468999999999987       3


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchh-----------hHHHHHHHHhcCCCCCCCCCC------CCHHHHH
Q 024828          145 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT-----------SFYELMEAIVDQPPPSAPSDQ------FSPEFCS  207 (262)
Q Consensus       145 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~------~~~~l~~  207 (262)
                      .++.++|||||||++|+|++|..||........+.           ..................+..      .++++.+
T Consensus       211 ~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (336)
T 3g2f_A          211 SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE  290 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHH
T ss_pred             ccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHH
Confidence            45678999999999999999977665433322111           111111112222211111122      3347999


Q ss_pred             HHHHhhcCCcCCCCCHHHHh------cCccccccCC
Q 024828          208 FISACVQKEPQQRLSAQELM------THPFLKMYGD  237 (262)
Q Consensus       208 li~~~l~~~p~~Rpt~~~~l------~h~~~~~~~~  237 (262)
                      ||.+||+.||++|||++|++      .++|-++...
T Consensus       291 li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~  326 (336)
T 3g2f_A          291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV  326 (336)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred             HHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence            99999999999999999994      4566655443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-38  Score=263.77  Aligned_cols=214  Identities=26%  Similarity=0.374  Sum_probs=170.4

Q ss_pred             HHHHHHHHHHHhc--CCCCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828           12 RRQIAQELKINQS--SQCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        12 ~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .+.+.+|.+++..  ++||||+++++++....    ..++||||+++++|.+++.+ .+++...+..++.|++.||+|||
T Consensus        78 ~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH  156 (342)
T 1b6c_B           78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLH  156 (342)
T ss_dssp             HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH
Confidence            4567788888877  79999999999998765    79999999999999999976 57899999999999999999999


Q ss_pred             --------hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC----CcccccccccccCcccccCCC------CC
Q 024828           86 --------HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISGGK------YG  147 (262)
Q Consensus        86 --------~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~------~~  147 (262)
                              + .|++|+||+|+||+++.++.++|+|||++........    ......++..|+|||.+.+..      ++
T Consensus       157 ~~~~~~~~~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  235 (342)
T 1b6c_B          157 MEIVGTQGK-PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF  235 (342)
T ss_dssp             CCBCSTTCB-CEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHH
T ss_pred             HHHhhhccc-CCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccC
Confidence                    7 9999999999999999999999999999876654332    223457899999999998752      33


Q ss_pred             cchhHHHHHHHHHHHHhC----------CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHh
Q 024828          148 YKSDIWSLGLVLLECATG----------QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISAC  212 (262)
Q Consensus       148 ~~~Di~slG~~l~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~  212 (262)
                      .++||||||+++|+|++|          ..||........  ........+.........+     ...++.+.+|+.+|
T Consensus       236 ~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  313 (342)
T 1b6c_B          236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC  313 (342)
T ss_dssp             HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHH
T ss_pred             CcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc--cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHH
Confidence            689999999999999999          778876543321  1222333333322222111     12345789999999


Q ss_pred             hcCCcCCCCCHHHHhcC
Q 024828          213 VQKEPQQRLSAQELMTH  229 (262)
Q Consensus       213 l~~~p~~Rpt~~~~l~h  229 (262)
                      |+.||++|||+++++++
T Consensus       314 l~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          314 WYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCSSGGGSCCHHHHHHH
T ss_pred             hccChhhCCCHHHHHHH
Confidence            99999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3e-38  Score=281.72  Aligned_cols=212  Identities=25%  Similarity=0.392  Sum_probs=175.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ..+..++++.+|+.++++++||||+++++++. ++..++||||+++++|.+++...+ .++...+..++.|++.||+|||
T Consensus       430 ~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH  508 (656)
T 2j0j_A          430 TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE  508 (656)
T ss_dssp             TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            35667789999999999999999999999985 456899999999999999998654 6899999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      + .|++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       509 ~-~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  587 (656)
T 2j0j_A          509 S-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  587 (656)
T ss_dssp             H-TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             h-CCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence            9 9999999999999999999999999999876543221 1122345678999999988889999999999999999997


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                       |..||.+....       +....+..+..... +..+++++.+++.+||..||.+|||+.++++
T Consensus       588 ~g~~Pf~~~~~~-------~~~~~i~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          588 HGVKPFQGVKNN-------DVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TSCCTTTTCCHH-------HHHHHHHHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCCHH-------HHHHHHHcCCCCCC-CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             99999875432       23334444443333 3578999999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-38  Score=274.83  Aligned_cols=224  Identities=21%  Similarity=0.319  Sum_probs=177.7

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCC-CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLK   79 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~   79 (262)
                      ++|+........++.+|+++++.++| ++++.+..++.++...++||||+ +++|.+++.. .+.+++..++.++.||+.
T Consensus        36 AvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~  114 (483)
T 3sv0_A           36 AIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN  114 (483)
T ss_dssp             EEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHH
T ss_pred             EEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHH
Confidence            33433333344568899999999976 66666667777888999999999 8899999985 467999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEE---ccCCcEEEEecccccccccCCC-------CcccccccccccCcccccCCCCCcc
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      ||+|||+ .|++|+||||+|||+   +.++.++|+|||++........       ......|+..|+|||.+.+..++.+
T Consensus       115 aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~  193 (483)
T 3sv0_A          115 RVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR  193 (483)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred             HHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChH
Confidence            9999999 999999999999999   5788999999999976654322       1224578999999999999999999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +|||||||++|+|++|+.||...........+............ ......+++++.+|+.+||..+|.+||+++++++
T Consensus       194 sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          194 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999886654433333333222221111 1111467899999999999999999999998765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=273.52  Aligned_cols=215  Identities=22%  Similarity=0.405  Sum_probs=172.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECC--eEEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHH
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ...+.+.+|++++++++||||+++++++.+..  ..++||||++|++|.+++.....   ++...+..++.|++.||+||
T Consensus        49 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L  128 (396)
T 4eut_A           49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL  128 (396)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            34567789999999999999999999998754  78999999999999999976543   99999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEE----ccCCcEEEEecccccccccCCCCcccccccccccCcccccC--------CCCCcchhH
Q 024828           85 HHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--------GKYGYKSDI  152 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di  152 (262)
                      |+ .|++|+||||+||++    +.++.++|+|||++....... ......|+..|+|||.+.+        ..++.++||
T Consensus       129 H~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di  206 (396)
T 4eut_A          129 RE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL  206 (396)
T ss_dssp             HH-TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHH
T ss_pred             HH-CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHH
Confidence            99 999999999999999    667779999999997654332 2334568999999999864        457789999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCC-----------------------CCCCCCHHHHHHH
Q 024828          153 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA-----------------------PSDQFSPEFCSFI  209 (262)
Q Consensus       153 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li  209 (262)
                      |||||++|+|++|+.||..........   +.+..+..+.+...                       ....+++.+.+++
T Consensus       207 wSlG~il~el~tg~~Pf~~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll  283 (396)
T 4eut_A          207 WSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL  283 (396)
T ss_dssp             HHHHHHHHHHHHSSCSEECTTCTTTCH---HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCCcccchH---HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHH
Confidence            999999999999999997655433222   23333333322111                       1123456788999


Q ss_pred             HHhhcCCcCCCCCHHHHhcC
Q 024828          210 SACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       210 ~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      .+||..||++|||+++++++
T Consensus       284 ~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          284 ANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHSCCCTTTSCCHHHHHHH
T ss_pred             HHhhccChhhhccHHHHHHH
Confidence            99999999999999998543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-38  Score=256.45  Aligned_cols=199  Identities=27%  Similarity=0.450  Sum_probs=157.3

Q ss_pred             HHHHHHHHHH-hcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 024828           13 RQIAQELKIN-QSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        13 ~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ..+.+|+.++ +..+||||+++++++.+    +...++||||++|++|.+++...+  .++...+..++.|++.||+|||
T Consensus        55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH  134 (299)
T 3m2w_A           55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  134 (299)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3566888887 56699999999999987    677999999999999999998764  6999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEcc---CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .|++|+||+|+||+++.   ++.++|+|||++....                      +..++.++|+||||+++|+|
T Consensus       135 ~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el  191 (299)
T 3m2w_A          135 S-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYIL  191 (299)
T ss_dssp             H-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHH
T ss_pred             h-CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHH
Confidence            9 99999999999999988   7889999999875422                      23467899999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      ++|+.||............   ............  ....+++++.+|+.+||+.||.+|||++++++||||+....
T Consensus       192 ~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          192 LCGYPPFYSNHGLAISPGM---KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             HHSSCSCCC-------CCS---CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             HHCCCCCCCCcchhhhHHH---HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence            9999999765432110000   000000000000  01457899999999999999999999999999999977653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=259.99  Aligned_cols=212  Identities=14%  Similarity=0.178  Sum_probs=169.6

Q ss_pred             HHHHHHHHHHHHhcCC---CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHH
Q 024828           11 ARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-----VKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...++.+|+++++.++   |+||+++++.+..++..++||||++|++|.+++..     .+.+++..+..++.|++.||+
T Consensus       107 ~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~  186 (365)
T 3e7e_A          107 NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE  186 (365)
T ss_dssp             CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHH
T ss_pred             ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHH
Confidence            3446777788777775   99999999999999999999999999999999974     456999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEcc-----------CCcEEEEeccccccccc--CCCCcccccccccccCcccccCCCCCcc
Q 024828           83 YLHHEKHIIHRDLKPSNLLINH-----------RGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~-----------~~~~~l~df~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      |||+ .|++|+||||+||+++.           ++.++|+|||++.....  .........|+..|+|||++.+..++.+
T Consensus       187 ~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  265 (365)
T 3e7e_A          187 QVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ  265 (365)
T ss_dssp             HHHT-TTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH
T ss_pred             HHhh-CCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc
Confidence            9998 99999999999999988           88999999999965432  2223344578999999999999889999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc-
Q 024828          150 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT-  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-  228 (262)
                      +|||||||++|+|++|+.||.........          ....   ......++.+.+++.+||+.+|.+|++..+.+. 
T Consensus       266 ~DiwslG~il~elltg~~pf~~~~~~~~~----------~~~~---~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          266 IDYFGVAATVYCMLFGTYMKVKNEGGECK----------PEGL---FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             HHHHHHHHHHHHHHHSSCCCEEEETTEEE----------ECSC---CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhCCCccccCCCCcee----------echh---ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            99999999999999999999654332100          0000   111134677899999999999999975444444 


Q ss_pred             --CccccccC
Q 024828          229 --HPFLKMYG  236 (262)
Q Consensus       229 --h~~~~~~~  236 (262)
                        ..|+....
T Consensus       333 ~l~~~l~~~~  342 (365)
T 3e7e_A          333 KLKKVFQQHY  342 (365)
T ss_dssp             HHHHHHHHHT
T ss_pred             HHHHHHHHhh
Confidence              34554433

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-37  Score=263.37  Aligned_cols=211  Identities=17%  Similarity=0.214  Sum_probs=163.5

Q ss_pred             HHHHHHHHHHHHHhcCCC-Cee---------------------EeeceEEEE-----CCeEEEEEeecCCCCHHHHHHh-
Q 024828           10 SARRQIAQELKINQSSQC-PYV---------------------VVCYQSFYS-----NGAISIILEYMDGGSLADFLKK-   61 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h-~~i---------------------~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~-   61 (262)
                      ...+.+.+|+.+++.++| ++.                     ..+...+..     ....+++|+.+ +++|.++++. 
T Consensus       120 ~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l  198 (413)
T 3dzo_A          120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL  198 (413)
T ss_dssp             -CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHh
Confidence            346778999999999976 211                     111111222     23478888887 4599999852 


Q ss_pred             ------cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccc
Q 024828           62 ------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY  135 (262)
Q Consensus        62 ------~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y  135 (262)
                            .+.++...+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++......   .....| +.|
T Consensus       199 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y  273 (413)
T 3dzo_A          199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGF  273 (413)
T ss_dssp             HHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTT
T ss_pred             hcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-Cce
Confidence                  2347788999999999999999998 99999999999999999999999999998765433   334567 999


Q ss_pred             cCcccc----------cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 024828          136 MSPERI----------SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  205 (262)
Q Consensus       136 ~~PE~~----------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  205 (262)
                      +|||++          .+..++.++|||||||++|+|++|+.||......+.....       ..      ....+++++
T Consensus       274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~-------~~------~~~~~~~~~  340 (413)
T 3dzo_A          274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI-------FR------SCKNIPQPV  340 (413)
T ss_dssp             CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG-------GS------SCCCCCHHH
T ss_pred             eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH-------Hh------hcccCCHHH
Confidence            999998          5556889999999999999999999999876554332211       11      113678999


Q ss_pred             HHHHHHhhcCCcCCCCCHHHHhcCccccccCCcc
Q 024828          206 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  239 (262)
Q Consensus       206 ~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~~  239 (262)
                      .+||.+||+.||++|||+.++++||||+...+.-
T Consensus       341 ~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~  374 (413)
T 3dzo_A          341 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL  374 (413)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence            9999999999999999999999999998876543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-36  Score=273.11  Aligned_cols=204  Identities=21%  Similarity=0.319  Sum_probs=168.2

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCe-----EEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-----ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      +......+.+|++++++++||||+++++++.+.+.     .|+||||++|++|.+++..  .++...+..++.|++.||.
T Consensus       119 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~  196 (681)
T 2pzi_A          119 DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALS  196 (681)
T ss_dssp             CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHH
Confidence            45677789999999999999999999999987655     7999999999999988765  7999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |||+ .|++|+||||+||+++. +.++|+|||++......    ....|++.|+|||++.+. .+.++||||||+++++|
T Consensus       197 ~lH~-~giiHrDlkp~NIll~~-~~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l  269 (681)
T 2pzi_A          197 YLHS-IGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL  269 (681)
T ss_dssp             HHHH-TTEECCCCSGGGEEECS-SCEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred             HHHH-CCCeecccChHHeEEeC-CcEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence            9999 99999999999999976 48999999998765432    345689999999998765 48899999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      ++|..||........               ....+....++.+.++|.+||+.||.+||+..+.+.|+|+...
T Consensus       270 ~~g~~~~~~~~~~~~---------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          270 TLDLPTRNGRYVDGL---------------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HSCCCEETTEECSSC---------------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HhCCCCCcccccccc---------------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            999888865322110               0000111235789999999999999999999999999998654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.2e-36  Score=250.26  Aligned_cols=203  Identities=21%  Similarity=0.248  Sum_probs=155.3

Q ss_pred             HHHHHHHHHHHhcCC---------CCeeEeece-----------------EEEE-------------CCeEEEEEeecCC
Q 024828           12 RRQIAQELKINQSSQ---------CPYVVVCYQ-----------------SFYS-------------NGAISIILEYMDG   52 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~---------h~~i~~~~~-----------------~~~~-------------~~~~~lv~e~~~~   52 (262)
                      .+.+.+|+++++.++         ||||+++.+                 ++.+             .+..|+||||+.+
T Consensus        67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~  146 (336)
T 2vuw_A           67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG  146 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred             HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence            367778888887775         555555554                 4443             6789999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hcCCeeeCCCCCCCEEEccCC--------------------cEEEE
Q 024828           53 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH-HEKHIIHRDLKPSNLLINHRG--------------------EVKIT  111 (262)
Q Consensus        53 ~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh-~~~~i~H~dl~p~nil~~~~~--------------------~~~l~  111 (262)
                      +++.+.+.+ +.+++..+..++.|++.||+||| + .|++|+||||+||+++.++                    .++|+
T Consensus       147 g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~  224 (336)
T 2vuw_A          147 GIDLEQMRT-KLSSLATAKSILHQLTASLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII  224 (336)
T ss_dssp             CEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEEC
T ss_pred             CccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEe
Confidence            876666644 67899999999999999999999 8 9999999999999999887                    89999


Q ss_pred             ecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCccCchhhHHHHHHHHhc
Q 024828          112 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV-LLECATGQFPYSPPEQQDGWTSFYELMEAIVD  190 (262)
Q Consensus       112 df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~-l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  190 (262)
                      |||++......     ...|++.|+|||++.+.. +.++||||++++ .+++++|..||....    |  .......+..
T Consensus       225 DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~--~~~~~~~~~~  292 (336)
T 2vuw_A          225 DYTLSRLERDG-----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----W--LHYLTDKMLK  292 (336)
T ss_dssp             CCTTCBEEETT-----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----H--HHHHHHHHHH
T ss_pred             eccccEecCCC-----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----h--hhHHHHhhhh
Confidence            99999865432     347899999999999766 899999998777 777888988884310    0  0112222221


Q ss_pred             CC-CCCCC----CCCCCHHHHHHHHHhhcCCcCCCCCHHHHh-cCcccc
Q 024828          191 QP-PPSAP----SDQFSPEFCSFISACVQKEPQQRLSAQELM-THPFLK  233 (262)
Q Consensus       191 ~~-~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l-~h~~~~  233 (262)
                      .. .....    ...+++++.+||++||+.|     |++|+| +||||+
T Consensus       293 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          293 QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             TCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            11 11111    1246788999999999976     999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.8e-35  Score=235.62  Aligned_cols=186  Identities=14%  Similarity=0.137  Sum_probs=151.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      +...+.+.+|+.++.+++||||+++++++.+++..|+||||++|++|.+++++ + .....+..++.|++.||+|||+ .
T Consensus        72 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~-~  148 (286)
T 3uqc_A           72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHR-A  148 (286)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHH-C
Confidence            56778899999999999999999999999999999999999999999999965 3 4566788999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  168 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  168 (262)
                      |++|+||||+||+++.+|.++|++++.                    ++       .++.++||||||+++|+|++|+.|
T Consensus       149 givH~Dikp~NIll~~~g~~kl~~~~~--------------------~~-------~~~~~~Di~slG~il~elltg~~P  201 (286)
T 3uqc_A          149 GVALSIDHPSRVRVSIDGDVVLAYPAT--------------------MP-------DANPQDDIRGIGASLYALLVNRWP  201 (286)
T ss_dssp             TCCCCCCSGGGEEEETTSCEEECSCCC--------------------CT-------TCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred             CCccCCCCcccEEEcCCCCEEEEeccc--------------------cC-------CCCchhHHHHHHHHHHHHHHCCCC
Confidence            999999999999999999999985432                    22       368899999999999999999999


Q ss_pred             CCCCCccCchhhHHHHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          169 YSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |......+......    .......+  ......+++++.+++.+||+.||.+| |+.++++.
T Consensus       202 f~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          202 LPEAGVRSGLAPAE----RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             SCCCSBCCCSEECC----BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             CCcCCcchhhHHHH----HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            98765533110000    00001000  01124688999999999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.8e-33  Score=246.94  Aligned_cols=154  Identities=16%  Similarity=0.208  Sum_probs=121.8

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ++..++++.+|+++|+++ +|+||+++++++++++..||||||++|++|.+++.+.++++..   .|+.||+.||+|+|+
T Consensus       281 ~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~  357 (569)
T 4azs_A          281 SQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK  357 (569)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH
Confidence            456677899999999999 7999999999999999999999999999999999998888865   478999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                       .||+||||||+|||++.+|.+||+|||++.............+||+.|++||++.+ ....++|+|++|++++.+.++.
T Consensus       358 -~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          358 -QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             -TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             -CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence             99999999999999999999999999999876655555566789999999999986 4577899999999888776543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=7e-25  Score=191.44  Aligned_cols=149  Identities=19%  Similarity=0.238  Sum_probs=125.5

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..++++.+|++++++++||||+++..++.+....|+||||++|++|.+++.+        +..++.|++.+|.|||+ .|
T Consensus       381 ~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~-~g  451 (540)
T 3en9_A          381 IRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHK-ND  451 (540)
T ss_dssp             HHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH-Cc
Confidence            3467789999999999999999777776677788999999999999999876        67899999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-------cccccccccccCcccccC--CCCCcchhHHHHHHHHH
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-------ANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~  160 (262)
                      ++|+||||+||+++.  .++|+|||++.........       .....|++.|+|||++.+  ..|+...|+|+..+-..
T Consensus       452 IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l  529 (540)
T 3en9_A          452 VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELM  529 (540)
T ss_dssp             EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHH
T ss_pred             CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHH
Confidence            999999999999987  9999999999876432211       134578999999999986  45777889999888777


Q ss_pred             HHHhCCCCC
Q 024828          161 ECATGQFPY  169 (262)
Q Consensus       161 ~l~~g~~p~  169 (262)
                      +-+.++-+|
T Consensus       530 ~~v~~r~rY  538 (540)
T 3en9_A          530 KDVERRARY  538 (540)
T ss_dssp             HHHHTCSCC
T ss_pred             HHHHhcccc
Confidence            777666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.74  E-value=7.4e-19  Score=141.39  Aligned_cols=106  Identities=21%  Similarity=0.245  Sum_probs=86.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      .+..+.+|+.++++++  | +++.+++.. +..|+||||++|++|.+ +..      .....++.|++.||.+||+ .|+
T Consensus       147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~-~gi  214 (282)
T 1zar_A          147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYH-RGI  214 (282)
T ss_dssp             HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHH-CCC
Confidence            5678999999999999  4 666666554 44699999999999988 421      2355799999999999998 999


Q ss_pred             eeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc
Q 024828           91 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS  142 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  142 (262)
                      +|+||||+||+++ ++.++|+|||++..             ...+.|||.+.
T Consensus       215 iHrDlkp~NILl~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          215 VHGDLSQYNVLVS-EEGIWIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             ECSCCSTTSEEEE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             EeCCCCHHHEEEE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence            9999999999999 99999999998853             23456777664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.54  E-value=4.9e-15  Score=117.59  Aligned_cols=97  Identities=16%  Similarity=0.236  Sum_probs=76.8

Q ss_pred             HHHHHHHHHHHhcCCCCee--EeeceEEEECCeEEEEEeecCC-----CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSSQCPYV--VVCYQSFYSNGAISIILEYMDG-----GSLADFLKKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-----~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ...+.+|++++.++.|+++  +.++..    ...++||||+.+     .+|.++...   .+...+..++.|++.+|.+|
T Consensus       114 ~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~l  186 (258)
T 1zth_A          114 FIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRL  186 (258)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHH
Confidence            4578899999999987764  333322    346899999942     278776543   23456788999999999999


Q ss_pred             h-hcCCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           85 H-HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        85 h-~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      | + .|++|+||||+||+++.  .++|+|||++..
T Consensus       187 H~~-~givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          187 YQE-AELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             HHT-SCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             HHH-CCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            9 8 99999999999999987  899999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.24  E-value=4.2e-12  Score=105.28  Aligned_cols=95  Identities=16%  Similarity=0.167  Sum_probs=69.9

Q ss_pred             HHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCC
Q 024828           15 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD   94 (262)
Q Consensus        15 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~d   94 (262)
                      +.+|...|.++.+.++.... .+.... .++||||++|.+|..+..    .  .....++.|++.+|.+||+ .|++|+|
T Consensus       160 A~kE~~nL~rL~~~gv~vp~-p~~~~~-~~LVME~i~G~~L~~l~~----~--~~~~~l~~qll~~l~~lH~-~gIVHrD  230 (397)
T 4gyi_A          160 AIKEFAFMKALYEEGFPVPE-PIAQSR-HTIVMSLVDALPMRQVSS----V--PDPASLYADLIALILRLAK-HGLIHGD  230 (397)
T ss_dssp             HHHHHHHHHHHHHTTCSCCC-EEEEET-TEEEEECCSCEEGGGCCC----C--SCHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred             HHHHHHHHHHHHhcCCCCCe-eeeccC-ceEEEEecCCccHhhhcc----c--HHHHHHHHHHHHHHHHHHH-CCCcCCC
Confidence            45677778777555543222 222222 379999999988865422    2  2345788999999999998 9999999


Q ss_pred             CCCCCEEEccCC----------cEEEEecccccc
Q 024828           95 LKPSNLLINHRG----------EVKITDFGVSAI  118 (262)
Q Consensus        95 l~p~nil~~~~~----------~~~l~df~~~~~  118 (262)
                      |||.|||++.++          .+.++||+.+..
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999999998776          389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.00  E-value=7.6e-10  Score=87.65  Aligned_cols=101  Identities=17%  Similarity=0.117  Sum_probs=80.3

Q ss_pred             HHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---
Q 024828           12 RRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE---   87 (262)
Q Consensus        12 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~---   87 (262)
                      ...+.+|+.+++.+ ++..++++++++.+.+..|+|||+++|.+|.+.+.     +......++.++..+|+.||+-   
T Consensus        53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~  127 (263)
T 3tm0_A           53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDIS  127 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcc
Confidence            34688999999888 46778899999999999999999999999987531     1223457788889999999970   


Q ss_pred             -------------------------------------------------------CCeeeCCCCCCCEEEccCCcEEEEe
Q 024828           88 -------------------------------------------------------KHIIHRDLKPSNLLINHRGEVKITD  112 (262)
Q Consensus        88 -------------------------------------------------------~~i~H~dl~p~nil~~~~~~~~l~d  112 (262)
                                                                             .+++|+|++|.||+++.++.+.++|
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lID  207 (263)
T 3tm0_A          128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFID  207 (263)
T ss_dssp             TCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECC
T ss_pred             cCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEE
Confidence                                                                   3489999999999997655567999


Q ss_pred             ccccc
Q 024828          113 FGVSA  117 (262)
Q Consensus       113 f~~~~  117 (262)
                      |+.+.
T Consensus       208 we~a~  212 (263)
T 3tm0_A          208 LGRSG  212 (263)
T ss_dssp             CTTCE
T ss_pred             chhcc
Confidence            98653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.91  E-value=2.2e-10  Score=90.51  Aligned_cols=96  Identities=14%  Similarity=0.109  Sum_probs=72.2

Q ss_pred             HHHHHHHHHHhcCCCCe--eEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-
Q 024828           13 RQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-   89 (262)
Q Consensus        13 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~-   89 (262)
                      ..+.+|+.+++.+.+.+  +++++....+++..++||||++|.+|.  ..   ..+   ...++.+++..|..||+ .. 
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~-~~~  128 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHT-LDP  128 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTT-SCG
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhC-CCC
Confidence            45778898888885433  567888888888899999999998884  11   122   23566777777777776 32 


Q ss_pred             ---------------------------------------------------------eeeCCCCCCCEEEccCCcEEEEe
Q 024828           90 ---------------------------------------------------------IIHRDLKPSNLLINHRGEVKITD  112 (262)
Q Consensus        90 ---------------------------------------------------------i~H~dl~p~nil~~~~~~~~l~d  112 (262)
                                                                               ++|+|++|.||+++.++.+.++|
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD  208 (264)
T 1nd4_A          129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFID  208 (264)
T ss_dssp             GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECC
T ss_pred             CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEc
Confidence                                                                     99999999999997665566999


Q ss_pred             ccccc
Q 024828          113 FGVSA  117 (262)
Q Consensus       113 f~~~~  117 (262)
                      |+.+.
T Consensus       209 ~~~a~  213 (264)
T 1nd4_A          209 CGRLG  213 (264)
T ss_dssp             CTTCE
T ss_pred             chhcc
Confidence            99764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.90  E-value=1.3e-09  Score=90.34  Aligned_cols=106  Identities=19%  Similarity=0.296  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHHHhcCC--CCeeEeeceEEEEC---CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 024828           11 ARRQIAQELKINQSSQ--CPYVVVCYQSFYSN---GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ...++.+|+.+++.+.  +..+++++..+.+.   +..++|||+++|..+.+.  ....++......++.+++.+|+.||
T Consensus        79 ~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH  156 (359)
T 3dxp_A           79 SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMH  156 (359)
T ss_dssp             ---CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHh
Confidence            3467889999999886  45578888887765   458999999999777431  1134678888899999999999999


Q ss_pred             h---------------------------------------------------------cCCeeeCCCCCCCEEEccCCc-
Q 024828           86 H---------------------------------------------------------EKHIIHRDLKPSNLLINHRGE-  107 (262)
Q Consensus        86 ~---------------------------------------------------------~~~i~H~dl~p~nil~~~~~~-  107 (262)
                      +                                                         ..+++|+|+++.||+++.++. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~  236 (359)
T 3dxp_A          157 TVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPR  236 (359)
T ss_dssp             HSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSC
T ss_pred             CCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCc
Confidence            6                                                         146999999999999987753 


Q ss_pred             -EEEEecccccc
Q 024828          108 -VKITDFGVSAI  118 (262)
Q Consensus       108 -~~l~df~~~~~  118 (262)
                       +.++||+.+..
T Consensus       237 v~~viDwe~a~~  248 (359)
T 3dxp_A          237 VLAVLDWELSTL  248 (359)
T ss_dssp             EEEECCCTTCEE
T ss_pred             EEEEECcccccc
Confidence             68999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.77  E-value=3e-09  Score=86.13  Aligned_cols=164  Identities=16%  Similarity=0.197  Sum_probs=101.6

Q ss_pred             cccchhHHHHHHHHHHHHHHhcC-CCCe--eEeeceEEEECC---eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSS-QCPY--VVVCYQSFYSNG---AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ   76 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~   76 (262)
                      .|+.........+.+|..+++.+ .+..  +++++.....+.   ..|+||++++|.+|.+...  ..++.+....++.+
T Consensus        45 lR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~  122 (304)
T 3sg8_A           45 FKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKD  122 (304)
T ss_dssp             EEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHH
T ss_pred             EEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHH
Confidence            34444445677899999999877 3333  344444433332   3578999999988865332  24677777788888


Q ss_pred             HHHHHHHHhh---------------------------------------------------------cCCeeeCCCCCCC
Q 024828           77 VLKGLLYLHH---------------------------------------------------------EKHIIHRDLKPSN   99 (262)
Q Consensus        77 l~~~l~~lh~---------------------------------------------------------~~~i~H~dl~p~n   99 (262)
                      ++..++.||+                                                         ...++|+|++|.|
T Consensus       123 l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N  202 (304)
T 3sg8_A          123 LARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDH  202 (304)
T ss_dssp             HHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGG
T ss_pred             HHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCccc
Confidence            8888888874                                                         0247999999999


Q ss_pred             EEEcc--CCcEEEEecccccccccCCCCcccccccccccCcccccC-----CC---------CCcchhHHHHHHHHHHHH
Q 024828          100 LLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-----GK---------YGYKSDIWSLGLVLLECA  163 (262)
Q Consensus       100 il~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~---------~~~~~Di~slG~~l~~l~  163 (262)
                      |+++.  .+.+.++||+.+.............. ...-..|+....     +.         .....+.|+++.+++.+.
T Consensus       203 ~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~-~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~  281 (304)
T 3sg8_A          203 ILFDTEKNTICGIIDFGDAAISDPDNDFISLME-DDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKE  281 (304)
T ss_dssp             EEEETTTTEEEEECCCTTCEEECTTHHHHTTCC-TTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCEEEEEeCCCCccCChHHHHHHHHh-hccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            99987  45578999998754311100000000 000012221110     00         112368899999999999


Q ss_pred             hCCCCC
Q 024828          164 TGQFPY  169 (262)
Q Consensus       164 ~g~~p~  169 (262)
                      +|+.+|
T Consensus       282 ~g~~~~  287 (304)
T 3sg8_A          282 YGYMDW  287 (304)
T ss_dssp             TTCHHH
T ss_pred             cCCHHH
Confidence            997655

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.44  E-value=7.6e-07  Score=72.04  Aligned_cols=113  Identities=19%  Similarity=0.203  Sum_probs=74.8

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCC---eeEeeceEEE-ECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCP---YVVVCYQSFY-SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK   79 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~   79 (262)
                      |+.........+.+|.++|+.+.+.   .+++++.+.. ..+..++||++++|.++.+..-  ..++......++.++..
T Consensus        45 R~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~  122 (306)
T 3tdw_A           45 RFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAE  122 (306)
T ss_dssp             EEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHH
T ss_pred             EecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHH
Confidence            3334445677899999999998542   3566666664 3456789999999988876321  12344444444444444


Q ss_pred             HHHHHhh-----------------------------------------------------------cCCeeeCCCCCCCE
Q 024828           80 GLLYLHH-----------------------------------------------------------EKHIIHRDLKPSNL  100 (262)
Q Consensus        80 ~l~~lh~-----------------------------------------------------------~~~i~H~dl~p~ni  100 (262)
                      .|+.||+                                                           ...++|+|+++.||
T Consensus       123 ~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~  202 (306)
T 3tdw_A          123 FMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHF  202 (306)
T ss_dssp             HHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGE
T ss_pred             HHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccE
Confidence            4444443                                                           13469999999999


Q ss_pred             EEcc---CCc-EEEEecccccc
Q 024828          101 LINH---RGE-VKITDFGVSAI  118 (262)
Q Consensus       101 l~~~---~~~-~~l~df~~~~~  118 (262)
                      +++.   ++. +.++||+.+..
T Consensus       203 l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          203 LTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EECTTCSSCCEEEECCCTTCEE
T ss_pred             EEecCCCCCceEEEEehhhcCC
Confidence            9987   355 47999997654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.44  E-value=1.4e-06  Score=69.09  Aligned_cols=103  Identities=13%  Similarity=0.116  Sum_probs=74.8

Q ss_pred             HHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---
Q 024828           11 ARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH---   86 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~---   86 (262)
                      ....+.+|...|+.+. +--+++++.++.+++..++|||+++|.++.+.....    ......+..++...|..||.   
T Consensus        62 ~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~  137 (272)
T 4gkh_A           62 VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPV  137 (272)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCG
T ss_pred             CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCc
Confidence            4567888999988773 444778889999999999999999998887765431    12223444555555555553   


Q ss_pred             ------------------------------------------------------cCCeeeCCCCCCCEEEccCCcEEEEe
Q 024828           87 ------------------------------------------------------EKHIIHRDLKPSNLLINHRGEVKITD  112 (262)
Q Consensus        87 ------------------------------------------------------~~~i~H~dl~p~nil~~~~~~~~l~d  112 (262)
                                                                            ...++|+|+++.||+++.++.+-++|
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viD  217 (272)
T 4gkh_A          138 CNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCID  217 (272)
T ss_dssp             GGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred             ccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEE
Confidence                                                                  01268999999999998766677999


Q ss_pred             ccccc
Q 024828          113 FGVSA  117 (262)
Q Consensus       113 f~~~~  117 (262)
                      |+.+.
T Consensus       218 we~a~  222 (272)
T 4gkh_A          218 VGRVG  222 (272)
T ss_dssp             CTTCE
T ss_pred             Ccccc
Confidence            98764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.20  E-value=3.9e-05  Score=57.95  Aligned_cols=136  Identities=18%  Similarity=0.184  Sum_probs=91.0

Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccc
Q 024828           53 GSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  131 (262)
Q Consensus        53 ~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~  131 (262)
                      -||.++++.. .++++++++.++.|.+.+|..+-..+.-...=+.|..|++..+|.|.+.+ +.+.            ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~   99 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG   99 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence            4899999866 58999999999999999987763212222333557889999999887774 1110            11


Q ss_pred             cccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 024828          132 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  211 (262)
Q Consensus       132 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  211 (262)
                      ...+.|||... ...+.+.-||+||+++|.-+--    .-..                      .....+++++-+||..
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy----gL~e----------------------~eE~eLS~~LE~LL~~  152 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY----GLKE----------------------NEERELSPPLEQLIDH  152 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHTT----TCCT----------------------TEEECCCHHHHHHHHH
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc----CCCc----------------------ccchhhCHHHHHHHHH
Confidence            33566887764 3456889999999999998752    2111                      1124788999999999


Q ss_pred             hhcC-------------------------CcCCCCCHHHHhc
Q 024828          212 CVQK-------------------------EPQQRLSAQELMT  228 (262)
Q Consensus       212 ~l~~-------------------------~p~~Rpt~~~~l~  228 (262)
                      |..-                         .+..|++++++++
T Consensus       153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             HTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             HHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            9765                         3467888988875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.78  E-value=1.4e-05  Score=65.94  Aligned_cols=31  Identities=19%  Similarity=0.313  Sum_probs=25.6

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      ..++|+|+++.||++++++.+.++||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            5799999999999998544578999987653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.56  E-value=0.00046  Score=56.20  Aligned_cols=31  Identities=16%  Similarity=0.371  Sum_probs=27.4

Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      ..+++|+|+++.||+++.++.+.++||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3789999999999999878889999998653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.27  E-value=0.00014  Score=58.36  Aligned_cols=30  Identities=23%  Similarity=0.228  Sum_probs=25.0

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      ..++|+|+.+.||+ ..++.+.++||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            34899999999999 5677889999987653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.89  E-value=0.0012  Score=55.05  Aligned_cols=29  Identities=24%  Similarity=0.433  Sum_probs=24.8

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      ..++|||+++.||+++.+ .+.++||..+.
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            679999999999999765 48999997664

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.88  E-value=0.0022  Score=52.08  Aligned_cols=31  Identities=29%  Similarity=0.458  Sum_probs=26.7

Q ss_pred             CCeeeCCCCCCCEEEccC----CcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHR----GEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~----~~~~l~df~~~~~  118 (262)
                      ..++|+|+++.||+++.+    +.+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            579999999999999764    6799999997754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.69  E-value=0.0023  Score=51.68  Aligned_cols=44  Identities=18%  Similarity=0.089  Sum_probs=35.8

Q ss_pred             HHHHHHHHHHHhcCC---CCeeEeeceEEEECCeEEEEEeecCCCCH
Q 024828           12 RRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAISIILEYMDGGSL   55 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~sL   55 (262)
                      ...+..|...|+.+.   ...+++++......+..++||||++|..+
T Consensus        72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            567888988888873   36788888888878889999999998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.51  E-value=0.013  Score=49.20  Aligned_cols=30  Identities=20%  Similarity=0.402  Sum_probs=26.7

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      ..++|||+++.||+++.++ +.++||+.+..
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            7899999999999998766 99999987754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.97  E-value=0.39  Score=36.22  Aligned_cols=114  Identities=11%  Similarity=0.139  Sum_probs=76.6

Q ss_pred             CCCeeEeeceEEEECCeEEEEEeecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhhcCCeeeCCCCCCCEEEc
Q 024828           26 QCPYVVVCYQSFYSNGAISIILEYMD-GGSLADFLKKVKTIPEEYLAAICEQVLKGLL-YLHHEKHIIHRDLKPSNLLIN  103 (262)
Q Consensus        26 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~-~lh~~~~i~H~dl~p~nil~~  103 (262)
                      .||++  -..+-.+++.+.+.++.-+ +.+... ++   ..+...++.++.+|+.... +++   .-+|--++|+|++++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~---~~~~~eKlrll~nl~~L~~~~~~---~r~tf~l~P~NL~f~  118 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR---KTTLLSRIRAAIHLVSKVKHHSA---RRLIFIVCPENLMFN  118 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH---TSCHHHHHHHHHHHHHHHSSCCS---SSEECCCCGGGEEEC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH---hcCHHHHHHHHHHHHHHHHHhhh---CceeEEEeCceEEEe
Confidence            57777  4444466777777777653 334443 33   4789999999999988766 444   368999999999999


Q ss_pred             cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828          104 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus       104 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      .++.+++.-.|.-.                 -+||.-     .+...=.-..=|++..++.++..|.
T Consensus       119 ~~~~p~i~hRGi~~-----------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          119 RALEPFFLHVGVKE-----------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             TTCCEEESCCEETT-----------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CCCcEEEEEcCCcc-----------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999998766421                 123322     1222223366688888888877663

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=93.64  E-value=0.021  Score=45.89  Aligned_cols=31  Identities=23%  Similarity=0.253  Sum_probs=25.7

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      .+++|+|+++.||+++.++.+.++||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            4699999999999998765568999987643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.41  E-value=0.082  Score=42.50  Aligned_cols=28  Identities=18%  Similarity=0.198  Sum_probs=24.4

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      ..++|+|+++.||+++ + .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            5689999999999998 4 89999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=93.35  E-value=0.068  Score=45.46  Aligned_cols=36  Identities=31%  Similarity=0.294  Sum_probs=23.3

Q ss_pred             HHHHHHHhcCCCCee-EeeceEEEECCeEEEEEeecCCCCH
Q 024828           16 AQELKINQSSQCPYV-VVCYQSFYSNGAISIILEYMDGGSL   55 (262)
Q Consensus        16 ~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL   55 (262)
                      .+|..+++.+...++ +++++.+.  +.  +|++|++|.+|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence            478888887754444 56666653  22  59999987444

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=93.26  E-value=0.073  Score=43.27  Aligned_cols=31  Identities=19%  Similarity=0.428  Sum_probs=27.1

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      .+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            5699999999999998778899999987653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.90  E-value=0.28  Score=36.92  Aligned_cols=115  Identities=10%  Similarity=0.084  Sum_probs=77.2

Q ss_pred             CCCeeEeeceEEEECCeEEEEEeecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEcc
Q 024828           26 QCPYVVVCYQSFYSNGAISIILEYMD-GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  104 (262)
Q Consensus        26 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~  104 (262)
                      .||+++.. .+-.+++.+.+.++.-+ +.+... +   ...+....+.++.+|+....++++   -+|--++|+|++++.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELFFTR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEEECT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEEEcC
Confidence            57888766 56666676666555543 223332 2   347899999999999887755543   588999999999999


Q ss_pred             CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828          105 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus       105 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      ++.+++.--|+-..                 ++|.     ..+...=.-..=|++..+++++..|.
T Consensus       115 ~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          115 DGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999886664221                 2222     12223333466688889999887774

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.72  E-value=0.14  Score=42.06  Aligned_cols=29  Identities=24%  Similarity=0.460  Sum_probs=23.9

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEeccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  117 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~  117 (262)
                      .+++|+|+++.||+++.+ .+.++||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~-~~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNK-CLRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC--CEEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCC-cEEEEEecCCC
Confidence            458999999999999654 48999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=92.35  E-value=0.055  Score=45.61  Aligned_cols=18  Identities=28%  Similarity=0.497  Sum_probs=15.2

Q ss_pred             CCeeeCCCCCCCEEEccC
Q 024828           88 KHIIHRDLKPSNLLINHR  105 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~  105 (262)
                      ..++|+|+.+.||+++.+
T Consensus       249 ~v~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKA  266 (429)
T ss_dssp             EEEECSCCCGGGEEEEC-
T ss_pred             eEEEeCCCCCCeEEeeCC
Confidence            358999999999999875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=91.69  E-value=0.11  Score=43.02  Aligned_cols=103  Identities=15%  Similarity=0.142  Sum_probs=61.3

Q ss_pred             HHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHH--------------HHHH---hc-----CCCC--
Q 024828           12 RRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLA--------------DFLK---KV-----KTIP--   66 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~--------------~~l~---~~-----~~~~--   66 (262)
                      ...+.+|.++++.+. +.-.+++++.+.+  .  +|+||++|.+|.              ..+.   ..     +...  
T Consensus        97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l  172 (379)
T 3feg_A           97 VDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL  172 (379)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence            455668988888773 2223566655543  2  999999985542              1111   10     1111  


Q ss_pred             HHHHHHHHHHHHH-------------------HHHHHh----h---cCCeeeCCCCCCCEEEccC----CcEEEEecccc
Q 024828           67 EEYLAAICEQVLK-------------------GLLYLH----H---EKHIIHRDLKPSNLLINHR----GEVKITDFGVS  116 (262)
Q Consensus        67 ~~~~~~i~~~l~~-------------------~l~~lh----~---~~~i~H~dl~p~nil~~~~----~~~~l~df~~~  116 (262)
                      ...+..+..++-.                   .+..|.    .   ...++|+|+.+.||+++.+    +.+.++||..+
T Consensus       173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence            2344445544321                   122222    1   2358999999999999876    68999999876


Q ss_pred             cc
Q 024828          117 AI  118 (262)
Q Consensus       117 ~~  118 (262)
                      ..
T Consensus       253 ~~  254 (379)
T 3feg_A          253 SY  254 (379)
T ss_dssp             EE
T ss_pred             Cc
Confidence            43

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.35  E-value=0.28  Score=40.86  Aligned_cols=30  Identities=23%  Similarity=0.418  Sum_probs=24.7

Q ss_pred             CeeeCCCCCCCEEEc------cCCcEEEEecccccc
Q 024828           89 HIIHRDLKPSNLLIN------HRGEVKITDFGVSAI  118 (262)
Q Consensus        89 ~i~H~dl~p~nil~~------~~~~~~l~df~~~~~  118 (262)
                      .++|+|+.+.||++.      .++.+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            368999999999993      456799999988754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=85.45  E-value=0.67  Score=38.88  Aligned_cols=30  Identities=33%  Similarity=0.581  Sum_probs=25.8

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      ..++|+|+.+.||+ +.++.+.++||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            35899999999999 7778899999987753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	262
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-81
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-67
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-67
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-66
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-66
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-66
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-65
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-60
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-60
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-60
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-60
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-60
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-58
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-58
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-57
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-54
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-54
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-52
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-52
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-51
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-50
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-48
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-47
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-47
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-46
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-46
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-45
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-45
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-45
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-43
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-42
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-39
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-38
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-34
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-16

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (628), Expect = 1e-81
 Identities = 109/282 (38%), Positives = 160/282 (56%), Gaps = 37/282 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK
Sbjct: 38  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  
Sbjct: 98  AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----- 176
           +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++     
Sbjct: 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215

Query: 177 ------------------------------GWTSFYELMEAIVDQPPPSAPSDQFSPEFC 206
                                            + +EL++ IV++PPP  PS  FS EF 
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275

Query: 207 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 248
            F++ C+ K P +R   ++LM H F+K      VD + +   
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCS 317

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 6e-68
 Identities = 66/237 (27%), Positives = 119/237 (50%), Gaps = 18/237 (7%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV- 62
           ++ E+ ++ +  E+ + +  + P +V  Y      +N  + I++EY +GG LA  + K  
Sbjct: 41  SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT 100

Query: 63  ---KTIPEEYLAAICEQVLKGLLYLH----HEKHIIHRDLKPSNLLINHRGEVKITDFGV 115
              + + EE++  +  Q+   L   H        ++HRDLKP+N+ ++ +  VK+ DFG+
Sbjct: 101 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160

Query: 116 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
           + I+   +  A  FVGT  YMSPE+++   Y  KSDIWSLG +L E      P++   Q+
Sbjct: 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220

Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 232
                  EL   I +      P  ++S E    I+  +  +   R S +E++ +P +
Sbjct: 221 -------ELAGKIREGKFRRIP-YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 3e-67
 Identities = 68/239 (28%), Positives = 119/239 (49%), Gaps = 15/239 (6%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLA 56
            +    + +S R++  +E ++ +  Q P +V  Y S+ S       I ++ E M  G+L 
Sbjct: 41  ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 100

Query: 57  DFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHR-GEVKITDFG 114
            +LK+ K +  + L + C Q+LKGL +LH     IIHRDLK  N+ I    G VKI D G
Sbjct: 101 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 160

Query: 115 VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 174
           ++ +  ++   A   +GT  +M+PE     KY    D+++ G+ +LE AT ++PYS    
Sbjct: 161 LATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS---- 213

Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                +  ++   +     P++      PE    I  C+++   +R S ++L+ H F +
Sbjct: 214 --ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 8e-67
 Identities = 70/235 (29%), Positives = 118/235 (50%), Gaps = 13/235 (5%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPE 67
           E        E+ I  S   P +V    +FY    + I++E+  GG++   + +  + + E
Sbjct: 50  EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 109

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
             +  +C+Q L  L YLH +  IIHRDLK  N+L    G++K+ DFGVSA    T  + +
Sbjct: 110 SQIQVVCKQTLDALNYLH-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168

Query: 128 TFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
           +F+GT  +M+PE +         Y YK+D+WSLG+ L+E A  + P+             
Sbjct: 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMR 222

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 237
            L++    +PP  A   ++S  F  F+  C++K    R +  +L+ HPF+ +  +
Sbjct: 223 VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  206 bits (525), Expect = 3e-66
 Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 15/229 (6%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
                + I +E++  Q  + P  +     +       +++EY  G +        K + E
Sbjct: 55  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
             +AA+    L+GL YL H  ++IHRD+K  N+L++  G VK+ DFG ++IMA      N
Sbjct: 115 VEIAAVTHGALQGLAYL-HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N 169

Query: 128 TFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +FVGT  +M+PE I     G+Y  K D+WSLG+  +E A  + P                
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SA 222

Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           +  I     P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+ 
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 3e-66
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 12/226 (5%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +     Q+ +E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E
Sbjct: 46  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 105

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +  A    ++   L Y H  K +IHRD+KP NLL+   GE+KI DFG S    S+  +  
Sbjct: 106 QRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRT 162

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           T  GT +Y+ PE I G  +  K D+WSLG++  E   G+ P+          ++ E  + 
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-------TYQETYKR 215

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           I          D  +      IS  ++  P QR   +E++ HP++ 
Sbjct: 216 ISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-66
 Identities = 71/232 (30%), Positives = 123/232 (53%), Gaps = 8/232 (3%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           ++  +  I  E+ + + ++ P +V    S+     + +++EY+ GGSL D + +   + E
Sbjct: 57  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDE 115

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
             +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TDFG  A +     + +
Sbjct: 116 GQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

Query: 128 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 187
           T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY              L   
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY------LNENPLRALYLI 228

Query: 188 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 239
             +  P     ++ S  F  F++ C+  + ++R SA+EL+ H FLK+   L+
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-65
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 10/235 (4%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           ++ M         I +E+ IN+      VV  Y          + LEY  GG L D ++ 
Sbjct: 37  IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 96

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +PE        Q++ G++YLH    I HRD+KP NLL++ R  +KI+DFG++ +   
Sbjct: 97  DIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155

Query: 122 TSGQ--ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
            + +   N   GT  Y++PE +   ++     D+WS G+VL     G+ P+      D  
Sbjct: 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------DQP 209

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           +   +      ++     P  +      + +   + + P  R++  ++    +  
Sbjct: 210 SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (485), Expect = 2e-60
 Identities = 62/252 (24%), Positives = 115/252 (45%), Gaps = 14/252 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            I     E     +  E+ +    + P +V     + S G + +I++ + GG L D + +
Sbjct: 41  CIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE 100

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAI 118
                E   + +  QVL  + YL H+  I+HRDLKP NLL    +   ++ I+DFG+S +
Sbjct: 101 KGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159

Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
               S   +T  GT  Y++PE ++   Y    D WS+G++      G  P+         
Sbjct: 160 EDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--- 215

Query: 179 TSFYELMEAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 236
               +L E I+  +    S   D  S     FI   ++K+P++R + ++ + HP++    
Sbjct: 216 ----KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271

Query: 237 DLNVDLSEYFTD 248
            L+ ++ +  ++
Sbjct: 272 ALDKNIHQSVSE 283

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-60
 Identities = 56/227 (24%), Positives = 106/227 (46%), Gaps = 11/227 (4%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPE 67
               +    E+ + + ++   +++    + +   ++I+ ++ +G SL   L  ++T    
Sbjct: 45  PQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEM 103

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--Q 125
             L  I  Q  +G+ YLH  K IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q
Sbjct: 104 IKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162

Query: 126 ANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 182
                G+  +M+PE I       Y ++SD+++ G+VL E  TGQ PYS    +D      
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QII 219

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            ++      P  S             ++ C++K+  +R    +++  
Sbjct: 220 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  189 bits (482), Expect = 3e-60
 Identities = 61/236 (25%), Positives = 113/236 (47%), Gaps = 18/236 (7%)

Query: 9   ESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           +  R    +E+ I +  S  P ++    ++ +N    ++ + M  G L D+L +  T+ E
Sbjct: 50  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 109

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           +    I   +L+ +  L H+ +I+HRDLKP N+L++    +K+TDFG S  +     +  
Sbjct: 110 KETRKIMRALLEVICAL-HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLR 167

Query: 128 TFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
              GT +Y++PE I          YG + D+WS G+++     G  P+   +Q       
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------ 221

Query: 182 YELMEAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
             ++  I+  +    S   D +S      +S  +  +PQ+R +A+E + HPF + Y
Sbjct: 222 -LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  192 bits (488), Expect = 3e-60
 Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 14/233 (6%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIP 66
            ES +  + +E++     + P +V  + +F  +  + +I E+M GG L + +  +   + 
Sbjct: 63  HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 122

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSG 124
           E+       QV KGL ++H E + +H DLKP N++   +   E+K+ DFG++A +     
Sbjct: 123 EDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQ 180

Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
                 GT  + +PE   G   GY +D+WS+G++     +G  P+             E 
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ET 233

Query: 185 MEAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
           +  +   D     +     S +   FI   +  +P  R++  + + HP+L   
Sbjct: 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 4e-60
 Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 18/235 (7%)

Query: 7   VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 66
           ++E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  
Sbjct: 47  IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD 106

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSG 124
           E        +++  L YL H K IIHRDLKP N+L+N    ++ITDFG + +++  S   
Sbjct: 107 ETCTRFYTAEIVSALEYL-HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165

Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           +AN+FVGT  Y+SPE ++       SD+W+LG ++ +   G  P+    +       Y +
Sbjct: 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLI 218

Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLK 233
            + I+         ++F P+    +   +  +  +RL  +E      L  HPF +
Sbjct: 219 FQKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 4e-58
 Identities = 56/230 (24%), Positives = 110/230 (47%), Gaps = 11/230 (4%)

Query: 5   MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 64
           + +++     + ++  ++ + + P++   + +F +   +  ++EY++GG L   ++    
Sbjct: 40  VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK 99

Query: 65  IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 124
                      +++ GL +LH  K I++RDLK  N+L++  G +KI DFG+         
Sbjct: 100 FDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158

Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
           + NTF GT +Y++PE + G KY +  D WS G++L E   GQ P+   +++       EL
Sbjct: 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------EL 211

Query: 185 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA-QELMTHPFLK 233
             +I    P          E    +     +EP++RL    ++  HP  +
Sbjct: 212 FHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 8e-58
 Identities = 50/235 (21%), Positives = 104/235 (44%), Gaps = 14/235 (5%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
            + V+ + +  + +E+ I   ++   ++  ++SF S   + +I E++ G  + + +    
Sbjct: 37  FVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA 96

Query: 64  -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMA 120
             + E  + +   QV + L +LH   +I H D++P N++   R    +KI +FG +  + 
Sbjct: 97  FELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL- 154

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
                         Y +PE          +D+WSLG ++    +G  P+     Q     
Sbjct: 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----- 209

Query: 181 FYELMEAIVDQ--PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
             +++E I++           + S E   F+   + KE + R++A E + HP+LK
Sbjct: 210 --QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  185 bits (471), Expect = 1e-57
 Identities = 55/231 (23%), Positives = 105/231 (45%), Gaps = 14/231 (6%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIP 66
               +  +  E+ I      P ++  + +F     + +ILE++ GG L D +  +   + 
Sbjct: 66  YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 125

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTSG 124
           E  +     Q  +GL ++H E  I+H D+KP N++        VKI DFG++  + +   
Sbjct: 126 EAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDE 183

Query: 125 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 184
                  T  + +PE +     G+ +D+W++G++     +G  P++  +         E 
Sbjct: 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ET 236

Query: 185 MEAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
           ++ +   D           SPE   FI   +QKEP++RL+  + + HP+LK
Sbjct: 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  179 bits (455), Expect = 3e-55
 Identities = 64/237 (27%), Positives = 118/237 (49%), Gaps = 15/237 (6%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
           I+M   E+        L +  +  CP++V    +F++   +S IL+ M+GG L   L + 
Sbjct: 42  IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 101

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
               E  +     +++ GL ++ H + +++RDLKP+N+L++  G V+I+D G++     +
Sbjct: 102 GVFSEADMRFYAAEIILGLEHM-HNRFVVYRDLKPANILLDEHGHVRISDLGLACDF--S 158

Query: 123 SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
             + +  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  P+   + +D     
Sbjct: 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----K 214

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 233
           +E+    +         D FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 215 HEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-54
 Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 14/224 (6%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFL--KKVKTI 65
           ++  +    E  +    +   +V          G + I+ EYM  GSL D+L  +    +
Sbjct: 41  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 100

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
             + L      V + + YL    + +HRDL   N+L++     K++DFG++   +ST   
Sbjct: 101 GGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157

Query: 126 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 185
            +T      + +PE +   K+  KSD+WS G++L E  +      P           +++
Sbjct: 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVV 210

Query: 186 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
             +       AP D   P     +  C   +   R S  +L   
Sbjct: 211 PRVEKGYKMDAP-DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-54
 Identities = 60/239 (25%), Positives = 105/239 (43%), Gaps = 15/239 (6%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFL 59
            +     ARR++    +    SQCP++V     + +       + I++E +DGG L   +
Sbjct: 44  MLQDCPKARREVELHWRA---SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 100

Query: 60  KK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFG 114
           +    +   E   + I + + + + YLH   +I HRD+KP NLL   +     +K+TDFG
Sbjct: 101 QDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFG 159

Query: 115 VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 174
             A   ++     T   T  Y++PE +   KY    D+WSLG+++     G  P+     
Sbjct: 160 F-AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218

Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                     +  +     P+    + S E    I   ++ EP QR++  E M HP++ 
Sbjct: 219 LAISPGMKTRIR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 4e-53
 Identities = 62/235 (26%), Positives = 114/235 (48%), Gaps = 15/235 (6%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           ++ + +        E ++ Q+++ P++     +F ++  +  ++EY +GG L   L + +
Sbjct: 41  EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER 100

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
              EE       +++  L Y  H + +++RD+K  NL+++  G +KITDFG+     S  
Sbjct: 101 VFTEERARFYGAEIVSALEY-LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159

Query: 124 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
               TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +        
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------R 212

Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 233
           L E I+ +          SPE  S ++  ++K+P+QRL      A+E+M H F  
Sbjct: 213 LFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 5e-53
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 18/241 (7%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-K 60
           V++   E++   ++ +E +I      PY+V       +   + +++E   GG L  FL  
Sbjct: 43  VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVG 101

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           K + IP   +A +  QV  G+ YL   K+ +HRDL   N+L+ +R   KI+DFG+S  + 
Sbjct: 102 KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160

Query: 121 STSGQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD 176
           +                + +PE I+  K+  +SD+WS G+ + E  + GQ PY       
Sbjct: 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK------ 214

Query: 177 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL---MTHPFLK 233
                 E+M  I        P +   PE  + +S C   + + R     +   M   +  
Sbjct: 215 -KMKGPEVMAFIEQGKRMECPPE-CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

Query: 234 M 234
           +
Sbjct: 273 L 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-52
 Identities = 46/234 (19%), Positives = 98/234 (41%), Gaps = 17/234 (7%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 67
           + + + ++  E  + Q    PY+V          +  +++E  + G L  +L++ + + +
Sbjct: 48  DPALKDELLAEANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKD 106

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
           + +  +  QV  G+ YL    + +HRDL   N+L+  +   KI+DFG+S  + +      
Sbjct: 107 KNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165

Query: 128 T---FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE 183
                     + +PE I+  K+  KSD+WS G+++ E  + GQ PY   +         E
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------E 218

Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT---HPFLKM 234
           +   +        P+     E    ++ C   + + R     +     + +  +
Sbjct: 219 VTAMLEKGERMGCPAG-CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-52
 Identities = 60/237 (25%), Positives = 117/237 (49%), Gaps = 15/237 (6%)

Query: 3   IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
            + +    +R  I +E+ I +  Q P V+  ++ + +   + +ILE + GG L DFL + 
Sbjct: 48  TKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK 107

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAI 118
           +++ EE      +Q+L G+ Y  H   I H DLKP N+++  R      +KI DFG++  
Sbjct: 108 ESLTEEEATEFLKQILNGVYY-LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166

Query: 119 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
           +   + +     GT  +++PE ++    G ++D+WS+G++     +G  P+    +Q   
Sbjct: 167 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--- 222

Query: 179 TSFYELMEAI--VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
               E +  +  V+           S     FI   + K+P++R++ Q+ + HP++K
Sbjct: 223 ----ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (428), Expect = 3e-52
 Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 17/237 (7%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVK 63
           + S   +  +E +   +   P +V  Y +  +         I++EY+DG +L D +    
Sbjct: 47  DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG 106

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--- 120
            +  +    +     + L + H +  IIHRD+KP+N++I+    VK+ DFG++  +A   
Sbjct: 107 PMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165

Query: 121 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 180
           ++  Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++         S
Sbjct: 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-------GDS 218

Query: 181 FYELMEAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 235
              +    V  D  PPSA  +  S +  + +   + K P+ R      M    ++++
Sbjct: 219 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 8e-52
 Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 12/229 (5%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KV 62
            +     +  +  +E K+  +     +V  Y        I II EYM  G L ++L+   
Sbjct: 35  MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 94

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
                + L  +C+ V + + YL   K  +HRDL   N L+N +G VK++DFG+S  +   
Sbjct: 95  HRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153

Query: 123 SGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 180
              ++        +  PE +   K+  KSDIW+ G+++ E  + G+ PY      + +T+
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------ERFTN 207

Query: 181 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
             E  E I        P    S +  + + +C  ++  +R + + L+++
Sbjct: 208 -SETAEHIAQGLRLYRPHL-ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-51
 Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 14/236 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           V  +     +      E  + +  Q   +V  Y +  +   I II EYM+ GSL DFLK 
Sbjct: 42  VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKT 100

Query: 62  VKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
              I      L  +  Q+ +G+ ++  E++ IHRDL+ +N+L++     KI DFG++ ++
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159

Query: 120 ASTSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
                 A         + +PE I+ G +  KSD+WS G++L E  T      P       
Sbjct: 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----- 214

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL--MTHPFL 232
            +  E+++ +        P D    E    +  C ++ P+ R +   L  +   F 
Sbjct: 215 -TNPEVIQNLERGYRMVRP-DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 8e-51
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 23/236 (9%)

Query: 3   IQMNVEESARRQIAQELKINQ--SSQCPYVVVCYQSFYSNGAISIILEYMDGGS-LADFL 59
           I    E     ++  E+ + +  SS    V+     F    +  +ILE  +    L DF+
Sbjct: 42  ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 101

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAI 118
            +   + EE   +   QVL+ + + H    ++HRD+K  N+LI+ +RGE+K+ DFG  A+
Sbjct: 102 TERGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160

Query: 119 MASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
           +  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   E    
Sbjct: 161 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 214

Query: 178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                E++   V          + S E    I  C+   P  R + +E+  HP+++
Sbjct: 215 -----EIIRGQVFFRQ------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  166 bits (421), Expect = 1e-50
 Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 18/235 (7%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           ++ V          E  +      P+++  + +F     I +I++Y++GG L   L+K +
Sbjct: 40  EIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ 99

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
             P         +V   L YLH  K II+RDLKP N+L++  G +KITDFG +  +   +
Sbjct: 100 RFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158

Query: 124 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
               T  GT +Y++PE +S   Y    D WS G+++ E   G  P+             +
Sbjct: 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------K 208

Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
             E I++          F+ +    +S  + ++  QRL       +++  HP+ K
Sbjct: 209 TYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-50
 Identities = 54/252 (21%), Positives = 98/252 (38%), Gaps = 21/252 (8%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           +   ++   R   +E+K+ Q    P ++    +F     IS++ ++M+            
Sbjct: 36  RSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL 95

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            +   ++ A     L+GL YLH +  I+HRDLKP+NLL++  G +K+ DFG++    S +
Sbjct: 96  VLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154

Query: 124 GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQD------ 176
                 V T  Y +PE + G + YG   D+W++G +L E              D      
Sbjct: 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214

Query: 177 ---------GWTSFYELMEAIVDQPPPSAPSDQF----SPEFCSFISACVQKEPQQRLSA 223
                     W     L + +  +  P  P          +    I       P  R++A
Sbjct: 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274

Query: 224 QELMTHPFLKMY 235
            + +   +    
Sbjct: 275 TQALKMKYFSNR 286

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-50
 Identities = 51/228 (22%), Positives = 92/228 (40%), Gaps = 10/228 (4%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKV 62
            +     +     +E ++      P +V  Y        I ++ E+M+ G L+D+   + 
Sbjct: 36  TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 95

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS- 121
                E L  +C  V +G+ YL  E  +IHRDL   N L+     +K++DFG++  +   
Sbjct: 96  GLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
               +        + SPE  S  +Y  KSD+WS G+++ E  +               S 
Sbjct: 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP------YENRSN 208

Query: 182 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            E++E I        P    S      ++ C ++ P+ R +   L+  
Sbjct: 209 SEVVEDISTGFRLYKPRL-ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-50
 Identities = 52/237 (21%), Positives = 98/237 (41%), Gaps = 14/237 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF--L 59
           +  +     +     QE ++ +  +   +V  Y +  S   I I+ EYM  GSL DF   
Sbjct: 46  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKG 104

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
           +  K +    L  +  Q+  G+ Y+    + +HRDL+ +N+L+      K+ DFG++ ++
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLI 163

Query: 120 ASTSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
                 A         + +PE    G++  KSD+WS G++L E  T      P       
Sbjct: 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----- 218

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL--MTHPFLK 233
               E+++ +        P +         +  C +KEP++R + + L      +  
Sbjct: 219 -VNREVLDQVERGYRMPCPPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (416), Expect = 4e-50
 Identities = 54/235 (22%), Positives = 90/235 (38%), Gaps = 16/235 (6%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LK 60
            ++    E  RR    E  I      P V+        +  + II E+M+ GSL  F  +
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
                    L  +   +  G+ YL    + +HRDL   N+L+N     K++DFG+S  + 
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 121 STSGQANT-----FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 174
             +                + +PE I   K+   SD+WS G+V+ E  + G+ PY     
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239

Query: 175 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
           Q       +++ AI        P D         +  C QK+   R    +++  
Sbjct: 240 Q-------DVINAIEQDYRLPPPMD-CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-49
 Identities = 59/255 (23%), Positives = 98/255 (38%), Gaps = 35/255 (13%)

Query: 2   VIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           +++   + S R  +  ELK+  Q      +V    +   +G I +I EY   G L ++L+
Sbjct: 74  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 61  K-----------------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
                                   +  +  E L     QV KG+ +L   K  +HRDL  
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAA 192

Query: 98  SNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSL 155
            N+L+ H   VKI DFG++  + S S             +M+PE +  G Y  KSD+WS 
Sbjct: 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252

Query: 156 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 214
           G++L E  + G  PY                  ++            + E    + +C  
Sbjct: 253 GILLWEIFSLGVNPYPGIPVD-------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA 305

Query: 215 KEPQQRLSAQELMTH 229
            + ++R S   L + 
Sbjct: 306 FDSRKRPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-48
 Identities = 61/269 (22%), Positives = 105/269 (39%), Gaps = 29/269 (10%)

Query: 2   VIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
            ++    +   R  A EL++  +    P ++    +    G + + +EY   G+L DFL+
Sbjct: 44  RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 103

Query: 61  K----------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
           K                  T+  + L      V +G+ YL  +K  IHRDL   N+L+  
Sbjct: 104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGE 162

Query: 105 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 164
               KI DFG+S        +         +M+ E ++   Y   SD+WS G++L E  +
Sbjct: 163 NYVAKIADFGLSRGQ-EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221

Query: 165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 224
                          +  EL E +        P +    E    +  C +++P +R S  
Sbjct: 222 LGGTPYCGM------TCAELYEKLPQGYRLEKPLN-CDDEVYDLMRQCWREKPYERPSFA 274

Query: 225 ELMTH--PFLKMYGD-LNVDLSEYFTDAG 250
           +++      L+     +N  L E FT AG
Sbjct: 275 QILVSLNRMLEERKTYVNTTLYEKFTYAG 303

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 1e-48
 Identities = 52/252 (20%), Positives = 87/252 (34%), Gaps = 34/252 (13%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
           +++       +    +E  +      P +V           + ++ EYM  G L +FL+ 
Sbjct: 50  MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 109

Query: 62  V------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 97
           +                          +       I  QV  G+ YL   K  +HRDL  
Sbjct: 110 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLAT 168

Query: 98  SNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSL 155
            N L+     VKI DFG+S  + S               +M PE I   +Y  +SD+W+ 
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228

Query: 156 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 215
           G+VL E  +           +      E++  + D    + P +    E  + +  C  K
Sbjct: 229 GVVLWEIFSYGLQPYYGMAHE------EVIYYVRDGNILACP-ENCPLELYNLMRLCWSK 281

Query: 216 EPQQRLSAQELM 227
            P  R S   + 
Sbjct: 282 LPADRPSFCSIH 293

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-48
 Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 12/231 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            ++      A ++I  E  +  S   P+V        ++    I      G  L    + 
Sbjct: 45  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH 104

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              I  +YL   C Q+ KG+ YL   + ++HRDL   N+L+     VKITDFG++ ++ +
Sbjct: 105 KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163

Query: 122 TSGQANT--FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 178
              + +         +M+ E I    Y ++SD+WS G+ + E  T G  PY      DG 
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGI 217

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
            +  E+   +        P    + +    +  C   +   R   +EL+  
Sbjct: 218 PA-SEISSILEKGERLPQPPI-CTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-48
 Identities = 54/230 (23%), Positives = 89/230 (38%), Gaps = 12/230 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LK 60
            ++    E  R     E  I        ++           + II EYM+ G+L  F  +
Sbjct: 43  TLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE 102

Query: 61  KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 120
           K        L  +   +  G+ Y     + +HRDL   N+L+N     K++DFG+S ++ 
Sbjct: 103 KDGEFSVLQLVGMLRGIAAGMKY-LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161

Query: 121 STSGQANTF---VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 177
                  T         + +PE IS  K+   SD+WS G+V+ E  T             
Sbjct: 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP------YW 215

Query: 178 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
             S +E+M+AI D      P D         +  C Q+E  +R    +++
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMD-CPSAIYQLMMQCWQQERARRPKFADIV 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  157 bits (399), Expect = 1e-47
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 11/229 (4%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-- 59
           V  +  +     +  +E  + +  + P +V             II E+M  G+L D+L  
Sbjct: 47  VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
              + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S +M
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165

Query: 120 ASTSGQANTFV-GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
              +  A+        + +PE ++  K+  KSD+W+ G++L E AT      P       
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-- 223

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
               ++ E +        P      +    + AC Q  P  R S  E+ 
Sbjct: 224 ----QVYELLEKDYRMERPEG-CPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 2e-47
 Identities = 53/252 (21%), Positives = 99/252 (39%), Gaps = 27/252 (10%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLK 60
            +  S  R++A  L+  ++ + P VV  +             ++++ E++D        K
Sbjct: 49  GMPLSTIREVA-VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 107

Query: 61  -KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
                +P E +  +  Q+L+GL +LH    ++HRDLKP N+L+   G++K+ DFG++ I 
Sbjct: 108 VPEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166

Query: 120 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS--------- 170
            S      + V T  Y +PE +    Y    D+WS+G +  E    +  +          
Sbjct: 167 -SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225

Query: 171 ---------PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 221
                      E      +            P               +  C+   P +R+
Sbjct: 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285

Query: 222 SAQELMTHPFLK 233
           SA   ++HP+ +
Sbjct: 286 SAYSALSHPYFQ 297

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  156 bits (394), Expect = 5e-47
 Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 22/249 (8%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
             +E       +E+ I +  +   +V  Y   ++   + ++ E++D             +
Sbjct: 38  KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL 97

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
                 +   Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+KI DFG++        +
Sbjct: 98  ESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156

Query: 126 ANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD-------- 176
               + T  Y +P+ + G  KY    DIWS+G +  E   G   +    + D        
Sbjct: 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

Query: 177 -------GWTSFYELMEAIVDQP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 224
                   W +  EL +   +       P  +            +S  ++ +P QR++A+
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

Query: 225 ELMTHPFLK 233
           + + H + K
Sbjct: 277 QALEHAYFK 285

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 5e-47
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 15/239 (6%)

Query: 4   QMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV 62
            +  +         E ++     Q P++V  + +F +   + +IL+Y++GG L   L + 
Sbjct: 64  TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           +   E  +     +++  L +  H+  II+RD+K  N+L++  G V +TDFG+S    + 
Sbjct: 124 ERFTEHEVQIYVGEIVLALEH-LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182

Query: 123 SGQ-ANTFVGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWT 179
             + A  F GT  YM+P+ + GG  G+    D WSLG+++ E  TG  P++   +++   
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--- 239

Query: 180 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 233
           S  E+   I+   PP     + S      I   + K+P++RL      A E+  H F +
Sbjct: 240 SQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 5e-47
 Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 11/231 (4%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL- 59
              +    +S R +  QE    +    P++V       +   + II+E    G L  FL 
Sbjct: 41  KTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQ 99

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
            +  ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M
Sbjct: 100 VRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158

Query: 120 -ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 178
             ST  +A+       +M+PE I+  ++   SD+W  G+ + E                 
Sbjct: 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ------G 212

Query: 179 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
               +++  I +      P +   P   S ++ C   +P +R    EL   
Sbjct: 213 VKNNDVIGRIENGERLPMPPN-CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 9e-47
 Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 14/225 (6%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIP 66
           +  A     +E+    S     ++  Y        + ++ E    GSL D L K      
Sbjct: 51  QPEAMDDFIREVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL 109

Query: 67  EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ- 125
              L+    QV +G+ YL   K  IHRDL   NLL+  R  VKI DFG+   +       
Sbjct: 110 LGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168

Query: 126 --ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 182
                    + + +PE +    + + SD W  G+ L E  T GQ P+          +  
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGS 221

Query: 183 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 227
           +++  I  +       +    +  + +  C   +P+ R +   L 
Sbjct: 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-46
 Identities = 53/247 (21%), Positives = 98/247 (39%), Gaps = 28/247 (11%)

Query: 2   VIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           +++ +   + R  +  ELK+ +       +V    +    G   +I EY   G L +FL+
Sbjct: 60  MLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119

Query: 61  KVK------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 102
           + +                   +  E L +   QV KG+ +L   K+ IHRDL   N+L+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILL 178

Query: 103 NHRGEVKITDFGVSAIMASTSGQANT--FVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 160
            H    KI DFG++  + + S             +M+PE I    Y ++SD+WS G+ L 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

Query: 161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 220
           E  +      P    D           ++ +       +    E    +  C   +P +R
Sbjct: 239 ELFSLGSSPYPGMPVD------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 221 LSAQELM 227
            + ++++
Sbjct: 293 PTFKQIV 299

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 8e-46
 Identities = 55/269 (20%), Positives = 98/269 (36%), Gaps = 37/269 (13%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--------NGAISIILEYMDG 52
            V+  N +E       +E+KI Q  +   VV   +   +         G+I ++ ++ + 
Sbjct: 42  KVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 101

Query: 53  GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 112
                    +       +  + + +L GL Y+H    I+HRD+K +N+LI   G +K+ D
Sbjct: 102 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDGVLKLAD 160

Query: 113 FGVSAIM----ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQF 167
           FG++        S   +    V T  Y  PE + G + YG   D+W  G ++ E  T   
Sbjct: 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

Query: 168 PY-----------------SPPEQQDGWTSFYELMEAIV------DQPPPSAPSDQFSPE 204
                              S   +       YEL E +        +      +    P 
Sbjct: 221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 280

Query: 205 FCSFISACVQKEPQQRLSAQELMTHPFLK 233
               I   +  +P QR+ + + + H F  
Sbjct: 281 ALDLIDKLLVLDPAQRIDSDDALNHDFFW 309

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 1e-45
 Identities = 58/254 (22%), Positives = 108/254 (42%), Gaps = 23/254 (9%)

Query: 6   NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 65
           + +E       +E+ + +  +   +V  +   +S+  ++++ E+ D      F      +
Sbjct: 39  DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL 98

Query: 66  PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 125
             E + +   Q+LKGL + H  ++++HRDLKP NLLIN  GE+K+ +FG++         
Sbjct: 99  DPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

Query: 126 ANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPE----------- 173
            +  V T  Y  P+ + G K Y    D+WS G +  E A    P  P             
Sbjct: 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217

Query: 174 -----QQDGWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSA 223
                 ++ W S  +L +       P+  S      + +      +   ++  P QR+SA
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

Query: 224 QELMTHPFLKMYGD 237
           +E + HP+   +  
Sbjct: 278 EEALQHPYFSDFCP 291

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (386), Expect = 1e-45
 Identities = 46/249 (18%), Positives = 93/249 (37%), Gaps = 16/249 (6%)

Query: 1   MVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFL 59
           + I++   ++   Q+  E KI +  Q    +   +   + G    +++E +       F 
Sbjct: 35  VAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN 94

Query: 60  KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVS 116
              +    + +  + +Q++  + Y+H  K+ IHRD+KP N L+        V I DFG++
Sbjct: 95  FCSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153

Query: 117 AIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
                          +     GT  Y S     G +   + D+ SLG VL+    G  P+
Sbjct: 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213

Query: 170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ---EL 226
              +       +  + E  +  P        +  EF ++++ C       +       +L
Sbjct: 214 QGLKAATKRQKYERISEKKMSTPIEVLCKG-YPSEFATYLNFCRSLRFDDKPDYSYLRQL 272

Query: 227 MTHPFLKMY 235
             + F +  
Sbjct: 273 FRNLFHRQG 281

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-45
 Identities = 54/260 (20%), Positives = 94/260 (36%), Gaps = 37/260 (14%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
           +     E S  R+   E+      +   ++       +   +   + ++ +Y + GSL D
Sbjct: 33  IFSSREERSWFREA--EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 90

Query: 58  FLKKVKTIPEEYLAAICEQVLKGLLYLH-------HEKHIIHRDLKPSNLLINHRGEVKI 110
           +L +  T+  E +  +      GL +LH        +  I HRDLK  N+L+   G   I
Sbjct: 91  YLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149

Query: 111 TDFGVSAIMAS----TSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLL 160
            D G++    S         N  VGT  YM+PE +         +   ++DI+++GLV  
Sbjct: 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209

Query: 161 ECATGQFPYSPPEQQD--------GWTSFYELMEAIVDQ-----PPPSAPSDQFSPEFCS 207
           E A         E              S  E+ + + +Q      P    S +       
Sbjct: 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 269

Query: 208 FISACVQKEPQQRLSAQELM 227
            +  C       RL+A  + 
Sbjct: 270 IMRECWYANGAARLTALRIK 289

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  153 bits (387), Expect = 3e-45
 Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 18/235 (7%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
           Q  V+         E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++ 
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
              E +      Q++    YLH    +I+RDLKP NLLI+ +G +++TDFG +  +    
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---K 192

Query: 124 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 183
           G+  T  GT   ++PE I    Y    D W+LG+++ E A G  P+   +         +
Sbjct: 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------Q 245

Query: 184 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 233
           + E IV           FS +    +   +Q +  +R         ++  H +  
Sbjct: 246 IYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-45
 Identities = 52/245 (21%), Positives = 102/245 (41%), Gaps = 27/245 (11%)

Query: 2   VIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 60
           +++ +  E     +  E+++     +   ++    +   +G + +I+EY   G+L ++L+
Sbjct: 52  MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ 111

Query: 61  ----------------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 104
                             + +  + L +   QV +G+ YL   K  IHRDL   N+L+  
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTE 170

Query: 105 RGEVKITDFGVSAIMASTSGQANTFV--GTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 162
              +KI DFG++  +        T        +M+PE +    Y ++SD+WS G++L E 
Sbjct: 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

Query: 163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 222
            T      P           EL + + +      PS+  + E    +  C    P QR +
Sbjct: 231 FTLGGSPYP------GVPVEELFKLLKEGHRMDKPSN-CTNELYMMMRDCWHAVPSQRPT 283

Query: 223 AQELM 227
            ++L+
Sbjct: 284 FKQLV 288

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-45
 Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 23/247 (9%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPE 67
           E       +E+ + +    P +V      ++   + ++ E++             T IP 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 101

Query: 68  EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 127
             + +   Q+L+GL + H    ++HRDLKP NLLIN  G +K+ DFG++           
Sbjct: 102 PLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160

Query: 128 TFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQD---------- 176
             V T  Y +PE + G KY     DIWSLG +  E  T +  +    + D          
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

Query: 177 -----GWTSFYELMEAIVDQP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 226
                 W     + +     P       S        +  S +S  +  +P +R+SA+  
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

Query: 227 MTHPFLK 233
           + HPF +
Sbjct: 281 LAHPFFQ 287

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-45
 Identities = 54/266 (20%), Positives = 109/266 (40%), Gaps = 32/266 (12%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 57
            I     ++  ++  +E+KI    +   ++    +             ++ ++ G  L  
Sbjct: 40  KISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK 99

Query: 58  FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 117
            LK  + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ 
Sbjct: 100 LLKT-QHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157

Query: 118 IMASTSGQ---ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPY---- 169
           +             +V T  Y +PE +     Y    DIWS+G +L E  + +  +    
Sbjct: 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217

Query: 170 -------------SPPEQQDGWTSFYELMEAIVDQP-----PPSAPSDQFSPEFCSFISA 211
                        SP ++        +    ++  P     P +        +    +  
Sbjct: 218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277

Query: 212 CVQKEPQQRLSAQELMTHPFLKMYGD 237
            +   P +R+  ++ + HP+L+ Y D
Sbjct: 278 MLTFNPHKRIEVEQALAHPYLEQYYD 303

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-44
 Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 27/248 (10%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFL 59
           +++     S  R +  ELKI         VV          G + +I+E+   G+L+ +L
Sbjct: 50  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 109

Query: 60  KKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 103
           +  +                 +  E+L     QV KG+ +L   +  IHRDL   N+L++
Sbjct: 110 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLS 168

Query: 104 HRGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 161
            +  VKI DFG++  +       +         +M+PE I    Y  +SD+WS G++L E
Sbjct: 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228

Query: 162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 221
             +      P  + D           + +     AP D  +PE    +  C   EP QR 
Sbjct: 229 IFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRP 282

Query: 222 SAQELMTH 229
           +  EL+ H
Sbjct: 283 TFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-44
 Identities = 51/265 (19%), Positives = 99/265 (37%), Gaps = 33/265 (12%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
            +        R +   E  + +   C +VV             +I+E M  G L  +L+ 
Sbjct: 57  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 116

Query: 62  VK----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 111
           ++                +  +  ++  G+ YL+     +HRDL   N ++     VKI 
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIG 175

Query: 112 DFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           DFG++  +       +    +    +MSPE +  G +   SD+WS G+VL E AT     
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235

Query: 170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT- 228
                 +      +++  +++      P D         +  C Q  P+ R S  E+++ 
Sbjct: 236 YQGLSNE------QVLRFVMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

Query: 229 -----HPFLKMYGDLNVDLSEYFTD 248
                 P  +       ++S Y+++
Sbjct: 289 IKEEMEPGFR-------EVSFYYSE 306

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-43
 Identities = 62/279 (22%), Positives = 100/279 (35%), Gaps = 36/279 (12%)

Query: 12  RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGGSLA---DFLKKV 62
           +R   +EL+I +      +V     FYS+G       ++++L+Y+          + +  
Sbjct: 57  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMAS 121
           +T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++    V K+ DFG +  +  
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 181
                +     Y            Y    D+WS G VL E   GQ  +      D     
Sbjct: 176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235

Query: 182 YELMEA--------------------IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 221
            +++                      I   P       +  PE  +  S  ++  P  RL
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295

Query: 222 SAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 260
           +  E   H F     D NV L       G     L N +
Sbjct: 296 TPLEACAHSFFDELRDPNVKLPN-----GRDTPALFNFT 329

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-43
 Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 14/234 (5%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFLK 60
            +    +     Q   E  I +    P V+        S G+  ++L YM  G L +F++
Sbjct: 62  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121

Query: 61  KVKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 119
                P    L     QV KG+      K  +HRDL   N +++ +  VK+ DFG++  M
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM-KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 120 ASTSGQANTF----VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 175
                 +            +M+ E +   K+  KSD+WS G++L E  T   P  P    
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-- 238

Query: 176 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
               + +++   ++       P           +  C   + + R S  EL++ 
Sbjct: 239 ----NTFDITVYLLQGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (360), Expect = 7e-42
 Identities = 44/257 (17%), Positives = 83/257 (32%), Gaps = 17/257 (6%)

Query: 2   VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK 61
                 +    R   +  K+   + C  +   Y          ++++ +           
Sbjct: 37  FEPRRSDAPQLRDEYRTYKL--LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-----HRGEVKITDFGVS 116
            +    + +A   +Q+L  +  +H EK +++RD+KP N LI      +   + + DFG+ 
Sbjct: 95  GRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153

Query: 117 AIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
                          +     GT  YMS     G +   + D+ +LG V +    G  P+
Sbjct: 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213

Query: 170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 229
              +       +  + E     P     +  F  EF  ++                L   
Sbjct: 214 QGLKAATNKQKYERIGEKKQSTPLRELCAG-FPEEFYKYMHYARNLAFDATPDYDYLQ-G 271

Query: 230 PFLKMYGDLNVDLSEYF 246
            F K+   LN    E F
Sbjct: 272 LFSKVLERLNTTEDENF 288

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  138 bits (349), Expect = 7e-40
 Identities = 50/261 (19%), Positives = 106/261 (40%), Gaps = 39/261 (14%)

Query: 7   VEESARRQIAQELKINQS-SQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVK 63
           ++   +++I +E+KI ++    P ++          +   +++ E+++        +   
Sbjct: 68  LKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-- 125

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMAST 122
            + +  +     ++LK L Y H    I+HRD+KP N++I+H   ++++ D+G++      
Sbjct: 126 -LTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183

Query: 123 SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSP---------- 171
             + N  V +  +  PE +   + Y Y  D+WSLG +L      + P+            
Sbjct: 184 Q-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242

Query: 172 ------PEQQDGWTSFYELMEAI-------------VDQPPPSAPSDQFSPEFCSFISAC 212
                  E    +   Y +                  ++   S      SPE   F+   
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302

Query: 213 VQKEPQQRLSAQELMTHPFLK 233
           ++ + Q RL+A+E M HP+  
Sbjct: 303 LRYDHQSRLTAREAMEHPYFY 323

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-39
 Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 35/258 (13%)

Query: 9   ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS------IILEYMDGGSLADFLKKV 62
           E   ++  +EL++ +  +   V+     F  +  +       +++ +M  G+    L K 
Sbjct: 58  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH 115

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           + + E+ +  +  Q+LKGL Y+H    IIHRDLKP NL +N   E+KI DFG++      
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QA 171

Query: 123 SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPY------------ 169
             +   +V T  Y +PE I    +Y    DIWS+G ++ E  TG+  +            
Sbjct: 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231

Query: 170 -----SPPEQQDGWTSFYELMEAIVDQP-----PPSAPSDQFSPEFCSFISACVQKEPQQ 219
                +PP +        E    +   P       ++     SP   + +   +  + +Q
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291

Query: 220 RLSAQELMTHPFLKMYGD 237
           R++A E + HP+ +   D
Sbjct: 292 RVTAGEALAHPYFESLHD 309

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 4e-38
 Identities = 53/269 (19%), Positives = 104/269 (38%), Gaps = 44/269 (16%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGGSLADFLKK 61
            ++  ++  +EL + +      ++     F           + +++E MD         +
Sbjct: 56  NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 115

Query: 62  VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 121
              +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++     +KI DFG++     
Sbjct: 116 ---LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-G 170

Query: 122 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY------------ 169
           TS     +V T  Y +PE I G  Y    DIWS+G ++ E    +  +            
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

Query: 170 -------SPPEQQDGWTSFYELMEAIVDQPPPSAPS--------------DQFSPEFCSF 208
                   P   +    +    +E        + P                  + +    
Sbjct: 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290

Query: 209 ISACVQKEPQQRLSAQELMTHPFLKMYGD 237
           +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 291 LSKMLVIDPAKRISVDDALQHPYINVWYD 319

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 1e-34
 Identities = 54/260 (20%), Positives = 107/260 (41%), Gaps = 33/260 (12%)

Query: 8   EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS-----IILEYMDGGSLADFLKKV 62
                ++  +EL++ +  +   V+     F    ++       ++ ++ G  L + +K  
Sbjct: 57  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC- 115

Query: 63  KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 122
           + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N   E+KI DFG++      
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHT--- 171

Query: 123 SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPY------------ 169
             +   +V T  Y +PE +     Y    DIWS+G ++ E  TG+  +            
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

Query: 170 -----SPPEQQDGWTSFYELMEAIVDQP-----PPSAPSDQFSPEFCSFISACVQKEPQQ 219
                +P  +     S       I           +      +P     +   +  +  +
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291

Query: 220 RLSAQELMTHPFLKMYGDLN 239
           R++A + + H +   Y D +
Sbjct: 292 RITAAQALAHAYFAQYHDPD 311

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (294), Expect = 1e-31
 Identities = 65/283 (22%), Positives = 107/283 (37%), Gaps = 60/283 (21%)

Query: 8   EESARRQIAQELKINQ-------SSQCPYVVVCYQSFY---SNGAISIILEYMDGGSLAD 57
            E+A  +I    ++N        S    +++     F     NG   +++  + G +L  
Sbjct: 53  TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA 112

Query: 58  FLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG------EVK 109
            +KK +   IP  Y+  I +Q+L GL Y+H    IIH D+KP N+L+          ++K
Sbjct: 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172

Query: 110 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 169
           I D G +             + T  Y SPE + G  +G  +DIWS   ++ E  TG F +
Sbjct: 173 IADLGNAC---WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229

Query: 170 SPPEQQDGWTSFYELMEAIVDQPPPSAP-------------------------------- 197
            P E          + + I       +                                 
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289

Query: 198 -------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 233
                  S   + E   F+S  +Q +P++R  A  L+ HP+LK
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.4 bits (174), Expect = 8e-16
 Identities = 29/161 (18%), Positives = 58/161 (36%), Gaps = 22/161 (13%)

Query: 4   QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 63
            ++    A R    E +  Q  Q   V   Y    +    ++++E +D         ++ 
Sbjct: 50  DLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELY 98

Query: 64  TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 123
            +  E    + + +L+ +   +H + I+H DL   N+L++  G + I DF  S  +    
Sbjct: 99  RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEG 156

Query: 124 GQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLE 161
            +               I       Y  + DI S    +L+
Sbjct: 157 WR------EILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	262
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.69
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.03
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.59
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.1
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.28
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.21
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	93.89

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=349.97  Aligned_cols=220  Identities=32%  Similarity=0.607  Sum_probs=190.9

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..++.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+ +.+++..+..++.|++.||+|||+ .|
T Consensus        59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~-~~  136 (293)
T d1yhwa1          59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQ  136 (293)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            3467899999999999999999999999999999999999999999998876 579999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++||||||+||+++.++.++|+|||++..............||+.|+|||++.+..++.++||||+||++|+|++|+.||
T Consensus       137 iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf  216 (293)
T d1yhwa1         137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY  216 (293)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCC
Confidence            99999999999999999999999999987765555556678999999999999988999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .+....+      ...............+..+++++++||.+||+.||++|||++|+++||||+....
T Consensus       217 ~~~~~~~------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         217 LNENPLR------ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             TTSCHHH------HHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             CCCCHHH------HHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence            7654321      1222222233323334578999999999999999999999999999999986543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=345.21  Aligned_cols=214  Identities=30%  Similarity=0.496  Sum_probs=189.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~-~~  126 (263)
T d2j4za1          48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KR  126 (263)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34667899999999999999999999999999999999999999999999998999999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||||+||+++.++.++|+|||++......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       127 ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf  204 (263)
T d2j4za1         127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF  204 (263)
T ss_dssp             CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             eeeeeeccccceecCCCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCC
Confidence            999999999999999999999999999765432  334567999999999999988999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      ...+.       .+....+......  .+..+++++.+|+.+||+.||++|||++|+++||||++.
T Consensus       205 ~~~~~-------~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         205 EANTY-------QETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             CCSSH-------HHHHHHHHTTCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             CCCCH-------HHHHHHHHcCCCC--CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            76443       2334444444332  235689999999999999999999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-55  Score=347.18  Aligned_cols=220  Identities=25%  Similarity=0.450  Sum_probs=186.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      .+..+++.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        44 ~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~-~  122 (271)
T d1nvra_          44 VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I  122 (271)
T ss_dssp             -----CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-c
Confidence            445678999999999999999999999999999999999999999999999888899999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g  165 (262)
                      |++||||||+||+++.++.++|+|||+|.......  .......||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       123 ~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G  202 (271)
T d1nvra_         123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  202 (271)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence            99999999999999999999999999998654332  23345679999999999988775 5789999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      +.||.......      ..................+++++.+|+.+||+.||++|||++|+++||||++.
T Consensus       203 ~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         203 ELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             SCSCSSSSTTS------HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CCCCCCCChHH------HHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            99997654432      12222333333333445789999999999999999999999999999999753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-54  Score=342.10  Aligned_cols=216  Identities=31%  Similarity=0.597  Sum_probs=187.6

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ++..++++.+|++++++++||||+++++++.+    +..+|+||||++|++|.+++.+.+.+++..+..++.|++.||+|
T Consensus        48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y  127 (270)
T d1t4ha_          48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  127 (270)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence            56667889999999999999999999999875    35689999999999999999998999999999999999999999


Q ss_pred             HhhcCC--eeeCCCCCCCEEEc-cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           84 LHHEKH--IIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        84 lh~~~~--i~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      ||+ .|  ++||||||+||+++ .++.++|+|||++.....  .......||+.|+|||++.+ .++.++||||+||++|
T Consensus       128 LH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvily  203 (270)
T d1t4ha_         128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML  203 (270)
T ss_dssp             HHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred             HHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHH
Confidence            998 88  99999999999996 478999999999975332  23345689999999999875 5899999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      +|++|+.||.....      .......+..+..+.......++++.+||.+||+.||++|||++|+++||||+
T Consensus       204 el~~g~~Pf~~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         204 EMATSEYPYSECQN------AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHCCCCCCCccc------HHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999975432      22444555566555555567889999999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-55  Score=356.47  Aligned_cols=238  Identities=45%  Similarity=0.836  Sum_probs=200.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ++..++++.+|+++|++++||||++++++|.+++..|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||+.
T Consensus        44 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~  123 (322)
T d1s9ja_          44 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  123 (322)
T ss_dssp             CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            45667889999999999999999999999999999999999999999999999989999999999999999999999962


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~  167 (262)
                      .||+||||||+|||++.++.++|+|||+|......  .....+||+.|+|||++.+..++.++||||+||++|+|++|+.
T Consensus       124 ~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~  201 (322)
T d1s9ja_         124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY  201 (322)
T ss_dssp             HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            48999999999999999999999999999865432  2335689999999999999999999999999999999999999


Q ss_pred             CCCCCCccCc-----------------------------------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 024828          168 PYSPPEQQDG-----------------------------------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  212 (262)
Q Consensus       168 p~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  212 (262)
                      ||.+.+..+.                                   .....+..........+..+...+++++.+||.+|
T Consensus       202 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~  281 (322)
T d1s9ja_         202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC  281 (322)
T ss_dssp             CSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHH
Confidence            9976543210                                   01122233344444445555556789999999999


Q ss_pred             hcCCcCCCCCHHHHhcCccccccCCcccchhhHhh
Q 024828          213 VQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  247 (262)
Q Consensus       213 l~~~p~~Rpt~~~~l~h~~~~~~~~~~~~~~~~~~  247 (262)
                      |+.||++|||++|+|+||||+........+...+.
T Consensus       282 L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d~~~~~~  316 (322)
T d1s9ja_         282 LIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLC  316 (322)
T ss_dssp             TCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHHH
T ss_pred             cCCChhHCcCHHHHhhCHhhCcCCcccccHHHHHH
Confidence            99999999999999999999988777666655544

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=345.36  Aligned_cols=221  Identities=31%  Similarity=0.608  Sum_probs=187.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +....+++.+|++++++++||||+++++++.+++..++||||++|++|.+++.+. +++++..+..++.|++.||.|||+
T Consensus        49 ~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~  128 (288)
T d2jfla1          49 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD  128 (288)
T ss_dssp             SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3445678899999999999999999999999999999999999999999997654 579999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCccccc-----CCCCCcchhHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~Di~slG~~l~~  161 (262)
                       .|++|+||||+||+++.++.++|+|||+|..............|++.|+|||++.     +..++.++||||+||++|+
T Consensus       129 -~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye  207 (288)
T d2jfla1         129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE  207 (288)
T ss_dssp             -TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred             -CCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence             9999999999999999999999999999876544333344567999999999984     3457899999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      |++|+.||.+....+       ....+..... ....+..+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       208 mltg~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         208 MAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             HHHSSCTTTTSCGGG-------HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             HhhCCCCCCCCCHHH-------HHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999998765432       2223333332 2223357899999999999999999999999999999998543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=338.60  Aligned_cols=217  Identities=30%  Similarity=0.536  Sum_probs=176.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~l~~~   80 (262)
                      .++...+.+.+|++++++++||||+++++++.+  ++.+|+||||++||+|.+++.+    .+.+++..++.++.|++.|
T Consensus        42 ~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~a  121 (269)
T d2java1          42 MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA  121 (269)
T ss_dssp             SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHH
Confidence            356677889999999999999999999999865  4568999999999999999864    3579999999999999999


Q ss_pred             HHHHhhcCC-----eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHH
Q 024828           81 LLYLHHEKH-----IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        81 l~~lh~~~~-----i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      |.|||+ .|     ++||||||+||+++.++.++|+|||++..............||+.|+|||++.+..++.++|||||
T Consensus       122 l~ylH~-~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl  200 (269)
T d2java1         122 LKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL  200 (269)
T ss_dssp             HHHHHH-HCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred             HHHHHH-hcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence            999998 65     999999999999999999999999999876555445556789999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccc
Q 024828          156 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  232 (262)
Q Consensus       156 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~  232 (262)
                      ||++|+|++|+.||...+.       .+....+..+..+.. +..+++++.+||.+||+.||++|||++|+++|||+
T Consensus       201 Gvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~~~-~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         201 GCLLYELCALMPPFTAFSQ-------KELAGKIREGKFRRI-PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCCC-CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999999999986443       234444444544433 35789999999999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-52  Score=340.86  Aligned_cols=221  Identities=27%  Similarity=0.453  Sum_probs=175.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      +...+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .
T Consensus        48 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~  126 (307)
T d1a06a_          48 EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-L  126 (307)
T ss_dssp             -------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh-c
Confidence            344567889999999999999999999999999999999999999999999998899999999999999999999998 9


Q ss_pred             CeeeCCCCCCCEEEc---cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||||+||++.   .++.++|+|||++...... .......||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus       127 ~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g  205 (307)
T d1a06a_         127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG  205 (307)
T ss_dssp             TCCCSCCCGGGEEESSSSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             eeeeEEecccceeecccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhC
Confidence            999999999999995   4678999999999765433 233456799999999999998999999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCCc
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  238 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~~  238 (262)
                      +.||.+....       +....+......  ......+|+++.+||.+||+.||++|||++|+++||||+.....
T Consensus       206 ~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  273 (307)
T d1a06a_         206 YPPFYDENDA-------KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL  273 (307)
T ss_dssp             SCSCCCSSHH-------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC
T ss_pred             CCCCCCCCHH-------HHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc
Confidence            9999874432       333444444332  22235789999999999999999999999999999999865443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=339.13  Aligned_cols=222  Identities=28%  Similarity=0.526  Sum_probs=190.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      +...+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++...+.+++..+..++.|++.||+|||+ .
T Consensus        49 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~-~  127 (288)
T d1uu3a_          49 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-K  127 (288)
T ss_dssp             TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc-c
Confidence            344567999999999999999999999999999999999999999999999999999999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      |++||||||+||+++.++.++|+|||++.......  .......||+.|+|||++.+..++.++||||+||++|+|++|+
T Consensus       128 ~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~  207 (288)
T d1uu3a_         128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL  207 (288)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCC
Confidence            99999999999999999999999999998664332  2333457999999999999999999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHH------HhcCccccccCCccc
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE------LMTHPFLKMYGDLNV  240 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~------~l~h~~~~~~~~~~~  240 (262)
                      .||.+.+.       ......+......  .+..+++++.+||.+||+.||++|||++|      +++||||+......+
T Consensus       208 ~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         208 PPFRAGNE-------YLIFQKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             CSSCCSSH-------HHHHHHHHTTCCC--CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             CCCCCcCH-------HHHHHHHHcCCCC--CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence            99987543       2334444444332  23578999999999999999999999987      588999988765443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-52  Score=338.63  Aligned_cols=218  Identities=32%  Similarity=0.528  Sum_probs=191.3

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +....+++.+|++++++++||||+++++++.+++..|+|||||.|++|..++...+++++..+..++.|++.||.|||+ 
T Consensus        55 ~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~-  133 (309)
T d1u5ra_          55 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-  133 (309)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-
Confidence            5566788999999999999999999999999999999999999999998888888899999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC---CCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++||||||+||+++.++.++|+|||++.....    .....||+.|+|||++.+   +.++.++|||||||++|+|++
T Consensus       134 ~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~  209 (309)
T d1u5ra_         134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (309)
T ss_dssp             TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCEeccCCCcceEEECCCCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence            9999999999999999999999999999876432    334579999999999864   358899999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccCC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |+.||.+...       ......+..+..+......+++++.+||.+||+.||.+|||++|+|+||||.....
T Consensus       210 g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~  275 (309)
T d1u5ra_         210 RKPPLFNMNA-------MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (309)
T ss_dssp             SSCTTTTSCH-------HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             CCCCCCCCCH-------HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence            9999976433       23344455555555556678999999999999999999999999999999976543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=339.37  Aligned_cols=217  Identities=29%  Similarity=0.549  Sum_probs=193.6

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+++|++++||||+++++++.+++.+|+||||++|++|.+++.+.+.+++..++.++.|++.||+|||+ .|
T Consensus        47 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~-~~  125 (337)
T d1o6la_          47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RD  125 (337)
T ss_dssp             TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh-cC
Confidence            34577899999999999999999999999999999999999999999999999999999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++||||||+||+++.+|.++|+|||+|..............||+.|+|||++.+..++.++|+|||||++|+|++|+.||
T Consensus       126 iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf  205 (337)
T d1o6la_         126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCC
Confidence            99999999999999999999999999987665555566678999999999999999999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~  236 (262)
                      .+.+..       +..+.+......  .+..+++++.+||.+||+.||.+|++     ++|+++||||+...
T Consensus       206 ~~~~~~-------~~~~~i~~~~~~--~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         206 YNQDHE-------RLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             CCSSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CCcCHH-------HHHHHHhcCCCC--CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence            875532       334444444332  23578999999999999999999994     99999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-51  Score=339.04  Aligned_cols=220  Identities=24%  Similarity=0.447  Sum_probs=188.5

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .....+.+.+|++++++++||||+++++++.+++.+|+||||++|++|.+++.+ .+++++..+..++.||+.||+|||+
T Consensus        63 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~  142 (350)
T d1koaa2          63 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE  142 (350)
T ss_dssp             SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            455677899999999999999999999999999999999999999999999954 4679999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEcc--CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           87 EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                       .|++|+||||+||+++.  ++.++|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       143 -~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~  220 (350)
T d1koaa2         143 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS  220 (350)
T ss_dssp             -TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH
T ss_pred             -cCCeeeeechhHeeeccCCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh
Confidence             99999999999999964  578999999999876433 33445678999999999999899999999999999999999


Q ss_pred             CCCCCCCCCccCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          165 GQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       165 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      |+.||.+.+..       +....+.....  +......+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       221 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         221 GLSPFGGENDD-------ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             SSCSSCCSSHH-------HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             CCCCCCCCCHH-------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999875432       23333333332  2222246899999999999999999999999999999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.5e-51  Score=338.23  Aligned_cols=219  Identities=24%  Similarity=0.440  Sum_probs=188.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...++.+.+|++++++++||||++++++|.+++.+|+|||||+|++|.+++.+.+ ++++..+..++.||+.||.|||+ 
T Consensus        67 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-  145 (352)
T d1koba_          67 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-  145 (352)
T ss_dssp             HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            4556788999999999999999999999999999999999999999998876654 69999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEc--cCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLIN--HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g  165 (262)
                      .|++||||||+|||++  .++.++|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       146 ~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG  224 (352)
T d1koba_         146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG  224 (352)
T ss_dssp             TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             CCeeecccccccccccccCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC
Confidence            9999999999999997  5689999999999876533 334456789999999999999999999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      +.||.+.+..       +....+.....  +......+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       225 ~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         225 LSPFAGEDDL-------ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             CCSSCCSSHH-------HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCCCCCCCHH-------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            9999875432       33334433332  2333357899999999999999999999999999999998643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.8e-51  Score=325.42  Aligned_cols=218  Identities=28%  Similarity=0.500  Sum_probs=188.5

Q ss_pred             HHHHHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            9 ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      +..++++.+|++++++++ ||||+++++++.++++.|+||||++|++|.++++..+++++..+..++.||+.||+|||+ 
T Consensus        50 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~-  128 (277)
T d1phka_          50 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-  128 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence            445678999999999996 999999999999999999999999999999999999999999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC------CCCCcchhHHHHHHHHHH
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~Di~slG~~l~~  161 (262)
                      .|++|+||||+||+++.++.++|+|||++....... ......|+..|.|||.+.+      ..++.++||||+||++|+
T Consensus       129 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilye  207 (277)
T d1phka_         129 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT  207 (277)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred             cCCcccccccceEEEcCCCCeEEccchheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhh
Confidence            999999999999999999999999999998765433 3445679999999998753      346889999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCC--CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      |++|+.||.+.+..       .....+..+..  +......+|+++++|+.+||+.||++|||++|+++||||+++
T Consensus       208 ml~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         208 LLAGSPPFWHRKQM-------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HHHSSCSSCCSSHH-------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             hccCCCCCCCCCHH-------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            99999999875432       22333333322  222334789999999999999999999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=329.72  Aligned_cols=217  Identities=28%  Similarity=0.492  Sum_probs=187.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Q 024828           11 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI   90 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i   90 (262)
                      ..+.+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+ .|+
T Consensus        56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~-~~i  134 (293)
T d1jksa_          56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQI  134 (293)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh-cce
Confidence            4678999999999999999999999999999999999999999999999998999999999999999999999998 999


Q ss_pred             eeCCCCCCCEEEccCC----cEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 024828           91 IHRDLKPSNLLINHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        91 ~H~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~  166 (262)
                      +|+||||+||+++.++    .++++|||++....... ......+++.|+|||.+.+..++.++||||+||++|+|++|+
T Consensus       135 vHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~  213 (293)
T d1jksa_         135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  213 (293)
T ss_dssp             ECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             eecccccceEEEecCCCcccceEecchhhhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCC
Confidence            9999999999998776    59999999998764332 334557899999999999888999999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      .||.+.+..       +....+.......  .....+|+++.+||++||+.||++|||++|+++||||+...
T Consensus       214 ~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         214 SPFLGDTKQ-------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             CSSCCSSHH-------HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             CCCCCCCHH-------HHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999875432       3334444433221  12246889999999999999999999999999999998654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.8e-51  Score=331.32  Aligned_cols=214  Identities=28%  Similarity=0.515  Sum_probs=189.7

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+.++++++||||+++++++.+++..|+||||+.|++|..++.....++...+..++.|++.||+|||+ .|
T Consensus        46 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~  124 (316)
T d1fota_          46 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KD  124 (316)
T ss_dssp             TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TT
T ss_pred             HHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc-Cc
Confidence            34567899999999999999999999999999999999999999999999999999999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++||||||+||+++.+|.++|+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       125 iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf  201 (316)
T d1fota_         125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF  201 (316)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEccccCchheeEcCCCCEEEecCccceEecc---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCC
Confidence            99999999999999999999999999987543   234567999999999999988999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      .+.+..       +....+..+...  .+..+++++.+++.+||..||.+|+     |++++++||||+...
T Consensus       202 ~~~~~~-------~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         202 YDSNTM-------KTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             CCSSHH-------HHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             CCcCHH-------HHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence            875432       334444444332  2346899999999999999999996     999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-50  Score=331.09  Aligned_cols=215  Identities=26%  Similarity=0.461  Sum_probs=190.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ...+.+.+|+++|++++||||+++++++.+....++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||+ .|
T Consensus        83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~  161 (350)
T d1rdqe_          83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LD  161 (350)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            34567899999999999999999999999999999999999999999999998999999999999999999999998 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++||||||+|||++.+|.++|+|||++.....   ......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       162 iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf  238 (350)
T d1rdqe_         162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             EecCcCCHHHcccCCCCCEEeeeceeeeeccc---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCC
Confidence            99999999999999999999999999987543   234567999999999999999999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccCC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGD  237 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~~  237 (262)
                      .+.+.       ......+..+....  +..+++++.+||++||..||.+|+     |++++++||||+....
T Consensus       239 ~~~~~-------~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         239 FADQP-------IQIYEKIVSGKVRF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             CCSSH-------HHHHHHHHHCCCCC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             CCcCH-------HHHHHHHhcCCCCC--CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence            86433       23444444444322  357899999999999999999995     9999999999987653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=331.73  Aligned_cols=222  Identities=23%  Similarity=0.370  Sum_probs=185.6

Q ss_pred             HHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Q 024828           12 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII   91 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~   91 (262)
                      .+.+.+|++++++++||||+++++++.++++.|+||||+.|+++..+....+.+++..+..++.|++.||+|||+ .|++
T Consensus        44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~ii  122 (299)
T d1ua2a_          44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWIL  122 (299)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-ccee
Confidence            457889999999999999999999999999999999999987777777767789999999999999999999999 9999


Q ss_pred             eCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 024828           92 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYS  170 (262)
Q Consensus        92 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~  170 (262)
                      |+||||+||+++.++.++|+|||.+..............+++.|+|||.+.+. .++.++||||+||++|+|++|..||.
T Consensus       123 HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~  202 (299)
T d1ua2a_         123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP  202 (299)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence            99999999999999999999999998776655555667899999999998755 47999999999999999999999998


Q ss_pred             CCCccCchhhHHHHHHHHhcCCCC------------------CC----CCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          171 PPEQQDGWTSFYELMEAIVDQPPP------------------SA----PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~------------------~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +....+....+.   +........                  ..    .....++++.+||.+||+.||++|||++|+|+
T Consensus       203 ~~~~~~~l~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         203 GDSDLDQLTRIF---ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CSSHHHHHHHHH---HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHH---HhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            765433222211   111100000                  00    01246789999999999999999999999999


Q ss_pred             CccccccCC
Q 024828          229 HPFLKMYGD  237 (262)
Q Consensus       229 h~~~~~~~~  237 (262)
                      ||||+..+.
T Consensus       280 Hp~f~~~p~  288 (299)
T d1ua2a_         280 MKYFSNRPG  288 (299)
T ss_dssp             SGGGTSSSC
T ss_pred             CHhhCCCCC
Confidence            999987664

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=328.88  Aligned_cols=216  Identities=26%  Similarity=0.507  Sum_probs=189.1

Q ss_pred             HHHHHHHHHHHHh-cCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           11 ARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        11 ~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      ..+.+.+|..++. .++||||+++++++.+++..|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        45 ~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~-~~  123 (320)
T d1xjda_          45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KG  123 (320)
T ss_dssp             CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CC
Confidence            3456677777665 689999999999999999999999999999999999999999999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  169 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  169 (262)
                      ++|+||||+||+++.++.++|+|||++..............|++.|+|||++.+..++.++||||+||++|+|++|+.||
T Consensus       124 iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF  203 (320)
T d1xjda_         124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF  203 (320)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCC
Confidence            99999999999999999999999999987665555556678999999999999999999999999999999999999999


Q ss_pred             CCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH-HHhcCccccccC
Q 024828          170 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ-ELMTHPFLKMYG  236 (262)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~~l~h~~~~~~~  236 (262)
                      .+.+..       +....+..+..  ..+..+++++.+||.+||+.||.+|||+. ++++||||+...
T Consensus       204 ~~~~~~-------~~~~~i~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         204 HGQDEE-------ELFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             CCSSHH-------HHHHHHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             CCCCHH-------HHHHHHHcCCC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence            875432       33444444433  22357899999999999999999999996 899999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-49  Score=327.93  Aligned_cols=213  Identities=28%  Similarity=0.527  Sum_probs=182.7

Q ss_pred             HHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeeCC
Q 024828           15 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD   94 (262)
Q Consensus        15 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~d   94 (262)
                      ..+|+++++.++||||+++++++.+.+.+|+||||++|++|.+++.+.+.+++..+..++.||+.||+|||+ .|++|+|
T Consensus        54 e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrD  132 (364)
T d1omwa3          54 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRD  132 (364)
T ss_dssp             HHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             HHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH-CCcccee
Confidence            345577888899999999999999999999999999999999999999999999999999999999999999 9999999


Q ss_pred             CCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 024828           95 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPE  173 (262)
Q Consensus        95 l~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  173 (262)
                      |||+|||++.+|.++|+|||+|......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       133 lKP~NILl~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  210 (364)
T d1omwa3         133 LKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  210 (364)
T ss_dssp             CSGGGEEECSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             eccceeEEcCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999999865433  3345679999999999875 458999999999999999999999998755


Q ss_pred             ccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCC-----HHHHhcCccccccC
Q 024828          174 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  236 (262)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-----~~~~l~h~~~~~~~  236 (262)
                      ..+    ..........  .+...+..+++++.+||.+||+.||++|||     ++|+++||||+...
T Consensus       211 ~~~----~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         211 TKD----KHEIDRMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             SSC----HHHHHHHSSS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             HHH----HHHHHHhccc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            432    1222222222  222334578999999999999999999999     79999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=329.22  Aligned_cols=224  Identities=22%  Similarity=0.387  Sum_probs=188.9

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l   81 (262)
                      |.+..+......+.+|+++|++++||||++++++|.+++.+|+|||||+|++|.+++.+.+ ++++..+..++.||+.||
T Consensus        36 K~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al  115 (321)
T d1tkia_          36 KFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL  115 (321)
T ss_dssp             EEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHH
T ss_pred             EEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence            3344445556678899999999999999999999999999999999999999999998765 799999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccC--CcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      +|||+ .|++||||||+||+++.+  ..++++|||++...... .......+++.|+|||...+..++.++||||+||++
T Consensus       116 ~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvil  193 (321)
T d1tkia_         116 QFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV  193 (321)
T ss_dssp             HHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHH
T ss_pred             HHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccccC-CcccccccccccccchhccCCCCCchhhcccHHHHH
Confidence            99998 999999999999999854  47999999998765432 233445788999999999998999999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      |+|++|..||......       +....+.......  .....+++++.+||.+||..||++|||++|+++||||+..
T Consensus       194 y~ll~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         194 YVLLSGINPFLAETNQ-------QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHSSCTTCCSSHH-------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            9999999999875432       3334443333221  1123689999999999999999999999999999999753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=320.74  Aligned_cols=216  Identities=21%  Similarity=0.398  Sum_probs=183.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ++..++++.+|++++++++||||+++++++.+ +..++||||+++|+|.+++.+...+++..+..++.|++.||+|||+ 
T Consensus        48 ~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~-  125 (277)
T d1xbba_          48 DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-  125 (277)
T ss_dssp             -CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh-
Confidence            44557789999999999999999999999865 4578999999999999999998999999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      .|++||||||+||+++.++.++++|||++........   ......|++.|+|||.+.+..++.++||||||+++|||++
T Consensus       126 ~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt  205 (277)
T d1xbba_         126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS  205 (277)
T ss_dssp             TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhh
Confidence            9999999999999999999999999999976543322   2223468899999999998889999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH---hcCcccc
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL---MTHPFLK  233 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~---l~h~~~~  233 (262)
                       |+.||.+...       .+....+..+..++.+ ..+|+++.+|+.+||+.||++|||++++   |+|+|++
T Consensus       206 ~g~~Pf~~~~~-------~~~~~~i~~~~~~~~p-~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         206 YGQKPYRGMKG-------SEVTAMLEKGERMGCP-AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TTCCSSTTCCH-------HHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCH-------HHHHHHHHcCCCCCCC-cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence             8999987543       2344455555555443 5789999999999999999999999998   4566654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=316.41  Aligned_cols=214  Identities=25%  Similarity=0.425  Sum_probs=174.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      ++...+.+.+|++++++++||||+++++++. ++..++||||++|++|.+++... +.+++..+..++.|++.||+|||+
T Consensus        44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~  122 (276)
T d1uwha_          44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA  122 (276)
T ss_dssp             CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            5667789999999999999999999999865 45689999999999999999765 569999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCcccccCC---CCCcchhHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLE  161 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~~  161 (262)
                       .|++||||||+||+++.++.++|+|||+|.......  .......||+.|+|||++.+.   .++.++||||||+++||
T Consensus       123 -~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~e  201 (276)
T d1uwha_         123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE  201 (276)
T ss_dssp             -TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHH
T ss_pred             -CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHH
Confidence             999999999999999999999999999997654322  223345789999999998643   47899999999999999


Q ss_pred             HHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC---CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          162 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       162 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      |++|+.||.+.....      .....+..+...   ......+++++.+|+.+||+.||++|||++|++++
T Consensus       202 l~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         202 LMTGQLPYSNINNRD------QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHSSCTTTTCCCHH------HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHCCCCCCCCChHH------HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999998754322      222222222222   22345789999999999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=315.75  Aligned_cols=217  Identities=27%  Similarity=0.458  Sum_probs=185.7

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .++...+++.+|++++++++||||+++++++.+ +..|+||||++|++|.+++... +.+++..+..++.|++.||+|||
T Consensus        48 ~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH  126 (285)
T d1u59a_          48 TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE  126 (285)
T ss_dssp             CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            456778899999999999999999999999865 4589999999999999998654 57999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .|++|+||||+||+++.++.++|+|||++........   ......+++.|+|||.+.+..++.++|||||||++|||
T Consensus       127 ~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~  205 (285)
T d1u59a_         127 E-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA  205 (285)
T ss_dssp             H-TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred             h-CCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHH
Confidence            9 9999999999999999999999999999986643321   22234678899999999988899999999999999999


Q ss_pred             Hh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH---hcCcccc
Q 024828          163 AT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL---MTHPFLK  233 (262)
Q Consensus       163 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~---l~h~~~~  233 (262)
                      ++ |+.||.+....       +....+..+..++.+ ..+|+++.+|+.+||+.||++|||+.++   |+|+|+.
T Consensus       206 lt~G~~Pf~~~~~~-------~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         206 LSYGQKPYKKMKGP-------EVMAFIEQGKRMECP-PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HTTSCCTTTTCCTH-------HHHHHHHTTCCCCCC-TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhCCCCCCCCCCHH-------HHHHHHHcCCCCCCC-CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            98 89999875432       344555566655544 5789999999999999999999999888   5677764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=319.93  Aligned_cols=224  Identities=25%  Similarity=0.435  Sum_probs=183.3

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ...+++.+|++++++++||||+++++++.+++..|+||||+.+ ++.+++..  .+.+++..+..++.|++.||.|||+ 
T Consensus        43 ~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~-  120 (298)
T d1gz8a_          43 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-  120 (298)
T ss_dssp             -CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-
Confidence            3467899999999999999999999999999999999999976 55555533  3569999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .|++|+||||+||+++.++.++++|||.+..............|++.|+|||.+.... ++.++|+||+|+++|+|++|+
T Consensus       121 ~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~  200 (298)
T d1gz8a_         121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR  200 (298)
T ss_dssp             TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCC
Confidence            9999999999999999999999999999987766666666678999999999877665 588999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCCCC-------------C---C-------CCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQPPP-------------S---A-------PSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~---~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      .||.+.+..+...   ............             .   .       ....+++++.+|+.+||+.||++|||+
T Consensus       201 ~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~  277 (298)
T d1gz8a_         201 ALFPGDSEIDQLF---RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA  277 (298)
T ss_dssp             CSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCCCCCHHHHHH---HHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence            9998755432211   111111110000             0   0       012567889999999999999999999


Q ss_pred             HHHhcCccccccCCc
Q 024828          224 QELMTHPFLKMYGDL  238 (262)
Q Consensus       224 ~~~l~h~~~~~~~~~  238 (262)
                      +|+++||||+.....
T Consensus       278 ~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         278 KAALAHPFFQDVTKP  292 (298)
T ss_dssp             HHHHTSGGGTTCCCC
T ss_pred             HHHhCCHhhccCCCC
Confidence            999999999877543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.8e-49  Score=316.47  Aligned_cols=214  Identities=25%  Similarity=0.406  Sum_probs=175.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .++..++++.+|+++|++++||||+++++++.+++..++||||+++++|.+++... +.+++..+..++.|++.||+|||
T Consensus        66 ~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH  145 (299)
T d1jpaa_          66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA  145 (299)
T ss_dssp             CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh
Confidence            35677789999999999999999999999999999999999999999999988775 56999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-----cccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      + .|++||||||+|||++.++.++|+|||++.........     .....+++.|+|||.+.+..++.++|||||||++|
T Consensus       146 ~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~  224 (299)
T d1jpaa_         146 D-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW  224 (299)
T ss_dssp             H-TTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred             h-CCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHH
Confidence            9 99999999999999999999999999999765432211     11235688999999999889999999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||+| |+.||.+...       .+....+..+..++.+ ..+++++.+|+.+||+.||++|||++|++++
T Consensus       225 el~t~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         225 EVMSYGERPYWDMTN-------QDVINAIEQDYRLPPP-MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHTTSCCTTTTCCH-------HHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHhCCCCCCCCCCH-------HHHHHHHHcCCCCCCC-ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9998 8999987543       2444555555544443 5789999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=312.55  Aligned_cols=218  Identities=24%  Similarity=0.445  Sum_probs=174.6

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l   81 (262)
                      |++..+....+++.+|++++++++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||
T Consensus        35 K~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl  114 (263)
T d1sm2a_          35 KTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM  114 (263)
T ss_dssp             EECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHH
T ss_pred             EEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHH
Confidence            444444555678999999999999999999999999999999999999999999998765 5689999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      +|||+ .+++||||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++||||||+++|
T Consensus       115 ~~lH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~  193 (263)
T d1sm2a_         115 AYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW  193 (263)
T ss_dssp             HHHHH-TTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             Hhhhc-cceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHH
Confidence            99999 9999999999999999999999999999976644332 223356889999999999999999999999999999


Q ss_pred             HHHhC-CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          161 ECATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       161 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||+++ .+||.....       .+....+..+..+..+ ...++++.+|+.+||+.||++|||++|+++|
T Consensus       194 el~t~~~~~~~~~~~-------~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         194 EVFSEGKIPYENRSN-------SEVVEDISTGFRLYKP-RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHTTSCCTTCSCCH-------HHHHHHHHHTCCCCCC-TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHCCCCCCCCCCH-------HHHHHHHHhcCCCCCc-cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            99994 666654322       2344444445444433 5679999999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.5e-49  Score=317.35  Aligned_cols=223  Identities=23%  Similarity=0.391  Sum_probs=180.7

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ++...+++.+|++++++++||||+++++.+.+++..+++++++.++.+..+.+..+.+++..+..++.|++.||+|||+ 
T Consensus        40 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-  118 (286)
T d1ob3a_          40 DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-  118 (286)
T ss_dssp             GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc-
Confidence            3445678999999999999999999999999999999999999887777777777889999999999999999999998 


Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCC
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ  166 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~  166 (262)
                      .||+|+||||+||+++.++.++++|||.+..............+++.|.|||.+.+.. ++.++|+||+||++++|++|+
T Consensus       119 ~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~  198 (286)
T d1ob3a_         119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT  198 (286)
T ss_dssp             TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence            9999999999999999999999999999987766555555667899999999987654 689999999999999999999


Q ss_pred             CCCCCCCccCchhhHHHHHHHHhcCC-----------------------CCCCCCCCCCHHHHHHHHHhhcCCcCCCCCH
Q 024828          167 FPYSPPEQQDGWTSFYELMEAIVDQP-----------------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSA  223 (262)
Q Consensus       167 ~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  223 (262)
                      .||.+.+..+....+   ........                       .........++++.+|+++||+.||++|||+
T Consensus       199 ~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~  275 (286)
T d1ob3a_         199 PLFPGVSEADQLMRI---FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA  275 (286)
T ss_dssp             CSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCCCCCHHHHHHHH---HHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence            999876543322111   11111000                       0011124568899999999999999999999


Q ss_pred             HHHhcCccccc
Q 024828          224 QELMTHPFLKM  234 (262)
Q Consensus       224 ~~~l~h~~~~~  234 (262)
                      +|+++||||+.
T Consensus       276 ~ell~Hp~f~~  286 (286)
T d1ob3a_         276 KQALEHAYFKE  286 (286)
T ss_dssp             HHHHTSGGGGC
T ss_pred             HHHhcCcccCc
Confidence            99999999984

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=319.75  Aligned_cols=215  Identities=27%  Similarity=0.404  Sum_probs=179.5

Q ss_pred             hhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------------
Q 024828            7 VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------------   63 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------   63 (262)
                      .+......+.+|+.++.++ +||||+++++++.+.+..++||||++||+|.+++++..                      
T Consensus        79 ~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (325)
T d1rjba_          79 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL  158 (325)
T ss_dssp             -----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-------------------
T ss_pred             cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhcccccccccccc
Confidence            3455667899999999998 89999999999999999999999999999999997642                      


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCccc
Q 024828           64 -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPER  140 (262)
Q Consensus        64 -~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~  140 (262)
                       .+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||+|.........  .....+|+.|+|||.
T Consensus       159 ~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  237 (325)
T d1rjba_         159 NVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  237 (325)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHH-TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHH
Confidence             48899999999999999999999 99999999999999999999999999999765544322  223467899999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          141 ISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       141 ~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      +.+..++.++|||||||++|||++ |..||.+....+      ...+.+..+..++ .+..+++++.+||.+||+.||++
T Consensus       238 l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~------~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~  310 (325)
T d1rjba_         238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA------NFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRK  310 (325)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCCCC-CCCcCCHHHHHHHHHHcCCChhH
Confidence            998899999999999999999997 899998755432      1222333333333 34578999999999999999999


Q ss_pred             CCCHHHHhcC
Q 024828          220 RLSAQELMTH  229 (262)
Q Consensus       220 Rpt~~~~l~h  229 (262)
                      |||++||++|
T Consensus       311 RPt~~ei~~~  320 (325)
T d1rjba_         311 RPSFPNLTSF  320 (325)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=325.38  Aligned_cols=219  Identities=26%  Similarity=0.423  Sum_probs=176.8

Q ss_pred             HHHHHHHHHHhc-CCCCeeEeeceEEEE----CCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 024828           13 RQIAQELKINQS-SQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus        13 ~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ..+.+|+.++.+ .+||||++++++|.+    +..+|+|||||+||+|.+++.+.  ..+++..+..++.|++.||+|||
T Consensus        49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH  128 (335)
T d2ozaa1          49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  128 (335)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            456689988655 589999999999976    46789999999999999999875  36999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEcc---CCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .|++||||||+||+++.   .+.++|+|||++...... .......|++.|+|||++.+..++.++|||||||++|+|
T Consensus       129 ~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~l  206 (335)
T d2ozaa1         129 S-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL  206 (335)
T ss_dssp             H-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHH
T ss_pred             H-cCCccccccccccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHH
Confidence            9 99999999999999975   457999999999766543 334456899999999999988899999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ++|+.||.+........   .....+......  ......+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       207 ltg~~Pf~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         207 LCGYPPFYSNHGLAISP---GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             TTSSCSCEETTCC-----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             hhCCCCCCCCCHHHHHH---HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            99999997655432211   111111111111  111125789999999999999999999999999999996543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-48  Score=312.86  Aligned_cols=223  Identities=23%  Similarity=0.357  Sum_probs=184.1

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~~   80 (262)
                      |++..+....+++.+|++++++++||||+++++++.+++..++||||+++|+|.+++.+.  ..+++..+..++.|++.|
T Consensus        48 K~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~g  127 (287)
T d1opja_          48 KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA  127 (287)
T ss_dssp             EECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHH
T ss_pred             EEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHH
Confidence            444445556678999999999999999999999999999999999999999999999764  568999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC-cccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      |+|||+ .|++||||||+|||++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||+||++
T Consensus       128 L~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l  206 (287)
T d1opja_         128 MEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL  206 (287)
T ss_dssp             HHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred             HHHHHH-CCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHH
Confidence            999998 99999999999999999999999999999865433222 2223578899999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      |+|++|..|+......      ....+.+..+..+.. +..+++++.+|+.+||+.||++|||++++++  +|+.+
T Consensus       207 ~ell~~~~p~~~~~~~------~~~~~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         207 WEIATYGMSPYPGIDL------SQVYELLEKDYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             HHHHTTSCCSSTTCCH------HHHHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             HHHHhCCCCCCCcchH------HHHHHHHhcCCCCCC-CccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence            9999976665443221      233344444444443 3578999999999999999999999999965  45443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=306.62  Aligned_cols=218  Identities=24%  Similarity=0.414  Sum_probs=186.6

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l   81 (262)
                      |++..+....+++.+|++++++++||||+++++++.+++..++||||+.+|+|..++... ..+++..+..++.|++.||
T Consensus        34 K~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl  113 (258)
T d1k2pa_          34 KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM  113 (258)
T ss_dssp             EEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred             EEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHH
Confidence            444444555678999999999999999999999999999999999999999999997654 5789999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC-CcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      +|||+ .|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|
T Consensus       114 ~~LH~-~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~  192 (258)
T d1k2pa_         114 EYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW  192 (258)
T ss_dssp             HHHHH-TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HHHhh-cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhH
Confidence            99998 9999999999999999999999999999976544322 222356888999999999889999999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||++ |+.||......       +....+..+..+.. +...++++.+|+.+||+.||++|||++++++|
T Consensus       193 el~t~g~~Pf~~~~~~-------~~~~~i~~~~~~~~-p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         193 EIYSLGKMPYERFTNS-------ETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHTTSCCTTTTSCHH-------HHHHHHHTTCCCCC-CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hHHhcCCCCCCCCCHH-------HHHHHHHhCCCCCC-cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9998 89999875432       34455555555443 36789999999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=312.47  Aligned_cols=223  Identities=26%  Similarity=0.434  Sum_probs=184.9

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLK   79 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~   79 (262)
                      ||++..+....+++.+|++++++++||||+++++++.+ +..++||||+++|+|.+++...  .+++...+..++.|++.
T Consensus        42 vK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~  120 (272)
T d1qpca_          42 VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE  120 (272)
T ss_dssp             EEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHH
T ss_pred             EEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHH
Confidence            34444555566789999999999999999999998754 5578999999999999987544  35999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV  158 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~  158 (262)
                      ||.|||+ .|++||||||+||+++.++.++|+|||++....... .......+++.|+|||++.+..++.++||||||++
T Consensus       121 gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvv  199 (272)
T d1qpca_         121 GMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL  199 (272)
T ss_dssp             HHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHH
T ss_pred             HHHHHHh-CCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHH
Confidence            9999998 999999999999999999999999999998664332 22234467889999999998889999999999999


Q ss_pred             HHHHHhCCC-CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc--Cccccc
Q 024828          159 LLECATGQF-PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLKM  234 (262)
Q Consensus       159 l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~--h~~~~~  234 (262)
                      +|||+||.. |+....       ..+....+..+..+..+ ..+++++.+|+.+||+.||++|||++++++  ++||..
T Consensus       200 l~ellt~~~~~~~~~~-------~~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         200 LTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRP-DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCc-ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            999999654 444432       22445555555555443 578999999999999999999999999998  888864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=304.98  Aligned_cols=206  Identities=28%  Similarity=0.463  Sum_probs=176.8

Q ss_pred             HHHHHHHHHHhcCC--CCeeEeeceEEEECCeEEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           13 RQIAQELKINQSSQ--CPYVVVCYQSFYSNGAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        13 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .++.+|+.++++++  ||||+++++++.+.+..++|||++.+ +++.+++.+.+.+++..+..++.|++.||+|||+ .|
T Consensus        52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~-~~  130 (273)
T d1xwsa_          52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CG  130 (273)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CC
Confidence            34678999999986  89999999999999999999999975 6889999988999999999999999999999999 99


Q ss_pred             eeeCCCCCCCEEEccC-CcEEEEecccccccccCCCCcccccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCC
Q 024828           90 IIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQF  167 (262)
Q Consensus        90 i~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~  167 (262)
                      ++||||||+||+++.+ +.++|+|||++......  ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus       131 iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~  208 (273)
T d1xwsa_         131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI  208 (273)
T ss_dssp             EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccccCcccceEEecCCCeEEECccccceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence            9999999999999854 78999999999764332  3345679999999999987664 677999999999999999999


Q ss_pred             CCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          168 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       168 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ||...+             .+..+..  .....+|+++.+||.+||+.||++|||++|+++||||+...
T Consensus       209 Pf~~~~-------------~i~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         209 PFEHDE-------------EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             SCCSHH-------------HHHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             CCCCch-------------HHhhccc--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            997521             1122222  22346899999999999999999999999999999998753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=312.44  Aligned_cols=225  Identities=22%  Similarity=0.381  Sum_probs=175.9

Q ss_pred             HHHHHHHHHHHhcC---CCCeeEeeceEEEE-----CCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Q 024828           12 RRQIAQELKINQSS---QCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus        12 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      ...+.+|+++++.+   +||||++++++|..     +...++++|++.++++...... ...+++..+..++.|++.||+
T Consensus        51 ~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~  130 (305)
T d1blxa_          51 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD  130 (305)
T ss_dssp             BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            34556777766655   89999999999863     3468999999988666544433 356999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      |||+ .|++||||||+|||++.++.++++|||.+...... .......||+.|+|||++.+..++.++||||+||++|+|
T Consensus       131 yLH~-~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~el  208 (305)
T d1blxa_         131 FLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM  208 (305)
T ss_dssp             HHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             HHHh-CCEEecCCCccEEEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHH
Confidence            9998 99999999999999999999999999998754332 334456899999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHH------------------hcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAI------------------VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      ++|+.||.+.+..+....+.......                  ............+++++.+||.+||+.||++|||++
T Consensus       209 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~  288 (305)
T d1blxa_         209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY  288 (305)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence            99999998765433222211111000                  000000111245788999999999999999999999


Q ss_pred             HHhcCccccccCCc
Q 024828          225 ELMTHPFLKMYGDL  238 (262)
Q Consensus       225 ~~l~h~~~~~~~~~  238 (262)
                      |+|+||||+.....
T Consensus       289 e~L~Hpff~~i~~~  302 (305)
T d1blxa_         289 SALSHPYFQDLERC  302 (305)
T ss_dssp             HHHTSGGGTTCCCC
T ss_pred             HHhcChhhcCchhh
Confidence            99999999987654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=302.92  Aligned_cols=226  Identities=24%  Similarity=0.395  Sum_probs=189.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      .++....++.+|+.++++++||||+++++++.+....++|++++.|++|..++...+.+++..+..++.|++.||+|||+
T Consensus        40 ~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~  119 (292)
T d1unla_          40 DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS  119 (292)
T ss_dssp             SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhc
Confidence            34566789999999999999999999999999999999999999999999999988899999999999999999999998


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhC
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g  165 (262)
                       .|++|+||||+||+++.++.++++|||.+..............++..|.|||.+.+.. ++.++||||+||++++|++|
T Consensus       120 -~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g  198 (292)
T d1unla_         120 -RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             -TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             -CCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhC
Confidence             9999999999999999999999999999988766655555667788999999988765 68999999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCC------------------------CCCCCCCCCCHHHHHHHHHhhcCCcCCCC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQP------------------------PPSAPSDQFSPEFCSFISACVQKEPQQRL  221 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  221 (262)
                      +.||.......   .....+.......                        ........+++++.+|+.+||+.||++||
T Consensus       199 ~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~  275 (292)
T d1unla_         199 GRPLFPGNDVD---DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI  275 (292)
T ss_dssp             SCCSCCCSSHH---HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             CCCCCCCCCHH---HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc
Confidence            99875443321   1111121211111                        11112235678999999999999999999


Q ss_pred             CHHHHhcCccccccC
Q 024828          222 SAQELMTHPFLKMYG  236 (262)
Q Consensus       222 t~~~~l~h~~~~~~~  236 (262)
                      |++|+|+||||+...
T Consensus       276 sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         276 SAEEALQHPYFSDFC  290 (292)
T ss_dssp             CHHHHTTSGGGSSCS
T ss_pred             CHHHHhcChhhcCCC
Confidence            999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-47  Score=301.44  Aligned_cols=213  Identities=24%  Similarity=0.387  Sum_probs=172.9

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .++..++.+.+|++++++++||||+++++++. ++..++||||+++++|.+++... +.+++..+..++.|++.||.|||
T Consensus        47 ~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH  125 (273)
T d1mp8a_          47 TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE  125 (273)
T ss_dssp             TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc
Confidence            45777889999999999999999999999986 46789999999999999987654 57999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  164 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~  164 (262)
                      + .|++|+||||+||+++.++.++++|||++....... .......+++.|+|||.+.+..++.++||||||+++|||++
T Consensus       126 ~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt  204 (273)
T d1mp8a_         126 S-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  204 (273)
T ss_dssp             H-TTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred             c-cCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHh
Confidence            9 999999999999999999999999999997654322 22334567889999999998899999999999999999998


Q ss_pred             -CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          165 -GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       165 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                       |.+||......+       ....+..+..++. +..+|+++.+||.+||+.||++|||++|++++
T Consensus       205 ~g~~P~~~~~~~~-------~~~~i~~~~~~~~-~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         205 HGVKPFQGVKNND-------VIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             TSCCTTTTCCGGG-------HHHHHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCHHH-------HHHHHHcCCCCCC-CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence             899998765542       3344455554443 35789999999999999999999999999876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-47  Score=303.43  Aligned_cols=226  Identities=23%  Similarity=0.372  Sum_probs=181.6

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLK   79 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~l~~   79 (262)
                      +|++..+....+.+.+|+.++++++||||+++++++.+ +..++||||+.+|+|..++...  +.+++..+..++.|++.
T Consensus        46 iK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~  124 (285)
T d1fmka3          46 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS  124 (285)
T ss_dssp             EEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHH
T ss_pred             EEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHH
Confidence            34455555566789999999999999999999999865 4578999999999999988543  57999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC-CCcccccccccccCcccccCCCCCcchhHHHHHHH
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV  158 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~  158 (262)
                      ||+|||+ .|++|+||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++||||||++
T Consensus       125 gl~~LH~-~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Gii  203 (285)
T d1fmka3         125 GMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL  203 (285)
T ss_dssp             HHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             HHHHHhh-hheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHH
Confidence            9999998 999999999999999999999999999997654332 22233568899999999998899999999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc--CccccccC
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLKMYG  236 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~--h~~~~~~~  236 (262)
                      +|||++|..|+.....      ..+....+..+..++. +..+++++.+|+.+||+.||++|||+++++.  ++||....
T Consensus       204 l~el~t~~~p~~~~~~------~~~~~~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         204 LTELTTKGRVPYPGMV------NREVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHTTTCCSSTTCC------HHHHHHHHHTTCCCCC-CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHhCCCCCCCCCC------HHHHHHHHHhcCCCCC-CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            9999996555544322      2344555555554444 3578999999999999999999999999988  88887643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.8e-47  Score=302.41  Aligned_cols=219  Identities=26%  Similarity=0.467  Sum_probs=175.0

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY   83 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~   83 (262)
                      ++...+++.+|++++++++||||+++++++.+.+    ..|+||||++|++|.+++...+++++..+..++.|++.||+|
T Consensus        47 ~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~  126 (277)
T d1o6ya_          47 DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF  126 (277)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence            5667788999999999999999999999987643    489999999999999999999999999999999999999999


Q ss_pred             HhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC---CCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           84 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        84 lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      ||+ .|++|+||||+||+++.++..+++|||.+.......   .......|++.|+|||++.+..++.++||||+||++|
T Consensus       127 lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvily  205 (277)
T d1o6ya_         127 SHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY  205 (277)
T ss_dssp             HHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             HHh-CCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHH
Confidence            998 999999999999999999999999999876543222   2334457899999999999888999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCcccc
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  233 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~  233 (262)
                      +|++|++||......+      .....+.....+ ......+|+++.+||.+||+.||.+||+..+.+.|+|.+
T Consensus       206 elltG~~Pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         206 EVLTGEPPFTGDSPVS------VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHSSCSCCCSSHHH------HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHhCCCCCCCcCHHH------HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999998654321      122223333222 233457899999999999999999999544444567664

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=299.33  Aligned_cols=214  Identities=24%  Similarity=0.333  Sum_probs=175.7

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      ..+....++.+|++++++++||||+++++++.+.+..++||||+.++++.+++.+. +.++...+..++.|++.||+|||
T Consensus        48 ~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH  127 (283)
T d1mqba_          48 YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA  127 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc
Confidence            35566778999999999999999999999999999999999999999999988765 57999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC---cccccccccccCcccccCCCCCcchhHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  162 (262)
                      + .|++||||||+|||++.++.+||+|||++.........   .....|++.|+|||.+.+..++.++||||||+++|||
T Consensus       128 ~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el  206 (283)
T d1mqba_         128 N-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV  206 (283)
T ss_dssp             H-TTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred             c-cccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHH
Confidence            9 99999999999999999999999999999765433221   2223578899999999999999999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          163 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +++..|+.....      ..+....+..+..++.+ ..+++++.+|+.+||+.||++|||+.++++
T Consensus       207 ~t~~~~~~~~~~------~~~~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         207 MTYGERPYWELS------NHEVMKAINDGFRLPTP-MDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HTTSCCTTTTCC------HHHHHHHHHTTCCCCCC-TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HhCCCCccccCC------HHHHHHHHhccCCCCCc-hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            996555443222      22445556666555544 568999999999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=309.19  Aligned_cols=225  Identities=27%  Similarity=0.461  Sum_probs=182.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC------eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~   80 (262)
                      .++...+++.+|+++|++++||||++++++|...+      .+|+||||+ +.+|..+.+. +++++..+..++.|++.|
T Consensus        56 ~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~a  133 (346)
T d1cm8a_          56 QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKG  133 (346)
T ss_dssp             SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHH
Confidence            46677889999999999999999999999997654      579999999 6688887765 679999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVL  159 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l  159 (262)
                      |+|||+ .|++|+||||+||+++.++.++++|||.+.....   ......+++.|+|||.+.+. .++.++||||+||++
T Consensus       134 L~~LH~-~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil  209 (346)
T d1cm8a_         134 LRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM  209 (346)
T ss_dssp             HHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred             HHHHHh-CCCcccccCcchhhcccccccccccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence            999998 9999999999999999999999999999976543   33456789999999998765 468999999999999


Q ss_pred             HHHHhCCCCCCCCCccCchhhHHHH--------------------HHHHhcCC--CCCCCCCCCCHHHHHHHHHhhcCCc
Q 024828          160 LECATGQFPYSPPEQQDGWTSFYEL--------------------MEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEP  217 (262)
Q Consensus       160 ~~l~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p  217 (262)
                      |+|++|+.||.+.+..+........                    ........  .........++++.+||.+||..||
T Consensus       210 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP  289 (346)
T d1cm8a_         210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA  289 (346)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred             HHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCCh
Confidence            9999999999876543222111110                    00000000  0111224578999999999999999


Q ss_pred             CCCCCHHHHhcCccccccCC
Q 024828          218 QQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       218 ~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      .+|||++|+|+||||+...+
T Consensus       290 ~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         290 EQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             TTSCCHHHHHHSGGGTTTC-
T ss_pred             hHCcCHHHHhcChhhCcCCC
Confidence            99999999999999998653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=300.29  Aligned_cols=214  Identities=23%  Similarity=0.414  Sum_probs=173.1

Q ss_pred             ccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHH
Q 024828            4 QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKG   80 (262)
Q Consensus         4 ~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~l~~~   80 (262)
                      |.-.++...+.+.+|++++++++||||+++++++.+ .+.+++||||+++|+|.+++.+.+  .++...+..++.|++.|
T Consensus        36 K~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~a  115 (262)
T d1byga_          36 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA  115 (262)
T ss_dssp             EECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhh
Confidence            333445566789999999999999999999998854 456899999999999999997643  58999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |.|||+ .+++|+||+|+||+++.++.++++|||++.....   ......++..|+|||.+.+..++.++||||||+++|
T Consensus       116 l~ylH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~  191 (262)
T d1byga_         116 MEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW  191 (262)
T ss_dssp             HHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             cccccc-CceeccccchHhheecCCCCEeecccccceecCC---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHH
Confidence            999999 9999999999999999999999999999875432   223446788999999998889999999999999999


Q ss_pred             HHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          161 ECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       161 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||++ |++||......       +....+..+..++.+ ..+++++.+|+.+||+.||++|||+.+++++
T Consensus       192 el~t~~~~p~~~~~~~-------~~~~~i~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         192 EIYSFGRVPYPRIPLK-------DVVPRVEKGYKMDAP-DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHTTSCCSCTTSCGG-------GHHHHHTTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHCCCCCCCCCCHH-------HHHHHHHcCCCCCCC-ccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            9998 78888765443       234445555555554 5789999999999999999999999999773

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-46  Score=302.62  Aligned_cols=221  Identities=27%  Similarity=0.502  Sum_probs=187.2

Q ss_pred             HHHHHHHHHHHHHhcCCC-CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 024828           10 SARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK   88 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~   88 (262)
                      ...+.+.+|++++++++| |||+++++.+.+....+++|||+.|++|.+++...+.+++..+..++.|++.||.|+|+ .
T Consensus        70 ~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~-~  148 (322)
T d1vzoa_          70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-L  148 (322)
T ss_dssp             SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             HHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc-C
Confidence            345678899999999966 89999999999999999999999999999999999999999999999999999999999 9


Q ss_pred             CeeeCCCCCCCEEEccCCcEEEEecccccccccC-CCCcccccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhC
Q 024828           89 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-SGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        89 ~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g  165 (262)
                      |++|+||||+||+++.++.++|+|||++...... ........+++.|++||.+.+..  ++.++||||+||++|+|++|
T Consensus       149 ~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG  228 (322)
T d1vzoa_         149 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG  228 (322)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred             CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence            9999999999999999999999999998765332 23344567899999999997653  68899999999999999999


Q ss_pred             CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCC-----CHHHHhcCccccccC
Q 024828          166 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  236 (262)
Q Consensus       166 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~h~~~~~~~  236 (262)
                      +.||......+.....   .........+  .+..+++++.+||.+||++||++||     |++|+++||||+...
T Consensus       229 ~~PF~~~~~~~~~~~i---~~~~~~~~~~--~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         229 ASPFTVDGEKNSQAEI---SRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             SCTTSCTTSCCCHHHH---HHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CCCCCCCCHHHHHHHH---HHhcccCCCC--CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            9999887665543332   2222222222  2246899999999999999999999     589999999998654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-46  Score=295.65  Aligned_cols=211  Identities=24%  Similarity=0.366  Sum_probs=176.4

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHH   86 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh~   86 (262)
                      +++..+++.+|++++++++||||+++++++.+ ...++||||++++++.+.+... +.++...+..++.|++.||.|||+
T Consensus        51 ~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  129 (273)
T d1u46a_          51 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES  129 (273)
T ss_dssp             -CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh
Confidence            34556789999999999999999999999975 4678999999999999887654 569999999999999999999999


Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                       .|++||||||+||+++.++.++|+|||++........   ......++..|+|||.+.+..++.++||||||+++|||+
T Consensus       130 -~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml  208 (273)
T d1u46a_         130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF  208 (273)
T ss_dssp             -TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             -CCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence             9999999999999999999999999999987643322   222345678899999999888999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      + |..||.+.+..       +....+.........+..+|+++.+|+.+||+.||++|||+++++
T Consensus       209 t~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         209 TYGQEPWIGLNGS-------QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             TTSCCTTTTCCHH-------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hCCCCCCCCcCHH-------HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            8 89999875432       344455444433344467899999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=304.51  Aligned_cols=226  Identities=26%  Similarity=0.412  Sum_probs=175.9

Q ss_pred             HHHHHHHHhcCCCCeeEeeceEEEEC------CeEEEEEeecCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHH
Q 024828           15 IAQELKINQSSQCPYVVVCYQSFYSN------GAISIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus        15 ~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~l----~~~~~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      ..+|+++|++++||||++++++|...      .++|+||||+++ ++.+.+    .....+++..+..++.|++.||+||
T Consensus        60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~-~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL  138 (350)
T d1q5ka_          60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI  138 (350)
T ss_dssp             CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCC-ccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            45799999999999999999998542      358999999976 444333    3445799999999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCC-cEEEEecccccccccCCCCcccccccccccCcccccCC-CCCcchhHHHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLEC  162 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l  162 (262)
                      |+ .||+||||||+|||++.++ .++|+|||++...... .......|+..|+|||.+.+. .++.++||||+||++|+|
T Consensus       139 H~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el  216 (350)
T d1q5ka_         139 HS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL  216 (350)
T ss_dssp             HT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             Hh-cCCcccCCCcceEEEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEeh
Confidence            98 9999999999999998775 8999999998765433 334456789999999988754 589999999999999999


Q ss_pred             HhCCCCCCCCCccCchhhHHHH--------HHHHh----cCCCCC--------CCCCCCCHHHHHHHHHhhcCCcCCCCC
Q 024828          163 ATGQFPYSPPEQQDGWTSFYEL--------MEAIV----DQPPPS--------APSDQFSPEFCSFISACVQKEPQQRLS  222 (262)
Q Consensus       163 ~~g~~p~~~~~~~~~~~~~~~~--------~~~~~----~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt  222 (262)
                      ++|+.||......+....+...        .....    ....+.        ......++++.+||.+||..||++|||
T Consensus       217 ~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t  296 (350)
T d1q5ka_         217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT  296 (350)
T ss_dssp             HHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             hhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC
Confidence            9999999876543322221111        01110    000000        112357889999999999999999999


Q ss_pred             HHHHhcCccccccCCcccchh
Q 024828          223 AQELMTHPFLKMYGDLNVDLS  243 (262)
Q Consensus       223 ~~~~l~h~~~~~~~~~~~~~~  243 (262)
                      +.|+|+||||+...+.....+
T Consensus       297 a~e~L~Hp~f~~~~~~~~~~~  317 (350)
T d1q5ka_         297 PLEACAHSFFDELRDPNVKLP  317 (350)
T ss_dssp             HHHHHTSGGGGGGGCTTCCCT
T ss_pred             HHHHhcCHhhccccCCCCCCC
Confidence            999999999998876655433

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=300.60  Aligned_cols=222  Identities=23%  Similarity=0.364  Sum_probs=175.9

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeEeeceEEEE--------CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 024828            9 ESARRQIAQELKINQSSQCPYVVVCYQSFYS--------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         9 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~   80 (262)
                      +...+++.+|+++|++++||||+++++++..        +...|+|||++.++.+.........+++..++.++.|++.|
T Consensus        50 ~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~  129 (318)
T d3blha1          50 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG  129 (318)
T ss_dssp             TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHH
Confidence            4455678899999999999999999998854        34689999999886666666666789999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC----CCcccccccccccCcccccCC-CCCcchhHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----GQANTFVGTYNYMSPERISGG-KYGYKSDIWSL  155 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~sl  155 (262)
                      |.|||+ .|++||||||+||+++.++.++++|||++.......    .......||+.|+|||.+.+. .++.++||||+
T Consensus       130 l~~lH~-~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl  208 (318)
T d3blha1         130 LYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA  208 (318)
T ss_dssp             HHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHhcc-CCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence            999999 999999999999999999999999999997554222    223335689999999998765 58999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCC---------------------------CCCHHHHHH
Q 024828          156 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD---------------------------QFSPEFCSF  208 (262)
Q Consensus       156 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~l  208 (262)
                      ||++|+|++|+.||.+.+..+.    ...+........+.....                           ..++++.+|
T Consensus       209 Gvil~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dL  284 (318)
T d3blha1         209 GCIMAEMWTRSPIMQGNTEQHQ----LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL  284 (318)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHH
T ss_pred             CceeeeHhhCCCCCCCCCHHHH----HHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHH
Confidence            9999999999999987544322    122222222211111100                           125678899


Q ss_pred             HHHhhcCCcCCCCCHHHHhcCcccccc
Q 024828          209 ISACVQKEPQQRLSAQELMTHPFLKMY  235 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h~~~~~~  235 (262)
                      |.+||++||++|||++|+|+||||+..
T Consensus       285 l~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         285 IDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             HHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             HHHHCcCChhHCcCHHHHHcChhhccC
Confidence            999999999999999999999999853

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=299.07  Aligned_cols=213  Identities=26%  Similarity=0.397  Sum_probs=178.7

Q ss_pred             hhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHH
Q 024828            7 VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEY   69 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~   69 (262)
                      ..++..+++.+|+++|+++ +||||+++++++.+++..++||||++||+|.+++.+.                ..++...
T Consensus        49 ~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~  128 (309)
T d1fvra_          49 ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ  128 (309)
T ss_dssp             ------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHH
T ss_pred             cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHH
Confidence            3455677899999999999 7999999999999999999999999999999999754                4689999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcc
Q 024828           70 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        70 ~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      +..++.|++.||.|+|+ .|++||||||+|||++.++.++|+|||++....... ......++..|+|||.+.+..++.+
T Consensus       129 ~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~  206 (309)
T d1fvra_         129 LLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTN  206 (309)
T ss_dssp             HHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHH
T ss_pred             HHHHHHHHHHHHHhhhc-CCccccccccceEEEcCCCceEEccccccccccccc-cccceecCCcccchHHhccCCCCcc
Confidence            99999999999999999 999999999999999999999999999987544332 2334568899999999998899999


Q ss_pred             hhHHHHHHHHHHHHhCC-CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc
Q 024828          150 SDIWSLGLVLLECATGQ-FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  228 (262)
Q Consensus       150 ~Di~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~  228 (262)
                      +||||||+++|+|++|. +||.+.+.       .+....+..+..++.+ ..+++++.+||.+||+.||++|||++++++
T Consensus       207 sDvwSfGvil~ell~~~~~p~~~~~~-------~~~~~~i~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~RPs~~eil~  278 (309)
T d1fvra_         207 SDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQGYRLEKP-LNCDDEVYDLMRQCWREKPYERPSFAQILV  278 (309)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHGGGTCCCCCC-TTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ceeehhHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHhcCCCCCC-ccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999965 56766432       3455556666555544 578999999999999999999999999998


Q ss_pred             C
Q 024828          229 H  229 (262)
Q Consensus       229 h  229 (262)
                      +
T Consensus       279 ~  279 (309)
T d1fvra_         279 S  279 (309)
T ss_dssp             H
T ss_pred             H
Confidence            7

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=300.08  Aligned_cols=213  Identities=25%  Similarity=0.422  Sum_probs=176.3

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLH   85 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lh   85 (262)
                      .+....+++.+|++++++++||||+++++++.++ ..+++++++.+++|.+++... ..+++..+..++.|++.||+|||
T Consensus        50 ~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH  128 (317)
T d1xkka_          50 TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE  128 (317)
T ss_dssp             ---CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3445677899999999999999999999999865 467888888899999888764 57999999999999999999999


Q ss_pred             hcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 024828           86 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  163 (262)
Q Consensus        86 ~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  163 (262)
                      + .|++||||||+||+++.++.++|+|||++.........  .....|++.|+|||.+.+..++.++|||||||++|||+
T Consensus       129 ~-~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~  207 (317)
T d1xkka_         129 D-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM  207 (317)
T ss_dssp             H-TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             H-cCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHH
Confidence            9 99999999999999999999999999999866443322  22346789999999999889999999999999999999


Q ss_pred             h-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          164 T-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       164 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      | |..||......+       ....+..+..++.+ ..+++++.+|+.+||+.||++|||+.|++.|
T Consensus       208 t~g~~p~~~~~~~~-------~~~~i~~~~~~~~p-~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         208 TFGSKPYDGIPASE-------ISSILEKGERLPQP-PICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             TTSCCTTTTSCGGG-------HHHHHHHTCCCCCC-TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HCCCCCCCCCCHHH-------HHHHHHcCCCCCCC-cccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            8 789998755432       23334444444333 5789999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.4e-45  Score=294.73  Aligned_cols=213  Identities=25%  Similarity=0.386  Sum_probs=181.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-----------------------
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----------------------   63 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------   63 (262)
                      .+.+..+++.+|++++++++||||+++++++......+++||++.+++|.+++....                       
T Consensus        55 ~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (301)
T d1lufa_          55 ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP  134 (301)
T ss_dssp             CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------
T ss_pred             cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCC
Confidence            355677899999999999999999999999999999999999999999999996532                       


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCC--CCcccccccccccCccc
Q 024828           64 -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPER  140 (262)
Q Consensus        64 -~~~~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~~PE~  140 (262)
                       .++...+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.......  .......+++.|+|||.
T Consensus       135 ~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (301)
T d1lufa_         135 PPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  213 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHhhhccc-CCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence             37899999999999999999998 999999999999999999999999999987553322  22334567889999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCC
Q 024828          141 ISGGKYGYKSDIWSLGLVLLECATGQ-FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ  219 (262)
Q Consensus       141 ~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  219 (262)
                      +.+..++.++||||||+++|||++|. +||.....       .+....+..+..++.+ ..+++++.+|+.+||+.+|++
T Consensus       214 ~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-------~e~~~~v~~~~~~~~p-~~~~~~~~~li~~cl~~~P~~  285 (301)
T d1lufa_         214 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-------EEVIYYVRDGNILACP-ENCPLELYNLMRLCWSKLPAD  285 (301)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGG
T ss_pred             HccCCCChhhhhccchhhHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCCCCC-ccchHHHHHHHHHHcCCChhH
Confidence            99989999999999999999999985 67776443       2445556666655443 578999999999999999999


Q ss_pred             CCCHHHHhc
Q 024828          220 RLSAQELMT  228 (262)
Q Consensus       220 Rpt~~~~l~  228 (262)
                      |||+.|+++
T Consensus       286 RPt~~ev~~  294 (301)
T d1lufa_         286 RPSFCSIHR  294 (301)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999954

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-45  Score=301.64  Aligned_cols=227  Identities=22%  Similarity=0.415  Sum_probs=177.9

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC-----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL   82 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~   82 (262)
                      .+...+++.+|+.+|++++||||+++++++....     ..|+++ ++.|++|.++++. +++++..+..++.|++.||+
T Consensus        46 ~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~  123 (345)
T d1pmea_          46 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLK  123 (345)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHH
Confidence            4566778999999999999999999999987643     355555 5558899999976 57999999999999999999


Q ss_pred             HHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC---CcccccccccccCcccccCC-CCCcchhHHHHHHH
Q 024828           83 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLV  158 (262)
Q Consensus        83 ~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~  158 (262)
                      |||+ .|++||||||+||+++.++.++|+|||++........   ......+++.|+|||.+... .++.++|+||+||+
T Consensus       124 yLH~-~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i  202 (345)
T d1pmea_         124 YIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI  202 (345)
T ss_dssp             HHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHH
T ss_pred             HHHH-CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCce
Confidence            9998 9999999999999999999999999999876543321   23445789999999998554 57899999999999


Q ss_pred             HHHHHhCCCCCCCCCccCchhhHHHHH-----------------HHHhcCC-CCC----CCCCCCCHHHHHHHHHhhcCC
Q 024828          159 LLECATGQFPYSPPEQQDGWTSFYELM-----------------EAIVDQP-PPS----APSDQFSPEFCSFISACVQKE  216 (262)
Q Consensus       159 l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~-~~~----~~~~~~~~~l~~li~~~l~~~  216 (262)
                      +++|++|+.||......+.........                 ....... ...    ......++++.+|+.+||+.|
T Consensus       203 l~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  282 (345)
T d1pmea_         203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN  282 (345)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS
T ss_pred             ehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCC
Confidence            999999999998765432211111100                 0000000 000    012356789999999999999


Q ss_pred             cCCCCCHHHHhcCccccccCC
Q 024828          217 PQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       217 p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |.+|||++|+|+||||+....
T Consensus       283 P~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         283 PHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             TTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhHCcCHHHHhcCHhhccCCC
Confidence            999999999999999986654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.4e-45  Score=300.05  Aligned_cols=222  Identities=22%  Similarity=0.396  Sum_probs=175.7

Q ss_pred             HHHHHHHHHHHHhcCC-CCeeEeeceEEEE--CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc
Q 024828           11 ARRQIAQELKINQSSQ-CPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE   87 (262)
Q Consensus        11 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~   87 (262)
                      ..+++.+|+++|++++ ||||++++++|..  ....++||||+.+++|..+.   +.+++..+..++.||+.||+|||+ 
T Consensus        72 ~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~-  147 (328)
T d3bqca1          72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS-  147 (328)
T ss_dssp             CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhh-
Confidence            3567889999999995 9999999999985  45699999999999987653   469999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEEccCC-cEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhC
Q 024828           88 KHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG  165 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g  165 (262)
                      .||+|+||||+|||++.++ .++++|||++...... .......++..|+|||.+.+.. ++.++|+||+||+++++++|
T Consensus       148 ~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g  226 (328)
T d3bqca1         148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR  226 (328)
T ss_dssp             TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccceEEcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccC
Confidence            9999999999999998665 6999999998765433 2344567899999999988754 79999999999999999999


Q ss_pred             CCCCCCCCccCc-hhhHHHH---------HHHHhcC-------------------CCCCCCCCCCCHHHHHHHHHhhcCC
Q 024828          166 QFPYSPPEQQDG-WTSFYEL---------MEAIVDQ-------------------PPPSAPSDQFSPEFCSFISACVQKE  216 (262)
Q Consensus       166 ~~p~~~~~~~~~-~~~~~~~---------~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~~l~~~  216 (262)
                      +.||........ ...+...         .......                   .........+++++.+||++||..|
T Consensus       227 ~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d  306 (328)
T d3bqca1         227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD  306 (328)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSS
T ss_pred             CCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCC
Confidence            999976554321 1111110         0000000                   0111112346889999999999999


Q ss_pred             cCCCCCHHHHhcCccccccCC
Q 024828          217 PQQRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       217 p~~Rpt~~~~l~h~~~~~~~~  237 (262)
                      |++|||++|+|+||||+...+
T Consensus       307 P~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         307 HQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGGSCCHHHHHTSGGGTTSCC
T ss_pred             hhHCcCHHHHhcCcccCCCCC
Confidence            999999999999999987653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=291.41  Aligned_cols=214  Identities=24%  Similarity=0.431  Sum_probs=184.6

Q ss_pred             chhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC----------------CCCHH
Q 024828            6 NVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEE   68 (262)
Q Consensus         6 ~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~   68 (262)
                      ..++....++.+|...+.++ +||||+++++++.+++..++||||+++|+|.+++....                .++..
T Consensus        56 ~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~  135 (299)
T d1fgka_          56 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK  135 (299)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHH
T ss_pred             ccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHH
Confidence            34566778899999999888 89999999999999999999999999999999997543                48999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCC
Q 024828           69 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKY  146 (262)
Q Consensus        69 ~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~  146 (262)
                      .+..++.|++.||+|||+ .|++||||||+|||++.++.++|+|||++........  ......+++.|+|||.+.+..+
T Consensus       136 ~~~~~~~qi~~al~ylH~-~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y  214 (299)
T d1fgka_         136 DLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHhhh-CCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC
Confidence            999999999999999999 9999999999999999999999999999986644332  2334568889999999998899


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHH
Q 024828          147 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE  225 (262)
Q Consensus       147 ~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  225 (262)
                      +.++||||||+++|+|++ |.+||.....       ......+..+..++.+ ..+++++.+||.+||+.||++|||+.|
T Consensus       215 ~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~dP~~Rps~~e  286 (299)
T d1fgka_         215 THQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRMDKP-SNCTNELYMMMRDCWHAVPSQRPTFKQ  286 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCCC-SSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CchhhhHHhHHHHHHhccCCCCCCCCCCH-------HHHHHHHHcCCCCCCC-ccchHHHHHHHHHHccCCHhHCcCHHH
Confidence            999999999999999998 7888876443       2344555555555544 578999999999999999999999999


Q ss_pred             Hhc
Q 024828          226 LMT  228 (262)
Q Consensus       226 ~l~  228 (262)
                      +++
T Consensus       287 il~  289 (299)
T d1fgka_         287 LVE  289 (299)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-45  Score=294.31  Aligned_cols=214  Identities=29%  Similarity=0.437  Sum_probs=171.3

Q ss_pred             hHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhc----------------CCCCHHH
Q 024828            8 EESARRQIAQELKINQSS-QCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKV----------------KTIPEEY   69 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~----------------~~~~~~~   69 (262)
                      .....+.+.+|..++.++ +|+||+.+++.+.. +...++||||+++++|.+++...                ..+++..
T Consensus        56 ~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~  135 (299)
T d1ywna1          56 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH  135 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHH
T ss_pred             CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHH
Confidence            455567788888888777 68999999998765 45689999999999999999753                2488999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCC
Q 024828           70 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYG  147 (262)
Q Consensus        70 ~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~  147 (262)
                      +..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||+|........  ......||+.|+|||.+.+..++
T Consensus       136 ~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~  214 (299)
T d1ywna1         136 LICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHh-CCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence            99999999999999999 9999999999999999999999999999976543322  23345789999999999998999


Q ss_pred             cchhHHHHHHHHHHHHhC-CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHH
Q 024828          148 YKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  226 (262)
Q Consensus       148 ~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~  226 (262)
                      .++||||+||++|+|++| .+||......+      .....+..+..+.. +..+++++.+|+.+||+.||++|||++|+
T Consensus       215 ~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~ei  287 (299)
T d1ywna1         215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSEL  287 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHHHHHHTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cccceeehHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCCCCC-CccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            999999999999999986 56787654432      23333444444443 35689999999999999999999999999


Q ss_pred             hcC
Q 024828          227 MTH  229 (262)
Q Consensus       227 l~h  229 (262)
                      ++|
T Consensus       288 l~~  290 (299)
T d1ywna1         288 VEH  290 (299)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-44  Score=291.59  Aligned_cols=215  Identities=23%  Similarity=0.341  Sum_probs=180.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE-CCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYL   84 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~~l~~l   84 (262)
                      .+....+++.+|++++++++||||+++++++.+ ++..++||||+++++|.+++.... ..+...+..++.|++.||.|+
T Consensus        67 ~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~l  146 (311)
T d1r0pa_          67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL  146 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhh
Confidence            467778899999999999999999999999876 568999999999999999988654 577889999999999999999


Q ss_pred             hhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC----CcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           85 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        85 h~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |+ .|++||||||+|||++.++.++|+|||++........    ......++..|+|||.+.+..++.++||||||+++|
T Consensus       147 H~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~  225 (311)
T d1r0pa_         147 AS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW  225 (311)
T ss_dssp             HH-TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             cc-cCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHH
Confidence            98 9999999999999999999999999999976543221    222346788999999999889999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      ||++|..||.......      .....+..+..+..+ ..+++++.+|+.+||+.||++|||++|+++|
T Consensus       226 El~t~~~p~~~~~~~~------~~~~~i~~g~~~~~p-~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         226 ELMTRGAPPYPDVNTF------DITVYLLQGRRLLQP-EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHTTSCCSCC------------CHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHCCCCCCCCCCHH------HHHHHHHcCCCCCCc-ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999877776543222      233445555555443 5789999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-44  Score=288.75  Aligned_cols=218  Identities=24%  Similarity=0.399  Sum_probs=185.1

Q ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHH
Q 024828            8 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----------KTIPEEYLAAICEQV   77 (262)
Q Consensus         8 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~l   77 (262)
                      +......+.+|++++++++||||+++++++..+...++||||+.+|+|.+++...          ..++...+..++.|+
T Consensus        63 ~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  142 (308)
T d1p4oa_          63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI  142 (308)
T ss_dssp             CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHH
Confidence            5566678999999999999999999999999999999999999999999998643          247899999999999


Q ss_pred             HHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC--CcccccccccccCcccccCCCCCcchhHHHH
Q 024828           78 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSL  155 (262)
Q Consensus        78 ~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  155 (262)
                      +.||.|||+ .+++||||||+|||++.+++++|+|||++........  ......+++.|+|||.+.+..++.++|||||
T Consensus       143 a~gl~~LH~-~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~  221 (308)
T d1p4oa_         143 ADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  221 (308)
T ss_dssp             HHHHHHHHH-TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHhh-CCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccH
Confidence            999999999 9999999999999999999999999999976543322  2233467899999999999899999999999


Q ss_pred             HHHHHHHHhC-CCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhc------
Q 024828          156 GLVLLECATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT------  228 (262)
Q Consensus       156 G~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~------  228 (262)
                      |+++|||++| ..||.+...       .+....+..+..++.+ ..+++++.++|.+||+.+|++|||++++++      
T Consensus       222 G~il~El~t~~~~p~~~~~~-------~~~~~~i~~~~~~~~p-~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         222 GVVLWEIATLAEQPYQGLSN-------EQVLRFVMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHHHHHHHTSCCTTTTSCH-------HHHHHHHHTTCCCCCC-TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhCCCCCCc-ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            9999999998 577766433       2444555555555444 578999999999999999999999999998      


Q ss_pred             Cccccc
Q 024828          229 HPFLKM  234 (262)
Q Consensus       229 h~~~~~  234 (262)
                      +|+|++
T Consensus       294 ~~~~~~  299 (308)
T d1p4oa_         294 EPGFRE  299 (308)
T ss_dssp             CTTHHH
T ss_pred             CCCCcC
Confidence            566643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=296.76  Aligned_cols=226  Identities=24%  Similarity=0.400  Sum_probs=175.2

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEEC-----CeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL   81 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l   81 (262)
                      .+....+++.+|+++|++++||||+++++++...     ...+++++++.|++|.+++.. +++++..+..++.||+.||
T Consensus        56 ~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL  134 (348)
T d2gfsa1          56 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGL  134 (348)
T ss_dssp             SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHH
Confidence            3556677899999999999999999999998642     334566677778899999865 5799999999999999999


Q ss_pred             HHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCC-CCcchhHHHHHHHHH
Q 024828           82 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL  160 (262)
Q Consensus        82 ~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~  160 (262)
                      +|||+ .|++||||||+||+++.++.++++|||.+.....   ......|+..|+|||...+.. ++.++|+||+||++|
T Consensus       135 ~~LH~-~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~  210 (348)
T d2gfsa1         135 KYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  210 (348)
T ss_dssp             HHHHH-TTCCCCCCCGGGEEECTTCCEEECCC----CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHH
T ss_pred             HHHHh-CCCcccccCCccccccccccccccccchhcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHH
Confidence            99999 9999999999999999999999999999876433   334457889999999877654 689999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHHHHH----------------HHHhcCCC--CCC----CCCCCCHHHHHHHHHhhcCCcC
Q 024828          161 ECATGQFPYSPPEQQDGWTSFYELM----------------EAIVDQPP--PSA----PSDQFSPEFCSFISACVQKEPQ  218 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~--~~~----~~~~~~~~l~~li~~~l~~~p~  218 (262)
                      +|++|+.||.+.+.......+....                ........  +..    .....++++.+||.+||..||+
T Consensus       211 ~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~  290 (348)
T d2gfsa1         211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD  290 (348)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGG
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChh
Confidence            9999999998765432211111100                00000000  000    0135789999999999999999


Q ss_pred             CCCCHHHHhcCccccccCC
Q 024828          219 QRLSAQELMTHPFLKMYGD  237 (262)
Q Consensus       219 ~Rpt~~~~l~h~~~~~~~~  237 (262)
                      +|||++|+|+||||+....
T Consensus       291 ~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         291 KRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             GSCCHHHHHTSGGGTTTCC
T ss_pred             hCcCHHHHhcCHhhCCCCC
Confidence            9999999999999997754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-44  Score=290.90  Aligned_cols=214  Identities=26%  Similarity=0.413  Sum_probs=179.4

Q ss_pred             hhHHHHHHHHHHHHHHhcC-CCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC------------------CCCH
Q 024828            7 VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK------------------TIPE   67 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~~~   67 (262)
                      .....+.++.+|+.+++++ +||||+++++++.+....++||||+++++|.+++.+..                  .+++
T Consensus        65 ~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~  144 (311)
T d1t46a_          65 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL  144 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCH
T ss_pred             cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCH
Confidence            4566777899999999999 69999999999999999999999999999999997543                  5899


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCC--cccccccccccCcccccCCC
Q 024828           68 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGK  145 (262)
Q Consensus        68 ~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~  145 (262)
                      ..+..++.|++.||+|||+ .|++|+||||+||+++.++.++++|||.+.........  .....+++.|+|||.+.+..
T Consensus       145 ~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  223 (311)
T d1t46a_         145 EDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV  223 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHh-CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence            9999999999999999999 99999999999999999999999999999866543322  22357889999999999888


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH
Q 024828          146 YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  224 (262)
Q Consensus       146 ~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  224 (262)
                      ++.++||||||+++|+|++ |.+||......+   .   ..+.+..+..+. .+...++++.+||.+||+.||++|||++
T Consensus       224 ~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~---~---~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~  296 (311)
T d1t46a_         224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---K---FYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFK  296 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---H---HHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCcccccchHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999998 566665544432   1   112222333333 3357899999999999999999999999


Q ss_pred             HHhc
Q 024828          225 ELMT  228 (262)
Q Consensus       225 ~~l~  228 (262)
                      ++++
T Consensus       297 ~il~  300 (311)
T d1t46a_         297 QIVQ  300 (311)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-44  Score=296.10  Aligned_cols=225  Identities=24%  Similarity=0.427  Sum_probs=170.7

Q ss_pred             hhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEE------CCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 024828            7 VEESARRQIAQELKINQSSQCPYVVVCYQSFYS------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG   80 (262)
Q Consensus         7 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~   80 (262)
                      .++....++.+|+.++++++||||++++++|..      ..+.|+||||+.| ++.+.+.  ..+++..+..++.|++.|
T Consensus        55 ~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~g  131 (355)
T d2b1pa1          55 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCG  131 (355)
T ss_dssp             SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHH
Confidence            356677889999999999999999999999964      3679999999976 5655553  468999999999999999


Q ss_pred             HHHHhhcCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHHH
Q 024828           81 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  160 (262)
Q Consensus        81 l~~lh~~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~  160 (262)
                      |+|||+ .|++|+||||+||+++.++.++++|||++...... .......+++.|+|||.+.+..++.++||||+||+++
T Consensus       132 l~~LH~-~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~  209 (355)
T d2b1pa1         132 IKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG  209 (355)
T ss_dssp             HHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             HHHhhh-cccccccCCccccccccccceeeechhhhhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHH
Confidence            999999 99999999999999999999999999988765433 3334557899999999999989999999999999999


Q ss_pred             HHHhCCCCCCCCCccCchhhHH---------------HHHHHHhcCCCCCCC------------------CCCCCHHHHH
Q 024828          161 ECATGQFPYSPPEQQDGWTSFY---------------ELMEAIVDQPPPSAP------------------SDQFSPEFCS  207 (262)
Q Consensus       161 ~l~~g~~p~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~------------------~~~~~~~l~~  207 (262)
                      +|++|+.||.+.+.......+.               ...............                  ....++++.+
T Consensus       210 ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  289 (355)
T d2b1pa1         210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD  289 (355)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred             HHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHH
Confidence            9999999998755332211111               011111111111100                  0113567899


Q ss_pred             HHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          208 FISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       208 li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                      ||++||..||++|||++|+|+||||+...
T Consensus       290 ll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         290 LLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=278.84  Aligned_cols=226  Identities=23%  Similarity=0.310  Sum_probs=169.1

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCCCCeeEeeceEEEECC----eEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 024828            3 IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL   78 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~   78 (262)
                      |++..+.........|+..+.+++||||+++++++.+.+    .+|+||||+++++|.+++++ .+++...+..++.|++
T Consensus        32 K~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia  110 (303)
T d1vjya_          32 KIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTA  110 (303)
T ss_dssp             EEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHH
T ss_pred             EEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHH
Confidence            344444444444556667777889999999999997643    58999999999999999987 4689999999999999


Q ss_pred             HHHHHHhh-------cCCeeeCCCCCCCEEEccCCcEEEEecccccccccCCC----CcccccccccccCcccccCCC--
Q 024828           79 KGLLYLHH-------EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISGGK--  145 (262)
Q Consensus        79 ~~l~~lh~-------~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~--  145 (262)
                      .||+|+|+       ..|++|+||||+||+++.++.++|+|||++........    ......|++.|+|||++.+..  
T Consensus       111 ~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  190 (303)
T d1vjya_         111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM  190 (303)
T ss_dssp             HHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCT
T ss_pred             HHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccc
Confidence            99999996       25999999999999999999999999999987644332    233457899999999987643  


Q ss_pred             ----CCcchhHHHHHHHHHHHHhCCCCCCCCCccC--------chhhHHHHHHHHhcCCC-CCCCCC----CCCHHHHHH
Q 024828          146 ----YGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWTSFYELMEAIVDQPP-PSAPSD----QFSPEFCSF  208 (262)
Q Consensus       146 ----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~l~~l  208 (262)
                          ++.++|||||||++|||++|..||.......        ................. +..+..    ..+..+.+|
T Consensus       191 ~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~l  270 (303)
T d1vjya_         191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI  270 (303)
T ss_dssp             TCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHH
T ss_pred             cCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHH
Confidence                5678999999999999999988775433221        01122233333333222 222111    122458899


Q ss_pred             HHHhhcCCcCCCCCHHHHhcC
Q 024828          209 ISACVQKEPQQRLSAQELMTH  229 (262)
Q Consensus       209 i~~~l~~~p~~Rpt~~~~l~h  229 (262)
                      +.+||+.||++|||+.|++++
T Consensus       271 i~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         271 MRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999763

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-42  Score=279.02  Aligned_cols=231  Identities=20%  Similarity=0.324  Sum_probs=174.5

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCCCe-eEeeceEEEECCeEEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLK   79 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~l~~   79 (262)
                      ++|+...+...+++.+|+++++.++|++ |+.+..++.+++..++|||++.+ +|.+.+.. .+.++...+..++.|++.
T Consensus        36 AvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~  114 (299)
T d1ckia_          36 AIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMIS  114 (299)
T ss_dssp             EEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHH
T ss_pred             EEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHH
Confidence            3444333344457889999999997665 55556667888899999999954 77766654 467999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEcc---CCcEEEEecccccccccCCC-------CcccccccccccCcccccCCCCCcc
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYK  149 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~  149 (262)
                      ||+|||+ .|++||||||+||+++.   +..++++|||+|........       ......||+.|+|||.+.+..++.+
T Consensus       115 ~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  193 (299)
T d1ckia_         115 RIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR  193 (299)
T ss_dssp             HHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH
T ss_pred             HHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCCh
Confidence            9999999 99999999999999864   44699999999987643321       2234579999999999999889999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHH---HH
Q 024828          150 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ---EL  226 (262)
Q Consensus       150 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~---~~  226 (262)
                      +|||||||++|+|++|+.||...................... ........+|+++.+++.+||+.+|++||+++   ++
T Consensus       194 ~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~  272 (299)
T d1ckia_         194 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  272 (299)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHH
T ss_pred             hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999998766544333322222221111 11222346899999999999999999999987   55


Q ss_pred             hcCcccccc
Q 024828          227 MTHPFLKMY  235 (262)
Q Consensus       227 l~h~~~~~~  235 (262)
                      |+|+|.+..
T Consensus       273 l~~~~~~~~  281 (299)
T d1ckia_         273 FRNLFHRQG  281 (299)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHcC
Confidence            778776543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.9e-41  Score=271.30  Aligned_cols=224  Identities=19%  Similarity=0.275  Sum_probs=177.8

Q ss_pred             ccccchhHHHHHHHHHHHHHHhcCCC-CeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHH
Q 024828            2 VIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLK   79 (262)
Q Consensus         2 ~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~l~~   79 (262)
                      ++|+.........+.+|++.++.+.| +|++.+++++.++...++|||++ +++|.+++...+ .++...+..++.|++.
T Consensus        34 AvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~  112 (293)
T d1csna_          34 AIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLA  112 (293)
T ss_dssp             EEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHH
T ss_pred             EEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHH
Confidence            34443333344567889999999965 89999999999999999999999 679999997654 6999999999999999


Q ss_pred             HHHHHhhcCCeeeCCCCCCCEEEcc-----CCcEEEEecccccccccCC-------CCcccccccccccCcccccCCCCC
Q 024828           80 GLLYLHHEKHIIHRDLKPSNLLINH-----RGEVKITDFGVSAIMASTS-------GQANTFVGTYNYMSPERISGGKYG  147 (262)
Q Consensus        80 ~l~~lh~~~~i~H~dl~p~nil~~~-----~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~  147 (262)
                      ||++||+ .|++||||||+||+++.     ++.++++|||++.......       .......||+.|+|||++.+..++
T Consensus       113 ~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~  191 (293)
T d1csna_         113 RVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS  191 (293)
T ss_dssp             HHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred             HHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC
Confidence            9999998 99999999999999964     5689999999997654321       123345799999999999998999


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCccCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHh
Q 024828          148 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  227 (262)
Q Consensus       148 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l  227 (262)
                      +++|+||||+++|+|++|+.||.................... ..........+|+++.+++..|+..+|++||+++.+.
T Consensus       192 ~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         192 RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            999999999999999999999987655443332222222211 1111222346889999999999999999999988774


Q ss_pred             c
Q 024828          228 T  228 (262)
Q Consensus       228 ~  228 (262)
                      +
T Consensus       271 ~  271 (293)
T d1csna_         271 G  271 (293)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-38  Score=263.69  Aligned_cols=231  Identities=26%  Similarity=0.433  Sum_probs=166.3

Q ss_pred             cccchhHHHHHHHHHHHHHHhcCC-----------CCeeEeeceEEEE--CCeEEEEEeecCCCC-HHHHHH--hcCCCC
Q 024828            3 IQMNVEESARRQIAQELKINQSSQ-----------CPYVVVCYQSFYS--NGAISIILEYMDGGS-LADFLK--KVKTIP   66 (262)
Q Consensus         3 ~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~s-L~~~l~--~~~~~~   66 (262)
                      |++..+....+.+.+|+++++.++           |+||+++++++..  ....++++.++.+.. ......  ....++
T Consensus        44 Kvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  123 (362)
T d1q8ya_          44 KIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP  123 (362)
T ss_dssp             EEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCC
T ss_pred             EEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCc
Confidence            444555666778889999988774           5789999998865  345666666654433 333332  235689


Q ss_pred             HHHHHHHHHHHHHHHHHHhhcCCeeeCCCCCCCEEEccCC------cEEEEecccccccccCCCCcccccccccccCccc
Q 024828           67 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPER  140 (262)
Q Consensus        67 ~~~~~~i~~~l~~~l~~lh~~~~i~H~dl~p~nil~~~~~------~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~  140 (262)
                      +..+..++.|++.||+|||+..||+|+||||+||+++.++      .++++|||.+.....   ......+++.|+|||+
T Consensus       124 ~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~  200 (362)
T d1q8ya_         124 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEV  200 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc---ccccccccccccChhh
Confidence            9999999999999999999768999999999999998665      399999999875433   3345678999999999


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCchhh---HHHHHHHHh-----------------cCC------C-
Q 024828          141 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS---FYELMEAIV-----------------DQP------P-  193 (262)
Q Consensus       141 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~-----------------~~~------~-  193 (262)
                      +.+..++.++|+||+||++++|++|+.||...+.......   .......+.                 ...      . 
T Consensus       201 ~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (362)
T d1q8ya_         201 LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK  280 (362)
T ss_dssp             HHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCC
T ss_pred             ccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhcccc
Confidence            9988899999999999999999999999976543221111   111111000                 000      0 


Q ss_pred             ------------CCCCCCCCCHHHHHHHHHhhcCCcCCCCCHHHHhcCccccccC
Q 024828          194 ------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  236 (262)
Q Consensus       194 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~h~~~~~~~  236 (262)
                                  ........++++.+||.+||..||.+|||++|+|+||||+...
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         281 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             CCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             ccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence                        0000122357799999999999999999999999999998553

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.69  E-value=3.2e-18  Score=128.06  Aligned_cols=134  Identities=20%  Similarity=0.171  Sum_probs=93.1

Q ss_pred             HHHHHHHHHHHHHhcCCCCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 024828           10 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH   89 (262)
Q Consensus        10 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~~~~   89 (262)
                      .....+.+|...+.++.|++++..++...    .+++||++++..+.       .++......++.|++.++.+||+ .|
T Consensus        56 ~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~-~g  123 (191)
T d1zara2          56 LAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYH-RG  123 (191)
T ss_dssp             HHHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHH-TT
T ss_pred             HHHHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhh-CC
Confidence            34556678999999999999988775432    37999999885543       24555677899999999999999 99


Q ss_pred             eeeCCCCCCCEEEccCCcEEEEecccccccccCCCCcccccccccccCcccccCCCCCcchhHHHHHHHH
Q 024828           90 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL  159 (262)
Q Consensus        90 i~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l  159 (262)
                      ++|+||||+||+++++ .++++|||.+.....+..... ...+... -.+. ....++.++|+||+.--+
T Consensus       124 iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~-l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         124 IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREI-LERDVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHH-HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHH-HHHHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            9999999999999754 589999999865432211000 0000000 0011 124578889999965433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.03  E-value=8.3e-06  Score=62.25  Aligned_cols=101  Identities=17%  Similarity=0.121  Sum_probs=65.9

Q ss_pred             HHHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh----
Q 024828           12 RRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH----   86 (262)
Q Consensus        12 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~l~~~l~~lh~----   86 (262)
                      ...+.+|...++.+. +--+++++.+..+++..++||++++|.++.+.....  .   ....++.++...++.||+    
T Consensus        53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--~---~~~~~~~~l~~~l~~lH~~~~~  127 (263)
T d1j7la_          53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--Q---SPEKIIELYAECIRLFHSIDIS  127 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--S---CHHHHHHHHHHHHHHHHTSCCT
T ss_pred             hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--c---cHHHHHHHHHHHHHHHhccCcc
Confidence            335677888877663 444677888888889999999999998876543210  0   111222333333333332    


Q ss_pred             ------------------------------------------------------cCCeeeCCCCCCCEEEccCCcEEEEe
Q 024828           87 ------------------------------------------------------EKHIIHRDLKPSNLLINHRGEVKITD  112 (262)
Q Consensus        87 ------------------------------------------------------~~~i~H~dl~p~nil~~~~~~~~l~d  112 (262)
                                                                            ...++|+|+.|.||+++.++.+-++|
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lID  207 (263)
T d1j7la_         128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFID  207 (263)
T ss_dssp             TCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred             ccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEee
Confidence                                                                  12278999999999997665567999


Q ss_pred             ccccc
Q 024828          113 FGVSA  117 (262)
Q Consensus       113 f~~~~  117 (262)
                      |+.+.
T Consensus       208 we~a~  212 (263)
T d1j7la_         208 LGRSG  212 (263)
T ss_dssp             CTTCE
T ss_pred             chhcc
Confidence            98754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.59  E-value=2.9e-05  Score=58.81  Aligned_cols=42  Identities=12%  Similarity=0.032  Sum_probs=31.3

Q ss_pred             HHHHHHHHHhcCC--CCeeEeeceEEEECCeEEEEEeecCCCCH
Q 024828           14 QIAQELKINQSSQ--CPYVVVCYQSFYSNGAISIILEYMDGGSL   55 (262)
Q Consensus        14 ~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL   55 (262)
                      .+..|...++.+.  .-.+++++....+++..++||++++|.++
T Consensus        50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4667777776663  23366778888888889999999998665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.10  E-value=0.00039  Score=56.11  Aligned_cols=30  Identities=23%  Similarity=0.411  Sum_probs=24.8

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      ..++|||+++.||+++.+ .++++||.++..
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            358999999999999765 489999987643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.28  E-value=0.00029  Score=56.87  Aligned_cols=39  Identities=21%  Similarity=0.177  Sum_probs=25.3

Q ss_pred             HHHHHHHHHHhcCC-CCeeEeeceEEEECCeEEEEEeecCCCCH
Q 024828           13 RQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGSL   55 (262)
Q Consensus        13 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL   55 (262)
                      ....+|..+++.+. +.-.+++++++.  +  .+|++|++|.+|
T Consensus        89 idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~efi~g~~l  128 (395)
T d1nw1a_          89 SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred             hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEEeccccC
Confidence            34567888888774 333456666664  2  478999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.21  E-value=0.0027  Score=49.23  Aligned_cols=32  Identities=22%  Similarity=0.240  Sum_probs=27.5

Q ss_pred             cCCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           87 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        87 ~~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      ..|++|+|+.++||+++.+...-++||+.++.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            46799999999999998777678999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=93.89  E-value=0.034  Score=42.99  Aligned_cols=29  Identities=21%  Similarity=0.244  Sum_probs=23.3

Q ss_pred             CCeeeCCCCCCCEEEccCCcEEEEecccccc
Q 024828           88 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  118 (262)
Q Consensus        88 ~~i~H~dl~p~nil~~~~~~~~l~df~~~~~  118 (262)
                      .+++|+|+++.||+++ ++ ..++||+.+..
T Consensus       192 ~~liHgDlh~~NvL~~-~~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWR-DG-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEES-SS-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEe-CC-ceEEechhccc
Confidence            5689999999999996 34 45899997653